PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Reith, FCM; Lingsma, HF; Gabbe, BJ; Lecky, FE; Roberts, I; Maas, AIR				Reith, Florence C. M.; Lingsma, Hester F.; Gabbe, Belinda J.; Lecky, Fiona E.; Roberts, Ian; Maas, Andrew I. R.			Differential effects of the Glasgow Coma Scale Score and its Components: An analysis of 54,069 patients with traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Components; Floor and ceiling effects; Glasgow Coma Scale Score; GCS; Prognosis; TBI	PROGNOSTIC VALUE; MOTOR SCORE; CLASSIFICATION; PREDICTION; GUIDELINES; MORTALITY; CHILDREN; LEVEL	Introduction: The Glasgow Coma Scale (GCS) is widely used in the assessment of clinical severity and prediction of outcome after traumatic brain injury (TBI). The sum score is frequently applied, but the differential influence of the components infrequently addressed. We aimed to investigate the contribution of the GCS components to the sum score, floor and ceiling effects of the components, and their prognostic effects. Methods: Data on adult TBI patients were gathered from three data repositories: TARN (n = 50,064), VSTR (n = 14,062), and CRASH (n = 9,941). Data on initial hospital GCS-assessment and discharge mortality were extracted. A descriptive analysis was performed to identify floor and ceiling effects. The relation between GCS and outcome was studied by comparing case fatality rates (CFR) between different component-profiles adding up to identical sum scores using Chi2-tests, and by quantifying the prognostic value of each component and sum score with Nagelkerke's R-2 derived from logistic regression analyses across TBI severities. Results: In the range 3-7, the sum score is primarily determined by the motor component, as the verbal and eye components show floor-effects at sum scores 7 and 8, respectively. In the range 8-12, the effect of the motor component attenuates and the verbal and eye components become more relevant. The motor, eye and verbal scores reach their ceiling-effects at sum 13, 14 and 15, respectively. Significant variations were exposed in CFR between different component-profiles despite identical sum scores, except in sum scores 6 and 7. Regression analysis showed that the motor score had highest R2 values in severe TBI patients, whereas the other components were more relevant at higher sum scores. The prognostic value of the three components combined was consistently higher than that of the sum score alone. Conclusion: The GCS-components contribute differentially across the spectrum of consciousness to the sum score, each having floor and ceiling effects. The specific component-profile is related to outcome and the three components combined contain higher prognostic value than the sum score across different TBI severities. We, therefore, recommend a multidimensional use of the three-component GCS both in clinical practice, and in prognostic studies. (C) 2017 Elsevier Ltd. All rights reserved.	[Reith, Florence C. M.; Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium; [Reith, Florence C. M.; Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Lingsma, Hester F.] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands; [Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Gabbe, Belinda J.] Swansea Univ, Farr Inst CIPHER, Singleton Pk, Swansea, W Glam, Wales; [Lecky, Fiona E.] Univ Sheffield, Emergency Med Res Sheffield EMRiS Grp, Hlth Serv Res Sch Hlth & Related Res SCHaRR, Sheffield, S Yorkshire, England; [Lecky, Fiona E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal Hosp,Fac Biol Med & Hlth, Trauma Audit & Res Network,Ctr Epidemiol,Inst Pop, Salford, Lancs, England; [Roberts, Ian] London Sch Hyg & Trop Med, Clin Trials Unit, London, England		Reith, FCM (corresponding author), Antwerp Univ Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	florence.reith@uza.be	Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264	European UnionEuropean Commission [602150-2]; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [GNT1048731]; Transport Accident Commission (TAC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M009211/1] Funding Source: UKRI	This work was in part supported by the Framework 7 program of the European Union in the context of CENTER-TBI (grant number 602150-2); Belinda Gabbe was supported by a Career Development Fellowship from the National Health and Medical Research Council of Australia (GNT1048731).; The Victorian State Trauma Registry is a Department of Health and Human Services, State Government of Victoria and Transport Accident Commission (TAC) funded project.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; BHATTY GB, 1993, ACTA NEUROCHIR, V120, P132, DOI 10.1007/BF02112031; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Christensen MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6797; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; Gabbe BJ, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0047-z; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hirai S, 1996, NEUROSURGERY, V39, P441, DOI 10.1097/00006123-199609000-00002; JAGGER J, 1983, LANCET, V2, P97; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Jennett B., 2002, TRAUMA, V4, P91, DOI DOI 10.1191/1460408602TA2330A; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KOZIOL JA, 1990, J NEUROL, V237, P461, DOI 10.1007/BF00314762; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Osler T, 2016, INJURY, V47, P1879, DOI 10.1016/j.injury.2016.04.016; Peters MJ, 2010, PEDIATR CRIT CARE ME, V11, P423, DOI 10.1097/PCC.0b013e3181d4fcb1; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; SUGIURA K, 1983, NEUROSURGERY, V12, P411, DOI 10.1227/00006123-198304000-00007; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; Van de Voorde P, 2008, RESUSCITATION, V76, P175, DOI 10.1016/j.resuscitation.2007.07.007; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	38	31	32	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2017	48	9					1932	1943		10.1016/j.injury.2017.05.038			12	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FE2LA	WOS:000408046600014	28602178	Green Accepted			2022-02-06	
J	Dillahunt-Aspillaga, C; Nakase-Richardson, R; Hart, T; Powell-Cope, G; Dreer, LE; Eapen, BC; Barnett, SD; Mellick, D; Haskin, A; Silva, MA				Dillahunt-Aspillaga, Christina; Nakase-Richardson, Risa; Hart, Tessa; Powell-Cope, Gail; Dreer, Laura E.; Eapen, Blessen C.; Barnett, Scott D.; Mellick, Dave; Haskin, Adam; Silva, Marc A.			Predictors of Employment Outcomes in Veterans With Traumatic Brain Injury: A VA Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						employment; return to work; service members; traumatic brain injury; unemployment; veterans	POSTTRAUMATIC-STRESS-DISORDER; VOCATIONAL-REHABILITATION; DISABILITY COMPENSATION; COGNITIVE RECOVERY; RACIAL-DIFFERENCES; FUNCTIONAL STATUS; ENDURING FREEDOM; SERVICE MEMBERS; PAIN DIAGNOSES; IRAQI FREEDOM	Objectives: To examine the length of time to return to work (RTW) among service members and veterans (SM/V) with traumatic brain injury (TBI) and to identify variables predictive of RTW. Setting: Department of Veterans Affairs Polytrauma Rehabilitation Centers (VA PRC). Participants: SM/V enrolled in the VA PRC Traumatic Brain Injury Model Systems database who were of 18 to 60 years of age and admitted with the diagnosis of TBI. Design: Prospective observational cohort study. Main OutcomeMeasures: Employment status at 1-year postinjury follow-up; Time to Employment (ie, number of days it took to RTW) as documented during 1-year postinjury follow-up. Results: The final sample (n = 293) included male (96%) SM/V with severe TBI (69%). Approximately 21% of the sample participants were employed at 1 year postinjury. Younger individuals who self-identified as nonminority returned to work sooner. Significant associations were observed for time to employment for cause of injury and injury severity. Conclusions: Few SM/V with moderate to severe TBI returned to work at 1 year postinjury. Predictors such as younger age at the time of injury, minority status, and severity of TBI affected time to and probability of RTW. Findings from this study have important implications for rehabilitation planning and service delivery across the continuum of recovery.	[Dillahunt-Aspillaga, Christina] Univ S Florida, Rehabil & Mental Hlth Counseling Program, Tampa, FL USA; [Dillahunt-Aspillaga, Christina; Nakase-Richardson, Risa; Powell-Cope, Gail; Barnett, Scott D.; Silva, Marc A.] James A Haley Vet Hosp, HSR&D Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL USA; [Nakase-Richardson, Risa; Barnett, Scott D.; Haskin, Adam; Silva, Marc A.] Def & Vet Brain Injury Ctr, Def Ctr Excellence Psychol Hlth, Tampa, FL USA; [Nakase-Richardson, Risa; Barnett, Scott D.; Haskin, Adam; Silva, Marc A.] Def & Vet Brain Injury Ctr, Def Ctr Traumat Brain Injury, Tampa, FL USA; [Nakase-Richardson, Risa; Barnett, Scott D.; Silva, Marc A.] James A Haley Vet Hosp, MHBS, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Mellick, Dave] Craig Hosp, Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Haskin, Adam] Gen Dynam Hlth Solut, Tampa, FL USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, Tampa, FL USA		Dillahunt-Aspillaga, C (corresponding author), HSR&D Ctr Innovat Disabil & Rehabil Res, 8900 Grand Oak Circle, Tampa, FL 33637 USA.	cdillahuntas@usf.edu	Silva, Marc A./J-1874-2019	Silva, Marc A./0000-0002-3879-6054	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U.S. Department of Veterans Affairs [W91YTZ-13-C-0015, 1 I50 HX001233-01, W81XWH-13-2-0095]; U.S. Department of Defense Congressionally Directed Medical Research Programs	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U.S. Department of Veterans Affairs grants (1 I50 HX001233-01, W81XWH-13-2-0095), and U.S. Department of Defense Congressionally Directed Medical Research Programs.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Bahadur S, 2016, J ROY ARMY MED CORPS, V162, P120, DOI 10.1136/jramc-2014-000393; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cifu D.X., 2015, TRAUMATIC BRAIN INJU, P6; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Defense and Veterans Brain Injury Center, 2016, WORLDW NUMB TBI; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dillahunt-Aspillaga C, 2014, PLOS ONE, V9, P1; Dillahunt-Aspillaga C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/924027; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Drew D, 2001, PSYCHIATR SERV, V52, P1479, DOI 10.1176/appi.ps.52.11.1479; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; French LM, 2011, CLIN MANUAL MANAGEME, P383; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Golding H, 2009, J REHABIL RES DEV, V46, pVII, DOI 10.1682/JRRD.2009.06.0081; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hankins AB, 2015, J OCCUP REHABIL, V25, P599, DOI 10.1007/s10926-015-9568-3; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Lew HL, 2013, J REHABIL RES DEV, V50, pXI, DOI 10.1682/JRRD.2013.09.0212; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Rueda S, 2012, AM J PUBLIC HEALTH, V102, P541, DOI 10.2105/AJPH.2011.300401; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; SAS Institute I, 2011, SAS 9 2; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; Tsai J, 2013, J OCCUP REHABIL, V23, P504, DOI 10.1007/s10926-013-9419-z; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Xiong C, 2016, DISABIL HEALTH J, V9, P439, DOI 10.1016/j.dhjo.2015.12.002; Zasler N. D., 2012, BRAIN INJURY MED PRI	90	31	31	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					271	282		10.1097/HTR.0000000000000275			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200015	28060203				2022-02-06	
J	Hoshizaki, TB; Post, A; Kendall, M; Cournoyer, J; Rousseau, P; Gilchrist, MD; Brien, S; Cusimano, M; Marshall, S				Hoshizaki, T. Blaine; Post, Andrew; Kendall, Marshall; Cournoyer, Janie; Rousseau, Philippe; Gilchrist, Michael D.; Brien, Susan; Cusimano, Michael; Marshall, Shawn			The development of a threshold curve for the understanding of concussion in sport	TRAUMA-ENGLAND			English	Article						Concussion; mild traumatic brain injury (mTBI); Wayne State Concussion Tolerance Curve; brain injury	BRAIN-INJURY; ACCIDENT RECONSTRUCTION; PROFESSIONAL FOOTBALL; BIOMECHANICS; ACCELERATION; PREDICTION; MECHANISMS; IMPACTS	Much of what is known concerning human brain injury thresholds is based upon impacts to cadavers and animal models that were used to generate the Wayne State Concussion Tolerance Curve (WSTC) and similar curves. These curves are the foundation for predictive metrics used in standard development as well as helmet design. These curves were based upon a very narrow range of impacts; impacts whose characteristics differ greatly from how the head is impacted in sport. This research examines the uses of time-based curves like the WSTC in the context of understanding mechanisms of brain injury and head protection. Published linear/rotational acceleration magnitude/duration data from Hybrid III laboratory reconstructions of brain injury events were plotted. This research further develops the understanding of injury thresholds in comparison to threshold curves such as the WSTC and Brain Injury Curve Leuven. The data demonstrate the relationships between magnitude and duration of dynamic response on minor traumatic brain injury (mTBI) in sport.	[Hoshizaki, T. Blaine; Post, Andrew; Kendall, Marshall; Cournoyer, Janie; Rousseau, Philippe; Gilchrist, Michael D.; Brien, Susan] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Brien, Susan] Hull Hosp, Gatineau, PQ, Canada; [Cusimano, Michael] St Michaels Hosp, Toronto, ON, Canada; [Marshall, Shawn] Ottawa Hosp, Res Inst, Ottawa, ON, Canada		Post, A (corresponding author), 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019				Auer C, 2001, INT SOC BIOM 18 C ZU, P1; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cournoyer J, 2014, SPORT CONC C CHIC IL; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Fahlstedt M, 2012, IRCOBI, P800; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Forero Rueda MA, 2013, COMPUT METHOD BIOMEC, V14, P1021; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gennarelli TA, 1972, 720970 SAE; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; GURDJIAN E S, 1964, J Trauma, V4, P309; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Hitosugi M, 2014, BIOMED RES-TOKYO, V35, P339, DOI 10.2220/biomedres.35.339; Hodgson VR, 1970, 700901 SAE; Holbourn AHS, 1943, LANCET, V2, P438; Hoshizaki T.B., 2014, J NEUROL NEUROPHYS, V5, P1, DOI 10.4172/2155-9562.1000181; Kendall M, 2013, IRCOBI, P430; Kendall M., 2016, THESIS; King A. I., 2003, IRCOBI C LISB PORT; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Morrison III B., 2003, 20032200066 SAE; Newman JA, 1998, BIOM HLTH R, V21, P200; O'Donoghue D, 1999, THESIS; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ono K., 1980, 801303 SAE; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rousseau P., 2014, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Sano K, 1972, Scand J Rehabil Med, V4, P47; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stapp JP, 1970, IMPACT INJURY CRASH, P308; Van Lierde C, 2005, THESIS; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; WILLINGER R, 1994, ACCIDENT ANAL PREV, V26, P767, DOI 10.1016/0001-4575(94)90053-1; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	59	31	31	1	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JUL	2017	19	3					196	206		10.1177/1460408616676503			11	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	EX6EL	WOS:000403335300004					2022-02-06	
J	Mir, S; Cai, WK; Carlson, SW; Saatman, KE; Andres, DA				Mir, Sajad; Cai, Weikang; Carlson, Shaun W.; Saatman, Kathryn E.; Andres, Douglas A.			IGF-1 mediated Neurogenesis Involves a Novel RIT1/Akt/Sox2 Cascade	SCIENTIFIC REPORTS			English	Article							GROWTH-FACTOR-I; NEURAL STEM-CELLS; ADULT HIPPOCAMPAL NEUROGENESIS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTORS; PROGENITOR CELLS; ANALYSIS REVEALS	Insulin-like growth factor 1 (IGF-1) is known to have diverse effects on brain structure and function, including the promotion of stem cell proliferation and neurogenesis in the adult dentate gyrus. However, the intracellular pathways downstream of the IGF-1 receptor that contribute to these diverse physiological actions remain relatively uncharacterized. Here, we demonstrate that the Ras-related GTPase, RIT1, plays a critical role in IGF-1-dependent neurogenesis. Studies in hippocampal neuronal precursor cells (HNPCs) demonstrate that IGF-1 stimulates a RIT1-dependent increase in Sox2 levels, resulting in pro-neural gene expression and increased cellular proliferation. In this novel cascade, RIT1 stimulates Akt-dependent phosphorylation of Sox2 at T118, leading to its stabilization and transcriptional activation. When compared to wild-type HNPCs, RIT1(-/-)HNPCs show deficient IGF-1-dependent Akt signaling and neuronal differentiation, and accordingly, Sox2-dependent hippocampal neurogenesis is significantly blunted following IGF-1 infusion in knockout (RIT1(-/-)) mice. Consistent with a role for RIT1 function in the modulation of activity-dependent plasticity, exercise-mediated potentiation of hippocampal neurogenesis is also diminished in RIT1(-/-)mice. Taken together, these data identify the previously uncharacterized IGF1-RIT1-Akt-Sox2 signaling pathway as a key component of neurogenic niche sensing, contributing to the regulation of neural stem cell homeostasis.	[Mir, Sajad; Cai, Weikang; Andres, Douglas A.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Cai, Weikang] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02215 USA; [Carlson, Shaun W.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Carlson, Shaun W.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA; [Carlson, Shaun W.] Univ Pittsburgh, Dept Neurosurg, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Andres, DA (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	dandres@uky.edu	Cai, Weikang/K-2394-2019	Carlson, Shaun/0000-0002-1413-5075; Cai, Weikang/0000-0001-5638-0805	National Institutes of Health from the NINDS [R01 NS045103, R01 NS072302]; Kentucky Spinal Cord and Head Injury Research Trust [12-1A, 16-1]; Kentucky Lung Cancer Research Grant; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30GM110787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM110787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045103, R01NS072302] Funding Source: NIH RePORTER	This work was supported in part by National Institutes of Health Grant R01 NS045103(DAA) and R01 NS072302 (KES) from the NINDS and the Kentucky Spinal Cord and Head Injury Research Trust (Grants 12-1A and 16-1)(DAA) and a Kentucky Lung Cancer Research Grant(DAA). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. We wish to thank Dr. Michael Mendenhall for assistance in the generation of recombinant viruses. The authors acknowledge the use of facilities in the University of Kentucky Center for Molecular Medicine Genetic Technologies Core. This core is supported in part by NIH Grant Number P30GM110787. We also acknowledge Linda Simmerman in the Spinal Cord and Brain Injury Center and Dr. Carole Moncman in the Department of Molecular and Cellular Biochemistry for help with confocal microscopy.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Amador-Arjona A, 2015, P NATL ACAD SCI USA, V112, pE1936, DOI 10.1073/pnas.1421480112; Amiri A, 2012, J NEUROSCI, V32, P5880, DOI 10.1523/JNEUROSCI.5462-11.2012; Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Berger AH, 2014, ONCOGENE, V33, P4418, DOI 10.1038/onc.2013.581; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Brooker GJF, 2000, J NEUROSCI RES, V59, P332, DOI 10.1002/(SICI)1097-4547(20000201)59:3<332::AID-JNR6>3.0.CO;2-2; Bruel-Jungerman E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007901; Cai WK, 2012, NEUROSCI LETT, V531, P125, DOI 10.1016/j.neulet.2012.10.036; Cai WK, 2012, J NEUROSCI, V32, P9887, DOI 10.1523/JNEUROSCI.0375-12.2012; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Chaker Z, 2015, AGING CELL, V14, P847, DOI 10.1111/acel.12365; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; D'Addio F, 2015, CELL STEM CELL, V17, P486, DOI 10.1016/j.stem.2015.07.010; Darcy MJ, 2014, HIPPOCAMPUS, V24, P1317, DOI 10.1002/hipo.22313; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Ferretti C, 2014, TISSUE ENG PT A, V20, P2473, DOI [10.1089/ten.tea.2013.0453, 10.1089/ten.TEA.2013.0453]; Fletcher L, 2009, J NEUROSURG, V111, P164, DOI 10.3171/2009.2.JNS081199; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guo WX, 2012, NAT PROTOC, V7, P2005, DOI 10.1038/nprot.2012.123; Hodge RD, 2011, DEV NEUROBIOL, V71, P680, DOI 10.1002/dneu.20882; Kalluri HSG, 2007, EUR J NEUROSCI, V25, P1041, DOI 10.1111/j.1460-9568.2007.05336.x; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Liu W, 2009, J NEUROSCI RES, V87, P2821, DOI 10.1002/jnr.22129; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; Merkle FT, 2015, DEVELOPMENT, V142, P633, DOI 10.1242/dev.117978; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mir S, 2017, J BIOL CHEM, V292, P2054, DOI 10.1074/jbc.M116.749770; Mir S, 2014, MOL CELL, V56, P786, DOI 10.1016/j.molcel.2014.10.019; Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Nieto-Estevez V, 2016, STEM CELLS, V34, P2194, DOI 10.1002/stem.2397; O'Kusky J, 2012, FRONT NEUROENDOCRIN, V33, P230, DOI 10.1016/j.yfrne.2012.06.002; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Oishi K, 2009, P NATL ACAD SCI USA, V106, P13064, DOI 10.1073/pnas.0808400106; Park DH, 2014, CELL REP, V8, P1290, DOI 10.1016/j.celrep.2014.07.060; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ransome MI, 2013, MOL CELL NEUROSCI, V54, P93, DOI 10.1016/j.mcn.2013.01.005; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Siegle JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5511; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Ye P, 2006, J NEUROSCI RES, V83, P1, DOI 10.1002/jnr.20688; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Yuan HH, 2015, MOL NEUROBIOL, V51, P512, DOI 10.1007/s12035-014-8717-6; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]; Zheng HQ, 2014, INT J MOL SCI, V15, P10974, DOI 10.3390/ijms150610974; Zhu W, 2008, STROKE, V39, P1254, DOI 10.1161/STROKEAHA.107.500801; Ziegler AN, 2015, NAT REV ENDOCRINOL, V11, P161, DOI 10.1038/nrendo.2014.208	84	31	34	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 12	2017	7								3283	10.1038/s41598-017-03641-9			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2UD	WOS:000403081900074	28607354	Green Published, gold			2022-02-06	
J	Arumugam, TV; Manzanero, S; Furtado, M; Biggins, PJ; Hsieh, YH; Gelderblom, M; MacDonald, KPA; Salimova, E; Li, YI; Korn, O; Dewar, D; Macrae, IM; Ashman, RB; Tang, SC; Rosenthal, NA; Ruitenberg, MJ; Magnus, T; Wells, CA				Arumugam, Thiruma V.; Manzanero, Silvia; Furtado, Milena; Biggins, Patrick J.; Hsieh, Yu-Hsuan; Gelderblom, Mathias; MacDonald, Kelli P. A.; Salimova, Ekaterina; Li, Yu-I; Korn, Othmar; Dewar, Deborah; Macrae, I. Mhairi; Ashman, Robert B.; Tang, Sung-Chun; Rosenthal, Nadia A.; Ruitenberg, Marc J.; Magnus, Tim; Wells, Christine A.			An atypical role for the myeloid receptor Mincle in central nervous system injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						C-type lectin; ischemia; middle cerebral artery occlusion; microglia; sterile inflammation	TOLL-LIKE RECEPTORS; SPINAL-CORD-INJURY; FOCAL CEREBRAL-ISCHEMIA; C-TYPE LECTIN; CANDIDA-ALBICANS; INNATE IMMUNITY; BLOOD-FLOW; STROKE; BRAIN; INFLAMMATION	The C-type lectin Mincle is implicated in innate immune responses to sterile inflammation, but its contribution to associated pathologies is not well understood. Herein, we show that Mincle exacerbates neuronal loss following ischemic but not traumatic spinal cord injury. Loss of Mincle was beneficial in a model of transient middle cerebral artery occlusion but did not alter outcomes following heart or gut ischemia. High functional scores in Mincle KO animals using the focal cerebral ischemia model were accompanied by reduced lesion size, fewer infiltrating leukocytes and less neutrophil-derived cytokine production than isogenic controls. Bone marrow chimera experiments revealed that the presence of Mincle in the central nervous system, rather than recruited immune cells, was the critical regulator of a poor outcome following transient middle cerebral artery occlusion. There was no evidence for a direct role for Mincle in microglia or neural activation, but expression in a subset of macrophages resident in the perivascular niche provided new clues on Mincle's role in ischemic stroke.	[Arumugam, Thiruma V.; Hsieh, Yu-Hsuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Arumugam, Thiruma V.; Manzanero, Silvia; Biggins, Patrick J.; Ruitenberg, Marc J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Manzanero, Silvia; Korn, Othmar; Wells, Christine A.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Furtado, Milena; Salimova, Ekaterina; Rosenthal, Nadia A.] Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic, Australia; [Furtado, Milena; Rosenthal, Nadia A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Gelderblom, Mathias; Magnus, Tim] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [MacDonald, Kelli P. A.] Queensland Inst Med Res, Brisbane, Qld, Australia; [Li, Yu-I; Tang, Sung-Chun] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Li, Yu-I; Tang, Sung-Chun] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Li, Yu-I; Tang, Sung-Chun] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Dewar, Deborah; Macrae, I. Mhairi] Univ Glasgow, Inst Neurosci & Psychol, Wellcome Surg Inst, Glasgow, Lanark, Scotland; [Ashman, Robert B.] Univ Queensland, Sch Dent, Brisbane, Qld, Australia; [Tang, Sung-Chun] Natl Taiwan Univ Hosp, Stroke Ctr, Dept Neurol, Taipei, Taiwan; [Ruitenberg, Marc J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Wells, Christine A.] Univ Melbourne, Fac Med, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia		Wells, CA (corresponding author), Univ Melbourne, Fac Med, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia.	wells.c@unimelb.edu.au	Ashman, Robert B/F-1238-2010; Arumugam, Thiruma/AAG-6958-2019; MacDonald, Kelli PA/O-2722-2016; MacDonald, Kelli/AAV-5365-2020; Wells, Christine/A-5071-2010	MacDonald, Kelli PA/0000-0003-3451-4221; Manzanero, Silvia/0000-0002-5294-7082; Ruitenberg, Marc/0000-0002-6917-0708; Arumugam, Thiruma/0000-0002-3377-0939; Biggins, Patrick/0000-0002-9388-1411; Tang, Sung-Chun/0000-0003-3731-5973; , Ekaterina/0000-0002-4362-7108; Rosenthal, Nadia/0000-0002-7599-7365; Wells, Christine/0000-0003-3133-3628	Australian National Health & Medical Research CouncilNational Health and Medical Research Council of Australia [1057846, 1060538]; Spinal Cure Australia (Career Development Fellowship); Singapore National Medical Research Council Collaborative Research GrantNational Medical Research Council, Singapore [NMRC-CBRG-0102/2016]; State Government of Victoria; Australian GovernmentAustralian GovernmentCGIAR; University of QueenslandUniversity of Queensland; Australian Research CouncilAustralian Research Council	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by Australian National Health & Medical Research Council (1057846, 1060538 and Fellowship to NAR), Spinal Cure Australia (Career Development Fellowship to MJR), the Australian Research Council, Singapore National Medical Research Council Collaborative Research Grant (NMRC-CBRG-0102/2016 to TA), the State Government of Victoria, the Australian Government and The University of Queensland.	Andre P, 2011, BLOOD, V118, P5000, DOI 10.1182/blood-2011-06-360743; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Brea D, 2011, J CEREBR BLOOD F MET, V31, P1424, DOI 10.1038/jcbfm.2010.231; Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; de Rivero Vaccari JC, 2014, J NEUROTRAUM, V236, P228; Downes CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057948; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Fernandez-Klettl F, 2015, J CEREBR BLOOD F MET, V35, P883, DOI 10.1038/jcbfm.2015.60; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048; He Y, 2015, STROKE, V46, P2277, DOI 10.1161/STROKEAHA.115.010088; Heiman A, 2014, BRAIN BEHAV IMMUN, V42, P232, DOI 10.1016/j.bbi.2014.06.203; Holloway PM, 2015, ARTERIOSCL THROM VAS, V35, P1936, DOI 10.1161/ATVBAHA.115.305348; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Maestrini I, 2015, NEUROLOGY, V85, P1408, DOI 10.1212/WNL.0000000000002029; Masumoto M, 1999, J IMMUNOL, V163, P5039; MORI E, 1992, STROKE, V23, P712, DOI 10.1161/01.STR.23.5.712; Murray KN, 2013, MOL CELL NEUROSCI, V53, P14, DOI 10.1016/j.mcn.2012.09.004; Neumann J, 2015, ACTA NEUROPATHOL, V129, P259, DOI 10.1007/s00401-014-1355-2; Pamuk ON, 2010, AM J PHYSIOL-GASTR L, V299, pG391, DOI 10.1152/ajpgi.00198.2010; Perdiguero EG, 2013, GLIA, V61, P112, DOI 10.1002/glia.22393; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Shi XR, 2010, CELL TISSUE RES, V342, P21, DOI 10.1007/s00441-010-1040-2; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Suzuki Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03177; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tarr D, 2013, J CEREBR BLOOD F MET, V33, P1556, DOI 10.1038/jcbfm.2013.107; Vartanian KB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-140; Vijayan D, 2012, IMMUNOL CELL BIOL, V90, P889, DOI 10.1038/icb.2012.24; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wells CA, 2013, STEM CELL RES, V10, P387, DOI 10.1016/j.scr.2012.12.003; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P10388, DOI 10.1073/pnas.1205210109	47	31	32	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2017	37	6					2098	2111		10.1177/0271678X16661201			14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	EV8BL	WOS:000402005200016	27492949	Green Submitted, hybrid, Green Accepted, Green Published			2022-02-06	
J	Tigchelaar, S; Streijger, F; Sinha, S; Flibotte, S; Manouchehri, N; So, K; Shortt, K; Okon, E; Rizzuto, MA; Malenica, I; Courtright-Lim, A; Eisen, A; Van Keuren-Jensen, K; Nislow, C; Kwon, BK				Tigchelaar, Seth; Streijger, Femke; Sinha, Sunita; Flibotte, Stephane; Manouchehri, Neda; So, Kitty; Shortt, Katelyn; Okon, Elena; Rizzuto, Michael A.; Malenica, Ivana; Courtright-Lim, Amanda; Eisen, Andrew; Van Keuren-Jensen, Kendall; Nislow, Corey; Kwon, Brian K.			Serum MicroRNAs Reflect Injury Severity in a Large Animal Model of Thoracic Spinal Cord Injury	SCIENTIFIC REPORTS			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; STRUCTURAL BIOMARKERS; CIRCULATING MICRORNAS; BLOOD BIOMARKERS; CLINICAL-TRIALS; PORCINE MODEL; EXPRESSION; MIRNA	Therapeutic development for spinal cord injury is hindered by the difficulty in conducting clinical trials, which to date have relied solely on functional outcome measures for patient enrollment, stratification, and evaluation. Biological biomarkers that accurately classify injury severity and predict neurologic outcome would represent a paradigm shift in the way spinal cord injury clinical trials could be conducted. MicroRNAs have emerged as attractive biomarker candidates due to their stability in biological fluids, their phylogenetic similarities, and their tissue specificity. Here we characterized a porcine model of spinal cord injury using a combined behavioural, histological, and molecular approach. We performed next-generation sequencing on microRNAs in serum samples collected before injury and then at 1, 3, and 5 days post injury. We identified 58, 21, 9, and 7 altered miRNA after severe, moderate, and mild spinal cord injury, and SHAM surgery, respectively. These data were combined with behavioural and histological analysis. Overall miRNA expression at 1 and 3 days post injury strongly correlates with outcome measures at 12 weeks post injury. The data presented here indicate that serum miRNAs are promising candidates as biomarkers for the evaluation of injury severity for spinal cord injury or other forms of traumatic, acute, neurologic injury.	[Tigchelaar, Seth; Streijger, Femke; Manouchehri, Neda; So, Kitty; Shortt, Katelyn; Okon, Elena; Rizzuto, Michael A.; Kwon, Brian K.] Univ British Columbia, ICORD, Vancouver, BC, Canada; [Sinha, Sunita; Flibotte, Stephane; Nislow, Corey] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Malenica, Ivana; Courtright-Lim, Amanda; Van Keuren-Jensen, Kendall] Translat Genom, Phoenix, AZ USA; [Eisen, Andrew] Acorda Therapeut, Ardsley, NY USA; [Kwon, Brian K.] Univ British Columbia, Vancouver Spine Surg Inst, Dept Orthoped, Vancouver, BC, Canada		Kwon, BK (corresponding author), Univ British Columbia, ICORD, Vancouver, BC, Canada.; Kwon, BK (corresponding author), Univ British Columbia, Vancouver Spine Surg Inst, Dept Orthoped, Vancouver, BC, Canada.	brian.kwon@ubc.ca	Malenica, Ivana/J-2007-2019	Malenica, Ivana/0000-0002-7404-8088; Okon, Elena/0000-0001-8568-5771; Tigchelaar, Seth/0000-0002-2207-9034; Rizzuto, Michael/0000-0001-7743-4454; Eisen, Andrew/0000-0002-1447-2725	veterinarian staff and animal care technicians at the Centre for Comparative Medicine (CCM), UBC; Brain Canada Foundation; Rick Hansen Institute,; Acorda Therapeutics	The authors gratefully acknowledge the expertise and support of the veterinarian staff and animal care technicians at the Centre for Comparative Medicine (CCM), UBC. C.N. is the Canada Research Chair in Translational Genomics. B.K.K. is the Canada Research Chair in Spinal Cord Injury and Dvorak Chair in Spinal Trauma. The authors also acknowledge grant-funding support from the Brain Canada Foundation and the Rick Hansen Institute, and also a collaborative research agreement with Acorda Therapeutics to conduct this research.	Aanes H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089158; Andrews S., 2010, BABRAHAM BIOINFORMAT; [Anonymous], 2014, J SPINAL CORD MED, V37, P243; Bao F, 2012, J NEUROTRAUM, V29, P1626, DOI 10.1089/neu.2011.2190; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Boon H, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12622; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.1984.03340250025015; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; BYRNES JJ, 1975, BIOCHEMISTRY-US, V14, P796, DOI 10.1021/bi00675a023; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Eguchi A, 2014, J HEPATOL, V60, P1063, DOI 10.1016/j.jhep.2013.12.026; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Hachisuka S, 2014, SPINAL CORD, V52, P596, DOI 10.1038/sc.2014.86; Hu JR, 2013, J PHARMACOL SCI, V121, P343, DOI 10.1254/jphs.12235SC; Jee MK, 2012, BRAIN, V135, P1237, DOI 10.1093/brain/aws047; Jickling GC, 2011, NEUROTHERAPEUTICS, V8, P349, DOI 10.1007/s13311-011-0050-4; Jing L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11953; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kwon B. K., 2016, J NEUROTRAUMA; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; Lee RS, 2012, J CLIN NEUROSCI, V19, P1338, DOI 10.1016/j.jocn.2012.02.015; Lehmann-Werman R, 2016, P NATL ACAD SCI USA, V113, pE1826, DOI 10.1073/pnas.1519286113; Li XQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0246-3; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Ma YD, 2015, INT J CLIN EXP PATHO, V8, P1682; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Martin M, 2011, CUTADAPT REMOVES ADA, V17; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nakanishi K, 2010, SPINAL CORD, V48, P192, DOI 10.1038/sc.2009.89; Nieto-Diaz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00053; Ning B, 2014, INT J BIOL SCI, V10, P997, DOI 10.7150/ijbs.9058; Paczynska P, 2015, BMC GENET, V15, DOI 10.1186/s12863-015-0166-3; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Streijger F, 2015, J NEUROTRAUM, V32, P908, DOI 10.1089/neu.2014.3707; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Theis T., 2016, MOL NEUROBIOL; van Rossum IA, 2010, J ALZHEIMERS DIS, V20, P881, DOI 10.3233/JAD-2010-091606; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Whiteley W, 2012, STROKE, V43, P86, DOI 10.1161/STROKEAHA.111.634089; Wohl SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep35423; Wu D, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00035; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Yunta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034534; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang LF, 2009, PROCEEDINGS OF THE 2009 INTERNATIONAL CONFERENCE ON PUBLIC ECONOMICS AND MANAGEMENT ICPEM 2009, VOL 1, P5, DOI 10.1371/journal.pgen.1000716	62	31	34	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 3	2017	7								1376	10.1038/s41598-017-01299-x			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET7PX	WOS:000400490600001	28469141	Green Published, gold			2022-02-06	
J	Oberlander, TJ; Olson, BL; Weidauer, L				Oberlander, Tyler J.; Olson, Bernadette L.; Weidauer, Lee			Test-Retest Reliability of the King-Devick Test in an Adolescent Population	JOURNAL OF ATHLETIC TRAINING			English	Article						sport concussion; oculomotor function; saccadic rhythm	MILD HEAD-INJURY; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; VISUAL SCREENING TOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; EPIDEMIOLOGY; BALANCE; PLAYERS; VISION	Context: The King-Devick (KD) test is a screening tool designed to assess cognitive visual impairments, namely saccadic rhythm, postconcussion. Test-retest reliability of the KD in a healthy adolescent population has not yet been established. Objective: To investigate the overall test-retest reliability of the KD among a sample of healthy adolescents. Additionally, we sought to determine if sex and age influenced reliability. Design: Cross-sectional study. Setting: Secondary school. Patients or Other Participants: Sixty-eight healthy adolescents, 41 boys (age = 15.4 +/- 1.9 years) and 27 girls (age = 15.4 +/- 1.9 years). Main Outcome Measure(s): Participants completed the KD (version 1) at 3 testing sessions (days 1, 30, and 45) following standard instructions. We recorded total time to complete the reading of 3 cards for each participant during each testing session. Two-way random-effects intraclass correlation coefficients (ICCs) using single measurements repeated over time and repeatability coefficients were calculated. Linear mixed models were used to determine whether differences existed at each testing time and to examine whether changes that took place among visits were different by sex or age. Results: Adolescents who completed the KD demonstrated acceptable reliability (ICC = 0.81; 95% confidence interva = 0.73, 0.87); however, the repeatability coefficient was large (68.76 seconds). The sample demonstrated improvements between visits 1 and 2 (mean +/- standard error = 4.3 +/- 0.5 seconds, P < .001) and between visits 2 and 3 (2.4 +/- 0.5 seconds, P < .001) for a total improvement of 6.9 seconds over 3 tests. No significant visit-by-sex or visit-by-age interactions were observed. Conclusions: Despite the ICC being clinically acceptable, providers using the KD test for serial assessment of concussion in adolescents should be cautious in interpreting the results due to a large learning effect. Incorporating multiple measures can ensure accurate detection of sport concussion.	[Oberlander, Tyler J.] Great Plains Hlth Sports & Therapy, North Platte, NE USA; [Olson, Bernadette L.; Weidauer, Lee] South Dakota State Univ, Hlth & Nutrit Sci, Box 2203,SIM 116, Brookings, SD 57007 USA		Olson, BL (corresponding author), South Dakota State Univ, Hlth & Nutrit Sci, Box 2203,SIM 116, Brookings, SD 57007 USA.	bernie.olson@sdstate.edu					Augustine G., 2001, NEUROSCIENCE; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Comstock D, SUMMARY REPORT NATL; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Jinguji TM, 2011, PHYS MED REH CLIN N, V22, P565, DOI 10.1016/j.pmr.2011.08.001; Keightley M, 2009, BMJ CASE REP, V2009; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Krumholtz I, 2000, Optometry, V71, P426; Kulp M T, 1997, J Am Optom Assoc, V68, P589; Kulp MT, 1997, OPTOMETRY VISION SCI, V74, P37, DOI 10.1097/00006324-199701000-00018; Kulp MT, 1998, OPTOMETRY VISION SCI, V75, P284, DOI 10.1097/00006324-199804000-00026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Leong DF, 2014, CLIN PEDIATR, V53, P858, DOI 10.1177/0009922814532520; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Marshall Cameron M, 2012, J Can Chiropr Assoc, V56, P299; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Riemann BL, 1997, J SPORT REHABIL, V6, P283, DOI 10.1123/jsr.6.3.283; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	55	31	31	0	11	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2017	52	5					439	445		10.4085/1062-6050-52.2.12			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EY7ED	WOS:000404150400005	28362161	Green Published, Bronze			2022-02-06	
J	Laskowitz, DT; Wang, HC; Chen, T; Lubkin, DT; Cantillana, V; Tu, TM; Kernagis, D; Zhou, GN; Macy, G; Kolls, BJ; Dawson, HN				Laskowitz, Daniel T.; Wang, Haichen; Chen, Tony; Lubkin, David T.; Cantillana, Viviana; Tu, Tian Ming; Kernagis, Dawn; Zhou, Guanen; Macy, Gary; Kolls, Bradley J.; Dawson, Hana N.			Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model	SCIENTIFIC REPORTS			English	Article							NECROSIS-FACTOR-ALPHA; LONG-TERM DISABILITY; E-MIMETIC PEPTIDES; PROTEIN 88 MYD88; APOLIPOPROTEIN-E; UNITED-STATES; APOE GENOTYPE; MULTIPLE PATHWAYS; MOTOR DEFICITS; RECEPTOR	At present, there are no proven pharmacological treatments demonstrated to improve long term functional outcomes following traumatic brain injury (TBI). In the setting of non-penetrating TBI, sterile brain inflammatory responses are associated with the development of cerebral edema, intracranial hypertension, and secondary neuronal injury. There is increasing evidence that endogenous apolipoprotein E (apoE) modifies the neuroinflammatory response through its role in downregulating glial activation, however, the intact apoE holoprotein does not cross the blood-brain barrier due to its size. To address this limitation, we developed a small 5 amino acid apoE mimetic peptide (CN-105) that mimics the polar face of the apoE helical domain involved in receptor interactions. The goal of this study was to investigate the therapeutic potential of CN-105 in a murine model of closed head injury. Treatment with CN-105 was associated with a durable improvement in functional outcomes as assessed by Rotarod and Morris Water Maze and a reduction in positive Fluoro-Jade B stained injured neurons and microglial activation. Administration of CN-105 was also associated with reduction in mRNA expression of a subset of inflammatory and immune-related genes.	[Laskowitz, Daniel T.; Wang, Haichen; Chen, Tony; Lubkin, David T.; Cantillana, Viviana; Tu, Tian Ming; Kernagis, Dawn; Zhou, Guanen; Macy, Gary; Kolls, Bradley J.; Dawson, Hana N.] Duke Univ, Sch Med, Dept Neurol, Durham, NC 27710 USA; [Laskowitz, Daniel T.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [Laskowitz, Daniel T.] Aegis CN LLC, Durham, NC 27705 USA; [Tu, Tian Ming] Tan Tock Seng Hosp, Natl Neurosci Inst, Dept Neurol, Singapore, Singapore; [Kernagis, Dawn] Florida Inst Human & Machine Cognit, Pensacola, FL 32502 USA; [Zhou, Guanen] Huanhu Hosp, Dept Neurol, Tianjin 300060, Peoples R China		Laskowitz, DT (corresponding author), Duke Univ, Sch Med, Dept Neurol, Durham, NC 27710 USA.; Laskowitz, DT (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.; Laskowitz, DT (corresponding author), Aegis CN LLC, Durham, NC 27705 USA.	daniel.laskowitz@dm.duke.edu	Tu, Tian Ming/AAI-3949-2020; Kolls, Brad/R-9154-2019	Tu, Tian Ming/0000-0002-7175-0357; 	North Carolina Biotechnology Center [2014-794 CFG-8004, W81XWH-16-C-0142]	The study was supported by a grant from the North Carolina Biotechnology Center (2014-794 CFG-8004 and CDMRP#W81XWH-16-C-0142).	ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Amor S, 2014, IMMUNOLOGY, V141, P287, DOI 10.1111/imm.12134; Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Biffi A, 2011, LANCET NEUROL, V10, P702, DOI 10.1016/S1474-4422(11)70148-X; Can A, 2011, GENES BRAIN BEHAV, V10, P434, DOI 10.1111/j.1601-183X.2011.00682.x; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Croy JE, 2004, BIOCHEMISTRY-US, V43, P7328, DOI 10.1021/bi036208p; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; Lanterna LA, 2007, NEUROLOGY, V69, P766, DOI 10.1212/01.wnl.0000267640.03300.6b; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Le Thuc O, 2015, ANN NY ACAD SCI, V1351, P127, DOI 10.1111/nyas.12855; Lei BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34834; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li LZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002028; Li W, 2013, J SURG RES, V180, P133, DOI 10.1016/j.jss.2012.10.928; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P409, DOI 10.1007/978-3-211-85578-2_80; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; MACLEOD JN, 1987, XENOBIOTICA, V17, P1095, DOI 10.3109/00498258709044208; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mesis Rachel G, 2006, Neurosurg Focus, V21, pE4; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; Mora J, 2016, J MOL CELL BIOL, V8, P426, DOI 10.1093/jmcb/mjw006; Morris PG, 2004, ACTA NEUROL SCAND, V109, P205, DOI 10.1034/j.1600-0404.2003.00206.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Ophir G, 2003, NEUROBIOL DIS, V12, P56, DOI 10.1016/S0969-9961(02)00005-0; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Said-Sadier Najwane, 2012, Biomed J, V35, P437, DOI 10.4103/2319-4170.104408; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sheng ZY, 2008, NEUROPHARMACOLOGY, V55, P204, DOI 10.1016/j.neuropharm.2008.05.016; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Wang H, 2013, EXP NEUROL, V241, P67, DOI 10.1016/j.expneurol.2012.11.027; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Yuan XL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/807976; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	83	31	31	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 21	2017	7								46461	10.1038/srep46461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0WX	WOS:000399986800001	28429734	gold, Green Published			2022-02-06	
J	Posti, JP; Hossain, I; Takala, RSK; Liedes, H; Newcombe, V; Outtrim, J; Katila, AJ; Frantzen, J; Ala-Seppala, H; Coles, JP; Kyllonen, A; Maanpaa, HR; Tallus, J; Hutchinson, PJ; van Gils, M; Menon, DK; Tenovuo, O				Posti, Jussi P.; Hossain, Iftakher; Takala, Riikka S. K.; Liedes, Hilkka; Newcombe, Virginia; Outtrim, Joanne; Katila, Ari J.; Frantzen, Janek; Ala-Seppala, Henna; Coles, Jonathan P.; Kyllonen, Anna; Maanpaa, Henna-Riikka; Tallus, Jussi; Hutchinson, Peter J.; van Gils, Mark; Menon, David K.; Tenovuo, Olli		TBIcare Investigators	Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Are Not Specific Biomarkers for Mild CT-Negative Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; GFAP; orthopedic injury; TBI; UCH-L1	CEREBROSPINAL-FLUID; SERUM-LEVELS; INTRACRANIAL LESIONS; COMPUTED-TOMOGRAPHY; DIAGNOSTIC MARKER; HEAD-INJURY; GFAP; PLASMA; S100B; L1	Glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1) have been studied as potential biomarkers of mild traumatic brain injury (mTBI). We report the levels of GFAP and UCH-L1 in patients with acute orthopedic injuries without central nervous system involvement, and relate them to the type of extracranial injury, head magnetic resonance imaging (MRI) findings, and levels of GFAP and UCH-L1 in patients with CT-negative mTBI. Serum UCH-L1 and GFAP were longitudinally measured from 73 patients with acute orthopedic injury on arrival and on days 1, 2, 3, 7 after admission, and on the follow-up visit 3-10 months after the injury. The injury types were recorded, and 71% patients underwent also head MRI. The results were compared with those found in patients with CT-negativemTBI (n = 93). The levels of GFAP were higher in patients with acute orthopedic trauma than in patients with CT-negative mTBI (p = 0.026) on arrival; however, no differences were found on the following days. The levels of UCH-L1 were not significantly different between these two groups at any measured point of time. Levels of GFAP and UCH-L1 were not able to distinguish patients with CT-negative mTBI from patients with orthopedic trauma. Patients with orthopedic trauma and high levels of UCH-L1 or GFAP values may be falsely diagnosed as having a concomitant mTBI, predisposing them to unwarranted diagnostics and unnecessary brain imaging. This casts a significant doubt on the diagnostic value of GFAP and UCH-L1 in cases with mTBI.	[Posti, Jussi P.; Frantzen, Janek] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, POB 52, FI-20521 Turku, Finland; [Posti, Jussi P.; Frantzen, Janek; Tenovuo, Olli] Turku Univ Hosp, Dept Rehabil & Brain Trauma, Div Clin Neurosci, Turku, Finland; [Posti, Jussi P.; Hossain, Iftakher; Ala-Seppala, Henna; Kyllonen, Anna; Maanpaa, Henna-Riikka; Tallus, Jussi; Tenovuo, Olli] Univ Turku, Dept Neurol, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari J.] Turku Univ Hosp, Perioperat Serv, Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari J.] Univ Turku, Turku, Finland; [Liedes, Hilkka; van Gils, Mark] VTT Tech Res Ctr Finland Ltd, Med Syst, Tampere, Finland; [Newcombe, Virginia; Outtrim, Joanne; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England; [Coles, Jonathan P.; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurosurg Unit, Cambridge, England		Posti, JP (corresponding author), Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, POB 52, FI-20521 Turku, Finland.	jussi.posti@utu.fi	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Ala-Seppala, Henna/0000-0002-1577-3028; Hossain, Iftakher/0000-0003-4836-1158; van Gils, Mark/0000-0002-0029-1771; Coles, Jonathan/0000-0003-4013-679X; Newcombe, Virginia/0000-0001-6044-9035; Liedes, Hilkka/0000-0003-4655-7675	European Commission under the 7th Framework Programme [FP7-270259-TBIcare]; personal Government's Special Financial Transfer tied to academic research in Health Sciences; Maire Taponen Foundation; Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship; National Institute for Health Research (NIHR) Research Fellowship; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-CSF4-Newcombe] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, ACF-2009-14-007, NF-SI-0512-10090] Funding Source: researchfish	This work was partially funded by the European Commission under the 7th Framework Programme (FP7-270259-TBIcare), personal Government's Special Financial Transfer tied to academic research in Health Sciences (J.P.P. and R.S.K.T.), personal EVO funding and grant from Maire Taponen Foundation (J.P.P.), Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship (V.N.), National Institute for Health Research (NIHR) Research Fellowship (P.J.H.) The authors thank research nurses Patricia Bertenyi and Satu Timlin for their valuable contribution to this study.	BAKAY RAE, 1986, NEUROSURGERY, V18, P376, DOI 10.1227/00006123-198603000-00026; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Cape E, 2014, J PSYCHOSOM RES, V77, P219, DOI 10.1016/j.jpsychores.2014.06.014; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Carotti S, 2008, LIVER TRANSPLANT, V14, P806, DOI 10.1002/lt.21436; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Chuang D, 2005, ANZ J SURG, V75, P813, DOI 10.1111/j.1445-2197.2005.03530.x; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fellenberg J, 2010, INT J CANCER, V127, P1804, DOI 10.1002/ijc.25205; Gurnett CA, 2003, EPILEPSIA, V44, P1455, DOI 10.1046/j.1528-1157.2003.21603.x; Hainfellner JA, 2001, J NEUROPATH EXP NEUR, V60, P449, DOI 10.1093/jnen/60.5.449; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hsu SH, 2010, CLIN CHIM ACTA, V411, P1920, DOI 10.1016/j.cca.2010.07.035; Ilhan A, 2011, J CLIN ONCOL, V29, pE756, DOI 10.1200/JCO.2011.36.6401; Isokuortti H, 2014, INJURY, V45, P1340, DOI 10.1016/j.injury.2014.04.012; JESSEN KR, 1984, J NEUROCYTOL, V13, P187, DOI 10.1007/BF01148114; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kiviniemi A, 2015, J NEURO-ONCOL, V124, P237, DOI 10.1007/s11060-015-1829-7; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Riol H, 1997, J NEUROSCI RES, V48, P53; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Romner B, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00053; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; VIALE G, 1991, VIRCHOWS ARCH A, V418, P339, DOI 10.1007/BF01600164; VIALE G, 1988, AM J PATHOL, V133, P363; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	54	31	31	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1427	1438		10.1089/neu.2016.4442			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600012	27841729	Green Submitted			2022-02-06	
J	Salzar, RS; Treichler, D; Wardlaw, A; Weiss, G; Goeller, J				Salzar, Robert S.; Treichler, Derrick; Wardlaw, Andrew; Weiss, Greg; Goeller, Jacques			Experimental Investigation of Cavitation as a Possible Damage Mechanism in Blast-Induced Traumatic Brain Injury in Post-Mortem Human Subject Heads	JOURNAL OF NEUROTRAUMA			English	Article						brain; bTBI; cavitation; DYSMAS; pressure	MILITARY; MODEL; SYSTEM; IMPACT; SHELL; RISK	The potential of blast-induced traumatic brain injury from the mechanism of localized cavitation of the cerebrospinal fluid (CSF) is investigated. While the mechanism and criteria for non-impact blast-induced traumatic brain injury is still unknown, this study demonstrates that local cavitation in the CSF layer of the cranial volume could contribute to these injuries. The cranial contents of three post-mortem human subject (PMHS) heads were replaced with both a normal saline solution and a ballistic gel mixture with a simulated CSF layer. Each were instrumented with multiple pressure transducers and placed inside identical shock tubes at two different research facilities. Sensor data indicates that cavitation may have occurred in the PMHS models at pressure levels below those for a 50% risk of blast lung injury. This study points to skull flexion, the result of the shock wave on the front of the skull leading to a negative pressure in the contrecoup, as a possible mechanism that contributes to the onset of cavitation. Based on observation of intracranial pressure transducer data from the PMHS model, cavitation onset is thought to occur from approximately a 140 kPa head-on incident blast.	[Salzar, Robert S.] Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA; [Treichler, Derrick; Wardlaw, Andrew; Goeller, Jacques] Adv Technol & Res, Columbia, MD USA; [Weiss, Greg] Appl Res Associates Inc, Littleton, CO USA		Salzar, RS (corresponding author), Univ Virginia, Ctr Appl Biomech, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	salzar@virginia.edu		Treichler, Derrick/0000-0002-3007-2967	SBIR Enhancement Program by the Defense Research Project Agency (DARPA); US Army Medical Research and Materiel Command (MRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W911NF-10-C-0044]	The work was jointly funded under and SBIR Enhancement Program by the Defense Research Project Agency (DARPA) and the US Army Medical Research and Materiel Command (MRMC; contract W911NF-10-C-0044). The authors would like to acknowledge the support provided by Dr. Judah Goldwasser of DARPA/DSO, and Dr. Kenneth Curley of MRMC. The effort was administered by Dr. Ralph Anthenien of the Army Research Office. The authors would also like to acknowledge the support provided by Dr. Carol Chancey and Mr. Tyler Rooks of the USAARL in completing the PMHS shock tube tests, and Dr. Daniel Tollin of the University of Colorado for providing CT scan support.	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Aihaiti M., 2008, EQUATION STATE BALLI; Bailey M. R., 2003, ACOUST PHYS, P49; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Brenner M., 2007, JSR07200 JASON MITR; BRUNO LA, 1987, CLIN SPORT MED, V6, P17; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chafi S. M., 2007, ASME P, P211; EDBERG S, 1963, LAB INVEST, V12, P1305; ENGIN AE, 1978, AVIAT SPACE ENVIR MD, V49, P120; Faul M, 2010, TRAUMATIC BRAIN INJU; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Gennarelli TA, 1972, STAPP CAR CRASH J, V16, P296; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Hannah Fischer, 2015, GUIDE US MILITARY CA; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; HICKLING R, 1973, J BIOMECH, V6, P115, DOI 10.1016/0021-9290(73)90081-X; IREMONGER MJ, 1997, SCI FDN TRAUMA, P189; Johnson E., 2006, SAE TECH PAPERS; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; LUBOCK P, 1980, J BIOMECH, V13, P1041, DOI 10.1016/0021-9290(80)90048-2; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss W.C., 2009, J ACOUST SOC AM, V125, P2650; Nicholas N, 2004, I NONLETHAL DEFENSE; NUSHOLTZ GS, 1995, J NEUROTRAUM, V12, P707, DOI 10.1089/neu.1995.12.707; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Sotudeh-Chafi M., 2007, ASME 2007 INT MECH E, V2, P211; SUH C, 1972, J BIOMECH, V5, P181, DOI 10.1016/0021-9290(72)90054-1; Ward C, 1980, P 24 STAPP CAR CRASH; WARD JW, 1948, SCIENCE, V107, P349, DOI 10.1126/science.107.2779.349; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wardlaw A, 2010, IFMBE PROC, V32, P34, DOI 10.1007/978-3-642-14998-6_9; Wardlaw Jr A.B, 2500 NSWCIH; Young F. R., 1999, CAVITATION, V4, P143; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242; Ziejewski M., 2007, BRAIN INJ PROF, V4, P10	41	31	35	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1589	1602		10.1089/neu.2016.4600			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500011	27855566				2022-02-06	
J	Sufrinko, AM; Marchetti, GF; Cohen, PE; Elbin, RJ; Re, V; Kontos, AP				Sufrinko, Alicia M.; Marchetti, Gregory F.; Cohen, Paul E.; Elbin, R. J.; Re, Valentina; Kontos, Anthony P.			Using Acute Performance on a Comprehensive Neurocognitive, Vestibular, and Ocular Motor Assessment Battery to Predict Recovery Duration After Sport-Related Concussions	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; recovery; neurocognitive; vestibular; ocular motor	HIGH-SCHOOL; ADOLESCENTS; SYMPTOMS; AGE; RELIABILITY; IMPAIRMENT; MIGRAINE; SCALE	Background: A sport-related concussion (SRC) is a heterogeneous injury that requires a multifaceted and comprehensive approach for diagnosis and management, including symptom reports, vestibular/ocular motor assessments, and neurocognitive testing. Purpose: To determine which acute (eg, within 7 days) vestibular, ocular motor, neurocognitive, and symptom impairments predict the duration of recovery after an SRC. Study Design: Cohort study (prognosis); Level of evidence, 2. Methods: Sixty-nine patients with a mean age of 15.3 +/- 1.9 years completed a neurocognitive, vestibular/ocular motor, and symptom assessment within 7 days of a diagnosed concussion. Patients were grouped by recovery time: <= 14 days (n = 27, 39.1%), 15-29 days (n = 25, 36.2%), and 30-90 days (n = 17, 24.6%). Multinomial regression was used to identify the best subset of predictors associated with prolonged recovery relative to <= 14 days. Results: Acute visual motor speed and cognitive-migraine-fatigue symptoms were associated with an increased likelihood of recovery times of 30-90 days and 15-29 days relative to a recovery time of <= 14 days. A model with visual motor speed and cognitive-migraine-fatigue symptoms within the first 7 days of an SRC was 87% accurate at identifying patients with a recovery time of 30-90 days. Conclusion: The current study identified cognitive-migraine-fatigue symptoms and visual motor speed as the most robust predictors of protracted recovery after an SRC according to the Post-concussion Symptom Scale, Immediate Post-concussion Assessment and Cognitive Testing, and Vestibular/Ocular Motor Screening (VOMS). While VOMS components were sensitive in identifying a concussion, they were not robust predictors for recovery. Clinicians may consider particular patterns of performance on clinical measures when providing treatment recommendations and discussing anticipated recovery with patients.	[Sufrinko, Alicia M.; Cohen, Paul E.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA; [Marchetti, Gregory F.] Duquesne Univ, John G Rangos Sr Sch Hlth Sci, Pittsburgh, PA 15219 USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Re, Valentina] Univ Milan, Milan, Italy		Sufrinko, AM (corresponding author), Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	sufrinkoam@upmc.edu		Kontos, Anthony/0000-0002-3749-4310			Abu-Arafeh I, 2010, DEV MED CHILD NEUROL, V52, P1088, DOI 10.1111/j.1469-8749.2010.03793.x; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T., 2014, ATHL TRAIN SPORT HLT, DOI [10.3928/19425864-20140916-01, DOI 10.3928/19425864-20140916-01]; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pastor Patricia N, 2008, Vital Health Stat 10, P1; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e	27	31	31	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	APR	2017	45	5					1187	1194		10.1177/0363546516685061			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	ET4HK	WOS:000400239900026	28192036				2022-02-06	
J	Guida, F; Boccella, S; Iannotta, M; De Gregorio, D; Giordano, C; Belardo, C; Romano, R; Palazzo, E; Scafuro, MA; Serra, N; de Novellis, V; Rossi, F; Maione, S; Luongo, L				Guida, Francesca; Boccella, Serena; Iannotta, Monica; De Gregorio, Danilo; Giordano, Catia; Belardo, Carmela; Romano, Rosaria; Palazzo, Enza; Scafuro, Maria A.; Serra, Nicola; de Novellis, Vito; Rossi, Francesco; Maione, Sabatino; Luongo, Livio			Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; Palmitoylethanolamide; medial prefrontal cortex; mice depression; aggressive; behavior; in vivo electrophysiology	MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; NEURONS; AMYGDALA; PAIN; INFLAMMATION; INTERLEUKIN-1-BETA; INTERNEURONS; HIPPOCAMPAL; PLASTICITY	Traumatic brain injury (TBI) represents a major public health problem, which is associated with neurological dysfunction. In severe or moderate cases of TBI, in addition to its high mortality rate, subjects may encounter diverse behavioral dysfunctions. Previous reports suggest that an association between TBI and chronic pain syndromes tends to be more common in patients with mild forms of brain injury. Despite causing minimal brain damage, mild TBI (mTBI) often leads to persistent psychologically debilitating symptoms, which can include anxiety, various forms of memory and learning deficits, and depression. At present, no effective treatment options are available for these symptoms, and little is known about the complex cellular activity affecting neuronal activity that occurs in response to TBI during its late phase. Here, we used a mouse model to investigate the effect of Palmitoylethanolamide (PEA) on both the sensorial and neuropsychiatric dysfunctions associated with mTBI through behavioral, electrophysiological, and biomolecular approaches. Fourteen-day mTBI mice developed anxious, aggressive, and reckless behavior, whilst depressive-like behavior and impaired social interactions were observed from the 60th day onward. Altered behavior was associated with changes in interleukin 1 beta (IL-1 beta) expression levels and neuronal firing activity in the medial prefrontal cortex. Compared with vehicle, PEA restored the behavioral phenotype and partially normalized the biochemical and functional changes occurring at the supraspinal level. In conclusion, our findings reveal some of the supraspinal modifications responsible for the behavioral alterations associated with mTBI and suggest PEA as a pharmacological tool to ameliorate neurological dysfunction induced by the trauma.	[Guida, Francesca; Boccella, Serena; Iannotta, Monica; De Gregorio, Danilo; Giordano, Catia; Belardo, Carmela; Romano, Rosaria; Palazzo, Enza; de Novellis, Vito; Rossi, Francesco; Maione, Sabatino; Luongo, Livio] Univ Campania Luigi Vanvitelli Ex SUN, Dept Expt Med, Sect Pharmacol L Donatelli, Naples, Italy; [Guida, Francesca; Maione, Sabatino; Luongo, Livio] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy; [Scafuro, Maria A.] Univ Campania Luigi Vanvitelli Ex SUN, Dept Anesthesiol Surg & Emergency, Naples, Italy; [Serra, Nicola] Univ Campania Luigi Vanvitelli Ex SUN, Dept Radiol, Naples, Italy; [Luongo, Livio] Young Pain YAP Italian Grp, Naples, Italy		Maione, S; Luongo, L (corresponding author), Univ Campania Luigi Vanvitelli Ex SUN, Dept Expt Med, Sect Pharmacol L Donatelli, Naples, Italy.; Maione, S; Luongo, L (corresponding author), CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy.; Luongo, L (corresponding author), Young Pain YAP Italian Grp, Naples, Italy.	sabatino.maione@unina2.it; livio.luongo@gmail.com	De Gregorio, Danilo/AAC-2010-2022	De Gregorio, Danilo/0000-0002-8623-0661; Maione, Sabatino/0000-0003-3850-6704; Serra, Nicola/0000-0001-8086-6362	fund "Ricerca di Ateneo"	This study is supported by the fund "Ricerca di Ateneo" 2014 of LL.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Apps R, 2015, NAT REV NEUROSCI, V16, P642, DOI 10.1038/nrn4028; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Cordaro M, 2016, MOL PHARMACOL, V90, P549, DOI 10.1124/mol.116.105668; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Cuzzocrea S, 2012, FASEB J, V26; D'Agostino G, 2015, MOL METAB, V4, P528, DOI 10.1016/j.molmet.2015.04.005; del Rey A, 2013, BRAIN BEHAV IMMUN, V33, P15, DOI 10.1016/j.bbi.2013.05.011; FAGNI L, 1987, EXP BRAIN RES, V65, P513; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Floresco SB, 2007, J NEUROSCI, V27, P2045, DOI 10.1523/JNEUROSCI.5474-06.2007; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gabbott PLA, 2006, NEUROSCIENCE, V139, P1039, DOI 10.1016/j.neuroscience.2006.01.026; Gao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22490; Giordano C, 2012, CEREB CORTEX, V22, P2495, DOI 10.1093/cercor/bhr328; Guida F, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0139-5; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Ishikawa A, 2003, J NEUROSCI, V23, P9987; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Lampa J, 2012, P NATL ACAD SCI USA, V109, P12728, DOI 10.1073/pnas.1118748109; Laviolette SR, 2006, J NEUROSCI, V26, P6458, DOI 10.1523/JNEUROSCI.0707-06.2006; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Luongo L, 2013, CNS NEUROL DISORD-DR, V12, P45, DOI 10.2174/1871527311312010009; Luongo L, 2013, NEUROPHARMACOLOGY, V66, P317, DOI 10.1016/j.neuropharm.2012.05.047; Mann Aniv, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P209, DOI 10.1515/jbcpp-2015-0092; Mannelli LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128080; Martinez-Vargas M, 2013, INT J MOL SCI, V14, P23341, DOI 10.3390/ijms141223341; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; Mori F, 2014, NEUROMOL MED, V16, P38, DOI 10.1007/s12017-013-8249-7; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nistico R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0162; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; PEREZJARANAY JM, 1991, BRAIN RES, V564, P97, DOI 10.1016/0006-8993(91)91357-7; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Simone Donald A., 2008, Shengli Xuebao, V60, P635; Skaper SD, 2013, MOL NEUROBIOL, V48, P340, DOI 10.1007/s12035-013-8487-6; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Vialou V, 2014, J NEUROSCI, V34, P3878, DOI 10.1523/JNEUROSCI.1787-13.2014; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	54	31	32	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	MAR 6	2017	8								95	10.3389/fphar.2017.00095			14	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EM5ZU	WOS:000395393400001	28321191	gold, Green Published			2022-02-06	
J	Khan, F; Amatya, B; Galea, MP; Gonzenbach, R; Kesselring, J				Khan, Fary; Amatya, Bhasker; Galea, Mary P.; Gonzenbach, Roman; Kesselring, Jurg			Neurorehabilitation: applied neuroplasticity	JOURNAL OF NEUROLOGY			English	Article						Neurological disorder; Rehabilitation; Neuroplasticity; Disability	MULTIPLE-SCLEROSIS; BRAIN PLASTICITY; REHABILITATION; STROKE; DISABILITY; NEUROLOGY; PROGRAM; INJURY	The prevalence of disability due to neurological conditions is escalating worldwide. Neurological disorders have significant disability-burden with long-term functional and psychosocial issues, requiring specialized rehabilitation services for comprehensive management, especially treatments tapping into brain recovery 'neuroplastic' processes. Neurorehabilitation is interdisciplinary and cross-sectorial, requiring coordinated effort of diverse sectors, professions, patients and community to manage complex condition-related disability. This review provides evidence for a range of neurorehabilitation interventions for four common neurological conditions: multiple sclerosis (MS), stroke, traumatic brain injury and Parkinson's disease using the Grade of Recommendation, Assessment, Development and Evaluation tool for quality of evidence. Although, existing best-evidence for many interventions is still sparse, the overall findings suggest 'strong' evidence for physical therapy and psychological intervention for improved patient outcomes; and. 'moderate' evidence for multidisciplinary rehabilitation for longer term gains at the levels of activity (disability) and participation in MS and stroke population. The effect of other rehabilitation interventions is inconclusive, due to a paucity of methodologically robust studies. More research is needed to improve evidence-base for many promising rehabilitation interventions.	[Khan, Fary; Amatya, Bhasker; Galea, Mary P.] Royal Melbourne Hosp, Dept Rehabil Med, 34-54 Poplar Rd, Parkville, Vic 3052, Australia; [Khan, Fary; Amatya, Bhasker; Galea, Mary P.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Grattan St, Parkville, Vic, Australia; [Khan, Fary] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Gonzenbach, Roman; Kesselring, Jurg] Rehabil Ctr, Dept Neurol & Neurorehabil, Valens, Switzerland		Khan, F (corresponding author), Royal Melbourne Hosp, Dept Rehabil Med, 34-54 Poplar Rd, Parkville, Vic 3052, Australia.; Khan, F (corresponding author), Univ Melbourne, Dept Med, Royal Melbourne Hosp, Grattan St, Parkville, Vic, Australia.; Khan, F (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	fary.khan@mh.org.au	Amatya, Bhasker/E-1062-2017; Galea, Mary/F-4242-2010; Kesselring, Jurg/AAN-5783-2020	Amatya, Bhasker/0000-0003-4793-1104; Galea, Mary/0000-0003-0045-7978; 			American Psychological Association, 2016, ROAD RES; Aziz NA, 2008, COCHRANE DB SYST REV, V2; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Barclay-Goddard R. E., 2011, COCHRANE DB SYST REV, V5; Bennett M, 2004, COCHRANE DB SYST REV, V1; Bennett M.H., 2004, COCHRANE DB SYST REV, V4; BOURBONNAIS D, 1989, AM J OCCUP THER, V43, P313, DOI 10.5014/ajot.43.5.313; Bowen A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub3; BRADT J, 2010, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD006787.PUB2; Braun K, 2011, DEV MED CHILD NEUROL, V53, P14, DOI 10.1111/j.1469-8749.2011.04056.x; Burke D, 1988, Adv Neurol, V47, P401; Cheng D, 2015, COCHRANE DB SYST REV, V6; Chung CSY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008391.pub2; Corbetta D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004433.pub3; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; das Nair R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008754.pub2; De Wit L, 2005, STROKE, V36, P1977, DOI 10.1161/01.STR.0000177871.59003.e3; Dekker JJ, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003608, 10.1002/14651858.CD003608, 10.1002/14651858CD003608]; Demetrios M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009689.pub2; Den Hertog HM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001247.pub2; DIETZ V, 1983, EXP NEUROL, V79, P680, DOI 10.1016/0014-4886(83)90032-8; Dixon L, 2007, COCHRANE DB SYST REV, V3; Dobkin BH, 2013, CURR OPIN NEUROL, V26, P602, DOI 10.1097/WCO.0000000000000026; Elbers RG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010925.pub2; Elsner B, 2013, COCHRANE DB SYST REV, V6; Elsner B, 2015, COCHRANE DB SYST REV, V5; Elsner B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009645.pub2; English C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007513.pub2; Farinotti M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004192.pub3; Fletcher-Smith JC, 2013, COCHRANE DB SYST REV, V6; Frasca Diana, 2013, Front Hum Neurosci, V7, P31, DOI 10.3389/fnhum.2013.00031; Freedman MS, 2011, NEUROLOGY, V76, pS26, DOI 10.1212/WNL.0b013e318205051d; French B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006073.pub2; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Galea M, 2016, J REHABIL MED, V48, P522, DOI 10.2340/16501977-2087; George S, 2014, COCHRANE DB SYST REV, V2; Guo TZ, 2014, J PAIN, V15, P1033, DOI 10.1016/j.jpain.2014.07.004; Hao ZL, 2013, SAO PAULO MED J, V131, P440, DOI [10.1590/1516-3180.20131316T2, 10.1002/14651858.CD008862.pub2]; Hassett LM, 2008, COCHRANE DB SYST REV, V2, P1; Heine M, 2015, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD009956.PUB2; Herd CP, 2012, COCHRANE DB SYST REV, V8; Herd CP, 2012, COCHRANE DB SYST REV, V8; Jagannath VA, 2010, COCHRANE DB SYST REV, V12; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Khan F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006036.pub2; Khan F, 2015, EUR J PHYS REHAB MED, V51, P311; Khan F, 2015, COCHRANE DB SYST REV, V4; Khan F, 2010, COCHRANE DB SYST REV, V10; Khan F, 2015, PHYS MED REHABIL INT, V2, P1070; Khan F, 2009, COCHRANE DB SYST REV, V1; Khan F., 2013, INNOV RES CHEM, V1, P1; Khan F, 2016, J REHABIL MED, V48, P417, DOI 10.2340/16501977-2081; Khan F, 2010, J REHABIL MED, V42, P708, DOI 10.2340/16501977-0592; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Kolb B, 2012, DEV PSYCHOBIOL, V54, P311, DOI 10.1002/dev.20515; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Krakauer JW, 2005, SEMIN NEUROL, V25, P384, DOI 10.1055/s-2005-923533; Lane-Brown A, 2009, COCHRANE DB SYST REV, V2; Laver KE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010255.pub2; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Loetscher T, 2013, COCHRANE DB SYST REV, V5; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Medical Research Council, 2000, FRAM DEV EV RCTS COM; Mehrholz J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub2; Mehrholz J, 2011, COCHRANE DB SYST REV, V1; Mehrholz J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007830.pub4; Mehrholz J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002840.pub3; Mehrholz J, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006876.pub3, 10.1002/14651858.CD006876.pub4]; Melzack R, 1989, CHALLENGE PAIN; Nair RD, 2007, COCHRANE DB SYST REV, V3; Pajaro-Blazquez M, 2013, AM J PHYS MED REH S1, V92, pe1; Pang TYC, 2013, NEUROPHARMACOLOGY, V64, P515, DOI 10.1016/j.neuropharm.2012.06.029; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Pollock A, 2014, COCHRANE DB SYST REV, V5; Prokopenko M, 2009, HFSP J, V3, P287, DOI 10.1080/19552068.2009.9635816; Qiu TM, 2014, J NEUROL NEUROSUR PS, V85, P99, DOI 10.1136/jnnp-2013-304956; Rietberg MB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003980.pub2; Rosti-Otajarvi EM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009131.pub3; Royal College of Physicians National Council for Palliative Care British Society of Rehabilitation Medicine, 2008, CONCISE GUIDANCE GOO, V10; Saunders DH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub5; Saxena M, 2014, COCHRANE DB SYST REV, V8; SCHIERHOUT G, 2000, COCHRANE DB SYST REV, V2; Rabert MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009097.pub2; Soo C, 2007, COCHRANE DB SYST REV, V3; States RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006075.pub2; Stifani N, 2014, FRONT CELL NEUROSCI, V8, P1, DOI 10.3389/fncel.2014.00293; Thieme H, 2012, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD008449.PUB2; Thomson P, 2006, CAMBRIDGE INTRO LIT, P1, DOI [10.2277/ 0521542510, 10.1002/14651858.CD004431.pub2]; Tomlinson CL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002815.pub2; Tomlinson CL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002817.pub4; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Turner-Stokes L, 2008, CLIN MED, V8, P186, DOI 10.7861/clinmedicine.8-2-186; Turner-Stokes L, 2007, CLIN MED, V7, P129, DOI 10.7861/clinmedicine.7-2-129; van der Putten JJMF, 1999, J NEUROL NEUROSUR PS, V66, P480, DOI 10.1136/jnnp.66.4.480; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Winter J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006609.pub2; World Health Organization, 2007, INT CLASS FUNCT DIS; Xiao Y, 2012, COCHRANE DB SYST REV, V5; Yin D, 2015, INT J NEUROREHABILIT, V2, P151	103	31	33	2	32	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	MAR	2017	264	3					603	615		10.1007/s00415-016-8307-9			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EN6RV	WOS:000396132000028	27778158				2022-02-06	
J	Lu, KT; Huang, TC; Tsai, YH; Yang, YL				Lu, Kwok-Tung; Huang, Tai-Chun; Tsai, Ya-Hsin; Yang, Yi-Ling			Transient receptor potential vanilloid type 4 channels mediate Na-K-Cl-co-transporter-induced brain edema after traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						brain edema; mitogen-activated protein kinases cascade; NKCC1; traumatic brain injury; TRPV4	CORTICAL IMPACT INJURY; PROTEIN-KINASE-C; CATION CHANNEL; ACTIVATE TRPV4; EXPRESSION; RATS; NEURONS; CYCLOOXYGENASE-2; DAMAGE; MODEL	Na+-K+-2Cl(-) co-transporter (NKCC1) plays an important role in traumatic brain injury (TBI)-induced brain edema via the MAPK cascade. The transient receptor potential vanilloid type 4 (TRPV4) channel participates in neurogenic inflammation, pain transmission, and edema. In this study, we investigated the relationship between NKCC1 and TRPV4 and the related signaling pathways in TBI-induced brain edema and neuronal damage. TBI was induced by the calibrated weight-drop device. Adult male Wistar rats were randomly assigned into sham and experimental groups for time-course studies of TRPV4 expression after TBI. Hippocampal TRPV4, NKCC1, MAPK, and PI-3K cascades were analyzed by western blot, and brain edema was also evaluated among the different groups. Expression of hippocampal TRPV4 peaked at 8h after TBI, and phosphorylation of the MAPK cascade and Akt was significantly elevated. Administration of either the TRPV4 antagonist, RN1734, or NKCC1 antagonist, bumetanide, significantly attenuated TBI-induced brain edema through decreasing the phosphorylation of MEK, ERK, and Akt proteins. Bumetanide injection inhibited TRPV4 expression, which suggests NKCC1 activation is critical to TRPV4 activation. Our results showed that hippocampal NKCC1 activation increased TRPV4 expression after TBI and then induced severe brain edema and neuronal damage through activation of the MAPK cascade and Akt-related signaling pathway.	[Lu, Kwok-Tung; Huang, Tai-Chun; Tsai, Ya-Hsin] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Yang, Yi-Ling] Natl Chiayi Univ, Inst Biochem Sci & Technol, Chiayi, Taiwan		Yang, YL (corresponding author), Natl Chiayi Univ, Inst Biochem Sci & Technol, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw			Ministry of Science and Technology (MOST), Taiwan	This study was supported by the Ministry of Science and Technology (MOST), Taiwan. There is no conflict of interest to declare.	Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Alexander R, 2013, BRIT J PHARMACOL, V168, P761, DOI 10.1111/j.1476-5381.2012.02186.x; AMANN R, 1990, EUR J PHARMACOL, V186, P169, DOI 10.1016/0014-2999(90)90430-E; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; BULLOCK R, 1990, ACT NEUR S, V51, P286; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Fichna J, 2012, NEUROGASTROENT MOTIL, V24, pe557, DOI 10.1111/j.1365-2982.2012.01999.x; Fu Y, 2006, AM J PHYSIOL-RENAL, V290, pF1305, DOI 10.1152/ajprenal.00391.2005; Gradilone SA, 2010, GASTROENTEROLOGY, V139, P304, DOI 10.1053/j.gastro.2010.04.010; Grunnet M, 2005, BBA-BIOMEMBRANES, V1714, P114, DOI 10.1016/j.bbamem.2005.05.012; Guilak F, 2010, ANN NY ACAD SCI, V1192, P404, DOI 10.1111/j.1749-6632.2010.05389.x; Kraus JF, 1996, OCCUP MED, V11, P201; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Li L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00017; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lipski J, 2006, BRAIN RES, V1077, P187, DOI 10.1016/j.brainres.2006.01.016; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2015, PFLUG ARCH EUR J PHY, V467, P1651, DOI 10.1007/s00424-014-1588-x; Ma YY, 2008, BIOL PHARM BULL, V31, P426, DOI 10.1248/bpb.31.426; Mackrell PJ, 2001, SURGERY, V130, P826, DOI 10.1067/msy.2001.116669; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; O'Donnell ME, 2006, J CEREBR BLOOD F MET, V26, P1234, DOI 10.1038/sj.jcbfm.9600278; Panet R, 2006, J CELL PHYSIOL, V206, P578, DOI 10.1002/jcp.20506; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Stroop R, 1998, ACT NEUR S, V71, P303; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; Unterberg AW, 1997, ACT NEUR S, V70, P106; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Weiss B, 1997, NEUROCHEM INT, V31, P321, DOI 10.1016/S0197-0186(96)00105-2; Yan ZP, 2004, CELL IMMUNOL, V232, P116, DOI 10.1016/j.cellimm.2005.03.001	49	31	31	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2017	140	5					718	727		10.1111/jnc.13920			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EM8OX	WOS:000395571900004	27926982	Bronze			2022-02-06	
J	Randall, D; Thomas, M; Whiting, D; McGrath, A				Randall, Diane; Thomas, Matt; Whiting, Diane; McGrath, Andrew			Depression Anxiety Stress Scales (DASS-21): Factor Structure in Traumatic Brain Injury Rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; confirmatory factor analysis; construct validity; depression; Depression Anxiety Stress Scales (DASS-21); structural equation modeling; traumatic brain injury	CONCUSSION SYMPTOMS QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; NORMATIVE DATA; PSYCHIATRIC-DISORDERS; HOSPITAL ANXIETY; PERCENTILE NORMS; FIT INDEXES; INDIVIDUALS; VALIDITY; VERSION	Objective: To confirm the construct validity of the Depression Anxiety Stress Scales-21 (DASS-21) by investigating the fit of published factor structures in a sample of adults with moderate to severe traumatic brain injury (posttraumatic amnesia > 24 hours). Participants: Archival data from 504 patient records at the Brain Injury Rehabilitation Unit at Liverpool Hospital, Australia. Participants were aged between 16 and 71 years and were engaged in a specialist rehabilitation program. Main Measure: The DASS-21. Results: Two of the 6 models had adequate fit using structural equation modeling. The data best fit Henry and Crawford's quadripartite model, which comprised a Depression, Anxiety and Stress factor, as well as a General Distress factor. The data also adequately fit Lovibond and Lovibond's original 3-factor model, and the internal consistencies of each factor were very good (alpha = 0.82-0.90). Conclusion: This study confirms the structure and construct validity of the DASS-21 and provides support for its use as a screening tool in traumatic brain injury rehabilitation.	[Randall, Diane; Thomas, Matt; McGrath, Andrew] Charles Sturt Univ, Bathurst, NSW, Australia; [Whiting, Diane] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool, Australia		Thomas, M (corresponding author), Charles Sturt Univ, Bathurst, NSW, Australia.	mathomas@csu.edu.au	McGrath, Andrew/AAJ-1648-2020; Whiting, Diane/AAN-2522-2021	McGrath, Andrew/0000-0001-9249-0219; Whiting, Diane/0000-0003-1912-6626			A.B.o. Statistics, 2007, NAT SURV MENT HLTH W; AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arbuckle J.L, 2010, IBM SPSS AMOS 19 USE; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bottesi G, 2015, COMPR PSYCHIAT, V60, P170, DOI 10.1016/j.comppsych.2015.04.005; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown M.W., 1993, SOCIOL METHOD RES, P136; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Byrne BM., 2013, STRUCTURAL EQUATION; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; Crawford J, 2011, AUST PSYCHOL, V46, P3, DOI 10.1111/j.1742-9544.2010.00003.x; Crawford JR, 2009, BRIT J CLIN PSYCHOL, V48, P163, DOI 10.1348/014466508X377757; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Daza P, 2002, J PSYCHOPATHOL BEHAV, V24, P195, DOI 10.1023/A:1016014818163; Deb S, 1999, AM J PSYCHIAT, V156, P374; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; First MB, 2002, COMMUNICATION; FORTUNE N, 1999, DEFINITION INCIDENCE; Gloster AT, 2011, PSYCHOL ASSESSMENT, V23, P970, DOI 10.1037/a0024135; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Helps Y., 2008, HOSP SEPARATIONS DUE; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kline R. B, 2009, BECOMING BEHAV SCI R; Linhart H, 1986, MODEL SELECTION, V27; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; O'Rance L., 2007, DISABILITY AUSTR ACQ; Osman A, 2012, J CLIN PSYCHOL, V68, P1322, DOI 10.1002/jclp.21908; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Psychology Foundation of Australia, 2016, DEPR ANX STRESS SCAL; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; S/rbom, 1981, ANAL LINEAR STRUCTUR; Schumacker R.E., 2010, BEGINNERS GUIDE STRU, V3rd ed.; Sinclair SJ, 2012, EVAL HEALTH PROF, V35, P259, DOI 10.1177/0163278711424282; Skilbeck C, 2011, BRAIN IMPAIR, V12, P22, DOI 10.1375/brim.12.1.22; Snaith R., 1994, HOSP ANXIETY DEPRESS; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Tully PJ, 2009, J ABNORM CHILD PSYCH, V37, P717, DOI 10.1007/s10802-009-9306-4; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Ullman JB, 2013, USING MULIVARIATE ST; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; West S. G., 1995, STRUCTURAL EQUATION, P56, DOI DOI 10.1037/0008-400X.26.2.210; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662	66	31	32	1	25	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					134	144		10.1097/HTR.0000000000000250			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700015	27455437				2022-02-06	
J	Michailidou, I; Naessens, DMP; Hametner, S; Guldenaar, W; Kooi, EJ; Geurts, JJG; Baas, F; Lassmann, H; Ramaglia, V				Michailidou, Iliana; Naessens, Daphne M. P.; Hametner, Simon; Guldenaar, Willemijn; Kooi, Evert-Jan; Geurts, Jeroen J. G.; Baas, Frank; Lassmann, Hans; Ramaglia, Valeria			Complement C3 on Microglial Clusters in Multiple Sclerosis Occur in Chronic but Not Acute Disease: Implication for Disease Pathogenesis	GLIA			English	Article						microglia; pathology; lesions	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; SYSTEMIC INFLAMMATION; LESIONS; ACTIVATION; HETEROGENEITY; EXPRESSION; ANTIBODIES; RECOVERY; ABILITY	Microglial clusters with C3d deposits are observed in the periplaque of multiple sclerosis (MS) brains and were proposed as early stage of lesion formation. As such they should appear in the brain of MS donors with acute disease but thus far this has not been shown. Using postmortem brain tissue from acute (n=10) and chronic (n=15) MS cases we investigated whether C3d+ microglial clusters are part of an acute attack against myelinated axons, which could have implications for disease pathogenesis. The specificity of our findings to MS was tested in ischemic stroke cases (n=8) with initial or advanced lesions and further analyzed in experimental traumatic brain injury (TBI, n=26), as both conditions are primarily nondemyelinating but share essential features of neurodegeneration with MS lesions. C3d+ microglial clusters were found in chronic but not acute MS. They were not associated with antibody deposits or terminal complement activation. They were linked to slowly expanding lesions, localized on axons with impaired transport and associated with neuronal C3 production. C3d+ microglial clusters were not specific to MS as they were also found in stroke and experimental TBI. We conclude that C3d+ microglial clusters in MS are not part of an acute attack against myelinated axons. As such it is unlikely that they drive formation of new lesions but could represent a physiological mechanism to remove irreversibly damaged axons in chronic disease.	[Michailidou, Iliana; Naessens, Daphne M. P.; Baas, Frank; Ramaglia, Valeria] Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 Amsterdam, Netherlands; [Hametner, Simon; Lassmann, Hans] Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria; [Guldenaar, Willemijn; Kooi, Evert-Jan; Geurts, Jeroen J. G.] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, De Boelelaan 1118, NL-1081 Amsterdam, Netherlands		Ramaglia, V (corresponding author), Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 Amsterdam, Netherlands.	v.ramaglia@amc.uva.nl	Lassmann, Hans/Z-2269-2019; Baas, Frank/F-9574-2010	Lassmann, Hans/0000-0001-8617-5052; Baas, Frank/0000-0003-3912-5428; Naessens, Daphne/0000-0001-7898-2559; Michailidou, Iliana/0000-0001-6196-4944	Boehringer Ingelheim FondsBoehringer Ingelheim; Stichting MS Research travel grant [ES63]; National Multiple Sclerosis Society grantNational Multiple Sclerosis Society [RG 4775A1/1]; Brain Foundation of the Netherlands Fellowship [F2010(1)-05]	This work was funded by the Boehringer Ingelheim Fonds travel grant to I.M.; the Stichting MS Research travel grant no. ES63 to I.M.; the National Multiple Sclerosis Society grant no. RG 4775A1/1 to F.B. and V.R.; the Brain Foundation of the Netherlands Fellowship F2010(1)-05 to V.R.	Barnett MH, 2009, ANN NEUROL, V65, P32, DOI 10.1002/ana.21524; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Groot CJA, 2001, BRAIN, V124, P1635, DOI 10.1093/brain/124.8.1635; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Frischer JM, 2015, ANN NEUROL, V78, P710, DOI 10.1002/ana.24497; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Geurts JJG, 2012, LANCET NEUROL, V11, P1082, DOI 10.1016/S1474-4422(12)70230-2; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; King G, 1997, J PATHOL, V183, P237, DOI 10.1002/(SICI)1096-9896(199710)183:2<237::AID-PATH893>3.0.CO;2-0; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lassmann H, 2015, NEUROINFLAMMATION: NEW INSIGHTS INTO BENEFICIAL AND DETRIMENTAL FUNCTIONS, P3; Li YF, 2015, J BIOL CHEM, V290, P11918, DOI 10.1074/jbc.M115.645903; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Lipscomb DC, 1998, STROKE, V29, P487, DOI 10.1161/01.STR.29.2.487; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Liu GJ, 2009, EUR J NEUROSCI, V29, P1108, DOI 10.1111/j.1460-9568.2009.06659.x; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Marburg O., 1906, JB PSYCHIAT NEUROL, V27, P211; Mena H, 2004, ACTA NEUROPATHOL, V108, P524, DOI 10.1007/s00401-004-0918-z; Metz I, 2014, ANN NEUROL, V75, P728, DOI 10.1002/ana.24163; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Misu T, 2013, ACTA NEUROPATHOL, V125, P815, DOI 10.1007/s00401-013-1116-7; Moreno B, 2011, ANN NEUROL, V70, P932, DOI 10.1002/ana.22550; Nakajima K, 2001, NEUROSCI LETT, V307, P171, DOI 10.1016/S0304-3940(01)01943-7; Nijland PG, 2014, GLIA, V62, P1125, DOI 10.1002/glia.22667; Palin K, 2008, NEUROBIOL DIS, V30, P19, DOI 10.1016/j.nbd.2007.11.012; Peferoen LAN, 2015, J NEUROPATH EXP NEUR, V74, P48, DOI 10.1097/NEN.0000000000000149; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; PIDDLESDEN SJ, 1993, AM J PATHOL, V143, P555; Prineas JW, 2001, ANN NEUROL, V50, P646, DOI 10.1002/ana.1255; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Singh S, 2013, ACTA NEUROPATHOL, V125, P595, DOI 10.1007/s00401-013-1082-0; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; van der Valk P, 2009, CURR OPIN NEUROL, V22, P207, DOI 10.1097/WCO.0b013e32832b4c76; van Horssen J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-156; van Noort JM, 2010, J NEUROPATH EXP NEUR, V69, P694, DOI 10.1097/NEN.0b013e3181e4939c; VANGURI P, 1982, P NATL ACAD SCI-BIOL, V79, P3290, DOI 10.1073/pnas.79.10.3290	50	31	31	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	FEB	2017	65	2					264	277		10.1002/glia.23090			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK1ER	WOS:000393669100004	27778395	Green Published, hybrid			2022-02-06	
J	Wang, R; Seifert, P; Jakobs, TC				Wang, Rui; Seifert, Philip; Jakobs, Tatjana C.			Astrocytes in the Optic Nerve Head of Glaucomatous Mice Display a Characteristic Reactive Phenotype	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						astrocytes; glial lamina; glaucoma; electron microscopy; confocal microscopy	ELEVATED INTRAOCULAR-PRESSURE; RETROGRADE AXOPLASMIC-TRANSPORT; INDUCED OCULAR HYPERTENSION; RETINAL GANGLION-CELLS; LAMINA-CRIBROSA; DBA/2J MICE; RAT GLAUCOMA; MOUSE MODEL; INHERITED GLAUCOMA; AXONAL-TRANSPORT	PURPOSE. Optic nerve head astrocytes, a subtype of white-matter astrocytes, become reactive early in the course of glaucoma. It was shown recently that in the DBA/2J mouse model of inherited glaucoma optic nerve astrocytes extend new longitudinal processes into the axon bundles before ganglion cell loss becomes apparent. The present study aims at testing whether this behavior of astrocytes is typical of early glaucomatous damage. METHODS. Mice expressing green fluorescent protein in individual astrocytes were used to evaluate the early response of astrocytes in the glial lamina of the optic nerve head after increasing the IOP using the microbead occlusion method. Tissue sections from the glial lamina were imaged consecutively by confocal and electron microscopy. RESULTS. Confocal and electron microscope images show that astrocytes close to the myelination transition zone in the hypertensive nerve heads extend new processes that follow the longitudinal axis of the optic nerve and invade axon bundles in the nerve head. Ultrastructurally, the longitudinal processes were largely devoid of subcellular organelles except for degenerating mitochondria. CONCLUSIONS. The longitudinal processes are a common feature of glaucomatous optic nerve astrocytes, whereas they are not observed after traumatic nerve injury. Thus, astrocytes appear to fine-tune their responses to the nature and/or timing of the injury to the neurons that they surround.	[Wang, Rui] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Wang, Rui; Seifert, Philip; Jakobs, Tatjana C.] Harvard Med Sch, Schepens Eye Res Inst, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA USA		Jakobs, TC (corresponding author), Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	Tatjana_Jakobs@meei.harvard.edu		Wang, Rui/0000-0002-8246-3433; Jakobs, Tatjana/0000-0002-8104-9206	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2R01EY019703, R01EY022092, P30EY003790]; Chinese Scholarship CouncilChina Scholarship Council; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY022092, P30EY014104, R01EY019703, P30EY003790] Funding Source: NIH RePORTER	Supported by NIH Grants 2R01EY019703 and R01EY022092, the NIH Core Grant for vision research P30EY003790, and grants from the Chinese Scholarship Council and Research to Prevent Blindness.	Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Balaratnasingam C, 2008, BRAIN RES, V1244, P142, DOI 10.1016/j.brainres.2008.09.044; Baltan S, 2010, J NEUROSCI, V30, P5644, DOI 10.1523/JNEUROSCI.5956-09.2010; Bosco A, 2016, EXP EYE RES, V150, P34, DOI 10.1016/j.exer.2016.01.014; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Cone FE, 2012, EXP EYE RES, V99, P27, DOI 10.1016/j.exer.2012.04.006; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; Cooper ML, 2016, EXP EYE RES, V150, P22, DOI 10.1016/j.exer.2015.11.016; Coughlin L, 2015, INVEST OPHTH VIS SCI, V56, P1437, DOI 10.1167/iovs.14-16126; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Dai C, 2012, GLIA, V60, P13, DOI 10.1002/glia.21242; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Gao S, 2016, AM J PATHOL, V186, P985, DOI 10.1016/j.ajpath.2015.11.026; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Howell GR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-429; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; JOHANSSON JO, 1986, EXP EYE RES, V43, P653, DOI 10.1016/S0014-4835(86)80031-8; JOHANSSON JO, 1983, INVEST OPHTH VIS SCI, V24, P1552; JOHANSSON JO, 1988, EXP EYE RES, V46, P223, DOI 10.1016/S0014-4835(88)80079-4; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Johnson EC, 2015, INVEST OPHTH VIS SCI, V56, P412, DOI 10.1167/iovs.14-15094; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Kiumehr S, 2012, ARCH OPHTHALMOL-CHIC, V130, P552, DOI 10.1001/archopthalmol.2011.1309; Li RX, 2008, MOL VIS, V14, P745; Li Y, 2015, GLIA, V63, P1537, DOI 10.1002/glia.22825; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; May CA, 2006, ACTA NEUROPATHOL, V111, P158, DOI 10.1007/s00401-005-0011-2; May CA, 2002, INVEST OPHTH VIS SCI, V43, P2206; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; Morcos Y, 2000, J NEUROCYTOL, V29, P665, DOI 10.1023/A:1010835404754; MORRISON J, 1995, EXP EYE RES, V60, P127, DOI 10.1016/S0014-4835(95)80002-6; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Morrison JC, 2008, PROG BRAIN RES, V173, P285, DOI 10.1016/S0079-6123(08)01121-7; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Nolte C, 2001, GLIA, V33, P72; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; Ramirez AI, 2010, INVEST OPHTH VIS SCI, V51, P5690, DOI 10.1167/iovs.10-5248; Rojas B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-133; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Sigal IA, 2014, BRIT J OPHTHALMOL, V98, P34, DOI 10.1136/bjophthalmol-2013-304751; Soto I, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017269; Soto I, 2011, INVEST OPHTH VIS SCI, V52, P434, DOI 10.1167/iovs.10-5856; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P9431, DOI 10.1167/iovs.11-7922; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Tehrani S, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14969; Varela HJ, 1997, J GLAUCOMA, V6, P303; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448	69	31	32	0	3	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	FEB	2017	58	2								10.1167/iovs.16-20571			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EO8LC	WOS:000396939600028	28170536	Green Submitted, Green Published, gold			2022-02-06	
J	Fazio, RL; Denning, JH; Denney, RL				Fazio, Rachel L.; Denning, John H.; Denney, Robert L.			TOMM Trial 1 as a performance validity indicator in a criminal forensic sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						Forensic neuropsychology; malingering; performance validity; response bias; Test of Memory Malingering	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; ALBANY CONSISTENCY INDEX; RESPONSE BIAS SCALE; CLASSIFICATION ACCURACY; MENTAL-RETARDATION; COLLEGE-STUDENTS; RETENTION TRIAL; TEST FAILURE; WORD MEMORY	Objective: To determine the effectiveness of the Test of Memory Malingering Trial 1 (TOMM1) as a freestanding Performance Validity Test (PVT) as compared to the full TOMM in a criminal forensic sample. Method: Participants included 119 evaluees in a Midwestern forensic hospital. Criterion groups were formed based on passing/failing scores on other freestanding PVTs. This resulted in three groups: +MND (Malingered Neurocognitive Dysfunction), who failed two or more freestanding PVTs; possible MND (pMND), who failed one freestanding PVT; and -MND, who failed no other freestanding PVTs. All three groups were compared initially, but only+MND and -MND groups were retained for final analyses. TOMM1 performance was compared to standard TOMM performance using Receiver Operating Characteristic (ROC) analyses. Results: TOMM1 was highly predictive of the standard TOMM decision rules (AUC=.92). Overall accuracy rate for TOMM1 predicting failure on 2 PVTs was quite robust as well (AUC=.80), and TOMM139 provided acceptable diagnostic statistics (Sensitivity=.68, Specificity=.89). These results were essentially no different from the standard TOMM accuracy statistics. In addition, by adjusting for those strongly suspected of being inaccurately placed into the -MND group (e.g. false negatives), TOMM1 diagnostics slightly improved (AUC=.84) at a TOMM140 (sensitivity=.71, specificity=.94). Conclusions: Results support use of TOMM1 in a criminal forensic setting where accuracy, shorter evaluation times, and more efficient use of resources are often critical in informing legal decision-making.	[Fazio, Rachel L.] Carter Psychol Ctr, Bradenton, FL 34207 USA; [Denning, John H.] Ralph H Johnson VA Med Ctr, Charleston, SC USA; [Denning, John H.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA; [Denney, Robert L.] Neuropsychol Associates Southwest Missouri, Springfield, MO USA		Fazio, RL (corresponding author), Carter Psychol Ctr, Bradenton, FL 34207 USA.	rlfazio@gmail.com					Allen R., 1997, MANUAL COMPUTERIZED; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P147, DOI 10.1080/23279095.2014.880842; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Benitez A, 2011, ARCH CLIN NEUROPSYCH, V26, P184, DOI 10.1093/arclin/acr001; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Buddin WH, 2014, CLIN NEUROPSYCHOL, V28, P525, DOI 10.1080/13854046.2014.906658; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Davis JJ, 2012, ARCH CLIN NEUROPSYCH, V27, P706, DOI 10.1093/arclin/acs078; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Denning JH, 2014, APPL NEUROPSYCH-ADUL, V21, P269, DOI 10.1080/23279095.2013.811076; Dennis Richard, 2008, CLIN NEUROPSYCHOLOGY, P1; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Fazio RL, 2015, ARCH CLIN NEUROPSYCH, V30, P293, DOI 10.1093/arclin/acv024; Frederick R. I., 2004, VALIDITY INDICATOR P; Frederick RI, 1998, CLIN NEUROPSYCHOL, V12, P193, DOI 10.1076/clin.12.2.193.2006; Gottfried E, 2016, ASSESSMENT, V23, P672, DOI 10.1177/1073191115599640; Graue LO, 2007, CLIN NEUROPSYCHOL, V21, P929, DOI 10.1080/13854040600932137; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green P, 2004, GREENS MED SYMPTOM V; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P117, DOI 10.1016/j.acn.2005.06.009; Gunner JH, 2012, ARCH CLIN NEUROPSYCH, V27, P1, DOI 10.1093/arclin/acr089; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heyanka DJ, 2015, ARCH CLIN NEUROPSYCH, V30, P369, DOI 10.1093/arclin/acv025; Jasinski LJ, 2011, CLIN NEUROPSYCHOL, V25, P1415, DOI 10.1080/13854046.2011.630024; Johnstone L, 2003, BRIT J CLIN PSYCHOL, V42, P303, DOI 10.1348/01446650360703401; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kaufmann PM, 2009, CLIN NEUROPSYCHOL, V23, P1130, DOI 10.1080/13854040903107809; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lindstrom WA, 2009, ARCH CLIN NEUROPSYCH, V24, P659, DOI 10.1093/arclin/acp071; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McCaffrey R.J., 2003, J FORENSIC NEUROPSYC, V3, P45, DOI [https://doi.org/10.1300/J151v03n03_03, DOI 10.1300/J151V03N03_03]; Morgan J. E., 2009, NEUROPSYCHOLOGY MALI; Mossman D, 2012, PSYCHOL ASSESSMENT, V24, P815, DOI 10.1037/a0028195; Musso MW, 2011, ARCH CLIN NEUROPSYCH, V26, P756, DOI 10.1093/arclin/acr078; Nelson N.W., 2013, MILD TRAUMATIC BRAIN, P119; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Rey A, 1958, LEXAMEN CLINIQUE PSY; Robles L., 2015, J CLIN EXPT NEUROPSY, P1; Rogers R., 1992, COMMUNICATION; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Salazar X.F., 2007, ASSESSMENT FEIGNED C, P405; Schroeder RW, 2013, ARCH CLIN NEUROPSYCH, V28, P21, DOI 10.1093/arclin/acs094; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Stenclik JH, 2013, APPL NEUROPSYCH-ADUL, V20, P243, DOI 10.1080/09084282.2012.704603; Strutt AM, 2012, BRAIN INJURY, V26, P853, DOI 10.3109/02699052.2012.655366; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh T. N., 2002, DETECTION RESPONSE B, P69; Weinborn M, 2003, J CLIN EXP NEUROPSYC, V25, P979, DOI 10.1076/jcen.25.7.979.16481; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; Whitney KA, 2013, ARCH CLIN NEUROPSYCH, V28, P222, DOI 10.1093/arclin/act012; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	78	31	31	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	1					251	267		10.1080/13854046.2016.1213316			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EK2VR	WOS:000393785300016	27456971				2022-02-06	
J	Gardner, AJ; Howell, DR; Levi, CR; Iverson, GL				Gardner, Andrew J.; Howell, David R.; Levi, Christopher R.; Iverson, Grant L.			Evidence of Concussion Signs in National Rugby League Match Play: a Video Review and Validation Study	SPORTS MEDICINE-OPEN			English	Article						Concussion; Video analysis; Injury management; Return to play	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; PROLONGED RECOVERY; PREDICTORS; SEVERITY; FOOTBALL	Background: Many professional sports have introduced sideline video review to help recognise concussions. The reliability and validity of identifying clinical and observable signs of concussion using video analysis has not been extensively explored. This study examined the reliability and validity of clinical signs of concussion using video analysis in the National Rugby League (NRL). Methods: All 201 professional NRL matches from the 2014 season were reviewed to document six signs of possible concussion (unresponsiveness, slow to get up, clutching/shaking head, gait ataxia, vacant stare, and seizure). Results: A total of 127,062 tackles were reviewed. Getting up slowly was the most common observable sign (2240 times in the season, 1.8% of all tackles) but only 223 times where it appeared to be a possible concussion (0.2% of all tackles and 10.0% of the times it occurred). Additionally, clutching/shaking the head occurred 361 times (on 212 occasions this sign appeared to be due to a possible concussion), gait ataxia was observed 102 times, a vacant stare was noted 98 times, unresponsiveness 52 times, and a possible seizure 4 times. On 383 occasions, one or more of the observable signs were identified and deemed associated with a possible concussion. There were 175 incidences in which a player appeared to demonstrate two or more concussion signs, and 54 incidences where a player appeared to demonstrate three or more concussion signs. A total of 60 diagnosed concussions occurred, and the concussion interchange rule was activated 167 times. Intra-rater reliability (kappa = 0.65-1.00) was moderate to perfect for all six video signs; however, the inter-rater reliability was not as strong (kappa = 0.22-0.76). Most of the signs had relatively low sensitivity (0.18-0.75), but high specificity (0.85-1.00). Conclusions: Using video replay, observable signs of concussion appear to be sensitive to concussion diagnoses when reviewing known injuries among professional rugby league players. When reviewing an entire season, however, certain signs occur very commonly and did not identify concussion. Thus, the implementation of video review in the NRL is challenging, but can provide a useful addition to sideline concussion identification and removal from play decisions.	[Gardner, Andrew J.; Levi, Christopher R.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Levi, Christopher R.] John Hunter Hosp, Hunter New England Local Hlth Dist Sports Concuss, Newcastle, NSW, Australia; [Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.] Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Boston, MA USA; [Howell, David R.] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Iverson, Grant L.] Harvard Med Sch, Ctr Hlth & Rehabil, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sport Concuss Program, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Gardner, Andrew J.] Calvary Mater Hosp, Prior Res Ctr Stroke & Brain Injury, Level 5,McAuley Bldg, Waratah, NSW 2298, Australia		Gardner, AJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Callaghan, NSW, Australia.; Gardner, AJ (corresponding author), Calvary Mater Hosp, Prior Res Ctr Stroke & Brain Injury, Level 5,McAuley Bldg, Waratah, NSW 2298, Australia.	Andrew.Gardner@neurogard.com.au		Levi, Christopher/0000-0002-9474-796X; Iverson, Grant/0000-0001-7348-9570; Gardner, Andrew/0000-0001-5031-5586	Hunter Medical Research Institute (HMRI)	Funding was provided by Hunter Medical Research Institute (HMRI) supported by Anne Greaves.	Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chermann JF, 2014, ASIAN J SPORTS MED, V5; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Davis G, 2016, J SCI MED SPORT; Echemendia RJ, 2017, BRIT J SPORT MED; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Gardner A, 2014, BRIT J SPORT MED; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0093-0; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Gardner AW, 2016, INT J VASC MED, V2016, DOI 10.1155/2016/2191350; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hutchison MG, 2014, BRIT J SPORT MED, V48, P125, DOI 10.1136/bjsports-2012-092059; IBM Corp, IBM SPSS STAT MAC VE; Kohler R, 2017, BR J SPORTS MED, V51, pA78; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Makdissi M, 2016, J SCI MED SPORT; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Savage J, 2013, J SPORTS MED; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	41	31	32	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open		2017	3								29	10.1186/s40798-017-0097-9			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VI8CR	WOS:000514830000028	28831759	Green Published, gold			2022-02-06	
J	Phillips, NL; Mandalis, A; Benson, S; Parry, L; Epps, A; Morrow, A; Lah, S				Phillips, Natalie Lynette; Mandalis, Anna; Benson, Suzanne; Parry, Louise; Epps, Adrienne; Morrow, Angie; Lah, Suncica			Computerized Working Memory Training for Children with Moderate to Severe Traumatic Brain Injury: A Double-Blind, Randomized, Placebo-Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						cognitive training; pediatric; randomized controlled trial; traumatic brain injury; working memory	COGNITIVE REHABILITATION; ADHD; ADOLESCENTS; ATTENTION; DEFICITS; OUTCOMES; LIFE	Pediatric traumatic brain injury (TBI) places children at risk for deficits in working memory (WM; comprising a central executive [CE], and two storage systems: phonological loop [PL] and visuospatial sketchpad [VSSP]), which is strongly related to attention and academic skills in childhood. This study aimed to examine whether different components of WM can be improved following adaptive WM training (Cogmed) and whether improvements in WM generalize to other cognitive (attention) and academic skills (reading and mathematics) in children with TBI. Twenty-seven children with moderate to severe TBI were randomized to adaptive (Cogmed; n = 13) or non-adaptive training (active placebo; n = 14) and evaluated at baseline, post-training, and 3-months follow-up. Three children in the adaptive group and one child in the non-adaptive group withdrew from the study before completion of training. Complete case (CC) and intention-to-treat (ITT) analyses were conducted. Children in the adaptive group demonstrated significantly greater gains on select WM tasks (VSSP, but not PL or CE) from pre-to post-training (pre-post) and pre-training to follow-up (pre-follow-up; CC and ITT analyses). No gains were found on tests of attention. Adaptive training resulted in significantly greater gains on select academic skills (reading, but not mathematics): reading comprehension pre-post-training (ITT analyses) and reading accuracy pre-follow-up (CC and ITT analyses). This first, to our knowledge, study to examine the efficacy of adaptive WM training for children with TBI provides preliminary evidence of near and far transfer of training to WM and academic skills, respectively.	[Phillips, Natalie Lynette; Lah, Suncica] Univ Sydney, Sch Psychol, Brennan MacCallum Bldg A18, Sydney, NSW 2006, Australia; [Phillips, Natalie Lynette; Lah, Suncica] ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Mandalis, Anna; Parry, Louise] Sydney Childrens Hosp Randwick, Dept Psychol, Sydney, NSW, Australia; [Parry, Louise; Epps, Adrienne] Sydney Childrens Hosp Randwick, Brain Injury Rehabil Program, Sydney, NSW, Australia; [Benson, Suzanne; Morrow, Angie] Childrens Hosp Westmead, Kids Rehab, Sydney, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol, Brennan MacCallum Bldg A18, Sydney, NSW 2006, Australia.	suncica.lah@sydney.edu.au		Lah, Suncica/0000-0003-2282-4812; Phillips, Natalie/0000-0001-7505-9670	Australian Postgraduate Award scholarship from the Australian Government; University of Sydney Thompson Fellowship	Natalie Philips was supported by an Australian Postgraduate Award scholarship from the Australian Government. Suncica Lah was in part supported by the University of Sydney Thompson Fellowship.	Akerlund E, 2013, BRAIN INJURY, V27, P1649, DOI 10.3109/02699052.2013.830195; Alloway T., 2007, AUTOMATED WORKING ME; Alloway TP, 2013, J COGN PSYCHOL, V25, P84, DOI 10.1080/20445911.2012.748027; Alloway TP, 2010, BRIT J EDUC PSYCHOL, V80, P567, DOI 10.1348/000709910X494566; Astle DE, 2015, J NEUROSCI, V35, P6277, DOI 10.1523/JNEUROSCI.4517-14.2015; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bergman-Nutley S, 2014, PSYCHOL RES-PSYCH FO, V78, P869, DOI 10.1007/s00426-014-0614-0; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; BROWN DSO, 1991, SOC SCI MED, V33, P283, DOI 10.1016/0277-9536(91)90362-G; Catroppa C, 2015, BRAIN INJURY, V29, P1317, DOI 10.3109/02699052.2015.1043345; Chacko A, 2014, J CHILD PSYCHOL PSYC, V55, P247, DOI 10.1111/jcpp.12146; Dahlin K.I., 2013, J ED LEARNING, V2, P118, DOI [DOI 10.5539/JEL.V2N1P118, https://doi.org/10.5539/jel.v2n1p118, 10.5539/jel.v2n1p118]; Dunning DL, 2014, MEM COGNITION, V42, P854, DOI 10.3758/s13421-014-0410-5; Dunning DL, 2013, DEVELOPMENTAL SCI, V16, P915, DOI 10.1111/desc.12068; Efird J, 2011, INT J ENV RES PUB HE, V8, P15, DOI 10.3390/ijerph8010015; Egeland J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075660; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Friso-van den Bos I, 2013, EDUC RES REV-NETH, V10, P29, DOI 10.1016/j.edurev.2013.05.003; Gathercole, 2003, ED CHILD PSYCHOL, V20 (3), P123; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; Gray SA, 2012, J CHILD PSYCHOL PSYC, V53, P1277, DOI 10.1111/j.1469-7610.2012.02592.x; Hellgren L., 2015, OPEN J THERAPY REHAB, V3, P46, DOI [DOI 10.4236/OJTR.2015.32007, 10.4236/ojtr.2015.32007]; Holmes J, 2014, EDUC PSYCHOL-UK, V34, P440, DOI 10.1080/01443410.2013.797338; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Manly T., 1999, TEST EVERYDAY ATTENT; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Phillips N. L., 2015, CHILD NEUROPSYCHOL; Roberts G, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2015.4568; Sattler J. M., 2004, ASSESSMENT CHILDREN; Schuchardt K, 2008, J LEARN DISABIL-US, V41, P514, DOI 10.1177/0022219408317856; Shatil E, 2003, J EXP CHILD PSYCHOL, V86, P1, DOI 10.1016/S0022-0965(03)00106-1; Shipstead Z, 2015, ATTEN PERCEPT PSYCHO, V77, P1863, DOI 10.3758/s13414-015-0899-0; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Soderqvist S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01711; Spencer-Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119522; Stevens M. C., 2015, BRAIN IMAGING BEHAV, P3; TEASDALE G, 1974, LANCET, V2, P81; van Dongen-Boomsma M, 2014, J CHILD PSYCHOL PSYC, V55, P886, DOI 10.1111/jcpp.12218; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wechsler D., 2005, WECHSLER INDIVIDUAL, V2nd; Wechsler D, 2003, WECHSLER INTELLIGENC; Weicker J., 2015, NEUROPSYCHOLOGIA, P3; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	56	31	33	0	22	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2097	2104		10.1089/neu.2015.4358			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800005	27050628				2022-02-06	
J	Sparvero, LJ; Amoscato, AA; Fink, AB; Anthonymuthu, T; New, LA; Kochanek, PM; Watkins, S; Kagan, VE; Bayir, H				Sparvero, Louis J.; Amoscato, Andrew A.; Fink, Arthur B.; Anthonymuthu, Tamil; New, Lee Ann; Kochanek, Patrick M.; Watkins, Simon; Kagan, Valerian E.; Bayir, Hulya			Imaging mass spectrometry reveals loss of polyunsaturated cardiolipins in the cortical contusion, hippocampus, and thalamus after traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						cardiolipin; hippocampus; imaging mass spectrometry; lipids; thalamus; traumatic brain injury	SPINAL-CORD-INJURY; IMPROVES MITOCHONDRIAL-FUNCTION; CYTOSOLIC PHOSPHOLIPASE A(2); ARACHIDONIC-ACID METABOLISM; ALPHA-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; RAT-BRAIN; NUTRITIONAL DEPRIVATION; ANTIOXIDANT THERAPIES; OXIDATIVE LIPIDOMICS	Traumatic brain injury (TBI) leads to changes in ion fluxes, alterations in mitochondrial function, and increased generation of reactive oxygen species, resulting in secondary tissue damage. Mitochondria play important signaling rolesincoordination of multiple metabolic platforms in addition to their well-known role in bioenergetics. Mitochondrial signaling strongly depends on cardiolipin (CL), a mitochondria-specific structurally unusual anionic phospholipid containing four fatty acyl chains. While our previous reports indicated that CL is selectively oxidized and presents itself as a target for the redox therapy following TBI, the topography of changes of CL in the injured brain remained to be defined. Here, we present a matrix-assisted laser desorption/ionization imaging study which reports regio-specific changes in CL, in a controlled cortical impact model of TBI in rats. Matrix-assisted laser desorption/ionization imaging revealed that TBI caused early decreases in CL in the contusional cortex, ipsilateral hippocampus, and thalamus with the most highly unsaturated CL species being most susceptible to loss. Phosphatidylinositol was the only other lipid species that exhibited a significant decrease, albeit to a lesser extent than CL. Signals for other lipids remained unchanged. Thisis the first study evaluating the spatial distribution of CL loss after acute brain injury. We propose that the CL loss may constitute an upstream mechanism for CL-driven signaling in different brain regions as an early response mechanism and may also underlie the bioenergetic changes that occur in hippocampal, cortical, and thalamic mitochondria after TBI.	[Sparvero, Louis J.; Amoscato, Andrew A.; Fink, Arthur B.; Kagan, Valerian E.; Bayir, Hulya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Sparvero, Louis J.; Amoscato, Andrew A.; Fink, Arthur B.; Kagan, Valerian E.; Bayir, Hulya] Univ Pittsburgh, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA USA; [Anthonymuthu, Tamil; New, Lee Ann; Kochanek, Patrick M.; Bayir, Hulya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Anthonymuthu, Tamil; New, Lee Ann; Kochanek, Patrick M.; Bayir, Hulya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Watkins, Simon] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA		Bayir, H (corresponding author), Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kagan, VE (corresponding author), Bridgeside Point,100 Technol Dr,Room 330, Pittsburgh, PA 15219 USA.	kagan@pitt.edu; bayihx@ccm.upmc.edu	Anthonymuthu, Tamil/I-5534-2019; Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Amoscato, Andrew/0000-0002-1340-9150; Kagan, Valerian E./0000-0002-7245-1885	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ES020693, U19AIO68021, NS076511, NS061817]; NIOSHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [OH008282]; Fulbright Canada; UPCI Cancer Biomarkers Facility [P30CA047904];  [U54 GM103529 08];  [WH81XWH-10-1-0623];  [WH81XWH-14-2-0018]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES020693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM103529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061817, R01NS076511] Funding Source: NIH RePORTER	This work was supported by NIH: ES020693, U19AIO68021, NS076511, NS061817; NIOSH OH008282; U54 GM103529 08 (SCW); partial support from Fulbright Canada (VEK); WH81XWH-10-1-0623 and WH81XWH-14-2-0018 (PMK). This project used the UPCI Cancer Biomarkers Facility that is supported in part by award P30CA047904. The authors declare no competing financial interests.	Amoscato AA, 2014, ANAL CHEM, V86, P6587, DOI 10.1021/ac5011876; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bazan N. G., 1992, ADV NEUROCHEM, V7, P321; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Bazan NG, 2006, CELL MOL NEUROBIOL, V26, P901, DOI 10.1007/s10571-006-9064-6; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen C, 2005, PROSTAG OTH LIPID M, V77, P65, DOI 10.1016/j.prostaglandins.2005.07.001; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Contreras MA, 2000, J NEUROCHEM, V75, P2392, DOI 10.1046/j.1471-4159.2000.0752392.x; DeMar JC, 2004, J NEUROCHEM, V91, P1125, DOI 10.1111/j.1471-4159.2004.02789.x; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Farooqui AA, 2000, NEUROSCIENTIST, V6, P169, DOI 10.1177/107385840000600308; Farooqui AA, 2010, MOL NEUROBIOL, V41, P267, DOI 10.1007/s12035-009-8091-y; Faul M, 2010, TRAUMATIC BRAIN INJU; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; HIRASHIMA Y, 1992, J NEUROCHEM, V59, P708, DOI 10.1111/j.1471-4159.1992.tb09426.x; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Igarashi M, 2007, J LIPID RES, V48, P152, DOI 10.1194/jlr.M600396-JLR200; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kim C, 2008, BMB REP, V41, P555, DOI 10.5483/BMBRep.2008.41.8.555; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Lee H, 2004, J NEUROCHEM, V91, P936, DOI 10.1111/j.1471-4159.2004.02786.x; Lee HJ, 2008, J LIPID RES, V49, P162, DOI 10.1194/jlr.M700406-JLR200; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; McEwen ML, 2011, NEUROTHERAPEUTICS, V8, P168, DOI 10.1007/s13311-011-0031-7; Mejia EM, 2016, J BIOENERG BIOMEMBR, V48, P99, DOI 10.1007/s10863-015-9601-4; Mejia EM, 2015, BIOCHEM J, V471, P123, DOI 10.1042/BJ20150648; Mejia Edgard M., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P98; Mejia EM, 2014, CHEM PHYS LIPIDS, V179, P11, DOI 10.1016/j.chemphyslip.2013.10.001; Mitchell RW, 2009, BBA-BIOMEMBRANES, V1788, P2015, DOI 10.1016/j.bbamem.2009.06.002; Mu XJ, 2002, J NEUROTRAUM, V19, P917, DOI 10.1089/089771502320317078; MURPHY EJ, 1994, MOL CHEM NEUROPATHOL, V23, P13, DOI 10.1007/BF02858504; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Paxinos G, 1982, RAT BRAIN STEROTAXIC; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Race AM, 2012, J PROTEOMICS, V75, P5111, DOI 10.1016/j.jprot.2012.05.035; Rapoport SI, 1999, NEUROCHEM RES, V24, P1403, DOI 10.1023/A:1022584707352; Rapoport SI, 2001, J MOL NEUROSCI, V16, P243, DOI 10.1385/JMN:16:2-3:243; Rapoport SI, 2001, J LIPID RES, V42, P678; Rapoport SI, 2008, J NUTR, V138, P2515, DOI 10.1093/jn/138.12.2515; Robertson CL, 2004, DEV BRAIN RES, V151, P141, DOI 10.1016/j.devbrainres.2004.04.007; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Robichaud G, 2013, J AM SOC MASS SPECTR, V24, P718, DOI 10.1007/s13361-013-0607-z; Rosca M, 2011, BBA-BIOENERGETICS, V1807, P1373, DOI 10.1016/j.bbabio.2011.02.003; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; SAUNDERS RD, 1987, J NEUROCHEM, V49, P24, DOI 10.1111/j.1471-4159.1987.tb03388.x; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schramm T, 2012, J PROTEOMICS, V75, P5106, DOI 10.1016/j.jprot.2012.07.026; Singh I. N., 2006, J CEREB BLOOD FLOW M, V26, P1; Sparvero LJ, 2012, CHEM PHYS LIPIDS, V165, P545, DOI 10.1016/j.chemphyslip.2012.06.001; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Stys P. K., 1999, J NEUROTRAUM, V16, P984; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Taylor WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048628; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; Tyurina Y. Y., 2014, NAT CHEM, V26, P1407; Vaishnav RA, 2010, J NEUROTRAUM, V27, P1311, DOI 10.1089/neu.2009.1172; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winge DR, 2012, MOL CELL BIOL, V32, P2647, DOI 10.1128/MCB.00573-12; Wirtz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018897; Wolfe L. S., 1994, EICOSANOIDS BASIC NE, P475; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Xu FY, 2010, BBA-BIOMEMBRANES, V1798, P1577, DOI 10.1016/j.bbamem.2010.04.007; Xu Y, 2014, CHEM PHYS LIPIDS, V179, P17, DOI 10.1016/j.chemphyslip.2013.10.005	107	31	31	0	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	NOV	2016	139	4					659	675		10.1111/jnc.13840			17	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EC1DD	WOS:000387842800013	27591733	Green Accepted			2022-02-06	
J	Li, Q; Yu, P; Zeng, QT; Luo, B; Cai, SQ; Hui, KL; Yu, G; Zhu, CS; Chen, XD; Duan, ML; Sun, XJ				Li, Qian; Yu, Pan; Zeng, Qiuting; Luo, Bing; Cai, Shenquan; Hui, Kangli; Yu, Gao; Zhu, Changsong; Chen, Xingdong; Duan, Manlin; Sun, Xuejun			Neuroprotective Effect of Hydrogen-Rich Saline in Global Cerebral Ischemia/Reperfusion Rats: Up-Regulated Tregs and Down-Regulated miR-21, miR-210 and NF-kappa B Expression	NEUROCHEMICAL RESEARCH			English	Article						Global cerebral ischemia/reperfusion; Neuroprotection; Hydrogen; Regulatory T cells; MiRNA; Immuno-inflammatory response	TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; MOLECULAR-HYDROGEN; OXIDATIVE DAMAGE; PROSTATE-CANCER; CARDIAC-ARREST; T-CELLS; PROTECTS; MODEL; INFLAMMATION	Recently, it has been suggested that molecular hydrogen (H-2) can selectively reduce the levels of hydroxyl radicals (.OH), and ameliorate oxidative and inflammatory injuries to organs in global cerebral ischemia reperfusion models. Global cerebral ischemia/reperfusion (I/R) can induce a sudden activation of inflammatory cytokines and later influence the systemic immunoreactivity which may contribute to a worse outcome. Regulatory T cells (Tregs) are involved in several pathological aspects of cerebral I/R. In addition, miRNA took part in the processes of cellular response to hypoxia. Since the expression of a specific set of miRNA called "hypoxamirs" is upregulated by hypoxia. Therefore, the aim of this study was to analyze the effect of HRS on I/R inducing cerebral damage, Tregs, and specific miRNA. Our results showed that rats undergone global cerebral I/R and treated with HRS have milder injury than I/R animals without HRS treatment. miR-210 expression in the hippocampus of the I/R group at 6, 24 and 96 h after reperfusion was significantly increased at each time point, while its expression in the group treated with HRS was significantly decreased. In addition, Tregs number in group I/R was decreased at each time points, while its number in the group treated with HRS was increased at 24 and 96 h after reperfusion. We focus on the relationship among Tregs, TGF-beta 1, TNF-alpha and NF-kappa B at 24 h, and we found that there is a high correlation among them. Therefore, our results indicated that the brain resuscitation mechanism in the HRS-treated rats may be related with the effect of upregulating the number of Treg cells.	[Li, Qian; Luo, Bing; Cai, Shenquan; Hui, Kangli; Yu, Gao; Zhu, Changsong; Chen, Xingdong; Duan, Manlin] Jinling Hosp, Dept Anesthesia, 305 Zhongshan East Rd, Nanjing 210002, Jiangsu, Peoples R China; [Yu, Pan] Jinling Hosp, Dept Burn & Plast Surg, 305 Zhongshan East Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zeng, Qiuting] Southeast Univ, Zhongda Hosp, Dept Anesthesia, 87 Hunan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Sun, Xuejun] Second Mil Med Univ, Fac Naval Med, Dept Naval Aeromed, Shanghai 200433, Peoples R China		Chen, XD; Duan, ML (corresponding author), Jinling Hosp, Dept Anesthesia, 305 Zhongshan East Rd, Nanjing 210002, Jiangsu, Peoples R China.	mengguren_cxd@163.com; dml9001@163.com	sun, xuejun/A-5561-2010	sun, xuejun/0000-0003-2387-5531	Medical technology innovation Foundation of Nanjing Military [MS120]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401602]; Medical Technology Foundation of the PLA [CNJ13J006]; Medical Foundation of Nanjing General Hospital of Nanjing Military Command [2015069]	This research was supported by the Medical technology innovation Foundation of Nanjing Military (MS120, 2013), the National Natural Science Foundation of China (No. 81401602), the Medical Technology Foundation of the PLA (No. CNJ13J006) and Medical Foundation of Nanjing General Hospital of Nanjing Military Command (No. 2015069).	Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Albertsmeier M, 2007, RESUSCITATION, V74, P552, DOI 10.1016/j.resuscitation.2007.01.040; Assadiasl S, 2014, IRAN J IMMUNOL, V11, P139, DOI IJIv11i3A1; Bik W, 2008, NEUROENDOCRINOL LETT, V29, P359; Cai JM, 2009, BRAIN RES, V1256, P129, DOI 10.1016/j.brainres.2008.11.048; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chang LL, 2011, BRAIN BEHAV IMMUN, V25, P260, DOI 10.1016/j.bbi.2010.09.017; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Cui YM, 2014, J SURG RES, V192, P564, DOI 10.1016/j.jss.2014.05.060; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.427, 10.1002/iub.00427]; Fayyad-Kazan H, 2012, J BIOL CHEM, V287, P9910, DOI 10.1074/jbc.M111.337154; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Ha Tai-You, 2011, Immune Netw, V11, P135, DOI [10.4110/in.2011.11.1.11, 10.4110/in.2011.11.3.135]; Han L, 2015, BRAIN RES, V1615, P129, DOI 10.1016/j.brainres.2015.04.038; Harms H, 2011, CEREBROVASC DIS, V32, P552, DOI 10.1159/000331922; Hayashida K, 2014, CIRCULATION, V130, P2173, DOI 10.1161/CIRCULATIONAHA.114.011848; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Ji Q, 2011, SURG RES, V168, P95; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Jiang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117982; Lee JC, 2015, FREE RADICAL BIO MED, V79, P78, DOI 10.1016/j.freeradbiomed.2014.11.022; Liu J, 2012, CHIN J TRAUMATOL, V15, P13, DOI 10.3760/cma.j.issn.1008-1275.2012.01.003; Liu P, 2013, CLIN TRANSL ONCOL, V15, P741, DOI 10.1007/s12094-012-0999-4; Lu L, 2012, ACTA PHARMACOL SIN, V33, P531, DOI 10.1038/aps.2011.180; Ma L., 2015, ANN OPER RES, V2015, P1, DOI DOI 10.11817/J.ISSN.1672-7347.2015.11.002]; Mano Y, 2014, FREE RADICAL BIO MED, V69, P324, DOI 10.1016/j.freeradbiomed.2014.01.037; Mei Y, 2013, J CELL BIOCHEM, V114, P1374, DOI 10.1002/jcb.24479; Merlo A, 2012, J CLIN ENDOCR METAB, V97, pE2194, DOI 10.1210/jc.2012-2410; Miko I, 2010, CLIN HEMORHEOL MICRO, V45, P281, DOI 10.3233/CH-2010-1307; Nakao A, 2010, J HEART LUNG TRANSPL, V29, P544, DOI 10.1016/j.healun.2009.10.011; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Pulsinelli WA, 1988, STROKE, V199, P13; Quero L, 2011, RADIOTHER ONCOL, V101, P203, DOI 10.1016/j.radonc.2011.05.063; Singhal AB, 2008, STROKE, V39, P289, DOI 10.1161/STROKEAHA.107.511485; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sun HY, 2011, J HEPATOL, V54, P471, DOI 10.1016/j.jhep.2010.08.011; Tian RF, 2016, BRAIN RES, V1637, P1, DOI 10.1016/j.brainres.2016.01.029; Toda S, 2002, ACTA NEUROCHIR, V144, P1297, DOI 10.1007/s00701-002-1010-x; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Wang Y, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0110-3; Xu WH, 2012, J CLIN IMMUNOL, V32, P975, DOI 10.1007/s10875-012-9685-0; Yang L.-X., 2012, DISCRETE DYN NAT SOC, V2012, P1, DOI DOI 10.1186/1471-2229-13-53; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046	47	31	35	3	13	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	OCT	2016	41	10					2655	2665		10.1007/s11064-016-1978-x			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA1TY	WOS:000386376000016	27386874	Green Published, hybrid			2022-02-06	
J	Rigon, A; Turkstra, L; Mutlu, B; Duff, M				Rigon, Arianna; Turkstra, Lyn; Mutlu, Bilge; Duff, Melissa			The female advantage: sex as a possible protective factor against emotion recognition impairment following traumatic brain injury	COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE			English	Article						Traumatic brain injury; Emotion recognition; Facial affect recognition; Sex difference	FACIAL AFFECT RECOGNITION; SOCIAL COGNITION; EXPRESSION; PERCEPTION; DEFICITS; CHILDREN; ADULTS; IDENTIFICATION; ADOLESCENTS; FRAMEWORK	Although moderate to severe traumatic brain injury (TBI) leads to facial affect recognition impairments in up to 39% of individuals, protective and risk factors for these deficits are unknown. The aim of the current study was to examine the effect of sex on emotion recognition abilities following TBI. We administered two separate emotion recognition tests (one static and one dynamic) to 53 individuals with moderate to severe TBI (females = 28) and 49 demographically matched comparisons (females = 22). We then investigated the presence of a sex-by-group interaction in emotion recognition accuracy. In the comparison group, there were no sex differences. In the TBI group, however, females significantly outperformed males in the dynamic (but not the static) task. Moreover, males (but not females) with TBI performed significantly worse than comparison participants in the dynamic task. Further analysis revealed that sex differences in emotion recognition abilities within the TBI group could not be explained by lesion location, TBI severity, or other neuropsychological variables. These findings suggest that sex may serve as a protective factor for social impairment following TBI and inform clinicians working with TBI as well as research on the neurophysiological correlates of sex differences in social functioning.	[Rigon, Arianna; Duff, Melissa] Univ Iowa, Interdisciplinary Neurosci Program, 420-1 Seashore Hall,328 Iowa Ave, Iowa City, IA 52242 USA; [Turkstra, Lyn] Univ Wisconsin, Dept Commun Sci & Disorders, 474 Goodnight Hall 1975 Willow Dr, Madison, WI 53706 USA; [Mutlu, Bilge] Univ Wisconsin, Dept Comp Sci, 1210 W Dayton St,Room 6381, Madison, WI 53706 USA; [Duff, Melissa] Univ Iowa, Dept Commun Sci & Disorders, Wendell Johnson Speech & Hearing Clin 121D, 250 Hawkins Dr, Iowa City, IA 52242 USA; [Duff, Melissa] Univ Iowa, Dept Neurol, 2007 Roy Carver Pavil,200 Hawkins Dr, Iowa City, IA 52242 USA		Rigon, A (corresponding author), Univ Iowa, Interdisciplinary Neurosci Program, 420-1 Seashore Hall,328 Iowa Ave, Iowa City, IA 52242 USA.	arianna-rigon@uiowa.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NICHD/NCMRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD071089]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	This work was supported by NICHD/NCMRR grant R01 HD071089.	Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Costa PJ, 2014, J BIOPHARM STAT, V24, P1115, DOI 10.1080/10543406.2014.926366; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Derogatis L, 1983, BRIEF SYMPTOM INVENT, V13, P595, DOI DOI 10.1017/S0033291700048017; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Farace E, 2000, Neurosurg Focus, V8, pe6; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martins AT, 2012, NEURAL REGEN RES, V7, P101, DOI 10.3969/j.issn.1673-5374.2012.02.004; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Merz CJ, 2012, SOC COGN AFFECT NEUR, V7, P819, DOI 10.1093/scan/nsr063; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Neumann D, 2016, BRAIN IMAGING BEHAV, V10, P569, DOI 10.1007/s11682-015-9415-3; Olson IR, 2013, SOC COGN AFFECT NEUR, V8, P123, DOI 10.1093/scan/nss119; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rigon A., 2015, J NEUROTRAUM, DOI [10.1089/neu.2014.3847, DOI 10.1089/NEU.2014.3847]; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Veroude K, 2014, SOC COGN AFFECT NEUR, V9, P513, DOI 10.1093/scan/nst015; Wehrle T, 2000, J PERS SOC PSYCHOL, V78, P105, DOI 10.1037/0022-3514.78.1.105; Weisenbach SL, 2014, SOC COGN AFFECT NEUR, V9, P316, DOI 10.1093/scan/nss137; Welborn BL, 2009, SOC COGN AFFECT NEUR, V4, P328, DOI 10.1093/scan/nsp028; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Willis ML, 2015, SOC COGN AFFECT NEUR, V10, P1677, DOI 10.1093/scan/nsv057; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Wood W, 2000, AM PSYCHOL, V55, P1062, DOI 10.1037/0003-066X.55.9.1062; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	54	31	32	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1530-7026	1531-135X		COGN AFFECT BEHAV NE	Cogn. Affect. Behav. Neurosci.	OCT	2016	16	5					866	875		10.3758/s13415-016-0437-0			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	DV6DV	WOS:000383022300008	27245826	Green Accepted, Bronze			2022-02-06	
J	Albrecht, JS; Hirshon, JM; McCunn, M; Bechtold, KT; Rao, V; Simoni-Wastila, L; Smith, GS				Albrecht, Jennifer S.; Hirshon, Jon Mark; McCunn, Maureen; Bechtold, Kathleen T.; Rao, Vani; Simoni-Wastila, Linda; Smith, Gordon S.			Increased Rates of Mild Traumatic Brain Injury Among Older Adults in US Emergency Departments, 2009-2010	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						emergency departments; mild traumatic brain injury; NHAMCS; older adults	ACCURACY; MORTALITY; OUTCOMES; VISITS; RISK	Objective: To estimate rates of emergency department (ED) visits for mild traumatic brain injury (TBI) among older adults. We defined possible mild TBI cases to assess underdiagnoses. Design: Cross-sectional. Setting: National sample of ED visits in 2009-2010 captured by the National Hospital Ambulatory Medical Care Survey. Participants: Aged 65 years and older. Measurements: Mild TBI defined by International Classification of Diseases, Ninth Revision, Clinical Modification, codes (800.0x-801.9x, 803. xx, 804. xx, 850. xx-854.1x, 950.1x-950.3x, 959.01) and a Glasgow Coma Scale score of 14 or more or missing, excluding those admitted to the hospital. Possible mild TBI was defined similarly among those without mild TBI and with a fall or motor vehicle collision as cause of injury. We calculated rates of mild TBI and examined factors associated with a diagnosis of mild TBI. Results: Rates of ED visits for mild TBI were 386 per 100 000 among those aged 65 to 74 years, 777 per 100 000 among those aged 75 to 84 years, and 1205 per 100 000 among those older than 84 years. Rates for women (706/100 000) were higher than for men (516/100 000). Compared with a possible mild TBI, a diagnosis of mild TBI was more likely in the West (odds ratio = 2.31; 95% confidence interval, 1.02-5.24) and less likely in the South/Midwest (odds ratio = 0.52; 95% confidence interval, 0.29-0.96) than in the Northeast. Conclusions: This study highlights an upward trend in rates of ED visits for mild TBI among older adults.	[Albrecht, Jennifer S.; Hirshon, Jon Mark; Smith, Gordon S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 S Pine St,MSTF 334C, Baltimore, MD 21201 USA; [Hirshon, Jon Mark] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA; [McCunn, Maureen] Univ Maryland, Sch Med, Dept Anesthesiol, Div Trauma Anesthesiol,R Adams Cowley Shock Traum, Baltimore, MD 21201 USA; [McCunn, Maureen] Univ Maryland, Sch Med, Dept Anesthesiol, Div Surg Crit Care,R Adams Cowley Shock Trauma Ct, Baltimore, MD 21201 USA; [Bechtold, Kathleen T.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Rao, Vani] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Simoni-Wastila, Linda] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Hirshon, Jon Mark; Smith, Gordon S.] Univ Maryland, Natl Study Ctr Trauma & Emergency Med Serv, Shock Trauma & Anesthesiol Res STAR Organized Res, Baltimore, MD 21201 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 S Pine St,MSTF 334C, Baltimore, MD 21201 USA.	jalbrecht@epi.umaryland.edu		Smith, Gordon/0000-0002-2911-3071; Albrecht, Jennifer/0000-0003-4838-2274	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12HD43489-13, R01AA18707]; DODUnited States Department of Defense [W81XWH-13-1-0469]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018707] Funding Source: NIH RePORTER	Dr Albrecht is supported by NIH grant K12HD43489-13. Dr Rao is supported by DOD grant W81XWH-13-1-0469. Dr Smith is supported by NIH grant R01AA18707.	Albrecht JS, 2015, J HEAD TRAUMA REHAB, V30, pE62, DOI 10.1097/HTR.0000000000000035; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; American College of Emergency Physicians/Centers for Disease Control and Prevention Panel to Revise the 2002 Clinical Policy, 2008, ANN EMERG MED, V52, P714; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Centers for Disease Control and Prevention, 2014, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention, AMB HLTH CAR SURV; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kamel H, 2013, J STROKE CEREBROVASC, V22, pE142, DOI 10.1016/j.jstrokecerebrovasdis.2012.09.016; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marr A., 2004, CENTRAL NERVOUS SYST; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; National Center for Injury Prevention and Control C. f. d. C. a. i. P., 2003, REP C MILD TRAUM BRA; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Scheetz LJ, 2011, AACN ADV CRIT CARE, V22, P128, DOI 10.1097/NCI.0b013e3182122c93; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; SVARSTAD BL, 1987, MED CARE, V25, P1089, DOI 10.1097/00005650-198711000-00007; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Vincent G. K., 2010, NEXT 4 DECADES OLDER; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307	40	31	31	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					E1	E7		10.1097/HTR.0000000000000190			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600001	26479396	Green Accepted			2022-02-06	
J	Palmer, BW; Harmell, AL				Palmer, Barton W.; Harmell, Alexandrea L.			Assessment of Healthcare Decision-making Capacity	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Schizophrenia; Alzheimer's disease	MILD COGNITIVE IMPAIRMENT; DIFFERENT LEGAL STANDARDS; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; MEDICAL DECISIONS; CLINICAL-RESEARCH; BIPOLAR DISORDER; INFORMED-CONSENT; OLDER PATIENTS	It is often necessary for neuropsychologists, clinical psychologists, and other healthcare professionals to assess an individual's capacity to consent to treatment related to healthcare. This task can be challenging and requires a delicate balance of both respect for individuals' autonomy, as well as the protection of individuals with diminished capacity to make an autonomous decision. The purpose of the present review is to provide an overview of the conceptual model of decisional capacity as well as a brief summary of some of the currently available instruments designed to help evaluate medical decision making. In addition, current empirical literature on the relationship between neuropsychological abilities and decision-making capacity is discussed and a brief set of recommendations is provided to further aid clinicians or consultants when they are required to complete the ethically important but difficult task of making determinations about healthcare decision-making capacity.	[Palmer, Barton W.; Harmell, Alexandrea L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Palmer, Barton W.] Vet Med Res Fdn, San Diego, CA USA; [Palmer, Barton W.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Palmer, Barton W.; Harmell, Alexandrea L.] Univ Calif San Diego, Stein Inst Res Aging, Ctr Hlth Aging, San Diego, CA 92093 USA; [Harmell, Alexandrea L.] San Diego State Univ, Univ Calif San Diego Joint Doctoral Program Clin, San Diego, CA 92182 USA		Palmer, BW (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,MC 0993, La Jolla, CA 92093 USA.	bpalmer@ucsd.edu	Palmer, Barton/ABA-7519-2020; Palmer, Barton/A-6030-2019	Palmer, Barton/0000-0002-7618-3144; Palmer, Barton/0000-0002-7618-3144	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG028827, R01MH097274, T32MH019934]; Department of Veterans AffairsUS Department of Veterans Affairs; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH097274, T32MH019934] Funding Source: NIH RePORTER	Supported, in part, by National Institutes of Health (R01AG028827, R01MH097274, and T32MH019934) and by the Department of Veterans Affairs.	Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Alvarez M. I., 2014, MED CLIN, V143, P201; Amalraj S, 2009, ONCOLOGY-NY, V23, P369; American Bar Association Commission on Law and Aging & American Psychological Association, 2008, ASS OLD AD DIM CAP H; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Bambara JK, 2007, EPILEPSY BEHAV, V10, P63, DOI 10.1016/j.yebeh.2006.10.003; BEAN G, 1994, CAN J PSYCHIAT, V39, P368, DOI 10.1177/070674379403900804; Beauchamp T., 2001, PRINCIPLES BIOMEDICA, V5th; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; Braun MM, 2009, GENERATIONS, V33, P78; Burton CZ, 2012, AM J GERIAT PSYCHIAT, V20, P306, DOI 10.1097/JGP.0b013e3182436987; Cairns R, 2005, BRIT J PSYCHIAT, V187, P379, DOI 10.1192/bjp.187.4.379; Carney MT, 2001, J CLIN ETHIC, V12, P17; Carpenter WT, 2000, ARCH GEN PSYCHIAT, V57, P533, DOI 10.1001/archpsyc.57.6.533; Cea CD, 2003, MENT RETARD, V41, P78, DOI 10.1352/0047-6765(2003)041<0078:HCDMBA>2.0.CO;2; CHAPMAN LJ, 1973, PSYCHOL BULL, V79, P380, DOI 10.1037/h0034541; Chapman LJ, 2001, J ABNORM PSYCHOL, V110, P31, DOI 10.1037/0021-843X.110.1.31; Cochrane Database of Systematic Reviews, 2015, WITHDR PUBL ACC ASS; da Silva RD, 2015, PSYCHIAT QUART, V86, P395, DOI 10.1007/s11126-015-9340-z; Doyle KL, 2016, J CLIN PSYCHOL MED S, V23, P135, DOI 10.1007/s10880-016-9455-x; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Dunn LB, 2006, AM J PSYCHIAT, V163, P1323, DOI 10.1176/appi.ajp.163.8.1323; Dunn LB., 2007, HUMAN FRONTAL LOBES, P335; Dymek MP, 2001, NEUROLOGY, V56, P17, DOI 10.1212/WNL.56.1.17; Edelstein B, 2000, J AGING STUD, V14, P423, DOI 10.1016/S0890-4065(00)80006-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gerstenecker A, 2016, ASSESSMENT, V23, P232, DOI 10.1177/1073191115599053; Gerstenecker A, 2015, CANCER-AM CANCER SOC, V121, P2013, DOI 10.1002/cncr.29326; Griffith HR, 2010, AGING NEUROPSYCHOL C, V17, P492, DOI 10.1080/13825581003646135; Grisso T, 1997, PSYCHIATR SERV, V48, P1415; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P127, DOI 10.1007/BF01499322; Grisso T., 1998, ASSESSING COMPETENCE; Grisso T., 1998, MACARTHUR COMPETENCE; Gurrera RJ, 2007, AM J GERIAT PSYCHIAT, V15, P168, DOI 10.1097/JGP.0b013e31802e705c; Gurrera RJ, 2014, AM J GERIAT PSYCHIAT, V22, P1200, DOI 10.1016/j.jagp.2013.03.010; Hafen B. C., 1976, BYU LAW REV, V605; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hein I. M., 2014, COCHRANE DATABASE SY; Jeste DV, 2008, J PSYCHIATR RES, V42, P1, DOI 10.1016/j.jpsychires.2006.10.004; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; Jurica P. L., 1991, DEMENTIA RATING SCAL; Karel MJ, 2010, J CLIN ETHIC, V21, P58; Karel MJ, 2000, J AGING STUD, V14, P403, DOI 10.1016/S0890-4065(00)80005-5; Kim SYH, 2011, ARCH GEN PSYCHIAT, V68, P214, DOI 10.1001/archgenpsychiatry.2010.191; Kitamura T, 2000, PSYCHIAT CLIN NEUROS, V54, P515, DOI 10.1046/j.1440-1819.2000.00746.x; Kontos N, 2015, PSYCHOSOMATICS, V56, P217, DOI 10.1016/j.psym.2014.11.004; Lamont S, 2013, J CLIN NURS, V22, P2387, DOI 10.1111/jocn.12215; Mackenzie C, 2013, INT J LAW CONTEXT, V9, P37, DOI 10.1017/S174455231200047X; Marson D., 1993, Journal of the American Geriatrics Society, V41, pSA43; Marson D, 1999, Semin Clin Neuropsychiatry, V4, P41; Marson DC, 2000, J AM GERIATR SOC, V48, P911, DOI 10.1111/j.1532-5415.2000.tb06887.x; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P955, DOI 10.1001/archneur.1995.00540340035011; Marson DC, 1996, NEUROLOGY, V46, P666, DOI 10.1212/WNL.46.3.666; Marson DC, 1997, J AM GERIATR SOC, V45, P453, DOI 10.1111/j.1532-5415.1997.tb05170.x; Marson DC, 2001, INT J LAW PSYCHIAT, V24, P267, DOI 10.1016/S0160-2527(01)00064-4; Martin RC, 2008, MOVEMENT DISORD, V23, P1867, DOI 10.1002/mds.22170; MATARAZZO JD, 1990, AM PSYCHOL, V45, P999, DOI 10.1037/0003-066X.45.9.999; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MOYE J, 1999, ADV MED PSYCHOTHERAP, V10, P71; Moye J, 2006, CLIN PSYCHOL REV, V26, P1054, DOI 10.1016/j.cpr.2005.04.013; Moye J, 2013, AM J GERIAT PSYCHIAT, V21, P326, DOI 10.1016/j.jagp.2012.09.001; Moye J, 2007, CLIN GERONTOLOGIST, V31, P37, DOI 10.1080/07317110802072140; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979, BELM REP ETH PRINC G; Norman D., 1980, ATTENTION ACTION WIL; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; O'Callaghan C, 2014, PSYCHO-ONCOLOGY, V23, P1391, DOI 10.1002/pon.3576; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Okonkwo OC, 2008, J INT NEUROPSYCH SOC, V14, P297, DOI 10.1017/S1355617708080338; Palmer B. W., 2012, CIVIL CAPACITIES CLI, P69; Palmer BW, 2007, J INT NEUROPSYCH SOC, V13, P1047, DOI 10.1017/S1355617707071299; Palmer BW, 2007, J CLIN PSYCHIAT, V68, P689, DOI 10.4088/JCP.v68n0505; Palmer BW, 2013, AM J GERIAT PSYCHIAT, V21, P373, DOI 10.1016/j.jagp.2012.11.008; Palmer Barton W, 2012, IRB, V34, P1; Palmer BW, 2006, SCHIZOPHRENIA BULL, V32, P98; Palmer BW, 2004, ARCH GEN PSYCHIAT, V61, P230, DOI 10.1001/archpsyc.61.3.230; ROTH LH, 1977, AM J PSYCHIAT, V134, P279; Savla GN, 2012, SCHIZOPHRENIA BULL, V38, P760, DOI 10.1093/schbul/sbq149; SCHANK RC, 1980, CONTEMP PSYCHOL, V25, P814; Schmand B, 1999, ALZ DIS ASSOC DIS, V13, P80, DOI 10.1097/00002093-199904000-00004; Sessums LL, 2011, JAMA-J AM MED ASSOC, V306, P420, DOI 10.1001/jama.2011.1023; Stroup S, 2005, SCHIZOPHR RES, V80, P1, DOI 10.1016/j.schres.2005.08.007; Sturman ED, 2005, CLIN PSYCHOL REV, V25, P954, DOI 10.1016/j.cpr.2005.04.010; THOMPSON B, 1995, EDUC PSYCHOL MEAS, V55, P525, DOI 10.1177/0013164495055004001; Tomoda A, 1997, J CLIN PSYCHOL, V53, P443, DOI 10.1002/(SICI)1097-4679(199708)53:5<443::AID-JCLP4>3.0.CO;2-O; Triebel KL, 2009, NEUROLOGY, V73, P2086, DOI 10.1212/WNL.0b013e3181c67bce; Urbina S, 1997, PSYCHOL TESTING; Vellinga A, 2004, INT J GERIATR PSYCH, V19, P645, DOI 10.1002/gps.1139; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x	90	31	31	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2016	31	6					530	540		10.1093/arclin/acw051			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DZ7AU	WOS:000386016000006	27551024	Bronze, Green Published			2022-02-06	
J	Barateiro, A; Afonso, V; Santos, G; Cerqueira, JJ; Brites, D; van Horssen, J; Fernandes, A				Barateiro, Andreia; Afonso, Vera; Santos, Gisela; Cerqueira, Joo Jos; Brites, Dora; van Horssen, Jack; Fernandes, Adelaide			S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis	MOLECULAR NEUROBIOLOGY			English	Article						Cerebellar organotypic slice cultures; Demyelination; Glial inflammatory response; Human samples; Multiple sclerosis; S100B	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; END-PRODUCTS; NEUROBIOCHEMICAL MARKERS; S-100 PROTEIN; IN-VITRO; DEMYELINATION; RECEPTOR	Multiple sclerosis (MS) pathology is characterized by neuroinflammation and demyelination. Recently, the inflammatory molecule S100B was identified in cerebrospinal fluid (CSF) and serum of MS patients. Although seen as an astrogliosis marker, lower/physiological levels of S100B are involved in oligodendrocyte differentiation/maturation. Nevertheless, increased S100B levels released upon injury may induce glial reactivity and oligodendrocyte demise, exacerbating tissue damage during an MS episode or delaying the following remyelination. Here, we aimed to unravel the functional role of S100B in the pathogenesis of MS. Elevated S100B levels were detected in the CSF of relapsing-remitting MS patients at diagnosis. Active demyelinating MS lesions showed increased expression of S100B and its receptor, the receptor for advanced glycation end products (RAGE), in the lesion area, while chronic active lesions displayed increased S100B in demyelinated areas with lower expression of RAGE in the rim. Interestingly, reactive astrocytes were identified as the predominant cellular source of S100B, whereas RAGE was expressed by activated microglia/macrophages. Using an ex vivo demyelinating model, cerebral organotypic slice cultures treated with lysophosphatidylcholine (LPC), we observed a marked elevation of S100B upon demyelination, which co-localized mostly with astrocytes. Inhibition of S100B action using a directed antibody reduced LPC-induced demyelination, prevented astrocyte reactivity and abrogated the expression of inflammatory and inflammasome-related molecules. Overall, high S100B expression in MS patient samples suggests its usefulness as a diagnostic biomarker for MS, while the beneficial outcome of its inhibition in our demyelinating model indicates S100B as an emerging therapeutic target in MS.	[Barateiro, Andreia; Afonso, Vera; Santos, Gisela; Brites, Dora; Fernandes, Adelaide] Univ Lisbon, Res Inst Med iMed ULisboa, Fac Pharm, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal; [Cerqueira, Joo Jos] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Campus Gualtar, P-4710057 Braga, Portugal; [Cerqueira, Joo Jos] ICVS 3Bs PT Govt Associate Lab, Braga Guimaraes, Portugal; [Brites, Dora; Fernandes, Adelaide] Univ Lisbon, Dept Biochem & Human Biol, Fac Pharm, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal; [van Horssen, Jack] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Neurosci Campus Amsterdam,POB 7057, NL-1007 MB Amsterdam, Netherlands		Fernandes, A (corresponding author), Univ Lisbon, Res Inst Med iMed ULisboa, Fac Pharm, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.	amaf@ff.ulisboa.pt	Barateiro, Andreia/AAE-1711-2021; Brites, Dora/AAW-2001-2021; Cerqueira, Joao J/B-4579-2008; Santos, Gisela/AAG-1929-2019; Brites, Dora/M-8293-2013; Fernandes, Adelaide/AAX-4091-2020; Fernandes, Adelaide/A-4787-2011; iMed.ULisboa, NeuronGliaBiol/B-5403-2014; Barateiro, Andreia/I-5746-2014	Brites, Dora/0000-0002-3024-9777; Cerqueira, Joao J/0000-0003-3155-2775; Brites, Dora/0000-0002-3024-9777; Fernandes, Adelaide/0000-0002-2782-9519; Fernandes, Adelaide/0000-0002-2782-9519; Barateiro, Andreia/0000-0002-0378-4854; Santos, Gisela/0000-0002-7264-9162	Medal of Honor L'Oreal for Women in Science (FCT, UNESCO, L'Oreal); Ordem dos Farmaceuticos; Fundacao para a Ciencia e TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission [FCT-SFRH/BPD/96794/2013]; DuPre Grant from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS);  [FCT-Pest-OE/SAU/UI4013]	This work was supported by Medal of Honor L'Oreal for Women in Science (FCT, UNESCO, L'Oreal) and innovation grant (Ordem dos Farmaceuticos) to AF, a post-doctoral grant from Fundacao para a Ciencia e Tecnologia (FCT-SFRH/BPD/96794/2013) and a DuPre Grant from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) to AB, and by FCT-Pest-OE/SAU/UI4013 to iMed.ULisboa.	Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Andersson A, 2008, J LEUKOCYTE BIOL, V84, P1248, DOI 10.1189/jlb.1207844; Astrand Ramona, 2013, Methods Mol Biol, V963, P373, DOI 10.1007/978-1-62703-230-8_23; Bartosik-Psujek H, 2011, ACTA NEUROL SCAND, V123, P252, DOI 10.1111/j.1600-0404.2010.01393.x; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Blakemore WF, 2003, EXP NEUROL, V184, P955, DOI 10.1016/S0014-4886(03)00347-9; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Cammer W, 1999, J NEUROIMMUNOL, V97, P37, DOI 10.1016/S0165-5728(99)00045-4; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Chen YC, 2012, J NEUROIMMUNOL, V243, P56, DOI 10.1016/j.jneuroim.2011.12.008; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Deloulme JC, 2004, MOL CELL NEUROSCI, V27, P453, DOI 10.1016/j.mcn.2004.07.008; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Dyer JK, 2005, SPINAL CORD, V43, P417, DOI 10.1038/sj.sc.3101737; Falcao AS, 2014, NEUROTOX RES, V26, P1, DOI 10.1007/s12640-013-9427-y; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Goncalves DS, 2000, NEUROREPORT, V11, P807, DOI 10.1097/00001756-200003200-00030; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; HIDAKA H, 1983, J BIOL CHEM, V258, P2705; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Inoue M, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/859145; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Kooi EJ, 2011, ACTA NEUROPATHOL, V122, P313, DOI 10.1007/s00401-011-0849-4; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lu B, 2013, PROTEIN CELL, V4, P163, DOI 10.1007/s13238-012-2118-2; MICHETTI F, 1979, NEUROSCI LETT, V11, P171, DOI 10.1016/0304-3940(79)90122-8; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; NEEPER M, 1992, J BIOL CHEM, V267, P14998; O'Connell KE, 2014, AUTOIMMUNITY, V47, P505, DOI 10.3109/08916934.2014.930734; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Pan WH, 2010, METHODS MOL BIOL, V629, P367, DOI 10.3791/2039; Park JW, 2013, YONSEI MED J, V54, P567, DOI 10.3349/ymj.2013.54.3.567; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; Reali C, 2005, J NEUROSCI RES, V81, P677, DOI 10.1002/jnr.20584; Rejdak K, 2008, MULT SCLER J, V14, P59, DOI 10.1177/1352458507082061; Rejdak K, 2007, J NEURAL TRANSM, V114, P1011, DOI 10.1007/s00702-007-0667-y; Robinson AP, 2013, J AUTOIMMUN, V43, P32, DOI 10.1016/j.jaut.2013.02.005; Rossi S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-32; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Sheridan GK, 2012, GLIA, V60, P382, DOI 10.1002/glia.22272; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sorci Guglielmo, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/656481; Steiner J, 2008, NEUROSCIENCE, V154, P496, DOI 10.1016/j.neuroscience.2008.03.060; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; Su ZD, 2011, J NEUROTRAUM, V28, P1089, DOI 10.1089/neu.2010.1597; TAKAHASHI K, 1984, VIRCHOWS ARCH B, V45, P385, DOI 10.1007/BF02889881; Turco F, 2014, GUT, V63, P105, DOI 10.1136/gutjnl-2012-302090; van der Valk P, 2000, NEUROPATH APPL NEURO, V26, P2, DOI 10.1046/j.1365-2990.2000.00217.x; VANELDIK LJ, 1987, BRAIN RES, V436, P367, DOI 10.1016/0006-8993(87)91681-7; Villarreal A, 2014, J NEUROCHEM, V131, P190, DOI 10.1111/jnc.12790; Villarreal A, 2011, J NEUROCHEM, V117, P321, DOI 10.1111/j.1471-4159.2011.07207.x; Witte ME, 2009, J PATHOL, V219, P193, DOI 10.1002/path.2582; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Zhang LY, 2011, GLIA, V59, P486, DOI 10.1002/glia.21118	71	31	32	1	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2016	53	6					3976	3991		10.1007/s12035-015-9336-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR2AO	WOS:000379707600040	26184632	Green Submitted			2022-02-06	
J	Fino, PC; Nussbaum, MA; Brolinson, PG				Fino, Peter C.; Nussbaum, Maury A.; Brolinson, Per Gunnar			Locomotor deficits in recently concussed athletes and matched controls during single and dual-task turning gait: preliminary results	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						mTBI; Concussion; Brain injury; Gait; Turning; Dual-task	TRAUMATIC BRAIN-INJURY; STABILITY FOLLOWING CONCUSSION; SPORTS-RELATED CONCUSSION; GOAL-ORIENTED LOCOMOTION; BALANCE CONTROL; HUMAN WALKING; DIVIDED ATTENTION; DYNAMIC STABILITY; CURVED PATHS; HUMANS	Background: There is growing evidence that mild traumatic brain injury (concussion) can affect locomotor characteristics for prolonged periods of time even when physical signs and symptoms are absent. While most locomotor deficits post-concussion have involved straight walking, turning gait has received little attention despite its pervasiveness in everyday locomotion and athletic competition. Methods: This study longitudinally examined kinematic characteristics during preplanned turning in a small sample of recently concussed athletes (n = 4) and healthy matched control athletes (n = 4) to examine potential deficits during single and dual-task turning gait over the initial 6 weeks post-injury, with a one-year follow-up. Turning path kinematics (curvature, obstacle clearance, path length), stride kinematics (stride length, stride width, stride time), and inclination angles were calculated from motion capture of participants walking around an obstacle. Results: Concussed athletes had larger dual-task costs in turning speed and stride time compared to healthy controls. After controlling for speed and turn curvature, recently concussed athletes increased their inclination towards the inside of the turn over time and decreased their stride time compared to controls indicating a prolonged recovery. Kinematic differences between groups were estimated to recover to healthy levels between 100 and 300 days post-injury, suggesting future prospective longitudinal studies should span 6-12 months post-injury. Conclusion: Turning gait should be included in future studies of concussion and may be a clinically useful tool. Future longitudinal studies should consider examining gait changes for up to 6-12 months post-injury.	[Fino, Peter C.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,L226, Portland, OR 97239 USA; [Fino, Peter C.; Brolinson, Per Gunnar] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA; [Nussbaum, Maury A.] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA USA; [Brolinson, Per Gunnar] Edward Via Coll Osteopath Med, Blacksburg, VA USA		Fino, PC (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,L226, Portland, OR 97239 USA.; Fino, PC (corresponding author), Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA.	fino@ohsu.edu	Nussbaum, Maury A/A-9655-2008	Nussbaum, Maury A/0000-0002-1887-8431; Fino, Peter/0000-0002-8621-3706	NSF Graduate Research FellowshipNational Science Foundation (NSF) [DGE0822220]; Virginia Tech's Open Access Subvention Fund	PCF was supported by an NSF Graduate Research Fellowship (Grant No. DGE0822220). Opinions and findings do not represent the views of the NSF. Additional support for publication was provided by Virginia Tech's Open Access Subvention Fund.	Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cinelli ME, 2014, PHYSL REP, V2; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Courtine G, 2006, EXP BRAIN RES, V170, P320, DOI 10.1007/s00221-005-0215-7; Courtine G, 2003, EUR J NEUROSCI, V18, P191, DOI 10.1046/j.1460-9568.2003.02737.x; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Fino P, 2014, J BIOMECH, V47, P1395, DOI 10.1016/j.jbiomech.2014.01.032; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Fino PC, 2015, J BIOMECH, V48, P104, DOI 10.1016/j.jbiomech.2014.10.034; Glaister BC, 2007, J BIOMECH, V40, P3527, DOI 10.1016/j.jbiomech.2007.05.014; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Grabiner Mark D, 2005, J Neuroeng Rehabil, V2, P25, DOI 10.1186/1743-0003-2-25; Hewett TE, 2009, BRIT J SPORT MED, V43, P417, DOI 10.1136/bjsm.2009.059162; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Huxham F, 2006, GAIT POSTURE, V23, P159, DOI 10.1016/j.gaitpost.2005.01.001; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Olivier AH, 2007, NEUROSCI LETT, V412, P148, DOI 10.1016/j.neulet.2006.11.005; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pham QC, 2007, EUR J NEUROSCI, V26, P2391, DOI 10.1111/j.1460-9568.2007.05835.x; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Reed N., 2013, NEUROL NEUROPHYSIOL, V4, P171, DOI DOI 10.4172/2155-9562.1000171; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sreenivasa MN, 2008, EXP BRAIN RES, V191, P313, DOI 10.1007/s00221-008-1525-3; Takei Y, 1996, BRAIN RES BULL, V40, P491, DOI 10.1016/0361-9230(96)00147-5; Taylor MJD, 2005, HUM MOVEMENT SCI, V24, P558, DOI 10.1016/j.humov.2005.07.005; TENENBAUM G, 1993, HDB RES SPORT PSYCHO, P171; VIVIANI P, 1985, J EXP PSYCHOL HUMAN, V11, P828, DOI 10.1037/0096-1523.11.6.828; Yamaguchi T, 2013, GAIT POSTURE, V38, P209, DOI 10.1016/j.gaitpost.2012.11.007; Yamaguchi T, 2012, J BIOMECH, V45, P2624, DOI 10.1016/j.jbiomech.2012.08.006; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	54	31	31	0	17	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	JUL 25	2016	13								65	10.1186/s12984-016-0177-y			15	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	DR7QD	WOS:000380093900001	27456969	Green Published, gold			2022-02-06	
J	Hall, ANB; Joseph, B; Brelsfoard, JM; Saatman, KE				Hall, Amanda N. Bolton; Joseph, Binoy; Brelsfoard, Jennifer M.; Saatman, Kathryn E.			Repeated Closed Head Injury in Mice Results in Sustained Motor and Memory Deficits and Chronic Cellular Changes	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; MOUSE MODEL; AXONAL INJURY; BEHAVIORAL IMPAIRMENTS; COGNITIVE IMPAIRMENT; ASTROCYTE ACTIVATION; OPTIC-NERVE; MILD; CONCUSSION	Millions of mild traumatic brain injuries (TBIs) occur every year in the United States, with many people subject to multiple head injuries that can lead to chronic behavioral dysfunction. We previously reported that mild TBI induced using closed head injuries (CHI) repeated at 24h intervals produced more acute neuron death and glial reactivity than a single CHI, and increasing the length of time between injuries to 48h reduced the cumulative acute effects of repeated CHI. To determine whether repeated CHI is associated with behavioral dysfunction or persistent cellular damage, mice receiving either five CHI at 24h intervals, five CHI at 48h intervals, or five sham injuries at 24h intervals were evaluated across a 10 week period after injury. Animals with repeated CHI exhibited motor coordination and memory deficits, but not gait abnormalities when compared to sham animals. At 10wks post-injury, no notable neuron loss or glial reactivity was observed in the cortex, hippocampus, or corpus callosum. Argyrophilic axons were found in the pyramidal tract of some injured animals, but neither silver stain accumulation nor inflammatory responses in the injury groups were statistically different from the sham group in this region. However, argyrophilic axons, microgliosis and astrogliosis were significantly increased within the optic tract of injured animals. Repeated mild CHI also resulted in microgliosis and a loss of neurofilament protein 200 in the optic nerve. Lengthening the inter-injury interval from 24h to 48h did not effectively reduce these behavioral or cellular responses. These results suggest that repeated mild CHI results in persistent behavioral dysfunction and chronic pathological changes within the visual system, neither of which was significantly attenuated by lengthening the inter-injury interval from 24h to 48h.	[Hall, Amanda N. Bolton; Joseph, Binoy; Brelsfoard, Jennifer M.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA; [Hall, Amanda N. Bolton; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA; [Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Neurosurg, Lexington, KY 40506 USA		Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.; Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA.; Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Dept Neurosurg, Lexington, KY 40506 USA.	k.saatman@uky.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS077889, F31 NS087878-02, P30 NS051220]; Kentucky Spinal Cord and Head Injury Trust [14-13A, 9-13]	This study was supported by the National Institute of Neurological Disorders and Stroke T32 NS077889 and National Institute of Neurological Disorders and Stroke F31 NS087878-02 (ANBH); National Institute of Neurological Disorders and Stroke P30 NS051220, Kentucky Spinal Cord and Head Injury Trust 14-13A, Kentucky Spinal Cord and Head Injury Trust 9-13 (KES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Balaratnasingam C, 2010, INVEST OPHTH VIS SCI, V51, P3019, DOI 10.1167/iovs.09-4692; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Faul M, 2010, TRAUMATIC BRAIN INJU; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GRONWALL D, 1975, LANCET, V2, P995; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Huynh T, 2006, AM SURGEON, V72, P1162; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Selwyn RG, 2015, J NEUROTRAUMA; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Springer JE, 2010, J NEUROTRAUM, V27, P139, DOI 10.1089/neu.2009.0952; Syed A T, 2007, Int J Health Sci (Qassim), V1, P131; Tellier A, 1999, BRAIN INJURY, V13, P463; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Xu L, 2014, EXP NEUROL; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	79	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159442	10.1371/journal.pone.0159442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	WOS:000380169300067	27427961	Green Submitted, Green Published, gold			2022-02-06	
J	Kuo, C; Wu, LC; Hammoor, BT; Luck, JF; Cutcliffe, HC; Lynall, RC; Kait, JR; Campbell, KR; Mihalik, JP; Bass, CR; Camarillo, DB				Kuo, Calvin; Wu, Lyndia C.; Hammoor, Brad T.; Luck, Jason F.; Cutcliffe, Hattie C.; Lynall, Robert C.; Kait, Jason R.; Campbell, Kody R.; Mihalik, Jason P.; Bass, Cameron R.; Camarillo, David B.			Effect of the mandible on mouthguard measurements of head kinematics	JOURNAL OF BIOMECHANICS			English	Article						Instrumented mouthguard; Mild traumatic brain injury; Head kinematics; Drop test	PROFESSIONAL FOOTBALL; CONCUSSION; IMPACTS; HELMET	Wearable sensors are becoming increasingly popular for measuring head motions and detecting head impacts. Many sensors are worn on the skin or in headgear and can suffer from motion artifacts introduced by the compliance of soft tissue or decoupling of headgear from the skull. The instrumented mouthguard is designed to couple directly to the upper dentition, which is made of hard enamel and anchored in a bony socket by stiff ligaments. This gives the mouthguard superior coupling to the skull compared with other systems. However, multiple validation studies have yielded conflicting results with respect to the mouthguard's head kinematics measurement accuracy. Here, we demonstrate that imposing different constraints on the mandible (lower jaw) can alter mouthguard kinematic accuracy in dummy headform testing. In addition, post mortem human surrogate tests utilizing the worst-case unconstrained mandible condition yield 40% and 80% normalized root mean square error in angular velocity and angular acceleration respectively. These errors can be modeled using a simple spring-mass system in which the soft mouthguard material near the sensors acts as a spring and the mandible as a mass. However, the mouthguard can be designed to mitigate these disturbances by isolating sensors from mandible loads, improving accuracy to below 15% normalized root mean square error in all kinematic measures. Thus, while current mouthguards would suffer from measurement errors in the worst case unconstrained mandible condition, future mouthguards should be designed to account for these disturbances and future validation testing should include unconstrained mandibles to ensure proper accuracy. (C) 2016 Elsevier Ltd. All rights reserved.	[Kuo, Calvin; Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Wu, Lyndia C.; Hammoor, Brad T.; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Luck, Jason F.; Cutcliffe, Hattie C.; Kait, Jason R.; Bass, Cameron R.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Lynall, Robert C.; Campbell, Kody R.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Kuo, C (corresponding author), 443 Via Ortega, Stanford, CA 94305 USA.	calvink@stanford.edu	Kuo, Calvin/AAH-1933-2019; Lynall, Robert/M-2888-2014; Wu, Lyndia/AAQ-1106-2020	Kuo, Calvin/0000-0001-8401-9136; Lynall, Robert/0000-0002-0785-6640; Wu, Lyndia/0000-0002-8236-032X; Campbell, Kody/0000-0002-4534-5497; Cutcliffe, Hattie/0000-0001-8456-1996	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [3R21EB01761101S1]; National Institute of Bio-medical Imaging and Bioengineering (NIBIB)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [3R21EB01761101S1]; Stanford Child Health Research Institute Transdisciplinary Initiatives Program; Stanford Bio-X Graduate Research Fellowship Program; University of Pennsylvania Prime; US Army Research Office [W911NF-10-1-0526]; Duke University Pratt School of Engineering	This study was supported by the National Institutes of Health (NIH) (Grant number 3R21EB01761101S1) National Institute of Bio-medical Imaging and Bioengineering (NIBIB) 3R21EB01761101S1, the Stanford Child Health Research Institute Transdisciplinary Initiatives Program, and the Stanford Bio-X Graduate Research Fellowship Program. The authors appreciate additional funding from the University of Pennsylvania Prime, US Army Research Office W911NF-10-1-0526 and the Duke University Pratt School of Engineering.	Abramowitz M., 1965, HDB MATH FUNCTIONS F, V55; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Ferrario VF, 2004, J ORAL REHABIL, V31, P18, DOI 10.1046/j.0305-182X.2003.01179.x; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hernandez F., 2014, ANN BIOMED ENG, V43, P1; Hernandez F., 2015, J BIOMECH; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; KING AI, 1995, J TRAUMA, V38, P564, DOI 10.1097/00005373-199504000-00016; Luck J., 2014, WORLD C BIOM; NOYES DH, 1973, J BIOMECH, V6, P439, DOI 10.1016/0021-9290(73)90002-X; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Siegmund G.P., 2015, ANN BIOMED ENG; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Society of Automotive Engineers, 2007, TECHNICAL REPORT; Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Walker L.B., 1973, P 17 STAPP CAR CRASH, P523; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Withnall C., 2010, SAE TECHNICAL PAPER; Wu L.C., 2015, ANN BIOMED ENG	27	31	31	1	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUN 14	2016	49	9					1845	1853		10.1016/j.jbiomech.2016.04.017			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	DO4DE	WOS:000377731200058	27155744				2022-02-06	
J	Tweedie, D; Fukui, K; Li, YZ; Yu, QS; Barak, S; Tamargo, IA; Rubovitch, V; Holloway, HW; Lehrmann, E; Wood, WH; Zhang, YQ; Becker, KG; Perez, E; Van Praag, H; Luo, Y; Hoffer, BJ; Becker, RE; Pick, CG; Greig, NH				Tweedie, David; Fukui, Koji; Li, Yazhou; Yu, Qian-sheng; Barak, Shani; Tamargo, Ian A.; Rubovitch, Vardit; Holloway, Harold W.; Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.; Perez, Evelyn; Van Praag, Henriette; Luo, Yu; Hoffer, Barry J.; Becker, Robert E.; Pick, Chaim G.; Greig, Nigel H.			Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; FLUID-PERCUSSION INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; OXIDATIVE STRESS; ACETYLCHOLINESTERASE INHIBITION; GENE-EXPRESSION; RISK-FACTOR; CELL-DEATH	Traumatic brain injury (TBI), often caused by a concussive impact to the head, affects an estimated 1.7 million Americans annually. With no approved drugs, its pharmacological treatment represents a significant and currently unmet medical need. In our prior development of the anti-cholinesterase compound phenserine for the treatment of neurodegenerative disorders, we recognized that it also possesses non-cholinergic actions with clinical potential. Here, we demonstrate neuroprotective actions of phenserine in neuronal cultures challenged with oxidative stress and glutamate excitotoxicity, two insults of relevance to TBI. These actions translated into amelioration of spatial and visual memory impairments in a mouse model of closed head mild TBI (mTBI) two days following cessation of clinically translatable dosing with phenserine (2.5 and 5.0 mg/kg BID x 5 days initiated post mTBI) in the absence of anti-cholinesterase activity. mTBI elevated levels of thiobarbituric acid reactive substances (TBARS), a marker of oxidative stress. Phenserine counteracted this by augmenting homeostatic mechanisms to mitigate oxidative stress, including superoxide dismutase [SOD] 1 and 2, and glutathione peroxidase [GPx], the activity and protein levels of which were measured by specific assays. Microarray analysis of hippocampal gene expression established that large numbers of genes were exclusively regulated by each individual treatment with a substantial number of them co-regulated between groups. Molecular pathways associated with lipid peroxidation were found to be regulated by mTBI, and treatment of mTBI animals with phenserine effectively reversed injury-induced regulations in the 'Blalock Alzheimer's Disease Up' pathway. Together these data suggest that multiple phenserine-associated actions underpin this compound's ability to ameliorate cognitive deficits caused by mTBI, and support the further evaluation of the compound as a therapeutic for TBI.	[Tweedie, David; Fukui, Koji; Li, Yazhou; Yu, Qian-sheng; Tamargo, Ian A.; Holloway, Harold W.; Becker, Robert E.; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Fukui, Koji] Shibaura Inst Technol, Div Biosci & Engn, Saitama 3378570, Japan; [Barak, Shani; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.] NIA, Lab Genet & Genom, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Perez, Evelyn] NIA, Lab Behav Neurosci, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Van Praag, Henriette] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Luo, Yu; Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Becker, Robert E.] 7123 Pinebrook Rd, Park City, UT 84098 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel		Greig, NH (corresponding author), NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	greign@mail.nih.gov	Fukui, Koji/I-7067-2019	Fukui, Koji/0000-0003-2748-3228; Luo, Yu/0000-0002-7939-5505; van Praag, Henriette/0000-0002-5727-434X; Lehrmann, Elin/0000-0002-9869-9475; Holloway, Courtney Jean/0000-0003-3661-1957	Intramural Research Program of the National Institute on Aging, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Ari and Regine Aprijaskis Fund, at Tel-Aviv University; Israel Science FoundationIsrael Science Foundation [108/09]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZICAG000616, ZIAAG000328, ZIAAG000311] Funding Source: NIH RePORTER	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, (ii) the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, and (iii) a grant from the Israel Science Foundation, grant number 108/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, (ii) the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, and (iii) a grant from the Israel Science Foundation, grant number 108/09.	AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Allen TGJ, 2006, J NEUROSCI, V26, P1588, DOI 10.1523/JNEUROSCI.3979-05.2006; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Araujo JA, 2011, J ALZHEIMERS DIS, V26, P143, DOI 10.3233/JAD-2011-110005; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barger SW, 2004, FRONT BIOSCI-LANDMRK, V9, P3286, DOI 10.2741/1481; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; Boyajyan A, 2015, RECENT ADV DNA GENE; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099818; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cox CD, 2008, J NEUROTRAUM, V25, P1355, DOI 10.1089/neu.2008.0671; Crepaldi L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003699; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dixon CE, 1979, EXP NEUROL, V146, P479; Djordjevic J, 2016, CURR ALZHEIMER RES; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Dumas JA, 2011, PHARMACOL BIOCHEM BE, V99, P254, DOI 10.1016/j.pbb.2011.02.022; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Faul M, 2010, TRAUMATIC BRAIN INJU; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Greig NH, 2000, ACTA NEUROL SCAND, V102, P74, DOI 10.1034/j.1600-0404.2000.00311.x; Greig Nigel H., 2005, Current Alzheimer Research, V2, P483, DOI 10.2174/156720505774330564; Hendrickx A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099467; HEPPNER F, 1958, Monatsschr Unfallheilkd Versicherungsmed, V61, P257; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; IKARI H, 1995, NEUROREPORT, V6, P481, DOI 10.1097/00001756-199502000-00019; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jenkner FL, 1954, NERVENARZT, V25, P77; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Klein BD, 2004, EPILEPSY RES, V62, P13, DOI 10.1016/j.eplepsyres.2004.06.007; Lahiri DK, 2003, J ALZHEIMERS DIS, V5, P81, DOI 10.3233/JAD-2003-5203; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; LECHNER H, 1963, Wien Klin Wochenschr, V75, ppassim; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058752; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Lusardi TA, 2009, CURR NEUROPHARMACOL, V7, P228, DOI 10.2174/157015909789152137; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; METZ B, 1971, J NEUROSURG, V35, P523, DOI 10.3171/jns.1971.35.5.0523; Mikkilineni S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/142372; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Parsons CG, 2013, NEUROTOX RES, V24, P358, DOI 10.1007/s12640-013-9398-z; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pike BR, 1997, J NEUROTRAUM, V14, P897, DOI 10.1089/neu.1997.14.897; Pilipovic K, 2011, NEUROCHEM RES, V36, P913, DOI 10.1007/s11064-011-0424-3; Poole NA, 2008, BRAIN INJURY, V22, P519, DOI 10.1080/02699050802132495; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reale M, 2014, CURR ALZHEIMER RES, V11, P608, DOI 10.2174/1567205010666131212113218; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; RUGE D, 1954, J NEUROSURG, V11, P77, DOI 10.3171/jns.1954.11.1.0077; Ruszkiewicz J, 2015, NEUROCHEM INT, V88, P66, DOI 10.1016/j.neuint.2014.12.012; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Saso L, 2014, CURR DRUG TARGETS, V15, P1177, DOI 10.2174/1389450115666141024113925; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Scarr E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00055; Schliebs R, 2006, J NEURAL TRANSM, V113, P1625, DOI 10.1007/s00702-006-0579-2; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Wang XD, 1999, NEUROSCI LETT, V272, P21, DOI 10.1016/S0304-3940(99)00567-4; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yu QS, 2001, J MED CHEM, V44, P4062, DOI 10.1021/jm010080x; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	127	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156493	10.1371/journal.pone.0156493			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	WOS:000377218700033	27254111	Green Published, gold, Green Submitted			2022-02-06	
J	Schmidt, JL; Tweten, DJ; Benegal, AN; Walker, CH; Portnoi, TE; Okamoto, RJ; Garbow, JR; Bayly, PV				Schmidt, J. L.; Tweten, D. J.; Benegal, A. N.; Walker, C. H.; Portnoi, T. E.; Okamoto, R. J.; Garbow, J. R.; Bayly, P. V.			Magnetic resonance elastography of slow and fast shear waves illuminates differences in shear and tensile moduli in anisotropic tissue	JOURNAL OF BIOMECHANICS			English	Article						MR Elastography; Shear waves; Anisotropy; Transversely isotropic material	VISCOELASTIC PROPERTIES; MR ELASTOGRAPHY; IN-VIVO; MECHANICAL-PROPERTIES; BRAIN-TISSUE; PARAMETERS; INVERSION	Mechanical anisotropy is an important property of fibrous tissues; for example, the anisotropic mechanical properties of brain white matter may play a key role in the mechanics of traumatic brain injury (TBI). The simplest anisotropic material model for small deformations of soft tissue is a nearly incompressible, transversely isotropic (M) material characterized by three parameters: minimum shear modulus (mu), shear anisotropy (phi = (mu 1)/(mu) - 1) and tensile anisotropy (zeta= (E1)/(E2) - 1). These parameters can be determined using magnetic resonance elastography (MRE) to visualize shear waves, if the angle between the shear-wave propagation direction and fiber direction is known. Most MRE studies assume isotropic material models with a single shear (mu) or tensile (E) modulus. In this study, two types of shear waves, "fast" and "slow", were analyzed for a given propagation direction to estimate anisotropic parameters mu, phi, and zeta in two fibrous soft materials: turkey breast ex vivo and aligned fibrin gels. As expected, the speed of slow shear waves depended on the angle between fiber direction and propagation direction. Fast shear waves were observed when the deformations due to wave motion induced stretch in the fiber direction. Finally, MRE estimates of anisotropic mechanical properties in turkey breast were compared to estimates from direct mechanical tests. (C) 2016 Elsevier Ltd. All rights reserved.	[Schmidt, J. L.; Tweten, D. J.; Okamoto, R. J.; Bayly, P. V.] Washington Univ, Mech Engn & Mat Sci, 1 Brookings Dr, St Louis, MO 63105 USA; [Benegal, A. N.; Walker, C. H.; Bayly, P. V.] Washington Univ, Biomed Engn, St Louis, MO 63105 USA; [Portnoi, T. E.] MIT, Elect Engn, Cambridge, MA 02139 USA; [Garbow, J. R.] Washington Univ, Radiol, Biomed Magnet Resonance Lab, St Louis, MO 63105 USA		Bayly, PV (corresponding author), Washington Univ, Mech Engn & Mat Sci, 1 Brookings Dr, St Louis, MO 63105 USA.	pvb@wustl.edu		Okamoto, Ruth/0000-0002-3085-3878	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS055951]; NSFNational Science Foundation (NSF) [CMMI-1332433]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	This study was supported by NIH Grant NS055951 (Bayly) and NSF Grant CMMI-1332433 (Bayly).	Aristizabal S, 2014, PHYS MED BIOL, V59, P7735, DOI 10.1088/0031-9155/59/24/7735; Asbach P, 2008, MAGN RESON MED, V60, P373, DOI 10.1002/mrm.21636; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Auld B. A., 1990, ACOUSTIC FIELDS WAVE; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; Flugge W., 1975, VISCOELASTICITY; Gennisson JL, 2003, J ACOUST SOC AM, V114, P536, DOI 10.1121/1.1579008; Green MA, 2013, NMR BIOMED, V26, P1387, DOI 10.1002/nbm.2964; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guo J, 2015, MAGN RESON MED; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Klatt D, 2010, PHYS MED BIOL, V55, P6445, DOI 10.1088/0031-9155/55/21/007; Klatt D, 2010, BIORHEOLOGY, V47, P133, DOI 10.3233/BIR-2010-0565; Manduca A, 2003, MED IMAGE ANAL, V7, P465, DOI 10.1016/S1361-8415(03)00038-0; Mariappan YK, 2009, MAGN RESON MED, V62, P1457, DOI 10.1002/mrm.22091; Murphy MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081668; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Namani R, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006848; Namani R, 2009, J BIOMECH, V42, P2047, DOI 10.1016/j.jbiomech.2009.06.007; Okamoto RJ, 2011, PHYS MED BIOL, V56, P6379, DOI 10.1088/0031-9155/56/19/014; Papazoglou S, 2006, MAGN RESON MED, V56, P489, DOI 10.1002/mrm.20993; Qin EC, 2014, RADIOLOGY, V273, P726, DOI 10.1148/radiol.14132661; Qin EC, 2013, J MAGN RESON IMAGING, V37, P217, DOI 10.1002/jmri.23797; Riek K, 2011, J BIOMECH, V44, P1380, DOI 10.1016/j.jbiomech.2010.12.031; Romano A, 2014, MAGN RESON MED, V72, P1755, DOI 10.1002/mrm.25067; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Rouze NC, 2013, J BIOMECH, V46, P2761, DOI 10.1016/j.jbiomech.2013.09.008; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sinkus R, 2005, MAGNET RESON MED, V53, P372, DOI 10.1002/mrm.20355; Tweten DJ, 2015, J BIOMECH, V48, P4002, DOI 10.1016/j.jbiomech.2015.09.009; Wang M, 2013, IEEE T MED IMAGING, V32, P1671, DOI 10.1109/TMI.2013.2262948	36	31	31	4	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAY 3	2016	49	7					1042	1049		10.1016/j.jbiomech.2016.02.018			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	DM0RB	WOS:000376052400009	26920505	Bronze, Green Accepted			2022-02-06	
J	Gupta, D; Sharma, D; Kannan, N; Prapruettham, S; Mock, C; Wang, J; Qiu, Q; Pandey, RM; Mahapatra, A; Dash, HH; Hecker, JG; Rivara, FP; Rowhani-Rahbar, A; Vavilala, MS				Gupta, Deepak; Sharma, Deepak; Kannan, Nithya; Prapruettham, Suchada; Mock, Charles; Wang, Jin; Qiu, Qian; Pandey, Ravindra M.; Mahapatra, Ashok; Dash, Hari Har; Hecker, James G.; Rivara, Frederick P.; Rowhani-Rahbar, Ali; Vavilala, Monica S.			Guideline Adherence and Outcomes in Severe Adult Traumatic Brain Injury for the CHIRAG (Collaborative Head Injury and Guidelines) Study	WORLD NEUROSURGERY			English	Article						Guidelines; Outcomes; Traumatic brain injury	CARE	We examined the effect of early intensive care unit (ICU) adherence to 2007 Brain Trauma Foundation Guideline indicators after traumatic brain injury (TBI) on inpatient mortality at a level 1 trauma center in India (Jay Prakash Narayan Apex Trauma Center [JPNATC]) and Harborview Medical Center (HMC) in U.S. among adults older than 18 years with severe TBI. At each site, ICU Guideline adherence in first 72 hours for 17 indicators was determined and expressed as a percentage. Outcomes were in-hospital mortality and Glasgow Outcome Scale (GOS) scores at 3, 6, and 12 months after discharge. JPNATC and HMC Guideline adherence rates were 74.9% [11.0] and 71.6%(SD +/- 10.4), and overall in-hospital mortality was 24% and 27%, respectively. At JPNATC, less than 65% ICU Guideline adherence was associated with higher inpatient mortality (adjusted relative risk [aRR], 1.92; 95% confidence interval [CI], 1.11-3.33) and an increase in ICU Guideline adherence rate by 1% was associated with a 3% lower in-hospital mortality (aRR, 0.97; 95% CI, 0.95-0.99). Among patients discharged with a GOS score of 2-4 at JPNATC, 67% improved at 12 months (R-2 = 0.991; P < 0.01; 99% follow-up rate) compared with discharge, but 35%, 25%, and 14% of patients discharged with a GOS score of 3-5 deteriorated at 3, 6, and 12 months to a lower GOS at home. Achieving early ICU adherence to guideline indicators was feasible and associated with significantly lower in-hospital mortality at JPNATC. Although the intracranial pressure (ICP) monitoring rates varied, in-hospitals deaths were similar between the two institutions. Although long-term outcomes generally improved, patients discharged with favorable GOS score often deteriorated at home.	[Gupta, Deepak; Prapruettham, Suchada; Mahapatra, Ashok] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neurosurg, New Delhi, India; [Pandey, Ravindra M.] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Pandey, Ravindra M.] All India Inst Med Sci, Epidemiol Unit, New Delhi, India; [Sharma, Deepak; Qiu, Qian; Hecker, James G.; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Kannan, Nithya; Mock, Charles; Rivara, Frederick P.; Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Mock, Charles] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Wang, Jin; Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dash, Hari Har] Fortis Mem Res Inst, Dept Anesthesiol, Gurgaon, India		Vavilala, MS (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.; Vavilala, MS (corresponding author), Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.; Vavilala, MS (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	vavilala@u.washington.edu		Rowhani-Rahbar, Ali/0000-0002-2705-4485	National Institutes of Health (U.S.) NINDS [5R21NS077444-02]; Department of Biotechnology (India)Department of Biotechnology (DBT) India [DBT N-1349]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS077444] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health (U.S.) NINDS 5R21NS077444-02 and Department of Biotechnology (India) DBT N-1349.	Agrawal Amit, 2014, Int J Crit Illn Inj Sci, V4, P293, DOI 10.4103/2229-5151.147521; Agrawal M, 2014, BRAIN INJURY, V28, P292, DOI 10.3109/02699052.2013.865266; Altman D.G., 1990, PRACTICAL STAT MED R; [Anonymous], 2008, SURV SAMPL SIZ SOFTW; Biswas R, 2009, J EVAL CLIN PRACT, V15, P873, DOI 10.1111/j.1365-2753.2009.01271.x; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Buck CJ, 2010, INT CLASSIFICATION D; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Centers for Disease Control and Prevention, 2015, TRAUM BRAIN INJ US F; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleiss JH., 1981, STAT METHODS RATES P; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hintze J., 2008, PASS 2008; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1976, LANCET, V1, P1031; Khan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132229; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Sahu Madhusmita, 2014, Int J Electron Healthc, V7, P269, DOI 10.1504/IJEH.2014.064327; Sinha S, 2013, NEUROL INDIA, V61, P501, DOI 10.4103/0028-3886.121920; World Health Organization, 2015, VIOL INJ PREV INJ VI; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	27	31	33	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2016	89						169	179		10.1016/j.wneu.2015.12.097			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DM6GM	WOS:000376448700026	26806065	Green Accepted			2022-02-06	
J	Willigenburg, NW; Borchers, JR; Quincy, R; Kaeding, CC; Hewett, TE				Willigenburg, Nienke W.; Borchers, James R.; Quincy, Richard; Kaeding, Christopher C.; Hewett, Timothy E.			Comparison of Injuries in American Collegiate Football and Club Rugby: A Prospective Cohort Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						epidemiology; rugby; American football; head injury; concussion; ACL injury	SURVEILLANCE SYSTEM; EPIDEMIOLOGY; PATTERNS; UNION	Background: American football and rugby players are at substantial risk of injury because of the full-contact nature of these sports. Methodological differences between previous epidemiological studies hamper an accurate comparison of injury rates between American football and rugby. Purpose: To directly compare injury rates in American collegiate football and rugby, specified by location, type, mechanism, and severity of injury, as reported by licensed medical professionals. Study Design: Cohort study; Level of evidence, 2. Methods: Licensed medical professionals (athletic trainer or physician) associated with the football and rugby teams of a National Collegiate Athletic Association Division I university reported attendance and injury details over 3 autumn seasons. Injuries were categorized by the location, type, mechanism, and severity of injury, and the injury rate was calculated per 1000 athlete-exposures (AEs). Injury rate ratios (IRRs) were calculated to compare overall, game, and practice injury rates within and between sports. Results: The overall injury rate was 4.9/1000 AEs in football versus 15.2/1000 AEs in rugby: IRR = 3.1 (95% CI, 2.3-4.2). Game injury rates were higher than practice injury rates: IRR = 6.5 (95% CI, 4.5-9.3) in football and IRR = 5.1 (95% CI, 3.0-8.6) in rugby. Injury rates for the shoulder, wrist/hand, and lower leg and for sprains, fractures, and contusions in rugby were >4 times as high as those in football (all P 0.006). Concussion rates were 1.0/1000 AEs in football versus 2.5/1000 AEs in rugby. Most injuries occurred via direct player contact, especially during games. The rate of season-ending injuries (>3 months of time loss) was 0.8/1000 AEs in football versus 1.0/1000 AEs in rugby: IRR = 1.3 (95% CI, 0.4-3.4). Conclusion: Overall injury rates were substantially higher in collegiate rugby compared with football. Similarities between sports were observed in the most common injury types (sprains and concussions), locations (lower extremity and head), and mechanisms (direct player contact). Upper extremity injuries were more common in rugby, and the rate of season-ending injuries was similar between sports.	[Willigenburg, Nienke W.; Borchers, James R.; Quincy, Richard; Kaeding, Christopher C.; Hewett, Timothy E.] Ohio State Univ, Columbus, OH 43210 USA; [Hewett, Timothy E.] Mayo Clin, Dept Orthoped, 200 First St SW, Rochester, MN 55905 USA; [Willigenburg, Nienke W.; Borchers, James R.; Kaeding, Christopher C.; Hewett, Timothy E.] Ohio State Univ, Sports Hlth & Performance Inst, Columbus, OH 43210 USA; [Willigenburg, Nienke W.] OLVG, Dept Orthopaed Surg, JointRes, Amsterdam, Netherlands; [Borchers, James R.] Ohio State Univ, Dept Family Med, Columbus, OH 43210 USA; [Quincy, Richard; Kaeding, Christopher C.] Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA		Hewett, TE (corresponding author), Mayo Clin, Dept Orthoped, 200 First St SW, Rochester, MN 55905 USA.; Hewett, TE (corresponding author), Ohio State Univ, Sports Hlth & Performance Inst, Columbus, OH 43210 USA.	hewett.timothy@mayo.edu	Borchers, James/E-2778-2011		National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01-AR049735, R01-AR055563, R01-AR056259]; Sports Health and Performance Institute at The Ohio State University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR055563, R01AR056259, R01AR049735] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: Funding support was received from National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grants (R01-AR049735, R01-AR055563, and R01-AR056259 to T.E.H.) and from the Sports Health and Performance Institute at The Ohio State University.	Albright JP, 2004, AM J SPORT MED, V32, P1394, DOI 10.1177/0363546504264159; [Anonymous], 2013 14 HIGH SCH ATH; [Anonymous], SPORTS SPONS PART RA; Chadwick S., 2010, EC IMPACT REPORT GLO; Dean A, OPENEPI OPEN SOURCE; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hwang JTG, 2001, STAT SINICA, V11, P807; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; Willigenburg NW, 2014, ANN SPORTS MED RES, V1, P1005	14	31	32	0	30	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2016	44	3					753	760		10.1177/0363546515622389			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DF9CQ	WOS:000371658300031	26786902				2022-02-06	
J	Meier, TB; Bellgowan, PSF; Bergamino, M; Ling, JM; Mayer, AR				Meier, Timothy B.; Bellgowan, Patrick S. F.; Bergamino, Maurizio; Ling, Josef M.; Mayer, Andrew R.			Thinner Cortex in Collegiate Football Players With, but not Without, a Self-Reported History of Concussion	JOURNAL OF NEUROTRAUMA			English	Article						anterior cingulate; concussion; cortical thickness; football; fractional anisotropy	TRAUMATIC BRAIN-INJURY; CORTICAL THICKNESS; NEUROCOGNITIVE PERFORMANCE; DEPRESSIVE SYMPTOMS; ABNORMALITIES; DYSFUNCTION; VALIDATION; DISORDER; VALIDITY; VOLUME	Emerging evidence suggests that a history of sports-related concussions can lead to long-term neuroanatomical changes. The extent to which similar changes are present in young athletes is undetermined at this time. Here, we tested the hypothesis that collegiate football athletes with (n=25) and without (n=24) a self-reported history of concussion would have cortical thickness differences and altered white matter integrity relative to healthy controls (n=27) in fronto-temporal regions that appear particularly susceptible to traumatic brain injury. Freesurfer software was used to estimate cortical thickness, fractional anisotropy was calculated in a priori white matter tracts, and behavior was assessed using a concussion behavioral battery. Groups did not differ in self-reported symptoms (p>0.10) or cognitive performance (p>0.10). Healthy controls reported significantly higher happiness levels than both football groups (all p<0.01). Contrary to our hypothesis, no differences in fractional anisotropy were observed between our groups (p>0.10). However, football athletes with a history of concussion had significantly thinner cortex in the left anterior cingulate cortex, orbital frontal cortex, and medial superior frontal cortex relative to healthy controls (p=0.02, d= -0.69). Further, football athletes with a history of concussion had significantly thinner cortex in the right central sulcus and precentral gyrus relative to football athletes without a history of concussion (p=0.03, d= -0.71). No differences were observed between football athletes without a history of concussion and healthy controls. These results suggest that previous concussions, but not necessarily football exposure, may be associated with cortical thickness differences in collegiate football athletes.	[Meier, Timothy B.; Ling, Josef M.; Mayer, Andrew R.] Mind Res Network, Lovelace Biomed & Environm Res Inst, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Meier, Timothy B.; Bergamino, Maurizio] Laureate Inst Brain Res, Tulsa, OK USA; [Bellgowan, Patrick S. F.] NINDS, NIH, North Bethesda, MD USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Meier, TB (corresponding author), Mind Res Network, Lovelace Biomed & Environm Res Inst, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	tmeier@mrn.org	Meijer, Anna/K-5118-2016				Albaugh M. D., 2014, J PEDIAT, V166, P394; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Iverson G. L., 2014, J NEUROTRAUMA; Johnson DR, 2008, ARCH CLIN NEUROPSYCH, V23, P73, DOI 10.1016/j.acn.2007.10.001; Jones TB, 2010, NEUROIMAGE, V49, P401, DOI 10.1016/j.neuroimage.2009.07.051; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mori S, 2007, AM J PSYCHIAT, V164, P1005, DOI 10.1176/appi.ajp.164.7.1005; Narr KL, 2009, J AM ACAD CHILD PSY, V48, P1014, DOI 10.1097/CHI.0b013e3181b395c0; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pardoe HR, 2013, HUM BRAIN MAPP, V34, P3000, DOI 10.1002/hbm.22120; Porto L, 2011, EUR J PAEDIATR NEURO, V15, P493, DOI 10.1016/j.ejpn.2011.06.004; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	57	31	31	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					330	338		10.1089/neu.2015.3919			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800002	26061068	Green Published			2022-02-06	
J	La Fountaine, MF; Toda, M; Testa, AJ; Hill-Lombardi, V				La Fountaine, Michael F.; Toda, Michita; Testa, Anthony J.; Hill-Lombardi, Vicci			Autonomic Nervous System Responses to Concussion: Arterial Pulse Contour Analysis	FRONTIERS IN NEUROLOGY			English	Article						concussion; sympathetic nervous system; arterial stiffness; exercise intolerance	QT INTERVAL VARIABILITY; BLOOD-PRESSURE; STATEMENT; DETERMINANTS; DYSFUNCTION; PREDICTOR; DISEASE; SPORT; REST	The arterial pulse wave (APW) has a distinct morphology whose contours reflect dynamics in cardiac function and peripheral vascular tone as a result of sympathetic nervous system (SNS) control. With a transition from rest to increased metabolic demand, the expected augmentation of SNS outflow will not only affect arterial blood pressure and heart rate but it will also induce changes to the contours of the APW. Following a sports concussion, a transient state cardiovascular autonomic dysfunction is present. How this state affects the APW has yet to be described. A prospective, parallel-group study on cardiovascular autonomic control (i.e., digital electrocardiogram and continuous beat to-beat blood pressure) was performed in the seated upright position in 10 athletes with concussion and 7 non-injured control athletes. Changes in APW were compared at rest and during the first 60 s (F60) of an isometric handgrip test (IHGT) in concussed athletes and non injured controls within 48 h and 1 week of injury. The concussion group was further separated by the length of time until they were permitted to return to play (RTP > 1week; RTP <= 1week). SysSlope, an indirect measurement of stroke volume, was significantly lower in the concussion group at rest and during F60 at 48 h and 1week; a paradoxical decline in SysSlope occurred at each visit during the transition from rest to IHGT F60. The RTP > 1week group had lower SysSlope (405 200; 420 +/- 88; 454 +/- 236 mmHg/s, respectively) at rest 48 h compared to the RTP <= 1week and controls. Similarly at 48 h rest, several measurements of arterial stiffness were abnormal in RTP > 1week compared to RTP <= 1week and controls: peak-to-notch latency (0.12 +/- 0.04; 0.16 +/- 0.02; 0.17 +/- 0.05, respectively), notch relative amplitude (0.70 +/- 0.03; 0.71 +/- 0.04; 0.66 +/- 0.14, respectively), and stiffness index (6.4 +/- 0.2; 5.7 +/- 0.4; 5.8 +/- 0.5, respectively). Use of APW revealed that concussed athletes have a transient increase in peripheral artery stiffness, which may be a compensatory adaptation to a paradoxical decline of stroke volume during the transition from rest to a state of increased metabolic demand within 48 h of concussion. This dysfunction of the SNS appeared to be more pronounced among concussed athletes who were removed from participation for >1 week compared to those who resumed play within 7 days.	[La Fountaine, Michael F.; Hill-Lombardi, Vicci] Seton Hall Univ, Sch Hlth & Med Sci, S Orange, NJ 07079 USA; [La Fountaine, Michael F.; Hill-Lombardi, Vicci] Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, S Orange, NJ 07079 USA; [Toda, Michita] Univ Wisconsin, Dept Athlet, Madison, WI USA; [Testa, Anthony J.] Seton Hall Univ, Dept Athlet, S Orange, NJ 07079 USA		La Fountaine, MF (corresponding author), Seton Hall Univ, Sch Hlth & Med Sci, S Orange, NJ 07079 USA.; La Fountaine, MF (corresponding author), Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, S Orange, NJ 07079 USA.	lafounmi@shu.edu	La Fountaine, Michael/Q-6769-2019				Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Conder RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00890; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; DELIUS W, 1972, ACTA PHYSIOL SCAND, V84, P82, DOI 10.1111/j.1748-1716.1972.tb05158.x; Domanski MJ, 2001, AM J CARDIOL, V87, P675, DOI 10.1016/S0002-9149(00)01482-X; Drew BJ, 2004, CIRCULATION, V110, P2721, DOI 10.1161/01.CIR.0000145144.56673.59; Duprez DA, 2004, AM J HYPERTENS, V17, P647, DOI 10.1016/j.amjhyper.2004.03.671; Fagard RH, 2008, J HUM HYPERTENS, V22, P57, DOI 10.1038/sj.jhh.1002258; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; HARLEY A, 1969, J CLIN INVEST, V48, P895, DOI 10.1172/JCI106048; Herizman AB, 1937, AM J PHYSIOL, V119, P334; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; JOANNIDES R, 1995, AM J PHYSIOL-HEART C, V268, pH794, DOI 10.1152/ajpheart.1995.268.2.H794; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2014, INT J CARDIOL, V172, pE511, DOI 10.1016/j.ijcard.2014.01.095; La Fountaine MF, 2011, J ATHL TRAINING, V46, P230; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; LIND AR, 1964, CLIN SCI, V27, P229; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Middleton K, 2010, CLIN J SPORT MED, V20, P491, DOI 10.1097/JSM.0b013e3181fac088; Millasseau SC, 2002, CLIN SCI, V103, P371, DOI 10.1042/cs1030371; Millasseau SC, 2003, AM J HYPERTENS, V16, P467, DOI 10.1016/S0895-7061(03)00569-7; PARATI G, 1989, HYPERTENSION, V13, P647, DOI 10.1161/01.HYP.13.6.647; Sandercock GRH, 2005, INT J CARDIOL, V103, P238, DOI 10.1016/j.ijcard.2004.09.013; Shi P., 2009, Journal of Medical Engineering & Technology, V33, P628, DOI 10.3109/03091900903150980; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Yildiran T, 2010, TEX HEART I J, V37, P284	33	31	31	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 13	2016	7								13	10.3389/fneur.2016.00013			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE2CF	WOS:000370433100001	26925028	gold, Green Published			2022-02-06	
J	Colantonio, A				Colantonio, Angela			Sex, Gender, and Traumatic Brain Injury: A Commentary	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Brain injuries; Gender identity; Rehabilitation; Sex; Women	HEALTH; WOMEN; TRANSITION; OUTCOMES; ADULTS; WORK	The goal of this supplemental issue is to address major knowledge, research, and clinical practice gaps regarding the limited focus on brain injury in girls and women as well as limited analysis of the effect of sex and gender in research on acquired brain injury. Integrating sex and gender in research is recognized as leading to better science and, ultimately, to better clinical practice. A sex and gender analytical approach to rehabilitation research is crucial to understanding traumatic brain injury and improving quality of life outcomes for survivors. Put another way, the lack of focus on sex and gender reduces the rigor of research design, the generalizability of study findings, and the effectiveness of clinical implementation and knowledge dissemination practices. The articles in this supplement examine sex and gender using a variety of methodological approaches and research contexts. Recommendations for future research on acquired brain injury that consciously incorporates sex and gender are made throughout this issue. This supplement is a product of the Girls and Women with ABI Task Force of the American Congress of Rehabilitation Medicine. (C) 2016 by the American Congress of Rehabilitation Medicine	[Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Rehabil Sci Inst, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Ontario Neurotrauma Foundation; Toronto Rehabilitation Institute University Health Network; Canadian Institutes of Health Research Research Chair in Gender, Work and Health [CGW-126580]; Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute	Supported by the Ontario Neurotrauma Foundation and the Toronto Rehabilitation Institute University Health Network as well as through a Canadian Institutes of Health Research Research Chair in Gender, Work and Health (#CGW-126580) and the Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute.	Albrecht JS, 2015, J HEAD TRAUMA REHAB; Canadian Institutes of Health Research -Institute of Gender and Health, ONL TRAIN MOD INT SE; Canadian Institutes of Health Research -Institute of Gender and Health, DEF SEX GEND; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Cohen PN, 2013, SOCIOL COMPASS, V7, P889, DOI 10.1111/soc4.12083; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Faul M, 2010, TRAUMATIC BRAIN INJU; Gahagan J, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0144-4; Government of Canada, GEND BAS AN PLUS; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Johnson JL, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-14; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lindsay S, 2016, ARCH PHYS MED REHAB, V97, pS33, DOI 10.1016/j.apmr.2014.04.032; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Nalder E, 2016, ARCH PHYS MED REHAB, V97, pS46, DOI 10.1016/j.apmr.2014.07.428; National Institutes of Health -Office of Research on Women's Health, WHATS DIFF SEX GEND; National Institutes of Health -Office of Research on Women's Health, SCI SEX GEND HUM HLT; Oliffe JL, 2008, J MENS HEALTH, V5, P194, DOI 10.1016/j.jomh.2008.03.016; Raukar NP, 2014, ACAD EMERG MED, V21, P1370, DOI 10.1111/acem.12535; Saverino C, 2015, ARCH PHYS MED REHABI; Sharman Z, 2012, SOC SCI MED, V74, P1812, DOI 10.1016/j.socscimed.2011.08.039; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; The Cochrane Collaboration -Sex and Gender Methods Group, WHY SEX GEND MATT SY; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; World Health Organization, SOC DET HLTH WOM GEN; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532	34	31	31	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2016	97	2		1			S1	S4		10.1016/j.apmr.2015.12.002			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DC4RI	WOS:000369207600001	26804988	Bronze			2022-02-06	
J	Chang, CY; Lui, TN; Lin, JW; Lin, YL; Hsing, CH; Wang, JJ; Chen, RM				Chang, Chia-Yu; Lui, Tai-Ngar; Lin, Jia-Wei; Lin, Yi-Ling; Hsing, Chung-Hsi; Wang, Jhi-Joung; Chen, Ruei-Ming			Roles of microRNA-1 in hypoxia-induced apoptotic insults to neuronal cells	ARCHIVES OF TOXICOLOGY			English	Article						Hypoxia; Neural apoptosis; miR-1; HSP-70; Intrinsic mechanism	HEAT-SHOCK PROTEINS; TUMOR HYPOXIA; BRAIN-INJURY; BAX; ACTIVATION; EXPRESSION; MIR-1; HSP70; MITOCHONDRIA; OSTEOBLASTS	Hypoxia is a common occurrence in brain tumors and traumatic brain injury. microRNA (miR)-1 participates in the regulation of brain development and neuronal function. Interestingly, miR-1 can mediate ischemia-induced injury to cardiomyocytes. This study was designed to evaluate the roles of miR-1 in hypoxia-induced insults to neurons and the possible mechanisms. Exposure of neuro-2a cells to oxygen/glucose deprivation (OGD) or cobalt chloride decreased cell viability and induced cell apoptosis in time-dependent manners. In parallel, OGD caused augmentation of cellular Bax and cytochrome c levels, a reduction in the mitochondrial membrane potential (MMP), activation of caspase-3, and fragmentation of DNA. miR-1 was induced in neuro-2a cells by OGD. Knocking down miR-1 expression using specific antisense inhibitors significantly alleviated OGD-induced neuronal death. Administration of OGD to neuro-2a cells induced heat-shock protein (HSP)-70 messenger (m)RNA and protein expressions. A bioinformatic search revealed that miR-1-specific binding elements exist in the 3'-untranslated region of HSP-70 mRNA. Overexpression of miR-1 simultaneously attenuated OGD-induced HSP-70 mRNA and protein expressions. In comparison, knocking down miR-1 expression synergistically enhanced OGD-induced HSP-70 mRNA. As to the mechanism, reducing miR-1 expression lowered OGD-induced alterations in the MMP, caspase-3 activation, DNA fragmentation, and cell apoptosis. Taken together, this study shows that miR-1 can target HSP-70 expression and consequently mediate hypoxia-induced apoptotic insults to neuro-2a cells via an intrinsic Bax-mitochondrion-caspase protease pathway.	[Chang, Chia-Yu] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Chang, Chia-Yu; Lin, Jia-Wei; Chen, Ruei-Ming] Taipei Med Univ, Ctr Comprehens Canc, Taipei 110, Taiwan; [Lui, Tai-Ngar] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Lin, Yi-Ling; Chen, Ruei-Ming] Taipei Med Univ, Wan Fang Hosp, Brain Dis Res Ctr, Taipei 110, Taiwan; [Lin, Yi-Ling; Chen, Ruei-Ming] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei 110, Taiwan; [Hsing, Chung-Hsi; Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ Hosp, Anesthet & Toxicol Res Ctr, Taipei, Taiwan		Chen, RM (corresponding author), Taipei Med Univ, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan.	rmchen@tmu.edu.tw		chang, chia-yu/0000-0002-3403-7165	Chi-Mei Medical Center, Tainan, Taiwan [100CM-TMU-13-3]; Wan-Fang Hospital [101wf-eva-06]; National Science CouncilMinistry of Science and Technology, Taiwan [NSC101-2314-B-038-008-MY3, NSC101-2314-B-038-003-MY3]; Health and Welfare Surcharge of Tobacco Products, Taipei, Taiwan [MOHW103-TD-B-111-01]	This project was supported by grants from the Chi-Mei Medical Center (100CM-TMU-13-3), Tainan, Taiwan; Wan-Fang Hospital (101wf-eva-06), the National Science Council (NSC101-2314-B-038-008-MY3; NSC101-2314-B-038-003-MY3), and Health and Welfare Surcharge of Tobacco Products (MOHW103-TD-B-111-01), Taipei, Taiwan.	ABE K, 1993, J CEREBR BLOOD F MET, V13, P773, DOI 10.1038/jcbfm.1993.98; Ariffin AB, 2014, CANCER RES, V74, P2655, DOI 10.1158/0008-5472.CAN-13-3696; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chang HC, 2011, J CEREBR BLOOD F MET, V31, P842, DOI 10.1038/jcbfm.2010.180; Chen RM, 2010, J BONE MINER RES, V25, P2193, DOI 10.1002/jbmr.121; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chio CC, 2013, ARCH TOXICOL, V87, P459, DOI 10.1007/s00204-012-0965-5; Chuang CY, 2011, ARCH TOXICOL, V85, P209, DOI 10.1007/s00204-010-0585-x; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Gerstner ER, 2009, NAT REV CLIN ONCOL, V6, P229, DOI 10.1038/nrclinonc.2009.14; Goyal L, 2001, CELL, V104, P805, DOI 10.1016/S0092-8674(01)00276-8; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lee ST, 2009, BRIT J ANAESTH, V102, P80, DOI 10.1093/bja/aen322; Liao MH, 2014, BRIT J NUTR, V111, P55, DOI 10.1017/S0007114513002043; Lin JW, 2012, NEURO-ONCOLOGY, V14, P302, DOI 10.1093/neuonc/nor217; Lin YL, 2010, J NUTR, V140, P2187, DOI 10.3945/jn.110.123505; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Mazzeo AT, 2007, J NEUROL SCI, V261, P1, DOI 10.1016/j.jns.2007.04.026; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; Okouchi M, 2007, ANTIOXID REDOX SIGN, V9, P1059, DOI 10.1089/ars.2007.1511; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Patterson AJ, 2010, CURR MOL MED, V10, P653; Qi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069509; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shi Q, 2007, CELL MOL IMMUNOL, V4, P53; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Varendi K, 2014, CELL MOL LIFE SCI, V71, P4443, DOI 10.1007/s00018-014-1628-x; Wang H, 2006, BRAIN RES, V1114, P212, DOI 10.1016/j.brainres.2006.07.056; Wang PF, 2014, J IMMUNOL, V192, P4783, DOI 10.4049/jimmunol.1303108; Wei JD, 2012, J ORTHOP RES, V30, P1058, DOI 10.1002/jor.22046; Wu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072404; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Zhang Y, 2010, CELL PHYSIOL BIOCHEM, V26, P991, DOI 10.1159/000324012	44	31	32	0	19	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	JAN	2016	90	1					191	202		10.1007/s00204-014-1364-x			12	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	DD8SJ	WOS:000370196900010	25238743				2022-02-06	
J	Fisher, LB; Pedrelli, P; Iverson, GL; Bergquist, TF; Bombardier, CH; Hammond, FM; Hart, T; Ketchum, JM; Giacino, J; Zafonte, R				Fisher, Lauren B.; Pedrelli, Paola; Iverson, Grant L.; Bergquist, Thomas F.; Bombardier, Charles H.; Hammond, Flora M.; Hart, Tessa; Ketchum, Jessica M.; Giacino, Joseph; Zafonte, Ross			Prevalence of suicidal behaviour following traumatic brain injury: Longitudinal follow-up data from the NIDRR Traumatic Brain Injury Model Systems	BRAIN INJURY			English	Article						Traumatic brain injury; depression; suicide; suicidal ideation; suicide attempt; prevalence	MAJOR DEPRESSIVE DISORDER; MINOR DEPRESSION; UNITED-STATES; RISK-FACTORS; REHABILITATION; IDEATION; HEALTH; RATES; EPIDEMIOLOGY; POPULATION	Objective: This study utilized the Traumatic Brain Injury Model Systems (TBIMS) National Database to examine the prevalence of depression and suicidal behaviour in a large cohort of patients who sustained moderate-to-severe TBI.Method: Participants presented to a TBIMS acute care hospital within 72 hours of injury and received acute care and comprehensive rehabilitation in a TBIMS designated brain injury inpatient rehabilitation programme. Depression and suicidal ideation were measured with the Patient Health Questionnaire (PHQ-9). Self-reported suicide attempts during the past year were recorded at each follow-up examination, at 1, 2, 3, 10, 15 and 20 years post-injury.Results: Throughout the 20 years of follow-up, rates of depression ranged from 24.8-28.1%, suicidal ideation ranged from 7.0-10.1% and suicide attempts (past year) ranged from 0.8-1.7%. Participants who endorsed depression and/or suicidal behaviour at year 1 demonstrated consistently elevated rates of depression and suicidal behaviour 5 years after TBI.Conclusion: Compared to the general population, individuals with TBI are at greater risk for depression and suicidal behaviour many years after TBI. The significant psychiatric symptoms evidenced by individuals with TBI highlight the need for routine screening and mental health treatment in this population.	[Fisher, Lauren B.; Pedrelli, Paola; Giacino, Joseph] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Fisher, Lauren B.; Pedrelli, Paola] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Iverson, Grant L.; Giacino, Joseph; Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.; Giacino, Joseph; Zafonte, Ross] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med Rochester, Dept Psychol, Rochester, MN USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med Rochester, Dept Psychiat, Rochester, MN USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med Rochester, Dept Phys Med & Rehabil, Rochester, MN USA; [Bombardier, Charles H.] Univ Washington, Dept Rehabil Med, Div Clin & Neuropsychol, Seattle, WA 98195 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Ketchum, Jessica M.] Georgia Regents Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [Zafonte, Ross] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA		Fisher, LB (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Depress Clin & Res Program, One Bowdoin Sq,6th Floor, Boston, MA 02114 USA.	lbfisher@mgh.harvard.edu	Bombardier, Charles H./AAZ-3260-2021; Ketchum, Jessica/AAE-8200-2020; Giacino, Joseph/AAF-1952-2021	Bombardier, Charles H./0000-0003-4758-6283; Giacino, Joseph/0000-0002-7916-9698; Iverson, Grant/0000-0001-7348-9570	Department of Health and Human Services, National Institute on Disability, Independent Living and Rehabilitation Research [H133A120085, H133A 120026, H133A120028, H133A120035, H133A120037, H133A120031]; Harvard Medical School; Avanir; INTRuST Post-traumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Programme [X81XWH-07-CC-CSDoD]	The contents of this manuscript were developed under a grant from the Department of Health and Human Services, National Institute on Disability, Independent Living and Rehabilitation Research grant numbers H133A120085, H133A 120026, H133A120028, H133A120035, H133A120037 and H133A120031. However, those contents do not necessarily represent the policy of the Department of Education and you should not assume endorsement by the Federal Government. Lauren B. Fisher, PhD received a fellowship grant from Harvard Medical School to support the current work. Flora Hammond, MD, has received personal fees from Avanir for participation on the PRISM II Steering Committee and stock ownership [Stock ownership in health care companies include: ABBVIE INC SHS ($34 247 market value), ELI LILLY & CO ($14 535), GLAXOSMITHKLINE PLC ADR ($23 794), Exchange Traded Funds ($84 545) and Mutual Funds ($47 095)]. Joseph Giacino, PhD, is a member of the Advisory Board of the TBIMS National Data and Statistical Center. Dr. Zafonte and Dr. Iverson acknowledge additional support from the INTRuST Post-traumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Programme (X81XWH-07-CC-CSDoD). Grant Iverson, PhD, has been reimbursed by the government, professional scientific bodies and commercial organizations for discussing or presenting research relating to MTBI and sport-related concussion atmeetings, scientific conferences and symposiums. He has a clinical practice in forensic neuropsychology involving individuals who have sustained mild TBIs. He has received honorariums for serving on research panels that provide scientific peer review of programmes. He is a co-investigator, collaborator or consultant on grants relating to mild TBI funded by several organizations. For the remaining authors, no conflicts were declared.	Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; First M., 1995, STRUCTURED CLIN INTE, V9, P92; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Moller HJ, 2003, ACTA PSYCHIAT SCAND, V108, P73, DOI 10.1034/j.1600-0447.108.s418.15.x; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; PHILLIPS DP, 1993, SUICIDE LIFE-THREAT, V23, P307; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Uebelacker Lisa A, 2011, Prim Care Companion CNS Disord, V13, DOI 10.4088/PCC.10m01027; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	33	31	31	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	11					1311	1318		10.1080/02699052.2016.1195517			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DZ8TP	WOS:000386144900004	27541868	Green Submitted			2022-02-06	
J	Jackson, ACW; Roche, SL; Byrne, AM; Ruiz-Lopez, AM; Cotter, TG				Jackson, Alice C. Wyse; Roche, Sarah L.; Byrne, Ashleigh M.; Ruiz-Lopez, Ana M.; Cotter, Thomas G.			Progesterone receptor signalling in retinal photoreceptor neuroprotection	JOURNAL OF NEUROCHEMISTRY			English	Article						neuroprotection; Norgestrel; PGRMC1; photoreceptor; progesterone; retinal degeneration	BREAST-CANCER CELLS; MEMBRANE COMPONENT-1 PGRMC1; TRAUMATIC BRAIN-INJURY; TIME QUANTITATIVE PCR; RETINITIS-PIGMENTOSA; ANTIAPOPTOTIC ACTION; GRANULOSA-CELLS; UP-REGULATION; 661W CELLS; PROTEIN	Norgestrel', a synthetic form of the female hormone progesterone has been identified as potential drug candidate for the treatment of the degenerative eye disease retinitis pigmentosa. However, to date, no work has looked at the compound's specific cellular target. Therefore, this study aimed to identify the receptor target of Norgestrel and begin to examine its potential mechanism of action in the retina. In this work, we identify and characterize the expression of progesterone receptors present in the C57 wild type and rd10 mouse model of retinitis pigmentosa. Classical progesterone receptors A and B (PR A/B), progesterone receptor membrane components 1 and 2 (PGRMC1, PGRMC2) and membrane progesterone receptors , and were found to be expressed. All receptors excluding PR A/B were also found in the 661W photoreceptor cell line. PGRMC1 is a key regulator of apoptosis and its expression is up-regulated in the degenerating rd10 mouse retina. Activated by Norgestrel through nuclear trafficking, siRNA knock down of PGRMC1 abrogated the protective properties of Norgestrel on damaged photoreceptors. Furthermore, specific inhibition of PGRMC1 by AG205 blocked Norgestrel-induced protection in stressed retinal explants. Therefore, we conclude that PGRMC1 is crucial to the neuroprotective effects of Norgestrel on stressed photoreceptors.	[Jackson, Alice C. Wyse; Roche, Sarah L.; Byrne, Ashleigh M.; Ruiz-Lopez, Ana M.; Cotter, Thomas G.] Natl Univ Ireland Univ Coll Cork, Biosci Res Inst, Dept Biochem, Cell Dev & Dis Lab, Cork, Ireland		Cotter, TG (corresponding author), Natl Univ Ireland Univ Coll Cork, Biosci Res Inst, Dept Biochem, Cell Dev & Dis Lab, Cork, Ireland.	t.cotter@ucc.ie		Cotter, Thomas/0000-0003-4626-5613	Fighting Blindness Ireland; Science Foundation Ireland (SFI)Science Foundation Ireland	The authors would like to thank Ms Jennifer Moloney for useful discussions relating to this work. The authors also gratefully acknowledge all members of the Biological Services Unit (BSU) for their assistance. This work was supported by Fighting Blindness Ireland and Science Foundation Ireland (SFI).	Ait-Hmyed O, 2013, EUR J NEUROSCI, V37, P1048, DOI 10.1111/ejn.12103; Ashley RL, 2006, ENDOCRINOLOGY, V147, P4151, DOI 10.1210/en.2006-0002; Barone I, 2014, MOL VIS, V20, P1545; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; Borowicz Kinga K, 2011, Front Endocrinol (Lausanne), V2, P50, DOI 10.3389/fendo.2011.00050; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Choksuchat C, 2009, CONTRACEPTION, V79, P139, DOI 10.1016/j.contraception.2008.08.008; Compagnone NA, 2008, J STEROID BIOCHEM, V109, P307, DOI 10.1016/j.jsbmb.2008.03.022; Crudden G, 2006, J PHARMACOL EXP THER, V316, P448, DOI 10.1124/jpet.105.094631; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Deniselle MCG, 2002, NEUROBIOL DIS, V11, P457, DOI 10.1006/nbdi.2002.0564; Diederen RMH, 2008, MOL VIS, V14, P255; Doonan F, 2012, EXPERT OPIN INV DRUG, V21, P579, DOI 10.1517/13543784.2012.667400; Doonan F, 2011, J NEUROCHEM, V118, P915, DOI 10.1111/j.1471-4159.2011.07354.x; Doonan F, 2009, J NEUROCHEM, V109, P631, DOI 10.1111/j.1471-4159.2009.05995.x; Dressing GE, 2007, STEROIDS, V72, P111, DOI 10.1016/j.steroids.2006.10.006; Dressing GE, 2012, HORM CANCER-US, V3, P101, DOI 10.1007/s12672-012-0106-x; Espinosa-Garcia C, 2014, BRAIN RES, V1545, P23, DOI 10.1016/j.brainres.2013.11.030; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Friberg PA, 2009, BIOL REPROD, V80, P1160, DOI 10.1095/biolreprod.108.073932; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gomez-Vicente V, 2005, CELL DEATH DIFFER, V12, P796, DOI 10.1038/sj.cdd.4401621; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Guerin MB, 2011, CLIN EXP OPHTHALMOL, V39, P243, DOI 10.1111/j.1442-9071.2011.02496.x; Hanna RN, 2010, BIOL REPROD, V82, P112, DOI 10.1095/biolreprod.109.078527; Intlekofer KA, 2011, NEUROSCIENCE, V176, P86, DOI 10.1016/j.neuroscience.2010.12.033; Kupchak BR, 2009, BIOCHEMISTRY-US, V48, P5504, DOI 10.1021/bi9006258; Lange CA, 2008, J STEROID BIOCHEM, V108, P203, DOI 10.1016/j.jsbmb.2007.09.019; Li YC, 1997, J MOL NEUROSCI, V8, P145, DOI 10.1007/BF02736779; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losel RM, 2008, STEROIDS, V73, P929, DOI 10.1016/j.steroids.2007.12.017; Lu Na, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P2026; Mackey AM, 2008, CELL DEATH DIFFER, V15, P1291, DOI 10.1038/cdd.2008.43; Mastrodimou N, 2008, INVEST OPHTH VIS SCI, V49, P342, DOI 10.1167/iovs.07-0341; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Moussatche P, 2012, BIOCHEM SOC T, V40, P200, DOI 10.1042/BST20110638; Mygind T, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-17; Okumichi H, 2008, EXP EYE RES, V86, P727, DOI 10.1016/j.exer.2008.01.019; Pang YF, 2011, STEROIDS, V76, P921, DOI 10.1016/j.steroids.2011.01.008; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Peluso JJ, 2008, J CLIN ENDOCR METAB, V93, P1592, DOI 10.1210/jc.2007-2771; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Peluso JJ, 2014, BIOL REPROD, V91, DOI [10.1095/biolreprod.114.122986, 10.1095/biolreprod.114.117481]; Peluso JJ, 2012, STEROIDS, V77, P1007, DOI 10.1016/j.steroids.2012.01.013; Penha FM, 2013, OPHTHALMOLOGICA, V230, P41, DOI 10.1159/000354251; Petersen SL, 2013, J NEUROENDOCRINOL, V25, P991, DOI 10.1111/jne.12060; Qin YB, 2015, J STEROID BIOCHEM, V154, P302, DOI 10.1016/j.jsbmb.2015.01.002; Roglio I, 2008, NEUROSCIENCE, V155, P673, DOI 10.1016/j.neuroscience.2008.06.034; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Samadi A, 2002, PFLUG ARCH EUR J PHY, V444, P700, DOI 10.1007/s00424-002-0889-7; Samardzija M, 2012, EXP EYE RES, V99, P17, DOI 10.1016/j.exer.2012.04.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sobolewska B, 2013, CURR EYE RES, V38, P662, DOI 10.3109/02713683.2012.746991; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Swiatek-De Lange M, 2007, GLIA, V55, P1061, DOI 10.1002/glia.20523; Thomas P, 2007, ENDOCRINOLOGY, V148, P705, DOI 10.1210/en.2006-0974; Thomas P, 2012, NEUROENDOCRINOLOGY, V96, P162, DOI 10.1159/000339822; WEN DX, 1994, MOL CELL BIOL, V14, P8356, DOI 10.1128/MCB.14.12.8356; Wendler A, 2013, STEROIDS, V78, P555, DOI 10.1016/j.steroids.2012.12.002; Wickham LA, 2000, ACTA OPHTHALMOL SCAN, V78, P146, DOI 10.1034/j.1600-0420.2000.078002146.x; WONG F, 1993, ARCH OPHTHALMOL-CHIC, V111, P754, DOI 10.1001/archopht.1993.01090060042020; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	70	31	34	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JAN	2016	136	1					63	77		10.1111/jnc.13388			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CZ6DZ	WOS:000367192700006	26447367	Bronze			2022-02-06	
J	Mehta, H; Acharya, J; Mohan, AL; Tobias, ME; LeCompte, L; Jeevan, D				Mehta, H.; Acharya, J.; Mohan, A. L.; Tobias, M. E.; LeCompte, L.; Jeevan, D.			Minimizing Radiation Exposure in Evaluation of Pediatric Head Trauma: Use of Rapid MR Imaging	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							BRAIN-INJURY; COMPUTED-TOMOGRAPHY; DECISION-ANALYSIS; CLINICAL ARTICLE; UNITED-STATES; CT; MILD; CHILDREN; HYDROCEPHALUS; MANAGEMENT	This study is a retrospective review of 103 pediatric patients who underwent initial head CT and subsequent follow-up rapid MR imaging between January 2010 and July 2013. Patients had minor head injuries that required imaging. There was almost perfect agreement in the ability to detect extra-axial hemorrhage on rapid MR imaging and CT (kappa = 0.84). Evaluation of hemorrhagic contusion/hemorrhage demonstrated a moderate level of agreement between MR imaging and CT (kappa = 0.61). The authors conclude that rapid MRI is an adequate imaging technique for the follow-up of pediatric patients with minor head trauma. BACKGROUND AND PURPOSE: With >473,000 annual emergency department visits for children with traumatic brain injuries in the United States, the risk of ionizing radiation exposure during CT examinations is a real concern. The purpose of this study was to assess the validity of rapid MR imaging to replace CT in the follow-up imaging of patients with head trauma. MATERIALS AND METHODS: A retrospective review of 103 pediatric patients who underwent initial head CT and subsequent follow-up rapid MR imaging between January 2010 and July 2013 was performed. Patients had minor head injuries (Glasgow Coma Scale, >13) that required imaging. Initial head CT was performed, with follow-up rapid MR imaging completed within 48 hours. A board-certified neuroradiologist, blinded to patient information and scan parameters, then independently interpreted the randomized cases. RESULTS: There was almost perfect agreement in the ability to detect extra-axial hemorrhage on rapid MR imaging and CT ( = 0.84, P < .001). Evaluation of hemorrhagic contusion/intraparenchymal hemorrhage demonstrated a moderate level of agreement between MR imaging and CT ( = 0.61, P < .001). The ability of MR imaging to detect a skull fracture also showed a substantial level of agreement with CT ( = 0.71, P < .001). Detection of diffuse axonal injury demonstrated a slight level of agreement between MR imaging and CT ( = 0.154, P = .04). However, the overall predictive agreement for the detection of an axonal injury was 91%. CONCLUSIONS: Rapid MR imaging is a valid technique for detecting traumatic cranial injuries and an adequate examination for follow-up imaging in lieu of repeat CT.	[Mehta, H.; Acharya, J.; LeCompte, L.] New York Med Coll, Dept Radiol, Valhalla, NY 10595 USA; [Mohan, A. L.; Tobias, M. E.; Jeevan, D.] New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA		Mehta, H (corresponding author), New York Med Coll, Dept Radiol, 100 Woods Rd, Valhalla, NY 10595 USA.	MehtaH@wcmc.com					af Geijerstam JL, 2004, EMERG MED J, V21, P54, DOI 10.1136/emj.2003.003178; Ashley WW, 2005, J NEUROSURG, V103, P124, DOI 10.3171/ped.2005.103.2.0124; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Cote CJ, 2000, PEDIATRICS, V106, P633, DOI 10.1542/peds.106.4.633; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Ikeda K, 2000, J PERINAT MED, V28, P151, DOI 10.1515/JPM.2000.021; JENKINS A, 1986, LANCET, V2, P445; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Klig JE, 2006, CURR OPIN PEDIATR, V18, P231, DOI 10.1097/01.mop.0000193319.06322.76; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Linton OW, 2003, AM J ROENTGENOL, V181, P321, DOI 10.2214/ajr.181.2.1810321; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Malviya S, 2000, BRIT J ANAESTH, V84, P743, DOI 10.1093/oxfordjournals.bja.a013586; Missios S, 2008, J NEUROS-PEDIATR, V2, P438, DOI 10.3171/PED.2008.2.12.438; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morrison J, 2013, PEDIATR EMERG CARE, V29, P1189, DOI 10.1097/PEC.0b013e3182a9f7c1; O'Neill BR, 2013, WORLD NEUROSURG, V80, pE307, DOI 10.1016/j.wneu.2012.10.066; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Partovi S, 1999, NEUROIMAG CLIN N AM, V9, P553; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Thompson EM, 2014, J NEUROSURG-PEDIATR, V13, P636, DOI 10.3171/2014.2.PEDS13567; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; White KS, 1996, PEDIATR RADIOL, V26, P5, DOI 10.1007/BF01403695; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	35	31	31	0	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JAN	2016	37	1					11	18		10.3174/ajnr.A4464			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DA0DI	WOS:000367466500007	26381555	hybrid, Green Published			2022-02-06	
J	Moore, DR; Pindus, DM; Raine, LB; Drollette, ES; Scudder, MR; Ellemberg, D; Hillman, CH				Moore, Davis R.; Pindus, Dominika M.; Raine, Lauren B.; Drollette, Eric S.; Scudder, Mark R.; Ellemberg, Dave; Hillman, Charles H.			The persistent influence of concussion on attention, executive control and neuroelectric function in preadolescent children	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Sport-concussion; Children; Brain function; Event related potentials; Cognition	TRAUMATIC BRAIN-INJURY; COGNITIVE CONTROL; WORKING-MEMORY; NEUROPSYCHOLOGICAL FUNCTION; PEDIATRIC CONCUSSION; HEAD-INJURY; ADOLESCENTS; OUTCOMES; PERFORMANCE; RECOVERY	The aim of this investigation was to examine the influence of pediatric sport-related concussion on brain and cognitive function. To do so, we used a between-participants design, measures of executive control, and event related potentials (ERPs). The findings demonstrate that children with a history of concussion exhibit behavioral deficits in attention, working memory and impulse control, as well as neuroelectric alterations in ERP indices of visual attention (N1), conflict resolution (N2) and attentional resource allocation (P3). Furthermore, the age at injury related to the magnitude of several concussion-related deficits. Accordingly, a single sports-related concussive incident during childhood (m = 2.1 years prior to testing) may lead to subtle, yet pervasive alterations in the behavioral and neural indices of attention and executive control, and age at injury may moderate injury outcomes. (C) 2015 Elsevier B.V. All rights reserved.	[Moore, Davis R.; Raine, Lauren B.; Drollette, Eric S.; Scudder, Mark R.; Hillman, Charles H.] Univ Illinois, Urbana, IL 61801 USA; [Pindus, Dominika M.] Univ Loughborough, Loughborough, Leics, England; [Ellemberg, Dave] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Ellemberg, Dave] 2100 Blvd Edouard Montpetit, Montreal, PQ H3T 1J4, Canada; [Pindus, Dominika M.] Ashby Rd, Loughborough LE11 3TU, Leics, England; [Raine, Lauren B.; Drollette, Eric S.; Scudder, Mark R.; Hillman, Charles H.] 906 S Goodwin Ave, Urbana, IL 61801 USA		Moore, DR (corresponding author), 2100 Blvd Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	robert.moore@umontreal.ca; D.M.Pindus@lboro.ac.uk; lraine19@gmail.com; droeri@gmail.com; mscudde2@illinois.edu; dave.ellemberg@umontreal.ca; chhillma@gmail.com	Meijer, Anna/K-5118-2016; Hillman, Charles/AAD-4828-2019	Pindus, Dominika M/0000-0001-7288-7921; Hillman, Charles/0000-0002-3722-5612			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bar-Or O, 1983, PEDIATRIC SPORTS MED, P1; Beste C, 2010, NEUROPSYCHOLOGIA, V48, P366, DOI 10.1016/j.neuropsychologia.2009.09.023; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Birnbaum AS, 2002, AM J HEALTH BEHAV, V26, P284, DOI 10.5993/AJHB.26.4.5; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chaddock L, 2012, J SPORT SCI, V30, P421, DOI 10.1080/02640414.2011.647706; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Conners C.K., 2001, CONNERS CHILD ADHD D; Control and Prevention, 1997, INT J TRAUMA NURS, V3, P88; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Faul M, 2010, TRAUMATIC BRAIN INJU; FREEDSON PS, 1993, PEDIATRIC LABORATORY EXERCISE TESTING, P91; Gajewski PD, 2013, INT J PSYCHOPHYSIOL, V87, P273, DOI 10.1016/j.ijpsycho.2012.08.007; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gothe N, 2013, J PHYS ACT HEALTH, V10, P488, DOI 10.1123/jpah.10.4.488; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hillman CH, 2014, PEDIATRICS, V134, pE1063, DOI 10.1542/peds.2013-3219; Hillman CH, 2012, DEV COGN NEUROS-NETH, V2, pS90, DOI 10.1016/j.dcn.2011.07.004; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hoffman B, 2009, LEARN INDIVID DIFFER, V19, P91, DOI 10.1016/j.lindif.2008.08.001; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kamijo K, 2012, OBESITY, V20, P2406, DOI 10.1038/oby.2012.112; Kamijo K, 2011, DEVELOPMENTAL SCI, V14, P1046, DOI 10.1111/j.1467-7687.2011.01054.x; Kaufman A., 1990, AM GUIDANCE SERVICE; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Kirkwood M, 2012, MILD TRAUMATIC BRAIN; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Luna B, 2009, ADV CHILD DEV BEHAV, V37, P233, DOI 10.1016/S0065-2407(09)03706-9; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Neuroscan C., 2003, OFFLINE ANAL ACQUIRE; Nolin P., 2000, Annales de Readaptation et de Medecine Physique, V43, P236, DOI 10.1016/S0168-6054(00)89087-X; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; Smith JL, 2010, INT J PSYCHOPHYSIOL, V75, P217, DOI 10.1016/j.ijpsycho.2009.11.002; Taylor SJC, 2001, PAEDIATR PERINAT EP, V15, P88; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Utter AC, 2002, MED SCI SPORT EXER, V34, P139, DOI 10.1097/00005768-200201000-00021; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1017/S0048577200981265; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	78	31	32	0	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	JAN	2016	99						85	95		10.1016/j.ijpsycho.2015.11.010			11	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	DC4MA	WOS:000369193800011	26608697				2022-02-06	
J	Raithatha, R; Carrico, C; Powell, ES; Westgate, PM; Chelette, KC; Lee, K; Dunsmore, L; Salles, S; Sawaki, L				Raithatha, Ravi; Carrico, Cheryl; Powell, Elizabeth Salmon; Westgate, Philip M.; Chelette, Kenneth C., II; Lee, Kara; Dunsmore, Laura; Salles, Sara; Sawaki, Lumy			Non-invasive brain stimulation and robot-assisted gait training after incomplete spinal cord injury: A randomized pilot study	NEUROREHABILITATION			English	Article						Lower extremity; motor function; neuroplasticity; treadmill training; transcranial direct current stimulation	MOTOR FUNCTION; CHRONIC STROKE; CORTICAL EXCITABILITY; MUSCLE STRENGTH; TRAUMATIC BRAIN; DC STIMULATION; REHABILITATION; RELIABILITY; VALIDITY; PLASTICITY	BACKGROUND: Locomotor training with a robot-assisted gait orthosis (LT-RGO) and transcranial direct current stimulation (tDCS) are interventions that can significantly enhance motor performance after spinal cord injury (SCI). No studies have investigated whether combining these interventions enhances lower extremity motor function following SCI. OBJECTIVE: Determine whether active tDCS paired with LT-RGO improves lower extremity motor function more than a sham condition, in subjects with motor incomplete SCI. METHODS: Fifteen adults with SCI received 36 sessions of either active (n = 9) or sham (n = 6) tDCS (20 minutes) preceding LT-RGO (1 hour). Outcome measures included manual muscle testing (MMT; primary outcome measure); 6-Minute Walk Test (6MinWT); 10-Meter Walk Test (10MWT); Timed Up and Go Test (TUG); Berg Balance Scale (BBS); and Spinal Cord Independence Measure-III (SCIM-III). RESULTS: MMT showed significant improvements after active tDCS, with the most pronounced improvement in the right lower extremity. 10MWT, 6MinWT, and BBS showed improvement for both groups. TUG and SCIM-III showed improvement only for the sham tDCS group. CONCLUSION: Pairing tDCS with LT-RGO can improve lower extremity motor function more than LT-RGO alone. Future research with a larger sample size is recommended to determine longer-term effects on motor function and activities of daily living.	[Raithatha, Ravi] Univ Pikeville, Kentucky Coll Osteopath Med, Pikeville, KY USA; [Carrico, Cheryl; Powell, Elizabeth Salmon; Chelette, Kenneth C., II; Salles, Sara; Sawaki, Lumy] Univ Kentucky, Dept Phys Med & Rehabil, Lexington, KY 40504 USA; [Westgate, Philip M.] Univ Kentucky, Dept Biostat, Coll Publ Hlth, Lexington, KY 40504 USA; [Lee, Kara] Univ Kentucky, Coll Hlth Sci, Lexington, KY 40504 USA; [Dunsmore, Laura; Sawaki, Lumy] HealthSouth Cardinal Hill Rehabil Hosp, Lexington, KY USA		Sawaki, L (corresponding author), Univ Kentucky, Dept Phys Med & Rehabil, HealthSouth Cardinal Hill Hosp, 2050 Versailles Rd, Lexington, KY 40504 USA.	lsawa2@uky.edu			Christopher and Dana Reeve Foundation [SAC1-1001-2]; Cardinal Hill Stroke and Spinal Cord Endowment [1215375670]	This study was funded by Christopher and Dana Reeve Foundation (SAC1-1001-2) and the Cardinal Hill Stroke and Spinal Cord Endowment (1215375670). There are no financial benefits to the authors. Partial results of this study were first presented in poster form at Reeve Foundation's fourth Spinal Cord Symposium: August 2010; Phoenix, AZ. There are no conflicts of interest related to this research or this manuscript.	[Anonymous], 2014, J Spinal Cord Med, V37, P117, DOI 10.1179/1079026813Z.000000000249; Behrman AL, 2006, PHYS THER, V86, P1406, DOI 10.2522/ptj.20050212; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; Cabral ME, 2015, NEUROREPORT, V26, P618, DOI 10.1097/WNR.0000000000000397; Carda S, 2012, NEUROREHAB NEURAL RE, V26, P1027, DOI 10.1177/1545968312446753; Chang MC, 2015, BRAIN STIMUL, V8, P561, DOI 10.1016/j.brs.2015.01.411; Chen G, 2006, J REHABIL RES DEV, V43, P485, DOI 10.1682/JRRD.2005.04.0063; Grecco LAC, 2014, RES DEV DISABIL, V35, P2840, DOI 10.1016/j.ridd.2014.07.030; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Cuthbert Scott C, 2007, Chiropr Osteopat, V15, P4, DOI 10.1186/1746-1340-15-4; Danzl MM, 2013, NEUROREHABILITATION, V33, P67, DOI 10.3233/NRE-130929; Dietz V, 2009, BRAIN RES BULL, V78, pI, DOI 10.1016/S0361-9230(08)00410-3; Dietz V, 2012, EXP NEUROL, V235, P110, DOI 10.1016/j.expneurol.2011.04.007; Dobkin BH, 2009, CURR OPIN NEUROL, V22, P563, DOI 10.1097/WCO.0b013e3283314b11; Downs S, 2013, J PHYSIOTHER, V59, P93, DOI 10.1016/S1836-9553(13)70161-9; Edwards DJ, 2009, RESTOR NEUROL NEUROS, V27, P199, DOI 10.3233/RNN-2009-0470; Fan E, 2010, INTENS CARE MED, V36, P1038, DOI 10.1007/s00134-010-1796-6; Field-Fote EC, 2011, PHYS THER, V91, P62, DOI 10.2522/ptj.20090359.ar; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Geroin C, 2011, CLIN REHABIL, V25, P537, DOI 10.1177/0269215510389497; Giacobbe V, 2013, NEUROREHABILITATION, V33, P49, DOI 10.3233/NRE-130927; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1508, DOI 10.1016/j.apmr.2011.01.024; Hesse S, 2007, RESTOR NEUROL NEUROS, V25, P9; Hesse S, 2003, CURR OPIN NEUROL, V16, P705, DOI 10.1097/00019052-200312000-00010; Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632; Hornby TG, 2010, PM&R, V2, P214, DOI 10.1016/j.pmrj.2010.02.013; Hummel F, 2005, NEUROREHAB NEURAL RE, V19, P14, DOI 10.1177/1545968304272698; Itzkovich M, 2007, DISABIL REHABIL, V29, P1926, DOI 10.1080/09638280601046302; Jackson AB, 2008, J SPINAL CORD MED, V31, P487, DOI 10.1080/10790268.2008.11753644; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Kaski D, 2014, CLIN REHABIL, V28, P1115, DOI 10.1177/0269215514534277; Knikou M, 2010, CLIN NEUROPHYSIOL, V121, P1655, DOI 10.1016/j.clinph.2010.01.039; Koenig AC, 2009, IEEE ENG MED BIO, P1758, DOI 10.1109/IEMBS.2009.5333096; Koganemaru S, 2015, NEUROSCI RES, V92, P29, DOI 10.1016/j.neures.2014.10.004; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Krewer C, 2007, GAIT POSTURE, V26, P372, DOI 10.1016/j.gaitpost.2006.10.003; Labruyere R, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-4; Lammertse D, 2007, SPINAL CORD, V45, P232, DOI 10.1038/sj.sc.3102010; Lapitskaya N, 2011, BRAIN INJURY, V25, P1070, DOI 10.3109/02699052.2011.607782; Dumont AJL, 2015, J PHYS THER SCI, V27, P955, DOI 10.1589/jpts.27.955; Lynskey JV, 2008, J REHABIL RES DEV, V45, P229, DOI 10.1682/JRRD.2007.03.0047; Martinez M, 2009, EUR J NEUROSCI, V30, P2356, DOI 10.1111/j.1460-9568.2009.07019.x; Mehrholz Jan, 2008, Spine (Phila Pa 1976), V33, pE768, DOI 10.1097/BRS.0b013e3181849747; MERZENICH MM, 1990, COLD SH Q B, V55, P873; MERZENICH MM, 1982, TRENDS NEUROSCI, V5, P434, DOI 10.1016/0166-2236(82)90235-1; Neckel N, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2698; Nitsche MA, 2002, NERVENARZT, V73, P332, DOI 10.1007/s00115-002-1272-9; Nudo Randolph J, 2003, Phys Med Rehabil Clin N Am, V14, pS57, DOI 10.1016/S1047-9651(02)00054-2; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROSCI, V16, P785; Paternostro-Sluga T, 2008, J REHABIL MED, V40, P665, DOI 10.2340/16501977-0235; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Scivoletto G, 2011, SPINAL CORD, V49, P736, DOI 10.1038/sc.2010.180; Shin JC, 2014, ANN REHABIL MED-ARM, V38, P719, DOI 10.5535/arm.2014.38.6.719; Stephenson JL, 2010, GAIT POSTURE, V31, P109, DOI 10.1016/j.gaitpost.2009.09.008; Sullivan J, 2011, NEUROLOGY SECTION ST; Swinnen E, 2010, J REHABIL MED, V42, P520, DOI 10.2340/16501977-0538; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; van Hedelt HJA, 2008, NEUROL RES, V30, P61, DOI 10.1179/016164107X230775; Vaney C, 2012, NEUROREHAB NEURAL RE, V26, P212, DOI 10.1177/1545968311425923; WADSWORTH CT, 1987, PHYS THER, V67, P1342, DOI 10.1093/ptj/67.9.1342; Williams JA, 2009, J REHABIL MED, V41, P305, DOI 10.2340/16501977-0356; Wirz M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-60	72	31	31	1	22	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	1					15	25		10.3233/NRE-151291			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DE6CC	WOS:000370719800003	26889794				2022-02-06	
J	Seal, KH; Bertenthal, D; Samuelson, K; Maguen, S; Kumar, S; Vasterling, JJ				Seal, Karen H.; Bertenthal, Daniel; Samuelson, Kristin; Maguen, Shira; Kumar, Sant; Vasterling, Jennifer J.			Association between mild traumatic brain injury and mental health problems and self-reported cognitive dysfunction in Iraq and Afghanistan Veterans	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						cognitive dysfunction; concussion; depression; mental health; mild traumatic brain injury; population-based screening; postdeployment; posttraumatic stress disorder; primary care; recovery expectations; Veterans	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; NEUROPSYCHOLOGICAL OUTCOMES; WAR VETERANS; HEAD-INJURY; COMPLAINTS; PERFORMANCE; DEPLOYMENT; SOLDIERS; CONSEQUENCES	The Department of Veterans Affairs traumatic brain injury (TBI) screening program is intended to detect and expedite treatment for TBI and postconcussive symptoms. Between April 14, 2007, and May 31, 2012, of 66,089 Iraq and Afghanistan Veterans who screened positive on first-level TBI screening and later completed comprehensive TBI evaluation that includes the Neurobehavioral Symptoms Inventory, 72% reported moderate to very severe cognitive impairment (problems with attention, concentration, memory, etc.) that interfered with daily activities. This included 42% who were found not to have sustained combat-related mild TBI (mTBI). In contrast, 70.0% received a posttraumatic stress disorder (PTSD) diagnosis and 45.8% received a depression diagnosis. Compared with Veterans without mTBI, PTSD, or depression diagnoses, the lowest risk for self-reported cognitive impairment was in Veterans with confirmed mTBI only; a greater risk was found in those with PTSD diagnoses, with the greatest risk in Veterans with PTSD, depression, and confirmed mTBI, suggesting only a weakly additive effect of mTBI. These findings suggest that Veterans with multiple mental health comorbidities, not just those with TBI, report moderate to very severe cognitive impahment. Mental health treatment for conditions such as PTSD and depression (with or without TBI) may result in improvements in cognitive functioning and/or include assessment and support for Veterans experiencing cognitive problems.	[Seal, Karen H.; Bertenthal, Daniel; Samuelson, Kristin; Maguen, Shira; Kumar, Sant] San Francisco Dept Vet Affairs VA Hlth Care Syst, San Francisco, CA USA; [Seal, Karen H.; Maguen, Shira] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Samuelson, Kristin] Alliant Int Univ, Calif Sch Profess Psychol, San Francisco, CA USA; [Vasterling, Jennifer J.] VA Boston Healthcare Syst, Boston, MA USA; [Vasterling, Jennifer J.] Boston Univ, Sch Med, Boston, MA 02118 USA		Seal, KH (corresponding author), San Francisco VA Med Ctr, 4150 Clement St,Box 111A-1, San Francisco, CA 94121 USA.	Karen.Seal@va.gov		Kumar, Sant/0000-0001-5294-3682	VA Health Services Research and DevelopmentUS Department of Veterans Affairs [SDR-08-408]	This material was based on work supported by VA Health Services Research and Development (award SDR-08-408).	Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; OCONNOR DW, 1990, ARCH GEN PSYCHIAT, V47, P224; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Prouteau A, 2004, SCHIZOPHR RES, V69, P85, DOI 10.1016/j.schres.2003.08.011; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Tarrier N, 1999, J CONSULT CLIN PSYCH, V67, P13, DOI 10.1037/0022-006X.67.1.13; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tischler L, 2006, ANN NY ACAD SCI, V1071, P405, DOI 10.1196/annals.1364.031; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2009, J INT NEUROPSYCH SOC, V15, P826, DOI 10.1017/S1355617709990683; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2	41	31	31	0	20	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	2					185	198		10.1682/JRRD.2014.12.0301			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DH4QX	WOS:000372771600002	27148692	gold			2022-02-06	
J	Walker, WC; Carne, W; Franke, LM; Nolen, T; Dikmen, SD; Cifu, DX; Wilson, K; Belanger, HG; Williams, R				Walker, W. C.; Carne, W.; Franke, L. M.; Nolen, T.; Dikmen, S. D.; Cifu, D. X.; Wilson, K.; Belanger, H. G.; Williams, R.			The Chronic Effects of Neurotrauma Consortium (CENC) multi-centre observational study: Description of study and characteristics of early participants	BRAIN INJURY			English	Article						Concussion; traumatic brain injury; military; veterans; post-concussion syndrome; cohort studies	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COMMON DATA ELEMENTS; IRAQI FREEDOM; DSM-IV; BLAST; SYMPTOMS; VETERANS; CONCUSSION; SOLDIERS	Primary objectives: To establish and comprehensively evaluate a large cohort of US veterans who served in recent military conflicts in order to better understand possible chronic and late-life effects of mild traumatic brain injury (mTBI), including those that may stem from neurodegeneration.Research design: Cross-sectional and prospective longitudinal.Methods and procedures: Inclusion criteria are prior combat exposure and deployment(s) in Operation Enduring Freedom, Operation Iraqi Freedom or one of their follow-on conflicts (collectively OEF/OIF). Effects of mTBI will be assessed by enrolling participants across the entire spectrum of mTBI, from entirely negative to many mTBIs. Longitudinal assessments consist of in-person comprehensive testing at least every 5 years, with interval annual telephonic testing. The primary outcome is the composite score on the NIH Toolbox neuropsychological test battery. Assessments also include structured interviews, questionnaires, traditional neuropsychological testing, motor, sensory and vestibular functions, neuroimaging, electrophysiology, genotypes and biomarkers.Main outcomes and results: The authors fully describe the study methods and measures and report demographic and exposure characteristics from the early portion of the cohort of OEF/OIF veterans.Conclusions: This centrepiece observational study of the Chronic Effects of Neurotrauma Consortium (CENC) is successfully launched and, within several years, should provide fertile data to begin investigating its aims.	[Walker, W. C.; Carne, W.; Franke, L. M.; Cifu, D. X.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Walker, W. C.; Carne, W.; Franke, L. M.; Cifu, D. X.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Walker, W. C.; Franke, L. M.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Nolen, T.; Wilson, K.; Williams, R.] RTI Int, Res Triangle Pk, NC USA; [Dikmen, S. D.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Belanger, H. G.] HSR&D Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL USA; [Belanger, H. G.] James A Haley Vet Hosp VH, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Belanger, H. G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA		Walker, WC (corresponding author), VCU Dept PM&R, MCV Stn,Box 677, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Franke, Lude/P-7036-2016	Franke, Lude/0000-0002-5159-8802; Cifu, David/0000-0003-1600-9387; Nolen, Tracy/0000-0003-2512-343X	Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC); Hunter Holmes McGuire Veterans Affairs Medical Center (VAMC) in Richmond, VA; James A. Haley Veterans Hospital (VH), Tampa, FL; Michael E. DeBakey VAMC, Houston, TX; Audie L. Murphy Memorial VH, San Antonio, TXUS Department of Veterans Affairs	The CENC Observational Study Site PIs or co-PIs also include: Blessen Eapen, MD (SanAntonio), Carlos Jaramillo, MD (SanAntonio), Ajit Pai, MD (Richmond), Maulik Purohit, MD (Fort Belvoir), and Randall Scheibel, PhD (Houston). We also acknowledge the efforts of the entire CENC Observational Study Leadership Working Group and Core Team members who also include: Justin Alicea, Ramon Diaz-Arrastia (Consortium Co-PI), Jessica Berumen, Katrina Burson, Margaret Clarke, Doreen Collins, Shannon Cusack, Cheryl Ford-Smith, George Gitchel, Harvey Levin, Henry Lew, Daryl Matthews, Scott McDonald, Tamara McKenzie-Hartman, Nicholas Pastorek, Judy Pulliam, Risa Richardson, Robert Shin, James K. Sickinger, Chris Siege, Nancy Temkin, Doug Theriaque, Maya Troyanskaya, Rodney Vanderploeg, and Elizabeth Wilde. This material is based upon work supported with resources and the use of facilities at: Hunter Holmes McGuire Veterans Affairs Medical Center (VAMC) in Richmond, VA; James A. Haley Veterans Hospital (VH), Tampa, FL; Michael E. DeBakey VAMC, Houston, TX; Audie L. Murphy Memorial VH, San Antonio, TX; and is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC).	Andrikopoulos J, 2014, JAMA NEUROL, V71, P654, DOI 10.1001/jamaneurol.2013.6408; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Brown DW, 2003, PREV MED, V37, P520, DOI 10.1016/S0091-7435(03)00179-8; Brueton VC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000032.pub2; Brundage John F, 2015, MSMR, V22, P2; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Dretsch MN, 2015, J NEUROTRAUM, V32, P1217, DOI 10.1089/neu.2014.3637; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jaffee M, 2010, MIL MED, V175, P37, DOI 10.7205/MILMED-D-10-00170; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Olichney JM, 2006, CLIN NEUROPHYSIOL, V117, P1319, DOI 10.1016/j.clinph.2006.02.022; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Schwarzer R, 2000, HEALTH PSYCHOL, V19, P487, DOI 10.1037/0278-6133.19.5.487; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thompson HJ, 2015, ANNU REV NURS RES-SE, V33, P1, DOI 10.1891/0739-6686.33.1; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	50	31	31	2	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1469	1480		10.1080/02699052.2016.1219061			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100009	27834538				2022-02-06	
J	Zagorchev, L; Meyer, C; Stehle, T; Wenzel, F; Young, S; Peters, J; Weese, J; Paulsen, K; Garlinghouse, M; Ford, J; Roth, R; Flashman, L; McAllister, T				Zagorchev, Lyubomir; Meyer, Carsten; Stehle, Thomas; Wenzel, Fabian; Young, Stewart; Peters, Jochen; Weese, Juergen; Paulsen, Keith; Garlinghouse, Matthew; Ford, James; Roth, Robert; Flashman, Laura; McAllister, Thomas			Differences in Regional Brain Volumes Two Months and One Year after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						mild traumatic brain injury; MRI; subcortical structures; volume	GRAY-MATTER ABNORMALITIES; SEGMENTATION; ATROPHY; MODEL	Conventional structural imaging is often normal after mild traumatic brain injury (mTBI). There is a need for structural neuroimaging biomarkers that facilitate detection of milder injuries, allow recovery trajectory monitoring, and identify those at risk for poor functional outcome and disability. We present a novel approach to quantifying volumes of candidate brain regions at risk for injury. Compared to controls, patients with mTBI had significantly smaller volumes in several regions including the caudate, putamen, and thalamus when assessed 2 months after injury. These differences persisted but were reduced in magnitude 1 year after injury, suggesting the possibility of normalization over time in the affected regions. More pronounced differences, however, were found in the amygdala and hippocampus, suggesting the possibility of regionally specific responses to injury.	[Zagorchev, Lyubomir] Philips Res North Amer, Briarcliff Manor, NY 10510 USA; [Zagorchev, Lyubomir; Paulsen, Keith] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Meyer, Carsten; Stehle, Thomas; Wenzel, Fabian; Young, Stewart; Peters, Jochen; Weese, Juergen] Philips Res Hamburg, Digital Imaging, Hamburg, Germany; [Garlinghouse, Matthew; Ford, James; Roth, Robert; Flashman, Laura; McAllister, Thomas] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA		Zagorchev, L (corresponding author), Philips Res North Amer, 345 Scarborough Rd, Briarcliff Manor, NY 10510 USA.	lyubomir.zagorchev@philips.com	Ford, James/AAF-7039-2020		Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD048176]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048176] Funding Source: NIH RePORTER	The TBI study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, R01 HD048176: Role of Candidate Alleles in Cognitive Outcome After TBI. The authors would like to gratefully acknowledge the assistance of Mary Hynes, RN, for her help with numerous phases of the data collection.	ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Babalola KO, 2009, NEUROIMAGE, V47, P1435, DOI 10.1016/j.neuroimage.2009.05.029; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Ecabert O, 2008, IEEE T MED IMAGING, V27, P1189, DOI 10.1109/TMI.2008.918330; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Weese J., 2001, Information Processing in Medical Imaging. 17th International Conference, IPMI 2001. Proceedings (Lecture Notes in Computer Science Vol.2082), P380; Weese J., 2014, SHAPE ANAL MED IMAGE, P151; Zagorchev L, 2011, LECT NOTES COMPUT SC, V7012, P52, DOI 10.1007/978-3-642-24446-9_7; Zagorchev L, 2011, LECT NOTES COMPUT SC, V7012, P118, DOI 10.1007/978-3-642-24446-9_15; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	20	31	32	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					29	34		10.1089/neu.2014.3831			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200004	25970552	Green Published			2022-02-06	
J	Cincotta, M; Giovannelli, F; Chiaramonti, R; Bianco, G; Godone, M; Battista, D; Cardinali, C; Borgheresi, A; Sighinolfi, A; D'Avanzo, AM; Breschi, M; Dine, Y; Lino, M; Zaccara, G; Viggiano, MP; Rossi, S				Cincotta, Massimo; Giovannelli, Fabio; Chiaramonti, Roberta; Bianco, Giovanni; Godone, Marco; Battista, Donato; Cardinali, Consuelo; Borgheresi, Alessandra; Sighinolfi, Antonella; D'Avanzo, Anna Maria; Breschi, Marco; Dine, Ylli; Lino, Mario; Zaccara, Gaetano; Viggiano, Maria Pia; Rossi, Simone			No effects of 20 Hz-rTMS of the primary motor cortex in vegetative state: A randomised, sham-controlled study	CORTEX			English	Article						Vegetative state; Disorders of consciousness; Transcranial magnetic stimulation; rTMS	TRANSCRANIAL MAGNETIC STIMULATION; MINIMALLY CONSCIOUS STATE; UNRESPONSIVE WAKEFULNESS SYNDROME; DEEP BRAIN-STIMULATION; COMA RECOVERY; EXCITABILITY; DISORDERS	We assessed the effects of a non-invasive neuromodulatory intervention with repetitive transcranial magnetic stimulation (rTMS) of the motor cortex in patients with vegetative state (VS) by a randomised, sham-controlled study with a cross-over design. Eleven patients classified as being in VS (9 post-anoxic, 2 post-traumatic, time elapsed from the injury 9-85 months) were included in the study. Real or sham 20 Hz rTMS were applied to the left primary motor cortex (M1) for 5 consecutive days. Primary outcome measures were changes in the JFK Coma Recovery Scale-Revised (CRS-R) scale total score and Clinical Global Impression Improvement (CGI-I) scale. Additional measures were EEG changes and impression of the patients relatives using the CGI-I scale. Evaluations were blindly performed at baseline, after the first day of treatment, immediately after the end of the 5-days treatment, 1 week and 1 month later. Slight changes observed in the CRS-R and CGI-I scores did not significantly differ between real or sham stimulation conditions. EEG was not significantly changed on average, although spots of brain reactivity were occasionally found underneath the stimulation point. Findings did not provide evidence of therapeutic effect of 20 Hz rTMS of the M1 in chronic VS, at least with conventional coils and current safety parameters. Therefore, they might be useful to better allocate human and financial resources in future trials. (C) 2015 Elsevier Ltd. All rights reserved.	[Cincotta, Massimo; Giovannelli, Fabio; Chiaramonti, Roberta; Battista, Donato; Cardinali, Consuelo; Borgheresi, Alessandra; Zaccara, Gaetano] Azienda Sanit Firenze, Neurol Unit, Florence, Italy; [Giovannelli, Fabio; Viggiano, Maria Pia] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Florence, Italy; [Bianco, Giovanni; Godone, Marco; Rossi, Simone] Azienda Osped Univ Senese, Brain Invest & Neuromodulat Lab, UOC Neurol & Clin Neurophysiol, Dept Neurosci,Si BIN Lab, Siena, Italy; [Sighinolfi, Antonella; D'Avanzo, Anna Maria; Breschi, Marco; Dine, Ylli; Lino, Mario] Casa Cura Villa Terme, Florence, Italy		Cincotta, M (corresponding author), Osped San Giovanni di Dio, Azienda Sanit Firenze, UO Neurol, Via Torregalli 3, I-50143 Florence, Italy.	cincotta@unifi.it	Rossi, Simone/AAC-6067-2022; Giovannelli, Fabio/AAC-1571-2019; Borgheresi, Alessandra/AAA-7582-2019; Viggiano, Mariapia/AAC-1556-2019; Cincotta, Massimo/AAA-7532-2019	Rossi, Simone/0000-0001-6697-9459; Giovannelli, Fabio/0000-0003-1059-9945; Borgheresi, Alessandra/0000-0002-1513-8665; Viggiano, Mariapia/0000-0002-3230-0935; Cincotta, Massimo/0000-0001-5223-646X	'Ente Cassa di Risparmio di Firenze', Florence, ItalyFondazione Cassa Risparmio Firenze [2013.0193]	The Unit of Neurology, Azienda Sanitaria di Firenze, was supported by a grant from 'Ente Cassa di Risparmio di Firenze' (Grant no. 2013.0193), Florence, Italy.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Denslow S, 2005, BIOL PSYCHIAT, V57, P752, DOI 10.1016/j.biopsych.2004.12.017; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gosseries O, 2011, FRONT COLLECT, P29, DOI 10.1007/978-3-642-18047-7_2; Guy W., 1976, ASSESSMENT MANUAL PS, P76; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Manganotti P, 2013, BRAIN STIMUL, V6, P913, DOI 10.1016/j.brs.2013.06.006; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Naro A, 2015, NEUROREHAB NEURAL RE, V29, P603, DOI 10.1177/1545968314562114; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P159, DOI 10.3233/RNN-140448; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Piccione F, 2011, NEUROREHAB NEURAL RE, V25, P98, DOI 10.1177/1545968310369802; Ragazzoni A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057069; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rossi S, 2007, CLIN NEUROPHYSIOL, V118, P709, DOI 10.1016/j.clinph.2006.11.005; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini P. M., 2015, CLIN NEUROPHYSIOLOGY; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sommer J, 2006, CLIN NEUROPHYSIOL, V117, P440, DOI 10.1016/j.clinph.2005.09.025; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Yamamoto T, 2002, ACT NEUR S, V79, P79; Yamamoto T, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.04.010	27	31	35	0	5	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	OCT	2015	71						368	376		10.1016/j.cortex.2015.07.027			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CS5PV	WOS:000362131300033	26301875				2022-02-06	
J	Sun, LQ; Gao, JL; Zhao, MM; Cui, JZ; Li, YX; Yang, XJ; Jing, XB; Wu, ZX				Sun, Liqian; Gao, Junling; Zhao, Manman; Cui, Jianzhong; Li, Youxiang; Yang, Xinjian; Jing, Xiaobin; Wu, Zhongxue			A novel cognitive impairment mechanism that astrocytic p-connexin 43 promotes neuronic autophagy via activation of P2X7R and down-regulation of GLT-1 expression in the hippocampus following traumatic brain injury in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Cognitive function; Hippocampus; Autophagy; Hippocampal slices	FOCAL CEREBRAL-ISCHEMIA; RECEPTORS; MODEL; NEUROPROTECTION; HEMICHANNELS; STIMULATION; INVOLVEMENT; DEFICITS; CELLS	Connexin 43 (Cx43) is one of the major gap junction proteins in astrocytes. Our previous studies reported that astrocytic phosphorylated Cx43 (p-CX43) regulated neuronic autophagy levels in the rat hippocampus after traumatic brain injury (TBI). In this study, we explored the underlying molecular mechanism by which gap junctional intercellular communication influenced neuronic autophagy and therefore initiated cognitive and memory impairments after TBI. The gap junctional blocker carbenoxolone (CBX) or autophagy inhibitor 3-methyladenine (3-MA) reduced latencies, as compared to TBI rats. Similarly, CBX or 3-MA restored long-term potentiation (LTP), relative to TBI hippocampal slices. Immunoblotting analysis showed that the expression of autophagy-related gene Beclin-1 in the hippocampus post-TBI were decreased in response to treatment with CBX, the P2X7 receptor (P2X7R) antagonist Oxidized ATP (OxATP) or ceftriaxone (Cef) which increased the expression and activity of the glutamate transporter (GLT-1) in the central nervous system (CNS). Moreover, CBX or OxATP pretreatment increased GLT-1 level in the rat hippocampus after TBI. However, CBX pretreatment suppressed P2X7R expression whereas maintained P2X7 level post-TBI. Confocal images revealed that p-CX43, P2X7 and GLT-1 strongly colocalized with glial fibrillary acidic protein (GFAP). Taken together, these results implied that Cx43, might induce neuronic autophagy by activation of P2X7R and reduce the expression of GLT-1 in the hippocampus, promoting TBI-induced cognitive deficits repair. Therefore, control of this communication may be serve as therapeutic strategies for intervention against TBI. (C) 2015 Elsevier B.V. All rights reserved.	[Sun, Liqian; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China; [Sun, Liqian; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Gao, Junling; Zhao, Manman] North China Univ Sci & Technol, Sch Basic Med Sci, Dept Histol & Embryol, Tangshan 063000, Hebei, Peoples R China; [Cui, Jianzhong] Tangshan Gongren Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China; [Jing, Xiaobin] Tangshan Ophthalmol Hosp, Dept Ophthalmol, Tangshan 063000, Hebei, Peoples R China		Wu, ZX (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China.	zhongxuewu@yeah.net		Gao, Junling/0000-0001-5267-5884; Yang, Xinjian/0000-0001-7306-0125	Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2015ZZ-49]; Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [H2014105079]	The present study was supported by a grant from the Project supported by Beijing Postdoctoral Research Foundation (no. 2015ZZ-49) the Natural Science Foundation of Hebei Province (no. H2014105079). The authors would like to acknowledge the technical assistance of Junling Gao and Manman Zhao.	Caplan L. R., 1997, PRIMER CEREBROVASCUL; Figiel M, 2007, MOL CELL NEUROSCI, V35, P130, DOI 10.1016/j.mcn.2007.02.009; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; Khorasani MZ, 2009, PAK J PHARM SCI, V22, P349; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Knight MM, 2009, J ANAT, V214, P275, DOI 10.1111/j.1469-7580.2008.01021.x; Krieglstein J, 1997, EUR J PHARM SCI, V5, P181, DOI 10.1016/S0928-0987(97)00276-5; Lai Y, 2007, J CEREB BLOOD FLOW M, V28, P540; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Morioka N, 2008, GLIA, V56, P528, DOI 10.1002/glia.20634; Odero GL, 2010, NEUROSCIENCE, V169, P532, DOI 10.1016/j.neuroscience.2010.04.004; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Pannicke T, 2000, J NEUROSCI, V20, P5965, DOI 10.1523/JNEUROSCI.20-16-05965.2000; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sun L, 2013, NEUROL SCI, P1; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Yanagisawa D, 2008, BIOL PHARM BULL, V31, P1121, DOI 10.1248/bpb.31.1121; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0	26	31	35	1	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	SEP 15	2015	291						315	324		10.1016/j.bbr.2015.05.049			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CN5FI	WOS:000358454800039	26031379				2022-02-06	
J	Delano-Wood, L; Bangen, KJ; Sorg, SF; Clark, AL; Schiehser, DM; Luc, N; Bondi, MW; Werhane, M; Kim, RT; Bigler, ED				Delano-Wood, L.; Bangen, K. J.; Sorg, S. F.; Clark, A. L.; Schiehser, D. M.; Luc, N.; Bondi, M. W.; Werhane, M.; Kim, R. T.; Bigler, E. D.			Brainstem white matter integrity is related to loss of consciousness and postconcussive symptomatology in veterans with chronic mild to moderate traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Diffusion tensor imaging; DTI; White matter; Brainstem; Postconcussive syndrome; PCS; Traumatic brain injury; TBI	DIFFUSE AXONAL INJURY; SF-36 HEALTH SURVEY; HEAD-INJURY; PSYCHOMETRIC PROPERTIES; CORPUS-CALLOSUM; IQOLA PROJECT; WEIGHTED MRI; TENSOR; CONCUSSION; NEUROPATHOLOGY	We investigated associations between DTI indices of three brainstem white matter tracts, traumatic brain injury (TBI) injury characteristics, and postconcussive symptomatology (PCS) in a well-characterized sample of veterans with history of mild to moderate TBI (mTBI). 58 military veterans (mTBI: n = 38, mean age = 33.2, mean time since injury = 90.9 months; military controls [MC]; n = 20; mean age = 29.4) were administered 3T DTI scans as well as a comprehensive neuropsychiatric evaluation including evaluation of TBI injury characteristics and PCS symptoms (e.g., negative mood, dizziness, balance and coordination difficulties). Tractography was employed by seeding ROIs along 3 brainstem white matter tracts (i.e., medial lemniscus-central tegmentum tract [ML-CTT]; corticospinal tracts [CST], and pontine tegmentum [PT]), and mean DTI values were derived from fractional anisotropic (FA) maps. Results showed that there were no significant difference in FA between the MC and TBI groups across the 3 regions of interest; however, among the TBI group, CST FA was significantly negatively associated with LOC duration. Additionally, lower FA of certain tracts-most especially the PT-was significantly associated with increased PCS symptoms (i.e., more severe vestibular symptoms, poorer physical functioning, and greater levels of fatigue), even after adjusting for PTSD symptoms. Our findings show that, in our sample of veterans with mTBI, tractography-based DTI indices of brainstem white matter tracts of interest are related to the presence and severity of PCS symptoms. Findings are promising as they show linkages between brainstem white matter integrity and injury severity (LOC), and they raise the possibility that the pontine tegmentum in particular may be a useful marker of PCS symptoms. Collectively, these data point to important neurobiological substrates of the chronic and complex constellation of symptoms following the 'signature injury' of our combat-exposed veterans.	[Delano-Wood, L.; Bangen, K. J.; Sorg, S. F.; Schiehser, D. M.; Luc, N.; Bondi, M. W.; Kim, R. T.] Vet Affairs San Diego Healthcare Syst 116B, San Diego, CA 92161 USA; [Delano-Wood, L.; Sorg, S. F.; Schiehser, D. M.; Luc, N.; Kim, R. T.] Ctr Excellence Stress & Mental Hlth CESAMH, San Diego, CA 92161 USA; [Delano-Wood, L.; Bangen, K. J.; Sorg, S. F.; Schiehser, D. M.; Bondi, M. W.] Univ Calif La Jolla, Dept Psychiat, San Diego, CA 92093 USA; [Clark, A. L.; Werhane, M.] San Diego State Univ, Univ Calif San Diego, San Diego SDSU UCSD Joint Doctoral Program Clin P, San Diego, CA USA; [Bigler, E. D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, E. D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, E. D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, E. D.] Univ Utah, Brain Inst Utah, Salt Lake City, UT USA		Delano-Wood, L (corresponding author), Vet Affairs San Diego Healthcare Syst 116B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu			VA Clinical Science Research Development; Department of Defense Investigator-Initiated Research GrantUnited States Department of Defense; VA Merit ReviewUS Department of Veterans Affairs; Veterans AffairsUS Department of Veterans Affairs [I01CX000842] Funding Source: NIH RePORTER	The current study was supported by a VA Clinical Science Research & Development (Career Development Award-2 to L.D-W, D.S.); Department of Defense Investigator-Initiated Research Grant (L.D-W); and VA Merit Review (L.D-W.)	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bammer R, 2002, MAGNET RESON MED, V48, P128, DOI 10.1002/mrm.10184; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; CHASON JL, 1958, J NEUROSURG, V15, P135, DOI 10.3171/jns.1958.15.2.0135; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Dixon C. E., 1995, CENTRAL NERVOUS SYST, P255; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gean AD, 1994, IMAGING HEAD TRAUMA; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Haines DE., 2000, NEUROANATOMY ATLAS S; Heitger M.H., 2009, BRAIN; Helton KJ, 2006, AM J NEURORADIOL, V27, P786; Inoue T, 2005, CLIN NEUROL NEUROSUR, V107, P174, DOI 10.1016/j.clineuro.2004.06.011; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lin W. M., 2014, BIOMED RES INT, V2014, P340; Lui YW, 2007, NEUROSURGERY, V61, P1199, DOI 10.1227/01.neu.0000306098.38141.81; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; McIntosh TK, 1996, LAB INVEST, V74, P315; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Nagae-Poetscher LM, 2004, AM J NEURORADIOL, V25, P1325; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ommaya A. K., 1966, ARCS, V38, P317; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Plum R., 1980, DIAGNOSIS STUPOR COM; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reep RL, 2009, NEUROBIOL LEARN MEM, V91, P104, DOI 10.1016/j.nlm.2008.08.010; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Salamon N, 2005, NEURORADIOLOGY, V47, P895, DOI 10.1007/s00234-005-1439-8; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Shetter A G, 1979, Adv Neurol, V22, P5; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; STRICH SJ, 1961, LANCET, V2, P443; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Sullivan EV, 2003, ALCOHOL CLIN EXP RES, V27, P1409, DOI 10.1097/01.ALC.0000085586.91726.46; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Traumatic Brain Injury Task Force, 2009, REP SURG GEN TBI TAS; Uh J, 2013, INT J RADIAT ONCOL, V86, P292, DOI 10.1016/j.ijrobp.2013.01.028; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Verhaal A., 1975, HDB CLIN NEUROLOGY, P417; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; WARD AA, 1958, J NEUROSURG, V15, P129, DOI 10.3171/jns.1958.15.2.0129; Ware J.E., 1994, SF 36 PHYS MENTAL SU; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; Weathers FW, 1991, PCL C FOR DSM 4; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zhang WH, 2009, NEUROIMAGE, V44, P906, DOI 10.1016/j.neuroimage.2008.09.013	98	31	32	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					500	512		10.1007/s11682-015-9432-2			13	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CR8LQ	WOS:000361604300011	26248618				2022-02-06	
J	Kilbaugh, TJ; Karlsson, M; Byro, M; Bebee, A; Ralston, J; Sullivan, S; Duhaime, AC; Hansson, MJ; Elmer, E; Margulies, SS				Kilbaugh, Todd J.; Karlsson, Michael; Byro, Melissa; Bebee, Ashley; Ralston, Jill; Sullivan, Sarah; Duhaime, Ann-Christine; Hansson, Magnus J.; Elmer, Eskil; Margulies, Susan S.			Mitochondrial bioenergetic alterations after focal traumatic brain injury in the immature brain	EXPERIMENTAL NEUROLOGY			English	Article						Pediatric traumatic brain injury; Mitochondria; Axonal injury; Bioenergetics; Contusion; Swine	MATURATION-DEPENDENT RESPONSE; ELECTRON-TRANSPORT CHAIN; COMMON DATA ELEMENTS; METABOLIC CRISIS; POSTNATAL-DEVELOPMENT; UNITED-STATES; CELL-DEATH; RAT; DYSFUNCTION; ISCHEMIA	Traumatic brain injury (TBI) is one of the leading causes of death in children worldwide. Emerging evidence suggests that alterations in mitochondrial function are critical components of secondary injury cascade initiated by TBI that propogates neurodegeneration and limits neuroregeneration. Unfortunately, there is very little known about the cerebral mitochondrial bioenergetic response from the immature brain triggered by traumatic biomechanical forces. Therefore, the objective of this study was to perform a detailed evaluation of mitochondrial bioenergetics using high-resolution respirometry in a high-fidelity large animal model of focal controlled cortical impact injury (CCI) 24 h post-injury. This novel approach is directed at analyzing dysfunction in electron transport, ADP phosphorylation and leak respiration to provide insight into potential mechanisms and possible interventions for mitochondrial dysfunction in the immature brain in focal TBI by delineating targets within the electron transport system (ETS). Development and application of these methodologies have several advantages, and adds to the interpretation of previously reported techniques, by having the added benefit that any toxins or neurometabolites present in the ex-vivo samples are not removed during the mitochondrial isolation process, and simulates the in situ tricarboxylic acid (TCA) cycle by maximizing key substrates for convergent flow of electrons through both complexes I and II To investigate alterations in mitochondrial function after CCI, ipsilateral tissue near the focal impact site and tissue from the corresponding contralateral side were examined. Respiration per mg of tissue was also related to citrate synthase activity (CS) and calculated flux control ratios (FCR), as an attempt to control for variability in mitochondrial content. Our biochemical analysis of complex interdependent pathways of electron flow through the electron transport system, by most measures, reveals a bilateral decrease in complex I-driven respiration and an increase in complex II-driven respiration 24 h after focal TBI. These alterations in convergent electron flow though both complex I and II-driven respiration resulted in significantly lower maximal coupled and uncoupled respiration in the ipsilateral tissue compared to the contralateral side, for all measures. Surprisingly, increases in complex II and complex IV activities were most pronounced in the contralateral side of the brain from the focal injury, and where oxidative phosphoryladon was increased significantly compared to sham values. We conclude that 24 h after focal TBI in the immature brain, there are significant alterations in cerebral mitochondrial bioenergetics, with pronounced increases in complex II and complex IV respiration in the contralateral hemisphere. These alterations in mitochondrial bioenergetics present multiple targets for therapeutic intervention to limit secondary brain injury and support recovery. (C) 2015 Elsevier Inc. All rights reserved.	[Kilbaugh, Todd J.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Karlsson, Michael; Hansson, Magnus J.; Elmer, Eskil] Lund Univ, Dept Clin Sci, Mitochondrial Med, SE-22184 Lund, Sweden; [Byro, Melissa; Bebee, Ashley; Ralston, Jill; Sullivan, Sarah; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA		Kilbaugh, TJ (corresponding author), 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	kilbaugh@chop.edu; michael.karlsson@med.lu.se; melissa.byro@gmail.com; ashley.n.durban@gmail.com; ralstonjm@gmail.com; sarahsul@seas.upenn.edu; aduhaime@partners.org; magnus.hansson@med.lu.se; eskil.elmer@med.lu.se; margulie@seas.upenn.edu	Karlsson, Michael/AAL-8743-2020; Elmer, Eskil/F-9341-2014; Hansson, Magnus/G-4486-2014	Karlsson, Michael/0000-0002-7247-2133; Elmer, Eskil/0000-0001-7901-1826; Hansson, Magnus/0000-0002-0201-0638; Kilbaugh, Todd/0000-0002-4959-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UO1 NS069545]; Endowed Chair of Critical Care Medicine at the Children's Hospital of Philadelphia; Stephenson Fund Department of Bioengineering the University of Pennsylvania; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545] Funding Source: NIH RePORTER	The authors would like to thank Albana Shahini and Saori Morota for their invaluable technical support. The Oroboros Oxygraph used in the study was a loan from NeuroVive Pharmaceutical AB, Lund Sweden. Studies were supported by the NIH UO1 NS069545, Endowed Chair of Critical Care Medicine at the Children's Hospital of Philadelphia, and Stephenson Fund Department of Bioengineering the University of Pennsylvania.	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; ALMEIDA A, 1995, DEV NEUROSCI-BASEL, V17, P212, DOI 10.1159/000111289; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; BATES TE, 1994, DEV NEUROSCI-BASEL, V16, P321, DOI 10.1159/000112126; BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Chepelev NL, 2009, J ENZYM INHIB MED CH, V24, P1319, DOI 10.3109/14756360902852586; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DELMAESTRO R, 1987, MECH AGEING DEV, V41, P29, DOI 10.1016/0047-6374(87)90051-0; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Faul M, 2010, TRAUMATIC BRAIN INJU; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; Hagen CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071904, 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201]; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hattori N, 2003, J NUCL MED, V44, P1709; Karlsson M, 2013, INT J BIOCHEM CELL B, V45, P151, DOI 10.1016/j.biocel.2012.08.008; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kunz WS, 2000, ANN NEUROL, V48, P766, DOI 10.1002/1531-8249(200011)48:5<766::AID-ANA10>3.0.CO;2-M; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Loor G, 2011, BBA-MOL CELL RES, V1813, P1382, DOI 10.1016/j.bbamcr.2010.12.008; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Miller AC, 2012, J NEUROTRAUM, V29, P634, DOI 10.1089/neu.2011.1932; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Navarro A, 2009, J BIOENERG BIOMEMBR, V41, P517, DOI 10.1007/s10863-009-9250-6; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Saito A, 2005, MOL NEUROBIOL, V31, P105, DOI 10.1385/MN:31:1-3:105; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; SIMS NR, 1986, J NEUROCHEM, V47, P496; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Suchadolskiene O, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-2; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Watson William D, 2013, Front Neuroenergetics, V5, P12, DOI 10.3389/fnene.2013.00012; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263	57	31	32	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2015	271						136	144		10.1016/j.expneurol.2015.05.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT2JG	WOS:000362627200015	26028309	Green Accepted			2022-02-06	
J	Raible, DJ; Frey, LC; Del Angel, YC; Carlsen, J; Hund, D; Russek, SJ; Smith, B; Brooks-Kayal, AR				Raible, Daniel J.; Frey, Lauren C.; Del Angel, Yasmin Cruz; Carlsen, Jessica; Hund, Dana; Russek, Shelley J.; Smith, Bret; Brooks-Kayal, Amy R.			JAK/STAT pathway regulation of GABA(A) receptor expression after differing severities of experimental TBI	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; GABA(A) receptor; JAK/STAT pathway; STAT3	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; DENTATE GRANULE CELLS; CLOSED-HEAD INJURY; POSTTRAUMATIC EPILEPSY; STATUS EPILEPTICUS; REDUCED INHIBITION; SUBUNIT EXPRESSION	Synaptic inhibition in the adult brain is primarily mediated by the gamma-aminobutyric acid (GABA) type A receptor (GABA(A)R). The distribution, properties, and dynamics of these receptors are largely determined by their subunit composition. Alteration of subunit composition after a traumatic brain injury (TBI) may result in abnormal increased synaptic firing and possibly contribute to injury-related pathology. Several studies have shown that the Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signaling pathway can alter GABA(A)R subunit expression. The present study investigated changes in JAK/STAT pathway activation after two different severities of experimental TBI in the mouse using the controlled cortical impact (CCI) model. It also investigated whether modulating the activation of the JAK/STAT pathway after severe controlled cortical impact (CCI-S) with a JAK/STAT inhibitor (WP1066) alters post-traumatic epilepsy development and/or neurological recovery after injury. Our results demonstrated differential changes in both the activation of STAT3 and the expression of the GABA(A)R alpha 1 and gamma 2 subunit levels that were dependent on the severity of the injury. The change in the GABA(A)R alpha 1 subunit levels appeared to be at least partly transcriptionally mediated. We were able to selectively reverse the decrease in GABA(A)R alpha 1 protein levels with WP1066 treatment after CCI injury. WP1066 treatment also improved the degree of recovery of vestibular motor function after injury. These findings suggest that the magnitude of JAK/STAT pathway activation and GABA(A)R alpha 1 subunit level decrease is dependent on injury severity in this mouse model of TBI. In addition, reducing JAK/STAT pathway activation after severe experimental TBI reverses the decrease in the GABA(A)R alpha 1 protein levels and improves vestibular motor recovery. (C) 2015 Elsevier Inc. All rights reserved.	[Raible, Daniel J.; Brooks-Kayal, Amy R.] Univ Colorado, Neurosci Program, Aurora, CO 80045 USA; [Frey, Lauren C.; Brooks-Kayal, Amy R.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Del Angel, Yasmin Cruz; Carlsen, Jessica; Hund, Dana; Brooks-Kayal, Amy R.] Univ Colorado, Sch Med, Dept Pediat, Div Neurol, Aurora, CO USA; [Russek, Shelley J.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Smith, Bret] Univ Kentucky, Dept Physiol, Coll Med, Chandler Med Ctr MS508, Lexington, KY 40536 USA; [Brooks-Kayal, Amy R.] Childrens Hosp Colorado, Aurora, CO USA		Brooks-Kayal, AR (corresponding author), Univ Colorado, Neurosci Program, Anschutz Med Campus, Aurora, CO 80045 USA.	draible09@gmail.com; Lauren.Frey@ucdenver.edu; Yasmin.cruzdelangel@ucdenver.edu; Jessica.Carlsen@ucdenver.edu; Dana.hund@ucdenver.edu; srussek@bu.edu; bret.smith@uky.edu; Amy.Brooks-Kayal@childrenscolorado.org		Carlsen, Jessica/0000-0002-1191-9974	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0501]; NIH/NCRR Colorado CTSI Grant [TL1 RR025778]; National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051710]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1RR025778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS048154, R01NS051710, R21NS083057] Funding Source: NIH RePORTER	The funding for this research was provided by the Department of Defense award number W81XWH-11-1-0501 (to ABK, LCF & BNS), NIH/NCRR Colorado CTSI Grant Number TL1 RR025778 (to DJR), and National Institutes of Neurological Disorders and Stroke award number R01NS051710 (to ABK and SJR). Contents are the authors' sole responsibility and do not necessarily represent official DOD or NIH views.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Faderl S, 2007, LEUKEMIA RES, V31, P91, DOI 10.1016/j.leukres.2006.05.027; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hunt RF, 2012, EPILEPSY RES, V99, P167, DOI 10.1016/j.eplepsyres.2011.10.011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kobayashi M, 2003, J NEUROSCI, V23, P8471; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kupferman Michael E, 2009, J Exp Ther Oncol, V8, P117; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Liang J, 2006, J NEUROSCI, V26, P1749, DOI 10.1523/JNEUROSCI.4702-05.2006; Lund IV, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162396; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Nusser Z, 1998, J NEUROSCI, V18, P1693; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Raol YH, 2006, J NEUROSCI, V26, P11342, DOI 10.1523/JNEUROSCI.3329-06.2006; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Shao LR, 2005, J NEUROPHYSIOL, V94, P952, DOI 10.1152/jn.01342.2004; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Sun CS, 2004, BRAIN RES, V1029, P207, DOI 10.1016/j.brainres.2004.09.056; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Wei WZ, 2003, J NEUROSCI, V23, P10650; Wen TC, 2001, NEUROSCI LETT, V303, P153, DOI 10.1016/S0304-3940(01)01711-6; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Zhang G, 2004, NEUROSCIENCE, V125, P299, DOI 10.1016/j.neuroscience.2004.01.040; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018	50	31	31	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2015	271						445	456		10.1016/j.expneurol.2015.07.001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT2JG	WOS:000362627200045	26172316	Bronze, Green Accepted			2022-02-06	
J	Zhao, ZR; Sabirzhanov, B; Wu, JF; Faden, AI; Stoica, BA				Zhao, Zaorui; Sabirzhanov, Boris; Wu, Junfang; Faden, Alan I.; Stoica, Bogdan A.			Voluntary Exercise Preconditioning Activates Multiple Antiapoptotic Mechanisms and Improves Neurological Recovery after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						exercise; traumatic brain injury; controlled cortical impact; neuroprotection	SPINAL-CORD-INJURY; CONTROLLED CORTICAL IMPACT; TAIL SUSPENSION TEST; TREADMILL EXERCISE; PROGRESSIVE NEURODEGENERATION; NEURONAL APOPTOSIS; RECOGNITION MEMORY; BH3-ONLY PROTEINS; PHYSICAL-EXERCISE; CDK INHIBITOR	Physical activity can attenuate neuronal loss, reduce neuroinflammation, and facilitate recovery after brain injury. However, little is known about the mechanisms of exercise-induced neuroprotection after traumatic brain injury (TBI) or its modulation of post-traumatic neuronal cell death. Voluntary exercise, using a running wheel, was conducted for 4 weeks immediately preceding (preconditioning) moderate-level controlled cortical impact (CCI), a well-established experimental TBI model in mice. Compared to nonexercised controls, exercise preconditioning (pre-exercise) improved recovery of sensorimotor performance in the beam walk task, as well as cognitive/affective functions in the Morris water maze, novel object recognition, and tail-suspension tests. Further, pre-exercise reduced lesion size, attenuated neuronal loss in the hippocampus, cortex, and thalamus, and decreased microglial activation in the cortex. In addition, exercise preconditioning activated the brain-derived neurotrophic factor pathway before trauma and amplified the injury-dependent increase in heat shock protein 70 expression, thus attenuating key apoptotic pathways. The latter include reduction in CCI-induced up-regulation of proapoptotic B-cell lymphoma 2 (Bcl-2)-homology 3-only Bcl-2 family molecules (Bid, Puma), decreased mitochondria permeabilization with attenuated release of cytochrome c and apoptosis-inducing factor (AIF), reduced AIF translocation to the nucleus, and attenuated caspase activation. Given these neuroprotective actions, voluntary physical exercise may serve to limit the consequences of TBI.	[Stoica, Bogdan A.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA		Stoica, BA (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Bressler Res Bldg,655 West Baltimore St, Baltimore, MD 21201 USA.	bstoica@anes.umm.edu	STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434; Faden, Alan I./0000-0003-0128-2348	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS037313, R01 NS052568]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037313, R01NS052568] Funding Source: NIH RePORTER	The authors thank Titilola Akintola for expert technical assistance and Dr. David Loane for critical review of the manuscript. This work was supported by National Institutes of Health grants R01 NS037313 and R01 NS052568 (to A.I.F.).	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Almeida S, 2009, NEUROBIOL DIS, V35, P448, DOI 10.1016/j.nbd.2009.06.006; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chen YW, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.033829; Clark RE, 2000, J NEUROSCI, V20, P8853; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Faul M, 2010, TRAUMATIC BRAIN INJU; Gresack JE, 2007, BRAIN RES, V1160, P91, DOI 10.1016/j.brainres.2007.05.033; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Heck TG, 2011, CELL BIOCHEM FUNCT, V29, P215, DOI 10.1002/cbf.1739; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Liebelt B, 2010, NEUROSCIENCE, V166, P1091, DOI 10.1016/j.neuroscience.2009.12.067; Liu X, 2010, NEUROSCI LETT, V476, P99, DOI 10.1016/j.neulet.2010.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Quadrato G, 2012, P NATL ACAD SCI USA, V109, pE1499, DOI 10.1073/pnas.1202068109; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sabirzhanov B, 2012, J NEUROCHEM, V123, P542, DOI 10.1111/j.1471-4159.2012.07927.x; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Smith RS, 2007, DNA SEQUENCE, V18, P47, DOI 10.1080/10425170601060707; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Stoica BA, 2010, ACUTE NEURONAL INJURY: THE ROLE OF EXCITOTOXIC PROGRAMMED CELL DEATH MECHANISMS, P169, DOI 10.1007/978-0-387-73226-8_12; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Zhang HT, 2008, NEUROPSYCHOPHARMACOL, V33, P1611, DOI 10.1038/sj.npp.1301537; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107	65	31	32	1	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2015	32	17					1347	1360		10.1089/neu.2014.3739			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CP0KP	WOS:000359564500008	25419789	Green Published			2022-02-06	
J	Wang, HK; Lee, YC; Huang, CY; Liliang, PC; Lu, K; Chen, HJ; Li, YC; Tsai, KJ				Wang, H. -K.; Lee, Y. -C.; Huang, C. -Y.; Liliang, P. -C.; Lu, K.; Chen, H. -J.; Li, Y. -C.; Tsai, K. -J.			TRAUMATIC BRAIN INJURY CAUSES FRONTOTEMPORAL DEMENTIA AND TDP-43 PROTEOLYSIS	NEUROSCIENCE			English	Article						traumatic brain injury; frontotemporal dementia; TAR-DNA binding protein 43	AMYOTROPHIC-LATERAL-SCLEROSIS; ENVIRONMENTAL RISK-FACTORS; LOBAR DEGENERATION; ALZHEIMERS-DISEASE; MOUSE MODEL; RATS; DIAGNOSIS; AGGREGATION; PROGRANULIN; POPULATION	Traumatic brain injury (TBI) is a major risk factor for dementia. Recently, TBI has also been suggested as a risk factor for frontotemporal dementia (FTD), and plasma immunoreactivity to the TAR-DNA binding protein 43 (TDP-43) has been observed in both patients with acute TBI and long-term survivors of this condition. We used a population-based study to estimate and compare the risk of FTD in individuals with and without TBI. Furthermore, we used a rat model of TBI to show that increased TDP-43 proteolysis following TBI produces FTD-like impairments, including abnormal limb-clasping, and impaired performances in the Morris water maze. We recruited 24,585 patients who received ambulatory or hospital care for TBI and 122,925 patients without TBI for this study. Each individual was investigated for 4 years to evaluate FTD development, and data were analyzed by Cox proportional hazard regression. In the TBI rat model, behavior and TDP-43 inclusions were assessed following intracranial administration of a caspase-3 inhibitor or vehicle. FTD was more likely to occur in the TBI group than in the group without TBI (adjusted hazard ratio, 4.43; 95% confidence interval, 3.85-5.10; P<0.001). Rats developed behavioral impairments similar to those in patients with FTD after TBI. Further, the behavioral impairments were likely associated with TDP-43 short fragment mislocalization and accumulation. Our findings suggest that in humans, TBI is associated with a greater occurrence of FTD. Moreover, clinical FTD manifestations may be associated with TDP-43 proteolysis, since impaired behaviors in TBI rats were reminiscent of those in humans with FTD. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wang, H. -K.; Lee, Y. -C.; Huang, C. -Y.; Tsai, K. -J.] Natl Cheng Kung Univ, Inst Clin Med, Tainan 701, Taiwan; [Wang, H. -K.; Liliang, P. -C.; Lu, K.; Chen, H. -J.] I Shou Univ, E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Lee, Y. -C.] I Shou Univ, E Da Hosp, Dept Nephrol, Kaohsiung, Taiwan; [Huang, C. -Y.] Natl Cheng Kung Univ Hosp, Dept Surg, Neurosurg Serv, Tainan 70428, Taiwan; [Lu, K.; Chen, H. -J.; Li, Y. -C.] Natl Sun Yat Sen Univ, Inst Hlth Care Management, Kaohsiung 80424, Taiwan		Tsai, KJ (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Tainan 701, Taiwan.	kjtsai@mail.ncku.edu.tw	Tsai, Kuen-Jer/B-9393-2009; Tsai, Kuen-Jer/AAZ-2714-2021	Tsai, Kuen-Jer/0000-0002-2170-9735; Tsai, Kuen-Jer/0000-0002-2170-9735; Wang, Hao-Kuang/0000-0002-1928-7502	E-Da Hospital, Kaohsiung, Taiwan [EDAHP-101026, EDAHP-103012, NCKUEDA10303]	This study was supported in part by grants from the E-Da Hospital, Kaohsiung, Taiwan (EDAHP-101026, EDAHP-103012, and NCKUEDA10303). This study was based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health, Taiwan, and managed by the National Health Research Institutes. The interpretations and conclusions contained herein do not represent those of the Bureau of National Health Insurance, the Department of Health, or the National Health Research Institutes.	Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kanazawa M, 2011, J NEUROCHEM, V116, P957, DOI 10.1111/j.1471-4159.2010.06860.x; Kleinberger G, 2010, J NEUROCHEM, V115, P735, DOI 10.1111/j.1471-4159.2010.06961.x; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Rossor MN, 2010, LANCET NEUROL, V9, P793, DOI 10.1016/S1474-4422(10)70159-9; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; World Health Organization, 2012, DEM PUBL HLTH PRIOR, P19; Xu ZS, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-27; Yang Z, 2014, J CEREB BLOOD FLOW M, V34, P1444; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	40	31	32	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 6	2015	300						94	103		10.1016/j.neuroscience.2015.05.013			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL2IQ	WOS:000356767400010	25982564				2022-02-06	
J	Carlozzi, NE; Beaumont, JL; Tulsky, DS; Gershon, RC				Carlozzi, Noelle E.; Beaumont, Jennifer L.; Tulsky, David S.; Gershon, Richard C.			The NIH Toolbox Pattern Comparison Processing Speed Test: Normative Data	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						NIH Toolbox; Processing speed; Pattern Comparison Processing Speed Test; Cognition; Neuropsychological assessment	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; ADULT AGE-DIFFERENCES; ADDITION TASK PASAT; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; WORKING-MEMORY; BEHAVIORAL FUNCTION; EXECUTIVE FUNCTION; VASCULAR DEMENTIA	The NIH Toolbox Pattern Comparison Processing Speed Test was developed to assess processing speed. While initial validation work provides preliminary support for this test in both children and adults, more work is needed to ensure dependability and generalizability. Thus, this replication study examines descriptive data (including age effects), test-retest reliability, and construct validity in n = 4,859 participants ages 3-85 years (matched to 2010 census data). Although the Pattern Comparison was not appropriate for all 3 and 4 years old, by ages 5 and 6, more meaningful scores were apparent. There was evidence for convergent and discriminant validity. There was also a moderate practice effect (i.e., increase of 5.5 points) over a 1-week time frame. Pattern Comparison exhibits a number of strengths: it is appropriate for use across the lifespan (ages 5-85), it is short and easy to administer, and there is support for construct validity.	[Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Beaumont, Jennifer L.; Gershon, Richard C.] Northwestern Univ, Dept Med Social Sci, Chicago, IL 60611 USA; [Tulsky, David S.] Univ Delaware Hlth Sci, Dept Phys Therapy, Newark, DE USA; [Tulsky, David S.] Kessler Fdn, Neuropsychol & Neurosci Lab, Spinal Cord Injury Lab, West Orange, NJ USA		Carlozzi, NE (corresponding author), Ctr Clin Outcomes Dev & Applicat, Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	Beaumont, Jennifer/AAA-2825-2020	Beaumont, Jennifer/0000-0002-1484-260X; Tulsky, David/0000-0002-4335-4509	National Institute of Health; NIH Toolbox for Assessment of Neurological and Behavioral Function [N01AG60007]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [N44AA002006] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health; NIH Toolbox for Assessment of Neurological and Behavioral Function (contract number: N01AG60007).	Baudouin A, 2009, BRAIN COGNITION, V71, P240, DOI 10.1016/j.bandc.2009.08.007; Beaumont JL, 2013, NEUROLOGY, V80, pS87, DOI 10.1212/WNL.0b013e3182872e70; Bell NL, 2001, J CLIN PSYCHOL, V57, P417, DOI 10.1002/jclp.1024; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Breed S, 2008, J HEAD TRAUMA REHAB, V23, P149, DOI 10.1097/01.HTR.0000319931.76966.ff; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Carlozzi NE, 2013, MONOGR SOC RES CHILD, V78, P88, DOI 10.1111/mono.12036; Casaletto K. B., J INT NEURO IN PRESS; Chiaravalloti ND, 2003, J CLIN EXP NEUROPSYC, V25, P489, DOI 10.1076/jcen.25.4.489.13878; Clay OJ, 2009, J AGING HEALTH, V21, P547, DOI 10.1177/0898264309333326; Coyle TR, 2011, PSYCHOL SCI, V22, P1265, DOI 10.1177/0956797611418243; de Jager CA, 2004, NEUROL RES, V26, P481, DOI 10.1179/016164104225016209; de Jager CA, 2003, PSYCHOL MED, V33, P1039, DOI 10.1017/S0033291703008031; De Monte VE, 2010, J CLIN EXP NEUROPSYC, V32, P28, DOI 10.1080/13803390902806519; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Denney DR, 2011, ARCH CLIN NEUROPSYCH, V26, P110, DOI 10.1093/arclin/acq104; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Duff K, 2007, ARCH CLIN NEUROPSYCH, V22, P15, DOI 10.1016/j.acn.2006.08.013; Earles JL, 1999, EXP AGING RES, V25, P243, DOI 10.1080/036107399244011; Forn C, 2008, J CLIN EXP NEUROPSYC, V30, P789, DOI 10.1080/13803390701779560; Funder DC, 2014, PERS SOC PSYCHOL REV, V18, P3, DOI 10.1177/1088868313507536; Gerritsen MJJ, 2003, J CLIN EXP NEUROPSYC, V25, P1, DOI 10.1076/jcen.25.1.1.13622; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Gontkovsky ST, 2006, INT J NEUROSCI, V116, P1317, DOI 10.1080/00207450500516537; Gonzalez R, 2006, CLIN NEUROPSYCHOL, V20, P396, DOI 10.1080/13854040590967559; Gonzalez-Blanch C, 2010, SCHIZOPHR RES, V119, P18, DOI 10.1016/j.schres.2010.02.1072; Heyanka DJ, 2010, INT J NEUROSCI, V120, P409, DOI 10.3109/00207451003597177; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; Kail R, 1998, J CLIN EXP NEUROPSYC, V20, P98, DOI 10.1076/jcen.20.1.98.1483; KLINTEBERG B. A., 1987, PERCEPT MOTOR SKILL, V65, P683; Leskela M, 1999, EUR J NEUROL, V6, P653, DOI 10.1046/j.1468-1331.1999.660653.x; LINDENBERGER U, 1993, PSYCHOL AGING, V8, P207, DOI 10.1037/0882-7974.8.2.207; Llorente AM, 2004, APPL NEUROPSYCHOL, V11, P47, DOI 10.1207/s15324826an1101_6; Loranger M, 2000, PSYCHOL REP, V87, P893, DOI 10.2466/PR0.87.7.893-900; Machulda MM, 2013, CLIN NEUROPSYCHOL, V27, P1247, DOI 10.1080/13854046.2013.836567; Majeres RL, 1999, MEM COGNITION, V27, P246, DOI 10.3758/BF03211409; Majeres RL, 1997, PERCEPT MOTOR SKILL, V85, P1243, DOI 10.2466/pms.1997.85.3f.1243; Makel MC, 2014, PSYCHOL AESTHET CREA, V8, P27, DOI 10.1037/a0035811; Manly J., 2003, CLIN INTERPRETATION, P181, DOI DOI 10.1016/B978-012703570-3/50010-9; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mayes SD, 2007, CHILD NEUROPSYCHOL, V13, P469, DOI 10.1080/09297040601112773; McCaffrey RJ, 2000, PRACTITIONERS GUIDE; Mendez MF, 1997, BRAIN COGNITION, V34, P301, DOI 10.1006/brcg.1997.0923; Morrens M, 2008, Cogn Neuropsychiatry, V13, P457, DOI 10.1080/13546800802439312; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; Ojeda N, 2008, SCHIZOPHR RES, V101, P225, DOI 10.1016/j.schres.2007.12.483; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Peters M, 1997, J MOTOR BEHAV, V29, P290, DOI 10.1080/00222899709600016; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P471, DOI 10.1080/01688638908400907; ROIG M, 1992, PERCEPT MOTOR SKILL, V74, P1143, DOI 10.2466/PMS.74.4.1143-1148; SALTHOUSE TA, 1993, DEV PSYCHOL, V29, P722, DOI 10.1037/0012-1649.29.4.722; SALTHOUSE TA, 1983, LIFE-SPAN DEV BEHAV, V5, P89; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SALTHOUSE TA, 1993, J GERONTOL, V48, pP245, DOI 10.1093/geronj/48.5.P245; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Schwartz BS, 2004, ENVIRON HEALTH PERSP, V112, P314, DOI 10.1289/ehp.6727; Sliwinski M, 1999, PSYCHOL AGING, V14, P18, DOI 10.1037/0882-7974.14.1.18; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Tulsky DS, 2014, J INT NEUROPSYCH SOC, V20, P599, DOI 10.1017/S135561771400040X; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	69	31	31	2	18	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2015	30	5					359	368		10.1093/arclin/acv031			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CO3PS	WOS:000359071300001	26025230	Green Published, Bronze			2022-02-06	
J	Wolf, GK; Kretzmer, T; Crawford, E; Thors, C; Wagner, HR; Strom, TQ; Eftekhari, A; Klenk, M; Hayward, L; Vanderploeg, RD				Wolf, Gregory K.; Kretzmer, Tracy; Crawford, Eric; Thors, Christina; Wagner, H. Ryan; Strom, Thad Q.; Eftekhari, Afsoon; Klenk, Megan; Hayward, Laura; Vanderploeg, Rodney D.			Prolonged Exposure Therapy With Veterans and Active Duty Personnel Diagnosed With PTSD and Traumatic Brain Injury	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH-SERVICES; PSYCHOMETRIC PROPERTIES; AFGHANISTAN VETERANS; CHECKLIST PCL; IRAQ; SYMPTOMS; VALIDITY; VICTIMS; HISTORY	The present study used archival clinical data to analyze the delivery and effectiveness of prolonged exposure (PE) and ancillary services for posttraumatic stress disorder (PTSD) among Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn veterans (N = 69) with histories of mild to severe traumatic brain injury (TBI). Data from standard clinical assessments of veterans and active duty personnel treated in both inpatient and outpatient programs at 2 Department of Veteran Affairs medical centers were examined. Symptoms were assessed with self-report measures of PTSD (PTSD Checklist) and depression (Beck Depression Inventory-II) before and throughout therapy. Mixed linear models were utilized to determine the slope of reported symptoms throughout treatment, and the effects associated with fixed factors such as site, treatment setting (residential vs. outpatient), and TBI severity were examined. Results demonstrated significant decreases in PTSD, B = -3.00, 95% CI [-3.22, -2.78]; t(210) = -13.5; p < .001, and in depressive symptoms, B = -1.46, 95% CI [-1.64, -1.28]; t(192) = -8.32; p < .001. The effects of PE treatment did not differ by clinical setting and participants with moderate to severe injuries reported more rapid gains than those with a history of mild TBI. The results provide evidence that PE may well be effective for veterans with PTSD and TBI.	[Wolf, Gregory K.; Kretzmer, Tracy; Thors, Christina; Vanderploeg, Rodney D.] James A Haley VA Med Ctr, MHBS, Tampa, FL 33612 USA; [Crawford, Eric; Wagner, H. Ryan] VA Mid Atlantic Reg Mental Illness Res Educ & Cli, Durham, NC USA; [Crawford, Eric; Wagner, H. Ryan; Klenk, Megan] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Strom, Thad Q.] Dept Vet Affairs Med Ctr, Mental Hlth Serv Minneapolis, Minneapolis, MN USA; [Strom, Thad Q.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Eftekhari, Afsoon] VA Palo Alto HCS, Natl Ctr PTSD, Disseminat & Training Div, Menlo Pk, CA USA; [Hayward, Laura] Syracuse VA Med Ctr, Dept Psychol, Syracuse, NY USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA		Wolf, GK (corresponding author), James A Haley VA Med Ctr, MHBS, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Gregory.Wolf2@va.gov		Strom, Thad/0000-0001-6743-9999			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Cook JM, 2013, J TRAUMA STRESS, V26, P56, DOI 10.1002/jts.21769; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Foa, 2003, J COGN PSYCHOTHER, V17, P113, DOI [10.1891/jcop.17.2.113.57434, DOI 10.1891/JC0P.17.2.113.57434]; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; Foa EB, 2002, J CONSULT CLIN PSYCH, V70, P1022, DOI 10.1037//0022-006X.70.4.1022; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Molenberghs G., 2000, LINEAR MIXED MODELS; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Rauch SAM, 2009, DEPRESS ANXIETY, V26, P732, DOI 10.1002/da.20518; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Resick PA, 2014, COGNITIVE PROCESSING; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tuerk PW, 2013, PSYCHOL SERV, V10, P401, DOI 10.1037/a0030549; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; U.S. Department of Veteran Affairs and Department of Defense, 2010, TRAUM BRAIN INJ VET; U.S. Department of Veterans Affairs, 2010, VA CONS C PRACT REC; U.S. Department of Veterans Affairs and Department of Defense (VA/DoD), 2009, VA DOD CLIN PRACT GU; U.S. Department of Veterans Affairs and Department of Defense (VA/DoD), 2010, VA DOD CLIN PRACT GU; US Department of Defense, 2012, US MIL CAS STAT OP N; VansMinnen A., 2012, EUROPEAN J PSYCHOTRA, V3, DOI [10.3402/ejpt.v3i0.18805, DOI 10.3402/EJPT.V3I0.18805]; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f	45	31	31	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	AUG	2015	28	4					339	347		10.1002/jts.22029			9	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	CP5HR	WOS:000359912400010	26201688				2022-02-06	
J	Wilcox, BJ; Beckwith, JG; Greenwald, RM; Raukar, NP; Chu, JJ; McAllister, TW; Flashman, LA; Maerlender, AC; Duhaime, AC; Crisco, JJ				Wilcox, Bethany J.; Beckwith, Jonathan G.; Greenwald, Richard M.; Raukar, Neha P.; Chu, Jeffrey J.; McAllister, Thomas W.; Flashman, Laura A.; Maerlender, Arthur C.; Duhaime, Ann-Christine; Crisco, Joseph J.			Biomechanics of head impacts associated with diagnosed concussion in female collegiate ice hockey players	JOURNAL OF BIOMECHANICS			English	Article						Impact biomechanics; Concussion; Female; Hockey	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; ACCELERATION; SYMPTOMS; EXPOSURE; GENDER; GAME; SEX	Epidemiological evidence suggests that female athletes may be at a greater risk of concussion than their male counterparts. The purpose of this study was to examine the biomechanics of head impacts associated with diagnosed concussions in a cohort of female collegiate ice hockey players. Instrumented helmets were worn by 58 female ice hockey players from 2 NCAA programs over a three year period. Kinematic measures of single impacts associated with diagnosed concussion and head impact exposure on days with and without diagnosed concussion were evaluated. Nine concussions were diagnosed. Head impact exposure was greater in frequency and magnitude on days of diagnosed concussions than on days without diagnosed concussion for individual athletes. Peak linear accelerations of head impacts associated with diagnosed concussion in this study are substantially lower than those previously reported in male athletes, while peak rotational accelerations are comparable. Further research is warranted to determine the extent to which female athletes' biomechanical tolerance to concussion injuries differs from males. (C) 2015 Elsevier Ltd. All rights reserved.	[Wilcox, Bethany J.; Crisco, Joseph J.] Brown Univ, Warren Alpert Med Sch, Bioengn Lab, Dept Orthopaed, Providence, RI 02903 USA; [Wilcox, Bethany J.; Crisco, Joseph J.] Rhode Isl Hosp, Providence, RI USA; [Beckwith, Jonathan G.; Greenwald, Richard M.; Chu, Jeffrey J.] Simbex, Lebanon, NH USA; [Greenwald, Richard M.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Raukar, Neha P.] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02903 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Flashman, Laura A.] Geisel Sch Med Dartmouth, Dept Psychiat, Lebanon, NH USA; [Maerlender, Arthur C.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Pediat Neurosurg, Boston, MA 02114 USA		Wilcox, BJ (corresponding author), Brown Univ, Alpert Med Sch, Bioengn Lab, Dept Orthopaed, CORO West,Suite 404,1 Hoppin St, Providence, RI 02903 USA.	Bethany_Wilcox@brown.edu		Crisco, Joseph/0000-0002-8786-0905	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of General Medical Sciences at the National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01HD048638, RO1NS055020, R25GM083270, R25GM083270-S1]; National Operating Committee on Standards for Athletic Equipment (NOCSAE); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104937, R25GM083270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055020] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Child Health and Human Development, the National Institute of Neurological Disorders and Stroke, and the National Institute of General Medical Sciences at the National Institute of Health under award numbers R01HD048638, RO1NS055020, R25GM083270 and R25GM083270-S1 and the National Operating Committee on Standards for Athletic Equipment (NOCSAE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or NOCSAE. We gratefully acknowledge and thank the engineering team at Simbex for all of their technical support. We would like to thank Lindley Brainard and Wendy Chamberlin at Simbex for their role in data collection and clinical coordination. We would also like to thank Russell Fiore, M.Ed., A.T.C, Emily Burmeister M.S., A.T.C, and Brian Daigneault, MS, A.T.C at Brown University; Jeff Frechette, A.T.C., and Tracey Poro, A.T.C.at Dartmouth College Sports Medicine and Mary Hynes, R.N., M.P.H. at Dartmouth Medical School for their support on this project.	Agel J, 2010, CAN J SURG, V53, P319; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chu JJ, 2006, J BIOMECH S1, V39, pS534; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Dick R.W., 2009, BR J SPORTS MED S1, V43, pSi46; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004	29	31	31	3	20	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUL 16	2015	48	10					2201	2204		10.1016/j.jbiomech.2015.04.005			4	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CN5HG	WOS:000358459800073	25913243	Green Published, Green Accepted, Green Submitted			2022-02-06	
J	Cheng, T; Yang, B; Li, DP; Ma, SS; Tian, Y; Qu, RN; Zhang, WJ; Zhang, YT; Hu, K; Guan, FX; Wang, J				Cheng, Tian; Yang, Bo; Li, Dongpeng; Ma, Shanshan; Tian, Yi; Qu, Ruina; Zhang, Wenjin; Zhang, Yanting; Hu, Kai; Guan, Fangxia; Wang, Jian			Wharton's Jelly Transplantation Improves Neurologic Function in a Rat Model of Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Cognition; Traumatic brain injury; Wharton's jelly; Transplantation; BDNF	MESENCHYMAL STEM-CELLS; CEREBRAL-ISCHEMIA; HEMORRHAGIC BRAIN; CORD; EXPRESSION	Traumatic brain injury (TBI), which can lead to disability, dysfunction, and even death, is a prominent health problem worldwide. Effective therapy for this serious and debilitating condition is needed. Human umbilical cord matrix, known as Wharton's jelly (WJ), provides a natural, interface scaffold that is enriched in mesenchymal stem cells. In this study, we tested the efficacy of WJ tissue transplantation in a weight-drop model of TBI in rats. WJ tissue was cultured and transplanted into the injury site 24 h after TBI. The modified neurologic severity score, body weight, brain edema, and lesion volume were evaluated at various time points after TBI. Cognitive behavior was assessed by the novel object recognition test and the Morris water maze test. Expression of brain-derived neurotrophic factor (BDNF) in the perilesional brain area was measured at day 14 after TBI. We found that WJ tissue transplantation lessened TBI-induced brain edema (day 3), reduced lesion volume (day 28), improved neurologic function (days 21-28), and promoted memory and cognitive recovery. Additionally, expression of BDNF mRNA and protein was higher in WJ tissue-treated rats than in sham-operated or vehicle-treated rats. These data suggest that WJ tissue transplantation can reduce TBI-induced brain injury and may have therapeutic potential for the treatment of TBI.	[Cheng, Tian; Yang, Bo; Li, Dongpeng; Tian, Yi; Zhang, Wenjin; Guan, Fangxia] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Cheng, Tian; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Ma, Shanshan; Qu, Ruina; Zhang, Yanting; Guan, Fangxia] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China; [Hu, Kai] Henan Acad Med Sci, Zhengzhou 450003, Henan, Peoples R China		Guan, FX (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China.	13613813972@126.com; jwang79@jhmi.edu	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471306, U1404313]; Innovative Research Team (in Science and Technology); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01AG031926, R01NS078026, R01AT007317]; China Scholarship CouncilChina Scholarship Council; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG031926] Funding Source: NIH RePORTER	This study was supported by Natural Science Foundation of China (81471306, U1404313), Innovative Research Team (in Science and Technology) and NIH K01AG031926, R01NS078026, and R01AT007317. T.C. is the recipient of the China Scholarship Council Joint PhD Training award. We thank Jiarui Wang and Claire Levine for assistance with this manuscript.	Arien-Zakay H, 2012, J MOL NEUROSCI, V48, pS66; Bakhtiary M, 2011, IRAN J BASIC MED SCI, V14, P327; Bennett MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004609.pub3; Camussi G, 2010, CURR OPIN NEPHROL HY, V19, P7, DOI 10.1097/MNH.0b013e328332fb6f; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Fang B, 2014, INT J MOL SCI, V15, P6378, DOI 10.3390/ijms15046378; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Jiang C, 2013, BEHAV BRAIN RES, V250, P222, DOI 10.1016/j.bbr.2013.05.011; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Malkowski A, 2007, ACTA BIOCHIM POL, V54, P357, DOI 10.18388/abp.2007_3257; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Sobolewski K, 2005, PLACENTA, V26, P747, DOI 10.1016/j.placenta.2004.10.008; Vatansever F, 2013, PROC SPIE, V8569, DOI 10.1117/12.2001900; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Wu H, 2010, NEUROCHEM INT, V57, P248, DOI 10.1016/j.neuint.2010.06.002; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Zan L, 2014, NEUROSCIENCE, V262, P118, DOI 10.1016/j.neuroscience.2013.12.060; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhou CH, 2011, CELL IMMUNOL, V272, P33, DOI 10.1016/j.cellimm.2011.09.010; Zhu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097423	27	31	31	0	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JUL	2015	35	5					641	649		10.1007/s10571-015-0159-9			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CL2JJ	WOS:000356769400005	25638565	Green Accepted			2022-02-06	
J	Villacampa, N; Almolda, B; Vilella, A; Campbell, IL; Gonzalez, B; Castellano, B				Villacampa, Nadia; Almolda, Beatriz; Vilella, Antonietta; Campbell, Iain L.; Gonzalez, Berta; Castellano, Bernardo			Astrocyte-Targeted Production of IL-10 Induces Changes in Microglial Reactivity and Reduces Motor Neuron Death After Facial Nerve Axotomy	GLIA			English	Article						microglia; transgenic animal; neuronal survival; lymphocytes; nerve injury; neurodegeneration; cytokines; IL-10R; CD18; CD16; 32; MHC-II; CD39; arginase-1; Ym-1; CD150	SPINAL-CORD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INTERLEUKIN-10 RECEPTOR; T-CELLS; LYMPHOCYTE RECRUITMENT; CELLULAR-LOCALIZATION; MOLECULAR-MECHANISMS; IMMUNE SURVEILLANCE; PROMOTES SURVIVAL; CEREBRAL-CORTEX	Interleukin-10 (IL-10) is a cytokine that plays a crucial role in regulating the inflammatory response and immune reactions. In the central nervous system (CNS), IL-10 is mainly produced by astrocytes and microglia and it is upregulated after various insults, such as experimental autoimmune encephalomyelitis, middle cerebral artery occlusion, excitotoxicity and traumatic brain injury. To better understand the effects of IL-10 in the normal and injured CNS, we generated transgenic mice (termed GFAP-IL-10Tg) that expressed the murine IL-10 gene under the transcriptional control of the glial fibrillary acidic protein (GFAP) promoter. Previous studies demonstrated marked changes in the microglial phenotype in these mice under basal conditions. The objective of the present study was to investigate the effects of local astrocyte-targeted IL-10 production on glial activation, neuronal degeneration and leukocyte recruitment after axotomy. GFAP-IL-10Tg mice had marked changes in the phenotype of activated microglial cells, as well as in the number of microglial clusters and in microglial cell density. These microglial changes are accompanied by a twofold increase in lymphocyte infiltration in GFAP-IL-10Tg mice and around twofold decrease in neuronal cell death at 21 dpi. Altogether, our findings suggested that astrocyte-targeted production of IL-10 impacted the microglial response and lymphocyte recruitment and culminated in a beneficial effect on neuronal survival. GLIA 2015;63:1166-1184	[Villacampa, Nadia; Almolda, Beatriz; Gonzalez, Berta; Castellano, Bernardo] Univ Autonoma Barcelona, Inst Neurosci, Dept Cell Biol Physiol & Immunol, E-08193 Barcelona, Spain; [Vilella, Antonietta] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, I-41125 Modena, Italy; [Campbell, Iain L.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia		Villacampa, N (corresponding author), Univ Autonoma Barcelona, Fac Med, Unitat Histol, Torre M5, E-08193 Barcelona, Spain.	nadia.villacampa@uab.cat	Almolda, Beatriz/L-6920-2014; VILELLA, ANTONIETTA/AAU-3373-2021; Castellano, Bernardo/G-1428-2010; Villacampa, Dr Nadia/K-5304-2014; Vilella, Antonietta/AAF-2084-2019; Gonzalez, Berta/G-1428-2010	Almolda, Beatriz/0000-0001-6631-4385; Castellano, Bernardo/0000-0003-1976-971X; Villacampa, Dr Nadia/0000-0001-6513-0250; Gonzalez, Berta/0000-0002-1860-3980; Vilella, Antonietta/0000-0003-3820-0115	Spanish Ministry of Science and InnovationSpanish Government [BFU2011-27400]; NHMRCNational Health and Medical Research Council of Australia [632754]	Grant sponsor: Spanish Ministry of Science and Innovation; Grant number: BFU2011-27400 (to BCL); Grant sponsor: NHMRC; Grant number: 632754 (to ILC)	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Aldskogius Hakan, 2011, Front Biosci (Schol Ed), V3, P857; Almolda B, 2015, BRAIN BEHAV IMMUN, V45, P80, DOI 10.1016/j.bbi.2014.10.015; Almolda B, 2014, GLIA, V62, P1142, DOI 10.1002/glia.22668; Almolda B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027473; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Atkins S, 2007, J PERIPHER NERV SYST, V12, P269, DOI 10.1111/j.1529-8027.2007.00148.x; Benveniste EN, 1998, CYTOKINE GROWTH F R, V9, P259, DOI 10.1016/S1359-6101(98)00015-X; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Bohatschek M, 2004, J NEUROIMMUNOL, V156, P132, DOI 10.1016/j.jneuroim.2004.07.018; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Bulavina L, 2013, PURINERG SIGNAL, V9, P199, DOI 10.1007/s11302-012-9339-y; Byram SC, 2004, J NEUROSCI, V24, P4333, DOI 10.1523/JNEUROSCI.5276-03.2004; Conde JR, 2006, NEUROBIOL AGING, V27, P1451, DOI 10.1016/j.neurobiolaging.2005.07.012; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Ferri CC, 1998, J NEUROBIOL, V34, P1; Galiano M, 2001, EUR J NEUROSCI, V14, P327, DOI 10.1046/j.0953-816x.2001.01647.x; Gonzalez P, 2009, J NEUROPATH EXP NEUR, V68, P391, DOI 10.1097/NEN.0b013e31819dca30; GRAEBER MB, 1993, ACTA NEUROPATHOL, V86, P179, DOI 10.1007/BF00334886; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Ha GK, 2006, J NEUROIMMUNOL, V172, P1, DOI 10.1016/j.jneuroim.2005.10.012; Hao HP, 2007, J NEUROSCI RES, V85, P2196, DOI 10.1002/jnr.21357; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; Hulshof S, 2002, GLIA, V38, P24, DOI 10.1002/glia.10050; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Jinno S, 2011, NEURON GLIA BIOL, V7, P55, DOI 10.1017/S1740925X11000135; Jones KJ, 2005, BRAIN BEHAV IMMUN, V19, P12, DOI 10.1016/j.bbi.2004.05.004; Jones LL, 2000, J COMP NEUROL, V426, P468, DOI 10.1002/1096-9861(20001023)426:3<468::AID-CNE9>3.0.CO;2-I; Jones LL, 1997, EUR J NEUROSCI, V9, P1854, DOI 10.1111/j.1460-9568.1997.tb00752.x; Jovanova-Nesic Katica, 2012, Curr Aging Sci, V5, P209; Kalla R, 2001, J COMP NEUROL, V436, P182; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; KIEFER R, 1991, J NEUROIMMUNOL, V34, P99, DOI 10.1016/0165-5728(91)90119-R; Kloss CUA, 1999, J COMP NEUROL, V411, P162, DOI 10.1002/(SICI)1096-9861(19990816)411:1<162::AID-CNE12>3.0.CO;2-W; Kloss CUA, 1997, J NEUROSCI RES, V49, P248; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Ledeboer A, 2002, EUR J NEUROSCI, V16, P1175, DOI 10.1046/j.1460-9568.2002.02200.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makwana M, 2005, FEBS J, V272, P2628, DOI 10.1111/j.1742-4658.2005.04699.x; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; MIZUNO T, 1994, BIOCHEM BIOPH RES CO, V205, P1907, DOI 10.1006/bbrc.1994.2893; Molina-Holgado F, 2001, GLIA, V33, P97, DOI 10.1002/1098-1136(200102)33:2<97::AID-GLIA1009>3.0.CO;2-N; Moller JC, 1996, GLIA, V17, P121; MONETA ME, 1993, J NEUROIMMUNOL, V45, P203, DOI 10.1016/0165-5728(93)90181-W; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; MOSMANN TR, 1991, ANN NY ACAD SCI, V628, P337, DOI 10.1111/j.1749-6632.1991.tb17266.x; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; OLSSON T, 1992, AUTOIMMUNITY, V13, P117, DOI 10.3109/08916939209001912; Park KW, 2007, EXP MOL MED, V39, P812, DOI 10.1038/emm.2007.88; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Petitto JN, 2003, J NEUROIMMUNOL, V134, P95, DOI 10.1016/S0165-5728(02)00422-8; Pousset F, 2001, J NEUROCHEM, V79, P726, DOI 10.1046/j.1471-4159.2001.00569.x; Raivich G, 1998, J NEUROSCI, V18, P5804; Raivich G, 2003, J NEUROSCI RES, V72, P726, DOI 10.1002/jnr.10621; Raivich G, 1998, J COMP NEUROL, V395, P342, DOI 10.1002/(SICI)1096-9861(19980808)395:3<342::AID-CNE6>3.0.CO;2-2; RAIVICH G, 1994, EUR J NEUROSCI, V6, P1615, DOI 10.1111/j.1460-9568.1994.tb00552.x; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; RINAMAN L, 1991, NEUROSCIENCE, V44, P765, DOI 10.1016/0306-4522(91)90096-7; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Samoilova EB, 1998, CELL IMMUNOL, V188, P118, DOI 10.1006/cimm.1998.1365; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; SCHOEN SW, 1992, GLIA, V6, P314, DOI 10.1002/glia.440060410; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; Serpe CJ, 2000, J NEUROSCI RES, V62, P273, DOI 10.1002/1097-4547(20001015)62:2<273::AID-JNR11>3.3.CO;2-3; Serpe CJ, 2003, BRAIN BEHAV IMMUN, V17, P393, DOI 10.1016/S0889-1591(03)00028-X; Serpe CJ, 1999, J NEUROSCI, V19; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Strle K, 2002, J NEUROIMMUNOL, V122, P9, DOI 10.1016/S0165-5728(01)00444-1; SVENSSON M, 1994, NEUROPATH APPL NEURO, V20, P185; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; van Horssen J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-156; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Werner A, 1998, J NEUROCYTOL, V27, P219, DOI 10.1023/A:1006928830251; Xin JP, 2008, BRAIN BEHAV IMMUN, V22, P528, DOI 10.1016/j.bbi.2007.10.006; Xin JP, 2011, BRAIN BEHAV IMMUN, V25, P820, DOI 10.1016/j.bbi.2010.08.004; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018	86	31	35	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JUL	2015	63	7					1166	1184		10.1002/glia.22807			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG6IC	WOS:000353402100005	25691003				2022-02-06	
J	Herou, E; Romner, B; Tomasevic, G				Herou, Erik; Romner, Bertil; Tomasevic, Gregor			Acute Traumatic Brain Injury: Mortality in the Elderly	WORLD NEUROSURGERY			English	Article						aSDH; Craniotomy; Elderly; Head injury; TBI; Trauma	GLASGOW COMA SCALE; REACTION LEVEL SCALE; PROGNOSTIC VALUE; ADMISSION CHARACTERISTICS; INTRACRANIAL HEMORRHAGE; IMPACT; AGE; OUTCOMES; ANTIPLATELET; VALIDATION	OBJECTIVE: Despite recent progress, prognosis for the elderly (defined as aged >= 70 years) afflicted by traumatic brain injury (TBI) is unfavorable and surgical intervention remains controversial. Research during the past decade on the mortality rates or prognostic factors for survival in the elderly is limited. METHODS: We analyzed 97 patients aged >= 70 years who were treated surgically for closed TBI at our neurosurgical unit between January 1, 2003 and December 31, 2012. In addition, we analyzed 22 patients aged >= 70 years who had sustained a closed TBI and on whom no neurosurgical intervention was performed. Outcome in both groups was measured as 30-, 90- and 180-day mortality. RESULTS: Surgically treated patients: median age, 76 years' 30- day overall mortality rate, 36%. Higher mortality was seen with lower level of consciousness, high energy trauma, one pupil fixed and dilated, and more extensive intracranial pathology. Presence of warfarin, more advanced age, or degree of midline shift were not associated with worsened outcome. Patients not treated neurosurgically: median age. 81.5 years; 30-day overall mortality rate, 23%. Mortality for patients with Glasgow coma scale (GCS) 10-15 was 6%, GCS 6-9 67%, and GCS 3-5 100%. CONCLUSIONS: Selected patients aged >= 70 years can benefit from surgical intervention for closed TBI. Level of consciousness, radiologic type of injury, mechanism of injury, and pupil abnormalities should be carefully evaluated. There also seems to exist a group of patients in whom surgical intervention offers little benefit, as mortality rate is low without surgical intervention.	[Herou, Erik; Romner, Bertil; Tomasevic, Gregor] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden		Herou, E (corresponding author), Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden.	Erik.Herou@skane.se		Herou, Erik/0000-0002-8071-0381	Lund University Medical School [31434411014]	This work was funded by grants from Lund University Medical School (fund no. 31434411014).	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Borger V, 2012, ACTA NEUROCHIR, V154, P1549, DOI 10.1007/s00701-012-1434-x; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; *CDCP, TRAUM BRAIN INJ US; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Hanley JP, 2004, J CLIN PATHOL, V57, P1132, DOI 10.1136/jcp.2003.008904; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inamasu J, 2010, NEUROL MED-CHIR, V50, P1051, DOI 10.2176/nmc.50.1051; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; The Brain TraumaFoundation, 2000, J NEUROTRAUM, V17, P583, DOI [10.1089/neu.2000.17.583, DOI 10.1089/NEU.2000.17.583]; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4	32	31	31	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2015	83	6					996	1001		10.1016/j.wneu.2015.02.023			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CK3TN	WOS:000356138800021	25731794				2022-02-06	
J	Tavender, EJ; Bosch, M; Gruen, RL; Green, SE; Michie, S; Brennan, SE; Francis, JJ; Ponsford, JL; Knott, JC; Meares, S; Smyth, T; O'Connor, DA				Tavender, Emma J.; Bosch, Marije; Gruen, Russell L.; Green, Sally E.; Michie, Susan; Brennan, Sue E.; Francis, Jill J.; Ponsford, Jennie L.; Knott, Jonathan C.; Meares, Sue; Smyth, Tracy; O'Connor, Denise A.			Developing a targeted, theory-informed implementation intervention using two theoretical frameworks to address health professional and organisational factors: a case study to improve the management of mild traumatic brain injury in the emergency department	IMPLEMENTATION SCIENCE			English	Article						Intervention design; Intervention development; Theory use; Theoretical domains framework; Diffusion of innovations in service organisations	BEHAVIOR-CHANGE; KNOWLEDGE TRANSLATION; COLLABORATING-CENTER; HEAD-INJURIES; TASK-FORCE; CARE; TAXONOMY; PROTOCOL; DETERMINANTS; STRATEGIES	Background: Despite the availability of evidence-based guidelines for the management of mild traumatic brain injury in the emergency department (ED), variations in practice exist. Interventions designed to implement recommended behaviours can reduce this variation. Using theory to inform intervention development is advocated; however, there is no consensus on how to select or apply theory. Integrative theoretical frameworks, based on syntheses of theories and theoretical constructs relevant to implementation, have the potential to assist in the intervention development process. This paper describes the process of applying two theoretical frameworks to investigate the factors influencing recommended behaviours and the choice of behaviour change techniques and modes of delivery for an implementation intervention. Methods: A stepped approach was followed: (i) identification of locally applicable and actionable evidence-based recommendations as targets for change, (ii) selection and use of two theoretical frameworks for identifying barriers to and enablers of change (Theoretical Domains Framework and Model of Diffusion of Innovations in Service Organisations) and (iii) identification and operationalisation of intervention components (behaviour change techniques and modes of delivery) to address the barriers and enhance the enablers, informed by theory, evidence and feasibility/acceptability considerations. We illustrate this process in relation to one recommendation, prospective assessment of post-traumatic amnesia (PTA) by ED staff using a validated tool. Results: Four recommendations for managing mild traumatic brain injury were targeted with the intervention. The intervention targeting the PTA recommendation consisted of 14 behaviour change techniques and addressed 6 theoretical domains and 5 organisational domains. The mode of delivery was informed by six Cochrane reviews. It was delivered via five intervention components : (i) local stakeholder meetings, (ii) identification of local opinion leader teams, (iii) a train-the-trainer workshop for appointed local opinion leaders, (iv) local training workshops for delivery by trained local opinion leaders and (v) provision of tools and materials to prompt recommended behaviours. Conclusions: Two theoretical frameworks were used in a complementary manner to inform intervention development in managing mild traumatic brain injury in the ED. The effectiveness and cost-effectiveness of the developed intervention is being evaluated in a cluster randomised trial, part of the Neurotrauma Evidence Translation (NET) program.	[Tavender, Emma J.; Bosch, Marije; Gruen, Russell L.; Ponsford, Jennie L.] Monash Univ, Alfred, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Tavender, Emma J.; Bosch, Marije; Gruen, Russell L.] Monash Univ, Cent Clin Sch, Dept Surg, Melbourne, Vic 3004, Australia; [Gruen, Russell L.] Alfred Hosp, Dept Trauma, Melbourne, Vic, Australia; [Green, Sally E.; Brennan, Sue E.; O'Connor, Denise A.] Monash Univ, Sch Publ Hlth & Preventat Med, Melbourne, Vic 3004, Australia; [Michie, Susan] UCL, Dept Clin Educ & Hlth Psychol, London, England; [Francis, Jill J.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Knott, Jonathan C.] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Knott, Jonathan C.] Royal Melbourne Hosp, Dept Emergency Med, Melbourne, Vic, Australia; [Meares, Sue] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Smyth, Tracy] Westmead Hosp, Emergency Dept, Westmead, NSW 2145, Australia		Tavender, EJ (corresponding author), Monash Univ, Alfred, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia.	emma.tavender@monash.edu	O'Connor, Denise/ABC-6655-2020	O'Connor, Denise/0000-0002-6836-122X; Meares, Susanne/0000-0002-3859-9974; Tavender, Emma/0000-0002-7230-712X; Brennan, Sue/0000-0003-1789-8809; Francis, Jill/0000-0001-5784-8895; Green, Sally Elizabeth/0000-0002-9564-9050	Victorian Transport Accident Commission, Australia; Australian Postgraduate Award, Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Australian National Health and Medical Research Council Public Health FellowshipNational Health and Medical Research Council of Australia; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	The NET Program is funded by the Victorian Transport Accident Commission, Australia. EJT is supported by an Australian Postgraduate Award, Australian National Health and Medical Research Council. DOC is supported by an Australian National Health and Medical Research Council Public Health Fellowship. RLG is supported by a Practitioner Fellowship from the Australian National Health and Medical Research Council.	Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bessen T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3056; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; Bosch M, 2013, J EVAL CLIN PRACT, V19, P763, DOI 10.1111/j.1365-2753.2012.01835.x; Brehaut JC, 2007, ACAD EMERG MED, V14, P984, DOI 10.1197/j.aem.2007.06.025; Buetow S, 2010, J HEALTH SERV RES PO, V15, P123, DOI 10.1258/jhsrp.2009.009081; Cane J, 2015, BRIT J HEALTH PSYCH, V20, P130, DOI 10.1111/bjhp.12102; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Colquhoun H, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-51; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Flottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35; Forsetlund L, 2009, COCHRANE DB SYST REV, V3; Foy R, 2011, BMJ QUAL SAF, V20, P453, DOI 10.1136/bmjqs.2010.047993; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; French SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065471; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Giguere A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub3; Goh M, 2012, MILD TRAUMATIC BRAIN; Gould NJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0092-1; Green SE, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-74; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Grimshaw JM, 2014, IMPLEMENT SCI, V7, P50; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hrisos S, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-11; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Jabbour M, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-55; Kerr J, 2005, EMERG MED J, V22, P850, DOI 10.1136/emj.2004.022673; Kolehmainen N, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-100; Leeman J, 2007, J ADV NURS, V58, P191, DOI 10.1111/j.1365-2648.2006.04207.x; Lippke S, 2008, APPL PSYCHOL-INT REV, V57, P698, DOI 10.1111/j.1464-0597.2008.00339.x; Lloyd JJ, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-73; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mazza D, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-32; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S., 2014, BEHAV CHANGE WHEEL G, V2nd; Michie S., 2014, ABC BEHAV CHANGE THE, V1st; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; O'Brien MA, 2007, COCHRANE DB SYST REV, V17; Ovretveit JC, 2011, BMJ QUAL SAF, V20, P604, DOI 10.1136/bmjqs.2010.047035; Peachey T, 2011, EMERG MED J, V28, P707, DOI 10.1136/emj.2010.093872; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Porcheret M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-42; Powell BJ, 2012, MED CARE RES REV, V69, P123, DOI 10.1177/1077558711430690; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-139; Scott SD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-65; Shojania KG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001096.pub2; Squires JE, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-80; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tabak RG, 2012, AM J PREV MED, V43, P337, DOI 10.1016/j.amepre.2012.05.024; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; The Cochrane Library, 2014, BOOK COCHR LIB; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Toma A, 2010, CRIT CARE MED, V38, P504, DOI 10.1097/CCM.0b013e3181cb0a02; Wasserberg J, 2002, BMJ-BRIT MED J, V325, P454, DOI 10.1136/bmj.325.7362.454	69	31	31	0	21	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	MAY 25	2015	10								74	10.1186/s13012-015-0264-7			22	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	CJ0KN	WOS:000355164600001	26003785	Green Published, Green Accepted, gold			2022-02-06	
J	Di Pietro, V; Amorini, AM; Lazzarino, G; Yakoub, KM; D'Urso, S; Lazzarino, G; Belli, A				Di Pietro, Valentina; Amorini, Angela Maria; Lazzarino, Giacomo; Yakoub, Kamal Makram; D'Urso, Serafina; Lazzarino, Giuseppe; Belli, Antonio			S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						Biomarkers; GFAP; Hippocampal stretch injury; S100B; Traumatic brain injury	CEREBROSPINAL-FLUID; MULTIPLE TRAUMA; GENE-EXPRESSION; MESSENGER-RNA; NITRIC-OXIDE; BIOMARKERS; GFAP; RAT; AGE; ISCHEMIA	Traumatic brain injury (TBI) is a leading and rising cause of death and disability worldwide. There is great interest in S100B and Glial Fibrillary Acid Protein (GFAP) as candidate biomarkers of TBI for diagnosis, triage, prognostication and drug development. However, conflicting results especially on S100B hamper their routine application in clinical practice. To try to address this question, we mimicked TBI damage utilizing a well-validated, simplified in vitro model of graded stretch injury induced in rat organotypic hippocampal slice cultures (OHSC). Different severities of trauma, from mild to severe, have been tested by using an equi-biaxial stretch of the OHSCs at a specified Lagrangian strain of 0 (controls), 5, 10, 20 and 50 %. OHSC were analysed at 3, 6, 18, 24, 48 and 96 h post-injury. Cell death, gene expressions and release into the culture medium of S100B and GFAP were determined at each time point. Gene expression and release of S100B slightly increased only in 20 and 50 % stretched OHSC. GFAP over-expression occurred in 10, 20 and 50 % and was inversely correlated with time post-injury. GFAP release significantly increased with time at any level of injury (p < 0.01 with respect to controls). Consequently, the total amount of GFAP released showed a strong linear relationship with the severity of injury (R-2 = 0.7662; p < 0.001). Under these experimental conditions, S100B seems to be useful in diagnosing only moderate to severe TBI-like injuries. Differently, GFAP demonstrates adequate biomarker requisites since its cellular release is affected by all grades of injury severity.	[Di Pietro, Valentina; Yakoub, Kamal Makram; Belli, Antonio] Univ Birmingham, Neurobiol Sect, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Amorini, Angela Maria; Lazzarino, Giacomo] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, I-00168 Rome, Italy; [D'Urso, Serafina; Lazzarino, Giuseppe] Univ Catania, Dept Biol Geol & Environm Sci, Div Biochem & Mol Biol, Bldg 2,3 Floor,Viale A Doria 6, I-95125 Catania, Italy; [Belli, Antonio] Queen Elizabeth Hosp, Natl Inst Hlth, Res Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England		Lazzarino, G (corresponding author), Univ Catania, Dept Biol Geol & Environm Sci, Div Biochem & Mol Biol, Bldg 2,3 Floor,Viale A Doria 6, I-95125 Catania, Italy.	lazzarig@unict.it	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Di Pietro, Valentina/0000-0001-9430-4723; AMORINI, Angela Maria/0000-0003-3525-9955; Lazzarino, Giacomo/0000-0003-1639-0966	Wessex Medical Research Centre; Smile4rich	We wish to thank the Wessex Medical Research Centre and Smile4rich for funding this study and for their support to our research.	Agosto DV, 2012, FRONT NEUROL SERUM B; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Astrand Ramona, 2013, Methods Mol Biol, V963, P373, DOI 10.1007/978-1-62703-230-8_23; Bettermann K, 2012, RSC DRUG DISCOV, V24, P1, DOI 10.1039/9781849734745-00001; Bharosay A, 2012, INDIAN J CLIN BIOCHE, V27, P186, DOI 10.1007/s12291-011-0172-9; Bouvier D, 2013, ANN BIOL CLIN-PARIS, V71, P145, DOI 10.1684/abc.2013.0812; Buniatian GH, 2002, ANAT RECORD, V267, P296, DOI 10.1002/ar.10115; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; FANO G, 1993, NEUROSCIENCE, V53, P919, DOI 10.1016/0306-4522(93)90477-W; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P16; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; Goyal A, 2012, NEUROTRAUMA, V30, P946; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hu JR, 1997, J NEUROCHEM, V69, P2294; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Johnsson P, 1995, J CARDIOTHOR VASC AN, V9, P694, DOI 10.1016/S1053-0770(05)80231-9; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Morgan TE, 1997, FREE RADICAL BIO MED, V23, P524, DOI 10.1016/S0891-5849(97)00120-2; Morgan TE, 1999, NEUROSCIENCE, V89, P687, DOI 10.1016/S0306-4522(98)00334-0; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Mussack T, 2006, CLIN CHEM LAB MED, V44, P1140, DOI 10.1515/CCLM.2006.190; NICHOLS NR, 1995, NEUROBIOL AGING, V16, P105, DOI 10.1016/0197-4580(95)80013-H; Papa L, 2010, NEUROTHERAPEUTICS, V7, P100; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Romner B, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00053; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	48	31	31	0	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2015	40	5					991	999		10.1007/s11064-015-1554-9			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CH5SH	WOS:000354095100013	25898931				2022-02-06	
J	Wang, FY; Di, HB; Hu, XH; Jing, S; Thibaut, A; Di Perri, C; Huang, WS; Nie, YZ; Schnakers, C; Laureys, S				Wang, Fuyan; Di, Haibo; Hu, Xiaohua; Jing, Shan; Thibaut, Aurore; Di Perri, Carol; Huang, Wangshan; Nie, Yunzhi; Schnakers, Caroline; Laureys, Steven			Cerebral response to subject's own name showed high prognostic value in traumatic vegetative state	BMC MEDICINE			English	Article						Functional MRI; Own name; Prognosis; Traumatic brain injury; Vegetative state/unresponsive wakefulness syndrome	BRAIN; DISORDERS; ACTIVATION; RECOVERY	Background: Previous studies have shown the prognostic value of stimulation elicited blood-oxygen-level-dependent (BOLD) signal in traumatic patients in vegetative state/unresponsive wakefulness syndrome (VS/UWS). However, to the best of our knowledge, no studies have focused on the relevance of etiology and level of consciousness in patients with disorders of consciousness (DOC) when explaining the relationship between BOLD signal and both outcome and signal variability. We herein propose a study in a large sample of traumatic and non-traumatic DOC patients in order to ascertain the relevance of etiology and level of consciousness in the variability and prognostic value of a stimulation-elicited BOLD signal. Methods: 66 patients were included, and the response of each subject to his/her own name said by a familiar voice (SON-FV) was recorded using fMRI; 13 patients were scanned twice in the same day, respecting the exact same conditions in both cases. A behavioral follow-up program was carried out at 3, 6, and 12 months after scanning. Results: Of the 39 VS/UWS patients, 12 (75%) out of 16 patients with higher level activation patterns recovered to minimally conscious state (MCS) or emergence from MCS (EMCS) and 17 (74%) out of 23 patients with lower level activation patterns or no activation had a negative outcome. Taking etiology into account for VS/UWS patients, a higher positive predictive value was assigned to traumatic patients, i.e., up to 92% (12/13) patients with higher level activation pattern achieved good recovery whereas 11 out of 13 (85%) non-traumatic patients with lower level activation or without activation had a negative clinical outcome. The reported data from visual analysis of fMRI activation patterns were corroborated using ROC curve analysis, which supported the correlation between auditory cortex activation volume and VS/UWS patients' recovery. The average brain activity overlap in primary and secondary auditory cortices in patients scanned twice was 52%. Conclusions: The activation type and volume in auditory cortex elicited by SON-FV significantly correlated with VS/UWS patients' prognosis, particularly in patients with traumatic etiology, however, this could not be established in MCS patients. Repeated use of this simple fMRI task might help obtain more reliable prognostic information.	[Wang, Fuyan; Di, Haibo; Hu, Xiaohua; Huang, Wangshan; Nie, Yunzhi] Hangzhou Normal Univ, Int Vegetat State & Consciousness Sci Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Fuyan] Hangzhou Normal Univ, Affiliated Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Hu, Xiaohua; Jing, Shan] Hangzhou Wujing Hosp, Dept Rehabil, Hangzhou, Zhejiang, Peoples R China; [Di, Haibo; Thibaut, Aurore; Di Perri, Carol; Schnakers, Caroline; Laureys, Steven] Univ Liege, Coma Sci Grp, GIGA Res, Liege, Belgium; [Di, Haibo; Thibaut, Aurore; Di Perri, Carol; Schnakers, Caroline; Laureys, Steven] Univ Hosp Liege, Liege, Belgium; [Schnakers, Caroline] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA		Di, HB (corresponding author), Hangzhou Normal Univ, Int Vegetat State & Consciousness Sci Inst, Hangzhou, Zhejiang, Peoples R China.	Dihaibo19@aliyun.com	Thibaut, Aurore/U-8101-2019; Laureys, Steven/A-3349-2011; Wang, Fuyan/AAE-9666-2019; Laureys, Steven/AAN-2097-2021	Laureys, Steven/0000-0002-3096-3807; Di Perri, Carol/0000-0003-0284-770X; wang, fuyan/0000-0001-9629-6712	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [KG14086, KG08027, KG13007]; Science and Technology Department of Zhejiang Province [KZ09037]; Hangzhou Normal University [JTAS2011-01-016]	This paper is funded by the National Natural Science Foundation of China (KG14086, KG08027, KG13007), Science and Technology Department of Zhejiang Province (KZ09037), Hangzhou Normal University (JTAS2011-01-016). We thank Professor Yizhang Chen, Professor Xuchu Weng, Dr. Zirui Huang, Professor Shizheng Zhang, Dr. Lianhe zhang, Dr. Shenmin Yu, Dr. Jingqi Li, Lijuan Cheng, Professor Jianping Ding, Ying Zhang, Xiaojing Yu, and Lizette Heine for their kind help.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; CAMPAIN R, 1976, BRAIN LANG, V3, P318, DOI 10.1016/0093-934X(76)90026-2; Chen LK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-154; Coleman MR, 2009, PROG BRAIN RES, V177, P231, DOI 10.1016/S0079-6123(09)17716-6; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Di HB, 2008, CLIN MED, V8, P502, DOI 10.7861/clinmedicine.8-5-502; Emmorey K, 2003, P NATL ACAD SCI USA, V100, P10049, DOI 10.1073/pnas.1730169100; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gosseries O, 2014, ANNU REV NEUROSCI, V37, P457, DOI 10.1146/annurev-neuro-062012-170339; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; JANCKE L, 1994, NEUROREPORT, V5, P1161; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Owen AM, 2005, NEUROPSYCHOL REHABIL, V15, P290, DOI 10.1080/09602010443000579; PANDYA DN, 1995, REV NEUROL, V151, P486; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; ZWEIG MH, 1993, CLIN CHEM, V39, P561	32	31	36	4	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7015			BMC MED	BMC Med.	APR 15	2015	13								83	10.1186/s12916-015-0330-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4LN	WOS:000353257200001	25880206	Green Published, gold			2022-02-06	
J	Piitulainen, JM; Posti, JP; Aitasalo, KMJ; Vuorinen, V; Vallittu, PK; Serlo, W				Piitulainen, Jaakko M.; Posti, Jussi P.; Aitasalo, Kalle M. J.; Vuorinen, Ville; Vallittu, Pekka K.; Serlo, Willy			Paediatric cranial defect reconstruction using bioactive fibre-reinforced composite implant: early outcomes	ACTA NEUROCHIRURGICA			English	Article; Proceedings Paper	15th European Congress of Neurosurgery	OCT 12-17, 2014	Prague, CZECH REPUBLIC			Cranioplasty; Craniectomy; Craniofacial bone reconstruction; Fibre-reinforced composite; FRC; Bioactive glass; Paediatric; Skull bone defect	TRAUMATIC BRAIN-INJURY; AUTOGENOUS BONE-GRAFT; DECOMPRESSIVE CRANIECTOMY; GLASS S53P4; IN-VITRO; CLINICAL ARTICLE; CHRONIC OSTEOMYELITIS; FLAP RESORPTION; RISK-FACTORS; CRANIOPLASTY	In children, approximately half of cryopreserved allograft bone flaps fail due to infection and resorption. Synthetic materials offer a solution for allograft bone flap resorption. Fibre-reinforced composite with a bioactive glass particulate filling is a new synthetic material for bone reconstruction. Bioactive glass is capable of chemically bonding with bone and is osteoinductive, osteoconductive and bacteriostatic. Fibre-reinforced composite allows for fabricating thin (0.8 mm) margins for implant, which are designed as onlays on the existing bone. Bioactive glass is dissolved over time, whereas the fibre-reinforced composite serves as a biostable part of the implant, and these have been tested in preclinical and adult clinical trials. In this study, we tested the safety and other required properties of this composite material in large skull bone reconstruction with children. Eight cranioplasties were performed on seven patients, aged 2.5-16 years and having large (> 16 cm(2)) skull bone defects. The implant used in this study was a patient-specific, glass-fibre-reinforced composite, which contained a bioactive glass particulate compound, S53P4. During follow-up (average 35.1 months), one minor complication was observed and three patients needed revision surgery. Two surgical site infections were observed. After treatment of complications, a good functional and cosmetic outcome was observed in all patients. The implants had an onlay design and fitted the defect well. In clinical and imaging examinations, the implants were in the original position with no signs of implant migration, degradation or mechanical breakage. Here, we found that early cranioplasty outcomes with the fibre-reinforced composite implant were promising. However, a longer follow-up time and a larger group of patients are needed to draw firmer conclusions regarding the long-term benefits of the proposed novel biomaterial and implant design. The glass-fibre-reinforced composite implant incorporated by particles of bioactive glass may offer an original, non-metallic and bioactive alternative for reconstruction of large skull bone defects in a paediatric population.	[Piitulainen, Jaakko M.; Aitasalo, Kalle M. J.] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, Turku 20521, Finland; [Posti, Jussi P.; Vuorinen, Ville] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku 20521, Finland; [Piitulainen, Jaakko M.; Vallittu, Pekka K.] Univ Turku, Inst Dent, Dept Biomat Sci, Turku, Finland; [Piitulainen, Jaakko M.; Vallittu, Pekka K.] Univ Turku, Inst Dent, TCBC, Turku, Finland; [Vallittu, Pekka K.] Oral Hlth Care, City Turku Welf Div, Turku, Finland; [Serlo, Willy] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland		Piitulainen, JM (corresponding author), Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, POB 52, Turku 20521, Finland.	jaakko.piitulainen@utu.fi	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Piitulainen, Jaakko/0000-0001-9788-8904			Aitasalo KMJ, 2014, HEAD NECK-J SCI SPEC, V36, P722, DOI 10.1002/hed.23370; Ballo AM, 2009, CLIN ORAL IMPLAN RES, V20, P608, DOI 10.1111/j.1600-0501.2008.01700.x; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; DeLuca L, 1997, PLAST RECONSTR SURG, V99, P1324, DOI 10.1097/00006534-199704001-00019; Drago L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-584; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Engstrand T, 2014, J NEUROSURG, V120, P273, DOI 10.3171/2013.6.JNS1360; Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312; Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5; Goldstein JA, 2013, CURR OPIN OTOLARYNGO, V21, P400, DOI 10.1097/MOO.0b013e328363003e; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309; Kamdar MR, 2009, PLAST RECONSTR SURG, V124, P2072, DOI 10.1097/PRS.0b013e3181bcefc4; KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212; Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5; Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876; Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5; Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1; Neovius E, 2010, J PLAST RECONSTR AES, V63, P1615, DOI 10.1016/j.bjps.2009.06.003; Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Ritter L, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130088; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Rogers GF, 2012, J CRANIOFAC SURG, V23, P323, DOI 10.1097/SCS.0b013e318241dcba; Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Tuusa SMR, 2008, J BIOMED MATER RES B, V84B, P510, DOI 10.1002/jbm.b.30898; Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813; Wang DY, 2013, CLIN ORAL INVEST, V17, P1601, DOI 10.1007/s00784-012-0841-y; Yli-Urpo H, 2003, ACTA ODONTOL SCAND, V61, P241, DOI 10.1080/00016350310004719; Zehnder M, 2006, ORAL SURG ORAL MED O, V101, P530, DOI 10.1016/j.tripleo.2005.03.014; Zehnder M, 2004, J ENDODONT, V30, P220, DOI 10.1097/00004770-200404000-00009; Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564	41	31	31	0	24	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2015	157	4					681	687		10.1007/s00701-015-2363-2			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	CE0RD	WOS:000351511300024	25663141				2022-02-06	
J	Sufrinko, A; Pearce, K; Elbin, RJ; Covassin, T; Johnson, E; Collins, M; Kontos, AP				Sufrinko, Alicia; Pearce, Kelly; Elbin, R. J.; Covassin, Tracey; Johnson, Eric; Collins, Michael; Kontos, Anthony P.			The Effect of Preinjury Sleep Difficulties on Neurocognitive Impairment and Symptoms After Sport-Related Concussion	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; sleep problems; injury	BASE-LINE; POSTTRAUMATIC MIGRAINE; UNITED-STATES; BRAIN-INJURY; CHILDREN; RESTRICTION; PERFORMANCE; RELIABILITY; PREVALENCE; MANAGEMENT	Background: Researchers have reported that sleep duration is positively related to baseline neurocognitive performance. However, researchers have yet to examine the effect of preinjury sleep difficulties on postconcussion impairments. Purpose: To compare neurocognitive impairment and symptoms of athletes with preinjury sleep difficulties to those without after a sport-related concussion (SRC). Study Design: Cohort study; Level of evidence, 3. Methods: The sample included 348 adolescent and adult athletes (age, mean SD, 17.43 2.34 years) with a diagnosed SRC. The sample was divided into 2 groups: (1) 34 (10%) participants with preinjury sleep difficulties (sleeping less as well as having trouble falling asleep; SLEEP SX) and (2) 231 (66%) participants without preinjury sleep difficulties (CONTROL). The remaining 84 (24%) participants with minimal sleep difficulties (1 symptom) were excluded. Participants completed the Immediate Postconcussion Assessment and Cognitive Test (ImPACT) and Postconcussion Symptom Scale (PCSS) at baseline and 3 postinjury intervals (2, 5-7, and 10-14 days after injury). A series of repeated-measures analyses of covariance with Bonferroni correction, controlling for baseline non-sleep-related symptoms, were conducted to compare postinjury neurocognitive performance between groups. Follow-up exploratory t tests examined between-group differences at each time interval. A series of analyses of variance were used to examine total PCSS score, sleep-related, and non-sleep-related symptoms across time intervals between groups. Results: Groups differed significantly in PCSS scores across postinjury intervals for reaction time (P < .001), with the preinjury SLEEP SX group performing worse than controls at 5-7 days (mean +/- SD, 0.70 +/- 0.32 [SLEEP SX], 0.60 +/- 0.14 [CONTROL]) and 10-14 days (0.61 +/- 0.17 [SLEEP SX]; 0.57 +/- 0.10 [CONTROL]) after injury. Groups also differed significantly on verbal memory performance (P = .04), with the SLEEP SX (68.21 +/- 18.64) group performing worse than the CONTROL group (76.76 +/- 14.50) 2 days after injury. The SLEEP SX group reported higher total symptom (P = .02) and sleep-related symptom (P = .02) scores across postinjury time intervals. Conclusion: Preinjury sleep difficulties may exacerbate neurocognitive impairment and symptoms after concussion. The findings may help clinicians identify athletes who are at risk for worse impairments after a concussion due to preinjury sleep difficulties.	Univ Pittsburgh, Pittsburgh, PA 15203 USA; Michigan State Univ, E Lansing, MI 48824 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Med Ctr, Ctr Sports Med, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu	Meijer, Anna/K-5118-2016	Kontos, Anthony/0000-0002-3749-4310			Abu-Arafeh I, 2010, DEV MED CHILD NEUROL, V52, P1088, DOI 10.1111/j.1469-8749.2010.03793.x; Alchanatis M, 2005, J SLEEP RES, V14, P69, DOI 10.1111/j.1365-2869.2004.00436.x; Alfano CA, 2009, DEPRESS ANXIETY, V26, P503, DOI 10.1002/da.20443; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dinges DF, 1997, SLEEP, V20, P267; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jan JE, 2010, EUR J PAEDIATR NEURO, V14, P380, DOI 10.1016/j.ejpn.2010.05.001; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; MADSEN PL, 1991, CEREBROVAS BRAIN MET, V3, P281; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McClure DJ, 2013, ORTHOP J SPORTS ME S, V1; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Michael WL Chee,, 2013, Journal of sleep medicine, V10, P1; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; MILLER JH, 2007, AM J SPORTS MED, P35; MORRISON DN, 1992, J AM ACAD CHILD PSY, V31, P94, DOI 10.1097/00004583-199201000-00014; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2013, APPL NEUROPSYCH-CHIL, DOI [10.1080/21622965.2013.791825, DOI 10.1080/216229.65.2013.791825]; Muzur A, 2002, TRENDS COGN SCI, V6, P475, DOI 10.1016/S1364-6613(02)01992-7; Novati A, 2011, NEUROSCIENCE, V190, P145, DOI 10.1016/j.neuroscience.2011.06.027; O'Brien LM, 2011, SLEEP MED CLIN, V6, P109, DOI 10.1016/j.jsmc.2010.12.007; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Reuben C.A., 2008, VITAL HLTH STAT, V10, P1; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2004, SLEEP, V27, P423; Vedaa O, 2012, SCAND J EDUC RES, V56, P55, DOI 10.1080/00313831.2011.567396; Wesensten NJ, 2012, DRUG DISCOV TODAY, V8, P139	46	31	31	1	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	APR	2015	43	4					830	838		10.1177/0363546514566193			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	CF4PA	WOS:000352531100010	25649087				2022-02-06	
J	Chong, SL; Liu, N; Barbier, S; Ong, MEH				Chong, Shu-Ling; Liu, Nan; Barbier, Sylvaine; Ong, Marcus Eng Hock			Predictive modeling in pediatric traumatic brain injury using machine learning	BMC MEDICAL RESEARCH METHODOLOGY			English	Article						Brain injuries; Child; Prediction rules; Machine learning	ARTIFICIAL NEURAL-NETWORK; LOGISTIC-REGRESSION; HEAD-INJURY; COMPUTED-TOMOGRAPHY; RISK; SCORE; CHILDHOOD; MORTALITY; CHILDREN; SCANS	Background: Pediatric traumatic brain injury (TBI) constitutes a significant burden and diagnostic challenge in the emergency department (ED). While large North American research networks have derived clinical prediction rules for the head injured child, these may not be generalizable to practices in countries with traditionally low rates of computed tomography (CT). We aim to study predictors for moderate to severe TBI in our ED population aged < 16 years. Methods: This was a retrospective case-control study based on data from a prospective surveillance head injury database. Cases were included if patients presented from 2006 to 2014, with moderate to severe TBI. Controls were age-matched head injured children from the registry, obtained in a 4 control: 1 case ratio. These children remained well on diagnosis and follow up. Demographics, history, and physical examination findings were analyzed and patients followed up for the clinical course and outcome measures of death and neurosurgical intervention. To predict moderate to severe TBI, we built a machine learning (ML) model and a multivariable logistic regression model and compared their performances by means of Receiver Operating Characteristic (ROC) analysis. Results: There were 39 cases and 156 age-matched controls. The following 4 predictors remained statistically significant after multivariable analysis: Involvement in road traffic accident, a history of loss of consciousness, vomiting and signs of base of skull fracture. The logistic regression model was created with these 4 variables while the ML model was built with 3 extra variables, namely the presence of seizure, confusion and clinical signs of skull fracture. At the optimal cutoff scores, the ML method improved upon the logistic regression method with respect to the area under the ROC curve (0.98 vs 0.93), sensitivity (94.9% vs 82.1%), specificity (97.4% vs 92.3%), PPV (90.2% vs 72.7%), and NPV (98.7% vs 95.4%). Conclusions: In this study, we demonstrated the feasibility of using machine learning as a tool to predict moderate to severe TBI. If validated on a large scale, the ML method has the potential not only to guide discretionary use of CT, but also a more careful selection of head injured children who warrant closer monitoring in the hospital.	[Chong, Shu-Ling] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore; [Liu, Nan; Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore; [Liu, Nan; Barbier, Sylvaine] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Ong, Marcus Eng Hock] Duke NUS Grad Med Sch, Hlth Serv & Syst Res, Singapore, Singapore		Liu, N (corresponding author), Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore.	liu.nan@sgh.com.sg	Liu, Nan/L-9529-2013	Liu, Nan/0000-0003-3610-4883	SGH Centre Grant from the National Medical Research Council, Singapore [NMRC/CG/016/2013]	The ongoing prospective head injury surveillance is supported by the Paediatrics Academic Clinical Program (Paeds ACP) Young Researcher Pilot Grant, Singapore. This publication was supported in part by the SGH Centre Grant from the National Medical Research Council, Singapore (ref: NMRC/CG/016/2013). We would like to thank Ms Dianna Sri, Ms Lau Yew Ping and Ms Jasmine Feng for their contributions in data collection.	Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Toledo P, 2009, IEEE T INF TECHNOL B, V13, P794, DOI 10.1109/TITB.2009.2020434; DiRusso SM, 2000, J TRAUMA, V49, P212, DOI 10.1097/00005373-200008000-00006; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Griffin ES, 2014, J EMERG NURS, V40, P98, DOI 10.1016/j.jen.2013.07.001; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Jaimes F, 2005, CRIT CARE, V9, pR150, DOI 10.1186/cc3054; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Liu N, 2014, IEEE J BIOMED HEALTH, V18, P1894, DOI 10.1109/JBHI.2014.2303481; Liu N, 2010, IEEE SIGNAL PROC LET, V17, P754, DOI 10.1109/LSP.2010.2053356; Lyttle MD, 2013, EMERG MED J, V30, P790, DOI 10.1136/emermed-2012-201887; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mihindu E, 2014, AM SURGEON, V80, P841; Ong MEH, 2012, CRIT CARE, V16, DOI 10.1186/cc11396; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Ottenbacher KJ, 2004, ANN EPIDEMIOL, V14, P551, DOI 10.1016/j.annepidem.2003.10.005; Pal'a A, 2014, J CHILD NEUROL, P1; Pearce CB, 2006, PANCREATOLOGY, V6, P123, DOI 10.1159/000090032; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peng SY, 2010, EUR J NEUROL, V17, P945, DOI 10.1111/j.1468-1331.2010.02955.x; Rojas R., 1996, NEURAL NETWORKS SYST; Rose S, 2013, AM J EPIDEMIOL, V177, P443, DOI 10.1093/aje/kws241; Rose Sherri, 2008, Int J Biostat, V4, P19, DOI 10.2202/1557-4679.1115; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; THOMPSON WD, 1994, EPIDEMIOL REV, V16, P33, DOI 10.1093/oxfordjournals.epirev.a036143; Thurman DJ, 2014, J CHILD NEUROL, V31, P1; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9	34	31	32	1	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	MAR 17	2015	15								22	10.1186/s12874-015-0015-0			9	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	CE3JI	WOS:000351722100001	25886156	Green Published, gold			2022-02-06	
J	Gatson, JW; Simpkins, JW; Uteshev, VV				Gatson, Joshua W.; Simpkins, James W.; Uteshev, Victor V.			High therapeutic potential of positive allosteric modulation of alpha 7 nAChRs in a rat model of traumatic brain injury: Proof-of-concept	BRAIN RESEARCH BULLETIN			English	Article						Nicotinic; PNU120596; PNU-120596; Alpha7; Choline; Traumatic brain injury	NICOTINIC ACETYLCHOLINE-RECEPTOR; ACH RECEPTORS; FREE CHOLINE; IN-VITRO; ACTIVATION; PNU-120596; AGONIST; HIPPOCAMPUS; MEMORY; NEUROPROTECTION	There are currently no clinically efficacious drug therapies to treat brain damage secondary to traumatic brain injury (TBI). In this proof-of-concept study, we used a controlled cortical impact model of TBI in young adult rats to explore a novel promising approach that utilizes PNU-120596, a previously reported highly selective Type-II positive allosteric modulator (alpha-PAM) of alpha 7 nicotinic acetylcholine receptors (nAChRs). alpha 7-PAMs enhance and prolong alpha 7 nAChR activation, but do not activate alpha 7 nAChRs when administered without an agonist. The rational basis for the use of an alpha 7-PAM as a post-TBI treatment is tripartite and arises from: (1) the intrinsic ability of brain injury to elevate extracellular levels of choline (a ubiquitous cell membrane-building material and a selective endogenous agonist of alpha 7 nAChRs) due to the breakdown of cell membranes near the site and time of injury; (2) the ubiquitous expression of functional alpha 7 nAChRs in neuronal and glial/immune brain cells; and (3) the potent neuroprotective and anti-inflammatory effects of alpha 7 nAChR activation. Therefore, both neuroprotective and anti-inflammatory effects can be achieved post-TBI by targeting only a single player (i.e., the alpha 7 nAChR) using alpha 7-PAM5 to enhance the activation of alpha 7 nAChRs by injury-elevated extracellular choline. Our data support this hypothesis and demonstrate that subcutaneous administration of PNU-120596 post-TBI in young adult rats significantly reduces both brain cell damage and reactive gliosis. Therefore, our results introduce post-TBI systemic administration of alpha 7-PAMs as a promising therapeutic intervention that could significantly restrict brain injury post-TBI and facilitate recovery of TBI patients. (C) 2015 Elsevier Inc. All rights reserved.	[Gatson, Joshua W.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dept Neurosurg, Dallas, TX 75390 USA; [Simpkins, James W.] W Virginia Univ, Ctr Basic & Translat Stroke Res, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA; [Uteshev, Victor V.] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76248 USA		Uteshev, VV (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, 3500 Camp Bowie Blvd, Ft Worth, TX 76248 USA.	Victor.Uteshev@unthsc.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK082625]; NIDA Research Resources Drug Supply Program [PNU-120596]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK082625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG027956] Funding Source: NIH RePORTER	This study was supported by a grant DK082625 from the National Institute of Health to VVU. We thank the NIDA Research Resources Drug Supply Program for PNU-120596.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; ARENDASH GW, 1995, BRAIN RES, V674, P252, DOI 10.1016/0006-8993(94)01449-R; Bertrand N, 1996, NEUROCHEM INT, V28, P293, DOI 10.1016/0197-0186(95)00086-0; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Brown KL, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00166; Callahan PM, 2013, NEUROPHARMACOLOGY, V67, P201, DOI 10.1016/j.neuropharm.2012.10.019; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; DJURICIC B, 1991, J CEREBR BLOOD F MET, V11, P308, DOI 10.1038/jcbfm.1991.63; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; Felix R, 1997, NEUROSCIENCE, V81, P1009, DOI 10.1016/S0306-4522(97)00224-8; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Freitas K, 2013, BRIT J PHARMACOL, V169, P567, DOI 10.1111/j.1476-5381.2012.02226.x; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Guan Y.Z., 2014, MOL NEUROBIOL; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; Gusev AG, 2010, J PHARMACOL EXP THER, V332, P588, DOI 10.1124/jpet.109.162099; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Harris JG, 2004, NEUROPSYCHOPHARMACOL, V29, P1378, DOI 10.1038/sj.npp.1300450; Hartmann J, 2008, NEUROCHEM INT, V52, P972, DOI 10.1016/j.neuint.2007.10.008; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; JOPE RS, 1991, NEUROCHEM RES, V16, P1219, DOI 10.1007/BF00966699; De Rosa MJ, 2009, LIFE SCI, V85, P444, DOI 10.1016/j.lfs.2009.07.010; Kalappa BI, 2013, BRIT J PHARMACOL, V169, P1862, DOI 10.1111/bph.12247; Kalappa BI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013964; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Klein J, 1998, NEUROCHEM INT, V32, P479, DOI 10.1016/S0197-0186(97)00127-7; Lendvai B, 2013, BRAIN RES BULL, V93, P86, DOI 10.1016/j.brainresbull.2012.11.003; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Li YX, 1999, BRAIN RES, V830, P218, DOI 10.1016/S0006-8993(99)01372-4; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Malysz J, 2009, J PHARMACOL EXP THER, V330, P257, DOI 10.1124/jpet.109.151886; McLean SL, 2012, J PSYCHOPHARMACOL, V26, P1265, DOI 10.1177/0269881111431747; Munro G, 2012, BRIT J PHARMACOL, V167, P421, DOI 10.1111/j.1476-5381.2012.02003.x; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Parada E., 2013, ANTIOXID REDOX SIGNA; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; Quik M, 2009, BIOCHEM PHARMACOL, V78, P677, DOI 10.1016/j.bcp.2009.05.003; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; SCREMIN OU, 1991, STROKE, V22, P643, DOI 10.1161/01.STR.22.5.643; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Sun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073581; Thomsen MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027014; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; Uteshev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032951; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Wallace TL, 2011, BIOCHEM PHARMACOL, V82, P891, DOI 10.1016/j.bcp.2011.06.034; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Zapata A, 1998, J NEUROSCI, V18, P3597	64	31	31	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	MAR	2015	112						35	41		10.1016/j.brainresbull.2015.01.008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE6TF	WOS:000351970400005	25647232	Green Accepted			2022-02-06	
J	Moser, RS; Schatz, P; Lichtenstein, JD				Moser, Rosemarie Scolaro; Schatz, Philip; Lichtenstein, Jonathan D.			The Importance of Proper Administration and Interpretation of Neuropsychological Baseline and Postconcussion Computerized Testing	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						sports-related concussion; concussion assessment and management; mild traumatic brain injury	SPORTS-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; MEDICINE PROFESSIONALS; MANAGEMENT; STATEMENT; PERFORMANCE; KNOWLEDGE; IMPACT	Media coverage, litigation, and new legislation have resulted in a heightened awareness of the prevalence of sports concussion in both adult and youth athletes. Baseline and postconcussion testing is now commonly used for the assessment and management of sports-related concussion in schools and in youth sports leagues. With increased use of computerized neurocognitive sports concussion testing, there is a need for standards for proper administration and interpretation. To date, there has been a lack of standardized procedures by which assessments are administered. More specifically, individuals who are not properly trained often interpret test results, and their methods of interpretation vary considerably. The purpose of this article is to outline factors affecting the validity of test results, to provide examples of misuse and misinterpretation of test results, and to communicate the need to administer testing in the most effective and useful manner. An increase in the quality of test administration and application may serve to decrease the prevalence of invalid test results and increase the accuracy and utility of baseline test results if an athlete sustains a concussion. Standards for test use should model the American Psychological Association and Centers for Disease Control and Prevention guidelines, as well as the recent findings of the joint position paper on computerized neuropsychological assessment devices.	[Moser, Rosemarie Scolaro; Schatz, Philip; Lichtenstein, Jonathan D.] Sports Concuss Ctr New Jersey, Lawrenceville, NJ 08648 USA; [Moser, Rosemarie Scolaro] Int Brain Res Fdn, Flanders, NY USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Moser, RS (corresponding author), Sports Concuss Ctr New Jersey, 3131 Princeton Pike,Bldg 5,Suite 110, Lawrenceville, NJ 08648 USA.	Rmoser@SportsConcussionNJ.com					American Psychological Association, 1999, AM PSYCH ASS AM ED R; American Psychological Association, 2010, AM PSYCH ASS ETH PRI; [Anonymous], 2012, CONC VIT SIGNS; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Barth JT, 1989, MILD HEAD INJURY, P257; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Centers for Disease Control and Prevention, 2012, FAQS BAS TEST YOUNG; Centers for Disease Control & Prevention, 2010, CONC SPORTS; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Erlanger DM, 1999, CONCUSSION RESOLUTIO; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; ImPACT, 2012, IMPACT TEST ADM; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lovell M. R., 2007, IMPACT VERS 6 0 CLIN; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Mayo Clinic, 2012, 40 000 AR STUD ATHL; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Moser R.S., 2012, AHEAD GAME PARENTS G; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; National Athletic Trainers' Association, 2012, ATHL TRAIN FILL NEC; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Simovska A., 2012, MANDATORY TEST TRACK; U. S. Food & Drug Administration., 2012, REG INF; Udall T., 2012, CNN; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Webbe F. M., 2010, HDB SPORT NEUROPSYCH, P1630; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	43	31	31	0	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JAN 2	2015	4	1					41	48		10.1080/21622965.2013.791825			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	AY0KW	WOS:000347286400005	24236894				2022-02-06	
J	Lillie, EM; Urban, JE; Weaver, AA; Powers, AK; Stitzel, JD				Lillie, Elizabeth M.; Urban, Jillian E.; Weaver, Ashley A.; Powers, Alexander K.; Stitzel, Joel D.			Estimation of skull table thickness with clinical CT and validation with microCT	JOURNAL OF ANATOMY			English	Article						computed tomography; cortex; skull; thickness	MECHANICAL-PROPERTIES; THIN STRUCTURES; DENSITY; ACCURACY; FLEXURE	Brain injuries resulting from motor vehicle crashes (MVC) are extremely common yet the details of the mechanism of injury remain to be well characterized. Skull deformation is believed to be a contributing factor to some types of traumatic brain injury (TBI). Understanding biomechanical contributors to skull deformation would provide further insight into the mechanism of head injury resulting from blunt trauma. In particular, skull thickness is thought be a very important factor governing deformation of the skull and its propensity for fracture. Current computed tomography (CT) technology is limited in its ability to accurately measure cortical thickness using standard techniques. A method to evaluate cortical thickness using cortical density measured from CT data has been developed previously. This effort validates this technique for measurement of skull table thickness in clinical head CT scans using two postmortem human specimens. Bone samples were harvested from the skulls of two cadavers and scanned with microCT to evaluate the accuracy of the estimated cortical thickness measured from clinical CT. Clinical scans were collected at 0.488 and 0.625mm in plane resolution with 0.625mm thickness. The overall cortical thickness error was determined to be 0.078 +/- 0.58mm for cortical samples thinner than 4mm. It was determined that 91.3% of these differences fell within the scanner resolution. Color maps of clinical CT thickness estimations are comparable to color maps of microCT thickness measurements, indicating good quantitative agreement. These data confirm that the cortical density algorithm successfully estimates skull table thickness from clinical CT scans. The application of this technique to clinical CT scans enables evaluation of cortical thickness in population-based studies.	[Lillie, Elizabeth M.; Urban, Jillian E.; Weaver, Ashley A.; Stitzel, Joel D.] Wake Forest Univ, Virginia Tech, Ctr Injury Biomech, Winston Salem, NC 27157 USA; [Lillie, Elizabeth M.; Urban, Jillian E.; Weaver, Ashley A.; Powers, Alexander K.; Stitzel, Joel D.] Wake Forest Univ, Sch Med, Winston Salem, NC 27157 USA; [Powers, Alexander K.] Wake Forest Univ, Dept Neurosurg, Winston Salem, NC 27157 USA		Stitzel, JD (corresponding author), Wake Forest Univ, Virginia Tech, Ctr Injury Biomech, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jdstitzel@gmail.com	Weaver, Ashley/ABB-5845-2021; Stitzel, Joel/B-4045-2012	Weaver, Ashley/0000-0002-4383-0106; Stitzel, Joel/0000-0001-9762-3033	National Highway Traffic Safety Administration [DTN22-09-H-00242]	The authors would like to thank the Wake Forest School of Medicine Department of Neurobiology & Anatomy, especially Robert Bowden, for assistance in obtaining the cadaveric skulls. Funding was provided by the National Highway Traffic Safety Administration under Cooperative Agreement Number DTN22-09-H-00242. Views expressed are those of the authors and do not represent the views of NHTSA. Additionally the authors would like to thank Debra Fuller for her aid in collecting CT scans as well as Kevin Guley at the University of North Carolina Chapel Hill for his help with microCT imaging.	Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dougherty G, 1999, MED PHYS, V26, P1341, DOI 10.1118/1.598629; Faul M, 2010, TRAUMATIC BRAIN INJU; Hodgson V., 1970, P 14 STAPP CAR CRASH, P341; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; HUBBARD RP, 1971, J BIOMECH, V4, P491, DOI 10.1016/0021-9290(71)90039-X; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Licata A, 2009, CLEV CLIN J MED, V76, P331, DOI 10.3949/ccjm.76a.08041; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Newman DL, 1998, PHYS MED BIOL, V43, P619, DOI 10.1088/0031-9155/43/3/013; Nusholtz G.S., 1984, 841657 SAE, P41; Peterson J, 2003, ANAT REC PART A, V274A, P785, DOI 10.1002/ar.a.10096; Peterson J, 2002, ANAT REC, V268, P7, DOI 10.1002/ar.10131; Poole KES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038466; Prevrhal S, 2003, MED PHYS, V30, P1, DOI 10.1118/1.1521940; Prevrhal S, 1999, PHYS MED BIOL, V44, P751, DOI 10.1088/0031-9155/44/3/017; Ruan J, 2001, Stapp Car Crash J, V45, P395; Saladin K. S., 2007, ANATOMY PHYSL UNITY; Shatsky SA, 1974, P STAPP CAR CRASH C, P351; Treece GM, 2012, MED IMAGE ANAL, V16, P952, DOI 10.1016/j.media.2012.02.008; Treece GM, 2010, MED IMAGE ANAL, V14, P276, DOI 10.1016/j.media.2010.01.003; Urban JE, 2012, J NEUROTRAUM, V29, P2774, DOI 10.1089/neu.2012.2373; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Yoganandan N, 2007, J TRAUMA, V66, P7; Yoganandan N, 2010, ACCIDENT ANAL PREV, V42, P1370, DOI 10.1016/j.aap.2010.02.017	27	31	33	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	JAN	2015	226	1					73	80		10.1111/joa.12259			8	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	AW9NF	WOS:000346583500007	25441171	Green Published, Bronze			2022-02-06	
J	Moser, RS; Schatz, P; Glenn, M; Kollias, KE; Iverson, GL				Moser, Rosemarie Scolaro; Schatz, Philip; Glenn, Megan; Kollias, Kelly E.; Iverson, Grant L.			Examining prescribed rest as treatment for adolescents who are slow to recover from concussion	BRAIN INJURY			English	Article						Concussion; baseline testing; comprehensive rest; concussion management	TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; INTERPRETING CHANGE; VOLUNTARY EXERCISE; FOOTBALL PLAYERS; CLINICAL-SAMPLES; TEMPORAL WINDOW; UP-REGULATION	Objective: Rest is a widely recommended treatment for concussion, but its utility is unclear following the acute stage of recovery. This study examined the effects of 1-week of prescribed rest in concussed adolescent athletes. Method: Participants were 13 adolescent athletes with persistent symptoms following a concussion. More than three-quarters (77%) had self-reported ADHD, learning disability or two prior concussions. All completed ImPACT (R) at another facility, but none completed a period of comprehensive rest prior to examination at a specialty practice. Three time points of test data were compared, to control for possible spontaneous recovery: Test 1 (external facility), Test 2 (before prescribed rest) and Test 3 (following prescribed rest). Results: Repeated measures ANOVAs revealed a significant effect of prescribed rest on all ImPACT (R) composite scores and the total symptom score. Post-hoc analyses revealed no significant differences between Time 1 and Time 2, whereas significant differences were present after prescribed rest. Following prescribed rest, having two or more reliably improved cognitive test scores or having improved symptoms was present in eight of the 13 patients (61.5%). Conclusions: A substantial percentage of adolescents with persistent symptoms following concussion showed improvement in symptoms and cognitive functioning following education, reassurance and 1-week of prescribed rest.	[Moser, Rosemarie Scolaro; Glenn, Megan; Kollias, Kelly E.] RSM Psychol Ctr LLC, Sports Concuss Ctr New Jersey, Lawrenceville, NJ USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Sport Concuss Clin, Boston, MA 02114 USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA		Moser, RS (corresponding author), Sports Concuss Ctr NJ, 3131 Princeton Pike,Bldg 5 Ste 110, Lawrenceville, NJ 08648 USA.	rmoser@sportsconcussionnj.com	Meijer, Anna/K-5118-2016	Iverson, Grant/0000-0001-7348-9570	ImPACT Applications, Inc.; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc.)	Data were collected at the Sports Concussion Center of New Jersey (SCCNJ). Dr Rosemarie Moser is the owner of SCCNJ and some of the authors are employees or consultants at the Center. There were no other study sponsors. In the past, Dr Moser has served as a consultant to the International Brain Research Foundation, ImPACT Applications, Inc. and Pearson. These organizations had no role in the conceptualization or content of the current manuscript or the decision to submit for publication. In addition, she receives royalties from a book on youth concussion and special journal issue on mild traumatic brain injury. Philip Schatz, PhD, is a consultant to the Sports Concussion Center of New Jersey. He has also served as a consultant to the International Brain Research Foundation and to ImPACT Applications, Inc. to study the effects of concussion in high school and collegiate athletes. However, the latter two entities had no role in the conceptualization or content of the current manuscript or the decision to submit for publication. Grant Iverson, PhD has been reimbursed by the government, professional scientific bodies and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences and symposiums. He has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including professional athletes). He has received research funding from several test publishing companies, including ImPACT Applications, Inc., CNS Vital Signs and Psychological Assessment Resources (PAR, Inc.). He has not received research support from ImPACT Applications, Inc. in the past 3 years. He receives royalties from two books relating to neuropsychology and one test (WCST-64).	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Giza CC, 2001, J ATHL TRAINING, V36, P228; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 1998, INT J GERIATR PSYCH, V13, P661, DOI 10.1002/(SICI)1099-1166(1998100)13:10<661::AID-GPS838>3.0.CO;2-0; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Iverson GL, BRAIN INJUR IN PRESS; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2004, BRIT J SPORT MED, V29, P196; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Moser RS, 2013, AM J SPORTS MED, V39, P2325; Schatz P, 2009, ARCH CLIN NEUROPSYCH, V24, P502; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8	37	31	31	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					58	63		10.3109/02699052.2014.964771			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000008	25279423				2022-02-06	
J	Rundhaug, NP; Moen, KG; Skandsen, T; Schirmer-Mikalsen, K; Lund, SB; Hara, S; Vik, A				Rundhaug, Nils Petter; Moen, Kent Goran; Skandsen, Toni; Schirmer-Mikalsen, Kari; Lund, Stine B.; Hara, Sozaburo; Vik, Anne			Moderate and severe traumatic brain injury: effect of blood alcohol concentration on Glasgow Coma Scale score and relation to computed tomography findings	JOURNAL OF NEUROSURGERY			English	Article						ethanol; craniocerebral trauma; x-ray computed tomography; intracranial hypertension; consciousness disorders; traumatic brain injury	SEVERE HEAD-INJURY; INTOXICATION; CLASSIFICATION; GUIDELINES; MANAGEMENT; OUTCOMES; LEVEL	OBJECT The influence of alcohol is assumed to reduce consciousness in patients with traumatic brain injury (TBI), but research findings are divergent. The aim of this investigation was to study the effects of different levels of blood alcohol concentration (BAC) on the Glasgow Coma Scale (GCS) scores in patients with moderate and severe TBI and to relate the findings to brain injury severity based on the admission CT scan. METHODS In this cohort study, 265 patients (age range 16-70 years) who were admitted to St. Olavs University Hospital with moderate and severe TBI during a 7-year period were prospectively registered. Of these, 217 patients (82%) had measured BAC. Effects of 4 BAC groups on GCS score were examined with ordinal logistic regression analyses, and the GCS scores were inverted to give an OR > 1. The Rotterdam CT score based on admission CT scan was used to adjust for brain injury severity (best score 1 and worst score 6) by stratifying patients into 2 brain injury severity groups (Rotterdam CT scores of 1-3 and 4-6). RESULTS Of all patients with measured BAC, 91% had intracranial CT findings and 43% had BAC > 0 mg/dl. The median GCS score was lower in the alcohol-positive patients (6.5, interquartile range [ION 4-10) than in the alcohol-negative patients (9, IQR 6-13; p < 0.01). No significant differences were found between alcohol-positive and alcohol-negative patients regarding other injury severity variables. Increasing BAC was a significant predictor of lower GCS score in a dose-dependent manner in age-adjusted analyses, with OR 2.7 (range 1.4-5.0) and 3.2 (range 1.5-6.9) for the 2 highest BAC groups (p < 0.01). Subgroup analyses showed an increasing effect of BAC group on GCS scores in patients with Rotterdam CT scores of 1-3: OR 3.1 (range 1.4-6.6) and 6.7 (range 2.7-16.7) for the 2 highest BAC groups (p < 0.01). No such relationship was found in patients with Rotterdam CT scores of 4-6 (p = 0.14-0.75). CONCLUSIONS Influence of alcohol significantly reduced the GCS score in a dose-dependent manner in patients with moderate and severe TBI and with Rotterdam CT scores of 1-3. In patients with Rotterdam CT scores of 4-6, and therefore more CT findings indicating increased intracranial pressure, the brain injury itself seemed to overrun the depressing effect of the alcohol on the CNS. This finding is in agreement with the assumption of many clinicians in the emergency situation.	[Rundhaug, Nils Petter; Moen, Kent Goran; Skandsen, Toni; Vik, Anne] Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway; [Schirmer-Mikalsen, Kari] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7491 Trondheim, Norway; [Moen, Kent Goran; Lund, Stine B.; Hara, Sozaburo; Vik, Anne] Univ Trondheim Hosp, Dept Neurosurg, Trondheim, Norway; [Skandsen, Toni] Univ Trondheim Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Schirmer-Mikalsen, Kari] Univ Trondheim Hosp, St Olavs Hosp, Dept Anaesthesia & Acute Med, Trondheim, Norway		Moen, KG (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, Postboks 3250 Sluppen, N-7491 Trondheim, Norway.	kent.g.moen@ntnu.no			Liaison Committee	During part of the study period, Dr. Schirmer-Mikalsen received a research grant from the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology. The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons AANS/CNS Joint Section on Neurotrauma and Critical Care, 2008, J NEUROTRAUM, V25, P276; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Farshchian N, 2012, J INJ VIOLENCE RE S1, V4; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Skandsen T, 2012, MANAGEMENT SEVERE TR, P389; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; SULLIVAN JB, 1987, J FORENSIC SCI, V32, P1660; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50	26	31	32	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2015	122	1					211	218		10.3171/2014.9.JNS14322			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AX5DQ	WOS:000346947600030	25361494	Bronze			2022-02-06	
J	Ryan, NP; Catroppa, C; Cooper, JM; Beare, R; Ditchfield, M; Coleman, L; Silk, T; Crossley, L; Rogers, K; Beauchamp, MH; Yeates, KO; Anderson, VA				Ryan, Nicholas P.; Catroppa, Cathy; Cooper, Janine M.; Beare, Richard; Ditchfield, Michael; Coleman, Lee; Silk, Timothy; Crossley, Louise; Rogers, Kirrily; Beauchamp, Miriam H.; Yeates, Keith O.; Anderson, Vicki A.			Relationships between acute imaging biomarkers and theory of mind impairment in post-acute pediatric traumatic brain injury: A prospective analysis using susceptibility weighted imaging (SWI)	NEUROPSYCHOLOGIA			English	Article						Child; Brain injuries; Magnetic resonance imaging; Theory of Mind; Neurobiology	DIFFUSE AXONAL INJURY; SOCIAL BRAIN; CLINICAL-APPLICATIONS; CHILDREN; DEFICITS; EMOTION; LESIONS; ADOLESCENTS; COMPETENCE; OUTCOMES	Theory of Mind (ToM) forms an integral component of socially skilled behavior, and is critical for attaining developmentally appropriate goals. The protracted development of ToM is mediated by increasing connectivity between regions of the anatomically distributed 'mentalizing network', and may be vulnerable to disruption from pediatric traumatic brain injury (TBI). The present study aimed to evaluate the post-acute effects of TBI on first-order ToM, and examine relations between ToM and both local and global indices of macrostructural damage detected using susceptibility-weighted imaging (SWI). 104 children and adolescents with TB! and 43 age-matched typically developing (TD) controls underwent magnetic resonance imaging including a susceptibility-weighted imaging (SWI) sequence 2-8 weeks post-injury and were assessed on cognitive ToM tasks at 6-months after injury. Compared to TD controls and children with mild-moderate injuries, children with severe TBI showed significantly poorer ToM. Moreover, impairments in ToM were related to diffuse neuropathology, and parietal lobe lesions. Our findings support the vulnerability of the immature social brain network to disruption from TBI, and suggest that global macrostructural damage commonly associated with traumatic axonal injury (TAI) may contribute to structural disconnection of anatomically distributed regions that underlie ToM. This study suggests that SWI may be a valuable imaging biomarker to predict outcome and recovery of social cognition after pediatric TBI. (C) 2014 Elsevier Ltd. All rights reserved.	[Ryan, Nicholas P.; Catroppa, Cathy; Cooper, Janine M.; Beare, Richard; Silk, Timothy; Crossley, Louise; Rogers, Kirrily; Anderson, Vicki A.] Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic 3052, Australia; [Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Rogers, Kirrily; Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Ditchfield, Michael] Monash Hlth, Melbourne, Vic, Australia; [Ditchfield, Michael] Monash Univ, Melbourne, Vic 3004, Australia; [Coleman, Lee] Royal Childrens Hosp, Dept Radiol, Melbourne, Vic 3052, Australia; [Silk, Timothy] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.] Ste Justine Res Ctr, Montreal, PQ, Canada; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada		Ryan, NP (corresponding author), Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Flemington Rd, Melbourne, Vic 3052, Australia.	nicholas.ryan@mcri.edu.au; cathy.catroppa@mcri.edu.au; janine.cooper@mcri.edu.au; richard.beare@mcri.edu.au; michael.ditchfield@southemhealth.org.au; lee.coleman@rch.org.au; tim.silk@mcri.edu.au; louise.crossley@mcri.edu.au; kirrilyrogers@gmail.com; Miriam.beauchamp@umontreal.ca; kyeates@ucalgary.ca; vicki.anderson@rch.org.au	Silk, Tim/K-4295-2019; Yeates, Keith/AAJ-4223-2020; Catroppa, Cathy/AAX-9458-2021; Ryan, Nicholas/K-5445-2019	Catroppa, Cathy/0000-0002-9750-0436; Ryan, Nicholas/0000-0002-0878-8889; Yeates, Keith/0000-0001-7680-2892; Beare, Richard/0000-0002-7530-5664; Rogers, Kirrily/0000-0001-8282-537X; Silk, Tim/0000-0002-7290-512X	Victoria Neuro-trauma Initiative, Australia; Victorian Government Operational Infrastructure Support Program [CO6E1]	This work was supported by a grant from the Victoria Neuro-trauma Initiative, Australia and the Victorian Government Operational Infrastructure Support Program (No. CO6E1).	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anderson V, 2014, SOC NEUROSCI-UK, V9, P471, DOI 10.1080/17470919.2014.932308; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Coffey CE, 1991, PSYCHOPATHOL BRAIN, P243; Cohen J., 2013, STAT POWER ANAL BEHA; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Dal Monte O, 2014, CORTEX, V58, P9, DOI 10.1016/j.cortex.2014.05.002; Denham SA, 2003, CHILD DEV, V74, P238, DOI 10.1111/1467-8624.00533; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Tabachnick B.G., 2001, USING MULTIVARIATE S; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Walz NC, 2009, DEV NEUROPSYCHOL, V34, P507, DOI 10.1080/87565640902964490; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zaitchik D, 2010, NEUROPSYCHOLOGIA, V48, P2528, DOI 10.1016/j.neuropsychologia.2010.04.031	60	31	31	0	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JAN	2015	66						32	38		10.1016/j.neuropsychologia.2014.10.040			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CA0SG	WOS:000348626200004	25445779				2022-02-06	
J	Bryczkowski, SB; Lopreiato, MC; Yonclas, PP; Sacca, JJ; Mosenthal, AC				Bryczkowski, Sarah B.; Lopreiato, Maeve C.; Yonclas, Peter P.; Sacca, James J.; Mosenthal, Anne C.			Risk factors for delirium in older trauma patients admitted to the surgical intensive care unit	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Delirium; trauma; SICU; benzodiazepines; mechanical ventilation	POSTOPERATIVE DELIRIUM; PREDICTOR	BACKGROUND: Adults (age > 50 years) admitted to the surgical intensive care unit (SICU) are at high risk for delirium. Little is known about the role traumatic injury plays in the development of delirium because these patients have often been excluded from studies. Identification of specific risk factors for delirium among older adults following injury would be useful to guide prevention strategies. We attempted to identify modifiable factors that would predict delirium in an older trauma population admitted to the SICU. METHODS: Data were collected prospectively from July 2012 to August 2013 at a Level I trauma center on consecutive trauma patients, older than 50 years, admitted to the SICU. Patients who died in the SICU were excluded. Delirium was assessed every 12 hours using the Confusion Assessment Method for the ICU scale. Demographic, injury, social, and clinical variables were reviewed. Bivariate analysis determined significant factors associated with delirium. A multivariate logistic regression model was used to predict delirium risk. After preliminary results, additional analysis compared patients with chest injury (defined as chest Abbreviated Injury Scale [AIS] score >= 3) with those without. RESULTS: A total of 115 patients met criteria, with a mean age of 67 years, Injury Severity Score (ISS) of 19, and Glasgow Coma Scale (GCS) score of 14. The incidence of delirium was 61%. Variables present on admission, which were positive predictors of delirium, were as follows: age, ISS greater than 17, GCS score less than 15, substance abuse, and traumatic brain injury (defined as head AIS score >= 3). Chest injury (defined as chest AIS score >= 3) was a negative predictor of delirium. Significant risk factors influenced by clinical treatment included doses of opioids and propofol, restraint use, and hours deeply sedated (Richmond Agitation Sedation Scale [RASS] score <= -3). Clinical treatments with negative predictability were ventilator-free days/30 (vent-free), benzodiazepine-free days/30 (benzo-free), and restraint-free days/30. In a regression model considering age, vent-free days, chest injury, traumatic brain injury, GCS score, benzo-free days, and hours sedated, only age (odds ratio [OR], 1.1; 95% confidence interval [CI], 1.01-1.1; p = 0.03) was a predictor of delirium, while vent-free days (OR, 0.79; 95% CI, 0.65-0.96; p = 0.02) and chest injury (OR, 0.3; 95% CI, 0.09-0.83; p = 0.02) were significant negative predictors of delirium. Patients with chest injury had lower delirium incidence (44%) versus those without (75%) (p = 0.002) despite similar GCS score, ISS, and clinical variables. CONCLUSION: Delirium is common in older trauma patients admitted to the SICU, and for every year for those older than 50 years, the chance of delirium increases by 10%. While higher ISS increases delirium risk, we identified several modifiable treatment variables including days patients were deeply sedated, mechanically ventilated, and physically restrained. Interestingly, patients with chest injury experienced less delirium, despite similar injury severity and clinical variables, perhaps owing to frequent health care provider interactions. (Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Bryczkowski, Sarah B.; Lopreiato, Maeve C.; Yonclas, Peter P.; Sacca, James J.; Mosenthal, Anne C.] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA		Bryczkowski, SB (corresponding author), Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA.	Sarahb459@gmail.com					Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Aldemir M, 2001, CRIT CARE, V5, P265, DOI 10.1186/cc1044; Angles EM, 2008, AM J SURG, V196, P864, DOI 10.1016/j.amjsurg.2008.07.037; Brummel NE, 2013, CRIT CARE MED, V42, P1; Eastern Metropolitan Region Palliative Care Consortium, 2010, OP CONV RAT GUID PRA; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fineberg SJ, 2013, SPINE, V38, P1790, DOI 10.1097/BRS.0b013e3182a0d507; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; Khan BA, 2012, CHEST, V142, P48, DOI 10.1378/chest.11-2100; Lat I, 2009, CRIT CARE MED, V37, P1898, DOI 10.1097/CCM.0b013e31819ffe38; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; Marcantonio ER, 1998, AM J MED, V105, P380, DOI 10.1016/S0002-9343(98)00292-7; National Center for Injury Prevention and Control, WISQARS LEAD CAUS DE; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Pisani MA, 2009, CRIT CARE MED, V37, P177, DOI 10.1097/CCM.0b013e318192fcf9; Soja SL, 2008, INTENS CARE MED, V34, P1263, DOI 10.1007/s00134-008-1031-x; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	21	31	36	2	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2014	77	6					944	951		10.1097/TA.0000000000000427			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AU8EE	WOS:000345828500035	25248058				2022-02-06	
J	Shin, SS; Dixon, CE; Okonkwo, DO; Richardson, RM				Shin, Samuel S.; Dixon, C. Edward; Okonkwo, David O.; Richardson, R. Mark			Neurostimulation for traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; neuromodulation; neurostimulation; deep brain stimulation; transcranial magnetic stimulation; direct cortical stimulation	TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX STIMULATION; ADVANCED PARKINSON-DISEASE; DEEP-BRAIN; ELECTRICAL-STIMULATION; CORTICAL STIMULATION; ANTERIOR THALAMUS; WORKING-MEMORY; MAJOR DEPRESSION; HEAD-INJURY	Traumatic brain injury (TBI) remains a significant public health problem and is a leading cause of death and disability in many countries. Durable treatments for neurological function deficits following TBI have been elusive, as there are currently no FDA-approved therapeutic modalities for mitigating the consequences of TBI. Neurostimulation strategies using various forms of electrical stimulation have recently been applied to treat functional deficits in animal models and clinical stroke trials. The results from these studies suggest that neurostimulation may augment improvements in both motor and cognitive deficits after brain injury. Several studies have taken this approach in animal models of TBI, showing both behavioral enhancement and biological evidence of recovery. There have been only a few studies using deep brain stimulation (DBS) in human TBI patients, and future studies are warranted to validate the feasibility of this technique in the clinical treatment of TBI. In this review, the authors summarize insights from studies employing neurostimulation techniques in the setting of brain injury. Moreover, they relate these findings to the future prospect of using DBS to ameliorate motor and cognitive deficits following TBI.	[Shin, Samuel S.; Dixon, C. Edward; Okonkwo, David O.; Richardson, R. Mark] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA		Shin, SS (corresponding author), Univ Pittsburgh, Med Ctr, Dept Neurol Surg, 200 Lothrop St,Ste B400, Pittsburgh, PA 15213 USA.	shinss@upmc.edu	Richardson, Robert/AAY-4969-2021; Richardson, Robert/C-6819-2016	Richardson, Robert/0000-0003-2620-7387	MedtronicMedtronic	Dr. Richardson has received research device support from Medtronic. The other authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Ameli M, 2009, ANN NEUROL, V66, P298, DOI 10.1002/ana.21725; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Bashir S, 2010, PM&R, V2, pS253, DOI 10.1016/j.pmrj.2010.10.015; BERKLEY KJ, 1983, J COMP NEUROL, V220, P229, DOI 10.1002/cne.902200210; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boroojerdi B, 2001, NEUROLOGY, V56, P526, DOI 10.1212/WNL.56.4.526; Boroojerdi B, 1996, J NEUROL SCI, V144, P160, DOI 10.1016/S0022-510X(96)00222-5; BROGGI G, 1993, MOVEMENT DISORD, V8, P206, DOI 10.1002/mds.870080217; Brown JA, 2003, NEUROL RES, V25, P815, DOI 10.1179/016164103771953907; Brown JA, 2006, NEUROSURGERY, V58, P464, DOI 10.1227/01.NEU.0000197100.63931.04; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Canavero S, 2002, J NEUROSURG, V97, P1208, DOI 10.3171/jns.2002.97.5.1208; Carmel JB, 2013, EUR J NEUROSCI, V37, P1090, DOI 10.1111/ejn.12119; Carmel JB, 2010, J NEUROSCI, V30, P10918, DOI 10.1523/JNEUROSCI.1435-10.2010; Carvalho KS, 2014, J CLIN NEUROSCI, V21, P153, DOI 10.1016/j.jocn.2013.02.009; CEBALLOSBAUMAN AO, 1995, ANN NEUROL, V37, P746, DOI 10.1002/ana.410370608; Chang WH, 2010, J REHABIL MED, V42, P758, DOI 10.2340/16501977-0590; Chuang C, 2002, J NEUROL NEUROSUR PS, V72, P59, DOI 10.1136/jnnp.72.1.59; Cilia R, 2008, EUR J NEUROL, V15, P18, DOI 10.1111/j.1468-1331.2007.01993.x; Classen J, 1997, BRAIN, V120, P605, DOI 10.1093/brain/120.4.605; Constantoyannis C, 2009, MOVEMENT DISORD, V24, P306, DOI 10.1002/mds.22350; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; De Rose M, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/502096; Desmond JE, 2005, ANN NEUROL, V58, P553, DOI 10.1002/ana.20604; Di Lazzaro V, 2008, CLIN NEUROPHYSIOL, V119, P715, DOI 10.1016/j.clinph.2007.11.049; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Encinas JM, 2011, J COMP NEUROL, V519, P6, DOI 10.1002/cne.22503; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Evers S, 2001, NEUROREPORT, V12, P2915, DOI 10.1097/00001756-200109170-00032; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; Floel A, 2011, STROKE, V42, P2065, DOI 10.1161/STROKEAHA.110.609032; Fontaine D, 2009, J NEUROSURG, V110, P251, DOI 10.3171/2008.6.17602; Foote KD, 2006, NEUROSURGERY, V58, P280, DOI 10.1227/01.NEU.0000192692.95455.FD; Fregni F, 2006, COGN BEHAV NEUROL, V19, P21, DOI 10.1097/00146965-200603000-00003; Fregni F, 2006, STROKE, V37, P2115, DOI 10.1161/01.STR.0000231390.58967.6b; Ghika J, 2002, NEUROLOGY, V58, P311, DOI 10.1212/WNL.58.2.311; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Gonzalez MMC, 2013, J NEUROTRAUM, V30, P119, DOI 10.1089/neu.2012.2499; Grafton ST, 2006, NEUROLOGY, V66, P1192, DOI 10.1212/01.wnl.0000214237.58321.c3; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Hamani C, 2011, EXP NEUROL, V232, P100, DOI 10.1016/j.expneurol.2011.08.023; Hamani C, 2010, EXP NEUROL, V225, P154, DOI 10.1016/j.expneurol.2010.06.007; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Huang M, 2008, TOP STROKE REHABIL, V15, P160, DOI 10.1310/tsr1502-160; Ilinsky IA, 2002, MOVEMENT DISORD, V17, pS9, DOI 10.1002/mds.10137; Issar NM, 2013, PARKINSONISM RELAT D, V19, P1100, DOI 10.1016/j.parkreldis.2013.07.022; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Kanno T, 2009, NEUROMODULATION, V12, P33, DOI 10.1111/j.1525-1403.2009.00185.x; Katayama Y, 1997, STEREOT FUNCT NEUROS, V69, P73, DOI 10.1159/000099855; KATAYAMA Y, 1994, STEREOT FUNCT NEUROS, V62, P295, DOI 10.1159/000098635; Katsakiori PF, 2009, ACTA NEUROCHIR, V151, P473, DOI 10.1007/s00701-009-0281-x; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Kim JP, 2012, ACTA NEUROCHIR, V154, P823, DOI 10.1007/s00701-012-1306-4; Kim YH, 2006, STROKE, V37, P1471, DOI 10.1161/01.STR.0000221233.55497.51; King RB, 2001, J NEUROSURG, V94, P309, DOI 10.3171/jns.2001.94.2.0309; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Koch G, 2008, BRAIN, V131, P3147, DOI 10.1093/brain/awn273; Kohler S, 2004, J COGNITIVE NEUROSCI, V16, P178, DOI 10.1162/089892904322984490; Krauss J K, 1997, Parkinsonism Relat Disord, V3, P117, DOI 10.1016/S1353-8020(96)00043-0; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Levy R, 2008, J NEUROSURG, V108, P707, DOI 10.3171/JNS/2008/108/4/0707; Lim DA, 2007, STEREOT FUNCT NEUROS, V85, P144, DOI 10.1159/000099072; Lim JY, 2010, J REHABIL MED, V42, P447, DOI 10.2340/16501977-0553; Loher TJ, 2000, J NEUROSURG, V92, P457, DOI 10.3171/jns.2000.92.3.0457; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; Lozano AM, 2012, J NEUROSURG, V116, P315, DOI 10.3171/2011.10.JNS102122; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Luber B, 2007, BRAIN RES, V1128, P120, DOI 10.1016/j.brainres.2006.10.011; Lujan JL, 2013, BRAIN STIMUL, V6, P737, DOI 10.1016/j.brs.2013.03.008; Malcolm MP, 2007, AM J PHYS MED REHAB, V86, P707, DOI 10.1097/PHM.0b013e31813e0de0; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; Medina J, 2012, APHASIOLOGY, V26, P1153, DOI 10.1080/02687038.2012.710316; MEYERSON BA, 1993, ACTA NEUROCHIR, P150; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Molnar GF, 2006, NEUROLOGY, V66, P566, DOI 10.1212/01.wnl.0000198254.08581.6b; Monfils MH, 2004, CEREB CORTEX, V14, P586, DOI 10.1093/cercor/bhh020; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Morimoto T, 2011, CELL TRANSPLANT, V20, P1049, DOI 10.3727/096368910X544915; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Mull BR, 2001, CLIN NEUROPHYSIOL, V112, P1672, DOI 10.1016/S1388-2457(01)00606-X; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; NGUYEN JP, 1993, ARCH NEUROL-CHICAGO, V50, P498, DOI 10.1001/archneur.1993.00540050050014; Nguyen JP, 1997, ADV STER F, V12, P54; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; Ohyama M, 1996, STROKE, V27, P897, DOI 10.1161/01.STR.27.5.897; Oliveri M, 2000, BRAIN, V123, P1939, DOI 10.1093/brain/123.9.1939; Osaka N, 2007, NEUROSCI LETT, V418, P232, DOI 10.1016/j.neulet.2007.01.087; Pagni CA, 2005, ACT NEUR S, V93, P113; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Peran P, 2014, J NEUROTRAUM, V31, P642, DOI 10.1089/neu.2013.3103; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Roth Y, 2002, J CLIN NEUROPHYSIOL, V19, P361, DOI 10.1097/00004691-200208000-00008; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Schiff ND, 2008, NATURE, V452, P120, DOI 10.1038/nature06818; Schiff ND, 2012, ANN NY ACAD SCI, V1265, P56, DOI 10.1111/j.1749-6632.2012.06712.x; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; SELLAL F, 1993, MOVEMENT DISORD, V8, P515, DOI 10.1002/mds.870080418; Shah PP, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00888; Shahaduzzaman M, 2013, MED HYPOTHESES, V81, P675, DOI 10.1016/j.mehy.2013.07.025; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Shindo K, 2006, J REHABIL MED, V38, P65, DOI 10.1080/16501970500441807; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; Silva S, 2008, CLIN NEUROPHYSIOL, V119, P2405, DOI 10.1016/j.clinph.2008.07.248; SILVER JK, 1994, ARCH PHYS MED REHAB, V75, P885, DOI 10.1016/0003-9993(94)90113-9; STERIADE M, 1982, J NEUROPHYSIOL, V48, P352, DOI 10.1152/jn.1982.48.2.352; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Strafella AP, 2007, MOVEMENT DISORD, V22, P2113, DOI 10.1002/mds.21691; Stypulkowski PH, 2013, STEREOT FUNCT NEUROS, V91, P220, DOI 10.1159/000345493; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Taghva AS, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.10.068; Takeuchi N, 2008, J REHABIL MED, V40, P298, DOI 10.2340/16501977-0181; Tani N, 2007, MOVEMENT DISORD, V22, P1645, DOI 10.1002/mds.21593; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Teskey GC, 2003, NEUROL RES, V25, P794, DOI 10.1179/016164103771953871; Toda H, 2008, J NEUROSURG, V108, P132, DOI 10.3171/JNS/2008/108/01/0132; TOFTS PS, 1990, PHYS MED BIOL, V35, P1119, DOI 10.1088/0031-9155/35/8/008; Tohyama Takamichi, 2011, Keio Journal of Medicine, V60, P114; Trost M, 2006, NEUROIMAGE, V31, P301, DOI 10.1016/j.neuroimage.2005.12.024; Tsubokawa T, 1990, Brain Inj, V4, P315; TSUBOKAWA T, 1993, J NEUROSURG, V78, P393, DOI 10.3171/jns.1993.78.3.0393; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Wassermann EM, 2012, PHARMACOL THERAPEUT, V133, P98, DOI 10.1016/j.pharmthera.2011.09.003; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Williams JM, 2003, HIPPOCAMPUS, V13, P109, DOI 10.1002/hipo.10082; Wong JC, 2013, CRIT REV CL LAB SCI, V50, P103, DOI 10.3109/10408363.2013.844678; Wu CY, 2013, NEUROMODULATION, V16, P10, DOI 10.1111/j.1525-1403.2012.00501.x; Yamamoto T, 2005, ACTA NEUROCHIR SUPPL, V93, P101; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353; Yamamoto T, 2012, NEUROL MED-CHIR, V52, P475, DOI 10.2176/nmc.52.475; Yamamoto T, 2010, EUR J NEUROSCI, V32, P1145, DOI 10.1111/j.1460-9568.2010.07412.x; Yoon YS, 2012, ANN REHABIL MED-ARM, V36, P596, DOI 10.5535/arm.2012.36.5.596; Zheng J, 2013, BRAIN RES, V1504, P25, DOI 10.1016/j.brainres.2013.01.015; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P192, DOI 10.1016/j.clinph.2005.09.015	164	31	32	1	30	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2014	121	5					1219	1231		10.3171/2014.7.JNS131826			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AR4AM	WOS:000343530400030	25170668				2022-02-06	
J	Muroski, ME; Morgan, TJ; Levenson, CW; Strouse, GF				Muroski, Megan E.; Morgan, Thomas J., Jr.; Levenson, Cathy W.; Strouse, Geoffrey F.			A Gold Nanoparticle Pentapeptide: Gene Fusion To Induce Therapeutic Gene Expression in Mesenchymal Stem Cells	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							STABLE TRANSGENE EXPRESSION; PENETRATING PEPTIDES; IN-VIVO; NONVIRAL VECTORS; DELIVERY; TRANSFECTION; SURFACE; SIRNA; SIZE; TRANSDUCTION	Mesenchymal stem cells (MSC) have been identified as having great potential as autologous cell therapeutics to treat traumatic brain injury and spinal injury as well as neuronal and cardiac ischemic events. All future clinical applications of MSC cell therapies must allow the MSC to be harvested, transfected, and induced to express a desired protein or selection of proteins to have medical benefit. For the full potential of MSC cell therapy to be realized, it is desirable to systematically alter the protein expression of therapeutically beneficial biomolecules in harvested MSC cells with high fidelity in a single transfection event. We have developed a delivery platform on the basis of the use of a solid gold nanoparticle that has been surface modified to produce a fusion containing a zwitterionic, pentapeptide designed from Bax inhibiting peptide (Ku70) to enhance cellular uptake and a linearized expression vector to induce enhanced expression of brain-derived neurotrophic factor (BDNF) in rat-derived MSCs. Ku70 is observed to effect >80% transfection following a single treatment of femur bone marrow isolated rat MSCs with efficiencies for the delivery of a 6.6 kbp gene on either a Au nanoparticle (NP) or CdSe/ZnS quantum dot (QD). Gene expression is observed within 4 d by optical measurements, and secretion is observed within 10 d by Western Blot analysis. The combination of being able to selectively engineer the NP, to colocalize biological agents, and to enhance the stability of those agents has provided the strong impetus to utilize this novel class of materials to engineer primary MSCs.	[Muroski, Megan E.; Strouse, Geoffrey F.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Morgan, Thomas J., Jr.; Levenson, Cathy W.; Strouse, Geoffrey F.] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA		Strouse, GF (corresponding author), Florida State Univ, Dept Chem & Biochem, 95 Chieftan Way, Tallahassee, FL 32306 USA.	Strouse@chem.fsu.edu		Levenson, Cathy W/0000-0003-4463-3136; /0000-0002-6491-1589	National Science FoundationNational Science Foundation (NSF) [CHE-0911080]; Florida State University Office of Research Planning grant [CRC-PG 075000-140]	We wish to acknowledge the National Science Foundation under CHE-0911080 for support of the research as well as the Florida State University Office of Research Planning grant CRC-PG 075000-140.	Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067; Albanese A, 2011, ACS NANO, V5, P5478, DOI 10.1021/nn2007496; Aluigi M, 2006, STEM CELLS, V24, P454, DOI 10.1634/stemcells.2005-0198; Aronovich EL, 2011, HUM MOL GENET, V20, pR14, DOI 10.1093/hmg/ddr140; Barrow Katie A., 2006, V329, P283; Bernstein HS, 2012, PEDIATR RES, V71, P491, DOI 10.1038/pr.2011.61; Breshike CJ, 2013, J PHYS CHEM C, V117, P23942, DOI 10.1021/jp407259r; Chen CY, 2011, MOL PHARMACEUT, V8, P1505, DOI 10.1021/mp100368d; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen LQ, 2012, ANAL CHEM, V84, P3099, DOI 10.1021/ac202810b; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Choi HS, 2010, MOL IMAGING, V9, P291, DOI 10.2310/7290.2010.00031; Chompoosor A, 2008, BIOCONJUGATE CHEM, V19, P1342, DOI 10.1021/bc8000694; Choudhary S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/264350; Chugh A, 2010, IUBMB LIFE, V62, P183, DOI 10.1002/iub.297; Cumberland SL, 2002, LANGMUIR, V18, P269, DOI 10.1021/la011278n; Deng DW, 2013, BIOSENS BIOELECTRON, V49, P216, DOI 10.1016/j.bios.2013.05.018; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Fang B, 2013, BIOCHIMIE, V95, P251, DOI 10.1016/j.biochi.2012.09.020; Ferreira E, 2008, GENE THER, V15, P537, DOI 10.1038/gt.2008.9; Flanagan M, 2011, CANCER GENE THER, V18, P579, DOI 10.1038/cgt.2011.27; Foerg C, 2005, BIOCHEMISTRY-US, V44, P72, DOI 10.1021/bi048330+; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Gandra N, 2013, ANGEW CHEM INT EDIT, V52, P11278, DOI 10.1002/anie.201301113; Giljohann DA, 2009, J AM CHEM SOC, V131, P2072, DOI 10.1021/ja808719p; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Greco SJ, 2012, THER DELIV, V3, P997, DOI 10.4155/TDE.12.69; Gresch O, 2012, METHODS MOL BIOL, V801, P65, DOI 10.1007/978-1-61779-352-3_5; Guo ST, 2010, ACS NANO, V4, P5505, DOI 10.1021/nn101638u; Haes AJ, 2005, MRS BULL, V30, P368, DOI 10.1557/mrs2005.100; Hakkinen H, 2012, NAT CHEM, V4, P443, DOI [10.1038/NCHEM.1352, 10.1038/nchem.1352]; Hamm A, 2002, TISSUE ENG, V8, P235, DOI 10.1089/107632702753725003; Hong R, 2006, J AM CHEM SOC, V128, P1078, DOI 10.1021/ja056726i; Honmou O, 2012, TRENDS MOL MED, V18, P292, DOI 10.1016/j.molmed.2012.02.003; Jain PK, 2006, J AM CHEM SOC, V128, P2426, DOI 10.1021/ja056769z; Jang JH, 2011, MOL THER, V19, P1407, DOI 10.1038/mt.2011.111; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kawano T, 2006, J CONTROL RELEASE, V111, P382, DOI 10.1016/j.jconrel.2005.12.022; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kim JH, 2005, EXP MOL MED, V37, P36; Kogot JM, 2008, J AM CHEM SOC, V130, P16156, DOI 10.1021/ja8064717; Lee JS, 2009, NANO LETT, V9, P2402, DOI 10.1021/nl9009793; Lei Y, 2008, BIOCONJUGATE CHEM, V19, P421, DOI 10.1021/bc0700685; Len J. G., 2012, NANOMED-NANOTECHNOL, V8, P767; Levy R, 2004, J AM CHEM SOC, V126, P10076, DOI 10.1021/ja0487269; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Liu F, 2002, J CONTROL RELEASE, V78, P259, DOI 10.1016/S0168-3659(01)00494-1; Locke M, 2011, TISSUE ENG PART C-ME, V17, P949, DOI [10.1089/ten.tec.2011.0153, 10.1089/ten.TEC.2011.0153]; Madeira C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/735349; Mansouri S, 2004, EUR J PHARM BIOPHARM, V57, P1, DOI 10.1016/S0939-6411(03)00155-3; Meade BR, 2007, ADV DRUG DELIVER REV, V59, P134, DOI 10.1016/j.addr.2007.03.004; Moschos SA, 2007, BIOCONJUGATE CHEM, V18, P1450, DOI 10.1021/bc070077d; Muroski ME, 2012, J AM CHEM SOC, V134, P19722, DOI 10.1021/ja307502x; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Oh E, 2010, LANGMUIR, V26, P7604, DOI 10.1021/la904438s; Park JS, 2010, BIOMATERIALS, V31, P124, DOI 10.1016/j.biomaterials.2009.09.023; Peister A, 2004, GENE THER, V11, P224, DOI 10.1038/sj.gt.3302163; Peng LH, 2011, DRUG DISCOV TODAY, V16, P957, DOI 10.1016/j.drudis.2011.07.009; Pouton CW, 2001, ADV DRUG DELIVER REV, V46, P187, DOI 10.1016/S0169-409X(00)00133-2; Reagan MR, 2011, STEM CELLS, V29, P920, DOI 10.1002/stem.645; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Samper E, 2013, STEM CELL REV REP, V9, P266, DOI 10.1007/s12015-012-9353-z; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; Santos JL, 2011, CURR GENE THER, V11, P46; Santra S, 2005, CHEM COMMUN, P3144, DOI 10.1039/b503234b; Scheibe F, 2012, GENE THER, V19, P550, DOI 10.1038/gt.2011.139; Seferos DS, 2007, J AM CHEM SOC, V129, P15477, DOI 10.1021/ja0776529; Seth P, 2005, CANCER BIOL THER, V4, P512, DOI 10.4161/cbt.4.5.1705; Shah K, 2012, ADV DRUG DELIVER REV, V64, P739, DOI 10.1016/j.addr.2011.06.010; Silva FH, 2006, MED HYPOTHESES, V67, P922, DOI 10.1016/j.mehy.2006.01.065; Sokolova IB, 2011, B EXP BIOL MED+, V151, P130, DOI 10.1007/s10517-011-1274-3; Song HP, 2010, BIOMATERIALS, V31, P769, DOI 10.1016/j.biomaterials.2009.09.085; Sykova E, 2007, PROG BRAIN RES, V161, P367, DOI 10.1016/S0079-6123(06)61026-1; Tawonsawatruk Tulyapruek, 2012, J Med Assoc Thai, V95 Suppl 10, pS189; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Trounson A, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-29; Woehrle GH, 2005, J AM CHEM SOC, V127, P2172, DOI 10.1021/ja0457718; Wuelfing WP, 1998, J AM CHEM SOC, V120, P12696, DOI 10.1021/ja983183m; Ye Zhaohui, 2008, V430, P243, DOI 10.1007/978-1-59745-182-6_17; Yi T, 2012, ARCH PHARM RES, V35, P213, DOI 10.1007/s12272-012-0202-z; Zeng JM, 2007, STEM CELLS, V25, P1055, DOI 10.1634/stemcells.2006-0616; Zhu ZJ, 2012, ANAL CHEM, V84, P4321, DOI 10.1021/ac203408v	86	31	32	2	99	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863	1520-5126		J AM CHEM SOC	J. Am. Chem. Soc.	OCT 22	2014	136	42					14763	14771		10.1021/ja505190q			9	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	AR6ID	WOS:000343686500031	25198921				2022-02-06	
J	Chen, JW; Vakil-Gilani, K; Williamson, KL; Cecil, S				Chen, Jefferson William; Vakil-Gilani, Kiana; Williamson, Kay Lyn; Cecil, Sandy			Infrared pupillometry, the Neurological Pupil index and unilateral pupillary dilation after traumatic brain injury: implications for treatment paradigms	SPRINGERPLUS			English	Article						Infrared pupillometry; Neurological Pupil index; Traumatic third nerve palsy; Pupillometer; Oculomotor nerve palsy; Traumatic brain injury; Pupillary outcome	OCULOMOTOR NERVE PALSY; MILD HEAD-INJURY; QUANTITATIVE PUPILLOMETRY; CEREBRAL-ARTERY; NORMATIVE DATA; LIGHT REFLEX; 3RD; PUPILLOGRAPHY; RECOVERY; SEDATION	Pupillary dysfunction, a concerning finding in the neurologic examination of the patient with an acute traumatic brain injury often dictates the subsequent treatment paradigm. Patients were monitored closely with an infrared pupillometer, with NPi technology, for acute changes in pupillary function. NPi technology applies a scalar value to pupillary function. A retrospective chart review was performed of traumatic brain injury patients with acute unilateral pupillary dilation, admitted to Legacy Emanuel Medical Center's NeuroTrauma Unit, Portland, OR, and followed as outpatients, between January 2012 and December 2013. Clinical exam findings of pupillary size, NPi scores, and brain Magnetic Resonance Imaging and Computed Tomography images were analyzed. Five traumatic brain injury patients were identified with unilateral pupillary dysfunction with long-term follow-up after the initial injury. Each patient was monitored closely in the trauma bay for neurological deterioration with a pupillometer and the clinical exam. Two patients underwent subsequent intracranial pressure monitoring based on a deteriorating clinical scenario, including consistent abnormal unilateral NPi scores. One patient with consistent abnormal NPi scores and an improved clinical exam did not undergo invasive interventions. Two patients showed early improvement in NPi scores correlating with the normalization of their pupillary reactivity. Anisocoria improved in all patients despite concurrent abnormal NPi scores. Magnetic Resonance Imaging and Computed Tomography imaging studies, with a focus on the third nerve, revealed focal abnormalities consistent with the clinical findings. A unilateral blown pupil and abnormal NPi score in a traumatic brain injury patient are not necessarily indicative of intracranial pressure issues, and must be correlated with the entire clinical scenario, to determine the etiology of the third nerve injury and direct potential therapeutic interventions. Early NPi score normalization suggests pupillary function may improve. We found that NPi scores, as a component of the clinical exam, provide a sensitive, noninvasive and quantitative means of following pupillary function acutely and chronically after a traumatic brain injury.	[Chen, Jefferson William; Vakil-Gilani, Kiana; Williamson, Kay Lyn; Cecil, Sandy] Legacy Emanuel Med Ctr, Dept Neurol Surg, Portland, OR 97227 USA; [Chen, Jefferson William] Univ Calif Irvine, Dept Neurol Surg, Orange, CA 92868 USA		Chen, JW (corresponding author), Legacy Emanuel Med Ctr, Dept Neurol Surg, 2801 N Gantenbein Ave, Portland, OR 97227 USA.	jeffewc1@uci.edu	chen, jeff/AAR-7375-2020	chen, jeff/0000-0003-0624-6864			[Anonymous], 2010, TRAUMATIC BRAIN INJU; Behrends M, 2012, RESUSCITATION, V83, P1223, DOI 10.1016/j.resuscitation.2012.05.013; BELANI KG, 1993, ANESTHESIOLOGY, V79, P23, DOI 10.1097/00000542-199307000-00006; Bhatti MT, 2006, ARCH NEUROL-CHICAGO, V63, P771, DOI 10.1001/archneur.63.5.771; Boev AN, 2005, J NEUROSURG, V103, P496, DOI 10.3171/ped.2005.103.6.0496; Brazis PW, 2009, SEMIN NEUROL, V29, P14, DOI 10.1055/s-0028-1124019; Chaudhary N, 2009, J NEURO-OPHTHALMOL, V29, P238, DOI 10.1097/WNO.0b013e3181b415f4; Chen CC, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.016311; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Du R, 2005, NEUROSURGERY, V57, P198, DOI 10.1227/01.NEU.0000163425.79170.CB; Fotiou F, 2000, CLIN PHYSIOL, V20, P336, DOI 10.1046/j.1365-2281.2000.00259.x; Fountas KN, 2006, NEUROCRIT CARE, V5, P55, DOI 10.1385/NCC:5:1:55; Garcia-Rivera CA, 2001, NEUROLOGY, V57, P1755, DOI 10.1212/WNL.57.10.1755; Guresir E, 2012, J NEUROSURG, V117, P904, DOI 10.3171/2012.8.JNS111239; Hallman MR., 2013, CURR ANESTHESIOL REP, V3, P89; HELLER PH, 1990, INVEST OPHTH VIS SCI, V31, P156; Hou RH, 2007, PSYCHOPHARMACOLOGY, V195, P41, DOI 10.1007/s00213-007-0884-y; Hults Kathryn N, 2006, J Neurosci Nurs, V38, P447; Kau HC, 2007, AM J OPHTHALMOL, V143, P280, DOI 10.1016/j.ajo.2006.10.035; Kim SC, 2009, J KOREAN NEUROSURG S, V45, P240, DOI 10.3340/jkns.2009.45.4.240; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Kwon HG, 2013, J NEUROL NEUROSUR PS, V84, P1073, DOI 10.1136/jnnp-2013-305111; Larson MD, 1997, ANESTHESIOLOGY, V87, P849, DOI 10.1097/00000542-199710000-00019; LARSON MD, 1995, ARCH NEUROL-CHICAGO, V52, P369, DOI 10.1001/archneur.1995.00540280051018; Lee AG, 2009, CLIN EXP OPHTHALMOL, V37, P30, DOI 10.1111/j.1442-9071.2008.01822.x; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Lin C, 2013, J NEUROSURG, V118, P364, DOI 10.3171/2012.9.JNS12702; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; LOWENSTEIN O, 1958, ARCH OPHTHALMOL-CHIC, V59, P352, DOI 10.1001/archopht.1958.00940040058007; Manley GT, 2002, J NEUROSURG ANESTH, V14, P223, DOI 10.1097/00008506-200207000-00009; Martinez-Ricarte F, 2013, NEUROLOGIA, V28, P41, DOI 10.1016/j.nrl.2010.07.028; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Motoyama Y, 2012, NEUROL MED-CHIR, V52, P202, DOI 10.2176/nmc.52.202; Murchison AP, 2011, ARCH OPHTHALMOL-CHIC, V129, P301, DOI 10.1001/archophthalmol.2011.25; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; Najafi MR, 2012, ARCH IRAN MED, V15, P583, DOI 012159/AIM.0015; Nistri M, 2007, J NEUROL NEUROSUR PS, V78, P197, DOI 10.1136/jnnp.2006.098129; Ortube MC, 2013, INVEST OPHTH VIS SCI, V54, P9, DOI 10.1167/iovs.12-10241; Prasad S, 2010, NEUROL CLIN, V28, P803, DOI 10.1016/j.ncl.2010.04.001; Pula JH, 2011, CURR OPIN OPHTHALMOL, V22, P451, DOI 10.1097/ICU.0b013e32834c46aa; Quisling SV, 2006, J NEURO-OPHTHALMOL, V26, P47, DOI 10.1097/01.wno.0000204660.41183.1b; Rebolleda G, 2013, ARCH SOC ESP OFTALMO, V88, P125, DOI [10.1016/j.oftal.2013.02.014, DOI 10.1016/J.0FTAL.2013.02.014]; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rollins MD, 2014, ANESTHESIOLOGY, V121, P1037, DOI 10.1097/ALN.0000000000000384; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Rouche O, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-5; Sadagopan KA, 2013, CURR OPIN OPHTHALMOL, V24, P438, DOI 10.1097/ICU.0b013e3283645a9b; Saremi F, 2005, AM J ROENTGENOL, V185, P1487, DOI 10.2214/AJR.04.1518; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; The Brain TraumaFoundation, 2000, J NEUROTRAUM, V17, P583, DOI [10.1089/neu.2000.17.583, DOI 10.1089/NEU.2000.17.583]; Volpe NJ, 2000, OPHTHALMOLOGY, V107, P1913, DOI 10.1016/S0161-6420(00)00354-7; Wachler BSB, 1999, OPHTHALMOLOGY, V106, P319; Yanovitch T, 2007, CURR OPIN OPHTHALMOL, V18, P373, DOI 10.1097/ICU.0b013e328270b8db	54	31	32	0	5	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	SEP 23	2014	3								548	10.1186/2193-1801-3-548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3WS	WOS:000359092500001	25332854	gold, Green Published			2022-02-06	
J	Kerr, ZY; Collins, CL; Mihalik, JP; Marshall, SW; Guskiewicz, KM; Comstock, RD				Kerr, Zachary Y.; Collins, Christy L.; Mihalik, Jason P.; Marshall, Stephen W.; Guskiewicz, Kevin M.; Comstock, R. Dawn			Impact Locations and Concussion Outcomes in High School Football Player-to-Player Collisions	PEDIATRICS			English	Article						epidemiology; injury surveillance; traumatic brain injury	SPORT-RELATED CONCUSSION; STATES HIGH-SCHOOL; UNITED-STATES; ATHLETIC-TRAINERS; HEAD IMPACTS; BRAIN-INJURY; COLLEGIATE; EPIDEMIOLOGY; BIOMECHANICS	BACKGROUND: Little research has examined concussion outcomes in terms of impact location (ie, the area on the head in which the impact occurred). This study describes the epidemiology of concussions resulting from player-to-player collision in high school football by impact location. METHODS: National High School Sports-Related Injury Surveillance Study data (2008/2009-2012/2013) were analyzed to calculate rates and describe circumstances of football concussion (eg, symptomology, symptom resolution time, return to play) resulting from player-to-player collisions by impact location (ie, front-, back-, side-, and top-of-the-head). RESULTS: Most concussions resulting from player-to-player collisions occurred from front-of-the-head (44.7%) and side-of-the-head (22.3%) impacts. Number of symptoms reported, prevalence of reported symptoms, symptom resolution time, and length of time to return to play were not associated with impact location. However, a larger proportion of football players sustaining concussions from top-of-the-head impacts experienced loss of consciousness (8.0%) than those sustaining concussions from impacts to other areas of the head (3.5%) (injury proportion ratio 2.3; 95% confidence interval 1.2-4.2; P = .008). Players had their head down at the time of impact in a higher proportion of concussions caused by top-of-the-head impacts (86.4%) than concussions from impacts to other areas of the head (24.0%) (injury proportion ratio 3.6; 95% confidence interval 3.2-4.0; P < .001). CONCLUSIONS: Among high school football players who sustained concussions due to player-to-player collisions, concussion outcomes were generally independent of impact location. Recommended strategies for reducing the proportion of top-of-the-head impacts include improved education regarding tackling with proper "head-up" technique.	[Kerr, Zachary Y.; Mihalik, Jason P.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Chapel Hill, NC USA; [Collins, Christy L.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Collins, Christy L.] Ohio State Univ, Columbus, OH 43210 USA; [Comstock, R. Dawn] Univ Denver, Aurora, CO USA		Comstock, RD (corresponding author), Univ Colorado Denver, PIPER Program, 13001 East 17th Pl,Mailstop B119, Aurora, CO 80045 USA.	Comstock@UCDenver.edu		Marshall, Stephen/0000-0002-2664-9233; Guskiewicz, Kevin/0000-0002-8682-2130; Kerr, Zachary/0000-0003-1423-1259; Mihalik, Jason/0000-0001-6085-8322	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172, R49CE000674] Funding Source: NIH RePORTER	The content of this report was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01. We acknowledge the generous research funding contributions of the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the Centers for Disease Control and Prevention or any of the other institutions that provided financial support for this research.	Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dick R, 2007, J ATHL TRAINING, V42, P173; Gabbett TJ, 2006, J STRENGTH COND RES, V20, P215; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heck JF, 2004, J ATHL TRAINING, V39, P101; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; MUELLER FO, 1994, AM SOC TEST MATER, V1229, P20, DOI 10.1520/STP12800S; Mueller FO, 2012, ANN SURVEY FOOTBALL; National Federation of State High School Associations, 2013, HIGH SCH SPORTS PART; Patel Dilip R, 2002, Adolesc Med, V13, P569; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Pryor RR, 2014, 2014 YOUTH SPORTS SA; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Sosin DM, 1996, BRAIN INJURY, V10, P47; US Census Bureau, 2009, CENS REG US; Yard EE, 2009, J ATHL TRAINING, V44, P645, DOI 10.4085/1062-6050-44.6.645	29	31	31	0	34	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2014	134	3					489	496		10.1542/peds.2014-0770			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AO5DN	WOS:000341362600048	25113292				2022-02-06	
J	Shivers, KY; Nikolopoulou, A; Machlovi, SI; Vallabhajosula, S; Figueiredo-Pereira, ME				Shivers, Kai-Yvonne; Nikolopoulou, Anastasia; Machlovi, Saima Ishaq; Vallabhajosula, Shankar; Figueiredo-Pereira, Maria E.			PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Prostaglandin J2; PET; Microglia; PACAP; Parkinson; PK11195	TRAUMATIC BRAIN-INJURY; CYCLOPENTENONE PROSTAGLANDINS; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); UBIQUITIN/PROTEASOME PATHWAY; ENDOGENOUS ELECTROPHILE; MOUSE MODEL; WILD-TYPE; J-SERIES	Neuroinflammation is a major risk factor in Parkinson's disease (PD). Alternative approaches are needed to treat inflammation, as anti-inflammatory drugs such as NSAIDs that inhibit cyclooxygenase-2 (COX-2) can produce devastating side effects, including heart attack and stroke. New therapeutic strategies that target factors downstream of COX-2, such as prostaglandin J2 (PGJ2), hold tremendous promise because they will not alter the homeostatic balance offered by COX-2 derived prostanoids. In the current studies, we report that repeated microinfusion of PGJ2 into the substantia nigra of non-transgenic mice, induces three stages of pathology that mimic the slow-onset cellular and behavioral pathology of PD: mild (one injection) when only motor deficits are detectable, intermediate (two injections) when neuronal and motor deficits as well as microglia activation are detectable, and severe (four injections) when dopaminergic neuronal loss is massive accompanied by microglia activation and motor deficits. Microglia activation was evaluated in vivo by positron emission tomography (PET) with [C-11(R)PK11195 to provide a regional estimation of brain inflammation. PACAP27 reduced dopaminergic neuronal loss and motor deficits induced by PGJ2, without preventing microglia activation. The latter could be problematic in that persistent microglia activation can exert long-term deleterious effects on neurons and behavior. In conclusion, this PGJ2-induced mouse model that mimics in part chronic inflammation, exhibits slow-onset PD-like pathology and is optimal for testing diagnostic tools such as PET, as well as therapies designed to target the integrated signaling across neurons and microglia, to fully benefit patients with PD. (C) 2014 Elsevier B.V. All rights reserved.	[Shivers, Kai-Yvonne; Machlovi, Saima Ishaq; Figueiredo-Pereira, Maria E.] CUNY, Grad Sch, Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Shivers, Kai-Yvonne; Machlovi, Saima Ishaq; Figueiredo-Pereira, Maria E.] CUNY, Univ Ctr, New York, NY 10065 USA; [Nikolopoulou, Anastasia; Vallabhajosula, Shankar] Cornell Univ, Weill Cornell Med Coll, Citigrp Biomed Imaging Ctr, Dept Radiol, New York, NY 10065 USA		Figueiredo-Pereira, ME (corresponding author), CUNY, Hunter Coll, Dept Biol Sci, 695 Pk Ave,Room 827N, New York, NY 10065 USA.	pereira@genectr.hunter.cuny.edu			CTSC GRANT [UL1-RR024996]; Hunter College [1R25GM097634];  [NIH: AG028847/NIA];  [NS041073/NINDS (SNRP)];  [MD007599/NIMHD/RCMI]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM097634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS080686, U54NS041073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG028847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R24DA012136] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [G12MD007599] Funding Source: NIH RePORTER	The authors thank Dalila Ordonez, Carolyn Diaz, Vanessa Jacob (Hunter College), Michael Synan and Dr. Bin He (Weill Cornell Medical College) for their excellent technical assistance. Supported by NIH: AG028847/NIA to M.F.-P.; and NS041073/NINDS (SNRP) to M.F.-P. (head of subproject); CTSC GRANT UL1-RR024996 (TL1 training award to K.-Y.S.); and MD007599/NIMHD/RCMI to Hunter College; and Training Program at Hunter College (BP-Endure Grant 1R25GM097634 to S.I.M.). The authors declare no competing financial interests.	ABDELHALIM MS, 1977, PROSTAGLANDINS, V14, P633, DOI 10.1016/0090-6980(77)90190-3; Anglade P, 1996, NEURODEGENERATION, V5, P121, DOI 10.1006/neur.1996.0018; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Atlasz T, 2010, BRAIN RES BULL, V81, P497, DOI 10.1016/j.brainresbull.2009.09.004; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Bartels AL, 2010, CURR NEUROPHARMACOL, V8, P62, DOI 10.2174/157015910790909485; Becker C, 2010, PARKINSONISM RELAT D, V16, P31, DOI 10.1016/j.parkreldis.2009.06.005; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Betarbet R, 2004, EXP NEUROL, V187, P76, DOI 10.1016/j.expneurol.2003.12.012; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Carvalho MM, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-14; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; CHIU EKY, 1985, GEN PHARMACOL-VASC S, V16, P163, DOI 10.1016/0306-3623(85)90064-3; COX HM, 1992, BRIT J PHARMACOL, V106, P498, DOI 10.1111/j.1476-5381.1992.tb14363.x; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Deguil J, 2010, NEUROTOX RES, V17, P142, DOI 10.1007/s12640-009-9091-4; Dejda A, 2011, PEPTIDES, V32, P1207, DOI 10.1016/j.peptides.2011.04.003; Deleidi M, 2013, CELL MOL LIFE SCI, V70, P4259, DOI 10.1007/s00018-013-1352-y; Dogrukol-Ak D, 2004, CURR PHARM DESIGN, V10, P1325, DOI 10.2174/1381612043384934; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Esposito E, 2007, EXP NEUROL, V205, P295, DOI 10.1016/j.expneurol.2007.02.008; FAHN S, 1971, J NEUROL SCI, V14, P427, DOI 10.1016/0022-510X(71)90178-X; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Feng ZH, 2003, NEUROREPORT, V14, P1927, DOI 10.1097/00001756-200310270-00009; Golovko MY, 2008, NEUROSCI LETT, V432, P243, DOI 10.1016/j.neulet.2007.12.031; Grealish S, 2010, EUR J NEUROSCI, V31, P2266, DOI 10.1111/j.1460-9568.2010.07265.x; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Henderson JM, 1999, EUR J NEUROSCI, V11, P2749, DOI 10.1046/j.1460-9568.1999.00692.x; Herlong JL, 2006, IMMUNOL LETT, V102, P121, DOI 10.1016/j.imlet.2005.10.004; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Higdon AN, 2012, ANTIOXID REDOX SIGN, V17, P1580, DOI 10.1089/ars.2012.4523; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Huang H, 2013, CELL BIOCHEM BIOPHYS, V67, P55, DOI 10.1007/s12013-013-9628-2; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Iadecola C, 2005, STROKE, V36, P182, DOI 10.1161/01.STR.0000153797.33611.d8; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Joo KM, 2004, J COMP NEUROL, V476, P388, DOI 10.1002/cne.20231; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Klivenyi P, 2003, J MOL NEUROSCI, V21, P191, DOI 10.1385/JMN:21:3:191; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; Li ZM, 2004, BIOCHEM BIOPH RES CO, V319, P1171, DOI 10.1016/j.bbrc.2004.05.098; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Liu H, 2013, NEUROTOXICOLOGY, V39, P35, DOI 10.1016/j.neuro.2013.08.001; Liu H, 2013, NEUROTOX RES, V24, P191, DOI 10.1007/s12640-013-9377-4; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Martinez B, 2005, J LIPID RES, V46, P736, DOI 10.1194/jlr.M400392-JLR200; McGeer EG, 2007, CNS DRUGS, V21, P789, DOI 10.2165/00023210-200721100-00001; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; Metcalfe MJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.70; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Monneret G, 2002, J IMMUNOL, V168, P3563, DOI 10.4049/jimmunol.168.7.3563; Moody TW, 2011, CURR OPIN ENDOCRINOL, V18, P61, DOI 10.1097/MED.0b013e328342568a; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Myeku N, 2012, NEUROSCI LETT, V527, P126, DOI 10.1016/j.neulet.2012.08.051; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Ogburn KD, 2006, NEUROBIOL DIS, V22, P294, DOI 10.1016/j.nbd.2005.11.006; Ogburn KD, 2006, J BIOL CHEM, V281, P23274, DOI 10.1074/jbc.M600635200; Ohtaki H, 2010, J MOL NEUROSCI, V42, P397, DOI 10.1007/s12031-010-9350-0; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Pierre SR, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-18; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Reglodi D, 2004, BEHAV BRAIN RES, V151, P303, DOI 10.1016/j.bbr.2003.09.007; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Rodriguez-Grande B, 2013, BRAIN BEHAV IMMUN, V29, P51, DOI 10.1016/j.bbi.2012.11.017; Satoh T, 2007, TRENDS NEUROSCI, V30, P37, DOI 10.1016/j.tins.2006.11.004; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shibata T, 2003, BIOCHEMISTRY-US, V42, P13960, DOI 10.1021/bi035215a; Shih AY, 2006, J NEUROSCI, V26, P3887, DOI 10.1523/JNEUROSCI.0936-06.2006; Silveira MS, 2006, ADV EXP MED BIOL, V557, P164; Sousa N, 2006, GENES BRAIN BEHAV, V5, P5, DOI 10.1111/j.1601-183X.2006.00228.x; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006.abs; Takei N, 1998, J NEUROSCI RES, V54, P698, DOI 10.1002/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5; Tan YV, 2011, ASN NEURO, V3, P195, DOI 10.1042/AN20110024; Tanaka S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-143; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Uchida H, 2010, INT J EXP PATHOL, V91, P256, DOI 10.1111/j.1365-2613.2010.00712.x; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Venneti S, 2013, GLIA, V61, P10, DOI 10.1002/glia.22357; Wang G, 2008, NEUROPEPTIDES, V42, P267, DOI 10.1016/j.npep.2008.03.002; Wang ZY, 2006, J BIOL CHEM, V281, P21377, DOI 10.1074/jbc.M601201200; Warraich ST, 2009, BRAIN RES BULL, V78, P85, DOI 10.1016/j.brainresbull.2008.08.023; Watson MB, 2013, NEUROSCIENCE, V240, P277, DOI 10.1016/j.neuroscience.2013.03.002	92	31	31	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	SEP	2014	1842	9					1707	1719		10.1016/j.bbadis.2014.06.020			13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AO0BZ	WOS:000340975400042	24970746	Green Accepted, Bronze			2022-02-06	
J	Zhu, XX; Park, J; Golinski, J; Qiu, JH; Khuman, J; Lee, CCH; Lo, EH; Degterev, A; Whalen, MJ				Zhu, Xiaoxia; Park, Juyeon; Golinski, Julianne; Qiu, Jianhua; Khuman, Jugta; Lee, Christopher C. H.; Lo, Eng H.; Degterev, Alexei; Whalen, Michael J.			Role of Akt and mammalian target of rapamycin in functional outcome after concussive brain injury in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Akt; concussion; mice; necrostatin-1; rapamycin; traumatic brain injury	CONTROLLED CORTICAL IMPACT; SYNAPTIC PLASTICITY; MTOR; PHOSPHORYLATION; KINASE; ACTIVATION; SURVIVAL; MEMORY; DAMAGE; ALPHA	Akt (protein kinase B) and mammalian target of rapamycin (mTOR) have been implicated in the pathogenesis of cell death and cognitive outcome after cerebral contusion in mice; however, a role for Akt/mTOR in. concussive brain injury has not been well characterized. In a mouse closed head injury (CHI) concussion traumatic brain injury (TBI) model, phosphorylation of Akt (p-Akt), mTOR (p-mTOR), and S6RP (p-S6RP) was increased by 24 hours in cortical and hippocampal brain homogenates (P<0.05 versus sham for each), and p-S6RP was robustly induced in IBA-1 + microglia and glial fibrillary acidic protein-positive (GFAP+) astrocytes. Pretreatment with inhibitors of Akt or mTOR individually by the intracerebroventricular route reduced phosphorylation of their respective direct substrates FOXO1 (P<0.05) or S6RP (P<0.05) after CHI, confirming the activity of inhibitors. Rapamycin pretreatment significantly worsened hidden platform (P<0.01) and probe trial (P<0.05) performance in CHI mice. Intracerebroventricular administration of necrostatin-1 (Nec-1) before CHI increased hippocampal Akt and S6RP phosphorylation and improved place learning (probe trials, P<0.001 versus vehicle), whereas co-administration of rapamycin or Akt inhibitor with Nec-1 eliminated improved, probe trial performance. These data suggest a beneficial role for Akt/mTOR signaling after concussion TBI independent of cell death that may contribute to improved outcome by Nec-1.	[Zhu, Xiaoxia; Park, Juyeon; Golinski, Julianne; Qiu, Jianhua; Khuman, Jugta; Lee, Christopher C. H.; Lo, Eng H.; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Neurosci, Charlestown, MA 02129 USA; [Zhu, Xiaoxia; Park, Juyeon; Golinski, Julianne; Qiu, Jianhua; Khuman, Jugta; Lee, Christopher C. H.; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA 02129 USA; [Zhu, Xiaoxia] Fudan Univ, Huashan Hosp, Dept Rheumatol, Shanghai 200433, Peoples R China; [Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA; [Degterev, Alexei] Tufts Univ, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA		Whalen, MJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA 02129 USA.	mwhalen@partners.org			Harvard Catalyst; Harvard University; affiliated academic health care centers [1UL1 TR001102-01]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5RO1NS047447]; National Football League Players Association; Harvard Catalyst [1UL1 TR001102-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047447, P01NS055104] Funding Source: NIH RePORTER	This work was conducted with support from Harvard Catalyst and financial contributions from Harvard University and its affiliated academic health care centers, grant number 1UL1 TR001102-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. This work was supported by a grant from NINDS 5RO1NS047447 (MJW), a grant from the National Football League Players Association, and Harvard Catalyst (1UL1 TR001102-01). Authors have no disclosures or conflict of interest to report.	Troca-Marin JA, 2014, CNS NEUROL DISORD-DR, V13, P34, DOI 10.2174/18715273113126660184; Troca-Marin JA, 2012, PROG NEUROBIOL, V96, P268, DOI 10.1016/j.pneurobio.2012.01.005; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Centers for Disease C Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1337; Chao CC, 2007, J NEUROSCI, V27, P6243, DOI 10.1523/JNEUROSCI.1531-07.2007; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gipson TT, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/486402; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Ji K, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/627325; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McNamara CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056576; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Sanchez-Perez AM, 2006, NEUROCHEM INT, V49, P351, DOI 10.1016/j.neuint.2006.02.005; Santello M, 2012, ADV EXP MED BIOL, V970, P307, DOI 10.1007/978-3-7091-0932-8_14; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238	39	31	31	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2014	34	9					1531	1539		10.1038/jcbfm.2014.113			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AO4WT	WOS:000341342800014	24938400	Green Published, Bronze			2022-02-06	
J	Brown, HJ; Siegmund, GP; Guskiewicz, KM; Van den Doel, K; Cretu, E; Blouin, JS				Brown, Harrison J.; Siegmund, Gunter P.; Guskiewicz, Kevin M.; Van den Doel, Kees; Cretu, Edmond; Blouin, Jean-Sebastien			Development and Validation of an Objective Balance Error Scoring System	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						STANDING BALANCE; POSTURAL CONTROL; CONCUSSION EVALUATION; BALANCE ERROR SCORING SYSTEM	COLLEGIATE FOOTBALL PLAYERS; MILD HEAD-INJURY; POSTURAL STABILITY; CONCUSSION; SPORT; MANAGEMENT; RELIABILITY; SCHOOL	Introduction: Limited access to sophisticated technology and the unreliability of simple tools prevent accurate and reliable human standing balance assessments outside research laboratory settings. The goal of this study was to develop and validate a simple objective balance assessment tool that provides an accurate, reliable, and affordable alternative to currently available laboratory and clinical methods. Methods: Thirty healthy subjects were filmed performing the Balance Error Scoring System (BESS) while wearing inertial measurement units (IMU) measuring linear accelerations and angular velocities from seven locations of the body: forehead, sternum, waist, right and left wrist, and right and left shin. Each video was scored by four experienced BESS raters, whose mean scores were used to develop an algorithm computing objective BESS (oBESS) scores solely from IMU data. Interrater reliability and accuracy of oBESS scores were assessed using intraclass correlations (ICC). Results: Raters displayed low variability in scoring (ICC3,1 = 0.91). The oBESS was able to produce scores with accurate fit to raters (ICC3,1 = 0.92) and predicted individual BESS scores (ICC3,1 = 0.90) using data from one IMU placed at the forehead. oBESS was unable to produce accurate scores (ICC3,1 = 0.68) when using IMU data from the subset of conditions (firm surface only) used in popular concussion identification protocols. Conclusion: The oBESS can reliably predict total BESS scores in healthy subjects. Pending further validation, oBESS could represent a valid tool to assess balance by offering an objective and reliable alternative to the current scoring methods of the BESS.	[Brown, Harrison J.; Siegmund, Gunter P.; Blouin, Jean-Sebastien] Univ British Columbia, Sch Kinesiol, Vancouver, BC V6T 1Z1, Canada; [Siegmund, Gunter P.] MEA Forens Engineers & Scientists, Richmond, BC, Canada; [Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Van den Doel, Kees] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1Z1, Canada; [Cretu, Edmond] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z1, Canada		Blouin, JS (corresponding author), Univ British Columbia, Sch Kinesiol, 210-6081 Univ Blvd, Vancouver, BC V6T 1Z1, Canada.	jsblouin@mail.ubc.ca	Siegmund, Gunter P/B-7003-2013	Siegmund, Gunter/0000-0003-2387-941X; Guskiewicz, Kevin/0000-0002-8682-2130	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Canadian Institutes of Health Research/Canadian Chiropractic Research FoundationCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	This work was supported by the Natural Sciences and Engineering Research Council of Canada grant to J. S. Blouin and G. P. Siegmund. J. S. Blouin received salary support from the Canadian Institutes of Health Research/Canadian Chiropractic Research Foundation and the Michael Smith Foundation for Health Research. G. P. Siegmund owns shares in a consulting company, and both he and the company may derive benefit from being associated with this work.	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Davis GA, 2009, BRIT J SPORT MED, V43, P136; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; MacInnis MJ, 2012, HIGH ALT MED BIOL, V13, P93, DOI 10.1089/ham.2011.1085; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Onate JA, 2007, J ATHL TRAINING, V42, P446; Osborne JW, 2007, BEST PRACTICES QUANT, P48; Paloski WH, 2006, GAIT POSTURE, V23, P315, DOI 10.1016/j.gaitpost.2005.04.009; Portney LG, 1993, FDN CLIN RES APPL PR, P514; Randolph C, 2005, J ATHL TRAINING, V40, P139; Riemann BL, 2000, J ATHL TRAINING, V35, P19; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Valovich McLeod TC, 2003, J ATHL TRAINING, V38, P51; Zammit E, 2005, PHYS THER SPORT, V6, P116, DOI 10.1016/j.ptsp.2005.05.002	31	31	31	3	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	AUG	2014	46	8					1610	1616		10.1249/MSS.0000000000000263			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AL6RF	WOS:000339259700017	24500539	Green Published, Green Submitted			2022-02-06	
J	Colletti, G; Battista, VMA; Allevi, F; Giovanditto, F; Rabbiosi, D; Biglioli, F				Colletti, Giacomo; Battista, Valeria Marinella Augusta; Allevi, Fabiana; Giovanditto, Federica; Rabbiosi, Dimitri; Biglioli, Federico			Extraoral approach to mandibular condylar fractures: Our experience with 100 cases	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Condylar fracture; Extraoral approach; Retromandibular access; Mini-retromandibular access	MINI-RETROMANDIBULAR ACCESS; CLOSED TREATMENT; SUBCONDYLAR FRACTURES; FIXATION	Introduction: Mandibular condylar fractures are very common. The current literature contains many indications and methods of treatment. Extraoral approaches are complicated by the need to avoid injury to the facial nerve. On the other hand intraoral approaches can make fracture reduction and/or fixation difficult. The mini-retromandibular approach provides an excellent view of the surgical field, minimises the risk of injury to the facial nerve, and allows rapid and easy management of condylar fractures. We have collected and reviewed our first 100 condylar fractures treated by means of a mini-retromandibular approach. Patients and methods: Between June 2006 and June 2012, Eighty-seven patients with extracapsular condylar fractures underwent open reduction and rigid fixation for 100 extracapsular condylar fractures via a mini-retromandibular approach. Results: Dental occlusion and anatomic reduction were restored in all 100 condylar fractures. Postoperative infection developed in three patients. There was one sialocele and one case of plate fracture. Four patients experienced transient palsy of the buccal branch of the facial nerve. No permanent deficit of any facial nerve branch was observed. No patient showed condylar head resorption. Conclusions: Our experience with the treatment of the first 100 condylar fractures using the mini-retromandibular approach has demonstrated that this technique has allowed the Authors to safely manage extracapsular condylar fractures at all levels. (C) 2013 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Colletti, Giacomo; Battista, Valeria Marinella Augusta; Allevi, Fabiana; Giovanditto, Federica; Rabbiosi, Dimitri; Biglioli, Federico] Univ Milan, San Paolo Hosp, Dept Maxillo Facial Surg, I-20100 Milan, Italy		Colletti, G (corresponding author), Piazza Repubbl 1-A, I-20121 Milan, Italy.	giacomo.colletti@gmail.com	Colletti, Giacomo/G-8620-2012; Allevi, Fabiana/AAO-2330-2020	Colletti, Giacomo/0000-0001-6975-495X; Rabbiosi, Dimitri/0000-0001-5207-2055; ALLEVI, FABIANA/0000-0002-5012-4031			Arcuri F, 2012, J CRANIOFAC SURG, V23, pE196, DOI 10.1097/SCS.0b013e31824de328; Biglioli F, 2010, Minerva Stomatol, V59, P603; Biglioli F, 2008, J CRANIO MAXILL SURG, V36, P378, DOI 10.1016/j.jcms.2008.05.001; Biglioli F, 2009, J ORAL MAXIL SURG, V67, P2418, DOI 10.1016/j.joms.2009.04.066; Brusati R, 2005, RIV ITAL CHIR MAXILL, V16, P15; Brusati R, 2010, J CRANIO MAXILL SURG, V38, P179, DOI 10.1016/j.jcms.2009.04.010; Choi KY, 2012, ARCH PLAST SURG-APS, V39, P291, DOI 10.5999/aps.2012.39.4.291; Chrcanovic BR, 2012, ORAL MAXILLOFAC SURG, V16, P245, DOI 10.1007/s10006-012-0344-7; Chrcanovic BR, 2012, ORAL MAXILLOFAC SURG, V16, P257, DOI 10.1007/s10006-012-0337-6; CLEMENTSCHITSCH F, 1955, Dtsch Zahnarztl Z, V10, P380; Colletti G, 2012, J CRANIOFAC SURG, V23, pE400, DOI 10.1097/SCS.0b013e31825bd004; Danda AK, 2010, J ORAL MAXIL SURG, V68, P1238, DOI 10.1016/j.joms.2009.09.042; Delaire J, 1975, Rev Stomatol Chir Maxillofac, V76, P331; Eckelt U, 2006, J CRANIO MAXILL SURG, V34, P306, DOI 10.1016/j.jcms.2006.03.003; Ellis E, 2000, J ORAL MAXIL SURG, V58, P719, DOI 10.1053/joms.2000.7253; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; Ellis E, 2000, J ORAL MAXIL SURG, V58, P260, DOI 10.1016/S0278-2391(00)90047-8; Eulert S, 2007, ANN ANAT, V189, P377, DOI 10.1016/j.aanat.2007.02.010; Handschel J, 2012, J CRANIOMAXILLOFAC S; Hovinga J, 1999, INT J ORAL MAX SURG, V28, P429, DOI 10.1034/j.1399-0020.1999.280606.x; IIZUKA T, 1991, ORAL SURG ORAL MED O, V72, P400, DOI 10.1016/0030-4220(91)90547-P; Jacobovicz J, 1998, PLAST RECONSTR SURG, V101, P437, DOI 10.1097/00006534-199802000-00030; Kellman RM, 2009, FACIAL PLAST SURG, V25, P23, DOI 10.1055/s-0028-1112228; Kohler A, 1956, DTSCH STOMATOL, V6, P561; Kokemueller H, 2012, J ORAL MAXIL SURG, V70, P384, DOI 10.1016/j.joms.2011.02.035; Landes CA, 2008, ORAL MAXILLOFAC SURG, V12, P79, DOI 10.1007/s10006-008-0108-6; Mueller Reid V, 2006, Facial Plast Surg Clin North Am, V14, P1; Myall RWT, 1994, CONTROVERSIES ORAL M, V17, P191; Rabbiosi D, 2012, MINERVA STOMATOL, V61, P431; Schmelzeisen R, 2009, J ORAL MAXIL SURG, V67, P147, DOI 10.1016/j.joms.2008.09.019; SILVENNOINEN U, 1992, J ORAL MAXIL SURG, V50, P1032, DOI 10.1016/0278-2391(92)90484-H; Silverman SL, 1925, DENT COSMOS, V67, P876; Steinhauser E., 1964, DTSCH ZAHNARZTL Z, V19, P694; Throckmorton GS, 2000, INT J ORAL MAX SURG, V29, P421, DOI 10.1034/j.1399-0020.2000.290605.x; Vesnaver A, 2011, J CRANIOMAXILLOFAC S; Wa&beta;mund M, 1934, DTSCH KIEFERCHIR, V1, P27; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854	37	31	33	0	4	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	JUL	2014	42	5					E186	E194		10.1016/j.jcms.2013.08.005			9	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	AX5NH	WOS:000346973000021	24099654				2022-02-06	
J	De Luca, R; Calabro, RS; Gervasi, G; De Salvo, S; Bonanno, L; Corallo, F; De Cola, MC; Bramanti, P				De Luca, Rosaria; Calabro, Rocco Salvatore; Gervasi, Giuseppe; De Salvo, Simona; Bonanno, Lilla; Corallo, Francesco; De Cola, Maria Cristina; Bramanti, Placido			Is computer-assisted training effective in improving rehabilitative outcomes after brain injury? A case-control hospital-based study	DISABILITY AND HEALTH JOURNAL			English	Article						Computerized cognitive training; Recovery; Rehabilitation outcomes; Stroke; TBI	OF-THE-LITERATURE; COGNITIVE REHABILITATION; WORKING-MEMORY; HEAD-INJURY; PEOPLE	Background: Rehabilitation of impaired cognitive functions begins to be considered a standard component of medical care after acquired brain injury. Indeed, many evidences support the effectiveness of the two major categories of techniques, i.e. the traditional and computer-assisted ones, which are widely used in cognitive rehabilitative treatment. Objective: Aim of this study is to evaluate the effects of pc - cognitive training in brain injury patients. Methods: We studied 35 subjects (randomly divided into two groups), affected by traumatic or vascular brain injury, having attended from January 2010 to December 2012 the Laboratory of Robotic and Cognitive Rehabilitation of IRCCS Neurolesi of Messina. Cognitive impairment was investigated through psychometric battery, administered before (T0) and two months (T1) after the cognitive pc-training, which was performed only by the experimental group, in addition to conventional treatment. Statistical analysis was performed using Wilcoxon test with a p < 0.01. Results: At time T0, all patients showed language deficits and cognitive alterations in visual attention and memory abilities. After the rehabilitation program we noted a global improvement in both the groups. However, at T1, the experimental group showed a greater cognitive improvement than the control group, with significant differences in nearly all the neuropsychological tests performed. Conclusions: Our data suggest that cognitive pc-training may be a promising methodology to optimize the rehabilitation outcomes following brain injury. (C) 2014 Elsevier Inc. All rights reserved.	[De Luca, Rosaria; Calabro, Rocco Salvatore; Gervasi, Giuseppe; De Salvo, Simona; Bonanno, Lilla; Corallo, Francesco; De Cola, Maria Cristina; Bramanti, Placido] IRCCS Ctr Neurolesi Bonino Pulejo, I-98124 Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it	Gervasi, Giuseppe/A-7875-2016; calabro, rocco salvatore/L-9570-2019; De Salvo, Simona/K-3180-2016; Calabro, Rocco S/K-7520-2016; Bonanno, Lilla/K-3937-2016; Bramanti, Placido/K-5117-2016; De Cola, Maria C/B-7714-2017; Gervasi, Giuseppe/AAE-8044-2019; corallo, francesco/K-5932-2016	Gervasi, Giuseppe/0000-0001-8527-645X; calabro, rocco salvatore/0000-0002-8566-3166; De Salvo, Simona/0000-0001-9501-3258; Bonanno, Lilla/0000-0002-0282-405X; De Cola, Maria C/0000-0002-7509-3833; Gervasi, Giuseppe/0000-0001-8527-645X; corallo, francesco/0000-0003-4862-3832			Adrian JA, 2003, APHASIOLOGY, V17, P981, DOI 10.1080/02687030344000256; Alderson AL, 2002, J HEAD TRAUMA REHAB, V17, P210, DOI 10.1097/00001199-200206000-00003; Alladi S, 2002, NEUROL INDIA, V50, pS102; Ashman TA, 2006, MT SINAI J MED, V73, P999; Batchelor J, 1988, J HEAD TRAUMA REHAB, V3, P78, DOI DOI 10.1097/00001199-198809000-00012; Cappa SF, 2005, EUR J NEUROL, V12, P665; Chen SHA, 1997, BRAIN INJURY, V11, P197; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; Fernandez E, 2012, MEDICC REV, V14, P32, DOI 10.37757/MR2012V14.N4.8; Goldstein G, 1998, J REHABIL RES DEV, V35, P238; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; KIRSCH NL, 1992, J HEAD TRAUMA REHAB, V7, P13, DOI DOI 10.1097/00001199-199209000-00004; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Schneider William N, 2011, Continuum (Minneap Minn), V17, P462, DOI 10.1212/01.CON.0000399067.69567.f2; Tam SF, 2004, BRAIN INJURY, V18, P461, DOI 10.1080/02699050310001646099; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wilson BA, 2002, NEUROREHAB NEURAL RE, V16, P207, DOI 10.1177/0888439002016002003	24	31	31	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	JUL	2014	7	3					356	360		10.1016/j.dhjo.2014.04.003			5	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	AJ8UR	WOS:000337983800014	24947578				2022-02-06	
J	Effgen, GB; Vogel, EW; Lynch, KA; Lobel, A; Hue, CD; Meaney, DF; Bass, CR; Morrison, B				Effgen, Gwen B.; Vogel, Edward W., III; Lynch, Kimberly A.; Lobel, Ayelet; Hue, Christopher D.; Meaney, David F.; Bass, Cameron R.; Morrison, Barclay, III			Isolated Primary Blast Alters Neuronal Function with Minimal Cell Death in Organotypic Hippocampal Slice Cultures	JOURNAL OF NEUROTRAUMA			English	Article						blast; hippocampus; in vitro; neuron; shock tube	TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION INJURY; RISK-ASSESSMENT; RAT; DEPRESSION; STRETCH; MODEL	An increasing number of U.S. soldiers are diagnosed with traumatic brain injury (TBI) subsequent to exposure to blast. In the field, blast injury biomechanics are highly complex and multi-phasic. The pathobiology caused by exposure to some of these phases in isolation, such as penetrating or inertially driven injuries, has been investigated extensively. However, it is unclear whether the primary component of blast, a shock wave, is capable of causing pathology on its own. Previous in vivo studies in the rodent and pig have demonstrated that it is difficult to deliver a primary blast (i.e., shock wave only) without rapid head accelerations and potentially confounding effects of inertially driven TBI. We have previously developed a well-characterized shock tube and custom in vitro receiver for exposing organotypic hippocampal slice cultures to pure primary blast. In this study, isolated primary blast induced minimal hippocampal cell death (on average, below 14% in any region of interest), even for the most severe blasts tested (424 kPa peak pressure, 2.3 ms overpressure duration, and 248 kPa*ms impulse). In contrast, measures of neuronal function were significantly altered at much lower exposures (336 kPa, 0.84 ms, and 86.5 kPa*ms), indicating that functional changes occur at exposures below the threshold for cell death. This is the first study to investigate a tolerance for primary blast-induced brain cell death in response to a range of blast parameters and demonstrate functional deficits at subthreshold exposures for cell death.	[Effgen, Gwen B.; Vogel, Edward W., III; Lynch, Kimberly A.; Lobel, Ayelet; Hue, Christopher D.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bass, Cameron R.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904 1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Meaney, David/0000-0002-0954-4122	NDSEG; Multi-disciplinary University Research Initiative from the Army Research Office [W911MF-10-1-05026]	This work was supported by an NDSEG Graduate Fellowship (EV) and Multi-disciplinary University Research Initiative from the Army Research Office (W911MF-10-1-05026). The authors thank Charles J. Levin for his skilled technical assistance in experimental setup, operation, and characterization of the shock tube as well as Lamia Ateshian for her skilled technical assistance with experimental setup, imaging, and image analysis. Additionally, the authors thank Garrett Wood for his skilled technical assistance in blast level scaling and CONWEP analysis.	Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Connell S, 2011, J NEUROTRAUM, V28, P1229, DOI 10.1089/neu.2011.1832; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Faul M, 2010, TRAUMATIC BRAIN INJU; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Muller M, 1999, J NEUROPHYSIOL, V82, P1818, DOI 10.1152/jn.1999.82.4.1818; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Pun P, 2011, FRONT NEUROL, V2, P1; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Richmond DR., 1968, ESTIMATE MANS TOLERA; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Shridharani J. K., 2012, PERS AM SYST S SEPT; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; U.S. Department of Health, 2009, BLAST INJ TRAUM BRAI; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wood G., 2013, J NEUROTRAUMA UNPUB; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009	39	31	31	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2014	31	13					1202	1210		10.1089/neu.2013.3227			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AL2VK	WOS:000338983500009	24558968				2022-02-06	
J	Levy, AS; Orlando, A; Salottolo, K; Mains, CW; Bar-Or, D				Levy, Andrew Stewart; Orlando, Alessandro; Salottolo, Kristin; Mains, Charles W.; Bar-Or, David			Outcomes of a Nontransfer Protocol for Mild Traumatic Brain Injury with Abnormal Head Computed Tomography in a Rural Hospital Setting	WORLD NEUROSURGERY			English	Article						Brain injuries; Hemorrhage; Neurosurgery; Outcome assessment	NEW-ORLEANS CRITERIA; INTRACRANIAL INJURY; CT; RULE; VALIDATION; MANAGEMENT; PREDICTORS; CARE	OBJECTIVE: This study sought to investigate outcomes after a novel nontransfer protocol for mild traumatic brain injuries patients with small intracranial hemorrhage (ICH) in a rural trauma center without neurosurgical capabilities. METHODS: This was a retrospective cohort study. In 2007, a nontransfer protocol was implemented at a Level III Trauma Center. It included adult patients from April 2007 through December 2012 with mild traumatic brain injury (mTBI) (Glasgow Coma Scale score 13 to 15) and computed tomography (CT) showing small ICH and no coagulopathy. The following ICHs were allowed: 1) minimal or small traumatic subarachnoid hemorrhage, 2) punctuate or minimal superficial cerebral contusion, 3) punctuate or minimal intraparenchymal hemorrhage, or 4) very small subdural hemorrhage (SDH) without mass effect (a very thin smear SDH along the tentorium or falx). CT scans were reviewed by the on-call neurosurgeon at an affiliated Level I Trauma Center, and consensus was obtained on the suitability for nontransfer. RESULTS: A total of 76 patients were included. The median hospital length of stay was 1 day (interquartile range = 1 day). No patient required a neurosurgical intervention or postadmission transfer to a Level I facility. There were no in-hospital deaths, and all patients were discharged with stable head CTs and in good neurologic condition. Two patients were readmitted for nonprotocol-related reasons: 1 acute-on-chronic SDH 6 weeks postdischarge, and 1 visual eye change with normal CT 2 days postdischarge. CONCLUSIONS: Our 6-year study corroborates the low neurosurgical rate reported in the literature for mTBI with small ICH. Nontransfer protocols may lead to a more efficient use of hospital resources while providing safe, effective and economical health care.	[Levy, Andrew Stewart] St Antonius Hosp, InterMountain Neurosurg, Lakewood, CO USA; [Orlando, Alessandro; Salottolo, Kristin; Bar-Or, David] St Antonius Hosp, Trauma Res Dept, Lakewood, CO 80228 USA; [Mains, Charles W.] St Antonius Hosp, Trauma Serv Dept, Lakewood, CO USA; [Mains, Charles W.; Bar-Or, David] Rocky Vista Univ, Coll Osteopath Med, Parker, CO USA		Bar-Or, D (corresponding author), St Antonius Hosp, Trauma Res Dept, Lakewood, CO 80228 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020				Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Clement CM, 2006, ANN EMERG MED, V48, P245, DOI 10.1016/j.annemergmed.2006.04.008; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Faul M, 2010, TRAUMATIC BRAIN INJU; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huynh T, 2006, AM SURGEON, V72, P1162; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Livingston DH, 1991, J TRAUMA, V31, P487; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	20	31	31	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL-AUG	2014	82	1-2					E319	E323		10.1016/j.wneu.2013.11.008			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AQ6HM	WOS:000342911400076	24240025				2022-02-06	
J	Taub, E; Uswatte, G; Mark, VW				Taub, Edward; Uswatte, Gitendra; Mark, Victor W.			The functional significance of cortical reorganization and the parallel development of CI therapy	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						CI therapy; cortical reorganization; neurorehabilitation; neuroplasticity; stroke; traumatic brain injury; cerebral palsy; multiple sclerosis	INDUCED MOVEMENT THERAPY; PHANTOM-LIMB PAIN; PRIMARY SOMATOSENSORY CORTEX; CONSTRAINT-INDUCED APHASIA; REPETITIVE STRAIN INJURY; UPPER EXTREMITY FUNCTION; CROSS-MODAL PLASTICITY; FOCAL HAND DYSTONIA; MOTOR FUNCTION-TEST; FORCED-USE THERAPY	For the nineteenth and the better part of the twentieth centuries two correlative beliefs were strongly held by almost all neuroscientists and practitioners in the field of neurorehabilitation. The first was that after maturity the adult CNS was hardwired and fixed, and second that in the chronic phase after CNS injury no substantial recovery of function could take place no matter what intervention was employed. However, in the last part of the twentieth century evidence began to accumulate that neither belief was correct. First, in the 1960s and 1970s, in research with primates given a surgical abolition of somatic sensation from a single forelimb, which rendered the extremity useless, it was found that behavioral techniques could convert the limb into an extremity that could be used extensively. Beginning in the late 1980s, the techniques employed with deafferented monkeys were translated into a rehabilitation treatment, termed Constraint Induced Movement therapy or CI therapy, for substantially improving the motor deficit in humans of the upper and lower extremities in the chronic phase after stroke. CI therapy has been applied successfully to other types of damage to the CNS such as traumatic brain injury, cerebral palsy, multiple sclerosis, and spinal cord injury, and it has also been used to improve function in focal hand dystonia and for aphasia after stroke. As this work was proceeding, it was being shown during the 1980s and 1990s that sustained modulation of afferent input could alter the structure of the CNS and that this topographic reorganization could have relevance to the function of the individual. The alteration in these once fundamental beliefs has given rise to important recent developments in neuroscience and neurorehabilitation and holds promise for further increasing our understanding of CNS function and extending the boundaries of what is possible in neurorehabilitation.	[Taub, Edward; Uswatte, Gitendra; Mark, Victor W.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Uswatte, Gitendra] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL 35294 USA; [Mark, Victor W.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; [Mark, Victor W.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA		Taub, E (corresponding author), Univ Alabama Birmingham, Ctr Psychiat Med 714, 1720 2nd Ave South, Birmingham, AL 35294 USA.	etaub@uab.edu	LUO, JINGJING/AAZ-6697-2021; Mark, Victor/AAT-3772-2020	LUO, JINGJING/0000-0002-3222-1276; 			ALHO K, 1993, ELECTROEN CLIN NEURO, V86, P418, DOI 10.1016/0013-4694(93)90137-K; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bach-y-Rita P, 1992, J NEUROL REHABIL, V6, P191, DOI [10.1177/136140969200600404, DOI 10.1177/136140969200600404]; BACHYRITA P, 1990, CAN J PSYCHOL, V44, P148, DOI 10.1037/h0084247; Bara-Jimenez W, 1998, ANN NEUROL, V44, P828, DOI 10.1002/ana.410440520; BARD GREGORY, 1965, ARCH PHYS MED REHABIL, V46, P567; Bauder H, 1999, PSYCHOPHYSIOLOGY, V36, pS31; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Birbaumer N, 1997, J NEUROSCI, V17, P5503; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Braun C, 2000, J NEUROSCI, V20, P446, DOI 10.1523/JNEUROSCI.20-01-00446.2000; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Byl NN, 1997, PHYS THER, V77, P269, DOI 10.1093/ptj/77.3.269; Byl NN, 1996, NEUROLOGY, V47, P508, DOI 10.1212/WNL.47.2.508; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Candia V, 1999, LANCET, V353, P42, DOI 10.1016/S0140-6736(05)74865-0; Candia V, 2002, ARCH PHYS MED REHAB, V83, P1342, DOI 10.1053/apmr.2002.35094; Casey K., 1991, PAIN CENTRAL NERVOUS; CHAMBERS W W, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P721; Charles J, 2001, Pediatr Phys Ther, V13, P68, DOI 10.1097/00001577-200107000-00003; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cronholm B., 1951, ACTA PSYCHIAT SCAND, V72, P151; Croteau C, 2006, APHASIOLOGY, V20, P327, DOI 10.1080/02687030500475051; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Draganski B, 2006, NEUROIMAGE, V31, P951, DOI 10.1016/j.neuroimage.2006.01.018; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Dromerick AW, 2000, STROKE, V31, P2984, DOI 10.1161/01.STR.31.12.2984; Elbert T, 2002, J NEUROSCI, V22, P9941; Elbert T, 1997, EXP BRAIN RES, V117, P161, DOI 10.1007/s002210050210; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; Elbert T, 1998, NEUROREPORT, V9, P3571, DOI 10.1097/00001756-199811160-00006; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Flor H, 2000, NEUROREPORT, V11, P1407, DOI 10.1097/00001756-200005150-00011; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Foster L., 1996, NEUROLOGY REPORT, V20, P10, DOI [DOI 10.1097/01253086-199620040-00030, 10.1097/01253086-199620040-00030]; Franz S. I., 1915, JAMA-J AM MED ASSOC, V65, P2150, DOI [10.1001/jama.1915.02580250022007, DOI 10.1001/JAMA.1915.02580250022007]; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; GOULD E, 1992, J NEUROSCI, V12, P3642; Gritsenko V., 2001, Society for Neuroscience Abstracts, V27, P562; HALBERSTAM J L, 1971, Archives of Physical Medicine and Rehabilitation, V52, P318; HENDERSON WR, 1948, J NEUROL NEUROSUR PS, V11, P88, DOI 10.1136/jnnp.11.2.88; INCE LP, 1969, PSYCHON SCI, V16, P49; James W., 1887, P AM SOC PSYCHIC RES, V1, P249; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Johnson ML, 2014, AM J SPEECH-LANG PAT, V23, P60, DOI 10.1044/1058-0360(2013/12-0168); Johnson MJ, 2001, ASSIST TECHN RES SER, V9, P123; KATZ J, 1991, J PAIN SYMPTOM MANAG, V6, P73, DOI 10.1016/0885-3924(91)90521-5; Kedlaya D., 2001, ARCH PHYS MED REHAB, V82, P1340; KEW JJM, 1994, J NEUROPHYSIOL, V72, P2517, DOI 10.1152/jn.1994.72.5.2517; Kirmess M, 2010, APHASIOLOGY, V24, P725, DOI 10.1080/02687030903437682; KNAPP H D, 1959, Trans Am Neurol Assoc, V84, P185; KNAPP HD, 1963, EXP NEUROL, V7, P305, DOI 10.1016/0014-4886(63)90077-3; Knecht S, 1996, BRAIN, V119, P1213, DOI 10.1093/brain/119.4.1213; Knecht S, 1998, BRAIN, V121, P717, DOI 10.1093/brain/121.4.717; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; KUJALA T, 1992, ELECTROEN CLIN NEURO, V84, P469, DOI 10.1016/0168-5597(92)90034-9; Kujala T, 1997, PSYCHOPHYSIOLOGY, V34, P213, DOI 10.1111/j.1469-8986.1997.tb02134.x; KUJALA T, 1995, EXP BRAIN RES, V104, P519; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lashley KS, 1924, ARCH NEURO PSYCHIATR, V12, P249, DOI 10.1001/archneurpsyc.1924.02200030002001; LASSEK AM, 1953, J NEUROPATH EXP NEUR, V12, P83, DOI 10.1097/00005072-195301000-00008; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Liepert J, 1998, NEUROSCI LETT, V250, P5, DOI 10.1016/S0304-3940(98)00386-3; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Liepert J, 2001, J NEUROL, V248, P315, DOI 10.1007/s004150170207; LIU CN, 1958, ARCH NEURO PSYCHIATR, V79, P46, DOI 10.1001/archneurpsyc.1958.02340010064005; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maher LM, 2006, J INT NEUROPSYCH SOC, V12, P843, DOI 10.1017/S1355617706061029; Mall V, 2005, NEUROPEDIATRICS, V36, P373, DOI 10.1055/s-2005-873077; Mark VW, 2008, MULT SCLER J, V14, P992, DOI 10.1177/1352458508090223; Mark V W, 2006, Eura Medicophys, V42, P269; Mark VW, 2013, ARCH PHYS MED REHAB, V94, P753, DOI 10.1016/j.apmr.2012.09.032; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Meinzer M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-20; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; Mitchell S. W., 1871, LIPPINCOTTS MAGAZINE, V8, P563; Morris D, 2010, IMPROVING FUNCTIONAL, P232; Morris D M, 2006, Eura Medicophys, V42, P257; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Mott F.W., 1895, P ROY SOC LOND, V57, P481, DOI DOI 10.1098/RSP1.1894.0179; MUCHNIK C, 1991, SCAND AUDIOL, V20, P19, DOI 10.3109/01050399109070785; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nudo RJ, 1996, J NEUROSCI, V16, P785; Ogden R., 1917, PSYCHOBIOLOGY, V1, P33, DOI [10.1037/h0074814, DOI 10.1037/H0074814]; OSTENDORF CG, 1981, PHYS THER, V61, P1022, DOI 10.1093/ptj/61.7.1022; Parker V M, 1986, Int Rehabil Med, V8, P69; Peter C., 1997, J NEUROGICAL REHABIL, V3, P137; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; Ploughman M, 2004, ARCH PHYS MED REHAB, V85, P1417, DOI 10.1016/j.apmr.2004.01.018; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; Ramachandran VS, 2000, ARCH NEUROL-CHICAGO, V57, P317, DOI 10.1001/archneur.57.3.317; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; RAUSELL E, 1992, P NATL ACAD SCI USA, V89, P2571, DOI 10.1073/pnas.89.7.2571; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1015, DOI 10.1152/jn.1992.67.5.1015; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1057, DOI 10.1152/jn.1992.67.5.1057; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B, 1996, COGNITIVE BRAIN RES, V4, P77, DOI 10.1016/0926-6410(96)00024-9; Roder B, 1997, PSYCHOPHYSIOLOGY, V34, P292, DOI 10.1111/j.1469-8986.1997.tb02400.x; ROSLER F, 1993, COGNITIVE BRAIN RES, V1, P145, DOI 10.1016/0926-6410(93)90022-W; Shaw S. E., 2003, J NEUROL PHYS THER, V27, P180, DOI [10.1682/JRRD.2005.06.0094, DOI 10.1682/JRRD.2005.06.0094]; Sherman R. A., 1997, PHANTOM PAIN, DOI [10.1007/978-1-4757-6169-6, DOI 10.1007/978-1-4757-6169-6]; SHERMAN RA, 1984, PAIN, V18, P83, DOI 10.1016/0304-3959(84)90128-3; Sherrington CS, 1931, BRAIN, V54, P1, DOI 10.1093/brain/54.1.1; Skinner B.F., 1968, TECHNOLOGY TEACHING; Skinner BF, 1938, BEHAV ORGANISMS; STEIN JF, 1989, Q J EXP PHYSIOL CMS, V74, P583, DOI 10.1113/expphysiol.1989.sp003314; Sterling C, 2013, PEDIATRICS, V131, pE1664, DOI 10.1542/peds.2012-2051; Sterr A, 2003, NEUROLOGY, V61, P842, DOI 10.1212/WNL.61.6.842; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1374, DOI 10.1053/apmr.2002.35108; Sterr A, 1998, NATURE, V391, P134, DOI 10.1038/34322; Stevenson T, 2012, PHYSIOTHER CAN, V64, P397, DOI 10.3138/ptc.2011-24; TAUB E, 1975, EXP NEUROL, V46, P178, DOI 10.1016/0014-4886(75)90040-0; TAUB E, 1965, J COMP PHYSIOL PSYCH, V59, P275, DOI 10.1037/h0021817; Taub E, 2006, Eura Medicophys, V42, P241; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; TAUB E, 1977, ANN NY ACAD SCI, V290, P348, DOI 10.1111/j.1749-6632.1977.tb39737.x; Taub E, 2004, AM PSYCHOL, V59, P692, DOI 10.1037/0003-066X.59.8.692; Taub E, 2004, PEDIATRICS, V113, P305, DOI 10.1542/peds.113.2.305; TAUB E, 1975, BIOL PSYCHIAT, V10, P609; TAUB E, 1963, J COMP PHYSIOL PSYCH, V56, P1012, DOI 10.1037/h0048315; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taub E, 1999, J REHABIL RES DEV, V36, P237; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Taub E., 1995, J NIH RES, V1, P49; Taub E, 1980, BEHAV PSYCHOL REHABI, P371; Taub E, 1968, NEUROPSYCHOLOGY SPAT, P173; Taub Edward, 2007, Dev Neurorehabil, V10, P3, DOI 10.1080/13638490601151836; Taub E, 2006, NEUROREHABILITATION, V21, P93; Taub E, 2013, STROKE, V44, P1383, DOI 10.1161/STROKEAHA.111.000559; Taub E, 2013, ARCH PHYS MED REHAB, V94, P86, DOI 10.1016/j.apmr.2012.07.029; Taub E, 2011, J CHILD NEUROL, V26, P1163, DOI 10.1177/0883073811408423; Tower SS, 1940, BRAIN, V63, P36, DOI 10.1093/brain/63.1.36; TWITCHELL TE, 1954, J NEUROPHYSIOL, V17, P239, DOI 10.1152/jn.1954.17.3.239; TWITCHELL TE, 1951, BRAIN, V74, P443, DOI 10.1093/brain/74.4.443; UHL F, 1993, NEUROSCI LETT, V150, P162, DOI 10.1016/0304-3940(93)90526-Q; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Uswatte G., 2009, HDB NEUROSCIENCE BEH, V2, P1296; Uswatte G, 2006, NEUROREHABILITATION, V21, P147; Uswatte G, 2013, PROG BRAIN RES, V207, P379, DOI 10.1016/B978-0-444-63327-9.00015-1; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Weeks R, 2000, J NEUROSCI, V20, P2664; Weiss T, 2004, EUR J NEUROSCI, V20, P3413, DOI 10.1111/j.1460-9568.2004.03790.x; Weiss T, 1999, NEUROSCI LETT, V272, P131, DOI 10.1016/S0304-3940(99)00595-9; Wittenberg GF, 2003, NEUROREHAB NEURAL RE, V17, P48, DOI 10.1177/0888439002250456; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; WOLF SL, 1983, PHYS THER, V63, P1393, DOI 10.1093/ptj/63.9.1393; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wolf SL, 2008, LANCET NEUROL, V7, P33, DOI 10.1016/S1474-4422(07)70294-6; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Woods TM, 2000, J NEUROSCI, V20, P3884, DOI 10.1523/JNEUROSCI.20-10-03884.2000; Yamashima T, 2004, HIPPOCAMPUS, V14, P861, DOI 10.1002/hipo.20001; YANG TT, 1994, NATURE, V368, P592, DOI 10.1038/368592b0	172	31	31	0	57	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUN 27	2014	8								396	10.3389/fnhum.2014.00396			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	AM6BK	WOS:000339945600001	25018720	gold, Green Published			2022-02-06	
J	Kamnaksh, A; Budde, MD; Kovesdi, E; Long, JB; Frank, JA; Agoston, DV				Kamnaksh, Alaa; Budde, Matthew D.; Kovesdi, Erzsebet; Long, Joseph B.; Frank, Joseph A.; Agoston, Denes V.			Diffusion Tensor Imaging Reveals Acute Subcortical Changes after Mild Blast-Induced Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							LONG-TERM CONSEQUENCES; AXONAL INJURY; MILITARY; CONCUSSION; BIOMARKERS; VETERANS; COMBAT; MODEL; RATS; MRI	Mild blast-induced traumatic brain injury (mbTBI) poses special diagnostic challenges due to its overlapping symptomatology with other neuropsychiatric conditions and the lack of objective outcome measures. Diffusion tensor imaging (DTI) can potentially provide clinically relevant information toward a differential diagnosis. In this study, we aimed to determine if single and repeated (5 total; administered on consecutive days) mild blast overpressure exposure results in detectable structural changes in the brain, especially in the hippocampus. Fixed rat brains were analyzed by ex vivo DTI at 2 h and 42 days after blast (or sham) exposure(s). An anatomy-based region of interest analysis revealed significant interactions in axial and radial diffusivity in a number of subcortical structures at 2 h only. Differences between single-and multiple-injured rats were largely in the thalamus but not the hippocampus. Our findings demonstrate the value and the limitations of DTI in providing a better understanding of mbTBI pathobiology.	[Kamnaksh, Alaa; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Kamnaksh, Alaa] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Budde, Matthew D.; Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD 20892 USA; [Kovesdi, Erzsebet] US Dept Vet Affairs, Vet Affairs Cent Off, Washington, DC 20420 USA; [Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA		Agoston, DV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	denes.agoston@usuhs.edu	Frank, Joseph/W-2021-2019		Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G1703F]; CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	We thank the Neurotrauma Team at the Walter Reed Army Institute of Research for their technical help during the exposures, along with Eric Gold and Lindsay Janes for assistance with the MRI experiments. This work was supported by the Center for Neuroscience and Regenerative Medicine grant number G1703F.	Adluru N, 2012, NEUROIMAGE, V59, P306, DOI 10.1016/j.neuroimage.2011.07.029; Agoston Denes V, 2012, Front Neurol, V3, P3, DOI 10.3389/fneur.2012.00003; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Budde MD, 2012, NEUROIMAGE, V63, P1, DOI 10.1016/j.neuroimage.2012.06.042; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Crestani CC, 2013, CURR NEUROPHARMACOL, V11, P141, DOI 10.2174/1570159X11311020002; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Ferris CF, 2011, REV NEUROSCIENCE, V22, P665, DOI 10.1515/RNS.2011.050; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu HB, 2010, MAGN RESON IMAGING, V28, P146, DOI 10.1016/j.mri.2009.05.019; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Paxinos G, 2007, RAT BRAIN STEREOTACT; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Rodrigo J, 2002, HISTOL HISTOPATHOL, V17, P973, DOI 10.14670/HH-17.973; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004	59	31	32	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 2	2014	4								4809	10.1038/srep04809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1ZZ	WOS:000335216000001	24786839	Green Published, gold			2022-02-06	
J	Ellis, A; Wieseler, J; Favret, J; Johnson, KW; Rice, KC; Maier, SF; Falci, S; Watkins, LR				Ellis, Amanda; Wieseler, Julie; Favret, Jacob; Johnson, Kirk W.; Rice, Kenner C.; Maier, Steven F.; Falci, Scott; Watkins, Linda R.			Systemic Administration of Propentofylline, Ibudilast, and (+)-Naltrexone Each Reverses Mechanical Allodynia in a Novel Rat Model of Central Neuropathic Pain	JOURNAL OF PAIN			English	Article						Avulsion; toll-like receptor 4; D-naltrexone; glia; pain	SPINAL-CORD-INJURY; MIGRATION INHIBITORY FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; ROOT AVULSION; NEURONAL HYPEREXCITABILITY; RECEPTOR 4; PHOSPHODIESTERASE INHIBITOR; GLIAL ACTIVATION; ELEVATING AGENTS	Central neuropathic pain (CNP) is a debilitating consequence of central nervous system damage for which current treatments are ineffective. To explore mechanisms underlying CNP, we developed a rat model involving T13/L1 dorsal root avulsion. The resultant dorsal horn damage creates bilateral below-level (L4-L6) mechanical allodynia. This allodynia, termed spinal neuropathic avulsion pain, occurs in the absence of confounding paralysis. To characterize this model, we undertook a series of studies aimed at defining whether spinal neuropathic avulsion pain could be reversed by any of 3 putative glial activation inhibitors, each with distinct mechanisms of action. Indeed, the phosphodiesterase inhibitor propentofylline, the macrophage migration inhibitory factor inhibitor ibudilast, and the toll-like receptor 4 antagonist (+)-naltrexone each reversed below-level allodynia bilaterally. Strikingly, none of these impacted spinal neuropathic avulsion pain upon first administration but required 1 to 2 weeks of daily administration before pain reversal was obtained. Given reversal of CNP by each of these glial modulatory agents, these results suggest that glia contribute to the maintenance of such pain and enduring release of macrophage migration inhibitory factor and endogenous agonists of toll-like receptor 4 is important for sustaining CNP. The markedly delayed efficacy of all 3 glial modulatory drugs may prove instructive for interpretation of apparent drug failures after shorter dosing regimens. Perspective: CNP that develops after trauma is often described by patients as severe and intolerable. Unfortunately, current treatments are not effective. This work suggests that using pharmacologic treatments that target glial cells could be an effective clinical treatment for CNP. (C) 2014 by the American Pain Society. Published by Elsevier Inc. All rights reserved	[Ellis, Amanda; Wieseler, Julie; Favret, Jacob; Maier, Steven F.; Watkins, Linda R.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Johnson, Kirk W.] Medicinova, San Diego, CA USA; [Rice, Kenner C.] NIDA, Chem Biol Res Branch, Rockville, MD USA; [Rice, Kenner C.] NIAAA, NIH, Rockville, MD 20852 USA; [Falci, Scott] Craig Hosp, Englewood, CO USA		Ellis, A (corresponding author), Univ Colorado, Dept Psychol & Neurosci, 345 UCB, Boulder, CO 80309 USA.	ellisal@colorado.edu		Falci, Scott/0000-0003-4209-0959	Craig Hospital;  [DA024044]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE021966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K05DA024044, ZIADA000530] Funding Source: NIH RePORTER	Financial and material support was given by Craig Hospital and DA024044. All animal work was done on the University of Colorado Boulder campus.	Alexander JK, 2012, EXP NEUROL, V236, P351, DOI 10.1016/j.expneurol.2012.04.018; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; BANATI RB, 1994, J CEREBR BLOOD F MET, V14, P145, DOI 10.1038/jcbfm.1994.19; Bao F, 2011, J NEUROTRAUM, V28, P1035, DOI 10.1089/neu.2010.1575; Berland D, 2012, AM FAM PHYSICIAN, V86, P252; Berman JS, 1998, PAIN, V75, P199, DOI 10.1016/S0304-3959(97)00220-0; Bland ST, 2009, BRAIN BEHAV IMMUN, V23, P492, DOI 10.1016/j.bbi.2009.01.014; Boivie J, 2006, HAND CLINIC, V81, P715, DOI 10.1016/S0072-9752(06)80052-7; Breuer B, 2007, CLIN THER, V29, P2022, DOI 10.1016/j.clinthera.2007.09.023; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Burstein R, 2004, ANN NEUROL, V55, P19, DOI 10.1002/ana.10786; Calvo M, 2012, EXP NEUROL, V234, P271, DOI 10.1016/j.expneurol.2011.08.018; Carlstedt T, 2008, RESTOR NEUROL NEUROS, V26, P225; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chew DJ, 2011, NEUROPATH APPL NEURO, V37, P613, DOI 10.1111/j.1365-2990.2011.01176.x; Chew DJ, 2013, J NEUROTRAUM, V30, P160, DOI 10.1089/neu.2012.2481; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; EDGAR RE, 1993, J SPINAL DISORD, V6, P48; Eigler A, 1998, J LEUKOCYTE BIOL, V63, P101, DOI 10.1002/jlb.63.1.101; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; Falci S, 2002, J NEUROSURG, V97, P193, DOI 10.3171/spi.2002.97.2.0193; Finnerup NB, 2008, CURR OPIN ANESTHESIO, V21, P586, DOI 10.1097/ACO.0b013e32830a4c11; Fujimoto T, 1999, J NEUROIMMUNOL, V95, P35, DOI 10.1016/S0165-5728(98)00251-3; Graeber MB, 2012, EXP NEUROL, V234, P255, DOI 10.1016/j.expneurol.2012.01.007; Gwak YS, 2009, NEUROSCIENCE, V161, P895, DOI 10.1016/j.neuroscience.2009.03.055; Gwak YS, 2009, EXP NEUROL, V220, P154, DOI 10.1016/j.expneurol.2009.08.012; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Gwak YS, 2007, J NEUROSCI RES, V85, P2352, DOI 10.1002/jnr.21379; Hagman S, 2011, J NEUROIMMUNOL, V234, P141, DOI 10.1016/j.jneuroim.2011.02.009; Hama AT, 2012, J NEUROTRAUM, V29, P600, DOI 10.1089/neu.2011.1863; HARVEY LO, 1986, BEHAV RES METH INSTR, V18, P623, DOI 10.3758/BF03201438; Heblich Fay, 2008, Channels (Austin), V2, P4; Hook MA, 2007, BEHAV BRAIN RES, V179, P281, DOI 10.1016/j.bbr.2007.02.035; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Hutchinson MR, 2011, PHARMACOL REV, V63, P772, DOI 10.1124/pr.110.004135; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jones TL, 2004, J PHARMACOL EXP THER, V310, P223, DOI 10.1124/jpet.103.064741; Jung S, 1997, J AUTOIMMUN, V10, P519, DOI 10.1006/jaut.1997.0159; Kim Y, 2012, PAIN, V153, P1022, DOI 10.1016/j.pain.2012.02.003; Kirchner V., 2003, COCHRANE DB SYST REV, V2; Kukkar A, 2013, ARCH PHARM RES, V36, P237, DOI 10.1007/s12272-013-0057-y; Ledeboer A, 2006, NEURON GLIA BIOL, V2, P279, DOI 10.1017/S1740925X0700035X; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; Lee JY, 2012, BRAIN RES, V1431, P97, DOI 10.1016/j.brainres.2011.11.007; Li HG, 2007, DIGEST DIS SCI, V52, P1973, DOI 10.1007/s10620-006-9211-4; Li LC, 2008, ARTHRIT RHEUM-ARTHR, V59, P1171, DOI 10.1002/art.23931; Madelian V, 1996, BIOCHEM PHARMACOL, V51, P1739, DOI 10.1016/0006-2952(96)00167-0; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Morales F, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4030; NAGATA K, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1034; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nishio Y, 2009, ACTA NEUROPATHOL, V117, P321, DOI 10.1007/s00401-008-0476-x; Obata H, 2010, BRAIN RES, V1363, P72, DOI 10.1016/j.brainres.2010.09.105; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Rahn KA, 2011, BRAIN RES, V1381, P243, DOI 10.1016/j.brainres.2011.01.036; Rile G, 2001, THROMB RES, V102, P239, DOI 10.1016/S0049-3848(01)00258-4; Rintala DH, 2007, ARCH PHYS MED REHAB, V88, P1547, DOI 10.1016/j.apmr.2007.07.038; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Schubert P, 2000, ANN NY ACAD SCI, V903, P24, DOI 10.1111/j.1749-6632.2000.tb06346.x; Sebastiani G, 2006, NEUROBIOL AGING, V27, P691, DOI 10.1016/j.neurobiolaging.2005.03.024; Shichita T, 2012, J NEUROCHEM, V123, P29, DOI 10.1111/j.1471-4159.2012.07941.x; Siddall PJ, 1999, PAIN, V81, P187, DOI 10.1016/S0304-3959(99)00023-8; Siegmund B, 1997, EUR J PHARMACOL, V321, P231, DOI 10.1016/S0014-2999(96)00947-8; Stein A, 2013, ARCH PHYS MED REHAB, V94, P1498, DOI 10.1016/j.apmr.2013.04.004; Sweitzer Sarah, 2011, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-642-13443-2_8; Sweitzer SM, 2001, J PHARMACOL EXP THER, V297, P1210; Tawfik VL, 2008, NEUROSCIENCE, V152, P1086, DOI 10.1016/j.neuroscience.2008.01.065; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Theberge FR, 2013, BIOL PSYCHIAT, V73, P729, DOI 10.1016/j.biopsych.2012.12.019; Thompson CD, 2013, J NEUROTRAUM, V30, P1311, DOI 10.1089/neu.2012.2651; Toh ML, 2006, J IMMUNOL, V177, P4818, DOI 10.4049/jimmunol.177.7.4818; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Vakili A, 2011, DARU, V19, P306; Wang LJ, 2009, STROKE, V40, P973, DOI 10.1161/STROKEAHA.108.530535; Watkins LR, 2012, EXP NEUROL, V234, P351, DOI 10.1016/j.expneurol.2012.01.006; Whitehead KJ, 2010, BRAIN BEHAV IMMUN, V24, P569, DOI 10.1016/j.bbi.2009.12.007; Wieseler J, 2012, METHODS MOL BIOL, V851, P171, DOI 10.1007/978-1-61779-561-9_12; Wieseler J, 2010, J NEUROTRAUM, V27, P1697, DOI 10.1089/neu.2010.1311; Woller SA, 2012, J NEUROTRAUM, V29, P1650, DOI 10.1089/neu.2011.2100; Yoshikawa M, 1999, MULT SCLER J, V5, P126, DOI 10.1191/135245899678847194; Yoshioka A, 1998, J NEUROCHEM, V70, P2416; ZHANG Y, 1994, BIOCHEM PHARMACOL, V48, P2025, DOI 10.1016/0006-2952(94)90501-0; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018	89	31	31	0	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	APR	2014	15	4					407	421		10.1016/j.jpain.2013.12.007			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF3YM	WOS:000334648600007	24412802	Green Accepted			2022-02-06	
J	Godwin, E; Chappell, B; Kreutzer, J				Godwin, Emilie; Chappell, Brittney; Kreutzer, Jeffrey			Relationships after TBI: A grounded research study	BRAIN INJURY			English	Article						Ambiguous loss; marriage and TBI; qualitative research; relational coring; relational recycling; relationships after TBI; traumatic brain injury	TRAUMATIC BRAIN-INJURY; AMBIGUOUS LOSS; ADJUSTMENT; CAREGIVERS; IDENTITY; QUALITY; MARRIAGE; FAMILIES	Background: While study on the emotional effects of traumatic brain injury (TBI) for individuals and caregivers has increased dramatically over the years, insufficient research has been performed on TBI's impact on the coupled relationship or the healing process successful couples go through following injury. As such, couples are left on their own to adjust to the complex challenges that TBI brings. Methods: This qualitative study aims to develop a framework for conceptualizing and assessing couples after TBI. Additionally, it purposes to establish a foundation built upon the practises of successful couples that have subsisted TBI from which methods of treatment can be drawn. Existing personal narratives written by survivors of TBI and their caregivers were analysed. Data triangulation with clinician-authored literature was performed. Constant comparative analysis of the data was then performed through an involving substantive and theoretical coding. Results: Five primary themes emerged: Ambiguous Losses, Identity Reformations, Tenuous Stability, Non Omnes Moriar and The New Us. From these, two grounded theories were developed: Relational Coring and Relational Recycling. Conclusions: These theories will allow researchers and practitioners to grasp the impact of TBI on the coupled relationship, familiarize themselves with the process by which relational experiences following TBI interact and understand the ways in which couples respond to these interacting experiences to work toward relational healing.	[Godwin, Emilie; Chappell, Brittney; Kreutzer, Jeffrey] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Chappell, B (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, POB 980206, Richmond, VA 23298 USA.	bschappell@vcu.edu			National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Department of Education, Washington, DC [H133A120031]	The authors report no conflicts of interest. This work was supported by Grant # H133A120031 from the National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Department of Education, Washington, DC.	Assari S, 2009, IRAN J KIDNEY DIS, V3, P242; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bogdan R, 2006, QUALITATIVE RES ED I; BOSS P, 1977, J MARRIAGE FAM, V39, P141, DOI 10.2307/351070; Boss P, 2000, AMBIGUOUS LOSS LEARN; Boss P, 2007, FAM RELAT, V56, P105, DOI 10.1111/j.1741-3729.2007.00444.x; *Brown K. G., 1996, THESIS; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; CLIPP EC, 1992, CANCER, V69, P1074, DOI 10.1002/1097-0142(19920215)69:4<1074::AID-CNCR2820690440>3.0.CO;2-L; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Coyne JC, 2001, AM J CARDIOL, V88, P526, DOI 10.1016/S0002-9149(01)01731-3; Crabtree B. F., 1999, DOING QUALITATIVE RE; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Department of Health, 2005, NAT SERV FRAM LONG T; Dye F., 2000, QUAL REP, V4, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Glaser B., 1967, DISCOVERY GROUNDED T; Glaser B.G., 1978, THEORETICAL SENSITIV; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Glesne C., 1992, BECOMING QUALITATIVE; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kean S, 2010, NURS CRIT CARE, V15, P66, DOI 10.1111/j.1478-5153.2010.00379.x; KIECOLTGLASER JK, 1988, PSYCHOSOM MED, V50, P213, DOI 10.1097/00006842-198805000-00001; Kolb S.M., 2012, J EMERGING TRENDS ED, V3, P83; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marwit SJ, 2006, BRAIN INJURY, V20, P1419, DOI 10.1080/02699050601082214; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pinsof WH, 2000, J MARITAL FAM THER, V26, P1, DOI 10.1111/j.1752-0606.2000.tb00270.x; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Rossman G. B., 2003, LEARNING FIELD INTRO; Roundhill S. J., 2007, QUALITATIVE RES PSYC, V4, P241, DOI [DOI 10.1080/14780880701473540, 10.1080/14780880701473540]; Ruddle JA., 2005, ILLNESS, V13, P235; Sabat Ayesha, 2006, S Afr J Commun Disord, V53, P17; Segal D, 2010, INT J CHILD YOUTH FA, V1, P293, DOI 10.18357/ijcyfs13/420102093; Sexton T., 2004, BERGIN GARFIELDS HDB, P590; Sexton TL, 2004, J MARITAL FAM THER, V30, P131, DOI 10.1111/j.1752-0606.2004.tb01229.x; Stets JE, 2000, SOC PSYCHOL QUART, V63, P224, DOI 10.2307/2695870; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Strauss A., 1990, BASICS QUALITATIVE R; Taylor SJ., 1998, INTRO QUALITATIVE RE, V3; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Walsh F., 2003, NORMAL FAMILY PROCES; Yin R, 2004, CASE STUDY ANTHOLOGY, V296	54	31	31	1	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					398	413		10.3109/02699052.2014.880514			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900002	24475746				2022-02-06	
J	Nirula, R; Millar, D; Greene, T; McFadden, M; Shah, L; Scalea, TM; Stein, DM; Magnotti, LJ; Jurkovich, GJ; Vercruysse, G; Demetriades, D; Scherer, LA; Peitzman, A; Sperry, J; Beauchamp, K; Bell, S; Feiz-Erfan, I; O'Neill, P; Coimbra, R				Nirula, Ram; Millar, D.; Greene, Tom; McFadden, Molly; Shah, Lubdha; Scalea, Thomas M.; Stein, Deborah M.; Magnotti, Louis J.; Jurkovich, Gregory J.; Vercruysse, Gary; Demetriades, Demetrios; Scherer, Lynette A.; Peitzman, Andrew; Sperry, Jason; Beauchamp, Kathryn; Bell, Scott; Feiz-Erfan, Iman; O'Neill, Patrick; Coimbra, Raul			Decompressive craniectomy or medical management for refractory intracranial hypertension: An AAST-MIT propensity score analysis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Decompressive craniectomy; mortality; propensity; brain injury	TRAUMATIC BRAIN-INJURY; CHILDREN; ICP	BACKGROUND Moderate/severe traumatic brain injury (TBI) management involves minimizing cerebral edema to maintain brain oxygen delivery. While medical therapy (MT) consisting of diuresis, hyperosmolar therapy, ventriculostomy, and barbiturate coma is the standard of care, decompressive craniectomy (DC) for refractory intracranial hypertension (ICH) has gained renewed interest. Since TBI treatment guidelines consider DC a second-tier intervention after MT failure, we sought to determine if early DC (< 48 hours) was associated with improved survival in patients with refractory ICH. METHODS Eleven Level 1 trauma centers provided clinical data and head computed tomographic scans for patients with a Glasgow Coma Scale (GCS) score of 13 or less and radiographic evidence of TBI excluding deaths within 48 hours. Computed tomographic scans were graded according to the Marshall classification. A propensity score to receive DC (regardless of whether DC was performed) was calculated for each patient based on patient characteristics, physiology, injury severity, GCS, severity of intracranial injury, and treatment center. Patients who actually received a DC were matched to patients with similar propensity scores who received MT for analysis. Outcomes were compared between early (< 48 hours of injury) primary or secondary DC and matched controls and then between early primary DC only and matched controls. RESULTS There were 2,602 patients who met the inclusion criteria ,of whom 264 (10.1%) received DC (either primary or secondary to another cranial procedure) and 109 (5%) had a DC that was primary. Variables associated with performing a DC included sex, race, intracranial pressure monitor placement, in-house trauma attending, traumatic subarachnoid hemorrhage, midline shift, and basal cistern compression. There was no survival benefit with early primary DC compared with the controls (relative risk, 1.07; 95% confidence interval, 0.67-1.73; p = 0.77), and resource use was higher. CONCLUSION Early DC does not seem to significantly improve mortality in patients with refractory ICH compared with MT. Neurosurgeons should pause before entertaining this resource-demanding form of therapy. LEVEL OF EVIDENCE Therapeutic care/management, level III.	[Nirula, Ram; Millar, D.; Greene, Tom; McFadden, Molly; Shah, Lubdha] Univ Utah, Salt Lake City, UT 84132 USA; [Scalea, Thomas M.; Stein, Deborah M.] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; [Magnotti, Louis J.] Univ Tennessee, Memphis, TN USA; [Jurkovich, Gregory J.] Univ Washington, Seattle, WA 98195 USA; [Vercruysse, Gary] Emory Univ, Atlanta, GA 30322 USA; [Demetriades, Demetrios] Univ So Calif, Los Angles Cty Med Ctr, Los Angeles, CA USA; [Scherer, Lynette A.] Univ Calif Davis, Sacramento, CA 95817 USA; [Coimbra, Raul] Univ Calif San Diego, San Diego, CA 92103 USA; [Peitzman, Andrew; Sperry, Jason] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Beauchamp, Kathryn; Bell, Scott] Univ Colorado, Denver Hlth, Denver, CO 80202 USA; [Feiz-Erfan, Iman; O'Neill, Patrick] Maricopa Integrated Hlth Syst, Phoenix, AZ USA		Nirula, R (corresponding author), Univ Utah, Dept Surg, 50 North Med Dr, Salt Lake City, UT 84132 USA.	r.nirula@hsc.utah.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Greene, Tom/0000-0002-3706-7570	American Recovery and Reinvestment Act/NIH National Institute of Neurological Disorders and Stroke [1RC1NS069066-01, 5RC1NS069066-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC1NS069066] Funding Source: NIH RePORTER	This study was supported by a Challenge Grant supported by the American Recovery and Reinvestment Act/NIH National Institute of Neurological Disorders and Stroke (1RC1NS069066-01 and 5RC1NS069066-02).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Ahmadi SA, 2010, BRAIN INJURY, V24, P1539, DOI 10.3109/02699052.2010.523049; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Bergstralh E, 2003, LOCALLY WRITTEN SAS; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Cavusoglu H, 2010, ULUS TRAVMA ACIL CER, V16, P119; Centers for Disease Control and Prevention (CDC), 2008, TRAUMATIC BRAIN INJU; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Finkelstein E., 2006, INCIDENCE EC BURDEN; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Hutchinson P, 2011, CAN J NEUROL SCI, V38, P541, DOI 10.1017/S0317167100012051; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kunze E, 1998, ACT NEUR S, V71, P16; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Li G, 2008, CHIN J TRAUMATOL, V11, P253, DOI 10.1016/S1008-1275(08)60052-8; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Rekate Harold L., 2001, Child's Nervous System, V17, P632, DOI 10.1007/s003810100487; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Schneider GH, 2002, ACT NEUR S, V81, P77; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Wang HK, 2012, INJURY, V43, P594, DOI 10.1016/j.injury.2010.06.004; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yatsushige H, 2010, ACTA NEUROCHIR SUPPL, V106, P265, DOI 10.1007/978-3-211-98811-4_50	40	31	31	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2014	76	4					944	952		10.1097/TA.0000000000000194			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AE7FF	WOS:000334161500012	24662856				2022-02-06	
J	Starkstein, SE; Pahissa, J				Starkstein, Sergio E.; Pahissa, Jaime			Apathy Following Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Apathy; Traumatic brain injury; Depression; Cognitive deficits; Psychotropic medication; Psychotherapy	NOSOLOGICAL POSITION; ALZHEIMERS-DISEASE; EVALUATION SCALE; DEPRESSION; VALIDITY; RELIABILITY; DISORDERS; INVENTORY; DAMAGE	Traumatic brain injury (TBI) may result in significant emotional and behavioral changes, such as depression, impulsivity, anxiety, aggressive behavior, and posttraumatic stress disorder. Apathy has been increasingly recognized as a relevant sequela of TBI, with a negative impact on the patients' quality of life as well as their participation in rehabilitation activities. This article reviews the nosologic and phenomenological aspects of apathy in TBI, diagnostic issues, frequency and prevalence, relevant comorbid conditions, potential mechanisms, and treatment.	[Starkstein, Sergio E.] Univ Western Australia, Fremantle Hosp T 7, Sch Psychiat & Clin Neurosci, Fremantle, WA 6959, Australia; [Pahissa, Jaime] CEMIC Univ, Dept Psychiat, RA-1430 Buenos Aires, DF, Argentina		Starkstein, SE (corresponding author), Univ Western Australia, Fremantle Hosp T 7, Sch Psychiat & Clin Neurosci, Fremantle, WA 6959, Australia.	sergio.starkstein@uwa.edu.au					Al-Adawi S, 2004, J NEUROPSYCH CLIN N, V16, P435, DOI 10.1176/appi.neuropsych.16.4.435; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Finset A, 2000, BRAIN INJURY, V14, P887; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Goldfine AM, 2011, CURR OPIN NEUROL, V24, P564, DOI 10.1097/WCO.0b013e32834cd4f5; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Habib M, 2004, J NEUROPSYCH CLIN N, V16, P509, DOI 10.1176/appi.neuropsych.16.4.509; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kant R, 2002, NEUROREHABILITATION, V17, P325; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Laplane D, 2001, MOVEMENT DISORD, V16, P810, DOI 10.1002/mds.1185; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; MULLER U, 1994, PROG NEURO-PSYCHOPH, V18, P1103, DOI 10.1016/0278-5846(94)90114-7; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Niemeier JP, 2013, REHABIL PSYCHOL, V58, P51, DOI 10.1037/a0031612; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; Rao V, 2013, PSYCHOSOMATICS, V54, P403, DOI 10.1016/j.psym.2013.01.001; Raymont V, 2013, HUM BRAIN MAPP; Ribot TH, 1904, MALADES VOLONTE; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Sims A., 2003, SYMPTOMS MIND, V3rd Edn; SMITH RB, 1994, BRAIN INJURY, V8, P357, DOI 10.3109/02699059409150986; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Spalletta G, 2013, HUM BRAIN MAPP, V34, P3193, DOI 10.1002/hbm.22137; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Starkstein SE, 2000, INT PSYCHOGERIATR, V12, P135, DOI 10.1017/S1041610200006918; STARKSTEIN SE, 1989, INT J PSYCHIAT MED, V19, P155; STARKSTEIN SE, 2002, PSYCHIAT COGNITIVE D; Starkstein SE, 2009, MOVEMENT DISORD, V24, P1211, DOI 10.1002/mds.22577; Strauss ME, 2002, NEUROPSY NEUROPSY BE, V15, P176, DOI 10.1097/01.WNN.0000020010.79870.C3; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; World Health Organization, 1993, ICD 10 CLASS MENT BE	50	31	32	0	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2014	37	1					103	+		10.1016/j.psc.2013.10.002			11	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	AD8UM	WOS:000333541200008	24529426				2022-02-06	
J	Santo, KP; Berkowitz, ML				Santo, Kolattukudy P.; Berkowitz, Max L.			Shock wave interaction with a phospholipid membrane: Coarse-grained computer simulations	JOURNAL OF CHEMICAL PHYSICS			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; TRAUMATIC BRAIN-INJURY; CAVITATION BUBBLES; MODEL; ULTRASOUND; MIXTURES; WATER	We used MARTINI coarse-grained force field to study poration of a lipid bilayer by a shock wave induced nanobubble collapse. Different systems containing different sized nanobubbles that were exposed to shock waves propagating with different velocities were simulated. We observed creation of pores and damage to bilayers and also subsequent pore closing and the bilayer recovery after shock wave passed the bilayer. In all our systems where bilayers were damaged, they recovered; nevertheless we observed that a large amount of water crossed the pore that was temporarily created. We also observed that not every lipid molecule remained in the bilayer after recovery, some lipids moved out into water and created micelles. (C) 2014 AIP Publishing LLC.	[Santo, Kolattukudy P.; Berkowitz, Max L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA		Santo, KP (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.		Poulose, Santo/AAC-7499-2021	Poulose, Santo/0000-0001-6817-737X; Berkowitz, Max/0000-0002-9116-0362	Office of Naval ResearchOffice of Naval Research [N000141310396]	The support by a grant (Grant No. N000141310396) from the Office of Naval Research is gratefully acknowledged.	Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Chiang YW, 2007, J PHYS CHEM B, V111, P11260, DOI 10.1021/jp0732110; Choubey A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3518472; Feller SE, 1997, LANGMUIR, V13, P6555, DOI 10.1021/la970746j; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; Goetz R, 1999, PHYS REV LETT, V82, P221, DOI 10.1103/PhysRevLett.82.221; Henderson L. F., 2001, HDB SHOCK WAVES, V1, P143; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holian BL, 1998, SCIENCE, V280, P2085, DOI 10.1126/science.280.5372.2085; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ng KY, 2002, MED RES REV, V22, P204, DOI 10.1002/med.10004; Ohl CD, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.214502; Ohl CD, 2006, BIOPHYS J, V91, P4285, DOI 10.1529/biophysj.106.075366; Rosetti C, 2012, J PHYS CHEM B, V116, P3525, DOI 10.1021/jp212406u; RYBAKOV AP, 1995, EUR J MECH B-FLUID, V14, P323; Rzepiela AJ, 2010, FARADAY DISCUSS, V144, P431, DOI 10.1039/b901615e; Shekhar A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.184503; Sundaram J, 2003, BIOPHYS J, V84, P3087, DOI 10.1016/S0006-3495(03)70034-4; Tomita Y, 2003, J APPL PHYS, V94, P2809, DOI 10.1063/1.1594277; Vedadi M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.014503; ZHANG YH, 1995, J CHEM PHYS, V103, P10252, DOI 10.1063/1.469927	29	31	31	1	43	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0021-9606	1089-7690		J CHEM PHYS	J. Chem. Phys.	FEB 7	2014	140	5							054906	10.1063/1.4862987			9	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Physics	AA7PK	WOS:000331289200064	24511978				2022-02-06	
J	Sato, S; Kawauchi, S; Okuda, W; Nishidate, I; Nawashiro, H; Tsumatori, G				Sato, Shunichi; Kawauchi, Satoko; Okuda, Wataru; Nishidate, Izumi; Nawashiro, Hiroshi; Tsumatori, Gentaro			Real-Time Optical Diagnosis of the Rat Brain Exposed to a Laser-Induced Shock Wave: Observation of Spreading Depolarization, Vasoconstriction and Hypoxemia-Oligemia	PLOS ONE			English	Article							CLOSED-HEAD-INJURY; CONTROLLED CORTICAL IMPACT; INDUCED STRESS WAVES; FLUID-PERCUSSION MODEL; BLAST OVERPRESSURE; EXPLOSIVE BLAST; INDUCED NEUROTRAUMA; HIPPOCAMPAL SLICE; CEREBRAL-CORTEX; VISUAL-CORTEX	Despite many efforts, the pathophysiology and mechanism of blast-induced traumatic brain injury (bTBI) have not yet been elucidated, partially due to the difficulty of real-time diagnosis and extremely complex factors determining the outcome. In this study, we topically applied a laser-induced shock wave (LISW) to the rat brain through the skull, for which real-time measurements of optical diffuse reflectance and electroencephalogram (EEG) were performed. Even under conditions showing no clear changes in systemic physiological parameters, the brain showed a drastic light scattering change accompanied by EEG suppression, which indicated the occurrence of spreading depression, long-lasting hypoxemia and signal change indicating mitochondrial energy impairment. Under the standard LISW conditions examined, hemorrhage and contusion were not apparent in the cortex. To investigate events associated with spreading depression, measurement of direct current (DC) potential, light scattering imaging and stereomicroscopic observation of blood vessels were also conducted for the brain. After LISW application, we observed a distinct negative shift in the DC potential, which temporally coincided with the transit of a light scattering wave, showing the occurrence of spreading depolarization and concomitant change in light scattering. Blood vessels in the brain surface initially showed vasodilatation for 3-4 min, which was followed by long-lasting vasoconstriction, corresponding to hypoxemia. Computer simulation based on the inverse Monte Carlo method showed that hemoglobin oxygen saturation declined to as low as similar to 35% in the long-term hypoxemic phase. Overall, we found that topical application of a shock wave to the brain caused spreading depolarization/depression and prolonged severe hypoxemia-oligemia, which might lead to pathological conditions in the brain. Although further study is needed, our findings suggest that spreading depolarization/depression is one of the key events determining the outcome in bTBI. Furthermore, a rat exposed to an LISW(s) can be a reliable laboratory animal model for blast injury research.	[Sato, Shunichi; Kawauchi, Satoko] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan; [Okuda, Wataru; Nishidate, Izumi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo, Japan; [Nawashiro, Hiroshi] Tokorozawa Cent Hosp, Div Neurosurg, Tokorozawa, Saitama, Japan; [Tsumatori, Gentaro] Natl Def Med Coll, Dept Def Med, Tokorozawa, Saitama 359, Japan		Sato, S (corresponding author), Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan.	shunsato@ndmc.ac.jp	NISHIDATE, IZUMI/C-8826-2013		Ministry of Defense; General Insurance Association of Japan	This study was supported by the Research Promotion Program for Defense Medicine under the Ministry of Defense and a research grant from The General Insurance Association of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Aizawa K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253325; Ando T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051744; ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Bahar S, 2000, J NEUROPHYSIOL, V84, P311; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Center for Chemical Process Safety, 1994, GUID EV CHAR VAP CLO, P351; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 1996, CHINESE J TRAUMATOL, V12, P28; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dreckhahn C, 2012, BRAIN, V135, P853; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Ebersberger A, 2001, ANN NEUROL, V49, P7, DOI 10.1002/1531-8249(200101)49:1<7::AID-ANA4>3.3.CO;2-B; Elsayed NM, 1997, TOXICOLOGY, V121, P81, DOI 10.1016/S0300-483X(97)03657-3; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fischer H, 2013, CRS REP C; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guy RJ, 1998, J TRAUMA, V45, P983, DOI 10.1097/00005373-199812000-00001; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hatano B, 2011, P SPIE, V7897; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; JAFFIN JH, 1987, J TRAUMA, V27, P349, DOI 10.1097/00005373-198704000-00002; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kawauchi S, 2008, APPL OPTICS, V47, P4164, DOI 10.1364/AO.47.004164; Kawauchi S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.015003; Kawauchi S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3542046; Kurita A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3628313; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Manor T, 2008, NEUROL RES, V30, P1075, DOI 10.1179/174313208X346107; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mourant JR, 2003, BIOMEDICAL PHOTONICS; NARAYAN SM, 1995, J CEREBR BLOOD F MET, V15, P754, DOI 10.1038/jcbfm.1995.95; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Ogura M, 2004, LASER SURG MED, V34, P242, DOI 10.1002/lsm.20024; OKUSKY J, 1982, J COMP NEUROL, V210, P307, DOI 10.1002/cne.902100309; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; PAINTAL AS, 1969, J PHYSIOL-LONDON, V203, P511, DOI 10.1113/jphysiol.1969.sp008877; PIPER RD, 1991, AM J PHYSIOL, V261, pH96, DOI 10.1152/ajpheart.1991.261.1.H96; Polischuk TM, 1998, NEUROBIOL DIS, V4, P423, DOI 10.1006/nbdi.1998.0172; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Sato S, 2011, OPT LETT, V36, P4545, DOI 10.1364/OL.36.004545; Satoh Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2128432; Satoh Y, 2010, LASER SURG MED, V42, P313, DOI 10.1002/lsm.20899; Schumacher RN, 1977, 2724 US BALL RES LAB; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; Showstack R., 2013, EOS T AGU, V94, P87; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Somjen GG, 2008, J COMPUT NEUROSCI, V25, P349, DOI 10.1007/s10827-008-0083-9; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; VANDERZEE P, 1993, P SOC PHOTO-OPT INS, V1888, P454, DOI 10.1117/12.154665; VANHARREVELD A, 1956, AM J PHYSIOL, V184, P312; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wharton DC, 1966, BIOCH COPPER, P235; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963; Zuckerman S, 1940, LANCET, V2, P219	96	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82891	10.1371/journal.pone.0082891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	WOS:000329862500022	24416150	Green Published, gold, Green Submitted			2022-02-06	
J	Diedler, J; Santos, E; Poli, S; Sykora, M				Diedler, Jennifer; Santos, Edgar; Poli, Sven; Sykora, Marek			Optimal cerebral perfusion pressure in patients with intracerebral hemorrhage: an observational case series	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBROVASCULAR AUTOREGULATION; INTRACRANIAL-PRESSURE; REACTIVITY; MANAGEMENT	Introduction: Current guidelines for spontaneous intracerebral hemorrhage (ICH) recommend maintaining cerebral perfusion pressure (CPP) between 50 and 70 mmHg, depending on the state of autoregulation. We continuously assessed dynamic cerebral autoregulation and the possibility of determination of an optimal CPP (CPPopt) in ICH patients. Associations between autoregulation, CPPopt and functional outcome were explored. Methods: Intracranial pressure (ICP), mean arterial pressure (MAP) and CPP were continuously recorded in 55 patients, with 38 patients included in the analysis. The pressure reactivity index (PRx) was calculated as moving correlation between MAP and ICP. CPPopt was defined as the CPP associated with the lowest PRx values. CPPopt was calculated using hourly updated of 4 hour windows. The modified Rankin Scale (mRS) was assessed at 3 months and associations between PRx, CPPopt and outcomes were explored using Pearson correlation and Fisher's exact test. Multivariate stepwise logistic regression models were calculated including standard outcome predictors along with percentage of time with PRx > 0.2 and percentage of time within the CPPopt range. Results: An overall PRx indicating impairment of pressure reactivity was found in 47% of patients (n = 18). The mean PRx and the time spent with a PRx > 0.2 significantly correlated with mRS at 3 months (r = 0.50, P = 0.002; r = 0.46, P = 0.004). CPPopt was calculable during 57% of the monitoring time. The median CPP was 78 mmHg, the median CPPopt 83 mmHg. Mortality was lowest in the group of patients with a CPP close to their CPPopt. However, for none of the CPPopt variables a significant association to outcome was found. The percentage of time with impaired autoregulation and hemorrhage volume were independent predictors for acceptable outcome (mRS 1 to 4) at three months. Conclusions: Failure of pressure reactivity seems common following severe ICH and is associated with unfavorable outcome. Real-time assessment of CPPopt is feasible in ICH and might provide a tool for an autoregulation-oriented CPP management. A larger trial is needed to explore if a CPPopt management results in better functional outcomes.	[Diedler, Jennifer; Poli, Sven] Univ Tubingen, Dept Neurol, D-72076 Tubingen, Germany; [Diedler, Jennifer] Univ Tubingen, Dept Neurosurg, D-72076 Tubingen, Germany; [Diedler, Jennifer; Poli, Sven; Sykora, Marek] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany; [Santos, Edgar] Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany		Diedler, J (corresponding author), Univ Tubingen, Dept Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	jennifer.diedler@med.uni-tuebingen.de	Santos, Edgar/AAV-2506-2021	Santos, Edgar/0000-0002-8976-5549	Olympia-Morata scholarship of the University of Heidelberg	JD was supported by the Olympia-Morata scholarship of the University of Heidelberg. There was no special funding for the study.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diedler J, 2009, STROKE, V40, P815, DOI 10.1161/STROKEAHA.108.531020; Fernandes HM, 2000, ACT NEUR S, V76, P463; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Ko SB, 2011, STROKE, V42, P3087, DOI 10.1161/STROKEAHA.111.623165; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nakagawa K, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-108; Oeinck M, 2013, STROKE, V44, P2722, DOI 10.1161/STROKEAHA.113.001913; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Reinhard M, 2010, INTENS CARE MED, V36, P264, DOI 10.1007/s00134-009-1698-7; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	19	31	36	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2014	18	2							R51	10.1186/cc13796			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM1SA	WOS:000339627400069	24666981	Green Published, gold			2022-02-06	
J	Hackenberg, B; Lee, C; Caterson, EJ				Hackenberg, Berit; Lee, Cameron; Caterson, E. J.			Management of Subcondylar Mandible Fractures in the Adult Patient	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Subcondylar mandible fracture; open reduction; maxillomandibular fixation; endoscopic; treatment algorithm	CONDYLAR PROCESS FRACTURES; CLOSED TREATMENT; TEMPOROMANDIBULAR-JOINT; OPEN REDUCTION; POSTTRAUMATIC ANKYLOSIS; NONSURGICAL TREATMENT; CONCOMITANT INJURIES; ENDOSCOPIC APPROACH; FACIAL FRACTURES; CURRENT THOUGHTS	The treatment of subcondylar mandible fractures is a topic of debate and can be variable even though these fractures are commonly seen. Historically, the treatment algorithm was between open reduction and closed treatment. Now, recent technical advances regarding the use of the endoscope in the field of craniofacial surgery provide additional treatment options. This article aimed to evaluate 3 current management strategies: closed reduction with maxillomandibular fixation, open reduction with internal fixation, and endoscopic-assisted reduction with internal fixation. We present our rationale for surgical decision making and attempt to develop an algorithmic approach to subcondylar fractures. Ankylosis of the temporomandibular joint is a feared complication in these fractures that can lead to the decision to apply maxillomandibular fixation for potentially too short of a period. It is the condylar head fractures within the joint's capsule that contain the hemarthrosis that are often responsible for ankylosis. Subcondylar fractures are, by definition, below the attachment of the joint capsule and in general are devoid of ankylosis. Therefore, maxillomandibular fixation is recommended to be applied for a period of 4 to 6 weeks in most cases. Open reduction with internal fixation can increase the risk for facial nerve damage during the operative approach. However, open reduction is often necessary in fracture patterns with a high degree of displacement. In these cases, facial nerve monitoring can successfully mitigate risks to allow safe exposure for open reduction with internal fixation of subcondylar fractures. Endoscopic-assisted reduction with internal fixation combines the benefits of both techniques while minimizing their associated risks. Nevertheless, reduction can be difficult especially when there is significant medial displacement of the proximal fracture fragment. In our experience, the endoscopic option is optimal for mildly displaced fractures and for the patient with multiple injuries who cannot tolerate closed reduction.	[Hackenberg, Berit; Caterson, E. J.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Hackenberg, Berit] Heidelberg Univ, Sch Med, Heidelberg, Germany; [Lee, Cameron] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Caterson, E. J.] Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA		Caterson, EJ (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	ecaterson@partners.org					Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; AO Foundation, MAND DIAGN AO SURG R; Arakeri G, 2012, BRIT J ORAL MAX SURG, V50, P8, DOI 10.1016/j.bjoms.2010.09.012; Baker AW, 1998, INT J ORAL MAX SURG, V27, P258, DOI 10.1016/S0901-5027(05)80507-7; Brandt MT, 2003, J ORAL MAXIL SURG, V61, P1324, DOI 10.1016/S0278-2391(03)00735-3; Lee GYC, 2008, MED ORAL PATOL ORAL, V13, pE511; Choi BH, 1999, ORAL SURG ORAL MED O, V88, P292, DOI 10.1016/S1079-2104(99)70030-2; Danda AK, 2010, J ORAL MAXIL SURG, V68, P1238, DOI 10.1016/j.joms.2009.09.042; Ebenezer V, 2011, J MAXILLOFAC ORAL SU, V10, P38, DOI 10.1007/s12663-010-0145-1; Ellis E, 2000, J ORAL MAXIL SURG, V58, P950, DOI 10.1053/joms.2000.8734; Ellis E, 2000, J ORAL MAXIL SURG, V58, P719, DOI 10.1053/joms.2000.7253; Ellis E, 2000, J ORAL MAXIL SURG, V58, P260, DOI 10.1016/S0278-2391(00)90047-8; Ellis E, 2000, J ORAL MAXILLOFAC SU, V58, P729; Ellis ED, 2001, J ORAL MAXIL SURG, V59, P389, DOI 10.1053/joms.2001.21873; Farahvash MR, 2013, AESTHET SURG J, V33, P201, DOI 10.1177/1090820X12473104; Ferretti C, 2005, INT J ORAL MAX SURG, V34, P376, DOI 10.1016/j.ijom.2004.09.003; Haug RH, 2001, J ORAL MAXIL SURG, V59, P370, DOI 10.1053/joms.2001.21868; Haug RH, 2007, PLAST RECONSTR SURG, V120, p90S, DOI 10.1097/01.prs.0000260730.43870.1b; Jacobovicz J, 1998, PLAST RECONSTR SURG, V101, P437, DOI 10.1097/00006534-199802000-00030; Kellman Robert M, 2004, Facial Plast Surg, V20, P239, DOI 10.1055/s-2004-861780; Kellman Robert M, 2003, Arch Facial Plast Surg, V5, P244, DOI 10.1001/archfaci.5.3.244; Kellman RM, 2009, FACIAL PLAST SURG, V25, P23, DOI 10.1055/s-0028-1112228; Konstantinovic FX, 1992, J ORAL MAXILLOFAC SU, V50, P352; KONSTANTINOVIC VS, 1992, J ORAL MAXIL SURG, V50, P349, DOI 10.1016/0278-2391(92)90395-G; Kostakis G, 2012, OR SURG OR MED OR PA, V114, pS69, DOI 10.1016/j.tripleo.2011.08.029; Kyrgidis A, 2013, J CRANIO MAXILL SURG, V41, P637, DOI 10.1016/j.jcms.2012.11.046; Lee Jing-Wei, 2010, Plast Reconstr Surg, V125, P609, DOI 10.1097/PRS.0b013e3181c82ff0; Meng FW, 2009, MED HYPOTHESES, V73, P92, DOI 10.1016/j.mehy.2009.01.024; Mueller R, 2008, FACIAL PLAST SURG, V24, P78, DOI 10.1055/s-2008-1037452; Palmieri C, 1999, J ORAL MAXIL SURG, V57, P764, DOI 10.1016/S0278-2391(99)90810-8; Palmieri C, 1999, J ORAL MAXILLOFAC SU, V57, P775; Pham Annette M, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P234, DOI 10.1097/01.moo.0000233593.84175.6e; Santler G, 1999, J ORAL MAXIL SURG, V57, P392, DOI 10.1016/S0278-2391(99)90276-8; Schubert W, 2009, J CRANIOFAC SURG, V20, P154, DOI 10.1097/SCS.0b013e318191cfb8; SILVENNOINEN U, 1992, J ORAL MAXIL SURG, V50, P1032, DOI 10.1016/0278-2391(92)90484-H; Singh V, 2010, J ORAL MAXIL SURG, V68, P1304, DOI 10.1016/j.joms.2010.01.001; Smith Hayden, 2012, J Trauma Nurs, V19, P57, DOI 10.1097/JTN.0b013e31823a4c0e; Troulis Maria J, 2006, Facial Plast Surg Clin North Am, V14, P45, DOI 10.1016/j.fsc.2005.11.003; Troulis MJ, 2004, J ORAL MAXIL SURG, V62, P1269, DOI 10.1016/j.joms.2004.04.016; Villarreal PM, 2004, J ORAL MAXIL SURG, V62, P155, DOI 10.1016/j.joms.2003.08.010; Vural E, 2004, ARCH OTOLARYNGOL, V130, P1228, DOI 10.1001/archotol.130.10.1228; WORSAAE N, 1994, J ORAL MAXIL SURG, V52, P353, DOI 10.1016/0278-2391(94)90436-7; Worsaae N, 1994, J ORAL MAXILLOFAC SU, P360; Yang WG, 2002, J TRAUMA, V52, P498, DOI 10.1097/00005373-200203000-00014; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854; Zide MF, 2001, J ORAL MAXIL SURG, V59, P375, DOI 10.1053/joms.2001.21869	46	31	32	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2014	25	1					166	171		10.1097/SCS.0000000000000498			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AH2CP	WOS:000335928600071	24406572				2022-02-06	
J	Lehrner, A; Yehuda, R				Lehrner, Amy; Yehuda, Rachel			PTSD IN THE MILITARY: PREVALENCE, PATHOPHYSIOLOGY, TREATMENT Biomarkers of PTSD: military applications and considerations	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						Posttraumatic stress disorder; biomarkers; clinical utility; ethics; translation	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; PREDICTS TREATMENT RESPONSE; EXTREME STRESS; ANTERIOR CINGULATE; MAJOR DEPRESSION; NATIONAL-SURVEY; CORTISOL; PSYCHOTHERAPY	Background: Although there are no established biomarkers for posttraumatic stress disorder (PTSD) as yet, biological investigations of PTSD have made progress identifying the pathophysiology of PTSD. Given the biological and clinical complexity of PTSD, it is increasingly unlikely that a single biomarker of disease will be identified. Rather, investigations will more likely identify different biomarkers that indicate the presence of clinically significant PTSD symptoms, associate with risk for PTSD following trauma exposure, and predict or identify recovery. While there has been much interest in PTSD biomarkers, there has been less discussion of their potential clinical applications, and of the social, legal, and ethical implications of such biomarkers. Objective: This article will discuss possible applications of PTSD biomarkers, including the social, legal, and ethical implications of such biomarkers, with an emphasis on military applications. Method: Literature on applications of PTSD biomarkers and on potential ethical and legal implications will be reviewed. Results: Biologically informed research findings hold promise for prevention, assessment, treatment planning, and the development of prophylactic and treatment interventions. As with any biological indicator of disorder, there are potentially positive and negative clinical, social, legal, and ethical consequences of using such biomarkers. Conclusions: Potential clinical applications of PTSD biomarkers hold promise for clinicians, patients, and employers. The search for biomarkers of PTSD should occur in tandem with an interdisciplinary discussion regarding the potential implications of applying biological findings in clinical and employment settings.	[Lehrner, Amy; Yehuda, Rachel] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA; [Yehuda, Rachel] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Yehuda, Rachel] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA		Lehrner, A (corresponding author), James J Peters Vet Affairs Med Ctr, Mental Hlth Patient Care Ctr, 526 OOMH PTSD 116-A,130 West Kingsbridge Rd, Bronx, NY 10468 USA.	amy.lehrner@va.gov					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Aupperle RL, 2013, PSYCHIAT RES-NEUROIM, V214, P48, DOI 10.1016/j.pscychresns.2013.05.001; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; Barsaglini A, 2014, PROG NEUROBIOL, V114, P1, DOI 10.1016/j.pneurobio.2013.10.006; Baum M, 2013, BIOPREDICTION BIOMAR, P12; Bomyea J, 2012, CLIN PSYCHOL REV, V32, P630, DOI 10.1016/j.cpr.2012.06.008; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bottalico B, 2012, INT J LAW PSYCHIAT, V35, P112, DOI 10.1016/j.ijlp.2011.12.001; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Bryant RA, 2008, PSYCHOL MED, V38, P555, DOI 10.1017/S0033291707002231; Bryant RA, 2008, J PSYCHIATR NEUROSCI, V33, P142; Caux C, 2007, SOC SCI MED, V65, P344, DOI 10.1016/j.socscimed.2007.03.041; Cisler JM, 2014, J PSYCHIATR RES, V48, P47, DOI 10.1016/j.jpsychires.2013.09.013; Cloitre M, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.20706; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Dalenberg CJ, 2012, DEPRESS ANXIETY, V29, P671, DOI 10.1002/da.21926; Delahanty DL, 2005, PSYCHONEUROENDOCRINO, V30, P121, DOI 10.1016/j.psyneuen.2004.06.004; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Delahanty DL, 2013, CNS SPECTRUMS, V18, P103, DOI 10.1017/S1092852913000096; DiGangi JA, 2013, CLIN PSYCHOL REV, V33, P728, DOI 10.1016/j.cpr.2013.05.002; Dyer C, 2002, BRIT MED J, V324, P563, DOI 10.1136/bmj.324.7337.563; Falconer E, 2013, J CLIN PSYCHIAT, V74, P895, DOI 10.4088/JCP.12m08020; Farrow TFD, 2005, PSYCHIAT RES-NEUROIM, V140, P45, DOI 10.1016/j.pscychresns.2005.05.012; Felmingham K, 2007, PSYCHOL SCI, V18, P127, DOI 10.1111/j.1467-9280.2007.01860.x; Forbes D, 2010, J TRAUMA STRESS, V23, P340, DOI 10.1002/jts.20526; Ford JD, 1999, J CONSULT CLIN PSYCH, V67, P3, DOI 10.1037/0022-006X.67.1.3; Ford JD, 1998, J TRAUMA STRESS, V11, P743, DOI 10.1023/A:1024497400891; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Fuzery AK, 2013, CLIN PROTEOM, V10, DOI 10.1186/1559-0275-10-13; Gauthier S, 2013, PROG NEUROBIOL, V110, P102, DOI 10.1016/j.pneurobio.2013.01.003; Hampel H., 2011, PROGR NEUROBIOLOGY, V95, P517, DOI [10.1016/j.pneurobio.2011.11.009, DOI 10.1016/J.PNEUR0BIO.2011.11.009]; Heber R, 2002, J CLIN PSYCHOL, V58, P1521, DOI 10.1002/jclp.10102; HERMAN JL, 1992, J TRAUMA STRESS, V5, P377, DOI 10.1002/jts.2490050305; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Illes J, 2007, ANN NY ACAD SCI, V1097, P278, DOI 10.1196/annals.1379.030; Institute of Medicine Committee on Treatment of Posttraumatic Stress Disorder Board on Population Health and Public Health Practice, 2008, TREATM POSTTR STRESS; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; Lakhan Shaheen E, 2010, Int Arch Med, V3, P1, DOI 10.1186/1755-7682-3-1; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Lindauer RJL, 2008, PSYCHOL MED, V38, P543, DOI 10.1017/S0033291707001432; Mechelli A, 2010, MED HYPOTHESES, V75, P594, DOI 10.1016/j.mehy.2010.07.042; Mickleborough MJS, 2011, J PSYCHIATR NEUROSCI, V36, P6, DOI 10.1503/jpn.080188; Miller AH, 2008, BIOL PSYCHIAT, V64, P263, DOI 10.1016/j.biopsych.2008.05.018; Morris MC, 2012, CLIN PSYCHOL REV, V32, P301, DOI 10.1016/j.cpr.2012.02.002; Olff M, 2007, PSYCHONEUROENDOCRINO, V32, P619, DOI 10.1016/j.psyneuen.2007.04.001; Otlowski M, 2012, ANNU REV GENOM HUM G, V13, P433, DOI 10.1146/annurev-genom-090711-163800; Pelcovitz D, 1997, J TRAUMA STRESS, V10, P3, DOI 10.1023/A:1024800212070; Peres JFP, 2007, PSYCHOL MED, V37, P1481, DOI 10.1017/S003329170700997X; Peres JFP, 2011, J PSYCHIATR RES, V45, P727, DOI 10.1016/j.jpsychires.2010.11.004; Perlis RH, 2011, MOL PSYCHIATR, V16, P1076, DOI 10.1038/mp.2011.63; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Roy MJ, 2010, ANN NY ACAD SCI, V1208, P142, DOI 10.1111/j.1749-6632.2010.05689.x; Schmidt U, 2013, DIS MARKERS, V2013, P43, DOI 10.1155/2013/835876; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Silver K, 2006, J OCCUP ENVIRON MED, V48, P434, DOI 10.1097/01.jom.0000200878.16077.3b; Singh I, 2009, NATURE, V460, P202, DOI 10.1038/460202a; Slats D., 2010, J NEUROL NEUROSUR PS, V81, P124, DOI [10.1136/jnnp.2009.176412, DOI 10.1136/4NNP.2009.176412]; Steudte S, 2013, BIOL PSYCHIAT, V74, P639, DOI 10.1016/j.biopsych.2013.03.011; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; van der Kolk BA, 2005, J TRAUMA STRESS, V18, P389, DOI 10.1002/jts.20047; van der Kolk BA., 2002, TREATING TRAUMA SURV, P127; van Zuiden M, 2013, BRAIN BEHAV IMMUN, V30, P12, DOI 10.1016/j.bbi.2012.08.015; Wolf EJ, 2012, ARCH GEN PSYCHIAT, V69, P698, DOI 10.1001/archgenpsychiatry.2011.1574; Wolf EJ, 2010, J ABNORM PSYCHOL, V119, P320, DOI 10.1037/a0019035; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; Yehuda R, 2013, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00118; Yehuda R, 2013, PSYCHONEUROENDOCRINO, V38, P1912, DOI 10.1016/j.psyneuen.2013.06.009; Yehuda R, 2009, EXPERT REV NEUROTHER, V9, P1113, DOI 10.1586/ERN.09.79; Yehuda R, 2009, PSYCHONEUROENDOCRINO, V34, P1304, DOI 10.1016/j.psyneuen.2009.03.018; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	74	31	31	0	20	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8198	2000-8066		EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.		2014	5								23797	10.3402/ejpt.v5.23797			11	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	AO2HF	WOS:000341138600001		Green Published, Green Submitted			2022-02-06	
J	Post, A; Oeur, A; Walsh, E; Hoshizaki, B; Gilchrist, MD				Post, Andrew; Oeur, Anna; Walsh, Evan; Hoshizaki, Blaine; Gilchrist, Michael D.			A centric/non-centric impact protocol and finite element model methodology for the evaluation of American football helmets to evaluate risk of concussion	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						concussion; impact biomechanics; American football; standards; finite element modelling	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; INTRACRANIAL-PRESSURE; AXONAL DAMAGE; HEAD IMPACTS; ENCEPHALOPATHY; RECONSTRUCTION; ACCELERATION; BIOMECHANICS; PREDICTION	American football reports high incidences of head injuries, in particular, concussion. Research has described concussion as primarily a rotation dominant injury affecting the diffuse areas of brain tissue. Current standards do not measure how helmets manage rotational acceleration or how acceleration loading curves influence brain deformation from an impact and thus are missing important information in terms of how concussions occur. The purpose of this study was to investigate a proposed three-dimensional impact protocol for use in evaluating football helmets. The dynamic responses resulting from centric and non-centric impact conditions were examined to ascertain the influence they have on brain deformations in different functional regions of the brain that are linked to concussive symptoms. A centric and non-centric protocol was used to impact an American football helmet; the resulting dynamic response data was used in conjunction with a three-dimensional finite element analysis of the human brain to calculate brain tissue deformation. The direction of impact created unique loading conditions, resulting in peaks in different regions of the brain associated with concussive symptoms. The linear and rotational accelerations were not predictive of the brain deformation metrics used in this study. In conclusion, the test protocol used in this study revealed that impact conditions influences the region of loading in functional regions of brain tissue that are associated with the symptoms of concussion. The protocol also demonstrated that using brain deformation metrics may be more appropriate when evaluating risk of concussion than using dynamic response data alone.	[Post, Andrew; Oeur, Anna; Walsh, Evan; Hoshizaki, Blaine; Gilchrist, Michael D.] Univ Ottawa, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland		Post, A (corresponding author), Univ Ottawa, Ottawa, ON, Canada.	apost@uottawa.ca; aoeur016@uottawa.ca; ewals056@uottawa.ca; thoshiza@uottawa.ca; Michael.gilchrist@ucd.ie	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X; Post, Andrew/0000-0002-5960-5552			Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Augustine G., 2001, NEUROSCIENCE; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, 38 STAPP CAR CRASH C, P145; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBLIN; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T, 1971, P 15 STAPP CAR CRASH; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Kendall M, 2012, P IRCOBI SEPT 10 14; King AI, 2003, IRCOBI C SEPT 25 26; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, P IRCOBI, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Madsen DP, 2008, EUR J ORTHODONT, V30, P102; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miller RT, 1998, P 42 STAPP CAR CRASH; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nahum AM, 1977, P 21 STAPP CAR CRASH; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Ruan J. S., 1994, THESIS WAYNE STATE U; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Schreiber DI, 1997, P 41 STAPP CAR CRASH; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; Singh A, 2006, STAPP CAR CRASH J, V2006, P602; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	64	31	31	0	40	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2014	17	16					1785	1800		10.1080/10255842.2013.766724			16	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	AJ2YM	WOS:000337531300004	23477767				2022-02-06	
J	Tobin, RP; Mukherjee, S; Kain, JM; Rogers, SK; Henderson, SK; Motal, HL; Rogers, MKN; Shapiro, LA				Tobin, Richard P.; Mukherjee, Sanjib; Kain, Jessica M.; Rogers, Susannah K.; Henderson, Stephanie K.; Motal, Heather L.; Rogers, M. Karen Newell; Shapiro, Lee A.			Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						TBI; FPI; Fluid percussion injury; CD74; Neuroinflammation	DELTA-T-CELLS; ANTIGEN; EXPRESSION; RESPONSES; ALPHA; NEUROINFLAMMATION; SUSCEPTIBILITY; INFLAMMATION; TRAFFICKING; RESISTANCE	Introduction: Traumatic brain injury (TBI), a significant cause of death and disability, causes, as in any injury, an acute, innate immune response. A key component in the transition between innate and adaptive immunity is the processing and presentation of antigen by professional antigen presenting cells (APCs). Whether an adaptive immune response to brain injury is beneficial or detrimental is not known. Current efforts to understand the contribution of the immune system after TBI have focused on neuroinflammation and brain-infiltrating immune cells. Here, we characterize and target TBI-induced expansion of peripheral immune cells that may act as potential APCs. Because MHC Class II-associated invariant peptide (CLIP) is important for antigen processing and presentation, we engineered a competitive antagonist (CAP) for CLIP, and tested the hypothesis that peptide competition could reverse or prevent neurodegeneration after TBI. Results: We show that after fluid percussion injury (FPI), peripheral splenic lymphocytes, including CD4+ and CD8+T cells, regulatory T cells (Tregs), and gamma delta T cells, are increased in number within 24 hours after FPI. These increases were reversed by CAP treatment and this antagonism of CLIP also reduced neuroinflammation and neurodegeneration after TBI. Using a mouse deficient for the precursor of CLIP, CD74, we observed decreased peripheral lymphocyte activation, decreased neurodegeneration, and a significantly smaller lesion size following TBI. Conclusion: Taken together, the data support the hypothesis that neurodegeneration following TBI is dependent upon antigen processing and presentation that requires CD74.	[Tobin, Richard P.; Mukherjee, Sanjib; Kain, Jessica M.; Motal, Heather L.; Rogers, M. Karen Newell; Shapiro, Lee A.] Texas A&M Univ, Hlth Sci Ctr, Dept Surg, Temple, TX 76508 USA; [Mukherjee, Sanjib; Kain, Jessica M.; Shapiro, Lee A.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Rogers, Susannah K.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Henderson, Stephanie K.; Rogers, M. Karen Newell; Shapiro, Lee A.] Baylor Scott & White Hlth, Dept Surg, Temple, TX USA; [Rogers, M. Karen Newell] Texas ACM Hlth Sci Ctr, Baylor Scott & White Hlth, Temple, TX 76504 USA		Rogers, MKN (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Surg, Temple, TX 76508 USA.	newellrogers@tamhsc.edu		Kain, Jessica/0000-0003-1285-5690	Scott; White Healthcare Foundation (MKNR); Wounded Warrior Fund (MKNR); VG Life Sciences Inc; Texas A&M Health Sciences Center (MKNR, LAS); Texas A&M Health Science center (MKNR); Central Texas Veterans Health Care System, Temple, TX, USA (LAS)	This material is the result of work supported by the following: the Scott and White Healthcare Foundation (MKNR), the Wounded Warrior Fund (MKNR), VG Life Sciences Inc. (MKNR, RPT, LAS), Texas A&M Health Sciences Center (MKNR, LAS) and the use of facilities at the Texas A&M Health Science center (MKNR) and the Central Texas Veterans Health Care System, Temple, TX, USA (LAS). We are grateful to Evan W. Newell for his generous contributions to the design and generation of CAP. We gratefully acknowledge Glen Cryer for his support and his editorial assistance with the manuscript.	ALLEN PM, 1987, IMMUNOL REV, V98, P171, DOI 10.1111/j.1600-065X.1987.tb00524.x; Amini M, 2008, IRAN J PARASITOL, V3, P51; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BARKER CF, 1977, ADV IMMUNOL, V25, P1; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beschorner R, 2002, J NEUROIMMUNOL, V126, P107, DOI 10.1016/S0165-5728(02)00046-2; Bittner S, 2013, NAT MED, V19, P1161, DOI 10.1038/nm.3303; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; BUUS S, 1986, CELL, V47, P1071, DOI 10.1016/0092-8674(86)90822-6; Cheng L, 2008, J NEUROIMMUNOL, V203, P3, DOI 10.1016/j.jneuroim.2008.06.007; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Clausen F, 2007, J NEUOTRAUMA; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Collins RA, 1998, J LEUKOCYTE BIOL, V63, P707, DOI 10.1002/jlb.63.6.707; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DAVIDSON WF, 1975, J IMMUNOL METHODS, V7, P291, DOI 10.1016/0022-1759(75)90026-5; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; FREEDMAN MS, 1991, ANN NEUROL, V30, P794, DOI 10.1002/ana.410300608; Haribhai D, 2011, IMMUNITY, V35, P109, DOI [10.1016/.immuni.201103029, DOI 10.1016/.IMMUNI.201103029]; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Huang Z, 2007, NEUROSCI LETT, V417, P160, DOI 10.1016/j.neulet.2007.01.086; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; LANZAVECCHIA A, 1987, IMMUNOL REV, V99, P39, DOI 10.1111/j.1600-065X.1987.tb01171.x; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li PY, 2013, STROKE, V44, P3509, DOI 10.1161/STROKEAHA.113.002637; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Liao H, 2003, J BIOL CHEM, V278, P76, DOI 10.1074/jbc.M208820200; Liesz A, 2013, J NEUROSCI, V33, P17350, DOI 10.1523/JNEUROSCI.4901-12.2013; Ling CY, 2006, J NEUROSCI, V26, P731, DOI 10.1523/JNEUROSCI.3502-05.2006; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Newell MK, 2010, J LEUKOCYTE BIOL, V88, P779, DOI 10.1189/jlb.0410237; Oporto GH, 2014, INT J CLIN EXP MED, V7, P1669; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Schori H, 2002, J IMMUNOL, V169, P2861, DOI 10.4049/jimmunol.169.6.2861; Schori H, 2002, EUR J NEUROSCI, V16, P557, DOI 10.1046/j.1460-9568.2002.02134.x; Schori H, 2007, J IMMUNOL, V178, P163, DOI 10.4049/jimmunol.178.1.163; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Slavin AJ, 2001, J CLIN INVEST, V108, P1133, DOI 10.1172/JCI13360; Song A, 2000, IMMUNOL REV, V177, P236, DOI 10.1034/j.1600-065X.2000.17610.x; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Yang MS, 2002, GLIA, V38, P273, DOI 10.1002/glia.10057; Zeine R, 1998, J NEUROIMMUNOL, V87, P49, DOI 10.1016/S0165-5728(98)00047-2; Zhou W, 2012, J APPL MATH, DOI 10.1155/2012/136254	62	31	33	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.		2014	2								143	10.1186/s40478-014-0143-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V9K3A	WOS:000422389300109	25329434	gold, Green Published			2022-02-06	
J	Ubukata, S; Tanemura, R; Yoshizumi, M; Sugihara, G; Murai, T; Ueda, K				Ubukata, Shiho; Tanemura, Rumi; Yoshizumi, Miho; Sugihara, Genichi; Murai, Toshiya; Ueda, Keita			Social cognition and its relationship to functional outcomes in patients with sustained acquired brain injury	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						Eyes test; social emotion perception; social function; social participation; theory of mind	EMOTION RECOGNITION; PREFRONTAL LESIONS; FACIAL EXPRESSION; MIND; REHABILITATION; IMPAIRMENTS; DEFICITS; ASSOCIATION; ABILITIES; AWARENESS	Deficits in social cognition are common after traumatic brain injury (TBI). However, little is known about how such deficits affect functional outcomes. The purpose of this study was to investigate the relationship between social cognition and functional outcomes in patients with TBI. We studied this relationship in 20 patients with TBI over the course of 1 year post-injury. Patients completed neurocognitive assessments and social cognition tasks. The social cognition tasks included an emotion-perception task and three theory of mind tasks: the Faux Pas test, Reading the Mind in the Eyes (Eyes) test, and the Moving-Shapes paradigm. The Craig Handicap Assessment and Reporting Technique was used to assess functional outcomes. Compared with our database of normal subjects, patients showed impairments in all social cognition tasks. Multiple regression analysis revealed that theory of mind ability as measured by the Eyes test was the best predictor of the cognitive aspects of functional outcomes. The findings of this pilot study suggest that the degree to which a patient can predict what others are thinking is an important measure that can estimate functional outcomes over 1 year following TBI.	[Ubukata, Shiho; Yoshizumi, Miho; Sugihara, Genichi; Murai, Toshiya; Ueda, Keita] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto 6068507, Japan; [Ubukata, Shiho; Tanemura, Rumi] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Kobe, Hyogo 657, Japan		Ubukata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Psychiat, 54 Kawaharacho, Kyoto 6068507, Japan.	ubukata@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [23118004]; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [23791328, 26461766]; General Insurance Association of Japan; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26461766] Funding Source: KAKEN	We thank Uta and Chris Frith and their staff members for kindly providing the Moving-Shapes paradigm and rating descriptions. We also sincerely thank Katja Koelkebeck and Akira Oshita for their contribution to the data analysis. This work was supported by a Grant-in-Aid for Scientific Research in Innovative Areas (23118004) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant-in-Aid for Young Scientists B (23791328) and C (26461766) from the Japan Society for the Promotion of Science, and a research grant from the General Insurance Association of Japan.	Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Arlinghaus KA, 2005, TXB TRAUMATIC BRAIN; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Das P, 2012, SCHIZOPHR RES, V134, P158, DOI 10.1016/j.schres.2011.08.019; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hirao K, 2008, SCHIZOPHR RES, V105, P165, DOI 10.1016/j.schres.2008.07.021; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koelkebeck K, 2013, SOC NEUROSCI-UK, V8, P631, DOI 10.1080/17470919.2013.837094; Kubota Y, 2003, SCHIZOPHR RES, V61, P265, DOI 10.1016/S0920-9964(02)00298-0; Kumamoto K, 2002, SOGO REHABIL, V30, P249; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Manly T, 2012, CURR OPIN NEUROL, V25, P656, DOI 10.1097/WCO.0b013e3283594872; Matsumoto D., 1988, JAPANESE CAUCASIAN F; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Roca M, 2011, NEUROPSYCHOLOGIA, V49, P3525, DOI 10.1016/j.neuropsychologia.2011.09.003; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sato W, 2002, CORTEX, V38, P727, DOI 10.1016/S0010-9452(08)70040-6; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; WHITENECK G, 1987, REHABILITATION OUTCO; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilson BA., 1997, BEHAV ASSESSMENT DYS; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; World Health Organization, 1992, ICD 10 CLASS MENT BE	49	31	33	3	37	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2014	10						2061	2068		10.2147/NDT.S68156			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	AS1WJ	WOS:000344069600001	25395854	gold, Green Published, Green Submitted			2022-02-06	
J	Dillahunt-Aspillaga, C; Jorgensen-Smith, T; Ehlke, S; Sosinski, M; Monroe, D; Thor, J				Dillahunt-Aspillaga, Christina; Jorgensen-Smith, Tammy; Ehlke, Sarah; Sosinski, Melanie; Monroe, Douglas; Thor, Jennifer			Traumatic Brain Injury: Unmet Support Needs of Caregivers and Families in Florida	PLOS ONE			English	Article							INDIVIDUALS; VALIDATION; MANAGEMENT; QUALITY; CARERS; PEOPLE; ADULTS; SCALE; LIFE	Sustaining a Traumatic Brain Injury results in familial strain due to the significant impact the injury has upon the role and function of individuals and their families at home and in the community. Using the Stress Process Model of Caregiving, a caregiver needs assessment survey was developed and conducted to better understand the needs of individuals with a Traumatic Brain Injury and their caregivers. Survey results indicate that caregivers experience many challenges including unmet needs in areas of relational supports such as maintaining relationships, long-term emotional and financial support for themselves and the survivor, and the need for a patient or caregiver advocate. Implications for future practice are presented.	[Dillahunt-Aspillaga, Christina; Jorgensen-Smith, Tammy; Thor, Jennifer] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL 33620 USA; [Monroe, Douglas] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Ehlke, Sarah] Univ N Carolina, Dept Psychol, Wilmington, NC 28401 USA; [Sosinski, Melanie] Univ S Florida, Dept Social Work, Tampa, FL USA; [Dillahunt-Aspillaga, Christina] Brain Injury Assoc Florida Inc, Tallahassee, FL USA; [Monroe, Douglas] WellFlorida Council Inc, Gainesville, FL USA		Dillahunt-Aspillaga, C (corresponding author), Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL 33620 USA.	cdillahuntas@usf.edu		Jorgensen Smith, Tammy/0000-0001-6769-7269; Dillahunt-Aspillaga, Christina/0000-0002-1231-2023			Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Boycott N, 2013, J HEAD TRAUMA REHAB, V28, P106, DOI 10.1097/HTR.0b013e31823fe07e; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; Family Caregiver Alliance, 2012, FCA FAM CAR ALL NAT; Finkelstein E., 2006, INCIDENCE EC BURDEN; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hassan STS, 2011, J NEPAL MED ASSOC, V50, P53; Hassan STS, 2012, HEALTHMED, V6, P2423; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Reinhard S, 2008, PATIENT SAFETY QUALI; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; WellFlorida Council Inc, 2012, WHAT IS TRAUM BRAIN; WellFlorida Council Inc, 2007, TRAUM BRAIN INJ STAT; WellFlorida Council Inc, 2010, TBI STAT FLOR; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	37	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e82896	10.1371/journal.pone.0082896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GT	WOS:000328737700039	24358236	Green Published, gold, Green Submitted			2022-02-06	
J	Cannizzaro, MS; Coelho, CA				Cannizzaro, Michael S.; Coelho, Carl A.			Analysis of Narrative Discourse Structure as an Ecologically Relevant Measure of Executive Function in Adults	JOURNAL OF PSYCHOLINGUISTIC RESEARCH			English	Article						Narrative discourse; Executive function; Age; Story grammar	TRAUMATIC BRAIN-INJURY; AGE-DIFFERENCES; PREFRONTAL CORTEX; YOUNG-OLD; LANGUAGE; COMPREHENSION; METHODOLOGY; IMPAIRMENTS; DISRUPTION; ACTIVATION	This study examined the narrative discourse production and executive function (EF) abilities of 46 neuro-typical adults (18-98 years old). Two questions were addressed: Is the analysis of narrative structure sensitive to changes associated with aging? & What is the relationship between measures of narrative structure and EF? Narratives were elicited under two conditions and narrative structure was analyzed for the presence of organizing story grammar elements. Narrative structure was significantly correlated with age as well as linguistic and non-linguistic measures of EF. Factor analysis of story structure and EF variables yielded two factors reflecting constructs of output-fluidity and organizational-efficiency. These data suggest that narrative structure and EF represent aspects of goal-directed knowledge that are not bound by a traditional linguistic and non-linguistic division. Thus, narrative structure may represent a global and ecologically valid measure of goal-directed executive function knowledge that is also sensitive to changes associated with typical aging.	[Cannizzaro, Michael S.] Univ Vermont, Dept Commun Sci & Disorders, Burlington, VT 05405 USA; [Coelho, Carl A.] Univ Connecticut, Dept Commun Sci, Storrs, CT 06269 USA		Cannizzaro, MS (corresponding author), Univ Vermont, Dept Commun Sci & Disorders, 401 Pomeroy Hall,489 Main St, Burlington, VT 05405 USA.	mcannizz@uvm.edu					Alexander MP, 2006, J INT NEUROPSYCH SOC, V12, P236, DOI 10.1017/S1355617706060309; Arkin S, 2001, APHASIOLOGY, V15, P533, DOI 10.1080/02687040143000032; Ash S, 2006, NEUROLOGY, V66, P1405, DOI 10.1212/01.wnl.0000210435.72614.38; Ash S, 2009, J NEUROLINGUIST, V22, P370, DOI 10.1016/j.jneuroling.2008.12.001; Blair M, 2007, J INT NEUROPSYCH SOC, V13, P237, DOI 10.1017/S1355617707070269; Blake ML, 2006, AM J SPEECH-LANG PAT, V15, P255, DOI 10.1044/1058-0360(2006/024); BORGEN FH, 1987, J COUNS PSYCHOL, V34, P456, DOI 10.1037/0022-0167.34.4.456; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cannizzaro M. S., 2012, PERSPECTIVE IN PRESS; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Capilouto G, 2005, J COMMUN DISORD, V38, P431, DOI 10.1016/j.jcomdis.2005.03.005; Chapman SB, 2002, ALZ DIS ASSOC DIS, V16, P177, DOI 10.1097/00002093-200207000-00008; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COELHO CA, 1990, J PSYCHOLINGUIST RES, V19, P405, DOI 10.1007/BF01068887; COELHO CA, 1998, ANAL DISCOURSE COMMU, P115; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COOPER PV, 1990, J GERONTOL, V45, pP210, DOI 10.1093/geronj/45.5.P210; Crozier S, 1999, NEUROPSYCHOLOGIA, V37, P1469, DOI 10.1016/S0028-3932(99)00054-8; Day A., 1985, GOOD DOG CARL; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fleming V., 2009, CLIN APH C CO MAY 26; Gaesser B., 2010, CHARACTERIZING AGE R; GLOSSER G, 1992, J GERONTOL, V47, pP266, DOI 10.1093/geronj/47.4.P266; GORDON PC, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P23; Grafman J, 1999, LANCET, V354, P1921, DOI 10.1016/S0140-6736(99)90438-5; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 1993, J HEAD TRAUMA REHAB, V8, P73, DOI DOI 10.1097/00001199-199303000-00008; Grafman J., 1989, INTEGRATING THEORY P, P93; Grafman J., 2008, OXFORD HDB HUMAN ACT, V2; Grafman J, 2006, SER INT NEUROPSYCHOL, P69, DOI 10.1017/CBO9780511545917.005; Green S.B., 2003, USING SPSS WINDOWS M, V4th ed.; HELLER RB, 1993, PSYCHOL AGING, V8, P443, DOI 10.1037/0882-7974.8.3.443; Juncos-Rabadan O, 2005, BRAIN LANG, V95, P423, DOI 10.1016/j.bandl.2005.04.001; Krueger F, 2007, CEREB CORTEX, V17, P2346, DOI 10.1093/cercor/bhl143; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); LeDorze G, 1998, J COMMUN DISORD, V31, P53, DOI 10.1016/S0021-9924(97)00051-8; LEZAK MD, 2004, NEUROPSYCHOLOGICAL A, P611; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1995, J SPEECH HEAR RES, V38, P415, DOI 10.1044/jshr.3802.415; LILES BZ, 1985, J COMMUN DISORD, V18, P409, DOI 10.1016/0021-9924(85)90030-9; Mackenzie C, 2000, INT J LANG COMM DIS, V35, P269, DOI 10.1080/136828200247188; MANDLER JM, 1977, COGNITIVE PSYCHOL, V9, P111, DOI 10.1016/0010-0285(77)90006-8; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; Marini A, 2005, J PSYCHOLINGUIST RES, V34, P439, DOI 10.1007/s10936-005-6203-z; MCCABE A, 1984, J PSYCHOLINGUIST RES, V13, P457, DOI 10.1007/BF01068179; McCabe A, 2006, IMAGINATION COGNITIO, V25, P321; McGinnis D, 2008, APPL COGNITIVE PSYCH, V22, P171, DOI 10.1002/acp.1367; McGinnis D, 2009, J GERONTOL B-PSYCHOL, V64, P202, DOI 10.1093/geronb/gbp005; MERRITT DD, 1989, J SPEECH HEAR DISORD, V54, P438, DOI 10.1044/jshd.5403.438; Miller LMS, 2009, PSYCHOL AGING, V24, P63, DOI 10.1037/a0014586; MILLIGAN GW, 1987, APPL PSYCH MEAS, V11, P329, DOI 10.1177/014662168701100401; Motes MA, 2011, COGN NEUROSCI-UK, V2, P1, DOI 10.1080/17588928.2010.512974; Murphy DR, 2006, PSYCHOL AGING, V21, P49, DOI 10.1037/0882-7974.21.1.49; Murray LL, 1999, AM J SPEECH-LANG PAT, V8, P137, DOI 10.1044/1058-0360.0802.137; Noh SR, 2007, INT J BEHAV DEV, V31, P133, DOI 10.1177/0165025407073581; Noh SR, 2009, MEM COGNITION, V37, P769, DOI 10.3758/MC.37.6.769; NORTH AJ, 1986, INT J AGING HUM DEV, V23, P267, DOI 10.2190/BPF0-2BWD-BGNQ-HWCW; OBLER LK, 1994, STUDIES ADULT CLIN P, P00015; Partiot A, 1996, NEUROREPORT, V7, P761, DOI 10.1097/00001756-199602290-00020; Peelle JE, 2008, LANG LINGUIST COMPAS, V2, P18, DOI 10.1111/j.1749-818x.2007.00047.x; Roelofs A, 2002, COGNITIVE BRAIN RES, V15, P85, DOI 10.1016/S0926-6410(02)00218-5; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; SAS J., 2007, JMP SOFTW REL 7 0 1; Schneider P, 2002, J SPEECH LANG HEAR R, V45, P372, DOI 10.1044/1092-4388(2002/029); Shadden B.B., 1998, ANAL DISCOURSE COMMU, P35; SHEWAN CM, 1988, J COMMUN DISORD, V21, P139, DOI 10.1016/0021-9924(88)90002-0; Sirigu A, 1998, CORTEX, V34, P771, DOI 10.1016/S0010-9452(08)70780-9; Sirigu A, 1996, CORTEX, V32, P297, DOI 10.1016/S0010-9452(96)80052-9; Ska Bernadette, 2009, Psychol. Neurosci., V2, P101, DOI 10.3922/j.psns.2009.2.002; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Stemmer B, 1999, BRAIN LANG, V68, P402, DOI 10.1006/brln.1999.2120; Tisserand DJ, 2003, CORTEX, V39, P1107, DOI 10.1016/S0010-9452(08)70880-3; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Tye-Murray N, 2008, INT J AUDIOL, V47, pS31, DOI 10.1080/14992020802301662; ULATOWSKA HK, 1986, BRAIN LANG, V28, P24, DOI 10.1016/0093-934X(86)90088-X; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wlotko EW, 2010, LANG LINGUIST COMPAS, V4, P623, DOI 10.1111/j.1749-818x.2010.00224.x; Wood JN, 2005, CEREB CORTEX, V15, P1155, DOI 10.1093/cercor/bhh215; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Wright HH, 2011, J SPEECH LANG HEAR R, V54, P900, DOI 10.1044/1092-4388(2010/09-0253); Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; Ylvisaker M., 2008, LANGUAGE INTERVENTIO, P879; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Zalla T, 1998, CORTEX, V34, P621, DOI 10.1016/S0010-9452(08)70519-7	85	31	33	0	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6905	1573-6555		J PSYCHOLINGUIST RES	J. Psycholinguist. Res.	DEC	2013	42	6					527	549		10.1007/s10936-012-9231-5			23	Linguistics; Psychology, Experimental	Social Science Citation Index (SSCI)	Linguistics; Psychology	238MA	WOS:000325949500003	23192423				2022-02-06	
J	Greco, T; Hovda, D; Prins, M				Greco, Tiffany; Hovda, David; Prins, Mayumi			The Effects of Repeat Traumatic Brain Injury on the Pituitary in Adolescent Rats	JOURNAL OF NEUROTRAUMA			English	Article						adolescent; GH; mild TBI; pituitary; RTBI	GROWTH-HORMONE DEFICIENCY; HEAD TRAUMA; FOOTBALL PLAYERS; SOCIAL PHOBIA; GH DEFICIENCY; HIGH-SCHOOL; FACTOR-I; HYPOPITUITARISM; DYSFUNCTION; CONCUSSION	Adolescents are one of the highest groups at risk for sustaining both traumatic brain injury (TBI) and repeat TBI (RTBI). Consequences of endocrine dysfunction following TBI have been routinely explored in adults, but studies in adolescents are limited, and show an incidence rate of endocrine dysfunction in 16-61% in patients, 1-5 years after injury. Similar to in adults, the most commonly affected axis is growth hormone (GH) and insulin-like growth hormone 1 (IGF-1). Despite TBI being the primary cause of morbidity and mortality among the pediatric population, there are currently no experimental studies specifically addressing the occurrence of pituitary dysfunction in adolescents. The present study investigated whether a sham, single injury or four repeat injuries (24 h interval) delivered to adolescent rats resulted in disruption of the GH/IGF-1 axis. Circulating levels of basal GH and IGF-1 were measured at baseline, 24 h, 72 h, 1 week, and 1 month after injury, and vascular permeability of the pituitary gland was quantified via Evans Blue dye extravasation. Changes in weight and length of animals were measured as a potential consequence of GH and IGF-1 disruption. The results from the current study demonstrate that RTBI results in significant acute and chronic decreases in circulation of GH and IGF-1, reduction in weight gain and growth, and an increase in Evans Blue dye extravasation in the pituitary compared with sham and single injury animals. RTBI causes significant disruption of the GH/IGF-1 axis that may ultimately affect normal cognitive and physical development during adolescence.	[Greco, Tiffany; Hovda, David; Prins, Mayumi] Semel Inst, Dept Neurosurg, Los Angeles, CA 90095 USA; [Greco, Tiffany; Hovda, David; Prins, Mayumi] Semel Inst, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Hovda, David; Prins, Mayumi] Semel Inst, Interdept Program Neurosci, Los Angeles, CA 90095 USA; [Hovda, David] Semel Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Greco, T (corresponding author), Semel Inst, UCLA Dept Neurosurg, 10833 Le Conte Ave,Room 18-212, Los Angeles, CA 90095 USA.	tgreco@mednet.ucla.edu	Greco, Tiffany/ABA-3519-2021; Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NFL Charities; UCLA Brain Injury Research Center, Marilyn; Austin Anderson Fellowship [NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	This work was supported by NFL Charities, UCLA Brain Injury Research Center, Marilyn and Austin Anderson Fellowship, NS058489.	Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; ALFOLDI P, 1990, AM J PHYSIOL, V258, pR634, DOI 10.1152/ajpregu.1990.258.3.R634; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Becu-Villalobos D, 1997, CELL MOL NEUROBIOL, V17, P699, DOI 10.1023/A:1022542221535; Bellone S., 2012, PITUITARY; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Blakemore SJ, 2012, J ROY SOC MED, V105, P111, DOI 10.1258/jrsm.2011.110221; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Cameron JL, 2004, ANN NY ACAD SCI, V1021, P110, DOI 10.1196/annals.1308.012; Chambers RA, 1996, NEUROPSYCHOPHARMACOL, V15, P587, DOI 10.1016/S0893-133X(96)00132-7; Choi SJ, 1997, DEV BRAIN RES, V98, P134, DOI 10.1016/S0165-3806(96)00179-4; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colrain IM, 2011, NEUROPSYCHOL REV, V21, P5, DOI 10.1007/s11065-010-9155-5; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; De Sanctis V, 2008, Georgian Med News, P18; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dupuis C, 2010, INTENS CARE MED, V36, P1906, DOI 10.1007/s00134-010-2012-4; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; GABRIEL SM, 1992, NEUROENDOCRINOLOGY, V56, P619, DOI 10.1159/000126284; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Galdiero M, 2012, J ENDOCRINOL INVEST, V35, P782, DOI 10.1007/BF03345805; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; GRONWALL D, 1975, LANCET, V2, P995; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Hua K, 2009, GLIA, V57, P1062, DOI 10.1002/glia.20829; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; Isgaard J, 2007, Minerva Endocrinol, V32, P103; Ives JC, 2007, J ATHL TRAINING, V42, P431; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lauzier F., 2012, CRIT CARE S1, V16, pP299; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Loche S, 1996, Br J Clin Pract Suppl, V85, P1; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; McDonald A, 2008, J PEDIATR-US, V152, P590, DOI 10.1016/j.jpeds.2007.12.046; McHugh T, 2006, BRAIN COGNITION, V60, P209; Molina DP, 2012, NEUROBIOL AGING, V33, P1938, DOI 10.1016/j.neurobiolaging.2011.09.014; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; NANCE DM, 1983, NEUROSCI BIOBEHAV R, V7, P189, DOI 10.1016/0149-7634(83)90015-5; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Noguchi T, 1996, HORM RES, V45, P5, DOI 10.1159/000184752; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; PELTON EW, 1977, NEUROLOGY, V27, P282, DOI 10.1212/WNL.27.3.282; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; PRIMUS RJ, 1989, DEV PSYCHOBIOL, V22, P633, DOI 10.1002/dev.420220608; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Ramsey MM, 2004, NEUROSCIENCE, V129, P119, DOI 10.1016/j.neuroscience.2004.08.001; Rizzoti K, 2010, EUR J NEUROSCI, V32, P2053, DOI 10.1111/j.1460-9568.2010.07524.x; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schaeffer M, 2011, J MOL ENDOCRINOL, V47, pR59, DOI 10.1530/JME-11-0035; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider M., 2013, CELL TISSUE RES; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SPEAR LP, 1980, PSYCHOPHARMACOLOGY, V70, P47, DOI 10.1007/BF00432369; Srinivas R, 2010, CHILD NERV SYST, V26, P647, DOI 10.1007/s00381-009-1038-9; Stabler B, 1996, ANXIETY, V2, P86, DOI 10.1002/(SICI)1522-7154(1996)2:2<86::AID-ANXI4>3.0.CO;2-B; Stabler B, 1996, HORM RES, V45, P30, DOI 10.1159/000184755; STABLER B, 1992, CLIN ENDOCRINOL, V36, P467, DOI 10.1111/j.1365-2265.1992.tb02247.x; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; van Dam PS, 2004, EUR J PHARMACOL, V490, P87, DOI 10.1016/j.ejphar.2004.02.047; VANEDEN CG, 1990, PROG BRAIN RES, V85, P169; Veldhuis JD, 2006, ENDOCR REV, V27, P101, DOI 10.1210/er.2005-0006; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Verrillo E, 2011, NEUROENDOCRINOLOGY, V94, P66, DOI 10.1159/000326818; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Whitehead, 2001, ENDOCRINOLOGY INTEGR; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200	86	31	31	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1983	1990		10.1089/neu.2013.2990			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400007	23862570	Green Published			2022-02-06	
J	Savigni, DL; Doig, RLO; Szymanski, CR; Bartlett, CA; Lozic, I; Smith, NM; Fitzgerald, M				Savigni, Donna L.; Doig, Ryan L. O'Hare; Szymanski, Charis R.; Bartlett, Carole A.; Lozic, Ivan; Smith, Nicole M.; Fitzgerald, Melinda			Three Ca2+ channel inhibitors in combination limit chronic secondary degeneration following neurotrauma	NEUROPHARMACOLOGY			English	Article						Secondary degeneration; Ca2+ channel inhibitors; Myelin; Myelin compaction; Neurotrauma; Visual system; Node/paranode complex; Oxidative stress	SPINAL-CORD-INJURY; RETINAL GANGLION-CELLS; OPTIC-NERVE; NMDA RECEPTORS; AXONAL DEGENERATION; LIPID-PEROXIDATION; MYELIN; BLOCKER; RATS; OLIGODENDROCYTES	Following neurotrauma, cells beyond the initial trauma site undergo secondary degeneration, with excess Ca2+ a likely trigger for loss of neurons, compact myelin and function. Treatment using inhibitors of specific Ca2+ channels has shown promise in preclinical studies, but clinical trials have been disappointing and combinatorial approaches are needed. We assessed efficacy of multiple combinations of three Ca2+ channel inhibitors at reducing secondary degeneration following partial optic nerve transection in rat. We used lomerizine to inhibit voltage gated Ca2+ channels; oxidised adenosine-triphosphate (oxATP) to inhibit purinergic P2X(7) receptors and/or 2-[7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-1,2,3,4-tetrahydro quinoxalin-1-yl]acetic acid (INQ) to inhibit Ca2+ permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Only the three Ca2+ channel inhibitors delivered in combination significantly preserved visual function, as assessed using the optokinetic nystagmus visual reflex, at 3 months after injury. Preservation of retinal ganglion cells was partial and is unlikely to have accounted for differential effects on function. A range of the Ca2+ channel inhibitor combinations prevented swelling of optic nerve vulnerable to secondary degeneration. Each of the treatments involving lomerizine significantly increased the proportion of axons with normal compact myelin. Nevertheless, limiting decompaction of myelin was not sufficient for preservation of function in our model. Multiple combinations of Ca2+ channel inhibitors reduced formation of atypical node/paranode complexes; outcomes were not associated with preservation of visual function. However, prevention of lengthening of the paranodal gap that was only achieved by treatment with the three Ca2+ channel inhibitors in combination was an important additional effect that likely contributed to the associated preservation of the optokinetic reflex using this combinatorial treatment strategy. (C) 2013 Elsevier Ltd. All rights reserved.	[Savigni, Donna L.; Doig, Ryan L. O'Hare; Szymanski, Charis R.; Bartlett, Carole A.; Lozic, Ivan; Smith, Nicole M.; Fitzgerald, Melinda] Univ Western Australia, Crawley, WA 6009, Australia; [Savigni, Donna L.; Doig, Ryan L. O'Hare; Szymanski, Charis R.; Bartlett, Carole A.; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Crawley, WA 6009, Australia; [Lozic, Ivan; Smith, Nicole M.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Crawley, WA 6009, Australia.	lindy.fitzgerald@uwa.edu.au	Smith, Nicole/L-2502-2013; Doig, Ryan O'Hare/AAG-7585-2019; Fitzgerald, Melinda/C-4235-2011	Smith, Nicole/0000-0002-5519-8152; Fitzgerald, Melinda/0000-0002-4823-8179; Lozic, Ivan/0000-0001-7441-743X	Neurotrauma Research Program (Western Australia); National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [572550]	This work was supported by the Neurotrauma Research Program (Western Australia) and the National Health and Medical Research Council (NH&MRC, Grant ID: 572550). Our funding sources played no role in the conduct of the research or preparation of this article. We thank Mr. Michael Archer for technical assistance with electron microscopy, Dr K. Swaminathan Iyer for advice regarding synthesis of INQ and Ms Sophie C. Payne for helpful discussions and critical review of the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Araujo IM, 2007, CELL DEATH DIFFER, V14, P1635, DOI 10.1038/sj.cdd.4402171; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Back SA, 1998, J NEUROSCI, V18, P6241; Beazley LD, 1996, RESTOR NEUROL NEUROS, V10, P95, DOI 10.3233/RNN-1996-10205; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bizzozero OA, 2004, NEUROCHEM RES, V29, P1675, DOI 10.1023/B:NERE.0000035802.27087.16; Blair M, 2005, INVEST OPHTH VIS SCI, V46, P884, DOI 10.1167/iovs.04-0731; Buttermore ED, 2011, J NEUROSCI, V31, P8013, DOI 10.1523/JNEUROSCI.1015-11.2011; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; Camello-Almaraz MC, 2006, J CELL PHYSIOL, V206, P487, DOI 10.1002/jcp.20498; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dupree JL, 1998, J NEUROSCI, V18, P1642; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hara H, 1999, CLIN EXP PHARMACOL P, V26, P870, DOI 10.1046/j.1440-1681.1999.03154.x; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Imaizumi T, 1999, BRAIN RES, V817, P84, DOI 10.1016/S0006-8993(98)01214-1; Juurlink BHJ, 1998, GLIA, V22, P371, DOI 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6; Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karim MD, 2006, CURR EYE RES, V31, P273, DOI 10.1080/02713680500536647; Kennedy C., 2007, XPHARM COMPREHENSIVE, P1; Khodorov B, 2004, PROG BIOPHYS MOL BIO, V86, P279, DOI 10.1016/j.pbiomolbio.2003.10.002; Klein KU, 2010, BEST PRACT RES-CLIN, V24, P535, DOI 10.1016/j.bpa.2010.10.008; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li SX, 2000, J NEUROPHYSIOL, V84, P1116; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Matute C, 1998, P NATL ACAD SCI USA, V95, P10229, DOI 10.1073/pnas.95.17.10229; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Phokeo V, 2002, J COMP NEUROL, V451, P213, DOI 10.1002/cne.10330; Pitt D, 2010, BRAIN RES, V1309, P146, DOI 10.1016/j.brainres.2009.10.066; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Saggu SK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-97; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Selt M, 2010, BRAIN RES BULL, V81, P467, DOI 10.1016/j.brainresbull.2009.11.004; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Sykova E, 2008, NEUROCHEM INT, V52, P5, DOI 10.1016/j.neuint.2007.04.007; Syntichaki P, 2003, NAT REV NEUROSCI, V4, P672, DOI 10.1038/nrn1174; Takahashi M, 2002, CNS DRUG REV, V8, P337; Tamaki Y, 2003, INVEST OPHTH VIS SCI, V44, P4864, DOI 10.1167/iovs.02-1173; Toriu N, 2000, EXP EYE RES, V70, P475, DOI 10.1006/exer.1999.0809; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; WONG EHF, 1991, ANNU REV PHARMACOL, V31, P401; Yamada H, 2006, BRAIN RES, V1071, P75, DOI 10.1016/j.brainres.2005.11.072; YANAGISAWA K, 1988, J NEUROCHEM, V51, P803, DOI 10.1111/j.1471-4159.1988.tb01815.x	73	31	31	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	DEC	2013	75				SI		380	390		10.1016/j.neuropharm.2013.07.034			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	300UU	WOS:000330490300039	23958451	Green Submitted			2022-02-06	
J	Adnan, A; Crawley, A; Mikulis, D; Moscovitch, M; Colella, B; Green, R				Adnan, Areeba; Crawley, Adrian; Mikulis, David; Moscovitch, Morris; Colella, Brenda; Green, Robin			Moderate-severe traumatic brain injury causes delayed loss of white matter integrity: Evidence of fornix deterioration in the chronic stage of injury	BRAIN INJURY			English	Article						Chronic brain injury; diffusion tensor imaging; fornix; fractional anisotropy; neurodegeneration; traumatic brain injury	DIFFUSE AXONAL INJURY; HEAD-INJURY; TENSOR TRACTOGRAPHY; PROGRESSIVE ATROPHY; MEMORY; RATS; TBI; NEUROPATHOLOGY; DEGENERATION; ANISOTROPY	Objectives: To examine structural integrity loss in the fornix from 5-30 months after moderate and severe traumatic brain injury (TBI) using diffusion tensor imaging. Methods: MRIs were prospectively undertaken in 29 adults with moderate and severe TBI at two time points. Fractional anisotropy (FA) was calculated for the fornix (column/body, right crux and left crux) at 5 and 30 months post-injury. Results: Paired t-tests revealed significant FA reductions with large effect sizes across time in the column/body, p<0.001, right crux, p<0.001 and left crux, p<0.001. Conclusions: These data contribute to the growing body of evidence that loss of white matter continues in moderate and severe TBI even after the acute neurological effects of TBI have resolved. As the fornix plays a critical role in memory, this may be a contributing factor to the poor clinical outcomes observed in these patients.	[Adnan, Areeba] Toronto Rehabil Inst, Toronto, ON, Canada; [Crawley, Adrian; Mikulis, David] Univ Toronto, Univ Hlth Network, Div Neuroradiol, Dept Med Imaging, Toronto, ON, Canada; [Moscovitch, Morris] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Moscovitch, Morris] Baycrest Ctr Geriatr Hlth, Rotman Res Inst, Toronto, ON, Canada; [Colella, Brenda; Green, Robin] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada		Green, R (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	robin.green@uhn.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892; Green, Robin/0000-0001-9451-3963	Toronto Rehabilitation InstituteUniversity of Toronto; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Physicians Services Incorporated Foundation; Ontario Neurotrauma Foundation; Canada Research Chairs ProgramCanada Research Chairs	The authors acknowledge the support of Toronto Rehabilitation Institute, Canadian Institute of Health Research, Physicians Services Incorporated Foundation, the Ontario Neurotrauma Foundation, and the Canada Research Chairs Program. The authors report no conflicts of interest.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Andersson J., 2007, TR07JA2 FMRIB CTR; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, P1006; Fox RJ, 2011, AM J NEURORADIOL, V32, P85, DOI 10.3174/ajnr.A2238; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hannay HJ, 2004, NEUROPSYCHOLOGICAL A, P160; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jang SH, 2011, INT J NEUROSCI, V121, P94, DOI 10.3109/00207454.2010.531894; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kolb B, 2011, J COMMUN DISORD, V44, P503, DOI 10.1016/j.jcomdis.2011.04.007; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith C, 2012, NEUROPATHOLOGY APPL; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tsivilis D, 2008, NAT NEUROSCI, V11, P834, DOI 10.1038/nn.2149; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zhan W, 2010, SET2010 9TH INTERNAT, P1	59	31	32	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1415	1422		10.3109/02699052.2013.823659			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500012	24102365				2022-02-06	
J	Ning, YL; Yang, N; Chen, X; Xiong, RP; Zhang, XZ; Li, P; Zhao, Y; Chen, XY; Liu, P; Peng, Y; Wang, ZG; Chen, JF; Zhou, YG				Ning, Ya-Lei; Yang, Nan; Chen, Xing; Xiong, Ren-Ping; Zhang, Xiu-Zhu; Li, Ping; Zhao, Yan; Chen, Xing-Yun; Liu, Ping; Peng, Yan; Wang, Zheng-Guo; Chen, Jiang-Fan; Zhou, Yuan-Guo			Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						adenosine; brain trauma; cognitive impairment; experimental; neuroprotection	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; BONE-MARROW-CELLS; A(2A) RECEPTORS; SELECTIVE INACTIVATION; WORKING-MEMORY; BLOCKADE; INVOLVEMENT	Traumatic brain injury (TBI), particularly explosive blast-induced TBI (bTBI), has become the most prevalent injury among military personnel. The disruption of cognitive function is one of the most serious consequences of bTBI because its long-lasting effects prevent survivors fulfilling their active duty and resuming normal civilian life. However, the mechanisms are poorly understood and there is no treatment available. This study investigated the effects of adenosine A2A receptor (A2AR) on bTBI-induced cognitive deficit, and explored the underlying mechanisms. After being subjected to moderate whole-body blast injury, mice lacking the A2AR (A2AR knockout (KO)) showed less severity and shorter duration of impaired spatial reference memory and working memory than wild-type mice did. In addition, bTBI-induced cortical and hippocampal lesions, as well as proinflammatory cytokine expression, glutamate release, edema, cell loss, and gliosis in both early and prolonged phases of the injury, were significantly attenuated in A2AR KO mice. The results suggest that early injury and chronic neuropathological damages are important mechanisms of bTBI-induced cognitive impairment, and that the impairment can be attenuated by preventing A2AR activation. These findings suggest that A2AR antagonism is a potential therapeutic strategy for mild-to-moderate bTBI and consequent cognitive impairment.	[Ning, Ya-Lei; Yang, Nan; Chen, Xing; Xiong, Ren-Ping; Li, Ping; Zhao, Yan; Chen, Xing-Yun; Liu, Ping; Peng, Yan; Zhou, Yuan-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, Chongqing 400042, Peoples R China; [Ning, Ya-Lei; Yang, Nan; Chen, Xing; Xiong, Ren-Ping; Zhang, Xiu-Zhu; Li, Ping; Zhao, Yan; Chen, Xing-Yun; Liu, Ping; Peng, Yan; Wang, Zheng-Guo; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Zhang, Xiu-Zhu; Wang, Zheng-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Dept 4, Chongqing 400042, Peoples R China; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Zhou, YG (corresponding author), Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China.	yuanguo.zhou@gmail.com	Li, ping/J-6507-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31171022, 81201461]; Key Project of Medicine and Health of PLA [08G098]	This work was supported by grants from the National Natural Science Foundation of China (No. 31171022 and No. 81201461) and Key Project of Medicine and Health of PLA (No. 08G098).	Brambilla R, 2003, GLIA, V43, P190, DOI 10.1002/glia.10243; Bura SA, 2008, PAIN, V140, P95, DOI 10.1016/j.pain.2008.07.012; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 1999, WORLD J SURG, V23, P44, DOI 10.1007/s002689900563; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Cunha GMA, 2008, EXP NEUROL, V210, P776, DOI 10.1016/j.expneurol.2007.11.013; Cunha RA, 2008, CURR PHARM DESIGN, V14, P1512, DOI 10.2174/138161208784480090; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROCHEM, V113, P1536, DOI 10.1111/j.1471-4159.2010.06716.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gui L, 2009, BRAIN RES, V1297, P185, DOI 10.1016/j.brainres.2009.08.050; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Kensinger EA, 2003, NEUROPSYCHOLOGY, V17, P230, DOI 10.1037/0894-4105.17.2.230; Kochanek PM, 2005, J CEREBR BLOOD F MET, V25, P1596, DOI 10.1038/sj.jcbfm.9600154; Kusano Y, 2010, J CEREBR BLOOD F MET, V30, P808, DOI 10.1038/jcbfm.2009.244; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Minghetti L, 2007, J NEUROPATH EXP NEUR, V66, P363, DOI 10.1097/nen.0b013e3180517477; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Popoli P., 2003, Neurology, V61, pS69; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Scott HA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.008; Shen HY, 2010, J NEUROTRAUM, V27, P373, DOI 10.1089/neu.2009.0926; Takahashi RN, 2008, FRONT BIOSCI-LANDMRK, V13, P2614, DOI 10.2741/2870; Wang Z G, 1989, Zhonghua Yi Xue Za Zhi, V69, P7; Wei CJ, 2011, LEARN MEMORY, V18, P459, DOI 10.1101/lm.2136011; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103; Zhou SJ, 2009, BRAIN RES, V1303, P74, DOI 10.1016/j.brainres.2009.09.082	40	31	34	1	32	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2013	33	11					1789	1798		10.1038/jcbfm.2013.127			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	246SL	WOS:000326559300016	23921902	Bronze, Green Published			2022-02-06	
J	Avesani, R; Roncari, L; Khansefid, M; Formisano, R; Boldrini, P; Zampolini, M; Ferro, S; De Tanti, A; Dambruoso, F				Avesani, R.; Roncari, L.; Khansefid, M.; Formisano, R.; Boldrini, P.; Zampolini, M.; Ferro, S.; De Tanti, A.; Dambruoso, F.			The Italian National Registry of severe acquired brain injury: epidemiological, clinical and functional data of 1469 patients	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Rehabilitation; Outcome assessment; Hypoxia, brain; Cerebrovascular disorders; Brain injuries	DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; LENGTH-OF-STAY; CARDIAC-ARREST; MODEL SYSTEMS; REHABILITATION; DISCHARGE; RECOVERY; MODERATE; OUTCOMES	Background. The lack of knowledge about epidemiological and clinical data of patients with Acquired Brain Injury (ABI) admitted to Rehabilitation facilities in Italy led to the creation, in June 2008, of a data collection on-line registry. Aim. To collect epidemiological and clinical data and to evaluate functional outcome of patients with severe traumatic and non-traumatic ABI admitted to Rehabilitation facilities in Italy between June 2008 and December 2011 and to compare data of patients with ABI of different aetiologies. Design. Observational retrospective study. Setting. The study involved 29 Italian Rehabilitation facilities. Population. The study enrolled 1469 patients with severe traumatic (TBI) and non-traumatic ABI (NTBI). Methods. Data collected included demographic (number of patients with TBI and NTBI, gender, age) and clinical characteristics (provenience, number of days elapsed between onset and rehabilitation admission, rehabilitation length of stay, discharge destination, death and vegetative state diagnosis, presence of percutaneous endoscopic gastrostomy, tracheostomy, pressure sores and paraosteoarthropathies). Functional outcome was evaluated using the Disability Rating Scale. Results. Of the whole population studied, 44.31% and 55.69% patients had suffered a TBI and a NTBI, respectively. In the NTBI group 40.09% had a cerebrovascular injury, 12.04% an anoxic brain damage, 3.6% had a brain injury of other causes. The mean age was 43.67 and 56.68 for subjects with TBI and NTBI, respectively. Patients with TBI showed a lower onset-admission interval (OAI), compared with NTBI group; no difference in rehabilitation length of stay (LOS) was recorded between groups. Patients with TBI presented a lower DRS score at admission and discharge and returned home more frequently than NTBI group. Conclusions. The creation of a National registry allows the collection of data about patients with ABI in order to study the clinical course, the functional outcome and to establish a basis for comparison with other data sources. Clinical Rehabilitation Impact. Data collection could be useful in the evaluation and planning of rehabilitation pathways, and to assess the allocation of healthcare and rehabilitative resources.	[Avesani, R.; Khansefid, M.; Dambruoso, F.] Sacro Cuore Don Calabria Hosp, Dept Rehabil, I-37024 Verona, Italy; [Roncari, L.; Dambruoso, F.] Univ Verona, Dept Rehabil Med, I-37100 Verona, Italy; [Formisano, R.] S Lucia IRCCS Hosp, Dept Rehabil, Rome, Italy; [Boldrini, P.] Ca Foncello Hosp, Dept Rehabil, Treviso, Italy; [Zampolini, M.] ASL 3, Dept Rehabil, Umbria, Trevi Perugia, Italy; [Ferro, S.] Agenzia Sanitaria Reg Emilia Romagna, Serv Presidi Osped, Bologna, Italy; [De Tanti, A.] Cardinal Ferrari Hosp, Dept Rehabil, Fontanellato Parma, Italy		Avesani, R (corresponding author), Sacro Cuore Don Calabria Hosp, Dept Rehabil, Via Don A Sempreboni 5, I-37024 Verona, Italy.	renato.avesani@sacrocuore.it			National Health Services funds [502/92]	The work has been supported with National Health Services funds of research project in accordance with art. 12 of Italian Legislative Decree 502/92. Neither financial nor material support was required for the design and conduct of the study, in the collection, analysis and interpretation of the data, and in the preparation, review or approval of the manuscript.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Avesani R, 2012, EUR J PHYS REHAB MED, V48, P433; Avesani R, 2011, EUR J PHYS REHAB MED, V47, P203; Boldrini P, 2004, EUROPA MEDICOPHYS S1, V40, P9; Boldrini P, 2002, G ITAL MED RIABIL, V16, P61; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Gazzellini S, 2012, EUR J PHYS REHAB MED, V48, P423; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hakkennes S, 2012, INT J REHABIL RES, V35, P323, DOI 10.1097/MRR.0b013e328355dd00; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reinier K, 2011, CAN MED ASSOC J, V183, P1705, DOI 10.1503/cmaj.101512; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Sirois MJ, 2004, ARCH PHYS MED REHAB, V85, P184, DOI 10.1016/j.apmr.2003.06.009; Smania N, 2012, J HEAD TRAUMA REHABI; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taricco M, 2007, ITAL J REHAB MED MR, V21, P53; Tarrico M, 2004, EUROPA MEDICOPHYS S1, P73; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Toigo G, 2005, G GERONTOL, VLIII, P603; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358; Zampolini M, 2012, EUR J PHYS IN PRESS; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125	36	31	31	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	OCT	2013	49	5					611	618					8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	283TA	WOS:000329268700001	23558700				2022-02-06	
J	Jiang, XF; Huang, Y; Lin, W; Gao, DK; Fei, Z				Jiang, Xiaofan; Huang, Yi; Lin, Wei; Gao, Dakuan; Fei, Zhou			Protective effects of hydrogen sulfide in a rat model of traumatic brain injury via activation of mitochondrial adenosine triphosphate-sensitive potassium channels and reduction of oxidative stress	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Oxidative stress; Hydrogen sulfide; mitoK(ATP) channels	ISCHEMIA-REPERFUSION INJURY; K-ATP CHANNELS; SIGNALING MOLECULE; HEMORRHAGIC-SHOCK; NEURONAL CELLS; IN-VIVO; MICE; IMPACT; MARKERS; SALINE	Background: Hydrogen sulfide (H2S) is considered an important neuromodulator in the central nervous system. We designed the present study to investigate the effects of exogenous H2S in a rat model of traumatic brain injury (TBI) and the mechanism(s) that underlie this effect. Methods: We induced a TBI model by controlled cortical impact injury. We intraperitoneally administered sodium hydrosulfide (NaHS) (an H2S donor) (3 mg/kg) or vehicle alone at 5 min after a TBI operation. We then measured the H2S level, brain edema, blood-brain barrier integrity, neurologic dysfunction, and lesion volume in all animals. Moreover, we assessed the role of mitochondrial adenosine triphosphate-sensitive potassium (mitoK(ATP)) channels by intraperitoneal injection of the selective blocker 5-hydroxydecanoate before NaHS administration. In addition, we detected the levels of oxidative products and the activities of antioxidant enzymes in brain tissue. Results: Administration of NaHS significantly increased the H2S level of brain tissue in TBI-challenged rats. The TBI-challenged animals exhibited significant brain injuries, characterized by an increase of blood-brain barrier permeability, brain edema, and lesion volume, as well as neurologic dysfunction, which were significantly ameliorated by NaHS treatment. However, the protective effects of H2S in TBI could be abolished by the mitoK(ATP)channel blocker 5-hydroxydecanoate. Moreover, we found that NaHS treatment increased endogenous antioxidant enzymatic activities and decreased oxidative product levels in brain tissue of TBI-challenged rats. Conclusions: Exogenous H2S administered at an appropriate dose can exert a protective effect against TBI via activation of mitoK(ATP) channels and reduction of oxidative stress. (C) 2013 Elsevier Inc. All rights reserved.	[Jiang, Xiaofan; Lin, Wei; Gao, Dakuan; Fei, Zhou] Fourth Mil Med Univ, Dept Neurosurg, Xijing Inst Clin Neurosci, Xiing Hosp, Xian 710032, Shaanxi Provinc, Peoples R China; [Huang, Yi] Fourth Mil Med Univ, Dept Anesthesiol, Xiing Hosp, Xian 710032, Shaanxi Provinc, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Inst Clin Neurosci, Xiing Hosp, Xian 710032, Shaanxi Provinc, Peoples R China.	Tougaozy2011@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81071034]	This work was supported by grant 81071034 from the National Natural Science Foundation of China.	Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Benetti LR, 2013, EUR J PHARMACOL, V698, P463, DOI 10.1016/j.ejphar.2012.11.025; Busija DW, 2004, BRAIN RES REV, V46, P282, DOI 10.1016/j.brainresrev.2004.06.011; Chai W, 2012, J SURG RES, V176, P210, DOI 10.1016/j.jss.2011.07.016; Davis A E, 2000, Crit Care Nurs Clin North Am, V12, P447; Dogan A, 1997, J NEUROSURG, V87, P921, DOI 10.3171/jns.1997.87.6.0921; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hu LF, 2011, ANTIOXID REDOX SIGN, V15, P405, DOI 10.1089/ars.2010.3517; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Johansen D, 2006, BASIC RES CARDIOL, V101, P53, DOI 10.1007/s00395-005-0569-9; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kumar A, 2008, NEONATOLOGY, V94, P96, DOI 10.1159/000116633; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu DD, 2008, CRIT CARE MED, V36, P565, DOI 10.1097/01.CCM.0000299737.24338.5C; Liu YY, 2013, NEUROCHEM INT, V62, P603, DOI 10.1016/j.neuint.2012.12.010; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Peers C, 2012, ANTIOXID REDOX SIGN, V17, P95, DOI 10.1089/ars.2011.4359; Sakamoto M, 2002, NEUROL RES, V24, P301, DOI 10.1179/016164102101199783; Satpute RM, 2009, FOOD CHEM TOXICOL, V47, P2689, DOI 10.1016/j.fct.2009.06.007; Shen XG, 2011, FREE RADICAL BIO MED, V50, P1021, DOI 10.1016/j.freeradbiomed.2011.01.025; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Yang Guangdong, 2011, Expert Rev Clin Pharmacol, V4, P33, DOI 10.1586/ecp.10.131; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	45	31	32	3	23	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	OCT	2013	184	2					E27	E35		10.1016/j.jss.2013.03.067			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	215XE	WOS:000324243500004	23590867				2022-02-06	
J	Spitz, G; Bigler, ED; Abildskov, T; Maller, JJ; O'Sullivan, R; Ponsford, JL				Spitz, Gershon; Bigler, Erin D.; Abildskov, Tracy; Maller, Jerome J.; O'Sullivan, Richard; Ponsford, Jennie L.			Regional cortical volume and cognitive functioning following traumatic brain injury	BRAIN AND COGNITION			English	Article						Traumatic brain injury; MRI; Neuropsychology; Cognition	SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; WORKING-MEMORY; TEMPORAL-LOBE; WHITE-MATTER; LONGITUDINAL CHANGES; DIFFUSION-TENSOR; HEAD-INJURY; CONNECTIVITY; ATROPHY	There has been limited examination of the effect of brain pathology on subsequent function. The current study examined the relationships between regional variation in grey matter volume, age and cognitive impairment using a semi-automated image analysis tool. This study included 69 individuals with mild-to-severe TBI, 41 of whom also completed neuropsychological tests of attention, working memory, processing speed, memory and executive functions. A widespread reduction in grey matter volume was associated with increasing age. Regional volumes that were affected also related to the severity of injury, whereby the most severe TBI participants displayed the most significant pathology. Poorer retention of newly learned material was associated with reduced cortical volume in frontal, parietal, and occipital brain regions. In addition, poorer working memory and executive control performance was found for individuals with lower cortical volume in temporal, parietal, and occipital regions. These findings are largely in line with previous literature, which suggests that frontal, temporal, and parietal regions are integral for the encoding of memories into long-term storage, memory retrieval, and working memory. The present study suggests that automated image analysis methods may be used to explore the relationships between regional variation in grey matter volume and cognitive function following TBI. (c) 2013 Elsevier Inc. All rights reserved.	[Spitz, Gershon; Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Spitz, Gershon; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT 84132 USA; [Abildskov, Tracy] Brigham Young Univ, Dept Psychol Sci, Provo, UT 84602 USA; [Maller, Jerome J.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Maller, Jerome J.] Alfred Hosp, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [O'Sullivan, Richard] Epworth Med Fdn, Healthcare Imaging Serv, Melbourne, Vic, Australia		Spitz, G (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	Gershon.Spitz@monash.edu	Maller, Jerome J/H-4963-2014; Spitz, Gershon/H-7755-2014	Maller, Jerome J/0000-0003-4685-1508; Spitz, Gershon/0000-0002-7810-1480			Access Economics , 2009, EC COST SPIN CORD IN; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; Arenivas A., 2012, BRAIN IMAGING BEHAV, V13, P1; Axmacher N, 2007, J NEUROSCI, V27, P7807, DOI 10.1523/JNEUROSCI.0962-07.2007; BADDELEY A, 1994, DOORS PEOPLE; Beer AL, 2011, EXP BRAIN RES, V213, P299, DOI 10.1007/s00221-011-2715-y; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benton AL, 1994, MULTILINGUAL APHASIA; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Burgess P.W., 1997, HAYLING BRIXTON TEST; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Coughhlan AK, 2007, BIRT MEMORY INFORM P; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Makris N., 2012, BRAIN STRUCTURE FUNC; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Morris RG, 1997, COGN NEUROPSYCHOL, V14, P1007, DOI 10.1080/026432997381330; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; Park H, 2011, BRAIN CONNECT, V1, P460, DOI 10.1089/brain.2011.0046; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Reitan R, 1988, HALSTEAD REITAN NEUR; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith, 1973, SYMBOL DIGIT MODALIT; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Strangman G. E., 2010, FRONT HUM NEUROSCI, V4, P181; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	86	31	33	1	36	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	OCT	2013	83	1					34	44		10.1016/j.bandc.2013.06.007			11	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	210UK	WOS:000323860000005	23872098				2022-02-06	
J	Barker-Collo, S; Starkey, N; Theadom, A				Barker-Collo, Suzanne; Starkey, Nicola; Theadom, Alice			Treatment for depression following mild traumatic brain injury in adults: A meta-analysis	BRAIN INJURY			English	Article						Antidepressants; CBT; depression; interventions; Meta-analysis; mild brain injury; TBI; treatment	MAJOR DEPRESSION; HEAD-INJURY; SERTRALINE; EPIDEMIOLOGY; CITALOPRAM; DISORDERS; THERAPY; IMPACT; TRIALS	Primary objective: Development of depression after TBI is linked to poorer outcomes. The aim of this manuscript is to review evidence for the effectiveness of current treatments. Research design: Two meta-analyses were undertaken to examine the effectiveness of both pharmacological and non-pharmacological interventions for depression after mild TBI Method and procedures: PubMed, Medline, PsychInfo, Web of Science and Digital Dissertations were searched and 13 studies located. Meta Analyst Beta 3.13 was used to conduct analyses of pre- vs post-effects then to examine treatment group vs control group effects. Main outcomes and results: Studies using a pre-post design produced an overall effect size of 1.89 (95% CI = 1.20-2.58, p<0.001), suggesting that treatments were effective; however, the overall effect for controlled trials was 0.46 (95% CI = -0.44-1.36, p<0.001), which favoured the control rather than treatment groups. Conclusions: This study highlights the need for additional large well-controlled trials of effective treatments for depression post-TBI.	[Barker-Collo, Suzanne] Univ Auckland, Dept Psychol, Fac Sci, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Fac Arts & Social Sci, Sch Psychol, Hamilton, New Zealand; [Theadom, Alice] AUT Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Dept Psychol, Tamaki Campus,Private Bag 92019, Auckland, New Zealand.	s.barker-collo@auckland.ac.nz	Starkey, Nicola/AAJ-3795-2020	Starkey, Nicola/0000-0002-4370-8186; Theadom, Alice/0000-0003-0351-6216			Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Baker-Price L, 2003, PERCEPT MOTOR SKILL, V96, P965, DOI 10.2466/PMS.96.3.965-974; BakerPrice LA, 1996, PERCEPT MOTOR SKILL, V83, P491, DOI 10.2466/pms.1996.83.2.491; Borenstein M., 2009, INTRO METAANALYSIS, P69, DOI DOI 10.1002/9780470743386.CH12; Borenstein M, 2009, INTRO METAANALYSIS, P53; Borenstein M., 2009, INTRO METAANALYSIS, P139; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Gaultieri CT, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P411; Grant I, 1987, NEUROBEHAVIOURAL REC; Hedges LV., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kanetani Kouichi, 2003, Journal of Nippon Medical School, V70, P313; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Leonard KL, 2002, COGNITIVE BEHAV INTE; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Price A, 2011, J NEUROL NEUROSUR PS, V82, P914, DOI 10.1136/jnnp.2010.230862; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Robinson RG, 2005, TXB TRAUMATIC BRAIN, P201; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Villar J, 1997, J CLIN EPIDEMIOL, V50, P997, DOI 10.1016/S0895-4356(97)00148-0; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]	50	31	32	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2013	27	10					1124	1133		10.3109/02699052.2013.801513			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	204KW	WOS:000323365200004	23895287	Green Accepted			2022-02-06	
J	Hammeke, TA; McCrea, M; Coats, SM; Verber, MD; Durgerian, S; Flora, K; Olsen, GS; Leo, PD; Gennarelli, TA; Rao, SM				Hammeke, Thomas A.; McCrea, Michael; Coats, Sarah M.; Verber, Matthew D.; Durgerian, Sally; Flora, Kristin; Olsen, Gary S.; Leo, Peter D.; Gennarelli, Thomas A.; Rao, Stephen M.			Acute and Subacute Changes in Neural Activation during the Recovery from Sport-Related Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						fMRI; Brain activation; Mild TBI; Cognitive compensation; Brain injury; Attention networks	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; MILD HEAD-INJURY; WORKING-MEMORY; FUNCTIONAL ABNORMALITIES; NCAA CONCUSSION; ATTENTION; SYMPTOMS; FMRI; METAANALYSIS	To study the natural recovery from sports concussion, 12 concussed high school football athletes and 12 matched uninjured teammates were evaluated with symptom rating scales, tests of postural balance and cognition, and an event-related fMRI study during performance of a load-dependent working memory task at 13 h and 7 weeks following injury. Injured athletes showed the expected postconcussive symptoms and cognitive decline with decreased reaction time (RT) and increased RT variability on a working memory task during the acute period and an apparent full recovery 7 weeks later. Brain activation patterns showed decreased activation of right hemisphere attentional networks in injured athletes relative to controls during the acute period with a reversed pattern of activation (injured > controls) in the same networks at 7 weeks following injury. These changes coincided with a decrease in self-reported postconcussive symptoms and improved cognitive test performance in the injured athletes. Results from this exploratory study suggest that decreased activation of right hemisphere attentional networks mediate the cognitive changes and postconcussion symptoms observed during the acute period following concussion. Conversely, improvement in cognitive functioning and postconcussive symptoms during the subacute period may be mediated by compensatory increases in activation of this same attentional network.	[Hammeke, Thomas A.] Med Coll Wisconsin, Clement J Zablocki VA Med Ctr, Milwaukee, WI 53226 USA; [Hammeke, Thomas A.] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [McCrea, Michael; Gennarelli, Thomas A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Coats, Sarah M.] St Marys Hosp, Inst Rehabil, Enid, OK USA; [Verber, Matthew D.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Durgerian, Sally; Leo, Peter D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Flora, Kristin] Franklin Coll, Dept Psychol, Franklin, IN USA; [Olsen, Gary S.] Marshfield Clin Fdn Med Res & Educ, Dept Neuropsychol, Marshfield, WI USA; [Rao, Stephen M.] Cleveland Clin, Neurol Inst, Schey Ctr Cognit Neuroimaging, Cleveland, OH 44106 USA		Hammeke, TA (corresponding author), Clement J Zablocki VA Med Ctr, Bldg 111,Room 3301,5000 W Natl Ave, Milwaukee, WI 53295 USA.	thammeke@mcw.edu	Rao, Stephen M/A-2460-2010	Rao, Stephen M/0000-0002-6463-7460; Durgerian, Sally/0000-0003-3931-9679	National Institutes of Health General Clinical Research CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR00058]; National Academy of Neuropsychology; Green Bay Packer Foundation; Herbert Kohl Foundation; National Federation of State High School Associations; Milwaukee Bucks; Waukesha Memorial Hospital Foundation; Waukesha Charities Service Organization; NFL Charities; Medical College of WisconsinGeneral Electric; National Operating Committee on Standards for Athletic Equipment; Michael Emme; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000058] Funding Source: NIH RePORTER	We thank the athletes and their parents who participated in this study and its larger foundational study, the many athletic trainers and technicians who assisted in data collection, and our colleagues who had countless helpful suggestions concerning the study and manuscript. This work was supported in part by National Institutes of Health General Clinical Research Center [M01 RR00058] and grants from National Academy of Neuropsychology, Green Bay Packer Foundation, Herbert Kohl Foundation, National Federation of State High School Associations, Milwaukee Bucks, Waukesha Memorial Hospital Foundation, Waukesha Charities Service Organization, NFL Charities, Medical College of Wisconsin, National Operating Committee on Standards for Athletic Equipment and Michael Emme. The senior author receives income from personal injury medicolegal work, approximately 50% of which is done on behalf of the plaintiff and the same for the defense, and royalties from test publication-the test was not used in this study. The remaining authors have no conflicts of interest or relevant disclosures.	Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Heilman K.M., 2012, CLIN NEUROPSYCHOLOGY; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kelly JP, 1997, NEUROLOGY, V48, P581; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; Mesulam MM, 2000, PRINCIPLES BEHAV COG; Narayanan NS, 2005, NEUROPSYCHOLOGY, V19, P223, DOI 10.1037/0894-4105.19.2.223; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Sadek Joseph R, 2002, CNS Spectr, V7, P286; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652	31	31	32	1	50	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2013	19	8					863	872		10.1017/S1355617713000702			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	209AQ	WOS:000323725800003	23829951				2022-02-06	
J	Husby, IM; Skranes, J; Olsen, A; Brubakk, AM; Evensen, KAI				Husby, Ingrid Marie; Skranes, Jon; Olsen, Alexander; Brubakk, Ann-Mari; Evensen, Kari Anne I.			Motor skills at 23 years of age in young adults born preterm with very low birth weight	EARLY HUMAN DEVELOPMENT			English	Article						Fine motor skills; Gross motor skills; Grooved Pegboard test; High-level Mobility Assessment Tool; Long-term outcome; Motor speed; Movement Assessment Battery for Children-2; Prematurity; Trail Making Test-5	MOBILITY ASSESSMENT-TOOL; TRAUMATIC BRAIN-INJURY; NEURODEVELOPMENTAL DISABILITY; NEUROLOGICAL CONDITIONS; CHILDREN BORN; MRI FINDINGS; FOLLOW-UP; INFANTS; ADOLESCENTS; OUTCOMES	Background: Motor skills have previously not been reported in young adults born with very low birth weight (VLBW), although they are commonly reported in children and adolescents. Aim: To compare fine and gross motor skills in VLBW young adults with matched term-born controls, and to study longitudinal changes in the VLBW group. Study design: A geographically based follow-up study of a VLBW group and a control group. Subjects: Thirty-six VLBW (birth weight <= 1500 g) young adults, including four participants with cerebral palsy (CP), and 37 matched controls (birth weight >= 10th centile) were examined at 14 and 23 years of age. Outcome measures: Fine and gross motor skills were assessed using Grooved Pegboard test (GP), Trail Making Test-5 (TMT-5), Movement Assessment Battery for Children-2 (Movement ABC-2) and High-level Mobility Assessment Tool (HiMAT). Results: VLBW young adults were slower than controls on GP (p = 0.026) and TMT-5 (p < 0.001). Mean total Movement ABC-2 score was 69.7 +/- 20.2 in the VLBW group compared with 74.1 +/- 14.4 in the control group (p = 0.017). Differences were also seen in manual dexterity and balance. Additionally, HiMAT showed reduced balance and speed in gross motor skills in the VLBW group. The proportion of participants with motor problems did not change between age 14 and 23. After exclusion of participants with CP, scores were essentially the same. Conclusion: VLBW young adults had overall poorer fine and gross motor skills compared with controls. Reduced speed seemed to be an underlying problem. Longitudinal findings indicate that VLBW children have not outgrown their motor problems when entering adulthood. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Husby, Ingrid Marie; Skranes, Jon; Brubakk, Ann-Mari; Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7491 Trondheim, Norway; [Skranes, Jon] Sorlandet Hosp, Dept Pediat, Arendal, Norway; [Olsen, Alexander] Norwegian Univ Sci & Technol, MI Lab, N-7491 Trondheim, Norway; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7491 Trondheim, Norway; [Olsen, Alexander] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Brubakk, Ann-Mari] Univ Trondheim Hosp, St Olavs Hosp, Dept Pediat, Trondheim, Norway; [Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7491 Trondheim, Norway; [Evensen, Kari Anne I.] Trondheim Municipal, Dept Physiotherapy, Trondheim, Norway		Husby, IM (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Lab Med Childrens & Womens Hlth, POB 8905, N-7491 Trondheim, Norway.	ingrihu@stud.ntnu.no	Olsen, Alexander/P-5235-2019	Olsen, Alexander/0000-0001-8691-3860; Evensen, Kari Anne I./0000-0002-0129-0164	Research Council of NorwayResearch Council of Norway	The study was funded by the Research Council of Norway and was independent of commercial interest.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bracewell M, 2002, MENT RETARD DEV D R, V8, P241, DOI 10.1002/mrdd.10049; Bruininks, 1978, BRUININKS OSERETSKY; Davies PS, 2000, BIOL PHILOS, V15, P19, DOI 10.1023/A:1006525318699; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; Delis D, 2005, NORSK MANUAL S; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Evensen KAI, 2004, ARCH DIS CHILD-FETAL, V89, pF451, DOI 10.1136/adc.2003.037788; Evensen KAI, 2009, EARLY HUM DEV, V85, P511, DOI 10.1016/j.earlhumdev.2009.04.007; Evensen KAI, 2009, EUR J PAEDIATR NEURO, V13, P47, DOI 10.1016/j.ejpn.2008.02.009; Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316; Gaddlin PO, 2008, EARLY HUM DEV, V84, P343, DOI 10.1016/j.earlhumdev.2007.09.013; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Henderson S.E., 2007, MOVEMENT ASSESSMENT, V2nd ed.; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hollingshead AB, 1958, 2 FACTOR INDEX SOCIA; Johnson S, 2009, PEDIATRICS, V124, pE249, DOI 10.1542/peds.2008-3743; Lafayette I., 2002, LAFAYETTE INSTRUMENT; Largo RH, 2001, DEV MED CHILD NEUROL, V43, P436, DOI 10.1017/S0012162201000810; McCormick MC, 2011, ANNU REV PUBL HEALTH, V32, P367, DOI 10.1146/annurev-publhealth-090810-182459; McCormick MC, 1997, PEDIATRICS, V99, P869, DOI 10.1542/peds.99.6.869; Moen KT, 2011, HIMAT HIGH LEVEL MOB, P12; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; O'Brien F, 2004, ARCH DIS CHILD, V89, P207, DOI 10.1136/adc.2002.006676; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Rademaker KJ, 2005, ARCH DIS CHILD-FETAL, V90, pF489, DOI 10.1136/adc.2005.073908; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Skranes J, 2012, EARLY HUM DEV, V88, P103, DOI 10.1016/j.earlhumdev.2011.07.017; Skranes JS, 2005, PEDIATR RADIOL, V35, P758, DOI 10.1007/s00247-005-1446-2; Skranes JS, 1997, NEUROPEDIATRICS, V28, P149, DOI 10.1055/s-2007-973692; Sugden, 1992, MOVEMENT ASSESSMENT; Taylor HG, 2004, J INT NEUROPSYCH SOC, V10, P149, DOI 10.1017/S1355617704102038; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Volpe J. J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2004, HIGH LEVEL MOBILITY; Williams G, 2012, CLIN REHABIL, V26, P741, DOI 10.1177/0269215511429163; Williams G, 2010, BRAIN INJURY, V24, P1027, DOI 10.3109/02699052.2010.490517; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Wuang YP, 2012, DEV MED CHILD NEUROL, V54, P160, DOI 10.1111/j.1469-8749.2011.04177.x	49	31	33	0	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	SEP	2013	89	9					747	754		10.1016/j.earlhumdev.2013.05.009			8	Obstetrics & Gynecology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Obstetrics & Gynecology; Pediatrics	210ZT	WOS:000323874600023	23810435	Green Submitted			2022-02-06	
J	Walker, WC; Marwitz, JH; Wilk, AR; Ketchum, JM; Hoffman, JM; Brown, AW; Lucas, S				Walker, William C.; Marwitz, Jennifer H.; Wilk, Amber R.; Ketchum, Jessica M.; Hoffman, Jeanne M.; Brown, Allen W.; Lucas, Sylvia			Prediction of headache severity (density and functional impact) after traumatic brain injury: A longitudinal multicenter study	CEPHALALGIA			English	Article						Headache; outcomes; post-traumatic headache; traumatic brain injury; head injury	POSTTRAUMATIC HEADACHE; CHRONIC PAIN; DISABILITY; MODERATE; DURATION	Background: Headache (HA) following traumatic brain injury (TBI) is common, but predictors and time course are not well established, particularly after moderate to severe TBI. Methods: A prospective, longitudinal cohort study of HA severity post-TBI was conducted on 450 participants at seven participating rehabilitation centers. Generalized linear mixed-effects models (GLMMs) were used to model repeated measures (months 3, 6, and 12 post-TBI) of two outcomes: HA density (a composite of frequency, duration, and intensity) and HA disruptions to activities of daily living (ADL). Results: Although HA density and ADL disruptions were nominally highest during the first three months post-TBI, neither showed significant changes over time. At all time points, history of pre-injury migraine was by far the strongest predictor of both HA density and ADL disruptions (odds ratio (OR)=8.0 and OR=7.2, averaged across time points, respectively). Furthermore, pre-injury non-migraine HA (at three and six months post-TBI), penetrating-type TBI (at six months post-TBI), and female sex (at six and 12 months post-TBI) were each associated with an increase in the odds of a more severe HA density. Severity of TBI (post-traumatic amnesia (PTA) duration) was not associated with either outcome. Conclusion: Individuals with HA at three months after moderate-severe TBI do not improve over the ensuing nine months with respect to HA density or ADL disruptions. Those with pre-injury HA, particularly of migraine type, are at greatest risk for HA post-TBI. Other independent risk factors are penetrating-type TBI and, to a lesser degree and post-acutely only, female sex. Individuals with these risk factors should be monitored and considered for aggressive early intervention.	[Walker, William C.; Marwitz, Jennifer H.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Wilk, Amber R.; Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Richmond, VA 23298 USA; [Hoffman, Jeanne M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Lucas, Sylvia] Univ Washington, Dept Neurol, Seattle, WA 98195 USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, VCU Box 980661, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Ketchum, Jessica/AAE-8200-2020; Walker, William C/N-3162-2014	Brown, Allen W./0000-0001-7228-3351; Ketchum, Jessica/0000-0002-5566-3691	National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Dept. of Education, Washington, D.C. [H133A070013, H133A070032, H133A070036]	This work was supported by the National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Dept. of Education, Washington, D.C. (grant numbers H133A070013, H133A070032, and H133A070036).	Annoni J M, 1992, Disabil Rehabil, V14, P23; [Anonymous], 2004, CEPHALALGIA S1, V24, P9; BARNAT MR, 1986, HEADACHE, V26, P271, DOI 10.1111/j.1526-4610.1986.hed2606271.x; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; GOLDSTEIN J, 1991, MED CLIN N AM, V75, P641, DOI 10.1016/S0025-7125(16)30439-4; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Holroyd KA, 1999, PAIN, V83, P571, DOI 10.1016/S0304-3959(99)00165-7; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; JONES JH, 1992, ARCH PHYS MED REHAB, V73, P145; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; STEWART WF, 1994, NEUROLOGY, V44, P24; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x	27	31	31	0	14	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	SEP	2013	33	12					998	1008		10.1177/0333102413482197			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	193VZ	WOS:000322590900002	23575819				2022-02-06	
J	Deleglise, B; Lassus, B; Soubeyre, V; Alleaume-Butaux, A; Hjorth, JJ; Vignes, M; Schneider, B; Brugg, B; Viovy, JL; Peyrin, JM				Deleglise, Berangere; Lassus, Benjamin; Soubeyre, Vaneyssa; Alleaume-Butaux, Aurelie; Hjorth, Johannes J.; Vignes, Maeva; Schneider, Benoit; Brugg, Bernard; Viovy, Jean-Louis; Peyrin, Jean-Michel			Synapto-Protective Drugs Evaluation in Reconstructed Neuronal Network	PLOS ONE			English	Article							LONG-TERM DEPRESSION; NEUROFIBRILLARY PATHOLOGY; WALLERIAN DEGENERATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; RHO; NEURODEGENERATION; DYSFUNCTION; KINASE; MICE	Chronic neurodegenerative syndromes such as Alzheimer's and Parkinson's diseases, or acute syndromes such as ischemic stroke or traumatic brain injuries are characterized by early synaptic collapse which precedes axonal and neuronal cell body degeneration and promotes early cognitive impairment in patients. Until now, neuroprotective strategies have failed to impede the progression of neurodegenerative syndromes. Drugs preventing the loss of cell body do not prevent the cognitive decline, probably because they lack synapto-protective effects. The absence of physiologically realistic neuronal network models which can be easily handled has hindered the development of synapto-protective drugs suitable for therapies. Here we describe a new microfluidic platform which makes it possible to study the consequences of axonal trauma of reconstructed oriented mouse neuronal networks. Each neuronal population and sub-compartment can be chemically addressed individually. The somatic, mid axon, presynaptic and postsynaptic effects of local pathological stresses or putative protective molecules can thus be evaluated with the help of this versatile "brain on chip" platform. We show that presynaptic loss is the earliest event observed following axotomy of cortical fibers, before any sign of axonal fragmentation or post-synaptic spine alteration. This platform can be used to screen and evaluate the synapto-protective potential of several drugs. For instance, NAD(+) and the Rho-kinase inhibitor Y27632 can efficiently prevent synaptic disconnection, whereas the broad-spectrum caspase inhibitor zVAD-fmk and the stilbenoid resveratrol do not prevent presynaptic degeneration. Hence, this platform is a promising tool for fundamental research in the field of developmental and neurodegenerative neurosciences, and also offers the opportunity to set up pharmacological screening of axon-protective and synapto-protective drugs.	[Deleglise, Berangere; Lassus, Benjamin; Soubeyre, Vaneyssa; Brugg, Bernard; Peyrin, Jean-Michel] CNRS, UMR7102, Paris, France; [Deleglise, Berangere; Lassus, Benjamin; Soubeyre, Vaneyssa; Brugg, Bernard; Peyrin, Jean-Michel] Univ Paris 06, Paris, France; [Alleaume-Butaux, Aurelie; Schneider, Benoit] INSERM, UMR S 747, Paris, France; [Alleaume-Butaux, Aurelie; Schneider, Benoit] Univ Paris 05, Sorbonne Paris Cite, UMR S 747, Paris, France; [Vignes, Maeva; Viovy, Jean-Louis] Inst Curie, CNRS, UMR168, F-75231 Paris, France; [Hjorth, Johannes J.] Vrije Univ Amsterdam, CNCR, Amsterdam, Netherlands		Peyrin, JM (corresponding author), CNRS, UMR7102, Paris, France.	jean-michel.peyrin@upmc.fr	Hjorth, Johannes/A-2043-2009; Schneider, Benoit/AAF-3850-2019; Maeva, VIGNES L/Q-9495-2016	Hjorth, Johannes/0000-0002-9302-0750; Maeva, VIGNES L/0000-0002-4768-9648; Peyrin, Jean-Michel/0000-0002-0108-1266; Viovy, Jean-Louis/0000-0002-8223-4040; Peyrin, Jean-Michel/0000-0002-8705-8672	French Research National Agency "Agence Nationale de la Recherche"French National Research Agency (ANR); ANR RPIB "Neuroscreen"French National Research Agency (ANR); ANR "PrionsensiTNF"French National Research Agency (ANR); French 'Ministere de la Recherche'Ministry of Research, France	This work was supported by the French Research National Agency "Agence Nationale de la Recherche," ANR RPIB "Neuroscreen" and ANR "PrionsensiTNF." BD was supported by a PhD grant from the French 'Ministere de la Recherche.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Fainzilber M, 2006, NEURON, V50, P819, DOI 10.1016/j.neuron.2006.05.023; Finn JT, 2000, J NEUROSCI, V20, P1333; Garland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047552; Gillingwater TH, 2003, J ANAT, V203, P265, DOI 10.1046/j.1469-7580.2003.00214.x; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Gillingwater TH, 2006, BRAIN, V129, P1546, DOI 10.1093/brain/awl101; Gonzalez-Forero D, 2012, J NEUROSCI, V32, P68, DOI 10.1523/JNEUROSCI.3215-11.2012; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Jagust W, 2013, NEURON, V77, P219, DOI 10.1016/j.neuron.2013.01.002; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Marcello E, 2012, ADV EXP MED BIOL, V970, P573, DOI 10.1007/978-3-7091-0932-8_25; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Millet Larry J., 2012, Yale Journal of Biology and Medicine, V85, P501; Millet LJ, 2012, TRENDS NEUROSCI; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; Picconi B, 2012, ADV EXP MED BIOL, V970, P553, DOI 10.1007/978-3-7091-0932-8_24; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Schmitz SK, 2011, J NEUROSCI METH, V195, P185, DOI 10.1016/j.jneumeth.2010.12.011; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; To KCW, 2008, NEUROSCIENCE, V153, P645, DOI 10.1016/j.neuroscience.2008.02.043; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WATSON DF, 1993, J NEUROSCI, V13, P4354; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147; Wishart TM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002936; Yin DM, 2012, ADV EXP MED BIOL, V970, P493, DOI 10.1007/978-3-7091-0932-8_22; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	44	31	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71103	10.1371/journal.pone.0071103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	WOS:000323570200027	23976987	gold, Green Published, Green Submitted			2022-02-06	
J	Bryer, EJ; Medaglia, JD; Rostami, S; Hillary, FG				Bryer, E. J.; Medaglia, J. D.; Rostami, S.; Hillary, Frank G.			Neural Recruitment after Mild Traumatic Brain Injury Is Task Dependent: A Meta-analysis	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Functional magnetic resonance imaging; Working memory; Cognitive control; Hypoactivation; Hyperactivation	WORKING-MEMORY DYSFUNCTION; SUSTAINED ATTENTION; COGNITIVE-CONTROL; PERFORMANCE; DEFICITS; NETWORK; CORTEX; FMRI; ABNORMALITIES; CONNECTIVITY	Individuals with mild traumatic brain injury (TBI) often have deficits in processing speed and working memory (WM) and there is a growing literature using functional imaging studies to document these deficits. However, divergent results from these studies revealed both hypoactivation and hyperactivation of neural resources after injury. We hypothesized that at least part of this variance can be explained by distinct demands between WM tasks. Notably, in this literature some WM tasks use discrete periods of encoding, maintenance, and retrieval, whereas others place continuous demands on WM. The purpose of this meta-analysis is to examine the differences in neural recruitment after mTBI to determine if divergent findings can be explained as a function of task demand and cognitive load. A comprehensive literature review revealed 14 studies using functional magnetic resonance imaging to examine brain activity of individuals with mTBI during working memory tasks. Three of the fourteen studies included reported hypoactivity, five reported hyperactivity, and the remaining six reported both hypoactivity and hyperactivity. Studies were grouped according to task type and submitted to GingerALE maximum likelihood meta-analyses to determine the most consistent brain activation patterns. The primary findings from this meta-analysis suggest that the discrepancy in activation patterns is at least partially attributable to the classification of WM task, with hyperactivation being observed in continuous tasks and hypoactivation being observed during discrete tasks. We anticipate that differential task load expressed in continuous and discrete WM tasks contributes to these differences. Implications for the interpretation of fMRI signals in clinical samples are discussed.	[Bryer, E. J.; Medaglia, J. D.; Rostami, S.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, Bruce V Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021		New Jersey Commission on Brain Injury Research [0120090178]	Dr. Jen-Khai Chen (cf., Chen et al., 2008) provided data upon request. The authors declare that there are no conflicts of interest, either financial or otherwise, associated with this study and the resulting manuscript. This study was funded in part by a grant from the New Jersey Commission on Brain Injury Research (grant number 0120090178).	Baddeley A.D., 1994, NEUROPSYCHOLOGY, V8, P485, DOI [10.1037/0894-4105.8.4.485, DOI 10.1037/0894-4105.8.4.485]; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Courtney Susan M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P501, DOI 10.3758/CABN.4.4.501; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Goldman-Rakic P.S., 1987, CIRCUITRY PRIMATE PR; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hillary F. G., 2013, BRAIN IMAGING BEHAV; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kosslyn SM, 1999, PHILOS T ROY SOC B, V354, P1283, DOI 10.1098/rstb.1999.0479; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Research Imaging Institute UTHSCSA, MULT AN GUI VERS 2 6; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2004, BRAIN INJURY, V18, P219; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163; TEASDALE G, 1974, LANCET, V2, P81; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	55	31	32	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2013	19	7					751	762		10.1017/S1355617713000490			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	186CI	WOS:000322018900002	23656706				2022-02-06	
J	Williamson, MLC; Elliott, TR; Berry, JW; Underhill, AT; Stavrinos, D; Fine, PR				Williamson, Meredith L. C.; Elliott, Timothy R.; Berry, Jack W.; Underhill, Andrea T.; Stavrinos, Despina; Fine, Philip R.			Predictors of health-related quality-of-life following traumatic brain injury	BRAIN INJURY			English	Article						Depression; family satisfaction; pain; sructural equation modelling	1ST 5 YEARS; REHABILITATION; SATISFACTION; VALIDATION; PAIN; TRAJECTORIES; ADJUSTMENT; STRATEGIES; IMPACT; SCALE	Primary objective: To examine the predictive associations of family satisfaction, functional impairment, pain, and depression on health-related quality-of-life (HRQoL) among persons with traumatic brain injury (TBI) through structural equation modelling (SEM). Research design: Participants were part of a larger longitudinal study of adjustment following TBI. Direct and indirect effects of predictor variables on HRQoL were analyzed through SEM. Methods and procedures: The sample included 131 participants with TBI (89 men, 42 women) who had been discharged from an acute care hospital. The Sickness Impact Profile was administered to measure HRQoL at or beyond 24 months post-discharge. Predictor variable measures included the Functional Independence Measure, Family Satisfaction Scale and single items assessing the presence of pain and depression. Main outcomes and results: SEM revealed direct effects of functional impairment (p<0.001), family satisfaction (p<0.01), depression (p<0.05) and pain (p<0.01) on HRQoL. Indirect effects from functional impairment (p<0.05) and pain (p<0.05) to HRQoL through depression were also present. Conclusions: The presence of pain and depression, greater functional impairment and lower family satisfaction were predictively associated with lower HRQoL. Depression further mediated the effects of pain and functional impairment on HRQoL. The present study advances understanding of the ways in which pain, depression and functional impairment predict HRQoL.	[Williamson, Meredith L. C.; Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Berry, Jack W.] Samford Univ, Birmingham, AL USA; [Underhill, Andrea T.; Stavrinos, Despina; Fine, Philip R.] Univ Alabama Birmingham, Injury Res Control Ctr, Birmingham, AL USA		Williamson, MLC (corresponding author), 2902 B Silver Spur Circle, Bryan, TX 77801 USA.	mcmeredithcampbell@gmail.com	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Dunn D. S., OXFORD HDB IN PRESS; Dunn D.S., 2009, OXFORD HDB POSITIVE, P650, DOI [DOI 10.1093/OXFORDHB/9780195187243.013.0062, 10.1093/oxfordhb/9780195187243.013.0062]; Elliott TR, 2007, PSYCHOL MANAGEMENT P, P14; ELLIOTT TR, 2002, HDB POSITIVE PSYCHOL, P00687; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hutchinson SR, 1998, STRUCT EQU MODELING, V5, P344, DOI 10.1080/10705519809540111; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kline R., 2011, PRINCIPLES PRACTICES; Kosciulek JF, 1999, BRAIN INJURY, V13, P245, DOI 10.1080/026990599121610; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Muthen L. K., 1998, MPLUS USERS GUIDE, V7th; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Thompson B., 2006, FDN BEHAV STAT INSIG; Underhill AT, 2004, J REHABIL RES DEV, V41, P603, DOI 10.1682/JRRD.2003.06.0094; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Wilson, 1982, FAMILY INVENTORIES I, P25; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Yu C.Y., 2002, EVALUATION MODEL FIT	40	31	31	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2013	27	9					992	999		10.3109/02699052.2013.801512			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100002	23781905				2022-02-06	
J	Budinich, CS; Tucker, LB; Lowe, D; Rosenberger, JG; McCabe, JT				Budinich, Craig S.; Tucker, Laura B.; Lowe, Dennell; Rosenberger, John G.; McCabe, Joseph T.			Short and long-term motor and behavioral effects of diazoxide and dimethyl sulfoxide administration in the mouse after traumatic brain injury	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Diazoxide; TBI; DMSO; Open field; Morris water maze	DEPENDENT POTASSIUM CHANNELS; CONTROLLED CORTICAL IMPACT; CEREBRAL HYPOPERFUSION; OPEN-FIELD; OXIDATIVE STRESS; NERVOUS-SYSTEM; WATER-MAZE; RAT; DEFICITS; MITOCHONDRIAL	Traumatic brain injury (TBI) is a worldwide phenomenon that affects all ages and socioeconomic classes and results in varying degrees of immediate and delayed motor, cognitive, and emotional deficiencies. A plethora of pharmacologic interventions that target recognized initiators and propagators of pathology are being investigated in an attempt to ameliorate secondary injury processes that follow primary injury. Diazoxide (DZ), a K-ATP channel activator, has been shown to provide short- and long-term protective effects in a variety of in vitro and in vivo cerebral ischemia models. However, the effects of DZ on behavioral outcome following TBI have not been investigated. TBI was induced in male C57BL/6J mice by controlled cortical impact (CCI) and followed by intraperitoneal administration of either normal saline, dimethyl sulfoxide (DMSO), or 2.5 mg/kg DZ in DMSO, 30 min post-injury and daily for three days. Open field and beam walk performances were used to assess motor and behavioral function 1, 7, and 14 days following injury. Spatial learning and memory were assessed three weeks following injury using the Morris water maze. Injured mice were significantly impaired on the beam-walk and Morris water maze tasks, and were hyperactive and anxious in an open field environment. On post-injury days 1 and 14, mice treated with DMSO exhibited an increase in the amount of time required to perform the beam walk task. In addition, animals exposed to DMSO or DZ + DMSO exhibited slower swimming speed in the Morris water maze on the final day of testing. There was no therapeutic effect, however, of the treatment or vehicle on open field behavior or learning and memory function in the Morris water maze. In summary, CCI produced significant long-term impairment of motor, memory, and behavioral performance measures, and DZ administration, under the conditions used, provided no functional benefits following injury. Published by Elsevier Inc.	[Budinich, Craig S.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Grad Program Neurosci, Bethesda, MD 20814 USA; [Tucker, Laura B.; Lowe, Dennell; Rosenberger, John G.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Tucker, Laura B.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Joseph.McCabe@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399	TriService Nursing Research Program grant [N10-P09]; USUHS Intramural grant [RO704B]	This work was supported by TriService Nursing Research Program grant N10-P09 to C.S.B. and USUHS Intramural grant RO704B to J.T.M. The experiments were conducted according to the principles set forth in the Guide for Care and Use of Laboratory Animals, ILAR, National Research Council, DHEW Publ. # (NIH) 73-23. The opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army, Department of Defense, the U.S. Government, or the Uniformed Services University of the Health Sciences. The use of trade names does not constitute an official endorsement or approval of the use of such reagents or commercial hardware or software. This document may not be cited for purposes of advertisement. The investigators appreciated utilization of the Pre-Clinical Core facilities of the Center for Neuroscience and Regenerative Medicine, USUHS.	Abe E, 2010, BRAIN RES, V1330, P151, DOI 10.1016/j.brainres.2010.02.074; Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Ali BH, 2001, VET HUM TOXICOL, V43, P228; Arnoux JB, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-63; Arras M, 2001, COMPARATIVE MED, V51, P443; Authier N, 2002, TOXICOL LETT, V132, P117, DOI 10.1016/S0378-4274(02)00052-8; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Cavaletti G, 2000, TOXICOL LETT, V118, P103, DOI 10.1016/S0378-4274(00)00269-1; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; de Arriba SG, 1999, NEUROSCI LETT, V273, P13, DOI 10.1016/S0304-3940(99)00603-5; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Domoki F, 2005, AM J PHYSIOL-HEART C, V289, pH368, DOI 10.1152/ajpheart.00887.2004; Farkas E, 2006, BRAIN RES, V1087, P168, DOI 10.1016/j.brainres.2006.02.134; Farkas E, 2005, NEUROSCI LETT, V387, P168, DOI 10.1016/j.neulet.2005.06.036; Farkas E, 2005, NEUROSCI LETT, V373, P195, DOI 10.1016/j.neulet.2004.10.007; Farkas E, 2004, BRAIN RES, V1008, P252, DOI 10.1016/j.brainres.2004.02.037; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; He XM, 2008, J NEUROL SCI, V268, P18, DOI 10.1016/j.jns.2007.10.029; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kis B, 2003, J NEUROCHEM, V87, P969, DOI 10.1046/j.1471-4159.2003.02072.x; Lau AA, 2008, BEHAV BRAIN RES, V191, P130, DOI 10.1016/j.bbr.2008.03.024; Lei J, 2012, CHIN J TRAUMATOL, V15, P17, DOI 10.3760/cma.j.issn.1008-1275.2012.01.004; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nagy K, 2004, J NEUROSCI RES, V76, P697, DOI 10.1002/jnr.20120; Nasrallah FA, 2008, J NEUROSCI RES, V86, P208, DOI 10.1002/jnr.21477; O'Sullivan JC, 2007, J NEUROTRAUM, V24, P532, DOI 10.1089/neu.2006.0128; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rajapakse N, 2003, J NEUROSCI RES, V73, P206, DOI 10.1002/jnr.10657; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shake JG, 2001, ANN THORAC SURG, V72, P1849, DOI 10.1016/S0003-4975(01)03192-7; Shimizu K, 2002, AM J PHYSIOL-HEART C, V283, pH1005, DOI 10.1152/ajpheart.00054.2002; Stanley JL, 2005, J PSYCHOPHARMACOL, V19, P221, DOI 10.1177/0269881105051524; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhang H, 2010, J BIOCHEM, V148, P413, DOI 10.1093/jb/mvq074; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	53	31	31	1	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	JUL	2013	108						66	73		10.1016/j.pbb.2013.04.001			8	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	175LS	WOS:000321232800008	23583443				2022-02-06	
J	Norris, JN; Carr, W; Herzig, T; Labrie, W; Sams, R				Norris, Jacob N.; Carr, Walter; Herzig, Thomas; Labrie, Walter; Sams, Richard			ANAM4 TBI Reaction Time-Based Tests Have Prognostic Utility for Acute Concussion	MILITARY MEDICINE			English	Article							NEUROPSYCHOLOGICAL ASSESSMENT METRICS; SPORT-RELATED CONCUSSION; HEAD-INJURY; FOOTBALL PLAYERS; HIGH-SCHOOL; RETURN; PERFORMANCE; RECOVERY	The Concussion Restoration Care Center has used the Automated Neuropsychological Assessment Metrics version 4 Traumatic Brain Injury (ANAM4 TBI) battery in clinical assessment of concussion. The study's aim is to evaluate the prognostic utility of the ANAM4 TBI. In 165 concussed active duty personnel (all ultimately returned to duty) seen and tested on the ANAM4 TBI on days 3 and 5 (median times) from their injury, Spearman's rho statistics showed that all performance subtests (at day 5) were associated with fewer days return-to-duty (RTD) time, whereas concussion history or age did not. Kruskal Wallis statistics showed that ANAM4 TBI, loss of consciousness, and post-traumatic amnesia were associated with increased RTD time; ANAM4 TBI reaction time-based subtests, collectively, showed the largest effect sizes. A survival analysis using a Kaplan-Meier plot showed that the lowest 25% on the reaction time-based subtests had a median RTD time of 19 days, whereas those in the upper 25% had a median RTD time of approximately 7 days. Results indicate that until validated neurocognitive testing is introduced, the ANAM4 TBI battery, especially reaction time-based tests, has prognostic utility.	[Norris, Jacob N.; Carr, Walter] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD 20904 USA; [Herzig, Thomas] Naval Hlth Res Ctr, Warfighter Performance Dept, San Diego, CA 92106 USA; [Labrie, Walter] Naval Med Ctr Portsmouth, Dept Mental Hlth, Portsmouth, VA 23708 USA; [Sams, Richard] Kings Bay Branch Hlth Clin, Kings Bay, GA USA		Norris, JN (corresponding author), Naval Med Res Ctr, Neurotrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20904 USA.			Sams, Richard/0000-0003-3264-9616	Navy Bureau of Medicine and Surgery, under Work Unit [N24LB]	The authors thank CAPT Jack Tsao, CAPT Tara Zieber, CDR Peter Lunblad, and CDR Earl Frantz for their support and feedback on drafts of the manuscript. This report was supported by Navy Bureau of Medicine and Surgery, under Work Unit No. N24LB.	Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Department of Defense, DOD POL GUID MAN MIL; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Murphy P. J., 2002, FATIGUE MANAGEMENT O; Office of the Surgeon General, 2011, DOD ANAM PROGR CRIT; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Torg J, 1991, ATHLETIC INJURIES HE; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	34	31	31	0	5	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL	2013	178	7					767	774		10.7205/MILMED-D-12-00493			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7UA	WOS:000340805300012	23820351	hybrid			2022-02-06	
J	Roebuck-Spencer, TM; Vincent, AS; Schlegel, RE; Gilliland, K				Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Schlegel, Robert E.; Gilliland, Kirby			Evidence for Added Value of Baseline Testing in Computer-Based Cognitive Assessment	JOURNAL OF ATHLETIC TRAINING			English	Article						Automated Neuropsychological Assessment Metrics; computerized neuropsychological testing; concussions; mild traumatic brain injuries; military athletes	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; SPORT-RELATED CONCUSSION; DEPLOYMENT; PERFORMANCE; MANAGEMENT; IRAQ	Context: Large-scale baseline cognitive assessment for individuals at risk for concussion is a common part of the protocol for concussion-surveillance programs, particularly in sports. Baseline cognitive testing is also being conducted in US military service members before deployment. Recently, the incremental validity of large-scale baseline cognitive assessment has been questioned. Objective: To examine the added value of baseline cognitive testing in computer-based neuropsychological assessment by comparing 2 methods of classifying atypical performance in a presumed healthy sample. Design: Cross-sectional study. Setting: Military base. Patients or Other Participants: Military service members who took the Automated Neuropsychological Assessment Matrix (ANAM) before and after deployment (n = 8002). Main Outcome Measure(s): Rates of atypical performance in this healthy, active-duty sample were determined first by comparing postdeployment scores with a military normative database and then with each individual's personal baseline performance using a reliable change index. Results: Overall rates of atypical performance were comparable across these 2 methods. However, these methods were highly discordant in terms of which individuals were classified as atypical. When norm-referenced methods were used, 2.6% of individuals classified as normal actually demonstrated declines from baseline. Further, 65.7% of individuals classified as atypical using norm-referenced scores showed no change from baseline (ie, potential false-positive findings). Conclusions: Knowing an individual's baseline performance is important for minimizing potential false-positive errors and reducing the risks and stresses of misdiagnosis.	[Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Schlegel, Robert E.; Gilliland, Kirby] Univ Oklahoma, Norman, OK 73072 USA		Roebuck-Spencer, TM (corresponding author), Univ Oklahoma, Cognit Sci Res Ctr, 3200 Marshall Ave,Suite 260, Norman, OK 73072 USA.	tresa@ou.edu			US Army Medical Research & Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD [W81XWH-07-2-0097]	This project was conducted by the Cognitive Science Research Center (formerly the Center for the Study of Human Operator Performance: C-SHOP) at the University of Oklahoma and is made possible by a Department of Defense Grant that was awarded and administered by the US Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD, under contract number W81XWH-07-2-0097. We acknowledge the significant contributions of the many individuals, staff, and service members at the following organizations who made data collection for this analysis possible: Fort Campbell, KY; Neurocognitive Assessment Branch, Rehabilitation and Reintegration Division, US Army Office of the Surgeon General; and the Defense and Veterans Brain Injury Center.	Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P14, DOI 10.1093/arclin/acp100; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Heaton R. K., 2004, REVISED COMPREHENSIV; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Maassen GH, 2006, BRIT J SPORT MED, V40, P829, DOI 10.1136/bjsm.2005.023713; McCaffrey RJ, 2007, ARCH CLIN NEUROPS S1, V22, P1; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Roebuck-Spencer T, 2010, NAT AC NEUR OCT 13 1; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156	25	31	31	0	10	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-AUG	2013	48	4					499	505		10.4085/1062-6050-48.3.11			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	211GX	WOS:000323895400009	23724773	Green Published, Bronze			2022-02-06	
J	Chu, WH; Li, M; Li, F; Hu, R; Chen, Z; Lin, JK; Feng, H				Chu, Weihua; Li, Mei; Li, Fei; Hu, Rong; Chen, Zhi; Lin, Jiangkai; Feng, Hua			Immediate splenectomy down-regulates the MAPK-NF-kappa B signaling pathway in rat brain after severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; splenectomy; microglia; inflammation; MAPK-NF-kappa B	INNATE IMMUNITY; MICROGLIA; INFLAMMATION; ASTROCYTES; CHEMOKINES; EXPRESSION	BACKGROUND: The treatment of severe traumatic brain injury (TBI) remains a difficult process. One key to improving treatment efficacy is to reduce secondary brain injury. Local and systemic inflammatory responses play an important role in secondary injury after TBI, which if unchecked can lead to fatal cerebral edema. Previous studies focused mainly on local brain tissue, whereas little is known about the contribution of peripheral organs in the pathogenesis of TBI. We previously showed that immediate splenectomy decreases mortality and improves cognitive function in rats after severe TBI by inhibiting the release of proinflammatory cytokines both systematically and locally in the injured brain. In this study, we further investigated the molecular mechanisms responsible for the effect of the spleen on local brain inflammation after TBI. METHODS: We established a severe TBI model with rats and performed splenectomy to study the effect of the spleen on mitogen-activated protein kinase (MAPK)-NF-kappa B activation in the brain tissue. The expression of p38 MAPK, extracellular regulated protein kinases (ERK), and NF-kappa B protein in the trauma region was examined by Western blotting. The neuron-like PC-12 cell line and microglia-like BV-2 cell line were used for in vitro experiments to test the effects of spleen supernatant after TBI. Cell apoptosis (annexin V/propidium iodide staining), NF-kappa B nuclear translocation (immunofluorescence microscopy), and MAPK signaling (phosphorylation of p-p38 and p-ERK) were examined. RESULTS: We found that TBI significantly up-regulated MAPK signaling in the injured brain region, whereas immediate splenectomy suppressed MAPK activation. In vitro, the spleen supernatant from rats after TBI also resulted in increased MAPK activation and NF-kappa B nuclear translocation in microglia-like BV-2 cells, whereas the application of interleukin (IL)-1R antagonist (IL-1Ra) significantly reduced the expression of p-p38 and p-ERK as well as NF-kappa B nuclear translocation. In addition, spleen supernatant after TBI induced apoptosis in neuron-like PC-12 cells, and IL-1Ra could effectively reduce apoptosis. CONCLUSION: Our study demonstrates that immediate splenectomy down-regulates the MAPK-NF-kappa B signaling pathway in rat brain after severe TBI. We also provide experimental evidence for the potential use of IL-1Ra to alleviate brain inflammation after TBI. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Chu, Weihua; Li, Mei; Li, Fei; Hu, Rong; Chen, Zhi; Lin, Jiangkai; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China		Feng, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China.	fenghua8888@yahoo.com.cn	Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217	Health Sector Public Welfare Fund of China [200802017]; State Natural Science Fund of China [81000531]	This study was supported by the Health Sector Public Welfare Fund of China (grant no. 200802017) and the State Natural Science Fund of China (grant no. 81000531).	Biber K, 2008, J NEUROIMMUNOL, V198, P69, DOI 10.1016/j.jneuroim.2008.04.012; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gibbons LJ, 2009, BIODRUGS, V23, P111, DOI 10.2165/00063030-200923020-00004; Girard S, 2010, J IMMUNOL, V184, P3997, DOI 10.4049/jimmunol.0903349; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Kraft A, 2009, NEUROTOXICOLOGY, P30; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Mangat Halinder S, 2012, Continuum (Minneap Minn), V18, P532, DOI 10.1212/01.CON.0000415426.76524.e1; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Sarov-Blat L, 2010, ARTERIOSCL THROM VAS, V30, P2256, DOI 10.1161/ATVBAHA.110.209205; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wu S, 2006, EXP NEUROL, V200, P245, DOI 10.1016/j.expneurol.2006.01.027; Xie NC, 2010, NEUROSCI LETT, V482, P51, DOI 10.1016/j.neulet.2010.07.004; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	23	31	34	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2013	74	6					1446	1453		10.1097/TA.0b013e31829246ad			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AB4DO	WOS:000331739800010	23694871				2022-02-06	
J	Farst, K; Ambadwar, PB; King, AJ; Bird, TM; Robbins, JM				Farst, Karen; Ambadwar, Pratibha B.; King, Andrew J.; Bird, T. M.; Robbins, James M.			Trends in Hospitalization Rates and Severity of Injuries From Abuse in Young Children, 1997-2009	PEDIATRICS			English	Article						injury; maltreatment; child abuse; health policy	TRAUMATIC BRAIN-INJURY; PHYSICAL ABUSE; UNITED-STATES; HEAD TRAUMA; DISCHARGE DATA; MALTREATMENT; SURVEILLANCE; FRACTURES; MULTICENTER; DISPARITIES	OBJECTIVES: To examine trends in incidence of hospitalizations for injury from abuse in young children from 1997 through 2009 and to examine injury severity trends. METHODS: Cases were identified in the National Inpatient Sample database of the Healthcare Cost and Utilization Project by using International Classification of Diseases, Ninth Revision, Clinical Modification codes for child maltreatment and external cause of injury for assault in children aged 0 through 3 years. Incidence was calculated by age, gender, and region. Trends in incidence of hospitalization and injury severity were calculated over time. RESULTS: Hospitalization rates for injury from abuse showed no significant change over the study period, ranging from a low of 2.10 per 10 000 children in 1998 to a high of 3.01 per 10 000 children in 2005 (P = .755). Children aged <1 had significantly higher hospitalization rates for injury from abuse (6.01 vs 1.12, P < .001) and higher mean injury severity scores compared with children aged 1 to 3 years (12.50, SD = 0.14 vs 8.56, SD = 0.21, P < .001). Injury severity scores increased significantly over the study period. CONCLUSIONS: No significant change in hospitalization rates for injury from abuse among young children was observed from 1997 to 2009. These results coincide with other reports of stable or modestly increasing rates of serious physical abuse or death in young children but not with reports from child welfare data showing declines in physical abuse during the same period. Diverse sources of data may provide important complementary methods to track child abuse.	[Farst, Karen] Univ Arkansas Med Sci, Sect Children Risk, Little Rock, AR 72202 USA; [Ambadwar, Pratibha B.; King, Andrew J.; Robbins, James M.] Univ Arkansas Med Sci, Ctr Appl Res & Evaluat, Dept Pediat, Little Rock, AR 72202 USA; [Bird, T. M.] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72202 USA		Farst, K (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Sect Children Risk, 1 Childrens Way,Slot 512-24 A, Little Rock, AR 72202 USA.	kfarst@uams.edu		Robbins, James/0000-0003-2200-1947	Academic Pediatric Association	Partially supported by a Young Investigator Grant awarded by the Academic Pediatric Association in 2008 to Dr Karen Farst, who was the principal investigator for the grant.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belfer RA, 2001, AM J EMERG MED, V19, P122, DOI 10.1053/ajem.2001.21345; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Center for Injury Research and Policy of The Johns Hopkins University School of Public Health, 1997, ICDMAP 90 SOFTW; Centers for Disease Control and Prevention, INJ PREV CONTR DAT S; Chang DC, 2004, J TRAUMA, V57, P1189, DOI 10.1097/01.TA.0000145076.05111.E1; Coben JH, 2006, INJURY PREV, V12, P199, DOI 10.1136/ip.2005.010512; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Finkelhor D, 2006, J SOC ISSUES, V62, P685, DOI 10.1111/j.1540-4560.2006.00483.x; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Jones L, 2007, UPDATED TRENDS CHILD; Lane WG, 2012, CHILD ABUSE NEGLECT, V36, P142, DOI 10.1016/j.chiabu.2011.09.010; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Lawrence BA, 2007, ACCIDENT ANAL PREV, V39, P319, DOI 10.1016/j.aap.2006.08.001; Leventhal JM, 2008, PEDIATRICS, V122, P599, DOI 10.1542/peds.2007-1959; Leventhal JM, 2012, PEDIATRICS, V130, P847, DOI 10.1542/peds.2012-0922; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; McKenzie K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-7; National Center for Injury Prevention and Control Center for Disease Control, 2008, REC FRAM E COD GROUP; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Rangel EL, 2010, J TRAUMA, V69, P20, DOI 10.1097/TA.0b013e3181bbd7c3; Schnitzer PG, 2011, CHILD ABUSE NEGLECT, V35, P3, DOI 10.1016/j.chiabu.2010.06.008; Schnitzer PG, 2004, AM J PREV MED, V27, P379, DOI 10.1016/j.amepre.2004.08.007; Sedlak A.J., 2010, 4 NATL INCIDENCE STU; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; U.S. Census Bur, 2011, HLTH INS HIST TABL; US Department of Health and Human Services, NAT CHILD AB NEGL DA; Westfall JM, 2001, MED CARE, V39, P459, DOI 10.1097/00005650-200105000-00006; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031	31	31	31	0	15	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	JUN	2013	131	6					E1796	E1802		10.1542/peds.2012-1464			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	197HH	WOS:000322840200012	23690524				2022-02-06	
J	Melmed, S				Melmed, Shlomo			Idiopathic Adult Growth Hormone Deficiency	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							GH REPLACEMENT THERAPY; TRAUMATIC BRAIN-INJURY; BODY-MASS INDEX; PHYSICAL PERFORMANCE; PITUITARY-ADENOMAS; RADIATION-THERAPY; ENDOCRINE-SOCIETY; CONTROLLED-TRIAL; CHILDHOOD-ONSET; HEALTHY-ADULTS	GH secretion is controlled by hypothalamic as well as intrapituitary and peripheral signals, all of which converge upon the somatotroph, resulting in integrated GH synthesis and secretion. Enabling an accurate diagnosis of idiopathic adult GH deficiency (IAGHD) is challenged by the pulsatility of GH secretion, provocative test result variability, and suboptimal GH assay standardization. The spectrum between attenuated GH secretion associated with the normal aging process and with obesity and truly well-defined IAGHD is not distinct and may mislead the diagnosis. Adult-onset GHD is mainly caused by an acquired pituitary deficiency, commonly including prior head/neck irradiation, or an expanding pituitary mass causing functional somatotroph compression. To what extent rare cryptic causes account for those patients seemingly classified as IAGHD is unclear. About 15% of patients with adult GHD and receiving GH replacement in open-label surveillance studies are reported as being due to an idiopathic cause. These patients may also reflect a pool of subjects with an as yet to be determined occult defect, or those with unclear or incomplete medical histories (including forgotten past sports head injury or motor vehicle accident). Therefore, sub-maximal diagnostic evaluation likely leads to an inadvertent diagnosis of IAGHD. In these latter cases, adherence to rigorous biochemical diagnostic criteria and etiology exclusion may result in reclassification of a subset of these patients to a distinct known acquired etiology, or as GH-replete. Accordingly, rigorously verified IAGHD likely comprises less than 10% of adult GHD patients, an already rare disorder. Regardless of etiology, patients with adult GHD, including those with IAGHD, exhibit a well-defined clinical phenotype including increased fat mass, loss of lean muscle mass, decreased bone mass, and enhanced cardiac morbidity. Definition of unique efficacy and dosing parameters for GH replacement and resultant therapeutic efficacy markers in true IAGHD requires prospective study.	[Melmed, Shlomo] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA		Melmed, S (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,Room 2015, Los Angeles, CA 90048 USA.	melmed@csmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [CA 75979]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA075979] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant CA 75979.	Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Aimaretti G, 2001, EUR J ENDOCRINOL, V145, P267, DOI 10.1530/eje.0.1450267; Aimaretti G, 2000, J CLIN ENDOCR METAB, V85, P3693, DOI 10.1210/jc.85.10.3693; Alatzoglou KS, 2010, NAT REV ENDOCRINOL, V6, P562, DOI 10.1038/nrendo.2010.147; Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789; Attanasio AF, 1997, J CLIN ENDOCR METAB, V82, P82, DOI 10.1210/jc.82.1.82; Attanasio AF, 2011, J CLIN ENDOCR METAB, V96, P2255, DOI 10.1210/jc.2011-0448; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Bellastella G, 2010, J CLIN ENDOCR METAB, V95, P3750, DOI 10.1210/jc.2010-0551; Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Birzniece V, 2011, TRENDS ENDOCRIN MET, V22, P171, DOI 10.1016/j.tem.2011.02.005; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Brabant G, 2009, EUR J ENDOCRINOL, V161, pS25, DOI 10.1530/EJE-09-0273; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Bulow B, 1999, 81 ANN M END SOC JUN; Casanueva FF, 2008, P NATL ACAD SCI USA, V105, P20452, DOI 10.1073/pnas.0811680106; Chanson P, 2010, J CLIN ENDOCR METAB, V95, P3684, DOI 10.1210/jc.2010-0295; Chipman JJ, 1997, CLIN ENDOCRINOL, V46, P473, DOI 10.1046/j.1365-2265.1997.1660984.x; Cittadini A, 2002, J CLIN ENDOCR METAB, V87, P1654, DOI 10.1210/jc.87.4.1654; Clasey JL, 2001, J CLIN ENDOCR METAB, V86, P3845, DOI 10.1210/jc.86.8.3845; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Colao A, 2009, J CLIN ENDOCR METAB, V94, P4414, DOI 10.1210/jc.2009-1134; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; De Bellis A, 2011, CLIN ENDOCRINOL, V75, P361, DOI 10.1111/j.1365-2265.2011.04056.x; Fleetwood MR, 2012, J BIOL CHEM, V287, P25454, DOI 10.1074/jbc.M112.365825; FROHMAN LA, 1972, ENDOCRINOLOGY, V91, P262, DOI 10.1210/endo-91-1-262; Gasco V, 2008, PITUITARY, V11, P121, DOI 10.1007/s11102-008-0110-x; Gasperi M, 2002, J CLIN ENDOCR METAB, V87, P1961, DOI 10.1210/jc.87.5.1961; Gasperi M, 2002, J ENDOCRINOL INVEST, V25, P329, DOI 10.1007/BF03344013; Giannoulis MG, 2006, J CLIN ENDOCR METAB, V91, P477, DOI 10.1210/jc.2005-0957; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Gleeson HK, 2004, J CLIN ENDOCR METAB, V89, P662, DOI 10.1210/jc.2003-031224; Goldenberg N, 2007, ENDOCRIN METAB CLIN, V36, P37, DOI 10.1016/j.ecl.2006.11.003; Gotherstrom G, 2009, J CLIN ENDOCR METAB, V94, P809, DOI 10.1210/jc.2008-1538; Graham MR, 2008, HORM RES, V69, P343, DOI 10.1159/000117390; Hartman ML, 2013, J CLIN ENDOCR METAB, V98, P980, DOI 10.1210/jc.2012-2684; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; HOLMES SJ, 1995, CLIN ENDOCRINOL, V42, P613, DOI 10.1111/j.1365-2265.1995.tb02688.x; Holt RIG, 2009, GROWTH HORM IGF RES, V19, P320, DOI 10.1016/j.ghir.2009.04.009; Karges B, 2004, HORM RES, V61, P165, DOI 10.1159/000076007; Klose M, 2009, EUR J ENDOCRINOL, V161, pS75, DOI 10.1530/EJE-09-0328; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lipworth WL, 2012, MED J AUSTRALIA, V197, P204, DOI 10.5694/mja11.11572; LITTLEY MD, 1989, Q J MED, V70, P145; Liu H, 2008, ANN INTERN MED, V148, P747, DOI 10.7326/0003-4819-148-10-200805200-00215; Luque RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015767; Makimura H, 2008, J CLIN ENDOCR METAB, V93, P4254, DOI 10.1210/jc.2008-1333; Meinhardt U, 2010, ANN INTERN MED, V152, P568, DOI 10.7326/0003-4819-152-9-201005040-00007; Melmed S, 2006, NAT CLIN PRACT ENDOC, V2, P119, DOI 10.1038/ncpendmet0138; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Melmed S, 2010, WILLIAMS TXB ENDOCRI; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Monson JP, 2003, EUR J ENDOCRINOL, V148, pS9, DOI 10.1530/eje.0.148S009; Murray RD, 2007, J CLIN ENDOCR METAB, V92, P1705, DOI 10.1210/jc.2006-2055; Nystrom HF, 2011, PITUITARY, V14, P208, DOI 10.1007/s11102-010-0278-8; Olshansky SJ, 2008, JAMA-J AM MED ASSOC, V299, P2792, DOI 10.1001/jama.299.23.2792; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Shalet SM, 2010, CLIN ENDOCRINOL, V73, P432, DOI 10.1111/j.1365-2265.2010.03809.x; SNYDER PJ, 1986, AM J MED, V81, P457, DOI 10.1016/0002-9343(86)90299-8; Sotiropoulos A, 2006, P NATL ACAD SCI USA, V103, P7315, DOI 10.1073/pnas.0510033103; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Thorner MO, 2009, J GERONTOL A-BIOL, V64, P1039, DOI 10.1093/gerona/glp091; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; van Nieuwpoort IC, 2011, EUR J ENDOCRINOL, V164, P491, DOI 10.1530/EJE-10-0914; Veldhuis JD, 2011, J CLIN ENDOCR METAB, V96, P115, DOI 10.1210/jc.2010-1669; Wang J, 2004, J ENDOCRINOL, V180, P247, DOI 10.1677/joe.0.1800247; Webb SM, 2009, J CLIN ENDOCR METAB, V94, P392, DOI 10.1210/jc.2008-0713; Yamamoto M, 2011, J CLIN INVEST, V121, P113, DOI 10.1172/JCI44073; YAMASHITA S, 1987, J CLIN INVEST, V79, P449, DOI 10.1172/JCI112832; Young J, 2007, BRIT J SPORT MED, V41, P335, DOI 10.1136/bjsm.2006.030585; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	83	31	31	0	5	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	JUN	2013	98	6					2187	2197		10.1210/jc.2012-4012			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	155GS	WOS:000319736500018	23539718	Green Published, Bronze			2022-02-06	
J	Spanevello, MD; Tajouri, SI; Mirciov, C; Kurniawan, N; Pearse, MJ; Fabri, LJ; Owczarek, CM; Hardy, MP; Bradford, RA; Ramunno, ML; Turnley, AM; Ruitenberg, MJ; Boyd, AW; Bartlett, PF				Spanevello, Mark Damien; Tajouri, Sophie Ines; Mirciov, Cornel; Kurniawan, Nyoman; Pearse, Martin John; Fabri, Louis Jerry; Owczarek, Catherine Mary; Hardy, Matthew Philip; Bradford, Rebecca Anne; Ramunno, Melanie Louise; Turnley, Ann Maree; Ruitenberg, Marc Jan; Boyd, Andrew Wallace; Bartlett, Perry Francis			Acute Delivery of EphA4-Fc Improves Functional Recovery after Contusive Spinal Cord Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						EphA4; magnetic resonance imaging; neurotrauma; spinal cord injury	EX-VIVO; AXONAL REGENERATION; UP-REGULATION; EPHRINB3; PATTERNS; LESIONS; GROWTH; BOS	Blocking the action of inhibitory molecules at sites of central nervous system injury has been proposed as a strategy to promote axonal regeneration and functional recovery. We have previously shown that genetic deletion or competitive antagonism of EphA4 receptor activity promotes axonal regeneration and functional recovery in a mouse model of lateral hemisection spinal cord injury. Here we have assessed the effect of blocking EphA4 activation using the competitive antagonist EphA4-Fc in a rat model of thoracic contusive spinal cord injury. Using a ledged tapered balance beam and open-field testing, we observed significant improvements in recovery of locomotor function after EphA4-Fc treatment. Consistent with functional improvement, using high-resolution ex vivo magnetic resonance imaging at 16.4T, we found that rats treated with EphA4-Fc had a significantly increased cross-sectional area of the dorsal funiculus caudal to the injury epicenter compared with controls. Our findings indicate that EphA4-Fc promotes functional recovery following contusive spinal cord injury and provides further support for the therapeutic benefit of treatment with the competitive antagonist in acute cases of spinal cord injury.	[Spanevello, Mark Damien; Tajouri, Sophie Ines; Mirciov, Cornel; Ruitenberg, Marc Jan; Bartlett, Perry Francis] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Kurniawan, Nyoman] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Ruitenberg, Marc Jan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Boyd, Andrew Wallace] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Spanevello, Mark Damien; Boyd, Andrew Wallace] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Pearse, Martin John; Fabri, Louis Jerry; Owczarek, Catherine Mary; Hardy, Matthew Philip; Bradford, Rebecca Anne; Ramunno, Melanie Louise] CSL Ltd, Melbourne, Vic, Australia; [Turnley, Ann Maree] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia		Boyd, AW (corresponding author), Univ Queensland, Royal Brisbane Hosp, Queensland Inst Med Res, Locked Bag 2000, Herston, Qld 4029, Australia.	Andrew.Boyd@qimr.edu.au; p.bartlett@uq.edu.au	Bartlett, Perry/F-3813-2012; Kurniawan, Nyoman/D-9764-2011	Kurniawan, Nyoman/0000-0001-6340-182X; fabri, louis/0000-0003-4033-3304; Ruitenberg, Marc/0000-0002-6917-0708; Mirciov, Cornel/0000-0002-9083-2614	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [511212, APP1017308]; Australian Research CouncilAustralian Research Council [DP110103201]; Lisa Palmer bequest; Spinal Cure Australia	This work was supported by the National Health and Medical Research Council (Grants 511212 and APP1017308 to Prof. Bartlett) and the Australian Research Council (Grant DP110103201 to Prof. Bartlett). This work was also supported by funding from the Lisa Palmer bequest and Spinal Cure Australia. We acknowledge the assistance of Rowan Tweedale and Ashley Cooper (Queensland Brain Institute, The University of Queensland) for their critical review of this manuscript.	Anseloni VCZ, 2003, J NEUROSCI METH, V131, P93, DOI 10.1016/S0165-0270(03)00241-3; Arocho LC, 2011, CELL MOL NEUROBIOL, V31, P1057, DOI 10.1007/s10571-011-9705-2; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bilgen M, 2008, BIOMARK MED, V2, P113, DOI 10.2217/17520363.2.2.113; Blomster LV, 2013, NMR BIOMED, V26, P141, DOI 10.1002/nbm.2829; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Cruz-Orengo L, 2006, EXP NEUROL, V202, P421, DOI 10.1016/j.expneurol.2006.07.005; Day BW, 2006, PROTEIN PEPTIDE LETT, V13, P193, DOI 10.2174/092986606775101625; Dixon KJ, 2012, NEUROSCI LETT, V525, P66, DOI 10.1016/j.neulet.2012.07.023; Dobrzanski P, 2004, CANCER RES, V64, P910, DOI 10.1158/0008-5472.CAN-3430-2; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Dries JL, 2011, J PHYSIOL-LONDON, V589, P1725, DOI 10.1113/jphysiol.2010.202366; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Ellingson BM, 2010, J NEUROSURG-SPINE, V13, P181, DOI 10.3171/2010.3.SPINE09523; Ellingson BM, 2008, J MAGN RESON IMAGING, V28, P1068, DOI 10.1002/jmri.21578; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Fleming SM, 2009, INT REV NEUROBIOL, V89, P57, DOI 10.1016/S0074-7742(09)89003-X; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Ho SKY, 2009, NEUROSCIENCE, V160, P784, DOI 10.1016/j.neuroscience.2009.03.013; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lau E, 2010, CLIN EXP PHARMACOL P, V37, P417, DOI 10.1111/j.1440-1681.2009.05318.x; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Munro KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037635; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nielson JL, 2011, J COMP NEUROL, V519, P2852, DOI 10.1002/cne.22661; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Omoto S, 2011, NEUROSCI RES, V69, P187, DOI 10.1016/j.neures.2010.12.004; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Rossi SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011852; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; STEEVES JD, 1980, NEUROSCI LETT, V20, P283, DOI 10.1016/0304-3940(80)90161-5; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Wen YR, 2011, J FORMOS MED ASSOC, V110, P487, DOI 10.1016/S0929-6646(11)60074-0	54	31	31	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2013	30	12					1023	1034		10.1089/neu.2012.2729			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	168KZ	WOS:000320705900001	23557244	Green Published, Green Submitted			2022-02-06	
J	Johnstone, VPA; Yan, EB; Alwis, DS; Rajan, R				Johnstone, Victoria Philippa Anne; Yan, Edwin Bingbing; Alwis, Dasuni Sathsara; Rajan, Ramesh			Cortical Hypoexcitation Defines Neuronal Responses in the Immediate Aftermath of Traumatic Brain Injury	PLOS ONE			English	Article							RAT BARREL CORTEX; FLUID-PERCUSSION INJURY; SPREADING DEPRESSION; INTRATHECAL BACLOFEN; PYRAMIDAL NEURONS; POSTTRAUMATIC EPILEPSY; SOMATOSENSORY CORTEX; RECEPTOR AGONISTS; WHISKER VIBRATION; HIPPOCAMPAL CA1	Traumatic brain injury (TBI) from a blow to the head is often associated with complex patterns of brain abnormalities that accompany deficits in cognitive and motor function. Previously we reported that a long-term consequence of TBI, induced with a closed-head injury method modelling human car and sporting accidents, is neuronal hyper-excitation in the rat sensory barrel cortex that receives tactile input from the face whiskers. Hyper-excitation occurred only in supra-granular layers and was stronger to complex than simple stimuli. We now examine changes in the immediate aftermath of TBI induced with same injury method. At 24 hours post-trauma significant sensorimotor deficits were observed and characterisation of the cortical population neuronal responses at that time revealed a depth-dependent suppression of neuronal responses, with reduced responses from supragranular layers through to input layer IV, but not in infragranular layers. In addition, increased spontaneous firing rate was recorded in cortical layers IV and V. We postulate that this early post-injury suppression of cortical processing of sensory input accounts for immediate post-trauma sensory morbidity and sets into train events that resolve into long-term cortical hyper-excitability in upper sensory cortex layers that may account for long-term sensory hyper-sensitivity in humans with TBI.	[Johnstone, Victoria Philippa Anne; Yan, Edwin Bingbing; Alwis, Dasuni Sathsara; Rajan, Ramesh] Monash Univ, Dept Physiol, Monash, Vic, Australia		Rajan, R (corresponding author), Monash Univ, Dept Physiol, Monash, Vic, Australia.	ramesh.rajan@monash.edu	Johnstone, Victoria/B-5083-2015; rajan, ramesh/L-4842-2019	Johnstone, Victoria/0000-0001-9885-3607; Rajan, Ramesh/0000-0001-9862-0520	National Health & Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1029311]	This study was funded by the National Health & Medical Research Council of Australia (grant no. APP1029311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; Brands D. W. A., 2002, PREDICTING BRAIN MEC; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dischinger PC, 1998, ACCIDENT ANAL PREV, V30, P831, DOI 10.1016/S0001-4575(98)00036-0; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Francisco GE, 2007, BRAIN INJURY, V21, P335, DOI 10.1080/02699050701311018; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Fujioka H, 2004, STROKE, V35, pE346, DOI 10.1161/01.STR.0000130990.28734.9c; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; JENSEN KF, 1987, J NEUROSCI, V7, P3529; Kao T, 2011, J NEUROPHYSIOL, V106, P2662, DOI 10.1152/jn.01017.2010; KELLER A, 1985, BRAIN RES, V343, P159, DOI 10.1016/0006-8993(85)91171-0; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerner C, 2004, NEUROSCI LETT, V361, P21, DOI 10.1016/j.neulet.2003.12.074; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Larsen DD, 2006, J COMP NEUROL, V494, P398, DOI 10.1002/cne.20754; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Nance ML, 2006, ANN SURG, V243, P121, DOI 10.1097/01.sla.0000193838.11102.56; NELLGARD B, 1992, ACTA PHYSIOL SCAND, V146, P497, DOI 10.1111/j.1748-1716.1992.tb09451.x; NEUMANNHAEFELIN T, 1995, NEUROSCI LETT, V193, P101, DOI 10.1016/0304-3940(95)11677-O; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Reinert M, 2000, Neurosurg Focus, V8, pe10; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salin P, 1995, J NEUROSCI, V15, P8234; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Turner MS, 2003, ACT NEUR S, V87, P81; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1317, DOI 10.2174/156802609789869646; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wood DP, 2005, P I MECH ENG D-J AUT, V219, P183, DOI 10.1243/095440705X6703; Xu J, 2008, NEUROPHARMACOLOGY, V54, P1029, DOI 10.1016/j.neuropharm.2008.01.014; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Ydenius A, 2010, TRAFFIC INJ PREV, V11, P526, DOI 10.1080/15389588.2010.492053; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao H, 2010, INT J CRASHWORTHINES, V15, P313, DOI 10.1080/13588260903335290; Zhou C, 2008, J NEUROSCI RES, V86, P2973, DOI 10.1002/jnr.21728	105	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63454	10.1371/journal.pone.0063454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	WOS:000319654700150	23667624	gold, Green Published, Green Submitted			2022-02-06	
J	Kaiboriboon, K; Bakaki, PM; Lhatoo, SD; Koroukian, S				Kaiboriboon, Kitti; Bakaki, Paul M.; Lhatoo, Samden D.; Koroukian, Siran			Incidence and prevalence of treated epilepsy among poor health and low-income Americans	NEUROLOGY			English	Article							POPULATION-BASED COHORT; SELF-REPORTED EPILEPSY; NEW-YORK-CITY; LONG-TERM; UNPROVOKED SEIZURES; RISK-FACTOR; ADULTS; COMMUNITY; CARE; ORGANIZATIONS	Objectives: To determine the incidence and prevalence of treated epilepsy in an adult Medicaid population. Methods: We performed a retrospective, dynamic cohort analysis using Ohio Medicaid claims data between 1992 and 2006. Individuals aged 18-64 years were identified as prevalent cases if they had >= 2 claims of epilepsy (ICD-9-CM: 345.xx) or >= 3 claims of convulsion (ICD-9-CM: 780.3 or 780.39) and >= 2 claims of antiepileptic drugs. Incident cases were required to have no epilepsy or convulsion claims for >5 years before epilepsy diagnosis. Subjects were determined as having preexisting disability and/or comorbid conditions, including brain tumor, depression, developmental disorders, migraine, schizophrenia, stroke, and traumatic brain injury, when at least one of these conditions occurred before epilepsy onset. Results: There were 9,056 prevalent cases of treated epilepsy in 1992-2006 and 1,608 incident cases in 1997-2006. The prevalence was 13.2/1,000 (95% confidence interval, 13.0-13.5/1,000). The incidence was 362/100,000 person-years (95% confidence interval, 344-379/100,000 person-years). The incidence and prevalence were significantly higher in men, in older people, in blacks, and in people with preexisting disability and/or comorbid conditions. The most common preexisting conditions in epilepsy subjects were depression, developmental disorders, and stroke, whereas people with brain tumor, traumatic brain injury, and stroke had the higher risk of developing epilepsy. Conclusions: The Medicaid population has a high incidence and prevalence of epilepsy, in an order of magnitude greater than that reported in the US general population. This indigent population carries a disproportionate amount of the epilepsy burden and deserves more attention for its health care needs and support services. Neurology (R) 2013; 80: 1942-1949	[Kaiboriboon, Kitti; Lhatoo, Samden D.] Univ Hosp Case Med Ctr, Dept Neurol, Epilepsy Ctr, Cleveland, OH USA; [Bakaki, Paul M.; Koroukian, Siran] Case Western Reserve Univ, Dept Epidemiol & Biostat, Clin & Translat Sci Collaborat, Populat Hlth & Outcomes Res Core, Cleveland, OH 44106 USA		Kaiboriboon, K (corresponding author), Univ Hosp Case Med Ctr, Dept Neurol, Epilepsy Ctr, Cleveland, OH USA.	Kitti.Kaiboriboon@UHhospitals.org	Lhatoo, Samden/L-7341-2019		Epilepsy Foundation; Case Western Reserve University/Cleveland Clinic CTSA from the National Center for Research Resources (NCRR), a component of the NIH [UL1 RR024989]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024989] Funding Source: NIH RePORTER	K.K. and P. M. B. are supported by the Epilepsy Foundation. This study was also supported in part by the Case Western Reserve University/Cleveland Clinic CTSA grant number UL1 RR024989 from the National Center for Research Resources (NCRR), a component of the NIH and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.	ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Annegers JF, 1999, EPILEPSIA, V40, P502, DOI 10.1111/j.1528-1157.1999.tb00748.x; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Benn EKT, 2008, EPILEPSIA, V49, P1431, DOI 10.1111/j.1528-1167.2008.01564.x; Chen CC, 2012, EPILEPSIA, V53, P283, DOI 10.1111/j.1528-1167.2011.03332.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2; Elias R, MEDICAID RESOURCE BO; Ellis ER, MEDICAID ENROLLMENT; Fisher B, 2012, EPILEPSY BEHAV, V24, P488, DOI 10.1016/j.yebeh.2012.06.006; Gibson TB, 2009, MIL MED, V174, P936, DOI 10.7205/MILMED-D-03-7808; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Heaney DC, 2002, BMJ-BRIT MED J, V325, P1013, DOI 10.1136/bmj.325.7371.1013; Hesdorffer DC, 2005, EPILEPSIA, V46, P1297, DOI 10.1111/j.1528-1167.2005.10705.x; Hildebrand J, 2005, NEUROLOGY, V65, P212, DOI 10.1212/01.wnl.0000168903.09277.8f; Holden E Wayne, 2005, Dis Manag, V8, P1, DOI 10.1089/dis.2005.8.1; Holden EW, 2005, EPILEPSIA, V46, P311, DOI 10.1111/j.0013-9580.2005.30604.x; Kaiser Commission on Medicaid and the Uninsured, MED PROGR GLANC; Kelvin EA, 2007, EPILEPSY RES, V77, P141, DOI 10.1016/j.eplepsyres.2007.09.012; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Kobau R, 2007, EPILEPSIA, V48, P1904, DOI 10.1111/j.1528-1167.2007.01161.x; Kobau Rosemarie, 2012, Morbidity and Mortality Weekly Report, V61, P909; Kroner BL, 2013, EPILEPSY RES, V103, P279, DOI 10.1016/j.eplepsyres.2012.07.005; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Lossius MI, 2005, EPILEPSIA, V46, P1246, DOI 10.1111/j.1528-1167.2005.57904.x; MEIERKORD H, 1991, NEUROLOGY, V41, P1643, DOI 10.1212/WNL.41.10.1643; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Ottman R, 1996, ANN NEUROL, V39, P442, DOI 10.1002/ana.410390406; Reuber M, 2003, EPILEPSY BEHAV, V4, P205, DOI 10.1016/S1525-5050(03)00104-5; Seiber EE, 2011, MEDICARE MEDICAID RE, V1, pE1; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Winawer MR, 2010, NEUROLOGY, V74, P1166, DOI 10.1212/WNL.0b013e3181d90065	35	31	32	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	MAY	2013	80	21					1942	1949		10.1212/WNL.0b013e318293e1b4			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149PJ	WOS:000319332900011	23616158	Green Published			2022-02-06	
J	Sangiorgi, S; De Benedictis, A; Protasoni, M; Manelli, A; Reguzzoni, M; Cividini, A; Dell'Orbo, C; Tomei, G; Balbi, S				Sangiorgi, Simone; De Benedictis, Alessandro; Protasoni, Marina; Manelli, Alessandro; Reguzzoni, Marcella; Cividini, Andrea; Dell'Orbo, Carlo; Tomei, Giustino; Balbi, Sergio			Early-stage microvascular alterations of a new model of controlled cortical traumatic brain injury: 3D morphological analysis using scanning electron microscopy and corrosion casting Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						controlled cortical impact injury; cerebral edema; corrosion casting; scanning electron microscope; transmission electron microscope; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; CEREBRAL-CORTEX; BLOOD-VESSELS; SUBARACHNOID HEMORRHAGE; EDEMA; MICROVESSELS; HYPOXIA; ARTERIOLES	Object. This study was performed to study the microvascular changes that occur during the first 12 hours after traumatic brain injury (TBI) using the corrosion casting technique. Methods. The authors performed a qualitative and quantitative morphological study of the changes in cerebral vessels at acute (3 hours) and subacute (12 hours) stages after experimental TBI. They used a model of controlled cortical impact (CCI) injury induced by a recently developed electromagnetic device (impactor), focusing their observations mainly on the microvascular alterations responsible for the formation and maintenance of tissue edema and consequent brain swelling during the first hours after TBI. They used corrosion casting, scanning electron microscopy (SEM), light microscopy, and transmission electron microscopy (TEM) to obtain a morphological qualitative map with both 2D and 3D details. Results. Scanning electron microscopy analysis of vascular casts documented in 3 dimensions the typical injuries occurring after a TBI: subdural, subarachnoid, and intraparenchymal hemorrhages, along with alterations of the morphological characteristics and architecture of both medium-sized and capillary vessels, including ectasia of pial vessels, sphincter constrictions at the origin of the perforating vessels, focal swelling of perforating vessels, widening of intercellular junctions, and some indirect evidence of structural impairment of endothelial cells. All of these vascular alterations were confirmed in 2D analyses using light microscopy and TEM. Conclusions. The corrosion casting SEM technique applied to a CCI experimental model proved to be a reliable method for studying the pathophysiology of the vascular alterations occurring at acute and subacute stages after CCI injury. It was also possible to obtain topographical localization of the vascular and cellular events that usually lead to hyperemia, edema, and brain swelling. Moreover, by applying informatic software to anatomical images it was possible to perform quantification and statistical analysis of the observed events. (http://thejns.org/doi/abs/10.3171/2012.11.JNS12627)	[Sangiorgi, Simone; Cividini, Andrea; Tomei, Giustino; Balbi, Sergio] Univ Insubria, Dept Biotechnol & Life Sci, Neurosurg Unit, I-21100 Varese, Italy; [Protasoni, Marina; Reguzzoni, Marcella; Dell'Orbo, Carlo] Univ Insubria, Dept Morphol Sci, Lab Human Anat L Cattaneo, I-21100 Varese, Italy; [De Benedictis, Alessandro] IRCCS, Bambino Gesu Childrens Hosp, Dept Neurosci, Div Neurosurg, Rome, Italy; [Manelli, Alessandro] ASL 1 Imperiese, Phys Rehabil Unit, Imperia, Italy		Sangiorgi, S (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Neurosurg Unit, 57 Viale L Borri, I-21100 Varese, Italy.	simo.med@libero.it		Marcella, Reguzzoni/0000-0003-3738-6632; PROTASONI, MARINA/0000-0002-8405-596X; Balbi, Sergio/0000-0002-8391-0434			Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock M Ross, 2006, Neurosurgery, V58, pS7; CERVOSNAVARRO J, 1978, NEUROPATH APPL NEURO, V4, P369, DOI 10.1111/j.1365-2990.1978.tb01349.x; CRAIGIE EH, 1945, BIOL REV, V20, P133, DOI 10.1111/j.1469-185X.1945.tb00446.x; DAHL E, 1973, Z ZELLFORSCH MIK ANA, V145, P577, DOI 10.1007/BF00306725; Hodde K C, 1980, Scan Electron Microsc, P89; Hodde K. C., 1996, P111; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KRASZNAI L, 1994, NEUROL RES, V16, P40; LAMETSCHWANDTNER A, 1990, SCANNING MICROSCOPY, V4, P889; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; LEVESQUE MJ, 1979, ATHEROSCLEROSIS, V34, P457, DOI 10.1016/0021-9150(79)90070-4; LEWIS OJ, 1957, J ANAT, V91, P40; LONG DM, 1982, CLIN NEUR, V29, P174; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MIODONSKI A, 1980, ARCH OTOLARYNGOL, V106, P321; MIRONOV V, 1994, BRAIN RES, V660, P73, DOI 10.1016/0006-8993(94)90840-0; MIYOSHI Y, 1995, BRAIN RES, V681, P131, DOI 10.1016/0006-8993(95)00304-9; MOTTI EDF, 1987, SCANNING MICROSCOPY, V1, P207; MURAI N, 1992, J ELECTRON MICROSC, V41, P123; MURAKAMI T, 1971, Archivum Histologicum Japonicum, V32, P445; NAKAI K, 1989, SCANNING MICROSCOPY, V3, P337; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; NORTHOVER JMA, 1980, J ANAT, V130, P43; Ohkuma H, 1997, NEUROSURGERY, V41, P230, DOI 10.1097/00006123-199707000-00036; Portella G, 2002, ACT NEUR S, V81, P173; Raspanti M, 2005, MICROSC RES TECHNIQ, V67, P1, DOI 10.1002/jemt.20176; Reina-De La Torre F, 1998, ANAT RECORD, V251, P87, DOI 10.1002/(SICI)1097-0185(199805)251:1<87::AID-AR14>3.0.CO;2-7; Rodriguez-Baeza A, 1998, ANAT RECORD, V252, P176, DOI 10.1002/(SICI)1097-0185(199810)252:2<176::AID-AR3>3.0.CO;2-1; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; ROSENBLUM WI, 1994, HUMAN BRAIN CIRCULATION, P23; ROWBOTHAM GF, 1965, BRIT J SURG, V52, P8, DOI 10.1002/bjs.1800520104; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; Secomb TW, 2000, MICROCIRCULATION, V7, P237, DOI 10.1038/sj.mn.7300114; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; WEISS HR, 1976, MICROVASC RES, V12, P305, DOI 10.1016/0026-2862(76)90028-5	41	31	33	1	12	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2013	118	4					763	774		10.3171/2012.11.JNS12627			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	114BT	WOS:000316715700013	23350772				2022-02-06	
J	Clement, RC; Carr, BG; Kallan, MJ; Wolff, C; Reilly, PM; Malhotra, NR				Clement, R. Carter; Carr, Brendan G.; Kallan, Michael J.; Wolff, Catherine; Reilly, Patrick M.; Malhotra, Neil R.			Volume-outcome relationship in neurotrauma care	JOURNAL OF NEUROSURGERY			English	Article						neurotrauma; volume-outcome relationship; cost; center size; traumatic brain injury	TRAUMA CENTER DESIGNATION; HOSPITAL VOLUME; SURGEON VOLUME; UNITED-STATES; POTENTIAL BENEFITS; MORTALITY; ASSOCIATION; IMPACT; CANCER; COSTS	Object. A positive correlation between outcomes and the volume of patients seen by a provider has been supported by numerous studies. Volume-outcome relationships (VORs) have been well documented in the setting of both neurosurgery and trauma care and have shaped regionalization policies to optimize patient outcomes. Several authors have also investigated the correlation between patient volume and cost of care, known as the volume-cost relationship (VCR), with mixed results. The purpose of the present study was to investigate VORs and VCRs in the treatment of common intracranial injuries by testing the hypotheses that outcomes suffer at small-volume centers and costs rise at large-volume centers. Methods. The authors performed a cross-sectional cohort study of patients with neurological trauma using the 2006 Nationwide Inpatient Sample, the largest nationally representative all-payer data set. Patients were identified using ICD-9 codes for subdural, subarachnoid, and extradural hemorrhage following injury. Transfers were excluded from the study. In the primary analysis the association between a facility's neurotrauma patient volume and patient survival was tested. Secondary analyses focused on the relationships between patient volume and discharge status as well as between patient volume and cost. Analyses were performed using logistic regression. Results. In-hospital mortality in the overall cohort was 9.9%. In-hospital mortality was 14.9% in the group with the smallest volume of patients, that is, fewer than 6 cases annually. At facilities treating 6-11, 12-23, 24-59, and 60+ patients annually, mortality was 8.0%, 8.3%, 9.5%, and 10.0%, respectively. For these groups there was a significantly reduced risk of in-hospital mortality as compared with the group with fewer than 6 annual patients; the adjusted ORs (and corresponding 95% CIs) were 0.45 (0.29-0.68), 0.56 (0.38-0.81), 0.63 (0.44-0.90), and 059 (0.41-0.87), respectively. For these same groups (once again using < 6 cases/year as the reference), there were no statistically significant differences in either estimated actual cost or duration of hospital stay. Conclusions. A VOR exists in the treatment of neurotrauma, and a meaningful threshold for significantly improved mortality is 6 cases per year. Emergency and interfacility transport policies based on this threshold might improve national outcomes. Cost of care does not differ significantly with patient volume. (http://thejns.org/doi/abs/10.3171/2012.10.JNS12682)	[Clement, R. Carter] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Clement, R. Carter] Univ Penn, Wharton Sch Business, Philadelphia, PA 19104 USA; [Carr, Brendan G.] Leonard Davis Inst Healthcare Econ, Philadelphia, PA USA; [Carr, Brendan G.; Kallan, Michael J.; Wolff, Catherine] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Carr, Brendan G.] Hosp Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Reilly, Patrick M.] Hosp Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Malhotra, Neil R.] Hosp Univ Penn, Dept Neurol Surg, Philadelphia, PA 19104 USA		Malhotra, NR (corresponding author), Univ Penn, Dept Neurol Surg, 3 Silverstein Pavil,3400 Spruce St, Philadelphia, PA 19104 USA.	NRM@UPHS.UPenn.edu		Clement, Rutledge/0000-0002-9959-9644	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K08HS017960-04]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS017960] Funding Source: NIH RePORTER	Study funding was provided by NIH KO8 Grant No. 5K08HS017960-04 (B.G.C.).	Bardach NS, 2002, STROKE, V33, P1851, DOI 10.1161/01.STR.0000019126.43079.7B; Barker FG, 2003, J CLIN ENDOCR METAB, V88, P4709, DOI 10.1210/jc.2003-030461; Barker FG, 2005, NEURO-ONCOLOGY, V7, P49, DOI 10.1215/S1152851704000146; Bennett KM, 2011, J SURG RES, V167, P19, DOI 10.1016/j.jss.2010.05.020; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2004, SURGERY, V135, P569, DOI 10.1016/j.surg.2004.03.004; Birkmeyer JD, 2002, HEALTH AFFAIR, V21, P234, DOI 10.1377/hlthaff.21.5.234; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gooiker GA, 2011, BRIT J SURG, V98, P485, DOI 10.1002/bjs.7413; Gooiker G A, 2010, Eur J Surg Oncol, V36 Suppl 1, pS27, DOI 10.1016/j.ejso.2010.06.024; Goossens-Laan CA, 2011, EUR UROL, V59, P775, DOI 10.1016/j.eururo.2011.01.037; Gourin CG, 2011, LARYNGOSCOPE, V121, P85, DOI 10.1002/lary.21348; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003; Harmon JW, 1999, ANN SURG, V230, P404, DOI 10.1097/00000658-199909000-00013; Hastan D, 2009, OTOL NEUROTOL, V30, P975, DOI 10.1097/MAO.0b013e3181b0d04a; Ho V, 2008, MED CARE, V46, P718, DOI 10.1097/MLR.0b013e3181653d6b; Ho Vivian, 2007, Cost Eff Resour Alloc, V5, P7, DOI 10.1186/1478-7547-5-7; Holt PJE, 2007, BRIT J SURG, V94, P441, DOI 10.1002/bjs.5725; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Kates SL, 2011, J ORTHOP TRAUMA, V25, P233, DOI 10.1097/BOT.0b013e3181e5e901; Koelemay MJ, 2007, BRIT J SURG, V94, P1041, DOI 10.1002/bjs.5969; Konety BR, 2004, J UROLOGY, V172, P1056, DOI 10.1097/01.ju.0000136382.51688.21; Kuo EY, 2001, ANN THORAC SURG, V72, P1118, DOI 10.1016/S0003-4975(01)02962-9; Markar SR, 2012, J GASTROINTEST SURG, V16, P2055; Nathens A B, 2001, Adv Surg, V35, P61; Oyetunji TA, 2011, AM J SURG, V201, P445, DOI 10.1016/j.amjsurg.2010.10.006; Smith ER, 2004, J NEUROSURG, V100, P90, DOI 10.3171/ped.2004.100.2.0090; Solheim O, 2011, ACTA NEUROCHIR, V153, P1219, DOI 10.1007/s00701-011-0967-8; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Swisher SG, 2000, J THORAC CARDIOV SUR, V119, P1126, DOI 10.1067/mtc.2000.105644; van de Velde, 2010, EUR J SURG ONCOL S1, V36, pS55, DOI DOI 10.1016/j.ejso.2010.06.027; Vespa P, 2011, NEUROCRIT CARE, V15, P369, DOI 10.1007/s12028-011-9602-z; Wilson A, 2010, ANZ J SURG, V80, P24, DOI 10.1111/j.1445-2197.2009.05172.x	39	31	31	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2013	118	3					687	693		10.3171/2012.10.JNS12682			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	094DW	WOS:000315244200033	23240697				2022-02-06	
J	Kozlowski, AJ; Pretz, CR; Dams-O'Connor, K; Kreider, S; Whiteneck, G				Kozlowski, Allan J.; Pretz, Christopher R.; Dams-O'Connor, Kristen; Kreider, Scott; Whiteneck, Gale			An Introduction to Applying Individual Growth Curve Models to Evaluate Change in Rehabilitation: A National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems Report	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Longitudinal studies; Regression analysis; Rehabilitation; Treatment outcome	SPINAL-CORD-INJURY; LIFE SATISFACTION; LONGITUDINAL DATA; MULTILEVEL MODELS; PREDICTORS	The abundance of time-dependent information contained in the Spinal Cord Injury and the Traumatic Brain Injury Model Systems National Databases, and the increased prevalence of repeated-measures designs in clinical trials highlight the need for more powerful longitudinal analytic methodologies in rehabilitation research. This article describes the particularly versatile analytic technique of individual growth curve (IGC) analysis. A defining characteristic of IGC analysis is that change in outcome such as functional recovery can be described at both the patient and group levels, such that it is possible to contrast 1 patient with other patients, subgroups of patients, or a group as a whole. Other appealing characteristics of IGC analysis include its flexibility in describing how outcomes progress over time (whether in linear, curvilinear, cyclical, or other fashion), its ability to accommodate covariates at multiple levels of analyses to better describe change, and its ability to accommodate cases with partially missing outcome data. These features make IGC analysis an ideal tool for investigating longitudinal outcome data and to better equip researchers and clinicians to explore a multitude of hypotheses. The goal of this special communication is to familiarize the rehabilitation community with IGC analysis and encourage the use of this sophisticated research tool to better understand temporal change in outcomes. Archives of Physical Medicine and Rehabilitation 2013;94:589-96 (C) 2013 by the American Congress of Rehabilitation Medicine	[Kozlowski, Allan J.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Kozlowski, Allan J.] Northwestern Univ, Feinberg Med Sch, Ctr Healthcare Studies, Chicago, IL 60611 USA; [Pretz, Christopher R.; Kreider, Scott; Whiteneck, Gale] Craig Hosp, Englewood, CO USA; [Pretz, Christopher R.; Kreider, Scott; Whiteneck, Gale] Traumat Brain Injury Natl Stat & Data Ctr, Englewood, CO USA; [Dams-O'Connor, Kristen] Mt Sinai Sch Med, New York, NY USA		Kozlowski, AJ (corresponding author), Rehabil Inst Chicago, 345 E Ontario St, Chicago, IL 60611 USA.	akozlowski@ric.org			National Institute on Disability and Rehabilitation Research through the Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes [H133B090024]; Traumatic Brain Injury Model Systems National Data and Statistical Center [H133A110006]	Supported by the National Institute on Disability and Rehabilitation Research through the Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes (grant no. H133B090024), and the Traumatic Brain Injury Model Systems National Data and Statistical Center (grant no. H133A110006).	[Anonymous], 2012, HLM 7 STAT SOFTW HIE; [Anonymous], 2012, STAT AN STAT SOFTW; [Anonymous], 2012, MPLUS STAT SOFTW; Barker GM, 2010, ANN THORAC SURG, V89, P843, DOI 10.1016/j.athoracsur.2009.11.048; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chan L, 1997, NEW ENGL J MED, V337, P978, DOI 10.1056/NEJM199710023371406; Chen YY, 2008, ARCH PHYS MED REHAB, V89, P2285, DOI 10.1016/j.apmr.2008.06.008; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; DUNLOP DD, 1994, AM STAT, V48, P299, DOI 10.2307/2684838; Fitzmaurice GM, 2011, APPL LONGITUDINAL AN, V2nd; Hamsher K., 1989, MULTILINGUAL APHASIA; Hedeker D., 2006, LONGITUDINAL DATA AN; IBM, 2012, SPSS STAT VERS 20; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liu SW, 2012, PSYCHOL METHODS, V17, P15, DOI 10.1037/a0026971; Putzke JD, 2002, ARCH PHYS MED REHAB, V83, P555, DOI 10.1053/apmr.2002.31173; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI, VII; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; ROGOSA DR, 1985, PSYCHOMETRIKA, V50, P203, DOI 10.1007/BF02294247; SAS Institute, 2012, SAS STAT SOFTW VERS; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Skrondal A, 2012, MULTILEVEL LONGITUDI, VI; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); van Leeuwen CM, 2011, ARCH PHYS MED REHAB, V92, P207, DOI 10.1016/j.apmr.2010.10.011; Warschausky S, 2001, ARCH PHYS MED REHAB, V82, P329, DOI 10.1053/apmr.2001.21510; [No title captured]	28	31	31	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2013	94	3					589	596		10.1016/j.apmr.2012.08.199			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	106PZ	WOS:000316158500026	22902887				2022-02-06	
J	Ohta, M; Higashi, Y; Yawata, T; Kitahara, M; Nobumoto, A; Ishida, E; Tsuda, M; Fujimoto, Y; Shimizu, K				Ohta, Manabu; Higashi, Youichirou; Yawata, Toshio; Kitahara, Masahiro; Nobumoto, Atsuya; Ishida, Eri; Tsuda, Masayuki; Fujimoto, Yasunori; Shimizu, Keiji			Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic axonal injury; Edaravone; Free radical; Memory deficits; Amyloid precursor protein	FREE-RADICAL SCAVENGER; MEDIATED CYTOSKELETAL DEGRADATION; OXIDE SYNTHASE ISOFORMS; NITRIC-OXIDE; HEAD-INJURY; SUPEROXIDE-DISMUTASE; RAT HIPPOCAMPUS; TRANSIENT; DAMAGE; DISABILITY	Traumatic axonal injury (TAI), a feature of traumatic brain injury (TBI), progressively evolves over hours through impaired axonal transport and is thought to be a major contributor to cognitive dysfunction. In spite of various studies suggesting that pharmacologic or physiologic interventions might reduce TAI, clinical neuroprotective treatments are still unavailable. Edaravone, a free radical scavenger, has been shown to exert neuroprotective effects in animal models of several brain disorders. In this study, to evaluate whether edaravone suppresses TAI following TBI, mice were subjected to weight drop injury and had either edaravone (3.0 mg/kg) or saline administered intravenously immediately after impact. Axonal injury and oxidative stress were assessed using immunohistochemistry with antibodies against amyloid precursor protein, a marker of impaired axonal transport, and with 8-hydroxy-2'-deoxyguanosine, a marker of oxidative DNA damage. Edaravone significantly suppressed axonal injury and oxidative stress in the cortex, corpus callosum, and hippocampus 24 h after injury. The neuroprotective effects of edaravone were observed in mice receiving 1.0, 3.0, or 10 mg/kg of edaravone immediately after impact, but not after 0.3 mg/kg of edaravone. With treatment 1 h after impact, axonal injury was also significantly suppressed and this therapeutic effect persisted up to 6 h after impact. Furthermore, behavioral tests performed 9 days after injury showed memory deficits in saline-treated traumatized mice, which were not evident in the edaravone-treated group. These results suggest that edaravone protects against memory deficits following TBI and that this protection is mediated by suppression of TAI and oxidative stress. (c) 2012 Elsevier B.V. All rights reserved.	[Ohta, Manabu; Higashi, Youichirou; Yawata, Toshio; Kitahara, Masahiro; Ishida, Eri; Fujimoto, Yasunori; Shimizu, Keiji] Kochi Med Sch, Dept Neurosurg, Nankoku, Kochi 7838505, Japan; [Nobumoto, Atsuya; Tsuda, Masayuki] Kochi Med Sch, Inst Lab Anim Res, Nankoku, Kochi 7838505, Japan		Shimizu, K (corresponding author), Kochi Med Sch, Dept Neurosurg, Okoh Cho, Nankoku, Kochi 7838505, Japan.	b08d6b05@s.kochi-u.ac.jp; higasi@kochi-u.ac.jp; yawatat@kochi-u.ac.jp; mstsuda@kochi-u.ac.jp; yfujimoto@kochi-u.ac.jp; kshimizu@kochi-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24592133, 22791349]; General Insurance Association of Japan	This work was supported in part by Grants-in-Aid for Scientific Research ((C), No. 24592133) and for Young Scientists ((B), No. 22791349) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and the General Insurance Association of Japan. We thank Mitsubishi Tanabe Pharma for providing the edaravone used in this study.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Balaratnasingam C, 2009, BRAIN RES, V1263, P155, DOI 10.1016/j.brainres.2009.01.031; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Christensen DZ, 2008, ACTA NEUROPATHOL, V116, P647, DOI 10.1007/s00401-008-0451-6; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Johnson VE, EXP NEUROL IN PRESS; Kamida T, 2009, SEIZURE-EUR J EPILEP, V18, P71, DOI 10.1016/j.seizure.2008.06.012; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Mintz Y, 2002, ISRAEL MED ASSOC J, V4, P554; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Naritomi Hiroaki, 2010, Drugs R D, V10, P155, DOI 10.2165/11586550-000000000-00000; Otani H, 2005, EUR J PHARMACOL, V512, P129, DOI 10.1016/j.ejphar.2005.01.050; PARKIN AJ, 1984, CORTEX, V20, P479, DOI 10.1016/S0010-9452(84)80053-2; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013463; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Tang YP, 1997, BRIT J PHARMACOL, V122, P257, DOI 10.1038/sj.bjp.0701385; Vaziri ND, 2001, J PHARMACOL EXP THER, V298, P679; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Wu ZF, 2010, J CLIN BIOCHEM NUTR, V46, P187, DOI 10.3164/jcbn.09-104-2; YERMILOV V, 1995, FEBS LETT, V376, P207, DOI 10.1016/0014-5793(95)01281-6; Yoshida H, 2006, CNS DRUG REV, V12, P9, DOI 10.1111/j.1527-3458.2006.00009.x; Zakaria N, 2012, BRAIN RES, V1467, P81, DOI 10.1016/j.brainres.2012.05.046	45	31	32	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2013	1490						184	192		10.1016/j.brainres.2012.09.011			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	079BC	WOS:000314144200019	22982593				2022-02-06	
J	Adelson, PD; Fellows-Mayle, W; Kochanek, PM; Dixon, CE				Adelson, P. David; Fellows-Mayle, Wendy; Kochanek, Patrick M.; Dixon, C. Edward			Morris water maze function and histologic characterization of two age-at-injury experimental models of controlled cortical impact in the immature rat	CHILDS NERVOUS SYSTEM			English	Article						Age; Animal studies; Models of injury; Pediatric brain injury; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; COGNITIVE DEFICITS; SPATIAL NAVIGATION; MEMORY; MATURATION; ADULT; NEURODEGENERATION; HYPOTHERMIA; EXPRESSION	Controlled cortical impact (CCI) is commonly used in adult animals to study focal traumatic brain injury (TBI). Our study aims to further study injury mechanisms in children and variable models of pathology in the developing brain. Develop a focal injury model of experimental TBI in the immature, postnatal days (PND) 7 and 17 rats that underwent a CCI at varying depths of deflection, 1.5-2.5 mm compared with sham and then tested using the Morris water maze (MWM) beginning on post-injury day (PID) 11. Histopathologic analysis was performed at PID 1 and 28. In PND 7, the 1.75- and 2.0-mm deflections (diameter (d) = 3 mm; velocity = 4 m/s; and duration = 500 ms) resulted in significant MWM deficits while the 1.5-mm injury did not produce MWM deficits vs. sham controls. In PND 17, all injury levels resulted in significant MWM deficits vs. sham controls with a graded response; the 1.5-mm deflection (d = 6 mm; velocity = 4 m/s; and duration = 500 ms) produced significantly less deficits as compared WITH the 2.0- and 2.5-mm injuries. Histologically, a graded injury response was also seen in both ages at injury with cortical and more severe injuries, hippocampal damage. Cortical contusion volume increased in most injury severities from PID 1 to 28 in both ages at injury while hippocampal volumes subsequently decreased. CCI in PND 7 and 17 rat results in significant MWM deficits and cortical histopathology providing two different and unique experimental models of TBI in immature rats that may be useful in further investigations into the mechanisms and treatments of pediatric TBI.	[Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Fellows-Mayle, Wendy; Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurosurg, Childrens Hosp Pittsburgh, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA		Adelson, PD (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, 1919 E Thomas Rd,Bldg B,4th Floor, Phoenix, AZ 85016 USA.	dadelson@phoenixchildrens.com	Kochanek, Patrick M/D-2371-2015; Adelson, David/W-2083-2019	Kochanek, Patrick M/0000-0002-2627-913X; 	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH RO1 NS42298, NIH RO1 NS 30318, NS 38087]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038087, R01NS042298] Funding Source: NIH RePORTER	The authors wish to thank the National Institute of Health for its support for PDA (NIH RO1 NS42298) and PMK (NIH RO1 NS 30318 and NS 38087). The authors also wish to thank Ms. Christina Casanova for her help in the manuscript preparation.	Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; Armstead WM, 1998, J NEUROTRAUM, V15, P721, DOI 10.1089/neu.1998.15.721; BACHEVALIER J, 1993, HIPPOCAMPUS, V3, P191; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BERGERSWEENEY J, 1994, J NEUROSCI, V14, P4507; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Clark RSB, 1997, J NEUROSCI, V17, P9172; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fink Ericka L, 2004, Pediatr Crit Care Med, V5, P139, DOI 10.1097/01.PCC.0000112376.29903.8F; Frielingsdorf H, 2006, BEHAV BRAIN RES, V168, P37, DOI 10.1016/j.bbr.2005.10.008; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kraemer PJ, 1996, BRAIN RES BULL, V39, P17, DOI 10.1016/0361-9230(95)02028-4; KRAUS JF, 1987, PEDIATRICS, V79, P501; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kraus JF, 1987, HEAD INJURY, V2, P1; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; NEHLIG A, 1989, J CEREBR BLOOD F MET, V9, P579, DOI 10.1038/jcbfm.1989.83; NEHLIG A, 1988, J NEUROSCI, V8, P2321; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2003, DEV BRAIN RES, V140, P93, DOI 10.1016/S0165-3806(02)00588-6; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; SCHENK F, 1989, J NEUROSCI METH, V26, P249, DOI 10.1016/0165-0270(89)90123-4; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; Stevenson K. L., 2000, Journal of Neurotrauma, V17, P944; SUTHERLAND RJ, 1982, J COMP PHYSIOL PSYCH, V96, P563, DOI 10.1037/h0077914	65	31	33	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2013	29	1					43	53		10.1007/s00381-012-1932-4			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	064JN	WOS:000313071200006	23089934				2022-02-06	
J	Dennis, M; Agostino, A; Taylor, HG; Bigler, ED; Rubin, K; Vannatta, K; Gerhardt, CA; Stancin, T; Yeates, KO				Dennis, Maureen; Agostino, Alba; Taylor, H. Gerry; Bigler, Erin D.; Rubin, Kenneth; Vannatta, Kathryn; Gerhardt, Cynthia A.; Stancin, Terry; Yeates, Keith Owen			Emotional Expression and Socially Modulated Emotive Communication in Children with Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Emotion; Facial expression; Theory of mind; Closed head injury; Test; language comprehension; Social emotional communication	FACIAL EXPRESSION; RECOGNITION; MILD; NEUROSCIENCE; INTEGRATION; PERCEPTION; ABILITIES; DISORDER; DEFICITS; OUTCOMES	Facial emotion expresses feelings, but is also a vehicle for social communication. Using five basic emotions (happiness, sadness, fear, disgust, and anger) in a comprehension paradigm, we studied how facial expression reflects inner feelings (emotional expression) but may be socially modulated to communicate a different emotion from the inner feeling (emotive communication, a form of affective theory of mind). Participants were 8- to 12-year-old children with TBI (n = 78) and peers with orthopedic injuries (n = 56). Children with mild-moderate or severe TBI performed more poorly than the OI group, and chose less cognitively sophisticated strategies for emotive communication. Compared to the OI and mild-moderate TBI groups, children with severe TBI had more deficits in anger, fear, and sadness; neutralized emotions less often; produced socially inappropriate responses; and failed to differentiate the core emotional dimension of arousal. Children with TBI have difficulty understanding the dual role of facial emotions in expressing feelings and communicating socially relevant but deceptive emotions, and these difficulties likely contribute to their social problems. (JINS, 2013, 19, 34-43)	[Dennis, Maureen] Hosp Sick Children, Dept Psychol, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada; [Agostino, Alba] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Stancin, Terry] Rainbow Babies & Childrens Hosp, Dept Pediat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Rubin, Kenneth] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Vannatta, Kathryn; Gerhardt, Cynthia A.; Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Vannatta, Kathryn; Gerhardt, Cynthia A.; Yeates, Keith Owen] Nationwide Childrens Hosp, Ctr Biobehav Hlth, Res Inst, Columbus, OH USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Pediat, Cleveland, OH USA		Dennis, M (corresponding author), Hosp Sick Children, Dept Psychol, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	maureen.dennis@sickkids.ca	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019; Vannatta, Kathryn/E-4237-2011; Rubin, Kenneth H/M-5276-2018; Gerhardt, Cynthia/E-3109-2011	Rubin, Kenneth H/0000-0002-2608-2484; Agostino, Alexandra/0000-0001-8739-0061; Yeates, Keith/0000-0001-7680-2892	National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1 RO1 HD 04946]	This paper was supported by National Institute of Neurological Diseases and Stroke Grant 1 RO1 HD 04946, "Social Outcomes in Pediatric Traumatic Brain Injury.'' The information presented in this manuscript has never been published either electronically or in print elsewhere. No conflicts of interest exist regarding this manuscript.	Adams RB, 2006, MOTIV EMOTION, V30, P179, DOI 10.1007/s11031-006-9020-2; Bennett DS, 2002, INFANCY, V3, P97, DOI 10.1207/S15327078IN0301_5; Berkman ET, 2009, SOC PERSONAL PSYCHOL, V3, P475, DOI 10.1111/j.1751-9004.2009.00186.x; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Cunningham W.A., 2007, SOC NEUROSCI-UK, P227; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; GRAY JA, 1990, COGNITION EMOTION, V4, P269, DOI 10.1080/02699939008410799; Green MJ, 2003, COGNITION EMOTION, V17, P779, DOI 10.1080/02699930302282; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hauser RM, 1997, SOCIOL METHODOL, V27, P177, DOI 10.1111/1467-9531.271028; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Howard I, 2005, ETHNIC DIS, V15, pS51; Huang L, 2011, SOC PSYCHOL PERS SCI, V2, P351, DOI 10.1177/1948550610391677; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; RUSSELL JA, 1979, J PERS SOC PSYCHOL, V37, P345, DOI 10.1037/0022-3514.37.3.345; SAARNI C, 1984, CHILD DEV, V55, P1504, DOI 10.2307/1130020; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schrammel F, 2009, PSYCHOPHYSIOLOGY, V46, P922, DOI 10.1111/j.1469-8986.2009.00831.x; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; TEASDALE G, 1974, LANCET, V2, P81; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Wechsler D., 2011, WECHSLER ABBREVIATED; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	45	31	31	0	26	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2013	19	1					34	43		10.1017/S1355617712000884			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	063NB	WOS:000313005400004	23158960				2022-02-06	
J	Lannsjo, M; Backheden, M; Johansson, U; af Geijerstam, JL; Borg, J				Lannsjo, M.; Backheden, M.; Johansson, U.; af Geijerstam, J. L.; Borg, J.			Does head CT scan pathology predict outcome after mild traumatic brain injury?	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						brain concussion; head CT scan; mild traumatic brain injury; prediction	POST-CONCUSSION SYMPTOMS; CONSTRUCT-VALIDITY; FOLLOW-UP; QUESTIONNAIRE; RECOVERY; TRIAL; RELIABILITY; UPDATE; COHORT; ADULTS	Background and purpose: More evidence is needed to forward our understanding of the key determinants of poor outcome after mild traumatic brain injury (MTBI). A large, prospective, national cohort of patients was studied to analyse the effect of head CT scan pathology on the outcome. Methods: One-thousand two-hundred and sixty-two patients with MTBI (Glasgow Coma Scale score 15) at 39 emergency departments completed a study protocol including acute head CT scan examination and follow-up by the Rivermead Post Concussion Symptoms Questionnaire and the Glasgow Outcome Scale Extended (GOSE) at 3 months after MTBI. Binary logistic regression was used for the assessment of prediction ability. Results: In 751 men (60%) and 511 women (40%), with a mean age of 30 years (median 21, range 6-94), we observed relevant or suspect relevant pathologic findings on acute CT scan in 52 patients (4%). Patients aged below 30 years reported better outcome both with respect to symptoms and GOSE as compared to patients in older age groups. Men reported better outcome than women as regards symptoms (OR 0.64, CI 0.49-0.85 for >= 3 symptoms) and global function (OR 0.60, CI 0.39-0.92 for GOSE 1-6). Conclusions: Pathology on acute CT scan examination had no effect on self-reported symptoms or global function at 3 months after MTBI. Female gender and older age predicted a less favourable outcome. The findings support the view that other factors than brain injury deserve attention to minimize long-term complaints after MTBI.	[Lannsjo, M.] Uppsala Univ, Dept Rehabil Med, Inst Neurosci, Uppsala, Sweden; [Lannsjo, M.; Johansson, U.] Uppsala Univ, Cty Council Gavleborg, Ctr Res & Dev, Gavleborg, Sweden; [Backheden, M.] Karolinska Inst, Dept LIME, Med Stat Unit, Stockholm, Sweden; [af Geijerstam, J. L.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Borg, J.] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden		Lannsjo, M (corresponding author), Sandviken Hosp, SE-81189 Sandviken, Sweden.	marianne.lannsjo@lg.se		Lannsjo, Marianne/0000-0001-8792-3796; Borg, Jorgen/0000-0002-2372-7478	Centre for Research and Development Uppsala University/County Council of Gavleborg; Stockholm County CouncilStockholm County Council; AFA Insurance	Grants from the Centre for Research and Development Uppsala University/County Council of Gavleborg, the Stockholm County Council and AFA Insurance. Authors declare no conflicts of interest.	af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Gonzales PG, 2011, AM ACAD PHYS MED REH, V3, P413; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; National Institute for Clinical Excellence Head Injury, 2007, TRIAG ASS INV EARL M; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; World Health Organization, 1993, ICD 10 CLASS MENT BE	39	31	31	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	JAN	2013	20	1					124	129		10.1111/j.1468-1331.2012.03813.x			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	090RG	WOS:000314996200019	22812542				2022-02-06	
J	Levine, B; Kovacevic, N; Nica, EI; Schwartz, ML; Gao, F; Black, SE				Levine, Brian; Kovacevic, Natasa; Nica, Elena Irina; Schwartz, Michael L.; Gao, Fuqiang; Black, Sandra E.			Quantified MRI and cognition in TBI with diffuse and focal damage	NEUROIMAGE-CLINICAL			English	Article						Structural MRI; Neuropsychological assessment; Executive Function; Attention; Memory; Traumatic Brain Injury	TRAUMATIC BRAIN-INJURY; AUTOMATED IMAGE REGISTRATION; WHITE-MATTER; AUTOBIOGRAPHICAL MEMORY; CORPUS-CALLOSUM; FRONTAL-LOBE; ATROPHY; TENSOR; NEUROPATHOLOGY; PERFORMANCE	In patients with chronic-phase traumatic brain injury (TBI), structural MRI is readily attainable and provides rich anatomical information, yet the relationship between whole-brain structural MRI measures and neurocognitive outcome is relatively unexplored and can be complicated by the presence of combined focal and diffuse injury. In this study, sixty-three patients spanning the full range of TBI severity received high-resolution structural MRI concurrent with neuropsychological testing. Multivariate statistical analysis assessed covariance patterns between volumes of grey matter, white matter, and sulcal/subdural and ventricular CSF across 38 brain regions and neuropsychological test performance. Patients with diffuse and diffuse + focal injury were analyzed both separately and together. Tests of speeded attention, working memory, and verbal learning and memory robustly covaried with a distributed pattern of volume loss over temporal, ventromedial prefrontal, right parietal regions, and cingulate regions. This pattern was modulated by the presence of large focal lesions, but held even when analyses were restricted to those with diffuse injury. Effects were most consistently observed within grey matter. Relative to regional brain volumetric data, clinically defined injury severity (depth of comaat time of injury) showed only weak relation to neuropsychological outcome. The results showed that neuropsychological test performance in patients with TBI is related to a distributed pattern of volume loss in regions mediating mnemonic and attentional processing. This relationship holds for patients with and without focal lesions, indicating that diffuse injury alone is sufficient to cause significant neuropsychological disability in relation to regional volume loss. Quantified structural brain imaging data provides a highly sensitive index of brain integrity that is related to cognitive functioning in chronic phase TBI. (C) 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license.	[Levine, Brian; Kovacevic, Natasa; Black, Sandra E.] Rotman Res Inst, Toronto, ON, Canada; [Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Levine, Brian; Black, Sandra E.] Univ Toronto, Dept Med Neurol, Toronto, ON M5S 1A1, Canada; [Nica, Elena Irina] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Schwartz, Michael L.; Black, Sandra E.] Univ Toronto, Dept Surg Neurosurg, Toronto, ON M5S 1A1, Canada; [Black, Sandra E.] Sunnybrook Hlth Sci Ctr, Dept Med Neurol, Toronto, ON M4N 3M5, Canada; [Gao, Fuqiang; Black, Sandra E.] Sunnybrook Hlth Sci Ctr, LC Campbell Cognit Neurol Res Unit, Toronto, ON M4N 3M5, Canada; [Gao, Fuqiang; Black, Sandra E.] Sunnybrook Hlth Sci Ctr, Heart & Stroke Fdn, Ctr Stroke Recovery, Toronto, ON M4N 3M5, Canada		Levine, B (corresponding author), Rotman Res Inst Baycrest, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	blevine@research.baycrest.org	Levine, Brian/O-2725-2019; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Black, Sandra/0000-0001-7093-8289	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MT-14744, MOP-37535, MOP-108540]; NIH-NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD42385-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042385] Funding Source: NIH RePORTER	Ann Campbell, Catherine Hynes, Sabitha Kanagasabai, Colleen O'Toole, Marina Mandic, Karen Philp, Adriana Restagno, Joel Ramirez, Jovanka Skocic, and Gary Turner are thanked for technical assistance. We gratefully thank the TBI patients and non-injured volunteers for participating in this research. This research was supported by grants from the Canadian Institutes of Health Research (Grant #s MT-14744, MOP-37535, and MOP-108540), and the NIH-NICHD (Grant # HD42385-01) to B.L. B.L. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data and analysis.	Army Individual Test Battery, 1944, MAN DIR SCOR; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Christodoulou C, 2003, NEUROLOGY, V60, P1793, DOI 10.1212/01.WNL.0000072264.75989.B8; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; COURVILLE CB, 1937, PATHOLOGY CENTRAL 4; Dade LA, 2004, NEUROIMAGE, V22, P1492, DOI 10.1016/j.neuroimage.2004.03.023; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Edgington E. S., 1980, RANDOMIZATION TESTS; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gale S.D., 1994, NEUROPSY NEUROPSY BE, V7, P60; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gentry L.R., 1990, MAGNETIC RESONANCE I, P439; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; Green P., 1996, THE WORD MEMORY TEST; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kovacevic N, 2002, NEUROIMAGE, V17, P1087, DOI 10.1006/nimg.2002.1221; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levin HS., 1982, NEUROBEHAVIORAL CONS; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McKinnon MC, 2008, J COGNITIVE NEUROSCI, V20, P1839, DOI 10.1162/jocn.2008.20126; Morris R, 1999, EUR J NEUROSCI, V11, P2506, DOI 10.1046/j.1460-9568.1999.00672.x; Parmenter BA, 2007, MULT SCLER J, V13, P52, DOI 10.1177/1352458506070750; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raja Beharelle A, 2012, NEUROIMAGE, V60, P1528, DOI 10.1016/j.neuroimage.2012.01.037; Rosenbaum RS, 2008, J COGNITIVE NEUROSCI, V20, P1490, DOI 10.1162/jocn.2008.20105; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith A., 1978, SYMBOL DIGIT MODALIT; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; WASSERMAN S, 1989, PSYCHOPHYSIOLOGY, V26, P208, DOI 10.1111/j.1469-8986.1989.tb03159.x; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zachary R. A., 1986, SHIPLEY I LIVING SCA	60	31	31	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2013	2						534	541		10.1016/j.nicl.2013.03.015			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V37LH	WOS:000209276800058	24049744	Green Accepted, Green Published, gold			2022-02-06	
J	Schmidt, W; Schafer, F; Striggow, V; Frohlich, K; Striggow, F				Schmidt, W.; Schaefer, F.; Striggow, V.; Froehlich, K.; Striggow, F.			CANNABINOID RECEPTOR SUBTYPES 1 AND 2 MEDIATE LONG-LASTING NEUROPROTECTION AND IMPROVE MOTOR BEHAVIOR DEFICITS AFTER TRANSIENT FOCAL CEREBRAL ISCHEMIA	NEUROSCIENCE			English	Article						cerebral ischemia; endocannabinoid system; CB1 receptor; CB2 receptor; neuroprotection	ACID AMIDE HYDROLASE; TRAUMATIC BRAIN-INJURY; CB2 RECEPTOR; ENDOCANNABINOID SYSTEM; ALZHEIMERS-DISEASE; DIRECT SUPPRESSION; CEREBELLAR CORTEX; CELL ACTIVATION; BAY 38-7271; IN-VITRO	The endocannabinoid system is crucially involved in the regulation of brain activity and inflammation. We have investigated the localization of cannabinoid CB1 and CB2 receptors in adult rat brains before and after focal cerebral ischemia due to endothelin-induced transient occlusion of the middle cerebral artery (eMCAO). Using immunohistochernistry, both receptor subtypes were identified in cortical neurons. After eMCAO, neuronal cell death was accompanied by reduced neuronal CB1 and CB2 receptor-linked immunofluorescence. In parallel, CBI receptor was found in activated microglia/macrophages 3 days post eMCAO and in astroglia cells at days 3 and 7. CB2 receptor labeling was identified in activated microglia/macrophages or astroglia 3 and 7 days post ischemia, respectively. In addition, immune competent CD45-positive cells were characterized by pronounced CB2 receptor staining 3 and 7 days post eMCAO. KN38-72717, a potent and selective CBI and CB2 receptor agonist, revealed a significant, dose-dependent and long-lasting reduction of cortical lesion sizes due to eMCAO, when applied consecutively before, during and after eMCAO. In addition, severe motor deficits of animals suffering from eMCAO were significantly improved by KN38-7271. KN38-7271 remained effective, even if its application was delayed up to 6 h post eMCAO. Finally, we show that the endocannabinoid system assembles a comprehensive machinery to defend the brain against the devastating consequences of cerebral ischemia. In summary, this study underlines the therapeutic potential of CBI and/or CB2 receptor agonists against neurodegenerative diseases or injuries involving acute or chronic imbalances of cerebral blood flow and energy consumption. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Schmidt, W.; Striggow, F.] German Ctr Neurodegenerat Dis DZNE, AG Neurodegenerat & Intervent Strategies, D-39120 Magdeburg, Germany; [Schmidt, W.; Schaefer, F.; Striggow, V.; Froehlich, K.; Striggow, F.] KeyNeurotek Pharmaceut AG, D-39120 Magdeburg, Germany		Striggow, F (corresponding author), German Ctr Neurodegenerat Dis DZNE, AG Neurodegenerat & Intervent Strategies, Leipziger Str 44, D-39120 Magdeburg, Germany.	frank.striggow@dzne.de		Frohlich, Katja/0000-0002-9491-5927	Federal Ministry for Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [03IS2211I]	The authors would like to thank J. Hubner, C. Schinke and M. Hajri for their excellent technical assistance. This work was supported by the Federal Ministry for Education and Research (BMBF), Grant number 03IS2211I.	Albayram O, 2011, P NATL ACAD SCI USA, V108, P11256, DOI 10.1073/pnas.1016442108; Ashton JC, 2006, NEUROSCI LETT, V396, P113, DOI 10.1016/j.neulet.2005.11.038; Ashton JC, 2007, NEUROSCI LETT, V412, P114, DOI 10.1016/j.neulet.2006.10.053; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Benito C, 2005, J NEUROSCI, V25, P2530, DOI 10.1523/JNEUROSCI.3923-04.2005; Benito C, 2003, J NEUROSCI, V23, P11136; Brusco A, 2008, SYNAPSE, V62, P944, DOI 10.1002/syn.20569; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; Carayon P, 1998, BLOOD, V92, P3605, DOI 10.1182/blood.V92.10.3605.422k05_3605_3615; Carlisle SJ, 2002, INT IMMUNOPHARMACOL, V2, P69, DOI 10.1016/S1567-5769(01)00147-3; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Daniel H, 2001, J PHYSIOL-LONDON, V537, P793; DePetrocellis L, 1997, BIOCHEM BIOPH RES CO, V231, P82, DOI 10.1006/bbrc.1997.6000; DEROCQ JM, 1995, FEBS LETT, V369, P177, DOI 10.1016/0014-5793(95)00746-V; Deutsch DG, 1997, BIOCHEM PHARMACOL, V53, P255, DOI 10.1016/S0006-2952(96)00830-1; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Dittel BN, 2008, BRIT J PHARMACOL, V153, P271, DOI 10.1038/sj.bjp.0707493; Edlich F, 2006, J BIOL CHEM, V281, P14961, DOI 10.1074/jbc.M600452200; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL, V286, pS91, DOI 10.1016/j.mce.2008.01.001; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Harvey BS, 2012, NEUROTOXICOLOGY, V33, P138, DOI 10.1016/j.neuro.2011.12.015; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klegeris A, 2003, BRIT J PHARMACOL, V139, P775, DOI 10.1038/sj.bjp.0705304; Landucci E, 2011, NEUROPHARMACOLOGY, V60, P674, DOI 10.1016/j.neuropharm.2010.11.021; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mauler F, 2003, CNS DRUG REV, V9, P343; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; McCoy KL, 1999, J PHARMACOL EXP THER, V289, P1620; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 2012, ANNU REV PSYCHOL; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Mor M, 2004, J MED CHEM, V47, P4998, DOI 10.1021/jm031140x; Murikinati S, 2010, FASEB J, V24, P788, DOI 10.1096/fj.09-141275; Nagayama T, 1999, J NEUROSCI, V19, P2987; Onaivi ES, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001640; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P434, DOI 10.1196/annals.1432.036; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Paxinos G, 2005, RAT BRAIN STEREOTOXI; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Puente N, 2011, NAT NEUROSCI, V14, P1542, DOI 10.1038/nn.2974; Sanchez AJ, 2012, CLIN IMMUNOL, V142, P57, DOI 10.1016/j.clim.2011.02.010; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; SHARKEY J, 1995, J NEUROSCI METH, V60, P125, DOI 10.1016/0165-0270(95)00003-D; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Striggow F, 2002, NEW DRUGS, V1, P30; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; SUTHERLAND CA, 1982, J BIOL CHEM, V257, P4006; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Tarzia G, 2003, J MED CHEM, V46, P2352, DOI 10.1021/jm021119g; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wolf SA, 2008, CURR PHARM DESIGN, V14, P2266, DOI 10.2174/138161208785740090; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zurolo E, 2010, NEUROSCIENCE, V170, P28, DOI 10.1016/j.neuroscience.2010.07.004	80	31	32	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	DEC 27	2012	227						313	326		10.1016/j.neuroscience.2012.09.080			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051GB	WOS:000312113100030	23069763				2022-02-06	
J	Peterson, TC; Anderson, GD; Kantor, ED; Hoane, MR				Peterson, Todd C.; Anderson, Gail D.; Kantor, Eric D.; Hoane, Michael R.			A Comparison of the Effects of Nicotinamide and Progesterone on Functional Recovery of Cognitive Behavior following Cortical Contusion Injury in the Rat	JOURNAL OF NEUROTRAUMA			English	Article						CCI; nicotinamide; progesterone; recovery of function; therapy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NEUROPROTECTION; EXPRESSION; EDEMA	The primary goal of this study was to compare clinically relevant doses of progesterone and nicotinamide within the same injury model. Progesterone has been shown to reduce edema and inflammation and improve functional outcomes following brain injury. Nicotinamide has also been shown to be an effective neuroprotective agent in a variety of neurological injury models. In the current study, nicotinamide was administered beginning 4 h post-cortical contusion injury (CCI) with a loading dose (75 mg/kg, i.p.) combined with continuous infusion (12 mg/h/kg, s.c.) for 72 h post-injury. Progesterone was administered beginning 4 h post-CCI at a dose of 10 or 20 mg/kg, i.p. every 12 h for 72 h. This resulted in the following groups: Injured-nicotinamide treated, Injured-progesterone-10 treated, Injured-progesterone-20 treated, Injured-vehicle treated, and Sham. Functional recovery was assessed with two spatial memory tasks in the Morris water maze (MWM) the acquisition of a reference memory task and a reversal learning task. Neuropathological assessments were conducted in the cortex and hippocampus. It was found that both progesterone (10 mg/kg) and nicotinamide improved reference memory acquisition and reversal learning in the MWM compared with vehicle treatment. The lower dose of progesterone and nicotinamide also reduced tissue loss in the injured cortex and ipsilateral hippocampus compared with vehicle. The beneficial effects of progesterone appear to be dose dependent with the lower 10 mg/kg dose producing significant effects that were not observed at the higher dose. Direct comparison between nicotinamide and low dose progesterone appears to suggest that both are equally effective. The general findings of this study suggest that both nicotinamide and progesterone produce significant improvements in recovery of function following CCI.	[Peterson, Todd C.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Carbondale, IL 62901 USA; [Anderson, Gail D.; Kantor, Eric D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657	National Institutes of Health/National Institute of Child, Health, and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 HD061944-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER	The authors thank Jacob Ward and Mahala Logue for their assistance on this project. The research was supported by a grant from the National Institutes of Health/National Institute of Child, Health, and Development (R01 HD061944-01).	Anderson G.D., 2012, J NEUROTRAU IN PRESS; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; CDC, 2010, INJ PREV CONTR TRAUM; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Kerr AL, 2010, BEHAV GENET, V40, P76, DOI 10.1007/s10519-009-9296-6; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Noblett KL, 2003, BEHAV NEUROSCI, V117, P785, DOI 10.1037/0735-7044.117.4.785; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4	37	31	32	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2012	29	18					2823	2830		10.1089/neu.2012.2471			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	050ZE	WOS:000312092800012	23016598	Green Published			2022-02-06	
J	Terry, DP; Faraco, CC; Smith, D; Diddams, MJ; Puente, AN; Miller, LS				Terry, Douglas P.; Faraco, Carlos C.; Smith, Devin; Diddams, Max J.; Puente, Antonio N.; Miller, L. Stephen			Lack of long-term fMRI differences after multiple sports-related concussions	BRAIN INJURY			English	Article						FMRI; concussion; TBI; mild TBI; MTBI; Stroop; OSPAN; operation span	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; MINOR HEAD-INJURY; WORKING-MEMORY; RECURRENT CONCUSSION; POSTCONCUSSION SYNDROME; FUNCTIONAL ACTIVATION; RESPONSE-INHIBITION; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX	Introduction: Mild traumatic brain injury (mTBI) or concussion has been acutely associated with several cognitive symptoms, including deficits in response inhibition, working memory and motor performance. The pervasiveness of these cognitive symptoms has been more controversial. The effects of multiple concussions on neuropsychological functioning and brain activation following at least 6-months post-mTBI were examined. Methods: Twenty right-handed male athletes with a history of at least two concussions and 20 age/pre-morbid IQ/athletic-experience matched controls underwent neuropsychological assessment and fMRI scanning where they performed versions of a colour-word Stroop interference task, an operation-span working memory task and a finger-tapping task. Results: The Attention index score on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was lower for the concussion group, but only at liberal statistical threshold. Total RBANS score approached statistical significance. Reaction time during neurobehavioural tasks was similar across groups, but accuracy was reduced in the concussed group on the working memory task. Despite expected activation patterns within each group, there were no group differences in neural activation on any functional tasks using either whole-brain or ROI-specific analyses at liberal statistical thresholds. Conclusion: There were minimal differences between the two closely matched groups. Results point to the relative plasticity of younger adults' cognitive abilities following concussion.	[Terry, Douglas P.; Faraco, Carlos C.; Smith, Devin; Miller, L. Stephen] Univ Georgia, BioImaging Res Ctr, Athens, GA 30602 USA; [Terry, Douglas P.; Faraco, Carlos C.; Puente, Antonio N.; Miller, L. Stephen] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Smith, Devin] Georgia Hlth Sci Univ, Med Coll Georgia, Augusta, GA USA; [Diddams, Max J.] Carleton Coll, Dept Neurosci, Northfield, MN 55057 USA		Miller, LS (corresponding author), Univ Georgia, BioImaging Res Ctr, Coverdell Room 119B, Athens, GA 30602 USA.	lsmiller@uga.edu					Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Cabeza R, 1997, J NEUROSCI, V17, P391; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Faraco CC, 2011, NEUROIMAGE, V55, P773, DOI 10.1016/j.neuroimage.2010.12.033; Fletcher PC, 1998, ARCH GEN PSYCHIAT, V55, P1001, DOI 10.1001/archpsyc.55.11.1001; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2002, AM J PHYS MED REHAB, V81, P844, DOI 10.1097/00002060-200211000-00007; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; KAWASHIMA R, 1994, BRAIN RES, V663, P251, DOI 10.1016/0006-8993(94)91270-X; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kondo H, 2004, NEUROIMAGE, V21, P2, DOI 10.1016/j.neuroimage.2003.09.046; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Mani TM, 2007, NEUROCASE, V13, P229, DOI 10.1080/13554790701594862; Mani TM, 2007, BRAIN INJURY, V21, P1155, DOI 10.1080/02699050701687367; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Oztekin I, 2009, J COGNITIVE NEUROSCI, V21, P581, DOI 10.1162/jocn.2008.21016; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Werring DJ, 1998, J NEUROL NEUROSUR PS, V65, P863, DOI 10.1136/jnnp.65.6.863; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Yoo SS, 2005, INT J NEUROSCI, V115, P55, DOI 10.1080/00207450490512650	77	31	31	0	64	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1684	1696		10.3109/02699052.2012.722259			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700014	23163249				2022-02-06	
J	Gradisek, P; Osredkar, J; Korsic, M; Kremzar, B				Gradisek, Primoz; Osredkar, Josko; Korsic, Marjan; Kremzar, Boriana			Multiple indicators model of long-term mortality in traumatic brain injury	BRAIN INJURY			English	Article						S100B; NSE; GFAP; Glasgow Coma Scale; CT; prognostic model	FIBRILLARY ACIDIC PROTEIN; NEURON-SPECIFIC ENOLASE; SEVERE HEAD-INJURY; PROGNOSTIC MODELS; SERUM; S100B; DAMAGE; GFAP; VALIDATION; CLASSIFICATION	Objective: To examine the prognostic ability of protein S100B, neuron-specific enolase (NSE) and glial fibrillary acid protein (GFAP) for prediction of 1-year mortality in patients with traumatic brain injury (TBI) in relation to clinical and radiological characteristics of TBI. Methods: Brain injury was quantified in 84 patients (Glasgow Coma Scale [GCS] <= 12) using clinical (GCS, pupils), radiological (computed tomography [CT] classification and individual CT characteristics) and biochemical (S100B, NSE and GFAP) data at admission and in the acute post-injury period. Results: Initial and peak S100B, NSE and GFAP concentrations were higher in non-survivors (n = 26) than in survivors (p-value range: <0.001-0.018). Cox regression showed that GFAP and S100B concentration and the temporal profile of S100B were more powerful independent predictors of mortality than baseline clinical and radiological characteristics or clinical and radiological indicators of neurological deterioration. The prognostic models containing admission variables and those available during the subsequent clinical course showed the same discrimination ability (area under receiver characteristic curve 0.92), but the model based on variables available in the acute post-injury period calibrated better (p = 0.428). Conclusion: Mortality at 1-year post-TBI is accurately predicted by the combination of GFAP and S100B concentration and clinical and radiological characteristics at admission or in the acute post-injury period.	[Gradisek, Primoz; Kremzar, Boriana] Univ Med Ctr Ljubljana, Ctr Intens Therapy, Clin Dept Anaesthesiol & Intens Therapy, Ljubljana 1000, Slovenia; [Osredkar, Josko] Univ Med Ctr Ljubljana, Clin Inst Clin Chem & Clin Biochem, Ljubljana 1000, Slovenia; [Korsic, Marjan] Univ Med Ctr Ljubljana, Clin Dept Neurosurg, Ljubljana 1000, Slovenia		Gradisek, P (corresponding author), Univ Med Ctr Ljubljana, Ctr Intens Therapy, Clin Dept Anaesthesiol & Intens Therapy, Zaloska 7, Ljubljana 1000, Slovenia.	primoz.gradisek@kclj.si		Gradisek, Primoz/0000-0002-1741-3798			Altman DG, 1990, PRACTICAL STAT MED R, P365; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thelin E, 2009, J NEUROTRAUM, V26, pA44; Vissers JLM, 2006, CLIN CHIM ACTA, V366, P336, DOI 10.1016/j.cca.2005.11.017; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Xu XY, 2007, BRAIN INJURY, V21, P575, DOI 10.1080/02699050701426881	36	31	31	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1472	1481		10.3109/02699052.2012.694567			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400008	22721420				2022-02-06	
J	James, ML; Olson, DM; Graffagnino, C				James, M. L.; Olson, D. M.; Graffagnino, C.			A pilot study of cerebral and haemodynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury	ANAESTHESIA AND INTENSIVE CARE			English	Article						neurocritical care; sedation; dexmedetomidine; acute brain injury; microdialysis; human; clinical trial; propofol	INTENSIVE-CARE-UNIT; SUBARACHNOID HEMORRHAGE; CRITICALLY-ILL; MICRODIALYSIS; PHARMACOKINETICS; MIDAZOLAM	Sedation for the mechanically-ventilated, brain-injured patient remains challenging. The purpose of this pilot study was to compare the cerebral physiologic effects of sedation with propofol versus dexmedetomidine in mechanically-ventilated, brain-injured patients. Using a randomised, crossover, unblinded clinical trial, we enrolled patients with severe brain injury (Glasgow Coma Score <= 8) from traumatic injury, subarachnoid haemorrhage or intracerebral haemorrhage undergoing multimodal monitoring (intracranial pressure, brain temperature, oximetry and microdialysis). Patients received an infusion of either propofol or dexmedetomidine for six hours and then a crossover for the subsequent six hours after sufficient washout/in. Clinical and physiological measurements were recorded hourly. In eight patients, (four traumatic injury, three subarachnoid haemorrhage and one intracerebral haemorrhage), the mean dose of propofol used was 25.5 mu g/kg/minute while the mean dose of dexmedetomidine was 0.54 mu g/kg/hour. All subjects were effectively sedated to a goal of Richmond Agitation Sedation Scale -2 and Bispectral Index of 50-70 throughout the study period. We did not observe any statistically significant differences between the groups in systemic or cerebral physiologic metrics. Though differences were noted in cerebral metabolic substrates (lactate/pyruvate ratio), none were statistically significant. In our pilot cohort, dexmedetomidine and propofol appear equally effective in sedating severely brain-injured patients and neither is associated with adverse physiological effects as measured by multimodal monitoring. Larger long-term studies are required to determine whether clinically favourable benefits demonstrated in the medical critical care setting also apply to this patient population.	[James, M. L.; Olson, D. M.; Graffagnino, C.] Duke Univ Hosp, Neurosci Intens Care Unit, Durham, NC USA		James, ML (corresponding author), Duke Univ, Box 3094, Durham, NC 27710 USA.	michael.james@duke.edu	Olson, DaiWai/I-5932-2019; James, Michael L./AAJ-5592-2020	Olson, DaiWai/0000-0002-9280-078X; James, Michael L./0000-0002-8715-5210	Hospira Worldwide, Inc; American Heart Association Scientist Development GrantAmerican Heart Association	This study was made possible through grant-in-aid funding by Hospira Worldwide, Inc and the American Heart Association Scientist Development Grant. Dr M. L. James serves as a speaking consultant for Hospira Worldwide, Inc.	Arbour Richard, 2003, AACN Clin Issues, V14, P185, DOI 10.1097/00044067-200305000-00009; Blumenfeld H., 2002, NEUROANATOMY CLIN CA; Cortinez LI, 2010, BRIT J ANAESTH, V105, P448, DOI 10.1093/bja/aeq195; Cortinez LI, 2004, ANESTHESIOLOGY, V101, P1077, DOI 10.1097/00000542-200411000-00006; Greenberg MS, 2001, HDB NEUROSURGERY; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hughes CG, 2011, ANESTH ANALG, V112, P1212, DOI 10.1213/ANE.0b013e318215366d; King Cecil A, 2012, AORN J, V95, P365, DOI 10.1016/j.aorn.2011.06.009; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Miller A, 2000, ANESTHESIOLOGY; MIRSKI MA, 1995, CRIT CARE MED, V23, P2038, DOI 10.1097/00003246-199512000-00013; Mirski MA, 2010, INTENS CARE MED, V36, P1505, DOI 10.1007/s00134-010-1874-9; Murdoch S, 2000, INTENS CARE MED, V26, P922, DOI 10.1007/s001340051282; Nanas S, 2007, ANAESTH INTENS CARE, V35, P920, DOI 10.1177/0310057X0703500610; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Olson Daiwai M, 2005, Crit Care Nurs Clin North Am, V17, P257, DOI 10.1016/j.ccell.2005.04.008; Olson DM, 2009, NEUROCRIT CARE, V11, P20, DOI 10.1007/s12028-008-9184-6; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Padmanabhan U, 2009, ANESTH ANALG, V109, P1448, DOI 10.1213/ane.0b013e3181a6ad31; Peerdeman SM, 2003, J NEUROL, V250, P797, DOI 10.1007/s00415-003-1079-z; RONAN KP, 1995, CRIT CARE MED, V23, P286, DOI 10.1097/00003246-199502000-00014; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Schuttler J, 2000, ANESTHESIOLOGY, V92, P727, DOI 10.1097/00000542-200003000-00017; Skoglund K, 2012, CRIT CARE MED, V40, P216, DOI 10.1097/CCM.0b013e31822d7dbd; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Venn RM, 2001, BRIT J ANAESTH, V87, P684, DOI 10.1093/bja/87.5.684; Young C, 2000, CRIT CARE MED, V28, P854, DOI 10.1097/00003246-200003000-00041	29	31	38	2	12	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0310-057X	1448-0271		ANAESTH INTENS CARE	Anaesth. Intensive Care	NOV	2012	40	6					949	957		10.1177/0310057X1204000605			9	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	043HL	WOS:000311533400005	23194203	Bronze			2022-02-06	
J	Ji, XT; Tian, Y; Xie, KL; Liu, WP; Qu, Y; Fei, Z				Ji, Xituan; Tian, Ye; Xie, Keliang; Liu, Weiping; Qu, Yan; Fei, Zhou			Protective effects of hydrogen-rich saline in a rat model of traumatic brain injury via reducing oxidative stress	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury (TBI); Reactive oxygen species (ROS); Oxidative stress; Hydrogen-rich saline (HS)	INTESTINAL ISCHEMIA/REPERFUSION; REPERFUSION INJURY; GAS; MICE; ISCHEMIA; IMPACT; INHALATION; BIOMARKERS; MARKERS; DAMAGE	Background: Hydrogengas (H-2) has beenconsidered as a novel antioxidant to selectively reduce the toxic reactive oxygen species (ROS) such as hydroxyl radical (center dot OH) without affecting the other signal ROS. Our recent study shows that H-2 inhalation is beneficial to traumatic brain injury (TBI) via reducing oxidative stress. In contrast to H-2, hydrogen-rich saline (HS) may be more suitable for clinical application. The present study was designed to investigate whether HS has a protective effect against TBI via reducing oxidative stress in rats. Methods: TBI model was induced by controlled cortical impact injury. Different dosages of HS were intraperitoneally administered at 5 min after TBI operation. We then measured the brain edema, blood-brain barrier (BBB) breakdown, neurological dysfunction and injury volume in all animals. In addition, the oxidative products and antioxidant enzymes in brain tissues were detected. Results: TBI-challenged rats exhibited significant brain injuries characterized by the increase of BBB permeability, brain edema, and lesion volume as well as neurological dysfunction, which were dose-dependently ameliorated by HS treatment. Moreover, we found that HS treatment increased the endogenous antioxidant enzymatic activities and decreased the oxidative product levels in brain tissues of TBI-challenged rats. Conclusion: Hydrogen-rich saline can exert a protective effect against TBI via reducing oxidative stress. Molecular hydrogen may be a more effective therapeutic strategy for TBI patients. (C) 2012 Elsevier Inc. All rights reserved.	[Ji, Xituan; Liu, Weiping; Qu, Yan; Fei, Zhou] Fourth Mil Med Univ, Xiing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi Provinc, Peoples R China; [Tian, Ye] Xian Cent Hosp, Dept Neurol, Xian, Shaanxi Provinc, Peoples R China; [Xie, Keliang] Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Xiing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi Provinc, Peoples R China.	Tougaozy2011@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30930093, 81101409, 81071533]	This work was supported by research grants from the National Natural Science Foundation of China (nos. 30930093, 81101409, 81071533). The authors thank Professor Xuejun Sun for his kind help with information.	Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Cai JM, 2009, BRAIN RES, V1256, P129, DOI 10.1016/j.brainres.2008.11.048; Davis A E, 2000, Crit Care Nurs Clin North Am, V12, P447; Dogan A, 1997, J NEUROSURG, V87, P921, DOI 10.3171/jns.1997.87.6.0921; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088; George JF, 2010, KIDNEY INT, V77, P85, DOI 10.1038/ki.2009.432; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Kumar A, 2008, NEONATOLOGY, V94, P96, DOI 10.1159/000116633; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu DD, 2008, CRIT CARE MED, V36, P565, DOI 10.1097/01.CCM.0000299737.24338.5C; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Mao YF, 2009, BIOCHEM BIOPH RES CO, V381, P602, DOI 10.1016/j.bbrc.2009.02.105; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Matchett GA, 2009, BRAIN RES, V1259, P90, DOI 10.1016/j.brainres.2008.12.066; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta Shigeo, 2008, Nihon Ronen Igakkai Zasshi, V45, P355; Sakamoto M, 2002, NEUROL RES, V24, P301, DOI 10.1179/016164102101199783; Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020; Satpute RM, 2009, FOOD CHEM TOXICOL, V47, P2689, DOI 10.1016/j.fct.2009.06.007; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Xie KL, 2010, SHOCK, V34, P495, DOI 10.1097/SHK.0b013e3181def9aa; Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zheng XF, 2009, FREE RADICAL RES, V43, P478, DOI 10.1080/10715760902870603	40	31	32	0	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	NOV	2012	178	1					E9	E16		10.1016/j.jss.2011.12.038			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	028UV	WOS:000310450300002	22475349				2022-02-06	
J	Debray, TPA; Koffijberg, H; Vergouwe, Y; Moons, KGM; Steyerberg, EW				Debray, Thomas P. A.; Koffijberg, Hendrik; Vergouwe, Yvonne; Moons, Karel G. M.; Steyerberg, Ewout W.			Aggregating published prediction models with individual participant data: a comparison of different approaches	STATISTICS IN MEDICINE			English	Article						prediction research; prediction models; meta-analysis; logistic regression; multivariable; Bayesian inference	DEEP-VEIN THROMBOSIS; TRAUMATIC BRAIN-INJURY; LOGISTIC-REGRESSION ANALYSIS; SEVERE HEAD-INJURY; PROGNOSTIC MODELS; VENOUS THROMBOSIS; PATIENT DATA; EXTERNAL VALIDATION; PRIMARY-CARE; ROC CURVE	During the recent decades, interest in prediction models has substantially increased, but approaches to synthesize evidence from previously developed models have failed to keep pace. This causes researchers to ignore potentially useful past evidence when developing a novel prediction model with individual participant data (IPD) from their population of interest. We aimed to evaluate approaches to aggregate previously published prediction models with new data. We consider the situation that models are reported in the literature with predictors similar to those available in an IPD dataset. We adopt a two-stage method and explore three approaches to calculate a synthesis model, hereby relying on the principles of multivariate meta-analysis. The former approach employs a naive pooling strategy, whereas the latter accounts for within-study and between-study covariance. These approaches are applied to a collection of 15 datasets of patients with traumatic brain injury, and to five previously published models for predicting deep venous thrombosis. Here, we illustrated how the generally unrealistic assumption of consistency in the availability of evidence across included studies can be relaxed. Results from the case studies demonstrate that aggregation yields prediction models with an improved discrimination and calibration in a vast majority of scenarios, and result in equivalent performance (compared with the standard approach) in a small minority of situations. The proposed aggregation approaches are particularly useful when few participant data are at hand. Assessing the degree of heterogeneity between IPD and literature findings remains crucial to determine the optimal approach in aggregating previous evidence into new prediction models. Copyright (C) 2012 John Wiley & Sons, Ltd.	[Debray, Thomas P. A.; Koffijberg, Hendrik; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Vergouwe, Yvonne; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, Rotterdam, Netherlands		Debray, TPA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Stratenum 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	T.Debray@umcutrecht.nl	Steyerberg, Ewout W/C-1509-2018; Debray, Thomas/J-7413-2012	Steyerberg, Ewout W/0000-0002-7787-0122; Debray, Thomas/0000-0002-1790-2719; Koffijberg, Hendrik/0000-0002-1753-0652	Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [9120.8004, 918.10.615, 916.11.126]	We would like to thank Stan Buckens for his input and comments during the review process, and Netherlands Organization for Scientific Research (9120.8004, 918.10.615 and 916.11.126).	Abu-Hanna A, 2001, METHOD INFORM MED, V40, P1; Altman DG, 2009, CANCER INVEST, V27, P235, DOI 10.1080/07357900802572110; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Balazs K, 2006, APPL PSYCH MEAS, V30, P322, DOI 10.1177/0146621605286315; Becker BJ, 2007, STAT SCI, V22, P414, DOI 10.1214/07-STS243; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Brier GW, 1950, MON WEATHER REV, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Buller HR, 2009, ANN INTERN MED, V150, P229, DOI 10.7326/0003-4819-150-4-200902170-00003; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; de Leeuw CA, 2010, THESIS UTRECHT U UTR; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gagne P, 2009, PRESSE MED, V38, P525, DOI 10.1016/j.lpm.2008.09.022; Geersing GJ, 2010, BRIT J GEN PRACT, V60, P742, DOI 10.3399/bjgp10X532387; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ishak KJ, 2008, STAT MED, V27, P670, DOI 10.1002/sim.2913; Jackson D, 2011, STAT MED, V30, P2481, DOI 10.1002/sim.4172; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Janssen KJM, 2009, CAN J ANAESTH, V56, P194, DOI 10.1007/s12630-009-9041-x; JENNETT B, 1976, LANCET, V1, P1031; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Meads C, 2012, BREAST CANCER RES TR, V132, P365, DOI 10.1007/s10549-011-1818-2; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; R Development Core Team, 2011, R LANG ENV STAT COMP; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Riley RD, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-3; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2000, STAT MED, V19, P141, DOI 10.1002/(SICI)1097-0258(20000130)19:2<141::AID-SIM334>3.0.CO;2-O; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Subramaniam RM, 2006, ANN EMERG MED, V48, P678, DOI 10.1016/j.annemergmed.2006.04.010; Sutton AJ, 2008, STAT MED, V27, P651, DOI 10.1002/sim.2916; The European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURGERY, V80, P797; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Toll DB, 2008, FAM PRACT, V25, P3, DOI 10.1093/fampra/cmm075; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; VANHOUWELINGEN HC, 1995, STAT MED, V14, P1999, DOI 10.1002/sim.4780141806; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3	52	31	31	2	25	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715			STAT MED	Stat. Med.	OCT 15	2012	31	23					2697	2712		10.1002/sim.5412			16	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	007FP	WOS:000308874500009	22733546				2022-02-06	
J	Lauridsen, E; Hermann, NV; Gerds, TA; Ahrensburg, SS; Kreiborg, S; Andreasen, JO				Lauridsen, Eva; Hermann, Nuno Vibe; Gerds, Thomas Alexander; Ahrensburg, Soren Steno; Kreiborg, Sven; Andreasen, Jens Ove			Combination injuries 1. The risk of pulp necrosis in permanent teeth with concussion injuries and concomitant crown fractures	DENTAL TRAUMATOLOGY			English	Article						dental trauma; concussion; crown fracture; pulp necrosis; permanent teeth	RESTORATIVE DENTISTRY; DENTINAL TUBULES; INCISORS; ENAMEL; BIOLOGY; INVASION	Background: The reported risk of pulp necrosis (PN) is low in teeth with concussion injuries. A concomitant crown fracture may affect the risk of PN. Aim: To analyze the influence of a crown fracture (with and without pulp exposure) on the risk of PN in teeth with concussion injury. Material: The study included 469 permanent incisors with concussion from 358 patients (226 male, 132 female). Among these, 292 had a concomitant crown fracture (70 with and 222 without pulp exposure). All teeth were examined and treated according to standardized protocol. Statistical analysis: The risk of PN was analyzed by the KaplanMeier method and Cox regression. Risk factors included in the analysis: gender, age, stage of root development, type of crown fracture, and response to electric pulp test (EPT) at the initial examination. The level of significance was set at 5%. Results: The risk of PN was low in teeth with immature root development [1.1%, 95% confidence intervals (CI): 03.4]. The following factors significantly increased the risk of PN in teeth with mature root development: crown fracture without pulp exposure [hazard ratio 4.1 (95% CI: 1.411.9), P = 0.01] and no response to EPT at the initial examination [hazard ratio 30.7 (95% CI: 7.7121), P < 0.0001]. The overall risk of PN increased from 3.5% (95% CI: 0.26.8) to 11.0% (95% CI: 5.216.7) when a concomitant crown fracture without pulp exposure was present. If the tooth had both a crown fracture and gave no response to EPT, the risk further increased to 55.0% (95% CI: 34.375.8). Conclusion: No response to EPT at the initial examination or a concomitant crown fracture significantly increased the risk of PN in teeth with concussion injury and mature root development. If both risk factors were present there was a synergetic effect.	[Lauridsen, Eva; Hermann, Nuno Vibe; Kreiborg, Sven] Univ Copenhagen, Sch Dent, Fac Hlth Sci, Dept Pediat Dent & Clin Genet, DK-2200 Copenhagen N, Denmark; [Gerds, Thomas Alexander] Univ Copenhagen, Fac Hlth Sci, Dept Biostat, DK-2200 Copenhagen N, Denmark; [Ahrensburg, Soren Steno; Andreasen, Jens Ove] Copenhagen Univ Hosp, Rigshosp, Ctr Rare Oral Dis, Dept Oral & Maxillofacial Surg, Copenhagen, Denmark		Lauridsen, E (corresponding author), Univ Copenhagen, Sch Dent, Fac Hlth Sci, Dept Pediat Dent & Clin Genet, DK-2200 Copenhagen N, Denmark.	ela@sund.ku.dk		Gerds, Thomas Alexander/0000-0002-5955-816X; Hermann, Nuno Vibe/0000-0002-8079-8571			ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P160; ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P207; Andreasen JO, 2010, ENDOD TOPICS, V14, P80; [Anonymous], 2010, R LANG ENV STAT COMP; Cavalleri G, 1995, ENDOD DENT TRAUMATOL, V11, P294; Chuang SK, 2001, J DENT RES, V80, P2016, DOI 10.1177/00220345010800111301; CVEK M, 1990, ENDOD DENT TRAUMATOL, V6, P157; Cvek Miomir, 1993, Acta Stomatologica Croatica, V27, P167; Day PF, 2006, DENT TRAUMATOL, V22, P258, DOI 10.1111/j.1600-9657.2006.00439.x; FOUAD A. F., 2008, INGLES ENDODONTICS, V6, P343; Fuks A B, 1982, Pediatr Dent, V4, P240; Gerds TA., 2009, STAT METHODOLOGICAL, P259, DOI [10.1002/9780470744116.ch15, DOI 10.1002/9780470744116.CH15]; Glendor U., 2007, TXB COLOR ATLAS TRAU, P217; Gopikrishna V, 2009, INT J PAEDIATR DENT, V19, P3, DOI 10.1111/j.1365-263X.2008.00955.x; Heyeraas KJ, 2001, QUINTESSENCE INT, V32, P611; Jafarzadeh H, 2010, INT ENDOD J, V43, P945, DOI 10.1111/j.1365-2591.2010.01760.x; Love R M, 1997, Pract Periodontics Aesthet Dent, V9, P427; Love RM, 2002, CRIT REV ORAL BIOL M, V13, P171, DOI 10.1177/154411130201300207; Mjor IA, 2001, QUINTESSENCE INT, V32, P427; Mjor IA, 2001, QUINTESSENCE INT, V32, P771; NAGAOKA S, 1995, J ENDODONT, V21, P70, DOI 10.1016/S0099-2399(06)81098-8; Olsburgh S, 2002, DENT TRAUMATOL, V18, P103, DOI 10.1034/j.1600-9657.2002.00004.x; RAVN JJ, 1981, SCAND J DENT RES, V89, P117; RAVN JJ, 1981, SCAND J DENT RES, V89, P355; RAVN JJ, 1981, SCAND J DENT RES, V89, P213; Robertson A, 1998, ENDOD DENT TRAUMATOL, V14, P245; Robertson A, 2000, Int J Paediatr Dent, V10, P191, DOI 10.1046/j.1365-263x.2000.00191.x; ZADIK D, 1979, ORAL SURG ORAL MED O, V47, P173, DOI 10.1016/0030-4220(79)90175-0	28	31	32	0	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2012	28	5					364	370		10.1111/j.1600-9657.2011.01102.x			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	009ZC	WOS:000309063100006	22221538				2022-02-06	
J	Christensen, J				Christensen, Jakob			Traumatic brain injury: Risks of epilepsy and implications for medicolegal assessment	EPILEPSIA			English	Article						Antiepileptic drugs; Early seizures; Epidemiology; Prevention; Treatment	ACUTE SYMPTOMATIC SEIZURE; POSTTRAUMATIC SEIZURES; HOSPITALIZATION; PREVENTION; CHILDHOOD; MORTALITY; CHILDREN; ADULTS; TRIAL; AGE	Traumatic brain injury (TBI) is a potentially preventable cause of epilepsy. Increasing incidence among army personnel and the high incidence among children and young people raise concern. This article presents a review of selected studies dealing with the risks of TBI and the risk of posttraumatic epilepsy in humans. The incidence of persons admitted to hospital with TBI has decreased in developed countries in recent years. However, there is little change in TBI-associated deaths, and the decrease in hospitalization may merely reflect that more people with head injury are cared for on an outpatient basis. It is clear that epilepsy is a frequent consequence of brain injury, even many years after the injury. However, several well-controlled studies have been unable to identify therapies that prevent the development of epilepsy after TBI. Posttraumatic epilepsy has significant implications for the affected individuals, family, and society. Despite several interventions used to prevent posttraumatic epilepsy, the only proven intervention to date is to prevent TBI from occurring.	[Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Aarhus Univ, Dept Clin Pharmacol, Aarhus, Denmark		Christensen, J (corresponding author), Aarhus Univ Hosp, Dept Neurol, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	jakob@farm.au.dk		Christensen, Jakob/0000-0002-9385-6435	Danish Epilepsy Association; UCB NordicUCB Pharma SA	Dr. Jakob Christensen received research support from the Danish Epilepsy Association.; Dr. Jakob Christensen received honoraria from serving on the scientific advisory board of UCB Nordic and Eisai AB, received honoraria from giving lectures from UCB Nordic and Eisai AB, and received funding for a trip from UCB Nordic. The author confirms that he has read the Journal's position on issues involved in ethical publication and affirms that this report is consistent with those guidelines.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Centers for Disease Control and Prevention, 2012, TRAUMATIC BRAIN INJU, P2002; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hesdorffer DC, 2009, EPILEPSIA, V50, P1102, DOI 10.1111/j.1528-1167.2008.01945.x; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Sun YL, 2010, EPIDEMIOLOGY, V21, P650, DOI 10.1097/EDE.0b013e3181e94253; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	26	31	33	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580			EPILEPSIA	Epilepsia	SEP	2012	53			4	SI		43	47		10.1111/j.1528-1167.2012.03612.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	000RG	WOS:000308404700006	22946720				2022-02-06	
J	Jerusalem, A; Dao, M				Jerusalem, Antoine; Dao, Ming			Continuum modeling of a neuronal cell under blast loading	ACTA BIOMATERIALIA			English	Article						Continuum model; Neuron; Blast; Cell damage; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; HUMAN HEAD; VISCOELASTIC PROPERTIES; MECHANICAL-PROPERTIES; SHOCK HUGONIOT; IN-SITU; PRESSURE; IMPACT; DEFORMATION; BIOMECHANICS	Traumatic brain injuries have recently been put under the spotlight as one of the most important causes of accidental brain dysfunctions. Significant experimental and modeling efforts are thus underway to study the associated biological, mechanical and physical mechanisms. In the field of cell mechanics, progress is also being made at the experimental and modeling levels to better characterize many of the cell functions, including differentiation, growth, migration and death. The work presented here aims to bridge both efforts by proposing a continuum model of a neuronal cell submitted to blast loading. In this approach, the cytoplasm, nucleus and membrane (plus cortex) are differentiated in a representative cell geometry, and different suitable material constitutive models are chosen for each one. The material parameters are calibrated against published experimental work on cell nanoindentation at multiple rates. The final cell model is ultimately subjected to blast loading within a complete computational framework of fluid-structure interaction. The results are compared to the nanoindentation simulation, and the specific effects of the blast wave on the pressure and shear levels at the interfaces are identified. As a conclusion, the presented model successfully captures some of the intrinsic intracellular phenomena occurring during the cellular deformation under blast loading that potentially lead to cell damage. It suggests, more particularly, that the localization of damage at the nucleus membrane is similar to what has already been observed at the overall cell membrane. This degree of damage is additionally predicted to be worsened by a longer blast positive phase duration. In conclusion, the proposed model ultimately provides a new three-dimensional computational tool to evaluate intracellular damage during blast loading. (C) 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Jerusalem, Antoine] IMDEA Mat Inst, Madrid 28040, Spain; [Dao, Ming] MIT, Cambridge, MA 02139 USA		Jerusalem, A (corresponding author), IMDEA Mat Inst, C Prof Aranguren S-N, Madrid 28040, Spain.	antoine.jerusalem@imdea.org; mingdao@mit.edu	Dao, Ming/B-1602-2008	Dao, Ming/0000-0001-5372-385X; Jerusalem, Antoine/0000-0001-5026-8038	Spanish Ministry of Science and InnovationSpanish Government; European UnionEuropean Commission; Madrid Regional Government [ESTRUMAT-S2009/MAT-1585]; Cajal Blue Brain Project; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL094270]; Infectious Disease Interdisciplinary Research Group of the SMART Center; Singapore-MIT Alliance (SMA)Singapore-MIT Alliance for Research & Technology Centre (SMART); NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL094270] Funding Source: NIH RePORTER	The authors thank Prof. Subra Suresh for his insightful guidance and suggestions. The authors are also grateful to Javier Rodriguez, of Principia, for his immeasurable help with Abaqus. A.J. acknowledges support from the Juan de la Cierva grant from the Spanish Ministry of Science and Innovation, from the Amarout grant from the European Union, from the ESTRUMAT-S2009/MAT-1585 grant (Madrid Regional Government), and from the Cajal Blue Brain Project. M.D. acknowledges support from the National Institutes of Health (NIH) Grant R01HL094270, Infectious Disease Interdisciplinary Research Group of the SMART Center, and the Computational Systems Biology Programme of the Singapore-MIT Alliance (SMA).	Abolfathi N, 2008, International Journal of Modelling and Simulation, V28, P470; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Allena R, 2010, J MECH BEHAV BIOMED, V3, P313, DOI 10.1016/j.jmbbm.2010.01.001; Alley Matthew David, 2009, THESIS PURDUE U; Ayton GS, 2010, SEMIN CELL DEV BIOL, V21, P357, DOI 10.1016/j.semcdb.2009.11.011; Barnes PD, 2008, SEMIN PEDIATR NEUROL, V15, P178, DOI 10.1016/j.spen.2008.10.009; Barron T.H.K., 1999, HEAT CAPACITY THERMA; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; BETT KE, 1965, NATURE, V207, P620, DOI 10.1038/207620a0; BOEHLER R, 1977, J APPL PHYS, V48, P4183, DOI 10.1063/1.323455; Caille N, 2002, J BIOMECH, V35, P177, DOI 10.1016/S0021-9290(01)00201-9; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Christou G, 2010, INT J IMPACT ENG, V47, P48; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Connell S, 2011, J NEUROTRAUM, V28, P1229, DOI 10.1089/neu.2011.1832; Dao M, 2006, MAT SCI ENG C-BIO S, V26, P1232, DOI 10.1016/j.msec.2005.08.020; Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Deriu MA, J BIOMECH IN PRESS; Diez-Silva M, 2010, MRS BULL, V35, P382, DOI 10.1557/mrs2010.571; Dintwa E, 2011, J FOOD ENG, V103, P265, DOI 10.1016/j.jfoodeng.2010.10.023; Drumheller D. S., 1998, INTRO WAVE PROPAGATI; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Flaherty B, 2007, CELL BIOCHEM BIOPHYS, V49, P14, DOI 10.1007/s12013-007-0045-2; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; Gladilin E, 2007, PHYS BIOL, V4, P104, DOI 10.1088/1478-3975/4/2/004; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X; Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360; Guillaume AI, 2002, AVIAT SPACE ENVIR MD, V73, P171; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hu LL, 2006, J APPL PHYS, V100, DOI 10.1063/1.2356107; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Jean RP, 2005, J BIOMECH ENG-T ASME, V127, P594, DOI 10.1115/1.1933997; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kaliske M, 1997, COMPUT MECH, V19, P228, DOI 10.1007/s004660050171; Kamm R., 2000, ASME INT C MECH BIOL, V242, P1; Karcher H, 2003, BIOPHYS J, V85, P3336, DOI 10.1016/S0006-3495(03)74753-5; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lee KYK, 2011, NEUROIMAGE, V54, pS30, DOI 10.1016/j.neuroimage.2010.05.042; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li J, 2007, P NATL ACAD SCI USA, V104, P4937, DOI 10.1073/pnas.0700257104; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Mandadapu KK, 2008, J BIOMECH, V41, P1467, DOI 10.1016/j.jbiomech.2008.02.014; Marc A.M., 1994, DYNAMIC BEHAV MAT; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; McGarry J G, 2004, Eur Cell Mater, V7, P27; McGarry JP, 2009, ANN BIOMED ENG, V37, P2317, DOI 10.1007/s10439-009-9772-4; McNally HA, 2004, J NEUROCYTOL, V33, P251, DOI 10.1023/B:NEUR.0000030700.48612.0b; Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002; Miller P, 2010, J MECH BEHAV BIOMED, V3, P268, DOI 10.1016/j.jmbbm.2009.11.001; Mofrad M.R., 2006, CYTOSKELETAL MECH MO; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moreo P, 2008, ACTA BIOMATER, V4, P613, DOI 10.1016/j.actbio.2007.10.014; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Motherway J, 2009, Leg Med (Tokyo), V11 Suppl 1, pS220, DOI 10.1016/j.legalmed.2009.01.072; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; Nagayama K, 2006, SHOCK WAVES, V15, P267, DOI 10.1007/s00193-006-0030-5; Nagayama K, 2002, J APPL PHYS, V91, P476, DOI 10.1063/1.1421630; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Ofek G, 2009, J BIOMECH, V42, P873, DOI 10.1016/j.jbiomech.2009.01.024; Peeters EAG, 2005, J BIOMECH ENG-T ASME, V127, P237, DOI 10.1115/1.1865198; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Quinn DJ, 2011, ANN BIOMED ENG, V39, P1041, DOI 10.1007/s10439-010-0232-y; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Salvador-Silva M, 2004, GLIA, V45, P364, DOI 10.1002/glia.10342; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Simulia, 2010, AB 6 10; Slomka N, 2010, J BIOMECH, V43, P1806, DOI 10.1016/j.jbiomech.2010.02.011; Sonden A, 2000, LASER SURG MED, V26, P364, DOI 10.1002/(SICI)1096-9101(2000)26:4<364::AID-LSM4>3.0.CO;2-T; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Suzuki H, 2007, J MAMMAL OVA RES, V24, P107; Taylor R.L., 1970, INT J NUMER METH ENG, V2, P45, DOI [10.1002/nme.1620020106, DOI 10.1002/NME.1620020106]; Vaziri A, 2006, J MATER RES, V21, P2126, DOI 10.1557/JMR.2006.0262; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Willinger R, 2000, J SOUND VIB, V235, P611, DOI 10.1006/jsvi.1999.2931; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Willinger R, 2001, INT J CRASHWORTHINES, V6, P281, DOI 10.1533/cras.2001.0178; Yan KC, 2010, J BIOMECH, V43, P1031, DOI 10.1016/j.jbiomech.2009.12.018; Yoganandan N, 2010, ACCIDENT ANAL PREV, V42, P1370, DOI 10.1016/j.aap.2010.02.017; Young J, 2010, J BIOMECH, V43, P210, DOI 10.1016/j.jbiomech.2009.09.025; Zhang CY, 2007, PHILOS MAG, V87, P3415, DOI 10.1080/14786430701288094; Zhang CY, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021912; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Ziegler L, 2010, EXP NEUROL, V223, P119, DOI 10.1016/j.expneurol.2009.09.019	111	31	31	1	45	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	SEP	2012	8	9					3360	3371		10.1016/j.actbio.2012.04.039			12	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	990JD	WOS:000307625900018	22562014	Green Accepted			2022-02-06	
J	Jiang, Y; Brody, DL				Jiang, Yong; Brody, David L.			Administration of COG1410 Reduces Axonal Amyloid Precursor Protein Immunoreactivity and Microglial Activation after Controlled Cortical Impact in Mice	JOURNAL OF NEUROTRAUMA			English	Article						COG1410; controlled cortical impact injury; microglia; neuroprotection; traumatic axonal injury	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; CYCLOSPORINE-A; WHITE-MATTER; MIMETIC PEPTIDES; APOE; DAMAGE; MODEL	Traumatic axonal injury (TAI) accounts for at least 35% of the morbidity and mortality in traumatic brain injury (TBI) patients without space-occupying lesions. It is also believed to be a key determinant of adverse outcomes such as cognitive dysfunction across the spectrum of TBI severity. Previous studies have shown that COG1410, a synthetic peptide derived from the apolipoprotein E (apoE) receptor binding region, has anti-inflammatory effects after experimental TBI, with improvements in cognitive recovery. However, the effects of COG1410 on axonal injury following TBI are not known. The current study evaluated the effects of 1 mg/kg daily COG1410 versus saline administered intravenously starting 30 min after controlled cortical impact (CCI) injury on pericontusional TAI in young, wild-type C57BL6/J male mice. We found that COG1410 did not affect the number of amyloid precursor protein (APP)-immunoreactive axonal varicosities in the pericontusional corpus callosum and external capsule at 24 h, but reduced APP-immunoreactive varicosities by 31% at 3 days (p = 0.0023), and 36% at 7 days (p = 0.0009). COG1410 significantly reduced the number of Iba1-positive cells with activated microglial morphology at all three time points by 21-30%. There was no effect of COG1410 on pericontusional white matter volume or silver staining at any time point. This indicates a possible effect of COG1410 on delayed but not immediate TAI. Future studies are needed to investigate the underlying mechanisms, therapeutic time window, and physiological implications of this effect.	[Jiang, Yong; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Jiang, Yong] Luzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Luzhou, Peoples R China; [Brody, David L.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA		Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave,Campus Box 8111, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000528, 30973087]; Foundation for Sci & Tech Research Project of Sichuan Province [2009JY0126]; Project Foundation of Health Bureau of Sichuan Province [090217]; Project Foundation of Sichuan Province Education Committee [08zb049]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS065069]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065069] Funding Source: NIH RePORTER	This work was supported by the National Natural Science Foundation of China (grants 81000528 and 30973087), the Foundation for Sci & Tech Research Project of Sichuan Province (grant 2009JY0126), the Project Foundation of Health Bureau of Sichuan Province (grant 090217), the Project Foundation of Sichuan Province Education Committee (grant 08zb049), and the NIH (grant NS065069). We thank Thomas Esparza, Rachel Bennett, and Hien Tran for technical assistance, and Dr. David Holtzman for the use of his stereology system. We thank Cognosci Inc. for providing COG1410. None of the authors has a financial interest in Cognosci Inc.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McAdoo JD, 2005, NEUROSCI LETT, V381, P305, DOI 10.1016/j.neulet.2005.02.036; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sun XC, 2008, CHIN J TRAUMATOL, V11, P247, DOI 10.1016/S1008-1275(08)60051-6; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tukhovskaya EA, 2009, J NEUROSCI RES, V87, P677, DOI 10.1002/jnr.21874; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	70	31	40	2	7	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2012	29	13					2332	2341		10.1089/neu.2012.2362			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	000PU	WOS:000308399900009	22676717	Green Submitted, Green Published			2022-02-06	
J	Wall, PLH				Wall, Pamela L. (Herbig)			Posttraumatic Stress Disorder and Traumatic Brain Injury in Current Military Populations: A Critical Analysis	JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION			English	Article						posttraumatic stress disorder; PTSD; traumatic brain injury; TBI; postconcussive syndrome; veteran; military	PERSISTENT POSTCONCUSSIVE SYMPTOMS; NATIONAL-GUARD SOLDIERS; SERVICE MEMBERS; VETERANS; BLAST; PTSD; IRAQ; AFGHANISTAN; PREVALENCE; WAR	BACKGROUND: The use of unconventional weaponry combined with decreased mortality rates and servicemembers being exposed to intense ground combat during multiple deployments has increased the risk of servicemembers living with the consequences of traumatic brain injuries (TBI) and combat operational stress. OBJECTIVE: The purpose of this article is to perform a critical analysis of the literature to identify current rates of comorbid posttraumatic stress disorder (PTSD) and TBI in military and veteran populations who have served in Iraq or Afghanistan and their combined effects on persistent postconcussive symptoms. DESIGN: A search of the literature with military and veteran populations published after 2001 in Pubmed, OVID/Medline, Cochran Database, Embase, Scopus, CINAHL, and PsychInfo was conducted using keywords. RESULTS: Twenty studies met inclusion criteria. The literature search yielded mixed results for rates of PTSD, TBI, and comorbid conditions. CONCLUSIONS: There is some evidence that comorbid PTSD and TBI result in greater reports of postconcussive symptomology than either condition alone. Limitations include lack of consistency of measurements, sampling biases, and lack of experimental design, and these warrant further exploration. Future research is needed to decrease variability in study findings and elucidate relationships between these disorders and their effects on persistent postconcussive symptomology.	[Wall, Pamela L. (Herbig)] Univ Penn, Philadelphia, PA 19104 USA		Wall, PLH (corresponding author), 2nd Marine Corps Div, Div Psychiat, PSC Box 20003, Camp Lejuene, NC 28542 USA.	luvridley@aol.com			Jonas Center for Nursing excellence	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: the author received an educational grant from the Jonas Center for Nursing excellence to support PhD program.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Centers for Disease Control and Prevention, 1975, INT CLASS DIS; Centers for Disease Control and Prevention, 1990, INT CLASS DIS 10 REV; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Defense and Veterans Brain Injury Center, 2011, MIL ACUT CONC EV INF; Department of Defense & Department of Veterans Affairs, 2009, CLIN PRACT GUID MAN; Department of Veterans Affairs, 2011, VA EL HOM; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine, 2009, GULF WAR HLTH, V7; Iversen AC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-31; Iverson A. C., 2008, PSYCHOL MED, V38, P1; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mclay RN, 2008, AM J PSYCHIAT, V165, P775, DOI 10.1176/appi.ajp.2008.07121960; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Phillips CJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-52; Polit DF, 2008, NURSING RES GENERATI; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Romesser J, 2011, MIL MED, V176, P246, DOI 10.7205/MILMED-D-10-00056; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sandweiss DA, 2011, ARCH GEN PSYCHIAT, V68, P496, DOI 10.1001/archgenpsychiatry.2011.44; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Shen YC, 2010, MIL MED, V175, P763, DOI 10.7205/MILMED-D-10-00086; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Suri H, 2009, REV EDUC RES, V79, P395, DOI 10.3102/0034654308326349; Tan M., 2009, ARMYTIMES; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; U.S. Department of Defense Statistical Information and Analysis Division, 2011, US MIL CAS OIF OEF C; U.S. Department of Defense Statistical Information and Analysis Division, 2010, US MIL CAS OIF OEF C; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Veterans Administration, 2012, TSGLI SCHED LOSS; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	62	31	31	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3903	1532-5725		J AM PSYCHIAT NURSES	J. Am. Psych. Nurses Assoc.	SEP-OCT	2012	18	5					278	298		10.1177/1078390312460578			21	Nursing; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Psychiatry	V32PO	WOS:000208963300003	23053745				2022-02-06	
J	Youn, YA; Kim, SJ; Sung, IK; Chung, SY; Kim, YH; Lee, IG				Youn, Y. A.; Kim, S. J.; Sung, I. K.; Chung, S. Y.; Kim, Y. H.; Lee, I. G.			Serial Examination of Serum IL-8, IL-10 and IL-1Ra Levels is Significant in Neonatal Seizures Induced by Hypoxic-Ischaemic Encephalopathy	SCANDINAVIAN JOURNAL OF IMMUNOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; RECEPTOR ANTAGONIST; INTERLEUKIN-6; CYTOKINES; CHILDREN; EPILEPSY; PLASMA	We investigated changes in the levels of significant cytokines in relation to neonatal seizures, a pattern of cytokine concentrations serially and the severity of brain insult. The hypoxicischaemic encephalopathy-induced seizure group consisted of 13 patients, and another 15 normal newborns were enrolled as a control group. All of the initial samples were obtained within the first 24 h of admission, and the second samples were obtained between 48 and 72 h in both groups. Only the third samples were taken in the seizure group on the 5th day. During neonatal seizures, the levels of most cytokines increased within 24 h, and, in particular, the levels of interleukin (IL)-8 significantly increased (P < 0.05). After 4872 h of seizure onset, the levels of most cytokines decreased, especially, IL-1Ra; however, IL-8 and IL-10 remained increased (P < 0.05). During the prognosis, one patient who was diagnosed with quadriplegic cerebral palsy at 6 months of age presented extreme elevation of IL-1beta, IL-1Ra, IL-6, IL-8, IL-10 and tumor necrosis factor-alpha in the initial sample, reflecting the severity of brain damage. A significant increase in IL-8 may serve as a biomarker for earlier detection of brain damage in neonatal seizure, if detected within 24 and 4872 h of the seizure.	[Lee, I. G.] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Pediat, Seoul 137701, South Korea; [Chung, S. Y.] Catholic Univ Korea, Incheon St Marys Hosp, Dept Pediat, Kyonggi Do, South Korea; [Chung, S. Y.; Kim, Y. H.] Catholic Univ Korea, Coll Med, Kyonggi Do, South Korea; [Kim, Y. H.] Catholic Univ Korea, Uijeongbu St Marys Hosp, Dept Pediat, Kyonggi Do, South Korea		Lee, IG (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Pediat, 505 Banpo Dong, Seoul 137701, South Korea.	lea732@hanmail.net					Alapirtti T, 2009, J NEUROL SCI, V280, P94, DOI 10.1016/j.jns.2009.02.355; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Asano T, 2010, SCAND J IMMUNOL, V71, P447, DOI 10.1111/j.1365-3083.2010.02391.x; Bartha AI, 2004, PEDIATR RES, V56, P960, DOI 10.1203/01.PDR.0000144819.45689.BB; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Ergenekon E, 2004, BRAIN DEV-JPN, V26, P283, DOI 10.1016/S0387-7604(03)00166-9; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; Giulian D, 2004, NEUROBIOLOGY CENTRAL; Godukhin O V, 2009, Neurosci Behav Physiol, V39, P625, DOI 10.1007/s11055-009-9187-6; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Jeannin P, 1996, J IMMUNOL, V156, P3159; KIMELBERG HK, 1994, NEUROBIOLOGY CENTRAL, P193; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; MULLER R, 1979, J MED, V10, P307; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; PANAYIOTOPOULOS CP, 2005, EPILEPSIES SEIZURE S; Peltola J, 1998, EPILEPSY RES, V31, P129, DOI 10.1016/S0920-1211(98)00024-2; Penkowa M, 2001, NEUROSCIENCE, V102, P805, DOI 10.1016/S0306-4522(00)00515-7; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Silveira RC, 2003, J PEDIATR-US, V143, P625, DOI 10.1067/S0022-3476(03)00531-6; Sinha S, 2008, EPILEPSY RES, V82, P171, DOI 10.1016/j.eplepsyres.2008.07.018; Soares HD, 1995, J NEUROSCI, V15, P8223; Swaiman KF., 2006, PEDIAT NEUROLOGY PRI; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Volpe J, 2008, NEONATAL SEIZURES NE; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003	33	31	35	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-9475			SCAND J IMMUNOL	Scand. J. Immunol.	SEP	2012	76	3					286	293		10.1111/j.1365-3083.2012.02710.x			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	996MV	WOS:000308094200011	22537067	Bronze			2022-02-06	
J	Ahmad, A; Khan, MM; Javed, H; Raza, SS; Ishrat, T; Khan, MB; Safhi, MM; Islam, F				Ahmad, Ajmal; Khan, Mohd. Moshahid; Javed, Hayate; Raza, Syed Shadab; Ishrat, Tauheed; Khan, M. Badruzzaman; Safhi, Mohammed M.; Islam, Fakhrul			Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Oxidative stress; Cerebral ischemia; Antioxidant; Apoptosis; Neuroprotection	TRAUMATIC BRAIN-INJURY; ARTERY OCCLUSION; NEUROCHEMICAL CHANGES; ANTIOXIDANT; STROKE; DAMAGE; REPERFUSION; PROTECTS; NEURONS; MICE	Stroke is a life-threatening disease with major cause of mortality and morbidity worldwide. The neuronal damage following cerebral ischemia is a serious risk to stroke patients. Oxidative stress and apoptotic damage play an important role in cerebral ischemic pathogenesis and may represent a target for treatment. The objective of this study was to test the hypothesis that administration of edaravone (Edv) maintains antioxidant status in brain, improves the cholinergic dysfunction and suppresses the progression of apoptosis response in rat. To test this hypothesis, male Wistar rats were subjected to middle cerebral artery occlusion (MCAO) of 2 h followed by reperfusion for 22 h. Edv was administered (10 mg/kg bwt) intraperitoneally 30 min before the onset of ischemia and 1 h after reperfusion. After reperfusion, rats were tested for neurobehavioral activities and were sacrificed for the infarct volume, estimation of oxidative damage markers. Edv treatment significantly reduced ischemic lesion volume, improved neurological deficits, contended oxidative loads, and suppressed apoptotic damage. In conclusion, treatment with Edv ameliorated the neurological and histological outcomes with elevated endogenous anti-oxidants status as well as reduced induction of apoptotic responses in MCA occluded rat. We theorized that Edv is among the pharmacological agents that reduce free radicals and its associated cholinergic dysfunction and apoptotic damage and have been found to limit the extent of brain damage following stroke.	[Ahmad, Ajmal; Khan, Mohd. Moshahid; Javed, Hayate; Raza, Syed Shadab; Ishrat, Tauheed; Khan, M. Badruzzaman; Islam, Fakhrul] Jamia Hamdard, Neurotoxicol Lab, Dept Med Elementol & Toxicol, Fund Improvement Sci & Technology DST, New Delhi 110062, India; [Ahmad, Ajmal; Khan, Mohd. Moshahid; Javed, Hayate; Raza, Syed Shadab; Ishrat, Tauheed; Khan, M. Badruzzaman; Islam, Fakhrul] Jamia Hamdard, Special Assistance Programme UGC Sponsored, New Delhi 110062, India; [Ahmad, Ajmal] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA 30912 USA; [Khan, Mohd. Moshahid] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Ishrat, Tauheed] Univ Georgia, Dept Clin & Adm Pharm, Augusta, GA 30912 USA; [Safhi, Mohammed M.; Islam, Fakhrul] Jazan Univ, Fac Pharm, Neurosci & Toxicol Unit, Jazan, Saudi Arabia		Islam, F (corresponding author), Jamia Hamdard, Neurotoxicol Lab, Dept Med Elementol & Toxicol, Fund Improvement Sci & Technology DST, New Delhi 110062, India.	fislam2001@yahoo.co.in	Ahmad, Ajmal/AAY-6018-2020; Raza, Syed Shadab/AAE-5185-2019	Raza, Syed Shadab/0000-0002-6147-9399; ahmad, ajmal/0000-0003-2103-2944; Khan, Mohammad Moshahid/0000-0003-4679-294X; Javed, Hayate/0000-0003-0767-2830	Department of Ayurveda, Yoga and Naturalpathy, Unani, Siddha and Homeopath (AYUSH), Ministry of Health and Family Welfare, Government of India, New Delhi	Authors are thankful to the Department of Ayurveda, Yoga and Naturalpathy, Unani, Siddha and Homeopath (AYUSH), Ministry of Health and Family Welfare, Government of India, New Delhi for financial assistance. The authors wish to thanks Mr. Dharamvir Singh for his assistance.	Amemiya S, 2005, EUR J PHARMACOL, V516, P125, DOI 10.1016/j.ejphar.2005.04.036; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Chang Chia-Yu, 2009, Acta Neurol Taiwan, V18, P231; Cherubini A, 2000, STROKE, V31, P2295, DOI 10.1161/01.STR.31.10.2295; Cheung RTF, 2003, J PINEAL RES, V34, P153, DOI 10.1034/j.1600-079X.2003.00034.x; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Faraci FM, 2006, J APPL PHYSIOL, V100, P739, DOI 10.1152/japplphysiol.01044.2005; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Imam SZ, 2000, BRAIN RES, V855, P186, DOI 10.1016/S0006-8993(99)02249-0; Ishrat T, 2009, EUR NEUROPSYCHOPHARM, V19, P636, DOI 10.1016/j.euroneuro.2009.02.002; Islam F, 2002, BIOL TRACE ELEM RES, V90, P203, DOI 10.1385/BTER:90:1-3:203; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Jiao L, 2011, NEUROSCIENCE, V182, P177, DOI 10.1016/j.neuroscience.2011.01.017; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Khan MM, 2010, CHEM-BIOL INTERACT, V183, P255, DOI 10.1016/j.cbi.2009.10.003; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; LEVINE S, 1960, AM J PATHOL, V36, P1; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masuo Y, 1997, BRAIN RES PROTOC, V1, P321, DOI 10.1016/S1385-299X(97)00005-6; MOHANDAS J, 1984, CANCER RES, V44, P5086; Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046; Racay P, 2009, CELL MOL NEUROBIOL, V29, P901, DOI 10.1007/s10571-009-9373-7; Saleem S, 2006, J MED FOOD, V9, P246, DOI 10.1089/jmf.2006.9.246; Sarkar S, 2006, MECH AGEING DEV, V127, P391, DOI 10.1016/j.mad.2005.12.010; Sasaki T, 2006, J NEUROSCI RES, V84, P1187, DOI 10.1002/jnr.21036; SCHWARTING RKW, 1991, BRAIN RES, V554, P46, DOI 10.1016/0006-8993(91)90170-Z; Shah MK, 2010, J MAGN RESON IMAGING, V32, P796, DOI 10.1002/jmri.22302; Takano K, 1997, J NEUROL SCI, V153, P8, DOI 10.1016/S0022-510X(97)00184-6; Utley H.C., 1967, ARCH BIOCHEM BIOPHYS, V260, P521; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Watanabe T, 2008, CARDIOVASC THER, V26, P101, DOI 10.1111/j.1527-3466.2008.00041.x; Yamamoto Y, 2009, REDOX REP, V14, P251, DOI 10.1179/135100009X12525712409779; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; ZAHEER N, 1965, ARCH BIOCHEM BIOPHYS, V109, P646; Zeevalk GD, 1998, DEV NEUROSCI-BASEL, V20, P444, DOI 10.1159/000017342; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhao J, 2008, BRAIN RES, V1229, P224, DOI 10.1016/j.brainres.2008.06.117	45	31	42	0	13	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	AUG	2012	367	1-2					215	225		10.1007/s11010-012-1335-6			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	964GX	WOS:000305683100022	22648734				2022-02-06	
J	Gatson, JW; Liu, MM; Abdelfattah, K; Wigginton, JG; Smith, S; Wolf, S; Simpkins, JW; Minei, JP				Gatson, Joshua W.; Liu, Ming-Mei; Abdelfattah, Kareem; Wigginton, Jane G.; Smith, Scott; Wolf, Steven; Simpkins, James W.; Minei, Joseph P.			Estrone Is Neuroprotective in Rats after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain-derived neurotrophic factor; estrone; extracellular signal-regulated kinase (ERK); traumatic brain injury	AMYLOID PRECURSOR PROTEIN; SPINAL-CORD-INJURY; CEREBRAL-ARTERY OCCLUSION; RECEPTOR-BETA AGONIST; APOPTOTIC CELL-DEATH; PRIMARY CULTURES; CORTICAL CULTURES; INDUCED TOXICITY; UP-REGULATION; ADULT-RAT	In various animal and human studies, early administration of 17 beta-estradiol, a strong antioxidant, anti-inflammatory, and anti-apoptotic agent, significantly decreases the severity of injury in the brain associated with cell death. Estrone, the predominant estrogen in postmenopausal women, has been shown to be a promising neuroprotective agent. The overall goal of this project was to determine if estrone mitigates secondary injury following traumatic brain injury (TBI) in rats. Male rats were given either placebo (corn oil) or estrone (0.5 mg/kg) at 30 min after severe TBI. Using a controlled cortical impact device in rats that underwent a craniotomy, the right parietal cortex was injured using the impactor tip. Non-injured control and sham animals were also included. At 72 h following injury, the animals were perfused intracardially with 0.9% saline followed by 10% phosphate-buffered formalin. The whole brain was removed, sliced, and stained for TUNEL-positive cells. Estrone decreased cortical lesion volume (p < 0.01) and neuronal injury (p < 0.001), and it reduced cerebral cortical levels of TUNEL-positive staining (p < 0.0001), and decreased numbers of TUNEL-positive cells in the corpus callosum (p < 0.03). We assessed the levels of beta-amyloid in the injured animals and found that estrone significantly decreased the cortical levels of beta-amyloid after brain injury. Cortical levels of phospho-ERK1/2 were significantly ( p < 0.01) increased by estrone. This increase was associated with an increase in phospho-CREB levels (p < 0.021), and brain-derived neurotrophic factor (BDNF) expression (p < 0.0006). In conclusion, estrone given acutely after injury increases the signaling of protective pathways such as the ERK1/2 and BDNF pathways, decreases ischemic secondary injury, and decreases apoptotic-mediated cell death. These results suggest that estrone may afford protection to those suffering from TBI.	[Gatson, Joshua W.; Liu, Ming-Mei; Abdelfattah, Kareem; Wigginton, Jane G.; Smith, Scott; Wolf, Steven; Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, D FW Ctr Resuscitat Res, Dallas, TX 75390 USA; [Simpkins, James W.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Univ N Texas Hlth Sci Ctr, Dallas, TX 75390 USA		Gatson, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, D FW Ctr Resuscitat Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joshua.gatson@utsw.edu		Wolf, Steven/0000-0003-2972-3440; Wigginton, Jane/0000-0002-8561-3492	Department of Surgery, Division of Burn/Trauma/Critical Care, University of Texas Southwestern Medical Center, Dallas, Texas; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG022550, P01AG027956] Funding Source: NIH RePORTER	The authors would like to thank Martha Romero for technical assistance with the animal perfusion protocol and use of the fluorescence microscope. We would also like to acknowledge Dr. John Shelton for assisting with the slicing of the brains for immunohistochemical analysis and acquiring photomicrographs of the coronal brain slices. This work was supported by the Department of Surgery, Division of Burn/Trauma/Critical Care, University of Texas Southwestern Medical Center, Dallas, Texas.	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Bae YH, 2000, J KOREAN MED SCI, V15, P327, DOI 10.3346/jkms.2000.15.3.327; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bhavnani BR, 2003, J SOC GYNECOL INVEST, V10, P302, DOI 10.1016/S1071-5576(03)00087-X; Blair IA, 2010, STEROIDS, V75, P297, DOI 10.1016/j.steroids.2010.01.012; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Cirigliano M, 2007, J WOMENS HEALTH, V16, P600, DOI 10.1089/jwh.2006.0311; Conti AC, 1998, J NEUROSCI, V18, P5663; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Gatson JW, 2011, ENDOCRINOLOGY, V152, P207, DOI 10.1210/en.2010-0724; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kajta M, 2005, J PHYSIOL PHARMACOL, V56, P233; Kajta M, 2004, NEUROSCIENCE, V123, P515, DOI 10.1016/j.neuroscience.2003.09.005; Kajta M, 2002, POL J PHARMACOL, V54, P727; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Knoferl MW, 2000, ARCH SURG-CHICAGO, V135, P425, DOI 10.1001/archsurg.135.4.425; Kondo Y, 1997, NEUROSCI LETT, V238, P45, DOI 10.1016/S0304-3940(97)00847-1; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Mizushima Y, 2000, ANN SURG, V232, P673, DOI 10.1097/00000658-200011000-00009; Nakamura T, 2005, J NEUROSURG, V103, P97, DOI 10.3171/jns.2005.103.1.0097; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Palacios B, 1998, J CARDIOVASC PHARM, V31, P479, DOI 10.1097/00005344-199804000-00001; Perez E, 2005, BRAIN RES, V1038, P216, DOI 10.1016/j.brainres.2005.01.026; Pierce JES, 1996, J NEUROSCI, V16, P1083; Regan RF, 1997, BRAIN RES, V764, P133, DOI 10.1016/S0006-8993(97)00437-X; RINK A, 1995, AM J PATHOL, V147, P1575; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sener G, 2005, J SURG RES, V128, P70, DOI 10.1016/j.jss.2005.02.019; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shughrue PJ, 2003, NEUROSCIENCE, V116, P851, DOI 10.1016/S0306-4522(02)00790-X; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2003, ANN NY ACAD SCI, V993, P125, DOI 10.1111/j.1749-6632.2003.tb07521.x; Stanciu M, 2002, J BIOL CHEM, V277, P4010, DOI 10.1074/jbc.M104479200; Su C, 2011, J NEUROSCI RES, V89, P1542, DOI 10.1002/jnr.22683; Sudo S, 1997, NEUROSCI RES, V29, P345, DOI 10.1016/S0168-0102(97)00106-5; Suzuki S, 2007, J COMP NEUROL, V500, P1064, DOI 10.1002/cne.21240; Szalay L, 2005, AM J PHYSIOL-HEART C, V289, pH92, DOI 10.1152/ajpheart.01247.2004; Tomasevic G, 2010, J NEUROSCI RES, V88, P3414, DOI 10.1002/jnr.22491; Wakai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub2; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yang SH, 2003, ANN NY ACAD SCI, V1007, P101, DOI 10.1196/annals.1286.010; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Yu HP, 2006, AM J PHYSIOL-LUNG C, V290, pL1004, DOI 10.1152/ajplung.00504.2005; Yu HP, 2006, J MOL CELL CARDIOL, V40, P185, DOI 10.1016/j.yjmcc.2005.10.001; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7	69	31	32	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2012	29	12					2209	2219		10.1089/neu.2011.2274			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	993KZ	WOS:000307859900008	22435710	Green Published			2022-02-06	
J	Boyko, M; Melamed, I; Gruenbaum, BF; Gruenbaum, SE; Ohayon, S; Leibowitz, A; Brotfain, E; Shapira, Y; Zlotnik, A				Boyko, Matthew; Melamed, Israel; Gruenbaum, Benjamin Fredrick; Gruenbaum, Shaun Evan; Ohayon, Sharon; Leibowitz, Akiva; Brotfain, Evgeny; Shapira, Yoram; Zlotnik, Alexander			The Effect of Blood Glutamate Scavengers Oxaloacetate and Pyruvate on Neurological Outcome in a Rat Model of Subarachnoid Hemorrhage	NEUROTHERAPEUTICS			English	Article						Glutamate; Neurological outcome; Scavengers; Subarachnoid hemorrhage; Oxaloacetate; Pyruvate	TRAUMATIC BRAIN-INJURY; EXCITATORY AMINO-ACIDS; BARRIER PERMEABILITY CHANGES; ACUTE ISCHEMIC-STROKE; CLOSED-HEAD INJURY; CEREBROSPINAL-FLUID; CLINICAL-TRIALS; CEREBRAL VASOSPASM; EXCESS GLUTAMATE; PLASMA GLUTAMATE	Blood glutamate scavengers have been shown to effectively reduce blood glutamate concentrations and improve neurological outcome after traumatic brain injury and stroke in rats. This study investigates the efficacy of blood glutamate scavengers oxaloacetate and pyruvate in the treatment of subarachnoid hemorrhage (SAH) in rats. Isotonic saline, 250 mg/kg oxaloacetate, or 125 mg/kg pyruvate was injected intravenously in 60 rats, 60 minutes after induction of SAH at a rate of 0.1 ml/100 g/min for 30 minutes. There were 20 additional rats that were used as a sham-operated group. Blood samples were collected at baseline and 90 minutes after SAH. Neurological performance was assessed at 24 h after SAH. In half of the rats, glutamate concentrations in the cerebrospinal fluid were measured 24 h after SAH. For the remaining half, the blood brain barrier permeability in the frontal and parieto-occipital lobes was measured 48 h after SAH. Blood glutamate levels were reduced in rats treated with oxaloacetate or pyruvate at 90 minutes after SAH (p < 0.001). Cerebrospinal fluid glutamate was reduced in rats treated with pyruvate (p < 0.05). Neurological performance was significantly improved in rats treated with oxaloacetate (p < 0.05) or pyruvate (p < 0.01). The breakdown of the blood brain barrier was reduced in the frontal lobe in rats treated with pyruvate (p < 0.05) and in the parieto-occipital lobes in rats treated with either pyruvate (p < 0.01) or oxaloacetate (p < 0.01). This study demonstrates the effectiveness of blood glutamate scavengers oxaloacetate and pyruvate as a therapeutic neuroprotective strategy in a rat model of SAH.	[Boyko, Matthew; Gruenbaum, Benjamin Fredrick; Ohayon, Sharon; Leibowitz, Akiva; Brotfain, Evgeny; Shapira, Yoram; Zlotnik, Alexander] Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Med Ctr, Fac Hlth Sci, IL-84005 Beer Sheva, Israel; [Melamed, Israel] Ben Gurion Univ Negev, Dept Neurosurg, Soroka Med Ctr, Fac Hlth Sci, IL-84005 Beer Sheva, Israel; [Gruenbaum, Shaun Evan] Yale Univ, Dept Anesthesiol, Sch Med, New Haven, CT 06520 USA		Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Med Ctr, Fac Hlth Sci, IL-84005 Beer Sheva, Israel.	zlotnika@bgu.ac.il	Leibowitz, Akiva/F-1397-2012	Boyko, Matthew/0000-0003-3116-1643; Leibowitz, Akiva/0000-0003-4244-1915	European Society of Anesthesiologists	This work was supported by the grant awarded from the European Society of Anesthesiologists in 2010 (to A.Z.). We thank Sarah Boyko and Anastasia Zlotnik for their outstanding help as laboratory assistants. We thank Valeria Frishman, laboratory assistant at the Department of Clinical Biochemistry, Soroka Medical Center, Ben-Gurion University of the Negev, for her help with the biochemical analysis. We thank A. Alir and the staff at the Critical Care Unit, Soroka Medical Center, for their support and helpful discussions.	Abu Fanne R, 2011, AM J PHYSIOL-REG I, V301, pR668, DOI 10.1152/ajpregu.00058.2011; Andreadou E, 2008, IN VIVO, V22, P137; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; BERL S, 1962, J BIOL CHEM, V237, P2562; BERTRAND G, 1992, BRIT J PHARMACOL, V106, P354, DOI 10.1111/j.1476-5381.1992.tb14340.x; Boyko M, 2011, EUR J NEUROSCI, V34, P1432, DOI 10.1111/j.1460-9568.2011.07864.x; BUCHAN AM, 1993, STROKE, V24, pI148; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; Bunting H, 2010, OPHTHAL RES, V43, P197, DOI 10.1159/000272024; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Cross DT, 2003, J NEUROSURG, V99, P810, DOI 10.3171/jns.2003.99.5.0810; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; DOCZI T, 1985, ACTA NEUROCHIR, V77, P110, DOI 10.1007/BF01476215; DOCZI T, 1986, NEUROSURGERY, V18, P733, DOI 10.1227/00006123-198606000-00010; Espey MG, 2002, NEUROLOGY, V58, P1439, DOI 10.1212/WNL.58.9.1439; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; Germano A, 1998, ACTA NEUROCHIR, V140, P805, DOI 10.1007/s007010050182; Germano A, 2000, ACTA NEUROCHIR, V142, P575, DOI 10.1007/s007010050472; Germano A, 1998, J NEUROSURG, V88, P1075, DOI 10.3171/jns.1998.88.6.1075; GERMANO A, 1992, NEUROSURGERY, V30, P882, DOI 10.1227/00006123-199206000-00011; Germano A, 2007, J NEUROTRAUM, V24, P732, DOI 10.1089/neu.2006.0181; GONOI T, 1994, J BIOL CHEM, V269, P16989; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAF CJ, 1974, STROKE, V5, P557, DOI 10.1161/01.STR.5.4.557; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; HARMSEN P, 1992, STROKE, V23, P1410, DOI 10.1161/01.STR.23.10.1410; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Imperatore C, 2000, LIFE SCI, V66, P779, DOI 10.1016/S0024-3205(99)00651-7; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; JACKOWSKI A, 1990, J CEREBR BLOOD F MET, V10, P835, DOI 10.1038/jcbfm.1990.140; Jeon H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-103; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; King JT, 1997, NEUROIMAG CLIN N AM, V7, P659; Koura SS, 1998, ACT NEUR S, V71, P244; MARZATICO F, 1988, STROKE, V19, P378, DOI 10.1161/01.STR.19.3.378; Meguro T, 2001, NEUROL RES, V23, P761, DOI 10.1179/016164101101199144; MOLNAR E, 1995, FEBS LETT, V371, P253, DOI 10.1016/0014-5793(95)00890-L; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Phillis JW, 1996, NEUROCHEM INT, V29, P115, DOI 10.1016/0197-0186(95)00154-9; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; SOLOMON RA, 1985, STROKE, V16, P58, DOI 10.1161/01.STR.16.1.58; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Stegmayr B, 2004, STROKE, V35, P2059, DOI 10.1161/01.STR.0000138451.07853.b6; Stock CM., 2009, CLIN ANESTHESIA; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Teichberg VI, 2007, P NATL ACAD SCI USA, V104, P7315, DOI 10.1073/pnas.0702450104; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; VEELKEN JA, 1995, STROKE, V26, P1279, DOI 10.1161/01.STR.26.7.1279; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	75	31	31	1	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	JUL	2012	9	3					649	657		10.1007/s13311-012-0129-6			9	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	006NV	WOS:000308826800016	22711471	Green Published			2022-02-06	
J	Laxe, S; Tschiesner, U; Zasler, N; Lopez-Blazquez, R; Tormos, JM; Bernabeu, M				Laxe, Sara; Tschiesner, Uta; Zasler, Nathan; Lopez-Blazquez, Raquel; Tormos, Jose M.; Bernabeu, Montserrat			What domains of the International Classification of Functioning, Disability and Health are covered by the most commonly used measurement instruments in traumatic brain injury research?	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						ICF Core Set; Neurorehabilitation; Traumatic brain injury; Linking; Outcome measures; International classification of functioning; Disability and health	QUALITY-OF-LIFE; GLASGOW OUTCOME SCALE; ICF CORE SETS; HEAD-INJURY; RATING-SCALE; REHABILITATION; COMMUNITY; SETTINGS; RECOVERY; UPDATE	Objective: To identify the most frequently used outcome measurement instruments reported in clinical studies on TBI and to provide a content comparison in the framework of the International Classification of Functioning, Disability and Health (ICF). Patients and methods: A systematic literature review of clinical studies in TBI was performed using Medline, EMBASE and PsychINFO. The items of the measurement instruments present in more than 20% of the studies were linked to the ICF language. Results: 193 papers fulfilled the eligibility criteria. The frequency analysis identified six instruments: Functional Independence Measure (50%), Glasgow Outcome Scale (34%), Disability Rating Scale (32%), Wechsler Adult Intelligence Scale (29%), Trail Making Test (26%) and Community Integration Questionnaire (22%). The analysed instruments focus on different aspects of body functions (especially DRS, WAIS and TMT) and aspects of activities and participation in life (especially CIQ and FIM). Inter-researcher agreement for the ICF linking process was 0.83. Conclusions: Translating the items of different measurement instruments into the ICF language provides a practical tool to facilitate content comparisons among different outcome measures. The comparison can assist clinical researchers to integrate information acquired from different studies and different tools. (C) 2012 Elsevier B.V. All rights reserved.	[Laxe, Sara; Bernabeu, Montserrat] Univ Autonoma Barcelona, Brain Injury Unit, Guttmann Inst Hosp Neurorehabil, Badalona 08916, Spain; [Tschiesner, Uta] Univ Munich, Dept Otorhinolaryngol, D-80539 Munich, Germany; [Tschiesner, Uta] Univ Munich, ICF Res Branch, Dept Biopsychosocial Hlth, D-80539 Munich, Germany; [Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, VA 23233 USA; [Lopez-Blazquez, Raquel; Tormos, Jose M.] Univ Autonoma Barcelona, Res Dept, Guttmann Inst Hosp Neurorehabil, Badalona 08916, Spain		Laxe, S (corresponding author), Univ Autonoma Barcelona, Brain Injury Unit, Guttmann Inst Hosp Neurorehabil, Cami de Can Run Sn, Badalona 08916, Spain.	slaxe@guttmann.com; Uta.Tschiesner@med.uni-muenthen.de; nzasler@cccv-ltd.com; rlopez@guttmann.com; jmtormos@guttmann.com; mbernabeu@guttmann.com		Tormos Munoz, Jose Maria/0000-0002-8764-2289			Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Aringer M, 2006, LUPUS, V15, P248, DOI 10.1191/0961203306lu2298xx; Axelrod BN, 1999, J CLIN EXP NEUROPSYC, V21, P368, DOI 10.1076/jcen.21.3.368.916; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Cerniauskaite M, 2011, DISABIL REHABIL, V33, P281, DOI 10.3109/09638288.2010.529235; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Cieza A, 2009, J CLIN EPIDEMIOL, V62, P899, DOI 10.1016/j.jclinepi.2009.01.019; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Ewert T, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410015362; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Grill E, 2005, DISABIL REHABIL, V27, P361, DOI 10.1080/09638280400013974; Haigh R, 2001, J REHABIL MED, V33, P273; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC27; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Koskinen S, 2011, DISABIL REHABIL  MAY; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Laxe S, 2011, NEUROREHABILITATION, V29, P99, DOI 10.3233/NRE-2011-0683; Linden A, 2010, SCAND J OCCUP THER, V17, P267, DOI 10.3109/11038120903265022; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rauch A, 2008, EUR J PHYS REHAB MED, V44, P329; Reed GM, 2005, REHABIL PSYCHOL, V50, P122, DOI 10.1037/0090-5550.50.2.122; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN RM, 1994, J CLIN PSYCHOL, V50, P47, DOI 10.1002/1097-4679(199401)50:1<47::AID-JCLP2270500106>3.0.CO;2-X; Ryan JJ, 2006, J CLIN PSYCHOL, V62, P1319, DOI 10.1002/jclp.20307; Scarponi F, 2009, DISABIL REHABIL, V31, pS134, DOI 10.3109/09638280903317906; Schepers VPM, 2007, DISABIL REHABIL, V29, P221, DOI 10.1080/09638280600756257; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thonnard J L, 2007, Eura Medicophys, V43, P525; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Tschiesner U, 2008, EUR ARCH OTO-RHINO-L, V265, P627, DOI 10.1007/s00405-008-0641-9; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Xie F, 2007, J RHEUMATOL, V34, P2301	48	31	33	0	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2012	114	6					645	650		10.1016/j.clineuro.2011.12.038			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	969GY	WOS:000306044900021	22245447				2022-02-06	
J	Calvete, E; de Arroyabe, EL				Calvete, Esther; Lopez de Arroyabe, Elena			Depression and grief in Spanish family caregivers of people with traumatic brain injury: The roles of social support and coping	BRAIN INJURY			English	Article						Caregiver; coping; depression; distress; family; support system	NEEDS; STRESS; INDIVIDUALS; PREDICTORS; BURDEN; PERSPECTIVES; DISTRESS; OUTCOMES; DISEASE; IMPACT	Purpose: To examine the associations between social support, coping responses and depressive and grief symptoms in caregivers of people with traumatic brain injury (TBI). Methods and procedures: A cross-sectional study of Spanish primary caregivers of individuals with TBI. The study included 223 caregivers (72.2% female and 26.9% male). Main outcomes: Measures administered included the Family Needs Questionnaire, the Texas Revised Inventory of Grief, the Centre for Epidemiological Studies Depression Scale and the Responses to Stress Questionnaire. Results: A structural equation model indicated that secondary control coping (e.g. acceptance and positive thinking) was associated with less grief and depressive symptoms, whereas primary control coping (e.g. problem-solving and emotional expression) and disengagement were associated with more symptoms. Emotional and instrumental supports were directly associated with less depressive symptoms. In addition, emotional and professional supports were associated with symptoms through the use of primary control and disengagement coping. Conclusions: These results indicate that future interventions with families should improve social networks of emotional, instrumental and professional support, as well as help caregivers to develop adaptive coping strategies, such as acceptance and positive thinking.	[Calvete, Esther; Lopez de Arroyabe, Elena] Univ Deusto, Dept Personal Psychol Assessment & Treatment, Bilbao 48080, Spain		Calvete, E (corresponding author), Univ Deusto, Dept Personal Psychol Assessment & Treatment, Apdo 1, Bilbao 48080, Spain.	esther.calvete@deusto.es	Calvete, Esther/B-8418-2011	Calvete, Esther/0000-0002-6928-9557	Mapfre Foundation	This research was supported by a grant of Mapfre Foundation.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Blankfeld DF, 1999, PSYCHOL HEALTH, V14, P609, DOI 10.1080/08870449908410753; Boss P.G., 2006, LOSS TRAUMA RESILIEN; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; Calvete E, 2006, ANXIETY STRESS COPIN, V19, P47, DOI 10.1080/10615800500472963; Calvete E., 1999, AN PSICOL-SPAIN, V15, P179; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; CEADAC, DAN CER SOBR; Chan J, 2009, ADV MENT HEALTH, V8, P155, DOI 10.5172/jamh.8.2.155; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Chwalisz K, 1996, REHABIL PSYCHOL, V41, P91, DOI 10.1037/0090-5550.41.2.91; Cole DA, 2003, J ABNORM PSYCHOL, V112, P558, DOI 10.1037/0021-843X.112.4.558; Connor-Smith JK, 2004, ANXIETY STRESS COPIN, V17, P163, DOI 10.1080/10615800410001709412; Connor-Smith JK, 2000, J CONSULT CLIN PSYCH, V68, P976, DOI 10.1037/0022-006X.68.6.976; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Devany CW, 1992, ANN C REH SEV BRAIN; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Faschingbauer TR., 1981, TEXAS REVISED INVENT; Fernandez Guinea S, 1997, FAMILIAS PROCESO REH, V1; Fleishman JA, 2000, AM J COMMUN PSYCHOL, V28, P421, DOI 10.1023/A:1005132430171; Folkman S., 1984, STRESS; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gottlieb, 2000, SOCIAL SUPPORT MEASU; Harris JKJ, 2001, BRAIN INJURY, V15, P223; HOLAHAN CJ, 1987, J PERS SOC PSYCHOL, V52, P946, DOI 10.1037/0022-3514.52.5.946; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kendall E, 2008, SOC SCI MED, V67, P1217, DOI 10.1016/j.socscimed.2008.05.033; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Kreutzer JS, 1997, J HEAD TRAUMA REHAB, V12, P63, DOI 10.1097/00001199-199712000-00006; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Little TD, 2006, STRUCT EQU MODELING, V13, P59, DOI 10.1207/s15328007sem1301_3; Lopez de Arroyabe E, ANALES PSIC IN PRESS; Lopez de Arroyabe E, 2005, MAPFRE MED, V16, P266; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; Minnes P, 2000, BRAIN INJURY, V14, P737; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rokach A, 2001, SOC BEHAV PERSONAL, V29, P477, DOI 10.2224/sbp.2001.29.5.477; Sanders S, 2008, DEATH STUD, V32, P495, DOI 10.1080/07481180802138845; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Skinner EA, 2003, PSYCHOL BULL, V129, P216, DOI 10.1037/0033-2909.129.2.216; Sohlberg MM, 2001, J HEAD TRAUMA REHAB, V16, P498, DOI 10.1097/00001199-200110000-00008; Triandis H. C, 1995, INDIVIDUALISM COLLEC; Uchino B. N., 2004, SOCIAL SUPPORT PHYS; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303; Zinner ES, 1997, ARCH CLIN NEUROPSYCH, V12, P435, DOI 10.1016/S0887-6177(96)00034-0	69	31	32	0	29	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2012	26	6					834	843		10.3109/02699052.2012.655363			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500005	22583174				2022-02-06	
J	Kenning, TJ; Gooch, MR; Gandhi, RH; Shaikh, MP; Boulos, AS; German, JW				Kenning, Tyler J.; Gooch, M. Reid; Gandhi, Ravi H.; Shaikh, M. Parvez; Boulos, Alan S.; German, John W.			Cranial decompression for the treatment of malignant intracranial hypertension after ischemic cerebral infarction: decompressive craniectomy and hinge craniotomy	JOURNAL OF NEUROSURGERY			English	Article						craniectomy; hinge craniotomy; cerebral decompression; intracranial hypertension; malignant cerebral infarction; traumatic brain injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; ARTERY INFARCTION; STROKE SURVIVORS; HEMICRANIECTOMY; COMPLICATIONS; DETERMINANTS; MULTICENTER; CAREGIVERS; SURGERY	Object. Recent randomized trials have demonstrated a positive role (improved survival) in patients treated with cranial decompression for malignant cerebral infarction. However, many variables regarding operative decompression in this setting remain to be determined. Hinge craniotomy is an alternative to decompressive craniectomy, but its role in space-occupying cerebral infarctions has not been delineated. The objective of this study was to compare the authors' experiences with these 2 procedures in the management of space-occupying cerebral infarctions to determine the efficacy of each. Methods. The authors conducted a retrospective review of 28 cases involving patients who underwent cranial decompression (hinge craniotomy in 9 cases, decompressive craniectomy in 19) for treatment of malignant intracranial hypertension after ischemic cerebral infarction. Results. No significant differences were identified in baseline demographics, neurological examination, or Rotterdam score between the hinge craniotomy and decompressive craniectomy groups. Both treatments resulted in adequate control of intracranial pressure (ICP). The need for reoperation for persistent intracranial hypertension and duration of mechanical ventilation and intensive care unit stay were similar. Hospital survival was significantly higher in the decompressive craniectomy group (89% vs 56%), whereas long-term functional outcome was better in the hinge craniotomy group. Cranial defect size was comparable in the 2 groups. Postoperative imaging revealed a higher rate of subarachnoid hemorrhage, contusion/hematoma progression, and subdural effusions/hygromas after decompressive craniectomy. The requirement for cranial revision in survivors was higher for patients undergoing decompressive craniectomy (100%) than those undergoing hinge craniotomy (20%). Conclusions. Hinge craniotomy appears to be at least as good as decompressive craniectomy in providing postoperative ICP control at a similar therapeutic index. Although the in-hospital mortality was higher in patients treated with hinge craniotomy, that procedure resulted in superior long-term functional outcomes and may help limit postoperative complications. (http://thejns.org/doi/abs/10.3171/2012.2.JNS111772)	[Kenning, Tyler J.] Thomas Jefferson Univ Hosp, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Gooch, M. Reid; Gandhi, Ravi H.; Shaikh, M. Parvez; Boulos, Alan S.; German, John W.] Albany Med Ctr, Div Neurosurg, Albany, NY USA		Kenning, TJ (corresponding author), Thomas Jefferson Univ Hosp, Dept Neurosurg, 909 Walnut St,2nd Floor, Philadelphia, PA 19107 USA.	tyler.kenning@jeffersonhospital.org					Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Benejam B, 2009, J NEUROL, V256, P1126, DOI 10.1007/s00415-009-5083-9; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Foerch C, 2004, J NEUROSURG, V101, P248, DOI 10.3171/jns.2004.101.2.0248; Goettler CE, 2007, J TRAUMA, V62, P777, DOI 10.1097/TA.0b013e31802ee55e; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Green Theresa L, 2010, Can J Neurosci Nurs, V32, P24; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; JENNETT B, 1975, LANCET, V1, P480; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; Nakagawa K, 2010, NEUROCRIT CARE, V13, P118, DOI 10.1007/s12028-010-9340-7; Rigby H, 2009, INT J STROKE, V4, P152, DOI 10.1111/j.1747-4949.2009.00287.x; Saban KL, 2010, J NEUROSCI NURS, V42, P128, DOI 10.1097/JNN.0b013e3181d4a3ee; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wang HK, 2010, INJURY	26	31	32	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	2012	116	6					1289	1298		10.3171/2012.2.JNS111772			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	945RP	WOS:000304294000023	22462506				2022-02-06	
J	Min, KJ; Jeong, HK; Kim, B; Hwang, DH; Shin, HY; Nguyen, AT; Kim, JH; Jou, I; Kim, BG; Joe, EH				Min, Kyoung-Jin; Jeong, Hey-Kyeong; Kim, Beomsue; Hwang, Dong Hoon; Shin, Hae Young; An Tran Nguyen; Kim, Jong-hyeon; Jou, Ilo; Kim, Byung G.; Joe, Eun-hye			Spatial and temporal correlation in progressive degeneration of neurons and astrocytes in contusion-induced spinal cord injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Microglia; Monocytes; Astrocytes; Spinal cord injury; Secondary injury	GLUTAMATE TRANSPORTERS; MICROGLIAL CELLS; NITRIC-OXIDE; CULTURED ASTROCYTES; HUNTINGTONS-DISEASE; NEUROTROPHIC FACTOR; INFLAMMATORY CELLS; AMINO-ACIDS; MOUSE MODEL; RAT-BRAIN	Background: Traumatic spinal cord injury (SCI) causes acute neuronal death followed by delayed secondary neuronal damage. However, little is known about how microenvironment regulating cells such as microglia, astrocytes, and blood inflammatory cells behave in early SCI states and how they contribute to delayed neuronal death. Methods: We analyzed the behavior of neurons and microenvironment regulating cells using a contusion-induced SCI model, examining early (3-6 h) to late times (14 d) after the injury. Results: At the penumbra region close to the damaged core (P1) neurons and astrocytes underwent death in a similar spatial and temporal pattern: both neurons and astrocytes died in the medial and ventral regions of the gray matter between 12 to 24 h after SCI. Furthermore, mRNA and protein levels of transporters of glutamate (GLT-1) and potassium (Kir4.1), functional markers of astrocytes, decreased at about the times that delayed neuronal death occurred. However, at P1 region, ramified Iba-1(+) resident microglia died earlier (3 to 6 h) than neurons (12 to 24 h), and at the penumbra region farther from the damaged core (P2), neurons were healthy where microglia were morphologically activated. In addition, round Iba-1/CD45-double positive monocyte-like cells appeared after neurons had died, and expressed phagocytic markers, including mannose receptors, but rarely expressed proinflammatory mediators. Conclusion: Loss of astrocyte function may be more critical for delayed neuronal death than microglial activation and monocyte infiltration.	[Min, Kyoung-Jin; Jeong, Hey-Kyeong; Kim, Beomsue; An Tran Nguyen; Kim, Jong-hyeon; Jou, Ilo; Joe, Eun-hye] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 442721, Kyunggi Do, South Korea; [Jeong, Hey-Kyeong; Shin, Hae Young; Kim, Jong-hyeon; Jou, Ilo; Kim, Byung G.; Joe, Eun-hye] Ajou Univ, Sch Med, Neurosci Grad Program, Suwon 442721, Kyunggi Do, South Korea; [Hwang, Dong Hoon; Shin, Hae Young; Kim, Byung G.] Ajou Univ, Sch Med, Inst Med Sci, Suwon 442721, Kyunggi Do, South Korea; [Kim, Byung G.; Joe, Eun-hye] Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 442721, Kyunggi Do, South Korea; [Jou, Ilo; Kim, Byung G.; Joe, Eun-hye] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 442721, Kyunggi Do, South Korea		Joe, EH (corresponding author), Ajou Univ, Sch Med, Dept Pharmacol, San 5 Woncheon Dong, Suwon 442721, Kyunggi Do, South Korea.	ehjoe@ajou.ac.kr	Kim, Beomsue/X-3045-2019; Kim, Byung Gon/L-6884-2019	Kim, Beomsue/0000-0003-1207-7876; Kim, Byung Gon/0000-0003-2233-9569	KOSEF NRL Program grant; Korean government (MEST)Ministry of Education, Science and Technology, Republic of KoreaKorean Government [2-2008025-0]; Brain Research Center of the 21st Century Frontier Research ProgramMinistry of Education, Science and Technology, Republic of Korea [M103KV010011-06K2201-01110]; Ministry of Science and Technology, Republic of KoreaMinistry of Science and Technology (MOST) Korea; KOSEF grant through the Chronic Inflammatory Disease Research Center (CIDRC) at Ajou University [R13-2003-019]	This work was supported by a KOSEF NRL Program grant funded by the Korean government (MEST, 2-2008025-0), a grant (M103KV010011-06K2201-01110) from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea, and a KOSEF grant through the Chronic Inflammatory Disease Research Center (CIDRC) at Ajou University (R13-2003-019) to E Joe.	Adachi K, 2005, NEUROSCI RES, V51, P73, DOI 10.1016/j.neures.2004.10.007; Arzberger T, 1997, J NEUROPATH EXP NEUR, V56, P440, DOI 10.1097/00005072-199704000-00013; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bao F, 2006, NEUROSCIENCE, V140, P1011, DOI 10.1016/j.neuroscience.2006.02.061; Bao F, 2009, EXP NEUROL, V215, P308, DOI 10.1016/j.expneurol.2008.10.022; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; CHAO CC, 1992, J IMMUNOL, V149, P2736; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1987, J NEUROSCI, V7, P357; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davies SJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017328; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Elkabes S, 1996, J NEUROSCI, V16, P2508; Ermakova IV, 2005, B EXP BIOL MED+, V140, P677, DOI 10.1007/s10517-006-0052-0; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gegelashvili G, 1998, BRAIN RES BULL, V45, P233, DOI 10.1016/S0361-9230(97)00417-6; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; HERTZ L, 1978, BRAIN RES, V145, P202, DOI 10.1016/0006-8993(78)90812-0; HOLNESS CL, 1993, BLOOD, V81, P1607; Jeong HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013756; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kaiser M, 2006, J NEUROCHEM, V99, P900, DOI 10.1111/j.1471-4159.2006.04131.x; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Kim HM, 2011, GLIA, V59, P1094, DOI 10.1002/glia.21182; Kim JH, 2010, J NEUROCHEM, V115, P1161, DOI 10.1111/j.1471-4159.2010.07004.x; Koennecke LA, 1999, J NEUROCHEM, V73, P770, DOI 10.1046/j.1471-4159.1999.0730770.x; Kuhn PL, 1998, J NEUROTRAUM, V15, P125, DOI 10.1089/neu.1998.15.125; Lee D, 2005, GLIA, V51, P98, DOI 10.1002/glia.20190; Lee SM, 2011, J NEUROTRAUM, V28, P1893, DOI 10.1089/neu.2011.1860; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lehrmann E, 1998, GLIA, V24, P437, DOI 10.1002/(SICI)1098-1136(199812)24:4<437::AID-GLIA9>3.0.CO;2-X; Lepore AC, 2011, GLIA, V59, P1996, DOI 10.1002/glia.21241; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsumoto H, 2007, J NEUROSCI RES, V85, P994, DOI 10.1002/jnr.21198; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; MULLER HW, 1982, J NEUROSCI RES, V8, P195, DOI 10.1002/jnr.490080209; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Olsen ML, 2006, GLIA, V53, P516, DOI 10.1002/glia.20312; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; RONG H, 1993, BRAIN RES, V618, P346, DOI 10.1016/0006-8993(93)91289-5; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rozengurt N, 2003, HEARING RES, V177, P71, DOI 10.1016/S0378-5955(02)00799-2; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Speake T, 2001, MICROSC RES TECHNIQ, V52, P49, DOI 10.1002/1097-0029(20010101)52:1<49::AID-JEMT7>3.0.CO;2-C; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Takahashi S, 1999, EUR J PHARMACOL, V372, P297, DOI 10.1016/S0014-2999(99)00208-3; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Yawata I, 2008, LIFE SCI, V82, P1111, DOI 10.1016/j.lfs.2008.03.010; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; YOUNG W, 1982, BRAIN RES, V253, P115, DOI 10.1016/0006-8993(82)90678-3	68	31	33	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAY 25	2012	9								100	10.1186/1742-2094-9-100			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	993JQ	WOS:000307855300001	22632146	Green Published, gold			2022-02-06	
J	Gutierrez-Colina, AM; Topjian, AA; Dlugos, DJ; Abend, NS				Gutierrez-Colina, Ana M.; Topjian, Alexis A.; Dlugos, Dennis J.; Abend, Nicholas S.			Electroencephalogram Monitoring in Critically Ill Children: Indications and Strategies	PEDIATRIC NEUROLOGY			English	Article							INTENSIVE-CARE-UNIT; NONCONVULSIVE STATUS EPILEPTICUS; HYPOTHERMIC CIRCULATORY ARREST; TRAUMATIC BRAIN-INJURY; ELECTROGRAPHIC SEIZURES; NEONATAL SEIZURES; EEG; PREDICTORS	Continuous electroencephalographic monitoring often detects nonconvulsive seizures in critically ill children, but it is resource-intense and has not been demonstrated to improve outcomes. As institutions develop clinical pathways for monitoring, they should consider how seemingly minor variations may exert substantial impacts on resource utilization and cost. In our 1-month prospective observational study, each patient in a 45-bed pediatric intensive care unit was screened for potential monitoring indications. We screened 247 patients. Minor differences in monitoring indications would exert substantial impact on resource utilization. We then calculated the number of monitoring days required each month, based on two strategies that differed in monitoring duration. The prolonged-targeted and brief-targeted strategies would have required 106 and 33 monitoring days, respectively. Based on nonconvulsive seizure occurrence data, these strategies would detect 0.14, and 0.43 patients with seizures per monitoring day performed, respectively. A brief-targeted strategy provides a high yield for nonconvulsive seizure identification, but would fail to diagnose some patients with seizures. (C) 2012 Elsevier Inc. All rights reserved.	[Gutierrez-Colina, Ana M.; Dlugos, Dennis J.; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Topjian, Alexis A.] Childrens Hosp Philadelphia, Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA; [Dlugos, Dennis J.; Abend, Nicholas S.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Dlugos, Dennis J.; Abend, Nicholas S.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA		Abend, NS (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, 3501 Civ Ctr Blvd,Colket Translat Res Bldg,10th F, Philadelphia, PA 19104 USA.	abend@email.chop.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS049453]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS076550, K12NS049453] Funding Source: NIH RePORTER	N.S.A. received support from a National Institutes of Health Neurological Sciences Academic Development Award (NS049453).	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2007, PEDIATR NEUROL, V37, P165, DOI 10.1016/j.pediatrneurol.2007.05.012; Abend NS, 2011, NEUROCRIT CARE, V15, P70, DOI 10.1007/s12028-010-9380-z; Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Alehan FK, 2001, J CHILD NEUROL, V16, P484, DOI 10.2310/7010.2001.17060; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Carrera E, 2008, ARCH NEUROL-CHICAGO, V65, P1612, DOI 10.1001/archneur.65.12.1612; Chock VY, 2006, J PERINATOL, V26, P237, DOI 10.1038/sj.jp.7211459; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Clancy RR, 2005, EPILEPSIA, V46, P84, DOI 10.1111/j.0013-9580.2005.22504.x; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gaynor JW, 2005, J THORAC CARDIOV SUR, V130, P1278, DOI 10.1016/j.jtcvs.2005.02.065; Helmers SL, 1997, ELECTROEN CLIN NEURO, V102, P27, DOI 10.1016/S0013-4694(96)95079-8; Hosain SA, 2005, PEDIATR NEUROL, V32, P162, DOI 10.1016/j.pediatrneurol.2004.09.008; Hyllienmark L, 2007, EUR J PAEDIATR NEURO, V11, P70, DOI 10.1016/j.ejpn.2006.11.005; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; McBride MC, 2000, NEUROLOGY, V55, P506, DOI 10.1212/WNL.55.4.506; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Pisani F, 2007, NEUROLOGY, V69, P2177, DOI 10.1212/01.wnl.0000295674.34193.9e; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Saengpattrachai M, 2006, EPILEPSIA, V47, P1510, DOI 10.1111/j.1528-1167.2006.00624.x; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; Young GB, 1996, NEUROLOGY, V47, P83	31	31	31	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	MAR	2012	46	3					158	161		10.1016/j.pediatrneurol.2011.12.009			4	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	902JU	WOS:000301035200004	22353290	Green Accepted			2022-02-06	
J	Siopi, E; Calabria, S; Plotkine, M; Marchand-Leroux, C; Jafarian-Tehrani, M				Siopi, Eleni; Calabria, Silvia; Plotkine, Michel; Marchand-Leroux, Catherine; Jafarian-Tehrani, Mehrnaz			Minocycline Restores Olfactory Bulb Volume and Olfactory Behavior after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						minocycline; neuroprotection; olfactory avoidance test; olfactory bulb lesion; traumatic brain injury	POSTTRAUMATIC ANOSMIA; HEAD TRAUMA; MICROGLIAL ACTIVATION; STEROID TREATMENT; DYSFUNCTION; INFLAMMATION; SMELL; NEUROGENESIS; INFORMATION; MECHANISMS	Permanent olfactory dysfunction can often arise after traumatic brain injury (TBI) and while one of the main causes is the immediate loss of neurons in the olfactory bulb (OB), the emergent neuroinflammatory environment following TBI may further promote OB deterioration. Therefore, we examined the effects of acute antiinflammatory treatment with minocycline on post-TBI olfactory behavior and on OB surface. The mouse model of closed-head injury by mechanical percussion was applied to anesthetized Swiss mice. The treatment protocol included three injections of minocycline (i.p.) at 5 min (90 mg/kg), 3 h, and 9 h (45 mg/kg) post-TBI. An olfactory avoidance test was run up to 12 weeks post-TBI. The mice were then sacrificed and their OB surface was measured. Our results demonstrated a post-TBI olfactory behavior deficit that was significant up to at least 12 weeks post-TBI. Additionally, substantial post-TBI OB atrophy was observed that was strongly correlated with the behavioral impairment. Minocycline was able to attenuate both the olfactory lesions and corresponding functional deficit in the short and long term. These results emphasize the potential role of minocycline as a promising neuroprotective agent for the treatment of TBI-related olfactory bulb lesions and deficits.	[Siopi, Eleni; Calabria, Silvia; Plotkine, Michel; Marchand-Leroux, Catherine; Jafarian-Tehrani, Mehrnaz] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharmacol Circulat Cerebrale EA 4475, F-75006 Paris, France		Jafarian-Tehrani, M (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharmacol Circulat Cerebrale EA 4475, Sorbonne Paris Cite,4 Ave Observ, F-75006 Paris, France.	mehrnaz.jafarian@parisdescartes.fr	MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Jafarian-Tehrani, Mehrnaz/0000-0001-6895-5856	nonprofit organization Fondation des Gueules Cassees	This work was supported by the nonprofit organization Fondation des Gueules Cassees (grants to E.S. and M.J.T.).	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Collet S, 2009, B-ENT, P97; Doty RL, 2001, ANNU REV PSYCHOL, V52, P423, DOI 10.1146/annurev.psych.52.1.423; Doty RL, 1997, NEW ENGL J MED, V336, P1918, DOI 10.1056/NEJM199706263362617; Drummond M., 2007, BRAIN IMPAIR, V8, P31; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Familian A, 2006, GLIA, V53, P233, DOI 10.1002/glia.20268; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hebb ALO, 2002, NEUROPSYCHOPHARMACOL, V27, P744, DOI 10.1016/S0893-133X(02)00354-8; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Ikeda K, 1995, TOHOKU J EXP MED, V177, P343, DOI 10.1620/tjem.177.343; Jiang RS, 2010, EUR ARCH OTO-RHINO-L, V267, P1563, DOI 10.1007/s00405-010-1240-0; Jimenez D F, 1997, J Craniomaxillofac Trauma, V3, P8; Joung YI, 2007, J KOREAN NEUROSURG S, V42, P1; Kang HM, 2010, NEUROREPORT, V21, P179, DOI 10.1097/WNR.0b013e328334884c; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kobayashi M, 2009, CHEM SENSES, V34, P573, DOI 10.1093/chemse/bjp038; LEGG JW, 1873, LANCET, V2, P659, DOI DOI 10.1016/S0140-6736(02)66313-5; London B, 2008, ANN NEUROL, V63, P159, DOI 10.1002/ana.21293; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MOTT AE, 1991, MED CLIN N AM, V75, P1321, DOI 10.1016/S0025-7125(16)30391-1; Mucignat-Caretta C, 2004, NEUROBIOL DIS, V16, P386, DOI 10.1016/j.nbd.2004.03.007; Mucignat-Caretta C, 2006, PHYSIOL BEHAV, V89, P637, DOI 10.1016/j.physbeh.2006.08.003; NYBY J, 1985, J COMP PSYCHOL, V99, P479, DOI 10.1037/0735-7036.99.4.479; Ogawa T, 1999, ACTA OTO-LARYNGOL, P50; Ongle W., 1870, MED CHIR T, V53, P263; Prediger R.D., 2011, J NEURAL TRANSM; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; SLOTNICK BM, 1977, J COMP PHYSIOL PSYCH, V91, P942, DOI 10.1037/h0077370; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wachowiak M, 2009, ANN NY ACAD SCI, V1170, P286, DOI 10.1111/j.1749-6632.2009.04015.x; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	54	31	32	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					354	361		10.1089/neu.2011.2055			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300014	21910642				2022-02-06	
J	Epstein, DR; Babcock-Parziale, JL; Haynes, PL; Herb, CA				Epstein, Dana R.; Babcock-Parziale, Judith L.; Haynes, Patricia L.; Herb, Christine A.			Insomnia treatment acceptability and preferences of male Iraq and Afghanistan combat Veterans and their healthcare providers	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						cognitive-behavioral treatment; healthcare providers; insomnia; OIF/OEF Veterans; pharmacotherapy; polytrauma; sleep; traumatic brain injury; treatment acceptability; treatment preference	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; SLEEP DISTURBANCE; INVENTORY-II; DEPRESSION; INTERVENTION; NIGHTMARES; EFFICACY	Sleep difficulty is a prevalent problem among returning Veterans. Although there is strong evidence for the efficacy and durability of cognitive-behavioral treatment for insomnia (CBT-I) in the general population, the interventions require motivation, attention, and adherence from patients to achieve successful outcomes. Given the unique characteristics of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans who have experienced blast-related injuries and other trauma, CBT-I for these patients may require modification, including alternative delivery methods, to ensure effective implementation and positive outcomes. We interviewed 18 OIF/OEF Veterans who screened positive for mild traumatic brain injury and 19 healthcare providers to determine the acceptability of insomnia treatments and preferences for the interventions and treatment delivery. Veterans and providers had distinct preferences for insomnia treatment and its delivery. The treatments the Veterans found most acceptable were also the ones they preferred: relaxation treatment and pharmacotherapy. The providers identified relaxation therapy as the most acceptable treatment. Veterans preferred the individual treatment format as well as electronic methods of treatment delivery. Despite some differences between patients and providers, a compromise through modification of empirically supported behavioral treatments is feasible, and implications for preference-based insomnia intervention development and testing are discussed.	[Epstein, Dana R.; Herb, Christine A.] Phoenix Dept Vet Affairs VA Hlth Care Syst, Phoenix, AZ USA; [Epstein, Dana R.] Arizona State Univ, Phoenix, AZ USA; [Babcock-Parziale, Judith L.; Haynes, Patricia L.] Southern Arizona VA Healthcare Syst, Tucson, AZ USA; [Haynes, Patricia L.] Univ Arizona, Tucson, AZ USA		Epstein, DR (corresponding author), Phoenix VA Hlth Care Syst, 650 Indian Sch Rd RS-151, Phoenix, AZ 85012 USA.	dana.epstein@va.gov			VA Health Services Research and Development's Quality Enhancement Research Initiative (QUERI) [RRP 07-309]	This material was based on work supported by the VA Health Services Research and Development's Quality Enhancement Research Initiative (QUERI) (grant RRP 07-309).	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bootzin RR, 2011, ANNU REV CLIN PSYCHO, V7, P435, DOI 10.1146/annurev.clinpsy.3.022806.091516; Bootzin RR., 1978, PROGR BEHAV MODIFICA, P1; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; Calohan J, 2010, J TRAUMA STRESS, V23, P645, DOI 10.1002/jts.20570; Carter PA, 2006, CANCER NURS, V29, P95, DOI 10.1097/00002820-200603000-00003; Cook JM, 2010, J TRAUMA STRESS, V23, P553, DOI 10.1002/jts.20569; Edinger JD, 2007, SLEEP, V30, P203, DOI 10.1093/sleep/30.2.203; Edinger JD, 2003, SLEEP, V26, P177, DOI 10.1093/sleep/26.2.177; Epstein D, 2009, SLEEP, V32, pA272; Erbes CR, 2009, PSYCHOL SERV, V6, P175, DOI 10.1037/a0016662; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Goodie JL, 2009, J CLIN PSYCHOL, V65, P294, DOI 10.1002/jclp.20548; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jungquist CR, 2010, SLEEP MED, V11, P302, DOI 10.1016/j.sleep.2009.05.018; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; McCrae CS, 2007, AM J GERIAT PSYCHIAT, V15, P979, DOI 10.1097/JGP.0b013e31813547e6; Moldofsky H, 2001, SLEEP MED REV, V5, P387, DOI 10.1053/smrv.2001.0179; Morin CM, 2006, SLEEP MED, V7, pS15, DOI 10.1016/j.sleep.2006.03.005; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; MORIN CM, 1992, SLEEP, V15, P302, DOI 10.1093/sleep/15.4.302; National Center for PTSD, 2007, PTSD CHECKL PCL; National Institutes of Health, 2005, SLEEP, V28, P1049; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ong J, 2010, J CLIN PSYCHOL, V66, P1175, DOI 10.1002/jclp.20736; Ong JC, 2008, BEHAV THER, V39, P171, DOI 10.1016/j.beth.2007.07.002; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sidani S, 2006, WORLDV EVID-BASED NU, V3, P116, DOI 10.1111/j.1741-6787.2006.00060.x; Sidani S, 2009, RES NURS HEALTH, V32, P419, DOI 10.1002/nur.20329; Smith S, 2001, J SLEEP RES, V10, P229, DOI 10.1046/j.1365-2869.2001.00262.x; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Spielman AJ, 2010, MED PSYCHIATRY, P277; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Ulmer CS, 2011, J CLIN SLEEP MED, V7, P57; Vincent N, 2001, SLEEP, V24, P411, DOI 10.1093/sleep/24.4.411; Zayfert C, 2004, J TRAUMA STRESS, V17, P69, DOI 10.1023/B:JOTS.0000014679.31799.e7	54	31	32	0	11	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	6					867	878		10.1682/JRRD.2011.06.0114			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EX	WOS:000319302900005	23299258	Bronze			2022-02-06	
J	Nayil, K; Ramzan, A; Sajad, A; Zahoor, S; Wani, A; Nizami, F; Laharwal, M; Kirmani, A; Bhat, R				Nayil, Khursheed; Ramzan, Altaf; Sajad, Arif; Zahoor, Sheikh; Wani, Abrar; Nizami, Furqan; Laharwal, Masood; Kirmani, Altaf; Bhat, Rashid			Subdural Hematomas: An Analysis of 1181 Kashmiri Patients	WORLD NEUROSURGERY			English	Article						Head injury; Subdural empyema; Subdural hematoma	CLOSED-SYSTEM DRAINAGE; BURR-HOLE CRANIOSTOMY; SURGICAL-TREATMENT; RECURRENCE; HEMORRHAGE; CRANIOTOMY; SURGERY; SERIES; ADULTS	BACKGROUND: We endeavored to analyze patients of subacute and chronic subdural hematomas studied in a 4-year period at the Sher-i-Kashmir Institute of Medical Sciences, Kashmir, India. METHODS: The study was a retrospective analysis of 1181 patients of subdural hematomas. Demographic characteristics, clinico-radiologic features, operative modalities, and outcome were studied. Acute subdural hematomas were excluded from the study. RESULTS: The mean age was 60.4 +/- 12.4 and males outnumbered females. Chronic subdural collections were more common than subacute subdural hematomas and left side predominated. Two burr holes with closed-system drainage was used in most patients. Incidence of postoperative seizures is very low. Overall recurrence rates were low; however, multilocular hematomas had the highest incidence of recurrence. Morbidity and mortality were 7.53% and 2.96%, respectively. Preoperative neurologic grade correlated with outcome. CONCLUSIONS: Subdural hematomas are common in elderly males. Preoperative neurologic grade dictates the outcome. Multilocular hematomas have a higher chance of recurrence. Craniotomy should be reserved for recurrent hematomas, and there may be a scope of craniotomy for multilocular chronic subdural hematomas at the outset. Antiepileptic prophylaxis is not routinely recommended.	[Nayil, Khursheed; Ramzan, Altaf; Sajad, Arif; Zahoor, Sheikh; Wani, Abrar; Nizami, Furqan; Laharwal, Masood; Kirmani, Altaf; Bhat, Rashid] Sherikashmir Inst Med Sci, Dept Neurosurg, Kashmir, India		Nayil, K (corresponding author), Sherikashmir Inst Med Sci, Dept Neurosurg, Kashmir, India.	nkhursh@rediffmail.com					Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; BROTT T, 1994, STROKE, V25, P1122, DOI 10.1161/01.STR.25.6.1122; DESTANDAU J, 1987, NEUROCHIRURGIE, V33, P17; Diaz P, 2003, NEUROCIRUGIA, V14, P333; Drapkin AJ, 1997, SURG NEUROL, V48, P427, DOI 10.1016/S0090-3019(97)00211-5; Foerch C, 2005, LANCET, V366, P392, DOI 10.1016/S0140-6736(05)67024-9; Gastone P, 2004, NEUROL INDIA, V52, P475; Gazzeri R, 2007, ACTA NEUROCHIR, V149, P487, DOI 10.1007/s00701-007-1139-8; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; GRISOLI F, 1988, NEUROSURGERY, V23, P616, DOI 10.1227/00006123-198811000-00012; Gruber DP, 1997, PEDIATR NEUROSURG, V27, P292, DOI 10.1159/000121273; HAMILTON MG, 1993, NEUROSURGERY, V33, P67; Horn EM, 2006, SURG NEUROL, V65, P150, DOI 10.1016/j.surneu.2005.05.030; JENNETT B, 1975, LANCET, V1, P480; KOTWICA Z, 1991, British Journal of Neurosurgery, V5, P461, DOI 10.3109/02688699108998474; Kuroki T, 2001, ACTA NEUROCHIR, V143, P1041, DOI 10.1007/s007010170010; Kwon TH, 2000, J NEUROSURG, V93, P796, DOI 10.3171/jns.2000.93.5.0796; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; MacFarlane MR, 2009, J CLIN NEUROSCI, V16, P642, DOI 10.1016/j.jocn.2008.07.074; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Markwalder TM, 1975, ACTA NEUROCHIR WIEN, V79, P623; Matsumoto K, 1999, NEUROL RES, V21, P277, DOI 10.1080/01616412.1999.11740931; Mellergard P, 1996, ACTA NEUROCHIR, V138, P708, DOI 10.1007/BF01411476; Misra M, 1996, SURG NEUROL, V46, P378, DOI 10.1016/S0090-3019(96)00188-7; Mohamed EEHH, 2003, BRIT J NEUROSURG, V17, P244, DOI 10.1080/0268869031000153134; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Muzii V F, 2005, J Neurosurg Sci, V49, P41; Osborn AG, 1994, DIAGNOSTIC NEURORADI, P205; Rai P K, 2006, J Assoc Physicians India, V54, P665; Ratilal B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004893.pub2; RICHTER HP, 1984, ACTA NEUROCHIR, V71, P179, DOI 10.1007/BF01401313; ROHDE V, 2001, NEUROSURG REV, V69, P40; Sambasivan M, 1997, SURG NEUROL, V47, P418, DOI 10.1016/S0090-3019(97)00188-2; Smely C, 1997, ACTA NEUROCHIR, V139, P818, DOI 10.1007/BF01411399; Stanisic M, 1997, ACTA NEUROCHIR WIEN, V147, P1249; STROOBANDT G, 1995, ACTA NEUROCHIR, V137, P6, DOI 10.1007/BF02188772; Suzuki M, 1998, ACTA NEUROCHIR, V140, P51, DOI 10.1007/s007010050057; Trotter W, 1914, BRIT J SURG, V2, P271, DOI 10.1002/bjs.1800020608; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; WEISSE A, 1994, ACTA NEUROCHIR, V127, P37, DOI 10.1007/BF01808544; Wilkins RH, 1995, NEUROSURGERY, V2; Yoshimoto Y, 1997, BRIT J NEUROSURG, V11, P150; Zumofen D, 2009, NEUROSURGERY, V64, P1116, DOI 10.1227/01.NEU.0000345633.45961.BB	44	31	31	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2012	77	1					103	110		10.1016/j.wneu.2011.06.012			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	919DD	WOS:000302300300036	22405391				2022-02-06	
J	Tyerman, A				Tyerman, Andy			Vocational rehabilitation after traumatic brain injury: Models and services	NEUROREHABILITATION			English	Article						Brain injury; return to work; vocational rehabilitation models	QUALITY-OF-LIFE; FOLLOW-UP; COMMUNITY INTEGRATION; SUPPORTED EMPLOYMENT; PROGNOSTIC-FACTORS; SOCIAL-ADJUSTMENT; JOB PLACEMENT; HEAD-INJURY; WORK; RETURN	Background: A recent systematic review suggests that around 40% of people with traumatic brain injury (TBI) return to work (RTW). Yet in the UK currently only a small minority of people with TBI receive vocational rehabilitation (VR) to enable a RTW. Agencies with an interest in developing such services are likely to favour different models of VR. Objective: The primary objective of this paper was to review models of specialist VR after TBI and their outcomes to inform service development across relevant agencies. Method: A literature review on VR after TBI was undertaken in MEDLINE, EMBASE and PsychINFO (from 1967 to date). Papers reporting models of VR were selected for more detailed consideration. Results: Illustrative examples of VR models are outlined: brain injury rehabilitation programmes with added VR elements, VR models adapted for TBI, case coordination/resource facilitation models, and consumer-directed models. Models differ, both within and across these four broad categories, in provision of core TBI rehabilitation, work preparation, work trials and supported placements. Methodological variation limits direct comparison of outcomes across models with few comparative or controlled studies. Conclusions: There is evidence to support the benefits of a wide range of models of specialist VR after TBI. However, there remains a need for controlled studies to inform service development and more evidence on cost-effectiveness to inform funding decisions.	Camborne Ctr, Community Head Injury Serv, Aylesbury HP21 7ET, Bucks, England		Tyerman, A (corresponding author), Camborne Ctr, Community Head Injury Serv, Jansel Sq, Aylesbury HP21 7ET, Bucks, England.	andy.tyerman@buckspct.nhs.uk					Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Bjorkdahl A, 2010, BRAIN INJURY, V24, P1061, DOI 10.3109/02699052.2010.494588; BritishPsychological Society, 2005, CLIN NEUR REH SERV A; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Buffington ALH, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199710000-00002; Coetzer B R, 2002, Aust J Rural Health, V10, P229, DOI 10.1046/j.1440-1584.2002.00425.x; Conder R L, 1989, Brain Inj, V3, P1, DOI 10.3109/02699058909008067; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; Department of Health, 2005, NAT SERV FRAM LONG T; DESHPANDE P, 2004, SURVEY VOCATIONAL RE, P35; DEVANEY CW, 1991, J HEAD TRAUMA REHAB, V6, P59; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Haffey W.J., 1991, J HEAD TRAUMA REHAB, V6, P24; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hirsh A, 1996, J VOCAT REHABIL, V7, P217; Jacobs H. E., 1996, J VOCATIONAL REHABIL, V7, P169, DOI DOI 10.1016/1052-2263(96)00219-X; Jacobs HE, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199710000-00003; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Johnson R, 1987, Int Disabil Stud, V9, P49; Johnson R, 1998, NEUROPSYCHOL REHABIL, V8, P61, DOI 10.1080/713755552; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Johnstone B, 2006, NEUROREHABILITATION, V21, P335; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Kolakowsky-Hayner SA, 2001, NEUROREHABILITATION, V16, P41; Kregel J, 1994, NeuroRehabilitation, V4, P1, DOI 10.3233/NRE-1994-4103; Kreutzer J.S., 2000, COMMUNITY INTEGRATIO, pXIII; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; Meehan M., 2010, VOCATIONAL ASSESSMEN; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; Niemeier JP, 2010, J VOCAT REHABIL, V33, P167, DOI 10.3233/JVR-2010-0525; O'Brien L, 2007, BRAIN INJURY, V21, P465, DOI 10.1080/02699050701315134; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; O'Neill JH, 2004, ARCH PHYS MED REHAB, V85, pS68, DOI 10.1016/j.apmr.2003.08.114; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; PARENTE R, 1996, J VOCATIONAL REHABIL, V7, P181; Phillips J, 2010, BRIT J OCCUP THER, V73, P422, DOI 10.4276/030802210X12839367526138; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Radford K., 2011, RETURN WORK TRAUMATI; ROESSLER RT, 1992, J REHABIL, V58, P17; ROSENBAUM M, 1978, SCAND J REHABIL MED, V10, P1; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; TEASDALE TW, 1993, BRAIN INJURY, V7, P535, DOI 10.3109/02699059309008181; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; TURNERSTOKES L, 2003, REHABILITATION FOLLO; Tyerman A, 2008, PROCEEDINGS OF THE 16TH EUROPEAN CONGRESS OF PHYSICAL AND REHABILITATION MEDICINE, P269; Tyerman A., 1999, J APPL OCCUP PSYCHOL, V2, P31; Tyerman A., 2000, J APPL OCCUPATIONAL, V2, P13; Tyerman A, 2004, VOCATIONAL ASSESSMEN; Tyerman A., 2008, PSYCHOL APPROACHES R, P376; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Wall JR, 1998, NEUROREHABILITATION, V10, P39, DOI 10.3233/NRE-1998-10105; Wall JR, 1998, BRAIN INJURY, V12, P215; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; WEHMAN P, 1988, REHABIL COUNS BULL, V31, P298; WEHMAN P, 1994, AM J PHYS MED REHAB, V73, P280, DOI 10.1097/00002060-199407000-00010; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; Wilson B.A., 2000, INT HDB NEUROPSYCHOL, P231; [No title captured]	79	31	31	0	25	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	1					51	62		10.3233/NRE-2012-0774			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	976SU	WOS:000306605900006	22523013				2022-02-06	
J	Arango-Lasprilla, JC; Nicholls, E; Cabrera, TV; Drew, A; Jimenez-Maldonado, M; Martinez-Cortes, ML				Arango-Lasprilla, Juan Carlos; Nicholls, Elizabeth; Villasenor Cabrera, Teresita; Drew, Alison; Jimenez-Maldonado, Miriam; Luisa Martinez-Cortes, Maria			HEALTH-RELATED QUALITY OF LIFE IN CAREGIVERS OF INDIVIDUALS WITH TRAUMATIC BRAIN INJURY FROM GUADALAJARA, MEXICO	JOURNAL OF REHABILITATION MEDICINE			English	Article						quality of life; traumatic brain injury; caregivers	FAMILY CAREGIVERS; HEAD-INJURY; OUTCOMES; CARERS; SF-36; NEEDS	Objective: The goal of the present study was to assess the health-related quality of life of a group of family caregivers of individuals with traumatic brain injury from Guadalajara, Mexico. Patients and methods: Ninety family caregivers of individuals with traumatic brain injury and 83 healthy controls completed the Short-Form 36, a self-report health-related quality of life measure composed of 8 component areas: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, mental health, and role-emotional. The samples were statistically similar with respect to age, gender, marital status, and education. However, caregivers had significantly lower household income than controls. Results: After controlling for income, results showed significantly lower scores for traumatic brain injury caregivers compared with healthy controls on 6 Short-Form 36 subscales: role-emotional, vitality, mental health, social functioning, bodily pain, and general health. Conclusion: Caregivers of individuals with traumatic brain injury living in Guadalajara, Mexico report having poorer health-related quality of life across various domains including mental and general health. Future studies should be conducted to determine which specific factors (e.g. lack of services, physical strain of providing care) are responsible for reduced health-related quality of life in these areas. It is likely that resources, such as respite services, adult day-care, aides, outpatient rehabilitation, psycho-educational programs, and support groups would increase health-related quality of life for these individuals.	[Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Rehabil Psychol & Neuropsychol Sch Med, Richmond, VA 23219 USA; [Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam; Luisa Martinez-Cortes, Maria] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico		Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Rehabil Psychol & Neuropsychol Sch Med, Theater Row Bldg,730 E Broad St, Richmond, VA 23219 USA.	jcarangolasp@vcu.edu					ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Barraza-Llorens M, 2002, HEALTH AFFAIR, V21, P47, DOI 10.1377/hlthaff.21.3.47; Beery LC, 1997, OMEGA-J DEATH DYING, V35, P261, DOI 10.2190/9QT0-XBD0-V8E9-U650; BROOKS DN, 1984, CLOSED HEAD INJURY P, P148; Cunningham JM, 1999, HLTH CARE DISABILITY, P475; Grant JS, 2000, BRAIN INJURY, V14, P1089; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hickey AM, 1997, PSYCHOL HEALTH, V12, P827, DOI 10.1080/08870449708406743; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Lynch R. T., 1986, APPL REHABILITATION, P262; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Molloy M., 1983, AUSTR REHABILITATION, V7, P34; Moules S, 1999, BRAIN INJURY, V13, P983; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Nanda U, 1998, EVAL HEALTH PROF, V21, P179, DOI 10.1177/016327879802100204; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Smith LM, 1995, FAMILY SUPPORT PROGR; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zitnay GA, 2005, ACT NEUR S, V93, P131	27	31	35	0	8	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	NOV	2011	43	11					983	986		10.2340/16501977-0883			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	856QN	WOS:000297658600004	22031343	Green Submitted, gold			2022-02-06	
J	Dubourg, J; Messerer, M				Dubourg, Julie; Messerer, Mahmoud			Sports-related chronic repetitive head trauma as a cause of pituitary dysfunction	NEUROSURGICAL FOCUS			English	Article						concussion; hypopituitarism; sports-related concussion; traumatic brain injury	GROWTH-HORMONE DEFICIENCY; BRAIN-INJURY TBI; ANTIPITUITARY ANTIBODIES; APOLIPOPROTEIN-E; SUBARACHNOID HEMORRHAGE; DIABETES-INSIPIDUS; FOOTBALL-LEAGUE; GH DEFICIENCY; HIGH-RISK; HYPOPITUITARISM	Traumatic brain injury (TBI) is recognized as a cause of hypopituitarism even after mild TBI. Although over the past decade, a growing body of research has detailed neuroendocrine changes induced by TBI, the mechanisms and risk factors responsible for this pituitary dysfunction are still unclear. Around the world, sports-especially combative sports-are very popular. However, sports are not generally considered as a cause of TBI in most epidemiological studies, and the link between sports-related head trauma and hypopituitarism has not been investigated until recently. Thus, there is a paucity of data regarding this important concern. Because of the large number of young sports participants with near-normal life expectancy, the implications of undiagnosed or untreated postconcussion pituitary dysfunction can be dramatic. Understanding the pathophysiological mechanisms and risk factors of hypopituitarism caused by sports injuries is thus an important issue that concerns both medical staff and sponsors of sports. The aim of this paper was to summarize the best evidence for understanding the pathophysiological mechanisms and to discuss the current data and recommendations on sports-related head trauma as a cause of hypopituitarism. (DOI: 10.3171/2011.8.FOCUS11182)	[Messerer, Mahmoud] CHU Vaudois, Dept Neurosci Clin, Serv Neurochirurg, CH-1011 Lausanne, Switzerland; [Dubourg, Julie] Univ Lyon 1, Ctr Invest Clin 201, Grp Hosp Est, Hosp Civils Lyon, F-69622 Villeurbanne, France		Messerer, M (corresponding author), CHU Vaudois, Dept Neurosci Clin, Serv Neurochirurg, Rue Bugnon 21, CH-1011 Lausanne, Switzerland.	m.messerer@laposte.net	Dubourg, Julie/AAK-4332-2020; Messerer, Mahmoud/AAZ-3527-2020	Messerer, Mahmoud/0000-0002-0493-6151; Dubourg, Julie/0000-0002-5514-8075			Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Apuzzo MLJ, 2008, NEUROSURGERY, V62, P202, DOI 10.1227/01.NEU.0000311078.58272.3E; Bailes JE, 2009, J INT NEUROPSYCH SOC, V15, P509, DOI 10.1017/S1355617709090936; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BISTRITZER T, 1981, AM J DIS CHILD, V135, P966, DOI 10.1001/archpedi.1981.02130340070022; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Boughey JC, 2004, AM SURGEON, V70, P500; Casanueva FF, 2005, ARCH PHYS MED REHAB, V86, P463, DOI 10.1016/j.apmr.2004.05.018; Caturegli P, 2005, ENDOCR REV, V26, P599, DOI 10.1210/er.2004-0011; CEBALLOS R, 2002, ALA J MED SCI, V3, P185; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; DANIEL P M, 1963, Sci Basis Med Annu Rev, P83; DANIEL PM, 1959, LANCET, V2, P927; De Bellis A, 2003, J CLIN ENDOCR METAB, V88, P650, DOI 10.1210/jc.2002-021054; De Bellis A, 2006, J CLIN ENDOCR METAB, V91, P2484, DOI 10.1210/jc.2006-0040; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; GOUDIE RB, 1962, J PATHOL BACTERIOL, V83, P584, DOI 10.1002/path.1700830241; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Iglesias P, 1996, J ENDOCRINOL INVEST, V19, P320, DOI 10.1007/BF03347870; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Ives JC, 2007, J ATHL TRAINING, V42, P431; Jordan B. D., 1991, P MILD BRAIN INJ SPO, P43; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Manetti L, 2007, J CLIN ENDOCR METAB, V92, P2176, DOI 10.1210/jc.2006-2748; MASSOL J, 1987, NEURORADIOLOGY, V29, P299, DOI 10.1007/BF00451773; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rudehill S, 2006, ACTA NEUROCHIR, V148, P199, DOI 10.1007/s00701-005-0673-5; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Simmonds M, 1914, DEUT MED WOCHENSCHR, V40, P322, DOI 10.1055/s-0029-1190185; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Stein TD, 2002, J NEUROPATH EXP NEUR, V61, P1100, DOI 10.1093/jnen/61.12.1100; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91; WelshBohmer KA, 1997, ANN NEUROL, V42, P319, DOI 10.1002/ana.410420308; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; 1996, CLIN NEUROSURG, V14, P424	70	31	31	0	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2011	31	5							E2	10.3171/2011.8.FOCUS11182			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	844QL	WOS:000296762300003	22044101				2022-02-06	
J	Fourtassi, M; Hajjioui, A; El Ouahabi, A; Benmassaoud, H; Hajjaj-Hassouni, N; El Khamlichi, A				Fourtassi, Maryam; Hajjioui, Abderrazak; El Ouahabi, Abdessamad; Benmassaoud, Hind; Hajjaj-Hassouni, Najia; El Khamlichi, Abdeslam			Long term outcome following mild traumatic brain injury in Moroccan patients	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Mild traumatic brain injury; Outcome; Quality of life; Post-concussion syndrome	MINOR HEAD-INJURY; QUALITY-OF-LIFE; POST-CONCUSSION SYMPTOMS; POPULATION; ADULTS; EPIDEMIOLOGY	Primary objectives: To describe the symptoms of chronic post-concussion syndrome (PCS) and to investigate the relationship between the persistence of these symptoms and different aspects of social life (return to work, quality of life, sport and leisure activities and family relationships) in Moroccan patients with mild traumatic brain injury (MTBI), one year after the trauma. Methods: Forty-two adult patients who sustained MTBI were reviewed one year after trauma. We investigated the persistence of PCS by using the "Problem Checklist" questionnaire. We also assessed their quality of life using a visual analogue scale, and noted the changes in employment status, social activities and family relationships. Then, we examined whether there were significant relationships between these different data. Results: More than half of the patients (n = 23, 54.8%) were found with persistent post-concussion symptoms at one year post-injury. Chronic PCS was significantly more common in married persons (p = 0.008) and significantly related to both non return to work (p <= 0.01), and QoL deterioration (p <= 0.001). Conclusion: In this study, a large proportion of persons who sustained a MTBI experienced persistent symptoms up to one year after trauma. MTBI might have significant and lasting impact on the quality of life, which is to be verified by further studies. (C) 2011 Elsevier B.V. All rights reserved.	[Fourtassi, Maryam; Hajjioui, Abderrazak; Benmassaoud, Hind; Hajjaj-Hassouni, Najia] Mohammed V Univ, Phys Med & Rehabil Dept, Rabat, Morocco; [El Ouahabi, Abdessamad; El Khamlichi, Abdeslam] Mohammed V Univ, Dept Neurosurg, Rabat, Morocco		Fourtassi, M (corresponding author), Mohammed V Univ, Phys Med & Rehabil Dept, Rabat, Morocco.	fourtmary@yahoo.fr		El Ouahabi, Abdessamad/0000-0003-2132-3397; FOURTASSI, Maryam/0000-0003-4915-5399; Hajjioui, Abderrazak/0000-0002-2311-5543; Hajjaj-Hassouni, Najia/0000-0003-0722-6822			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; DIKMEN S, 1996, NEUROPSYCHOLOGICAL A; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; FERRARI R, 2002, MED SCI MONITOR, V8, P728; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, AUST PSYCHOL, V30, P125, DOI 10.1080/00050069508258916; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Teasdale TW, 1997, BRIT MED J, V315, P569; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218	30	31	31	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2011	113	9					716	720		10.1016/j.clineuro.2011.07.010			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	837EF	WOS:000296173200003	21840643				2022-02-06	
J	Zafar, SN; Millham, FH; Chang, YC; Fikry, K; Alam, HB; King, DR; Velmahos, GC; de Moya, MA				Zafar, Syed Nabeel; Millham, Frederick H.; Chang, Yuchiao; Fikry, Karim; Alam, Hasan B.; King, David R.; Velmahos, George C.; de Moya, Marc A.			Presenting Blood Pressure in Traumatic Brain Injury: A Bimodal Distribution of Death	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Mortality; Blood pressure	PREHOSPITAL HYPOTENSION; BLUNT TRAUMA; PROGNOSTIC VALUE; TEAM ACTIVATION; HEAD-INJURY; PREDICTOR; MORTALITY; CRITERIA; INSULTS	Background: Recent research explores the relationship between vital signs on arrival to the emergency department and early outcomes. This work has not included traumatic brain injury (TBI). We aimed to evaluate the relationship of the initial emergency department systolic blood pressure (EDSBP) with outcome. Methods: By using the National Trauma Data Bank (v7), we analyzed patients older than 16 years with isolated moderate to severe blunt TBI. TBI was defined by International Classification of Diseases-9th Rev diagnosis codes and Abbreviated Injury Scale scores. We determined mortality rates while controlling for age, gender, race, payment type, and injury severity using logistic regression. Survival analysis was performed to determine 3-day survival rates. Scores and rates were plotted against EDSBP. Results: A total of 7,238 patients were included in the analysis. Plots of adverse outcomes versus EDSBP demonstrated bimodal distributions. The mortality curve had one inflection point at EDSBP 120 mm Hg, indicating higher mortality when blood pressures were lower than this threshold. Another inflection began at EDSBP 140 mm Hg. The mortality rate was 21% when EDSBP was <120 mm Hg, 9% when it was between 120 mm Hg and 140 mm Hg, and 19% when EDSBP was >= 140 mm Hg. Multivariate analysis demonstrated that patients presenting with an EDSBP of <120 mm Hg and >= 140 mm Hg were 2.7 (95% confidence interval = 2.13,3.48) and 1.6 (95% confidence interval = 1.32,1.96) times more likely to die, respectively, than those who presented with a EDSBP of 120 mm Hg to 140 mm Hg. Conclusions: Mortality in moderate to severe TBI has a bimodal distribution. Like hypotension, hypertension at hospital admission seems to be associated with increased mortality in TBI, even after controlling for other factors.	[Fikry, Karim; Alam, Hasan B.; King, David R.; Velmahos, George C.; de Moya, Marc A.] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [Zafar, Syed Nabeel] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Millham, Frederick H.] Newton Wellesley Hosp, Dept Surg, Newton, MA USA; [Chang, Yuchiao] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA		de Moya, MA (corresponding author), Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, 165 Cambridge St,Suite 810, Boston, MA 02114 USA.	mdemoya@partners.org		Zafar, Syed Nabeel/0000-0003-3843-9687; King, David/0000-0003-1028-1478			Agarwal SK, 2008, J TRAUMA, V65, P1250; Bjerke HS, 2000, J TRAUMA, V48, P1037; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chan L, 1997, ACAD EMERG MED, V4, P785, DOI 10.1111/j.1553-2712.1997.tb03785.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Franklin GA, 2000, J TRAUMA, V48, P1034, DOI 10.1097/00005373-200006000-00006; Franklin GA, 2007, J TRAUMA, V63, P297; Kiening KL, 2005, ACT NEUR S, V95, P293; KNUDSON MM, 1994, ARCH SURG-CHICAGO, V129, P448; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehmann R, 2009, ARCH SURG-CHICAGO, V144, P853, DOI 10.1001/archsurg.2009.153; Lehmann RK, 2007, AM J SURG, V193, P630, DOI 10.1016/j.amjsurg.2007.01.017; Lipsky AM, 2006, J TRAUMA, V61, P1228, DOI 10.1097/01.ta.0000196694.52615.84; MACKERSIE RC, 1989, ARCH SURG-CHICAGO, V124, P809; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; NASSOURA Z, 1991, J TRAUMA, V31, P1596, DOI 10.1097/00005373-199112000-00005; Ng I., 1998, Annals Academy of Medicine Singapore, V27, P332; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rose JC, 2004, NEUROCRIT CARE, V1, P287, DOI 10.1385/NCC:1:3:287; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shapiro MJ, 2008, J TRAUMA, V65, P1245, DOI 10.1097/TA.0b013e31818c262f; Shapiro NI, 2003, J EMERG MED, V25, P175, DOI 10.1016/S0736-4679(03)00167-7; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0	30	31	31	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1179	1184		10.1097/TA.0b013e3182140d38			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	849IG	WOS:000297118600021	21502878				2022-02-06	
J	Finnoff, JT; Jelsing, EJ; Smith, J				Finnoff, Jonathan T.; Jelsing, Elena J.; Smith, Jay			Biomarkers, Genetics, and Risk Factors for Concussion	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; S-100 PROTEIN MEASUREMENTS; APOLIPOPROTEIN-E POLYMORPHISM; AMYLOID PRECURSOR PROTEIN; BIOCHEMICAL SERUM MARKERS; ICE HOCKEY INJURIES; HIGH-SCHOOL; DESCRIPTIVE EPIDEMIOLOGY	It is estimated that between 1.6 and 3.8 million concussions occur annually in the United States. Although frequently regarded as benign, concussions can lead to multiple different adverse outcomes, including prolonged postconcussive symptoms, chronic traumatic encephalopathy, cognitive impairment, early onset dementia, movement disorders, psychiatric disorders, motor neuron disease, and even death. Therefore it is important to identify individuals with concussion to provide appropriate medical care and minimize adverse outcomes. Furthermore, it is important to identify individuals who are predisposed to sustaining a concussion or to having an adverse outcome after concussion. This article will discuss the current research on serum biomarkers for concussion, genetic influence on concussion, risk factors associated with concussion predisposition and poor outcome, and practical suggestions for the application of this information in clinical practice. PM R 2011;3:S452-S459	[Finnoff, Jonathan T.; Smith, Jay] Mayo Clin Sports Med Ctr, Mayo Clin Coll Med, Rochester, MN 55905 USA; [Jelsing, Elena J.] Mayo Clin, Mayo Clin Coll Med, Rochester, MN USA		Finnoff, JT (corresponding author), Mayo Clin Sports Med Ctr, Mayo Clin Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	finnoff.jonathan@mayo.edu					Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P202; Agel J, 2007, J ATHL TRAINING, V42, P249; Bazarian JJ, 2006, RESTOR NEUROL NEUROS, V24, P163; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P194; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lambert JC, 1998, HUM MOL GENET, V7, P1511, DOI 10.1093/hmg/7.9.1511; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; LUCOTTE G, 1994, AM J MED GENET, V54, P286, DOI 10.1002/ajmg.1320540319; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCMORRIS T, 1994, PERCEPT MOTOR SKILL, V78, P123, DOI 10.2466/pms.1994.78.1.123; Missler U, 1997, ACTA NEUROL SCAND, V96, P142; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Poorkaj, 1998, ANN NEUROL, V44, P428; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothermundt M, 2001, MOL PSYCHIATR, V6, P445, DOI 10.1038/sj.mp.4000889; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Townend W, 2002, J NEUROL NEUROSUR PS, V65, P177; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Wiesmann M, 1999, BIOL PSYCHIAT, V45, P1508, DOI 10.1016/S0006-3223(98)00217-0; Williamson I, 2006, BRIT J SPORT MED, V40, P128; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	107	31	31	1	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S452	S459		10.1016/j.pmrj.2011.07.014			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	966YK	WOS:000305873100014	22035689				2022-02-06	
J	Franschman, G; Peerdeman, SM; Andriessen, TMJC; Greuters, S; Toor, AE; Vos, PE; Bakker, FC; Loer, SA; Boer, C				Franschman, Gaby; Peerdeman, Saskia M.; Andriessen, Teuntje M. J. C.; Greuters, Sjoerd; Toor, Annelies E.; Vos, Pieter E.; Bakker, Fred C.; Loer, Stephan A.; Boer, Christa		ALARM-TBI Investigators	Effect of Secondary Prehospital Risk Factors on Outcome in Severe Traumatic Brain Injury in the Context of Fast Access to Trauma Care	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	Annual Scientific Meeting of the Dutch-Association-of-Anaesthesiologists (NVA)	OCT 04, 2009	Ulm, GERMANY	Dutch Assoc Anesthesiol (NVA)		Traumatic brain injury; Prehospital endotracheal intubation; Emergency medical service; Outcome	RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; NEUROPROTECTIVE AGENTS; CLINICAL-TRIALS; IMPACT; HYPOXIA; HYPERVENTILATION; VENTILATION; MANAGEMENT; KETAMINE	Background: Prevention of secondary prehospital risk factors such as hypoxia and hypotension is likely to improve patient prognosis in severe traumatic brain injury (TBI). Because the Dutch trauma care organization is characterized by fast access to specialized trauma care due to the geographical situation, we investigated whether and to what extend secondary risk factors, such as hypoxia and hypotension, and measures, such as endotracheal intubation, affect outcome in severe TBI in the context of a region with fast access to trauma care. Methods: The medical records of 339 subsequent computed tomography-confirmed patients with TBI with a Glasgow coma scale (GCS) score <= 8 who were primarily referred to a Level I trauma center in Amsterdam or Nijmegen in the Netherlands were retrospectively analyzed. Results: Multinomial logistic regression revealed that the strongest outcome predictors in our population were a disturbed pupillary reflex (odds ratio [OR], 5.8), a GCS score of 3 (OR, 4.9), and arterial hypotension (OR, 3.5). Interestingly, we observed no differences between intubated and nonintubated patients with respect to metabolic and respiratory parameters or mortality whereby the injury severity score was slightly higher in endotracheally intubated patients (32 [25-41]) versus nonintubated patients (25 [22-29]). Conclusion: In agreement with others, GCS, a disturbed pupil reflex, and arterial hypotension were predictive for the prognosis of primarily referred patients with severe TBI in the Netherlands. In contrast, in the perspective of slightly higher injury scores in intubated patients, prehospital endotracheal intubation was not predictive for patient outcome.	[Franschman, Gaby; Greuters, Sjoerd; Loer, Stephan A.; Boer, Christa] Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, NL-1081 HV Amsterdam, Netherlands; [Peerdeman, Saskia M.] Vrije Univ Amsterdam Med Ctr, Dept Neurosurg, NL-1081 HV Amsterdam, Netherlands; [Bakker, Fred C.] Vrije Univ Amsterdam Med Ctr, Dept Traumatol, NL-1081 HV Amsterdam, Netherlands; [Andriessen, Teuntje M. J. C.; Vos, Pieter E.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6525 ED Nijmegen, Netherlands		Franschman, G (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	g.franschman@vumc.nl	Vos, Pieter/A-6043-2012	Boer, Christa/0000-0002-7781-6951			Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2008, PREHOSP EMERG CARE, V12, P46, DOI 10.1080/10903120701710470; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; *FDN NAT AMB EM RO, 2007, LAND PROT AMB LPA7; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang H E, 2001, Prehosp Emerg Care, V5, P134, DOI 10.1080/10903120190939995; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032	37	31	32	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2011	71	4					826	832		10.1097/TA.0b013e31820cebf0			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	833ZT	WOS:000295925700016	21427618				2022-02-06	
J	Kuo, JR; Lo, CJ; Chang, CP; Lin, KC; Lin, MT; Chio, CC				Kuo, Jinn-Rung; Lo, Chong-Jeh; Chang, Ching-Ping; Lin, Kao-Chang; Lin, Mao-Tsun; Chio, Chung-Ching			Agmatine-Promoted Angiogenesis, Neurogenesis, and Inhibition of Gliosis-Reduced Traumatic Brain Injury in Rats	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Agmatine; Angiogenesis; Neurogenesis; Gliosis	CLONIDINE-DISPLACING SUBSTANCE; NEUROTROPHIC FACTOR; CEREBRAL-ISCHEMIA; SURVIVAL FACTOR; MOUSE MODEL; GDNF; DYSFUNCTION; PRECURSORS; PROTECTION; RECOVERY	Background: The mechanisms of agmatine-induced neuroprotective effects in traumatic brain injury (TBI) remain unclear. This study was to test whether inhibition of gliosis, angiogenesis, and neurogenesis attenuating TBI could be agmatine stimulated. Methods: Anesthetized rats were randomly assigned to sham-operated group, TBI rats treated with saline (1 mL/kg, intraperitoneally), or TBI rats treated with agmatine (50 mg/kg, intraperitoneally). Saline or agmatine was injected 5 minutes after TBI and again once daily for the next 3 postoperative days. Results: Agmatine therapy in rats significantly attenuated TBI-induced motor function deficits (62 degrees vs. 52 degrees maximal angle) and cerebral infarction (88 mm(3) vs. 216 mm(3)), significantly reduced TBI-induced neuronal (9 NeuN-TUNEL double positive cells vs. 60 NeuN-TUNEL double positive cells) and glial (2 GFAP-TUNEL double positive cells vs. 20 GFAP-TUNEL double positive cells) apoptosis (increased TUNEL-positive and caspase-3-positive cells), neuronal loss (82 NeuN-positive cells vs. 60 NeuN-positive cells), gliosis (35 GFAP-positive cells vs. 72 GFAP-positive cells; 60 Iba1-positive cells vs. 90 Iba1-positive cells), and neurotoxicity (30 n-NOS-positive cells vs. 90 n-NOS-positive cells; 35 3-NT-positive cells vs. 90 3-NT-positive cells), and significantly promoted angiogenesis (3 BrdU/endothelial cells vs. 0.5 BrdU/endothelial cells; 50 vascular endothelial growth factor positive cells vs. 20 vascular endothelial growth factor-positive cells) and neurogenesis (27 BrdU/NeuN positive cells vs. 15 BrdU/NeuN positive cells). Conclusions: Resultantly, agmatine therapy may attenuate TBI in rats via promoting angiogenesis, neurogenesis, and inhibition of gliosis.	[Kuo, Jinn-Rung; Lin, Kao-Chang; Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Tainan 710, Taiwan; [Kuo, Jinn-Rung] Natl Cheng Kung Univ, Inst Clin Med, Sch Med, Tainan 70101, Taiwan; [Lo, Chong-Jeh] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Div Trauma & Emergency Surg, Kaohsiung, Taiwan; [Kuo, Jinn-Rung; Chang, Ching-Ping; Lin, Kao-Chang; Lin, Mao-Tsun] So Taiwan Univ, Dept Biotechnol, Tainan, Taiwan; [Lin, Mao-Tsun] Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan; [Lin, Mao-Tsun] Taipei Med Univ, Grad Inst Dis Prevent & Control, Taipei, Taiwan		Chio, CC (corresponding author), Chi Mei Med Ctr, Dept Surg, Tainan 710, Taiwan.	mtlin@ym.edu.tw		Chang, Ching-Ping/0000-0003-0890-9414	Center of Excellence for Clinical Trial and Research in Neuroscience [NSC99-2314-B-384-006-MY2, NSC99-2314-B-384-004-MY3, DOH99-TD-B-111-003]	Supported by grants NSC99-2314-B-384-006-MY2, NSC99-2314-B-384-004-MY3, and DOH99-TD-B-111-003 Center of Excellence for Clinical Trial and Research in Neuroscience.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Cai ZW, 1999, NEUROREPORT, V10, P3927, DOI 10.1097/00001756-199912160-00037; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; Demady DR, 2001, MOL PHARMACOL, V59, P24, DOI 10.1124/mol.59.1.24; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; GILAD GM, 1996, LIFE SCI, V58, P41; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kao CH, 2008, RESUSCITATION, V77, P395, DOI 10.1016/j.resuscitation.2008.01.023; Kim JH, 2004, EXP NEUROL, V189, P122, DOI 10.1016/j.expneurol.2004.05.029; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; PILETZ JE, 1995, J PHARMACOL EXP THER, V272, P581; Regunathan S, 2000, J NEUROCHEM, V74, P2201, DOI 10.1046/j.1471-4159.2000.0742201.x; Reis DJ, 2000, TRENDS PHARMACOL SCI, V21, P187, DOI 10.1016/S0165-6147(00)01460-7; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Wang Y, 1997, J NEUROSCI, V17, P4341; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZURN AD, 1994, NEUROREPORT, V6, P113, DOI 10.1097/00001756-199412300-00030	34	31	31	2	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2011	71	4					E87	E93		10.1097/TA.0b013e31820932e2			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	833ZT	WOS:000295925700003	21427621				2022-02-06	
J	Podvin, S; Gonzalez, AM; Miller, MC; Dang, XT; Botfield, H; Donahue, JE; Kurabi, A; Boissaud-Cooke, M; Rossi, R; Leadbeater, WE; Johanson, CE; Coimbra, R; Stopa, EG; Eliceiri, BP; Baird, A				Podvin, Sonia; Gonzalez, Ana-Maria; Miller, Miles C.; Dang, Xitong; Botfield, Hannah; Donahue, John E.; Kurabi, Arwa; Boissaud-Cooke, Matthew; Rossi, Ryan; Leadbeater, Wendy E.; Johanson, Conrad E.; Coimbra, Raul; Stopa, Edward G.; Eliceiri, Brian P.; Baird, Andrew			Esophageal Cancer Related Gene-4 Is a Choroid Plexus-Derived Injury Response Gene: Evidence for a Biphasic Response in Early and Late Brain Injury	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; SQUAMOUS-CELL CARCINOMA; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; RAT; EXPRESSION; ECRG4; HYPERMETHYLATION; PROLIFERATION; TRAFFICKING	By virtue of its ability to regulate the composition of cerebrospinal fluid (CSF), the choroid plexus (CP) is ideally suited to instigate a rapid response to traumatic brain injury (TBI) by producing growth regulatory proteins. For example, Esophageal Cancer Related Gene-4 (Ecrg4) is a tumor suppressor gene that encodes a hormone-like peptide called augurin that is present in large concentrations in CP epithelia (CPe). Because augurin is thought to regulate senescence, neuroprogenitor cell growth and differentiation in the CNS, we evaluated the kinetics of Ecrg4 expression and augurin immunoreactivity in CPe after CNS injury. Adult rats were injured with a penetrating cortical lesion and alterations in augurin immunoreactivity were examined by immunohistochemistry. Ecrg4 gene expression was characterized by in situ hybridization. Cell surface augurin was identified histologically by confocal microscopy and biochemically by sub-cellular fractionation. Both Ecrg4 gene expression and augurin protein levels were decreased 24-72 hrs post-injury but restored to uninjured levels by day 7 post-injury. Protein staining in the supraoptic nucleus of the hypothalamus, used as a control brain region, did not show a decrease of auguin immunoreactivity. Ecrg4 gene expression localized to CPe cells, and augurin protein to the CPe ventricular face. Extracellular cell surface tethering of 14 kDa augurin was confirmed by cell surface fractionation of primary human CPe cells in vitro while a 6-8 kDa fragment of augurin was detected in conditioned media, indicating release from the cell surface by proteolytic processing. In rat CSF however, 14 kDa augurin was detected. We hypothesize the initial release and proteolytic processing of augurin participates in the activation phase of injury while sustained Ecrg4 down-regulation is dysinhibitory during the proliferative phase. Accordingly, augurin would play a constitutive inhibitory function in normal CNS while down regulation of Ecrg4 gene expression in injury, like in cancer, dysinhibits proliferation.	[Podvin, Sonia; Dang, Xitong; Kurabi, Arwa; Coimbra, Raul; Eliceiri, Brian P.; Baird, Andrew] Univ Calif San Diego, Dept Surg, Sch Med, San Diego, CA 92103 USA; [Gonzalez, Ana-Maria; Botfield, Hannah; Boissaud-Cooke, Matthew; Leadbeater, Wendy E.] Univ Birmingham, Sch Clin & Expt Med, Dept Neuropharmacol & Neurobiol, Birmingham, W Midlands, England; [Miller, Miles C.; Donahue, John E.; Rossi, Ryan; Johanson, Conrad E.; Stopa, Edward G.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02903 USA; [Miller, Miles C.; Donahue, John E.; Rossi, Ryan; Johanson, Conrad E.; Stopa, Edward G.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Pathol, Providence, RI 02903 USA		Podvin, S (corresponding author), Univ Calif San Diego, Dept Surg, Sch Med, San Diego, CA 92103 USA.	anbaird@ucsd.edu	Coimbra, Raul/AAP-3019-2020; Donahue, John E/A-3000-2008	Coimbra, Raul/0000-0002-3759-6851; Donahue, John E/0000-0001-7186-2562; Johanson, Conrad/0000-0002-1297-5484; Baird, Andrew/0000-0003-0027-9905; Eliceiri, Brian/0000-0003-1811-1916	Hydrocephalus Association; United States National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; United States National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM078421]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY018479, HL073396, AG027910]; American Recovery and Reinvestment Act (ARRA); NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R21EY018479] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL073396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM078421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG027910] Funding Source: NIH RePORTER	Dr. Podvin is supported by a Mentored Young Investigator Award from the Hydrocephalus Association (www.hydroassoc.org). Dr. Baird, Dr. Eliceiri and Dr. Coimbra are supported by a United States National Institutes of Health (www.nih.gov) P20 Exploratory Center Grant for Would Healing Research from the United States National Institute of General Medical Sciences (www.nigms.nih.gov; P20 GM078421) and are also supported by the National Institutes of Health (NIH) EY018479 (Dr. Baird), (NIH) HL073396 (Dr. Eliceiri) and by supplemental funding through the American Recovery and Reinvestment Act (ARRA). No external funding was received for these studies for Dr. Miller, Dr. Dang, Dr. Donahue, Dr. Rossi or Dr. Stopa. Conrad Johanson is supported by NIH AG027910. All of the studies conducted at the University of Birmingham by Dr. Gonzalez, Dr. Botfield, Dr. Boissaud-Cooke and Dr. Leadbeater were funded by a grant from the School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, United Kingdom (www.medicine.bham.ac.uk). The funders had no role in study design, data collection and analysis, the decision to publish or preparation of the manuscript.	Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Allen Brain Atlas Resources, 2009, ALL BRAIN ATL RES; Baird A, 2011, METHODS MOL BIOL, V686, P483, DOI 10.1007/978-1-60761-938-3_25; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Boulougouris P, 2001, ANTICANCER RES, V21, P2769; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; Clarke WE, 2001, MOL CELL NEUROSCI, V17, P17, DOI 10.1006/mcne.2000.0920; Ennis SR, 2006, J CEREBR BLOOD F MET, V26, P675, DOI 10.1038/sj.jcbfm.9600224; Ghabriel MN, 2010, ACTA NEUROCHIR SUPPL, V106, P239, DOI 10.1007/978-3-211-98811-4_45; Gonzalez AM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-6; Johanson CE, 2000, CELL MOL NEUROBIOL, V20, P197, DOI 10.1023/A:1007097622590; Johanson C, 2011, TOXICOL PATHOL, V39, P186, DOI 10.1177/0192623310394214; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kujuro Y, 2010, P NATL ACAD SCI USA, V107, P8259, DOI 10.1073/pnas.0911446107; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; LOGAN A, 1992, J NEUROSCI, V12, P3828; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Mori Y, 2007, ONCOL REP, V18, P981; Norton WT, 1999, NEUROCHEM RES, V24, P213, DOI 10.1023/A:1022505903312; Ozawa A, 2011, MOL ENDOCRINOL, V25, P776, DOI 10.1210/me.2010-0389; PALM D, 1995, AM J PHYSIOL-REG I, V269, pR73, DOI 10.1152/ajpregu.1995.269.1.R73; Popovic Matija, 2011, J Mol Recognit, V24, P245, DOI 10.1002/jmr.1042; Qureshi IA, 2010, ARCH NEUROL-CHICAGO, V67, P1316, DOI 10.1001/archneurol.2010.275; ROBERTON A, 2009, SOC END BES 2009 HAR, V15, pS82; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Su Tao, 1998, Zhonghua Zhongliu Zazhi, V20, P254; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tadross JA, 2010, BRIT J PHARMACOL, V159, P1663, DOI 10.1111/j.1476-5381.2010.00655.x; Trudel C, 2000, J CELL PHYSIOL, V185, P260, DOI 10.1002/1097-4652(200011)185:2<260::AID-JCP11>3.0.CO;2-X; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Yue CM, 2003, WORLD J GASTROENTERO, V9, P1174, DOI 10.3748/wjg.v9.i6.1174; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7	39	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24609	10.1371/journal.pone.0024609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	WOS:000295039700031	21935431	Green Published, Green Accepted, gold			2022-02-06	
J	Mao, L; Wang, HD; Wang, XL; Liao, H; Zhao, XZ				Mao, Lei; Wang, Handong; Wang, Xiaoliang; Liao, Hong; Zhao, Xianzhong			Transcription Factor Nrf2 Protects the Spinal Cord from Inflammation Produced by Spinal Cord Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						sulforaphane; Nrf2; spinal cord injury; inflammation; neuroprotection	TRAUMATIC BRAIN-INJURY; SMOKE-INDUCED EMPHYSEMA; KAPPA-B ACTIVATION; NRF2-DEFICIENT MICE; INTRACEREBRAL HEMORRHAGE; ENHANCES SUSCEPTIBILITY; FUNCTIONAL RECOVERY; SULFORAPHANE; EXPRESSION; DAMAGE	Background. Inflammation plays an important role in the pathogenesis of secondary damage after spinal cord injury (SCI). Previous studies have suggested that nuclear factor-erythroid 2-related factor 2 (Nrf2), a pleiotropic transcription factor, may play a key role in modulating inflammation in a variety of experimental models. This study evaluated the neuroprotective role of Nrf2 in the inflammatory response after SCI in mice. Materials and Methods. Nrf2-deficient (Nrf2(-/-)) and wild-type (Nrf2(+/+)) mice spinal cord compression injury was induced by the application of vascular clips (force of 10 g) to the dura. Sulforaphane (SFN) was used to activate Nrf2 after SCI. Inflammatory cytokines, NF-kappa B activity, histologic injury score, dying neurons count in grey matter, water content of impaired spinal cord, and Basso open-field motor score (BMS) were assessed to determine the extent of SCI-mediated damage. Results. The results showed that SFN activated Nrf2 in impaired spinal cord tissue, improved hindlimb locomotor function assessed by BMS, reduced inflammatory damage, histologic injury, dying neurons count, and spinal cord edema caused by SCI. Nrf2(-/-) mice demonstrated more severe neurologic deficit and spinal cord edema after SCI and did not benefit from the protective effect of SFN. Conclusions. Taken together, our results suggest that Nrf2 may represent a strategic target for SCI therapies. (C) 2011 Elsevier Inc. All rights reserved.	[Mao, Lei; Wang, Handong; Wang, Xiaoliang] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, Nanjing 210002, Jiangsu, Peoples R China; [Liao, Hong] China Pharmaceut Univ, Natl Ctr Drug Screening, Nanjing 210009, Jiangsu, Peoples R China; [Zhao, Xianzhong] Nantong Univ, Dept Plast & Burn Surg, Affiliated Nantong Hosp 3, Nantong, Jiangsu, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hdwang_nj@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070974]; Jiangsu Provincial Key Subject [X4200722]; Jinling Hospital of Nanjing, China [2009Q016]	This work was supported by grants from the National Natural Science Foundation of China (no. 81070974), the Jiangsu Provincial Key Subject (X4200722), and Jinling Hospital of Nanjing, China (2009Q016). The authors thank Dr. Gengbao Feng and Dr. Jianya Xu for technical assistance.	Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bauchet L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P330, DOI 10.1016/j.annrmp.2008.10.004; Bethea JR, 2000, PROG BRAIN RES, V128, P33; Bethea JR, 1998, J NEUROSCI, V18, P3251; Boldin C, 2006, SPINE, V31, P554, DOI 10.1097/01.brs.0000201274.59427.a4; Brandenburg LO, 2010, INFLAMM RES, V59, P443, DOI 10.1007/s00011-009-0116-5; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Esposito E, 2008, J PINEAL RES, V45, P149, DOI 10.1111/j.1600-079X.2008.00569.x; Genovese T, 2007, NEUROSCI LETT, V423, P41, DOI 10.1016/j.neulet.2007.05.058; Genovese T, 2007, J PINEAL RES, V43, P140, DOI 10.1111/j.1600-079X.2007.00454.x; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Hurlbert RJ, 2006, SPINE, V31, pS16, DOI 10.1097/01.brs.0000218264.37914.2c; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kelly VP, 2000, CANCER RES, V60, P957; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Mao L, 2010, ANN CLIN LAB SCI, V40, P354; Mao L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/238321; Marques SA, 2009, J NEUROSCI METH, V177, P183, DOI 10.1016/j.jneumeth.2008.10.015; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Pledgie-Tracy A, 2007, MOL CANCER THER, V6, P1013, DOI 10.1158/1535-7163.MCT-06-0494; Pomeshchik Y, 2009, J NEUROTRAUM, V26, pA41; Probert L, 1997, J NEUROIMMUNOL, V72, P137, DOI 10.1016/S0165-5728(96)00184-1; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rice T, 2007, J NEUROPATH EXP NEUR, V66, P184, DOI 10.1097/01.jnen.0000248552.07338.7f; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P422, DOI 10.1196/annals.1344.037; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	63	31	32	1	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2011	170	1					E105	E115		10.1016/j.jss.2011.05.049			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	804BD	WOS:000293627800014	21764072				2022-02-06	
J	Majdan, M; Mauritz, W; Brazinova, A; Rusnak, M; Leitgeb, J; Janciak, I; Wilbacher, I				Majdan, Marek; Mauritz, Walter; Brazinova, Alexandra; Rusnak, Martin; Leitgeb, Johannes; Janciak, Ivan; Wilbacher, Ingrid			Severity and outcome of traumatic brain injuries (TBI) with different causes of injury	BRAIN INJURY			English	Article						Traumatic brain injuries; severity of outcome; causes of injury	EPIDEMIOLOGY; MANAGEMENT; VARIABLES; TREE	Introduction: Most epidemiological studies and reports have reached a consensus on the leading causes of traumatic brain injury (TBI). Despite the fact that the area of TBI is relatively well studied, reports on differences in severity and outcome of TBI with different causes are lacking. Goal: This paper analyses the differences in severity and in short- and long-term outcome of TBIs with different causes. Method: This study analysed data on 1109 patients with severe TBI by dividing them into three injury-cause groups: ''traffic-related'', ''falls'' and ''other causes''. Severity and outcome was evaluated using chosen direct and indirect indicators. Results: The most severe trauma occurred in the traffic-related group followed by falls and injuries with other causes. On the other hand, patients with traffic-related TBI had the best outcome. Age improves the outcome in the traffic-related group significantly. However, in the multivariate analysis after adjusting for age (and other important predictors including level of care) the odds for favourable long-term outcome stayed significantly higher in the traffic-related group. Conclusions: It is concluded that the causes of TBI should be considered by both clinicians and public health professionals as a lead in prognosis of outcome and policy planning.	[Majdan, Marek; Rusnak, Martin] Trnava Univ, Fac Hlth Care & Social Work, Dept Publ Hlth, Trnava 91843, Slovakia; [Majdan, Marek; Mauritz, Walter; Brazinova, Alexandra; Rusnak, Martin; Leitgeb, Johannes; Janciak, Ivan; Wilbacher, Ingrid] INRO Int Neurotrauma Res Org, Vienna, Austria		Majdan, M (corresponding author), Trnava Univ, Fac Hlth Care & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@igeh.org	Rusnak, Martin/K-9349-2016; Majdan, Marek/K-5017-2012; Brazinova, Alexandra/C-4265-2016	Rusnak, Martin/0000-0003-3321-1042; Majdan, Marek/0000-0001-8037-742X; Brazinova, Alexandra/0000-0003-0625-256X; Mauritz, Walter/0000-0001-9043-3712	European UnionEuropean Commission [ICA2-CT-2002-100]; Austrian Worker's Compensation Board [FK 33/2003]; Austrian National Bank [8987]	The data used for this study were collected for a project funded by a European Union grant (Project 'Research-Treat-TBI'; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; contract number: ICA2-CT-2002-100) and for another project funded by the Austrian Worker's Compensation Board (AUVA; contract number FK 33/2003) and by the 'Jubilaeumsfonds' of the Austrian National Bank (project number 8987). INRO was supported by an annual grant from Mrs Ala Auersperg-Isham and Mr Ralph Isham and by donations from various other sources.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; R Development Core Team, 2010, R LANG ENV STAT COMP; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	19	31	32	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2011	25	9					797	805		10.3109/02699052.2011.581642			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	790CY	WOS:000292567300001	21631184				2022-02-06	
J	New, PW; Simmonds, F; Stevermuer, T				New, P. W.; Simmonds, F.; Stevermuer, T.			Comparison of patients managed in specialised spinal rehabilitation units with those managed in non-specialised rehabilitation units	SPINAL CORD			English	Article						spinal cord injury; non-traumatic spinal cord injury; outcomes; epidemiology; rehabilitation; specialisation	FUNCTIONAL INDEPENDENCE MEASURE; AROC ANNUAL-REPORT; CORD-INJURY; AUSTRALIA; CARE; CENTERS; LENGTH; STATE	Study design: Prospective open cohort study. Objective: Compare the demographic characteristics and rehabilitation outcomes for both non-traumatic SCI (NT-SCI) and traumatic SCI (T-SCI) patients admitted into either specialist spinal cord injury rehabilitation units (SCIRUs) or non-specialist rehabilitation units (NSRUs). Setting: Rehabilitation units in Australia. Methods: The Australasian Rehabilitation Outcomes Centre maintains a national database on inpatients admitted to most (130/145) public and private rehabilitation units in Australia. Patients were included if they had a diagnosis of spinal cord injury (SCI) and were discharged between 1 January 2006 and 31 December 2006. Patients were excluded if admitted for <7 days, only for assessment, or were a readmission following a previous SCI. Results: There were 668 patients with confirmed SCI admitted (NT-SCI n = 361, 54.0%; T-SCI n = 307, 46.0%). NT-SCI patients were much less likely to be admitted into a specialist SCIRU (30.5%) compared with T-SCI patients (70.4%). For both NT-SCI and T-SCI patients, those admitted to a specialist SCIRU tended to be younger (P = 0.000), have a longer length of stay in rehabilitation (P = 0.000), and lower Functional Independence Measure (FIM) motor subscale score on admission (P = 0.000) than those admitted to a NSRU. For NT-SCI patients, after adjusting for covariates, those admitted into specialist SCIRU had greater improvement in their FIM motor score during rehabilitation. This finding was not demonstrated in T-SCI patients. Conclusions: There are differences in the characteristics of SCI patients admitted to SCIRU compared with NSRU. NT-SCI patients admitted to SCIRU have greater functional gain. Sponsorship: This project was made possible by a major research grant from the Victorian Neurotrauma Initiative. A minor research grant was also provided by the Australasian Faculty of Rehabilitation Medicine 2007 Ipsen research scholarship. The authors would like to thank these organisations for their support. These organisations had no role in the design, analysis or preparation of this manuscript. Spinal Cord (2011) 49, 909-916; doi:10.1038/sc.2011.29; published online 5 April 2011	[New, P. W.] Caulfield Hosp, Spinal Rehabil Unit, Caulfield, Vic 3162, Australia; [New, P. W.] Monash Univ, Epworth Monash Rehabil Med Unit, So Med Sch, Melbourne, Vic 3004, Australia; [Simmonds, F.; Stevermuer, T.] Univ Wollongong, Australasian Rehabil Outcome Ctr, Ctr Hlth Serv Dev, Wollongong, NSW, Australia		New, PW (corresponding author), Caulfield Hosp, Spinal Rehabil Unit, 260 Kooyong Rd, Caulfield, Vic 3162, Australia.	p.new@cgmc.org.au			Victorian Neurotrauma Initiative; Australasian Faculty of Rehabilitation Medicine	The authors would like to thank the assistance of all the hospitals contributing data to AROC, and especially those who participated in the data quality review undertaken as part of this project. Some of the results described here were presented at the 49th International Spinal Cord Society Annual Scientific Meeting, Florence, Italy, 21-24 October 2009. This project was made possible by a major research grant from the Victorian Neurotrauma Initiative. A minor research grant was also provided by the Australasian Faculty of Rehabilitation Medicine 2007 Ipsen research scholarship. We thank these organizations for their support. These organizations had no role in the design, analysis or preparation of this paper.	[Anonymous], 1997, GUID UN DAT SET MED; BEDBROOK GM, 1985, LIFETIME CARE PARAPL; Celani MG, 2001, ARCH PHYS MED REHAB, V82, P589, DOI 10.1053/apmr.2001.21948; CHARLES ED, 1977, PARAPLEGIA, V15, P302; Cripps R, 2008, INJURY RES STAT SERI, V48; DONOVAN WH, 1984, PARAPLEGIA, V22, P282, DOI 10.1038/sc.1984.46; FRANKEL H, 1987, PARAPLEGIA, V25, P239, DOI 10.1038/sc.1987.42; Guilcher SJT, 2010, SPINAL CORD, V48, P45, DOI 10.1038/sc.2009.78; Guttmann L., 1976, SPINAL CORD INJURIES; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; Hamilton B B, 1976, Paraplegia, V14, P87; HEINEMANN AW, 1989, ARCH NEUROL-CHICAGO, V46, P1098, DOI 10.1001/archneur.1989.00520460084017; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; National Health and Hospitals Reform Commission, 2009, HEALTH FUT ALL AUSTR; New PW, 2008, SPINAL CORD, V46, P406, DOI 10.1038/sj.sc.3102152; New Peter W, 2006, Aust Health Rev, V30, P353; NEW PW, SPINAL CORD, V49, P397; O'Connor PJ, 2000, SPINAL CORD, V38, P597, DOI 10.1038/sj.sc.3101048; Osterthun R, 2009, SPINAL CORD, V47, P339, DOI 10.1038/sc.2008.127; Simmonds F, 2007, AUST HEALTH REV, V31, pS31; Simmonds F, 2008, AUST HEALTH REV, V32, P85, DOI 10.1071/AH080085; Smith M, 2002, SPINAL CORD, V40, P11, DOI 10.1038/sj.sc.3101226; TATOR CH, 1995, PARAPLEGIA, V33, P254, DOI 10.1038/sc.1995.58; Wallace D, 2002, J CLIN EPIDEMIOL, V55, P922, DOI 10.1016/S0895-4356(02)00410-9; Wolfe DL, 2007, TOP SPINAL CORD INJ, V13, P11; YARKONY GM, 1985, PARAPLEGIA, V23, P265, DOI 10.1038/sc.1985.43	26	31	32	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	AUG	2011	49	8					909	916		10.1038/sc.2011.29			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	803HS	WOS:000293573000011	21468042	Bronze			2022-02-06	
J	Classen, S; Levy, C; Meyer, DL; Bewernitz, M; Lanford, DN; Mann, WC				Classen, Sherrilene; Levy, Charles; Meyer, Dustin L.; Bewernitz, Megan; Lanford, Desiree N.; Mann, William C.			Simulated Driving Performance of Combat Veterans With Mild Tramatic Brain Injury and Posttraumatic Stress Disorder: A Pilot Study	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						automobile driving; brain injuries; computer simulation; stress disorders, post-traumatic; veterans	VALIDITY	OBJECTIVE. We determined differences in driving errors between combat veterans with mild traumatic brain injury and posttraumatic stress disorder and healthy control participants. METHOD. We compared 18 postdeployed combat veterans with 20 control participants on driving errors in a driving simulator. RESULTS. Combat veterans were more likely to be male; were younger; and had more racial diversity, less formal education, and lower cognitive scores than control participants. Control participants made more signaling errors (t [19] = 2.138, p = .046, SE = 0.395), but combat veterans made more overspeeding (t[17.3] = 4.095, p = .001, SE = 0.708) and adjustment-to-stimuli (t[17] = 2.380, p = .029, SE = 0.140) errors. Young age was related to overspeeding. CONCLUSION. Combat veterans made more critical driving errors than did control participants. Such errors made on the road may lead to crashes or injuries. Although limited in generalizability, these findings provide early support for developing safe driving interventions for combat veterans.	[Classen, Sherrilene] Univ Florida, Inst Mobil Act & Participat, Gainesville, FL 32610 USA; [Classen, Sherrilene; Bewernitz, Megan; Lanford, Desiree N.; Mann, William C.] Univ Florida, Occupat Therapy Dept, Gainesville, FL 32610 USA; [Levy, Charles] Malcom Randall VA Vet Affairs Med Ctr, Phys Med & Rehabil Serv, Gainesville, FL USA; [Mann, William C.] Vet Affairs Rehabil Outcomes Res Ctr, Gainesville, FL USA; [Meyer, Dustin L.] Univ Florida, Hlth Sci Program, Gainesville, FL 32610 USA		Classen, S (corresponding author), Univ Florida, Inst Mobil Act & Participat, POB 100164, Gainesville, FL 32610 USA.	sclassen@phhp.ufl.edu	Bewernitz, Megan/D-3151-2019				*AM OCC THER ASS, 2005, AM J OCCUPATIONAL TH, V59, P666, DOI DOI 10.5014/AJOT.59.6.666; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; BROWN ID, 1988, ERGONOMICS, V31, P585, DOI 10.1080/00140138808966701; Classen Sherrilene, 2007, Traffic Inj Prev, V8, P69, DOI 10.1080/15389580600994339; Classen S, 2010, AM J OCCUP THER, V64, P233, DOI 10.5014/ajot.64.2.233; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIEDMAN M, PTSD 101; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; *I MED, 2007, GLOB WAR  HLTH LONGT; Justiss MD, 2006, TOP GERIATR REHABIL, V22, P121; KENNEDY RS, 1992, AVIAT SPACE ENVIR MD, V63, P588; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Radloff LS, 1986, COMMUNITY MENTAL HLT; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roley S., 2008, AM OCCUPATIONAL THER, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.62.6.625]; SHECHTMAN, 2010, THERAPY, V64, P242, DOI DOI 10.5014/AJ0T.64.2.242; Shechtman Oritz, 2007, Traffic Inj Prev, V8, P78, DOI 10.1080/15389580600994321; Staplin L, 2003, J SAFETY RES, V34, P389, DOI 10.1016/j.jsr.2003.09.002	24	31	31	0	9	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2011	65	4					419	427		10.5014/ajot.2011.000893			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	792YY	WOS:000292787500009	21834457				2022-02-06	
J	Johnson, CP; Juranek, J; Kramer, LA; Prasad, MR; Swank, PR; Ewing-Cobbs, L				Johnson, Chad P.; Juranek, Jenifer; Kramer, Larry A.; Prasad, Mary R.; Swank, Paul R.; Ewing-Cobbs, Linda			Predicting Behavioral Deficits in Pediatric Traumatic Brain Injury Through Uncinate Fasciculus Integrity	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Diffusion tensor imaging; Executive function; Neuropsychology; Child; Anisotropy; Behavior	CLOSED-HEAD INJURY; TEMPORAL-LOBE EPILEPSY; HUMAN CEREBRAL-CORTEX; DIFFUSION-TENSOR; WHITE-MATTER; EXECUTIVE FUNCTION; COGNITIVE CONTROL; CORPUS-CALLOSUM; SELF-REGULATION; CHILDREN	Behavioral dysregulation is a common and detrimental consequence of traumatic brain injury (TBI) in children that contributes to poor academic achievement and deficits in social development. Unfortunately, behavioral dysregulation is difficult to predict from either injury severity or early neuropsychological evaluation. The uncinate fasciculus (UF) connects orbitofrontal and anterior temporal lobes, which are commonly implicated in emotional and behavioral regulation. Using probabilistic diffusion tensor tractography (DTT), we examined the relationship between the integrity of the UF 3 months post-injury and ratings of executive functions 12 months post-injury in children with moderate to severe TBI and a comparison group with orthopedic injuries. As expected, fractional anisotropy of the UF was lower in the TBI group relative to the orthopedic injury group. DTT metrics from the UF served as a biomarker and predicted ratings of emotional and behavior regulation, but not metacognition. In contrast, the Glasgow Coma Scale score was not related to either UF integrity or to executive function outcomes. Neuroanatomical biomarkers like the uncinate fasciculus may allow for early identification of behavioral problems and allow for investigation into the relationship of frontotemporal networks to brain-behavior relationships. (JINS, 2011, 17, 663-673)	[Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dan L Duncan Childrens Neurodev Clin, Childrens Learning Inst, Dept Pediat, Houston, TX 77030 USA; [Johnson, Chad P.] Univ Houston, Dept Psychol, Houston, TX USA; [Kramer, Larry A.] Univ Texas Hlth Sci Ctr Houston, Dept Radiol, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA		Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dan L Duncan Childrens Neurodev Clin, Childrens Learning Inst, Dept Pediat, 7000 Fannin,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			Phillip M. Rennick award;  [NIH-NINDS-R01-NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This work was funded by NIH-NINDS-R01-NS046308 awarded to LEC. Portions of this study were awarded the Phillip M. Rennick award when presented as a poster at the 38th Annual Meeting of the International Neuropsychological Society in Acapulco. No conflicts of interest exist.	Allen JS, 2008, NEUROIMAGE, V42, P535, DOI 10.1016/j.neuroimage.2008.05.047; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Barkovich A.J., 2005, PEDIAT NEUROIMAGING; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Basser PJ, 1997, ANN NY ACAD SCI, V820, P123, DOI 10.1111/j.1749-6632.1997.tb46192.x; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bunge SA, 2007, CURR OPIN NEUROBIOL, V17, P243, DOI 10.1016/j.conb.2007.02.005; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Chao YP, 2008, MED ENG PHYS, V30, P989, DOI 10.1016/j.medengphy.2008.01.010; Cook PA, 2005, LECT NOTES COMPUT SC, V3749, P164; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Damasio A., 1994, DESCARTES ERROR EMOT; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FUSTER JM, 1991, PROG BRAIN RES, V87, P201, DOI DOI 10.1016/S0079-6123(08)63053-8; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gerring J, 2000, BRAIN INJURY, V14, P205; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Goldman PS, 1974, PLASTICITY RECOVERY; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hasan KM, 2006, RADIOLOGY, V239, P611, DOI 10.1148/radiol.2392051172; HASAN KM, 2003, MEDICAMUNDI, V49, P30; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Johansen-Berg H, 2006, CURR OPIN NEUROL, V19, P379, DOI 10.1097/01.wco.0000236618.82086.01; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kubicki M, 2002, HARVARD REV PSYCHIAT, V10, P324, DOI 10.1080/10673220216231; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lee JE, 2007, NEUROSCI LETT, V424, P127, DOI 10.1016/j.neulet.2007.07.042; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; LEVIN HS, 1993, CURR OPIN NEUROL, V6, P841, DOI 10.1097/00019052-199312000-00003; Lin JJ, 2008, EPILEPSY RES, V82, P162, DOI 10.1016/j.eplepsyres.2008.07.020; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Moseley M, 2002, BRAIN COGNITION, V50, P396, DOI 10.1016/S0278-2626(02)00524-9; Ochsner KN, 2009, PSYCHOL SCI, V20, P1322, DOI 10.1111/j.1467-9280.2009.02459.x; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pugliese L, 2009, NEUROIMAGE, V47, P427, DOI 10.1016/j.neuroimage.2009.05.014; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wallis LI, 2006, ACTA RADIOL, V47, P1094, DOI 10.1080/02841850600979048; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940	75	31	31	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2011	17	4					663	673		10.1017/S1355617711000464			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	781NL	WOS:000291939900010	21492497	Green Accepted			2022-02-06	
J	Liu, L; Wei, HJ; Chen, FL; Wang, JH; Dong, JF; Zhang, JN				Liu, Li; Wei, Huijie; Chen, Fanglian; Wang, Jinghua; Dong, Jing-fei; Zhang, Jianning			Endothelial progenitor cells correlate with clinical outcome of traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						endothelial progenitor cells; traumatic brain injury; clinical outcome; prognostic marker	ACTIVATED PLATELETS; PRECURSOR CELLS; CD34(+) CELLS; STEM-CELLS; DIFFERENTIATION; MOBILIZATION; ANGIOGENESIS; REPAIR; STROKE	Objective: Endothelial progenitor cells play an active role in vascular repair and revascularization of tissue damaged by traumatic, inflammatory, and ischemic injures. We correlate the changes in circulating endothelial progenitor cells with the severity of traumatic brain injury. The study is designed to investigate the endothelial progenitor cell mobilization after injury and a potential use of circulating endothelial progenitor cells as a prognostic marker for evaluating trauma severity and clinical outcomes. Design: A prospective cohort study conducted in two neurosurgical intensive care units of Tianjin Medical University General Hospital and Tianjin Huanhu Hospital (Tianjin, China). Patients: Patients with traumatic brain injury and age-and gender-matched healthy controls. Interventions: None. Measurements and Main Results: Changes in the levels of circulating endothelial progenitor cells were monitored for up to 21 days in 84 patients with traumatic brain injury. Results were correlated with the clinical assessment of injury severity as determined by the Glasgow Coma Scale. The level of circulating endothelial progenitor cells was found to be suppressed 24-48 hrs after injury but rapidly increased, reaching the highest at days 5-7 post-trauma. Circulating endothelial progenitor cells in patients with improved Glasgow Coma Scale scores were significantly higher than those with deteriorated conditions and remained persistently low in patients who died of trauma. Conclusions: The results suggest that the level of circulating endothelial progenitor cells correlates with the clinical severity and outcome of traumatic brain injury and may offer potential as a prognostic marker for traumatic brain injury. A long-term follow-up of these patients is ongoing. (Crit Care Med 2011; 39: 1760-1765)	[Liu, Li; Wei, Huijie; Chen, Fanglian; Wang, Jinghua; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin, Peoples R China; Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Dong, Jing-fei] Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA		Liu, L (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin, Peoples R China.	jfdong@bcm.tmc.edu; jianningzhang@hotmail.com			Chinese Science Foundation (Beijing, China) [2005CB522600, 30772229]; National Institutes of Health (Bethesda, MD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL71895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071895] Funding Source: NIH RePORTER	Supported, in part, by grants 2005CB522600 (JZ) and 30772229 (JZ) from the Chinese Science Foundation (Beijing, China) and grant HL71895 (JFD) from the National Institutes of Health (Bethesda, MD).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Gehling UM, 2000, BLOOD, V95, P3106; Gill M, 2001, CIRC RES, V88, P167; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Langer HF, 2007, SEMIN THROMB HEMOST, V33, P136, DOI 10.1055/s-2007-969026; Lev EI, 2005, J VASC RES, V42, P408, DOI 10.1159/000087370; Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401	20	31	36	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	JUL	2011	39	7					1760	1765		10.1097/CCM.0b013e3182186cee			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	778RF	WOS:000291721800019	21460712	Green Accepted			2022-02-06	
J	Rambousek, L; Bubenikova-Valesova, V; Kacer, P; Syslova, K; Kenney, J; Holubova, K; Najmanova, V; Zach, P; Svoboda, J; Stuchlik, A; Chodounska, H; Kapras, V; Adamusova, E; Borovska, J; Vyklicky, L; Vales, K				Rambousek, Lukas; Bubenikova-Valesova, Vera; Kacer, Petr; Syslova, Kamila; Kenney, Jana; Holubova, Kristina; Najmanova, Vera; Zach, Petr; Svoboda, Jan; Stuchlik, Ales; Chodounska, Hana; Kapras, Vojtech; Adamusova, Eva; Borovska, Jirina; Vyklicky, Ladislav; Vales, Karel			Cellular and behavioural effects of a new steroidal inhibitor of the N-methyl-D-aspartate receptor 3 alpha 5 beta-pregnanolone glutamate	NEUROPHARMACOLOGY			English	Article						Neuroactive steroid; 3 alpha 5 beta-Pregnanolone glutamate; Glutamate excitotoxicity; Neuroprotectivity; Cognitive function	TRAUMATIC BRAIN-INJURY; NEUROACTIVE STEROIDS; NMDA RECEPTOR; PLACE AVOIDANCE; ANTAGONIST; RATS; NEUROTOXICITY; ISCHEMIA; NEUROSTEROIDS; HIPPOCAMPUS	Preclinical studies have demonstrated a considerable role for N-methyl-h-aspartate (NMDA) receptors in excitotoxicity and the concurrent neuroprotective effect of NMDA receptor antagonists. Because NMDA receptors are one of the most widespread receptors in the central nervous system, application of their antagonist often leads to serious side effects ranging from motor impairment to induction of schizophrenic-like psychosis. Therefore, we have initiated development and testing of a novel synthetic NMDA receptor antagonist derived from naturally occurring neurosteroids. 20-oxo-5 beta-pregnan-3 alpha-yl-L-glutamyl-1-ester (3 alpha 5 beta P-Glu) is a novel synthetic steroidal inhibitor of the NMDA receptor. Our results show that 3 alpha 5 beta P-Glu preferentially inhibits tonically activated NMDA receptors, is able to cross the blood brain barrier, does not induce psychotomimetic symptoms (such as hyperlocomotion and sensorimotor gating deficit) and reduced an excitotoxic damage of brain tissue and subsequent behavioural impairment in rats. In particular, 3 alpha 5 beta P-Glu significantly ameliorated neuronal damage in the dentate gyrus and subiculum, and improved behavioural performance in active allothetic place avoidance tasks (AAPA, also known as the carousel maze) after bilateral NMDA-induced lesions to the hippocampi. These findings provide a possible new therapeutic approach for the treatment of diseases induced by NMDA receptor overactivation. (C) 2011 Elsevier Ltd. All rights reserved.	[Bubenikova-Valesova, Vera] Prague Psychiat Ctr, Dept Biochem & Brain Pathophysiol, Ustavni 91, Prague 18103 8, Czech Republic; [Rambousek, Lukas; Bubenikova-Valesova, Vera; Kenney, Jana; Holubova, Kristina; Svoboda, Jan; Stuchlik, Ales; Adamusova, Eva; Borovska, Jirina; Vyklicky, Ladislav; Vales, Karel] Acad Sci Czech Republ, Inst Physiol, Prague 4, Czech Republic; [Chodounska, Hana; Kapras, Vojtech] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 6, Czech Republic; [Zach, Petr] Charles Univ Prague, Fac Med 3, Prague 10, Czech Republic; [Rambousek, Lukas; Kacer, Petr; Syslova, Kamila; Najmanova, Vera] Inst Chem Technol, CR-16628 Prague 6, Czech Republic		Bubenikova-Valesova, V (corresponding author), Prague Psychiat Ctr, Dept Biochem & Brain Pathophysiol, Ustavni 91, Prague 18103 8, Czech Republic.	bubenikova@pcp.lf3.cuni.cz	Vyklicky, Ladislav/C-1851-2012; Zach, Petr/D-8955-2016; Kacer, Petr/AAW-2355-2021; Svoboda, Jan/C-2811-2012; Chodounska, Hana/A-9104-2010; Stuchlik, Ales/V-8543-2019; Rambousek, Lukas/F-8571-2012; Vales, Karel/C-2941-2012; Holubova, Kristina/Q-9408-2018	Vyklicky, Ladislav/0000-0002-0015-0098; Zach, Petr/0000-0003-1941-2972; Svoboda, Jan/0000-0002-0343-5347; Chodounska, Hana/0000-0002-4851-9472; Stuchlik, Ales/0000-0002-5394-6305; Vales, Karel/0000-0001-7892-4535; Holubova, Kristina/0000-0002-4936-2737; Kacer, Petr/0000-0002-5905-3516	IGA Ministry of Health [NS10365, NR 9180-3]; GACRGrant Agency of the Czech Republic [309/07/0271, 203/08/1498, 309/09/0286]; AS CRCzech Academy of Sciences [AVOZ 50110509]; ECEuropean CommissionEuropean Commission Joint Research Centre [LSHM-CT-2007-037765]; Ministry of Education, Youth and Sports of the Czech RepublicMinistry of Education, Youth & Sports - Czech Republic [1M0157, LC554];  [Z4 055 0506]	This work was supported by the IGA Ministry of Health NS10365, NR 9180-3 and GACR (309/07/0271; 203/08/1498; 309/09/0286), Research Project of the AS CR AVOZ 50110509, EC FP6 PHOTOLYSIS (LSHM-CT-2007-037765) and The Ministry of Education, Youth and Sports of the Czech Republic (1M0157 and LC554). Hana Chodonska was supported by Research Project Z4 055 0506.	Bowen CA, 1999, J PHARMACOL EXP THER, V289, P405; Bubenikova-Valesova V, 2006, NEUROCHEM INT, V48, P515, DOI 10.1016/j.neuint.2006.01.019; Bubenikova-Valesova V, 2008, NEUROSCI BIOBEHAV R, V32, P1014, DOI 10.1016/j.neubiorev.2008.03.012; Bubenikova-Valesova V, 2007, NEUROPHARMACOLOGY, V52, P1071, DOI 10.1016/j.neuropharm.2006.11.004; Bures J, 1998, NEUROPHARMACOLOGY, V37, P689, DOI 10.1016/S0028-3908(98)00031-8; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; CHOI DW, 1988, J NEUROSCI, V8, P185; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Gasior M, 1999, TRENDS PHARMACOL SCI, V20, P107, DOI 10.1016/S0165-6147(99)01318-8; Geyer M.A., 2001, CURRENT PROTOCOLS NE, P1; KNAPSTEIN P, 1968, STEROIDS, V11, P885, DOI 10.1016/S0039-128X(68)80102-3; Kubik S, 2006, PHYSIOL RES, V55, P445; Kussius CL, 2009, J NEUROSCI, V29, P6819, DOI 10.1523/JNEUROSCI.0281-09.2009; Lapchak PA, 2006, EXP NEUROL, V197, P531, DOI 10.1016/j.expneurol.2005.10.025; Lapchak PA, 2004, BRAIN RES, V997, P152, DOI 10.1016/j.brainres.2003.10.047; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Li H, 2001, BRAIN RES, V888, P263, DOI 10.1016/S0006-8993(00)03077-8; MacNevin CJ, 2009, J MED CHEM, V52, P6012, DOI 10.1021/jm900712n; Manahan-Vaughan D, 2008, HIPPOCAMPUS, V18, P125, DOI 10.1002/hipo.20367; MCDONALD JW, 1990, NEUROSCIENCE, V36, P589, DOI 10.1016/0306-4522(90)90002-L; Melcangi RC, 2008, CELL MOL LIFE SCI, V65, P777, DOI 10.1007/s00018-007-7403-5; Mellon SH, 2008, BRAIN RES REV, V57, P410, DOI 10.1016/j.brainresrev.2007.05.012; Morrow AL, 2007, PHARMACOL THERAPEUT, V116, P1, DOI 10.1016/j.pharmthera.2007.04.003; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; Park-Chung M., 1997, MOL PHARM, V46, P146; Paxinos G, 2004, RAT BRAIN STEREOTAXI; Petrovic M, 2005, J NEUROSCI, V25, P8439, DOI 10.1523/JNEUROSCI.1407-05.2005; Pringle AK, 2003, EUR J NEUROSCI, V18, P117, DOI 10.1046/j.1460-9568.2003.02734.x; Rao VLR, 2001, BRAIN RES, V911, P96; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Sadri-Vakili G, 2003, J NEUROCHEM, V86, P92, DOI 10.1046/j.1471-4159.2003.01814.x; Schauwecker PE, 2010, EXP NEUROL, V224, P207, DOI 10.1016/j.expneurol.2010.03.013; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sedlacek M, 2008, PHYSIOL RES, V57, pS49, DOI 10.33549/physiolres.931600; Shiigi Y, 1999, PSYCHOPHARMACOLOGY, V146, P67, DOI 10.1007/s002130051089; Stastna E, 2009, STEROIDS, V74, P256, DOI 10.1016/j.steroids.2008.11.011; Stuchlik A, 2008, BEHAV BRAIN RES, V189, P139, DOI 10.1016/j.bbr.2007.12.025; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; Wang MD, 1997, J STEROID BIOCHEM, V62, P299, DOI 10.1016/S0960-0760(97)00041-1; Weaver CE, 1997, P NATL ACAD SCI USA, V94, P10450, DOI 10.1073/pnas.94.19.10450; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005	43	31	31	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	JUL-AUG	2011	61	1-2					61	68		10.1016/j.neuropharm.2011.02.018			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	787WU	WOS:000292408200007	21354187				2022-02-06	
J	Sashindranath, M; Samson, AL; Downes, CE; Crack, PJ; Lawrence, AJ; Li, QX; Ng, AQP; Jones, NC; Farrugia, JJ; Abdella, E; Vassalli, JD; Madani, R; Medcalf, RL				Sashindranath, Maithili; Samson, Andre Laval; Downes, Catherine Eliza; Crack, Peter John; Lawrence, Andrew John; Li, Qiao-Xin; Ng, Ashley Quan Ping; Jones, Nigel Charles; Farrugia, Jessica Jade; Abdella, Eman; Vassalli, Jean-Dominique; Madani, Rime; Medcalf, Robert Lindsay			Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation	LABORATORY INVESTIGATION			English	Article						alzheimer's disease; amidolytic assay; head trauma; morphine; seizure; spinocerebellar ataxia; stroke; tissue-type plasminogen activator	APPSWE/PS1DE9 MOUSE MODEL; FOCAL CEREBRAL-ISCHEMIA; LONG-TERM POTENTIATION; A-BETA DEGRADATION; AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; EXPRESSION; SEIZURE; SYSTEM; MICE	Tissue-type plasminogen activator (tPA) is a major protease of the central nervous system. Most studies to date have used in situ-or gel-based zymographic assays to monitor in vivo changes in neural tPA activity. In this study, we demonstrate that the amidolytic assay can be adapted to accurately detect changes in net tPA activity in mouse brain tissues. Using the amidolytic assay, we examined differences in net tPA activity in the cerebral cortex, sub-cortical structures and cerebellum in wildtype (WT) and tPA(-/-) mice, and in transgenic mice selectively overexpressing tPA in neurons. In addition, we assessed changes in endogenous net tPA activity in WT mice following morphine administration, epileptic seizures, traumatic brain injury and ischaemic stroke-neurological settings in which tPA has a known functional role. Under these conditions, acute and compartment-specific regulation of tPA activity was observed. tPA also participates in various forms of chronic neurodegeneration. Accordingly, we assessed tPA activity levels in mouse models of Alzheimer's disease (AD) and spinocerebellar ataxia type-1 (SCA1). Decreased tPA activity was detected in the cortex and subcortex of AD mice, whereas increased tPA activity was found in the cerebellum of SCA1 mice. These findings extend the existing hypotheses that low tPA activity promotes AD, whereas increased tPA activity contributes to cerebellar degeneration. Collectively, our results exemplify the utility of the amidolytic assay and emphasise tPA as a complex mediator of brain function and dysfunction. On the basis of this evidence, we propose that alterations in tPA activity levels could be used as a biomarker for perturbations in brain homeostasis. Laboratory Investigation (2011) 91, 1079-1091; doi:10.1038/labinvest.2011.67; published online 25 April 2011	[Sashindranath, Maithili; Samson, Andre Laval; Farrugia, Jessica Jade; Abdella, Eman; Medcalf, Robert Lindsay] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Downes, Catherine Eliza; Crack, Peter John] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Lawrence, Andrew John] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Lawrence, Andrew John; Li, Qiao-Xin] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Li, Qiao-Xin] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Ng, Ashley Quan Ping; Jones, Nigel Charles] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Vassalli, Jean-Dominique; Madani, Rime] Univ Geneva, Fac Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland		Medcalf, RL (corresponding author), Monash Univ, Australian Ctr Blood Dis, Level 6,Burnet Bldg,89 Commercial Rd, Melbourne, Vic 3004, Australia.	robert.medcalf@monash.edu	Samson, Andre L/I-3432-2012; Sashindranath, Maithili/AAI-7408-2021; Crack, Peter/ABE-2065-2020; Medcalf, Robert L/E-9632-2011; Jones, Nigel C/K-7773-2012	Samson, Andre L/0000-0003-4825-1645; Sashindranath, Maithili/0000-0002-9712-4784; Crack, Peter/0000-0002-5030-0330; Samson, Andre/0000-0002-0637-2716; Jones, Nigel/0000-0002-1080-8439	National Health and Medical Research Council (NH&MRC) of AustraliaNational Health and Medical Research Council of Australia [606659]; NHMRCNational Health and Medical Research Council of Australia [491152, 606660, 628391, G 08M 3821]; Victorian Neurotrauma Initiative [D0-34]	We thank Prof Norman Saunders, Dr Mark Habgood, Dr Simone Beckham and Mr Adam Galle for constructing the electromagnetic CCI device. We also thank Ms Amanda Au for assisting in the preparation of mouse brain lysates following MCAo. Be'eri Niego for constructive comments regarding the amidolytic assay. Volga Tarlac and Elsdon Storey from the Van Cleef Roet Centre for Nervous Diseases for providing us with the SCA1 mutant and wild-type littermate mice, and Prof John Hamilton (Department of Medicine, Royal Melbourne Hospital) for providing the mice for the seizure studies. This study was supported by grant numbers 606659 awarded to RLM and ALS from the National Health and Medical Research Council (NH&MRC) of Australia and by grant numbers 491152 and 606660 awarded to RLM from the NH&MRC and D0-34 awarded to RLM from the Victorian Neurotrauma Initiative. This study was also supported by grant numbers 628391 and G 08M 3821 awarded to PJC from the NH&MRC and the National Heart Foundation of Australia, respectively, and by grant number 566544 awarded to NCJ from the NH&MRC. AJL and RLM are also supported with Senior Research Fellowships, and NCJ supported with a Career Development Award, from the NH&MRC.	Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; Cacquevel M, 2007, NEUROBIOL DIS, V27, P164, DOI 10.1016/j.nbd.2007.04.004; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Dietzmann K, 2000, PATHOL RES PRACT, V196, P15, DOI 10.1016/S0344-0338(00)80017-5; ERIKSSON E, 1987, THROMB RES, V46, P213, DOI 10.1016/0049-3848(87)90283-0; Fabbro S, 2009, J NEUROCHEM, V109, P303, DOI 10.1111/j.1471-4159.2009.05894.x; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; Hamann GF, 2004, STROKE, V35, P764, DOI 10.1161/01.STR.0000116866.60794.21; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Iyer AM, 2010, NEUROSCIENCE, V167, P929, DOI 10.1016/j.neuroscience.2010.02.047; Jacobsen JS, 2008, P NATL ACAD SCI USA, V105, P8754, DOI 10.1073/pnas.0710823105; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; KIM JW, 2010, NEUROCHEM INT; KINGSTON IB, 1995, NAT MED, V1, P138; Lahtinen L, 2006, EUR J NEUROSCI, V24, P1935, DOI 10.1111/j.1460-9568.2006.05062.x; Ledesma MD, 2000, EMBO REP, V1, P530; Li JX, 2006, P NATL ACAD SCI USA, V103, P7847, DOI 10.1073/pnas.0602440103; LIJNEN HR, 1984, EUR J BIOCHEM, V144, P541, DOI 10.1111/j.1432-1033.1984.tb08499.x; LIU RM, 2009, NEUROBIOL A IN PRESS; Lu WQ, 2002, DEVELOPMENT, V129, P2043; Lu WQ, 2002, J NEUROSCI, V22, P10781; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Melchor JP, 2003, J NEUROSCI, V23, P8867; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; Muller A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001641; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Niego B, 2008, BLOOD COAGUL FIBRIN, V19, P322, DOI 10.1097/MBC.0b013e3282f54568; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Roussel BD, 2009, BRAIN, V132, P2219, DOI 10.1093/brain/awp162; Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531, DOI 10.2174/156720509790147070; Salzberg M, 2007, EPILEPSIA, V48, P2079, DOI 10.1111/j.1528-1167.2007.01246.x; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Seeds NW, 2003, J NEUROSCI, V23, P7368; SHIMADA H, 1981, THROMB HAEMOSTASIS, V46, P507; STEPHENS R, 1987, J IMMUNOL METHODS, V105, P245, DOI 10.1016/0022-1759(87)90272-9; Thewke DP, 1999, BRAIN RES, V821, P356, DOI 10.1016/S0006-8993(99)01115-4; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; VERHEIJEN JH, 1982, THROMB HAEMOSTASIS, V48, P266; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Yepes M, 2000, BLOOD, V96, P569; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	54	31	32	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JUL	2011	91	7					1079	1091		10.1038/labinvest.2011.67			13	Medicine, Research & Experimental; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pathology	784WL	WOS:000292189100010	21519332	Bronze			2022-02-06	
J	Umeda, S; Kurosaki, Y; Terasawa, Y; Kato, M; Miyahara, Y				Umeda, Satoshi; Kurosaki, Yoshiko; Terasawa, Yuri; Kato, Motoichiro; Miyahara, Yasuyuki			Deficits in prospective memory following damage to the prefrontal cortex	NEUROPSYCHOLOGIA			English	Article						Prospective memory; Prefrontal cortex; Medial temporal lobe; Neuropsychological test; Executive function; Traumatic brain injury	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; REGIONS; INTENTIONS; REALIZATION; INVOLVEMENT; HYPOTHESIS; POSTERIOR; DEMANDS; DISEASE	Neuropsychological investigations of prospective memory (PM), representing memory of future intentions or plans, have evolved over the past two decades. The broadly accepted divisions involved in PM consist of a prospective memory component (PMC), a process for remembering to remember, and a retrospective memory component, a process for remembering the content of the intended action. Previous functional neuroimaing studies have provided some evidence that the rostral prefrontal cortex (BA10) is one of areas that is critical for prospective remembering. However, the question of whether damage to part of the prefrontal cortex affects attenuated performance for PMC remains unresolved. In this study, 74 participants with traumatic brain injury (TBI) including focal damage to frontal or temporal lobe areas were administered thirteen standard neuropsychological tests and the PM task. To identify influential areas contributing to PM performance, discriminant function analysis was conducted. The results indicated that the following three areas are highly contributory to PM performance: the right dorsolateral prefrontal cortex; the right ventromedial prefrontal cortex; and the left dorsomedial prefrontal cortex. Comparing differences in neuropsychological test scores showed that orientation scores were significantly higher in the greater PM performance group, suggesting that PMC represents an integrated memory function associated with awareness of current status. These data contribute to our understanding of the neural substrates and functional characteristics of the PMC. (C) 2011 Elsevier Ltd. All rights reserved.	[Umeda, Satoshi; Terasawa, Yuri] Keio Univ, CARLS, Dept Psychol, Minato Ku, Tokyo 1088345, Japan; [Kurosaki, Yoshiko] Ohtawara Red Cross Hosp, Dept Rehabil, Ohtawara, Tochigi 3248686, Japan; [Kato, Motoichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608582, Japan; [Miyahara, Yasuyuki] Ohtawara Red Cross Hosp, Dept Neurosurg, Ohtawara, Tochigi 3248686, Japan		Umeda, S (corresponding author), Keio Univ, CARLS, Dept Psychol, Minato Ku, 2-15-45 Mita, Tokyo 1088345, Japan.	umeda@flet.keio.ac.jp		Terasawa, Yuri/0000-0002-2812-0544	Japan Society for the Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [21530770]	This study was supported by a Grant-in-Aid for Scientific Research (No. 21530770) from the Japan Society for the Promotion of Science (JSPS). We are grateful to the patients who participated in our study.	BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; BRANDIMONTE MA, 1996, PROSPECTIVE MEMORY T; Brandimonte MA, 2011, MEMORY, V19, P56, DOI 10.1080/09658211.2010.535657; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Costa A, 2010, NEUROPSYCHOLOGY, V24, P327, DOI 10.1037/a0018015; Court J. H., 1990, COLOURED PROGRESSIVE; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein GO, 2010, J EXP PSYCHOL LEARN, V36, P1082, DOI 10.1037/a0019184; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; EINSTEIN GO, 2008, PSYCHOL LEARN MOTIV, P145; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster ER, 2009, NEUROPSYCHOLOGY, V23, P347, DOI 10.1037/a0014692; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Gupta S, 2010, J CLIN EXP NEUROPSYC, V32, P898, DOI 10.1080/13803391003596470; Handa T., 1989, J KEIO MED SOC, V66, P153; Hashimoto T, 2011, NEUROIMAGE, V54, P645, DOI 10.1016/j.neuroimage.2010.07.047; Hayashi C., 1952, ANN I STATISTICAL MA, V3, P69, DOI DOI 10.1007/BF02949778; Heaton R.K., 1981, WISCONSIN CARD SORTI; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Imai Y, 1994, J HONG KONG COLL PSY, V4, P20; Isaacs EB, 2003, P NATL ACAD SCI USA, V100, P13060, DOI 10.1073/pnas.1233825100; Jones CRG, 2011, J AUTISM DEV DISORD, V41, P455, DOI 10.1007/s10803-010-1067-y; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; Kinkingnehun S, 2007, NEUROIMAGE, V37, P1237, DOI 10.1016/j.neuroimage.2007.06.027; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kohs S.C., 1923, INTELLIGENCE MEASURE; Kumar D, 2005, J CLIN EXP NEUROPSYC, V27, P867, DOI 10.1080/13803390490919100; Livner A, 2009, J NEUROL SCI, V283, P235, DOI 10.1016/j.jns.2009.02.377; Maylor EA, 1995, NEUROCASE, V1, P285, DOI 10.1080/13554799508402372; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; MCKITRICK LA, 1992, J GERONTOL, V47, pP337, DOI 10.1093/geronj/47.5.P337; Morris AL, 2008, CONSCIOUS COGN, V17, P1378, DOI 10.1016/j.concog.2008.04.005; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Paraskevaides T, 2010, PSYCHOPHARMACOLOGY, V208, P301, DOI 10.1007/s00213-009-1731-0; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Smith RE, 2010, J EXP PSYCHOL LEARN, V36, P1089, DOI 10.1037/a0019183; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Thompson C, 2010, J INT NEUROPSYCH SOC, V16, P318, DOI 10.1017/S1355617709991354; Troyer AK, 2007, J INT NEUROPSYCH SOC, V13, P365, DOI 10.1017/S1355617707070452; Umeda S, 2006, REV NEUROSCIENCE, V17, P267; Umeda S, 2005, NEUROIMAGE, V26, P932, DOI 10.1016/j.neuroimage.2005.03.004; UMEDA S, 2000, JAPANESE J NEUROPSYC, V16, P193; Umeda S, 2010, SOC NEUROSCI-UK, V5, P19, DOI 10.1080/17470910902990584; Volle E, 2008, CEREB CORTEX, V18, P2460, DOI 10.1093/cercor/bhn010; Wechsler D, 1987, MEMORY SCALE REVISED; West R, 2006, NEUROPSYCHOLOGIA, V44, P197, DOI 10.1016/j.neuropsychologia.2005.05.003; West R, 2005, PSYCHOPHYSIOLOGY, V42, P698, DOI 10.1111/j.1469-8986.2005.00361.x; West R, 2007, NEUROCASE, V13, P115, DOI 10.1080/13554790701399247; West R, 2007, INT J PSYCHOPHYSIOL, V64, P215, DOI 10.1016/j.ijpsycho.2006.09.004; West R, 2011, NEUROPSYCHOLOGIA, V49, P2233, DOI 10.1016/j.neuropsychologia.2010.12.028; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Woods SP, 2008, ARCH CLIN NEUROPSYCH, V23, P257, DOI 10.1016/j.acn.2007.12.006; Woods SP, 2007, SCHIZOPHR RES, V90, P344, DOI 10.1016/j.schres.2006.11.005; Worthington A, 1999, NEUROCASE, V5, P47	77	31	33	1	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUL	2011	49	8			SI		2178	2184		10.1016/j.neuropsychologia.2011.03.036			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	793FL	WOS:000292805700005	21477605				2022-02-06	
J	Frugier, T; Crombie, D; Conquest, A; Tjhong, F; Taylor, C; Kulkarni, T; McLean, C; Pebay, A				Frugier, Tony; Crombie, Duncan; Conquest, Alison; Tjhong, Frisca; Taylor, Caroline; Kulkarni, Tejal; McLean, Catriona; Pebay, Alice			Modulation of LPA Receptor Expression in the Human Brain Following Neurotrauma	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Autotaxin; Human; Lysophosphatidic acid; Traumatic brain injury human brain	CENTRAL-NERVOUS-SYSTEM; LYSOPHOSPHATIDIC ACID; PHOSPHODIESTERASE-I; AUTOTAXIN; PROLIFERATION; LOCALIZATION; ACTIVATION; INITIATION; SIGNALS; GROWTH	Lysophosphatidic acid (LPA) is involved in physiological and pathological states, including in neural development and inflammation. We assessed the expression pattern of the LPA receptors 1-3 and of LPA-producing enzyme autotaxin in post-mortem human brain tissue, both in normal individuals and in individuals who died following traumatic brain injury. We found that LPA receptors and autotaxin are weakly expressed in the normal control adult brain. Quantitative PCR for the LPA receptors and autotaxin mRNA showed an increase of LPAR(2) and a decrease of autotaxin mRNA expression in the cortex following brain injury. Immunohistochemical analysis showed that LPAR(1) colocalized with astrocytes and that LPAR(2) is present on the ependymal cells lining the lateral ventricle in the brain samples from individuals who died following severe head injury. This work shows for the first time that key components of the LPA pathway are modulated following TBI in humans.	[Pebay, Alice] Univ Melbourne, Ctr Neurosci, Dept Pharmacol, Parkville, Vic 3010, Australia; [McLean, Catriona] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3004, Australia; [Crombie, Duncan; Tjhong, Frisca; Taylor, Caroline; Kulkarni, Tejal; Pebay, Alice] OBrien Inst, Fitzroy, Vic 3065, Australia; [Frugier, Tony; Conquest, Alison] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Frugier, Tony; Conquest, Alison] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia		Pebay, A (corresponding author), Univ Melbourne, Ctr Neurosci, Dept Pharmacol, Parkville, Vic 3010, Australia.	apebay@unimelb.edu.au		Pebay, Alice/0000-0002-7408-9453; Crombie, Duncan/0000-0002-4718-1967; Frugier, Tony/0000-0002-1275-5158; Taylor, Caroline/0000-0003-2151-8709	NHMRCNational Health and Medical Research Council of Australia [454723]; NHMRC/Victorian Neurotrauma Initiative Career Development AwardNational Health and Medical Research Council of Australia; Victorian State Government's Department of Innovation; Industry and Regional Development's Operational Infastructure Support Program; National Trauma Research Institute; University of MelbourneUniversity of Melbourne; Mental Health Research Institute of Victoria; Victorian Institute of Forensic Medicine; Victorian Neurotrauma Initiative, Neurosciences Australia	This work was supported by a NHMRC Project Grant 454723, a NHMRC/Victorian Neurotrauma Initiative Career Development Award (to AP) and the Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infastructure Support Program. Tissues were received from the Victorian Brain Bank Network, supported by The National Trauma Research Institute, The University of Melbourne, The Mental Health Research Institute of Victoria, The Victorian Institute of Forensic Medicine and funded by the Victorian Neurotrauma Initiative, Neurosciences Australia and the NHMRC. The authors wish to thank the Histology Facility, Department of Anatomy and Cell Biology, University of Melbourne and J. Palmer for their technical assistance.	Bouquet C, 2007, MOL CELL NEUROSCI, V36, P235, DOI 10.1016/j.mcn.2007.07.002; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dennis J, 2005, J NEUROSCI RES, V82, P737, DOI 10.1002/jnr.20686; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Elmes SJR, 2004, BRAIN RES, V1022, P205, DOI 10.1016/j.brainres.2004.07.005; Frohnert PW, 2003, J NEUROPATH EXP NEUR, V62, P520, DOI 10.1093/jnen/62.5.520; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Fujita R, 2007, NEUROCHEM INT, V50, P351, DOI 10.1016/j.neuint.2006.09.003; Fuss B, 1997, J NEUROSCI, V17, P9095; Goldshmit Y, 2010, CELL TISSUE RES, V341, P23, DOI 10.1007/s00441-010-0977-5; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P1170, DOI 10.1016/j.mcn.2003.09.001; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Keller JN, 1997, J NEUROCHEM, V69, P1073; Keller JN, 1996, J NEUROCHEM, V67, P2300; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Koike S, 2006, GENES CELLS, V11, P133, DOI 10.1111/j.1365-2443.2006.00924.x; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Liszewska E, 2009, ENDOCRINOLOGY, V150, P422, DOI 10.1210/en.2008-0749; Moller T, 1999, NEUROREPORT, V10, P2929; Moller T, 2001, J BIOL CHEM, V276, P25946, DOI 10.1074/jbc.M102691200; NARITA M, 1994, J BIOL CHEM, V269, P28235; Pebay A, 1999, GLIA, V28, P25, DOI 10.1002/(SICI)1098-1136(199910)28:1<25::AID-GLIA3>3.0.CO;2-D; Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004; Renback K, 1999, NEUROSCI LETT, V270, P59, DOI 10.1016/S0304-3940(99)00464-4; Renback K, 2000, MOL BRAIN RES, V75, P350, DOI 10.1016/S0169-328X(99)00333-2; Sato K, 2005, J NEUROCHEM, V92, P904, DOI 10.1111/j.1471-4159.2004.02933.x; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Stankoff B, 2002, MOL CELL NEUROSCI, V20, P415, DOI 10.1006/mcne.2002.1129; Takuwa Y, 2002, J BIOCHEM, V131, P767, DOI 10.1093/oxfordjournals.jbchem.a003163; TIGYI G, 1995, AM J PHYSIOL-HEART C, V268, pH2048, DOI 10.1152/ajpheart.1995.268.5.H2048; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weiner JA, 1998, J COMP NEUROL, V398, P587; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233; Yu NC, 2004, GLIA, V45, P17, DOI 10.1002/glia.10297; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	41	31	31	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2011	31	4					569	577		10.1007/s10571-011-9650-0			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	755AC	WOS:000289898000009	21234797				2022-02-06	
J	Lescot, T; Reina, V; Le Manach, Y; Boroli, F; Chauvet, D; Boch, AL; Puybasset, L				Lescot, Thomas; Reina, Vincent; Le Manach, Yannick; Boroli, Filippo; Chauvet, Dorian; Boch, Anne-Laure; Puybasset, Louis			In vivo accuracy of two intraparenchymal intracranial pressure monitors	INTENSIVE CARE MEDICINE			English	Article						Intracranial pressure; Cerebrospinal fluid pressure; Transducers; Pressure monitor; Traumatic brain injury; Subarachnoid hemorrhage	EXPERIENCE; AGREEMENT	To evaluate the in vivo accuracy of the new Pressio(A (R)) device for intraparenchymal monitoring of intracranial pressure (ICP) versus the Codman(A (R)) device and intraventricular measurement external ventricular drainage (EVD). Data were collected retrospectively for 30 consecutive patients admitted into a 25-bed neurosurgical intensive care unit of a university hospital between January and December 2009. Patients received both intraventricular and intraparenchymal ICP monitoring with Pressio(A (R)) (n = 15) or Codman(A (R)) (n = 15). We obtained 3,089 data points from the 30 patients. Mean difference between intraparenchymal and EVD pressure (bias) was -0.6 mmHg, and limits of agreement (1.96 SD of the bias) were -8.1 to 6.9 mmHg with Pressio(A (R)) and 0.3 mmHg with limits of agreement of -6.7 to 7.1 mmHg with Codman(A (R)) (NS). The temporal difference was -0.7 +/- A 1.6 mmHg/100 h of monitoring with Pressio(A (R)) and 0.1 +/- A 1.6 mmHg/100 h of monitoring with Codman(A (R)) over the study period (NS). Intraparenchymal pressure measured with both transducers approximates intraventricular cerebrospinal fluid pressure with an accuracy of +/- 7 mmHg.	[Lescot, Thomas] Grp Hosp Pitie Salpetriere, AP HP, Unite Neuroreanimat, Dept Anesthesia Reanimat, F-75651 Paris 13, France; [Lescot, Thomas; Reina, Vincent; Le Manach, Yannick; Boroli, Filippo; Chauvet, Dorian; Boch, Anne-Laure; Puybasset, Louis] Univ Paris 06, F-75651 Paris 13, France; [Lescot, Thomas; Le Manach, Yannick; Boroli, Filippo; Puybasset, Louis] Grp Hosp Pitie Salpetriere, AP HP, Anaesthesiol & Crit Care Dept, F-75651 Paris 13, France; [Reina, Vincent; Chauvet, Dorian; Boch, Anne-Laure] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurosurg, F-75651 Paris 13, France		Lescot, T (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Unite Neuroreanimat, Dept Anesthesia Reanimat, 47-83 Blvd Hop, F-75651 Paris 13, France.	thomas.lescot@psl.aphp.fr	Le Manach, Yannick/AAE-5700-2019	Le Manach, Yannick/0000-0003-0474-8545			Al-Tamimi YZ, 2009, NEUROSURGERY, V64, P94, DOI 10.1227/01.NEU.0000328392.98602.5A; Allin D, 2008, NEUROSURGERY, V62, P1158, DOI 10.1227/01.neu.0000325878.67752.eb; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; COURTOIS M, 1995, CIRCULATION, V92, P1994, DOI 10.1161/01.CIR.92.7.1994; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lescot T, 2005, INTENS CARE MED, V31, P1042, DOI 10.1007/s00134-005-2709-y; Lescot T, 2008, CURR OPIN CRIT CARE, V14, P129, DOI 10.1097/MCC.0b013e3282f63c51; Poca MA, 2002, J NEUROTRAUM, V19, P439, DOI 10.1089/08977150252932398; Schaller B, 2005, J TRAUMA, V59, P1521, DOI 10.1097/01.ta.0000197402.20180.6b; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9	16	31	31	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAY	2011	37	5					875	879		10.1007/s00134-011-2182-8			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747AG	WOS:000289291900021	21359608				2022-02-06	
J	Claudia, C; Claudia, R; Agostino, O; Simone, M; Stefano, G				Claudia, Casula; Claudia, Ranalli; Agostino, Ognibene; Simone, Magazzini; Stefano, Grifoni			Minor Head Injury in Warfarinized Patients: Indicators of Risk for Intracranial Hemorrhage	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head injury; Warfarin; Intracranial hemorrhage; Computed tomography; INR	ELDERLY TRAUMA PATIENTS; PREINJURY WARFARIN; ANTICOAGULATED PATIENTS; BRAIN-INJURY; IMPACT	Background: Head injury represents one of the most important and frequent traumatic pathology in the emergency department. Among the different risk factors, preinjury use of warfarin has received considerable attention in trauma literature. The aim of this study was to identify further risk indicators of intracranial hemorrhage (ICH) to improve risk stratification of warfarinized patients with minor head injuries. Methods: Medical records of 1,554 adult patients with minor head injuries evaluated by the Emergency Department of Azienda Ospedaliera, Universitaria Careggi from January 2007 to February 2008 were analyzed retrospectively. All the patients included in the study were subjected to blood tests. The international normalized ratio (INR) measured on admission was correlated with the results of head computed tomography scan. Results: Of the 1,410 patients included in the study, 75 (5.2%) were warfarin anticoagulated at the time of trauma. The INR measured on admission was 2.37 +/- 1.04 (mean +/- standard deviation), and this value was significantly associated with occurrence of ICH after head trauma (r = 0.37; p < 0.005). For 12 (of 75) patients of this group, the findings of the computed tomography scans were positive. The receiver operating characteristic curve show that the most effective INR cutoff value was 2.43, with a sensitivity of 92%, a specificity of 66%, and positive and negative predictive values of 33% and 97%, respectively. Conclusions: This study highlights the strong relationship between INR values and the probability of ICH, as shown in previous studies. The high negative predictive value of the identified cutoff, if confirmed, could be used to exclude ICH.	[Claudia, Casula; Claudia, Ranalli; Simone, Magazzini; Stefano, Grifoni] Azienda Osped Univ Careggi, Dept Emergency, I-50139 Florence, Italy; [Agostino, Ognibene] Azienda Osped Univ Careggi, Gen Lab Clin Biochem, I-50139 Florence, Italy		Agostino, O (corresponding author), Azienda Osped Univ Careggi, Dipartimento Lab, Lab Gen, Piastra Serv, Viale Morgagni 85, I-50139 Florence, Italy.	a.ognibene@med.unifi.it		Ognibene, Agostino/0000-0001-5287-4250			[Anonymous], 1996, J NEUROSURG SCI, V40, P11; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Karni A, 2001, AM SURGEON, V67, P1098; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Parmar K. A., 2006, SMJ Singapore Medical Journal, V47, P676; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Saab M, 1996, J ACCID EMERG MED, V13, P208; Volans AP, 1998, J ACCID EMERG MED, V15, P159; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	18	31	31	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2011	70	4					906	909		10.1097/TA.0b013e3182031ab7			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	750OV	WOS:000289558700030	21610395				2022-02-06	
J	Gray, E; Ginty, M; Kemp, K; Scolding, N; Wilkins, A				Gray, Elizabeth; Ginty, Mark; Kemp, Kevin; Scolding, Neil; Wilkins, Alastair			Peroxisome proliferator-activated receptor-alpha agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						fenofibrate; nitric oxide; peroxisome; peroxisome proliferator activated receptor	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE; MULTIPLE-SCLEROSIS; PPAR-ALPHA; IN-VITRO; NEURODEGENERATIVE DISEASES; AUTOIMMUNE-DISEASE; AXONAL INJURY; FATTY-ACIDS	Inflammation is known to cause significant neuronal damage and axonal injury in many neurological disorders. Among the range of inflammatory mediators, nitric oxide is a potent neurotoxic agent. Recent evidence has suggested that cellular peroxisomes may be important in protecting neurons from inflammatory damage. To assess the influence of peroxisomal activation on nitric oxide-mediated neurotoxicity, we investigated the effects of the peroxisomal proliferator-activated receptor (PPAR)-alpha agonist fenofibrate on cortical neurons exposed to a nitric oxide donor or co-cultured with activated microglia. Fenofibrate protected neurons and axons against both nitric oxide donor-induced and microglia-derived nitric oxide-induced toxicity. Moreover, cortical neurons treated with this compound showed a significant increase in gene expression of ABCD3 (the gene encoding for peroxisomal membrane protein-70), with a concomitant increase in protein levels of PPAR-alpha and catalase, which was associated with a functional increase in the activity of this enzyme. Collectively, these observations provide evidence that modulation of PPAR-alpha activity and peroxisomal function by fenofibrate attenuates nitric oxide-mediated neuronal and axonal damage, suggesting a new therapeutic approach to protect against neurodegenerative changes associated with neuroinflammation.	[Gray, Elizabeth; Ginty, Mark; Kemp, Kevin; Scolding, Neil; Wilkins, Alastair] Univ Bristol, Frenchay Hosp, Inst Clin Neurosci, Burden Ctr,MS Labs, Bristol BS16 1JB, Avon, England		Gray, E (corresponding author), Univ Bristol, Frenchay Hosp, Inst Clin Neurosci, Burden Ctr,MS Labs, Bristol BS16 1JB, Avon, England.	elizabeth.gray@bristol.ac.uk	; Kemp, Kevin/B-9755-2017	Scolding, Neil/0000-0001-9177-1043; Kemp, Kevin/0000-0003-1465-1309	Multiple Sclerosis Society of Great Britain; Multiple Sclerosis Society of Northern Ireland	This work was supported by a Junior Research Fellowship grant from the Multiple Sclerosis Society of Great Britain and Northern Ireland.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Bernardo A, 2009, J NEUROPATH EXP NEUR, V68, P797, DOI 10.1097/NEN.0b013e3181aba2c1; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Cunard R, 2002, J IMMUNOL, V169, P6806, DOI 10.4049/jimmunol.169.12.6806; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Deplanque D, 2003, J NEUROSCI, V23, P6264; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Drew PD, 2006, NEUROCHEM INT, V49, P183, DOI 10.1016/j.neuint.2006.04.003; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Finn JT, 2000, J NEUROSCI, V20, P1333; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Gocke AR, 2009, J IMMUNOL, V182, P4479, DOI 10.4049/jimmunol.0713927; Golde S, 2002, J NEUROCHEM, V82, P269, DOI 10.1046/j.1471-4159.2002.00973.x; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Guo QM, 2010, J CEREBR BLOOD F MET, V30, P70, DOI 10.1038/jcbfm.2009.185; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; Imanaka T, 2000, CELL BIOCHEM BIOPHYS, V32, P131, DOI 10.1385/CBB:32:1-3:131; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Jones DC, 2002, J BIOL CHEM, V277, P6838, DOI 10.1074/jbc.M106908200; Jung TW, 2007, J NEUROL SCI, V253, P53, DOI 10.1016/j.jns.2006.11.020; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LEE VMY, 1987, J NEUROSCI, V7, P3474; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Santos MJ, 2005, J BIOL CHEM, V280, P41057, DOI 10.1074/jbc.M505160200; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Singh I, 2004, BRAIN RES, V1022, P1, DOI 10.1016/j.brainres.2004.06.059; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; van Horssen J., 2010, BIOCHIM BIOPHYS ACTA, V1812, P141; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; Wilkins A, 2004, NEURON GLIA BIOL, V1, P297, DOI 10.1017/S1740925X05000104; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x	57	31	32	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	APR	2011	33	8					1421	1432		10.1111/j.1460-9568.2011.07637.x			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751TY	WOS:000289641700007	21375604				2022-02-06	
J	Li, LA; Jiang, QA; Qu, CS; Ding, GL; Li, QJ; Wang, SY; Lee, JH; Lu, M; Mahmood, A; Chopp, M				Li, Lian; Jiang, Quan; Qu, Chang Sheng; Ding, Guang Liang; Li, Qing Jiang; Wang, Shi Yang; Lee, Ji Hyun; Lu, Mei; Mahmood, Asim; Chopp, Michael			Transplantation of Marrow Stromal Cells Restores Cerebral Blood Flow and Reduces Cerebral Atrophy in Rats with Traumatic Brain Injury: In vivo MRI Study	JOURNAL OF NEUROTRAUMA			English	Article						cerebral atrophy; cerebral blood flow; marrow stromal cells; MRI; ventricular expansion	VOLUME; MODERATE; MILD; PERFUSION; ISCHEMIA; DAMAGE; DEATH	Cell therapy promotes brain remodeling and improves functional recovery after various central nervous system disorders, including traumatic brain injury (TBI). We tested the hypothesis that treatment of TBI with intravenous administration of human marrow stromal cells (hMSCs) provides therapeutic benefit in modifying hemodynamic and structural abnormalities, which are detectable by in vivo MRI. hMSCs were labeled with superparamagnetic iron oxide (SPIO) nanoparticles. Male Wistar rats (300-350 g, n = 18) subjected to controlled cortical impact TBI were intravenously injected with 1 mL of saline (n = 9) or hMSCs in suspension (n = 9, approximately 3 x 10(6) SPIO-labeled hMSCs) 5 days post-TBI. In vivo MRI measurements consisting of cerebral blood flow (CBF), T2-weighted imaging, and 3D gradient echo imaging were performed for all animals 2 days post-TBI and weekly for 6 weeks. Functional outcome was evaluated with modified neurological severity score and Morris water maze test. Cell engraftment was detected in vivo by 3D MRI and confirmed by double staining. Ventricle and lesion volumetric alterations were measured using T2 maps, and hemodynamic abnormality was tracked by MRI CBF measurements. Our data demonstrate that treatment with hMSCs following TBI diminishes hemodynamic abnormalities by early restoration and preservation of CBF in the brain regions adjacent to and remote from the impact site, and reduces generalized cerebral atrophy, all of which may contribute to the observed improvement of functional outcome.	[Li, Lian; Jiang, Quan; Ding, Guang Liang; Li, Qing Jiang; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Qu, Chang Sheng; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Wang, Shi Yang; Lee, Ji Hyun] Oakland Univ, Dept Phys, Rochester, MI USA		Jiang, QA (corresponding author), Henry Ford Hosp, Dept Neurol, Educ & Res Bldg,B126,2799 W Grand Blvd, Detroit, MI 48202 USA.	QJIANG1@hfhs.org	Wang, Shiyang/C-1729-2012	LEE, JI HYUN/0000-0003-0450-2879; Li, Lian/0000-0003-0097-1184; Ding, Guangliang/0000-0003-1286-5901	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS23393, PO1 NS42345, RO1 NS48349, RO1 NS38292, RO1 NS43324, HL64766]; Mort and Brigitte Harris Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134, R01NS048349, P01NS042345, P50NS023393, R01NS038292] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke (grants P50 NS23393, PO1 NS42345, RO1 NS48349, RO1 NS38292, RO1 NS43324, HL64766) and the Mort and Brigitte Harris Foundation.	Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Borlongan CV, 2004, BRAIN RES, V1009, P26, DOI 10.1016/j.brainres.2004.02.050; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; HOSSMANN KA, 1993, RESUSCITATION, V26, P225, DOI 10.1016/0300-9572(93)90143-E; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Li L, 2005, J MAGN RESON IMAGING, V21, P726, DOI 10.1002/jmri.20318; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; MORRIS PP, 2002, MAGNETIC RESONANCE I, P773; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; WILKINS A, 2009, CELL RES IN PRESS; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	43	31	32	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2011	28	4					535	545		10.1089/neu.2010.1619			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	746IW	WOS:000289240200005	21275806	Green Published			2022-02-06	
J	Hudak, A; Warner, M; de la Plata, CM; Moore, C; Harper, C; Diaz-Arrastia, R				Hudak, Anne; Warner, Matthew; de la Plata, Carlos Marquez; Moore, Carol; Harper, Caryn; Diaz-Arrastia, Ramon			Brain morphometry changes and depressive symptoms after traumatic brain injury	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						MRI; BDI-II; Cerebral atrophy	II PSYCHIATRIC-DISORDERS; SURFACE-BASED ANALYSIS; GLASGOW OUTCOME SCALE; MAJOR DEPRESSION; MOOD DISORDERS; HEAD-INJURY; AXIS-I; MILD; OUTPATIENTS; IMPAIRMENT	Traumatic brain injury (TBI) is associated with an increased risk of depressive symptoms. Recent imaging studies on spontaneous depression have implicated several brain structures: however, few studies have done the same for post-TBI depression. We report on a pilot observational study correlating atrophy of brain regions of interest in subjects after TBI with depressive symptoms measured by the Beck Depression Inventory-II. Regional brain volumes were calculated on both acute and 6-month MRI using an automated segmentation algorithm (FreeSurfer). Percent volume changes in brain regions were correlated with BDI-II scores using Spearman's rank order correlation coefficient. Correction for multiple comparisons was performed using the false discovery rate (FDR). Three regions of interest (left rostral anterior cingulate and bilateral orbitofrontal cortex) were found to be significantly correlated with depressive symptoms (FDR 0.05). With FDR 0.1, six regions were significantly correlated. The use of volumetric analysis of brain regions of interest to study post-TBI depression is worthy of further study. Regions associated with depressive symptoms in this pilot study were similar to those implicated in study of spontaneous depression. (C) 2010 Elsevier Ireland Ltd. All rights reserved.	[Hudak, Anne] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Warner, Matthew; Moore, Carol; Harper, Caryn; Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [de la Plata, Carlos Marquez] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75235 USA		Hudak, A (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Anne.Hudak@utsouthwestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	Mike Winters Fund; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS060827, R01 HD48179, U01 HD 42652]; NIH, Department of EducationUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [H133 A020526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS060827] Funding Source: NIH RePORTER	This publication was supported by the Mike Winters Fund (Anne Hudak), Doris Duke Charitable Foundation Clinical Research Fellowship (Matthew Warner), NIH K23 NS060827 (Carlos Marquez de la Plata), and NIH R01 HD48179, U01 HD 42652, Department of Education H133 A020526 (Ramon Diaz-Arrastia).	Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deb S, 1999, AM J PSYCHIAT, V156, P374; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Douglas KM, 2009, AUST NZ J PSYCHIAT, V43, P1105, DOI 10.3109/00048670903279887; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hamster K., 1983, MULTILINGUAL APHASIA; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jorge R, 2002, NEUROREHABILITATION, V17, P311; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kirkness Catherine J, 2002, J Neurosci Nurs, V34, P134; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kronenberg G, 2009, J PSYCHIATR RES, V43, P1112, DOI 10.1016/j.jpsychires.2009.03.007; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Mak AKY, 2009, PROG NEURO-PSYCHOPH, V33, P1184, DOI 10.1016/j.pnpbp.2009.06.025; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; NIMH, 2009, NIH PUBL, V09-4702; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reitan RM, 1992, TRAIL MAKING TEST MA; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; SAS, 2008, SAS WIND VERS 9 2; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Theberge Jean, 2008, Top Magn Reson Imaging, V19, P111, DOI 10.1097/RMR.0b013e3181808140; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yucel K, 2008, NEUROPSYCHOPHARMACOL, V33, P3157, DOI 10.1038/npp.2008.40	56	31	31	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	MAR 31	2011	191	3					160	165		10.1016/j.pscychresns.2010.10.003			6	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	739OW	WOS:000288728500002	21310594	Green Accepted			2022-02-06	
J	Nelson, DW; Thornquist, B; MacCallum, RM; Nystrom, H; Holst, A; Rudehill, A; Wanecek, M; Bellander, BM; Weitzberg, E				Nelson, David W.; Thornquist, Bjorn; MacCallum, Robert M.; Nystrom, Harriet; Holst, Anders; Rudehill, Anders; Wanecek, Michael; Bellander, Bo-Michael; Weitzberg, Eddie			Analyses of cerebral microdialysis in patients with traumatic brain injury: relations to intracranial pressure, cerebral perfusion pressure and catheter placement	BMC MEDICINE			English	Article							INTRACEREBRAL MICRODIALYSIS; BLOOD-FLOW; EXTRACELLULAR GLUCOSE; ARTERY OCCLUSION; METABOLISM; LACTATE; TISSUE; REPERFUSION; GLUTAMATE; DAMAGE	Background: Cerebral microdialysis (MD) is used to monitor local brain chemistry of patients with traumatic brain injury (TBI). Despite an extensive literature on cerebral MD in the clinical setting, it remains unclear how individual levels of real-time MD data are to be interpreted. Intracranial pressure (ICP) and cerebral perfusion pressure (CPP) are important continuous brain monitors in neurointensive care. They are used as surrogate monitors of cerebral blood flow and have an established relation to outcome. The purpose of this study was to investigate the relations between MD parameters and ICP and/or CPP in patients with TBI. Methods: Cerebral MD, ICP and CPP were monitored in 90 patients with TBI. Data were extensively analyzed, using over 7,350 samples of complete (hourly) MD data sets (glucose, lactate, pyruvate and glycerol) to seek representations of ICP, CPP and MD that were best correlated. MD catheter positions were located on computed tomography scans as pericontusional or nonpericontusional. MD markers were analyzed for correlations to ICP and CPP using time series regression analysis, mixed effects models and nonlinear (artificial neural networks) computer-based pattern recognition methods. Results: Despite much data indicating highly perturbed metabolism, MD shows weak correlations to ICP and CPP. In contrast, the autocorrelation of MD is high for all markers, even at up to 30 future hours. Consequently, subject identity alone explains 52% to 75% of MD marker variance. This indicates that the dominant metabolic processes monitored with MD are long-term, spanning days or longer. In comparison, short-term (differenced or.) changes of MD vs. CPP are significantly correlated in pericontusional locations, but with less than 1% explained variance. Moreover, CPP and ICP were significantly related to outcome based on Glasgow Outcome Scale scores, while no significant relations were found between outcome and MD. Conclusions: The multitude of highly perturbed local chemistry seen with MD in patients with TBI predominately represents long-term metabolic patterns and is weakly correlated to ICP and CPP. This suggests that disturbances other than pressure and/or flow have a dominant influence on MD levels in patients with TBI.	[Nelson, David W.; Thornquist, Bjorn; Rudehill, Anders; Wanecek, Michael; Weitzberg, Eddie] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anesthesiol & Intens Care, Stockholm, Sweden; [MacCallum, Robert M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Immunogen Grp, London, England; [Nystrom, Harriet] Karolinska Inst, Sect Neuroradiol, Dept Clin Neurosci, Stockholm, Sweden; [Holst, Anders] SICS, Kista, Sweden; [Bellander, Bo-Michael] Karolinska Inst, Sect Neurosurg, Dept Clin Neurosci, Stockholm, Sweden		Nelson, DW (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Anesthesiol & Intens Care, Stockholm, Sweden.	david.nelson@karolinska.se	Wanecek, Michael/AAE-7998-2021	Nelson, David/0000-0003-2530-8207	Karolinska InstitutetKarolinska Institutet; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Cancer and Traffic Injury Fund (CTRF); Stockholm County CouncilStockholm County Council	Funding for this study was provided in part by the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet, funds from the Karolinska Institutet, The Swedish Research Council, The Swedish Cancer and Traffic Injury Fund (CTRF). In addition, we thank Gunilla Bornhall Malmborg for her work with the Karolinska Brain Trauma Databank. The study was conducted at the neurointensive care unit of the Karolinska University Hospital.	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2009, J CEREBR BLOOD F MET, V29, P965, DOI 10.1038/jcbfm.2009.22; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 2003, SCAND CARDIOVASC J, V37, P13, DOI 10.1080/14017430310006974; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; JENNETT B, 1975, LANCET, V1, P480; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kerr ME, 2003, CRIT CARE MED, V31, P2371, DOI 10.1097/01.CCM.0000080484.72004.C4; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mazzeo AT, 2005, NEUROCRIT CARE, V2, P282, DOI 10.1385/NCC:2:3:282; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Peerdeman SM, 2000, INTENS CARE MED, V26, P662, DOI 10.1007/s001340051230; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; R Development Core Team, 2008, R LANG ENV STAT COMP; Reinert M, 2000, Neurosurg Focus, V8, pe10; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Salci Kontsantin, 2006, J Clin Monit Comput, V20, P25, DOI 10.1007/s10877-006-2864-x; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	51	31	33	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7015			BMC MED	BMC Med.	MAR 2	2011	9								21	10.1186/1741-7015-9-21			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763NG	WOS:000290565500001	21366904	gold, Green Published			2022-02-06	
J	Johnson, U; Nilsson, P; Ronne-Engstrom, E; Howells, T; Enblad, P				Johnson, Ulf; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Howells, Tim; Enblad, Per			Favorable Outcome in Traumatic Brain Injury Patients With Impaired Cerebral Pressure Autoregulation When Treated at Low Cerebral Perfusion Pressure Levels	NEUROSURGERY			English	Article						Cerebral perfusion pressure; Cerebrovascular pressure autoregulation; Head injury; Outcome	SEVERE HEAD-INJURY; BLOOD-FLOW; INTRACRANIAL HYPERTENSION; REACTIVITY; CRANIECTOMY; MANAGEMENT; DYNAMICS; PROTOCOL; THERAPY; INSULTS	BACKGROUND: Cerebral pressure autoregulation (CPA) is defined as the ability of the brain vasculature to maintain a constant blood flow over a range of different systemic blood pressures by means of contraction and dilatation. OBJECTIVE: To study CPA in relation to physiological parameters, treatment, and outcome in a series of traumatic brain injury patients. METHODS: In this prospective observational study, 44 male and 14 female patients (age, 15-72 years; mean, 38.7 years; Glasgow Coma Scale score, 4-13; median, 7) were analyzed. Patients were divided into groups on the basis of status of CPA (more pressure active vs more pressure passive) and level of cerebral perfusion pressure (CPP; low vs high CPP). The proportions of favorable outcome in the groups were assessed. Differences in physiological variables in the different groups were analyzed. RESULTS: Patients with more impaired CPA treated at CPP levels below median had a significantly higher proportion of favorable outcome compared with patients with more impaired CPA treated at CPP levels above median. No significant difference in outcome was seen between patients with more intact CPA when divided by level of CPP. In patients with more impaired CPA, CPP < 50 mm Hg and CPP < 60 mm Hg were associated with favorable outcome, whereas CPP > 70 mm Hg and CPP > 80 mm Hg were associated with unfavorable outcome. In patients with more intact CPA, no difference in physiological variables was seen between patients with favorable and unfavorable outcomes. CONCLUSION: Our results support that in traumatic brain injury patients with impaired CPA, CPP should not be elevated.	[Johnson, Ulf; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Howells, Tim; Enblad, Per] Univ Uppsala Hosp, Dept Neurosci, Neurosurg Sect, S-75185 Uppsala, Sweden		Johnson, U (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Neurosurg Sect, S-75185 Uppsala, Sweden.	ulf.johnson@neuro.uu.se		Johnson, Ulf/0000-0002-3879-6476	Swedish Research CouncilSwedish Research CouncilEuropean Commission	This work was supported by a Swedish Research Council grant. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Balestreri M, 2005, ACT NEUR S, V95, P25; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Chieregato A, 2007, INTENS CARE MED, V33, P856, DOI 10.1007/s00134-007-0604-4; Chieregato A, 2007, NEUROSURGERY, V60, P115, DOI 10.1227/01.NEU.0000249194.76527.28; Consonni F, 2009, NEUROCRIT CARE, V10, P232, DOI 10.1007/s12028-008-9151-2; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; CZOSNYKA M, 1992, ACTA NEUROCHIR, V115, P90, DOI 10.1007/BF01406364; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Huang SJ, 2007, J CLIN NEUROSCI, V14, P449, DOI 10.1016/j.jocn.2005.12.012; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Takahashi R, 2000, TOHOKU J EXP MED, V190, P129, DOI 10.1620/tjem.190.129; Thorat JD, 2008, J CLIN NEUROSCI, V15, P143, DOI 10.1016/j.jocn.2006.08.014; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; TODA N, 1976, BRIT J PHARMACOL, V58, P121, DOI 10.1111/j.1476-5381.1976.tb07700.x; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	32	31	36	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	2011	68	3					714	721		10.1227/NEU.0b013e3182077313			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	719WN	WOS:000287242300043	21311298				2022-02-06	
J	Zhang, LX; Seitz, LC; Abramczyk, AM; Liu, L; Chan, C				Zhang, Linxia; Seitz, Linsey C.; Abramczyk, Amy M.; Liu, Li; Chan, Christina			cAMP initiates early phase neuron-like morphology changes and late phase neural differentiation in mesenchymal stem cells	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						cAMP; Morphology; Apoptosis; Neural differentiation	MARROW STROMAL CELLS; PROTEIN-KINASE-A; IN-VITRO DIFFERENTIATION; TRAUMATIC BRAIN-INJURY; BONE-MARROW; CYCLIC-AMP; CARCINOMA-CELLS; PHOSPHORYLATION; RHO; INDUCTION	The intracellular second messenger cAMP is frequently used in induction media to induce mesenchymal stem cells (MSCs) into neural lineage cells. To date, an understanding of the role cAMP exerts on MSCs and whether cAMP can induce MSCs into functional neurons is still lacking. We found cAMP initiated neuron-like morphology changes early and neural differentiation much later. The early phase changes in morphology were due to cell shrinkage, which subsequently rendered some cells apoptotic. While the morphology changes occurred prior to the expression of neural markers, it is not required for neural marker expression and the two processes are differentially regulated downstream of cAMP-activated protein kinase A. cAMP enabled MSCs to gain neural marker expressions with neuronal function, such as, calcium rise in response to neuronal activators, dopamine, glutamate, and potassium chloride. However, only some of the cells induced by cAMP responded to the three neuronal activators and further lack the neuronal morphology, suggesting that although cAMP is able to direct MSCs towards neural differentiation, they do not achieve terminal differentiation.	[Zhang, Linxia; Seitz, Linsey C.; Abramczyk, Amy M.; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Liu, Li] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA		Chan, C (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, 2527 EB, E Lansing, MI 48824 USA.	krischan@egr.msu.edu	Seitz, Linsey/Y-4345-2019; liu, li/C-2428-2015	Seitz, Linsey/0000-0001-6831-6747	National Science FoundationNational Science Foundation (NSF) [CBET 0941055]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM079688, R21RR024439]; MUCI; MSU Foundation; Center for Systems Biology; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R21RR024439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM079688] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp SysNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [0941055] Funding Source: National Science Foundation	We thank Dr. Carlose Molina at New Jersey Medical School for kindly providing the ICER antibody and Dr. David Ginty at Johns Hopkins University for kindly providing the M1-CREB plasmid. This study was supported in part by the National Science Foundation (CBET 0941055), the National Institute of Health (R01GM079688 and R21RR024439), the MUCI, and the MSU Foundation and the Center for Systems Biology.	Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; BELL PB, 1995, SCANNING MICROSCOPY, V9, P843; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; BERRY L, 1992, J CELL SCI, V101, P333; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cauthron RD, 1998, MOL CELL BIOL, V18, P1416, DOI 10.1128/MCB.18.3.1416; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Deng J, 2006, STEM CELLS, V24, P1054, DOI 10.1634/stemcells.2005-0370; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flusberg DA, 2001, MOL BIOL CELL, V12, P3087, DOI 10.1091/mbc.12.10.3087; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Han JD, 1996, J BIOL CHEM, V271, P29211, DOI 10.1074/jbc.271.46.29211; Herbertson A, 1997, BONE, V21, P491, DOI 10.1016/S8756-3282(97)00197-X; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jori FP, 2005, J CELL BIOCHEM, V94, P645, DOI 10.1002/jcb.20315; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kuznetsov SA, 1997, J BONE MINER RES, V12, pF440; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Park SY, 2005, CANCER LETT, V224, P123, DOI 10.1016/j.canlet.2004.10.009; Patil S, 2007, EUR J NEUROSCI, V26, P2131, DOI 10.1111/j.1460-9568.2007.05797.x; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Rocchi S, 2000, BIOCHEM J, V352, P483, DOI 10.1042/0264-6021:3520483; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Tikhonov D B, 2009, Neurosci Behav Physiol, V39, P763, DOI 10.1007/s11055-009-9195-6; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Wang TT, 2007, BIOCHEM BIOPH RES CO, V357, P1021, DOI 10.1016/j.bbrc.2007.04.046; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhang Linxia, 2010, J Vis Exp, DOI 10.3791/1852	58	31	32	0	11	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	MAR	2011	68	5					863	876		10.1007/s00018-010-0497-1			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	719WY	WOS:000287243400009	20725762	Green Accepted			2022-02-06	
J	Murphy-Human, T; Welch, E; Zipfel, G; Diringer, MN; Dhar, R				Murphy-Human, Theresa; Welch, Emily; Zipfel, Gregory; Diringer, Michael N.; Dhar, Rajat			Comparison of Short-Duration Levetiracetam with Extended-Course Phenytoin for Seizure Prophylaxis After Subarachnoid Hemorrhage	WORLD NEUROSURGERY			English	Article						Levetiracetam; Phenytoin; Seizures; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; INTRAVENOUS LEVETIRACETAM; ANTIEPILEPTIC DRUGS; EPILEPSY; TRIAL; TOLERABILITY; ANEURYSMS; EFFICACY; ONSET	BACKGROUND: The optimal regimen for seizure prophylaxis after subarachnoid hemorrhage (SAH) remains uncertain. Based on data suggesting that a short course may be adequate, coupled with an association between phenytoin exposure and poor cognitive outcome, our institution modified their seizure prophylaxis protocol for patients with SAH from an extended course of phenytoin to 3 days of levetiracetam. This study sought to compare the incidence of seizures before and after this change to evaluate whether a short course of levetiracetam would be as effective in preventing in-hospital seizures. METHODS: This study analyzed 442 consecutive patients admitted with SAH between January 2003 and January 2008, including 297 patients treated before the protocol change (PHT group) and 145 treated afterward (LEV group). Occurrence of all seizures was extracted from a prospectively collected intensive care unit database and further review of medical records. In-hospital seizures were divided into early (occurring on or before day 3, all patients on prophylaxis) and those occurring late (after day 3, LEV group off prophylaxis). RESULTS: In-hospital seizures occurred in 3.4% of the PHT group and 8.3% of the LEV group (P = 0.03). Although the rate of early seizures was not different (1.4% PHT vs. 2.8% LEV, P = 0.45), there was a higher rate of late seizures (2% PHT vs. 5.5% LEV, P = 0.05). CONCLUSIONS: The use of short-duration levetiracetam for seizure prophylaxis after SAH was associated with a higher rate of in-hospital seizures than an extended course of phenytoin, mainly related to an increase in late seizures, when the levetiracetam had been discontinued. This suggests that a longer duration of prophylaxis may be required to minimize seizures in patients with SAH, although confirmatory studies are required.	[Murphy-Human, Theresa; Welch, Emily] Barnes Jewish Hosp, Dept Pharm, St Louis, MO 63110 USA; [Zipfel, Gregory; Diringer, Michael N.; Dhar, Rajat] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Zipfel, Gregory; Diringer, Michael N.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA		Murphy-Human, T (corresponding author), Barnes Jewish Hosp, Dept Pharm, St Louis, MO 63110 USA.	txm5120@bjc.org	Diringer, Michael N/C-1165-2008	Diringer, Michael N/0000-0003-2337-5537; Dhar, Rajat/0000-0002-5167-5097			Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Buczacki SJ, 2004, J NEUROL NEUROSUR PS, V75, P1620, DOI 10.1136/jnnp.2003.026856; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Cereghino JJ, 2000, NEUROLOGY, V55, P236, DOI 10.1212/WNL.55.2.236; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chumnanvej S, 2007, NEUROSURGERY, V60, P99, DOI 10.1227/01.NEU.0000249207.66225.D9; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; HART RG, 1981, NEUROSURGERY, V8, P417, DOI 10.1227/00006123-198104000-00002; HASAN D, 1993, ANN NEUROL, V33, P286; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Knake S, 2008, J NEUROL NEUROSUR PS, V79, P588, DOI 10.1136/jnnp.2007.130260; LaRoche SM, 2004, JAMA-J AM MED ASSOC, V291, P615, DOI 10.1001/jama.291.5.615; LaRoche SM, 2004, JAMA-J AM MED ASSOC, V291, P605, DOI 10.1001/jama.291.5.605; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; Lin CL, 2003, J NEUROSURG, V99, P978, DOI 10.3171/jns.2003.99.6.0978; Lin YJ, 2008, EUR J NEUROL, V15, P451, DOI 10.1111/j.1468-1331.2008.02096.x; Liu KC, 2007, NEUROCRIT CARE, V7, P175, DOI 10.1007/s12028-007-0061-5; Milligan TA, 2008, NEUROLOGY, V71, P665, DOI 10.1212/01.wnl.0000324624.52935.46; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Naidech AM, 2005, STROKE, V36, P583, DOI 10.1161/01.STR.0000141936.36596.1e; Newton HB, 2006, J NEURO-ONCOL, V78, P99, DOI 10.1007/s11060-005-9070-4; Pinto AN, 1996, J NEUROL, V243, P161, DOI 10.1007/BF02444009; Rhoney DH, 2000, NEUROLOGY, V55, P258, DOI 10.1212/WNL.55.2.258; ROSE FC, 1965, BRIT MED J, V1, P18, DOI 10.1136/bmj.1.5426.18; Rosengart AJ, 2007, J NEUROSURG, V107, P253, DOI 10.3171/JNS-07/08/0253; Ruegg S, 2008, EPILEPSY BEHAV, V12, P477, DOI 10.1016/j.yebeh.2008.01.004; Szaflarski JP, 2007, NEUROCRIT CARE, V7, P140, DOI 10.1007/s12028-007-0042-8; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; THOMSON T, 2007, COCHRANE DB SYST REV, V1; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Zubkov Alexander Y, 2008, Rev Neurol Dis, V5, P178	35	31	34	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2011	75	2					269	274		10.1016/j.wneu.2010.09.002			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	793JG	WOS:000292816700048	21492729				2022-02-06	
J	Barnes, PD				Barnes, Patrick D.			Imaging of Nonaccidental Injury and the Mimics: Issues and Controversies in the Era of Evidence-Based Medicine	RADIOLOGIC CLINICS OF NORTH AMERICA			English	Article						Evidence-based medicine; Nonaccidental injury; Nonaccidental trauma; Nonaccidental head injury; Child abuse	SHAKEN BABY SYNDROME; CHRONIC SUBDURAL-HEMATOMA; TRAUMATIC BRAIN-INJURY; INFLICTED HEAD-INJURY; CEREBRAL SINOVENOUS THROMBOSIS; BENIGN EXTERNAL HYDROCEPHALUS; PERIMACULAR RETINAL FOLDS; YOUNG-CHILDREN; INTRACRANIAL HEMORRHAGE; CLINICAL ANALYSIS	Because of the controversy involving the determination of child abuse, or nonaccidental injury (NAI), radiologists must be familiar with the issues, literature, and principles of evidence-based medicine to understand the role of imaging. Children with suspected NAI must receive protective evaluation along with a timely and complete clinical and imaging work-up. Imaging findings cannot stand alone and must be correlated with clinical findings, laboratory testing, and pathologic and forensic examinations. Only the child protection investigation may provide the basis for inflicted injury in the context of supportive clinical, imaging, biomechanical, or pathology findings.	Stanford Univ, Med Ctr, Dept Radiol, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA		Barnes, PD (corresponding author), Stanford Univ, Med Ctr, Dept Radiol, Lucile Packard Childrens Hosp, 725 Welch Rd, Palo Alto, CA 94304 USA.	pbarnes@stanford.edu					Alexander JM, 2006, OBSTET GYNECOL, V108, P885, DOI 10.1097/01.AOG.0000237116.72011.f3; AOKI N, 1990, J NEUROSURG, V73, P201, DOI 10.3171/jns.1990.73.2.0201; AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Aryan HE, 2005, J CLIN NEUROSCI, V12, P624, DOI 10.1016/j.jocn.2005.05.005; AZAIS M, 1992, ANN PEDIATR-PARIS, V39, P550; Bandak FA, 2005, FORENSIC SCI INT, V151, P71, DOI 10.1016/j.forsciint.2005.02.033; BARKOVICH AJ, 2005, PEDIAT NEUROIMAGING, P190; Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Barnes C, 2006, THROMB RES, V118, P67, DOI 10.1016/j.thromres.2005.05.021; BARNES P, 2009, PEDIAT RADIOLOGY REQ, P221; BARNES P, 2008, SCI SESS SCOTTSD AZ; Barnes Patrick D, 2007, Top Magn Reson Imaging, V18, P53, DOI 10.1097/RMR.0b013e3180d0a455; Barnes PD, 2008, SEMIN PEDIATR NEUROL, V15, P178, DOI 10.1016/j.spen.2008.10.009; Barnes PD, 2000, PEDIATR RADIOL, V30, P74, DOI 10.1007/s002470050018; BIRD CR, 1987, RADIOLOGY, V163, P373, DOI 10.1148/radiology.163.2.3562816; Bishop N, 2007, ARCH DIS CHILD, V92, P251, DOI 10.1136/adc.2006.106120; Blackmore C Craig, 2006, J Am Coll Radiol, V3, P505, DOI 10.1016/j.jacr.2006.03.003; Bonkowsky JL, 2008, PEDIATRICS, V122, P125, DOI 10.1542/peds.2007-3376; Brousseau TJ, 2005, J EMERG MED, V29, P283, DOI 10.1016/j.jemermed.2005.02.009; BROWN S, 2007, J AAPOS, V11, P85; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1984, BRIT MED J, V289, P715, DOI 10.1136/bmj.289.6447.715; Byard RW, 2007, PEDIATR DEVEL PATHOL, V10, P348, DOI 10.2350/06-08-0154.1; Carvalho KS, 2001, J CHILD NEUROL, V16, P574, DOI 10.2310/7010.2001.16834; *CDC NAT IMM PROGR, 2000, GEN PERT INF, P2; Chabrol B, 1999, CHILD ABUSE NEGLECT, V23, P217, DOI 10.1016/S0145-2134(98)00128-8; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; Chamnanvanakij S, 2002, PEDIATR NEUROL, V26, P301, DOI 10.1016/S0887-8994(01)00420-9; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; Clemetson C. A. B., 2004, J AM PHYS SURG, V9, P78; Clemetson CA, 2006, J AM PHYS SURG, V11, P20; Cohen MC, 2009, PEDIATR DEVEL PATHOL, V12, P169, DOI 10.2350/08-08-0509.1; COHEN RA, 1985, AM J NEURORADIOL, V6, P883; Collins Jannette, 2007, J Am Coll Radiol, V4, P551, DOI 10.1016/j.jacr.2006.12.007; Croft PR, 2009, AM J FOREN MED PATH, V30, P10, DOI 10.1097/PAF.0b013e31818737be; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Datta S, 2005, ARCH DIS CHILD, V90, P947, DOI 10.1136/adc.2002.021154; David TJ, 2008, PEDIATR RADIOL, V38, pS370, DOI 10.1007/s00247-008-0829-6; Denton S, 2003, AM J FOREN MED PATH, V24, P371, DOI 10.1097/01.paf.0000097851.18478.16; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; DeWolfe CC, 2005, PEDIATR CLIN N AM, V52, P1127, DOI 10.1016/j.pcl.2005.05.004; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; Donohoe M, 2003, AM J FOREN MED PATH, V24, P239, DOI 10.1097/01.paf.0000083635.85457.97; Doumouchtsis SK, 2008, CLIN PERINATOL, V35, P69, DOI 10.1016/j.clp.2007.11.006; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1996, PEDIATR NEUROSURG, V25, P116, DOI 10.1159/000121108; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Dyer O, 2003, BRIT MED J, V326, P616; Emerson MV, 2007, OPHTHALMOLOGY, V114, P1384, DOI 10.1016/j.ophtha.2007.04.015; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; Ernst LM, 2006, J PEDIATR-US, V148, P779, DOI 10.1016/j.jpeds.2006.01.040; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Fitzgerald KC, 2006, ARCH NEUROL-CHICAGO, V63, P405, DOI 10.1001/archneur.63.3.405; Forbes BJ, 2008, J AAPOS, V12, P177, DOI 10.1016/j.jaapos.2007.07.009; Forbes BJ, 2007, J AAPOS, V11, P179, DOI 10.1016/j.jaapos.2006.08.006; Frasier L, 2006, ABUSIVE HEAD TRAUMA; Fullerton HJ, 2001, NEUROLOGY, V57, P1155, DOI 10.1212/WNL.57.7.1155; Fung ELW, 2002, PEDIATR INT, V44, P37, DOI 10.1046/j.1442-200X.2002.01500.x; GALAZNIK J, 2007, PEDIATRICS, V19, P1232; Galaznik JG, 2008, DEV MED CHILD NEUROL, V50, P317; Ganesh A, 2004, OPHTHALMOLOGY, V111, P1428, DOI 10.1016/j.ophtha.2003.10.028; Gardner H, 2003, AM J OPHTHALMOL, V135, P745, DOI 10.1016/S0002-9394(02)02284-5; Gardner HB, 2007, ARCH OPHTHALMOL-CHIC, V125, P1142, DOI 10.1001/archopht.125.8.1142-c; Geddes JF, 2006, NEUROPATH APPL NEURO, V32, P625, DOI 10.1111/j.1365-2990.2006.00771.x; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GENA M, 2007, WISC LAW REV, V701, P1; Gilles EE, 2003, J PEDIATR-US, V143, P494, DOI 10.1067/S0022-3476(03)00416-5; Gilliland MGF, 2003, HISTOPATHOLOGY, V43, P592, DOI 10.1111/j.1365-2559.2003.01762.x; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Groninger A, 2005, PEDIATR NEUROL, V32, P140, DOI 10.1016/j.pediatrneurol.2004.07.011; GROOPMAN J, WALL ST J; GUYATT HRB, 2000, JAMA-J AM MED ASSOC, V284, P1290; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Hangique S, 2002, IND J RADIOL IMAG, V12, P197; HAYASHI T, 1987, CHILD NERV SYST, V3, P23, DOI 10.1007/BF00707189; HELFER RE, 1977, PEDIATRICS, V60, P533; Hellbusch LC, 2007, J NEUROSURG, V107, P119, DOI 10.3171/PED-07/08/119; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Holden KR, 1999, J CHILD NEUROL, V14, P708, DOI 10.1177/088307389901401104; HON STG, 2008, REPORT INQUIRY PEDIA; HOWARD MA, 1993, BRIT J NEUROSURG, V7, P355, DOI 10.3109/02688699309103489; Hwang SK, 2000, CHILD NERV SYST, V16, P590, DOI 10.1007/s003810000312; Hymel Kent P, 2002, Child Maltreat, V7, P329, DOI 10.1177/107755902237263; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; IKEDA A, 1987, CHILD NERV SYST, V3, P19, DOI 10.1007/BF00707188; Innis MD, 2006, J AM PHYS SURG, V11, P17; Jaspan T, 2008, PEDIATR RADIOL, V38, pS378, DOI 10.1007/s00247-008-0896-8; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jayawant S, 2007, ARCH DIS CHILD, V92, P343, DOI 10.1136/adc.2005.084988; Jenny C, 2007, PEDIATRICS, V119, P1232, DOI 10.1542/peds.2007-0883; Jenny C, 2006, PEDIATRICS, V118, P1299, DOI 10.1542/peds.2006-1795; KAWAKAMI Y, 1989, NEUROSURGERY, V25, P25, DOI 10.1227/00006123-198907000-00005; Keierleber JA, 2005, J FORENSIC SCI, V50, P1154; Keller KA, 2008, PEDIATR RADIOL, V38, P1210, DOI 10.1007/s00247-008-1001-z; Keller KA, 2009, PEDIATR RADIOL, V39, P1130, DOI 10.1007/s00247-009-1381-8; Kemp AM, 2002, ARCH DIS CHILD, V86, P98, DOI 10.1136/adc.86.2.98; Kim KA, 2000, NEUROSURG FOCUS, V8, P1; KIRSCHNER RH, 1985, AM J DIS CHILD, V139, P873, DOI 10.1001/archpedi.1985.02140110027022; Kleinman PK, 2008, PEDIATR RADIOL, V38, pS388, DOI 10.1007/s00247-008-0845-6; Kleinman PK, 1998, DIAGNOSTIC IMAGING C; KRASNOKUTSKY M, 2007, SCI PAP SESS MIAM FL; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; LANTZ PE, 2006, AAFS ANN M SEATTL WA; LEESTMA J, 2009, FORENSIC NEUROPATHOL, P603; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; Liesner R, 2004, BLOOD COAGUL FIBRIN, V15, pS41, DOI 10.1097/00001721-200405001-00009; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; LYONS G, 2003, UTAH LAW REV, V1109, P1; LYONS TJ, 1993, PEDIATRICS, V92, P125; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; Mackey M, 2006, ARCH DIS CHILD, V91, P873, DOI 10.1136/adc.2006.100719; Marinetti L, 2005, J ANAL TOXICOL, V29, P738, DOI 10.1093/jat/29.7.738; Maxeiner H, 2001, J FORENSIC SCI, V46, P85; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Menge T, 2005, ARCH NEUROL-CHICAGO, V62, P1673, DOI 10.1001/archneur.62.11.1673; Minns RA, 2005, ARCH DIS CHILD, V90, P883, DOI 10.1136/adc.2004.060657; Mohan Parvathi, 2002, Pediatr Rev, V23, P330, DOI 10.1542/pir.23-9-330; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; Mori K, 2002, J NEUROTRAUM, V19, P1017, DOI 10.1089/089771502760341938; Moritani T, 2005, AM J NEURORADIOL, V26, P216; Murakami H, 2002, J NEUROSURG, V96, P877, DOI 10.3171/jns.2002.96.5.0877; Murray JA, 2000, AM SURGEON, V66, P863; Nassogne MC, 2002, CHILD NERV SYST, V18, P729, DOI 10.1007/s00381-002-0630-z; NEWMAN DH, 2009, NY TIMES        0204; NEWMAN DH, 2009, AMA NEWS        0304; Ney JP, 2005, NEUROLOGY, V65, P517, DOI 10.1212/01.wnl.0000178166.06001.b0; OBI E, 2007, J AAPOS, V11, P99, DOI DOI 10.1016/J.JAAPOS.2007.01.031; Oehmichen M, 2005, NEUROPEDIATRICS, V36, P240, DOI 10.1055/s-2005-872812; Ommaya A.K., 1968, JAMA-J AM MED ASSOC, V204, P75; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Page M, 2000, EARLY HUM DEV, V59, P127, DOI 10.1016/S0378-3782(00)00093-1; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; Piatt JH, 1999, NEUROSURG FOCUS, V7, P1; Pierce MC, 2008, ANNU REV BIOMED ENG, V10, P85, DOI 10.1146/annurev.bioeng.9.060906.151907; Pittman T, 2003, PEDIATR NEUROSURG, V39, P57, DOI 10.1159/000071315; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Pollina J, 2001, PEDIATR NEUROSURG, V35, P113, DOI 10.1159/000050403; Powers CJ, 2007, PEDIATR NEUROSURG, V43, P25, DOI 10.1159/000097521; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Ravid S, 2003, PEDIATR NEUROL, V28, P139, DOI 10.1016/S0887-8994(02)00500-3; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Rooks VJ, 1998, PEDIATR RADIOL, V28, P193, DOI 10.1007/s002470050330; Rooms L, 2003, PEDIATRICS, V111, pE636, DOI 10.1542/peds.111.5.e636; Ross M G, 2000, J Matern Fetal Med, V9, P321; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Sebire G, 2005, BRAIN, V128, P477, DOI 10.1093/brain/awh412; SIROTNAK AP, 2006, ABUSIVE HEAD TRAUMA, P191; SLOVIS TL, 2005, EXPERT PANEL PEDIATR; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Steinbok P, 2007, NEUROSURGERY, V60, P689, DOI 10.1227/01.NEU.0000255398.00410.6B; Stoodley N, 2005, CLIN RADIOL, V60, P22, DOI 10.1016/j.crad.2004.06.023; Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Surridge J, 2007, ARCH DIS CHILD, V92, P970, DOI 10.1136/adc.2006.114082; Talbert DG, 2006, MED HYPOTHESES, V66, P691, DOI 10.1016/j.mehy.2005.10.025; TONGUE AC, 1991, OPHTHALMOLOGY, V98, P1009; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; Trenchs V, 2007, PEDIATR NEUROSURG, V43, P352, DOI 10.1159/000106382; Tuerkheimer D., 2009, WASHINGTON U LAW REV, V87; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; UDASHEN G, 2006, TEXAS V HURTADO DAUB; Uscinski R, 2002, BRIT J NEUROSURG, V16, P217, DOI 10.1080/02688690220148978; Vezina G, 2009, PEDIATR RADIOL, V39, P586, DOI 10.1007/s00247-009-1212-y; Vinchon M, 2004, J NEUROSURG, V101, P44, DOI 10.3171/ped.2004.101.2.0044; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Volpe J. J., 2000, NEUROLOGY NEWBORN; Wells RG, 2003, ARCH PEDIAT ADOL MED, V157, P1005, DOI 10.1001/archpedi.157.10.1005; Wells RG, 2002, ARCH PEDIAT ADOL MED, V156, P252, DOI 10.1001/archpedi.156.3.252; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; Wygnanski-Jaffe T, 2006, AM J OPHTHALMOL, V142, P233, DOI 10.1016/j.ajo.2006.03.038; YAZBAK F, MULTIPLE VACCINATION; ZIMMERMAN RA, 1978, NEURORADIOLOGY, V16, P39, DOI 10.1007/BF00395197; Zouros A, 2004, J NEUROSURG, V100, P512, DOI 10.3171/ped.2004.100.5.0512; ZUERRER M, 1991, NEURORADIOLOGY, V33, P223, DOI 10.1007/BF00588222; 2003, PERTUSSIS, P472	192	31	31	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0033-8389	1557-8275		RADIOL CLIN N AM	Radiol. Clin. N. Am.	JAN	2011	49	1					205	+		10.1016/j.rcl.2010.08.001			26	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	701VE	WOS:000285850900011	21111136				2022-02-06	
J	Castel, AD; Lee, SS; Humphreys, KL; Moore, AN				Castel, Alan D.; Lee, Steve S.; Humphreys, Kathryn L.; Moore, Amy N.			Memory Capacity, Selective Control, and Value-Directed Remembering in Children With and Without Attention-Deficit/Hyperactivity Disorder (ADHD)	NEUROPSYCHOLOGY			English	Article						ADHD; memory; cognitive control; metamemory; encoding strategies	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; EXECUTIVE FUNCTION; IV; INHIBITION; PERFORMANCE; VALIDITY; GENDER; RECALL	Objective: The ability to select what is important to remember, to attend to this information, and to recall high-value items leads to the efficient use of memory. The present study examined how children with and without attention-deficit/hyperactivity disorder (ADHD) performed on an incentive-based selectivity task in which to-be-remembered items were worth different point values. Method: Participants were 6-9 year old children with ADHD (n = 57) and without ADHD (n = 59). Using a selectivity task, participants studied words paired with point values and were asked to maximize their score, which was the overall value of the items they recalled. This task allows for measures of memory capacity and the ability to selectively remember high-value items. Results: Although there were no significant between-groups differences in the number of words recalled (memory capacity), children with ADHD were less selective than children in the control group in terms of the value of the items they recalled (control of memory). All children recalled more high-value items than low-value items and showed some learning with task experience, but children with ADHD Combined type did not efficiently maximize memory performance (as measured by a selectivity index) relative to children with ADHD Inattentive type and healthy controls, who did not differ significantly from one another. Conclusions: Children with ADHD Combined type exhibit impairments in the strategic and efficient encoding and recall of high-value items. The findings have implications for theories of memory dysfunction in childhood ADHD and the key role of metacognition, cognitive control, and value-directed remembering when considering the strategic use of memory.	[Castel, Alan D.; Lee, Steve S.; Humphreys, Kathryn L.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Moore, Amy N.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Castel, AD (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	castel@ucla.edu			UCLA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R03AA020186] Funding Source: NIH RePORTER	We thank David McCabe for assistance with the exploratory factor analysis and useful discussions regarding the data. We also thank the families for participation in the study and the research staff for their help with data collection and management. Portions of this research were supported through a UCLA Faculty Career Development Award to Alan D. Castel.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Ariel R, 2009, J EXP PSYCHOL GEN, V138, P432, DOI 10.1037/a0015928; BADDELEY A, 1992, Q J EXP PSYCHOL-A, V44, P1, DOI 10.1080/14640749208401281; Baddeley A.D., 2007, COMMUNICATION 0913; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; BARKLEY RA, 1990, J AM ACAD CHILD PSY, V29, P546, DOI 10.1097/00004583-199007000-00007; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Bedard AC, 2002, DEV NEUROPSYCHOL, V21, P93, DOI 10.1207/S15326942DN2101_5; Burgess C, 1997, LANG COGNITIVE PROC, V12, P177, DOI 10.1080/016909697386844; Castel AD, 2002, MEM COGNITION, V30, P1078, DOI 10.3758/BF03194325; Castel AD, 2007, PSYCHOL LEARN MOTIV, V48, P225, DOI 10.1016/S0079-7421(07)48006-9; Castel AD, 2007, MEM COGNITION, V35, P689, DOI 10.3758/BF03193307; Castel AD, 2009, NEUROPSYCHOLOGY, V23, P297, DOI 10.1037/a0014888; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; DOUGLAS VI, 1988, J CHILD PSYCHOL PSYC, V29, P453, DOI 10.1111/j.1469-7610.1988.tb00737.x; Engelhardt PE, 2008, J ABNORM PSYCHOL, V117, P591, DOI 10.1037/a0012593; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; Geurts HM, 2005, ARCH CLIN NEUROPSYCH, V20, P457, DOI 10.1016/j.acn.2004.11.001; Halperin JM, 2008, J CHILD PSYCHOL PSYC, V49, P958, DOI 10.1111/j.1469-7610.2008.01926.x; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hanten G, 2002, CHILD NEUROPSYCHOL, V8, P107, DOI 10.1076/chin.8.2.107.8729; Hanten G, 2007, DEV NEUROPSYCHOL, V32, P585, DOI 10.1080/87565640701361112; Hinshaw SP, 2002, J CONSULT CLIN PSYCH, V70, P1086, DOI 10.1037//0022-006X.70.5.1086; HINSHAW SP, 1997, J ATTEN DISORD, V1, P217, DOI DOI 10.1177/108705479700100403; Houghton S, 1999, J CHILD NEUROL, V14, P801, DOI 10.1177/088307389901401206; JONES TC, 1995, EUR J COGN PSYCHOL, V7, P65, DOI 10.1080/09541449508520158; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klorman R, 1999, J AM ACAD CHILD PSY, V38, P1148, DOI 10.1097/00004583-199909000-00020; Kohls G, 2009, DEVELOPMENTAL SCI, V12, P614, DOI 10.1111/j.1467-7687.2009.00816.x; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; LAHEY BB, 1994, AM J PSYCHIAT, V151, P1673; Lahey BB, 2004, AM J PSYCHIAT, V161, P2014, DOI 10.1176/appi.ajp.161.11.2014; Lee SS, 2008, J ABNORM CHILD PSYCH, V36, P373, DOI 10.1007/s10802-007-9184-6; Lowe PA, 2003, ARCH CLIN NEUROPSYCH, V18, P865, DOI 10.1016/S0887-6177(02)00162-2; Lynn R, 2008, INTELLIGENCE, V36, P226, DOI 10.1016/j.intell.2007.06.002; Mahone EM, 2009, J AM ACAD CHILD PSY, V48, P749, DOI 10.1097/CHI.0b013e3181a565f1; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Milich R, 2001, CLIN PSYCHOL-SCI PR, V8, P463, DOI 10.1093/clipsy/8.4.463; Nigg JT, 2002, J AM ACAD CHILD PSY, V41, P59, DOI 10.1097/00004583-200201000-00012; Oie M, 1999, NEUROPSYCHOLOGIA, V37, P1351, DOI 10.1016/S0028-3932(99)00043-3; ONeill ME, 1996, J PEDIATR PSYCHOL, V21, P73, DOI 10.1093/jpepsy/21.1.73; Owens EB, 2009, J CLIN CHILD ADOLESC, V38, P132, DOI 10.1080/15374410802575313; Sattler J. M., 2004, ASSESSMENT CHILDREN; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Watkins M. J., 1999, SELECTIVITY ME UNPUB; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2002, WECHSLER INDIVIDUAL, Vsecond; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005; [No title captured]	54	31	32	2	27	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2011	25	1					15	24		10.1037/a0020298			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	711AQ	WOS:000286558500002	20873928	Green Accepted			2022-02-06	
J	de la Plata, CDM; Yang, FG; Wang, JY; Krishnan, K; Bakhadirov, K; Paliotta, C; Aslan, S; Devous, MD; Moore, C; Harper, C; McColl, R; Cullum, CM; Diaz-Arrastia, R				de la Plata, Carlos D. Marquez; Yang, Fanpei Gloria; Wang, Jun Yi; Krishnan, Kamini; Bakhadirov, Khamid; Paliotta, Christopher; Aslan, Sina; Devous, Michael D., Sr.; Moore, Carol; Harper, Caryn; McColl, Roderick; Cullum, C. Munro; Diaz-Arrastia, Ramon			Diffusion Tensor Imaging Biomarkers for Traumatic Axonal Injury: Analysis of Three Analytic Methods	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						DTI; TAI; Traumatic Brain injury; Memory; Tractography; Cognitive outcomes	WHITE-MATTER INJURY; BRAIN-INJURY; CORPUS-CALLOSUM; FIBER TRACKING; HEAD-INJURY; MILD; TRACTOGRAPHY; MODERATE; DAMAGE; ATLAS	Traumatic axonal injury (TAI) is a common mechanism of traumatic brain injury not readily identified using conventional neuroimaging modalities. Novel imaging modalities such as diffusion tensor imaging (DTI) can detect microstructural compromise in white matter (WM) in various clinical populations including TAI. DTI-derived data can be analyzed using global methods (i.e.. WM histogram or voxel-based approaches) or a regional approach (i.e., tractography). While each of these methods produce qualitatively comparable results, it is not clear which is most useful in clinical research and ultimately in clinical practice. This study compared three methods of analyzing DTI-derived data with regard to detection of WM injury and their association with clinical outcomes. Thirty patients with TAI and 19 demographically similar normal controls were scanned using a 3 Tesla magnet. Patients were scanned approximately eight months postinjury,and underwent an outcomes assessment at that time. Histogram analysis of fractional anisotropy (FA) and mean diffusivity showed global WM integrity differences between patients and controls. Voxel-based and tractography analyses showed significant decreases in FA within centroaxial structures involved in TAI. All three techniques were associated with functional and cognitive outcomes. DTI measures of microstructural integrity appear robust, as the three analysis techniques studied showed adequate utility for detecting WM injury. (JINS, 2011,17, 24-35)	[Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [de la Plata, Carlos D. Marquez; Yang, Fanpei Gloria; Wang, Jun Yi; Krishnan, Kamini; Bakhadirov, Khamid] Univ Texas Dallas, Ctr Brain Hlth, Richardson, TX 75083 USA		Diaz-Arrastia, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ramon.diaz-arrastia@utsouthwestern.edu	Kennedy, Kristen M/B-4699-2008; Cullum, C. Munro/AAC-2496-2019	Kennedy, Kristen M/0000-0001-5373-9026; Cullum, C. Munro/0000-0001-9706-5465; Diaz-Arrastia, Ramon/0000-0001-6051-3594; McColl, Roderick/0000-0001-7022-100X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS060827, R01 HD48179, U01 HD42652]; Department of EducationUS Department of Education [H133 A020526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS060827] Funding Source: NIH RePORTER	This research was supported by funding to C. Marquez de la Plata (NIH K23 NS060827) and R. Diaz-Arrastia (NIH R01 HD48179, U01 HD42652 and Department of Education H133 A020526). We thank Evelyn Babcock, PhD, of the University of Texas Southwestern Medical Center for her assistance with image acquisition. We also thank Ana Arenivas, Carlee Culver, and Matthew Warner for their assistance with data analysis.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Benton A., 1976, MULTILINGUAL APHASIA; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Catheline G, 2010, NEUROBIOL AGING, V31, P1582, DOI 10.1016/j.neurobiolaging.2008.08.012; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Delis D.C., 2000, CALIFORNIA VERBAL LE; Diaz-Marchan PG, 1996, NEUROTRAUMA, V1st, P137; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; Hagler DJ, 2009, HUM BRAIN MAPP, V30, P1535, DOI 10.1002/hbm.20619; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Lee JS, 2005, NEUROIMAGE, V26, P771, DOI 10.1016/j.neuroimage.2005.02.036; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; MARK LP, 1995, AM J NEURORADIOL, V16, P1303; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; Pannek K, 2010, NEUROIMAGE, V50, P1044, DOI 10.1016/j.neuroimage.2010.01.020; Pfefferbaum A, 2007, BRAIN, V130, P48, DOI 10.1093/brain/awl242; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Saindane AM, 2007, AM J NEURORADIOL, V28, P767; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Thurnher MM, 2005, AM J NEURORADIOL, V26, P2275; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu Y, 2006, AM J NEURORADIOL, V27, P656; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Ylvisaker Mark, 1996, Seminars in Speech and Language, V17, P217, DOI 10.1055/s-2008-1064100; Zhang WH, 2008, NEUROIMAGE, V42, P771, DOI 10.1016/j.neuroimage.2008.04.241	49	31	31	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2011	17	1					24	35		10.1017/S1355617710001189			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	702KX	WOS:000285894700004	21070694	Green Accepted			2022-02-06	
J	Eonta, SE; Carr, W; McArdle, JJ; Kain, JM; Tate, C; Wesensten, NJ; Norris, JN; Balkin, TJ; Kamimori, GH				Eonta, Stephanie E.; Carr, Walter; McArdle, Joseph J.; Kain, Jason M.; Tate, Charmaine; Wesensten, Nancy J.; Norris, Jacob N.; Balkin, Thomas J.; Kamimori, Gary H.			Automated Neuropsychological Assessment Metrics: Repeated Assessment with Two Military Samples	AVIATION SPACE AND ENVIRONMENTAL MEDICINE			English	Article						neuropsychological assessment; computer-based testing; practice effects; repeated measures	WORKING-MEMORY; PERFORMANCE; TESTS	EONTA SE, CARR W, MCARDLE JJ, KAIN JM, TATE C, WESENSTEN NJ, No Rats JN, BALKIN TJ, KAMIMORI GH. Automated Neuropsychological Assessment Metrics: repeated assessment with two military samples. Aviat Space Environ Med 2011; 82:34-9. Introduction: U.S. military troops deploying to war zones are currently administered the Automated Neuropsychological Assessment Metrics (ANAM4) Traumatic Brain Injury (TBI) Battery to establish individual neurocognitive performance baselines. In part, the utility of the ANAM4 TBI Battery baseline measurement depends on test-retest reliability of this instrument. The purpose of this report was to evaluate performance following multiple administrations of the ANAM4 TBI Battery: does performance in a repeated measures paradigm constitute a stable, interpretable indication of baseline neurocognitive ability? Methods: The data presented here are from the ANAM4 TBI Battery administered four times to a group of U.S. Marines in Study 1 and eight times to a group of New Zealand Defence Force personnel in Study 2. Results: The results show practice effect in five of six performance sub-tests in both Study 1 and Study 2. Discussion: Results are consistent with expectations that multiple test sessions are required to reach stable performance on some computerized tasks. These results have implications for taking ANAM4 TBI Battery practice effects into account in test administration and in data interpretation.	[Eonta, Stephanie E.] USN, Med Res Ctr, Silver Spring, MD 20910 USA; Walter Reed Army Inst Res, Silver Spring, MD USA; USN, Hlth Res Ctr, Silver Spring, MD 20910 USA; New Zealand Def Force, Auckland, New Zealand		Eonta, SE (corresponding author), USN, Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	stephanie.eonta@med.navy.mil			 [602702E.0000.000A0811]	This work was supported and funded by work unit number 602702E.0000.000A0811. The study protocols were approved by the Naval Medical Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects.	Baddeley A, 2001, J EXP PSYCHOL GEN, V130, P641, DOI 10.1037//0096-3445.130.4.641; Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851; Basso MR, 2002, CLIN NEUROPSYCHOL, V16, P57, DOI 10.1076/clin.16.1.57.8329; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; BENDETTO J, 1995, EPRLTR9502 MANK STAT; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; *C SHOP, 2007, ANAM4 TBI US MAN; *C SHOP, 2007, AUT NEUR ASS METR; CARR W, 2010, J NEUROTRAUMA S, V27, pA29; CERASO J, 1967, SCI AM, V217, P117, DOI 10.1038/scientificamerican1067-117; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; MCCAFFREY RJ, 1993, ARCH CLIN NEUROPSYCH, V8, P519; MCCAFFREY RJ, 1992, NEUROPSYCHOL REV, V3, P235, DOI 10.1007/BF01109049; MCCAFFREY RJ, 1992, CLIN NEUROPSYCHOL, V0006, P00032, DOI [DOI 10.1080/138540492084041_15, DOI 10.1080/13854049208404115]; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Roebuck-Spencer T, 2007, ARCH CLIN NEUROPSYCH, V22, pS79, DOI 10.1016/j.acn.2006.10.011; Schranz S, 2009, WIEN KLIN WOCHENSCHR, V121, P405, DOI 10.1007/s00508-009-1193-8; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; WATSON FL, 1994, HUM PSYCHOPHARM CLIN, V9, P51, DOI 10.1002/hup.470090107; WICKENS DD, 1972, CODING PROCESSES HUM	28	31	31	0	13	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	0095-6562	1943-4448		AVIAT SPACE ENVIR MD	Aviat. Space Environ. Med.	JAN	2011	82	1					34	39		10.3357/ASEM.2799.2011			6	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	702OH	WOS:000285903500007	21235103				2022-02-06	
J	Fontainhas, AM; Townes-Anderson, E				Fontainhas, Aurora Maria; Townes-Anderson, Ellen			RhoA Inactivation Prevents Photoreceptor Axon Retraction in an In Vitro Model of Acute Retinal Detachment	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; CYCLIC-AMP; ACTIN CYTOSKELETON; PIGMENT EPITHELIUM; PROTEIN-KINASES; BINDING-PROTEIN; VISUAL RECOVERY; CNS NEURONS; LIM-KINASE	PURPOSE. An early injury response to retinal detachment is disruption of synaptic connectivity between photoreceptors and second-order neurons. Most dramatic is the retraction of rod cell axons and their terminals away from the outer synaptic layer and toward their cell bodies. This study tested whether axonal retraction in detached retina was due to the activation of the small GTPase RhoA and was preventable using RhoA antagonists. METHODS. Retinal detachments were created in in vitro preparations of porcine eyecups. RhoA activation was determined with a Rhotekin binding assay. To block axon retraction, drugs were applied to neural retinal explants either before or after detachment from the retinal pigment epithelium. Presynaptic movement was quantified by image analysis of double-labeled retinas examined with confocal microscopy. RESULTS. Active RhoA increases transiently after detachment followed by morphologic evidence of axonal retraction over the next 24 hours. Pretreating the retina with a RhoA antagonist, CT-04, or a Rho kinase inhibitor, Y27632, at multiple concentrations significantly inhibited axonal retraction. Reducing calcium influx through L-type calcium channels with nicardipine also blocked retraction. To create a more plausible therapeutic scenario, drug treatments were delayed and applied after retinal detachment. The Rho kinase inhibitor, but not nicardipine, significantly blocked rod axonal retraction when applied up to 6 hours after detachment. CONCLUSIONS. Thus, RhoA and downstream Rho kinase activity constitute part of the mechanism that produces rod axonal retraction in retinal explants. Treatments that manipulate RhoA signaling may promote synaptic stability after retinal detachment. (Invest Ophthalmol Vis Sci. 2011;52:579-587) DOI:10.1167/iovs.10-5744	[Townes-Anderson, Ellen] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Fontainhas, Aurora Maria; Townes-Anderson, Ellen] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Integrat Neurosci Program, Newark, NJ 07103 USA		Townes-Anderson, E (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, 185 S Orange Ave, Newark, NJ 07103 USA.	andersel@umdnj.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY 012031]; F. M. Kirby Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012031] Funding Source: NIH RePORTER	Supported by National Institutes of Health Grant EY 012031 and an award from the F. M. Kirby Foundation.	Alabed YZ, 2007, J NEUROSCI, V27, P1702, DOI 10.1523/JNEUROSCI.5055-06.2007; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; Couvillon AD, 2006, CELL SIGNAL, V18, P715, DOI 10.1016/j.cellsig.2005.06.012; Dergham P, 2002, J NEUROSCI, V22, P6570; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Emmert DA, 2004, AM J PHYSIOL-CELL PH, V286, pC8, DOI 10.1152/ajpcell.00428.2002; ERICKSON PA, 1983, INVEST OPHTH VIS SCI, V24, P927; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Fontainhas AM, 2008, INVEST OPHTH VIS SCI, V49, P4177, DOI 10.1167/iovs.07-1580; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; GUERIN CJ, 1993, INVEST OPHTH VIS SCI, V34, P175; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hiraga A, 2006, J PERIPHER NERV SYST, V11, P217, DOI 10.1111/j.1529-8027.2006.00091.x; Iandiev I, 2006, INVEST OPHTH VIS SCI, V47, P2161, DOI 10.1167/iovs.05-0595; Ishibashi H, 1997, NEUROREPORT, V8, P853, DOI 10.1097/00001756-199703030-00009; Khodair MA, 2005, INVEST OPHTH VIS SCI, V46, P967, DOI 10.1167/iovs.04-0579; Khodair MA, 2003, INVEST OPHTH VIS SCI, V44, P4976, DOI 10.1167/iovs.03-0036; Kitaoka Y, 2004, BRAIN RES, V1018, P111, DOI 10.1016/j.brainres.2004.05.070; KROLL AJ, 1968, AM J OPHTHALMOL, V66, P410, DOI 10.1016/0002-9394(68)91524-9; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Leung T, 2002, FEBS LETT, V532, P445, DOI 10.1016/S0014-5793(02)03736-5; Lewis GP, 1998, INVEST OPHTH VIS SCI, V39, P424; Lewis GP, 2003, MOL NEUROBIOL, V28, P159, DOI 10.1385/MN:28:2:159; Lewis GP, 2002, EYE, V16, P375, DOI 10.1038/sj.eye.6700202; Linberg KA, 2009, MOL VIS, V15, P10; Lu Q, 2009, CURR MED CHEM, V16, P1355, DOI 10.2174/092986709787846569; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MACHEMER R, 1968, AM J OPHTHALMOL, V66, P396, DOI 10.1016/0002-9394(68)91523-7; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Matsuoka T, 1997, BIOCHEM BIOPH RES CO, V240, P484, DOI 10.1006/bbrc.1997.7624; McKerracher L, 2006, J NEUROTRAUM, V23, P309, DOI 10.1089/neu.2006.23.309; McKerracher L, 2004, NAT MED, V10, P1052, DOI 10.1038/nm1004-1052; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Mimura F, 2006, J BIOL CHEM, V281, P15970, DOI 10.1074/jbc.M510934200; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Nakai K, 1997, BLOOD, V90, P3936, DOI 10.1182/blood.V90.10.3936; Nakamura S, 1966, Nihon Ganka Kiyo, V17, P920; Niederost B, 2002, J NEUROSCI, V22, P10368; Ozgur S, 2007, RETINA-J RET VIT DIS, V27, P358; Pai KS, 2002, J NEUROCHEM, V80, P715, DOI 10.1046/j.0022-3042.2001.00761.x; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rex TS, 2002, INVEST OPHTH VIS SCI, V43, P1234; Sakai T, 2001, INVEST OPHTH VIS SCI, V42, pS446; Sethi CS, 2005, INVEST OPHTH VIS SCI, V46, P329, DOI 10.1167/iovs.03-0518; Stella SL, 2000, EUR J NEUROSCI, V12, P3537, DOI 10.1046/j.1460-9568.2000.00235.x; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wickham L, 2006, ARCH OPHTHALMOL-CHIC, V124, P1779, DOI 10.1001/archopht.124.12.1779; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yatani A, 2005, AM J PHYSIOL-HEART C, V288, pH650, DOI 10.1152/ajpheart.00268.2004; Zadro-Lamoureux LA, 2009, INVEST OPHTH VIS SCI, V50, P1448, DOI 10.1167/iovs.08-2855	61	31	32	0	2	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	JAN	2011	52	1					579	587		10.1167/iovs.10-5744			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	718CL	WOS:000287097400030	20861490	Green Published			2022-02-06	
J	Hashimoto, T; Umeda, S; Kojima, S				Hashimoto, Teruo; Umeda, Satoshi; Kojima, Shozo			Neural substrates of implicit cueing effect on prospective memory	NEUROIMAGE			English	Article						BA10; Caudal ACC; fMRI; Prospective memory; Subliminal cue	ANTERIOR CINGULATE CORTEX; ROSTRAL PREFRONTAL CORTEX; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; MEDIAL FRONTAL-CORTEX; ALZHEIMERS-DISEASE; TASK; PERFORMANCE; DEFICITS; REGIONS	Functional magnetic resonance imaging was used to examine the maintenance of intentions during an ongoing task involving implicit cues. Participants were required to detect target words while engaging in the ongoing task. Cues matched to the target category and cues matched to the action for targets were presented implicitly during the ongoing task. Implicit categorical target cues were found to enhance prospective memory performance, and implicit action cues accelerated responses more than irrelevant implicit cues in the prospective memory task. We found increased caudal anterior cingulate cortex (cACC) activity during the ongoing task with both implicit target and action cues, suggesting that alertness or preparatory attentional processes were strengthened by implicit cues. Implicit target cues elicited enhanced activity in the lateral anterior prefrontal cortex (Brodmann's area 10), which may be involved in dual processing of the ongoing task and the maintained intention. These results suggest that implicit cues may boost primitive attention toward an intended action and may be accessible to off-line maintenance. The facilitation of prospective target detection and the action execution by target cues were associated with increased supplementary motor area (SMA) activity. In contrast, we found enhanced premotor cortex (PMC) activation with action cue during the prospective memory task, suggesting that the PMC may be involved in stimulus-induced and rather automatic action. These results demonstrate the effectiveness of implicit cues for examining the maintenance of intention. Overall, we found that implicit target cues can facilitate prospective memory performance, and implicit action cues can accelerate responses. The above-mentioned neural underpinnings suggest that attentional and motor control processes are involved in the enhancement of prospective memory. (C) 2010 Elsevier Inc. All rights reserved.	[Hashimoto, Teruo] Riken BSI Symbol Cognit Dev, Wako, Saitama 3510198, Japan; [Hashimoto, Teruo; Umeda, Satoshi; Kojima, Shozo] Keio Univ, Dept Psychol, Tokyo, Japan		Hashimoto, T (corresponding author), Riken BSI Symbol Cognit Dev, 21-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-hashimoto@brain.riken.jp	Hashimoto, Teruo/C-4196-2013	Hashimoto, Teruo/0000-0002-5327-0667	Keio University;  [21830174]	This work was supported by Grant-in-Aid for Scientific Research (21830174 to T.H.) and the Global Center Of Excellence Program (Keio University).	AMANO S, 2002, NTT DATABASE SERIES; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Cohen AL, 2001, AGING NEUROPSYCHOL C, V8, P1, DOI 10.1076/anec.8.1.1.845; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dumontheil I, 2008, DEV MED CHILD NEUROL, V50, P168, DOI 10.1111/j.1469-8749.2008.02026.x; Einstein GO, 1998, PSYCHOL SCI, V9, P284, DOI 10.1111/1467-9280.00056; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Foster ER, 2009, NEUROPSYCHOLOGY, V23, P347, DOI 10.1037/a0014692; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Guynn MJ, 1998, MEM COGNITION, V26, P287, DOI 10.3758/BF03201140; Haupt S, 2009, HUM BRAIN MAPP, V30, P3043, DOI 10.1002/hbm.20731; Heinzel A, 2008, CONSCIOUS COGN, V17, P699, DOI 10.1016/j.concog.2008.01.008; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Hintzman DL, 1998, MEM COGNITION, V26, P449, DOI 10.3758/BF03201155; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Ikehara S., 1999, GOI TAIKEI JAPANESE; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; Kliegel M, 2007, INT J PSYCHOPHYSIOL, V64, P226, DOI 10.1016/j.ijpsycho.2006.09.007; Kliegel M, 2006, CHILD NEUROPSYCHOL, V12, P407, DOI 10.1080/09297040600696040; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Mantyla T, 1993, Memory, V1, P203, DOI 10.1080/09658219308258233; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Marsh RL, 2005, J EXP PSYCHOL LEARN, V31, P68, DOI 10.1037/0278-7393.31.1.68; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel M. A., 1992, ADV LEARNING BEHAVIO, V7, P87; McDaniel MA, 1998, MEM COGNITION, V26, P121, DOI 10.3758/BF03211375; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; Nakajima T, 2009, J NEUROPHYSIOL, V101, P1883, DOI 10.1152/jn.90636.2008; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Postle N, 2008, NEUROIMAGE, V43, P634, DOI 10.1016/j.neuroimage.2008.08.006; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ratcliff R, 2009, PSYCHOL REV, V116, P59, DOI 10.1037/a0014086; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Salimpoor VN, 2010, J COGNITIVE NEUROSCI, V22, P790, DOI 10.1162/jocn.2009.21234; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith R, 2007, NEUROIMAGE, V36, P1387, DOI 10.1016/j.neuroimage.2007.04.032; Smith RE, 2005, EXP PSYCHOL, V52, P243, DOI 10.1027/1618-3169.52.4.243; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor K. S., 2008, HUM BRAIN MAPP; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Tyler LK, 2008, J COGNITIVE NEUROSCI, V20, P1381, DOI 10.1162/jocn.2008.20095; Umeda S, 2006, REV NEUROSCIENCE, V17, P267; Ursu S, 2009, BIOL PSYCHOL, V80, P279, DOI 10.1016/j.biopsycho.2008.10.008; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; West R, 2007, MEM COGNITION, V35, P1034, DOI 10.3758/BF03193476	68	31	32	1	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN 1	2011	54	1					645	652		10.1016/j.neuroimage.2010.07.047			8	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	675IY	WOS:000283825000066	20673802				2022-02-06	
J	Bigler, ED; McCauley, SR; Wu, TC; Yallampalli, R; Shah, S; MacLeod, M; Chu, ZL; Hunter, JV; Clifton, GL; Levin, HS; Wilde, EA				Bigler, Erin D.; McCauley, Stephen R.; Wu, Trevor C.; Yallampalli, Ragini; Shah, Sanjeev; MacLeod, Marianne; Chu, Zili; Hunter, Jill V.; Clifton, Guy L.; Levin, Harvey S.; Wilde, Elisabeth A.			The temporal stem in traumatic brain injury: preliminary findings	BRAIN IMAGING AND BEHAVIOR			English	Article						Temporal stem; White matter pathways; Traumatic brain injury; Diffusion tensor imaging (DTI); Memory; Neurobehavioral sequelae	DIFFUSION TENSOR TRACTOGRAPHY; VERBAL MEMORY; UNCINATE FASCICULUS; LOBE; WHITE; MRI; HIPPOCAMPUS; CORTEX; DAMAGE; TRACTS	The temporal stem (TS) of the temporal lobe is a major white matter (WM) region containing several major pathways that connect the temporal lobe with the rest of the brain. Because of its location, it may be particularly vulnerable to shear-strain effects resulting from traumatic brain injury (TBI). A case vignette is presented in a patient with severe brain injury and focal TS pathology. Also, 12 severe TBI subjects unselected for TS pathology were compared to demographically matched, neurologically-intact controls using diffusion tensor imaging (DTI) to examine white matter tracts associated with the TS, including the inferior fronto-occipital fasciculus (IFOF), inferior longitudinal fasciculus (ILF), arcuate fasciculus (AF), cingulum bundle (CB) and the uncinate fasciculus (UF). For each tract, fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were computed and compared between the two groups and also examined in relationship to memory performance in the TBI subjects. Significant FA and ADC differences were observed in all tracts in the TBI patients compared to controls, with several relationships with memory outcome noted in the IFOF, ILF and AF. Based on these preliminary findings, the potential role of TBI-induced WM disconnection involving the TS is discussed as well as the relationship of TS damage to neurobehavioral outcome. The need for future studies specifically examining the role of TS injury in TBI is emphasized.	[Bigler, Erin D.; Wu, Trevor C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [McCauley, Stephen R.; MacLeod, Marianne; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Chu, Zili; Hunter, Jill V.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Shah, Sanjeev; Chu, Zili; Hunter, Jill V.] Texas Childrens Hosp, EB Singleton Dept Diagnost Imaging, Houston, TX 77030 USA; [Yallampalli, Ragini] Univ Houston, Dept Psychol, Houston, TX USA; [Clifton, Guy L.] Univ Texas Houston, Sch Med, Dept Surg, Vivian L Smith Ctr Neurol Res, Houston, TX USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu			NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS43353]; Dana Foundation; Brigham Young University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS043353] Funding Source: NIH RePORTER	Parts of this were funded by grants from the NIH (NINDS) NS43353 (G.L.C.) and the Dana Foundation (E.A.W.) along with a grant from the College of Family, Home and Social Science from Brigham Young University (E.D.B.). The technical assistance of Tracy Abildskov for various facets of the DTI analyses and illustration preparation and Jo Ann Petrie for manuscript preparation are also gratefully acknowledged.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Andersen P., 2006, HIPPOCAMPUS BOOK; Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Bird CM, 2007, NEUROPSYCHOLOGIA, V45, P1160, DOI 10.1016/j.neuropsychologia.2006.10.011; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bracht T, 2009, PSYCHIAT RES-NEUROIM, V174, P217, DOI 10.1016/j.pscychresns.2009.05.001; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Choi CY, 2010, J KOREAN NEUROSURG S, V47, P365, DOI 10.3340/jkns.2010.47.5.365; Corkin S, 1997, J NEUROSCI, V17, P3964; Delis D.C., 2000, CALIFORNIA VERBAL LE; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; DUCKWORTH JL, 2010, CURRENT OPINION 0212; Eslinger PJ, 1996, CEREB CORTEX, V6, P530, DOI 10.1093/cercor/6.3.530; Fletcher PT, 2010, NEUROIMAGE, V51, P1117, DOI 10.1016/j.neuroimage.2010.01.083; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gaffan D, 2001, NEUROPSYCHOLOGIA, V39, P51, DOI 10.1016/S0028-3932(00)00097-X; Gaffan D, 2005, SCIENCE, V309, P2172, DOI 10.1126/science.1119445; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; Govindan RM, 2008, EPILEPSY RES, V80, P30, DOI 10.1016/j.eplepsyres.2008.03.011; Helmstaedter C, 2008, EPILEPSIA, V49, P88, DOI 10.1111/j.1528-1167.2007.01386.x; Hoogenraad F., 2002, MULTICENTER EVALUATI; HOREL JA, 1994, CORTEX, V30, P269, DOI 10.1016/S0010-9452(13)80198-0; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Lavenex P, 2007, DEV NEUROSCI-BASEL, V29, P179, DOI 10.1159/000096222; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MacDonald CL, 2008, NEUROLOGY, V71, P1199, DOI 10.1212/01.wnl.0000327521.69520.7f; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; NETSCH T, 2001, INT C COMP VIS; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Peltier J, 2010, J NEUROSURG, V112, P1033, DOI 10.3171/2009.6.JNS08132; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Pugliese L, 2009, NEUROIMAGE, V47, P427, DOI 10.1016/j.neuroimage.2009.05.014; Rempel-Clower NL, 2007, ANN NY ACAD SCI, V1121, P72, DOI 10.1196/annals.1401.026; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Robertson G.J., 2007, WIDE RANGE ACHIEVEME; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Schoene-Bake JC, 2009, NEUROIMAGE, V46, P569, DOI 10.1016/j.neuroimage.2009.03.013; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; SHAMY JL, 2010, HIPPOCAMPUS     0121; Sheslow D, 2004, WIDE RANGE ASSESSMEN; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang F, 2008, J NEUROSURG, V108, P775, DOI 10.3171/JNS/2008/108/4/0775; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wen HT, 1999, NEUROSURGERY, V45, P549, DOI 10.1097/00006123-199909000-00028; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	68	31	31	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2010	4	3-4					270	282		10.1007/s11682-010-9105-0			13	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	658SB	WOS:000282508600007	20835782				2022-02-06	
J	Pietrzak, RH; Morgan, CA; Southwick, SM				Pietrzak, Robert H.; Morgan, Charles A., III; Southwick, Steven M.			Sleep quality in treatment-seeking veterans of Operations Enduring Freedom and Iraqi Freedom: The role of cognitive coping strategies and unit cohesion	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Veterans; Combat; Posttraumatic stress disorder; Sleep; Social support; Coping	POSTTRAUMATIC-STRESS-DISORDER; THOUGHT CONTROL QUESTIONNAIRE; TRAUMATIC BRAIN-INJURY; RANDOMIZED CLINICAL-TRIAL; SOCIAL SUPPORT; BEHAVIORAL THERAPY; UNWANTED THOUGHTS; PRIMARY INSOMNIA; MENTAL-HEALTH; DISTURBANCE	Objective: Sleep difficulties are common in individuals exposed to stress or trauma, and maladaptive cognitive coping strategies, such as worry and fear of losing vigilance, as well as low social support, may further impair sleep quality. This study examined the severity and correlates of sleep difficulties in a sample of treatment-seeking veterans of Operations Enduring Freedom and Iraqi Freedom (OEF-OIF). Method: A total of 167 OEF-OIF veterans seeking behavioral or primary care services completed a questionnaire containing measures of sleep quality, combat exposure, psychopathology, fear of loss of vigilance, cognitive coping strategies, and unit and postdeployment social support within I year of returning from deployment. Results: Mean Pittsburgh Sleep Quality Inventory scores in the full sample were indicative of severely impaired sleep. Posttraumatic stress disorder (PTSD) was associated with increased sleep difficulties, most notably sleep disturbances, daytime dysfunction, and sleep quality. Hierarchical regression analysis in the full sample revealed that PTSD symptoms and scores on measures of worry and fear of loss of vigilance were positively associated with sleep difficulties and that scores on a measure of unit member support were negatively associated with sleep difficulties. Among veterans with PTSD, fear of loss of vigilance was positively associated with sleep difficulties and cognitive distraction and unit member support were negatively associated with sleep difficulties. Conclusions: Treatment-seeking OEF-OIF veterans report severe sleep difficulties, with more pronounced impairment in veterans with PTSD. The results of this study suggest that interventions to mitigate worry and fear of loss of vigilance and to enhance perceived unit member support may be helpful in reducing sleep difficulties following return from deployment in this population. (C) 2010 Elsevier Inc. All rights reserved.	[Pietrzak, Robert H.; Morgan, Charles A., III; Southwick, Steven M.] VA Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Clin Neurosci Div, Resilience Lab, West Haven, CT 06516 USA; [Pietrzak, Robert H.; Morgan, Charles A., III; Southwick, Steven M.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA		Pietrzak, RH (corresponding author), VA Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Clin Neurosci Div, Resilience Lab, 950 Campbell Ave 151E, West Haven, CT 06516 USA.	robert.pietrzak@yale.edu			Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder	This work was supported by the Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder and a private donation. These funding sources had no further role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. We thank the veterans who volunteered to participate in this survey. We appreciate the assistance of Amanda Russo, BA, Alison Rivers, BA, and Alicia Christensen, BA, in collecting and managing the data.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barahmand U, 2009, PSYCHIAT RES, V169, P240, DOI 10.1016/j.psychres.2008.06.029; Bazargan M, 1996, INT J AGING HUM DEV, V42, P143, DOI 10.2190/GM89-NRTY-DERQ-LC7D; Bennett SA, 2009, BEHAV RES THER, V47, P1018, DOI 10.1016/j.brat.2009.07.015; Brummett BH, 2006, HEALTH PSYCHOL, V25, P220, DOI 10.1037/0278-6133.25.2.220; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Cohen J., 2013, STAT POWER ANAL BEHA; Davis JL, 2007, J TRAUMA STRESS, V20, P123, DOI 10.1002/jts.20199; Edinger JD, 2009, SLEEP, V32, P499, DOI 10.1093/sleep/32.4.499; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Ellis Jason, 2002, Sleep Med, V3, P393, DOI 10.1016/S1389-9457(02)00039-4; EWING JA, 1984, CAGE QUESTIONNAIRE J, V252, P1905; Fabsitz RR, 1997, J SLEEP RES, V6, P50, DOI 10.1046/j.1365-2869.1997.00026.x; Gadinger MC, 2009, J SLEEP RES, V18, P229, DOI 10.1111/j.1365-2869.2008.00715.x; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; Gold MA, 2000, MIL MED, V165, P147, DOI 10.1093/milmed/165.2.147; Guthrie R, 2000, BEHAV RES THER, V38, P899, DOI 10.1016/S0005-7967(99)00120-5; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; INMAN DJ, 1990, J TRAUMA STRESS, V3, P429, DOI DOI 10.1007/BF00974782; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Lewis V, 2009, MIL MED, V174, P948, DOI 10.7205/MILMED-D-04-0208; Lu M, 2009, J TRAUMA STRESS, V22, P236, DOI 10.1002/jts.20407; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; Mayou RA, 2002, BEHAV RES THER, V40, P665, DOI 10.1016/S0005-7967(01)00069-9; MELLMAN TA, 1995, BIOL PSYCHIAT, V38, P174, DOI 10.1016/0006-3223(94)00238-X; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P110; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Nomura K, 2009, SLEEP MED, V10, P626, DOI 10.1016/j.sleep.2008.06.010; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Pillar G, 2000, SLEEP MED REV, V4, P183, DOI 10.1053/smrv.1999.0095; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Ree MJ, 2005, BEHAV RES THER, V43, P985, DOI 10.1016/j.brat.2004.07.003; Reynolds M, 1999, PSYCHOL MED, V29, P1089, DOI 10.1017/S003329179900104X; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Rona RJ, 2009, J TRAUMA STRESS, V22, P11, DOI 10.1002/jts.20383; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Scarpa A, 2009, BEHAV RES THER, V47, P809, DOI 10.1016/j.brat.2009.06.002; Singareddy Ravi Kumar, 2002, Ann Clin Psychiatry, V14, P183, DOI 10.1023/A:1021190620773; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thompson CE, 2008, J TRAUMA STRESS, V21, P417, DOI 10.1002/jts.20351; Tsao JCI, 2003, DEPRESS ANXIETY, V18, P177, DOI 10.1002/da.10074; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Warda G, 1998, BEHAV RES THER, V36, P1171, DOI 10.1016/S0005-7967(98)00082-5; WATTS FN, 1994, BRIT J CLIN PSYCHOL, V33, P211, DOI 10.1111/j.2044-8260.1994.tb01115.x; Weathers F.W., 1991, PTSD CHECKLIST MILIT; WELLS A, 1994, BEHAV RES THER, V32, P871, DOI 10.1016/0005-7967(94)90168-6; Zeitlhofer J, 2000, ACTA NEUROL SCAND, V102, P249, DOI 10.1034/j.1600-0404.2000.102004249.x	57	31	31	2	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999			J PSYCHOSOM RES	J. Psychosomat. Res.	NOV	2010	69	5					441	448		10.1016/j.jpsychores.2010.07.002			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	675LD	WOS:000283831300002	20955863				2022-02-06	
J	Roehl, AB; Hein, M; Loetscher, PD; Rossaint, J; Weis, J; Rossaint, R; Coburn, M				Roehl, Anna B.; Hein, Marc; Loetscher, Philipp D.; Rossaint, Jan; Weis, Joachim; Rossaint, Rolf; Coburn, Mark			Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury	BMC NEUROLOGY			English	Article							RESUSCITATION; MECHANISMS; CULTURES; ISCHEMIA	Background: We investigated the neuroprotective properties of levosimendan, a novel inodilator, in an in vitro model of traumatic brain injury. Methods: Organotypic hippocampal brain slices from mouse pups were subjected to a focal mechanical trauma. Slices were treated after the injury with three different concentrations of levosimendan (0.001, 0.01 and 0.1 mu M) and compared to vehicle-treated slices. After 72 hrs, the trauma was quantified using propidium iodide to mark the injured cells. Results: A significant dose-dependent reduction of both total and secondary tissue injury was observed in cells treated with either 0.01 or 0.1 mu M levosimendan compared to vehicle-treated slices. Conclusion: Levosimendan represents a promising new pharmacological tool for neuroprotection after brain injury and warrants further investigation in an in vivo model.	[Roehl, Anna B.; Hein, Marc; Loetscher, Philipp D.; Rossaint, Jan; Rossaint, Rolf; Coburn, Mark] RWTH Aachen Univ Hosp, Dept Anaesthesiol, D-52074 Aachen, Germany; [Weis, Joachim] RWTH Aachen Univ Hosp, Inst Neuropathol, D-52074 Aachen, Germany		Roehl, AB (corresponding author), RWTH Aachen Univ Hosp, Dept Anaesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	aroehl@ukaachen.de	Weis, Joachim/G-1984-2014	Weis, Joachim/0000-0003-3280-6773; Coburn, Mark/0000-0002-7930-0270			AbdelHamid KM, 1997, J NEUROSCI, V17, P3538; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Hein M, 2009, ACTA ANAESTH SCAND, V53, P941, DOI 10.1111/j.1399-6576.2009.01994.x; Koudouna E, 2007, ACTA ANAESTH SCAND, V51, P1123, DOI 10.1111/j.1399-6576.2007.01383.x; Lafci B, 2008, EUR SURG RES, V41, P1, DOI 10.1159/000121394; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Shimizu K, 2002, AM J PHYSIOL-HEART C, V283, pH1005, DOI 10.1152/ajpheart.00054.2002	11	31	35	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	OCT 21	2010	10								97	10.1186/1471-2377-10-97			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	678GX	WOS:000284063200001	20964834	Green Published, gold			2022-02-06	
J	Staniloiu, A; Markowitsch, HJ; Brand, M				Staniloiu, Angelica; Markowitsch, Hans J.; Brand, Matthias			Psychogenic amnesia - A malady of the constricted self	CONSCIOUSNESS AND COGNITION			English	Article						Dissociative amnesia; Inferolateral prefrontal cortex; Self-consciousness; Emotion; Autobiographical-episodic memory (AEM)	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PERSISTENT ANTEROGRADE AMNESIA; TEMPORAL-LOBE EPILEPSY; INFERIOR FRONTAL GYRUS; MENTAL TIME-TRAVEL; THEORY-OF-MIND; AUTOBIOGRAPHICAL MEMORY; EPISODIC MEMORY; RETROGRADE-AMNESIA	Autobiographical-episodic memory is the conjunction of subjective time. autonoetic consciousness and the experiencing self Understanding the neural correlates of autobiographical-episodic memory might therefore be essential for shedding light on the neurobiology underlying the experience of being an autonoetic self In this contribution we illustrate the intimate relationship between autobiographical-episodic memory and self by reviewing the clinical and neuropsychological features and brain functional imaging correlates of psychogenic amnesia - a condition that is usually characterized by severely impaired retrograde memory functioning, in absence of structural brain damage as detected by standard imaging We demonstrate that in this disorder the autobiographical-episodic memory deficits do not exist in isolation, but occur with impairments of the autonoetic self-consciousness, emotional processing, and theory of mind or executive functions Furthermore functional and metabolic brain alterations involving regions that are agreed upon to exert crucial roles in memory processes were frequently found to accompany the psychogenic memory "loss" (C) 2010 Elsevier Inc. All rights reserved.	[Staniloiu, Angelica; Markowitsch, Hans J.] Univ Bielefeld, D-33501 Bielefeld, Germany; [Markowitsch, Hans J.] Alfried Krupp Inst Adv Study, Greifswald, Germany; [Brand, Matthias] Univ Duisburg Essen, Duisburg, Germany; [Brand, Matthias] Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany		Staniloiu, A (corresponding author), Univ Bielefeld, POB 100131, D-33501 Bielefeld, Germany.		Brand, Matthias/B-1109-2011	Brand, Matthias/0000-0002-4831-9542			Addis DR, 2010, CORTEX, V46, P425, DOI 10.1016/j.cortex.2009.04.011; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; ADLER G, 1981, AM J PSYCHIAT, V138, P46; Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Allman JM, 2010, BRAIN STRUCT FUNCT, V214, P495, DOI 10.1007/s00429-010-0254-0; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Anterion CT, 2008, REV NEUROL-FRANCE, V164, P271, DOI 10.1016/j.neurol.2007.06.004; Arzy S, 2009, EUR J NEUROSCI, V30, P2009, DOI 10.1111/j.1460-9568.2009.06974.x; Augustine, 2001, CONFESSIONS; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bach I., 1998, COGNITIVE NEUROPSYCL, V3, P139, DOI [10.1080/135468098396215, DOI 10.1080/135468098396215]; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barbarotto R, 1996, NEUROPSYCHOLOGIA, V34, P575, DOI 10.1016/0028-3932(95)00141-7; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bass C, 2007, J ROY SOC MED, V100, P81, DOI 10.1258/jrsm.100.2.81; Batson CD, 1996, PERS SOC PSYCHOL B, V22, P474, DOI 10.1177/0146167296225005; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Becker-Blease KA, 2004, J CHILD PSYCHOL PSYC, V45, P522, DOI 10.1111/j.1469-7610.2004.00242.x; Bedny M, 2009, P NATL ACAD SCI USA, V106, P11312, DOI 10.1073/pnas.0900010106; Ben Shalom D, 2003, CORTEX, V39, P1129; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Bluck S, 2005, SOC COGNITION, V23, P91, DOI 10.1521/soco.23.1.91.59198; Boria S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005596; Borsci G, 2009, J AFFECT DISORDERS, V114, P208, DOI 10.1016/j.jad.2008.07.013; Bourget D, 2007, J AM ACAD PSYCHIATRY, V35, P469; Brand M, 2003, PRINCIPLES OF LEARNING AND MEMORY, P171; BRAND M, 2009, FESTSCHRIFT HONOR LG, P229; Brand M, 2008, HBK BEHAV NEUROSCI, V18, P317, DOI 10.1016/S1569-7339(08)00218-X; Brand M, 2009, PSYCHIAT RES-NEUROIM, V174, P32, DOI 10.1016/j.pscychresns.2009.03.008; Brandt J, 2006, SEMIN NEUROL, V26, P331, DOI 10.1055/s-2006-945519; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bright-Paul A, 2008, DEV PSYCHOL, V44, P1055, DOI 10.1037/0012-1649.44.4.1055; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; BUIE DH, 1981, J AM PSYCHOANAL ASS, V29, P281, DOI 10.1177/000306518102900201; Bull R, 2008, COGNITION, V107, P663, DOI 10.1016/j.cognition.2007.07.015; Burgl G., 1900, MUNCHEN MED WOCHEN, P1270; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Carlson EA, 1998, CHILD DEV, V69, P1107, DOI 10.1111/j.1467-8624.1998.tb06163.x; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Colvert E, 2008, J ABNORM CHILD PSYCH, V36, P1057, DOI 10.1007/s10802-008-9232-x; Conway MA, 2009, NEUROPSYCHOLOGIA, V47, P2305, DOI 10.1016/j.neuropsychologia.2009.02.003; Coons PM, 1992, DISSOCIATION, V5, P73; Corballis MC, 2010, BRAIN LANG, V112, P25, DOI 10.1016/j.bandl.2009.02.002; Corballis MC, 2009, EXP BRAIN RES, V192, P553, DOI 10.1007/s00221-008-1491-9; Corcoran R, 2003, PSYCHOL MED, V33, P897, DOI 10.1017/S0033291703007529; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; Damasio A., 1999, FEELING WHAT HAPPENS; Daniel R, 2010, J NEUROSCI, V30, P47, DOI 10.1523/JNEUROSCI.2205-09.2010; Darwin C, 2004, DESCENT MAN SELECTIO; de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945; DeRenzi E, 1997, NEUROPSYCHOLOGIA, V35, P781, DOI 10.1016/S0028-3932(97)00018-3; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; DIFIORINO M, 2003, BRIDGING E W PSYCH, V1, P56; DORAHY MJ, 2007, TRAUMATIC DISSOCIATI, P55; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eliot ThomasStearns., 1969, COMPLETE POEMS PLAYS; Fink GR, 1996, J NEUROSCI, V16, P4275; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Freud Sigmund, 1901, MONATSSCHRIFT PSYCHI, V4, P436; FUJIWARA E, 2008, J NEUROSCI, V26, P10935; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Ganser, 1903, ARCH PSYCHIAT NERVEN, V38, P34, DOI 10.1007/BF02173461; Ganser SJ, 1898, ARCH PSYCHIATRIE NER, V30:, P633, DOI 10.1007/BF02036039; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Glisky EL, 2004, NEUROPSYCHOLOGIA, V42, P1132, DOI 10.1016/j.neuropsychologia.2003.08.016; Govindan RM, 2010, CEREB CORTEX, V20, P561, DOI 10.1093/cercor/bhp122; GRASBY PM, 1994, BRAIN, V117, P1271, DOI 10.1093/brain/117.6.1271; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Hacking Ian, 1995, REWRITING SOUL MULTI; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Han SH, 2008, NAT REV NEUROSCI, V9, P646, DOI 10.1038/nrn2456; Happe F, 2001, NEUROPSYCHOLOGIA, V39, P83, DOI 10.1016/S0028-3932(00)00093-2; Harpaz-Rotem I, 2005, MEMORY, V13, P51, DOI 10.1080/09658210344000567; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Henke K, 2003, NEUROREPORT, V14, P1197, DOI 10.1097/00001756-200307010-00002; Hennig-Fast K, 2008, NEUROPSYCHOLOGIA, V46, P2993, DOI 10.1016/j.neuropsychologia.2008.06.014; HERING E, 1895, MEMORY GENERAL FUNCT; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; HOWE ML, 1993, PSYCHOL BULL, V113, P305, DOI 10.1037/0033-2909.113.2.305; Huntjens RJC, 2005, CONSCIOUS COGN, V14, P377, DOI 10.1016/j.concog.2004.10.001; Hurlemann R, 2005, J NEUROSCI, V25, P6343, DOI 10.1523/JNEUROSCI.0228-05.2005; HYMAN IE, 1992, NATO ADV SCI INST SE, V65, P207; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Inoue Y, 2004, J AFFECT DISORDERS, V82, P403, DOI 10.1016/j.jad.2004.04.004; James W, 1950, PRINCIPLES PSYCHOL, V1; Janet P., 1907, MAJOR SYMPTOMS HYSTE; Janet P., 1920, MAJOR SYMPTOMS HYSTE, Vsecond; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kanzer M, 1939, AM J PSYCHIAT, V96, P711, DOI 10.1176/ajp.96.3.711; Kapur N, 1997, BRAIN COGNITION, V35, P58, DOI 10.1006/brcg.1997.0927; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Kessler J, 1997, J CLIN EXP NEUROPSYC, V19, P604, DOI 10.1080/01688639708403746; Klein SB, 2010, ANN NY ACAD SCI, V1191, P1, DOI 10.1111/j.1749-6632.2010.05441.x; Kleinman Arthur., 1980, PATIENTS HEALERS CON; Kobayashi C, 2007, BRAIN RES, V1164, P95, DOI 10.1016/j.brainres.2007.06.022; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; Kopelman Michael D, 2008, Handb Clin Neurol, V88, P185, DOI 10.1016/S0072-9752(07)88008-0; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Krahn LE, 2008, PSYCHOSOMATICS, V49, P277, DOI 10.1176/appi.psy.49.4.277; Kritchevsky M, 2004, LEARN MEMORY, V11, P213, DOI 10.1101/lm.71404; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kuehnel S, 2008, BRAIN IMAGING BEHAV, V2, P163, DOI 10.1007/s11682-008-9026-3; Kumar S, 2007, PSYCHIAT CLIN NEUROS, V61, P583, DOI 10.1111/j.1440-1819.2007.01735.x; Kundera Milan, 1991, UNBEARABLE LIGHTNESS; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lanius RA, 2005, BIOL PSYCHIAT, V57, P873, DOI 10.1016/j.biopsych.2005.01.011; Lanius RA, 2003, AM J PSYCHIAT, V160, P667, DOI 10.1176/appi.ajp.160.4.667; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Leary MR, 2007, ANNU REV PSYCHOL, V58, P317, DOI 10.1146/annurev.psych.58.110405.085658; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Lemogne C, 2006, CONSCIOUS COGN, V15, P258, DOI 10.1016/j.concog.2005.07.005; Lemogne C, 2009, MEMORY, V17, P1, DOI 10.1080/09658210802438466; Lennox WG, 1943, AM J PSYCHIAT, V99, P732, DOI 10.1176/ajp.99.5.732; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Levine B, 2009, NEUROPSYCHOLOGIA, V47, P2188, DOI 10.1016/j.neuropsychologia.2008.12.026; Lind SE, 2009, J AUTISM DEV DISORD, V39, P1231, DOI 10.1007/s10803-009-0735-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; LOEWENSTEIN RJ, 1991, AM PSYCHIATRIC PRESS, V10, P189; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Luria A. R., 1987, MIND MNEMONIST LITTL; Maldonado J.R., 2008, AM PSYCHIAT PUBLISHI, V5th ed., P665; Maldonado JR, 2002, J TRAUMA STRESS, V15, P401, DOI 10.1023/A:1020137409097; Markowitsch H J, 1997, Cogn Neuropsychiatry, V2, P135, DOI 10.1080/135468097396379; Markowitsch H.J., 1992, INTELLECTUAL FUNCTIO; Markowitsch H.J., 2010, DEV AUTOBIOGRAPHICAL; Markowitsch HJ, 2010, CURR ISS MEM, P23; Markowitsch Hans J, 2008, Handb Clin Neurol, V88, P155, DOI 10.1016/S0072-9752(07)88007-9; Markowitsch HJ, 1999, CORTEX, V35, P243, DOI 10.1016/S0010-9452(08)70797-4; Markowitsch HJ, 2000, NEUROPSY NEUROPSY BE, V13, P60; Markowitsch HJ, 1999, NEUROCASE, V5, P189, DOI 10.1093/neucas/5.3.189; Markowitsch HJ, 1999, CORTEX, V35, P219, DOI 10.1016/S0010-9452(08)70795-0; Markowitsch HJ, 1997, NEUROCASE, V3, P445, DOI 10.1093/neucas/3.6.445; MARKOWITSCH HJ, 1988, BRAIN RES REV, V13, P351, DOI 10.1016/0165-0173(88)90012-4; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P627, DOI 10.1080/01688639308402586; MARKOWITSCH HJ, 1984, CORTEX, V20, P27, DOI 10.1016/S0010-9452(84)80021-0; Markowitsch HJ, 2003, SELF IN NEUROSCIENCE AND PSYCHIATRY, P180, DOI 10.1017/CBO9780511543708.010; Markowitsch HJ, 2003, CORTEX, V39, P643, DOI 10.1016/S0010-9452(08)70858-X; MARKOWITSCH HJ, 1985, J COMP NEUROL, V242, P425, DOI 10.1002/cne.902420310; Markowitsch HJ, 1998, NEUROPSYCHOLOGIA, V36, P77, DOI 10.1016/S0028-3932(97)00093-6; MARKOWITSCH HJ, 1994, NEUROREPORT, V5, P1349, DOI 10.1097/00001756-199406270-00013; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; MARKOWITSCH HJ, 1990, CORTEX, V26, P597, DOI 10.1016/S0010-9452(13)80309-7; MARKOWITSCH HJ, 1994, TRENDS NEUROSCI, V17, P513, DOI 10.1016/0166-2236(94)90150-3; Markowitsch HJ, 1997, PSYCHIAT RES-NEUROIM, V74, P119, DOI 10.1016/S0925-4927(97)03041-2; Markowitsch HJ, 1999, MEMORY, V7, P561, DOI 10.1080/096582199387751; Markowitsch HJ, 1999, CURR OPIN PSYCHIATR, V12, P331, DOI 10.1097/00001504-199905000-00014; MARKOWITSCH HJ, 2005, ENDOPHYSICS TIME QUA, P131; Masson J.M., 1985, COMPLETE LETT S FREU; Mattila AK, 2009, PSYCHOSOMATICS, V50, P59, DOI 10.1176/appi.psy.50.1.59; Mayou R, 2005, AM J PSYCHIAT, V162, P847, DOI 10.1176/appi.ajp.162.5.847; McCullough JP., 2000, TREATMENT CHRONIC DE; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McKay G. C. M., 2009, ADV PSYCHIAT TREAT, V15, P152, DOI [10.1192/apt.bp.105.001586, DOI 10.1192/APT.BP.105.001586]; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; Metcalfe J., 2005, MISSING LINK COGNITI, P4, DOI DOI 10.1093/ACPROF:OSO/9780195161564.003.0001; Metzinger T, 2008, PROG BRAIN RES, V168, P215, DOI 10.1016/S0079-6123(07)68018-2; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mishkin M., 1984, NEUROPSYCHOL MEM, V1984, P287; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mitchell Stephen A., 1995, FREUD HIST MODERN PS; Modell, 2006, IMAGINATION MEANINGF; Modestin J, 2002, PSYCHOL PSYCHOTHER-T, V75, P53, DOI 10.1348/147608302169544; Mondadori CRA, 2006, BRAIN, V129, P2908, DOI 10.1093/brain/awl266; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moriguchi Y, 2009, HUM BRAIN MAPP, V30, P2063, DOI 10.1002/hbm.20653; Moriguchi Y, 2006, NEUROIMAGE, V32, P1472, DOI 10.1016/j.neuroimage.2006.04.186; Morin A, 2007, BRAIN RES BULL, V74, P387, DOI 10.1016/j.brainresbull.2007.06.013; Morin A, 2009, CONSCIOUS COGN, V18, P524, DOI 10.1016/j.concog.2008.09.008; NAGEL T, 1974, PHILOS REV, V83, P435, DOI 10.2307/2183914; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Nelson K, 2003, AUTOBIOGRAPHICAL MEMORY AND THE CONSTRUCTION OF A NARRATIVE SELF: DEVELOPMENTAL AND CULTURAL PERSPECTIVES, P3; NELSON K, 2005, ORIGINS SOCIAL MIND, P319; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; Newen A, 2003, CONSCIOUS COGN, V12, P529, DOI 10.1016/S1053-8100(03)00080-1; Newen A, 2009, GRAZER PHILOS STUDIE, V79, P209; NIEUWENHUYS R, 1978, HUMAN CENTRAL NERVOU; OBrien JT, 1997, BRIT J PSYCHIAT, V170, P199, DOI 10.1192/S0007125000146513; OConnor M, 1997, BRAIN COGNITION, V35, P71, DOI 10.1006/brcg.1997.0928; Oddo S, 2010, CORTEX, V46, P29, DOI 10.1016/j.cortex.2008.07.003; Ouellet J, 2008, BEHAV NEUROL, V20, P27, DOI [10.1155/2008/520328, 10.3233/BEN-2008-0213]; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Pearce JMS, 2007, EUR NEUROL, V57, P126, DOI 10.1159/000098103; Peigneux P, 2010, CURR ISS MEM, P165; Perner J, 2001, SELF IN TIME: DEVELOPMENTAL PERSPECTIVES, P181; Perner J., 2000, OXFORD HDB MEMORY, P297; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pfeifer J. H., 2010, DEV SOCIAL COGNITIVE, P141; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Piefke M, 2005, HUM BRAIN MAPP, V24, P313, DOI 10.1002/hbm.20092; Piolino P, 2007, CONSCIOUS COGN, V16, P84, DOI 10.1016/j.concog.2005.09.010; Piolino P, 2005, COGN NEUROPSYCHOL, V22, P1005, DOI 10.1080/02643290442000428; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Plaza M, 2009, NEUROCASE, V15, P294, DOI 10.1080/13554790902729473; Post RM, 1995, ANN NY ACAD SCI, V771, P677, DOI 10.1111/j.1749-6632.1995.tb44720.x; Povinelli DJ, 1996, CHILD DEV, V67, P1540, DOI 10.1111/j.1467-8624.1996.tb01813.x; Pugliese L, 2009, NEUROIMAGE, V47, P427, DOI 10.1016/j.neuroimage.2009.05.014; Putnam F.W., 1997, DISSOCIATION CHILDRE; Rabin JS, 2010, J COGNITIVE NEUROSCI, V22, P1095, DOI 10.1162/jocn.2009.21344; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106; Rathbone CJ, 2009, NEUROCASE, V15, P405, DOI 10.1080/13554790902849164; Ray RD, 2010, SOC COGN AFFECT NEUR, V5, P318, DOI 10.1093/scan/nsp039; Reinhold N, 2006, CURR MED IMAGING, V2, P35, DOI 10.2174/157340506775541668; REINHOLD N, 2008, COMMUNICATION; Reinhold N, 2007, J NEUROPSYCHOL, V1, P53, DOI 10.1348/174866407X180819; Rinne T., 2007, TRAUMATIC DISSOCIATI, P139; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Robertson D, 2007, NEUROPSYCHOLOGIA, V45, P755, DOI 10.1016/j.neuropsychologia.2006.08.014; Romei V, 2008, PSYCHOTHER PSYCHOSOM, V77, P175, DOI 10.1159/000119737; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rosenbaum RS, 2007, SCIENCE, V318, P1257, DOI 10.1126/science.1148763; Rosenbaum RS, 2009, NEUROPSYCHOLOGIA, V47, P2181, DOI 10.1016/j.neuropsychologia.2008.11.028; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schneider K, 1912, Z GESAMTE NEUROL PSY, V8, P553, DOI 10.1007/BF02866053; Schneider K., 1928, HDB GEISTESKRANKHEIT, V1, P508; Schore AN, 2002, AUST NZ J PSYCHIAT, V36, P9, DOI 10.1046/j.1440-1614.2002.00996.x; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Seeley WW, 2008, CURR OPIN NEUROL, V21, P701, DOI 10.1097/WCO.0b013e3283168e2d; Seligman R, 2008, CULT MED PSYCHIAT, V32, P31, DOI 10.1007/s11013-007-9077-8; SEMON R, 1904, MNEME ERTHALTENDES P; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; Serra L, 2007, BEHAV NEUROL, V18, P53, DOI 10.1155/2007/193140; Shamay-Tsoory S, 2009, J NEUROPSYCH CLIN N, V21, P59, DOI 10.1176/appi.neuropsych.21.1.59; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shaw P, 2004, BRAIN, V127, P1535, DOI 10.1093/brain/awh168; Siebert M, 2003, BRAIN, V126, P2627, DOI 10.1093/brain/awg271; SIEGEL DJ, 2004, J AM ACAD CHILD ADOL, V40, P997; SMITH CN, 2010, NEUROPSYCHOLOGIA; Spiegel D, 2006, AM J PSYCHIAT, V163, P566, DOI 10.1176/appi.ajp.163.4.566; Spitzer C, 2008, BUNDESGESUNDHEITSBLA, V51, P46, DOI 10.1007/s00103-008-0418-8; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; St Jacques PL, 2009, J INT NEUROPSYCH SOC, V15, P819, DOI 10.1017/S1355617709990439; Staniloiu A., 2010, ASCS09, P316; STANILOIU A, J PSYCHOL IN PRESS; Staniloiu A, 2010, BEHAV BRAIN SCI, V33, P170, DOI 10.1017/S0140525X10000804; Staniloiu Angelica, 2009, Cogn Neuropsychiatry, V14, P180, DOI 10.1080/13546800902931036; STEINBERG M, 2000, COMPREHENSIVE TXB PS, P1544; Stickgold R, 2005, TRENDS NEUROSCI, V28, P408, DOI 10.1016/j.tins.2005.06.004; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Thomas-Anterion C, 2010, J NEUROL NEUROSUR PS, V81, P468, DOI 10.1136/jnnp.2008.163808; Tomasello M, 2008, JEAN NICOD LECT, P1; Tramoni E, 2009, NEUROPSYCHOLOGIA, V47, P611, DOI 10.1016/j.neuropsychologia.2008.11.012; Tranel D, 2009, NEUROCASE, V15, P217, DOI 10.1080/13554790902775492; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Tulving E., 1972, ORG MEMORY, P381; Tulving E., 1983, ELEMENTS EPISODIC ME; Tulving E, 2007, BEHAV BRAIN SCI, V30, P334, DOI 10.1017/S0140525X07002208; Tulving Endel, 1995, P839; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Valentino K, 2009, J CHILD PSYCHOL PSYC, V50, P1029, DOI 10.1111/j.1469-7610.2009.02072.x; van der Hart O, 2001, AUST NZ J PSYCHIAT, V35, P589; Van der Hart O, 2006, AM J PSYCHIAT, V163, P1646, DOI 10.1176/appi.ajp.163.9.1646-a; Vann SD, 2009, BRAIN, V132, P2372, DOI 10.1093/brain/awp175; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; VERCAMMEN A, 2010, SCHIZOPHRENIA B, V8, P4; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630; Vogeley K, 2007, SCHIZOPHRENIA BULL, V33, P157, DOI 10.1093/schbul/sbl056; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wang F, 2009, BIOL PSYCHIAT, V66, P516, DOI 10.1016/j.biopsych.2009.03.023; Wang Q, 2001, J PERS SOC PSYCHOL, V81, P220, DOI 10.1037//0022-3514.81.2.220; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; WelchRoss MK, 1997, DEV PSYCHOL, V33, P43, DOI 10.1037/0012-1649.33.1.43; Welzer H, 2005, MEMORY, V13, P63, DOI 10.1080/09658210344000576; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; WHO, 1992, CLASS MENT BEH DIS C; WILLIAMS JMG, 1988, PSYCHOL MED, V18, P689, DOI 10.1017/S0033291700008370; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Wood H, 2003, NAT REV NEUROSCI, V4, P774; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7; Yehuda R, 1997, J TRAUMA STRESS, V10, P453, DOI 10.1023/A:1024845422065; Zanarini MC, 2008, ACTA PSYCHIAT SCAND, V118, P291, DOI 10.1111/j.1600-0447.2008.01247.x; [No title captured]	309	31	31	1	38	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8100	1090-2376		CONSCIOUS COGN	Conscious. Cogn.	SEP	2010	19	3			SI		778	801		10.1016/j.concog.2010.06.024			24	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	660FM	WOS:000282625500010	20655759				2022-02-06	
J	Stulemeijer, M; Vos, PE; van der Werf, S; van Dijk, G; Rijpkema, M; Fernandez, G				Stulemeijer, Maja; Vos, Pieter E.; van der Werf, Sieberen; van Dijk, Gert; Rijpkema, Mark; Fernandez, Guillen			How Mild Traumatic Brain Injury May Affect Declarative Memory Performance in the Post-Acute Stage	JOURNAL OF NEUROTRAUMA			English	Article						functional magnetic resonance imaging; memory; mild brain concussion; neuropsychological tests	DIFFUSE AXONAL INJURY; MEDIAL TEMPORAL-LOBE; CLOSED-HEAD-INJURY; AUDITORY-EVOKED-RESPONSES; PHOTON EMISSION CT; WORKING-MEMORY; FUNCTIONAL MRI; TECHNETIUM-99M-HMPAO SPECT; POSTCONCUSSION SYNDROME; POSTTRAUMATIC AMNESIA	Memory deficits are among the most frequently reported sequelae of mild traumatic brain injury (MTBI), especially early after injury. To date, these cognitive deficits remain poorly understood, as in most patients the brain is macroscopically intact. To identify the mechanism by which MTBI causes declarative memory impairments, we probed the functionality of the medial temporal lobe (MTL) and the prefrontal cortex (PFC), within 6 weeks after injury in 43 patients from a consecutive cohort, and matched healthy controls. In addition to neuropsychological measures of declarative memory and other cognitive domains, all subjects underwent functional magnetic resonance imaging (fMRI). Behavioral results showed poorer declarative memory performance in patients than controls, and decreasing performance with increasing duration of post-traumatic amnesia (a measure of injury severity). Task performance in the scanner was, as intended by the task and design, similar in patients and controls, and did not relate to injury severity. The task used reliably activated the MTL and PFC. Although we did not find significant differences in brain activity when comparing patients and controls, we revealed, in agreement with our neuropsychological findings, an inverse correlation between MTL activity and injury severity. In contrast, no difference in prefrontal activation was found between patients and controls, nor was there a relation with injury severity. On a behavioral level, injury severity was inversely related to declarative memory performance. In all, these findings suggest that reduced medial temporal functionality may contribute to poorer declarative memory performance in the post-acute stage of MTBI, especially in patients with longer post-traumatic amnesia.	[Vos, Pieter E.; Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Stulemeijer, Maja; van der Werf, Sieberen] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6500 HB Nijmegen, Netherlands; [van Dijk, Gert] Canisius Wilhelmina Hosp, Dept Neurol, Nijmegen, Netherlands; [Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands		Vos, PE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol 935, POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.vos@neuro.umcn.nl	Vos, Pieter/A-6043-2012; Fernandez, Guillen/B-3771-2009; Rijpkema, Mark/D-1974-2010	Fernandez, Guillen/0000-0002-5522-0604; Rijpkema, Mark/0000-0002-8495-4703	Top Center Traumatology Nijmegen	We would like to thank all subjects for their participation, and Jeske Broeren, Sanne Rasing, and Paul Gaalman for their assistance with the data acquisition. The Top Center Traumatology Nijmegen is kindly acknowledged for its financial support.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Ahmed S, 2000, BRAIN INJURY, V14, P765; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen SHA, 2005, NEUROPSYCHOLOGIA, V43, P1227, DOI 10.1016/j.neuropsychologia.2004.12.015; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Delis DC, 1987, CALIFORNIA VERBAL LE; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; Easdon C, 2004, BRAIN COGNITION, V54, P136; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fernandez G, 2001, BRAIN RES BULL, V55, P1, DOI 10.1016/S0361-9230(01)00494-4; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; ICHISE M, 1994, J NUCL MED, V35, P217; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JACOBS A, 1994, J NUCL MED, V35, P942; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Joy S, 2003, ASSESSMENT, V10, P56, DOI 10.1177/0095399702250335; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Piekema C, 2006, NEUROIMAGE, V33, P374, DOI 10.1016/j.neuroimage.2006.06.035; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; RIZZO PA, 1983, NEUROPSYCHOBIOLOGY, V9, P78, DOI 10.1159/000117941; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Schmand B, 1991, Tijdschr Gerontol Geriatr, V22, P15; Schoenhuber R, 1983, J Neurosurg Sci, V27, P157; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Snaphaan L, 2009, BRAIN, V132, P1882, DOI 10.1093/brain/awp133; SOUSTIEL JF, 2005, BRAIN INJURY, V9, P805; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Ulug AM, 1999, AM J NEURORADIOL, V20, P1044; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; VAN DER NAALT J, 1999, J NEUROL NEUROSUR PS, V66, P207; VONWOWERN F, 1966, ACTA NEUROL SCAND, V42, P373; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7	82	31	31	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1585	1595		10.1089/neu.2010.1298			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500005	20629484	Green Submitted			2022-02-06	
J	Ralph, DM; Robinson, SR; Campbell, MS; Bishop, GM				Ralph, David M.; Robinson, Stephen R.; Campbell, Melissa S.; Bishop, Glenda M.			Histidine, cystine, glutamine, and threonine collectively protect astrocytes from the toxicity of zinc	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Astrocyte; Cystine; Free radicals; Glutamine; Glutathione; Glutathione reductase; Histidine; Threonine; Total antioxidant capacity; Zinc	TOTAL ANTIOXIDANT CAPACITY; CORTICAL NEURONAL DEATH; ZN2+-INDUCED CELL-DEATH; AMINO-ACIDS; GLUTATHIONE-REDUCTASE; ASTROGLIAL CULTURES; IN-VITRO; PLASMA; ZN2+; INJURY	In epilepsy, traumatic brain injury, and ischemic stroke, toxic levels of zinc released from neurons contribute to the brain damage associated with these disorders. Zinc causes oxidative stress by increasing the generation of reactive oxygen species and by inhibiting glutathione reductase (GR). This study investigated whether naturally occurring amino acids can protect cultured mouse astrocytes from zinc. Astrocytes incubated for 24 h with 33 mu M zinc acetate in a minimal medium displayed a loss of GR activity, a depletion of total glutathione, and a loss of total antioxidant capacity. These changes were accompanied by extensive cell death. Four amino acids (200 mu M L-histidine, 201 mu M L-cystine, 4 mM L-glutamine, 798 FM mu L-threonine), which are a subset of the 15 present in Dulbecco's modified Eagle medium, were found to collectively prevent zinc toxicity. Histidine was the most protective, followed by cystine, glutamine, and threonine. It is proposed that each of these amino acids protects against different aspects of zinc toxicity by chelating zinc, by serving as precursors for glutathione, or by converting to tricarboxylic acid cycle intermediates. It is possible that these 4 amino acids contribute in vivo to the protection of brain cells from the toxic effects of zinc. (C) 2010 Elsevier Inc. All rights reserved.	[Ralph, David M.; Robinson, Stephen R.; Campbell, Melissa S.; Bishop, Glenda M.] Monash Univ, Sch Psychol & Psychiat, Blood Brain Interact Grp, Clayton, Vic 3800, Australia		Bishop, GM (corresponding author), Monash Univ, Sch Psychol & Psychiat, Blood Brain Interact Grp, Clayton, Vic 3800, Australia.	glenda.bishop@monash.edu	Robinson, Stephen R./AAU-3219-2021; Bishop, Glenda M/G-6031-2010; Robinson, Stephen R/B-7155-2013	Robinson, Stephen R./0000-0002-0987-0075; Bishop, Glenda/0000-0002-2736-0415	National Health & Medical Research CouncilNational Health and Medical Research Council of Australia [284393]; School of Psychology & Psychiatry, Monash UniversityMonash University	G.M.B. was supported by a National Health & Medical Research Council Peter Doherty Fellowship (ID: 284393). Additional financial support was provided by the School of Psychology & Psychiatry, Monash University. We thank Hania Czerwinska for valuable technical support throughout the project and Jeff Liddell for adapting the TAC assays for use with cultured cells.	Abe S, 2006, J PHARMACOL SCI, V102, P103, DOI 10.1254/jphs.FP0060342; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Aki T, 2008, J PHARMACOL SCI, V107, P238, DOI 10.1254/jphs.08053FP; Apak R, 2004, J AGR FOOD CHEM, V52, P7970, DOI 10.1021/jf048741x; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop GM, 2007, FREE RADICAL BIO MED, V42, P1222, DOI 10.1016/j.freeradbiomed.2007.01.022; Canzoniero LMT, 2003, NEUROPHARMACOLOGY, V45, P420, DOI 10.1016/S0028-3908(03)00171-0; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Chen CJ, 2003, J NEUROCHEM, V85, P443, DOI 10.1046/j.1471-4159.2003.01691.x; Chen CJ, 2003, NEUROCHEM INT, V42, P471, DOI 10.1016/S0197-0186(02)00154-7; Chen L, 2006, NEUROSCI LETT, V409, P163, DOI 10.1016/j.neulet.2006.09.033; Cho IH, 2003, J NEUROSCI RES, V74, P736, DOI 10.1002/jnr.10794; CLOUES R, 1993, PFLUG ARCH EUR J PHY, V424, P152, DOI 10.1007/BF00374606; Deniel N, 2007, MOL CELL PROTEOMICS, V6, P1671, DOI 10.1074/mcp.M600428-MCP200; Dineley KE, 2000, NEUROBIOL DIS, V7, P310, DOI 10.1006/nbdi.2000.0303; Dolinska B, 2001, FARMACO, V56, P737, DOI 10.1016/S0014-827X(01)01129-6; Dringen R, 1998, DEV NEUROSCI-BASEL, V20, P401, DOI 10.1159/000017337; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Franek F, 2002, ARCH BIOCHEM BIOPHYS, V398, P141, DOI 10.1006/abbi.2001.2698; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; GOCKEL P, 1993, HELV CHIM ACTA, V76, P511, DOI 10.1002/hlca.19930760133; HALLMAN PS, 1971, BIOCHEM J, V121, P549, DOI 10.1042/bj1210549; HAMBERGER A, 1990, NEUROCHEM RES, V15, P307, DOI 10.1007/BF00968677; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Herraiz T, 2004, FREE RADICAL RES, V38, P323, DOI 10.1080/10611860310001648167; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; IKEDA T, 1980, J NUTR SCI VITAMINOL, V26, P357, DOI 10.3177/jnsv.26.357; Kawahara M, 2002, CELL MOL NEUROBIOL, V22, P87, DOI 10.1023/A:1015345813075; Kawahara Masahiro, 2007, Recent Pat CNS Drug Discov, V2, P145, DOI 10.2174/157488907780832698; Kim D, 2003, NEUROREPORT, V14, P187, DOI 10.1097/00001756-200302100-00005; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kranich O, 1998, GLIA, V22, P11, DOI 10.1002/(SICI)1098-1136(199801)22:1<11::AID-GLIA2>3.3.CO;2-Z; KROTKIEWSKA B, 1992, INT J BIOCHEM, V24, P1501, DOI 10.1016/0020-711X(92)90078-F; Lewinska A, 2007, CLIN EXP PHARMACOL P, V34, P781, DOI 10.1111/j.1440-1681.2007.04637.x; Lorca RA, 2005, J NEUROCHEM, V95, P499, DOI 10.1111/j.1471-4159.2005.03387.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; MIZE CE, 1962, J BIOL CHEM, V237, P1596; Nelson D. L., 2008, LEHNINGER PRINCIPLES; Noh KM, 2000, J NEUROSCI, V20; PERRY TL, 1975, J NEUROCHEM, V24, P587, DOI 10.1111/j.1471-4159.1975.tb07680.x; Ryu JR, 2002, EXP BRAIN RES, V143, P257, DOI 10.1007/s00221-001-0991-7; Sheline CT, 2004, GLIA, V46, P18, DOI 10.1002/glia.10313; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; SLOVITER RS, 1985, BRAIN RES, V330, P150, DOI 10.1016/0006-8993(85)90017-4; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Trzaskowski B, 2008, J BIOL INORG CHEM, V13, P133, DOI 10.1007/s00775-007-0306-y; van Overveld FWPC, 2000, CHEM-BIOL INTERACT, V127, P151, DOI 10.1016/S0009-2797(00)00179-4; Walther UI, 1999, BIOL TRACE ELEM RES, V67, P97, DOI 10.1007/BF02784066; WAPNIR RA, 1983, J NUTR, V113, P1346, DOI 10.1093/jn/113.7.1346; Yoo MH, 2004, INVEST OPHTH VIS SCI, V45, P1523, DOI 10.1167/iovs.03-1315	61	31	32	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	AUG 15	2010	49	4					649	657		10.1016/j.freeradbiomed.2010.05.023			9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	630TA	WOS:000280295800017	20570723				2022-02-06	
J	Lesko, MM; Woodford, M; White, L; O'Brien, SJ; Childs, C; Lecky, FE				Lesko, Mehdi M.; Woodford, Maralyn; White, Laura; O'Brien, Sarah J.; Childs, Charmaine; Lecky, Fiona E.			Using Abbreviated Injury Scale (AIS) codes to classify Computed Tomography (CT) features in the Marshall System	BMC MEDICAL RESEARCH METHODOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLASSIFICATION; PREDICTION	Background: The purpose of Abbreviated Injury Scale (AIS) is to code various types of Traumatic Brain Injuries (TBI) based on their anatomical location and severity. The Marshall CT Classification is used to identify those subgroups of brain injured patients at higher risk of deterioration or mortality. The purpose of this study is to determine whether and how AIS coding can be translated to the Marshall Classification Methods: Initially, a Marshall Class was allocated to each AIS code through cross-tabulation. This was agreed upon through several discussion meetings with experts from both fields (clinicians and AIS coders). Furthermore, in order to make this translation possible, some necessary assumptions with regards to coding and classification of mass lesions and brain swelling were essential which were all approved and made explicit. Results: The proposed method involves two stages: firstly to determine all possible Marshall Classes which a given patient can attract based on allocated AIS codes; via cross-tabulation and secondly to assign one Marshall Class to each patient through an algorithm. Conclusion: This method can be easily programmed in computer softwares and it would enable future important TBI research programs using trauma registry data.	[Lesko, Mehdi M.; Woodford, Maralyn; White, Laura; Lecky, Fiona E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, TARN, Salford Royal NHS Fdn Trust, Salford, Lancs, England; [O'Brien, Sarah J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Occupat & Environm Hlth Res Grp, Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Childs, Charmaine] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Childs, Charmaine] Univ Manchester, Brain Injury Res Grp, Salford Royal NHS Fdn Trust, Salford, Lancs, England		Lesko, MM (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, TARN, Salford Royal NHS Fdn Trust, Salford, Lancs, England.	Mehdi_m_lesko@yahoo.com	Childs, Charmaine/G-9928-2012	O'Brien, Sarah Jane/0000-0003-2896-8999	Trauma Audit and Research Network (TARN); Overseas Research Students (ORS) Award Scheme, University of Manchester	We would like to acknowledge the help of Prof. Andrew Mass from the IMPACT collaboration in discussion of the methods used to arrive at our final algorithm. This work is supported by the funding from the Trauma Audit and Research Network (TARN) and Overseas Research Students (ORS) Award Scheme, University of Manchester.	[Anonymous], TRAUMA AUDIT RES NET; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005; Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL 1990 R; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; INT MISSION PROGNOSI	15	31	31	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	AUG 6	2010	10								72	10.1186/1471-2288-10-72			10	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	649UY	WOS:000281801500001	20691038	Green Published, gold, Green Accepted			2022-02-06	
J	Patel, HC; Bouamra, O; Woodford, M; Yates, DW; Lecky, FE				Patel, H. C.; Bouamra, Omar; Woodford, Maralyn; Yates, David W.; Lecky, Fiona E.			Clinical article: mortality associated with severe head injury in the elderly	ACTA NEUROCHIRURGICA			English	Article						Elderly; Mortality; Severe head injury	TRAUMATIC BRAIN-INJURY; AGE; SCORE	Age is an important factor in determining prognosis following severe head injury (SHI), although mortality in patients a parts per thousand yen65 years is poorly reported. The aim of this study was to document mortality in patients with SHI a parts per thousand yen65 years. A retrospective analysis of prospectively collected data from the TARN (Trauma Audit and Research Network) database (1996-2004) was performed. Six hundred and sixty-nine patients aged a parts per thousand yen65 with a GCS < 9 after a head injury were identified, and mortality at 3 months was recorded. Mortality was 71% in 65- to 70-year-old patients (n = 137) (CI, 64-79), 75% for patients aged 70-75 years (n = 147) (CI, 68-82), 85% in patients aged 75-80 years (n = 160) (79-91), and 87% for patients > 80 years (n = 225) (CI, 83-91). Mortality for all patients a parts per thousand yen65 years with a GCS 3-5 was > 80%. A better outcome was observed in patients with a GCS = 6-8 [65-70 years, 47% (CI, 30-64); 70-75 years, 56% (CI, 43-69); 75-80 years, 73% (CI, 62-85); > 80 years, 79% (CI, 70-87)]. SHI-related mortality continues to increase with age. Overall, these data support a conservative approach to the severely head-injured elderly patient; however, patients presenting with a GCS = 6-8 and below the age of 75 may represent a group where more aggressive therapy may be indicated.	[Bouamra, Omar; Woodford, Maralyn; Yates, David W.; Lecky, Fiona E.] Univ Manchester, Hope Hosp, Trauma Audit & Res Network, Manchester Med Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England; [Patel, H. C.] Hope Hosp, Dept Neurosurg, Salford M6 8HD, Lancs, England		Lecky, FE (corresponding author), Univ Manchester, Hope Hosp, Trauma Audit & Res Network, Manchester Med Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England.	Fiona.Lecky@manchester.ac.uk	Patel, Hiren/AAL-3811-2021	Patel, Hiren/0000-0002-1439-8801	TARN	Omar Bouamra and Maralyn Woodford are employed by the University of Manchester as a result of TARN funding.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; *AM ASS NEUR SURG, 2000, EARL IND PROGN SEV T, P171; [Anonymous], 1990, ABBR INJ SCAL 1990 R; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; JOHNSON CL, 1994, AM SURGEON, V60, P899; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P5, DOI 10.1080/02688699944104; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763	16	31	33	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	AUG	2010	152	8					1353	1357		10.1007/s00701-010-0666-x			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	622YV	WOS:000279704300013	20437280				2022-02-06	
J	Hanell, A; Clausen, F; Bjork, M; Jansson, K; Philipson, O; Nilsson, LNG; Hillered, L; Weinreb, PH; Lee, D; McIntosh, TK; Gimbel, DA; Strittmatter, SM; Marklund, N				Hanell, Anders; Clausen, Fredrik; Bjork, Maria; Jansson, Kristine; Philipson, Ola; Nilsson, Lars N. G.; Hillered, Lars; Weinreb, Paul H.; Lee, Daniel; McIntosh, Tracy K.; Gimbel, David A.; Strittmatter, Stephen M.; Marklund, Niklas			Genetic Deletion and Pharmacological Inhibition of Nogo-66 Receptor Impairs Cognitive Outcome after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						cognition; mossy fiber sprouting; NgR(-/-) mice; Nogo-66 receptor; traumatic brain injury	CONTROLLED CORTICAL IMPACT; SPINAL-CORD-INJURY; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; AMYLOID PRECURSOR PROTEIN; AXONAL REGENERATION; TRANSGENIC MICE; POSTTRAUMATIC EPILEPSY; FUNCTIONAL RECOVERY; DOWN-REGULATION; BINDS NOGO-66	Functional recovery is markedly restricted following traumatic brain injury (TBI), partly due to myelin-associated inhibitors including Nogo-A, myelin-associated glycoprotein (MAG) and oligodendrocyte myelin glycoprotein (OMgp), that all bind to the Nogo-66 receptor-1 (NgR1). In previous studies, pharmacological neutralization of both Nogo-A and MAG improved outcome following TBI in the rat, and neutralization of NgR1 improved outcome following spinal cord injury and stroke in rodent models. However, the behavioral and histological effects of NgR1 inhibition have not previously been evaluated in TBI. We hypothesized that NgR1 negatively influences behavioral recovery following TBI, and evaluated NgR1(-/-) mice (NgR1(-/-) study) and, in a separate study, soluble NgR1 infused intracerebroventricularly immediately post-injury to neutralize NgR1 (sNgR1 study) following TBI in mice using a controlled cortical impact (CCI) injury model. In both studies, motor function, TBI-induced loss of tissue, and hippocampal beta-amyloid immunohistochemistry were not altered up to 5 weeks post-injury. Surprisingly, cognitive function (as evaluated with the Morris water maze at 4 weeks post-injury) was significantly impaired both in NgR1(-/-) mice and in mice treated with soluble NgR1. In the sNgR1 study, we evaluated hippocampal mossy fiber sprouting using the Timm stain and found it to be increased at 5 weeks following TBI. Neutralization of NgR1 significantly increased mossy fiber sprouting in sham-injured animals, but not in brain-injured animals. Our data suggest a complex role for myelin-associated inhibitors in the behavioral recovery process following TBI, and urge caution when inhibiting NgR1 in the early post-injury period.	[Hanell, Anders; Clausen, Fredrik; Bjork, Maria; Jansson, Kristine; Hillered, Lars; Marklund, Niklas] Uppsala Univ, Dept Neurosurg, Uppsala, Sweden; [Philipson, Ola; Nilsson, Lars N. G.] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Weinreb, Paul H.; Lee, Daniel] Biogen Idec Inc, Cambridge, MA USA; [McIntosh, Tracy K.; Marklund, Niklas] Univ Penn, Dept Neurosurg, Traumat Brain Injury Lab, Philadelphia, PA 19104 USA; [Gimbel, David A.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA		Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, Ing 85,3 Tr, SE-75185 Uppsala, Sweden.	niklas.marklund@neuro.uu.se	Strittmatter, Stephen/F-5739-2011; Hanell, Anders/E-4776-2011	Strittmatter, Stephen/0000-0001-8188-3092; Hanell, Anders/0000-0001-9369-3886; nilsson, lars/0000-0002-8362-1042; Clausen, Fredrik/0000-0003-3592-4417; Weinreb, Paul/0000-0002-0802-0052; Marklund, Niklas/0000-0002-9797-5626; Hillered, Lars/0000-0002-2808-9292	Upplandsstiftelsen; Swedish Brain Foundation; Uppsala University; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Jeanssons Foundation; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS RO1-40978, NIH NS RO1-56485, NIH NS RO1-42304, NIH NS P50-08803]; Veterans AdministrationUS Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042304, R01NS056485, R01NS040978, R37NS033020, P50NS008803, R01NS039962] Funding Source: NIH RePORTER	Supported by Upplandsstiftelsen and the Swedish Brain Foundation (to N.M.), Uppsala University (to N.M. and L. H.), Swedish Research Council (to N.M. and L. H.), Jeanssons Foundation (to N.M.), National Institutes of Health (NIH) NS RO1-40978 (to T. K. M.), NIH NS RO1-56485 (to S. M. S.), NIH NS RO1-42304 (to S. M. S.), a Merit Review Grant from the Veterans Administration (to T. K. M.), and NIH NS P50-08803 (to T. K. M.).	Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Harrington AW, 2008, J BIOL CHEM, V283, P24690, DOI 10.1074/jbc.M802188200; Harvey PA, 2009, J NEUROSCI, V29, P6285, DOI 10.1523/JNEUROSCI.5885-08.2009; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Li SX, 2003, J NEUROSCI, V23, P4219; Li SX, 2005, MOL CELL NEUROSCI, V29, P26, DOI 10.1016/j.mcn.2004.12.008; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Meier S, 2003, FASEB J, V17, P1153, DOI 10.1096/fj.02-0453fje; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Nissinen J, 2001, HIPPOCAMPUS, V11, P299, DOI 10.1002/hipo.1044; Park JH, 2006, J NEUROSCI, V26, P13279, DOI 10.1523/JNEUROSCI.4504-06.2006; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Philipson O, 2009, FEBS LETT, V583, P3021, DOI 10.1016/j.febslet.2009.08.009; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2006, ANN NEUROL, V60, P540, DOI 10.1002/ana.20953; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; 1996, NATL RES COUNCIL GUI, P1	59	31	31	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2010	27	7					1297	1309		10.1089/neu.2009.1255			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	631FD	WOS:000280331100014	20486800	Green Published			2022-02-06	
J	Jovanovic, V; Pekic, S; Stojanovic, M; Tasic, G; Djurovic, B; Soldatovic, I; Doknic, M; Miljic, D; Djurovic, M; Medic-Stojanoska, M; Popovic, V				Jovanovic, Vladimir; Pekic, Sandra; Stojanovic, Marko; Tasic, Goran; Djurovic, Branko; Soldatovic, Ivan; Doknic, Mirjana; Miljic, Dragana; Djurovic, Marina; Medic-Stojanoska, Milica; Popovic, Vera			Neuroendocrine dysfunction in patients recovering from subarachnoid hemorrhage	HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM			English	Article						Cerebral aneurysm; Hypopituitarism; Subarachnoid hemorrhage; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE DEFICIENCY; GH DEFICIENCY; HYPOPITUITARISM; DIAGNOSIS; ADULTS; IMPAIRMENT; PREVALENCE; GUIDELINES; LESIONS	OBJECTIVE: Subarachnoid hemorrhage (SAH) is a recently identified risk factor for hypopituitarism, particularly growth hormone (GH) and corticotrophins deficiencies. The aim of our study was to identify possible predictor(s) for neuroendocrine dysfunction in SAH survivors. DESIGN: Pituitary function was evaluated in 93 patients (30 males, 63 females), aged 48.0 +/- 1.1 years (mean +/- SE), and with a Glasgow Outcome Scale score of 4.6 +/- 0.6 (mean +/- SE) more than one year following SAH. In the acute phase, SAH was complicated by vasospasm (VS) in 18 and by hydrocephalus (HDC) in 9 patients. Baseline serum values of Insulin Growth Factor 1 (IGF-I), cortisol, Thyroxine (T4), Thyroid Stimulating Hormone (TSH), Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), testosterone (in males), estradiol (in females) and prolactin were determined. RESULTS: According to the results of baseline hormonal evaluation, 47 patients (50.5%) had no hormonal abnormalities. Seven patients (7.5%) had multiple pituitary hormone deficiencies: Four patients (4.3%) had two (GH and cortisol), one patient had three (gonadal, adrenal and GH) and two patients had deficiency of all pituitary axes. Thirty-nine patients (42%) had one abnormal axis (13 adrenal, 2 thyroid, 4 gonadal and 20 GH). None of the subjects was treated with desmopressin or exhibited symptomatic polyuria. The VS and HDC during the acute phase of SAH were related to abnormal pituitary status (VS with low IGF-I levels and HDC with low cortisol levels). CONCLUSION: Through a screening procedure, neuroendocrine dysfunction was identified in a substantial number of asymptomatic patients with previous SAH. Cerebral VS and HDC at the time of SAH emerged as risk factors possibly predicting development of pituitary dysfunction. Low basal levels of IGF 1 and cortisol may help in selecting patients requiring further evaluation of pituitary function.	[Pekic, Sandra; Stojanovic, Marko; Doknic, Mirjana; Miljic, Dragana; Djurovic, Marina; Popovic, Vera] Univ Clin Ctr, Inst Endocrinol, Belgrade 11000, Serbia; [Jovanovic, Vladimir; Tasic, Goran; Djurovic, Branko] Univ Clin Ctr, Inst Neurosurg, Belgrade 11000, Serbia; [Soldatovic, Ivan] Fac Med, Inst Med Stat & Hlth Res, Belgrade, Serbia; [Medic-Stojanoska, Milica] Univ Novi Sad, Inst Endocrinol, Novi Sad 21000, Serbia		Popovic, V (corresponding author), Univ Clin Ctr, Inst Endocrinol, Dr Subotica 13, Belgrade 11000, Serbia.		Pekic, Sandra/S-7175-2016	Soldatovic, Ivan/0000-0003-4893-1683			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2003, CLIN ENDOCRINOL, V59, P56, DOI 10.1046/j.1365-2265.2003.01794.x; Bjeljac M, 2002, ACT NEUR S, V82, P83; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HOFF WV, 1961, BRIT MED J, V5261, P1190; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; HUTTER BO, 1995, BRIT J NEUROSURG, V9, P465, DOI 10.1080/02688699550041106; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lamberts SWJ, 1998, LANCET, V352, P127; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mayer SA, 2002, NEUROLOGY, V59, P1750, DOI 10.1212/01.WNL.0000035748.91128.C2; Mukherjee A, 2009, EUR J ENDOCRINOL, V161, pS33, DOI 10.1530/EJE-09-0247; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Rap Z, 1971, Pol Med J, V10, P188; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sesmilo Gemma, 2007, Hormones (Athens), V6, P132; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306	30	31	32	0	5	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1109-3099	2520-8721		HORM-INT J ENDOCRINO	Horm.-Int. J. Endocrinol. Metab.	JUL-SEP	2010	9	3					235	244		10.14310/horm.2002.1273			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	642HW	WOS:000281200600005	20688621	Bronze			2022-02-06	
J	Grof, TM; Bledsoe, KA				Grof, Tina M.; Bledsoe, Kathleen A.			Evaluating the Use of Dexmedetomidine in Neurocritical Care Patients	NEUROCRITICAL CARE			English	Article						Dexmedetomidine; Analgesics; Sedatives; Intensive care unit; Adverse events	TRAUMATIC BRAIN-INJURY; SEDATION; AGITATION; UNIT; ADULT	Dexmedetomidine is a highly selective alpha(2)-adrenoreceptor agonist that produces dose-dependent sedation, anxiolysis, and analgesia without respiratory depression. Dexmedetomidine has been used in critically ill medical, surgical, and pediatric patients, as an adjunct to sedation and/or for treating drug or alcohol withdrawal. Information regarding the dosing and utilization of dexmedetomidine has been derived primarily from studies in critically ill patients in the medical intensive care unit. There has been no study designed specifically to evaluate dexmedetomidine for these therapeutic uses in the neurocritical care population. The primary and secondary objectives were to evaluate the starting dose of dexmedetomidine for neurocritical care patients and to assess the effect on hemodynamic parameters, respectively. This was a prospective, observational study conducted from October 2007 to March 2008. Patients were included if they were admitted to the Neuro-Intensive Care Unit and received dexmedetomidine infusion. Six patients met the criteria for the study. The mean initial dexmedetomidine infusion rate and mean maximum infusion rate were 0.67 +/- A 0.2 and 1.3 +/- A 0.5 mcg/kg/h, respectively. The mean duration of dexmedetomidine infusion was 66 +/- A 10 h. Two patients (33%) experienced a significant change in mean heart rate and systolic blood pressure after starting dexmedetomidine infusion. Neurocritically ill patients may require high doses of dexmedetomidine to achieve desired levels of sedation. The high rates and long duration of dexmedetomidine infusion had a statistically, but not clinically, significant impact on hemodynamic parameters.	[Grof, Tina M.; Bledsoe, Kathleen A.] Univ Virginia Hlth Syst, Charlottesville, VA USA		Grof, TM (corresponding author), Univ Virginia Hlth Syst, Charlottesville, VA USA.	tg9m@virginia.edu	Viani, Rafael/V-1196-2018				Bekker A, 2005, NEUROSURGERY, V57, P1, DOI 10.1227/01.NEU.0000163476.42034.A1; Gerlach AT, 2007, ANN PHARMACOTHER, V41, P245, DOI 10.1345/aph.1H314; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Kim E, 2002, NEUROREHABILITATION, V17, P297; Levy M, 2005, NEUROREHABILITATION, V20, P279; MacLaren R, 2007, PHARMACOTHERAPY, V27, P351, DOI 10.1592/phco.27.3.351; Prielipp RC, 2002, ANESTH ANALG, V95, P1052, DOI 10.1097/00000539-200210000-00048; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2004, INTENS CARE MED, V30, P2188, DOI 10.1007/s00134-004-2417-z; Venn RM, 2003, INTENS CARE MED, V29, P201, DOI 10.1007/s00134-002-1579-9; 2004, PRECEDEX DEXMEDETOMI	11	31	33	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	JUN	2010	12	3					356	361		10.1007/s12028-008-9156-x			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	590RJ	WOS:000277244700008	20217277				2022-02-06	
J	Ibrahim, NG; Ralston, J; Smith, C; Margulies, SS				Ibrahim, Nicole G.; Ralston, Jill; Smith, Colin; Margulies, Susan S.			Physiological and Pathological Responses to Head Rotations in Toddler Piglets	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; pediatric head injury; pig; toddler	TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; CORTICAL IMPACT; IMMATURE RAT; AGE; MODEL; DAMAGE; CHILDREN; CALCIUM	Closed head injury is the leading cause of death in children less than 4 years of age, and is thought to be caused in part by rotational inertial motion of the brain. Injury patterns associated with inertial rotations are not well understood in the pediatric population. To characterize the physiological and pathological responses of the immature brain to inertial forces and their relationship to neurological development, toddler-age (4-week-old) piglets were subjected to a single non-impact head rotation at either low (31.6 +/- 4.7 rad/sec(2), n = 4) or moderate (61.0 +/- 7.5 rad/sec(2), n = 6) angular acceleration in the axial direction. Graded outcomes were observed for both physiological and histopathological responses such that increasing angular acceleration and velocity produced more severe responses. Unlike low-acceleration rotations, moderate-acceleration rotations produced marked EEG amplitude suppression immediately post-injury, which remained suppressed for the 6-h survival period. In addition, significantly more severe subarachnoid hemorrhage, ischemia, and axonal injury by beta-amyloid precursor protein (beta-APP) were observed in moderate-acceleration animals than low-acceleration animals. When compared to infant-age (5-day-old) animals subjected to similar (54.1 +/- 9.6 rad/sec(2)) acceleration rotations, 4-week-old moderate-acceleration animals sustained similar severities of subarachnoid hemorrhage and axonal injury at 6 h post-injury, despite the larger, softer brain in the older piglets. We conclude that the traditional mechanical engineering approach of scaling by brain mass and stiffness cannot explain the vulnerability of the infant brain to acceleration-deceleration movements, compared with the toddler.	[Ibrahim, Nicole G.; Ralston, Jill; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Dept Neuropathol, Edinburgh, Midlothian, Scotland		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Smith, Colin/0000-0002-4507-5132	National Institute of Neurological Disorders and Stroke (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	This work was funded by the National Institute of Neurological Disorders and Stroke (NIH).	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Alberts B., 2002, MOL BIOL CELL, V4th; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; BRUCE D, 1990, HEAD INJURIES PEDIAT; Danelson KA, 2008, STAPP CAR C, V52, P59; Dobbing J, 1968, Prog Brain Res, V29, P417; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; DOBBING J, 1974, BRIT MED BULL, V30, P164, DOI 10.1093/oxfordjournals.bmb.a071188; Dobbing J, 1981, LATER DEV BRAIN ITS; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Eucker S. A., 2009, THESIS U PENNSYLVANI; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; FERREIRA A, 1993, J NEUROSCI, V13, P3112; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; IBRAHIM NG, 2009, THESIS U PENNSYLVANI; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Irwin AL, 1997, BIOMECHANICAL BASES; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1966, P 10 STAPP CAR CRASH, P191; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Snyder R.C., 1977, UMHSRI77 CONS PROD S; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Verger K, 2000, BRAIN INJURY, V14, P495; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yam PS, 1998, J NEUROTRAUM, V15, P441, DOI 10.1089/neu.1998.15.441; Zhang CL, 1999, FEMS MICROBIOL ECOL, V30, P367, DOI 10.1111/j.1574-6941.1999.tb00664.x	63	31	31	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2010	27	6					1021	1035		10.1089/neu.2009.1212			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	612VO	WOS:000278933300006	20560753	Green Published, Green Submitted			2022-02-06	
J	Bourdages, M; Bigras, JL; Farrell, CA; Hutchison, JS; Lacroix, J				Bourdages, Macha; Bigras, Jean-Luc; Farrell, Catherine A.; Hutchison, James S.; Lacroix, Jacques		Canadian Critical Care Trials Grp	Cardiac arrhythmias associated with severe traumatic brain injury and hypothermia therapy	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						clinical trial; critical care medicine; hypothermia therapy; arrhythmias; traumatic brain injury; pediatrics	PEDIATRIC HEAD-INJURY; CHILDREN; CATECHOLAMINES; ADULTS; TRIAL	Objective: Severe head trauma and/or severe hypothermia (<= 32 degrees C) can cause cardiac arrhythmias. Effect of moderate hypothermia (32-33 degrees C) on cardiac arrhythmias in children after severe traumatic brain injury is not well characterized. The objective is to determine the effect of moderate and short-term (24 hrs) hypothermia therapy on the incidence and severity of cardiac arrhythmias in children with severe traumatic brain injury compared with normothermic control subject using a 24-hr Holter recording. Design: Prospective ancillary study of a multicenter randomized, controlled clinical trial. Setting: A Canadian university-affiliated pediatric intensive care unit in a level III trauma center. Patients: Patients <18 yrs with severe traumatic brain injury. Interventions: Holter recording during moderate hypothermia (HYPO group; esophageal temperature 32-33 degrees C) or normothermia (NORMO group; 36.5-37.5 degrees C) induced for 24 hrs started within 8 hrs after a severe traumatic brain injury. Measurements and Main Results: Sixteen patients who had a median age of 12.7 yrs (range, 7.2-17.0 yrs) were enrolled. The time from the injury to the start of the cooling process was 7.3 hrs (range, 6.6-7.8 hrs). The temperature when Holter recording began was 32.9 degrees C (range, 31.6-34.4 degrees C) in the HYPO group. Overall, 44% of all patients (seven of 16 patients) had arrhythmias (two of nine in the NORMO group and five of seven in the HYPO group, p = .13). The most frequent arrhythmias were isolated premature atrial contractions. Hypothermic patients had lower heart rates than normothermic patients (p = .01), but none had a severe bradycardia. In the NORMO group, one patient had accelerated junctional rhythm associated with hypotension. In the HYPO group, one patient had nonsustained monomorphic ventricular tachycardia. Conclusions: Arrhythmias are frequent in severe pediatric traumatic brain injury. Further studies are needed to characterize the epidemiology and clinical impact of arrhythmias associated with severe pediatric head trauma and moderate hypothermia. (Pediatr Crit Care Med 2010;11:408-414)	[Bourdages, Macha] Univ Laval, CHUQ, Div Pediat Intens Care Med, Ctr Mere Enfant,Dept Pediat, Quebec City, PQ, Canada; [Bigras, Jean-Luc] Univ Montreal, CHU St Justine, Div Pediat Cardiol, Dept Pediat, Montreal, PQ, Canada; [Farrell, Catherine A.; Lacroix, Jacques] Univ Montreal, CHU St Justine, Div Pediat Intens Care Med, Dept Pediat, Montreal, PQ, Canada; [Hutchison, James S.] Hosp Sick Children, Dept Crit Care Med, Dept Pediat, Toronto, ON M5G 1X8, Canada		Bourdages, M (corresponding author), Univ Laval, CHUQ, Div Pediat Intens Care Med, Ctr Mere Enfant,Dept Pediat, Quebec City, PQ, Canada.	macha.bourdages@mail.chuq.qc.ca			Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec [004095-104]; Canadian Institutes of Health Research/Canadian Neurotrauma Research ProgramCanadian Institutes of Health Research (CIHR) [MCT50398]; Ontario Neurotrauma Foundation [ONBO-00009, ONRO-41]; Rick Hansen Institute; Hospital for Sick Children Foundation [XG 99-057]; Physicians Services Incorporated [98-62]; Children's Hospital of Eastern Ontario Research Institute [98/16S[E]]	Supported by a grant from the Fonds de la Recherche en Sante du Quebec (grant 004095-104). The HyP-HIT study was funded by the Canadian Institutes of Health Research/Canadian Neurotrauma Research Program (MCT50398), the Ontario Neurotrauma Foundation (ONBO-00009 and ONRO-41), the Rick Hansen Institute, the Hospital for Sick Children Foundation (XG 99-057), the Physicians Services Incorporated (98-62), and the Children's Hospital of Eastern Ontario Research Institute (98/16S[E]).	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Attari M, 2004, PEDIATR CLIN N AM, V51, P1355, DOI 10.1016/j.pcl.2004.04.007; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Dash M, 2003, J NEUROSURG ANESTH, V15, P270, DOI 10.1097/00008506-200307000-00017; DICKINSON DF, 1984, BRIT HEART J, V51, P179; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Fish FA, 2001, HEART DIS INFANTS CH, P482; GADKARY CS, 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001048; GARSON A, 1993, AM J CARDIOL, V72, pB14, DOI 10.1016/0002-9149(93)90034-A; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Grosse-Wortmann L, 2006, PEDIATR CARDIOL, V27, P286, DOI 10.1007/s00246-005-1248-1; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MCLEOD AA, 1982, BRIT HEART J, V47, P221; MOSS AJ, 1993, AM J CARDIOL, V72, pB23, DOI 10.1016/0002-9149(93)90036-C; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; NADAS AS, 1951, AM HEART J, V42, P888, DOI 10.1016/0002-8703(51)90061-0; NAGASHIMA M, 1987, PEDIATR CARDIOL, V8, P103, DOI 10.1007/BF02079464; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Natale JE, 2007, PEDIATR CRIT CARE ME, V8, P1, DOI 10.1097/01.pcc.0000256620.55512.5f; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; Oppenheimer SM, 1998, J NEUROL NEUROSUR PS, V64, P289, DOI 10.1136/jnnp.64.3.289; OSBORN JJ, 1953, AM J PHYSIOL, V175, P389, DOI 10.1152/ajplegacy.1953.175.3.389; Ozdemir D, 2005, PEDIATR EMERG CARE, V21, P658, DOI 10.1097/01.pec.0000181427.25342.e0; TAYLOR AA, 1998, SCI PRACTICE PEDIAT, P415; Wittebole X, 2005, J ELECTROCARDIOL, V38, P77, DOI 10.1016/j.jelectrocard.2004.09.004; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875	35	31	33	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2010	11	3					408	414		10.1097/PCC.0b013e3181c51dea			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	593WO	WOS:000277493200015	20464781				2022-02-06	
J	Forsyth, RJ; Salorio, CF; Christensen, JR				Forsyth, Rob J.; Salorio, Cynthia F.; Christensen, James R.			Modelling early recovery patterns after paediatric traumatic brain injury	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							HEAD-INJURY; CHILDREN; REHABILITATION; ADOLESCENTS; SEVERITY; INSTRUMENT; OUTCOMES; LESIONS; WEEFIM; MEMORY	Objective To describe the range of early recovery patterns seen in children admitted for inpatient rehabilitation after traumatic brain injury and to build simple predictive models of expected recovery. Patients 103 consecutive paediatric admissions to a neurological rehabilitation facility after closed head injury. Methods Children's recoveries were defined by repeated scores on the WeeFIM (a validated paediatric measure of functional independence) assembled into recovery trajectories. Non-linear mixed effects modelling was used to define 'typical' recoveries and to identify useful simple predictor variables. Results WeeFIM recovery curves showed a characteristic sigmoidal form with an initial slow phase followed by a mid-phase of fastest improvement and a late plateau. Final WeeFIM scores ranged from 18 to 125 (median 105, IQR 87-117). The time taken to reach 50% final WeeFIM score ranged from 5 to 145 days (median 27, IQR 17-46). Both final WeeFIM and time to reach 50% final WeeFIM correlated with time to follow commands (TFC), defined as the post-injury day on which a child was first observed to follow two simple commands in a 24 h period. Conclusions Simple models predicting outcome trajectory can be built incorporating early rate-of-recovery indices (such as TFC) as proxies of injury severity. Such models allow informed discussion with families of likely rates of progress and the CI on these estimates. Models of this nature also potentially allow identification of children making better-or worse-than-expected recoveries.	[Forsyth, Rob J.] Univ Newcastle, Royal Victoria Infirm, Sir James Spence Inst, Inst Neurosci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Salorio, Cynthia F.; Christensen, James R.] Johns Hopkins Sch Med, Kennedy Krieger Inst, Baltimore, MD USA		Forsyth, RJ (corresponding author), Univ Newcastle, Royal Victoria Infirm, Sir James Spence Inst, Inst Neurosci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	r.j.forsyth@newcastle.ac.uk	Forsyth, Rob/H-9193-2019; Forsyth, Rob J/I-9226-2012	Forsyth, Rob/0000-0002-5657-4180; Forsyth, Rob J/0000-0002-5657-4180			Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Chen CC, 2005, AM J PHYS MED REHAB, V84, P671, DOI 10.1097/01.phm.0000176439.32318.36; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Forsyth R, 2009, NEUROPSYCHOL REHABIL, V19, P891, DOI 10.1080/09602010903091066; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Golomb MR, 2004, PEDIATR NEUROL, V31, P311, DOI 10.1016/j.pediatrneurol.2004.05.011; GOTSCHALL CS, 1995, J NEUROTRAUM, V12, P611, DOI 10.1089/neu.1995.12.611; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kelly T P, 1999, Pediatr Rehabil, V3, P187; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Medical Research Council, 2000, FRAM DEV EV RCTS COM; *MRC CRASH TRIAL C, 2008, BMJ-BRIT MED J, V36, P425; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Pinheiro J, NLME LINEAR NONLINEA; Pinheiro J.C., 2004, MIXED EFFECTS MODELS; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; R Core Development Team, 2008, R LANG ENV STAT COMP; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Warschausky S, 2001, ARCH PHYS MED REHAB, V82, P329, DOI 10.1053/apmr.2001.21510; Wong PP, 2001, BRAIN INJURY, V15, P519, DOI 10.1080/02699050010005995; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	31	31	31	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	APR	2010	95	4					266	270		10.1136/adc.2008.147926			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	573QG	WOS:000275928900007	19948516				2022-02-06	
J	Petroni, G; Quaglino, M; Lujan, S; Kovalevski, L; Rondina, C; Videtta, W; Carney, N; Temkin, N; Chesnut, R				Petroni, Gustavo; Quaglino, Marta; Lujan, Silvia; Kovalevski, Leandro; Rondina, Carlos; Videtta, Walter; Carney, Nancy; Temkin, Nancy; Chesnut, Randall			Early Prognosis of Severe Traumatic Brain Injury in an Urban Argentinian Trauma Center	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic Brain Injury; Prognosis; Argentina	SEVERE HEAD-INJURY	Background: Previous studies indicate that age, Glasgow Coma Scale score (GCS), arterial hypotension, computed tomography (CT) findings, and pupillary reactivity are strong predictors of outcome for patients with severe traumatic brain injury (TBI). However, the predictive validity of these variables has never been rigorously tested in patients from the developing world. The objective of this study was to evaluate the prognostic value of these variables in a resource-limited setting and to test their predictive power by using them to create an outcome model. Methods: The study was conducted at Hospital Emergencias "Dr. Clemente Alvarez" in Rosario, Argentina. All patients with severe TBI meeting criteria between August 2000 and February 2003 were included. Outcome at 6 months postinjury was measured by mortality and by the Extended Glasgow Outcome Scale score. Two logistic regression models were created for predicting mortality and outcome. Results: Outcome measures were acquired for 100% of the sample (N = 148). There was 58% mortality; 30% had moderate to good recovery, and 12% were severely disabled. The model accurately predicted 83.9% of mortality, and 81.1% of outcome. Because of variation in timing of CT scans, the models were recalculated without the CT variable. The accuracy of prediction was 79.7% and 79% for mortality and Extended Glasgow Outcome Scale, respectively. Conclusions: This study provides rigorous, prospective data that (1) validates the generalizability of the five World Health Organization/Organization Mondiale de la Sante TBI prognostic predictors outside of the developed world, and (2) provides outcome benchmarks for mortality and morbidity from severe TBI in developing countries.	[Petroni, Gustavo; Lujan, Silvia; Rondina, Carlos] Hosp Emergencias Dr Clemente Alvarez, Intens Care Unit, Rosario, Santa Fe, Argentina; [Quaglino, Marta; Kovalevski, Leandro] Univ Nacl Rosario, Sch Econ & Stat, RA-2000 Rosario, Santa Fe, Argentina; [Videtta, Walter] Hosp Nacl Prof Dr Alejandro Posadas, Intens Care Unit, Buenos Aires, DF, Argentina; [Temkin, Nancy; Chesnut, Randall] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA		Petroni, G (corresponding author), 1734 10 Floor,Apt 2, RA-2000 Rosario, Santa Fe, Argentina.	gustavopetroni@gmail.com		Chesnut, Randall/0000-0001-6377-3666	U. S. Department of EducationUS Department of Education; National Institute on Disability and Rehabilitation Research [H133G 000154]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5 D43 TW007566]; National Institute of Neurological Disorders and Stroke and Fogarty International Center of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Fogarty International Center (FIC) [1 R01 NS058302]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW007566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058302] Funding Source: NIH RePORTER	Supported by U. S. Department of Education, National Institute on Disability and Rehabilitation Research grant H133G 000154, Fogarty International Center of the National Institutes of Health (NIH) grant 5 D43 TW007566, and National Institute of Neurological Disorders and Stroke and Fogarty International Center of the NIH grant 1 R01 NS058302.	*BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P559; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; Edwards P, 2005, LANCET, V365, P1957; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GUYATT GH, 2006, CLIN EPIDEMIOLOGY DO, P323; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; Ratanalert S, 2002, BRIT J NEUROSURG, V16, P487, DOI 10.1080/0268869021000030311; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1974, LANCET, V2, P81; TIEN R, 2000, HEAD INJURY, P457; WILBERGER JE, 2000, HEAD INJURY, P27; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	23	31	36	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2010	68	3					564	570		10.1097/TA.0b013e3181ce1eed			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	567ZY	WOS:000275491200014	20220417				2022-02-06	
J	Sarnaik, AA; Conley, YP; Okonkwo, DO; Barr, TL; Fink, EL; Szabo, C; Kochanek, PM; Clark, RSB				Sarnaik, Ajit A.; Conley, Yvette P.; Okonkwo, David O.; Barr, Taura L.; Fink, Ericka L.; Szabo, Csaba; Kochanek, Patrick M.; Clark, Robert S. B.			Influence of PARP-1 Polymorphisms in Patients after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ADP-ribosyltransferase; traumatic brain injury; poly(ADP-ribose) polymerase; poly-ADP-ribosylation	POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; NAD(+) DEPLETION; CELL-DEATH; ADP-RIBOSYLATION; OXIDATIVE STRESS; MICE; ACTIVATION; ISCHEMIA; PROTEINS; DAMAGE	Poly(ADP-ribose) polymerase-1 (PARP-1) plays an important role in the cellular response to stress and DNA damage. However, excessive activity of PARP-1 exacerbates brain injury via NAD(+) depletion and energy failure. The purpose of this study was to determine if tagging single nucleotide polymorphisms (tSNPs) covering multiple regions of the PARP-1 gene are related to outcome after traumatic brain injury (TBI) in humans. DNA from 191 adult patients with severe TBI was assayed for four tSNPs corresponding to haplotype blocks spanning the PARP-1 gene. Categorization as favorable or poor outcome was based on Glasgow Outcome Scale (GOS) score assigned at 6 months. PARP-1 enzyme activity was indirectly evaluated by quantifying poly-ADP-ribose (PAR)-modified proteins in cerebrospinal fluid (CSF) using an enzyme-linked immunosorbent assay. In multiple logistic regression analysis controlling for age, initial Glasgow Coma Scale score, and gender, the AA genotype of SNP rs3219119 was an independent predictor of favorable neurologic outcome. This SNP tags a haplotype block spanning the automodification and catalytic domains of the PARP-1 gene. SNP rs2271347 correlated with CSF PAR-modified protein level. This SNP, which did not correlate with outcome, tags a haplotype block spanning the promoter region of the PARP-1 gene. We conclude that after severe TBI in humans, a PARP-1 polymorphism within the automodification-catalytic domain is associated with neurological outcome, while a polymorphism within the promoter region was associated with CSF PAR-modified protein level. These findings must be replicated in a prospective study before the relevance of PARP-1 polymorphisms after TBI can be established.	[Sarnaik, Ajit A.; Fink, Ericka L.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Sarnaik, Ajit A.; Fink, Ericka L.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Conley, Yvette P.; Barr, Taura L.] Univ Pittsburgh, Dept Genet & Dev, Pittsburgh, PA 15260 USA; [Conley, Yvette P.; Barr, Taura L.] Univ Pittsburgh, Dept Hlth Promot, Pittsburgh, PA 15260 USA; [Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX USA; [Sarnaik, Ajit A.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Barr, Taura L.] NINR, Tissue Injury Unit, Bethesda, MD 20892 USA		Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Szabo, Csaba/ABG-2644-2021; Szabo, Csaba/D-1882-2013; Kochanek, Patrick M/D-2371-2015; Fink, Ericka/AAU-9792-2021	Kochanek, Patrick M/0000-0002-2627-913X; Fink, Ericka/0000-0002-3683-4571	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD 40686]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318]; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P01NS030318, P20NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The authors would like to thank the National Institute of Child Health and Human Development (T32 HD 40686), the National Institute of Neurological Disorders and Stroke (NS30318), and the National Institute of Nursing Research (R01NR008424).	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1998, EUR J PHARMACOL, V351, P377, DOI 10.1016/S0014-2999(98)00381-1; Fink EL, 2008, J CEREBR BLOOD F MET, V28, P1523, DOI 10.1038/jcbfm.2008.52; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; GANDHI S, 2005, MOL GENET, V14, P2749; Halmosi R, 2001, MOL PHARMACOL, V59, P1497, DOI 10.1124/mol.59.6.1497; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hur JW, 2006, RHEUMATOLOGY, V45, P711, DOI 10.1093/rheumatology/kei262; Infante J, 2007, J NEUROL SCI, V256, P68, DOI 10.1016/j.jns.2007.02.008; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Mabley JG, 2005, J PHARMACOL EXP THER, V315, P812, DOI 10.1124/jpet.105.090480; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nagayama T, 2000, J NEUROCHEM, V74, P1636, DOI 10.1046/j.1471-4159.2000.0741636.x; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang XG, 2007, BIOCHEM BIOPH RES CO, V354, P122, DOI 10.1016/j.bbrc.2006.12.162; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	30	31	32	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2010	27	3					465	471		10.1089/neu.2009.1171			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	575PJ	WOS:000276079100001	19925161	Green Published			2022-02-06	
J	Sommer, M; Heidinger, C; Arendasy, M; Schauer, S; Schmitz-Gielsdorf, J; Hausler, J				Sommer, M.; Heidinger, Ch.; Arendasy, M.; Schauer, S.; Schmitz-Gielsdorf, J.; Haeusler, J.			Cognitive and Personality Determinants of Post-injury Driving Fitness	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Stroke; Traumatic brain injury; Fitness to drive; Standardized driving test; Artificial neural network	TRAUMATIC BRAIN-INJURY; STROKE; ROAD; ACCIDENTS; DRIVERS; ABILITY; PERFORMANCE; MULTICENTER; VALIDATION; VALIDITY	Increasingly often, practitioners in neuropsychological rehabilitation centers are called upon to assess patients' fitness to drive after brain injury. There is, therefore, a need for valid and reliable psychometric test batteries that enable unsafe drivers to be identified. This article investigates the contribution of five driving-related personality traits to the prediction of fitness to drive in patients suffering from traumatic brain injuries (TBI) or strokes over and above cognitive ability traits that have already shown to be related to safe driving. A total of 178 patients suffering from either strokes or TBI participated in this study. All the participants completed a standardized psychometric test battery and subsequently took a standardized driving test. The contribution of the driving-related ability and personality traits to the prediction of fitness to drive was investigated by means of a logistic regression analysis and an artificial neural network. The results indicate that both cognitive ability and personality factors are important in predicting fitness to drive, although cognitive ability factors contribute slightly more to the prediction of patients' actual fitness to drive than personality factors. Furthermore, even though there are subtle differences in the predictive models obtained for the two subsamples (stroke and TBI patients), these differences are adequately accounted for by a more unitary model calculated by means of an artificial neural network that is capable of taking account of moderating effects between the predictor variables.	[Sommer, M.; Heidinger, Ch.; Haeusler, J.] SCHUHFRIED GmbH, Dept Psychol Assessment, A-2340 Modling, Austria; [Sommer, M.; Arendasy, M.] Graz Univ, Inst Psychol, Dept Psychol Methods & Computer Based Modelling, Graz, Austria; [Schauer, S.] Univ Munich, Humanwissensch Zentrum, Generat Res Program, Munich, Germany; [Schmitz-Gielsdorf, J.] Praxis Allgemeine & Neuropsychol Psychotherapie, Aachen, Germany		Sommer, M (corresponding author), SCHUHFRIED GmbH, Dept Psychol Assessment, Hyrtlstr 45, A-2340 Modling, Austria.	sommer@schuhfried.at			SCHUHFRIED GmbH, Modling, Austria	This work was supported by the SCHUHFRIED GmbH, Modling, Austria.; Sommer, Heidinger and Hausler worked at the SCHUHFRIED GmbH, who financially supported the present study. Schauer and Schmitz-Gielsdorf were responsible for the data collection for which they received financial support from the SCHUHFRIED GmbH. There are no conflicts of interests for Arendasy.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Akinwuntan AE, 2002, ARCH PHYS MED REHAB, V83, P334, DOI 10.1053/apmr.2002.29662; Anderson JA, 1988, NEUROCOMPUTING FDN R; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; BIEHL B, 1996, MANUAL TACHISTOSCOPI; Bishop C. M., 1995, NEURAL NETWORKS PATT; Bortz J., 1999, STAT SOZIALWISSENSCH; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; Bridle J. S., 1990, Neurocomputing, Algorithms, Architectures and Applications. Proceedings of the NATO Advanced Research Workshop, P227; BROOKE MM, 1992, AM J PHYS MED REHAB, V71, P177, DOI 10.1097/00002060-199206000-00009; Brown MT, 2000, HDB APPL MULTIVARIAT, P209, DOI DOI 10.1016/B978-012691360-6/50009-4; Brown S. D., 2000, HDB APPL MULTIVARIAT, P152; BUKASA B, 1990, VALIDIERUNG VERKEHRS; BURGARD E, 2005, THESIS LMU MUNCHEN; CHALOUPKA C, 1995, SAFETY SCI, V19, P137, DOI 10.1016/0925-7535(94)00015-U; Chapman P, 2000, APPL COGNITIVE PSYCH, V14, P31, DOI 10.1002/(SICI)1099-0720(200001)14:1<31::AID-ACP622>3.0.CO;2-9; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Dorn L., 2005, DRIVER BEHAV TRAININ, VII, P425; Evans L., 1991, TRAFFIC SAFETY DRIVE; FAHLMAN SE, 1988, FASTER LEARNING VARI; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; Golz D, 2004, Z NEUROPSYCHOL, V15, P157; Groeger J.A., 2000, UNDERSTANDING DRIVIN; GROEGER JA, 1997, ASSESSING DRIVER, P59; Hannen P, 1998, NERVENARZT, V69, P864, DOI 10.1007/s001150050355; HARTJE W, 2004, FAHREIGNUNG BEI NEUR, P19; HARTJE W, 1991, Z NEUROPSYCHOLOGIE, V2, P100; Hatakka M., 2002, TRANSPORT RES F TRAF, V5, P201, DOI 10.1016/s1369-8478(02)00018-9; HAUSLER J, 2005, 7 C TASK FORC PSYCH; Hergovich A., 2005, MANUAL VIENNA RISK T; Herle M., 2004, MANUAL INVENTORY DRI; Hjalmdahl M, 2004, TRANSPORT RES A-POL, V38, P127, DOI 10.1016/j.tra.2003.09.001; Hornke L. F., 2003, MANUAL ADAPTIVE MATR; Kinnebrock W, 1992, NEURONALE NETZE GRUN; Klebelsberg D., 1982, VERKEHRSPSYCHOLOGIE; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; MAHONEY F I, 1965, Md State Med J, V14, P61; Masters T., 1995, ADV ALGORITHMS NEURA; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; McKenna P, 2004, BRIT J CLIN PSYCHOL, V43, P325, DOI 10.1348/0144665031752952; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI [DOI 10.1007/978-1-4613-2173-6_19, 10.1007/978-1-4613-2173-6_19]; MIELKE A, 2001, NEURONALE NETZE; Niemann H, 1999, EMPIRISCHE VERKEHRSP, P69; NOURI FM, 1988, CLIN REHABIL, V2, P99; OWSLEY C, 1991, PSYCHOL AGING, V6, P403, DOI 10.1037/0882-7974.6.3.403; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Rakes T., 1991, DECISION LINE, V22, P11; RANNEY TA, 1994, ACCIDENT ANAL PREV, V26, P733, DOI 10.1016/0001-4575(94)90051-5; RIM PA, 1999, TRANSPORT RES F-TRAF, V2, P151; Risser R, 2008, ACCIDENT ANAL PREV, V40, P149, DOI 10.1016/j.aap.2006.12.018; Risser R., 1997, ASSESSING DRIVER, P89; Risser R., 1985, KLEINE FACHBUCHREIHE, V21; ROJAS R, 2000, NEURONAL NETWORKS SY; Scheiblechner H., 1985, TEST DESIGN DEV PSYC, P219; Schuhfried, 2005, MANUAL EXPERT SYSTEM; Schuhfried G., 1997, MANUAL REACTION TEST; Schuhfried G., 1998, MANUAL DETERMINATION; Schuhfried G., 2002, MANUAL PERIPHERAL PE; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Soderstrom ST, 2006, SCAND J PSYCHOL, V47, P419, DOI 10.1111/j.1467-9450.2006.00550.x; Somers MJ, 2001, J OCCUP ORGAN PSYCH, V74, P47, DOI 10.1348/096317901167226; Sommer M, 2008, TRANSPORT RES F-TRAF, V11, P362, DOI 10.1016/j.trf.2008.03.001; SOMMER M, 2008, FACTORIAL CRITERION; SOMMER M, 2008, ZWEIT OST S PSYCH MI; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; SZLYK JP, 1995, HUM FACTORS, V37, P430, DOI 10.1518/001872095779064645; Wagner M., 2001, MANUAL COGNITRONE CO; Wilde GJS., 1994, TARGET RISK DEALING	73	31	33	2	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2010	25	2					99	117		10.1093/arclin/acp109			19	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	555BD	WOS:000274481100003	20080833	Bronze			2022-02-06	
J	Bahrami, S; Pelinka, L; Khadem, A; Maitzen, S; Hawa, G; van Griensven, M; Redl, H				Bahrami, Soheyl; Pelinka, Linda; Khadem, Anna; Maitzen, Sonja; Hawa, Gerhard; van Griensven, Martijn; Redl, Heinz			Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						diagnosis; SIRS; traumatic brain injury; polytrauma; MOF; C-type natriuretic peptide	INFLAMMATORY RESPONSE SYNDROME; NATRIURETIC PEPTIDE; CNP; RECEPTORS; PROCALCITONIN; PITUITARY; FAILURE; ATRIAL; CELLS; FORMS	Objectives: C-type natriuretic peptide (CNP), a member of the natriuretic peptide family, is produced in vascular endothelium. We assessed the accuracy of natriuretic (NT)-proCNP, the N-terminal fragment of the C-type natriuretic peptide precursor, in predicting development of sepsis in multiple-traumatized patients with/without traumatic brain injury verified by computed tomography. Design: Retrospective clinical study. Setting: Level II trauma center. Patients: Three patient groups were stratified according to computed tomography results: isolated traumatic brain injury (n = 20), multiple-traumatized with traumatic brain injury (n = 26) and multiple-traumatized without traumatic brain injury (n = 26). During 13 days after multiple trauma, 37 (51%) patients developed sepsis. Measurements and Main Results: Circulating plasma NT-proCNP levels were measured daily (days 0-13) in all patients. Without any retrospective stratification of trauma patients, plasma NT-proNCP levels did not differ in septic (n = 37) and nonseptic (n = 35) patients (p = .505). Between days 2 and 6 posttrauma, there was a significant (p = .002) increase of circulating NT-proCNP in multi pie-traumatized patients without traumatic brain injury who developed sepsis (n = 19) compared with nonseptic multiple-traumatized patients without traumatic brain injury. Conversely, in septic patients either with traumatic brain injury alone or with multiple trauma and traumatic brain injury, the NT-proCNP showed a trend toward lower levels than in nonseptic patients. Prediction of sepsis (receiver-operating characteristic test) from days 2 to 6 after multiple trauma by NT-proCNP in patients without traumatic brain injury was accurate with an area under the curve of 0.84 +/- 0.03. The optimal cutoff value of 2.3 pmol/L produced sensitivity of 84% to 96% and specificity of 61% to 91% from day 2 to 6 after trauma. Conclusions: Our data showed that the levels of circulating NT-proCNP between multiple-traumatized patients without traumatic brain injury who do and do not develop sepsis are distinctly different. Plasma NT-proCNP concentration can potentially serve as an accurate predictor of sepsis in this cohort of patients. (Crit Care Med 2010; 38:161-166)	[Bahrami, Soheyl; Pelinka, Linda; Khadem, Anna; van Griensven, Martijn; Redl, Heinz] Res Ctr AUVA, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Maitzen, Sonja; Hawa, Gerhard] Biomed Med Prod GmbH & CoKG, Vienna, Austria		Bahrami, S (corresponding author), Res Ctr AUVA, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.	Soheyl.Bahrami@trauma.lbg.ac.at	van Griensven, Martijn/F-5808-2012; Redl, Heinz/AAD-8157-2019	van Griensven, Martijn/0000-0001-5104-9881; Bahrami, Soheyl/0000-0002-4563-6251			BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bossink AWJ, 1998, CHEST, V113, P1533, DOI 10.1378/chest.113.6.1533; Charles CJ, 1996, AM J PHYSIOL-REG I, V271, pR373, DOI 10.1152/ajpregu.1996.271.2.R373; Chauhan SD, 2003, P NATL ACAD SCI USA, V100, P1426, DOI 10.1073/pnas.0336365100; Daggubati S, 1997, CARDIOVASC RES, V36, P246, DOI 10.1016/S0008-6363(97)00164-8; Del Ry S, 2005, EUR J HEART FAIL, V7, P1145, DOI 10.1016/j.ejheart.2004.12.009; DREWETT JG, 1995, J BIOL CHEM, V270, P4668, DOI 10.1074/jbc.270.9.4668; ERTEL W, 1994, EUR J PEDIATR SURG, V4, P243, DOI 10.1055/s-2008-1066112; Garcha RS, 2006, J RENIN-ANGIO-ALDO S, V7, P87, DOI 10.3317/jraas.2006.014; Giamarellos-Bourboulis EJ, 2002, INTENS CARE MED, V28, P1351, DOI 10.1007/s00134-002-1398-z; HAGIWARA H, 1994, J BIOCHEM-TOKYO, V116, P606, DOI 10.1093/oxfordjournals.jbchem.a124567; HAGIWARA H, 1994, J BIOL CHEM, V269, P10729; HAMA N, 1994, BIOCHEM BIOPH RES CO, V198, P1177, DOI 10.1006/bbrc.1994.1166; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Hobbs A, 2004, CIRCULATION, V110, P1231, DOI 10.1161/01.CIR.0000141802.29945.34; Igaki T, 1998, HYPERTENS RES-CLIN E, V21, P7, DOI 10.1291/hypres.21.7; Jaszberenyi M, 1998, NEUROREPORT, V9, P2601, DOI 10.1097/00001756-199808030-00032; Kubo A, 2001, EXP HEMATOL, V29, P609, DOI 10.1016/S0301-472X(01)00625-7; Kuo JY, 2007, SCAND CARDIOVASC J, V41, P155, DOI 10.1080/14017430701302482; Marty B, 2001, J VOLCANOL GEOTH RES, V108, P1, DOI 10.1016/S0377-0273(00)00275-4; MCARDLE CA, 1994, ENDOCRINOLOGY, V135, P2794, DOI 10.1210/en.135.6.2794; MINAMINO N, 1991, BIOCHEM BIOPH RES CO, V179, P535, DOI 10.1016/0006-291X(91)91404-Z; Nishimura M, 1998, J HYPERTENS, V16, P1175; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Prickett TCR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1395, DOI 10.1152/ajpendo.00469.2006; Schachner T, 2004, EUR J CARDIO-THORAC, V25, P585, DOI 10.1016/j.ejcts.2003.07.013; Schulz S, 2005, PEPTIDES, V26, P1024, DOI 10.1016/j.peptides.2004.08.027; Scotland RS, 2005, P NATL ACAD SCI USA, V102, P14452, DOI 10.1073/pnas.0504961102; SHINOMIYA M, 1994, BIOCHEM BIOPH RES CO, V205, P1051, DOI 10.1006/bbrc.1994.2772; STINGO AJ, 1992, AM J PHYSIOL, V263, pH1318, DOI 10.1152/ajpheart.1992.263.4.H1318; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; Takida S, 1999, HYPERTENSION, V33, P124, DOI 10.1161/01.HYP.33.1.124; TOGASHI K, 1992, CLIN CHEM, V38, P2136; TOTSUNE K, 1994, PEPTIDES, V15, P37, DOI 10.1016/0196-9781(94)90167-8; Wright SP, 2004, HYPERTENSION, V43, P94, DOI 10.1161/01.HYP.0000105623.04382.C0; Wu CL, 2003, J BIOL CHEM, V278, P25847, DOI 10.1074/jbc.M301223200	37	31	32	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2010	38	1					161	166		10.1097/CCM.0b013e3181b78a06			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539AE	WOS:000273224800024	19730251				2022-02-06	
J	Demery, JA; Larson, MJ; Dixit, NK; Bauer, RM; Perlstein, WM				Demery, Jason A.; Larson, Michael J.; Dixit, Neha K.; Bauer, Russell M.; Perlstein, William M.			Operating Characteristics of Executive Functioning Tests Following Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Operating characteristics; Executive functioning; Traumatic brain injury	DEFICIT HYPERACTIVITY DISORDER; FRONTAL-LOBE LESIONS; MILD HEAD-INJURY; ATTENTION; OUTCOMES; SCORES; TRAIL; SCALE	The primary purposes of this study were to determine if controls, and mild and moderate/severe traumatic brain injury (TBI) patients performed differently on a battery of executive functioning (EF) tests, and to identify the operating characteristics of EF tests in this population. Participants consisted of 46 brain-injured individuals and 24 healthy controls. All participants completed an extensive battery of EF tests. Results showed that mild TBI participants performed worse than controls on the Trail Making Test Part B, and that moderate/severe TBI participants consistently performed worse than either group on a variety of EF measures. Tests of EF exhibited a wide range of operating characteristics, suggesting that some EF tests are better than others in identifying TBI-related neurocognitive impairment. Predictive values were better for individuals with moderate/severe TBI than mild TBI. Overall, the Digit Span Backward Test showed the best positive predictive power in differentiating TBI. Our results provide useful data that may guide test selection in evaluating EF in patients with traumatic brain injury.	[Demery, Jason A.; Dixit, Neha K.] N Florida S Georgia Vet Hlth Syst, Psychol Serv, Gainesville, FL 32608 USA; [Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Bauer, Russell M.; Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA		Demery, JA (corresponding author), N Florida S Georgia Vet Hlth Syst, Psychol Serv 116B, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	jasondemery@gmail.com	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	Evelyn F. McKnight Brain Research Grant Program; Florida Brain and Spinal Cord Injury Trust; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01 MH01857]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH073076, K01MH001857] Funding Source: NIH RePORTER	Supported by grants from the Evelyn F. McKnight Brain Research Grant Program, the Florida Brain and Spinal Cord Injury Trust Fund, and the National Institute of Mental Health (K01 MH01857) to W. M. P. We thank Kay Waid-Ebbs and Paul J. Seignourel for their assistance with patient recruitment and data collection. This research was conducted in partial fulfillment of the first author's Ph.D. dissertation.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Anderson V., 2002, PRINCIPLES FRONTAL L; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BENSON DF, 1999, BEHAV NEUROLOGY NEUR, P401; Bieliauskas LA, 1997, J CLIN EXP NEUROPSYC, V19, P889, DOI 10.1080/01688639708403769; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cohen J., 2013, STAT POWER ANAL BEHA; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; ELWOOD RW, 1993, CLIN NEUROPSYCHOL, V7, P224, DOI 10.1080/13854049308401527; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Golden J. C., 1978, STROOP COLOR WORD TE; Grodzinsky GM, 1999, CLIN NEUROPSYCHOL, V13, P12, DOI 10.1076/clin.13.1.12.1983; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovejoy DW, 1999, J INT NEUROPSYCH SOC, V5, P222, DOI 10.1017/S1355617799533055; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mittenberg W, 2008, TXB CLIN NEUROPSYCHO, P430; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1985, HALSTEADREITAN NEURO; RETZLAFF PD, 2000, CLIN GUIDE NEUROPSYC; ROEBUCKSPENCER T, 2008, TXB CLIN NEUROPSYCHO; Sarazin M, 1998, NEUROLOGY, V51, P142, DOI 10.1212/WNL.51.1.142; Spielberger CD., 1970, STATE TRAIT ANXIETY; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; [No title captured]	49	31	32	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2010	24	8					1292	1308	PII 929450664	10.1080/13854046.2010.528452			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	685LA	WOS:000284629000004	21069617	Green Accepted			2022-02-06	
J	Livingston, SC; Saliba, EN; Goodkin, HP; Barth, JT; Hertel, JN; Ingersoll, CD				Livingston, Scott C.; Saliba, Ethan N.; Goodkin, Howard P.; Barth, Jeffrey T.; Hertel, Jay N.; Ingersoll, Christopher D.			A preliminary investigation of motor evoked potential abnormalities following sport-related concussion	BRAIN INJURY			English	Article						Concussion; mild traumatic brain injury; motor evoked potential; transcranial magnetic stimulation	TRANSCRANIAL MAGNETIC STIMULATION; CENTRAL SOMATOSENSORY CONDUCTION; INDUCED AXONAL INJURY; BRAIN-INJURY; SPINAL-CORD; HEAD-INJURY; LONG-TERM; PROPAGATION; CORTEX; MILD	Background: Assessment of concussion is primarily based on self-reported symptoms, neurological examination and neuropsychological testing. The neurophysiologic sequelae and the integrity of the corticomotor pathways could be obtained by evaluating motor evoked potentials (MEPs). Objectives: To compare MEPs obtained through transcranial magnetic stimulation (TMS) in acutely concussed and non-concussed collegiate athletes. Methods: Eighteen collegiate athletes (12 males, six females, aged 20.4 +/- 1.3 years) including nine subjects with acute concussion (<= 24 hours) matched to nine control subjects. TMS was applied over the motor cortex and MEP responses were recorded from the contralateral upper extremity. MEP thresholds (%), latencies (milliseconds per metre) and amplitudes were assessed. Central motor conduction time (CMCT) was calculated from MEP, M response and F wave latencies. Testing was performed on days 1, 3, 5 and 10 post-concussion. Results: Ulnar MEP amplitudes were significantly different between post-concussion days 3 and 5 (F-3,F-48 = 3.13, p = 0.041) with smaller amplitudes recorded on day 3 (0.28 +/- 0.10 ms m(-1)). Median MEP latencies were significantly longer (F-3,F-48 = 4.53, p = 0.023) 10 days post-concussion (27.1 +/- 1.4 ms m(-1)) compared to day 1 (25.7 +/- 1.5 ms m(-1)). No significant differences for motor thresholds or CMCTs were observed (p > 0.05). Conclusion: MEP abnormalities among acutely concussed collegiate athletes provide direct electrophysiologic evidence for the immediate effects of concussion.	[Livingston, Scott C.] Univ Kentucky, Dept Rehabil Sci, Div Phys Therapy, Lexington, KY 40536 USA; [Saliba, Ethan N.] Univ Virginia, Dept Athlet Sports Med, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Barth, Jeffrey T.] Univ Virginia, Dept Psychiat Med, Charlottesville, VA USA; [Hertel, Jay N.] Univ Virginia, Dept Human Sci, Charlottesville, VA USA; [Ingersoll, Christopher D.] Cent Michigan Univ, Coll Hlth Sci, Mt Pleasant, MI 48859 USA		Livingston, SC (corresponding author), Univ Kentucky, Dept Rehabil Sci, Div Phys Therapy, 900 S Limestone, Lexington, KY 40536 USA.	scott.livingston@uky.edu	Ingersoll, Christopher/H-6474-2015	Ingersoll, Christopher/0000-0001-9157-6846; Goodkin, Howard/0000-0003-0528-4949	National Operating Committee on the Standards of Athletic Equipment [13-06]; National Athletic Trainers' Association Research and Education Foundation [305DGP002]	This project was funded by the National Operating Committee on the Standards of Athletic Equipment (grant 13-06) and the National Athletic Trainers' Association Research and Education Foundation (grant 305DGP002).	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, J ATHL TRAINING, V36, P236; BARKER AT, 1985, LANCET, V1, P1106; BRASILNETO JP, 1992, ELECTROEN CLIN NEURO, V85, P9, DOI 10.1016/0168-5597(92)90095-S; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; *COMMT INSTR LTD, 2001, MMS3000 T6V4 OWN MAN; Conforto AB, 2004, CLIN NEUROPHYSIOL, V115, P812, DOI 10.1016/j.clinph.2003.11.010; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; DUPIUS F, 2000, CLIN NEUROSCIENCE NE, V11, P4087; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; FACCO E, 1991, ELECTROEN CLIN NEURO, V80, P469, DOI 10.1016/0168-5597(91)90128-K; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GANDEVIA SC, 1987, BRAIN, V110, P1117, DOI 10.1093/brain/110.5.1117; GHEZZI A, 1991, ACTA NEUROL SCAND, V84, P503, DOI 10.1111/j.1600-0404.1991.tb05003.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2000, NEUROLOGIC ATHLETIC, P80; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; GUTLING E, 1993, ELECTROEN CLIN NEURO, V88, P369, DOI 10.1016/0168-5597(93)90013-F; Harris-Love ML, 2006, ARCH PHYS MED REHAB, V87, pS84, DOI 10.1016/j.apmr.2006.08.330; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Hugon M, 1973, NEW DEVELOPMENTS ELE, P277; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; Kaneko K, 1996, ELECTROMYOGR MOTOR C, V101, P478, DOI 10.1016/S0921-884X(96)96021-X; Kimura J, 1989, ELECTRODIAGNOSIS DIS; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefebvre R, 2004, J MANIP PHYSIOL THER, V27, P97, DOI 10.1016/j.jmpt.2003.12.004; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; LIVINGSTON S, J CLIN MONI IN PRESS; Livingston SC, 2008, INT J NEUROSCI, V118, P239, DOI 10.1080/00207450701668020; MERTON PA, 1982, LANCET, V2, P597; Mills KR, 1997, MUSCLE NERVE, V20, P570, DOI 10.1002/(SICI)1097-4598(199705)20:5<570::AID-MUS5>3.0.CO;2-6; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Mills KR, 1999, MAGNETIC STIMULATION; Miranda PC, 1997, ELECTROMYOGR MOTOR C, V105, P116, DOI 10.1016/S0924-980X(97)95720-9; MISULIS KE, 2001, SPEHLMANNS EVOKED PO, P25; MURRAY NMF, 1999, ELECTRODIAGNOSIS CLI, P549; Palmieri RM, 2004, J ATHL TRAINING, V39, P268; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; POWELL JW, 1994, P MILD BRAIN INJ SPO; Pridmore S, 1998, J ECT, V14, P25; Rossini PM, 2007, NEUROLOGY, V68, P484, DOI 10.1212/01.wnl.0000250268.13789.b2; ROSSINI PM, 1987, BRAIN RES, V415, P211, DOI 10.1016/0006-8993(87)90203-4; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; ROSSINI PM, 1991, BRAIN RES, V567, P111, DOI 10.1016/0006-8993(91)91442-4; ROSSINI PM, 1985, ELECTROEN CLIN NEURO, V61, P272, DOI 10.1016/0013-4694(85)91094-6; ROSSINI PM, 1985, ELECTROEN CLIN NEURO, V60, P320, DOI 10.1016/0013-4694(85)90006-9; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P583, DOI 10.1016/0013-4694(83)90026-3; Rutkove SB, 2001, MUSCLE NERVE, V24, P867, DOI 10.1002/mus.1084; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher RW, 2001, CLIN NEUROPHYSIOL, V112, P1729, DOI 10.1016/S1388-2457(01)00609-5; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; TOLEIKIS JR, 1991, ELECTROEN CLIN NEURO, V81, P443, DOI 10.1016/0013-4694(91)90006-P; Tredget John, 2005, Nurs Stand, V19, P49; UOZUMI T, 1991, ELECTROEN CLIN NEURO, V81, P251, DOI 10.1016/0168-5597(91)90010-U; von Bierbrauer A, 1998, ACTA NEUROL BELG, V98, P21; Weber M, 2002, MUSCLE NERVE, V25, P160; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; 2006, JALINOUS RGUIDE MAGN	68	31	31	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	6					904	913		10.3109/02699051003789245			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	620MT	WOS:000279504700013	20433286				2022-02-06	
J	Minnich, JE; Mann, SL; Stock, M; Stolzenbach, KA; Mortell, BM; Soderstrom, KE; Bohn, MC; Kozlowski, DA				Minnich, Jennie E.; Mann, Sarah L.; Stock, Megan; Stolzenbach, Kathryn A.; Mortell, Bridget M.; Soderstrom, Katherine E.; Bohn, Martha C.; Kozlowski, Dorothy A.			Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; growth factors; behavioral assessments; forelimb sensorimotor cortex; controlled cortical impact	NERVE GROWTH-FACTOR; ADENOVIRUS-MEDIATED EXPRESSION; CEREBRAL-ARTERY OCCLUSION; RETINAL GANGLION-CELLS; SUBSTANTIA-NIGRA; SPINAL-CORD; TARGETED TRANSDUCTION; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; ANIMAL-MODELS	Purpose: The therapeutic potential of glial cell line-derived neurotrophic factor (GDNF) gene delivery was examined in a rodent model of traumatic brain injury (TBI), the controlled cortical impact (CCI). Methods: An adenoviral vector harboring human GDNF (AdGDNF) or green fluorescent protein (AdGFP) was injected unilaterally into the forelimb sensorimotor cortex (FL-SMC) of the rat one week prior to a unilateral CCI. Tests of forelimb function and asymmetry were administered for 2 weeks post-injury. At 2 weeks post-injury, animals were sacrificed and contusion size, neuronal survival, neurodegeneration, and virally-mediated GDNF and GFP protein expression were measured. Results: Rats injected with AdGDNF had significantly smaller contusions, more surviving neurons, and less neurodegeneration than AdGFP injected and uninjected injured animals. GDNF gene delivery also resulted in significantly faster recovery of forelimb coordination and a smaller initial preference for the uninjured forelimb during exploration of the walls of a platform. However, overall recovery of symmetrical forelimb use was not achieved. Conclusions: The discrepancy between neural protection and behavioral recovery suggests that while GDNF gene delivery provided a high degree of protection of damaged cortical neurons in this model of TBI, it may not have fully protected their terminals and synaptic functioning, resulting in only mild protection against behavioral deficits.	[Minnich, Jennie E.; Mann, Sarah L.; Stock, Megan; Stolzenbach, Kathryn A.; Mortell, Bridget M.; Soderstrom, Katherine E.; Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA; [Bohn, Martha C.] Northwestern Univ, Dept Pediat, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA		Kozlowski, DA (corresponding author), Depaul Univ, Dept Biol Sci, 2325 N Clifton, Chicago, IL 60614 USA.	dkozlows@depaul.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R-15 NS42583-01]; Roy J. Carver Foundation for viral vector preparations; DePaul University Liberal Arts Sciences; University Research Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS042583] Funding Source: NIH RePORTER	The authors would like to thank the University of Iowa Gene Transfer Vector Core, supported in part by the NIH and the Roy J. Carver Foundation for viral vector preparations. This study was supported by: NIH R-15 NS42583-01 (D. A. K.), DePaul University Liberal Arts & Sciences Research Grant and University Research Council Grants (D. A. K.) We thank Anne Shea and Kevin McDonough for assistance in data collection and analysis.	Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Baumgartner BJ, 1997, J NEUROSCI, V17, P6504; Baumgartner BJ, 1998, EXP NEUROL, V153, P102, DOI 10.1006/exnr.1998.6878; Bemelmans AP, 1999, HUM GENE THER, V10, P2987, DOI 10.1089/10430349950016393; BETZ AL, 1995, J CEREBR BLOOD F MET, V15, P547, DOI 10.1038/jcbfm.1995.68; Betz AL, 1998, EXP NEUROL, V150, P136, DOI 10.1006/exnr.1997.6755; BilangBleuel A, 1997, P NATL ACAD SCI USA, V94, P8818, DOI 10.1073/pnas.94.16.8818; Bohn MC, 2000, NOVART FDN SYMP, V231, P70, DOI 10.1002/0470870834.ch5; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; CastelBarthe MN, 1996, NEUROBIOL DIS, V3, P76, DOI 10.1006/nbdi.1996.0008; Chen Q, 2005, CURR GENE THER, V5, P71; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Choi-Lundberg DL, 1998, EXP NEUROL, V154, P261, DOI 10.1006/exnr.1998.6887; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Clarkson ED, 1997, CELL TISSUE RES, V289, P207, DOI 10.1007/s004410050867; Connor B, 1999, GENE THER, V6, P1936, DOI 10.1038/sj.gt.3301033; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Giehl KM, 1997, EUR J NEUROSCI, V9, P2479, DOI 10.1111/j.1460-9568.1997.tb01665.x; Grondin R, 2003, PROG DRUG RES, V61, P101; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hendriks WTJ, 2004, PROG BRAIN RES, V146, P451; Hermann DM, 2001, NEUROBIOL DIS, V8, P964, DOI 10.1006/nbdi.2001.0448; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hovda D.A., 1996, NEUROTRAUMA, P1459; Iwai M, 2001, Hum Cell, V14, P27; Iwamoto Y, 1996, NEUROREPORT, V7, P609, DOI 10.1097/00001756-199601310-00056; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kitagawa H, 1999, J CEREBR BLOOD F MET, V19, P1336, DOI 10.1097/00004647-199912000-00007; Kochanek PM, 2001, J NEUROTRAUM, V18, P73, DOI 10.1089/089771501750055785; Kozlowski DA, 2000, EXP NEUROL, V166, P1, DOI 10.1006/exnr.2000.7463; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; KOZLOWSKI DA, 1994, RESTOR NEUROL NEUROS, V7, P119, DOI 10.3233/RNN-1994-7207; Kozlowski DA, 1997, BRAIN RES, V763, P159, DOI 10.1016/S0006-8993(97)00377-6; Kozlowski DA, 2001, MOL THER, V3, P256, DOI 10.1006/mthe.2000.0256; Lapchak PA, 1997, BRAIN RES, V777, P153, DOI 10.1016/S0006-8993(97)01100-1; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINNIK MD, 1995, STROKE, V26, P1670, DOI 10.1161/01.STR.26.9.1670; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Meijs MFL, 2004, J NEUROTRAUM, V21, P1415, DOI 10.1089/neu.2004.21.1415; Miller JD, 1996, NEUROTRAUMA, P61; Mohajeri MH, 1999, HUM GENE THER, V10, P1853, DOI 10.1089/10430349950017536; Pertusa A, 2008, NEUROBIOL AGING, V29, P1366, DOI 10.1016/j.neurobiolaging.2007.02.026; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Phillips RG, 2001, GENE THER, V8, P579, DOI 10.1038/sj.gt.3301397; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ribotta MGY, 1997, J NEUROSCI RES, V48, P281; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; Rosenblad C, 2000, EXP NEUROL, V161, P503, DOI 10.1006/exnr.1999.7296; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schmeer C, 2002, EUR J NEUROSCI, V15, P637, DOI 10.1046/j.1460-9568.2002.01893.x; Shin HK, 2004, CLIN EXP PHARMACOL P, V31, P1, DOI 10.1111/j.1440-1681.2004.03943.x; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Szentirmai O, 2004, NEUROSURGERY, V55, P283, DOI [10.1227/01.neu.0000333811.56907.13, 10.1227/01.NEU.0000129681.85731.00]; Tang XQ, 2004, NEUROREPORT, V15, P425, DOI 10.1097/00001756-200403010-00009; Tehranian R, 2006, BRAIN RES, V1101, P126, DOI 10.1016/j.brainres.2006.05.049; Tsai TT, 2000, EXP NEUROL, V166, P266, DOI 10.1006/exnr.2000.7505; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Tuszynski MH, 2004, PROG BRAIN RES, V146, P441; Wang Y, 2002, ANN NY ACAD SCI, V962, P423, DOI 10.1111/j.1749-6632.2002.tb04086.x; Watabe K, 2001, Hum Cell, V14, P7; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Weise J, 2000, NEUROBIOL DIS, V7, P212, DOI 10.1006/nbdi.2000.0285; Yagi T, 2000, BRAIN RES, V885, P273, DOI 10.1016/S0006-8993(00)02956-5; Zhang WR, 2002, BRAIN RES, V947, P140, DOI 10.1016/S0006-8993(02)02923-2	74	31	31	1	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2010	28	3					293	309		10.3233/RNN-2010-0528			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	606QP	WOS:000278442500001	20479525				2022-02-06	
J	Buritica, E; Villamil, L; Guzman, F; Escobar, MI; Garcia-Cairasco, N; Pimienta, HJ				Buritica, Efrain; Villamil, Liliana; Guzman, Francisco; Escobar, Martha I.; Garcia-Cairasco, Norberto; Pimienta, Heman J.			Changes in Calcium-Binding Protein Expression in Human Cortical Contusion Tissue	JOURNAL OF NEUROTRAUMA			English	Article						calcium-binding proteins; epileptogenesis; GABA interneurons; human traumatic brain injury	CHANDELIER CELL AXONS; HUMAN TEMPORAL CORTEX; PREFRONTAL CORTEX; PARVALBUMIN-IMMUNOREACTIVITY; SYNAPTIC CONNECTIONS; CALBINDIN D-28K; CEREBRAL-CORTEX; NEURONS; CALRETININ; RAT	Traumatic brain injury (TBI) produces several cellular changes, such as gliosis, axonal and dendritic plasticity, and inhibition-excitation imbalance, as well as cell death, which can initiate epileptogenesis. It has been demonstrated that dysfunction of the inhibitory components of the cerebral cortex after injury may cause status epilepticus in experimental models; we proposed to analyze the response of cortical interneurons and astrocytes after TBI in humans. Twelve contusion samples were evaluated, identifying the expression of glial fibrillary acidic protein (GFAP) and calcium-binding proteins (CaBPs). The study was made in sectors with and without preserved cytoarchitecture evaluated with NeuN immunoreactivity (IR). In sectors with total loss of NeuN-IR the results showed a remarkable loss of CaBP-IR both in neuropil and somata. In sectors with conserved cytoarchitecture less drastic changes in CaBP-IR were detected. These changes include a decrease in the amount of parvalbumin (PV-IR) neurons in layer II, an increase of calbindin (CB-IR) neurons in layers III and V, and an increase in calretinin (CR-IR) neurons in layer II. We also observed glial fibrillary acidic protein immunoreactivity (GFAP-IR) in the white matter, in the gray-white matter transition, and around the sectors with NeuN-IR total loss. These findings may reflect dynamic activity as a consequence of the lesion that is associated with changes in the excitatory circuits of neighboring hyperactivated glutamatergic neurons, possibly due to the primary impact, or secondary events such as hypoxia-ischemia. Temporal evolution of these changes may be the substrate linking severe cortical contusion and the resulting epileptogenic activity observed in some patients.	[Buritica, Efrain; Villamil, Liliana; Guzman, Francisco; Escobar, Martha I.; Pimienta, Heman J.] Univ Valle, Centro Estudios Cerebrales, Fac Salud, Cali, Valle, Colombia; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Dept Physiol, Ribeirao Preto Sch Med, Sao Paulo, Brazil		Pimienta, HJ (corresponding author), Univ Valle, Centro Estudios Cerebrales, Fac Salud, Calle 4B 36-00, Cali, Valle, Colombia.	hempim@yahoo.com	Cairasco, Norberto Garcia/E-3250-2015; Buritica, Efrain/C-3315-2011; Escobar, Martha Isabel/C-3310-2011; Escobar, Martha/E-4288-2015	Cairasco, Norberto Garcia/0000-0001-8857-3775; Escobar, Martha/0000-0002-0036-7473; Pimienta, Hernan/0000-0002-8254-2078; Buritica Ramirez, Efrain/0000-0001-6747-9587	ColcienciasDepartamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias [1106-04-16329]; Fundacao de amparo a Pesquisa do estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/50261-4]; FAPESP-CinapceFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/56447-7]; Conselho Nacional de Desenvolvimento cientifico e Technologico Programa Sud-Americano de Apoyoa a las actividades deCooperacion en Ciencia y technologia (CNPq-PROSUL) BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [490660/2007-0]	The authors wish to thanks Colciencias for financial support (code 1106-04-16329). N.G.C. is a principal investigator in Fundacao de amparo a Pesquisa do estado de Sao Paulo (FAPESP) (grant no. 2007/50261-4), FAPESP-Cinapce (grant no. 2005/56447-7,) and Conselho Nacional de Desenvolvimento cientifico e Technologico Programa Sud-Americano de Apoyoa a las actividades deCooperacion en Ciencia y technologia (CNPq-PROSUL) Brazil Project (grant no. 490660/2007-0). E.B., M.I.E., and H.J.P. are invited collaborators at the CNPq-PROSUL-Brazil Project. Special thanks to Olagide Wagner Castro and Artur Fernandes of the Neurophysiology and Experimental Neuroethology Laboratory for their excellent technical support and training on the use of the Olympus BX-60/Optronics/Image ProPlus image capturing system to E.B.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Ashman TA, 2006, MT SINAI J MED, V73, P999; Barbado MV, 2002, EXP NEUROL, V177, P133, DOI 10.1006/exnr.2002.7951; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Blumcke I, 1996, J NEUROPATH EXP NEUR, V55, P329; Buritica-Ramirez E, 2007, REV LAT AM PSICOL, V39, P127; Chu ZG, 2003, J NEUROSCI, V23, P96; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; DEFELIPE J, 1989, P NATL ACAD SCI USA, V86, P2093, DOI 10.1073/pnas.86.6.2093; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; DeFelipe J, 1999, BRAIN, V122, P1807, DOI 10.1093/brain/122.10.1807; delRio MR, 1997, J CHEM NEUROANAT, V13, P243, DOI 10.1016/S0891-0618(97)00050-1; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Fajardo C, 2008, NEUROSCI LETT, V435, P215, DOI 10.1016/j.neulet.2008.02.048; FONSECA M, 1993, NEUROSCIENCE, V55, P1107, DOI 10.1016/0306-4522(93)90324-9; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005; Gonzalez-Albo MC, 2001, CEREB CORTEX, V11, P1170, DOI 10.1093/cercor/11.12.1170; HOF PR, 1993, NEUROSCI LETT, V152, P145, DOI 10.1016/0304-3940(93)90504-E; Hof PR, 1999, J CHEM NEUROANAT, V16, P77, DOI 10.1016/S0891-0618(98)00065-9; Escobar MI, 2008, COLOMB MEDICA, V39, P51; Kang YS, 2002, NEUROSCI LETT, V330, P104, DOI 10.1016/S0304-3940(02)00723-1; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Marco P, 1996, BRAIN, V119, P1327, DOI 10.1093/brain/119.4.1327; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Medina AM, 2008, COLOMB MEDICA, V39, P14; MEDINA AM, 2002, REV COLOMB PSIQUIATR, V31, P187; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Pantazopoulos H, 2007, BIOL PSYCHIAT, V61, P640, DOI 10.1016/j.biopsych.2006.04.026; Phillis JW, 2000, BRAIN RES, V868, P105, DOI 10.1016/S0006-8993(00)02303-9; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Ruttimann E, 2004, BIOCHEM PHARMACOL, V68, P1613, DOI 10.1016/j.bcp.2004.07.019; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Tooney PA, 2004, PROG NEURO-PSYCHOPH, V28, P273, DOI 10.1016/j.pnpbp.2003.10.004; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Yang L, 1997, J NEUROPHYSIOL, V78, P2804, DOI 10.1152/jn.1997.78.5.2804; Yang L, 1998, NEUROSCI LETT, V257, P33, DOI 10.1016/S0304-3940(98)00798-8; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005; Yenari MA, 2001, STROKE, V32, P1028, DOI 10.1161/01.STR.32.4.1028	45	31	34	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2009	26	12					2145	2155		10.1089/neu.2009.0894			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	536AI	WOS:000273013200002	19645526				2022-02-06	
J	Lee, C; Agoston, DV				Lee, Cheol; Agoston, Denes V.			Inhibition of VEGF receptor 2 increased cell death of dentate hilar neurons after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Hilar neurons; VEGF; VEGFR2; Neuroprotection	ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; TYROSINE KINASE; ADULT-RAT; DEGENERATION; EPILEPSY; MODEL; ANGIOGENESIS; GYRUS	Post-traumatic epilepsy, partly due to the loss of hilar neurons of the hippocampus, is a frequent long-term consequence of traumatic brain injury (TBI). We and others found that the levels of vascular endothelial growth factor (VEGF) that can act as a neuroprotectant increase after TBI. Here we tested whether VEGF and its receptor VEGFR2 are involved in mediating the death or survival of hilar neurons after injury. We demonstrated that VEGFR2 is expressed by most, if not all, hilar neurons and that these neurons are dying in large numbers as indicated by Fluoro-Jade B histology after fluid percussion TBI. To directly test the involvement of VEGFR2 and VEGF in the injury-induced apoptotic death of hilar neurons, we delivered an inhibitor to VEGFR2, or recombinant VEGF into the ipsilateral cerebral ventricle of injured SU5416, We found that blocking VEGFR2 by SU5416 significantly increased the number of apoptotic (TUNEL-animals. positive) cells in the hilus. Infusion of VEGF, however, failed to reduce the number of TUNEL-positive cells. Our results suggest that VEGFR2 is involved in mediating death or survival of hilar neurons after injury but delivering additional exogenous VEGF does not provide further protection from TBI-induced death of hilar neurons. (C) 2009 Elsevier Inc. All rights reserved.	[Agoston, Denes V.] USUHS, APG, Dept Anat Physiol & Genet, Sch Med, Bethesda, MD 20814 USA		Agoston, DV (corresponding author), USUHS, APG, Dept Anat Physiol & Genet, Sch Med, 4301 Jones Br Rd, Bethesda, MD 20814 USA.	vagoston@usuhs.edu			Translational Research Program of Defense Brain; Spinal Cord Injury Program of the Department of DefenseUnited States Department of Defense	The authors thank Ms. A. Thorburn for her editorial assistance and Mr. P. Kwon for his technical assistance. C.L. was supported by the Translational Research Program of Defense Brain and Spinal Cord Injury Program of the Department of Defense.	Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; CAVENESS WF, 1976, EPILEPSIA, V17, P207, DOI 10.1111/j.1528-1157.1976.tb03398.x; Choi YS, 2007, J NEUROSCI, V27, P2999, DOI 10.1523/JNEUROSCI.4913-06.2007; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Houser CR, 2007, PROG BRAIN RES, V163, P217, DOI 10.1016/S0079-6123(07)63013-1; Kawai T, 2006, NEUROSCIENCE, V141, P1209, DOI 10.1016/j.neuroscience.2006.04.064; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Smolich BD, 2001, BLOOD, V97, P1413, DOI 10.1182/blood.V97.5.1413; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Yasuhara T, 2004, EUR J NEUROSCI, V19, P1494, DOI 10.1111/j.1460-9568.2004.03254.x; Yee KWH, 2002, BLOOD, V100, P2941, DOI 10.1182/blood-2002-02-0531; Yourey PA, 2000, J NEUROSCI, V20, P6781, DOI 10.1523/JNEUROSCI.20-18-06781.2000	33	31	33	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2009	220	2					400	403		10.1016/j.expneurol.2009.08.019			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	528FV	WOS:000272428700025	19733172				2022-02-06	
J	Senft, C; Schuster, T; Forster, MT; Seifert, V; Gerlach, R				Senft, Christian; Schuster, Thomas; Forster, Marie-Therese; Seifert, Volker; Gerlach, Ruediger			Management and outcome of patients with acute traumatic subdural hematomas and pre-injury oral anticoagulation therapy	NEUROLOGICAL RESEARCH			English	Article						Acute subdural hematoma; surgical treatment; traumatic brain injury; oral anticoagulation; outcome	PROTHROMBIN COMPLEX CONCENTRATE; ACTIVATED FACTOR-VII; INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; ELDERLY-PATIENTS; BRAIN-INJURY; HEAD-INJURY; COMATOSE PATIENTS; VITAMIN-K; REVERSAL	Background: Acute subdural hematomas (aSDHs) are found in up to one-third of patients with severe traumatic brain injury and are associated with an unfavorable outcome in the majority of cases. Mortality ranges between 40 and 60%, but was reported to be even higher in patients undergoing oral anticoagulation therapy (OAT) at the time of injury. The objective of this study is to specifically report on the peri-operative management and outcome of patients with aSDH and pre-injury OAT. Material and Methods: From June 2002 to June 2006, all patients with OAT who underwent surgical treatment of aSDH were retrospectively analysed. Results of pre-operative blood tests, the peri-operative and surgical management and the clinical courses were assessed. Patient outcome is reported according to the Glasgow Outcome Scale (GOS) at 6 months. Results: Eleven (10.3%) out of 107 patients with aSDH were on OAT. Patients with OAT were significantly older than patients without OAT (72.4 +/- 9.3 versus 59.9 +/- 17.5 years; p<0.05, Mann-Whitney U-test). Intensity of head trauma was moderate in four and severe in seven patients with a median pre-operative Glasgow Coma Scale (GCS) of 8. Median pre-treatment prothrombin time and international normalized ratio were 23% (range: 10-65%) and 3.3 (range: 1.5-10.6), respectively. Replacement therapy consisted of administration of prothrombin complex concentrates, vitamin K and FFP (fresh frozen plasma). In four patients, antithrombin was additionally given to prevent disseminated intravascular coagulation. Surgical treatment consisted of craniotomy (n = 10) or craniectomy (n = 1) and hematoma evacuation with intracranial pressure probe placement. Low molecular weight heparin was administered as pharmacological prophylaxis of thrombembolic events in an increasing dose post-operatively. At 6 months, six out of 11 patients survived with a median GOS of 4. All-cause mortality was 45.5%. A pre-operative GCS of <= 8 was not associated with an increased risk of mortality (p>0.5, Fisher's exact test). No relevant rebleedings or thrombembolic complications were observed. The mortality rate of patients who did not undergo OAT was 50%. Conclusion: A large number of patients with aSDH are on pre-injury OAT. Specific replacement therapy facilitates successful clot evacuation without bleeding complications. The overall outcome of these patients does not seem to differ from historical cohorts with aSDH without OAT, but a large prospective multicenter study is warranted to answer that question. [Neurol Res 2009; 31: 1012-1018]	[Senft, Christian; Schuster, Thomas; Forster, Marie-Therese; Seifert, Volker; Gerlach, Ruediger] Goethe Univ Frankfurt, Dept Neurosurg, D-60528 Frankfurt, Germany		Senft, C (corresponding author), Goethe Univ Frankfurt, Dept Neurosurg, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	c.senft@med.uni-frankfurt.de	Senft, Christian/F-4252-2010; Forster, Marie-Therese/AAY-5616-2020	Senft, Christian/0000-0003-1288-6913; 			Aguilar MI, 2007, MAYO CLIN PROC, V82, P82, DOI 10.1016/s0025-6196(11)60970-1; Akopov SE, 2005, CEREBROVASC DIS, V19, P337, DOI 10.1159/000085027; BOSTROM S, 1986, ACTA NEUROCHIR, V80, P83, DOI 10.1007/BF01812279; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Cartmill M, 2000, BRIT J NEUROSURG, V14, P458; Chen CS, 2000, EUR PHYS J-APPL PHYS, V11, P3, DOI 10.1051/epjap:2000139; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Couldwell WT., 2004, NEUROSURG FOCUS, V17, P1, DOI [10.3171/foc.2004.17.4.1, DOI 10.3171/F0C.2004.17.4.1]; Depreitere B, 2003, ACTA NEUROCHIR, V145, P541, DOI 10.1007/s00701-003-0020-7; Dunn AS, 2007, J THROMB HAEMOST, V5, P2211, DOI 10.1111/j.1538-7836.2007.02729.x; Epstein NE, 2005, SURG NEUROL, V64, P295, DOI 10.1016/j.surneu.2005.04.039; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; FELL DA, 1975, J NEUROSURG, V42, P37, DOI 10.3171/jns.1975.42.1.0037; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Garcia DA, 2008, J THROMB THROMBOLYS, V25, P116, DOI 10.1007/s11239-007-0124-7; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gerlach R, 2003, NEUROSURGERY, V53, P1028, DOI 10.1227/01.NEU.0000088565.15719.22; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HEIN L, 2006, ANTIKOAGULANTIEN THR; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iantosca MR, 2000, NEUROSURG CLIN N AM, V11, P447, DOI 10.1016/S1042-3680(18)30107-4; Iorio A, 2000, ARCH INTERN MED, V160, P2327, DOI 10.1001/archinte.160.15.2327; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2006, J TRAUMA, V61, P318, DOI 10.1097/01.ta.0000223944.25922.91; JENNETT B, 1975, LANCET, V1, P480; Karadimov D, 2003, J NEUROSURG ANESTH, V15, P330, DOI 10.1097/00008506-200310000-00008; Karni A, 2001, AM SURGEON, V67, P1098; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Khan ZH, 2007, J ANESTH, V21, P258, DOI 10.1007/s00540-006-0481-y; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Leissinger CA, 2008, AM J HEMATOL, V83, P137, DOI 10.1002/ajh.21046; Levine MN, 2004, CHEST, V126, p287S, DOI 10.1378/chest.126.3_suppl.287S; Lin J, 2003, J NEUROSURG, V98, P737, DOI 10.3171/jns.2003.98.4.0737; Lorenz R, 2007, BLOOD COAGUL FIBRIN, V18, P565, DOI 10.1097/MBC.0b013e3282010d7a; Machulda MM, 2000, NEUROSURG CLIN N AM, V11, P473, DOI 10.1016/S1042-3680(18)30110-4; Makris M, 1997, THROMB HAEMOSTASIS, V77, P477; Marion DW, 2006, NEUROSURGERY, V58, P655; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; O'Donnell M, 2003, CAN J SURG, V46, P129; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pautas E, 2006, DRUG AGING, V23, P13, DOI 10.2165/00002512-200623010-00002; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Preston FE, 2002, BRIT J HAEMATOL, V116, P619, DOI 10.1046/j.0007-1048.2001.03295.x; Raabe A, 2001, ACTA NEUROCHIR, V143, P1, DOI 10.1007/s007010170131; Saba Hussain I, 2006, Clin Adv Hematol Oncol, V4, P919; Schulman S, 2003, NEW ENGL J MED, V349, P675, DOI 10.1056/NEJMcp025373; Schulman S, 2007, TRANSFUS MED REV, V21, P37, DOI 10.1016/j.tmrv.2006.08.002; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; SILVA RL, 2007, REV PORT CARDIOL, V26, P769; Taborski U, 1999, SEMIN THROMB HEMOST, V25, P43, DOI 10.1055/s-2007-996423; TEASDALE G, 1974, LANCET, V2, P81; Veshchev Igor, 2002, Med Sci Monit, V8, pCS98; Wilberger JE, 2000, NEUROSURG CLIN N AM, V11, P435, DOI 10.1016/S1042-3680(18)30105-0; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; Woods K, 2007, J THROMB THROMBOLYS, V24, P93, DOI 10.1007/s11239-007-0022-z; Yasaka M, 2005, THROMB RES, V115, P455, DOI 10.1016/j.thromres.2004.09.002	63	31	31	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC	2009	31	10					1012	1018		10.1179/174313209X409034			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530XR	WOS:000272626800002	19570326				2022-02-06	
J	Chen, WA; Smith, R; Ji, SY; Ward, KR; Najarian, K				Chen, Wenan; Smith, Rebecca; Ji, Soo-Yeon; Ward, Kevin R.; Najarian, Kayvan			Automated ventricular systems segmentation in brain CT images by combining low-level segmentation and high-level template matching	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article; Proceedings Paper	International Workshop on Biomedical and Health Informatics	NOV 03, 2008	Philadelphia, PA				MAGNETIC-RESONANCE IMAGES; CLASSIFICATION; EXTRACTION; PLANE; MR	Background: Accurate analysis of CT brain scans is vital for diagnosis and treatment of Traumatic Brain Injuries (TBI). Automatic processing of these CT brain scans could speed up the decision making process, lower the cost of healthcare, and reduce the chance of human error. In this paper, we focus on automatic processing of CT brain images to segment and identify the ventricular systems. The segmentation of ventricles provides quantitative measures on the changes of ventricles in the brain that form vital diagnosis information. Methods: First all CT slices are aligned by detecting the ideal midlines in all images. The initial estimation of the ideal midline of the brain is found based on skull symmetry and then the initial estimate is further refined using detected anatomical features. Then a two-step method is used for ventricle segmentation. First a low-level segmentation on each pixel is applied on the CT images. For this step, both Iterated Conditional Mode (ICM) and Maximum A Posteriori Spatial Probability (MASP) are evaluated and compared. The second step applies template matching algorithm to identify objects in the initial low-level segmentation as ventricles. Experiments for ventricle segmentation are conducted using a relatively large CT dataset containing mild and severe TBI cases. Results: Experiments show that the acceptable rate of the ideal midline detection is over 95%. Two measurements are defined to evaluate ventricle recognition results. The first measure is a sensitivity-like measure and the second is a false positive-like measure. For the first measurement, the rate is 100% indicating that all ventricles are identified in all slices. The false positives-like measurement is 8.59%. We also point out the similarities and differences between ICM and MASP algorithms through both mathematically relationships and segmentation results on CT images. Conclusion: The experiments show the reliability of the proposed algorithms. The novelty of the proposed method lies in its incorporation of anatomical features for ideal midline detection and the two-step ventricle segmentation method. Our method offers the following improvements over existing approaches: accurate detection of the ideal midline and accurate recognition of ventricles using both anatomical features and spatial templates derived from Magnetic Resonance Images.	[Chen, Wenan; Smith, Rebecca; Ji, Soo-Yeon; Najarian, Kayvan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA; [Ward, Kevin R.] Virginia Commonwealth Univ, Dept Emergency Med, Richmond, VA USA		Chen, WA (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, 401 E Main St, Richmond, VA 23284 USA.	chenw6@vcu.edu; smithr@vcu.edu; jisy@vcu.edu; krward@vcu.edu; knajarian@vcu.edu	Najarian, Kayvan/B-2303-2010				BAK E, 2004, P INT C INF TECHN CO; BESAG J, 1986, J R STAT SOC B, V48, P259; CHEN W, 2008, BIOINF BIOM WORKSH 2, P48; DING F, 2005, 1 INT WORKSH COMP VI, P459; He RJ, 2008, ANN BIOMED ENG, V36, P1580, DOI 10.1007/s10439-008-9520-1; Kapur T, 1996, Med Image Anal, V1, P109, DOI 10.1016/S1361-8415(96)80008-9; Khoo VS, 1997, RADIOTHER ONCOL, V42, P1, DOI 10.1016/S0167-8140(96)01866-X; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee ME, 2007, INT C INTELL COMP CO, P105; Leung CK, 1997, IEE P-VIS IMAGE SIGN, V144, P161, DOI 10.1049/ip-vis:19971181; LI HY, 1995, IEEE T MED IMAGING, V14, P212, DOI 10.1109/42.387703; Liao CC, 2006, ICDM 2006: SIXTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, WORKSHOPS, P463; Liu YX, 2001, IEEE T MED IMAGING, V20, P175, DOI 10.1109/42.918469; LONCARIC S, 1997, P 9 INT C IM AN PROC, P388; Moore EE, 2003, TRAUMA; Novack T., 2000, TBI INFORM INTRO BRA; Ochs RA, 2007, MED IMAGE ANAL, V11, P315, DOI 10.1016/j.media.2007.03.004; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pitiot A, 2004, NEUROIMAGE, V23, pS85, DOI 10.1016/j.neuroimage.2004.07.040; Prima S, 2002, IEEE T MED IMAGING, V21, P122, DOI 10.1109/42.993131; Reddick WE, 1997, IEEE T MED IMAGING, V16, P911, DOI 10.1109/42.650887; Schonmeyer R, 2006, MAGN RESON IMAGING, V24, P1377, DOI 10.1016/j.mri.2006.08.013; VANLEEMPUT K, 2006, P MICCAI, P704; Weng J, 1997, IEEE T MED IMAGING, V16, P378, DOI 10.1109/42.611346; WM W, 1996, IEEE T MED IMAGING, V15, P429; Xia Y, 2004, NEUROIMAGE, V21, P269, DOI 10.1016/j.neuroimage.2003.09.029	26	31	31	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6947		BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	NOV 3	2009	9			1					S4	10.1186/1472-6947-9-S1-S4			14	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Medical Informatics	587XW	WOS:000277030800004	19891798	gold, Green Published			2022-02-06	
J	Genet, F; Marmorat, JL; Lautridou, C; Schnitzler, A; Mailhan, L; Denormandie, P				Genet, F.; Marmorat, J. -L.; Lautridou, C.; Schnitzler, A.; Mailhan, L.; Denormandie, P.			Impact of late surgical intervention on heterotopic ossification of the hip after traumatic neurological injury	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							SPINAL-CORD-INJURY; BRAIN-INJURY; BONE-FORMATION; ARTICULAR-CARTILAGE; RADIATION-THERAPY; RESECTION; IMMOBILIZATION; EXCISION; KNEE	Heterotopic ossification (HO) of the hip after injury to the central nervous system can lead to joint ankylosis. Surgery is usually delayed to avoid recurrence, even if the functional status is affected. We report a consecutive series of patients with HO of the hip after injury to the central nervous system who required surgery in a single, specialised tertiary referral unit. As was usual practice, they all underwent CT to determine the location of the HO and to evaluate the density of the femoral head and articular surface. The outcome of surgery was correlated with the pre-, peri- and post-operative findings. In all, 183 hips (143 patients) were included of which 70 were ankylosed. A total of 25 peri-operative fractures of the femoral neck occurred, all of which arose in patients with ankylosed hips and were associated with intra-articular lesions in 18 and severe osteopenia of the femoral head in seven. All the intra-articular lesions were predicted by CT and strongly associated with post-operative complications. The loss of the range of movement before ankylosis is a more important factor than the maturity of the HO in deciding the timing of surgery. Early surgical intervention minimises the development of intra-articular pathology, osteoporosis and the resultant complications without increasing the risk of recurrence of HO.	[Genet, F.] Hosp R Poincare, Serv Med Physioque & Readaptat, F-92380 Garches, France		Genet, F (corresponding author), Hosp R Poincare, Serv Med Physioque & Readaptat, 104 Blvd R Poincare, F-92380 Garches, France.	francois.genet@rpc.aphp.fr					AKESON WH, 1987, CLIN ORTHOP RELAT R, P28; BAIRD EO, 2009, J ORTHOP SURG RES, V20, P12; Baker W de C, 1969, J Bone Joint Surg Br, V51, P736; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Board TN, 2007, J BONE JOINT SURG BR, V89B, P434, DOI 10.1302/0301-620X.89B4.18845; Brissot R., 2005, Annales de Readaptation et de Medecine Physique, V48, P581, DOI 10.1016/j.annrmp.2005.04.014; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; Dai LY, 1998, CHINESE MED J-PEKING, V111, P1099; Denys P, 1996, BRAIN INJURY, V10, P149, DOI 10.1080/026990596124656; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; ENNEKING WF, 1972, J BONE JOINT SURG AM, VA 54, P973, DOI 10.2106/00004623-197254050-00003; Freebourn TM, 1999, SPINAL CORD, V37, P50, DOI 10.1038/sj.sc.3100719; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V242, P169; GUILLAUMAT M, 1988, CAHIERS ENSEIGNEMENT, P257; HARAN M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003321.PUB3; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Jaovisidha S, 1998, SPINAL CORD, V36, P647, DOI 10.1038/sj.sc.3100701; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; Maier D, 2005, ORTHOPADE, V34, P120, DOI 10.1007/s00132-004-0754-9; MAJOR P, 1980, RADIOLOGY, V136, P797, DOI 10.1148/radiology.136.3.6773108; Meiners T, 1997, SPINAL CORD, V35, P443, DOI 10.1038/sj.sc.3100415; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Narmoneva DA, 2002, J ORTHOP RES, V20, P83, DOI 10.1016/S0736-0266(01)00076-6; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; PAUKKONEN K, 1986, CLIN ORTHOP RELAT R, V206, P270; Pelissier J., 2002, Annales de Readaptation et de Medecine Physique, V45, P188, DOI 10.1016/S0168-6054(02)00202-7; SALTER RB, 1960, J BONE JOINT SURG AM, V42, P31, DOI 10.2106/00004623-196042010-00004; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; Shehab D, 2002, J NUCL MED, V43, P346; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; Subbarao J V, 1999, J Spinal Cord Med, V22, P273; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010	42	31	33	0	2	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X	2044-5377		J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	NOV	2009	91B	11					1493	1498		10.1302/0301-620X.91B11.22305			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	513ZK	WOS:000271362600017	19880896				2022-02-06	
J	Itoh, T; Satou, T; Nishida, S; Tsubaki, M; Hashimoto, S; Ito, H				Itoh, Tatsuki; Satou, Takao; Nishida, Shozo; Tsubaki, Masahiro; Hashimoto, Shigeo; Ito, Hiroyuki			The Novel Free Radical Scavenger, Edaravone, Increases Neural Stem Cell Number Around the Area of Damage Following Rat Traumatic Brain Injury	NEUROTOXICITY RESEARCH			English	Article						Neural stem cell; Traumatic brain injury; Nestin; Neurosphere; Edaravone	CENTRAL-NERVOUS-SYSTEM; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; OXYGEN RADICALS; SPINAL-CORD; MCI-186; ACTIVATION; PROLIFERATION; HIPPOCAMPUS; EXPRESSION	Edaravone is a novel free radical scavenger that is clinically employed in patients with acute cerebral infarction, but has not previously been used to treat traumatic brain injury (TBI). In this study, we investigated the effect of edaravone administration on rat TBI. In particular, we used immunohistochemistry to monitor neural stem cell (NSC) proliferation around the area damaged by TBI. Two separate groups of rats were administered saline or edaravone (3 mg/kg) after TBI and then killed chronologically. We also used ex vivo techniques to isolate NSCs from the damaged region and observed nestin-positive cells at 1, 3, and 7 days following TBI in both saline- and edaravone-treated groups. At 3 days following TBI in both groups, there were many large cells that morphologically resembled astrocytes. At 1 and 7 days following TBI in the saline group, there were a few small nestin-positive cells. However, in the edaravone group, there were many large nestin-positive cells at 7 days following TBI. At 3 and 7 days following TBI, the number of nestin-positive cells in the edaravone group increased significantly compared with the saline group. There were many single-stranded DNA-, 8-hydroxy-2'-deoxyguanosine-, and 4-hydroxy-2-nonenal-positive cells in the saline group following TBI, but only a few such cells in the edaravone group following TBI. Furthermore, almost all ssDNA-positive cells in the saline group co-localized with Hu, nestin, and glial fibrillary acidic protein (GFAP) staining, but not in the edaravone group. In the ex vivo study, spheres could only be isolated from injured brain tissue in the saline group at 3 days following TBI. However, in the edaravone group, spheres could be isolated from injured brain tissue at both 3 and 7 days following TBI. The number of spheres isolated from injured brain tissue in the edaravone group showed a significant increase compared with the saline group. The spheres isolated from both saline and edaravone groups were immunopositive for nestin, but not Tuj1 or vimentin. Moreover, the spheres differentiated into Tuj1-, GFAP-, and O4-positive cells after 4 days in culture without bFGF. This result indicated that the spheres were neurospheres composed of NSCs that could differentiate into neurons and glia. Edaravone administration inhibited production of free radicals known to induce neuronal degeneration and cell death after brain injury, and protected nestin-positive cells, including NSCs, with the potential to differentiate into neurons and glia around the area damaged by TBI.	[Itoh, Tatsuki; Satou, Takao; Ito, Hiroyuki] Kinki Univ, Sch Med, Dept Pathol, Osaka 5898511, Japan; [Satou, Takao] Kinki Univ Hosp, Sch Med, Div Hosp Pathol, Osaka, Japan; [Satou, Takao] Kinki Univ, Inst Life Sci, Div Sports Med, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Sch Pharmaceut Sci, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Dept Pathol, Osaka, Japan		Itoh, T (corresponding author), Kinki Univ, Sch Med, Dept Pathol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp					Arai T, 2008, J PHARMACOL EXP THER, V324, P529, DOI 10.1124/jpet.107.131391; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Dohi K, 2006, J NEUROTRAUM, V23, P1591, DOI 10.1089/neu.2006.23.1591; Douen AG, 2004, BRAIN RES, V1008, P139, DOI 10.1016/j.brainres.2003.08.070; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Ishii J, 2007, NEUROSCI LETT, V423, P225, DOI 10.1016/j.neulet.2007.07.029; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2006, NEUROCHEM RES, V31, P1381, DOI 10.1007/s11064-006-9186-8; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lin HJ, 2004, FEBS LETT, V570, P102, DOI 10.1016/j.febslet.2004.06.019; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mizuno A, 1998, GEN PHARMACOL-VASC S, V30, P575, DOI 10.1016/S0306-3623(97)00311-X; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236; Niyaz M, 2007, J NEUROSCI RES, V85, P2933, DOI 10.1002/jnr.21412; Parent JM, 1997, J NEUROSCI, V17, P3727; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Tsuji M, 2000, NEUROSCI LETT, V282, P41, DOI 10.1016/S0304-3940(00)00844-2; Walton KM, 1998, J NEUROCHEM, V70, P1764; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Wen J, 2006, BIOL PHARM BULL, V29, P713, DOI 10.1248/bpb.29.713; Wu T, 2006, BIOL PHARM BULL, V29, P1613, DOI 10.1248/bpb.29.1613; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yamamoto T, 1997, BRAIN RES, V762, P240, DOI 10.1016/S0006-8993(97)00490-3; Yasuoka N, 2004, DEV BRAIN RES, V151, P129, DOI 10.1016/j.devbrainres.2004.04.006	38	31	35	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428			NEUROTOX RES	Neurotox. Res.	NOV	2009	16	4					378	389		10.1007/s12640-009-9081-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	509OS	WOS:000271028000005	19590930				2022-02-06	
J	Adamides, AA; Rosenfeldt, FL; Winter, CD; Pratt, NM; Tippett, NJ; Lewis, PM; Bailey, MJ; Cooper, DJ; Rosenfeld, JV				Adamides, Alexios A.; Rosenfeldt, Franklin L.; Winter, Craig D.; Pratt, Naomi M.; Tippett, Nicholas J.; Lewis, Philip M.; Bailey, Michael J.; Cooper, D. James; Rosenfeld, Jeffrey V.			Brain Tissue Lactate Elevations Predict Episodes of Intracranial Hypertension in Patients with Traumatic Brain Injury	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							SEVERE HEAD-INJURY; MEMBRANE PHOSPHOLIPID DEGRADATION; INTRACEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; EXTRACELLULAR POTASSIUM; INTERSTITIAL GLYCEROL; METABOLISM; ISCHEMIA; HUMANS		[Adamides, Alexios A.; Winter, Craig D.; Lewis, Philip M.; Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Cooper, D. James] Alfred Hosp, Dept Crit Care, Melbourne, Vic, Australia; [Rosenfeldt, Franklin L.; Bailey, Michael J.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeldt, Franklin L.; Bailey, Michael J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Adamides, Alexios A.; Pratt, Naomi M.; Tippett, Nicholas J.; Cooper, D. James] Natl Trauma Res Inst, Melbourne, Vic, Australia		Adamides, AA (corresponding author), Royal Melbourne Hosp, Dept Neurosurg, Grattan St, Parkville, Vic 3050, Australia.		Cooper, D. James/G-7961-2013; Rosenfeld, Jeffrey V/B-7249-2011; Bailey, Michael J/A-4499-2012	Cooper, D. James/0000-0002-5872-9051; Bailey, Michael J/0000-0002-5551-1401; WINTER, Craig/0000-0003-4626-7280			Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Doppenberg EMR, 1999, ACT NEUR S, V75, P31; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Pellerin L, 2003, J CEREBR BLOOD F MET, V23, P1282, DOI 10.1097/01.WCB.0000096064.12129.3D; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROZSA L, 1989, NEUROSURG REV, V12, P133, DOI 10.1007/BF01741486; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Smith M, 2004, MICRODIALYSIS MONITORING TISSUE CHEMISTRY IN INTENSIVE CARE MEDICINE, P45; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	29	31	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515			J AM COLL SURGEONS	J. Am. Coll. Surg.	OCT	2009	209	4					531	539		10.1016/j.jamcollsurg.2009.05.028			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	506CD	WOS:000270749900012	19801326				2022-02-06	
J	Qu, CS; Xiong, Y; Mahmood, A; Kaplan, DL; Goussev, A; Ning, RZ; Chopp, M				Qu, Changsheng; Xiong, Ye; Mahmood, Asim; Kaplan, David L.; Goussev, Anton; Ning, Ruizhuo; Chopp, Michael			Treatment of traumatic brain injury in mice with bone marrow stromal cell-impregnated collagen scaffolds Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						scaffold; human marrow stromal cell; lesion volume; traumatic brain injury; collagen; mouse	MESENCHYMAL STEM-CELLS; ADULT RATS; EXTRACELLULAR-MATRIX; FUNCTIONAL RECOVERY; SPINAL-CORD; TRANSPLANTATION; TISSUE; STROKE; MODEL; MOUSE	Object. This study was designed to investigate new ways of delivering human marrow stromal cells (hMSCs) to the injured brain by impregnating them into collagen scaffolds in a mouse model of traumatic brain injury (TBI). Methods. Eight C57BL/6 J mice were injured with controlled cortical impact and received transplantation into the lesion cavity of 0.3 x 10(6) hMSCs impregnated into 3D porous collagen scaffolds. Additional experimental groups of 8 mice each received scaffolds implanted alone into the lesion cavity, hMSCs administered alone intracerebrally or intravenously, or saline injected into the lesion core. All treatments were performed 7 days after TBI. Spatial learning was measured using a modified Morris water maze test, and brain tissue samples were processed for histopathological analysis. Results. The results showed that hMSC-impregnated scaffolds were more effective than hMSCs administered alone (either intravenously or intracerebrally) in improving spatial learning, reducing lesion volume, and increasing vascular density after TBI. Conclusions. Collagen scaffolds populated with hMSCs may be a new way to reconstruct injured brain tissue and improve neurological function after TBI. (DOI: 10.3171/2009.4.JNS081681)	[Qu, Changsheng; Xiong, Ye; Mahmood, Asim; Goussev, Anton; Ning, Ruizhuo] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Qu, Changsheng; Xiong, Ye; Mahmood, Asim; Goussev, Anton; Ning, Ruizhuo] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA		Mahmood, A (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, K-11,2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu	ning, ruizhuo/E-6401-2012	Xiong, Ye/0000-0001-9770-6031	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01, NS042259, P01 NS42325]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS042345, R01NS042259] Funding Source: NIH RePORTER	Asim Mahmood received funding from NIH R01, NS042259, and P01 NS42325 for this study.	Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Day LB, 1996, BEHAV NEUROSCI, V110, P998; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Kon E, 2000, J BIOMED MATER RES, V49, P328; Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H; Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005; Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252; Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Reddi AH, 2000, BIOCHEM SOC T, V28, P345, DOI 10.1042/0300-5127:0280345; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Zanetta L, 2000, INT J CANCER, V85, P281, DOI 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	42	31	36	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2009	111	4					658	665		10.3171/2009.4.JNS081681			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	503PL	WOS:000270550000006	19425888	Green Accepted			2022-02-06	
J	Olivecrona, M; Rodling-Wahlstrom, M; Naredi, S; Koskinen, LOD				Olivecrona, Magnus; Rodling-Wahlstrom, Marie; Naredi, Silvana; Koskinen, Lars-Owe D.			Prostacyclin Treatment in Severe Traumatic Brain Injury: A Microdialysis and Outcome Study	JOURNAL OF NEUROTRAUMA			English	Article						lactate-pyruvate ratio; microdialysis; prostacyclin; severe traumatic brain injury	CAT SKELETAL-MUSCLE; LOW-DOSE PROSTACYCLIN; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL PERFUSION-PRESSURE; INTRACEREBRAL MICRODIALYSIS; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE; CAPILLARY-PERMEABILITY; TARGETED THERAPY; PROSTAGLANDIN ENDOPEROXIDES	Prostacyclin (PGI(2)) is a potent vasodilator, inhibitor of leukocyte adhesion, and platelet aggregation. In trauma the balance between PGI(2) and thromboxane A(2) (TXA(2)) is shifted towards TXA(2). Externally provided PGI(2) would, from a theoretical and experimental point of view, improve the microcirculation in injured brain tissue. This study is a prospective consecutive double-blinded randomized study on the effect of PGI(2) versus placebo in severe traumatic brain injury (sTBI). All patients with sTBI were eligible. Inclusion criteria: verified sTBI, Glasgow Coma Score (GCS) at intubation and sedation of <= 8, age 15-70 years, a first-recorded cerebral perfusion pressure (CPP) of >= 10 mm Hg, and arrival within 24 h of trauma. All subjects received an intracranial pressure (ICP) measuring device, bilateral intracerebral microdialysis catheters, and a microdialysis catheter in the abdominal subcutaneous adipose tissue. Subjects were treated according to an ICP-targeted therapy based on the Lund concept. 48 patients (mean age of 35.5 years and a median GCS of 6 [3-8]) were included. We found no significant effect of prostacyclin (epoprostenol, Flolan) on either the lactate-pyruvate ratio (L/P) at 24 h or the brain glucose levels. There was no significant difference in clinical outcome between the two groups. The median Glasgow Outcome Score (GOS) at 3 months was 4, and mortality was 12.5%. The favorable outcome (GOS 4-5) was 52%. The initial L/P did not prognosticate for outcome. Thus our results indicate that there is no effect of PGI(2) at a dose of 0.5 ng/kg/min on brain L/P, brain glucose levels, or outcome at 3 months.	[Olivecrona, Magnus; Koskinen, Lars-Owe D.] Umea Univ Hosp, Dept Neurosurg, S-90185 Umea, Sweden; [Rodling-Wahlstrom, Marie; Naredi, Silvana] Umea Univ Hosp, Dept Anaesthesiol, S-90185 Umea, Sweden		Koskinen, LOD (corresponding author), Univ Hosp, Dept Neurosurg, SE-90185 Umea, Sweden.	Lars-Owe.Koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Olivecrona, Magnus/0000-0001-8457-4711; Koskinen, Lars-Owe/0000-0003-3528-8502; Naredi, Silvana/0000-0002-4409-6089	Department of Clinical Neurosciences University Hospital Research Fund,; Tore Nilsson Fund, Kempe Fund, Capio Research Fund,; Umea University	We thank the staff at the neurosurgical department and intensive care unit of Umea University, without whose kindness, interest, and dedicated work the study could not have been performed. A special thanks to our research nurses, Kristin Nyman and Anna-Lena Ostund, for their invaluable help and support in making this study possible. This study was financially supported by the Department of Clinical Neurosciences University Hospital Research Fund, Tore Nilsson Fund, Kempe Fund, Capio Research Fund, and Umea University.	Agren-Wilsson A, 2005, J NEUROL NEUROSUR PS, V76, P1088, DOI 10.1136/jnnp.2004.042838; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Bentzer P, 2001, AM J PHYSIOL-HEART C, V280, pH2697, DOI 10.1152/ajpheart.2001.280.6.H2697; Bentzer P, 1999, J VASC RES, V36, P516, DOI 10.1159/000025695; BLEBEA J, 1990, J VASC SURG, V12, P657, DOI 10.1067/mva.1990.25129; BLEBEA J, 1990, J VASC SURG, V12, P665; BOULLIN DJ, 1979, BRIT J CLIN PHARMACO, V7, P139, DOI 10.1111/j.1365-2125.1979.tb00914.x; BRANDT L, 1981, J NEUROSURG, V55, P877, DOI 10.3171/jns.1981.55.6.0877; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; DAVIES MG, 1993, ANN SURG, V218, P593, DOI 10.1097/00000658-199321850-00003; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; ERLANSSON M, 1991, PROSTAGLANDINS, V41, P157, DOI 10.1016/0090-6980(91)90028-E; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; GRANHOLM L, 1969, ACTA PHYSIOL SCAND, V75, P257, DOI 10.1111/j.1748-1716.1969.tb04379.x; GRYGLEWSKI RJ, 1978, ACTA BIOL MED GER, V37, P715; Hutchinson P, 2002, ACT NEUR S, V81, P341; Jahr J, 1996, INTENS CARE MED, V22, P1453; JONES G, 1984, J PATHOL, V142, P51, DOI 10.1002/path.1711420110; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; LEWIS PJ, 1983, BRIT MED BULL, V39, P281, DOI 10.1093/oxfordjournals.bmb.a071834; Lourido J, 2002, SCAND J CLIN LAB INV, V62, P285, DOI 10.1080/003655102760145843; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; MIZUNOYAGYU Y, 1987, BIOCHEM PHARMACOL, V36, P3809; Moller AD, 1999, CRIT CARE MED, V27, P130, DOI 10.1097/00003246-199901000-00040; Moller AD, 1999, J VASC RES, V36, P245, DOI 10.1159/000025648; Moller AD, 1997, AM J PHYSIOL-HEART C, V273, pH200, DOI 10.1152/ajpheart.1997.273.1.H200; MONCADA S, 1979, FED PROC, V38, P66; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; MONCADA S, 1979, HAEMOSTASIS, V8, P252; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; MOREL NML, 1990, INFLAMMATION, V14, P571, DOI 10.1007/BF00914277; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; RITTER JM, 1983, LANCET, V1, P317; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; SEIFERT V, 1987, SURG NEUROL, V27, P243, DOI 10.1016/0090-3019(87)90037-1; Stahl N, 2003, ACTA NEUROL SCAND, V108, P211, DOI 10.1034/j.1600-0404.2003.00095.x; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; J NEUROTRAUMA S1, V24, pS59	53	31	32	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1251	1262		10.1089/neu.2008.0605			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900008	19226191	Green Submitted			2022-02-06	
J	Lundberg, J; Karimi, M; von Gertten, C; Holmin, S; Ekstrom, TJ; Sandberg-Nordqvist, AC				Lundberg, Johan; Karimi, Mohsen; von Gertten, Christina; Holmin, Staffan; Ekstrom, Tomas J.; Sandberg-Nordqvist, Ann-Christin			Traumatic brain injury induces relocalization of DNA-methyltransferase 1	NEUROSCIENCE LETTERS			English	Article						Methylation; Dnmt1; Traumatic brain injury; Astrocyte activation	METHYLATION; RATS	Secondary cerebral damage after traumatic brain injury (TBI) occurs following processes partly initiated by gene expression alterations. DNA methylation in promoter regions is one of several epigenetic modifications, that affect the regulation of gene expression and which is a part of the pathophysiological pathway following TBI. We have investigated expression and cellular localization of DNA-methyltransferase (Dnmts) enzymes by immunohistochemistry (1HC) and confocal microscopy. Nuclear as well as cytoplasmic Dnmt1 was observed in astrocytes, in contrast to its normal neuronal nuclear localization. Interestingly, double staining with Dnmt1 and nestin showed co-localization in some reactive astrocytes in the nucleus alone, while in others this expression pattern was evident both in the nucleus and cytoplasm, in a brain region specific manner. In normal brains, and contralateral to the injury, the great majority of Dnmt1 positive cells were neurons. We also observed cytoplasmic Dnmt1 in peri-ventricular nestin expressing cells. Our findings may form the basis for further epigenetic studies following TBI and new therapeutic strategies to treat TBI patients. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Lundberg, Johan; Holmin, Staffan] Karolinska Univ Hosp, Neuroradiol Sect, SE-17176 Stockholm, Sweden; [Lundberg, Johan; von Gertten, Christina; Sandberg-Nordqvist, Ann-Christin] Karolinska Univ Hosp, Sect Clin CNS Res, Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Karimi, Mohsen; Ekstrom, Tomas J.] Karolinska Univ Hosp, Lab Med Epigenet, SE-17176 Stockholm, Sweden; [Karimi, Mohsen] Karolinska Univ Hosp, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden		Ekstrom, TJ (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, Lab Med Epigenet, L8 01, S-17176 Stockholm, Sweden.	Tomas.Ekstrom@ki.se	Ekstrom, Tomas/B-7764-2013	Holmin, Staffan/0000-0002-1628-1615	Swedish Cancer Foundation; Karolinska InstitutetKarolinska Institutet; Ministry of Health, Iran	The work was supported by the Swedish Cancer Foundation, and funds from Karolinska Institutet. Mohsen Karimi was supported by a scholarship through the Pasteur Institute, Ministry of Health, Iran.	Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Holmin S, 2001, NEUROSCI LETT, V314, P151, DOI 10.1016/S0304-3940(01)02292-3; Kiefer JC, 2007, DEV DYNAM, V236, P1144, DOI 10.1002/dvdy.21094; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Szyf M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P533, DOI 10.1007/s10541-005-0147-7; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Wennersten A, 2006, EXP NEUROL, V199, P339, DOI 10.1016/j.expneurol.2005.12.035; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	13	31	31	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 19	2009	457	1					8	11		10.1016/j.neulet.2009.03.105			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	449WE	WOS:000266360300003	19429151				2022-02-06	
J	Radolovich, DK; Czosnyka, M; Timofeev, I; Lavinio, A; Hutchinson, P; Gupta, A; Pickard, JD; Smielewski, P				Radolovich, Danila K.; Czosnyka, Marek; Timofeev, Ivan; Lavinio, Andrea; Hutchinson, Peter; Gupta, Arun; Pickard, John D.; Smielewski, Peter			Reactivity of Brain Tissue Oxygen to Change in Cerebral Perfusion Pressure in Head Injured Patients	NEUROCRITICAL CARE			English	Article						Brain tissue oxygen; Autoregulation; Cerebral perfusion pressure; Head injury	CEREBROVASCULAR AUTOREGULATION; BLOOD-FLOW; LICOX	It has been reported recently that correlation between brain tissue oxygen (PbtO(2)) and cerebral perfusion pressure (CPP) may serve as an indicator of cerebral autoregulation after subarachnoid hemorrhage. We aimed to compare similar indices describing interaction between changes in intracranial pressure (ICP), arterial blood pressure (ABP), and brain tissue oxygen to verify their clinical utility in patients after traumatic brain injury. Retrospective analysis of multimodal monitoring of 32 patients suffering from head injury, admitted in the Neurosciences Critical Care Unit, Addenbrooke's Hospital, Cambridge, UK. Initial 24 h intervals of continuous ABP, ICP, and PbtO(2) recordings were analyzed. Index of tissue oxygen reactivity ORx was evaluated as the correlation coefficient between PbtO(2) and CPP over a period of 60 min and compared to the index of pressure reactivity PRx. "Optimal CPP" and a hypothetical "optimal PbtO(2)" were defined as the ranges of CPP and PbtO(2) at which PRx or ORx were indicating best cerebrovascular milieu. PRx and ORx mean values did not show any correlation with each other (R = 0.012; P = 0.95) between patients. There was also no correlation between ORx and PbtO(2) (R = 0.098; P = 0.61) and between PRx and PbtO(2) (R = 0.019; P = 0.923). No clear and consistent value of "optimal CPP" minimizing ORx or of hypothetical "optimal PbtO(2)" were found analyzing PbtO(2) or ORx trend over the 24 h of monitoring. However, in most of patients 'optimal CPP' has been found for PRx index. The same has been confirmed when the data from whole monitoring period were analyzed. There was no correlation between values of 'optimal CPP' assessed using ORx and 'optimal CPP' assessed with PRx. The relationships between PbtO(2), ORx, and CPP in head injury appear less useful than reported before for patients after subarachnoid hemorrhage.	[Radolovich, Danila K.; Czosnyka, Marek; Timofeev, Ivan; Lavinio, Andrea; Hutchinson, Peter; Pickard, John D.; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Acad Neurosurg Unit, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Radolovich, Danila K.] Univ Pavia, Dept Anaesthesiol & Intens Care, I-27100 Pavia, Italy; [Lavinio, Andrea; Gupta, Arun] Addenbrookes Hosp, Dept Anaesthesiol, Cambridge, England		Radolovich, DK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Acad Neurosurg Unit, Dept Clin Neurosci, POB 167, Cambridge CB2 2QQ, England.	dkr22@cam.ac.uk	Lavinio, Andrea/M-1778-2016; Timofeev, Ivan/AAE-7019-2019	Timofeev, Ivan/0000-0002-1168-0393; Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G9439390, G0600986, G0601025] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0601025, G0001237, G0600986] Funding Source: UKRI; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish		Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Hemphill JC, 2005, AM J NEURORADIOL, V26, P1095; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Valadka AB, 2002, ACT NEUR S, V81, P299	16	31	31	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2009	10	3					274	279		10.1007/s12028-009-9190-3			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	449KG	WOS:000266328900004	19184551				2022-02-06	
J	Ahmed, N; Bialowas, C; Kuo, YH; Zawodniak, L				Ahmed, Nasim; Bialowas, Christie; Kuo, Yen-Hong; Zawodniak, Leonard			Impact of Preinjury Anticoagulation in Patients with Traumatic Brain Injury	SOUTHERN MEDICAL JOURNAL			English	Article						aspirin; clopidogrel bisulfate; head injury; heparin; warfarin	HEAD-INJURY; INTRACRANIAL HEMORRHAGE; ELDERLY-PATIENTS; WARFARIN USE; ASPIRIN; RISK; CLOPIDOGREL; MORTALITY; INCREASE; AGE	'Introduction: This study was undertaken to examine the impact of various anticoagulation agents in head injury patients. Methods: The medical records and trauma registry were used to analyze the data. All adult trauma patients using aspirin, clopidogrel bisulfate (Plavix (R)), warfarin (Coumadin (R)), or heparin and admitted to the hospital with computed tomography (CT) scan evidence of brain injuries were included in the study. Patients were classified into three groups based on medication used. Results: From July 2004 through December 2006, 29 patients admitted to the trauma center were found to be on anticoagulation or antiplatelet agents. The control group consisted of 63 patients with CT evidence of head injury not on antiplatelet or anticoagulant medications. There were no significant differences among the groups regarding age, gender, Glasgow Coma Scale, Injury Severity Score, mortality (P = 0.65), ventilator days (P = 0.69), intensive care unit (ICU) days (P = 0.65), total hospital days (P = 0.41) or discharge disposition (P = 0.65). Conclusion: Prehead injury anticoagulation did not have any significant impact on outcomes.	[Ahmed, Nasim] Jersey Shore Univ, Dept Surg, Div Trauma & Surg Crit Care, Med Ctr, Neptune, NJ 07754 USA; Monmouth Med Ctr, Long Branch, NJ USA		Ahmed, N (corresponding author), Jersey Shore Univ, Dept Surg, Div Trauma & Surg Crit Care, Med Ctr, 1945 State Route 33, Neptune, NJ 07754 USA.	nahmed@meridianhealth.com					Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Parris R, 2007, EMERG MED J, V24, P435, DOI 10.1136/emj.2007.049528; Serebruany VL, 2003, AM HEART J, V146, P713, DOI 10.1016/S0002-8703(03)00260-6; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Wahl WL, 2001, J TRAUMA, V51, P1151; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	12	31	31	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0038-4348			SOUTH MED J	South.Med.J.	MAY	2009	102	5					476	480		10.1097/SMJ.0b013e31819f97a3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	445KI	WOS:000266049300013	19373146				2022-02-06	
J	Robinson, RG; Jorge, RE; Clarence-Smith, K; Starkstein, S				Robinson, Robert G.; Jorge, Ricardo E.; Clarence-Smith, Kathleen; Starkstein, Sergio			Double-Blind Treatment of Apathy in Patients with Poststroke Depression Using Nefiracetam	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; MOOD DISORDERS; STROKE; AMANTADINE; VALIDITY; RATS; RELIABILITY; DYSFUNCTION; MECHANISMS	Nefiracetam is a novel pyrrolidone-type nootropic compound shown in preliminary trials to increase blood flow and improve patient outlook and energy following stroke. Of 137 stroke patients with major depression, 70 also met published diagnostic criteria for apathy (51.1%) and were randomly assigned either to placebo or 600 mg or 900 mg of nefiracetam per day, and received at least 4 weeks of treatment. Using the group with at least 4 weeks of treatment as the intention-to-treat sample with last observation carried forward, repeated measures analysis of variance of Apathy Scale scores demonstrated a significant time-by-treatment interaction. Patients taking 900 mg nefiracetam had a significantly greater change in Apathy Scale scores compared to 600 mg of nefiracetam or placebo. Future studies should assess whether apathy without depression may respond to this novel treatment.	[Robinson, Robert G.; Jorge, Ricardo E.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Clarence-Smith, Kathleen] Prestwick Sci Capital, Washington, DC USA; [Starkstein, Sergio] Univ Western Australia, Dept Psychiat, Perth, WA 6009, Australia		Robinson, RG (corresponding author), Univ Iowa, Dept Psychiat, Carver Coll Med, 200 Hawkins Dr, Iowa City, IA 52242 USA.	robert-robinson@uiowa.edu	Robinson, Robert/AAF-6191-2021				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Ando T, 2005, EUR J PHARMACOL, V507, P49, DOI 10.1016/j.ejphar.2004.11.033; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Beck AT., 1987, DEPRESSION INVENTORY; Cummings Jeffrey L, 2005, Am J Geriatr Pharmacother, V3, P137, DOI 10.1016/S1543-5946(05)80020-0; Freo U, 2002, J NEURAL TRANSM, V109, P857, DOI 10.1007/s007020200070; Granger, 1987, FUNCTIONAL INDEPENDE; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOUSE A, 1990, BRAIN, V113, P1113, DOI 10.1093/brain/113.4.1113; Jin JJ, 2002, PHARMACOLOGY, V64, P119, DOI 10.1159/000056160; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kitano Y, 2005, EPILEPSIA, V46, P1561, DOI 10.1111/j.1528-1167.2005.00261.x; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; KRAUS MF, 1995, INT J PSYCHIAT MED, V25, P39, DOI 10.2190/BXRM-3M58-WBC5-A7EL; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; KUNITZ SC, 1984, STROKE, V15, P740, DOI 10.1161/01.STR.15.4.740; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Marin RA, 2005, TXB TRAUMATIC BRAIN, P337; MARIN RS, 1993, J AFFECT DISORDERS, V28, P117, DOI 10.1016/0165-0327(93)90040-Q; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Moriguchi S, 2003, J PHARMACOL EXP THER, V307, P160, DOI 10.1124/jpet.103.050823; Moriguchi S, 2007, MOL PHARMACOL, V71, P580, DOI 10.1124/mol.106.027607; Narahashi T, 2004, BIOL PHARM BULL, V27, P1701, DOI 10.1248/bpb.27.1701; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Nishizaki T, 1998, MOL PHARMACOL, V53, P1; Okada K, 1997, STROKE, V28, P2437, DOI 10.1161/01.STR.28.12.2437; OTOMO E, 1994, RINSHO IYAKU, V10, P1871; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; ROBINSON RG, 1983, STROKE, V14, P736, DOI 10.1161/01.STR.14.5.736; Robinson RG, 2008, JAMA-J AM MED ASSOC, V299, P2391, DOI 10.1001/jama.299.20.2391; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tsuchiya Y, 2003, EUR J PHARMACOL, V475, P119, DOI 10.1016/S0014-2999(03)02123-X; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Watanabe A, 2003, J NEUROPSYCH CLIN N, V15, P442, DOI 10.1176/appi.neuropsych.15.4.442; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Wing J. K., 1974, MEASUREMENT CLASSIFI; Yamagata S, 2004, STROKE, V35, P1935, DOI 10.1161/01.STR.0000135017.51144.c9; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014; Zhao XL, 2001, ANN NY ACAD SCI, V939, P179	45	31	33	0	6	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	MAY	2009	21	2					144	151					8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	472SL	WOS:000268152300005	19622685				2022-02-06	
J	Obrenovitch, TP; Chen, SB; Farkas, E				Obrenovitch, Tihomir P.; Chen, Shangbin; Farkas, Eszter			Simultaneous, live imaging of cortical spreading depression and associated cerebral blood flow changes, by combining voltage-sensitive dye and laser speckle contrast methods	NEUROIMAGE			English	Article							ISCHEMIC NEUROLOGICAL DEFICITS; PERIINFARCT DEPOLARIZATIONS; SUBARACHNOID HEMORRHAGE; LOCAL CHANGES; RAT CORTEX; BRAIN; SIGNAL; OXYGENATION; HEMOGLOBIN; ACTIVATION	Cortical spreading depression (i.e. waves of cellular depolarization, CSD) causes the aura symptoms in classical migraine, and may contribute to delayed cellular damage after an ischemic or traumatic insult to the brain. In the latter cases, secondary neuronal injury may be worsened by some of the cerebral blood flow (CBF) changes that are associated with CSD. Here, we describe a new method for the simultaneous, live imaging of local cellular depolarization and CBF changes (i.e. two variables with well-defined and important biological significance), through a closed cranial window prepared in anesthetized rats. This novel experimental strategy was validated by imaging the changes associated with CSD elicited by application of high K(+) medium on the cortical surface. CSD was visualized directly by using a fluorescent voltage-sensitive (VS) dye, whereas laser speckle contrast (LSC) imaging allowed the visualization of the corresponding CBF changes. In addition to the high temporal and spatial resolution of VS dye and LSC imaging, their novel combination allows to determine how CBF changes relate to a heterogeneous and evolving pattern of cellular depolarization, in any area of interest of the cortical region under study. This methodological development is especially pertinent and timely for investigations into the peri-lesion depolarizations that occur in models of focal brain injury, situations where their site of spontaneous elicitation and propagation pattern cannot be predicted. It should also help advance our knowledge in epilepsy, CBF pharmacology, and neurovascular coupling under normal and pathophysiological conditions. (C) 2008 Elsevier Inc. All rights reserved.	[Obrenovitch, Tihomir P.; Farkas, Eszter] Univ Bradford, Sch Life Sci, Div Pharmacol, Bradford BD7 1DP, W Yorkshire, England; [Chen, Shangbin] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Farkas, Eszter] Univ Szeged, Sch Med, Dept Physiol, Szeged, Hungary		Obrenovitch, TP (corresponding author), Univ Bradford, Sch Life Sci, Div Pharmacol, Bradford BD7 1DP, W Yorkshire, England.	t.obrenovitch@bradford.ac.uk		Farkas, Eszter/0000-0002-8478-9664	Wellcome TrustWellcome TrustEuropean Commission [079430/A/06/Z]; Royal SocietyRoyal Society of LondonEuropean Commission [2007/R3]	This study was supported by grants from the Wellcome Trust (079430/A/06/Z) and The Royal Society (International Incoming Short Visits, 2007/R3). This work would not have been possible without the contribution from D. Brown, G. Pearson and A. Kershaw (Workshop, Bradford School of Life Sciences).	Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; Briers JD, 2007, OPT APPL, V37, P139; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Chen G, 1999, J NEUROPHYSIOL, V81, P1992, DOI 10.1152/jn.1999.81.4.1992; Chen SB, 2006, NEUROSCI LETT, V396, P132, DOI 10.1016/j.neulet.2005.11.025; Cheng HY, 2007, OPT LETT, V32, P2188, DOI 10.1364/OL.32.002188; Cheng HY, 2003, J BIOMED OPT, V8, P559, DOI 10.1117/1.1578089; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Dreier JP, 2004, NEUROCRIT CARE, V1, P85, DOI 10.1385/NCC:1:1:85; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; FABRICIUS M, 1995, AM J PHYSIOL-HEART C, V269, pH23, DOI 10.1152/ajpheart.1995.269.1.H23; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; Goadsby PJ, 2007, TRENDS MOL MED, V13, P39, DOI 10.1016/j.molmed.2006.11.005; Gold L, 1998, BRAIN RES, V783, P188, DOI 10.1016/S0006-8993(97)01341-3; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V109, P1, DOI 10.1111/j.1748-1716.1980.tb06557.x; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; Jou MJ, 2004, ANN NY ACAD SCI, V1011, P45, DOI 10.1196/annals.1293.005; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lauritzen M, 2003, J NEUROSCI, V23, P3972; Lauritzen M, 2001, J CEREBR BLOOD F MET, V21, P1367, DOI 10.1097/00004647-200112000-00001; Li PC, 2006, OPT LETT, V31, P1824, DOI 10.1364/OL.31.001824; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Nielsen AN, 2000, J VASC RES, V37, P513, DOI 10.1159/000054084; Obrenovitch T.P., 2004, PHARM CEREBRAL ISCHE, P157; Paul JS, 2006, NEUROIMAGE, V29, P38, DOI 10.1016/j.neuroimage.2005.07.019; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; RICHTER F, 1993, NEUROSCI LETT, V152, P65, DOI 10.1016/0304-3940(93)90484-3; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Strong AJ, 2006, J CEREBR BLOOD F MET, V26, P645, DOI 10.1038/sj.jcbfm.9600240; Wang Z, 2007, NEUROSCI LETT, V424, P133, DOI 10.1016/j.neulet.2007.07.027	41	31	35	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	MAR	2009	45	1					68	74		10.1016/j.neuroimage.2008.11.025			7	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	414KR	WOS:000263862900009	19100842				2022-02-06	
J	Thornton, KE; Carmody, DP				Thornton, Kirtley E.; Carmody, Dennis P.			Traumatic Brain Injury Rehabilitation: QEEG Biofeedback Treatment Protocols	APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK			English	Article						EEG biofeedback; Traumatic brain injury; Cognitive rehabilitation; Activation QEEG; Memory rehabilitation; Cognitive challenge	CLOSED-HEAD-INJURY; DIFFUSION-TENSOR; QUANTITATIVE EEG; COHERENCE; NEUROTHERAPY; MEMORY; DELAY; INDEX; MRI	Interventions for improvement of cognitive problems in patients with traumatic brain injury (TBI) include electroencephalography biofeedback, also known as neurofeedback. Quantitative electroencephalography (QEEG) patterns are assessed in TBI patients and then compared to a database obtained from a normative population. Deviations in QEEG patterns from the normative group are the basis for an intervention plan. While QEEG patterns, obtained under an eyes closed, resting condition, provide information about deviations at rest, QEEG patterns obtained while the patient engages in cognitive tasks reflect specific deficiencies in brain functioning. This paper reviews and assesses QEEG patterns collected under both resting conditions as well as cognitive tasks. The article provides a theoretical and empirical base for QEEG interventions with TBI.	[Thornton, Kirtley E.] Brain Fdn, Edison, NJ 08817 USA; [Carmody, Dennis P.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Inst Study Child Dev, New Brunswick, NJ 08903 USA		Thornton, KE (corresponding author), Brain Fdn, 2 Ethel Rd,Ste 203C, Edison, NJ 08817 USA.	ket@chp-neurotherapy.com	Carmody, Dennis P./AAS-7734-2020	Carmody, Dennis/0000-0002-1288-104X; thornton, kirtley/0000-0002-3303-4747			Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Braver ER, 1997, JAMA-J AM MED ASSOC, V278, P1437, DOI 10.1001/jama.278.17.1437; Byers AP., 1995, J NEUROTHERAPY, V1, P22; CARTER GC, 1987, P IEEE, V75, P236, DOI 10.1109/PROC.1987.13723; *CDC, 1999, FACTS CONC BRAIN INJ; Collura T., 2008, J NEUROTHERAPY, V12, P99, DOI [10.1080/10874200802433274, DOI 10.1080/10874200802433274]; DEFILIPPIS NA, 1979, CATEGORY TEST; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; HARMONY T, 1990, INT J NEUROSCI, V54, P147, DOI 10.3109/00207459008986630; Heaton R.K., 1981, WISCONSIN CARD SORTI; HOOSHMAND H, 1989, CLIN ELECTROENCEPHAL, V20, P235, DOI 10.1177/155005948902000411; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; JOFFE D, 1992, LEXICOR NRS 24 BIOLE; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Keller I, 2001, J NEUROTHERAPY, V5, P19; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Leon-Carrion J, 2008, BRAIN INJURY, V22, P61, DOI 10.1080/02699050701824143; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; RANDOLPH C, 1988, NEUROPSYCHOBIOLOGY, V20, P43, DOI 10.1159/000118471; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; *SKIL, 2008, AN SOFTW; STEPHENS J, 2006, EFFECTIVENESS EEG BI; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Thornton K, 2003, ARCH CLIN NEUROPSYCH, V18, P363, DOI 10.1016/S0887-6177(02)00139-7; Thornton K., 2000, J NEUROTHERAPY, V3, P1, DOI DOI 10.1300/J184V03N03_01; Thornton K. E., 2002, J NEUROTHER, V6, P37, DOI [10.1300/j184v06n03_04, DOI 10.1300/J184V06N03_04]; Thornton KE, 2005, CHILD ADOL PSYCH CL, V14, P137, DOI 10.1016/j.chc.2004.07.001; Thornton KE, 1999, BRAIN INJURY, V13, P477, DOI 10.1080/026990599121395; THORNTON KE, 2007, INT SOC NEUR REG SAN; THORNTON KE, 2001, Patent No. 6309361; THORNTON KE, 2009, J NEUROTHER IN PRESS; Thornton KE, 2008, APPL PSYCHOPHYS BIOF, V33, P101, DOI 10.1007/s10484-008-9056-z; Tinius T. P., 2000, J NEUROTHER, V4, P27, DOI [DOI 10.1300/J184v04n02_05, 10.1300/J184v04n02_05]; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Walker J. E., 2002, J NEUROTHER, V6, P31, DOI DOI 10.1300/J184v06n02_05	45	31	33	0	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1090-0586	1573-3270		APPL PSYCHOPHYS BIOF	Appl. Psychophysiol. Biofeedback	MAR	2009	34	1					59	68		10.1007/s10484-009-9075-4			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	409RJ	WOS:000263523200007	19199027				2022-02-06	
J	Chen, X; Zhang, KL; Yang, SY; Dong, JF; Zhang, JN				Chen, Xin; Zhang, Ke-Li; Yang, Shu-Yuan; Dong, Jing-Fei; Zhang, Jian-Ning			Glucocorticoids Aggravate Retrograde Memory Deficiency Associated with Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; glucocorticoid; retrograde memory deficiency; traumatic brain injury	APOPTOTIC CELL-DEATH; HEAD-INJURY; BASOLATERAL AMYGDALA; DNA FRAGMENTATION; SPATIAL MEMORY; WATER-MAZE; RETRIEVAL; HIPPOCAMPUS; ISCHEMIA; IMPAIRMENT	Administration of glucocorticoid to patients with head injury has previously been demonstrated to impair memory. We hypothesize that glucocorticoids promote post-traumatic hippocampal apoptosis, resulting in retrograde memory deficiency associated with traumatic brain injury (TBI). In the present study, we tested this hypothesis by measuring spatial memory deficiency in rats subjected to fluid percussion injury (FPI) and receiving dexamethasone (DXM at 0.5-10 mg/kg) or methylprednisolone (MP at 5-30 mg/kg); we also examined neuronal apoptosis in hippocampus. Adult male Wistar rats were trained for the acquisition of spatial memory, then subjected to FPI and tested for spatial reference memory on post-injury days 7 and 14 using the Morris Water Maze. Brain tissue from injured rats was examined 24 h to 2 weeks after injury. The percent time in the goal quadrant, which measures spatial reference memory, was significantly lower in injured rats receiving either high-dose DXM or MP than in control groups. TUNEL-positive cells in hippocampus were first detected 24 h post-injury, plateauing at 48 h. The number of TUNEL-positive cells was significantly higher in injured rats treated with either DXM or MP. The data suggest that glucocorticoid therapy for TBI may increase neuronal apoptosis in hippocampus and, as a result, aggravate retrograde memory deficits induced by TBI.	[Chen, Xin; Yang, Shu-Yuan; Zhang, Jian-Ning] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China; [Dong, Jing-Fei] Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; [Zhang, Ke-Li] Tianjin Baodi Hosp, Dept Neurosurg, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			National 973 Projects of ChinaNational Basic Research Program of China [2005CB522605]; Tianjin Science and Techonology Development Plan [05YFGDSF02500]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [033611511]	We acknowledge Li Liu, Lanlan Luo, Weiyun Cui, Fanglian Chen, and Lei Zhou for excellent technical support. This work is supported by the National 973 Projects of China (grant 2005CB522605), Tianjin Science and Techonology Development Plan (grant 05YFGDSF02500), and Tianjin Natural Science Foundation (grant 033611511).	Allen TC, 1992, ARMED FORCES I PATHO, P53; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; LAURER HL, 2002, ENCY HUMAN BRAIN, P93; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nicotera P, 1999, TRENDS PHARMACOL SCI, V20, P46, DOI 10.1016/S0165-6147(99)01304-8; NITATORI T, 1995, J NEUROSCI, V15, P1001; Okuda S, 2004, P NATL ACAD SCI USA, V101, P853, DOI 10.1073/pnas.0307803100; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; RINK A, 1995, AM J PATHOL, V147, P1575; Roozendaal B, 2004, J NEUROSCI, V24, P8161, DOI 10.1523/JNEUROSCI.2574-04.2004; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; RUFF R, 2004, YOUMANS NEUROLOGICAL, P5181; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Woodson JC, 2003, LEARN MEMORY, V10, P326, DOI 10.1101/lm.62903; Wyllie A H, 1980, Int Rev Cytol, V68, P251	30	31	37	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2009	26	2					253	260		10.1089/neu.2007.0504			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	410NS	WOS:000263585100008	19236166				2022-02-06	
J	Jia, F; Mao, Q; Liang, YM; Jiang, JY				Jia, Feng; Mao, Qing; Liang, Yu-Min; Jiang, Ji-Yao			Effect of Post-Traumatic Mild Hypothermia on Hippocampal Cell Death after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						cell death; hippocampus; mild hypothermia; traumatic brain injury	CORTICAL IMPACT INJURY; MODERATE HYPOTHERMIA; NEURONAL DEATH; THERAPEUTIC HYPOTHERMIA; BEHAVIORAL DEFICITS; CEREBRAL-ISCHEMIA; HEAD-INJURY; APOPTOSIS; PROTECTION; NECROSIS	In this investigation, we evaluated the effect of post-traumatic mild hypothermia on cell death in the hippocampus after fluid percussion traumatic brain injury (TBI) in rats. Adult male Sprague-Dawley rats were randomly divided into three groups (n = 40/group): TBI with hypothermia treatment (32 degrees C), TBI with normothermia (37 degrees C), and sham injury. The TBI model was induced by a fluid percussion TBI device. Mild hypothermia (32 degrees C) was achieved by partial immersion in a water bath (0 degrees C) under general anesthesia for 4 h. All rats were killed at 24 or 72 h after TBI. The ipsilateral hippocampal CA1 in all rats were analyzed by hematoxylin and eosin staining, terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphatebiotin nick end labeling (TUNEL), and 4',6-diamidino-2-phenylindole (DAPI) staining for determining cell death. Caspase-3 expression was examined by reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting. At 24 h, based on TUNEL and DAPI results, the cell death index was 28.80 +/- 2.60% and 32.10 +/- 1.40% in the normothermia TBI group, while reaching only 14.30 +/- 2.70% and 18.40 +/- 2.10% in the hypothermic TBI group (p < 0.01). Based on RT-PCR and Western blotting results, the expression of caspase-3 was 210.20 +/- 5.30% and 170.30 +/- 4.80% in the normothermic TBI group, while reaching only 165.10 +/- 3.70% and 130.60 +/- 4.10% in the hypothermic TBI group (p < 0.05). At 72 h, based on TUNEL and DAPI results, the cell death index was 20.80 +/- 2.50% and 25.50 +/- 1.80% in the normothermic TBI group, while reaching only 10.20 +/- 2.60% and 15.50 +/- 2.10% in the hypothermic TBI group (p < 0.01). Based on RT-PCR and Western blotting results, the expression of caspase-3 was 186.20 +/- 6.20% and 142.30 +/- 5.10% in the normothermic TBI group, versus only 152.10 +/- 3.60% and 120.60 +/- 3.90% in the hypothermic TBI group (p < 0.05). Based on our findings, we conclude that post-traumatic hypothermia significantly attenuates cell death within the hippocampus following fluid percussion injury. Taken together with other studies, these observations support the premise that post-traumatic mild hypothermia can provide cerebral protection for patients with TBI.	[Jia, Feng; Mao, Qing; Liang, Yu-Min; Jiang, Ji-Yao] Shanghai Jiao Tong Univ, Shanghai Renji Hosp, Dept Neurosurg, Sch Med, Shanghai 200127, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, RenJi Hosp, Dept Neurosurg, Sch Med, Shanghai 200127, Peoples R China.	jiangjyb@online.sh.cn			National Key Basic Research ProjectNational Basic Research Program of China [2005CB522604]; National Science and Nature [30571908]; Science and Technology Committee of ShanghaiShanghai Science & Technology Committee [07JC14038]; Program for Shanghai Outstanding Medical Academic Leader	This work was supported by the National Key Basic Research Project (grant 2005CB522604), National Science and Nature Grants (grant 30571908), Science and Technology Committee of Shanghai (grant 07JC14038), and Program for Shanghai Outstanding Medical Academic Leader.	Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Celik SE, 2006, J NEUROTRAUM, V23, P1355, DOI 10.1089/neu.2006.23.1355; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Faden AI, 1996, JAMA-J AM MED ASSOC, V276, P569, DOI 10.1001/jama.276.7.569; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; FARBER E, 1994, MODERN PATHOL, V7, P605; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Greve KW, 2007, CLIN NEUROPSYCHOL, V21, P318, DOI 10.1080/13854040500488552; HAGERDAL M, 1979, ACTA ANAESTH SCAND, V23, P89; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; JESSIE T, 2005, BRAIN RES MOL BRAIN, V138, P124; Jiang JY, 2007, CURR OPIN CRIT CARE, V13, P153, DOI 10.1097/MCC.0b013e32807f2a80; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lin X, 2001, Chin J Traumatol, V4, P14; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; MAJNO G, 1995, AM J PATHOL, V146, P3; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; ORD JS, 2007, CLIN NEUROPSYCHOL, V13, P1; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Phanithi PB, 2000, NEUROPATHOLOGY, V20, P273, DOI 10.1046/j.1440-1789.2000.00346.x; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; RINK A, 1995, AM J PATHOL, V147, P1575; SEARLE J, 1982, PATHOL ANNU, V17, P229; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wu XH, 2007, J NEUROTRAUM, V24, P1502, DOI 10.1089/neu.2006.0228; Xu RX, 1998, NEUROSURGERY, V43, P107, DOI 10.1097/00006123-199807000-00070; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yang Xiao-feng, 2006, Chin J Traumatol, V9, P276; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	53	31	37	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2009	26	2					243	252		10.1089/neu.2008.0670			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	410NS	WOS:000263585100007	19236165				2022-02-06	
J	Silasi, G; MacLellan, CL; Colbourne, F				Silasi, Gergely; MacLellan, Crystal L.; Colbourne, Frederick			Use of Telemetry Blood Pressure Transmitters to Measure Intracranial Pressure (ICP) in Freely Moving Rats	CURRENT NEUROVASCULAR RESEARCH			English	Article						Telemetry; blood pressure sensor; rodent; stroke; ischemia	CEREBRAL-ARTERY OCCLUSION; SUBARACHNOID HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; BRAIN TEMPERATURE; INJURY; HYPOTHERMIA; AWAKE; ISCHEMIA; RODENTS; MODEL	Stroke and traumatic brain injuries often lead to cerebral edema and persistent elevations in intracranial pressure (ICP) that can be life threatening. Thus, rodent models would benefit from a simple and reliable method to measure ICP in awake, mobile animals. Up to now most techniques have been limited to anesthetized or immobile animals, which is not practical for following the prolonged elevations in ICP that follow stroke and traumatic brain injury. With an initial set of data, we describe a simple method that uses blood pressure telemetry sensors, which are commercially available (Data Sciences Int.) to measure ICP in freely moving rats for several days following implantation. Basically, an epidural cannula is secured to the skull and connected to the catheter of the telemetry probe, which is then secured inside a protective plastic shield on the skull. We confirm the sensitivity of our measurements by experimentally modifying ICP by either the Valsalva maneuver (abdominal compression) or a large ischemic brain injury. The Valsalva maneuver caused a small brief spike in ICP (lasting about 2-3 sec), whereas a transient middle cerebral artery occlusion substantially increased ICP (up to 50 mmHg) for approximately 3 days post-surgery. In summary, the current method allows for ICP to be continuously monitored in rats for several days, and thus is suitable for studies investigating mechanisms of raised ICP and in testing experimental treatments that mitigate it.	[Silasi, Gergely; Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB T6G 2E9, Canada; [Silasi, Gergely; Colbourne, Frederick] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2E9, Canada; [MacLellan, Crystal L.] Mem Univ Newfoundland, Div Biomed Sci, St John, NF, Canada		Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, P217 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082; Silasi, Gergely/0000-0003-1036-1304	Alberta Heritage Foundation for Medical Research (AHFMR)Alberta Heritage Foundation for Medical Research; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Canadian Stroke Network; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Astra-ZenecaAstraZeneca	Dr. Colbourne is supported by an Alberta Heritage Foundation for Medical Research ( AHFMR) senior medical scholar award. G. Silasi is supported by a Focus on Stroke doctoral research award from the Heart and Stroke Foundation of Canada, the Canadian Stroke Network, the Canadian Institutes of Health Research ( CIHR), and Astra-Zeneca. C. MacLellan is supported by a CIHR postdoctoral fellowship. Research supported by CIHR through a grant awarded to FC. The authors are also grateful to Cassandra Packham for the excellent technical assistance.	ANDREWS B T, 1988, Neurological Research, V10, P123; BARTH KNM, 1992, NEUROSURGERY, V30, P138, DOI 10.1227/00006123-199201000-00028; Chu XF, 2008, J NEUROSCI METH, V168, P1, DOI 10.1016/j.jneumeth.2007.08.030; Clark DL, 2008, EXP NEUROL, V212, P386, DOI 10.1016/j.expneurol.2008.04.016; Colbourne F, 1996, J NEUROSCI METH, V67, P185; DeBow S, 2003, METHODS, V30, P167, DOI 10.1016/S1046-2023(03)00080-X; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; Eide PK, 2007, ACTA ANAESTH SCAND, V51, P501, DOI 10.1111/j.1399-6576.2007.01269.x; Fingas M, 2007, EXP NEUROL, V208, P277, DOI 10.1016/j.expneurol.2007.08.018; GARCIA JH, 1993, AM J PATHOL, V142, P623; Jallo J, 1997, J NEUROSCI METH, V75, P155, DOI 10.1016/S0165-0270(97)00064-2; Kolb B, 1997, BRAIN RES, V751, P289, DOI 10.1016/S0006-8993(96)01410-2; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; LEVINGER IM, 1971, J ANAT, V108, P447; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MacLellan CL, 2006, STROKE, V37, P1266, DOI 10.1161/01.STR.0000217268.81963.78; MALKINSON TJ, 1985, BRAIN RES BULL, V15, P321, DOI 10.1016/0361-9230(85)90158-3; Morgalla MH, 2002, ACTA NEUROCHIR, V144, P57, DOI 10.1007/s701-002-8274-2; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Sehba FA, 2007, J NEUROSURG, V106, P321, DOI 10.3171/jns.2007.106.2.321; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Walberer M, 2008, J NEUROSURG, V109, P287, DOI 10.3171/JNS/2008/109/8/0287	22	31	32	0	11	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	FEB	2009	6	1					62	69		10.2174/156720209787466046			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	415SH	WOS:000263954500007	19355927				2022-02-06	
J	Boone, KB				Boone, Kyle Brauer			[image omitted] Fixed Belief in Cognitive Dysfunction Despite Normal Neuropsychological Scores: Neurocognitive Hypochondriasis?	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neurocognitive hypochondriasis; Fixed belief in cognitive dysfunction; Mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; TEST-PERFORMANCE; BASE-RATES; CHILDHOOD TRAUMA; SOMATIZATION; PERSONALITY; DEPRESSION; SYMPTOMS; AMPLIFICATION	A subset of patients who present for neuropsychological testing report dysfunction in daily life activities secondary to cognitive deficits, but are found on formal testing to have no objective abnormalities, raising the possibility of oneurocognitive hypochondriasis.o Such a case is presented, and the factors that appear to give rise to this presentation are explored. Cases of hypochondriacal overconcern regarding cognitive function are likely not rare, particularly given research showing there is little correlation between objective report of cognitive dysfunction and actual test scores in such conditions as mild traumatic brain injury, chronic fatigue syndrome, fibromyalgia, toxic mold exposure, and post-polio syndrome.	[Boone, Kyle Brauer] Alliant Univ, Ctr Forens Studies, Los Angeles, CA USA; [Boone, Kyle Brauer] Los Angeles Biomed Inst, Los Angeles, CA USA		Boone, KB (corresponding author), Alliant Int Univ LA, Ctr Forens Studies, 1000 S Fremont Ave, Alhambra, CA 91803 USA.	kboone@labiomed.org					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Applegate KL, 2005, J PAIN, V6, P92, DOI 10.1016/j.jpain.2004.11.001; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; BARSKY AJ, 1994, AM J PSYCHIAT, V151, P397; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; BARSKY AJ, 1993, AM J PSYCHIAT, V150, P1085; BARSKY AJ, 1992, PSYCHOSOMATICS, V33, P28, DOI 10.1016/S0033-3182(92)72018-0; BARSKY AJ, 1995, J PSYCHOSOM RES, V39, P489, DOI 10.1016/0022-3999(94)00166-3; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boone K. B., 2002, B TEST; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; BOONE KB, 1995, NEUROPSYCHOLOGY, V9, P390, DOI 10.1037/0894-4105.9.3.390; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; CARROLL LJ, 2004, J REHABILITATION MED, V37, P61; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; DEMICK J, 1997, HDB NORMATIVE DATA N; Demopulos C, 1996, PSYCHOSOM MED, V58, P314, DOI 10.1097/00006842-199607000-00003; Diaz-Asper CM, 2004, J INT NEUROPSYCH SOC, V10, P82; Ferguson E, 1998, BRIT J MED PSYCHOL, V71, P281, DOI 10.1111/j.2044-8341.1998.tb00992.x; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Fink P, 2004, AM J PSYCHIAT, V161, P1680, DOI 10.1176/appi.ajp.161.9.1680; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Geisser ME, 2003, PAIN, V102, P243, DOI 10.1016/S0304-3959(02)00417-7; GRAHAM JR, 2000, MMP 2 ASSESSING PERS; Greene R. L, 1991, MMPI 2 MMPI INTERPRE; Greiffenstein M. F., 2000, BRAIN INJ SOURCE, V4, P26; Guze S B, 1993, Ann Clin Psychiatry, V5, P225, DOI 10.3109/10401239309148821; Hadjistavropoulos HD, 2000, BEHAV RES THER, V38, P425, DOI 10.1016/S0005-7967(99)00044-3; Hakala M, 2002, PSYCHOL MED, V32, P1379, DOI 10.1017/S0033291702006578; Hawkins KA, 2001, J INT NEUROPSYCH SOC, V7, P875, DOI 10.1017/S1355617701777119; Hazendonk KM, 2000, NEUROPSY NEUROPSY BE, V13, P112; Hollifield M, 1999, PSYCHOSOMATICS, V40, P387, DOI 10.1016/S0033-3182(99)71203-X; JOHNSON SK, 2007, MED UNEXPLAINED ILLN; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Keeley R, 2000, ARCH FAM MED, V9, P46, DOI 10.1001/archfami.9.1.46; KELLNER R, 1987, J NERV MENT DIS, V175, P20, DOI 10.1097/00005053-198701000-00004; LAMBERTY GJ, 2007, UNDERSTANDING SOMATI; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; Lindberg MA, 2002, J PSYCHOL, V136, P125, DOI 10.1080/00223980209604144; Liu G, 1997, PSYCHOL MED, V27, P617, DOI 10.1017/S0033291797004844; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MACE CJ, 1994, J NERV MENT DIS, V182, P186, DOI 10.1097/00005053-199403000-00012; Mayou R, 2005, AM J PSYCHIAT, V162, P847, DOI 10.1176/appi.ajp.162.5.847; MEALEY L, 1995, BEHAV BRAIN SCI, V18, P523, DOI 10.1017/S0140525X00039595; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nakao M, 2007, NEUROSCI LETT, V415, P185, DOI 10.1016/j.neulet.2007.01.021; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Noyes R, 2005, J NERV MENT DIS, V193, P110, DOI 10.1097/01.nmd.0000152794.87100.92; Noyes R, 2004, J PSYCHOSOM RES, V57, P529, DOI 10.1016/j.jpsychores.2004.05.006; Noyes R, 2002, J NERV MENT DIS, V190, P503, DOI 10.1097/00005053-200208000-00002; Noyes R, 1999, PSYCHOSOMATICS, V40, P461, DOI 10.1016/S0033-3182(99)71183-7; Palmer BW, 1998, ARCH CLIN NEUROPSYCH, V13, P503, DOI 10.1016/S0887-6177(97)00037-1; PENNEBAKER JW, 1994, TOXICOL IND HEALTH, V10, P497; Persing JS, 2000, INT J PSYCHIAT MED, V30, P329, DOI 10.2190/KMXW-T53N-BTDW-GTGH; Rief W, 1998, J ABNORM PSYCHOL, V107, P587, DOI 10.1037/0021-843X.107.4.587; Rodriguez AM, 2005, J PSYCHOSOM RES, V58, P447, DOI 10.1016/j.jpsychores.2004.11.011; Russell EW, 2001, CLIN NEUROPSYCHOL, V15, P423, DOI 10.1076/clin.15.3.423.10267; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SELNES OA, 1991, PERCEPT MOTOR SKILL, V73, P539, DOI 10.2466/PMS.73.5.539-550; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Speckens AEM, 2000, PSYCHOL MED, V30, P841, DOI 10.1017/S0033291799002378; Stone DC, 2006, CLIN NEUROPSYCHOL, V20, P766, DOI 10.1080/13854040500428459; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Taylor S, 2004, TREATING HLTH ANXIET; Tiersky LA, 1997, J CLIN EXP NEUROPSYC, V19, P560, DOI 10.1080/01688639708403744; TRAHAN D, 1987, HDB NORMATIVE DATA N; Waldinger RJ, 2006, PSYCHOSOM MED, V68, P129, DOI 10.1097/01.psy.0000195834.37094.a4; Wearden A, 2003, J PSYCHOSOM RES, V55, P341, DOI 10.1016/S0022-3999(02)00635-9; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; WILLIAMSON DJ, 2007, ASSESSMENT FEIGNED C	77	31	32	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	6					1016	1036	PII 904178676	10.1080/13854040802441135			21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	473BG	WOS:000268178000007	18923966				2022-02-06	
J	Greve, KW; Binder, LM; Bianchini, KJ				Greve, Kevin W.; Binder, Laurence M.; Bianchini, Kevin J.			[image omitted] Rates of Below-Chance Performance in Forced-Choice Symptom Validity Tests	CLINICAL NEUROPSYCHOLOGIST			English	Article						Malingering; Symptom validity test; Below chance	TRAUMATIC BRAIN-INJURY; CLASSIFICATION ACCURACY; HEAD-INJURY	The rates of significantly below-chance results on three neuropsychological symptom validity tests (SVTs) including the Portland Digit Recognition Test (PDRT), Test of Memory Malingering (TOMM), and Word Memory Test (WMT) were compared in a private practice forensic sample of 1032 examinees with alleged mild traumatic brain injury, moderate to severe traumatic brain injury, alleged toxic exposure, and reported chronic pain. The PDRT and WMT were equivalent to one another in the rates of below-chance results, with both yielding more frequent below-chance results than the TOMM. Seemingly more difficult sections of the PDRT and WMT had higher yields than seemingly easier sections. Multiple SVTs were more likely to yield below-chance results than a single test, supporting the use of multiple SVTs in forensic neuropsychological evaluations.	[Greve, Kevin W.; Bianchini, Kevin J.] Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA; [Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA USA; [Binder, Laurence M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2002, DIAGN STAT MAN MENT, V4th; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P141; Bland M., 2000, INTRO MED STAT; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; FRANZEN MD, 1998, CLIN NEUROPSYCHOLOGY, P102; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Green P., 2003, GREENS WORD MEMORY T; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, NEUROTOXICOLOGY, V27, P940, DOI 10.1016/j.neuro.2006.06.009; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; ORD J, 2007, 35 ANN M INT NEUR SO; Reynolds CR, 1998, CRIT ISS NE, P261; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trueblood W, 1997, ARCH CLIN NEUROPSYCH, V12, P13, DOI 10.1016/S0887-6177(96)00027-3; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; [No title captured]	33	31	31	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	3					534	544	PII 908739028	10.1080/13854040802232690			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	423QH	WOS:000264510300011	19221937				2022-02-06	
J	Herrera-Soto, JA; Price, CT				Herrera-Soto, Jose A.; Price, Charles T.			Traumatic Hip Dislocations in Children and Adolescents: Pitfalls and Complications	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS			English	Article							FEMORAL-HEAD; CORE DECOMPRESSION; OPEN-REDUCTION; OSTEONECROSIS; CHILDHOOD; ARTHROGRAPHY; SEPARATION; EPIPHYSIS; FRACTURE; OSTEORADIOLOGY	Traumatic hip dislocation is an uncommon injury in children. Lack of familiarity with management of the treating physician may lead to complications. Hip dislocation in young children can occur with minor trauma; in adolescents, greater force is required to produce a traumatic complete hip dislocation. Transient hip dislocation with spontaneous but incomplete reduction is a diagnostic pitfall that can occur in adolescents. Any asymmetric widening of the hip joint warrants additional investigation. Most dislocations in children can be reduced with gentle manipulation. Urgent reduction of the hip within 6 hours of injury reduces the risk of osteonecrosis. However, closed reduction in adolescents should be performed with caution because of the risk of displacement of the femoral head during manipulation. Open reduction is indicated when closed reduction fails or when there is interposition of bone or soft tissue following attempted closed reduction. Late complications include osteonecrosis, coxa magna, and osteoarthritis.	[Herrera-Soto, Jose A.] Orlando Reg Med Ctr Inc, Pediat Orthopaed Fellowship Program, Orlando, FL 32806 USA		Herrera-Soto, JA (corresponding author), Orlando Reg Med Ctr Inc, Pediat Orthopaed Fellowship Program, 83 W Columbia St, Orlando, FL 32806 USA.						Adili A, 2003, CLIN ORTHOP RELAT R, P93, DOI 10.1097/01.blo.0000096815.78689.3e; AHMADI B, 1983, CLIN ORTHOP RELAT R, P209; Ashman CJ, 2000, AM J ROENTGENOL, V175, P541, DOI 10.2214/ajr.175.2.1750541; Banskota AK, 2007, J PEDIATR ORTHOPED, V27, P187, DOI 10.1097/BPO.0b013e31802c547e; BARQUET A, 1984, ARCH ORTHOP TRAUM SU, V103, P219, DOI 10.1007/BF00435558; BARQUET A, 1980, J TRAUMA, V20, P1003, DOI 10.1097/00005373-198011000-00022; BARQUET A, 1982, ACTA ORTHOP SCAND, V53, P815, DOI 10.3109/17453678208992299; BARQUET A, 1982, ACTA ORTHOP SCAND, V53, P809, DOI 10.3109/17453678208992298; Berbaum KS, 2001, AM J ROENTGENOL, V177, P252, DOI 10.2214/ajr.177.1.1770252c; CANALE ST, 1977, J BONE JOINT SURG AM, V59, P431, DOI 10.2106/00004623-197759040-00001; Cornwall R, 2000, CLIN ORTHOP RELAT R, P84; EPSTEIN HC, 1973, CLIN ORTHOP RELAT R, P116; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; Gent E, 2004, J PEDIATR ORTHOPED, V24, P235, DOI 10.1097/01241398-200403000-00019; GIANOM D, 1994, HELV CHIR ACTA, V60, P623; GLYNN TP, 1989, SKELETAL RADIOL, V18, P29, DOI 10.1007/BF00366768; Grecula MJ, 2005, ORTHOP CLIN N AM, V36, P231, DOI 10.1016/j.ocl.2005.02.005; GUINGAND O, 1985, REV CHIR ORTHOP, V71, P575; Herrera-Soto JA, 2006, J PEDIATR ORTHOPED, V26, P371, DOI 10.1097/01.bpo.0000214925.41056.b9; HOUGAARD K, 1989, ORTHOPEDICS, V12, P375; KLEIN A, 1982, AM J ROENTGENOL, V138, P963, DOI 10.2214/ajr.138.5.963; Kumar S, 2005, CLIN ORTHOP RELAT R, P9, DOI 10.1097/01.blo.0000152366.58660.ea; Kutty S, 2001, PEDIATR EMERG CARE, V17, P32, DOI 10.1097/00006565-200102000-00009; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000150312.53937.6f; MASS DP, 1980, CLIN ORTHOP RELAT R, P184; Mehlman CT, 2000, CLIN ORTHOP RELAT R, P68; Mont MA, 1998, J BONE JOINT SURG BR, V80B, P56, DOI 10.1302/0301-620X.80B1.7989; Mont MA, 2004, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000150128.57777.8e; Mont Michael A, 2006, Instr Course Lect, V55, P167; MOWERY CA, 1986, J PEDIATR ORTHOPED, V6, P7, DOI 10.1097/01241398-198601000-00002; Muratli Hasan Hilmi, 2004, Acta Orthop Traumatol Turc, V38, P149; NOTZLI HP, 1995, J PEDIATR ORTHOPED, V15, P16, DOI 10.1097/01241398-199501000-00004; Odent T, 2003, ACTA ORTHOP SCAND, V74, P49, DOI 10.1080/00016470310013653; OFFIERSKI CM, 1981, J BONE JOINT SURG BR, V63, P194, DOI 10.1302/0301-620X.63B2.7217141; OLSSON O, 1994, ACTA ORTHOP SCAND, V65, P476, DOI 10.3109/17453679408995496; Price CT, 2002, J ORTHOP TRAUMA, V16, P730, DOI 10.1097/00005131-200211000-00008; Ratliff A H, 1968, J Bone Joint Surg Br, V50, P757; Roberts C S, 1990, J Arthroplasty, V5, P89, DOI 10.1016/S0883-5403(06)80015-X; Rubinstein Richard A. Jr., 1993, Contemporary Orthopaedics, V27, P527; Salisbury RD, 2000, CLIN ORTHOP RELAT R, P106; SCHLONSKY J, 1973, J BONE JOINT SURG AM, VA 55, P1057, DOI 10.2106/00004623-197355050-00015; Schoenecker P L, 1997, Am J Orthop (Belle Mead NJ), V26, P257; *SCI RES COMM PENN, 1968, J BONE JOINT SURG AM, V50, P79; SCUDERI G, 1987, CLIN ORTHOP RELAT R, P179; SLAVIK M, 1986, ARCH ORTHOP TRAUM SU, V104, P385, DOI 10.1007/BF00454438; Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71; Tavares JO, 1998, J PEDIATR ORTHOPED, V18, P651, DOI 10.1097/00004694-199809000-00019; Trousdale R T, 1997, Am J Orthop (Belle Mead NJ), V26, P76; TROUSDALE RT, 1997, AM J ORTHOPSYCHIAT, V26, P76; Urbaniak J R, 1998, J Am Acad Orthop Surg, V6, P44; Vialle R, 2005, J PEDIATR ORTHOPED, V25, P138, DOI 10.1097/01.bpo.0000151059.85227.ea; Vialle R, 2004, PEDIATR RADIOL, V34, P970, DOI 10.1007/s00247-004-1299-0; VONTOBEL BJ, 1994, ARCH ORTHOP TRAUM SU, V113, P83, DOI 10.1007/BF00572911; WEDGE JH, 1987, CLIN ORTHOP RELAT R, P93; WILCHINSKY ME, 1985, J PEDIATR ORTHOPED, V5, P534, DOI 10.1097/01241398-198509000-00005; YANG RS, 1991, CLIN ORTHOP RELAT R, P218	56	31	36	0	2	AMER ACAD ORTHOPAEDIC SURGEONS	ROSEMENT	6300 N RIVER ROAD, ROSEMENT, IL 60018-4262 USA	1067-151X			J AM ACAD ORTHOP SUR	J. Am. Acad. Orthop. Surg.	JAN	2009	17	1					15	21		10.5435/00124635-200901000-00003			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Surgery	390UL	WOS:000262189100004	19136423				2022-02-06	
J	Holbein, M; Bechir, M; Ludwig, S; Sommerfeld, J; Cottini, SR; Keel, M; Stocker, R; Stover, JF				Holbein, Monika; Bechir, Markus; Ludwig, Silke; Sommerfeld, Jutta; Cottini, Silvia R.; Keel, Marius; Stocker, Reto; Stover, John F.			Differential influence of arterial blood glucose on cerebral metabolism following severe traumatic brain injury	CRITICAL CARE			English	Article							INTENSIVE INSULIN THERAPY; CORTICAL SPREADING DEPRESSION; PERIINFARCT DEPOLARIZATIONS; OXYGEN-METABOLISM; JUGULAR BULB; LACTATE/PYRUVATE RATIO; ENERGETIC IMPAIRMENT; LACTATE LEVELS; HEAD-INJURY; HYPERGLYCEMIA	Introduction Maintaining arterial blood glucose within tight limits is beneficial in critically ill patients. Upper and lower limits of detrimental blood glucose levels must be determined. Methods In 69 patients with severe traumatic brain injury (TBI), cerebral metabolism was monitored by assessing changes in arterial and jugular venous blood at normocarbia (partial arterial pressure of carbon dioxide (paCO(2)) 4.4 to 5.6 kPa), normoxia (partial arterial pressure of oxygen (paO(2)) 9 to 20 kPa), stable haematocrit (27 to 36%), brain temperature 35 to 38 C, and cerebral perfusion pressure (CPP) 70 to 90 mmHg. This resulted in a total of 43,896 values for glucose uptake, lactate release, oxygen extraction ratio (OER), carbon dioxide (CO2) and bicarbonate (HCO3) production, jugular venous oxygen saturation (SjvO(2)), oxygen-glucose index (OGI), lactate-glucose index (LGI) and lactate-oxygen index (LOI). Arterial blood glucose concentration-dependent influence was determined retrospectively by assessing changes in these parameters within pre-defined blood glucose clusters, ranging from less than 4 to more than 9 mmol/l. Results Arterial blood glucose significantly influenced signs of cerebral metabolism reflected by increased cerebral glucose uptake, decreased cerebral lactate production, reduced oxygen consumption, negative LGI and decreased cerebral CO2/HCO3 production at arterial blood glucose levels above 6 to 7 mmol/l compared with lower arterial blood glucose concentrations. At blood glucose levels more than 8 mmol/l signs of increased anaerobic glycolysis (OGI less than 6) supervened. Conclusions Maintaining arterial blood glucose levels between 6 and 8 mmol/l appears superior compared with lower and higher blood glucose concentrations in terms of stabilised cerebral metabolism. It appears that arterial blood glucose values below 6 and above 8 mmol/l should be avoided. Prospective analysis is required to determine the optimal arterial blood glucose target in patients suffering from severe TBI.	[Holbein, Monika; Keel, Marius] Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland		Holbein, M (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Dept Surg, Raemistr 100, CH-8091 Zurich, Switzerland.	monika.holbein@access.unizh.ch; john.stover@access.unizh.ch			Swiss National Research Foundation (SNF)Swiss National Science Foundation (SNSF)	The help of the nursing staff in collecting clinical data is gratefully acknowledged. This study was supported in parts by a grant from the Swiss National Research Foundation (SNF) to JFS and the SUVA Fonds to JFS and RS.	Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Barros LF, 2007, GLIA, V55, P1222, DOI 10.1002/glia.20375; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Beards SC, 1998, ANAESTHESIA, V53, P627; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Caesar K, 2008, J PHYSIOL-LONDON, V586, P1337, DOI 10.1113/jphysiol.2007.144154; Chesler M, 2005, GLIA, V50, P398, DOI 10.1002/glia.20141; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Chieregato A, 2007, J NEUROSURG ANESTH, V19, P222, DOI 10.1097/ANA.0b013e31806589f6; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; Gur RC, 2009, CEREB CORTEX, V19, P375, DOI 10.1093/cercor/bhn087; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hatazawa J, 1995, Ann Nucl Med, V9, P15; Hattori N, 2004, J NUCL MED, V45, P775; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Laitio RM, 2009, ANESTH ANALG, V108, P593, DOI 10.1213/ane.0b013e31818ffc9d; Leegsma-Vogt G, 2001, J NEUROSCI RES, V66, P795, DOI 10.1002/jnr.10046; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; McGoron Anthony J, 2008, BMC Med Imaging, V8, P4, DOI 10.1186/1471-2342-8-4; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; Moller K, 2002, ACTA ANAESTH SCAND, V46, P567, DOI 10.1034/j.1399-6576.2002.460515.x; Moritz S, 2008, J NEUROSURG ANESTH, V20, P8, DOI 10.1097/ANA.0b013e31814b1459; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Otori T, 2004, J NEUROTRAUM, V21, P707, DOI 10.1089/0897715041269623; Oz G, 2007, AM J PHYSIOL-ENDOC M, V292, pE946, DOI 10.1152/ajpendo.00424.2006; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Parsons MW, 2002, ANN NEUROL, V52, P20, DOI 10.1002/ana.10241; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Shulman RG, 2001, NMR BIOMED, V14, P389, DOI 10.1002/nbm.741; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; Strauss GI, 2003, LIVER TRANSPLANT, V9, P1244, DOI 10.1016/j.lts.2003.09.020; Strong AJ, 2000, STROKE, V31, P214, DOI 10.1161/01.STR.31.1.214; Strong AJ, 2007, CURR OPIN CRIT CARE, V13, P126, DOI 10.1097/MCC.0b013e32807faffb; Thomale UW, 2007, NEUROL RES, V29, P594, DOI 10.1179/016164107X166272; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	62	31	36	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2009	13	1							R13	10.1186/cc7711			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421IC	WOS:000264351600013	19196488	Green Accepted, gold, Green Published			2022-02-06	
J	Jorgensen, M; Togher, L				Jorgensen, Mikaela; Togher, Leanne			Narrative after traumatic brain injury: A comparison of monologic and jointly-produced discourse	BRAIN INJURY			English	Article						Traumatic brain injury; communication; discourse; narrative; jointly-produced; participation; friends	CLOSED-HEAD-INJURY; COMMUNICATION PARTNERS; PEOPLE; CONVERSATION; INDIVIDUALS; VALIDATION; ABILITIES; CHILDREN; QUALITY; APHASIA	Primary objective: To investigate the effects of a familiar communication partner on the production of narrative after traumatic brain injury (TBI). Method: Ten participants with TBI were matched with 10 control participants for sex, age, and education. Participants independently retold a story from a picture sequence and also retold a video segment with a friend to a researcher. The resulting discourse was analyzed for productivity, cohesion, story grammar, informational content and exchange structure. Results: There was a significant difference between participants with and without TBI for all measures in the monologic narrative. In the jointly-produced narrative, there was no significant difference in performance and participation between individuals with TBI and control participants. Participants with TBI demonstrated a significant improvement between the monologic and the jointly-produced task in story grammar and informational content. Conclusions: The natural scaffolding provided by the friends of participants with TBI in a meaningful narrative task facilitated competent participation in and production of narrative. These findings indicate an avenue for training everyday communication partners in supporting narrative skills after TBI, and for the use of jointly-produced narrative as an additional assessment tool to create a holistic view of everyday skills.	[Jorgensen, Mikaela; Togher, Leanne] Univ Sydney, Speech Pathol, Fac Hlth Sci, Sydney, NSW, Australia; [Jorgensen, Mikaela; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia		Jorgensen, M (corresponding author), Univ Sydney, Fac Hlth Sci, 75 E St,POB 170, Lidcombe, NSW 2141, Australia.	mikaela.jorgensen@gmail.com	Togher, Leanne/AAC-7083-2019; Jorgensen, Mikaela/A-2095-2016	Jorgensen, Mikaela/0000-0002-5490-0819; Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; BERRY M, 1981, STUDIES DISCOURSE AN, P120; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Body R, 1998, BRAIN INJURY, V12, P963, DOI 10.1080/026990598122016; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Chapey R, 2001, LANGUAGE INTERVENTIO; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Cherney L., 1993, CLIN APHASIOLOGY, V21, P123; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Eggins S., 1997, ANAL CASUAL CONVERSA; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; FERGUSON A, 1999, TEST LANGUAGE USE RE; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Halliday M., 2004, INTRO FUNCTIONAL GRA; Halliday M. K., 1976, COHESION ENGLISH; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hengst JA, 2005, J SPEECH LANG HEAR R, V48, P137, DOI 10.1044/1092-4388(2005/011); Hughes DL., 1997, GUIDE NARRATIVE LANG; JENNETT B, 1977, INTRO NEUROSURGERY; Johnston MV, 2006, BRAIN INJURY, V20, P391, DOI 10.1080/02699050500487795; Kertesz A., 1982, W APHASIA BATTERY; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kilov AM, 2009, APHASIOLOGY, V23, P584, DOI 10.1080/02687030701855382; *LANG AN LAB, 2002, SALT WIND STAND VERS; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LOBAN W, 2005, J SPEECH LANG HEAR R, V48, P1048; Lock S, 2001, INT J LANG COMM DIS, V36, P25, DOI 10.3109/13682820109177853; Murphy K.R., 2005, PSYCHOL TESTING PRIN, V6th Edn; NORRICK NR, 2000, CONVERSATIONAL NARRA; Nye CH, 1998, CLIN SOC WORK J, V26, P271, DOI 10.1023/A:1022820027167; Olness GS, 2005, APHASIOLOGY, V19, P251, DOI 10.1080/02687030444000723; Peterson C., 1983, DEV PSYCHOLINGUISTIC; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Quasthoff Uta, 2005, NARRATIVE INTERACTIO; Rayner H, 2003, INT J LANG COMM DIS, V38, P149, DOI 10.1080/1368282021000060308; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; *SPSS, 2005, SPSS VERS 14 0 WIND; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 2006, BRAIN IMPAIR, V7, P190, DOI DOI 10.1375/brim.7.3.190; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]; Ulatowska Hanna K., 2007, Seminars in Speech and Language, V28, P148, DOI 10.1055/s-2007-970572; VENTOLA E, 1996, SIGNS WORK SEMIOSIS; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303; [No title captured]	62	31	32	3	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	9					727	740	PII 913448130	10.1080/02699050903133954			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	475UR	WOS:000268387600004	19636998	Green Submitted			2022-02-06	
J	Eickhoff, SB; Dafotakis, M; Grefkes, C; Stoecker, T; Shah, NJ; Schnitzler, A; Zilles, K; Siebler, M				Eickhoff, S. B.; Dafotakis, M.; Grefkes, C.; Stoecker, T.; Shah, N. J.; Schnitzler, A.; Zilles, K.; Siebler, M.			fMRI reveals cognitive and emotional processing in a long-term comatose patient	EXPERIMENTAL NEUROLOGY			English	Article						Trauma; Language; Emotion; Persistent vegetative state; Minimally conscious state	MINIMALLY CONSCIOUS STATE; VEGETATIVE STATE; BRAIN-FUNCTION; VISUAL-CORTEX; COMPREHENSION; POTENTIALS; DISORDERS; AWARENESS; PROPOFOL; RECOVERY	We report on a 41-year old woman with prolonged comatose unresponsiveness following traumatic head injury. Structural MRI showed bilateral midbrain damage and ventriculomegalia. Functional MRI revealed robust cortical responses to visual, auditory and tactile stimulation. Speech stimuli moreover consistently elicited activation in Broca's and Wernicke's areas. Familiar speakers and direct addressing evoked significantly stronger amygdala activation than unfamiliar speakers and neutral phrases. This study hence demonstrates the potential of functional neuroimaging in the investigation of residual higher cortical functions in unresponsive comatose patients. (C) 2008 Elsevier Inc. All rights reserved.	[Eickhoff, S. B.; Dafotakis, M.; Stoecker, T.; Shah, N. J.; Zilles, K.] Forschungszentrum Julich, Inst Neurowissensch & Biophys Med INB 3, D-52425 Julich, Germany; [Grefkes, C.] Max Planck Inst Neurol Res, Cologne, Germany; [Zilles, K.] Univ Dusseldorf, C&O Vogt Inst Brain Res, Dusseldorf, Germany; [Shah, N. J.; Zilles, K.] Brain Imaging Ctr W BICW, Julich, Germany; [Schnitzler, A.] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-4000 Dusseldorf, Germany; [Schnitzler, A.] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany; [Zilles, K.] JARA Translat Brain Med, Julich, Germany; [Grefkes, C.] Univ Cologne, Dept Neurol, D-5000 Cologne 41, Germany		Eickhoff, SB (corresponding author), Forschungszentrum Julich, Inst Med IME, Postfach 1913, D-52425 Julich, Germany.	S.Eickhoff@fz-juelich.de	Eickhoff, Simon B./K-2061-2013; Shah, N. Jon/H-5849-2013; Schnitzler, Alfons/AAT-1054-2021; Zilles, Karl/J-9704-2013; Zilles, Karl/Y-3784-2019; Grefkes, Christian/H-3972-2013; Schnitzler, Alfons/Q-5520-2019	Eickhoff, Simon B./0000-0001-6363-2759; Shah, N. Jon/0000-0002-8151-6169; Zilles, Karl/0000-0001-9296-9959; Zilles, Karl/0000-0002-4705-4175; Grefkes, Christian/0000-0002-1656-720X; Schnitzler, Alfons/0000-0002-6414-7939; Dafotakis, Manuel/0000-0002-9680-7436	NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [KFO-112]; VolkswagenstiftungVolkswagen	This Human Brain Project/Neuroinformatics research was funded by the NIBIB, NINDS and NIMH. K.Z. acknowledges funding by the Deutsche Forschungsgemeinschaft (KFO-112) and the Volkswagenstiftung.	Bekinschtein T, 2005, NEUROPSYCHOL REHABIL, V15, P307, DOI 10.1080/09602010443000443; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Crinion J, 2005, BRAIN, V128, P2858, DOI 10.1093/brain/awh659; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, CEREB CORTEX, V17, P1800, DOI 10.1093/cercor/bhl090; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; HAYASHI T, 1999, MAPPING SOMATOSENSOR, P4451; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Heinke W, 2004, BRIT J ANAESTH, V92, P641, DOI 10.1093/bja/aeh133; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Laureys S, 2004, ADV EXP MED BIOL, V550, P229; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2002, NEUROCASE, V8, P394, DOI 10.1076/neur.8.4.394.16184; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	24	31	33	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2008	214	2					240	246		10.1016/j.expneurol.2008.08.007			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	380RW	WOS:000261483900010	18789930				2022-02-06	
J	Keenan, HT; Hall, GC; Marshall, SW				Keenan, Heather T.; Hall, Gillian C.; Marshall, Stephen W.			Early head injury and attention-deficit/hyperactivity disorder: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; DEFICIT-HYPERACTIVITY DISORDER; CHILDREN; SYMPTOMS; ILLNESS	Objective To explore the hypothesis that medically attended head injury in young children may be causal in the later development of attention- deficit/ hyperactivity disorder. Design Retrospective cohort study. Setting Health improvement network database ( 1988-2003), a longitudinal UK general practice dataset. Participants All children registered in the database from birth until their 10th birthday. Main outcome measures Risk of a child with a head injury before age 2 developing attention- deficit/ hyperactivity disorder before age 10 compared with children with a burn injury before age 2 and children with neither a burn nor a head injury. Results Of the 62 088 children who comprised the cohort, 2782 ( 4.5%) had a head injury and 1116 ( 1.8%) had a burn injury. The risk of diagnosis of attention- deficit/ hyperactivity disorder before 10 years of age after adjustment for sex, prematurity, socioeconomic status, and practice identification number was similar in the head injury ( relative risk 1.9, 95% confidence interval 1.5 to 2.5) and burn injury groups ( 1.7, 1.2 to 2.5) compared with all other children. Discussion Medically attended head injury before 2 years of age does not seem to be causal in the development of attention- deficit/ hyperactivity disorder. Medically attended injury before 2 years of age may be a marker for subsequent diagnosis of attention- deficit/ hyperactivity disorder.	[Keenan, Heather T.] Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27699 USA		Keenan, HT (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu		Marshall, Stephen/0000-0002-2664-9233			Bourke Alison, 2004, Inform Prim Care, V12, P171; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Huff N, 1999, J PUBLIC HEALTH MED, V21, P81, DOI 10.1093/pubmed/21.1.81; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	14	31	31	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2008	337								a1984	10.1136/bmj.a1984			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377FC	WOS:000261236100001	18988644	Green Published, hybrid			2022-02-06	
J	Dreer, LE; DeVivo, MJ; Novack, TA; Krzywanski, S; Marson, DC				Dreer, Laura E.; DeVivo, Michael J.; Novack, Thonias A.; Krzywanski, Sara; Marson, Daniel C.			Cognitive Predictors of Medical Decision-Making Capacity in Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						medical decision-making capacity; competency; traumatic brain injury; neurocognitive functioning	CLOSED-HEAD-INJURY; WORKING-MEMORY; ALZHEIMERS-DISEASE; COMPETENCE; CONSENT; IMPAIRMENT; RECOVERY; MODERATE; MODELS; STATE	Objective: To identify cognitive predictors of medical decision-making capacity (MDC) in participants with moderate to severe traumatic brain injury (TBI). Participants: At baseline, participants were 34 adults with TBI and 20 healthy adults. At 6-month follow-up, participants were 24 adults with TBI and 20 healthy adults. Main Outcome Measures: Participants were administered the Capacity to Consent to Treatment Instrument (CCTI) and neuropsychological test measures. Multivariate cognitive predictor models were developed for CCTI consent abilities/standards (S) of understanding (S5); reasoning (S4); and appreciation (S3). Results: At baseline, short-term verbal memory and semantic fluency predicted TBI group performance on understanding (S5): short-term verbal memory and attention predicted performance on reasoning (S4); and working memory predicted performance on appreciation (S3). At 6 month follow-up, executive function, verbal processing speed, and working memory predicted TBI performance on understanding (S5); working memory and short-term memory predicted reasoning (S4); and basic executive functioning predicted appreciation (S3). Conclusions: Multiple cognitive functions are associated with acute impairment and partial recovery of MDC in patients with TBI. Short-term verbal memory predicted consent capacity of TBI participants at the time of acute inpatient hospitalization, while executive functioning and working memory predicted improved capacity at six-month follow-up.	[Krzywanski, Sara; Marson, Daniel C.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35233 USA; [Dreer, Laura E.] Univ Alabama, Dept Ophthalmol, Tuscaloosa, AL 35487 USA; [DeVivo, Michael J.; Novack, Thonias A.] Univ Alabama, Dept Phys Med & Rehabil, Tuscaloosa, AL 35487 USA; [Krzywanski, Sara; Marson, Daniel C.] Univ Alabama, Alzheimers Dis Res Ctr, Tuscaloosa, AL 35487 USA		Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, Room JT1216, Birmingham, AL 35233 USA.	dmarson@uab.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007420, R01HD053074] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23EY017327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021927, P50AG016582, U01AG010483] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23 EY017327] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG021927, P50 AG016582-07, P50 AG016582, U01 AG010483, R01 AG021927-04] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD053074, T32 HD007420, R01 HD053074-01A1] Funding Source: Medline		Benton A.L., 1983, CONTRIBUTIONS NEUROP; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bontke CF, 1994, J HEAD TRAUMA REHAB, V9, P62; *CDCP, 1997, MMWR-MORBID MORTAL W, V48, P8; Childs NL, 1997, J HEAD TRAUMA REHAB, V12, P70, DOI 10.1097/00001199-199708000-00007; Cope D. N., 1989, J HEAD TRAUMA REHAB, V4, P13; Dymek MP, 2001, NEUROLOGY, V56, P17, DOI 10.1212/WNL.56.1.17; Dymek MP, 1999, J FORENSIC NEUROPSYC, V1, P27, DOI DOI 10.1300/J151V01N01_; Earnst KS, 2000, J AM GERIATR SOC, V48, P919, DOI 10.1111/j.1532-5415.2000.tb06888.x; FITTEN LJ, 1990, ARCH INTERN MED, V150, P1717, DOI 10.1001/archinte.150.8.1717; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Griffith HR, 2005, NEUROLOGY, V65, P483, DOI 10.1212/01.wnl.0000171346.02965.80; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P149, DOI 10.1007/BF01499323; GRISSO T, 1986, EVALUATING COMPETENC; Hamsher K., 1989, MULTILINGUAL APHASIA; HANNAY D, 2004, NEUROPSYCHOLOGICAL A, P158; Heaton RK, 1991, COMPREHENSIVE NORMS; Hillier SL, 1997, BRAIN INJURY, V11, P661; Jacobs ML, 2008, ARCH CLIN NEUROPSYCH, V23, P113, DOI 10.1016/j.acn.2007.09.003; Jennett B, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199708000-00003; KAPP M, 1992, GERIATRICS LAW PATIE; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Leon-Carrion J, 1998, INT J NEUROSCI, V94, P75, DOI 10.3109/00207459808986440; Levin H, 1979, J NERV MENT DIS, V20, P694; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Marsh D., 2001, AERU Discussion Paper, P1; MARSH OC, 1896, AM J SCI, V2, P59; MARSON D, 2001, 21 ANN C NAT AC NEUR; Marson DC, 2001, AGING NEUROPSYCHOL C, V8, P164, DOI 10.1076/anec.8.3.164.827; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; MARSON DC, 1994, ALZ DIS ASSOC DIS, V8, P5, DOI 10.1097/00002093-199424003-00002; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P955, DOI 10.1001/archneur.1995.00540340035011; Marson DC, 1996, NEUROLOGY, V46, P666, DOI 10.1212/WNL.46.3.666; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; Moye J, 2006, J GEN INTERN MED, V21, P78, DOI 10.1111/j.1525-1497.2005.00288.x; Mukherjee D, 2006, TOP STROKE REHABIL, V13, P75, DOI 10.1310/2M1U-71FQ-QV33-56PX; Okonkwo OC, 2008, J INT NEUROPSYCH SOC, V14, P297, DOI 10.1017/S1355617708080338; Phipps EJ, 1998, J HEAD TRAUMA REHAB, V13, P95, DOI 10.1097/00001199-199810000-00012; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Proctor A, 2000, BRAIN INJURY, V14, P633; Rao S., 1990, MANUAL BRIEF REPEATA; Reid-Proctor GM, 2001, BRAIN INJURY, V15, P377, DOI 10.1080/02699050010005977; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; ROTH LH, 1977, AM J PSYCHIAT, V134, P279; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Simon Robert I., 1994, P569; SMITH A, 1982, SYMBOL DIGIT METALIT; Taylor E., 1959, PSYCHOL APPRAISAL CH; TEASDALE G, 1974, LANCET, V2, P81; TEPPER AM, 1984, LAW HUMAN BEHAV, V8, P205, DOI 10.1007/BF01044693; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; WECHLSER D, 1997, MANUAL WECHSLER ADUL; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, MANUAL WECHSLER MEMO; Wolfson, 1993, HALSTEAD REITAN NEUR; Wong JG, 1999, PSYCHOL MED, V29, P437, DOI 10.1017/S0033291798008113; WONG TM, 1998, AVOIDING ETHICAL MIS, P187; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	65	31	31	0	7	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2008	53	4					486	497		10.1037/a0013798			12	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	381ER	WOS:000261518900008	20686627	Green Accepted, Green Published			2022-02-06	
J	Falcone, RA; Martin, C; Brown, RL; Garcia, VF				Falcone, Richard A., Jr.; Martin, Colin; Brown, Rebeccah L.; Garcia, Victor F.			Despite overall low pediatric head injury mortality, disparities exist between races	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	59th Annual Meeting of the American-Academy-of-Pediatrics	OCT 27-30, 2007	San Francisco, CA	Amer Acad Pediat		Racial disparities; Pediatric traumatic brain injury; Mortality	TRAUMATIC BRAIN-INJURY; HEALTH DISPARITIES; RACIAL DISPARITIES; UNITED-STATES; CHILDREN; CARE; OUTCOMES; SEVERITY; QUALITY; ABUSE	Background: To continually improve quality of care, it is important for centers caring for children with head injury to evaluate their overall outcome and that among diverse patient groups. Methods: Data on children with head injuries were extracted from the National Trauma Data Bank of the American College of Surgeons and our local trauma registry. Unadjusted mortality, as well as stratified analysis and logistic regression modeling, was used to evaluate overall and race-specific mortality. Results: There were 13,363 children in the National Trauma Data Base and 3111 in our database included. Our overall mortality rate compared favorably with the national data (3.2% vs 6.8%, P < .05). Our local data, however, showed a significant difference in mortality between white and African American (AA) children (2.2% vs 5.3%, P < .05), which was not identified in the national data. After stratification, the disparities by race persisted. Finally, multivariate regression modeling revealed that AA race was an independent predictor of mortality among our patient population, with an odds ratio of 3.1 (95% confidence interval, 1.2-7.8). Conclusion: Despite excellent outcomes for children with head injuries, we have uncovered unsettling inequities between AA and white children. These findings support the need to evaluate outcomes among specific groups to identify disparities that require further careful investigation. (C) 2008 Elsevier Inc. All rights reserved.	[Falcone, Richard A., Jr.; Martin, Colin; Brown, Rebeccah L.; Garcia, Victor F.] Univ Cincinnati, Coll Med, Div Pediat & Thorac Surg, Dept Surg,Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45229 USA		Falcone, RA (corresponding author), Univ Cincinnati, Coll Med, Div Pediat & Thorac Surg, Dept Surg,Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45229 USA.	richard.falcone@cchmc.org	Martin, COlin/AAU-6821-2021				Al West T, 2000, J TRAUMA, V49, P530, DOI 10.1097/00005373-200009000-00022; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Burd R, 2006, J PEDIATR SURG, V41, P97; Burd RS, 2006, J TRAUMA, V60, P792, DOI 10.1097/01.ta.0000214589.02515.dd; Cuff S, 2007, J TRAUMA, V63, P172, DOI 10.1097/TA.0b013e31805c14b1; Densmore JC, 2006, J PEDIATR SURG, V41, P92, DOI 10.1016/j.jpedsurg.2005.10.013; Epstein AM, 2003, MED CARE, V41, P1240, DOI 10.1097/01.MLR.0000093423.38746.8C; Falcone Jr RA, 2007, J PEDIATR SURG, V42, P6; FALCONE JRRA, 2007, J PEDIATR SURG, V42, P6; Falcone RA, 2007, J PEDIATR SURG, V42, P1031, DOI 10.1016/j.jpedsurg.2007.01.038; Falcone RA, 2007, J PEDIATR SURG, V42, P172, DOI 10.1016/j.jpedsurg.2006.09.015; Gonzalez PC, 2003, PEDIATR CARDIOL, V24, P103, DOI 10.1007/s00246-002-0244-y; GREEN AR, 2007, J GEN INTERN MED; Hagendorf BA, 2007, ANN SURG, V245, P118, DOI 10.1097/01.sla.0000242715.66878.f8; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hannan EL, 2000, J PEDIATR SURG, V35, P155, DOI 10.1016/S0022-3468(00)90001-0; HOWARD I, 2005, ETHN DIS S5, V15; Joseph L, 2004, J CLIN EPIDEMIOL, V57, P147, DOI 10.1016/j.jclinepi.2003.08.002; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kilbourne AM, 2006, AM J PUBLIC HEALTH, V96, P2113, DOI 10.2105/AJPH.2005.077628; Kokoska ER, 2007, J SURG RES, V137, P83, DOI 10.1016/j.jss.2006.06.020; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P194, DOI 10.2105/AJPH.93.2.194; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Malat J, 2006, HEALTH-LONDON, V10, P303, DOI 10.1177/1363459306064486; Mangione-Smith R, 1998, HEALTH SERV RES, V33, P1059; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Milazzo AS, 2002, J NATL MED ASSOC, V94, P875; Omoloja A, 2006, J NATL MED ASSOC, V98, P154; Ponsky TA, 2004, JAMA-J AM MED ASSOC, V292, P1977, DOI 10.1001/jama.292.16.1977; Randall TC, 2003, J CLIN ONCOL, V21, P4200, DOI 10.1200/JCO.2003.01.218; Rowell KS, 2007, J AM COLL SURGEONS, V204, P1293, DOI 10.1016/j.jamcollsurg.2007.03.024; Runy Lee Ann, 2006, Hosp Health Netw, V80, P48; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Services USDoHaH, 2000, HLTH PEOPL 2010 UND; Skinner J, 2003, NEW ENGL J MED, V349, P1350, DOI 10.1056/NEJMsa021569; Smedley BD, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Stallion A, 2007, J TRAUMA, V62, P1262; Stylianos S, 2006, J AM COLL SURGEONS, V202, P247, DOI 10.1016/j.jamcollsurg.2005.10.012; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; *TRAUM ACOS CO, 2005, NAT TRAUM DAT BANK R; van Ryn M, 2002, MED CARE, V40, P140; WEST TA, 2000, J TRAUMA, V49, P40	48	31	31	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	OCT	2008	43	10					1858	1864		10.1016/j.jpedsurg.2008.01.058			7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Surgery	364TX	WOS:000260359300017	18926221				2022-02-06	
J	Mowery, NT; Norris, PR; Riordan, W; Jenkins, JM; Williams, AE; Morris, JA				Mowery, Nathan Teague; Norris, Patrick R.; Riordan, William; Jenkins, Judith M.; Williams, Anna E.; Morris, John A., Jr.			Cardiac uncoupling and heart rate variability are associated with intracranial hypertension and mortality: A study of 145 trauma patients with continuous monitoring	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	65th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 28-30, 2006	New Orleans, LA	Amer Assoc Surg Trauma		heart rate variability (HRV); cardiac uncoupling; closed head injury; intracranial pressure; traumatic brain injury	SYSTEMS; DEATH	Background: A noninvasive tool reflecting intracranial hypertension (ICH) should prompt early invasive monitoring and reduce secondary injury after traumatic brain injury. We hypothesized that integer heart rate variability (HRV) may be associated with rises in intracranial pressure (ICP); changes in HRV may precede changes in ICP; and both increases in ICP and cardiac uncoupling (low HRV) predict mortality. Methods: Of 14,330 consecutive trauma admissions, 291 of these patients had an injury requiring intracranial monitoring. Of these patients 145 had simultaneous HRV and ICP monitoring with a Camino monitor. ICP and heart rate (HR) data were matched and divided into 5-minute intervals (N = 117,956, representing 24.4 million HR and ICP data points). In each interval, the median ICP, and SD of HR (HRSD5) were calculated. Cardiac uncoupling was defined as an interval with HRSD5 between 0.3 bpm and 0.6 bpm. Cardiac uncoupling was compared between ICP categories using the Wilcoxon Rank-Sum test, and logistic regression was used to assess the continuous relationship between ICP and risk of uncoupling. Results: Cardiac uncoupling increases as ICP increases (p < 0.001). Uncoupling nearly doubles when comparing acceptable ICP (<20mm Hg, 11% uncoupled) to ICH (31-50 mm Hg, 18% uncoupled), with uncoupling = 13% in the intermediate group (ICP 21-30 mm Hg). This trend continues at the level of malignant ICH (>50 mm Hg, 22% uncoupled). Conclusion: Cardiac uncoupling increases as ICP increases. Both cardiac uncoupling and ICH predict mortality. Cardiac uncoupling may precede ICH but is not yet an indication for invasive monitoring.	[Mowery, Nathan Teague; Norris, Patrick R.; Riordan, William; Jenkins, Judith M.; Williams, Anna E.; Morris, John A., Jr.] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA		Morris, JA (corresponding author), 404 Med Arts Bldg,1211 21st Ave S, Nashville, TN 37212 USA.	john.morris@vanderbilt.edu	Doucet, Jay J/O-3005-2018; Pockley, Alan G/I-4704-2015; Doucet, Jay/Y-7951-2019	Doucet, Jay J/0000-0001-9617-001X; Pockley, Alan G/0000-0001-9593-6431; Doucet, Jay/0000-0001-9617-001X			Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Bunten DC, 1998, CLIN AUTON RES, V8, P329, DOI 10.1007/BF02309623; Camm AJ, 1996, CIRCULATION, V93, P1043; Grogan EL, 2005, J TRAUMA, V58, P7, DOI 10.1097/01.TA.0000151179.74839.98; Grogan EL, 2004, ANN SURG, V240, P547, DOI 10.1097/01.sla.0000137143.65540.9c; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Morris JA, 2007, J AM COLL SURGEONS, V204, P885, DOI 10.1016/j.jamcollsurg.2007.01.019; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Norris PR, 2001, J AM MED INFORM ASSN, P498; Norris PR, 1997, J AM MED INFORM ASSN, P794; Riordan WP, 2006, CRIT CARE MED, V34, pA10, DOI 10.1097/00003246-200612002-00040; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010; [No title captured]	16	31	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2008	65	3					621	626		10.1097/TA.0b013e3181837980			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	350BC	WOS:000259326400023	18784576				2022-02-06	
J	Shuttleworth-Rdwards, AB; Radloff, SE				Shuttleworth-Rdwards, Ann B.; Radloff, Sarah E.			Compromised visuomotor processing speed in players of Rugby Union from school through to the national adult level	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						sports concussion; processing speed; rugby; MTBI	TRAUMATIC BRAIN-INJURY; FOOTBALL SOCCER; NEUROPSYCHOLOGICAL IMPAIRMENT; CONCUSSION; PERFORMANCE	The aim of this study was to investigate the residual effects of concussion amongst players of Rugby Union from school through to the national adult level, with pre-season testing on tests of visuomotor processing speed (Digit Symbol; Trail Making Test A and B). Comparison groups included 124 male rugby players versus 102 non-contact sport controls; 71 forward versus 53 backline players. Across groups there was equivalence for age, education, estimated IQ, and hand motor dexterity. There was a significantly higher percentage of rugby players with 2+ concussions than controls. Poorer performance was in evidence for rugby players compared with controls on all tests of visuomotor speed, and for forward versus backline players on Digit Symbol, with clinically relevant medium effect sizes. The results implicate Vulnerability amongst rugby players on the prototypically sensitive function of visuomotor processing in association with years of exposure to repetitive concussive and subconcussive injury. (C) 2008 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Shuttleworth-Rdwards, Ann B.] Rhodes Univ, Dept Psychol, ZA-6140 Grahamstown, South Africa; [Radloff, Sarah E.] Rhodes Univ, Dept Stat, ZA-6140 Grahamstown, South Africa		Shuttleworth-Rdwards, AB (corresponding author), Rhodes Univ, Dept Psychol, ZA-6140 Grahamstown, South Africa.	a.edwards@ru.ac.za					Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/0013164401614002; Cumming G, 2001, EXPLORATORY SOFTWARE; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; DELATORRE JC, 2002, STROKE, V33, P1; Demakis GJ, 2006, CLIN NEUROPSYCHOL, V20, P10, DOI 10.1080/13854040500203282; DENCKLA MB, 1973, DEV MED CHILD NEUROL, V15, P635; Farace E, 2003, J INT NEUROPSYCH SOC, V9, P207; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1997, NEUROLOGY, V48, P581; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LOWELL MR, 1999, CLIN J SPORT MED, V9, P193; MATSER E, 2000, JAMA-J AM MED ASSOC, V16, P883; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; *NAT I PERS RES HS, 1969, S AFR WECHSL AD INT; NATHAN M, 1983, S AFR MED J, V64, P132; Pettersen JA, 2000, PSYCHOBIOLOGY, V28, P81; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reitan R., 1979, MANUAL ADM NEUROPSYC; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Shuttleworth-Edwards A, 2004, STUD NEUROPSYCHOL DE, P149; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards AB, 2002, CLIN NEUROPSYCHOL, V16, P232, DOI 10.1076/clin.16.3.232.13855; Shuttleworth-Jordan AB, 1993, P 5 NAT NEUR C S AFR, P38; SHUTTLEWORTHEDW.AB, J CLIN EXPT IN PRESS; SHUTTLEWORTHEDW.AB, CLIN J SPORT M UNPUB; ShuttleworthJordan AB, 1996, S AFR J PSYCHOL, V26, P96, DOI 10.1177/008124639602600205; VANTONDER P, 2008, WISC 4 PERFORMANCE S; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	40	31	33	1	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2008	23	5					511	520		10.1016/j.acn.2008.05.002			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	351HN	WOS:000259415400004	18585890	Bronze			2022-02-06	
J	Goverover, Y; Chiaravalloti, N; DeLuca, J				Goverover, Yael; Chiaravalloti, Nancy; DeLuca, John			Self-generation to improve learning and memory of functional activities in persons with multiple sclerosis: Meal preparation and managing finances	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						activities of daily living; learning; memory; multiple sclerosis; rehabilitation	TRAUMATIC BRAIN-INJURY; COGNITIVE DYSFUNCTION; SEMANTIC MEMORY; CONTEXT MEMORY; ALZHEIMER-TYPE; DEMENTIA; WORDS; ACQUISITION; INFORMATION; IMPAIRMENT	Objective: To examine the utility of using a self-generation strategy to improve learning and performance of everyday functional tasks in persons with multiple sclerosis (MS). Design: Mixed-design with both a within- and between-subject factor. Setting: Nonprofit rehabilitation research institution. Participants: Participants (n=20) with MS and healthy controls (n=18). Interventions: Participants completed 2 meal preparation and 2 financial management tasks. One task in each area was presented in the provided condition, in which all instructions were provided to and read by the participants, and the other task was presented in the generated condition, in which participants were asked to generate (fill in the blank) the necessary items needed to perform each step of the task. Main Outcome Measures: Correct recall of task items and step sequence immediately and 1 week after initial learning and correct performance of task items and step sequence 30 minutes after initial learning. The maximum possible score in each of the recall tests was 24. Results: Although the MS and healthy groups did not differ in overall items recalled, in both groups tasks learned in the generated condition enhanced memory performance significantly for the tasks used when compared with similar tasks learned in the provided condition. Conclusions: Self-generation during learning can significantly improve subsequent recall of information and performance of activities of daily living for persons with MS. Implications of these findings for cognitive rehabilitation in MS are discussed.	[DeLuca, John] Kessler Med Rehabil Res & Educ Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA; [Chiaravalloti, Nancy; DeLuca, John] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Goverover, Yael] NYU, Dept Occupat Therapy, Steinhardt Sch Culture Educ & Human Dev, New York, NY USA		DeLuca, J (corresponding author), Kessler Med Rehabil Res & Educ Ctr, Neuropsychol & Neurosci Lab, 300 Execut Dr,Ste 010, W Orange, NJ 07052 USA.	jdeluca@kmrrec.org					[Anonymous], 1993, NEUROPSYCHOLOGY, V7, P364, DOI [DOI 10.1037/0894-4105.7.3.364, 10.1037/0894-4105.7.3.364]; Arnett PA, 1997, NEUROPSYCHOLOGY, V11, P535, DOI 10.1037/0894-4105.11.4.535; Barrett AM, 2000, NEUROLOGY, V54, P1258, DOI 10.1212/WNL.54.6.1258; Basso MR, 2006, J INT NEUROPSYCH SOC, V12, P640, DOI 10.1017/S1355617706060759; BEATTY WW, 1988, ARCH NEUROL-CHICAGO, V45, P611, DOI 10.1001/archneur.1988.00520300029013; Beatty WW, 1995, J NEUROL REHABIL, V9, P167; BEGG I, 1989, J EXP PSYCHOL LEARN, V15, P977, DOI 10.1037/0278-7393.15.5.977; BLOCH MW, 1989, AM J OCCUP THER, V43, P25, DOI 10.5014/ajot.43.1.25; Bobholz JA, 2003, CURR OPIN NEUROL, V16, P283, DOI 10.1097/00019052-200306000-00006; BOWER GH, 1979, J RES PERS, V13, P420, DOI 10.1016/0092-6566(79)90005-9; BUYER LS, 1989, AM J PSYCHOL, V102, P353, DOI 10.2307/1423055; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Chialva D, 2005, J HIGH ENERGY PHYS; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CRUTCHER RJ, 1989, J EXP PSYCHOL LEARN, V15, P669, DOI 10.1037/0278-7393.15.4.669; DELIS D, 1987, CALIFORNIA VERBAL LE; DELIS DC, 2000, DELISKAPLAN EXECUTIV; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; Demaree HA, 2000, J CLIN EXP NEUROPSYC, V22, P865, DOI 10.1076/jcen.22.6.865.961; DICK MB, 1989, BRAIN COGNITION, V9, P88, DOI 10.1016/0278-2626(89)90046-8; FISHER AG, 2001, ASSESSMENT MOTOR PRO; FRANKLIN GM, 1988, NEUROLOGY, V38, P1826, DOI 10.1212/WNL.38.12.1826; GARDINER JM, 1984, MEM COGNITION, V12, P443, DOI 10.3758/BF03198305; Gaudino EA, 2001, NEUROPSY NEUROPSY BE, V14, P32; Goverover Y, 2007, MULT SCLER, V13, P636, DOI 10.1177/1352458506072984; Hsieh S, 1999, PERCEPT MOTOR SKILL, V89, P355, DOI 10.2466/PMS.89.6.355-367; JOHNSON MK, 1981, AM J PSYCHOL, V94, P37, DOI 10.2307/1422342; Jurica PJ, 1999, MEM COGNITION, V27, P648, DOI 10.3758/BF03211558; Kaplan E, 1983, BOSTON NAMING TEST; KESSLER HR, 1992, INT J NEUROSCI, V62, P17, DOI 10.3109/00207459108999754; Kinjo H, 2000, AM J PSYCHOL, V113, P95, DOI 10.2307/1423462; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Ma HI, 1999, AM J OCCUP THER, V53, P138, DOI 10.5014/ajot.53.2.138; Marsh EJ, 2001, MEM COGNITION, V29, P798, DOI 10.3758/BF03196409; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; MITCHELL DB, 1986, J GERONTOL, V41, P79, DOI 10.1093/geronj/41.1.79; Mulligan NW, 2006, J EXP PSYCHOL LEARN, V32, P836, DOI 10.1037/0278-7393.32.4.836; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POZZILLI C, 1991, CORTEX, V27, P441, DOI 10.1016/S0010-9452(13)80039-1; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Schulz D, 2006, J NEUROL, V253, P1002, DOI 10.1007/s00415-006-0145-8; SLAMECKA NJ, 1983, J VERB LEARN VERB BE, V22, P153, DOI 10.1016/S0022-5371(83)90112-3; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Smith A., 1982, SYMBOL DIGITS MODALI; Smith KJ, 1996, J AM ACAD DERMATOL, V34, P63, DOI 10.1016/S0190-9622(96)90835-X; Sperling RA, 2001, ARCH NEUROL-CHICAGO, V58, P115, DOI 10.1001/archneur.58.1.115; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A; *SPSS INC, 1997, SPSS BAS APPL GUID; SWIRSKYSACCHETTI T, 1992, NEUROLOGY, V42, P1291, DOI 10.1212/WNL.42.7.1291; Thornton AE, 1997, NEUROPSYCHOLOGY, V11, P357, DOI 10.1037/0894-4105.11.3.357; Wechsler, 1997, WECHSLER ADULT INTEL; Westmacott R, 2003, MEM COGNITION, V31, P761, DOI 10.3758/BF03196114; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME	60	31	32	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2008	89	8					1514	1521		10.1016/j.apmr.2007.11.059			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	336UP	WOS:000258390400013	18586224				2022-02-06	
J	Fearing, MA; Bigler, ED; Wilde, EA; Johnson, JL; Hunter, JV; Li, XQ; Hanten, G; Levin, HS				Fearing, Michael A.; Bigler, Erin D.; Wilde, Elisabeth A.; Johnson, Jamie L.; Hunter, Jill V.; Li, Xiaoqi; Hanten, Gerri; Levin, Harvey S.			Morphometric MRI findings in the thalamus and brainstem in children after moderate to severe traumatic brain injury	JOURNAL OF CHILD NEUROLOGY			English	Article; Proceedings Paper	34th Annual Meeting of the International-Neuropsychological-Society	FEB 01-04, 2006	Boston, MA	Int Neuropsychol Soc		brainstem; morphometry; thalamus; traumatic brain injury	CLOSED-HEAD INJURY; MAGNETIC-RESONANCE; AXONAL INJURY; CELL-DEATH; DAMAGE; ADOLESCENTS; ATROPHY; MEMORY; ABNORMALITIES; TOMOGRAPHY	Generalized whole brain volume loss is well documented in moderate to severe traumatic brain injury. Whether this atrophy occurs in the thalamus and brainstem has not been systematically studied in children, Magnetic resonance imaging (MRI) quantitative analysis was used to investigate brain volume loss in the thalamus and brainstem in 16 traumatic brain injury subjects (age range 9-16 years) compared with 16 age and demographically matched controls. Based on Multiple analysis of covariance, controlling for age and head size, reduced volume in the thalamus and the midbrain region of the brainstem were found. General linear model analyses revealed a relation between processing speed on a working memory task and mid-brain and brain stein volumes. Reduced volume in thalamic and brainstem structures were associated with traumatic brain injury. Reduction in midbrain and thalamic Volume is probably a reflection of the secondary effects of diffuse axonal injury and reduction in cortical volume from brain injury.	[Wilde, Elisabeth A.; Hunter, Jill V.; Hanten, Gerri; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA; [Fearing, Michael A.] Hebrew SeniorLife, Inst Aging Res, Aging Brain Ctr, Boston, MA USA; [Fearing, Michael A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Bigler, Erin D.; Johnson, Jamie L.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Radiol & Psychiat, Salt Lake City, UT USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Diagnost Imaging, Houston, TX 77030 USA		Wilde, EA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1709 Dryden Rd,Ste 725, Houston, TX 77030 USA.	ewilde@bcm.tmc.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U19 HD035476] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS021889] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U19HD035476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Constantinidis Christos, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P444, DOI 10.3758/CABN.4.4.444; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Gerring J, 2000, BRAIN INJURY, V14, P205; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; LANGLOIS JA, 1997, MMWR-MORBID MORTAL W, V52, P1; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Nakamizo A, 2002, J CLIN NEUROSCI, V9, P685, DOI 10.1054/jocn.2002.1146; Natale JE, 2002, NEUROSCIENCE, V112, P665, DOI 10.1016/S0306-4522(02)00098-2; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Parton A, 2005, CURR OPIN NEUROL, V18, P675, DOI 10.1097/01.wco.0000189872.54245.13; Patrick PD, 2007, BRAIN INJURY, V21, P63, DOI 10.1080/02699050601111401; Pol HEH, 2000, NEUROREPORT, V11, P3039, DOI 10.1097/00001756-200009110-00042; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rosen GD, 2006, NEUROSCIENCE, V141, P875, DOI 10.1016/j.neuroscience.2006.04.035; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Seidler RD, 2004, NEUROIMAGE, V22, P1775, DOI 10.1016/j.neuroimage.2004.05.003; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wedekind C, 2005, BRAIN INJURY, V19, P681, DOI 10.1080/02699050400025182; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0	46	31	32	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUL	2008	23	7					729	737		10.1177/0883073808314159			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics	330GP	WOS:000257929000003	18658073				2022-02-06	
J	Stein, SC; Fabbri, A; Servadei, F				Stein, Sherman C.; Fabbri, Andrea; Servadei, Franco			Routine serial computed tomographic scans in mild traumatic brain injury: When are they cost-effective?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						mild traumatic brain injury, cranial computed tomography scan; serial computed tomography studies	MINOR HEAD-INJURY; BLUNT INTRACRANIAL INJURY; NEW-ORLEANS CRITERIA; EXTRADURAL HEMATOMAS; BENEFIT PATIENTS; PRACTICAL SCALE; CT; UTILITY; CHILDREN; RULE	Background: Most case series involving routine serial computed tomography (CT) scans of the head in patients with mild traumatic brain injury (TBI) have suggested that they only occasionally provide useful information and imply that the practice is unnecessary and wasteful. No study has looked at the special case in which the initial scan revealed an intracranial abnormality which did not require surgery. Methods: We performed a structured review of the literature for the probabilities and costs of various outcomes in patients with mild TBI who demonstrate at least one intracranial abnormality on their admission CT scans. We supplemented this data with additional information from a large database of mild TBI patients. We then constructed a decision-analytic model to calculate costs and outcomes, comparing the strategy of routine serial scanning with that of awaiting clinical deterioration before repeating the study (expectant strategy). Results: For the 20-year-old patient, the routine CT strategy is slightly more effective than the expectant strategy and is also only slightly more expensive. With advancing age, the relative cost-effectiveness of routine CT declines. Conclusions: Awaiting clinical deterioration in patients with mild TBI whose first CT scan reveals intracranial injury is not cost-effective compared with routine follow-up CT scans. Although the difference is not statistically significant, routine follow-up scanning is slightly more cost-effective, especially in younger patients.	[Stein, Sherman C.] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19106 USA; [Fabbri, Andrea] Osped Morgagni Pierantoni, Dept Emergency Med, Forli, Italy; [Servadei, Franco] Osped Bufalini, Dept Neurosurg, Cesena, Italy		Stein, SC (corresponding author), Hosp Univ Penn, Dept Neurosurg, 310 Spruce St, Philadelphia, PA 19106 USA.	sherman.stein@uphs.upenn.edu	Fabbri, Andrea/K-9994-2016	Fabbri, Andrea/0000-0002-9837-4638; Servadei, Franco/0000-0002-3595-3464			Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; *BDO, 2003, REP SHORTF MED FUND; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Chapman RH, 2004, HEALTH ECON, V13, P429, DOI 10.1002/hec.853; Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation National Research Council, 2005, HLTH RISKS EXP LOW L; Concato J, 1997, J INVEST MED, V45, P394; Dharap SB, 2005, INJURY, V36, P412, DOI 10.1016/j.injury.2004.06.020; DRUMMOND MF, 1997, PRESENTATION USE EC, P265; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Einarson TR, 1997, CLIN THER, V19, P559, DOI 10.1016/S0149-2918(97)80140-3; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; FELDMAN KW, 1995, CHILD ABUSE NEGLECT, V19, P307, DOI 10.1016/S0145-2134(94)00130-8; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Gold M., 1996, COST EFFECTIVENESS H; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; JENNETT B, 1975, LANCET, V1, P480; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; KING JT, 1994, J NEUROSURG, V81, P837, DOI 10.3171/jns.1994.81.6.0837; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; Schackman BR, 2004, PHARMACOECONOMICS, V22, P293, DOI 10.2165/00019053-200422050-00003; *SERV CFMAM, 2005, AC INP PROSP PAYM SY; SERVADEI F, 1995, ACTA NEUROCHIR, V133, P50, DOI 10.1007/BF01404947; Shackford SR, 2004, J TRAUMA, V56, P480; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sinson G, 2001, J TRAUMA, V51, P875; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Sox H.C., 1988, MED DECISION MAKING; STAMMLER U, 1989, Neurosurgical Review, V12, P159, DOI 10.1007/BF01790640; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; STEIN SC, 1995, PEDIAT SURG INT, V10, P271; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; TEASDALE G, 1974, LANCET, V2, P81; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	55	31	33	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2008	65	1					66	72		10.1097/TA.0b013e318068d75f			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	327ZP	WOS:000257767300012	18580532				2022-02-06	
J	Calvert, S; Miller, HE; Curran, A; Hameed, B; McCarter, R; Edwards, RJ; Hunt, L; Sharples, PM				Calvert, Sophie; Miller, Helen E.; Curran, Andrew; Hameed, Biju; McCarter, Renee; Edwards, Richard J.; Hunt, Linda; Sharples, Peta Mary			The King's Outcome Scale for Childhood Head Injury and injury severity and outcome measures in children with traumatic brain injury	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							QUALITY-OF-LIFE; ADOLESCENTS; COMA	The aim of this study was to relate discharge King's Outcome Scale for Childhood Head Injury (KOSCHI) category to injury severity and detailed outcome measures obtained in the first year post-traumatic brain injury (TBI). We used a prospective cohort study. Eighty-one children with TBI were studied: 29 had severe, 15 moderate, and 37 mild TBI. The male:female ratio was 1.8:1. The mean age was 11 years 10 months (SD 3.6, range 5-16y). Discharge KOSCHI categories were good (n=34), moderate (n=39), severe (n=6), and unclassifiable (n=2). KOSCHI category correlated strongly with admission Glasgow Coma Score, length of hospital stay, and post-traumatic amnesia. It also correlated significantly with Verbal IQ and Performance IQ (Wechsler); measures of attention; health status (Health Utilities Index [HUI]); health-related quality of life (Pediatric Quality of Life Inventory [PedsQL]); depressive symptoms (Birleson Depression Scale) assessed within 3 months postTBI; and with Verbal IQ, selective attention (map mission), and HUI and PedsQL domains assessed at least 6 months post-TBI discharge. KOSCHI did not correlate with behaviour or executive function. We conclude that the KOSCHI scored at hospital discharge correlates with severity of injury and some cognitive, health status, and HRQL outcomes early after TBI. It is not helpful at predicting later difficulties, or behavioural and emotional problems.	[Miller, Helen E.] Frenchay Hosp, Acad Ctr, Bristol BS16 1LE, Avon, England; [Hunt, Linda; Sharples, Peta Mary] Bristol Royal Hosp Children, Inst Child Life & Hlth, Bristol, Avon, England		Miller, HE (corresponding author), Frenchay Hosp, Acad Ctr, Room 1, Bristol BS16 1LE, Avon, England.	Helen.Miller@north-bristol.swest.nhs.uk		Edwards, Richard/0000-0001-8415-2180; Hameed, Biju/0000-0002-8783-6163	Department of HealthEuropean Commission Funding Source: Medline		Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BIRLESON P, 1987, J CHILD PSYCHOL PSYC, V28, P43, DOI 10.1111/j.1469-7610.1987.tb00651.x; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; CROUCHMAN MR, 1998, INJURY YOUNG, P263; Curran A., 2003, ARCH DIS CHILD S, V88, pA24; CURRAN AL, 2005, BRAIN INJ S1, V19, P22; Fasoli SE, 2004, NEUROREHAB NEURAL RE, V18, P88, DOI 10.1177/0888439004267434; FEENY D, 1992, J CLIN ONCOL, V10, P923, DOI 10.1200/JCO.1992.10.6.923; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; JENNETT B, 1975, LANCET, V1, P480; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LINDSAY JT, 1998, J NEUROTRAUM, V15, P573; MANLEY T, 1999, TEACH TEST EVERYDAY; MAROSSZEKEY NEV, 1998, PTA PROTOCOL GUIDELI; MILLER HE, 2004, ARCH DIS CHILD S, V89, pA56; SAS Institute Inc, SAS STAT SOFTW VERS; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sharples PM, 1998, INJURY YOUNG, V263-299; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; TEASDALE G, 1974, LANCET, V2, P81; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Yule W, 1997, CHILD PSYCHOL PORTFO	30	31	32	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JUN	2008	50	6					426	431		10.1111/j.1469-8749.2008.02061.x			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	302AC	WOS:000255937200010	18422680	Bronze			2022-02-06	
J	Feeney, TJ; Ylvisaker, M				Feeney, Timothy J.; Ylvisaker, Mark			Context-Sensitive Cognitive-Behavioral Supports for Young Children With TBI A Second Replication Study	JOURNAL OF POSITIVE BEHAVIOR INTERVENTIONS			English	Article						behavior disorders; pediatric rehabilitation; traumatic brain injury; positive behavior support; cognitive-behavioral intervention; functional assessment; school-based treatment; multicomponent intervention; ecological validity	TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE INJURY; CLOSED-HEAD INJURY; PSYCHIATRIC-DISORDERS; SHORT-TERM; FAMILY; ADOLESCENTS; PREDICTORS; REHABILITATION; SEVERITY	This study produced a second replication of an investigation of the effects of a multicomponent cognitive-behavioral intervention on the challenging behavior of young children with growing behavioral concerns after traumatic brain injury (TBI). The participants were two young elementary-age children with escalating behavior problems after severe TBI. Single-subject reversal designs were used to document the effects of the combined behavioral, cognitive, and executive function intervention on the following: frequency and intensity of aggressive behaviors and amount of work accomplished. The intervention included integrated components of positive behavior supports, cognitive supports (e.g., graphic organizers), and an executive function routine (goal-plan-do-review). Results included reduced frequency and intensity of challenging behaviors and increased quantity of work completed. These two successful single-subject,experiments replicated four previously published single-subject experiments demonstrating the potential for successfully treating, behavior disorders in young children with TBI using a support-oriented intervention that combines behavioral, cognitive, and executive function components.	[Feeney, Timothy J.] Sch & Community Supports, Schenectady, NY 12305 USA; [Ylvisaker, Mark] Coll St Rose, Albany, NY USA		Feeney, TJ (corresponding author), Sch & Community Supports, 600 Franklin St,Suite 110, Schenectady, NY 12305 USA.	tfeeney@scssconsulting.com	Berger, Emily/N-7268-2017	Berger, Emily/0000-0001-5550-807X			Aman MG., 1994, ABERRANT BEHAV CHECK; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barlow DH, 1984, SINGLE CASE EXPT DES; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; BIJOU SW, 1968, J APPL BEHAV ANAL, V1, P175, DOI 10.1901/jaba.1968.1-175; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Bronson MB, 2000, SELF-REGULATION IN EARLY CHILDHOOD, P1; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Carr EG, 2002, J POSIT BEHAV INTERV, V4, P4, DOI 10.1177/109830070200400102; CARR EG, 1994, COMMUNICATION BASED; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; COSTEFF H, 1985, SCAND J REHABIL MED, P10; Damasio A., 1994, DESCARTES ERROR EMOT; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Detterman DL, 1993, TRANSFER TRIAL INTEL; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; Durand V.M., 1992, MOTIVATION ASSESSMEN; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FEENEY T, 1997, STUDENTS ACQUIRED BR, P229; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Glesne C., 1992, BECOMING QUALITATIVE; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Harchik A E, 1993, Ann Clin Psychiatry, V5, P151, DOI 10.3109/10401239309148979; Hebb DO, 1947, AM PSYCHOL, V2, P737; KEPPEL G, 1991, DESIGN ANAL INVESTIG; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; Kolb B., 1995, BRAIN PLASTICITY BEH; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; MACE FC, 1990, J EXP ANAL BEHAV, V54, P163, DOI 10.1901/jeab.1990.54-163; Mace FC, 1997, J APPL BEHAV ANAL, V30, P1, DOI 10.1901/jaba.1997.30-1; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; REICHLE J, 1993, COMMUNICATIVE ALTERN; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; SCHEIBEL RS, 1997, DEV PREFRONTAL CORTE, P241; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Taylor S.J., 1984, INTRO QUALITATIVE RE, V2nd ed.; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; YLVISAKER M, 1994, TOP LANG DISORD, V15, P37, DOI 10.1097/00011363-199411000-00005; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Ylvisaker M., 1998, COLLABORATIVE BRAIN; YLVISAKER M, 2005, REHABILITATION TRAUM, P205; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	83	31	31	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1098-3007	1538-4772		J POSIT BEHAV INTERV	J. Posit. Behav. Interv.	APR	2008	10	2					115	128		10.1177/1098300707312540			14	Psychology, Clinical; Education, Special	Social Science Citation Index (SSCI)	Psychology; Education & Educational Research	390MQ	WOS:000262168800005					2022-02-06	
J	Schoenberg, MR; Ruwe, WD; Dawson, K; McDonald, NB; Houston, B; Forducey, PG				Schoenberg, Mike R.; Ruwe, William D.; Dawson, Kyra; McDonald, Nicholas B.; Houston, Beki; Forducey, Pamela G.			Comparison of functional outcomes and treatment cost between a computer-based cognitive rehabilitation teletherapy program and a face-to-face rehabilitation program	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						cognitive rehabilitation; telemedicine; teletherapy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DISABILITY RATING-SCALE; HEAD-INJURY; TELEMEDICINE; TELEREHABILITATION; RECOVERY; RECOMMENDATIONS; OPPORTUNITIES; TECHNOLOGY; SYSTEM	The authors compared outcomes of 19 participants who received computer-based cognitive teletherapy rehabilitation with 20 participants who received face-to-face speech-language rehabilitation. The study compared outcomes from 2 "real-word" treatment programs provided by an outpatient rehabilitation center. A total of 39 participants with moderate to severe closed head traumatic brain injuries and a minimum of I year following injury were analyzed. Outcome measures included clinical indicators of independent living status, return to work or school, and independent driving. Cost measures included the total cost of the treatment and a measure of service costs per hour. Time since injury was a covariate, and an analysis of covariance revealed no differences between groups in independent living, driving status, return to work or school, or total treatment costs. The computer-based teletherapy cognitive rehabilitation program provided similar functional outcomes as face-to-face speech-language therapy at a similar total cost.	[Schoenberg, Mike R.] Univ Hosp, Case Med Ctr, Dept Neurol, Cleveland, OH 44106 USA; [Ruwe, William D.] Univ Oklahoma, Hlth Sci Ctr, Norman, OK 73019 USA; [Houston, Beki] INTEGRIS Hosp, Oklahoma City, OK USA; [Forducey, Pamela G.] INTEGRIS Southwest Med Ctr, INTEGRIS Telehlth & Neurosci Inst, Oklahoma City, OK USA; [Dawson, Kyra] Cleveland State Univ, Cleveland, OH 44115 USA		Schoenberg, MR (corresponding author), Univ Hosp, Case Med Ctr, Dept Neurol, HH 5,11100 Euclid Ave, Cleveland, OH 44106 USA.	michael.schoenberg@uhhospitals.org	Schoenberg, Mike R/J-9018-2012	Schoenberg, Mike/0000-0003-1355-3651			Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Brunicardi BO, 1998, TELEMED J, V4, P49, DOI 10.1089/tmj.1.1998.4.49; Burns RB, 1998, ASSIST TECHNOL, V10, P126, DOI 10.1080/10400435.1998.10131970; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Chen SHA, 1997, BRAIN INJURY, V11, P197; Cicerone KD, 1999, J HEAD TRAUMA REHAB, V14, P316, DOI 10.1097/00001199-199906000-00011; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Conrad K. C., 1998, PROFESSIONAL PSYCHOL, V29, P525; Day SX, 2002, J COUNS PSYCHOL, V49, P499, DOI 10.1037/0022-0167.49.4.499; Fitzgerald Maureen H., 1992, World Health Forum, V13, P303; Hailey D, 2002, J TELEMED TELECARE, V8, P1; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Harley J. P., 1992, NEUROREHABILITATION, V2, P62; Lacroix A, 2002, TELEMED J E-HEALTH, V8, P149, DOI 10.1089/15305620260008084; Mair F, 2000, BMJ-BRIT MED J, V320, P1517, DOI 10.1136/bmj.320.7248.1517; Mair FS, 2000, J TELEMED TELECARE, V6, P38, DOI 10.1258/1357633001934096; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; *NAT AC NEUR, 2002, POS PAP COGN REH; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Phipps EJ, 1999, J HEAD TRAUMA REHAB, V14, P329, DOI 10.1097/00001199-199906000-00014; Popescu VG, 2000, IEEE T INF TECHNOL B, V4, P45, DOI 10.1109/4233.826858; Prigatano GP, 1999, J HEAD TRAUMA REHAB, V14, P308, DOI 10.1097/00001199-199906000-00009; *PSCYH CORP, 1999, MAN WECHSL ABBR SCAL; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Ricker J H, 1998, Appl Neuropsychol, V5, P184, DOI 10.1207/s15324826an0504_3; Riva G, 2000, Technol Health Care, V8, P113; Roine R, 2001, CAN MED ASSOC J, V165, P765; Salvatore Tony, 2002, Home Healthc Nurse, V20, P127; Sandberg L, 1998, Health Manag Technol, V19, P29; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Schopp L, 2000, PROF PSYCHOL-RES PR, V31, P179, DOI 10.1037/0735-7028.31.2.179; Sjogren LH, 2001, J TELEMED TELECARE, V7, pS12; Sosin DM, 1996, BRAIN INJURY, V10, P47; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Whitten P, 2000, J TELEMED TELECARE, V6, P4, DOI 10.1258/1357633001934177; Whitten PS, 2002, BRIT MED J, V324, P1434, DOI 10.1136/bmj.324.7351.1434; Winters JM, 2002, ANNU REV BIOMED ENG, V4, P287, DOI 10.1146/annurev.bioeng.4.112801.121923; Woods K, 1998, TELEMED J, V4, P353, DOI 10.1089/tmj.1.1998.4.353; Wootton R, 2001, BRIT MED J, V323, P557, DOI 10.1136/bmj.323.7312.557; Ziegler J, 1995, Bus Health, V13, P47; [No title captured]	44	31	32	0	17	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	APR	2008	39	2					169	175		10.1037/0735-7028.39.2.169			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	282WW	WOS:000254599000008					2022-02-06	
J	Shelton, SB; Pettigrew, DB; Hermann, AD; Zhou, W; Sullivan, PM; Crutcher, KA; Strauss, KI				Shelton, Shirley B.; Pettigrew, David B.; Hermann, Alison D.; Zhou, Weidong; Sullivan, Patrick M.; Crutcher, Keith A.; Strauss, Kenneth I.			A simple, efficient tool for assessment of mice after unilateral cortex injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						apolipoprotein E; targeted-replacernent; beam walk; foot fault; water maze	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; SENSORIMOTOR DYSFUNCTION; MOUSE STRAINS; HEAD TRAUMA; DEFICITS; SHIRPA; MODEL; RAT; PHENOTYPE	A refined battery of neurological tests, SNAP (Simple Neuroassessment of Asymmetric Impairment), was developed and validated to efficiently assess neurological deficits induced in a mouse model of traumatic brain injury. Four to 7-month old mice were subjected to unilateral controlled cortical impact or sham injury (craniectomy only). Several behavioral tests (SNAP, beam walk, foot fault, and water maze) were used to assess functional deficits. SNAP was unique among these in that it required no expensive equipment and was performed in less than 5 min per mouse. SNAP demonstrated a high level of sensitivity and specificity as determined by receiver-operator characteristics curve analysis. Interrater reliability was good, as determined by Cohen's Kappa method and by comparing the sensitivity and specificity across various raters. SNAP detected deficits in proprioception, visual fields, and motor strength in brain-injured mice at 3 days, and was sensitive enough to detect magnitude and recovery of injury. The contribution of individual battery components changed as a function of time after injury, however, each was important to the overall SNAP score. SNAP provided a sensitive, reliable, time-efficient and cost-effective means of assessing neurological deficits in mice after unilateral brain injury. (c) 2007 Elsevier B.V. All rights reserved.	[Shelton, Shirley B.; Pettigrew, David B.; Hermann, Alison D.; Zhou, Weidong; Crutcher, Keith A.; Strauss, Kenneth I.] Univ Cincinnati, Div Res, Dept Neurosurg, Cincinnati, OH 45267 USA; [Sullivan, Patrick M.] Duke Univ, Durham VA Med Ctr, Div Geriatr, Dept Med, Durham, NC 27705 USA		Shelton, SB (corresponding author), Univ Cincinnati, Div Res, Dept Neurosurg, 231 Albert Sabin Way,Med Sci Bldg, Cincinnati, OH 45267 USA.	sheitosb@uc.edu; pettigdb@email.uc.edu; alison.hermann@downstate.edu; zhouwd@email.uc.edu; p.sullivan@duke.edu; crutchka@email.uc.edu; kstrauss@uc.edu	Crutcher, Keith/B-5435-2019; Shelton, Shirley/A-8358-2008	Crutcher, Keith/0000-0002-9176-5759; 	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K01RR020360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038654, R01NS054890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG020249] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K01 RR020360, K01 RR020360-03, K01 RR020360-01A1, K01 RR020360-02] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG020249, R01 AG20249] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS054890-01A2, R01 NS054890, R01 NS38654, R01 NS038654] Funding Source: Medline		Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CRAWLEY JN, 2000, WHATS WRONG MY MOUSE, P65; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Glantz SA, 1992, PRIMER BIOSTATISTICS; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; Landini G., 2006, CORRECT BACKGROUND I; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leker RR, 2002, ACTA NEUROCHIR SUPPL, V83, P49; Maier NRF, 1935, J COMP NEUROL, V61, P395, DOI 10.1002/cne.900610209; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Motulsky H., 2003, PRISM 4 STAT GUIDE S, P122; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rosner B., 1995, FUNDAMENTALS BIOSTAT; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	31	31	31	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 15	2008	168	2					431	442		10.1016/j.jneumeth.2007.11.003			12	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	271YK	WOS:000253824400016	18164073	Green Accepted			2022-02-06	
J	Carter, BG; Butt, W; Taylor, A				Carter, B. G.; Butt, W.; Taylor, A.			ICP and CPP: excellent predictors of long term outcome in severely brain injured children	CHILDS NERVOUS SYSTEM			English	Article						intracranial pressure (ICP); cerebral perfusion pressure (CPP); outcome; predictive value of tests; traumatic brain injury; non-traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; TARGETED THERAPY; CHILDHOOD; SURVIVAL; CARE; LESIONS; AGE	Objective To determine the predictive powers of intracranial pressure (ICP) and cerebral perfusion pressure (CPP) amongst severely brain injured children. Materials and methods ICP and CPP were recorded from thirty-five severely brain injured children who were prospectively recruited after admission to paediatric intensive care. Twenty-five suffered traumatic brain injury (TBI) and ten suffered non-TBI. Peak ICP and minimum CPP recorded for each patient during their admission were related to 5 year Glasgow Outcome Scale outcome. Receiver operator characteristic curves determined that the optimum threshold for unfavourable outcome prediction was >= 40 mmHg for ICP and <= 49 mmHg for CPP. At these thresholds the sensitivity/specificity pairs for the prediction of unfavourable outcome were 33.3/100% and 55.6/100% for ICP and CPP, respectively, amongst patients suffering TBI and were 46.2/100% and 66.2/100% for ICP and CPP, respectively, amongst all patients. Conclusion ICP and CPP are accurate predictors of unfavourable outcome.	[Carter, B. G.; Butt, W.; Taylor, A.] Royal Childrens Hosp, Paediat Intens Care Unit, Parkville, Vic 3052, Australia; [Butt, W.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia		Carter, BG (corresponding author), Royal Childrens Hosp, Paediat Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.	icu.tech@rch.org.au					ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Altman D.G., 1999, PRACTICAL STAT MED R; Barlow KM, 1999, DEV MED CHILD NEUROL, V41, P220, DOI 10.1017/S0012162299000481; BARZILAY Z, 1988, INTENS CARE MED, V14, P417, DOI 10.1007/BF00262899; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Biggerstaff BJ, 2000, STAT MED, V19, P649, DOI 10.1002/(SICI)1097-0258(20000315)19:5&lt;649::AID-SIM371&gt;3.0.CO;2-H; Carter BG, 1999, INTENS CARE MED, V25, P722, DOI 10.1007/s001340050936; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CHAMBERS IR, 2003, BR NEUROSURG, V17, P478; CHO DY, 1985, PEDIATR NEUROSURG, V23, P192; Ciurea AV, 2005, ACT NEUR S, V93, P209; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Eder HG, 2000, CHILD NERV SYST, V16, P21, DOI 10.1007/s003810050005; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; GOITEIN KJ, 1983, J PEDIATR-US, V103, P40, DOI 10.1016/S0022-3476(83)80772-0; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307; JENNETT B, 1975, LANCET, V1, P480; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; KAISER G, 1984, NEUROPEDIATRICS, V15, P68, DOI 10.1055/s-2008-1052344; Kieslich M, 2001, DISABIL REHABIL, V23, P665; LEROUX PD, 1991, CHILD NERV SYST, V7, P34, DOI 10.1007/BF00263831; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Odetola FO, 2005, INTENS CARE MED, V31, P92, DOI 10.1007/s00134-004-2501-4; Papo I, 1982, J Neurosurg Sci, V26, P193; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; PFENNINGER J, 1984, Z KINDERCHIR, V39, P223; POPLE IK, 1985, PEDIATR NEUROSURG, V23, P64; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Ward J D, 1987, Brain Inj, V1, P21, DOI 10.3109/02699058709034440; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; ZWEIG MH, 1993, CLIN CHEM, V39, P561; 2002, PROTOCOL MANAGEMENT; 2003, PEDIAT CRIT CARE M S, V4, pS31; 2003, PEDIAT CRIT CARE M S, V4, pS65; 2003, PEDIAT CRIT CARE M S, V4, pS19; 2003, PEDIAT CRIT CARE M S, V4, pS25	47	31	32	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2008	24	2					245	251		10.1007/s00381-007-0461-z			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	244MW	WOS:000251871000016	17712566				2022-02-06	
J	Soustiel, JF; Mahamid, E; Goldsher, D; Zaaroor, M				Soustiel, Jean F.; Mahamid, Eugenia; Goldsher, Dorith; Zaaroor, Menashe			Perfusion-CT for early assessment of traumatic cerebral contusions	NEURORADIOLOGY			English	Article						perfusion-CT; traumatic brain injury; cerebral contusions; cerebral blood flow; cerebral blood volume	POSITRON-EMISSION-TOMOGRAPHY; DYNAMIC COMPUTED-TOMOGRAPHY; SEVERE HEAD TRAUMA; STABLE XENON-CT; BLOOD-FLOW; BRAIN-INJURY; QUANTITATIVE ASSESSMENT; TRANSIT-TIME; ACUTE STROKE; VOLUME	Introduction To investigate the value of perfusion-CT (PCT) for assessment of traumatic cerebral contusions (TCC) and to compare the abilities of early noncontrast CT and PCT modalities to evaluate tissue viability. Methods PCT studies performed in 30 patients suffering from TCC during the acute phase of their illness were retrospectively reviewed. Cerebral blood flow (CBF), volume (CBV) and mean transit time (MTT) were measured in three different areas: the hemorrhagic core of the TCC, the surrounding hypodense area and the perilesional normal-appearing parenchyma. TCC area was measured on CBF-, CBV- and MTT-derived maps and compared with the areas measured using the same slice obtained with CT scans performed on admission, at the time of PCT (follow-up CT) and at 1 week. Results TCC were characterized by low CBF and CBV values (9.2 +/- 6.6 ml/100 g per min and 0.9 +/- 0.7 ml/100 g, respectively) and a significant prolongation of MTT (11.9 +/- 10.7 s) in the hemorrhagic core whereas PCT parameters were more variable in the hypodense area. The TCC whole area showed a noticeable growth of the lesions during the first week of admission. In comparison with early noncontrast CT, CBV and CBF maps proved to be more congruent with the findings of noncontrast CT scans at 1 week. Conclusion PCT confirmed the results of xenon-CT studies and was shown to allow better evaluation of tissue viability than noncontrast CT. These findings suggest that PCT could be implemented in the future for the early assessment of patients with traumatic brain injury.	[Soustiel, Jean F.; Mahamid, Eugenia; Goldsher, Dorith; Zaaroor, Menashe] Technion Israel Inst Technol, Fac Med, Dept Neurosurg, Rambam Med Ctr, IL-31096 Haifa, Israel		Soustiel, JF (corresponding author), Technion Israel Inst Technol, Fac Med, Dept Neurosurg, Rambam Med Ctr, POB 9602, IL-31096 Haifa, Israel.	j_soustiel@rambam.health.gov.il					AXEL L, 1983, INVEST RADIOL, V18, P94, DOI 10.1097/00004424-198301000-00018; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Furukawa M, 2002, J COMPUT ASSIST TOMO, V26, P272, DOI 10.1097/00004728-200203000-00019; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; Kudo K, 2003, AM J NEURORADIOL, V24, P419; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Muir KW, 2006, J NEUROL NEUROSUR PS, V77, P334, DOI 10.1136/jnnp.2005.074179; NORMAN D, 1981, AM J ROENTGENOL, V136, P759, DOI 10.2214/ajr.136.4.759; Sakoh M, 2000, STROKE, V31, P1958, DOI 10.1161/01.STR.31.8.1958; Sase S, 2005, J COMPUT ASSIST TOMO, V29, P270, DOI 10.1097/01.rct.0000156400.40836.68; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schroder ML, 1998, ACT NEUR S, V71, P127; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Sorensen AG, 1999, RADIOLOGY, V210, P519, DOI 10.1148/radiology.210.2.r99fe06519; Soustiel JF, 2006, NEURORADIOLOGY, V48, P670, DOI 10.1007/s00234-006-0099-7; Sviri GE, 2006, NEUROSURGERY, V59, P319, DOI 10.1227/01.NEU.0000222819.18834.33; TEASDALE G, 1974, LANCET, V2, P81; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Wintermark M, 2001, EUR RADIOL, V11, P1220, DOI 10.1007/s003300000707	34	31	35	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0028-3940			NEURORADIOLOGY	Neuroradiology	FEB	2008	50	2					189	196		10.1007/s00234-007-0337-7			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	257AB	WOS:000252769900012	18040673				2022-02-06	
J	Park, C; Cho, IH; Kim, D; Jo, EK; Choi, SY; Oh, SB; Park, K; Kim, JS; Lee, SJ				Park, Chanhee; Cho, Ik-Hyun; Kim, Donghoon; Jo, Eun-Kyeong; Choi, Se-Young; Oh, Seog Bae; Park, Kyoungpyo; Kim, Joong Soo; Lee, Sung Joong			Toll-like receptor 2 contributes to glial cell activation and heme oxygenase-1 expression in traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						toll-like receptor 2; heme oxygenase-1; glial activation; stab-wound injury	SPINAL-CORD; MICROGLIAL CELLS; GENE-EXPRESSION; WALL COMPONENTS; STAB WOUNDS; RAT; ASTROCYTES; SIGNAL; ENCEPHALOMYELITIS; PROTEIN	Traumatic brain injury is accompanied by glial cell activation around the site of the injury. In this study, we investigated the role of toll-like receptor 2 (TLR2) in glial cell activation using a stab-wound injury (SWI) model with TLR2 knock-out mice. Penetration of a normal mouse brain with a 26-G needle using a stereotaxic instrument resulted in an 18- and 4-fold upregulation of GFAP and CD11b mRNA, respectively, along the needle track in the injury area. However, in the TLR2 knock-out mice, the induced expression of these genes was reduced by 70% and 40%, respectively. Likewise, there was a reduction in the area of activated glial cells detected by immunohistochemistry and the glial cells had a less-activated morphology in the TLR2 knock-out mice. In addition, the expression of the heme oxygenase-1 (HO-1) gene, a glia-expressing wound-responsive gene, was reduced after SWI in TLR2 knock-out mice. Taken together, these data argue that TLR2 contributes to the glial cell activation and HO-1 gene expression associated with traumatic brain injury. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	[Park, Chanhee; Kim, Donghoon; Choi, Se-Young; Oh, Seog Bae; Park, Kyoungpyo; Kim, Joong Soo; Lee, Sung Joong] Seoul Natl Univ, Sch Dent, Dept Oral Physiol, Program Mol & Cell Neurosci,DRI, Seoul 110749, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Coll Med, Dept Microbiol, Taejon, South Korea		Lee, SJ (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Physiol, Program Mol & Cell Neurosci,DRI, 28 Yeongun-dong, Seoul 110749, South Korea.	sjlee87@snu.ac.kr	Cho, Ik-Hyun/A-9348-2014; OH, Seog Bae/AAQ-2478-2020	Choi, Se-Young/0000-0001-7534-5167; Eun-Kyeong, Jo/0000-0001-7191-0587; Oh, Seog Bae/0000-0001-7975-6895			Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BARRETT CP, 1981, EXP NEUROL, V73, P365, DOI 10.1016/0014-4886(81)90272-7; Berman JW, 1996, J IMMUNOL, V156, P3017; Dwyer BE, 1996, MOL BRAIN RES, V38, P251, DOI 10.1016/0169-328X(95)00341-O; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; KIN KJ, 2006, J NEUROSCI, V26, P1880; Laflamme N, 2001, J NEUROCHEM, V79, P648, DOI 10.1046/j.1471-4159.2001.00603.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Orihara Yoshiyuki, 2003, Leg Med (Tokyo), V5 Suppl 1, pS278; Panizzon KL, 1996, NEUROREPORT, V7, P662, DOI 10.1097/00001756-199601310-00067; Park C, 2006, GLIA, V53, P248, DOI 10.1002/glia.20278; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schipper HM, 1999, NEUROTOX RES, V1, P57, DOI 10.1007/BF03033339; SMITH ME, 1983, BRAIN RES, V264, P241, DOI 10.1016/0006-8993(83)90822-3; Song W, 2006, J CELL PHYSIOL, V206, P655, DOI 10.1002/jcp.20509; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; VANDENBRINK WA, 1994, ACTA NEUROCHIR, P456	26	31	32	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 31	2008	431	2					123	128		10.1016/j.neulet.2007.11.057			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	266MK	WOS:000253439800006	18164130				2022-02-06	
J	Shum, D; Cross, B; Ford, R; Ownsworth, T				Shum, David; Cross, Belinda; Ford, Ruth; Ownsworth, Tamara			A Developmental Investigation of Prospective Memory: Effects of Interruption	CHILD NEUROPSYCHOLOGY			English	Article						Prospective memory; Executive function; Development; Children; Interruption; Prefrontal region	TRAUMATIC BRAIN-INJURY; COLOR-WORD; PERFORMANCE; COMPONENTS; CHILDHOOD; CHILDREN; TESTS	The effects of interrupting an event-based prospective memory (PM) task and its associated ongoing task were compared for two groups of children: 8- to 9-year-olds (n = 35) and 12- to 13-year-olds (n = 28). Additionally, PM performance was examined as a function of attainment on a battery of tests of executive functioning (viz., Controlled Oral Word Association Test, Letter Number Sequencing Test, Stroop Color and Word Test, and Trail Making Test). A significant main effect of age indicated that the older children correctly carried out intended actions more often than the younger children. Consistent with the prefrontal model of PM, interruption had no impact on PM accuracy in the older group but produced reliable decrements to the accuracy of the younger group. Whereas IQ showed no association with PM performance, reliable relations between PM skills and aspects of their executive functioning were found.	[Shum, David] Griffith Univ, Sch Psychol, Nathan, Qld 4111, Australia; Griffith Univ, Appl Cognit Neurosci Res Ctr, Nathan, Qld 4111, Australia		Shum, D (corresponding author), Griffith Univ, Sch Psychol, Nathan, Qld 4111, Australia.	d.shum@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021; Shum, David/A-3914-2008	Ownsworth, Tamara/0000-0003-1835-7094; Shum, David/0000-0002-4810-9262			Altmann EM, 2002, COGNITIVE SCI, V26, P39, DOI 10.1207/s15516709cog2601_2; Anderson V., 1995, NEUROPSYCHOLOGICAL A; Brandimonte, 1996, PROSPECTIVE MEMORY T, P115; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; GADDES WH, 1975, BRAIN LANG, V2, P257, DOI 10.1016/S0093-934X(75)80070-8; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Golden C, 2000, NEUROPSYCHOLOGICAL I; Golden CJ., 1978, STROOP COLOUR WORD T; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; HITCH GJ, 1989, MEM COGNITION, V17, P175, DOI 10.3758/BF03197067; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Lehr E, 1990, PSYCHOL MANAGEMENT T; Marlowe WB, 2000, DEV NEUROPSYCHOL, V18, P445, DOI 10.1207/S1532694209Marlowe; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; Passolunghi MC, 1995, INT J BEHAV DEV, V18, P631, DOI 10.1177/016502549501800404; Reitan R., 1979, MANUAL ADM NEUROPSYC; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; Ward H, 2005, CHILD NEUROPSYCHOL, V11, P527, DOI 10.1080/09297040490920186; WARD HJ, 2004, THESIS GRIFFITH U BR; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Yakovlev PI, 1967, REGIONAL DEV BRAIN E, P3	33	31	31	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2008	14	6					547	561	PII 792002276	10.1080/09297040801947051			15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	368GK	WOS:000260609400005	18608222				2022-02-06	
J	Wood, RL				Wood, R. Ll.			Long-term outcome of serious traumatic brain injury	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article; Proceedings Paper	Brain Annual Meeting	MAY 09-12, 2007	Brescia, ITALY			brain injury; trauma; psychology; outcome; neurobehavoural manifestations	SEVERE HEAD-INJURY; COMA-DATA-BANK; FOLLOW-UP; COMMUNITY INTEGRATION; ALZHEIMERS-DISEASE; PERSONALITY-TRAITS; COPING STRATEGIES; RISK-FACTOR; DISABILITY; PREDICTORS	Follow-up studies on individuals who suffer severe head injury give a picture of poor cognitive and psychosocial outcome. However, recent evidence suggests that with the passage of time, many individuals make adjustments that compensate for early disability, leading to a reduction in social handicap with a corresponding improvement in life quality and personal satisfaction. This article will attempt to briefly review the main sources of evidence contributing to long-term outcome following serious head trauma.	Univ Coll Swansea, Dept Psychol, Swansea SA2 8PP, W Glam, Wales		Wood, RL (corresponding author), Univ Coll Swansea, Dept Psychol, Singleton Pk Campus, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swansea.ac.uk					Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CORKIN S, 1989, J NEUROSCI, V9, P3876; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CRAIK FIM, 1990, NEUROPSYCHOLOGICAL I, P00247; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Finset A, 2000, BRAIN INJURY, V14, P887; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2001, BRAIN INJURY, V15, P189; JACOBS HE, 1989, TRAUMATIC BRAIN INJU; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KRIKNESS CJ, 2004, BIOL RES NURS, V5, P299; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Newcombe F, 1996, J CLIN EXP NEUROPSYC, V18, P1, DOI 10.1080/01688639608408258; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Phillips LH, 1998, LEARN INDIVID DIFFER, V10, P217, DOI 10.1016/S1041-6080(99)80131-9; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith J, 1998, CANADIAN J REHABILIT, V11, P131; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; TESDALE GM, 2004, REPORT CHIEF SCI; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; WALKER AE, 1989, ARCH NEUROL-CHICAGO, V46, P23, DOI 10.1001/archneur.1989.00520370025013; Walsh K. W., 1985, UNDERSTANDING BRAIN; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 2004, NEUROPSYCHOL REHABIL, V14, P329, DOI 10.1080/09602010343000255; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; WOOD RLI, 2006, BRAIN INJURY, V12, P1; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; [No title captured]	67	31	33	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.		2008	25			42			115	122		10.1017/S0265021507003432			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	283AY	WOS:000254610100020	18289428				2022-02-06	
J	Staal, JA; Dickson, TC; Chung, RS; Vickers, JC				Staal, J. A.; Dickson, T. C.; Chung, R. S.; Vickers, J. C.			Cyclosporin-A treatment attenuates delayed cytoskeletal alterations and secondary axotomy following mild axonal stretch injury	DEVELOPMENTAL NEUROBIOLOGY			English	Article						cytoskeleton; cytochrome-c; cyclosporin-A; axolemma permeability; neurofilament; axonal injury	TRAUMATIC BRAIN-INJURY; CYTOCHROME-C RELEASE; INTRAAXONAL NEUROFILAMENT COMPACTION; PIG OPTIC-NERVE; MITOCHONDRIAL DYSFUNCTION; PERMEABILITY TRANSITION; AXOLEMMAL PERMEABILITY; IN-VITRO; NEURONAL CYTOSKELETON; SPECTRIN PROTEOLYSIS	Following central nervous system trauma, diffuse axonal injury and secondary axotomy result from a cascade of cellular alterations including cytoskeletal and mitochondrial disruption. We have examined the link between intracellular changes following mild/ moderate axonal stretch injury and secondary axotomy in rat cortical neurons cultured to relative maturity (21 days in vitro). Axon bundles were transiently stretched to a strain level between 103% and 106% using controlled pressurized fluid. Double-immunohistochemical analysis of neurofilaments, neuronal spectrin, a-internexin, cytochrome-c, and ubiquitin was conducted at 24-, 48-, 72-, and 96-h postinjury. Stretch injury resulted in delayed cytoskeletal damage, maximal at 48-h postinjury. Accumulation of cytochrome-c and ubiquitin was also evident at 48 h following injury and colocalized to axonal regions of cytoskeletal disruption. Pretreatment of cultures with cyclosporin-A, an inhibitor of calcineurin and the mitochondrial membrane transitional pore, reduced the degree of cytoskeletal damage in stretch-injured axonal bundles. At 48-h postinjury, 20% of untreated cultures demonstrated secondary axotomy, whereas cyclosporin A-treated axon bundles remained intact. By 72-h postinjury, 50% of control preparations and 7% of cyclosporin A-treated axonal bundles had progressed to secondary axotomy, respectively. Statistical analyses demonstrated a significant (p < 0.05) reduction in secondary axotomy between treated and untreated cultures. In summary, these results suggest that cyclosporin-A reduces progressive cytoskeletal damage and secondary axotomy following transient axonal stretch injury in vitro. (c) 2007 Wiley Pedodicals, Inc.	Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas, Australia		Vickers, JC (corresponding author), Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas, Australia.	james.vickers@utas.edu.au	Chung, Roger/ABF-8395-2020; Vickers, James C/J-7464-2014	Vickers, James C/0000-0001-5671-4879; Dickson, Tracey/0000-0002-9196-1661; Chung, Roger/0000-0002-9286-947X			Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Fitzpatrick MO, 1998, BRIT J NEUROSURG, V12, P313; FRAPPIER T, 1992, EUR J BIOCHEM, V205, P85, DOI 10.1111/j.1432-1033.1992.tb16754.x; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Gallyas F, 2002, ACTA NEUROPATHOL, V103, P36, DOI 10.1007/s004010100424; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Haas MA, 2007, CELL MOTIL CYTOSKEL, V64, P274, DOI 10.1002/cm.20182; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; King AE, 2006, J COMP NEUROL, V498, P277, DOI 10.1002/cne.21053; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lifshitz J, 2006, EXP NEUROL, V197, P318, DOI 10.1016/j.expneurol.2005.10.002; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J NEUROTRAUM, V20, P139, DOI 10.1089/08977150360547062; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luetjens CM, 2000, J NEUROSCI, V20, P5715; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1997, J NEUROTRAUM, V14, P755; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mironov SL, 2005, J BIOL CHEM, V280, P715, DOI 10.1074/jbc.M409819200; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pike BR, 1998, J NEUROSCI RES, V52, P505, DOI 10.1002/(SICI)1097-4547(19980601)52:5<505::AID-JNR3>3.3.CO;2-Y; Posmantur RM, 2000, EXP NEUROL, V161, P15, DOI 10.1006/exnr.1999.7244; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, J NEUROTRAUMA, V9, P189; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	65	31	32	0	2	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	1932-8451			DEV NEUROBIOL	Dev. Neurobiol.	DEC	2007	67	14					1831	1842		10.1002/dneu.20552			12	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	239TG	WOS:000251540000001	17702000				2022-02-06	
J	Onate, JA; Beck, BC; Van Lunen, BL				Onate, James A.; Beck, Brian C.; Van Lunen, Bonnie L.			On-field testing environment and balance error scoring system performance during preseason screening of healthy collegiate baseball players	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; attention; environment; postural control	MILD HEAD-INJURY; POSTURAL STABILITY; STANDARDIZED ASSESSMENT; CONSTRUCT-VALIDITY; FOOTBALL PLAYERS; CONCUSSION; ATTENTION; SYMPTOMS; SPORTS; MANAGEMENT	Context: To determine if testing environment affects Balance Error Scoring System (BESS) scores in healthy collegiate baseball players. Design: Experimental, randomized, repeated-measures design with a sample of convenience. Setting: Uncontrolled sideline and controlled locker room baseball environments. Patients or Other Participants: A total of 21 healthy collegiate baseball players (age = 20.1 +/- 1.4 years, height = 185.1 +/- 6.8 cm, mass = 86.3 +/- 9.5 kg) with no history of head injury within the last 12 months, no lower extremity injuries reported within the past 2 months that caused them to miss 1 or more days of practice or game time, and no history of otitis media, Parkinson disease, or Meniere disease. Main Outcome Measure(s): Participants performed the BESS test in 2 environments, controlled locker room and uncontrolled sideline, in 2 testing sessions 1 week apart during the baseball preseason. The BESS scores were evaluated for each of the 6 conditions and total score across the testing sessions. Separate, paired-samples t tests with Bonferroni adjustment (P <.008) were used to examine differences between testing environments for each BESS subcategory and total score. Cohen d tests were calculated to evaluate effect sizes and relative change. Results: Significant group mean differences were found between testing environments for single-leg foam stance (P =.001), with higher scores reported for the uncontrolled sideline environment (7.33 +/- 2.11 errors) compared with the controlled clinical environment (5.19 +/- 2.16 errors). Medium to large effect sizes (0.53 to 1.03) were also found for single-leg foam, tandem foam, and total BESS scores, with relative increases (worse scores) of 30% to 44% in the sideline environment compared with the clinical environment. Conclusions: The BESS performance was impaired when participants were tested in a sideline environment compared with a clinical environment. Baseline testing for postural control using the BESS should be conducted in the setting or environment in which testing after injury will most likely be conducted.	[Onate, James A.; Beck, Brian C.; Van Lunen, Bonnie L.] Old Dominion Univ, Dept Exercise Sci Phys Educ & Recreat, Norfolk, VA 23529 USA		Onate, JA (corresponding author), Old Dominion Univ, Dept Exercise Sci Phys Educ & Recreat, 111 Spong Hall, Norfolk, VA 23529 USA.	jonate@odu.edu	Onate, James/E-3790-2011				Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Landers M, 2005, PHYSIOTHERAPY, V91, P152, DOI 10.1016/j.physio.2004.11.010; McCollum G, 1996, J THEOR BIOL, V180, P257, DOI 10.1006/jtbi.1996.0101; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Onate JA, 2000, J ATHL TRAINING, V35, P155; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Redfern MS, 2001, GAIT POSTURE, V14, P211, DOI 10.1016/S0966-6362(01)00144-8; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Susco TM, 2004, J ATHL TRAINING, V39, P241; THALHEIMER W, 2007, CALCULATE EFFECT SIZ; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Weeks DL, 2003, GERONTOLOGY, V49, P225, DOI 10.1159/000070402; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	35	31	32	0	11	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT-DEC	2007	42	4					446	451					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	251AQ	WOS:000252343100002	18174931				2022-02-06	
J	Wang, HE; Abo, BN; Lave, JR; Yeally, DM				Wang, Henry E.; Abo, Benjamin N.; Lave, Judith R.; Yeally, Donald M.			How would minimum experience standards affect the distribution of out-of-hospital endotracheal intubations?	ANNALS OF EMERGENCY MEDICINE			English	Article							RAPID-SEQUENCE INTUBATION; PERCUTANEOUS-CORONARY-INTERVENTION; TRAUMATIC BRAIN-INJURY; MYOCARDIAL-INFARCTION; CARE; HYPERVENTILATION; PERSONNEL; HYPOXIA	Study objective: Out-of-hospital endotracheal intubation is a complex intervention. One strategy for improving the quality of a complex intervention is to limit the procedure to practitioners or agencies that meet minimum procedure experience standards. The system-level influence of such limits is unknown. We seek to determine how minimum endotracheal intubation experience standards influence the number and distribution of out-of-hospital endotracheal intubations. Methods: We used 2003 Pennsylvania statewide emergency medical services (EMS) data. We included enclotracheal intubations that could be attributed to a valid rescuer, EMS agency, and minor civil division. We calculated the total number of enclotracheal intubations performed across the state. We calculated the absolute and relative changes in total, cardiac arrest, nonarrest, pediatric, and trauma enclotracheal intubation when the procedure was limited to on-scene rescuers meeting minimum enclotracheal intubation experience standards, ranging from zero to 20 annual enclotracheal intubations. We evaluated the same relationships when the procedure was limited to EMS agencies meeting minimum endotracheal intubation experience standards, ranging from zero to 200 annual enclotracheal intubations. We evaluated these relationships with line plots and geographic information system maps. Results: During the study period there were 11,771 enclotracheal intubations (7,854 cardiac arrest, 3,917 non-arrest, 1,325 trauma and 561 pediatric enclotracheal intubations). Limiting enclotracheal intubations to rescuers with at least 3, 5, 10, and 15 endotracheal intubations per year would result in relative endotracheal intubation reductions of 12%, 32%, 79%, and 93%, respectively. Limiting enclotracheal intubations to EMS agencies with at least 20, 30, 50, 100, and 150 endotracheal intubations per year would result in relative endotracheal intubation reductions of 15%, 27%, 41%, 65%, and 73%, respectively. Cardiac arrest endotracheal intubations would exhibit the largest absolute reduction. Conclusion: Minimum endotracheal intubation experience standards would result in absolute and relative reductions in total and subgroup endotracheal intubations. These findings provide vital perspectives about the system-wide organization of out-of-hospital airway management.	Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA USA		Wang, HE (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, 230 Mckee Pl,Suite 400, Pittsburgh, PA 15213 USA.	wanghe@upmc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS013628] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08-HS013628] Funding Source: Medline		Adams R, 2002, STROKE, V33, P326; Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL 1990; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Burton John H, 2003, Prehosp Emerg Care, V7, P352, DOI 10.1080/10903120390936554; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DELEO BC, 1977, HEART LUNG, V6, P851; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; *EM CARD CAR COMM, 2005, CIRCULATION S4, V112, P51; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GUSS DA, 1984, AM J EMERG MED, V2, P399, DOI 10.1016/0735-6757(84)90041-X; Hagberg C, 2006, ANESTH ANALG, V102, P621, DOI 10.1213/01.ane.0000189101.26403.06; Hulley S.B., 2001, DESIGNING CLIN RES E; JACOBS LM, 1983, JAMA-J AM MED ASSOC, V250, P2175, DOI 10.1001/jama.250.16.2175; Johnston BD, 2006, ACAD EMERG MED, V13, P1051, DOI 10.1197/j.aem.2006.06.031; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Luft HS, 1990, HOSP VOLUME PHYS VOL; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2006, CIRCULATION, V113, P222, DOI 10.1161/CIRCULATIONAHA.105.578195; National Highway Traffic Safety Administration, EM MED TECHN PAR NAT; Ornato JP, 1997, RESUSCITATION, V34, P3; Pepe Paul E, 2004, Crit Care Med, V32, pS414, DOI 10.1097/01.CCM.0000134264.88332.37; STEWART RD, 1984, CHEST, V85, P341, DOI 10.1378/chest.85.3.341; *US CENS BUR, GEOGR CHANG CENS 200; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Wang Henry E, 2005, Prehosp Emerg Care, V9, P156	34	31	31	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	SEP	2007	50	3					246	252		10.1016/j.annemergmed.2007.04.023			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	206YN	WOS:000249218900006	17597255				2022-02-06	
J	Suh, SW; Aoyama, K; Alano, CC; Anderson, CM; Hamby, AM; Swanson, RA				Suh, Sang Won; Aoyama, Koji; Alano, Conrad C.; Anderson, Christopher M.; Hamby, Aaron M.; Swanson, Raymond A.			Zinc inhibits astrocyte glutamate uptake by activation of poly(ADP-ribose) polymerase-1	MOLECULAR MEDICINE			English	Article; Proceedings Paper	6th Zinc Signals Conference	2006	Oliveto, ITALY				FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CELL-DEATH; NEURONAL DEATH; NITRIC-OXIDE; DNA-DAMAGE; INTRACELLULAR ZINC; ADP-RIBOSYLATION; CORTICAL-NEURONS; NERVOUS-SYSTEM	Several processes by which astrocytes protect neurons during ischemia are now well established. However, less is known about how neurons themselves may influence these processes. Neurons release zinc (Zn2+)from presynaptic terminals during ischemia, seizure, head trauma, and hypoglycemia, and modulate postsynaptic neuronal function. Peak extracellular zinc may reach concentrations as high as 400 mu M. Excessive levels of free, ionic zinc can initiate DNA damage and the subsequent activation of poly(ADP-ribose) polymerase I (PARP-1), which in turn lead to NAD(+) and ATP depletion when DNA damage is extensive. In this study, cultured cortical astrocytes were used to explore the effects of zinc on astrocyte glutamate uptake, an energy-dependent process that is critical for neuron survival, Astrocytes incubated with 100 or 400 mu M of zinc for 30 min showed significant decreases in ATP levels and glutamate uptake capacity. These changes were prevented by the PARP inhibitors benzamide or DPQ (3,4-dihydro-5-(4-(1-piperidinyl)butoxyl)-1 (2H-isoquinolinone) or PARP-1 gene deletion (PARP-1 KO). These findings suggest that release of Zn2+ from neurons during brain insults could induce PARP-1 activation in astrocytes, leading to impaired glutamate uptake and exacerbation of neuronal injury.	Vet Adm Med Ctr, Dept Neurol 127, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA		Suh, SW (corresponding author), Vet Adm Med Ctr, Dept Neurol 127, 4150 Clement St, San Francisco, CA 94121 USA.	song.suh@ucsf.edu	Anderson, Chris/J-7081-2014	Anderson, Christopher/0000-0003-0678-3002	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS041421] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS41421, R01 NS041421] Funding Source: Medline		Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Anderson CM, 2000, GLIA, V32, P1; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BURZIO LO, 1979, J BIOL CHEM, V254, P3029; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DAWSON VL, 1995, CLIN EXP PHARMACOL P, V22, P305, DOI 10.1111/j.1440-1681.1995.tb02005.x; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1659, DOI 10.1177/002215540205001210; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; GAAL JC, 1985, BIOCHEM J, V230, P1; GABRIELSSON B, 1986, BRAIN RES, V384, P218, DOI 10.1016/0006-8993(86)91157-1; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Lee H. L., 2000, International Journal of Manufacturing Technology and Management, V1, P79, DOI 10.1504/IJMTM.2000.001329; Noh KM, 2000, J NEUROSCI, V20; OBRENOVITCH TP, 1995, BRAIN METAB REV, V7, P297; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Rao VLR, 2001, NEUROCHEM RES, V26, P497; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sheline CT, 2003, EUR J NEUROSCI, V18, P1402, DOI 10.1046/j.1460-9568.2003.02865.x; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; Spiridon M, 1998, J PHYSIOL-LONDON, V506, P363, DOI 10.1111/j.1469-7793.1998.363bw.x; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2001, NEUROREPORT, V12, P1523, DOI 10.1097/00001756-200105250-00044; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; SWANSON RA, 1992, NEUROSCI LETT, V147, P143, DOI 10.1016/0304-3940(92)90580-Z; SWANSON RA, 1992, GLIA, V6, P198, DOI 10.1002/glia.440060307; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Vandenberg RJ, 1998, MOL PHARMACOL, V54, P189, DOI 10.1124/mol.54.1.189; WAHL F, 1994, J NEUROCHEM, V63, P1003; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Ying WH, 2000, NEUROREPORT, V11, P1385, DOI 10.1097/00001756-200005150-00007; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; YOKOYAMA M, 1986, NEUROSCI LETT, V71, P351, DOI 10.1016/0304-3940(86)90646-4; ZAHRADKA P, 1982, EUR J BIOCHEM, V127, P579; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	50	31	32	0	2	FEINSTEIN INST MED RES	MANHASSET	350 COMMUNITY DR, MANHASSET, NY 11030 USA	1076-1551			MOL MED	Mol. Med.	JUL-AUG	2007	13	7-8					344	349		10.2119/2007-00043.Suh			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	204NF	WOS:000249050300004	17728843	Green Published, gold			2022-02-06	
J	Tiesman, H; Young, T; Torner, JC; McMahon, M; Peek-Asa, C; Fiedler, J				Tiesman, Hope; Young, Tracy; Torner, James C.; McMahon, Mark; Peek-Asa, Corinne; Fiedler, John			Effects of a rural trauma system on traumatic brain injuries	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	133rd Annual Meeting of the American-Public-Health-Association	DEC 10-14, 2005	Philadelphia, PA	Amer Public Hlth Assoc		brain injuries; emergency medical services; rural hospitals	CARE; TRANSPORT; CHALLENGE; PATIENT	The response of trauma systems in rural areas is uncertain since distances between injury scenes and trauma care are considerable. Timely arrival at definitive care is critical for persons with traumatic brain injury (TBI) since secondary damage can occur during the hours following injury. We evaluated how the implementation of a trauma system in a predominately rural state affected the triage of TBI patients and their risk for mortality. The Iowa System Trauma Registry Dataset was analyzed, and included patients evaluated before trauma system implementation, 1997-1998, and after implementation, 2002-2003. Patients were identified using ICD9-CM codes or AIS codes, and included 710 pre-system patients and 886 post-system patients. Multivariate logistic regression assessed the effect of the trauma system on survival while controlling for confounders. Following implementation of the trauma system, patients treated in Level I or II facilities were older (p = 0.019), more often had multiple injuries (p = 0.0002), and had more severe TBI (p = 0.008). After controlling for confounders, transferred patients and those directly admitted were less likely to die in 72 h in the post-system than the pre-system (odds ratio [OR] = 0.56, 95% confidence interval (CI) = 0.36, 0.88; OR = 0.50, 95% CI = 0.32, 0.79). Implementation of the Iowa trauma system seems to have led to more appropriate triage and transport for TBI patients, and this likely contributed to reduced in-hospital mortality.	Univ Iowa, Injury Prevent Res Ctr, Iowa City, IA USA; Iowa Dept Publ Hlth, Des Moines, IA 50319 USA		Tiesman, H (corresponding author), NIOSH, Div Safety Res, 1095 Willowdale Rd,MS 1811, Morgantown, WV 26505 USA.	fto9@cdc.gov					*ACS, 1999, COMM TRAUM RES OPT C; Association for the Advancement of Automotive Medicine (AAAM), 1990, ABBR INJ SCAL 1990 R; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CALES RH, 1986, SYSTEM TRAUMA REGIST; CERTO TF, 1983, J TRAUMA, V23, P559, DOI 10.1097/00005373-198307000-00003; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLAY MN, 2001, MED CARE, V39, P643; *DIG INN INC, 2001, COLLECTOR SOFTW 1987; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; GROSSMAN DC, 1995, J TRAUMA, V38, P14, DOI 10.1097/00005373-199501000-00006; Hosmer D, 1989, APPL LOGISTIC REGRES; KEARNEY PA, 1991, ANN EMERG MED, V20, P882, DOI 10.1016/S0196-0644(05)81431-3; Lewis RJ, 2004, JAMA-J AM MED ASSOC, V291, P1382, DOI 10.1001/jama.291.11.1382; MARION DW, 1999, TRAUMATIC BRAIN INJU; Mullins RJ, 2002, J TRAUMA, V52, P1019, DOI 10.1097/00005373-200206000-00002; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1910; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; PAYNE SR, 1989, J TRAUMA, V29, P424, DOI 10.1097/00005373-198904000-00002; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; Rogers FB, 1999, J TRAUMA, V47, P802, DOI 10.1097/00005373-199910000-00038; Sollid S, 2003, J NEUROTRAUM, V20, P309, DOI 10.1089/089771503321532897; WALLER JA, 1988, J TRAUMA, V28, P1632, DOI 10.1097/00005373-198812000-00003; Wright KD, 1996, INJURY, V27, P719, DOI 10.1016/S0020-1383(96)00119-2; Young T, 2003, J EMERG MED, V24, P189, DOI 10.1016/S0736-4679(02)00724-2	26	31	32	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2007	24	7					1189	1197		10.1089/neu.2006.0196			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	186DV	WOS:000247760200010	17610358				2022-02-06	
J	Yurgel, VC; Ikuta, N; Da Rocha, AB; Lunge, VR; Schneider, RF; Fonseca, ASK; Grivicich, I; Zanoni, C; Regner, A				Yurgel, Virginia Campello; Ikuta, Nilo; Da Rocha, Adriana Brondani; Lunge, Vagner Ricardo; Schneider, Rogerio Fett; Kazantzi Fonseca, Andre Salvador; Grivicich, Ivana; Zanoni, Caroline; Regner, Andrea			Role of plasma DNA as a predictive marker of fatal outcome following severe head injury in males	JOURNAL OF NEUROTRAUMA			English	Article						plasma DNA; prognostic marker; real; time PCR; traumatic brain injury	GLASGOW COMA SCALE; TRAUMATIC BRAIN-INJURY; SERUM S-100B PROTEIN; INTRACRANIAL-PRESSURE; FETAL DNA; MATERNAL PLASMA; S100B; MANAGEMENT; MORTALITY; DAMAGE	The prediction of outcome is one of the major problems associated with traumatic brain injury. Recently, investigations have been performed on the potential use of circulating cell-free DNA in plasma for clinical diagnosis and prognosis of a variety of conditions. In this study, we investigated DNA plasma concentrations after severe traumatic brain injury (TBI) and its correlation with primary outcome. We studied 41 male victims of TBI, with isolated severe TBI or severe TBI with associated exracranial injuries. Control samples were obtained from 13 healthy male volunteers. Plasma DNA was measured by a real-time PCR assay for the beta-globin gene. The mean time for first sampling (study entry) was 11.7 +/- 5.2 h after injury; subsequent DNA determinations were performed 24 h after study entry. Mean plasma DNA concentrations were significantly increased in TBI patients (366,485 and 131,708 kilogenomes-equivalents/L, at study entry and 24 h later, respectively) compared with the control group (3031 kilogenomes-equivalents/L). Additionally, a significant correlation between higher plasma DNA concentrations, determined 24 h after study entry, and fatal outcome was observed. However, at second sampling, there was no significant correlation between plasma DNA concentrations and the presence of associated extracranial injuries. High plasma DNA concentrations at second sampling time predicted fatal outcome with a sensitivity of 67% and specificity of 76%, considering a cut-off value of 77,883 kilogenomes-equivalents/L. Thus, this study showed that severe TBI is associated with elevated DNA plasma levels and suggests that persistent DNA elevations correlate with mortality.	ULBRA, Ctr Pesquisa Ciencias Med, Lab Marcadores Estresse Celular, BR-92425900 Bairro Sao Jose Canoas, RJ, Brazil; Univ Luterana Brasil, Curso Med, Canoas, Brazil; Univ Luterana Brasil, Programa Posgrad Genet & Toxicol Aplicada, Canoas, Brazil; Univ Luterana Brasil, Programa Posgrad Diagnost Genet & Mol, Canoas, Brazil; Simbios Biotecnol, Rio Grande do Sul, Brazil; Hosp Municipal Pronto Socorro Porto Alegre, SAMU, Porto Alegre, RS, Brazil		Regner, A (corresponding author), ULBRA, Ctr Pesquisa Ciencias Med, Lab Marcadores Estresse Celular, Avenida Farroupilha 8001,Predio 22,5 Andar, BR-92425900 Bairro Sao Jose Canoas, RJ, Brazil.	regner@uol.com.br	Regner, Andrea/M-2596-2014; Grivicich, Ivana/A-6777-2013; Lunge, Vagner/D-7915-2013	Regner, Andrea/0000-0002-6657-7991; Grivicich, Ivana/0000-0001-9820-5730; Lunge, Vagner/0000-0003-4012-8650			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Basso A, 2001, WORLD J SURG, V25, P1174; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Burns S, 2004, ANN NY ACAD SCI, V1022, P323; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; FACKELMAYER FO, 2001, CANCER RES, V61, P1659; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Jarrar D, 2000, AM J PHYSIOL-HEART C, V279, pH1015, DOI 10.1152/ajpheart.2000.279.3.H1015; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Johnson PJ, 2002, CLIN CHEM, V48, P1186; Lai Y. C., 1998, Annals Academy of Medicine Singapore, V27, P326; Lam NYL, 2004, CLIN CHEM, V50, P213, DOI 10.1373/clinchem.2003.025783; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; Leone M, 2003, CHEST, V124, P2261, DOI 10.1378/chest.124.6.2261; Lo YMD, 1998, LANCET, V351, P1329, DOI 10.1016/S0140-6736(05)79055-3; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Navratil O, 2006, Bratisl Lek Listy, V107, P110; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Regner A, 2001, NEUROREPORT, V12, P691, DOI 10.1097/00001756-200103260-00015; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rothoerl RD, 1999, BRAIN INJURY, V13, P387; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Wang BG, 2003, CANCER RES, V63, P3966; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZAGARA G, 1992, J NEUROSURG SCI, V35, P77; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	44	31	34	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2007	24	7					1172	1181		10.1089/neu.2006.0160			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	186DV	WOS:000247760200008	17610356				2022-02-06	
J	Saboori, M; Ahmadi, M; Farajzadegan, Z				Saboori, Masih; Ahmadi, Mal; Farajzadegan, Zahra			Indications for brain CT scan in patients with minor head injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						minor head injury; brain CT scan; head traurna; mild head injury; computed tomography; traumatic brain injury	COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; INITIAL MANAGEMENT; TRAUMA; RISK; GUIDELINES; EXPERIENCE; ADMISSION; DIAGNOSIS; RULE	Objectives: Minor head injury is the most common type of head injury. Despite of high incidence and numerous studies performed, there is much controversy about correct evaluation of these patients. The aim of this study was to find clinical signs and symptoms which help to predict the indications for brain CT scan following minor head injury. Methods: A series of 682 consecutive patients who had been attended at two university hospitals (Alzahra and Kashani) with minor head injury (GCS = 15) were prospectively enrolled in this cohort study. In all cases clinical signs and symptoms were collected and a cranial computerized tomography (CT) scan was obtained. The relationship between the occurrence of clinical findings and appearance of intracranial posttraumatic lesions on cranial CT was analyzed by chi-square tests and statistic logistic regression methods, with 95% confidence intervals. Results: Of 682 patients, 46 (6.7%) presented brain injuries on CT scan. All patients with abnormal CT scans had at least one of the following factors (risk factors): posttraumatic amnesia, loss of consciousness, posttraumatic seizure, headache, vomiting, focal neurological deficit, skull fracture, coagulopathy or antecedent of treatment with anticoagulants and patient age older than 60 years. No abnormal CT scans were found among patients without any of those risk factors on admission. Vomiting, skull fracture and age greater than 60 years were risk factors significantly correlated to an abnormal cranial CT after head injury. The presence of several risk factors in a patient increased the probability of posttraumatic lesion on CT scan. Conclusion: Some clinical risk factors can be used as a guide to predict the probability of abnormal CT following minor head injury. (C) 2007 Elsevier B.V. All rights reserved.	Med Univ Isfahan, Dept Neurosurg, Sch Med, Esfahan, Iran; Isfahan Med Sch, Community Med Dept, Esfahan, Iran		Ahmadi, M (corresponding author), Med Univ Isfahan, Dept Neurosurg, Sch Med, Esfahan, Iran.	masih_saboori@yahoo.com; j_ahmadi@Resident.mui.ac.ir	saboori, masih/C-5247-2018	farajzadegan, ziba/0000-0001-8548-2843; Saboori, masih/0000-0002-1782-778X			Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Bellner J, 1999, Lakartidningen, V96, P5196; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brell M, 2001, NEUROCIRUGIA, V12, P105; DUUS BR, 1994, ANN EMERG MED, V23, P1279, DOI 10.1016/S0196-0644(94)70352-3; Eng J, 2003, NEUROIMAG CLIN N AM, V13, P273, DOI 10.1016/S1052-5149(03)00015-7; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; GETE Y, 2001, ULUS TRAVMA DERG, V7, P189; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; GREENBERG MS, 2004, HDB NEUROSURGERY, P626; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hung CC, 1996, J FORMOS MED ASSOC, V95, P294; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; LEVITT MA, 1994, ANN EMERG MED, V23, P1143; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MILLER EC, 1997, J EMERGENCY MED, V15, P435; Miller PF, 1996, SRA-J SOC RES ADMIN, V27, P3; Muller K, 2003, J TRAUMA, V55, P1029, DOI 10.1097/01.TA.0000100371.49160.2A; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; Nee PA, 1999, J NEUROL NEUROSUR PS, V66, P470, DOI 10.1136/jnnp.66.4.470; Rees PM, 2004, ARCH PHYS MED REHAB, V85, P862, DOI 10.1016/j.apmr.2004.03.002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Romner B, 2000, Lakartidningen, V97, P3186; Sacco Frank, 2004, Alaska Med, V46, P58; SERVADEI F, 1993, SURG NEUROL, V39, P269, DOI 10.1016/0090-3019(93)90003-J; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Servadei F, 2004, YOUMANS NEUROSURGICA, P5065; SHACKFORD SR, 1993, J TRAUMA, V35, P490, DOI 10.1097/00005373-199309000-00031; Shiomi N, 2004, NEUROL SURG TOKYO, V32, P465; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Viola L, 2000, ACTA NEUROCHIR, V142, P1281, DOI 10.1007/s007010070026; Von Wild K, 2001, BRAIN INJURY, V15, P273; WILKE GM, 2000, AM J EMERG MED, V18, P159; 1996, J NEUROSURG SA, V40, P11	46	31	33	2	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2007	109	5					399	405		10.1016/j.clineuro.2007.01.013			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	171UN	WOS:000246761000002	17350162				2022-02-06	
J	Glang, A; McLaughlin, K; Schroeder, S				Glang, Ann; McLaughlin, Karen; Schroeder, Susan			Using interactive multimedia to teach parent advocacy skills: An exploratory study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						advocacy; communication skills; interactive multimedia; parent training; traumatic brain injury; Web-based training	TRAUMATIC BRAIN-INJURY; PROBLEM-SOLVING INTERVENTION; PRELIMINARY EFFICACY; FAMILY INTERVENTION; ACADEMIC PLACEMENT; SOCIAL SUPPORT; CHILDREN; TERM; REHABILITATION; ADAPTATION	Objective: To examine the efficacy of Brain Injury Partners: Advocacy Skills for Parents, an interactive multimedia intervention that provides training in educational advocacy skills for parents of children with traumatic brain injury (TB I). Design: Randomized trial, with participants assigned to treatment (Brain Injury Partners CD-ROM) or control (alternate CD-ROM) conditions. Main Outcome Measures: Knowledge; skill application; and attitude, behavioral intention, and self efficacy to use key advocacy skills. Participants: Thirty-one parents of children with TBI. Results: The Brain Injury Partners group reported higher postintervention adjusted means for application, knowledge, and attitudes scale scores than did the control group. Conclusions: The results demonstrate the utility of a computer-delivered intervention for training parents in key skills for communicating with school personnel.	Oregon Ctr Appl Sci, Eugene, OR 97401 USA		Glang, A (corresponding author), Oregon Ctr Appl Sci, 260 E 11th Ave, Eugene, OR 97401 USA.	aglang@orcasinc.com		Glang, Ann/0000-0002-3057-1977	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43HD042892, R44HD042892] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD42892] Funding Source: Medline		Ajzen I., 1980, UNDERSTANDING ATTITU; Ajzen I., 2000, EUR REV SOC PSYCHOL, V11, P1, DOI DOI 10.1080/14792779943000116; ALLEN DA, 1987, MENT RETARD, V25, P133; Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Balcazar FE, 1996, MENT RETARD, V34, P341; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bandura A., 1977, SOCIAL LEARNING THEO; Bandura A, 1997, SELFEFFICACY EXERCIS; Beauchamp N, 2005, GERONTOLOGIST, V45, P793, DOI 10.1093/geront/45.6.793; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; *BRAIN RES INF NET, 2002, TENN BRAIN INJ COAL; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Centers for Disease Control and Prevention, NAT CTR HLTH STAT IN; Chapman PM, 2000, ENVIRON TOXICOL CHEM, V19, P3, DOI [10.1002/etc.5620190102, 10.1897/1551-5028(2000)019&lt;0003:WETTUL&gt;2.3.CO;2]; Cohen J., 2013, STAT POWER ANAL BEHA; Conoley J.C., 1997, CHILDHOOD TRAUMATIC, P177; DEPOMPEI R, 1999, REHABILITATION ADULT, P393; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Duncan TE, 2000, J BEHAV MED, V23, P59, DOI 10.1023/A:1005420304147; *ED TEST SERV, 1991, FOCUS, V26, P1; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; FEHRMANN PG, 1987, J EDUC RES, V80, P330, DOI 10.1080/00220671.1987.10885778; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; GLANG A, 1996, CHILDREN ACQUIRED BR, P149; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Henderson A.T., 1987, EVIDENCE CONTINUES G; HOOD D, 1999, FAMILY ADVOCACY SKIL; HOOD DR, 2001, HDB FAMILY ADVOCATES; Hourcade JJ, 2001, EDUC TRAIN MENT RET, V36, P272; Irvine AB, 2004, HEALTH EDUC RES, V19, P290, DOI 10.1093/her/cyg027; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Leathem J, 1996, BRAIN INJURY, V10, P27; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; MARTIN R, 1988, J LEARN DISABIL, V21, P471, DOI 10.1177/002221948802100804; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; PLUNGE M, 1996, BEHAV APPROACH ASSES, P583; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; SELIGMAN M, 1983, FAMILY HANDICAPPED C; SKINNER CS, 1994, AM J PUBLIC HEALTH, V84, P43, DOI 10.2105/AJPH.84.1.43; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TURNBULL AP, 1986, FAMILIES PROFESSIONA; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Walker B., 1989, SUPPORT CAREGIVING F, P103; Walker B.R., 1996, STUDENTS ACQUIRED BR, P295; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109; [No title captured]	69	31	31	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2007	22	3					198	205		10.1097/01.HTR.0000271121.42523.3a			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	174OH	WOS:000246951100007	17510596				2022-02-06	
J	Tarazi, RA; Mahone, EM; Zabel, TA				Tarazi, Reem A.; Mahone, E. Mark; Zabel, T. Andrew			Self-care independence in children with neurological disorders: An interactional model of adaptive demands and executive dysfunction	REHABILITATION PSYCHOLOGY			English	Article						executive function; adaptive skills; adolescent; transition	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; BEHAVIOR RATING INVENTORY; OF-THE-LITERATURE; HEAD-INJURY; INPATIENT REHABILITATION; NEUROPSYCHOLOGICAL TESTS; ECOLOGICAL VALIDITY; SEVERE HYPOGLYCEMIA; TOURETTE-SYNDROME	Objective: To describe a neuropsychological assessment model that proposes executive functioning as a key moderator in the development of self-care independence. Setting: Inpatient and outpatient rehabilitation facilities. Participants: Transition-age youths with congenital and acquired neurological disorders. Intervention: Transition to the adaptive roles and expectations of adulthood can be challenging for adolescents with neurological disorders and other chronic medical conditions. These individuals frequently encounter functional problems related to additional time requirements, new life skill demands, and increased need for organization and planning. In addition, the neuropsychological consequences of these disorders often include deficits in motor speed and coordination as well as executive control (including planning, organization, and working memory). Consideration of the integrity of executive function skills and the presence of atypical adaptive demands is crucial during planning for transition of individuals into self-care independence and development of an approach to assessment and intervention. Conclusions: Rehabilitation psychologists have the potential to improve the quality of life of adolescents with neurological disorders as they transition into adulthood by considering the "executive burden" posed to the individuals by various combinations of executive dysfunction and atypical adaptive demands.	Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21218 USA		Zabel, TA (corresponding author), Kennedy Krieger Inst, Dept Neuropsychol, 1750 E Fairmt Ave, Baltimore, MD 21231 USA.	zabela@kennedykrieger.org					Anderson CJ, 1998, J VOC REHABIL, V10, P103; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderton S, 2005, CHEM WORLD-UK, V2, P19; Arnett JJ, 1998, HUM DEV, V41, P295, DOI 10.1159/000022591; Bedell Gary M, 2002, Pediatr Rehabil, V5, P107, DOI 10.1080/1363849021000013540; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BORJESON MC, 1990, DEV MED CHILD NEUROL, V32, P698; Boss B J, 1994, SCI Nurs, V11, P3; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; BROWN M, 1987, ARCH PHYS MED REHAB, V68, P828; Buran CF, 2004, DEV MED CHILD NEUROL, V46, P244, DOI 10.1017/S0012162204000404; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cummings DD, 2002, CLIN NEUROPHARMACOL, V25, P325, DOI 10.1097/00002826-200211000-00009; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Davis M, 2005, J BEHAV HEALTH SER R, V32, P27, DOI 10.1007/BF02287326; Denckla MB, 1996, J DEV BEHAV PEDIATR, V17, P114; Erickson David V, 2004, J Wound Ostomy Continence Nurs, V31, P215; Farias ST, 2003, ARCH CLIN NEUROPSYCH, V18, P655, DOI 10.1016/S0887-6177(02)00159-2; Farmer J E, 1995, Appl Neuropsychol, V2, P107, DOI 10.1207/s15324826an0203&4_2; Fletcher JM, 2005, J NEUROSURG, V102, P268, DOI 10.3171/ped.2005.102.3.0268; Fletcher JM, 1996, DEV NEUROPSYCHOL, V12, P1, DOI 10.1080/87565649609540636; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA IP, 2000, BEHAV RATING INVENTO; GOLDSTEIN LH, 1993, J NEUROL NEUROSUR PS, V56, P274, DOI 10.1136/jnnp.56.3.274; Hannonen R, 2003, DEV MED CHILD NEUROL, V45, P262, DOI 10.1017/S0012162203000501; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hill, 1996, SCALES INDEPENDENT B; Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P177, DOI 10.1093/jpepsy/27.2.177; Hommet C, 1999, J CHILD NEUROL, V14, P144, DOI 10.1177/088307389901400302; Hooper CJ, 2004, DEV PSYCHOL, V40, P1148, DOI 10.1037/0012-1649.40.6.1148; Iddon JL, 2004, J NEUROL NEUROSUR PS, V75, P1112, DOI 10.1136/jnnp.2003.029058; Kilkens OJE, 2005, J REHABIL RES DEV, V42, P65, DOI 10.1682/JRRD.2004.08.0093; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1257, DOI 10.1016/j.apmr.2003.08.108; Ku JH, 2005, UROL RES, V33, P435, DOI 10.1007/s00240-005-0504-4; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Loss N, 1998, CHILD NEUROPSYCHOL, V4, P7, DOI 10.1076/chin.4.1.7.3192; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Mahone EM, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P287; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P258, DOI 10.1076/chin.8.4.258.13510; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P52, DOI 10.1076/chin.8.1.52.8719; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Mather N., 1990, WOODCOCK JOHNSON PSY; Nigg JT, 2005, J ABNORM PSYCHOL, V114, P706, DOI 10.1037/0021-843X.114.3.706; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; RICHARDS JS, 1991, ARCH PHYS MED REHAB, V72, P275; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; Russell EW, 2001, CLIN NEUROPSYCHOL, V15, P423, DOI 10.1076/clin.15.3.423.10267; Samuelson J J, 1992, Arch Psychiatr Nurs, V6, P287, DOI 10.1016/0883-9417(92)90040-P; Sawin Kathleen J, 2003, SCI Nurs, V20, P72; Schillerstrom JE, 2005, PSYCHOSOMATICS, V46, P508, DOI 10.1176/appi.psy.46.6.508; Schuck SEB, 2005, J LEARN DISABIL-US, V38, P262, DOI 10.1177/00222194050380030701; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Snow JH, 1999, CHILD HEALTH CARE, V28, P241, DOI 10.1207/s15326888chc2803_3; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Stineman MG, 1999, SPINAL CORD, V37, P717, DOI 10.1038/sj.sc.3100914; Strudwick SK, 2005, J PEDIATR-US, V147, P680, DOI 10.1016/j.jpeds.2005.06.010; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002; TARAZI R, 2007, J INT NEUROPSYCH SOC, V13, P168; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Thompson PM, 2005, INT REV NEUROBIOL, V67, P285, DOI 10.1016/S0074-7742(05)67009-2; Tsai PY, 2002, CHILD NERV SYST, V18, P48, DOI 10.1007/s00381-001-0531-6; Watkins LH, 2005, PSYCHOL MED, V35, P571, DOI 10.1017/S0033291704003691; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wells T, 2003, SOC FORCES, V82, P803, DOI 10.1353/sof.2004.0029; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WHO, 2002, INT CLASS FUNCT DIS; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; WOLRAICH M L, 1988, Pediatrician, V15, P21; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; ZABEL TA, 2004, CEREBROSPINAL FLUID, V1, pS57	88	31	31	2	13	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2007	52	2					196	205		10.1037/0090-5550.52.2.196			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	167EL	WOS:000246433900009					2022-02-06	
J	Ward, H; Shum, D; McKinlay, L; Baker, S; Wallace, G				Ward, Heather; Shum, David; McKinlay, Lyn; Baker, Simone; Wallace, Geoff			Prospective memory and pediatric traumatic brain injury: Effects of cognitive demand	CHILD NEUROPSYCHOLOGY			English	Article							WORKING-MEMORY; FRONTAL-LOBE; HEAD-INJURY; EXPLICIT MEMORY; CHILDREN; PERFORMANCE; CHILDHOOD; TASK; IMPLICIT; LESIONS	This study investigated the effects of pediatric traumatic brain injury (TBI) on prospective memory. Fourteen children and 14 adolescents with TBI were compared with 25 and 23 noninjured children and adolescents, respectively. Based on a prefrontal model, the cognitive demand on the ongoing component of a prospective-memory task was manipulated. Overall, those with TBI had poorer prospective-memory performance than their noninjured peers. Performance was worse in a high cognitive-demand condition than a low, and younger children performed worse than adolescents. Decreases in performance from the low- to high-demand conditions were not significantly different between the two children's groups but were between the two adolescents' groups. Furthermore, the age and injury effects were reflected in the performances on executive function tests: the Self-ordered Pointing Task (SOPT), and the Stroop Color Word Interference Test The Tower of London (TOL), which did not produce age or injury effects, was nevertheless found to be an important predictor of performance on the high-demand task in those with TBI. Although previous research has demonstrated impaired prospective memory performance in children with TBI, this study attempted to explain why this might occur, specifically that the prefrontal regions might be implicated.	Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; Griffith Univ, Appl Cognit Neurosci Res Ctr, Brisbane, Qld 4111, Australia; Royal Childrens Hosp, Queenland Paediat Rehabil Serv, Brisbane, Qld, Australia; Mater Childrens Hosp, Brisbane, Qld, Australia		Shum, D (corresponding author), Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia.	d.shum@griffith.edu.au	Wallace, Geoff/H-1252-2013; Shum, David/A-3914-2008	Wallace, Geoff/0000-0001-9306-3542; Shum, David/0000-0002-4810-9262; McKinlay, Lynne/0000-0002-6677-0628			ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Adelson PD, 1999, TRAUMATIC BRAIN INJU, P283; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; BROADBENT NJ, 2002, NEUROPSYCHOLOGY MEMO, P3; *CEDR CORP, 1966, SUPERLAB PRO EXP LAB; CLUTTERBUCK PM, 1990, ART TEACHING SPELLIN; DAIGNEAULT S, 1993, J CLIN EXP NEUROPSYC, V15, P881, DOI 10.1080/01688639308402605; DIAMOND A, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P339; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Golden C, 2000, NEUROPSYCHOLOGICAL I; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; HART K, 1988, J CLIN PSYCHOL, V44, P780, DOI 10.1002/1097-4679(198809)44:5<780::AID-JCLP2270440519>3.0.CO;2-1; HITCH GJ, 1988, MEM COGNITION, V16, P120, DOI 10.3758/BF03213479; HITCH GJ, 1989, MEM COGNITION, V17, P175, DOI 10.3758/BF03197067; Holbourn AHS, 1943, LANCET, V2, P438; Howell D. C., 1999, FUNDAMENTAL STAT BEH, V4th; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Leynes PA, 2003, CONSCIOUS COGN, V12, P1, DOI 10.1016/S1053-8100(02)00002-8; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; MAUJEAN A, 2003, BRAIN IMPAIRMENT; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Raizner RD, 2002, DEV NEUROPSYCHOL, V21, P1, DOI 10.1207/S15326942DN2101_1; RUSSO R, 1995, J EXP CHILD PSYCHOL, V59, P566, DOI 10.1006/jecp.1995.1026; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Shum D, 2000, BRAIN COGNITION, V44, P59; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P149, DOI 10.1076/jcen.21.2.149.929; Shum D. H. K., 1990, CLIN NEUROPSYCHOL, V4, P141; SNODGRASS JG, 1989, IMPLICIT MEMORY THEO, P261; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Tanner JM., 1990, FOETUS MAN PHYS GROW; TUNSTALL J, 1999, UNPUB IMPROVING UTIL; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; Ward H, 2005, CHILD NEUROPSYCHOL, V11, P527, DOI 10.1080/09297040490920186; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Yamadori A, 1996, COGNITIVE BRAIN RES, V5, P49, DOI 10.1016/S0926-6410(96)00040-7; YIVISAKER M, 1998, TRAUMATIC BRAIN INJU, P1	51	31	32	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	MAY	2007	13	3					219	239		10.1080/09297040600910003			21	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	164BR	WOS:000246208100002	17453831				2022-02-06	
J	Schultheis, MT; Rehimbas, J; Mourant, R; Millis, SR				Schultheis, Maria T.; Rehimbas, Jose; Mourant, Ronald; Millis, Scott R.			Examining the usability of a virtual reality driving simulator	ASSISTIVE TECHNOLOGY			English	Article						virtual reality; driving; cognition; user feedback; usability; human factors	REHABILITATION; PERFORMANCE	The current study examined specific aspects of usability of a newly developed VR driver rehabilitation (VR-DR) system. Measures of user feedback and user comfort were examined among 54 participants: 33 individuals with acquired brain injury (20 with traumatic brain injury and 13 with cerebral vascular accident) and 21 healthy controls. All participants were administered the VR-DR and completed the VR-DR User Feedback Questionnaire. To examine group differences, a one-way analysis of variance was performed, comparing the user feedback total score between the three groups. The results indicated that the two clinical populations (traumatic brain injury and cerebral vascular accident) varied from the nonclinical population (healthy controls). A standard multiple regression analysis revealed that age was the only significant participant factor that contributed to the differences in user feedback ratings. Finally, consistent across the three groups, a distinct relationship was found between the self-reported user rating and the onset of simulation sickness. The current findings indicate that individuals with traumatic brain injury and cerebral vascular accident provided less favorable user feedback ratings than healthy controls in the use of a new VR-DR system. This difference was not accounted for by differences in gender, education, or cognitive status and was only slightly accounted for by age. Delineating these various aspects of user feedback can assist in identifying potential confounds in VR-DR performance and help refine the application of the VR-DR for clinical decision making.	Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Northeastern Univ, Dept Mech Engn, Boston, MA 02115 USA; Rehabil Inst Michigan, Detroit, MI USA		Schultheis, MT (corresponding author), Drexel Univ, Dept Psychol, 3141 Chestnut St,PSA 218, Philadelphia, PA 19104 USA.	schultheis@drexel.edu		Schultheis, Maria/0000-0002-6558-548X			Brooks BM, 2003, NEUROREHABILITATION, V18, P147; Burdea G, 1997, Stud Health Technol Inform, V39, P141; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; HIMELSTEIN J, 2003, J INT NEUROPSYCH SOC, V9, P236; HIX D, 2005, 28 INT C REH ENG ASS; HIX D, 2002, HDB VIRTUAL ENV, P701; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; MATHEIS R, 2003, P 2 INT WORKSH VIRT; McComas J, 2002, CYBERPSYCHOL BEHAV, V5, P185, DOI 10.1089/109493102760147150; Morris MG, 2000, PERS PSYCHOL, V53, P375, DOI 10.1111/j.1744-6570.2000.tb00206.x; Preece Jenny., 1994, HUM-COMPUT INTERACT; Rizzo M, 2004, TRANSPORT RES REC, P1; Scerbo M. W., 2005, HUMAN FACTORS ERGONO, V48, P1; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; Schultheis MT, 2001, PRESENCE-TELEOP VIRT, V10, P431, DOI 10.1162/1054746011470271; Schultheis MT, 2001, NEUROLOGY, V56, P1089, DOI 10.1212/WNL.56.8.1089; SCHULTHEIS MT, 2001, ANN C NEW JERS BRAIN; SCHULTHEIS MT, 2005, 11 ANN M INT HUM COM; SCHULTHEIS MT, 2004, ARCH CLIN NEUROPSYCH, V19, P905; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wald J, 2001, ST HEAL T, V81, P564; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	24	31	31	1	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1040-0435	1949-3614		ASSIST TECHNOL	Assist. Technol.	SPR	2007	19	1					1	8		10.1080/10400435.2007.10131860			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	155XA	WOS:000245610700001	17461285				2022-02-06	
J	Vilar-Lopez, R; Santiago-Ramajo, S; Gomez-Rio, M; Verdejo-Garcia, A; Llamas, JM; Perez-Garcia, M				Vilar-Lopez, Raquel; Santiago-Ramajo, S.; Gomez-Rio, Manuel; Verdejo-Garcia, Antonio; Llamas, Jose M.; Perez-Garcia, Miguel			Detection of malingering in a Spanish population using three specific malingering tests	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; post-concussion syndrome; Spanish speakers; VSVT; TOMM; b test	SYMPTOM VALIDITY TEST; MEMORY IMPAIRMENT; PERFORMANCE; NEUROPSYCHOLOGY; VALIDATION; HISCOCK; RATES	\The detection of feigned cognitive impairment remains difficult and may be even more challenging in certain population groups. Studies on the use of neuropsychological tests in ethnic groups for which they were not designed have shown variations in performance associated with cultural differences. With this background, our group studied a Spanish population by applying commonly used procedures [Victoria Symptom Validity Test (VSVT), Test of Memory Malingering (TOMM), and the b test] in a group with post-concussion syndrome (PCs) (whether litigants or not) and in a group of analog malingerers (AN). These tests appeared to function adequately in this Spanish population, who showed similar performances to results published for North Americans. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Univ Granada, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, E-18071 Granada, Spain; Univ Granada, Hosp Virgen de las Nieves, Med Serv, E-18071 Granada, Spain; Univ Granada, Inst Neurosci, E-18071 Granada, Spain		Vilar-Lopez, R (corresponding author), Univ Granada, Fac Psicol, Dept Personalidad Evaluac & Tratamiento Psicol, Campus Cartuja S-N, E-18071 Granada, Spain.	raquelvilarlopez@hotmail.com	Garcia, Miguel Perez/F-9630-2010; Vilar-Lopez, Raquel/I-7847-2016; Santiago-Ramajo, Sandra/H-6801-2015; Verdejo-Garcia, Antonio/AAV-1147-2021	Garcia, Miguel Perez/0000-0003-4775-7556; Vilar-Lopez, Raquel/0000-0001-9639-0143; Santiago-Ramajo, Sandra/0000-0002-6358-6155; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Llamas-Elvira, Jose Manuel/0000-0002-4661-5030			Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; Bezeau S, 2001, J CLIN EXP NEUROPSYC, V23, P399, DOI 10.1076/jcen.23.3.399.1181; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P461, DOI 10.1076/clin.15.4.461.1890; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boone K., 2002, B TEST MANUAL; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gouvier WD, 2003, NEURO S B C, P405; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Holmquist LA, 2002, ARCH CLIN NEUROPSYCH, V17, P143, DOI 10.1016/S0887-6177(00)00106-2; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Prigatano GP, 1997, ARCH CLIN NEUROPSYCH, V12, P609, DOI 10.1016/S0887-6177(97)00020-6; Puente A. E., 2000, HDB MULTICULTURAL ME, P419; PUENTE AE, 2000, HDB PSYCHOL ASSESSME, P527; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Verdejo A, 2004, REV NEUROLOGIA, V39, P60, DOI 10.33588/rn.3901.2004229; World Health Organization, 2004, ICD 10 INT STAT CLAS; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	34	31	32	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2007	22	3					379	388		10.1016/j.acn.2007.01.012			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	196IO	WOS:000248475100012	17303375	Bronze			2022-02-06	
J	Zhang, ZY; Zhang, ZR; Fauser, U; Artelt, M; Burnet, M; Schluesener, HJ				Zhang, Zhiyuan; Zhang, Zhiren; Fauser, Uwe; Artelt, Matthias; Burnet, Michael; Schluesener, Hermann J.			FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						traumatic brain injury; FTY720; MHC-II; EMAP-II; monocytes	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ACTIVATING POLYPEPTIDE-II; SPINAL-CORD; INFLAMMATORY RESPONSE; LYMPHOCYTE EGRESS; HUMAN MICROGLIA; AXONAL INJURY; HLA-DR; EXPRESSION; CYTOKINES	FTY720 (Fingolimod) is a novel type of immunosuppressive agent inhibiting lymphocyte egress from secondary lymphoid tissues thereby causing peripheral lymphopenia. FTY720 can inhibit macrophage infiltration into inflammatory lesions under pathological conditions. FTY720 has been clinically evaluated for prophylaxis of allograft rejection and treatment of multiple sclerosis, showing promising immunosuppressive effects. A robust inflammatory response after traumatic brain injury (TBI) plays an important role in the secondary or delayed injuries of TBI. Here we have investigated by immunohistochemistry in a rat TBI model the effects of FTY720 on early cell accumulation into the inflammatory tissue response and on expression of major histo-compatibility complex class II (MHC-II) and endothelial-monocyte activating polypeptide II (EMAP-II). Accumulation of MHC-II+ or EMAP-II+ cells became significant 1 day after injury and continuously increased during the early time periods. Further, double-staining experiments confirmed that the major cellular sources of MHC-II were reactive macrophages, however MHC-II+ cells only constituted a small subpopulation of reactive macrophages. Immediately after TBI, peripheral administration of FTY720 (1 mg/kg in 1 mL saline, every second day) significantly attenuated the accumulation of MHC-II+ macrophages from Day 1 to 4 and significantly attenuated the accumulation of EMAP-II+ macrophages/microglia at Day 4. Our findings show that FTY720 attenuates early accumulation of EMAP-II+ and MHC-II+ reactive monocytes following TBI, indicating that FTY720 might be a drug candidate to inhibit brain inflammatory reaction following TBI.	Univ Tubingen, Inst Brain Res, D-72076 Tubingen, Germany; Synovo GmbH, Tubingen, Germany		Zhang, ZR (corresponding author), Univ Tubingen, Inst Brain Res, Calwer Str 3, D-72076 Tubingen, Germany.	zhangzhiren@yahoo.com	Burnet, Michael/AAB-2958-2019; Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835			ADACHI K, 1995, BIOORG MED CHEM LETT, V5, P853, DOI 10.1016/0960-894X(95)00127-F; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adelson PD, 1998, ACT NEUR S, V71, P104; AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; CARLOS TM, 1994, BLOOD, V84, P2068; Cho BP, 2006, GLIA, V53, P92, DOI 10.1002/glia.20265; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; DESIMONE R, 1995, J NEUROPATH EXP NEUR, V54, P175; Engel S, 1996, ACT NEUR S, V66, P87; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; FUJITA T, 1995, BIOORG MED CHEM LETT, V5, P847, DOI 10.1016/0960-894X(95)00126-E; GEHRMANN J, 1992, LAB INVEST, V67, P100; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; GRAEBER MB, 1994, NEUROPATH APPL NEURO, V20, P406, DOI 10.1111/j.1365-2990.1994.tb00987.x; Graeber MB, 1998, J NEUROSCI RES, V52, P1; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Kaneider NC, 2004, FASEB J, V18, P1309, DOI 10.1096/fj.03-1050fje; KAO J, 1992, J BIOL CHEM, V267, P20239; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Knies UE, 1998, P NATL ACAD SCI USA, V95, P12322, DOI 10.1073/pnas.95.21.12322; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; MCGEER PL, 1988, ACTA NEUROPATHOL, V76, P550, DOI 10.1007/BF00689592; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MORI N, 1992, EPILEPSIA, V33, P994, DOI 10.1111/j.1528-1157.1992.tb01749.x; Mueller CA, 2003, J NEUROTRAUM, V20, P1007, DOI 10.1089/089771503770195858; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; Rausch M, 2004, J MAGN RESON IMAGING, V20, P16, DOI 10.1002/jmri.20057; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Schmitt AB, 1998, NEUROPATH APPL NEURO, V24, P167; Schmitt AB, 2000, ACTA NEUROPATHOL, V100, P528, DOI 10.1007/s004010000221; Soares HD, 1995, J NEUROSCI, V15, P8223; STREIT WJ, 1989, EXP NEUROL, V105, P115, DOI 10.1016/0014-4886(89)90111-8; Suzuki S, 1996, TRANSPLANTATION, V61, P200, DOI 10.1097/00007890-199601270-00006; Tas MPR, 1996, INT J BIOCHEM CELL B, V28, P837, DOI 10.1016/1357-2725(96)00038-6; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; WEINSTEIN DL, 1990, J NEUROSCI RES, V26, P55, DOI 10.1002/jnr.490260107; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9	46	31	35	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	MAR-APR	2007	11	2					307	314		10.1111/j.1582-4934.2007.00019.x			8	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	166WX	WOS:000246412600008	17488479	Bronze, Green Published			2022-02-06	
J	Lark, SD; McCarthy, PW				Lark, Sally D.; McCarthy, Peter W.			Cervical range of motion and proprioception in rugby players versus non-rugby players	JOURNAL OF SPORTS SCIENCES			English	Article						cervical; range of motion; whiplash; neck; rugby; spine	HUMAN PERCEPTION; INJURIES; SPINE; HEAD; EPIDEMIOLOGY; STIMULATION; ORIENTATION; RELIABILITY; FOOTBALL; ROTATION	In this study, we examined the effects of number of years of playing rugby on neck function. Active cervical spine range of motion and proprioception were assessed in 14 non-rugby-playing but trained sportsmen ( mean age 28 years, s 7) and 46 rugby players ( 26 rugby forwards: mean age 26 years, s 5; mean years played 14 years; 20 backs: mean age 24 years, s 5; mean years played 14 years). Active cervical range of motion in flexion, extension, left and right lateral flexion, plus left and right rotation were measured using a cervical range of motion device. The ability to reposition the head in a central position with eyes closed was taken as a measure of proprioception. Results show that rugby forwards generally had the least active cervical range of motion, particularly neck extension ( forwards, 438; backs, 558; controls, 588), with the decrement correlating with the number of years played. In addition, repositioning was significantly worse in rugby players after neck extension than non- rugby players ( 68 vs. 38). The active cervical range of motion of rugby forwards is similar to that of whiplash patients, suggesting that participation in rugby can have an effect on neck range of motion that is equivalent to chronic disability. Reduced active cervical range of motion could also increase the likelihood of injury and exacerbate agerelated neck problems.	Univ Glamorgan, Sch Appl Sci, Pontypridd CF37 1DL, Wales		Lark, SD (corresponding author), Univ Glamorgan, Sch Appl Sci, Pontypridd CF37 1DL, Wales.	slark@glam.ac.uk					BARIN K, 1992, OTOLARYNG HEAD NECK, V106, P355, DOI 10.1177/019459989210600407; Berge J, 1999, AM J SPORT MED, V27, P422, DOI 10.1177/03635465990270040401; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Bottini E, 2000, BRIT J SPORT MED, V34, P94, DOI 10.1136/bjsm.34.2.94; CAPUANOPUCCI D, 1991, ARCH PHYS MED REHAB, V72, P338; Cohen J., 2013, STAT POWER ANAL BEHA; Dall'Alba PT, 2001, SPINE, V26, P2090, DOI 10.1097/00007632-200110010-00009; Feipel V, 1999, CLIN BIOMECH, V14, P462, DOI 10.1016/S0268-0033(98)90098-5; Gabbett TJ, 2000, BRIT J SPORT MED, V34, P98, DOI 10.1136/bjsm.34.2.98; GARFIN SR, 1995, SPINE, V20, P1810, DOI 10.1097/00007632-199508150-00012; GARRAWAY M, 1995, LANCET, V345, P1485; Karnath HO, 2002, EXP BRAIN RES, V143, P350, DOI 10.1007/s00221-001-0996-2; Kogler A, 2000, ACTA OTO-LARYNGOL, V120, P151; Loudon JK, 1997, SPINE, V22, P865, DOI 10.1097/00007632-199704150-00008; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Mergner T, 1997, J VESTIBUL RES-EQUIL, V7, P347; MERGNER T, 1991, EXP BRAIN RES, V85, P389; Mergner T, 1993, J Vestib Res, V3, P41; Pearl A J, 1979, Am J Sports Med, V7, P231, DOI 10.1177/036354657900700404; Quarrie KL, 2002, SPORTS MED, V32, P633, DOI 10.2165/00007256-200232100-00003; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Scher A T, 1991, Br J Sports Med, V25, P57; SCHER AT, 1990, S AFR MED J, V77, P557; SILVER JR, 1994, PARAPLEGIA, V32, P442, DOI 10.1038/sc.1994.71; Stephensen S, 1996, BRIT J SPORT MED, V30, P331, DOI 10.1136/bjsm.30.4.331; Targett SGR, 1998, CLIN J SPORT MED, V8, P280, DOI 10.1097/00042752-199810000-00005; Tousignant M, 2002, SPINE, V27, P812, DOI 10.1097/00007632-200204150-00007; Trott PH, 1996, CLIN BIOMECH, V11, P201, DOI 10.1016/0268-0033(95)00072-0; VELAY JL, 1994, VISION RES, V34, P2169, DOI 10.1016/0042-6989(94)90325-5; Wetzler MJ, 1998, AM J SPORT MED, V26, P177, DOI 10.1177/03635465980260020501; Wilson B D, 1999, J Sci Med Sport, V2, P153, DOI 10.1016/S1440-2440(99)80195-9; YOO JU, 1992, SPINE, V17, P1131, DOI 10.1097/00007632-199210000-00001; YOUDAS JW, 1991, PHYS THER, V71, P98, DOI 10.1093/ptj/71.2.98; ZACHARIAS GL, 1981, EXP BRAIN RES, V41, P159	34	31	32	0	13	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0264-0414			J SPORT SCI	J. Sports Sci.		2007	25	8					887	894		10.1080/02640410600944543			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	168JB	WOS:000246519100006	17474042				2022-02-06	
J	Lux, WE				Lux, Warren E.			A neuropsychiatric perspective on traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						behavior; cognition; depression; diffuse axonal injury; executive function; frontal lobes; mood; neuropsychiatry; rehabilitation; self-awareness; traumatic brain injury	CLOSED-HEAD-INJURY; OBSESSIVE-COMPULSIVE DISORDER; HOMOVANILLIC-ACID; 5-HYDROXYINDOLE-ACETIC ACID; CEREBROSPINAL-FLUID; EARLY INTERVENTION; REHABILITATION; CONSCIOUSNESS; DEPRESSION; LESIONS	Traumatic brain injury (TBI) due to closed mechanisms causes strain injuries to axons that increase in number and severity as injury severity increases. Axons that project up from the brain stem are vulnerable, even in milder concussive injuries, and include axons that participate in key monoaminergic pathways. Although called diffuse axonal injury, the supratentorial injury component typically shows an anterior preponderance in humans. As the injury forces increase, cerebral contusions may be superimposed on the axonal strain injuries, and these contusions show an anterior preponderance as well. The chronic neuropsychiatric manifestations of TBI reflect this injury distribution. In the cognitive sphere, these manifestations almost always include power function disturbances marked by difficulties with cognitive processing speed, multi-tasking, and cognitive endurance. These disturbances may then be followed by disturbances in executive function and self-awareness as injury severity increases. In the behavioral sphere, mood disturbances and disorders of behavioral control and regulation are particularly common.	[Lux, Warren E.] US EPA, Off Sci Advisor, Washington, DC 20460 USA; [Lux, Warren E.] Georgetown Univ, Ctr Clin Bioeth, Washington, DC USA		Lux, WE (corresponding author), US EPA, Off Sci Advisor, 1200 Penn Ave NW,Mail Code 8105R, Washington, DC 20460 USA.	lux.warren@epa.gov					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson J, 2004, PHILOS PSYCHIAT PSYC, V11, P279, DOI DOI 10.1353/PPP; BAKCHINE S, 1989, NEUROLOGY, V39, P777, DOI 10.1212/WNL.39.6.777; BAREGGI SR, 1975, EUR NEUROL, V13, P528, DOI 10.1159/000114709; Berthier ML, 1996, NEUROLOGY, V47, P353, DOI 10.1212/WNL.47.2.353; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Damasio A., 1994, DESCARTES ERROR EMOT; DAMASIO H, 1994, SCIENCE, V265, P1159; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fujii DEM, 1996, NEUROPSY NEUROPSY BE, V9, P133; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA, P34; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA, P109; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA, P37; Hollander E, 1996, NEUROPSY NEUROPSY BE, V9, P230; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEWIN J, 1992, BRIT J PSYCHIAT, V161, P261, DOI 10.1192/bjp.161.2.261; Lezak, 1989, ASSESSMENT BEHAV CON, V7, P113; LUX WE, 1996, RECOVERY TRAUMATIC B, P99; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; PORTA M, 1975, EUR NEUROL, V13, P545, DOI 10.1159/000114710; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Scheutzow MH, 1999, BRAIN INJURY, V13, P705; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VANWOERKOM TCAM, 1977, LANCET, V1, P812; VECHT CJ, 1975, LIFE SCI, V16, P1179, DOI 10.1016/0024-3205(75)90201-5; VECHT CJ, 1975, ARCH NEUROL-CHICAGO, V32, P792, DOI 10.1001/archneur.1975.00490540036004; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42	45	31	32	0	8	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2007	44	7					951	961		10.1682/JRRD.2007.01.0009			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	253NL	WOS:000252524800008	18075952	Bronze			2022-02-06	
J	Power, T; Catroppa, C; Coleman, L; Ditchfield, M; Anderson, V				Power, Tarah; Catroppa, Cathy; Coleman, Lee; Ditchfield, Michael; Anderson, Vicki			Do lesion site and severity predict deficits in attentional control after preschool traumatic brain injury (TBI)?	BRAIN INJURY			English	Article						child; traumatic brain injury; MRI; lesion location; severity; executive function; attention	CHILDHOOD HEAD-INJURY; EXECUTIVE FUNCTION; CHILDREN; PERFORMANCE; ADOLESCENTS; COGNITION; LONDON; SAMPLE; TOWER; TASKS	Primary objective: To determine the predictive value of structural neuroimaging in the clinical setting following TBI. Research design: Prospective between-group design, comparing groups with regard to: (i) the presence or absence of cerebral pathology and (ii) the location of cerebral pathology. The predictive value of injury variables was investigated using hierarchical regressions. Methods and procedures: Thirty-six children, between 6 and 14 years, who sustained a moderate to severe TBI 5 years previously participated in this study. Children's performances on five measures of attentional control were examined in relation to the presence, location and severity of their lesions, as coded by the Coffey classification system [ 1]. Main outcomes and results: Frontal lesion severity was not predictive of performance on any of the measures. However, generalized ( frontal and extrafrontal) and extrafrontal lesion severity was predictive of poor performance. Conclusions: These findings support the argument that functional organization in children may differ from that in adults, suggesting that multiple cerebral regions, or a diffuse cerebral network, may mediate children's executive functions ( EF). Results are also consistent with the hypothesis that the amount of damaged brain tissue, rather than its location, may be more predictive of neurobehavioural outcome following early TBI.	Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; Univ Melbourne, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic, Australia		Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Bigler E, 1997, DIAGNOSTIC CLIN NEUR; Bigler E. D., 1997, CHILDHOOD TRAUMATIC, P7; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P227, DOI 10.1016/S0887-6177(00)00081-0; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Casey BJ, 2002, DEVELOPMENTAL SCI, V5, P265, DOI 10.1111/1467-7687.00365; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; CATROPPA C, J PEDIAT PSYCHOL; Chase-Carmichael CA, 1999, CLIN NEUROPSYCHOL, V13, P405, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT405; Ciccetti D., 1984, VINELAND ADAPTIVE BE; COFFEY CE, 1991, AM PSYCHOP, P243; Daniel A., 1983, POWER PRIVILEGE PRES; DIAMOND A, 1991, J PIAGET SY, P67; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Fidell L.S., 2000, USING MULTIVARIATE S; FLETCHER JM, 1984, J CLIN NEUROPSYCHOL, V6, P39, DOI 10.1080/01688638408401195; Franzen M D, 2000, Crit Care Nurs Q, V23, P58; Fuster J., 1989, PREFRONTAL CORTEX AN; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gottlieb G, 1992, INDIVIDUAL DEV EVOLU; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Johnson M H, 1990, J Cogn Neurosci, V2, P81, DOI 10.1162/jocn.1990.2.2.81; Johnson M. H., 1997, DEV COGNITIVE NEUROS; Johnson MH, 2003, BIOL PSYCHIAT, V54, P1312, DOI 10.1016/S0006-3223(03)00426-8; Johnson MH, 2000, CHILD DEV, V71, P75, DOI 10.1111/1467-8624.00120; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 1989, NEUROPSYCHOLOGY, V3, P243, DOI 10.1037//0894-4105.3.4.243; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LEZAK MD, 1995, NEUROPSYCHOLOGCAL AS; Luria A.R., 1973, WORKING BRAIN; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T., 1999, TEST EVERYDAY ATTENT; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Miller EK, 2000, NEUROIMAGE, V11, P447, DOI 10.1006/nimg.2000.0574; Moses P, 2002, DEV PSYCHOBIOL, V40, P266, DOI 10.1002/dev.10031; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T, 1990, NEUROPSYCHOLOGY MENT; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; STUSS DT, 1983, LOCALIZATION NEUROPS, P429; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; Wechsler D., 1992, MANUAL WECHSLER INTE	70	31	31	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	3					279	292		10.1080/02699050701253095			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	168IW	WOS:000246518400003	17453756				2022-02-06	
J	Prigatano, GP; Gray, JA				Prigatano, George P.; Gray, Jennifer A.			Parental concerns and distress after paediatric traumatic brain injury: A qualitative study	BRAIN INJURY			English	Article						child; traumatic brain injury; parental distress; recovery; social integration	HEAD-INJURY; CHILDREN; FAMILY; REHABILITATION; RECOVERY; OUTCOMES; PERFORMANCE	Objective: To determine concerns of parents associated with high distress levels in the care of children with traumatic brain injury ( TBI). Setting and participants: Primary care hospital/ medical centre- based study on parental perspectives following TBI in school age children ( n = 100; 19 orthopaedic trauma controls and 81 children with a history of TBI). Main outcome measures: Verbatim reports regarding major concerns on the Child Behaviour Checklist ( CBCL), as well as parental ratings regarding their overall distress level when caring for the child. Results: Summary of verbatim comments indicated that parents who report high levels of distress in the care of their children were specifically concerned about the child's poor school performance, lack of friends, inability to control angry feelings and apathy. Fear of the future consequences of the TBI was also cited as a major concern. Parent ratings of distress level was significantly, but weakly correlated with the severity of TBI in their children ( r =+0.26, n = 94, p = 0.01). Conclusion: Reports of severe distress in the care of TBI children by parents are seen at all levels of severity of TBI. Addressing these parental concerns may increase parental engagement in the rehabilitation process.	St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA; Med Ctr, Phoenix, AZ USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	gprigat@chw.edu					Achenbach T. M., 2001, CHILD BEHAV CHECKLIS; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Bettelheim Bruno, 1975, USES ENCHANTMENT MEA; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Braga LW, 2005, CHILD TRAUMATIC BRAI; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; CORRIGAN PW, 2005, TXB TRAUMATIC BRAIN, P661; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Lenhard W, 2005, AM J MED GENET A, V133A, P170, DOI 10.1002/ajmg.a.30571; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; PRIGATANO GP, IN PRESS CLIN NEUROP; PRIGATANO GP, 2004, COMMUNITY SCH REINTE, P151; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Savage R. C., 1994, ED DIMENSIONS ACQUIR, P393; Shaffer D, 1975, Ciba Found Symp, P191; Silver JM, 2005, TXB TRAUMATIC BRAIN, P609; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	37	31	31	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	7					721	729		10.1080/02699050701481605			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	192LX	WOS:000248204400008	17653946				2022-02-06	
J	Tanriverdi, F; Ulutabanca, H; Unluhizarci, K; Selcuklu, A; Casanueva, FF; Kelestimur, F				Tanriverdi, Fatih; Ulutabanca, Halil; Unluhizarci, Kursad; Selcuklu, Ahmet; Casanueva, Felipe F.; Kelestimur, Fahrettin			Pituitary functions in the acute phase of traumatic brain injury: Are they related to severity of the injury or mortality?	BRAIN INJURY			English	Article						traumatic brain injury; Glasgow Coma Scale; mild brain injury; pituitary; hypopituitarism	CLOSED-HEAD INJURY; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; STIMULATION TEST; GH DEFICIENCY; HIGH-RISK; HYPOPITUITARISM; REHABILITATION; ABNORMALITIES; PREVALENCE	Primary objective: There are only limited data regarding pituitary functions in the acute phase of traumatic brain injury ( TBI) and previous studies have been conducted in only small cohorts of subjects. Therefore we have investigated the pituitary functions in the early acute phase, within 24 hours of trauma, in 104 patients with TBI. Additionally, the relationships between basal pituitary hormones, severity of the trauma and mortality due to trauma were also investigated. Methods and procedures: One hundred and four TBI patients were included in the study consecutively. All patients underwent basal hormonal evaluation within the first 24 hours of admission. Twenty of 104 patients died during the acute phase. Main outcomes: Prolactin levels were negatively correlated with the Glasgow coma scale ( GCS), cortisol levels were positively correlated with the GCS and cortisol levels were positively correlated with ACTH levels. Additionally there was a significant positive correlation between the total testosterone levels and the GCS in males. Logistic regression analysis revealed that mortality after TBI was unrelated to basal pituitary hormone levels. However age and GCS were significantly related to the mortality. The percentages of pituitary hormone deficiencies were as follows: 3.8% had TSH deficiency, 40.0% had gonadotrophin deficiency, 8.8% had ACTH deficiency and 20.0% had GH deficiency. Conclusions: Present data clearly demonstrate that pituitary function is disturbed in TBI and the most frequently deficient pituitary hormones were gonadotrophins in the early acute phase of TBI. Basal hormone levels including cortisol, prolactin and total testosterone were related to the severity of the trauma. However there was no relation between basal hormones and mortality due to TBI. Age and GCS were significantly related to mortality.	Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; Erciyes Univ, Sch Med, Dept Neurosurg, TR-38039 Kayseri, Turkey; Univ Santiago de Compostela, Sch Med, Dept Med, Santiago De Compostela, Spain; Univ Santiago de Compostela, Complejo Hosp Univ Santiago, Santiago De Compostela, Spain		Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	kelestimur, f/ABE-9873-2021				Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; Ceballos R, 1966, Ala J Med Sci, V3, P185; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DANIEL PM, 1959, LANCET, V2, P927; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; FEIBEL J, 1983, J CLIN ENDOCR METAB, V57, P1245, DOI 10.1210/jcem-57-6-1245; Greenwood E, 2003, NAT REV CANCER, V3, P7, DOI 10.1038/nrc978; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Iglesias P, 1996, J ENDOCRINOL INVEST, V19, P320, DOI 10.1007/BF03347870; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lamberts SWJ, 1998, LANCET, V352, P127; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Pentelenyi T, 1992, Acta Neurochir Suppl (Wien), V55, P21; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; TEASDALE G, 1974, LANCET, V2, P81; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209; ZIEGLER MG, 1990, CRIT CARE MED, V18, P253, DOI 10.1097/00003246-199003000-00001	33	31	35	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	4					433	439		10.1080/02699050701311083			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	168IY	WOS:000246518600009	17487641				2022-02-06	
J	Bowden, SC; Shores, EA; Mathias, JL				Bowden, Stephen C.; Shores, E. Arthur; Mathias, Jane L.			Does effort suppress cognition after traumatic brain injury? A re-examination of the evidence for the Word Memory Test	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	Conference of the Association-of-Forensic-Neuropsychology	FEB, 2004	London, ENGLAND				MALINGERED NEUROCOGNITIVE DYSFUNCTION; CLINICAL-PRACTICE; VALIDITY; DAUBERT; SCORES; MUNNS	Green, Rohling, Lees-Haley, and Allen (2001) suggested that scores on a test of "effort,'' the Word Memory Test (WMT), explains more variance in outcome after brain injury than does injury severity. As a consequence, Green and colleagues recommend using the WMT to control for sub-optimal effort in neuropsychological evaluations and group research. We re-examine the evidence for their conclusions and argue that identifying a larger proportion of explained variance is not in itself evidence of validity unless the premise to be proven is already assumed, namely, that the test is a valid measure of effort. Instead, the crux of Green and colleagues claim for the validity of the WMT implies an interaction between effort and injury severity on outcome scores, although the specific interaction has not been tested in their previous research. We failed to find any evidence for this interaction in a sample of 100 Australian litigants. We conclude that our data do not support the view that effort, as measured by the WMT, interacts with injury severity to suppress cognition after brain injury.	Univ Melbourne, Dept Psychol, Parkville, Vic 3010, Australia; Macquarie Univ, Sydney, NSW 2109, Australia; Univ Adelaide, Adelaide, SA, Australia		Bowden, SC (corresponding author), Univ Melbourne, Dept Psychol, Parkville, Vic 3010, Australia.	sbowden@unimelb.edu.au	Mathias, J L/L-6295-2013	Mathias, Jane/0000-0001-8957-8594; Shores, Edwin A/0000-0003-1553-5131			Bianchini KJ, 2003, CLIN NEUROPSYCHOL, V17, P574, DOI 10.1076/clin.17.4.574.27946; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bowden SC, 1999, PSYCHOL ASSESSMENT, V11, P339, DOI 10.1037/1040-3590.11.3.339; Bowden SC, 1998, NEUROPSYCHOL REHABIL, V8, P243, DOI 10.1080/713755573; BOWDEN SC, 1996, ANN C AUSTR PSYCH SO; Carstairs JR, 2000, AUST PSYCHOL, V35, P36, DOI 10.1080/00050060008257466; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen M.J., 1997, CHILDRENS MEMORY SCA; CONNOR C, 2004, ANN M AUSTR PSYCH SO; Draper N., 1981, APPL REGRESSION ANAL; EMBRETSON SE, 1983, PSYCHOL BULL, V0093, P00179, DOI DOI 10.1037/0033-2909.93.1.179; FAUST D, 2003, MALINGERING ILLNESS, P107; Flanagan D.P., 1997, SCHOOL PSYCHOL REV, V26, P189; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 1996, WORD MEMORY TEST USE; Halligan P.W., 2003, MALINGERING ILLNESS; HARRIS RJ, 1994, ANOVA ANAL VARIANCE; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Holdnack JA, 2004, AUST PSYCHOL, V39, P220, DOI 10.1080/00050060412331295072; Hom J, 2003, ARCH CLIN NEUROPSYCH, V18, P827, DOI 10.1016/S0887-6177(03)00076-3; HOSMER DW, 1995, STAT MED, V14, P2161, DOI 10.1002/sim.4780141909; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Mossman D, 2003, LAW HUMAN BEHAV, V27, P229, DOI 10.1023/A:1023437122752; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Petty RE, 1996, PSYCHOL SCI, V7, P247, DOI 10.1111/j.1467-9280.1996.tb00368.x; ROGERS R, 1997, CLINICAL ASSESSMENT; Rohling Martin L, 2002, CNS Spectr, V7, P387; ROSNOW RL, 1989, PSYCHOL BULL, V105, P143, DOI 10.1037/0033-2909.105.1.143; SACKETT DL, 2000, EVIDENCE BASED MED H; Schmidt FL, 1996, PSYCHOL METHODS, V1, P199, DOI 10.1037/1082-989X.1.2.199; Shores EA, 2000, AUST PSYCHOL, V35, P41, DOI 10.1080/00050060008257467; SHORES EA, 2004, ASS FOR NEUR C I CHI; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; The Psychological Corporation, 1997, WAIS III WMS III TEC; Vallabhajosula B, 2001, J AM ACAD PSYCHIATRY, V29, P207; Winer B.J., 1971, STAT PRINCIPLES EXPT; Wynkoop T.F., 2001, J FORENSIC NEUROPSYC, V2, P71	44	31	31	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2006	20	4					858	872		10.1080/13854040500246935			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	085IE	WOS:000240597000019	16980267				2022-02-06	
J	Thompson, HJ; Marklund, N; LeBold, DG; Morales, DM; Keck, CA; Vinson, M; Royo, NC; Grundy, R; McIntosh, TK				Thompson, Hilaire J.; Marklund, Niklas; LeBold, David G.; Morales, Diego M.; Keck, Carrie A.; Vinson, Mary; Royo, Nicolas C.; Grundy, Robert; McIntosh, Tracy K.			Tissue sparing and functional recovery following experimental traumatic brain injury is provided by treatment with an anti-myelin-associated glycoprotein antibody	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						adhesive/sticky paper test; head injury; hemispheric tissue loss; myelin-associated glycoprotein; osmotic minipumps; rat	CORTICAL LESION; NOGO RECEPTOR; COGNITIVE IMPAIRMENT; NEURITE OUTGROWTH; AXONAL INJURY; OPTIC-NERVE; HEAD-INJURY; ADULT RATS; MAG; INHIBITOR	Axonal injury is a hallmark of traumatic brain injury (TBI) and is associated with a poor clinical outcome. Following central nervous system injury, axons regenerate poorly, in part due to the presence of molecules associated with myelin that inhibit axonal outgrowth, including myelin-associated glycoprotein (MAG). The involvement of MAG in neurobehavioral deficits and tissue loss following experimental TBI remains unexplored and was evaluated in the current study using an MAG-specific monoclonal antibody (mAb). Anesthetized rats (n = 102) were subjected to either lateral fluid percussion brain injury (n = 59) or sham injury (n = 43). In surviving animals, beginning at 1 h post-injury, 8.64 mu g anti-MAG mAb (n = 33 injured, n = 21 sham) or control IgG (n = 26 injured, n = 22 sham) was infused intracerebroventricularly for 72 h. One group of these rats (n = 14 sham, n = 11 injured) was killed at 72 h post-injury for verification of drug diffusion and MAG immunohistochemistry. All other animals were evaluated up to 8 weeks post-injury using tests for neurologic motor, sensory and cognitive function. Hemispheric tissue loss was also evaluated at 8 weeks post-injury. At 72 h post-injury, increased immunoreactivity for MAG was seen in the ipsilateral cortex, thalamus and hippocampus of brain-injured animals, and anti-MAG mAb was detectable in the hippocampus, fimbria and ventricles. Brain-injured animals receiving anti-MAG mAb showed significantly improved recovery of sensorimotor function at 6 and 8 weeks (P < 0.01) post-injury when compared with brain-injured IgG-treated animals. Additionally, at 8 weeks post-injury, the anti-MAG mAb-treated brain-injured animals demonstrated significantly improved cognitive function and reduced hemispheric tissue loss (P < 0.05) when compared with their brain-injured controls. These results indicate that MAG may contribute to the pathophysiology of experimental TBI and treatment strategies that target MAG may be suitable for further evaluation.	Univ Penn, Dept Neurosurg, Traumat Brain Injury Lab, Philadelphia, PA 19104 USA; Univ Washington, Seattle, WA 98195 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA; Univ Uppsala Hosp, Dept Neurosurg, Uppsala, Sweden; GlaxoSmithKline, Neurol Ctr Excellence Drug Discovery, Harlow, Essex, England		Thompson, HJ (corresponding author), Univ Penn, Dept Neurosurg, Traumat Brain Injury Lab, Philadelphia, PA 19104 USA.	hilairet@u.washington.edu		Marklund, Niklas/0000-0002-9797-5626; Morales, Diego/0000-0001-6672-9046	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K12RR023265, K12 RR023265-02, K12 RR023265] Funding Source: Medline; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [L30 DC008284, L30 DC008284-01] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS043126-01A1, P50 NS008803-320013, T32-NS043126, T32 NS043126, R01 NS040978-04] Funding Source: Medline; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32-NR07106, T32 NR007106-07, T32 NR007106] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [P50-08803, R01-40978] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K12RR023265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126, R01NS040978, P50NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007106] Funding Source: NIH RePORTER		Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; BARTSCH U, 1989, J COMP NEUROL, V284, P451, DOI 10.1002/cne.902840310; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Blokland A, 1999, EUR J NEUROSCI, V11, P223, DOI 10.1046/j.1460-9568.1999.00431.x; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; CARONI P, 1988, PROG BRAIN RES, V78, P363; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; Cirulli F, 2004, HIPPOCAMPUS, V14, P802, DOI 10.1002/hipo.10220; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Emerick AJ, 2003, J NEUROSCI, V23, P4826; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; *INT BRAIN INJ ASS, 2005, BRAIN INJ FACTS; Irving EA, 2005, J CEREBR BLOOD F MET, V25, P98, DOI 10.1038/sj.jcbfm.9600011; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Laurer HL, 2001, CURR PHARM DESIGN, V7, P1505, DOI 10.2174/1381612013397285; Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Li SX, 2003, J NEUROSCI, V23, P4219; Maas AIR, 2002, NEUROL RES, V24, P19, DOI 10.1179/016164102101199495; Marcus J, 2002, J CELL BIOL, V156, P567, DOI 10.1083/jcb.200111047; Marklund N, 2005, J NEUROTRAUM, V22, P1229; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; MARKLUND N, 2004, SOC NEUR ABSTR; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKerracher L, 2002, NEURON, V36, P345, DOI 10.1016/S0896-6273(02)01018-8; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Paivalainen S, 2003, J NEUROCHEM, V84, P533, DOI 10.1046/j.1471-4159.2003.01539.x; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; PAXINOS G, 1994, RAT BRAIN STEREOTAXI; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Povlishock JT, 1999, ACT NEUR S, V73, P15; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; QUARLES RH, 1973, BRAIN RES, V58, P506, DOI 10.1016/0006-8993(73)90022-X; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Schaumburg Jochen, 2000, Silva Gabreta, V4, P29; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Silver MA, 2001, J COMP NEUROL, V436, P391, DOI 10.1002/cne.1075; Soares HD, 1995, J NEUROSCI, V15, P8223; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tang S, 2001, MOL CELL NEUROSCI, V18, P259, DOI 10.1006/mcne.2001.1020; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TRAPP BD, 1989, J NEUROCYTOL, V18, P47, DOI 10.1007/BF01188423; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Vinson M, 2003, MOL CELL NEUROSCI, V22, P344, DOI 10.1016/S1044-7431(02)00031-3; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Weiss MD, 2000, J NEUROSCI RES, V62, P772, DOI 10.1002/1097-4547(20001215)62:6<772::AID-JNR3>3.3.CO;2-O; Wong EV, 2003, J NEUROSCI, V23, P3112; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	71	31	32	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	DEC	2006	24	11					3063	3072		10.1111/j.1460-9568.2006.05197.x			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	124IO	WOS:000243361700010	17156367	Green Accepted			2022-02-06	
J	D'Innocenzo, J; Tjaden, K; Greenman, G				D'Innocenzo, Juliana; Tjaden, Kris; Greenman, Geoff			Intelligibility in dysarthria: Effects of listener familiarity and speaking condition	CLINICAL LINGUISTICS & PHONETICS			English	Article						dysarthria; treatment techniques; intelligibility	VOICE-TREATMENT-PROGRAM; ATAXIC DYSARTHRIA; SPEECH; MANIPULATIONS; PERCEPTION; SEQUENCES; SCLEROSIS; LOUDNESS; DISEASE	This study examined the effects of familiarization and speaking condition on sentence intelligibility for a speaker with dysarthria secondary to a traumatic brain injury (TBI). Familiarization procedures included hearing the speaker read a paragraph or a word list comprised of a random ordering of the words in the paragraph. Such an approach allowed for statements concerning the benefit of prior exposure to a sentence-level prosody and word level articulatory-acoustic patterns versus only word-level articulatory-acoustic patterns. Following word list, paragraph, or no familiarization, listeners orthographically transcribed sentences in either a habitual, slow, fast, or loud condition. Listeners receiving either word list or paragraph familiarization accurately transcribed a higher percentage of words in sentences than listeners receiving no familiarization. Intelligibility scores did not differ for word list or paragraph familiarization, however. Listeners also were more accurate transcribing sentences produced in the loud condition compared to habitual and fast conditions. Clinical implications are discussed.	SUNY Buffalo, Dept Communicat Disorders & Sci, Buffalo, NY 14214 USA; SL Hunter & Associates, Burlington, ON, Canada		Tjaden, K (corresponding author), SUNY Buffalo, Dept Communicat Disorders & Sci, 122 Cary Hall,3435 Main St, Buffalo, NY 14214 USA.	tjaden@acsu.buffalo.edu			NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC04689] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC004689] Funding Source: NIH RePORTER		DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; DEPAUL R, 2002, AM J SPEECH-LANG PAT, V9, P230; DINNOCENZO J, 2004, CONV AM SPEECH LANG; Duffy JR., 2020, MOTOR SPEECH DISORDE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hustad KC, 2003, AM J SPEECH-LANG PAT, V12, P198, DOI 10.1044/1058-0360(2003/066); Kent R.D., 1992, ACOUSTIC ANAL SPEECH; Liss JM, 2002, J ACOUST SOC AM, V112, P3022, DOI 10.1121/1.1515793; McHenry M., 1997, AM J SPEECH-LANG PAT, V6, P55; McHenry MA, 2003, J SPEECH LANG HEAR R, V46, P702, DOI 10.1044/1092-4388(2003/055); MILENKOVIC P, 2002, TF32 COMPUTER SOFTWA; MILENKOVIC P, 1997, CSPEECH COMPUTER SOF; Ramig L. O., 1994, J MED SPEECH-LANG PA, V2, P191; Sebastian-Galles N, 2000, PERCEPT PSYCHOPHYS, V62, P834, DOI 10.3758/BF03206926; Solomon NP, 2001, AM J SPEECH-LANG PAT, V10, P51, DOI 10.1044/1058-0360(2001/008); Spitzer SM, 2000, J MED SPEECH-LANG PA, V8, P285; *SYNTR CORP, 1999, COOL ED PRO COMP SOF; Theodoros DG, 1999, J MED SPEECH-LANG PA, V7, P157; Tjaden K, 2004, J SPEECH LANG HEAR R, V47, P766, DOI 10.1044/1092-4388(2004/058); Tjaden K, 2003, J SPEECH LANG HEAR R, V46, P990, DOI 10.1044/1092-4388(2003/077); TJADEN K, IN PRESS J SPEECH LA; Tjaden K., 1995, AM J SPEECH-LANG PAT, V4, P39, DOI [https://doi.org/10.1044/1058-0360.0401.39, DOI 10.1044/1058-0360.0401.39]; TJADEN KK, 1995, CLIN LINGUIST PHONET, V9, P139, DOI 10.3109/02699209508985329; TURNER GS, 1993, J SPEECH HEAR RES, V36, P1134, DOI 10.1044/jshr.3606.1134; Ward EC, 2000, J MED SPEECH-LANG PA, V8, P331; Weismer G, 2000, FOLIA PHONIATR LOGO, V52, P201, DOI 10.1159/000021536; Wohlert AB, 2000, J SPEECH LANG HEAR R, V43, P1229, DOI 10.1044/jslhr.4305.1229; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; Yorkston K. M., 1983, CLIN DYSARTHRIA, P155; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P398, DOI 10.1044/jshd.4604.398; YORKSTON KM, 1990, J SPEECH HEAR DISORD, V55, P550, DOI 10.1044/jshd.5503.550; YORKSTON KM, 1995, MANAGEMENT SPEECH SW	33	31	32	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	NOV	2006	20	9					659	675		10.1080/02699200500224272			17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	127KU	WOS:000243585600002	17342875				2022-02-06	
J	Finehout, EJ; Franck, Z; Relkin, N; Lee, KH				Finehout, Erin J.; Franck, Zsofia; Relkin, Norman; Lee, Kelvin H.			Proteomic analysis of cerebrospinal fluid changes related to postmortem interval	CLINICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; POTENTIAL BIOMARKERS; ALZHEIMERS-DISEASE; EARLY-DIAGNOSIS; ISCHEMIC BRAIN; ACUTE STROKE; PROTEIN; MARKERS; IDENTIFICATION; MICRODIALYSIS	Background: The study of proteins with altered production in postmortem cerebrospinal fluid (CSF) compared with antemortem CSF may improve the understanding of biochemical changes that occur immediately after death. Methods: Two CSF samples (1 antemortem and 1 postmortem) were collected from 7 patients and analyzed by 2-dimensional gel electrophoresis. An analysis was also performed to identify proteins that showed a correlation between concentration change and postmortem interval. Tandem mass spectrometry was used to identify the proteins. Results: Fifty-four protein spots were identified that showed a consistent and significant change in concentration in the postmortem CSF of all 7 patients (> 3.5-fold, P < 0.01). The proteins in these spots derive from a variety of functional groups, including cytoskeletal proteins, enzymes involved in glycolysis, and proteins that prevent oxidative stress. Fourteen protein spots were found to have an increase in production that correlated with postmortem interval. Conclusions: Changes in protein production of postmortem vs antemortem CSF were studied. The proteins observed to change production in the postmortem CSF include several proteins previously observed as potential stroke biomarkers. (c) 2006 American Association for Clinical Chemistry.	Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA; Cornell Univ, Coll Med, Dept Neurol & Neurosci, New York, NY USA		Lee, KH (corresponding author), 120 Olin Hall, Ithaca, NY 14853 USA.	KHL9@cornell.edu	Lee, Kelvin H/A-4673-2010; Crozier, Laura/C-2170-2011	Lee, Kelvin H/0000-0003-0908-2981; 	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH059926] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH59926] Funding Source: Medline		Allard L, 2005, CLIN CHEM, V51, P2043, DOI 10.1373/clinchem.2005.053942; CAPOCCHI G, 1987, ITAL J NEUROL SCI, V8, P567, DOI 10.1007/BF02333663; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; DAVSON H, 1987, PHYSL PATHOPHYSIOLOG, P1013; DONNAN GA, 1983, STROKE, V14, P266, DOI 10.1161/01.STR.14.2.266; Finehout EJ, 2004, ELECTROPHORESIS, V25, P2564, DOI 10.1002/elps.200406012; Finehout EJ, 2003, ELECTROPHORESIS, V24, P3508, DOI 10.1002/elps.200305615; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; GLANTZ SA, 1987, PRIMER BIOSTATISTICS, P230; Hatzimanikatis V, 1999, BIOTECHNOL PROGR, V15, P312, DOI 10.1021/bp990004b; HAY E, 1984, J NEUROL NEUROSUR PS, V47, P724, DOI 10.1136/jnnp.47.7.724; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; KARKELA JT, 1993, J FORENSIC SCI, V38, P603; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Long DJ, 2000, CHEM-BIOL INTERACT, V129, P99, DOI 10.1016/S0009-2797(00)00200-3; Marrif H, 1999, J NEUROSCI RES, V57, P255; PAULSON GW, 1971, CONFIN NEUROL, V33, P149; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Sommer JB, 2002, EUR NEUROL, V47, P224, DOI 10.1159/000057904; VAAGENES P, 1986, ARCH NEUROL-CHICAGO, V43, P357, DOI 10.1001/archneur.1986.00520040043017; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; WEISNER B, 1978, J NEUROL SCI, V37, P205, DOI 10.1016/0022-510X(78)90204-6; WERMUTH B, 1986, BIOCHEM PHARMACOL, V35, P1277, DOI 10.1016/0006-2952(86)90271-6; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200	29	31	33	0	2	AMER ASSOC CLINICAL CHEMISTRY	WASHINGTON	2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA	0009-9147	1530-8561		CLIN CHEM	Clin. Chem.	OCT	2006	52	10					1906	1913		10.1373/clinchem.2006.070508			8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	089CP	WOS:000240858000011	16887899	Bronze			2022-02-06	
J	Cazalis, F; Feydy, A; Valabregue, R; Pelegrini-Issac, M; Pierot, L; Azouvi, P				Cazalis, Fabienne; Feydy, Antoine; Valabregue, Romain; Pelegrini-Issac, Melanie; Pierot, Laurent; Azouvi, Philippe			fMRI study of problem-solving after severe traumatic brain injury	BRAIN INJURY			English	Article						Tower of London; anterior cingulate cortex; left dorsolateral pre-frontal cortex	CLOSED-HEAD INJURY; WORKING-MEMORY; PLANNING TASK; ACTIVATION; TOWER; MILD; PET; FLEXIBILITY; PERFORMANCE; ATTENTION	Objective: To assess the cerebral correlates of the dysexecutive syndrome after diffuse severe traumatic brain injury (TBI). Methods: Ten patients with sub-acute/chronic severe TBI without detectable focal cortical contusion and 11 matched healthy subjects were included in a parametric fMRI study using a planning task, the Tower of London. Results: Brain activation in the left Dorsolateral Pre-frontal Cortex (DLPFC) and the Anterior Cingulate Cortex (ACC) was closely related to performance. Patients with TBI who performed the task efficiently showed, like healthy controls who obtained a similar pattern of performance, a large activation in the left DLPFC and a small activation in the ACC. In contrast, poor performance was associated with a reduced activation in these both regions. Conclusion: Problem-solving deficits after severe diffuse TBI could be related to an impaired activation of the DLPFC and of the ACC.	Univ Calif Los Angeles, Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90025 USA; INSERM, U 483, Paris, France; Beaujon Hosp, Dept Neuroradiol, Clichy, France; Maison Blanche Hosp, Dept Radiol, Reims, France; R Poincare Hosp, Rehabil Dept, Garches, France		Cazalis, F (corresponding author), Univ Calif Los Angeles, Sch Med, Semel Inst Neurosci & Human Behav, 760 Westwood Plaza,Rm 58-217, Los Angeles, CA 90025 USA.	fabfab@ucla.edu	FEYDY, ANTOINE/P-5289-2016	Pelegrini-Issac, Melanie/0000-0003-3260-5795; valabregue, romain/0000-0002-1814-9570			Abernathy, 1990, ATLAS CEREBRAL SULCI; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Braun M, 2000, ANN FR ANESTH, V19, P296; Cazalis F, 2003, EUR J NEUROSCI, V17, P2219, DOI 10.1046/j.1460-9568.2003.02633.x; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Dagher A, 1999, BRAIN, V122, P1973, DOI 10.1093/brain/122.10.1973; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Elliott R, 1997, PSYCHOL MED, V27, P931, DOI 10.1017/S0033291797005187; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gron G, 2003, NEUROBIOL AGING, V24, P453, DOI 10.1016/S0197-4580(02)00128-8; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; JENKINS A, 1986, LANCET, V2, P445; Lazeron RHC, 2000, AM J NEURORADIOL, V21, P1407; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; MARIKO O, 2003, NEUROIMAGE, V18, P789; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MORRIS RG, 1993, NEUROPSYCHOLOGIA, V31, P1367, DOI 10.1016/0028-3932(93)90104-8; Netter FH, 1997, ATLAS HUMAN ANATOMY; Owen AM, 1998, BRAIN, V121, P949, DOI 10.1093/brain/121.5.949; Owen AM, 1996, EUR J NEUROSCI, V8, P353, DOI 10.1111/j.1460-9568.1996.tb01219.x; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prigatano GP, 2004, BRAIN INJURY, V18, P661, DOI 10.1080/02699050310001646170; Rowe JB, 2001, NEUROPSYCHOLOGIA, V39, P315, DOI 10.1016/S0028-3932(00)00109-3; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Talairach J., 1988, COPLANAR STEREOTAXIC; TRUWIT CL, 1994, HIGH RESOLUTION ATLA; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y	41	31	32	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2006	20	10					1019	1028		10.1080/02699050600664384			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	093FA	WOS:000241152100003	17060134				2022-02-06	
J	McGraw-Hunter, M; Faw, GD; Davis, PK				McGraw-Hunter, M.; Faw, G. D.; Davis, P. K.			The use of video self-modelling and feedback to teach cooking skills to individuals with traumatic brain injury: A pilot study	BRAIN INJURY			English	Article						modelling; video self-modelling; cooking; activities of daily living	CHILDREN; AUTISM; REHABILITATION; SETTINGS	Objective: To evaluate the effectiveness of video self-modelling plus prompting and feedback to teach a cooking skill to people with traumatic brain injury (TBI) and to examine skill generalization to a novel food item. Research design: Multiple probe across participants. Methods and procedures: Four individuals with TBI received instruction in cooking. They watched videotapes of themselves cooking and practiced that skill while receiving prompts and feedback. Treatment effects were evaluated by comparing performance before, during and after training and at a 2 and 4 week follow-up. Additionally, cooking performance on a novel food item was examined. Main outcomes and results: Three of the four individuals achieved criterion performance within four training sessions. Those individuals also substantially maintained their skills 2 and 4 weeks following training and generalized their skills to a novel food item. Conclusions: Video self-modelling plus prompting and feedback appears to be an effective treatment for teaching simple cooking skills to individuals with TBI. Further research should examine whether the video alone is sufficient for skill acquisition and evaluate the effectiveness of video self-modelling to teach other skills.	So Illinois Univ, Inst Rehabil, Carbondale, IL 62901 USA; Ctr Comprehens Serv, Carbondale, IL USA		Davis, PK (corresponding author), So Illinois Univ, Inst Rehabil, Carbondale, IL 62901 USA.	pdavis@siu.edu					ANDREW STV, 1993, J MENTAL HLTH COUNSE, V15, P206; Bandura A., 1977, SOCIAL LEARNING THEO; BARRY NJ, 1977, AM J MENT DEF, V82, P33; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Brady M.P., 1995, EDUC TREAT CHILD, V18, P389, DOI DOI 10.1014/S014134731P89324X; Charlop-Christy MH, 2003, J POSIT BEHAV INTERV, V5, P12, DOI 10.1177/10983007030050010101; CUVO AJ, 1990, HDB APPL BEHAV ANAL, P39; D'Ateno P, 2003, J POSIT BEHAV INTERV, V5, P5, DOI 10.1177/10983007030050010801; Fabiano RJ, 1998, J REHABIL, V64, P9; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; GLANG A, 1992, J HEAD TRAUMA REHAB, V7, P93; Goldenberg G, 2001, NEUROPSYCHOL REHABIL, V11, P147, DOI 10.1080/09602010042000204; HARING TG, 1987, J APPL BEHAV ANAL, V20, P89, DOI 10.1901/jaba.1987.20-89; Hepting NH, 1996, TOP EARLY CHILD SPEC, V16, P407, DOI 10.1177/027112149601600308; Hitchcock CH, 2003, REM SPEC EDUC, V24, P36, DOI 10.1177/074193250302400104; Landa-Gonzalez BELKIS, 2001, Occup Ther Int, V8, P49, DOI 10.1002/oti.131; MEHARG SS, 1990, ADV BEHAV RES THER, V12, P85, DOI 10.1016/0146-6402(90)90008-E; MERCER C, 1975, J LEARNING DISABILIT, V8, P45; Norman J. M., 2001, Journal of Special Education Technology, V16, P5; RICHARDS SB, 1999, SINGLE SUBJECT RES A; Sherer M, 2001, BEHAV MODIF, V25, P140, DOI 10.1177/0145445501251008; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Zhou J, 1996, J HEAD TRAUMA REHAB, V11, P51, DOI 10.1097/00001199-199602000-00007	23	31	32	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2006	20	10					1061	1068		10.1080/02699050600912163			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	093FA	WOS:000241152100008	17060139				2022-02-06	
J	Lundgren-Nilsson, A; Tennant, A; Grimby, G; Sunnerhagen, KS				Lundgren-Nilsson, A.; Tennant, A.; Grimby, G.; Sunnerhagen, K. S.			Cross-diagnostic validity in a generic instrument: an example from the Functional Independence Measure in Scandinavia	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article							RASCH MODEL; DISABILITY; REHABILITATION; ADAPTATION; INDEX; FIM	Background: To analyse the cross-diagnostic validity of the Functional Independence Measure (FIM(TM)) motor items in patients with spinal cord injury, stroke and traumatic brain injury and the comparability of summed scores between these diagnoses. Methods: Data from 471 patients on FIM T motor items at admission ( stroke 157, spinal cord injury 157 and traumatic brain injury 157), age range 11 - 90 years and 70 % male in nine rehabilitation facilities in Scandinavia, were fitted to the Rasch model. A detailed analysis of scoring functions of the seven categories of the FIM T motor items was made prior to testing fit to the model. Categories were re-scored where necessary. Fit to the model was assessed initially within diagnosis and then in the pooled data. Analysis of Differential Item Functioning (DIF) was undertaken in the pooled data for the FIM T motor scale. Comparability of sum scores between diagnoses was tested by Test Equating. Results: The present seven category scoring system for the FIM T motor items was found to be invalid, necessitating extensive rescoring. Despite rescoring, the item-trait interaction fit statistic was significant and two individual items showed misfit to the model, Eating and Bladder management. DIF was also found for Spinal Cord Injury, compared with the other two diagnoses. After adjustment, it was possible to make appropriate comparisons of sum scores between the three diagnoses. Conclusion: The seven-category response function is a problem for the FIM T instrument, and a reduction of responses might increase the validity of the instrument. Likewise, the removal of items that do not fit the underlying trait would improve the validity of the scale in these groups. Cross-diagnostic DIF is also a problem but for clinical use sum scores on group data in a generic instrument such as the FIM T can be compared with appropriate adjustments. Thus, when planning interventions ( group or individual), developing rehabilitation programs or comparing patient achievements in individual items, cross-diagnostic DIF must be taken into account.	Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol Rehabil Med, S-41345 Gothenburg, Sweden; Univ Leeds, Acad Unit Musculoskeletal Dis, Dept Rehabil Med, Leeds LS2 9NZ, W Yorkshire, England		Lundgren-Nilsson, A (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol Rehabil Med, Guldhedsgatan 19, S-41345 Gothenburg, Sweden.	asa.lundgren-nilsson@rehab.gu.se; alantennant@compuserve.com; gunnar.grimby@rehab.gu.se; ks.sunnerhagen@neuro.gu.se	Grimby, Gunnar/AAB-3178-2019; Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400			Andrich D., 2003, RUMM2020; Andrich David, 2003, J Appl Meas, V4, P205; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bode Rita K, 2003, J Appl Meas, V4, P124; Bode RK, 2003, ARCH PHYS MED REHAB, V84, pS52, DOI 10.1053/apmr.2003.50247; BOND TG, 2001, APPL RASCH MODEL FUN, pR24; Catz A, 1997, SPINAL CORD, V35, P850, DOI 10.1038/sj.sc.3100504; Claesson L, 2001, J REHABIL MED, V33, P137; Cohen ME, 2000, ARCH PHYS MED REHAB, V81, pS21, DOI 10.1053/apmr.2000.20620; Dallmeijer AJ, 2005, J REHABIL MED, V37, P346, DOI 10.1080/16501970510038284; Deutsch A, 1996, CRITICAL REV PHYS ME, V8, P267; Elhan AH, 2005, J REHABIL MED, V37, P306, DOI 10.1080/16501970510037573; Fisher W., 1992, RASCH MEAS T, V6, P238; Grimby G, 1996, ARCH PHYS MED REHAB, V77, P1109, DOI 10.1016/S0003-9993(96)90131-8; Haigh R, 2001, J REHABIL MED, V33, P273; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HEINEMANN AW, 2001, REDUSING STEP DISORD; KEITH RA, 1984, ARCH PHYS MED REHAB, V65, P74; Kucukdeveci AA, 2001, CLIN REHABIL, V15, P311, DOI 10.1191/026921501676877265; Lai J-S, 2002, RASCH MEAS T, V15, P850; LAWTON G, 2006, CROSS CULTURAL VALID; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lundgren-Nilsson A, 2005, J REHABIL MED, V37, P23, DOI 10.1080/16501970410032696; Luo Guanzhong, 2005, J Appl Meas, V6, P128; MARINO RJ, 1993, PARAPLEGIA, V31, P225, DOI 10.1038/sc.1993.41; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; Nilsson AL, 2005, ACTA NEUROL SCAND, V111, P264, DOI 10.1111/j.1600-0404.2005.00404.x; Orlando M, 2002, PSYCHOL ASSESSMENT, V14, P50, DOI 10.1037//1040-3590.14.1.50; PALLANT JFT, 2006, BRIT J CLIN PSYCHOL; RASCH G, 1980, PROBABILISTIC MODELS, pR23; Smith R M, 2000, J Appl Meas, V1, P199; STREINER DL, 1995, OXFORD MED PUBLICATI, pR8; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; van Buuren S, 2003, EUR J PUBLIC HEALTH, V13, P15, DOI 10.1093/eurpub/13.suppl_1.15; VANALPHEN A, 1994, J ADV NURS, V20, P196; Wright B. D., 2003, RASCH MEASUREMENT T, V17, P905; Wright BD, 1997, SCAND J REHABIL MED, V29, P267; WRIGHT BD, 1982, RATING SCALE ANAL, pR11; [No title captured]	41	31	32	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1477-7525		HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	AUG 23	2006	4								55	10.1186/1477-7525-4-55			8	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	091NF	WOS:000241034900001	16928268	Green Published, gold			2022-02-06	
J	Bruce, BB; Zhang, X; Kedar, S; Newman, NJ; Biousse, V				Bruce, B. B.; Zhang, X.; Kedar, S.; Newman, N. J.; Biousse, V.			Traumatic homonymous hemianopia	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							VISUAL-FIELD DEFECTS; REHABILITATION; PERIMETRY; GOLDMANN; INJURY	Objective: To describe the characteristics of patients with homonymous hemianopia from traumatic brain injury (TBI) seen in our unit between 1989 and 2004. Methods: Only patients with a history of TBI, who had detailed clinical information and results of neuroimaging, were included in our study. Demographic characteristics, clinical features, types of visual field defects, location of lesion and evolution of visual field defects were recorded. Results: Of the 880 patients with homonymous hemianopia seen in our unit, 103 patients (112 with homonymous hemianopia) had TBI (74 men and 29 women, mean age 30.7 (SD 15.3) years). Median time from injury to initial visual field testing was 5 (range 0.5-360) months. In all, 64 (57.1%) patients sustained injuries that were motor vehicle-related; 19 (17%) violence-related; 17 (15.2%) due to falls; and 12 (10.7%) because of other blunt head trauma. Visual field defects included complete homonymous hemianopia in 44 (39.3%) patients and incomplete homonymous hemianopia in 68 (60.7%) patients. The lesion was occipital in 14 (12.5%) patients, associated with optic radiation in 26 (23.2%) and the optic tract in 12 (10.7%), and multiple in 60 (53.6%). Conclusion: Most cases of homonymous hemianopia from TBI were motor vehicle-related. Patients were younger, more often male, and had multiple brain lesions more often than patients with homonymous hemianopia from causes other than TBI. A median delay of 5 months was observed before the documentation of the homonymous hemianopia, which may have a major effect on the success of rehabilitation and driving training in these young patients.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; Emory Univ, Dept Neurol, Atlanta, GA 30322 USA		Biousse, V (corresponding author), Emory Eye Ctr, Neuroophthalmol Unit, 1365 B Clifton Rd NE, Atlanta, GA 30322 USA.	vbiouss@emory.edu	Newman, Nancy/AAB-2532-2021; KEDAR, SACHIN/B-2579-2008	Bruce, Beau/0000-0003-3003-2962; Kedar, Sachin/0000-0002-7293-5556	NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY006360] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30-EY06360] Funding Source: Medline		Celesia GG, 1997, NEUROLOGY, V49, P88, DOI 10.1212/WNL.49.1.88; FUJINO T, 1986, NEURO-OPHTHALMOLOGY, V6, P17, DOI 10.3109/01658108608997320; GIANUTSOS R, 1988, ARCH PHYS MED REHAB, V69, P573; GRAY CS, 1989, AGE AGEING, V18, P419, DOI 10.1093/ageing/18.6.419; HEINEN M, 2005, NAT TRENDS INJ HOSP; KELTNER JL, 1987, OPHTHALMOLOGY, V94, P1180; Kerkhoff G, 1999, RESTOR NEUROL NEUROS, V15, P255; McKinnon, 2001, BLACK POPULATION 200; Pambakian A, 2005, J NEURO-OPHTHALMOL, V25, P136; SAVIR H, 1977, SCAND J REHABIL MED, V9, P151; SMITH JL, 1962, AM J OPHTHALMOL, V54, P616, DOI 10.1016/0002-9394(62)92192-X; Szatmary G, 2002, ARCH OPHTHALMOL-CHIC, V120, P1162; TROBE JD, 1973, ARCH OPHTHALMOL-CHIC, V89, P377, DOI 10.1001/archopht.1973.01000040379005; TROBE JD, 2001, NEUROLOGY VISION, P109; UZZELL BP, 1988, ARCH NEUROL-CHICAGO, V45, P420, DOI 10.1001/archneur.1988.00520280066017; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Wall M, 2005, WALSH HOYT CLIN NEUR, P83; Wong AMF, 2000, OPHTHALMOLOGY, V107, P527, DOI 10.1016/S0161-6420(99)00092-5; Zhang X, 2006, NEUROLOGY, V66, P906, DOI 10.1212/01.wnl.0000203913.12088.93; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22; ZIHL J, 1995, BRAIN, V118, P891, DOI 10.1093/brain/118.4.891	21	31	31	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	AUG	2006	77	8					986	988		10.1136/jnnp.2006.088799			3	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	063RP	WOS:000239037600026	16574725	Green Published			2022-02-06	
J	Marklund, N; Salci, K; Ronquist, G; Hillered, L				Marklund, Niklas; Salci, Konstantin; Ronquist, Gunnar; Hillered, Lars			Energy metabolic changes in the early post-injury period following traumatic brain injury in rats	NEUROCHEMICAL RESEARCH			English	Article						traumatic brain injury (TBI); adenylates; ATP; ADP; AMP; energy charge; microdialysis; hypoxanthine	LATERAL FLUID-PERCUSSION; CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; COMPRESSION CONTUSION TRAUMA; MITOCHONDRIAL DYSFUNCTION; BIOENERGETIC STATE; HEAD-INJURY; INTRACEREBRAL MICRODIALYSIS; LACTATE CONCENTRATIONS; EXTRACELLULAR GLUCOSE	Impaired cerebral energy metabolism may be a major contributor to the secondary injury cascade that occurs following traumatic brain injury (TBI). To estimate the cortical energy metabolic state following mild and severe controlled cortical contusion (CCC) TBI in rats, ipsi-and contralateral cortical tissues were frozen in situ at 15 and 40 min post-injury and adenylate (ATP, ADP, AMP) levels were analyzed using high-performance liquid chromatography (HPLC) and the energy charge (EC) was calculated. At 15 min post-injury, mildly brain-injured animals showed a 43% decrease in cortical ATP levels and a 2.4-fold increase in AMP levels (P < 0.05), and there was a significant reduction of the ipsilateral cortical EC when compared to sham-injured animals (P < 0.05). At 40 min post-injury, the ipsilateral adenylate levels and EC had recovered to the values observed in the sham-injury group. In the severe CCC group, there was a 51% decrease in ipsilateral cortical ATP levels and a 5.3-fold increase in AMP levels with a significant reduction of cortical EC at 15 min post-injury (P < 0.05). At 40 min post-injury, a 2.6-fold ipsilateral increase in AMP levels and an 11% and 44% decrease in EC and ATP levels, respectively, remained (P < 0.05). A 37-38% reduction of the total adenylate pool was observed ipsilaterally in both CCC severity groups at the early time-point, and a 19% and 28% decrease remained in the mild and severe CCC groups, respectively, at 40 min post-injury. Significant contralateral ATP and EC changes were only observed in the severe CCC group at 40 min post-injury (P < 0.05). The energy-requiring secondary injury cascades that occur early post-injury do not challenge the brain tissue to the extent of ATP depletion and may provide a window of opportunity for therapeutic intervention.	Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden		Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Ing 85,2 Tr, SE-75185 Uppsala, Sweden.	Niklas.Marklund@neurokir.uu.se		Marklund, Niklas/0000-0002-9797-5626			ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Emery DL, 2000, J COMP NEUROL, V424, P521; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; ERICSON A, 1983, CLIN CHIM ACTA, V127, P47, DOI 10.1016/0009-8981(83)90074-8; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; Folbergrova J, 1999, NEUROSCI LETT, V266, P121, DOI 10.1016/S0304-3940(99)00279-7; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GINSBERG MD, 1990, CEREBROVAS BRAIN MET, V2, P58; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; HAMMER DF, 1988, ANAL BIOCHEM, V169, P300, DOI 10.1016/0003-2697(88)90288-6; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J NEUROTRAUM, V20, P139, DOI 10.1089/08977150360547062; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Marklund N, 2000, ACTA NEUROCHIR, V142, P1135, DOI 10.1007/s007010070042; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MATZ H, 1989, J NEUROSCI RES, V24, P260, DOI 10.1002/jnr.490240218; Mautes AEM, 2001, J MOL NEUROSCI, V16, P33, DOI 10.1385/JMN:16:1:33; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; North RA, 2006, PFLUG ARCH EUR J PHY, V452, P479, DOI 10.1007/s00424-006-0060-y; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; RONQUIST G, 1993, CLIN CHIM ACTA, V223, P93, DOI 10.1016/0009-8981(93)90065-C; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Schuhmann MU, 2002, ACT NEUR S, V81, P209; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Stover JF, 2003, J NEUROTRAUM, V20, P315, DOI 10.1089/089771503765172273; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1990, J NEUROSCI, V10, P3524; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	79	31	31	0	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	AUG	2006	31	8					1085	1093		10.1007/s11064-006-9120-0			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	077TS	WOS:000240053900011	16909313				2022-02-06	
J	Shutter, L; Tong, KA; Lee, A; Holshouser, BA				Shutter, Lori; Tong, Karen A.; Lee, Ann; Holshouser, Barbara A.			Prognostic role of proton magnetic resonance spectroscopy in acute traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						diffuse axonal injury; proton magnetic resonance spectroscopy; traumatic brain injury	SEVERE HEAD-INJURY; OUTCOME PREDICTION; IN-VIVO; MR SPECTROSCOPY; AXONAL INJURY; METABOLISM; CHILDREN; RECOVERY; TREE	Proton magnetic resonance spectroscopy (MRS) is being used to evaluate individuals after acute traumatic brain injury. These studies have shown that changes in certain brain metabolites are associated with poor neurologic outcomes. The majority of MRS studies have been obtained relatively late after injury, but there have been a few reports of use early after injury to assist with outcome prediction. Altered brain metabolites may be sensitive indicators of injury and thus provide additional prognostic information when spectroscopy is done early after injury. This technology may provide a noninvasive means to evaluate early excitotoxic injury; and show changes associated with both neuronal injury and membrane disruption secondary to diffuse axonal injury. This article will review the technology of MRS, discuss its role in patient assessment after traumatic brain injury, and present a summary of our published and ongoing research.	Univ Cincinnati, Med Ctr, Dept Neurosurg, Cincinnati, OH 45267 USA; Loma Linda Univ, Med Ctr, Dept Radiol, Loma Linda, CA USA; DPF Orthoped, Rehabil Serv, Kansas City, MO USA		Shutter, L (corresponding author), Univ Cincinnati, Med Ctr, Dept Neurosurg, POB 670515, Cincinnati, OH 45267 USA.	shuttel@healthall.com	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628			*AM ASS NEUR SURG, 2000, GUID MAN SEV HEAD IN; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; Danielsen ER, 2003, NEURORADIOLOGY, V45, P722, DOI 10.1007/s00234-003-1068-z; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; HOLSHOUSER BA, 2002, JOINT S NAT INT NEUR; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEE A, 2004, COMP PREDICATIVE ACC; Macmillan CSA, 2002, ACTA NEUROCHIR, V144, P853, DOI 10.1007/s00701-002-0966-x; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; SHUTTER L, 2002, JOINT S NAT INT NEUR; Signoretti S, 2002, ACT NEUR S, V81, P373; Wild JM, 1999, MAGN RESON MATER PHY, V8, P109	30	31	31	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2006	21	4					334	349		10.1097/00001199-200607000-00005			16	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	064SJ	WOS:000239109100005	16915009				2022-02-06	
J	Koob, AO; Borgens, RB				Koob, Andrew O.; Borgens, Richard B.			Polyethylene glycol treatment after traumatic brain injury reduces beta-amyloid precursor protein accumulation in degenerating axons	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						membrane repair; secondary axotomy; polymer repair; cell survival	SPINAL-CORD-INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; AXOLEMMAL PERMEABILITY; CEREBROSPINAL-FLUID; MOLECULAR REPAIR; NERVE MEMBRANES; DAMAGE; PEPTIDE; RECOVERY	Polyethylene glycol (PEG; 2,000 MW; 30% v/v) is a nontoxic molecule that can be injected intravenously and possesses well-documented neuroprotective properties in the spinal cord of the guinea pig. Recent studies have shown that intravenous PEG can also enter the rat brain parenchyma after injury and repair cellular membrane damage in the region of the corpus callosum. Disrupted anterograde axonal transport and resulting P-amyloid precursor protein (APP) accumulation are byproducts of traumatic axonal injury (TAI) in the brain. APP accumulation indicates axonal degeneration as a result of axotomy, a detriment that can lead to cell death. In this study, we show that PEG treatment can eliminate APP accumulation in specific brain areas of rats receiving TAL Six areas of the brain were analyzed: the medial cortex, hippocampus, lateral cortex, thalamus, medial lemniscus, and medial longitudinal fasciculus. Increased APP expression after injury was abolished in the thalamus and reduced in the medial longitudinal fasciculus by PEG treatment. In all remaining areas except for the lateral cortex, APP expression was not increased between injured and uninjured brains, indicating that damage was undetected in those brain areas in this study. (c) 2006 Wiley-Liss, Inc.	Purdue Univ, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Borgens, RB (corresponding author), Purdue Univ, Ctr Paralysis Res, Dept Basic Med Sci, 408 S Univ St, W Lafayette, IN 47907 USA.	cpr@purdue.edu					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Blennow K, 2004, NEUROLOGY, V62, P159, DOI 10.1212/WNL.62.1.159; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Borgens R.B., 1986, Progress in Clinical and Biological Research, V210, P239; Borgens R.B., 2003, ADV ANAT EMBRYOL CEL, V171, P1; Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; Borgens RB, 2002, J EXP BIOL, V205, P1; Borgens RB, 2001, NEUROSURGERY, V49, P370, DOI 10.1097/00006123-200108000-00021; Borgens RB, 2001, J NEUROSCI RES, V66, P1179; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Donaldson J, 2002, NEUROSURGERY, V50, P147, DOI 10.1097/00006123-200201000-00023; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Harrington D, 2000, J Clin Forensic Med, V7, P19, DOI 10.1054/jcfm.2000.0359; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Koob AO, 2005, J NEUROTRAUM, V22, P1092, DOI 10.1089/neu.2005.22.1092; Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/neu.2004.21.1767; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Niess C, 2002, ACTA NEUROPATHOL, V104, P79, DOI 10.1007/s00401-002-0525-9; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Pierce JES, 1996, J NEUROSCI, V16, P1083; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Ramon y Cajal, 1928, DEGENERATION REGENER; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STRICH SJ, 1961, LANCET, V2, P443; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Working PK, 1997, ACS SYM SER, V680, P45	47	31	34	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2006	83	8					1558	1563		10.1002/jnr.20837			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051QX	WOS:000238176800019	16555285				2022-02-06	
J	Rutterford, NA; Wood, RLL				Rutterford, Neil A.; Wood, Rodger L. L.			Evaluating a theory of stress and adjustment when predicting long-term psychosocial outcome after brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						psychosocial factors; brain injuries; outcome studies; personality; stress; adjustment	CLOSED-HEAD-INJURY; FOLLOW-UP; PERSONALITY-TRAITS; IMPAIRED AWARENESS; SELF-AWARENESS; LIFE; INTEGRATION; DISABILITY; DEPRESSION; SCALE	Kendall and Terry (1996) include many psychosocial predictors in their theoretical model that explains individual differences in psychosocial adjustment (Lazarus & Folkman, 1984). The model depicts appraisal and coping variables as mediating relationships between situation factors, environmental and personal resources, and multidimensional outcome. The aim of this Study was to explore these theoretical relationships at very late stages of recovery from traumatic brain injury. A total of 131 participants who were more than 10 years post-injury (mean = 15.31 years) completed several psychosocial measures relating to outcome dimensions comprising employment. community integration, life satisfaction, quality of life (QoL), and emotion. There was no evidence that appraisal and coping variables mediated relationships between psychosocial and any of the outcome variables. However. when appraisal and coping variables were combined with psychosocial variables as direct predictors of outcome, every outcome except employment status was reliably predicted, accounting for between 31 and 46% of the variance. Personality significantly influenced all predicted outcomes. Self-efficacy contributed to the prediction of all outcomes except QoL. Data did not support for the theory of stress and adjustment as a framework for explaining the nature of predictive relationships between psychosocial variables and very long-term, multidimensional outcome after brain injury.	Univ Coll Swansea, Sch Human Sci, Dept Psychol, Swansea SA2 8PP, W Glam, Wales		Wood, RLL (corresponding author), Univ Coll Swansea, Sch Human Sci, Dept Psychol, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swansea.ac.uk					BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Finset A, 2000, BRAIN INJURY, V14, P887; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hoofien D, 2001, BRAIN INJURY, V15, P189; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Miller MA, 1997, J PSYCHOSOM RES, V43, P279, DOI 10.1016/S0022-3999(97)00118-9; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; POWER MJ, 1988, BRIT J CLIN PSYCHOL, V27, P349, DOI 10.1111/j.2044-8260.1988.tb00799.x; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Smith J, 1998, CANADIAN J REHABILIT, V11, P131; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; Thomsen I V, 1987, Brain Inj, V1, P131, DOI 10.3109/02699058709034452; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; [No title captured]; [No title captured]	40	31	31	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2006	12	3					359	367		10.1017/S1355617706060450			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	046PP	WOS:000237823800006	16903128				2022-02-06	
J	Su, W; Hui, T; Shaw, K				Su, Wendy; Hui, Thomas; Shaw, Kenneth			All-terrain vehicle injury patterns: are current regulations effective?	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	37th Annual Meeting of the Canadian-Association-of-Paediatric-Surgeons	SEP 22-25, 2005	Quebec City, CANADA	Canadian Assoc Paediat Surg		all-terrain vehicles; helmet use; injury prevention	CHILDREN; PREVENTION; TRAUMA; IMPACT; HELMET; ATV	Purpose: All-terrain vehicle (ATV)-related injuries continued to increase in recent years. We aimed to analyze the ATV injury patterns at our institution to help structure public awareness campaign and encourage governmental regulation, with the ultimate goal of injury prevention. Methods: A retrospective review of all ATV-related admissions at a pediatric trauma center was performed. Results: From 2001 to 2004, 50 ATV-related injuries requiting hospital admission were identified. The annual incidence had increased 2.5-fold from 2001 (8 admissions) to 2004 (20 admissions). The ages ranged from 3 to 17 years (median, 13 years), with equal sex distribution. Fifty-four percent of admissions were traumatic brain injuries, 28% had orthopedic injuries, 14% with facial fractures, and 4% with abdominal injuries. Average length of stay was 6 days (range, 1-47 days); 5 of the 7 intensive care unit admissions occurred in 2004. Eighty-four percent of patients did not wear helmet (97% among those from northern communities). Conclusions: Both the incidence and severity of ATV-related injuries are increasing in a regional pediatric trauma center. There is a lack of regulation enforcement and public awareness of the danger of ATV use in children. Efforts to ensure helmet use and limit operator age are urgently needed to reduce childhood ATV-related injuries. (c) 2006 Elsevier Inc. All rights reserved.	Montreal Childrens Hosp, Dept Surg, Montreal, PQ H3H 1P3, Canada		Shaw, K (corresponding author), Montreal Childrens Hosp, Dept Surg, Montreal, PQ H3H 1P3, Canada.	wendysu2@hotmail.com; kenneth.shaw@muhc.mcgill.ca					Aitken ME, 2004, INJURY PREV, V10, P303, DOI 10.1136/ip.2003.004176; American Academy of Pediatrics Committee on Accident and Poison Prevention, 1987, PEDIATRICS, V79, P306; Bercher D L, 2001, J Ark Med Soc, V97, P351; Bhutta ST, 2004, PEDIATR RADIOL, V34, P130, DOI 10.1007/s00247-003-1085-4; Bull MJ, 2000, PEDIATRICS, V105, P1352, DOI 10.1542/peds.105.6.1352; *CAN PAED SOC ACC, 1987, CMAJ, V136, P119; *CONS PROD SAF COM, 1998, TERR VEH EXP INJ DEA; Helmkamp J C, 2000, W V Med J, V96, P361; Helmkamp James C, 2003, W V Med J, V99, P224; Injury Prevention Committee, 2004, PAED CHILD HLTH, V9, P337; Keenan HT, 2004, PEDIATRICS, V113, pE330, DOI 10.1542/peds.113.4.e330; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; LEVENSON M, 2001, TERR VEH 2001 INJ EX; Lister DG, 1998, J PEDIATR SURG, V33, P1081, DOI 10.1016/S0022-3468(98)90535-8; Lynch JM, 1998, J PEDIATR SURG, V33, P329, DOI 10.1016/S0022-3468(98)90456-0; Mangus RS, 2004, INJURY PREV, V10, P56, DOI 10.1136/ip.2003.002626; Moroney P, 2003, INJURY, V34, P203, DOI 10.1016/S0020-1383(02)00317-0; Murphy N, 2004, J TRAUMA, V56, P1185, DOI 10.1097/01.TA.0000123038.94864.E2; NAGELBERG A, AM AC ORTH SURG POS; Ross RT, 1999, AM SURGEON, V65, P870; Russell A, 1998, PEDIATR EMERG CARE, V14, P31, DOI 10.1097/00006565-199802000-00009; Upperman JS, 2003, J PEDIATR SURG, V38, P1284, DOI 10.1016/S0022-3468(03)00383-X; KAWASAKI KFX50 INFOR	23	31	31	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAY	2006	41	5					931	934		10.1016/j.jpedsurg.2006.01.011			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Surgery	054PI	WOS:000238390700012	16677886				2022-02-06	
J	Yang, Y; Xie, YY; Chai, H; Fan, M; Liu, SH; Liu, H; Bruce, I; Wu, WT				Yang, Y; Xie, YY; Chai, H; Fan, M; Liu, SH; Liu, H; Bruce, I; Wu, WT			Microarray analysis of gene expression patterns in adult spinal motoneurons after different types of axonal injuries	BRAIN RESEARCH			English	Article						motoneuron; axotomy; avulsion; regeneration; gene expression; CDNA microarray	NITRIC-OXIDE SYNTHASE; SCIATIC-NERVE CRUSH; ROOT AVULSION; CORD-INJURY; NEUROTROPHIC FACTOR; C-JUN; TRAUMATIC INJURY; TRANSGENIC MICE; MOTOR-NEURONS; BRAIN-INJURY	Three experimental models of axonal injuries in adult rat spinal motoneurons were established to investigate changes of gene expression in response to such injuries. We took advantage of cDNA microarray analysis to determine the differential expression of genes in injured motoneurons following distal axotomy or root avulsion in the absence or presence of BDNF. The major finding was that, in response to proximal axonal injury (avulsion), expression of genes that are known to facilitate neuronal survival and axonal regeneration (e.g., IGFRII, PI3K, IGFBP-6, GSTs, GalR2) were down-regulated; but following treatment with BDNF they were up-regulated. In addition, the expression of genes known to be involved in apoptosis and DNA damage (e.g., ANX5, TS, ALR) were down-regulated in BDNF-treated animals with avulsion. Furthermore, many functional families of genes previously shown to play roles in the pathophysiology of axonal injury, including SNAP-2SA, SV2B, Ras-related ras3a/4b, ERK1/2, 14-3-3 proteins, proteasome proteins, oncogenes, GAP-43, and NMDAR1, were altered after either distal axotomy or avulsion injury. Some of the changes in gene expression, including Lim-2, FRAG1, GlaR2, GSTs, ALR, TS, ANX3/5, and nhe1/2, are first reported here in injured motoneurons. The differential expression of genes identified by the expression arrays was confirmed by gene-specific RT-PCR for eight genes (GAP-43, IGFR II, Lim-2, MIF, NDAP1, TS, PCC3, and FRAGI) and by in situ hybridization for Lim-2. These results suggest that abnormal regulation of particular biochemical pathways may induce motoneuron death after ventral root avulsion in adult animals. This study presents an approach for selecting specific genes and their products that may be involved in motoneuron degeneration following axonal injuries. (c) 2005 Elsevier B.V. All rights reserved.	Univ Hong Kong, Fac Med, Dept Anat, Hong Kong, Peoples R China; Beijing Inst Basic Med Sci, Dept Neurobiol, Beijing 100850, Peoples R China; Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Peoples R China		Wu, WT (corresponding author), Univ Hong Kong, Fac Med, Dept Anat, 21 Sassoon Rd, Hong Kong, Peoples R China.	wtwu@hkucc.hku.hk	Bruce, Iain C/K-8912-2017; Chai, Hong/H-5438-2011	Bruce, Iain C/0000-0002-5710-3970; Yang, Yanqi/0000-0002-3582-1277			Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Cao Xiaojian, 2002, Chin J Traumatol, V5, P228; Cao Xiaojian, 2002, Chin J Traumatol, V5, P131; Chai H, 1999, NEUROSCI LETT, V274, P147, DOI 10.1016/S0304-3940(99)00671-0; Counts SE, 2002, J NEUROCHEM, V83, P442, DOI 10.1046/j.1471-4159.2002.01148.x; Di Giovanni S, 2004, FASEB J, V18, P153, DOI 10.1096/fj.04-2694fje; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Donovan SL, 2002, J NEUROSCI, V22, P3543; Enge M, 2003, NEUROCHEM RES, V28, P271, DOI 10.1023/A:1022421001288; Erdmann KS, 1998, BIOCHEM BIOPH RES CO, V249, P891, DOI 10.1006/bbrc.1998.9219; FAWCETT JW, 1992, TRENDS NEUROSCI, V15, P5, DOI 10.1016/0166-2236(92)90338-9; Ford P, 2002, J MEMBRANE BIOL, V190, P117, DOI 10.1007/s00232-002-1030-8; Forsberg-Nilsson K, 2003, GLIA, V41, P276, DOI 10.1002/glia.10191; Fujimoto Shin, 1997, Hokkaido Journal of Medical Science, V72, P409; Gagliardini V, 2000, MOL CELL NEUROSCI, V16, P27, DOI 10.1006/mcne.2000.0850; Gu YM, 1997, DEV NEUROSCI-BASEL, V19, P255, DOI 10.1159/000111214; Harding DI, 1999, EUR J NEUROSCI, V11, P2237, DOI 10.1046/j.1460-9568.1999.00640.x; Hashimoto M, 2005, ACTA NEUROPATHOL, V109, P165, DOI 10.1007/s00401-004-0926-z; Hayashi T, 1998, J NEUROCHEM, V71, P356; HOKOH Y, 2001, FREE RADICAL RES, V33, P739; Hu J, 2002, EUR J NEUROSCI, V16, P1409, DOI 10.1046/j.1460-9568.2002.02218.x; Islamov RR, 2003, BRAIN RES, V966, P65, DOI 10.1016/S0006-8993(02)04191-4; Jacobsson G, 1996, MOL BRAIN RES, V37, P49, DOI 10.1016/0169-328X(95)00272-T; JOHNSON JA, 1993, J NEUROSCI, V13, P2013; Ju WK, 2002, NEUROREPORT, V13, P861, DOI 10.1097/00001756-200205070-00025; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kishino A, 2003, BRAIN RES, V964, P56, DOI 10.1016/S0006-8993(02)04066-0; Krasnova IN, 2002, FASEB J, V16, P1379, DOI 10.1096/fj.01-0796com; Kurihara S, 2000, ENDOCR J, V47, P739, DOI 10.1507/endocrj.47.739; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Lin Wan-Min, 2003, Shengli Xuebao, V55, P79; LINDA H, 1992, EXP BRAIN RES, V91, P284; Mahoney SA, 2003, J NEUROSCI, V23, P416, DOI 10.1523/JNEUROSCI.23-02-00416.2003; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026; Mason MRJ, 2000, EXP NEUROL, V165, P143, DOI 10.1006/exnr.2000.7445; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Nakamura M, 2001, EXP NEUROL, V169, P407, DOI 10.1006/exnr.2001.7670; Namikawa K, 1998, MOL BRAIN RES, V55, P315, DOI 10.1016/S0169-328X(98)00012-6; Nishio Y, 1999, BBA-MOL BASIS DIS, V1453, P74, DOI 10.1016/S0925-4439(98)00086-6; Novikova L, 1997, EUR J NEUROSCI, V9, P2774, DOI 10.1111/j.1460-9568.1997.tb01706.x; Oliveira ALR, 2000, NEUROSCI LETT, V293, P131, DOI 10.1016/S0304-3940(00)01506-8; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; Roldan V, 2002, REV ESP CARDIOL, V55, P1230, DOI 10.1016/S0300-8932(02)76794-8; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; Tachibana T, 2002, NEUROSCI LETT, V327, P133, DOI 10.1016/S0304-3940(02)00375-0; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Wang ZH, 1998, J NEURO-ONCOL, V36, P219, DOI 10.1023/A:1005883128175; Wehrle R, 2001, EUR J NEUROSCI, V13, P857, DOI 10.1046/j.1460-9568.2001.01452.x; WELLS MR, 1994, EXP BRAIN RES, V101, P53; WU W, 1994, NEUROSCIENCE, V61, P719, DOI 10.1016/0306-4522(94)90394-8; Wu WT, 1996, EXP NEUROL, V141, P190, DOI 10.1006/exnr.1996.0153; Wu WT, 2003, J NEUROTRAUM, V20, P603, DOI 10.1089/089771503767168528; WU WT, 1994, NEUROSCI LETT, V179, P157, DOI 10.1016/0304-3940(94)90958-X; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Zhao SR, 1998, NEUROSURGERY, V42, P1357, DOI 10.1097/00006123-199806000-00099; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155	62	31	34	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 23	2006	1075						1	12		10.1016/j.brainres.2005.12.060			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	029LS	WOS:000236564700001	16460709				2022-02-06	
J	Hyam, JA; Welch, CA; Harrison, DA; Menon, DK				Hyam, Jonathan A.; Welch, Catherine A.; Harrison, David A.; Menon, David K.			Case mix, outcomes and comparison of risk prediction models for admissions to adult, general and specialist critical care units for head injury: a secondary analysis of the ICNARC Case Mix Programme Database	CRITICAL CARE			English	Article							GLASGOW COMA SCALE; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE; MORTALITY PREDICTION; APACHE-III; PROGNOSIS; REGRESSION; SCORE; MANAGEMENT; SEVERITY	Introduction This report describes the case mix and outcome ( mortality, intensive care unit (ICU) and hospital length of stay) for admissions to ICU for head injury and evaluates the predictive ability of five risk adjustment models. Methods A secondary analysis was conducted of data from the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme, a high quality clinical database, of 374,594 admissions to 171 adult critical care units across England, Wales and Northern Ireland from 1995 to 2005. The discrimination and calibration of five risk prediction models, SAPS II, MPM II, APACHE II and III and the ICNARC model plus raw Glasgow Coma Score (GCS) were compared. Results There were 11,021 admissions following traumatic brain injury identified (3% of all database admissions). Mortality in ICU was 23.5% and in-hospital was 33.5%. Median ICU and hospital lengths of stay were 3.2 and 24 days, respectively, for survivors and 1.6 and 3 days, respectively, for non-survivors. The ICNARC model, SAPS II and MPM II discriminated best between survivors and non-survivors and were better calibrated than raw GCS, APACHE II and III in 5,393 patients eligible for all models. Conclusion Traumatic brain injury requiring intensive care has a high mortality rate. Non-survivors have a short length of ICU and hospital stay. APACHE II and III have poorer calibration and discrimination than SAPS II, MPM II and the ICNARC model in traumatic brain injury; however, no model had perfect calibration.	Intens Care Natl Audit & Res Ctr, London WC1H 9HR, England; Charing Cross Hosp, Dept Neurosurg, London, England; Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 2QQ, England		Welch, CA (corresponding author), Intens Care Natl Audit & Res Ctr, Tavistock House,Tavistock Sq, London WC1H 9HR, England.	cathy.welch@icnarc.org	Harrison, David A/O-4355-2018	Harrison, David A/0000-0002-9002-9098; Welch, Catherine/0000-0002-6687-964X			Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bennett-Guerrero E, 2003, BRIT J SURG, V90, P1593, DOI 10.1002/bjs.4347; BION J, 1995, BMJ-BRIT MED J, V310, P682, DOI 10.1136/bmj.310.6981.682; Brier GW, 1950, MONTHLY WEATHER REV, V75, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:V0FEIT>2.0.C0;2; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; *DEP HLTH, 2006, NHS REF COSTS 2005; EDNA TH, 1983, ACTA NEUROCHIR, V69, P15, DOI 10.1007/BF02055848; GROCOTT MPW, 2000, CLIN INTENSIVE CARE, V11, P263; Gupta D, 2004, CRIT CARE, V8, pR112, DOI 10.1186/cc2835; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; HARRISON DA, 2006, INTENSIVE CARE ME S1, V32, pS204; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1976, LANCET, V1, P1031; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Lane PL, 2000, CAN J SURG, V43, P442; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; LE GJ, 1993, JAMA-J AM MED ASSOC, V270, P2957; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Metcalfe MA, 1997, LANCET, V350, P7, DOI 10.1016/S0140-6736(96)10018-0; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; O'Jile JR, 2004, APPL NEUROPSYCHOL, V11, P107, DOI 10.1207/s15324826an1102_7; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; ROWAN K, 1992, THESIS U OXFORD; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P161; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Watkins LD, 2000, SURGERY, V18, P219; Wildman MJ, 2005, CRIT CARE, V9, DOI 10.1186/cc3719; Young JD, 2001, BRIT J ANAESTH, V87, P543, DOI 10.1093/bja/87.4.543	45	31	31	0	3	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1466-609X			CRIT CARE	Crit. Care		2006	10			2					S2	10.1186/cc5066			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185OA	WOS:000247719100002	17352796	Green Published, gold			2022-02-06	
J	Kulkarni, AR; Aggarwal, SP; Kulkarni, RR; Deshpande, MD; Walimbe, PB; Labhsetwar, AS				Kulkarni, AR; Aggarwal, SP; Kulkarni, RR; Deshpande, MD; Walimbe, PB; Labhsetwar, AS			Ocular manifestations of head injury: a clinical study	EYE			English	Article; Proceedings Paper	Annual Congress of the Royal-College-of-Ophthalmologists	2004	Manchester, ENGLAND	Royal Coll Ophthalmologists		ocular manifestations; head injury; outcome	NEUROOPHTHALMOLOGICAL FINDINGS; TRAUMA	Aim This prospective study aimed to clinically correlate the various ocular findings with the neurological status in cases of closed head injury. Methods A total of 200 consecutive cases of closed head injury admitted to a major teaching hospital underwent a thorough ophthalmic assessment. The Glasgow coma scale (GCS) and the Revised trauma score (RTS) were applied to grade the severity of injury and assess the prognosis. Kendall's tau-b and Fisher's exact test were used in the analysis. Results The main causes of head injury were road traffic accidents 52.5% followed by assaults in 34%. Ocular involvement was found in 167(83.5%) cases. These included corneal and scleral tears in 2%, subconjunctival haemorrhage or ecchymosis in 46%, orbital fractures 12%, pupillary involvement 6.5%, papilloedema 5.5%, intraocular trauma 5.5%, proptosis 3%, lateral rectus palsy 2%, lacrimal gland prolapse 1%, and optic nerve trauma 0.5%. All 21 patients (10.5%) who died had eye involvement. In all, 150 cases (75%) with a RTS of 12 had a good prognosis. Of these 124 (82.6%) had ocular involvement of no neurological significance. Conclusions Although sophisticated imaging techniques are available to localize lesions, early ophthalmic assessment in correlation with the GCS aids in prognosticating outcomes. Pupillary involvement, papilloedema, and ocular motor paresis pointed to a more severe head injury. To our knowledge, this is the only prospective study recording ocular findings in the first few hours and attempting a correlation with the final outcome.	Dudley Guest Hosp, Grp Hosp NHS Trust, Dept Ophthalmol, Dudley DY1 4SE, W Midlands, England; Alexandra Hosp, Dept Orthopaed & Trauma, Redditch, Worcs, England; HV Desai Eye Hosp, Dept Ophthalmol, Pune, Maharashtra, India; Univ Poona, Dept Ophthalmol, BJ Med Coll, Pune 411007, Maharashtra, India; Univ Poona, Sassoon Gen Hosp, Pune 411007, Maharashtra, India		Kulkarni, AR (corresponding author), Dudley Guest Hosp, Grp Hosp NHS Trust, Dept Ophthalmol, Tipton Rd, Dudley DY1 4SE, W Midlands, England.	ruparch2@hotmail.com					*ACS COMM TRAUM, 1993, ADV TRAUM LIF SUPP C; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Banks Michelle C., 2002, International Ophthalmology Clinics, V42, P1; KEANE JR, 1989, ARCH NEUROL-CHICAGO, V46, P761, DOI 10.1001/archneur.1989.00520430055017; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; LEPORE FE, 1995, ARCH NEUROL-CHICAGO, V52, P924, DOI 10.1001/archneur.1995.00540330106022; Mariak Z, 1997, Eur J Ophthalmol, V7, P68; Moster ML, 1999, NEUROLOGY, V52, pA23; *NAT I CLIN EXC LO, 2003, HEAD INJ TRIAG ASS; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; SMITH JL, 1966, CLIN NEUROSURG, V13, P181; Thurman DJ, 1996, WESTERN J MED, V165, P192; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012	14	31	32	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-222X	1476-5454		EYE	Eye	DEC	2005	19	12					1257	1263		10.1038/sj.eye.6701753			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Ophthalmology	992AX	WOS:000233857300003	15543173	Bronze			2022-02-06	
J	Brunelle, JP; Goulet, C; Arguin, H				Brunelle, JP; Goulet, C; Arguin, H			Promoting respect for the rules and injury prevention in ice hockey: evaluation of the Fair-Play program	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article							CONCUSSIONS; PENALTIES; CHECKING; CHILDREN; CANADA; YOUTH; SPORT	Objective: To reduce the number of transgressions to the rule, the occurrence of violent acts and to prevent injuries, Hockey Quebec adopted the Fair-Play Program (FPP). The objective of the present study was to evaluate the effectiveness of the FPP. Methods: 52 Bantam (14-15 years) teams participated in this cohort study. In total, 49 games (13 with the FPP, 36 without FPP) were systematically assessed for transgressions to the rule. Body checking was allowed in all games. Transgressions to the rule data were obtained using a real time observation system in a natural setting, while injury data were collected through a self-administered questionnaire. Data were analysed using generalised linear models with generalised estimating equations accounting for potential team effect. Results: The number of penalties per game was significantly lower (p < 0.01) for games played with the FPP. Overall, no difference was noted in the number of transgressions observed during games played with or without the FPP. Players in leagues where the FPP was used held their opponents more frequently (p < 0.0001). On the other hand, players in leagues without the FPP shoved and hit more (p = 0.05). No difference was noted in the injury rate for games played with or without the FPP. Conclusions: This study showed that the FPP is one of the tools available to help those in the hockey world promote fair play values. Moreover, this project clearly showed the importance of program evaluation and the value of direct observation in a natural setting.	Univ Sherbrooke, Fac Educ Phys & Sport, Sherbrooke, PQ J1K 2R1, Canada			claude.goulet@mels.gouv.qc.ca					AVANZINI G, 1994, REV SCI TECHNIQUES A, V15, P7; BERNARD D, 1993, ASTM STP, V1212, P44; CHALMERS DJ, 2002, INJ PREV S4, V8, P22; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Gilbert WD, 2000, AM SOC TEST MATER, V1341, P291, DOI 10.1520/STP15246S; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; *HOCK CAN, BACKGR CHECK; Hutchings CB, 2003, ACCIDENT ANAL PREV, V35, P3, DOI 10.1016/S0001-4575(01)00081-1; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; MacKay M, 2004, J SCI MED SPORT, V7, P58, DOI 10.1016/S1440-2440(04)80045-8; Marchie A, 2003, CAN MED ASSOC J, V169, P124; MARCOTTE G, 1993, ASTM STP, V1212, P100; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; MCMAHON KA, 1993, MED J AUSTRALIA, V159, P301, DOI 10.5694/j.1326-5377.1993.tb137864.x; Molsa J, 2003, AM J SPORT MED, V31, P751; PFISTER R, 1989, ETUDES PSYCHOTHERAPE, V20, P209; REGNIER G, 1989, ASTM STP, V1050, P84; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Tator CH, 2000, CAN MED ASSOC J, V162, P787; Trudel P, 2000, AM SOC TEST MATER, V1341, P274, DOI 10.1520/STP15245S; Trudel P, 2000, AM SOC TEST MATER, V1341, P237, DOI 10.1520/STP15242S; TRUDEL P, 1993, ASTM STP, V1212, P95; Watson RC, 1996, CLIN J SPORT MED, V6, P108, DOI 10.1097/00042752-199604000-00008; 1999, SAS SYSTEM WINDOWS P	25	31	31	0	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	SEP	2005	8	3					294	304		10.1016/S1440-2440(05)80040-4			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	974VB	WOS:000232618400006	16248470				2022-02-06	
J	Martinez-Lucas, P; Moreno-Cuesta, J; Garcia-Olmo, DC; Sanchez-Sanchez, F; Escribano-Martinez, J; del Pozo, AC; Lizan-Garcia, M; Garcia-Olmo, D				Martinez-Lucas, P; Moreno-Cuesta, J; Garcia-Olmo, DC; Sanchez-Sanchez, F; Escribano-Martinez, J; del Pozo, AC; Lizan-Garcia, M; Garcia-Olmo, D			Relationship between the Arg72Pro Polymorphism of p53 and outcome for patients with traumatic brain injury	INTENSIVE CARE MEDICINE			English	Article						single nucleotide polymorphism; brain injury; Glasgow Outcome Scale; p53	TUMOR-SUPPRESSOR GENE; POLYMORPHIC VARIANTS; HEAD-INJURY; APACHE-II; APOPTOSIS; CODON-72; EXPRESSION; SUSCEPTIBILITY; MORTALITY; ISCHEMIA	Objective: To determine the relationship between the Arg72Pro polymorphism of p53 and the outcome after traumatic brain injury (TBI) in humans. Design and setting: A prospective study was carried out in a ten-bed surgical intensive care unit (SICU) of a university hospital. Patients: The study included 90 caucasian patients who had experienced a severe TBI within the previous 24 h. The exclusion criterion was a previous deficit in the central nervous system. Measurements and results: The main recorded outcomes were values on the Glasgow Outcome Scale (GOS) at discharge from the SICU (GOS-0) and 6 months later (GOS-6). A blood sample was taken from each patient and all samples were analyzed by an allele-specific polymerase chain reaction for detection of Arg72Pro polymorphism of p53. These polymorphisms were tested for their association with values of GOS-0 and GOS-6. A two-tailed value of p < 0.05 was considered statistically significant. The frequency of the argine/argine (Arg/Arg) genotype was greater among the patients who had a bad outcome at GOS-0 (69 vs 31% in the bad-outcome group; p=0.029). A multiple logistic regression analysis showed that patients with the Arg/Arg variation had a 2.9-fold greater risk of having a bad outcome at discharge from the SICU (95% confidence interval, 1.05-8.31; p=0.039 ). There was no similar relationship with respect to GOS-6. Conclusion: The Arg/Arg genotype of the Arg72Pro polymorphism in p53 is associated with increased likelihood of a bad outcome at discharge from the SICU.	Gen Univ Hosp, Dept Anaesthesia, Albacete 02006, Spain; Gen Univ Hosp, Expt Res Unit, Albacete 02006, Spain; Univ Castilla La Mancha, Fac Med, Dept Genet, Albacete 02006, Spain; Gen Univ Hosp, Dept Epidemiol, Albacete 02006, Spain; Autonomous Univ Madrid, Dept Surg, E-28049 Madrid, Spain		Moreno-Cuesta, J (corresponding author), Gen Univ Hosp, Dept Anaesthesia, C Hermanos Falco 37, Albacete 02006, Spain.	jmocuest@med-ab.uclm.es	Garcia-Olmo, Dolores C./L-5733-2014; Escribano, Julio/D-9742-2015; , francisco/ABF-7718-2021	Garcia-Olmo, Dolores C./0000-0001-9071-547X; Escribano, Julio/0000-0002-8919-8134; Garcia Olmo, Damian/0000-0002-9369-2338			ARA S, 1990, NUCLEIC ACIDS RES, V18, P4961, DOI 10.1093/nar/18.16.4961; Bonafe M, 2004, CELL DEATH DIFFER, V11, P962, DOI 10.1038/sj.cdd.4401415; BROWN PJ, 1989, J TRAUMA, V29, P746; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Chopp M, 1999, BRAIN RES, V828, P197, DOI 10.1016/S0006-8993(99)01354-2; CLARK CG, 2000, TROPICAL MED SCI PRA, V2, P1; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fisher DE, 2001, APOPTOSIS, V6, P7, DOI 10.1023/A:1009659708549; Granja F, 2004, CANCER LETT, V210, P151, DOI 10.1016/j.canlet.2004.01.016; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; HARTLEY C, 1995, BRIT J NEUROSURG, V9, P179, DOI 10.1080/02688699550041520; Hughes PE, 1996, NEUROSCIENCE, V74, P1143, DOI 10.1016/0306-4522(96)00174-1; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Lai Y. C., 1998, Annals Academy of Medicine Singapore, V27, P326; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; MARTINEZLUCAS P, 2004, INTENS CARE MED S, V30, pS138; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Morrison RS, 1996, J NEUROSCI, V16, P1337; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Peters DL, 2003, CRIT CARE MED, V31, P1691, DOI 10.1097/01.CCM.0000065190.24116.A4; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Schneider-Stock R, 2004, AM J PATHOL, V164, P1233, DOI 10.1016/S0002-9440(10)63211-7; Silberstein Morry, 2002, Neurosurg Focus, V13, pecp2, DOI 10.3171/foc.2002.13.1.6; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Woischneck D, 1998, ACT NEUR S, V71, P138	39	31	35	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	SEP	2005	31	9					1168	1173		10.1007/s00134-005-2715-0			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965KK	WOS:000231949200006	16007417				2022-02-06	
J	Clausen, F; Lewen, A; Marklund, N; Olsson, Y; McArthur, DL; Hillered, L				Clausen, F; Lewen, A; Marklund, N; Olsson, Y; McArthur, DL; Hillered, L			Correlation of hippocampal morphological changes and Morris water maze performance after cortical contusion injury in rats	NEUROSURGERY			English	Article						alpha-phenyl-N- tert-butyl-nitrone; hippocampus; Morris water maze; rat; reactive oxygen species; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MICROTUBULE-ASSOCIATED PROTEIN-2; FOCAL CEREBRAL-ISCHEMIA; FLUID PERCUSSION INJURY; SPATIAL MEMORY; DELAYED TREATMENT; ARTERY OCCLUSION; NEURONAL DEATH; CNS INJURY; NITRONE	OBJECTIVE: The hippocampus is essential to the processing and formation of memory. This study analyzed the relationship among memory dysfunction as revealed by Morris water maze (MWM) trial, cortical lesion volume, and regional hippocampal morphological changes after controlled cortical contusion (CCC). We also analyzed the influence of pretreatment with the nitrone radical scavenger alpha-phenyl-N-tert-butylnitrone (PBN). METHODS: Rats were subjected to CCC. We used two levels of CCC (mild, 1.5 mm and severe, 2.5 mm) and pretreated some severely injured animals with PBN. The animals were killed 15 days postinjury. We evaluated morphological changes to the hippocampus semiquantitatively by scoring sections immunohistochemically stained for microtubule-associated protein 2 with a four-point scale for the cornu ammonis (CA) 1, CA2, CA3, and hilus of the dentate gyrus (HDG). The cortical lesion volume was quantified. RESULTS: Rats subjected to severe, but not mild, CCC demonstrated impaired spatial learning ability in the MWM, but this impairment was attenuated with pretreatment with the radical scavenger PBN. We documented bilateral morphological changes in CA1, CA3, and HDG and an ipsilateral neocortical cavitation in severely injured rats. PBN treatment attenuated (P < 0.05) the morphological characteristics of abnormality in the ipsilateral CA1, CA2, HDG, and the contralateral HDG and reduced the cortical lesion volume. Mild injury led to minor ipsilateral hippocampal and cortical damage but no MWM deficiency. Hippocampal morphological scores and total mean latencies in the MWM task were strongly correlated (r = 0.69; P < 0.001). The correlation between the cortical lesion volume and MWM latency was weaker (r = 0.48; P = 0.02). CONCLUSION: Severe CCC causes bilateral morphological changes in the hippocampus and ipsilateral neocortical cavitation, which correlate to impairment in a spatial learning task (MWM). PBN protected the structure of the CA2 ipsilaterally and HDG bilaterally and reduced the cortical lesion volume, correlating to improved functional outcome.	Univ Uppsala Hosp, Dept Neurosci, Div Neurosurg, SE-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Genet & Pathol, SE-75185 Uppsala, Sweden		Clausen, F (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Div Neurosurg, SE-75185 Uppsala, Sweden.	Fredrik.clausen@neurokir.uu.se	Lewen, Anders/A-5156-2013; McArthur, David/E-6442-2013	Lewen, Anders/0000-0003-4925-1348; McArthur, David/0000-0003-3385-1314; Marklund, Niklas/0000-0002-9797-5626; Clausen, Fredrik/0000-0003-3592-4417			CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Daugherty WP, 2001, BRAIN RES, V923, P103, DOI 10.1016/S0006-8993(01)03198-5; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Gerlai RT, 2002, BRAIN RES BULL, V57, P3, DOI 10.1016/S0361-9230(01)00630-X; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hannesson DK, 1998, BEHAV BRAIN RES, V90, P35, DOI 10.1016/S0166-4328(97)00081-8; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Iijima T, 1998, J NEUROTRAUM, V15, P277, DOI 10.1089/neu.1998.15.277; Isaksson J, 2001, ACTA NEUROPATHOL, V102, P246; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Kuroda S, 1996, NEUROBIOL DIS, V3, P149, DOI 10.1006/nbdi.1996.0015; Lenzlinger PM, 2001, HEAD TRAUMA, P3; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Li GL, 2000, APMIS, V108, P98; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; MELLONI E, 1989, TRENDS NEUROSCI, V12, P438, DOI 10.1016/0166-2236(89)90093-3; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; Roos MW, 2003, BRAIN RES, V961, P15, DOI 10.1016/S0006-8993(02)03829-5; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; See V, 2001, J BIOL CHEM, V276, P35049, DOI 10.1074/jbc.M104988200; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Warburton EC, 2001, J NEUROSCI, V21, P7323, DOI 10.1523/JNEUROSCI.21-18-07323.2001; Warburton EC, 2000, EUR J NEUROSCI, V12, P1714, DOI 10.1046/j.1460-9568.2000.00039.x; ZHAO Q, 1994, ACTA PHYSIOL SCAND, V152, P349, DOI 10.1111/j.1748-1716.1994.tb09816.x; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	56	31	36	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2005	57	1					154	162		10.1227/01.NEU.0000163412.07546.57			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	942ZQ	WOS:000230321800042	15987551				2022-02-06	
J	Soussignan, R; Ehrle, N; Henry, A; Schaal, B; Bakchine, S				Soussignan, R; Ehrle, N; Henry, A; Schaal, B; Bakchine, S			Dissociation of emotional processes in response to visual and olfactory stimuli following frontotemporal damage	NEUROCASE			English	Article							FUNCTIONAL NEUROANATOMY; AMYGDALA ACTIVATION; PREFRONTAL CORTEX; NEURAL MECHANISMS; HEDONIC VALENCE; BRAIN ACTIVITY; AWARENESS; ODORS; FMRI; AROUSAL	Contemporary neuropsychological studies have stressed the widely distributed and multicomponential nature of human affective processes. Here, we examined facial electromyographic (EMG) (zygomaticus and corrugator muscle activity), autonomic ( skin conductance and heart rate) and subjective measures of affective valence and arousal in patient TG, a 30 year-old man with left anterior mediotemporal and left orbitofrontal lesions resulting from a traumatic brain injury. Both TG and a normal control group were exposed to hedonically valenced visual and olfactory stimuli. In contrast with control subjects, facial EMG and electrodermal activity in TG did not differentiate among pleasant, unpleasant and neutral pictures. In addition, the controls reacted spontaneously with larger corrugator EMG activity and higher skin conductance to unpleasant odors. By contrast, the subjective feeling states (pleasure and arousal ratings) remained preserved in TG. The covariation between facial and self-report measures of negative valence was also a function of the nature of the olfactory task in the patient only. Taken together, the data suggest a functional dissociation between brain substrates supporting generation of emotion and those supporting representation of emotion.	Hop La Pitie Salpetriere, Lab Vulnerabil Adaptat Psychopathol, CNRS, UMR 7593, F-75013 Paris, France; Hop Maison Blanche, CHU Reims, Serv Neurol, Reims, France; Univ Bourgogne, Ctr Europeen Sci Gout, Dijon, France		Soussignan, R (corresponding author), Hop La Pitie Salpetriere, Lab Vulnerabil Adaptat Psychopathol, CNRS, UMR 7593, Pavillon Clerambault,47 Bd Hop, F-75013 Paris, France.	soussign@ext.jussieu.fr					Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Adolphs R, 2001, HANDBOOK OF AFFECT AND SOCIAL COGNITION, P27; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; ANDERSON AK, 2002, J COGNITIVE NEUROSCI, V14, P1; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; Averill J.R, 1994, NATURE EMOTION FUNDA, P379; Bechara A, 2004, NAT NEUROSCI, V7, P102, DOI 10.1038/nn0204-102; Bensafi M, 2002, NEUROSCI LETT, V319, P162, DOI 10.1016/S0304-3940(01)02572-1; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; BRADLEY MM, 1994, EMOTIONS: ESSAYS ON EMOTION THEORY, P97; CACIOPPO JT, 1992, PERS SOC PSYCHOL B, V18, P515, DOI 10.1177/0146167292185001; CAIN WS, 1979, SCIENCE, V203, P467, DOI 10.1126/science.760202; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/S1364-6613(04)00103-2; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Damasio A., 1994, DESCARTES ERROR EMOT; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damasio AR, 1998, BRAIN RES REV, V26, P83, DOI 10.1016/S0165-0173(97)00064-7; Damasio AR, 1995, NEUROSCIENTIST, V1, P19, DOI DOI 10.1177/107385849500100104; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; DEBONIS M, 1996, CONNAITRE EMOTIONS H; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; FRIDLUND AJ, 1991, J PERS SOC PSYCHOL, V60, P229, DOI 10.1037/0022-3514.60.2.229; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Glascher J, 2003, J NEUROSCI, V23, P10274; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; JENNINGS JR, 1987, PSYCHOPHYSIOLOGY, V24, P474, DOI 10.1111/j.1469-8986.1987.tb00320.x; Keillor JM, 2002, J INT NEUROPSYCH SOC, V8, P130, DOI 10.1017/S1355617701020136; KUBOTA Y, 2000, J NEUROSCI, V20, P1; Lane R. D, 2000, COGNITIVE NEUROSCIEN; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Lane RD, 1997, BIOL PSYCHIAT, V42, P834, DOI 10.1016/S0006-3223(97)00050-4; LANE RD, 2000, SER AFFECTIVE SCI, P345; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; Lang PJ, 2001, INT AFFECTIVE PICTUR; Liberzon I, 2000, NEUROPSYCHOPHARMACOL, V23, P508, DOI 10.1016/S0893-133X(00)00157-3; Luminet O, 2004, COGNITION EMOTION, V18, P741, DOI 10.1080/02699930341000275; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; OHMAN A, 2000, SER AFFECTIVE SCI, P296; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; PARDO JV, 1993, AM J PSYCHIAT, V150, P713; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; Rouby C, 2002, OLFACTION, TASTE, AND COGNITION, P140, DOI 10.1017/CBO9780511546389.015; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Royet JP, 2001, NEUROIMAGE, V13, P506, DOI 10.1006/nimg.2000.0704; Royet JP, 2000, J NEUROSCI, V20, P7752; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schaal B., 1998, GEOGRAPHIE ODEURS GE, P25; Schaal B., 1997, CHEM SENSES, V22, P212; Schneider F, 1997, PSYCHIAT RES-NEUROIM, V76, P75, DOI 10.1016/S0925-4927(97)00063-2; SCHWARTZ GE, 1980, PSYCHOPHYSIOLOGY, V17, P75, DOI 10.1111/j.1469-8986.1980.tb02463.x; Soussignan R, 1996, DEV PSYCHOL, V32, P367, DOI 10.1037/0012-1649.32.2.367; Soussignan R, 2004, ADV PSY RES, V31, P173; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; Vuilleumier P, 2002, NEUROPSYCHOLOGIA, V40, P2156, DOI 10.1016/S0028-3932(02)00045-3; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	78	31	31	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	APR	2005	11	2					114	128		10.1080/13554790590922513			15	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	920XZ	WOS:000228730100003	16036466				2022-02-06	
J	Constantinidou, F; Thomas, RD; Scharp, VL; Laske, KM; Hammerly, MD; Guitonde, S				Constantinidou, F; Thomas, RD; Scharp, VL; Laske, KM; Hammerly, MD; Guitonde, S			Effects of categorization training in patients with TBI during postacute rehabilitation - Preliminary findings	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; categorization; cognitive rehabilitation; effectiveness; efficacy; outcomes	BRAIN-INJURY; SYSTEMS; MEMORY; MODALITY; SCALE	Background: Previous research suggests that traumatic brain injury (TBI) interferes with the ability to extract and use attributes to describe objects. This study explored the effects of a systematic Categorization Program (CP) in participants with TBI and noninjured controls. Participants: Ten persons with moderate to severe TBI who received comprehensive postacute rehabilitation services and 13 matched-noninjured controls participated in the study. Intervention: All participants received CP training for 3 to 5 hours per week for 10 to 12 weeks that consisted of 8 levels and targeted concept formation, object categorization, and decision-making abilities. Main outcome measures: The Mayo-Portland Adaptability Inventory-3 (MPAI-3) and the Community Integration Questionnaire (CIQ). Two Categorization Tests (administered pretraining and posuraining) and 3 Probe Tasks (administered at specified intervals during training) assessed skills relating to categorization. Results: Both groups showed significant improvement in categorization performance after the CP training on the 2 Categorization Tests related to the CP They also were able to generalize and apply categorization and sorting skills in new situations (as measured by the Probe Tasks). Participants with TBI had improved functional outcome performance measured by the MPAI-3 and the CIQ. Conclusions: The systematic and hierarchical structure of the CP is beneficial to participants with TBI during postacute rehabilitation. This study contributes to the growing body of evidence supporting cognitive rehabilitation after moderate to severe TBI. Key words: brain injury, categorization, cognitive rehabilitation, effectiveness, efficacy, outcomes.	Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA; Miami Univ, Dept Psychol, Oxford, OH 45056 USA		Constantinidou, F (corresponding author), Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA.	constaf@muohio.edu		Constantinidou, Fofi/0000-0002-7928-8363	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R15HD044554A01A1] Funding Source: Medline		ADAMOVICH VV, 1985, COGNITIVE REHABILITA; *AM PSYCHI ASS, 1994, DSM 4 DIAGN STAT MAN; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bracy O. L., 1986, COGN REHABIL, V4, P11; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; COLTHEART M, 2001, DB COGNITIVE NEUROPS, P3; Constantinidou F, 2004, BRAIN LANG, V89, P216, DOI 10.1016/S0093-934X(03)00399-7; Constantinidou F, 1999, J MED SPEECH-LANG PA, V7, P283; CONSTANTINIDOU F, 2001, CATEGORIZATION PROGR; Constantinidou F., 2004, TRAUMATIC BRAIN INJU, P337; Duvvuri R., 1995, ED WORD FREQUENCY GU; Erickson MA, 1998, J EXP PSYCHOL GEN, V127, P107, DOI 10.1037/0096-3445.127.2.107; FARAH MJ, 1991, J EXP PSYCHOL GEN, V120, P339, DOI 10.1037/0096-3445.120.4.339; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENTILINI M, 1989, MILD HEAD INJURY, P163; Goodglass H., 2000, BOSTON DIAGNOSTIC AP; HAGEN C, 1957, REHABILITATION HEAD; Humphreys GW, 1999, PSYCHOL RES-PSYCH FO, V62, P118, DOI 10.1007/s004260050046; HUMPHREYS GW, 1994, COGNITIVE NEUROPSYCH, V11, P393, DOI 10.1080/02643299408251980; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; Kolb B., 1999, COGNITIVE NEUROREHAB, P9; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lamberts K, 2002, BRAIN DAM B, P291; LEVIN HS, 1992, SCAND J REHABIL MED, P14; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Luria AR, 1963, RESTORATION FUNCTION; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; MALEC JF, 1996, NEUROLOGY TRAUMA, P231; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; SPIKMAN JM, 1995, J CLIN EXP NEUROPSYC, V17, P29, DOI 10.1080/13803399508406578; Task Force on Promotion and Dissemination of Psychological Procedures, 1995, CLIN PSYCHOL, V48, P13; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002; ISHIHARA TEST COLOR	40	31	31	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2005	20	2					143	157		10.1097/00001199-200503000-00003			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	910VV	WOS:000227961200003	15803038				2022-02-06	
J	Isaksson, J; Farooque, M; Olsson, Y				Isaksson, J; Farooque, M; Olsson, Y			Improved functional outcome after spinal cord injury in iNOS-deficient mice	SPINAL CORD			English	Article						spinal cord injury; mouse; nitric oxide; iNOS	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; AMINOGUANIDINE TREATMENT; COMPRESSION INJURY; L-ARGININE; EXPRESSION; RATS; SUPEROXIDE; ROLES	Study design: Functional outcome was evaluated following experimental compression-type spinal cord injury (SCI) in wild-type mice and knockout mice, lacking the inducible nitric oxide synthase ( iNOS) gene. Objectives: To evaluate the role of the nitric oxide generating enzyme iNOS in SCI. Methods: The experimental animals were subjected to an extradural compression of the thoracic spinal cord. Functional outcome was studied during the first 2 weeks post-injury using a scoring system for assessment of hind limb motor function. Results: Injury resulted in initial paraplegia followed by gradual improvement of motor function in most cases. Mice lacking the iNOS gene ( iNOS -/-) clearly tended to have a better functional outcome than wild-type mice. The difference was significant on day 14 after injury. Conclusion: In accordance with a few earlier experimental studies, showing beneficial effects of pharmacological iNOS inhibition, the present report would indicate a destructive influence of iNOS following spinal cord trauma.	Univ Uppsala Hosp, Dept Genet & Pathol, Res Grp Neuropathol, Uppsala, Sweden; VA Med Ctr, Neurobiol Res Lab, Kansas City, MO USA		Isaksson, J (corresponding author), Karolinska Hosp, Dept Neurol, S-17176 Stockholm, Sweden.						BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; Cohen TI, 1996, J NEUROTRAUM, V13, P361, DOI 10.1089/neu.1996.13.361; Farooque M, 2000, ACTA NEUROPATHOL, V100, P13, DOI 10.1007/s004010051187; Farooque M, 2001, J NEUROTRAUM, V18, P105, DOI 10.1089/089771501750055811; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; KADER A, 1993, STROKE, V24, P1709, DOI 10.1161/01.STR.24.11.1709; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323	17	31	32	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	MAR	2005	43	3					167	170		10.1038/sj.sc.3101672			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	902HF	WOS:000227344800004	15520837	Bronze			2022-02-06	
J	Leon-Carrion, J; Dominguez-Morales, MR; Martin, JMBY				Leon-Carrion, J; Dominguez-Morales, MR; Martin, JMBY			Driving with cognitive deficits: neurorehabilitation and legal measures are needed for driving again after severe traumatic brain injury	BRAIN INJURY			English	Article						driving; acquired brain injury; neurorehabilitation; neuropsychology	HEAD-INJURY; FITNESS; RECOMMENDATIONS; DRIVERS; ISSUES; DAMAGE	Primary objective: This article presents a retrospective study on a group of survivors of severe traumatic brain injury with the purpose of discerning whether post- traumatic cognitive deficits prevent them from safely resuming driving and to see if holistic neurorehabilitation improves the rate of patients fit for returning to driving. Methods and procedures: We studied 17 patients who had suffered severe traumatic brain injury ( TBI) as measured by Glasgow Coma Scale scores. All subjects underwent a holistic, intensive and multidisciplinary neurorehabilitation program during a mean period of 10.53 months in the Centro de Rehabilitacion de Dano Cerebral ( CRECER(R)) - Center for Brain Injury Rehabilitation - in Seville, Spain. Patients were divided into two different groups: drivers ( patients who drove despite strong and repeated recommendations from the Center to desist from doing so when they began the rehabilitation program) and non- drivers ( patients not driving at the time they began the rehabilitation program although they had a pre- injury driver's license). The FIM+FAM- Revised Scale [ 1] was administered both before commencing treatment and upon termination. Results and conclusion: ( 1) Patients showing physical functionality above 80% returned to driving, regardless of their cognitive and/ or emotional deficits, and against doctor recommendations. ( 2) Severe TBI survivors that have not been certified as fit to drive are at increased risk for driving incidents other than collisions and traffic accidents. This is illustrated by significant incidents involving some of the subjects in our study that were due to disorientation, confusion and confrontations with people or situations. ( 3) We found that neurorehabilitation is worthwhile; after integral and multidisciplinary neurorehabilitation more than 70% of survivors of severe TBI can return to driving with regular safety. ( 4) We also suggest that laws be introduced to keep not- clinically- apt patients from driving.	Univ Seville, Fac Psicol, Dept Expt Psychol, Seville 41008, Spain; Ctr Brain Injury Rehabil, CRECER, Seville, Spain		Leon-Carrion, J (corresponding author), Univ Seville, Fac Psicol, Dept Expt Psychol, Campus Ramon y Cajal,C Camilo Jose Cela S-N, Seville 41008, Spain.	leoncarrion@us.es	Leon Carrion, Jose/D-5638-2012				Benton A., 1994, CONTRIBUTIONS NEUROP; BENTON AL, 1973, REV PSYCHOL APPL, V23, P1; BROOKE MM, 1992, AM J PHYS MED REHAB, V71, P177, DOI 10.1097/00002060-199206000-00009; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; Christensen AL., 1974, LURIAS NEUROPSYCHOLO; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; DOMINGUEZMORALE.MR, 2001, REV ESPANOLA NEUROPS, V3, P77; Fisk GD, 1998, BRAIN INJURY, V12, P683; FORMISANO R, 2001, EUROPA MEDICOPHYSICA, V37, P257; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; HANDLER BS, 1995, J REHABIL, V61, P43; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Hooper HE., 1983, HOOPER VISUAL ORG TE; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; JIMENEZ FL, 1999, REV ESPANOLA NEUROPS, V1, P105; KlOve H, 1963, MED CLIN N AM; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Leon-Carrion J, 1998, NEUROREHABILITATION, V11, P129, DOI 10.1016/S1053-8135(98)00017-1; Leon-Carrion J., 1999, REV ESPANOLA NEUROPS, V1, P49; LEONCARRION J, 1999, FIM FAM REVISITED SC; LEONCARRION J, 1999, NEUROPSYCHOLOGICAL T; LEONCARRION J, 2001, REV ESPANOLA NEUROPS, V33, P58; Lundqvist A, 2001, BRAIN INJURY, V15, P981, DOI 10.1080/02699050110065637; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Mosberg A, 2000, Tidsskr Nor Laegeforen, V120, P3392; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; PERINO C, 1997, GIORNALE ITALIANO RI, V1, P53; PIDIKITI RD, 1991, ARCH PHYS MED REHAB, V72, P109; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; STROKX LC, 1986, J CLIN EXPT NEUROPSY, V8, P421; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697	40	31	32	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2005	19	3					213	219		10.1080/02699050400017205			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	906WJ	WOS:000227675000007	15832895				2022-02-06	
J	Skoglund, TS; Nellgard, B				Skoglund, TS; Nellgard, B			Long-time outcome after transient transtentorial herniation in patients with traumatic brain injury	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						outcome; transtentorial herniation; traumatic brain injury	HEAD-INJURY; THERAPY; SECONDARY; RECOVERY; SCALE; UNIT	Background: This study investigates mortality and morbidity in patients with traumatic brain injury (TBI) who developed episode(s) of transtentorial herniation. The transtentorial herniation was defined as a deterioration of consciousness accompanied by uni- or bilateral pupil dilatation. Methods: The medical records of all patients with traumatic brain injury admitted during 1999 to the Neuro- or General Intensive Care Units at Sahlgrenska University Hospital were analyzed, and patients with at least one episode of transtentoryal herniation were includInformation regarding patient age, gender, type of trauma, initial GCS, precipitating reason for herniation, uni-/bilateral pupil dilatation, treatment(s) and outcome after at least 6 months, assessed with the Glasgow Outcome Scale (GOS), was collected from medical records. Results: The study included 27 patients, average age 44 years (range 6-81), with a male proportion of 81%. The majority of the patients were victims of traffic accidents and falls. The results demonstrated that 16/27(59%) of the patients had a favorable outcome (GOS 4/5), 4/27(15%) were severely disabled (GOS 3), none was vegetative (GOS 2) and 7/27(26%) died (GOS 1). When analyzing patient subgroups, best outcome was found in children where 3/4 (75%) had a GOS 4/5. Conclusion: Transtentorial herniation is a serious consequence of supratentorial edema/mass lesions in patients with TBI. However, with aggressive neurointensive care and neurosurgical treatments we found a 59% patient incidence of a favorable outcome.	Sahlgrens Univ Hosp, Dept Neurosurg, S-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Anaesthesia & Intens Care Med, S-41345 Gothenburg, Sweden		Skoglund, TS (corresponding author), Sahlgrens Univ Hosp, Dept Neurosurg, Bla Straket 7, S-41345 Gothenburg, Sweden.	thomas.skoglund@vgregion.se					ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; BRENDLER SJ, 1970, BRAIN, V93, P381, DOI 10.1093/brain/93.2.381; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; JENNETT B, 1975, LANCET, V1, P480; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; MUNRO D, 1952, NEW ENGL J MED, V247, P699, DOI 10.1056/NEJM195211062471901; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; NUSSBAUM ES, 1991, NEUROSURGERY, V29, P62, DOI 10.1227/00006123-199107000-00010; PLUM E, 1980, DIAGNOSIS STUPOR COM, P87; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Verderber L, 1990, J Tenn Med Assoc, V83, P119; ZERVAS NT, 1972, NEW ENGL J MED, V286, P1075, DOI 10.1056/NEJM197205182862003	20	31	34	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	MAR	2005	49	3					337	340		10.1111/j.1399-6576.2005.00624.x			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	902WI	WOS:000227387000013	15752399				2022-02-06	
J	Palmer, S; Bader, MK				Palmer, S; Bader, MK			Brain tissue oxygenation in brain death	NEUROCRITICAL CARE			English	Article						brain death; cerebral oxygen monitoring; traumatic brain injury; subarachnoid hemorrhage; neurosurgical critical care	DIAGNOSIS	Introduction: The value of brain tissue oxygenation (PbtO(2)) measurements in determining brain death is unknown. Methods: Eleven of 72 patients who had brain tissue oxygen monitors placed experienced brain death. Admission diagnoses included six severe traumatic brain injuries, one multiple trauma with cardiac arrest, one brain tumor, one subarachnoid hemorrhage, one intracerebral hemorrhage, and one cerebral stroke. Eleven males and zero females were studied, with an average age of 26 years (range: 20-70 years). Nine patients had Glasgow Coma Scores (GCS) of 3 on admission, one patient had a GCS of 5, and one patient had a GCS of 15. Results: Time from admission to declaration of brain death varied from 5 hours to 7 days; the most common interval was 1 or 2 days. Cerebral perfusion pressure (CPP) fell to 0 in eight patients, which indicated primary failure of cerebral perfusion. CPP stayed above 60 mmHg in three patients, indicating primary tissue failure, possibly of the cerebral microvasculature. PbtO(2) fell to 0 in all patients who experienced brain death, and all patients with PbtO(2) of 0 experienced brain death. None of the 61 patients who did not experience brain death had confirmed PbtO(2) readings of 0. Conclusion: PbtO(2) can be successfully and accurately used as a bedside adjunctive test for brain death. The use of PbtO(2) as a sole confirmatory test for brain death in the setting of an appropriate clinical examination will require the evaluation of a larger number of patients to assess its sensitivity and specificity.	Mission Hosp & Reg Med Ctr, Dept Neurosurg, Mission Viejo, CA 92651 USA		Palmer, S (corresponding author), Mission Hosp & Reg Med Ctr, Dept Neurosurg, NSMA 26732 Crown Valley Pkwy,Suite 561, Mission Viejo, CA 92651 USA.	sylvainpalmer@cox.net					[Anonymous], 1995, Neurology, V45, P1012; [Anonymous], 1976, BMJ-BRIT MED J, V2, P1187; [Anonymous], 1968, JAMA, V205, P337; BLACK PM, 1978, NEW ENGL J MED, V299, P338, DOI 10.1056/NEJM197808172990705; Bullock R, 1995, GUIDELINES MANAGEMEN; Capron AM, 2001, NEW ENGL J MED, V344, P1244, DOI 10.1056/NEJM200104193441611; Diaz-Reganon G, 2002, INTENS CARE MED, V28, P1724, DOI 10.1007/s00134-002-1543-8; Fisher C M, 1991, J Neurosci Nurs, V23, P330; Karakatsanis KG, 2002, ISSUES LAW MED, V18, P127; LANG CJG, 1995, NEUROLOGY, V45, P966, DOI 10.1212/WNL.45.5.966; Lovasik D, 2000, Crit Care Nurs Clin North Am, V12, P531; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; MOLLARET P., 1959, REV NEUROL [PARIS], V101, P3; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; PALMER S, 2001, EARLY CEREBRAL OXYGE; Swash M, 2002, NEUROLOGY, V58, P9, DOI 10.1212/WNL.58.1.9; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; 1976, BR MED J, V2, P1188	21	31	32	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2005	2	1					17	22		10.1385/NCC:2:1:017			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945FU	WOS:000230489200004	16174963				2022-02-06	
J	Prasad, MR; Kramer, LA; Ewing-Cobbs, L				Prasad, MR; Kramer, LA; Ewing-Cobbs, L			Cognitive and neuroimaging findings in physically abused preschoolers	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							TRAUMATIC BRAIN-INJURY; CHILDREN; CHILDHOOD	Aims: To characterise the cognitive, motor, and language skills of toddlers and preschoolers who had been physically abused and to obtain concurrent MRIs of the brain. Methods: A between groups design was used to compare a sample of 19 children, aged 14-77 months, who had been hospitalised for physical abuse with no evidence of neurological injury to a comparison group of 19 children matched for age and socioeconomic status. Children underwent cognitive, language, and motor testing within three months of their discharge from the hospital. Caregivers of the injured children were interviewed and were asked to complete questionnaires to characterise the child's developmental level and behaviour just prior to the hospitalisation. Results: Children who had been physically abused scored significantly lower than the comparison group on measures of cognitive functioning, motor skills, and language skills. The groups did not differ in child behaviour ratings completed by the caregivers. MRI of the brain was performed for 15 children in the physical abuse group; two were found to have significant cerebral atrophy. Conclusions: Children who have been physically abused are at high risk for delays in cognitive, motor, and language development. Standard of care for these children should include developmental testing as well as neuroimaging of the brain to detect occult brain injury.	Univ Texas, Hlth Sci Ctr Houston, Dept Pediat, Div Dev Pediat, Houston, TX 77025 USA; Univ Texas, Hlth Sci Ctr Houston, Dept Radiol, Houston, TX 77025 USA		Prasad, MR (corresponding author), Univ Texas, Hlth Sci Ctr Houston, Dept Pediat, Div Dev Pediat, 7000 Fannin,Suite 2401, Houston, TX 77025 USA.	mary.r.prasad@uth.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029462] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 29462-07] Funding Source: Medline		Abidin, 1995, PARENTING STRESS IND; Bayley N., 2006, BAYLEY SCALES INFANT, V3rd; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Ciccetti D., 1984, VINELAND ADAPTIVE BE; ECKENRODE J, 1993, DEV PSYCHOL, V29, P53, DOI 10.1037/0012-1649.29.1.53; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; HEDRICK DL, 1995, SEQUENCED INVENTORY; HOFFMANPLOTKIN D, 1984, CHILD DEV, V55, P794, DOI 10.2307/1130130; HOLLINGSHED A, 1975, 4 FACTOR INDEX SOCIA; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; McCarthy, 1972, MCCARTHY SCALES CHIL; PEREZ CM, 1994, CHILD ABUSE NEGLECT, V18, P617, DOI 10.1016/0145-2134(94)90012-4; ROGOSCH FA, 1995, DEV PSYCHOPATHOL, V7, P591, DOI 10.1017/S0954579400006738; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Sattler, 1986, STANFORDBINET INTELL; Semel E., 1995, CLIN EVALUATION LANG, VThird; VONDRA JI, 1990, CHILD ABUSE NEGLECT, V14, P525, DOI 10.1016/0145-2134(90)90101-X; WISSOW LS, 1995, NEW ENGL J MED, V332, P1425, DOI 10.1056/NEJM199505253322107	20	31	34	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	JAN	2005	90	1					82	85		10.1136/adc.2003.045583			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	881KH	WOS:000225865900021	15613522	Green Published, Bronze			2022-02-06	
J	Steiner, LA; Balestreri, M; Johnston, AJ; Czosnyka, M; Coles, JP; Chatfield, DA; Smielewski, P; Pickard, JD; Menon, DK				Steiner, LA; Balestreri, M; Johnston, AJ; Czosnyka, M; Coles, JP; Chatfield, DA; Smielewski, P; Pickard, JD; Menon, DK			Sustained moderate reductions in arterial CO2 after brain trauma Time-course of cerebral blood flow velocity and intracranial pressure	INTENSIVE CARE MEDICINE			English	Article						traumatic brain injury; human; carbon dioxide; ultrasonography; Doppler; transcranial; intracranial pressure; cerebral blood flow	SEVERE HEAD-INJURY; TRANSCRANIAL DOPPLER; CARBON-DIOXIDE; REACTIVITY; HYPERVENTILATION; HUMANS; HYPERTENSION; PROPOFOL; OXYGEN	Objective: In healthy volunteers cerebral blood flow starts to recover towards baseline within a few minutes of continued hyperventilation due to normalisation of perivascular pH. We investigated the time-course of changes in middle cerebral artery mean flow velocity (FVm) and intracranial pressure (ICP) in head-injured patients during sustained moderate reductions in arterial partial pressure of CO2 (PaCO2). Design: Observational study. Patients: Twenty-seven sedated, mechanically ventilated patients with severe head injury. Interventions: Measurements were made during and after routine determination Of CO2-reactivity: an acute 20% increase in respiratory minute volume was followed by a 10-min stabilisation period and 50 min of continued moderate hyperventilation at a constant PaCO2 (>3.5 kPa). Measurements and results: FVm was monitored with transcranial Doppler, ICP was monitored with intraparenchymal probes. During the 50-min period with stable PaCO2 FVm increased in 36% of patients. All other patients showed a decline in FVm over the same time period. Overall FVm recovery was -0.03+/-0.14%.min(-1). The time-course of ICP changes was significantly different from that of FVm, with ICP reaching its lowest value earlier than FVm (23+/-12 vs 37+/-20 min; P=0.001) and returning more rapidly towards baseline than FVm (0.23+/-0.23 vs -0.03+/-0.14%.min(-1) P<0.0001). Conclusions: Head-injured patients may adapt differently to hyperventilation than healthy volunteers. Potentially harmful reductions in cerebral blood flow may persist beyond the duration of useful ICP reduction.	Univ Basel Hosp, Dept Anaesthesia, CH-4031 Basel, Switzerland; Univ Cambridge, Addenbrookes Hosp, Univ Dept Anaesthesia, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England		Steiner, LA (corresponding author), Univ Basel Hosp, Dept Anaesthesia, CH-4031 Basel, Switzerland.	lsteiner@uhbs.ch	Steiner, Luzius/C-9836-2011; Steiner, Luzius/J-1987-2019	Smielewski, Peter/0000-0001-5096-3938; Coles, Jonathan/0000-0003-4013-679X	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		ARTRU AA, 1987, J CEREBR BLOOD F MET, V7, P471, DOI 10.1038/jcbfm.1987.90; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; ELLINGSEN I, 1987, ACTA PHYSIOL SCAND, V129, P157, DOI 10.1111/j.1748-1716.1987.tb08054.x; ENG C, 1992, ANESTHESIOLOGY, V77, P872, DOI 10.1097/00000542-199211000-00006; JENNETT B, 1975, LANCET, V1, P480; Johnston AJ, 2003, ACTA ANAESTH SCAND, V47, P391, DOI 10.1034/j.1399-6576.2003.00078.x; Kastrup A, 1997, STROKE, V28, P2353, DOI 10.1161/01.STR.28.12.2353; LAM AM, 1995, ANESTHESIOLOGY, V82, P1536, DOI 10.1097/00000542-199506000-00035; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Maddock RJ, 2001, J NEUROPSYCH CLIN N, V13, P22, DOI 10.1176/appi.neuropsych.13.1.22; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Poulin MJ, 1998, J APPL PHYSIOL, V85, P388, DOI 10.1152/jappl.1998.85.2.388; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; Ropper Allan H., 1993, P29; SHAPIRO HM, 1975, ANESTHESIOLOGY, V43, P445, DOI 10.1097/00000542-197510000-00010; SHENKIN HA, 1970, NEW ENGL J MED, V282, P1465, DOI 10.1056/NEJM197006252822606; STEINER LA, 2003, CRIT CARE, V7; STREBEL S, 1994, ANESTH ANALG, V78, P884; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6; ZABLOTNY W, 1994, INTRACRANIAL PRESSUR, V9, P439	25	31	32	0	3	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	DEC	2004	30	12					2180	2187		10.1007/s00134-004-2463-6			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882ZG	WOS:000225978300006	15480563	Green Submitted			2022-02-06	
J	Charles, PD				Charles, PD			Botulinum neurotoxin serotype A: A clinical update on non-cosmetic uses	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article						botulinum toxin A; dosage; drugs; Food and Drug Administration (US); skeletal muscle relaxants; toxicity	TOXIN TYPE-A; CHRONIC ANAL-FISSURE; DETRUSOR-SPHINCTER DYSSYNERGIA; PLACEBO-CONTROLLED TRIAL; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; CERVICAL DYSTONIA; CEREBRAL-PALSY; SPASMODIC TORTICOLLIS; ESOPHAGEAL ACHALASIA	Purpose. Clinical experience with botulinum toxin type A for non-cosmetic uses that are approved by the Food and Drug Administration (FDA) and various other non-cosmetic uses that are not approved by FDA, including some applications that are widely known and others that currently are emerging, is discussed. Summary. FDA-approved indications for botulinum toxin type A (Botox) include the temporary treatment of cervical dystonia (a neuromuscular disorder involving the head and neck), the oculomotor disorders strabismus (improperly aligned eyes) and blepharospasm (involuntary contraction of the eye muscles), and severe primary axillary hyperhidrosis (excessive sweating). Other uses of botulinum toxin type A that are widely known but not approved by FDA include spastic disorders associated with injury or disease of the central nervous system including trauma, stroke, multiple sclerosis, or cerebral palsy and focal dystonias affecting the limbs, face, jaw, or vocal cords. Treatment and prevention of chronic headache and chronic musculoskeletal pain are emerging uses for botulinum toxin type A. Conclusion. Many of the conditions for which botulinum toxin type A has been explored are common and difficult to treat. Temporary improvement in symptoms is associated with botulinum toxin type A injection, and repeat treatment often is required. The drug is well tolerated and has a wide margin of safety.	Vanderbilt Univ, Movement Disorders Clin, Nashville, TN 37240 USA		Charles, PD (corresponding author), Vanderbilt Univ, Movement Disorders Clin, Nashville, TN 37240 USA.	david.charles@vanderbilt.edu					*ALL INC, 2004, BOT PACK INS; *AM ASS OPHTH STRA, ADULT STRAB GEN INF; American Heart Association, HEART DIS STROK STAT; Annese V, 2000, GUT, V46, P597, DOI 10.1136/gut.46.5.597; ARTHURS B, 1987, CAN J OPHTHALMOL, V22, P24; Barwood S, 2000, DEV MED CHILD NEUROL, V42, P116, DOI 10.1017/S0012162200000220; *BEN ESS BLEPH RES, BEBRF BLEPH PAG; *BETH ISR MED CTR, PAIN MED; Binder WJ, 2000, OTOLARYNG HEAD NECK, V123, P669, DOI 10.1067/mhn.2000.110960; Blitzer A, 1998, LARYNGOSCOPE, V108, P1435, DOI 10.1097/00005537-199810000-00003; Blumenfeld AM, 2003, HEADACHE, V43, P884, DOI 10.1046/j.1526-4610.2003.03167.x; Bothwell JE, 2002, PEDIATR NEUROL, V27, P18, DOI 10.1016/S0887-8994(02)00381-8; Brans JWM, 1998, NEUROLOGY, V50, P1461, DOI 10.1212/WNL.50.5.1461; Brashear A, 2003, ARCH PHYS MED REHAB, V84, P103, DOI 10.1053/apmr.2003.50070; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Brashear A, 1999, NEUROLOGY, V53, P1439, DOI 10.1212/WNL.53.7.1439; Brin M F, 1997, Muscle Nerve Suppl, V6, pS208; Brin MF, 1999, NEUROLOGY, V53, P1431, DOI 10.1212/WNL.53.7.1431; Brisinda G, 1999, NEW ENGL J MED, V341, P65, DOI 10.1056/NEJM199907083410201; Chang L B, 1999, Zhonghua Yi Xue Za Zhi (Taipei), V62, P1; Dionne RA, 1997, ORAL SURG ORAL MED O, V83, P134, DOI 10.1016/S1079-2104(97)90104-9; Dogu O, 2004, CLIN NEUROL NEUROSUR, V106, P93, DOI 10.1016/j.clineuro.2003.10.012; *DYST MED RES FDN, DYST DEF; *EL PHARM INC, 2000, MYOBL PACK INS; Fehlings D, 2000, J PEDIATR-US, V137, P331, DOI 10.1067/mpd.2000.108393; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Foster L, 2001, NEUROLOGY, V56, P1290, DOI 10.1212/WNL.56.10.1290; Freund B, 1998, Oral Health, V88, P32; Freund BJ, 2000, HEADACHE, V40, P231, DOI 10.1046/j.1526-4610.2000.00033.x; Goldman A, 2000, AESTHET PLAST SURG, V24, P280, DOI 10.1007/s002660010046; Goldstein EM, 2001, J CHILD NEUROL, V16, P16, DOI 10.1177/088307380101600104; Gracies JM, 1997, MUSCLE NERVE, pS92; GRACIES JM, 1997, MUSCLE NERVE       S, V6, pS61; GREENE P, 1990, NEUROLOGY, V40, P1213, DOI 10.1212/WNL.40.8.1213; Hockstein NG, 2004, AM FAM PHYSICIAN, V69, P2628; Hu XH, 1999, ARCH INTERN MED, V159, P813, DOI 10.1001/archinte.159.8.813; *INT HYP SOC, UND HYP; Jankovic J, 1997, MUSCLE NERVE, pS129; Kessler KR, 1999, J NEUROL, V246, P265, DOI 10.1007/s004150050345; KOMAN LA, 1994, J PEDIATR ORTHOPED, V14, P299, DOI 10.1097/01241398-199405000-00005; Koman LA, 2000, J PEDIATR ORTHOPED, V20, P108, DOI 10.1097/00004694-200001000-00022; LANG AM, 2000, AM J PAIN MANAGE, V18, P108; Lew MF, 2000, NEUROLOGY, V55, pS29; Lew MF, 1997, NEUROLOGY, V49, P701, DOI 10.1212/WNL.49.3.701; Lindsey I, 2004, BRIT J SURG, V91, P270, DOI 10.1002/bjs.4531; LOVE SC, 1920, EUR J NEUROL S5, V8, P50; Lu Chin-Song, 1995, Journal of the Formosan Medical Association, V94, P189; *MARCH DIM BIRTH D, CER PALS; Mentes BB, 2003, DIS COLON RECTUM, V46, P232, DOI 10.1097/01.DCR.0000044712.58674.09; Muehldorfer SM, 1999, ENDOSCOPY, V31, P517, DOI 10.1055/s-1999-56; *NAL HEAD FDN, NHF HEAD FACTS; *NAT I NEUR DIS ST, NINDS CER PALS INF P; *NAT I NEUR DIS ST, NINDS SPAST INF PAG; *NAT LIB MED, MEDL PLUS ACH; *NAT LIBR MED, MEDL PLUS STRAB; *NAT MULT SCLER SO, CONTR SPAST MS; *NAT ORG RAR DIS I, FREYS SYNDR; Naumann M, 1997, ANN NEUROL, V42, P973; Naumann M, 2004, CURR MED RES OPIN, V20, P981, DOI 10.1185/030079904125003962; Naumann M, 2001, BRIT MED J, V323, P596, DOI 10.1136/bmj.323.7313.596; ODERGREN T, 1994, SCAND J REHABIL MED, V26, P191; Ondo WG, 2004, CEPHALALGIA, V24, P60, DOI 10.1111/j.1468-2982.2004.00641.x; Pal PK, 2000, NEUROLOGY, V54, P244, DOI 10.1212/WNL.54.1.244; POLO KB, 1994, MOVEMENT DISORD, V9, P233, DOI 10.1002/mds.870090221; Porta M, 2000, PAIN, V85, P101, DOI 10.1016/S0304-3959(99)00264-X; Reynard JM, 2003, SPINAL CORD, V41, P1, DOI 10.1038/sj.sc.3101378; Royal MA, 2001, NEUROLOGY, V56, pA350; Satkunam WE, 2003, CAN MED ASSOC J, V169, P1173; Schurch B, 1996, J UROLOGY, V155, P1023, DOI 10.1016/S0022-5347(01)66376-6; Sedano MJ, 2000, EUR NEUROL, V43, P137, DOI 10.1159/000008152; Sharma R R, 1992, J Postgrad Med, V38, P37; Silberstein S, 2000, HEADACHE, V40, P445, DOI 10.1046/j.1526-4610.2000.00066.x; Smuts JA, 1999, EUR J NEUROL, V6, pS99, DOI 10.1111/j.1468-1331.1999.tb00044.x; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; Sutherland DH, 1999, GAIT POSTURE, V10, P1, DOI 10.1016/S0966-6362(99)00012-0; Tejedor J, 2001, INVEST OPHTH VIS SCI, V42, P2542; Tejedor J, 1999, BRIT J OPHTHALMOL, V83, P783, DOI 10.1136/bjo.83.7.783; TSUI JKC, 1987, CAN J NEUROL SCI, V14, P533, DOI 10.1017/S0317167100038063; Utzig MJ, 2003, AM J GASTROENTEROL, V98, P968, DOI 10.1016/S0002-9270(03)00141-2; von Lindern JJ, 2000, CANCER-AM CANCER SOC, V89, P1659, DOI 10.1002/1097-0142(20001015)89:8<1659::AID-CNCR2>3.0.CO;2-M; Wissel J, 1999, NEUROPEDIATRICS, V30, P120, DOI 10.1055/s-2007-973475; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; Yazici Y, 1999, Clin Cornerstone, V2, P1, DOI 10.1016/S1098-3597(99)90010-8; YOSHIMURA DM, 1992, NEUROLOGY, V42, P627, DOI 10.1212/WNL.42.3.627; [No title captured]	85	31	33	0	11	AMER SOC HEALTH-SYSTEM PHARMACISTS	BETHESDA	7272 WISCONSIN AVE, BETHESDA, MD 20814 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	NOV 15	2004	61	22		6			S11	S23		10.1093/ajhp/61.suppl_6.S11			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	874UC	WOS:000225374300003	15598005				2022-02-06	
J	Hinton-Bayre, AD; Geffen, G; Friis, P				Hinton-Bayre, AD; Geffen, G; Friis, P			Presentation and mechanisms of concussion in professional Rugby League football	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article								The present study prospectively recorded the circumstances, incidence, mechanisms, injury detection and presentation of concussion in Rugby League. Forty-three consecutive concussions were recorded over three competitive seasons in 175 professional Rugby League players. Data showed (i) the incidence of concussion ranged from 5.9 to 9.8 injuries/1000 player hours across grades - except when age-group players were mismatched (18.4); (ii) 'head-high tackles' accounted for a significant number of concussions; (iii) concussion rarely involved a loss of consciousness with the most common indicators of concussion being amnesia, headache and unsteadiness, with the mechanism of injury often missed; and (iv) concussion often occurs concurrently with other injuries. Concussion (including repeated episodes) is a common injury in Rugby League. Systematic mental status questioning is warranted whenever concussion is suspected. Coaches, trainers and players need more education in the recognition and management of concussion. Stricter penalties for illegal 'head-high' tackling are strongly recommended.	Univ Queensland, Cognit Psychol Lab, St Lucia, Qld 4067, Australia; Univ Queensland, Sch Med, St Lucia, Qld 4067, Australia; Holy Spirit Hosp, Brisbane Orthopaed & Sports Med Ctr, Brisbane, Qld, Australia		Hinton-Bayre, AD (corresponding author), Univ Queensland, Cognit Psychol Lab, St Lucia, Qld 4067, Australia.						Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Estell J, 1995, Aust J Sci Med Sport, V27, P95; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; *NAT HLTH MRC, 1994, FOOTB INJ HEAD NECK; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x	6	31	32	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	SEP	2004	7	3					400	404		10.1016/S1440-2440(04)80035-5			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	861CV	WOS:000224394600015	15518305				2022-02-06	
J	Radford, KA; Lincoln, NB; Murray-Leslie, C				Radford, KA; Lincoln, NB; Murray-Leslie, C			Validation of the stroke drivers screening assessment for people with traumatic brain injury	BRAIN INJURY			English	Article							DRIVING PERFORMANCE; FITNESS; BEHAVIOR	Cognitive impairments resulting from brain injury affect driving performance. The question of fitness to drive often arises during rehabilitation. Healthcare professionals need reliable criteria against which decisions about driving fitness can be made. Nouri et al. developed the Stroke Drivers Screening Assessment (SDSA), which was found predictive of on-road driving performance in stroke patients. The purpose of this study was to determine whether the SDSA, either alone or combined with other tests, predicted fitness to drive in brain injured people. Fifty-two participants were assessed on the SDSA plus additional cognitive tests. Their fitness to drive was examined on the public road. The SDSA predictions based on equations developed for stroke patients were not an accurate predictor of road test performance. Discriminant analysis was used to identify tests predictive of fitness to drive. Results indicated that a combination of the SDSA, the Stroop and the AMIPB Information Processing tasks correctly classified 87% of cases and may be useful predictors of driving fitness following brain injury. However, cross-validation on an independent sample of people with brain injury is required.	Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England		Radford, KA (corresponding author), Univ Nottingham, Sch Psychol, Univ Pk, Nottingham NG7 2RD, England.	kate.radford@nottingham.ac.uk	Radford, Kate A/F-8571-2013; Lincoln, Nadina B/B-9149-2009	Radford, Kate A/0000-0001-6246-3180; 			BARNES M, 1998, REHABILITATION TRAUM; Barnes MP, 1995, CLIN REHABIL, V9, P115; BROOKE MM, 1992, AM J PHYS MED REHAB, V71, P177, DOI 10.1097/00002060-199206000-00009; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; CHRISTIE N, 2001, 485 DEP ENV TRANSP R; CORNWELL M, 1999, FORUM REGIONAL MOBIL; Fisk GD, 1998, BRAIN INJURY, V12, P683; FRYE A, 1995, GUIDE SERVICES DISAB; GALSKI T, 1990, AM J OCCUP THER, V44, P709, DOI 10.5014/ajot.44.8.709; GOUVIER WD, 1989, ARCH PHYS MED REHAB, V70, P745; GRONWELL DMA, 1974, PSYCHOL EFFECTS CONC; HUNT LA, 1994, HDB DEMENTING ILLNES, P529; Johansson K, 1996, J AM GERIATR SOC, V44, P1198, DOI 10.1111/j.1532-5415.1996.tb01369.x; KERTESZ A, 1985, NEUROLOGY, V35, P662, DOI 10.1212/WNL.35.5.662; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lincoln N., 1992, CLIN REHABIL, V6, P275, DOI DOI 10.1177/026921559200600402; Lundqvist A, 2001, BRAIN INJURY, V15, P981, DOI 10.1080/02699050110065637; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; LUNDQVIST A, 2000, APPL COGNITIVE PSYCH, V135, P16; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; McKenna P., 1998, J MENTAL HLTH, V7, P9; Nouri F M, 1987, Int Disabil Stud, V9, P110; Nouri F.M., 1994, STROKE DRIVERS SCREE; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; NOURI FM, 1993, BRIT MED J, V307, P482, DOI 10.1136/bmj.307.6902.482; PIDIKITI RD, 1991, ARCH PHYS MED REHAB, V72, P109; PRIDDY D A, 1990, Brain Injury, V4, P267, DOI 10.3109/02699059009026176; Radford KA, 2004, ARCH PHYS MED REHAB, V85, P324, DOI 10.1016/S0003-9993(03)00765-2; RADFORD KA, 2000, THESIS U NOTTINGHAM; RANNEY TA, 1994, ACCIDENT ANAL PREV, V26, P733, DOI 10.1016/0001-4575(94)90051-5; SHORE D, 1980, ARCH PHYS MED REHAB, V61, P481; SMITH T, 1980, THESIS CRANFIELD I T; The British Psychological Society, 2001, FITN DRIV COGN DOC M; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; WITHAAR FK, 2000, THESIS LEEUWARDEN; [No title captured]	39	31	33	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2004	18	8					775	786		10.1080/02699050310001657394			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	826AN	WOS:000221801300004	15204318				2022-02-06	
J	Akman, MN; Cetin, N; Bayramoglu, M; Isiklar, I; Kilinc, S				Akman, MN; Cetin, N; Bayramoglu, M; Isiklar, I; Kilinc, S			Value of the D-dimer test in diagnosing deep vein thrombosis in rehabilitation inpatients	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	63rd Annual Meeting of the American-Academy-of-Physical-Medicine-and-Rehabilitation	NOV 20-24, 2002	ORLANDO, FL	Amer Acad Phys Med & Rehabil		fibrin degradation products; rehabilitation; venous thrombosis	SPINAL-CORD-INJURY; VENOUS THROMBOSIS; BRAIN-INJURY; EXCLUSION; ASSAYS; ADMISSION	Objective: To assess the utility of the D-dimer test-a widely available, less costly, and less time-consuming test than others used to diagnose or exclude deep vein thrombosis (DVT) and pulmonary embolism. Design: Blind comparison. Setting: An inpatient rehabilitation facility in Turkey. Participants: Sixty-eight consecutive inpatients being rehabilitated after stroke, spinal cord injury, hip arthroplasty, or traumatic brain injury. Interventions: A latex D-dimer assay was performed on each patient at admission and then weekly throughout the hospital stay. Color Doppler ultrasonography of the lower limbs was also done for each patient at admission and was repeated when indicated by clinical signs and symptoms of DVT or by elevated D-dimer levels. Main Outcome Measures: Patients' clinical findings, D-dimer test results, and ultrasonography results were recorded. Sensitivity, specificity, and positive and negative predictive values were calculated for the D-dimer test, each clinical finding, and combinations of D-dimer results and clinical findings in relation to DVT diagnosis. Results: The sensitivity and negative predictive value of the D-dimer test were high, at 95.2% and 96.2%, respectively. The specificity and positive predictive value were low, at 55.3% and 48.7%, respectively. No single clinical finding was reliably diagnostic for DVT. Conclusions: The D-dimer assay is a reliable method for ruling out DVT. In the rehabilitation setting, it can be used as a routine screening test or to assess cases of suspected DVT. D-dimer testing may reduce the need for sophisticated, time-consuming, and expensive diagnostic workup of rehabilitation inpatients, a group that is at increased risk for DVT.	Baskent Univ, Fac Med, Dept Phys Med & Rehabil, TR-06490 Ankara, Turkey; Baskent Univ, Fac Med, Dept Radiol, TR-06490 Ankara, Turkey; Baskent Univ, Phys Med & Rehabil Ctr, TR-06490 Ankara, Turkey		Akman, MN (corresponding author), Baskent Univ, Fac Med, Dept Phys Med & Rehabil, 5 Sokak 48,Bahcelievler, TR-06490 Ankara, Turkey.	nafiza@baskent-ank.edu.tr	Bayramoglu, Meral/W-8293-2018; Cetin, Nuri/AAK-4129-2021; AYAS, SEHRI/AAJ-7520-2021	Cetin, Nuri/0000-0002-9950-8917; AYAS, SEHRI/0000-0002-5078-6529			[Anonymous], 1993, Thromb Haemost, V70, P909; Barloon TJ, 1997, AM FAM PHYSICIAN, V56, P791; Birdwell B, 1999, Curr Opin Hematol, V6, P275, DOI 10.1097/00062752-199909000-00001; Burn PR, 1997, CLIN RADIOL, V52, P625, DOI 10.1016/S0009-9260(97)80257-7; Cappeliez O, 1996, Rev Med Brux, V17, P127; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Elias A, 1996, THROMB HAEMOSTASIS, V76, P518; GARRISON SJ, 1993, REHABILITATION MED P, P801; Janssen MCH, 1998, SEMIN THROMB HEMOST, V24, P393, DOI 10.1055/s-2007-996028; Janssen MCH, 1997, THROMB HAEMOSTASIS, V77, P262; Kozman H, 1997, SOUTHERN MED J, V90, P907, DOI 10.1097/00007611-199709000-00009; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; MERLI GJ, 1993, ARCH PHYS MED REHAB, V74, P1199; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P285, DOI 10.1053/apmr.2003.50116; Michiels JJ, 1998, SEMIN THROMB HEMOST, V24, P401, DOI 10.1055/s-2007-996029; Powell M, 1999, ARCH PHYS MED REHAB, V80, P1044, DOI 10.1016/S0003-9993(99)90058-8; Rossi R, 1998, Minerva Cardioangiol, V46, P507; Roussi J, 1999, SPINAL CORD, V37, P548, DOI 10.1038/sj.sc.3100891; Zhang GJ, 1996, SURG TODAY, V26, P683, DOI 10.1007/BF00312084	19	31	33	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2004	85	7					1091	1094		10.1016/j.apmr.2003.10.023			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	835XU	WOS:000222519600008	15241755				2022-02-06	
J	Brvar, M; Mozina, H; Osredkar, J; Mozina, M; Noc, M; Brucan, A; Bunc, M				Brvar, M; Mozina, H; Osredkar, J; Mozina, M; Noc, M; Brucan, A; Bunc, M			S100B protein in carbon monoxide poisoning: a pilot study	RESUSCITATION			English	Article						carbon monoxide; hyperbaric oxygen; S100B; indications; prognosis	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; HYPERBARIC-OXYGEN; SERUM LEVELS; S-100B; MARKER	Carbon monoxide (CO) poisoning is the most common form of lethal poisoning. The aim of this prospective clinical study was to assess the possible role of S100B, the structural protein in the astroglia, as a biochemical marker of brain injury in carbon monoxide poisoning. Serum S100B determination was performed in 38 consecutive patients poisoned by carbon monoxide who were admitted to the Emergency Department (ED) in Ljubljana. All three unconscious patients had elevated S100B levels. The patient with the highest S100B died. S100B was elevated in two of the six patients with initial transitory unconsciousness at the scene. All 29 patients without loss of consciousness had normal S100B levels. Carbon monoxide poisoning appears to be associated with elevated S100B levels. (C) 2004 Elsevier Ireland Ltd. All rights reserved.	Sch Med, Inst Pathophysiol, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Clin Dept Cardiol, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Dept Emergency Med, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Ctr Intens Internal Med, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Poison Control Ctr, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Lab Biochem Anal, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Ctr Intens Internal Med, Ljubljana 1000, Slovenia; Ljubljana Med Ctr, Poison Control Ctr, Ljubljana 1000, Slovenia		Bunc, M (corresponding author), Sch Med, Inst Pathophysiol, Zaloska Cesta 4, Ljubljana 1000, Slovenia.	mbuncek@yahoo.com					Bertsch T, 2001, CLIN CHEM LAB MED, V39, P319, DOI 10.1515/CCLM.2001.050; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Bottiger BW, 2001, CIRCULATION, V103, P2694; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Gazzolo D, 2002, CRIT CARE MED, V30, P1356, DOI 10.1097/00003246-200206000-00037; Hampson NB, 2001, ANN EMERG MED, V38, P36, DOI 10.1067/mem.2001.115532; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; RAPHAEL JC, 1989, LANCET, V2, P414; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; Schiltz KL, 2000, UNDERSEA HYPERBAR M, V27, P48; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121	13	31	33	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	JUN	2004	61	3					357	360		10.1016/j.resuscitation.2004.01.009			4	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	831MQ	WOS:000222198900015	15172716				2022-02-06	
J	Ariza, M; Junque, C; Mataro, M; Poca, MA; Bargallo, N; Olondo, M; Sahuquillo, J				Ariza, M; Junque, C; Mataro, M; Poca, MA; Bargallo, N; Olondo, M; Sahuquillo, J			Neuropsychological correlates of basal ganglia and medial temporal lobe NAA/Cho reductions in traumatic brain injury	ARCHIVES OF NEUROLOGY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MR SPECTROSCOPY; AXONAL INJURY; HYPOXIA	Background: Proton magnetic resonance spectroscopy can assess neurochemical sequelae in traumatic brain injury. Metabolic abnormalities are present in the acute or subacute period in patients with traumatic brain injury and correlate with outcome on clinical scales. Objective: To investigate the use of proton magnetic resonance spectroscopy in detecting possible gray subcortical neurochemical impairments and their relationship with neuropsychological performance. Design: Group comparisons and correlations of brain metabolites with clinical and neuropsychological variables. Patients and Methods: Metabolite concentrations were acquired from voxels localized to the basal ganglia and medial temporal region in 20 patients with long-term moderate and severe traumatic brain injury and 20 matched control subjects. Both groups under-went neuropsychological assessment. Results: N-acetylaspartate-choline-containing compounds ratios were decreased in patients in the basal ganglia (t=-3.28, P=.002) and medial temporal region (t=-3.52, P=.001). The basal ganglia ratio correlated to measures of speed, motor scanning, and attention. Conclusion: Patients with long-term TBI present a regional correlation pattern that may help identify the neurological basis of cognitive sequelae in traumatic brain injury.	Vall Hebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; Hosp Clin Barcelona, Dept Radiol, Ctr Diagnost Imatge, Barcelona, Spain; Univ Barcelona, Dept Psiquiat & Psicobiol Clin, Inst Invest Biomed August Pi & Sunyer, E-08036 Barcelona, Spain		Junque, C (corresponding author), Univ Barcelona, Dept Psiquiat & Psicobiol Clin, Inst Invest Biomed August Pi & Sunyer, C Casanova 143, E-08036 Barcelona, Spain.	cjunque@ub.edu	Mataro, Maria/B-4524-2011; Poca, Maria A./B-8475-2008; Ariza, Mar/F-2754-2019; Junque, Carme/B-4400-2011; Bargallo, Nuria/G-6854-2016; Sahuquillo, Juan/B-3577-2008	Mataro, Maria/0000-0002-9946-2656; Poca, Maria A./0000-0002-3831-0536; Junque, Carme/0000-0002-6381-3063; Bargallo, Nuria/0000-0001-6284-5402; Sahuquillo, Juan/0000-0003-0713-5875; Ariza, Mar/0000-0003-1020-6945			Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; CALABRESI P, 1995, BRAIN, V118, P1027, DOI 10.1093/brain/118.4.1027; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; LUYTEN PR, 1986, RADIOLOGY, V161, P795, DOI 10.1148/radiology.161.3.3786735; Nakano K, 2000, J NEUROL, V247, P1; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; Sinson G, 2001, AM J NEURORADIOL, V22, P143	13	31	32	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0003-9942	1538-3687		ARCH NEUROL-CHICAGO	Arch. Neurol.	APR	2004	61	4					541	544		10.1001/archneur.61.4.541			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	810RX	WOS:000220722500012	15096403	Bronze			2022-02-06	
J	Wilson, S; Raghupathi, R; Saatman, KE; Mackinnon, MA; McIntosh, TK; Graham, DI				Wilson, S; Raghupathi, R; Saatman, KE; Mackinnon, MA; McIntosh, TK; Graham, DI			Continued in situ DNA fragmentation of microglia/macrophages in white matter weeks and months after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						human traumatic brain injury; TUNEL staining; Wallerian degeneration	SPINAL-CORD-INJURY; DIFFUSE AXONAL INJURY; MISSILE HEAD-INJURY; CONTROLLED CORTICAL IMPACT; VEGETATIVE STATE; CELL-DEATH; APOPTOSIS; RATS; NEUROPATHOLOGY; DAMAGE	Paraffin-embedded material from the pons of head-injured patients whose disability could be attributed to diffuse traumatic axonal injury, and controls, was identified from the department's archive. The cases were divided into three groups based on survival, viz Group I (n = 5) who survived for between 4 and 8 weeks, Group 2 (n = 5) for between 3 and 9 months, and Group 3 (n = 5) who survived for more that 12 months. Sections were stained by the TUNEL (TdT-mediated UTP nick end labelling) technique, and by H&E, LFB/CV and immunohistochemically for astrocytes (GFAP) and microglia/macrophages (CD68). Microscopic abnormalities were mapped onto line diagrams of two levels of the pons and quantitation of the response determined by an eye-piece graticule placed over the medial lemmisci, cortico-spinal and transverse fiber tracts. Data were pooled by region of interest. In the H&E and LFB/CV stained sections, there was variable pallor of staining in ascending and descending fiber tracts due to loss of myelin: within these same tracts there was an astrocytosis and increased numbers of microglia/macrophages compared with controls. In the white matter tracts of the controls, there was on average 1-2 TUNEL+ cells per unit area. In contrast, there were on average 2-16 TUNEL+ cells in the cortico-spinal tracts and in the medial lemnisci of all groups of head-injured patients. CD68(+) cells co-located with the TUNEL+, and their number mirrored the TUNEL I staining with on average 16-30 cells per unit area in Group 1, 14-27 cells per unit area in Group 2, and 12-14 cells per unit area in Group 3. There was a statistical association between the TUNEL+ and CD68(+) cells. Few changes were seen in the transverse fiber tracts of the pons. These findings indicate that most of the in situ DNA fragmentation occurred in microglia/macrophages in ascending and descending fiber tracts of the brain stem in which by conventional light microscopy there is Wallerian degeneration. However, in addition, a few TUNEL+ oligodendrocyte-like cells were also seen.	Univ Glasgow, Dept Neuropathol, Glasgow G12 8QQ, Lanark, Scotland; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Graham, DI (corresponding author), S Glasgow Hosp NHS Trust, So Gen Hosp, Acad Unit Neuropathol, Inst Neurol Sci, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	D.Graham@clinmed.gla.ac.uk			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R01-GN34690] Funding Source: Medline		Abe Y, 1999, J NEUROTRAUM, V16, P945, DOI 10.1089/neu.1999.16.945; ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; BARRES BA, 1993, DEVELOPMENT, V118, P283; Beattie MS, 1998, NEUROSCIENTIST, V4, P163, DOI 10.1177/107385849800400312; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BUNGE RP, 1998, ADV NEUROL, V59, P75; Clark D, 1999, IEEE INTERNET COMPUT, V3, P13; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Fowler J, 2002, CLIN NEUROPATHOL, V21, P156; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GEHRMANN J, 1991, ACTA NEUROPATHOL, V82, P442, DOI 10.1007/BF00293378; GEHRMANN J, 1992, LAB INVEST, V67, P100; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; GRCEVIC H, 1977, RAD JUN AKAD ZNS VMJ, V402, P265; Hayes KC, 1997, J NEUROTRAUM, V14, P235, DOI 10.1089/neu.1997.14.235; KERR JFR, 1972, J PATHOL, V106, pPR11; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Liu XZ, 1997, J NEUROSCI, V17, P5395; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; PETITO CK, 1995, J NEUROPATH EXP NEUR, V54, P761, DOI 10.1097/00005072-199511000-00002; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; RINK A, 1995, AM J PATHOL, V147, P1575; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; WYLLIE AH, 1993, BRIT J CANCER, V67, P205, DOI 10.1038/bjc.1993.40; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; [No title captured]; [No title captured]	54	31	31	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2004	21	3					239	250		10.1089/089771504322972031			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	806CI	WOS:000220411600002	15115599				2022-02-06	
J	Blackman, JA; Rice, SA; Matsumoto, JA; Conaway, MR; Elgin, KM; Patrick, PD; Farrell, WJ; Allaire, JH; Willson, DF				Blackman, JA; Rice, SA; Matsumoto, JA; Conaway, MR; Elgin, KM; Patrick, PD; Farrell, WJ; Allaire, JH; Willson, DF			Brain imaging as a predictor of early funcional outcome following traumatic brain injury in children, aldolescents, and young adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						functional outcome; neuroimaging; rehabilitation; traumatic brain injury; WeeFIM	CLOSED-HEAD INJURY; FUNCTIONAL INDEPENDENCE; ADOLESCENTS; DISABILITIES; TOMOGRAPHY; POPULATION; MODERATE; SEVERITY; MODEL; MILD	Objectives: A depth of lesion (DOL) model using brain imaging has been proposed to aid in medical decision-making and planning for rehabilitation resource needs. The purpose of this study was to determine the early prognostic value of a DOL classification system for children and young adults following severe traumatic brain injury. Methods and Outcome measures: CT/MRI brain imaging studies on 92 patients, aged 3 to 21, admitted to the Kluge Children's Rehabilitation Center, University of Virginia, were evaluated to determine DOL. Images were classified according to 5 DOL levels (cortical to brainstem). Functional outcomes in mobility, self-care, and cognition, as rated on the WeeFIM instrument, were compared by DOL levels. Results: Admission WeeFIM scores were significantly different for the DOL levels with the highest score for frontal and/or temporal lesions and the lowest for lesions including the brainstem or cerebellum (P < .001). However, the deeper the lesion, the greater the functional gains (P = .05), resulting in discharge WeeFIM scores that were not significantly different across DOL levels. Patients with deeper lesions tended to have longer lengths of stay in rehabilitation but were able to "catch up" with patients who had more superficial lesions. Conclusions: While relatively simple and convenient, the DOL classification system is limited in its usefulness as an early prognostic tool. It may not be possible to predict outcome in the early acute phase in the intensive care unit on the basis of standard brain imaging alone. Patients with deeper lesions may enter rehabilitation at a more impaired level but can make remarkable progress, though it may take longer than for less severely injured individuals.	Univ Virginia, Kluge Childrens Rehabil Ctr & Res Inst, Dept Pediat, Charlottesville, VA 22902 USA; Univ Virginia, Kluge Childrens Rehabil Ctr & Res Inst, Dept Radiol, Charlottesville, VA 22902 USA; Univ Virginia, Kluge Childrens Rehabil Ctr & Res Inst, Dept Hlth Evaluat Sci, Charlottesville, VA 22902 USA		Blackman, JA (corresponding author), Univ Virginia, Kluge Childrens Rehabil Ctr & Res Inst, Dept Pediat, 2270 Ivy Rd, Charlottesville, VA 22902 USA.		Matsumoto, Julie/D-6464-2013		NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24 HD39631] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039631] Funding Source: NIH RePORTER		BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; *CDCP, 2000, COMMUNICATION; Deutsch A, 1996, CRITICAL REV PHYS ME, V8, P267; Gean A D, 1995, New Horiz, V3, P549; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; JENKINS A, 1986, LANCET, V2, P445; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; MSALL ME, 1996, DEV DISABILITIES INF, P371; Msall ME., 1993, PHYS MED REH CLIN N, V4, P517; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Ottenbacher KJ, 1999, DEV MED CHILD NEUROL, V41, P186, DOI 10.1017/S0012162299000377; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; *STAT U NY BUFF, 1997, GUID UN DAT SET MED; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; *U BUFF, 1998, UN DAT SYST MED REH; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	30	31	32	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					493	503		10.1097/00001199-200311000-00003			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200003	14707879				2022-02-06	
J	Ohlsson, M; Bellander, BM; Langmoen, IA; Svensson, M				Ohlsson, M; Bellander, BM; Langmoen, IA; Svensson, M			Complement activation following optic nerve crush in the adult rat	JOURNAL OF NEUROTRAUMA			English	Article						axotomy; CNS; complement; glia; MAC; optic nerve	AXONAL REGENERATION; TERMINAL PATHWAY; REGROWTH FAILURE; FACIAL-NERVE; HUMAN BRAIN; CELL-LINES; INJURY; SYSTEM; MACROPHAGES; EXPRESSION	Activation of the complement cascade following peripheral nerve axotomy and following traumatic brain injury has been demonstrated in previous studies. This study investigates the temporal pattern of microglia/macrophages and complement activation following axotomy of sensory CNS neurons, using a standardized experimental crush injury of the optic nerve in adult rats. Numerous ED1-labeled macrophages were found at the lesion site and distal to the injury at 7 days post injury (dpi). Complement C3-mRNA was upregulated 2-28 days post lesion, indicating local synthesis of complement in the optic nerve. Furthermore, increased immunoreactivity (IR) for the end product of the complement cascade, the membrane attack complex (MAC), was detected along disintegrating axons co-labeled with anti-neurofilament distal to the injury. Double-labeling for microglia show MAC-immunoreactivity expressed in their immediate vicinity, indicating a key role of microglia/macrophages in complement activation. The complement regulator Clusterin was upregulated in astrocytes at the lesion site as well as in the distal portion of the injured optic nerve, suggesting activation of a defense response to endogenous complement attack. A crush injury of the optic nerve leads to complement activation at the site of lesion and along the distal portion of the nerve, as well as upregulation of the complement inhibitor Clusterin at least in astrocytes. Reactive microglial cells seem to have a key role in complement activation as a local source of C3. We suggest that the balance between complement activation and their regulators may have impact on axonal degeneration following optic nerve injury.	Karolinska Hosp & Inst, Neurosurg Sect, Dept Clin Neurosci, Stockholm, Sweden		Ohlsson, M (corresponding author), Karolinska Hosp & Inst, Neurosurg Sect, Dept Clin Neurosci, Stockholm, Sweden.	marcus.ohlsson@ks.se	Ohlsson, Marcus R/H-1395-2011; Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003			AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Ben Zeev-Brann A, 1998, GLIA, V23, P181, DOI 10.1002/(SICI)1098-1136(199807)23:3<181::AID-GLIA1>3.0.CO;2-8; BLAUGRUND E, 1992, EXP NEUROL, V118, P105, DOI 10.1016/0014-4886(92)90027-N; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Brecknell JE, 1996, BIOL REV, V71, P227, DOI 10.1111/j.1469-185X.1996.tb00748.x; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; D'Ambrosio AL, 2001, MOL MED, V7, P367, DOI 10.1007/BF03402183; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dieterich DC, 2002, NEUROSCI LETT, V317, P29, DOI 10.1016/S0304-3940(01)02418-1; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; Gasque P, 1996, J NEUROIMMUNOL, V66, P29, DOI 10.1016/0165-5728(96)00015-X; GASQUE P, 1995, J IMMUNOL, V154, P4726; Gasque P, 2002, MOL NEUROBIOL, V25, P1, DOI 10.1385/MN:25:1:001; Gasque P, 1997, AM J PATHOL, V150, P31; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; GIULIAN D, 1993, J NEUROSCI, V13, P29; Greenberg M.S., 1997, HDB NEUROSURGERY; Haga S, 1996, NEUROSCI LETT, V216, P191, DOI 10.1016/0304-3940(96)13040-8; Kandel E.R., 2000, PRINCIPLES NEURAL SC; LAW SKA, 1988, COMPLEMENT; Lazarov-Spiegler O, 1998, GLIA, V24, P329, DOI 10.1002/(SICI)1098-1136(199811)24:3<329::AID-GLIA7>3.0.CO;2-X; Lazarov-Spiegler O, 1999, VISION RES, V39, P169, DOI 10.1016/S0042-6989(98)00089-3; LazarovSpiegler O, 1996, FASEB J, V10, P1296, DOI 10.1096/fasebj.10.11.8836043; Liu L, 1998, GLIA, V23, P221, DOI 10.1002/(SICI)1098-1136(199807)23:3<221::AID-GLIA5>3.3.CO;2-Z; LIU L, 1995, NEUROSCIENCE, V68, P167, DOI 10.1016/0306-4522(95)00103-P; MacLaren RE, 1998, BRIT J OPHTHALMOL, V82, P577, DOI 10.1136/bjo.82.5.577; Mattsson P, 1998, J NEUROIMMUNOL, V91, P180, DOI 10.1016/S0165-5728(98)00178-7; Mattsson P, 2001, J COMP NEUROL, V437, P106, DOI 10.1002/cne.1273; Morgan BP, 1997, CLIN EXP IMMUNOL, V107, P1, DOI 10.1046/j.1365-2249.1997.d01-890.x; OHLSSON M, IN PRESS RESTORATIVE; Podhajsky RJ, 1997, EXP NEUROL, V143, P153, DOI 10.1006/exnr.1996.6354; RODDY J, 1994, J NEUROL, V241, P557, DOI 10.1007/BF00873519; Rus H, 2001, IMMUNOL RES, V24, P79, DOI 10.1385/IR:24:1:79; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; SCHMIDEK HH, 2000, OPERATIVE NEUROSURGI; Schwartz M, 1999, NEUROSURGERY, V44, P1041, DOI 10.1097/00006123-199905000-00057; Speth C, 1999, WIEN KLIN WOCHENSCHR, V111, P378; SVENSSON M, 1995, MOL CHEM NEUROPATHOL, V24, P53, DOI 10.1007/BF03160112; SVENSSON M, 1994, NEUROPATH APPL NEURO, V20, P185; SVENSSON M, 1992, J NEUROIMMUNOL, V40, P99, DOI 10.1016/0165-5728(92)90217-9; Tornqvist E, 1996, NEUROBIOL AGING, V17, P695; Yoles E, 1999, INVEST OPHTH VIS SCI, V40, P65; Yoles E, 1997, J NEUROTRAUM, V14, P665, DOI 10.1089/neu.1997.14.665; YOUMANS JR, 1997, NEUROLOGICAL SURG	46	31	32	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2003	20	9					895	904		10.1089/089771503322385827			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	725BB	WOS:000185521800008	14577867				2022-02-06	
J	Dunn, L; Henry, J; Beard, D				Dunn, L; Henry, J; Beard, D			Social deprivation and adult head injury: a national study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							BRAIN-INJURY; DISABILITY; MORTALITY; EPIDEMIOLOGY; SEVERITY; SURVIVAL; SCOTLAND; DISEASE	Objectives: To establish the association between measures of social deprivation, mechanisms of injury, patterns of care, and outcome following closed head injury. Methods: All Scottish adult A&E attendees with closed head injury (AIS Head greater than or equal to 3) between July 1996 and December 2000 were studied. Results: Trauma was more common in individuals from more deprived areas. Within the trauma population head injury was relatively more common in patients from deprived areas; these individuals were more likely to sustain an isolated head injury as a result of an assault. Admission GCS was higher and normal physiology ( as assessed by the RTS) was more common in individuals from more deprived areas. Recorded co-morbidity was similar between the two groups with the exception of a history of alcohol or substance abuse which was more common among patients from more deprived areas. Similar proportions of patients from more deprived and less deprived areas were transferred to the Regional Neurosurgical Centre. For patients who were transferred directly from A&E, time to neurosurgical theatre was similar for both groups. Length of hospital and ITU stay was less in patients from more deprived areas. After adjusting for known predictors of outcome using logistic regression analysis, there was no significant difference in mortality between patients from more deprived and less deprived areas. Conclusions: Residing in a more deprived area is not associated with increased mortality from head injury among adults in Scotland. It is associated with different patterns of injury and a different process of care following presentation to hospital.	Univ Glasgow, Dept Neurosurg, Glasgow G12 8QQ, Lanark, Scotland; Royal Infirm, STAG, Edinburgh EH3 9YW, Midlothian, Scotland		Dunn, L (corresponding author), So Gen Hosp, Inst Neurol Sci, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland.	ltd1x@udcf.gla.ac.uk					Beard D, 2000, Health Bull (Edinb), V58, P118; CARSTAIRS V, 1992, DEPRIVATION HLTH SCO; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; KRAUS JF, 1993, HEAD INJURY; McEntegart A, 1997, ANN RHEUM DIS, V56, P410, DOI 10.1136/ard.56.7.410; McKinney PA, 1999, EUR J CANCER, V35, P1816, DOI 10.1016/S0959-8049(99)00173-2; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; McLoone P., 1994, CARSTAIRS SCORES SCO; *MED AAFA, 1985, ABBR INJ SCAL 1985 R; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Morrison A, 1999, BRIT MED J, V318, P567, DOI 10.1136/bmj.318.7183.567; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; ROCKETT IRH, 1987, AM J PUBLIC HEALTH, V77, P1345, DOI 10.2105/AJPH.77.10.1345; SCHRIJVERS CTM, 1995, BRIT J CANCER, V72, P738, DOI 10.1038/bjc.1995.403; SHARPLES PM, 1990, BRIT MED J, V301, P1193, DOI 10.1136/bmj.301.6762.1193; Stark AD, 2002, BRIT MED J, V324, P457, DOI 10.1136/bmj.324.7335.457; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Williamson LM, 2002, J EPIDEMIOL COMMUN H, V56, P285, DOI 10.1136/jech.56.4.285; YATES DW, 1992, BRIT MED J, V305, P737, DOI 10.1136/bmj.305.6856.737	25	31	31	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	AUG	2003	74	8					1060	1064		10.1136/jnnp.74.8.1060			5	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	703MJ	WOS:000184283100013	12876234	Green Published, Bronze			2022-02-06	
J	Holtzer, R; Wegesin, DJ; Albert, SM; Marder, K; Bell, K; Albert, M; Brandt, J; Stern, Y				Holtzer, R; Wegesin, DJ; Albert, SM; Marder, K; Bell, K; Albert, M; Brandt, J; Stern, Y			The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease	ARCHIVES OF NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; NEUROPSYCHOLOGICAL TESTS; PATIENT DEPENDENCE; DEMENTIA; PREDICTION; OUTCOMES	Background: Previous studies revealed that cognitive test scores were related to functional outcome in Alzheimer disease (AD). However, the relationship between the rate of cognitive decline at the initial disease phase and the risk of reaching clinical milestones in subsequent years has not yet been examined. Objective: To examine whether the rate of cognitive decline predicts the risk of reaching functional milestones in patients with probable AD. Design: A 5-year prospective study was conducted at 3 sites. Setting: Outpatient research and treatment centers. Participants: Patients diagnosed with probable AD (N = 236, mean age, 73 years; 59% women; mean years of education, 13). Main Outcome Measures: Modified Mini-Mental State Examination (mMMSE) scores were used to assess the rate of cognitive decline over time. Total dependence score and 2 clinical milestones: (1) the need to be dressed, groomed, and washed and (2) receiving a level of care equivalent to a placement in a health-related facility, were derived from the Dependence Scale. Results: General estimating equation analyses revealed that the rate of cognitive decline during the entire follow-up period was positively related to an increase in total dependence scores. Cox analyses showed that a fast rate of decline during the first year was related to an increase in the risk of reaching clinical milestones in subsequent years. Analyses controlled for age, sex, education, and baseline mMMSE scores. Conclusion: A fast rate of cognitive decline was associated with increasing risk of reaching clinical milestones in AD.	Columbia Univ Coll Phys & Surg, Segievsky Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Harvard Univ, Massachusetts Gen Hosp, Med Ctr, Dept Psychiat, Boston, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Med Ctr, Dept Neurol, Boston, MA 02129 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Stern, Y (corresponding author), Columbia Univ Coll Phys & Surg, Segievsky Ctr, 630 W 168th St,19th Floor,P&S Box 16, New York, NY 10032 USA.	ys11@columbia.edu		Albert, Steven/0000-0001-6786-9956; Brandt, Jason/0000-0001-7381-6244; Stern, Yaakov/0000-0001-7542-3241; Holtzer, Roee/0000-0001-6639-0724	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR 00645] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 07370] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000645] Funding Source: NIH RePORTER		American Psychiatric Association, 1980, DIAGN STAT MAN MENT; BarbergerGateau P, 1997, DISABIL REHABIL, V19, P175, DOI 10.3109/09638289709166525; BENYISHA.Y, 1970, J CONSULT CLIN PSYCH, V34, P436, DOI 10.1037/h0029366; Brickman AM, 2002, ARCH NEUROL-CHICAGO, V59, P1304, DOI 10.1001/archneur.59.8.1304; DRACHMAN DA, 1990, ARCH NEUROL-CHICAGO, V47, P851, DOI 10.1001/archneur.1990.00530080033007; Feyereisen P, 1999, NEUROPSYCHOL REHABIL, V9, P169, DOI 10.1080/713755598; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; GALASKO D, 1995, NEUROLOGY, V45, P1451, DOI 10.1212/WNL.45.8.1451; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; GURLAND B, 1978, DEPENDENCY ELDERLY N; Hartman D. E., 1998, ECOLOGICAL VALIDITY, P113; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; JACOBS D, 1994, NEUROLOGY, V44, P1215, DOI 10.1212/WNL.44.7.1215; Kaplan E, 1983, BOSTON NAMING TEST; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORITZ DJ, 1995, AM J EPIDEMIOL, V141, P41, DOI 10.1093/oxfordjournals.aje.a117344; Njegovan V, 2001, J GERONTOL A-BIOL, V56, pM638, DOI 10.1093/gerona/56.10.M638; REED BR, 1989, GERONTOLOGIST, V29, P804, DOI 10.1093/geront/29.6.804; RICHARDS M, 1993, ALZ DIS ASSOC DIS, V7, P22, DOI 10.1097/00002093-199307010-00003; SCHERR PA, 1988, AM J EPIDEMIOL, V128, P1084; Searight HR, 1989, NEUROPSYCHOLOGY, V3, P135; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; STERN Y, 1987, Neurology, V37, P179; STERN Y, 1990, NEUROLOGY, V40, P8, DOI 10.1212/WNL.40.1.8; STERN Y, 1994, J GERONTOL, V49, pM216, DOI 10.1093/geronj/49.5.M216; Stern Y, 1996, J GERONTOL A-BIOL, V51, pM179, DOI 10.1093/gerona/51A.4.M179; STERN Y, 1993, ALZ DIS ASSOC DIS, V7, P3, DOI 10.1097/00002093-199307010-00002; VITALIANO PP, 1984, J GERONTOL, V39, P58, DOI 10.1093/geronj/39.1.58; Wechsler, 1997, WECHSLER ADULT INTEL; Wedding D., 1983, CLIN NEUROPSYCHOLOGY, V5, P49; Wild Katherine V., 1995, Clinical Gerontologist, V15, P3, DOI 10.1300/J018v15n03_02; WRIOGHT RE, 2000, READING UNDERSTANDIN, P263	33	31	33	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0003-9942	1538-3687		ARCH NEUROL-CHICAGO	Arch. Neurol.	AUG	2003	60	8					1137	1142		10.1001/archneur.60.8.1137			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	710RE	WOS:000184692600017	12925372	Bronze, Green Published			2022-02-06	
J	Altura, BM; Gebrewold, A; Zhang, AM; Altura, BT				Altura, BM; Gebrewold, A; Zhang, AM; Altura, BT			Low extracellular magnesium ions induce lipid peroxidation and activation of nuclear factor-kappa B in canine cerebral vascular smooth muscle: possible relation to traumatic brain injury and strokes	NEUROSCIENCE LETTERS			English	Article						Mg2+ deficits; vascular smooth muscle; nuclear transcription factor kappa B; I kappa B; reactive oxygen species; lipid peroxidation; stroke; traumatic brain injury	P-31-NMR IN-VIVO; ALCOHOL; CALCIUM; PLASMA; MG2+; RATS	The present study was designed to test the hypothesis that administration of low extracellular levels of magnesium ions ([Mg2+](o)) to primary cultured cerebral vascular smooth muscle cells will cause lipid peroxidation, degradation Of IbetaB-alpha, and activation of nuclear transcription factor kappa B (NF-kappaB) in cultured cerebral vascular smooth muscle cells. Low [Mg2+](o) (0, 0.15, 0.3 and 0.48 mM) resulted in concentration-dependent rises in malondialdehyde (MDA) in as little as 3 h after exposure to low [Mg2+](o), rising to levels 3-12 X normal after 18-24 h; the lower the [Mg2+](o), the higher the MDA level. Using electrophoretic mobility shift assays and specific antibodies, low [Mg2+](o) caused two DNA-binding proteins (p50, p65) to rise in nuclear extracts in a concentration-dependent manner. High [Mg2+](o) (i.e. 4.8 mM) downregulated p50 and p65. Using a rabbit antibody, IkappaB phosphorylation (and degradation) was stimulated by low [Mg2+](o) (in a concentration-dependent manner) and inhibited by a low concentration of the NF-kappaB inhibitor, pyrrolidine dithiocarbamate. These new biochemical and molecular data indicate that low [Mg2+](o), in concentrations found in the blood of patients, after traumatic brain injury (TBI) and diverse types of strokes, can elicit rapid lipid peroxidation and activation of NF-kappaB in cerebral vascular smooth muscle cells. The present results, when viewed in light of other recently published data, suggest that low [Mg2+](o)-induced lipid peroxidation and activation of NF-kappaB play important roles in TBI and diverse types of strokes. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.	SUNY Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Ctr Cardiovasc & Muscle Res, Brooklyn, NY 11203 USA		Altura, BM (corresponding author), SUNY Hlth Sci Ctr, Box 31,450 Clarkson Ave, Brooklyn, NY 11203 USA.				NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA008674] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA-08674] Funding Source: Medline		Altura BM, 1998, ALCOHOL, V15, P181, DOI 10.1016/S0741-8329(97)00107-9; Altura BM, 1997, BBA-MOL CELL RES, V1358, P1, DOI 10.1016/S0167-4889(97)00077-3; ALTURA BM, 1994, ALCOHOL CLIN EXP RES, V18, P1057, DOI 10.1111/j.1530-0277.1994.tb00082.x; ALTURA BM, 1995, ALCOHOL, V12, P131, DOI 10.1016/0741-8329(94)00072-7; ALTURA BM, 1997, MAGNESIUM CURRENT ST, P385; ALTURA BM, 1995, SCI AM SCI MED, V2, P28; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; ALTURA BT, 1982, MAGNESIUM EXP CLIN R, V1, P277; BAICHWAL VR, 1997, PHARM NEWS, V4, P17; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FLATMAN PW, 1991, ANNU REV PHYSIOL, V53, P259, DOI 10.1146/annurev.physiol.53.1.259; GUTTERIDGE JMC, 1978, ANAL BIOCHEM, V91, P250, DOI 10.1016/0003-2697(78)90838-2; Kinoshita Y, 2001, J NEUROTRAUM, V18, P435, DOI 10.1089/089771501750171038; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Morrill GA, 1997, FEBS LETT, V408, P191, DOI 10.1016/S0014-5793(97)00420-1; Regan RF, 1998, J NEUROCHEM, V70, P77; Siegel GJ, 1999, BASIC NEUROCHEMISTRY; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Yang ZW, 2000, PFLUG ARCH EUR J PHY, V439, P240, DOI 10.1007/s004240050935	23	31	37	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAY 8	2003	341	3					189	192		10.1016/S0304-3940(03)00134-4			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	669HW	WOS:000182346700005	12697280				2022-02-06	
J	Bentzer, P; Venturoli, D; Carlsson, O; Grande, PO				Bentzer, P; Venturoli, D; Carlsson, O; Grande, PO			Low-dose prostacyclin improves cortical perfusion following experimental brain injury in the rat	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; edema; endothelium; microvascular; permeability; surface area	CEREBRAL BLOOD-FLOW; HEAD-INJURY; HEMORRHAGIC HYPOTENSION; CAPILLARY PERFUSION; SKELETAL-MUSCLE; PERMEABILITY; ISCHEMIA; ILOPROST; EDEMA; TRANSPORT	It was recently shown that prostacyclin at a low dose reduces cortical cell death following brain trauma in the rat. Conceivably, prostacyclin with its vasodilatory, anti-aggregatory, anti-adhesive and permeability-reducing properties improved a compromised perfusion caused by post-traumatic vasoconstriction, microthrombosis and increased microvascular permeability. The objective of the present study was therefore to investigate the hemodynamic effects of low-dose prostacyclin in the traumatized rat cortex. Following a fluid percussion brain injury or a sham procedure, animals were treated with a continuous intravenous infusion of prostacyclin of 1 or 2 ng (.) kg(-1 .) min(-1), or vehicle. Blood flow ([C-14]-iodoantipyrine), the permeability-surface area product (PS) for [Cr-51]-EDTA, and brain water content were measured after 3 or 48 h of treatment. Blood flow values in the injured cortex were transiently reduced to 0.42 +/- 0.2 mL (.) min(-1) in the vehicle group 3 h following trauma from a corresponding value of about 1.6 mL (.) min(-1) in the sham group, with recovery of blood flow after 48 h. Prostacyclin treatment caused a dose-dependent increase in blood flow which reached statistical significance 48 h following trauma. Brain water content and PS increased in the injured cortex post trauma and the higher dose of prostacyclin increased these parameters further at 48 h compared to the vehicle group (p < 0.05). The latter effects of prostacyclin cannot be attributed to an increase in permeability, as prostacyclin did not influence PS or brain water content following sham trauma. In fact prostacyclin has been shown to have permeability-decreasing properties. We conclude that prostacyclin improves cortical perfusion following brain trauma. The simultaneous aggravation of brain edema can be explained by an increased surface area, perhaps in combination with increased capillary hydrostatic pressure.	Lund Univ, Dept Physiol Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Anesthesia & Intens Care, SE-22184 Lund, Sweden; Univ Lund Hosp, S-22185 Lund, Sweden		Bentzer, P (corresponding author), Lund Univ, Dept Physiol Sci, BMC F11, SE-22184 Lund, Sweden.	peter.bentzer@mphy.lu.se					Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Bentzer P, 1999, J VASC RES, V36, P516, DOI 10.1159/000025695; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; BLEBEA J, 1990, J VASC SURG, V12, P657, DOI 10.1067/mva.1990.25129; CRUMRINE RC, 1991, J CEREBR BLOOD F MET, V11, P272, DOI 10.1038/jcbfm.1991.59; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; ERLANSSON M, 1991, PROSTAGLANDINS, V41, P157, DOI 10.1016/0090-6980(91)90028-E; FENSTERMACHER JD, 1981, PHARMACOL THERAPEUT, V14, P217, DOI 10.1016/0163-7258(81)90062-0; FENSTERMACHER JD, 1984, EDEMA, P383; FUKUYAMA H, 1993, NEUROL RES, V15, P169; GOROG P, 1986, HAEMOSTASIS, V16, P337; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Heinert G, 1999, ACTA PHYSIOL SCAND, V166, P183; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HIGGS EA, 1978, PROSTAGLANDINS, V16, P17, DOI 10.1016/0090-6980(78)90197-1; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Jiang XW, 1998, AM J RESP CRIT CARE, V158, P1669, DOI 10.1164/ajrccm.158.5.9609082; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kuschinsky W, 1996, PFLUG ARCH EUR J PHY, V432, pR42; LO WD, 1987, STROKE, V18, P150, DOI 10.1161/01.STR.18.1.150; Maeda T, 1997, ACT NEUR S, V70, P102; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; MCCALDEN TA, 1984, LIFE SCI, V34, P1801, DOI 10.1016/0024-3205(84)90672-6; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MULLER B, 1987, PROSTA LEUKOTR MED, V29, P187, DOI 10.1016/0262-1746(87)90008-4; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; ORFEO T, 1994, J TRAUMA, V37, P347, DOI 10.1097/00005373-199409000-00003; PLUTA R, 1994, ACTA NEUROCHIR, P303; Raczka E, 1999, BRIT J PHARMACOL, V126, P1325, DOI 10.1038/sj.bjp.0702426; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; SARNA GS, 1977, BRAIN RES, V138, P550, DOI 10.1016/0006-8993(77)90692-8; SAWA Y, 1988, CIRCULATION, V78, P191; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHIMA K, 1995, ACTA NEUROCHIR, V137, P89, DOI 10.1007/BF02188788; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1984, J CEREBR BLOOD F MET, V4, P107, DOI 10.1038/jcbfm.1984.14; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Taoka Y, 1997, J NEUROSURG, V86, P1007, DOI 10.3171/jns.1997.86.6.1007; TERAWAKI T, 1998, EUR J PHARMACOL, V152, P63; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; WESTCOTT JY, 1987, PROSTAGLANDINS, V34, P877, DOI 10.1016/0090-6980(87)90068-2; WU NZ, 1992, MICROVASC RES, V44, P334, DOI 10.1016/0026-2862(92)90092-4; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	56	31	32	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2003	20	5					447	461		10.1089/089771503765355522			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	682MY	WOS:000183096900005	12803977				2022-02-06	
J	Reichard, RR; White, CL; Hladik, CL; Dolinak, D				Reichard, RR; White, CL; Hladik, CL; Dolinak, D			Beta-amyloid precursor protein staining of nonaccidental central nervous system injury in pediatric autopsies	JOURNAL OF NEUROTRAUMA			English	Article						beta-amyloid precursor protein; brain; diffuse axonal injury; immunohistochemistry; pediatric	DIFFUSE AXONAL INJURY; INFLICTED HEAD-INJURY; SHAKEN-BABY SYNDROME; BRAIN TRAUMA; NEUROPATHOLOGY; INFANTS; DAMAGE; DIAGNOSIS	Immunohistochemical staining for beta-amyloid precursor protein (betaAPP) is a well-established marker of traumatic axonal injury in adults. Recent studies have used similar techniques to evaluate nonaccidental central nervous system injury (NAI) in infants and young children. In this prospective study, we report the results of betaAPP immunohistochemistry on the brain and spinal cord in 28 pediatric cases of NAI. betaAPP-immunoreactive axons were present in 27/28 cases. Vascular axonal injury (VAI) due to brain swelling and secondary vascular compromise was the most common pattern of betaAPP immunoreactivity and was detected in 22 of 28 cases. Traumatic axonal injury was detected in 19/28 cases, although only eight of these cases showed brainstem staining, thus fulfilling the criteria for the diagnosis of diffuse traumatic axonal injury (dTAI). TAI and VAI were both present in 16/28 cases. Isolated TAI and VAI occurred in three and five cases, respectively. All children with isolated VAI were <18 months of age. An additional finding highlighted by PAPP immunostaining was a penumbra of axonal injury adjacent to focal lesions, such as lacerations. We conclude that betaAPP immunohistochemistry aids in documenting trauma in nonaccidental central nervous system injury in infants and young children and that VAI is a common finding.	SW Inst Forens Sci, Dallas, TX USA; Univ Texas, SW Med Sch, Dept Pathol, Immunohistochem Labs, Dallas, TX 75230 USA; Univ Texas, SW Med Sch, Dept Pathol, Neuropathol Lab, Dallas, TX 75230 USA		Reichard, RR (corresponding author), 922 Varian Way, Palo Alto, CA 94304 USA.		White, Charles L/AAJ-1858-2021	White, Charles L/0000-0002-3870-2804			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Dolinak D, 2000, NEUROPATH APPL NEURO, V26, P448, DOI 10.1046/j.1365-2990.2000.00273.x; Dolinak D, 2000, ACTA NEUROPATHOL, V100, P553, DOI 10.1007/s004010000218; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P197; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Reichard RR, 2003, J NEUROPATH EXP NEUR, V62, P237, DOI 10.1093/jnen/62.3.237; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185	20	31	31	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2003	20	4					347	355		10.1089/089771503765172309			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	673YY	WOS:000182609900004	12866814				2022-02-06	
J	Hillary, FG; Schultheis, MT; Challis, BH; Millis, SR; Carnevale, GJ; Galshi, T; DeLuca, J				Hillary, FG; Schultheis, MT; Challis, BH; Millis, SR; Carnevale, GJ; Galshi, T; DeLuca, J			Spacing of repetitions improves learning and memory after moderate and severe TBI	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DEFICITS; RECALL; PERFORMANCE; RETRIEVAL; SCALE	Extensive research has determined that new learning in healthy individuals is significantly improved when trials are distributed over time (spaced presentation) compared to consecutive learning trials (massed presentation). This phenomenon known as the "spacing effect" (SE) has been shown to enhance verbal and nonverbal learning in healthy adults of different ages and in different memory paradigms (e.g., recognition, recall, etc.). The purpose of this study was to examine whether learning in adults with moderate and severe traumatic brain injury (TBI) is improved using a spacing-of-repetitions procedure. Using a within-groups design, participants with TBI (n = 20) were presented a list of 115 words that were presented either once (single condition), twice consecutively (massed condition), or twice with 11 words between presentations (spaced condition). Participants were required to rank each word from 1 to 10 according to their familiarity with the word; they were not asked to "memorize" words for a later test. Word list learning was measured with a free recall test immediately following list presentation and with free recall and recognition tests after a 30-min delay. Participants recalled and recognized significantly more spaced words than massed words during this word list learning task. These results strongly indicate that the spacing of repetitions improves learning and memory in individuals who have sustained moderate to severe TBI. Implications for rehabilitation are discussed.	Kessler Med Rehabil Res & Educ Corp, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; Johnson & Johnson Pharmaceut Res & Dev LLC, New Brunswick, NJ USA; Kessler Inst Rehabil, W Orange, NJ USA		DeLuca, J (corresponding author), Kessler Med Rehabil Res & Educ Corp, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jdeluca@kmrrec.org	Hillary, Frank/AAN-8622-2021	Schultheis, Maria/0000-0002-6558-548X	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD07522] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133P970011] Funding Source: Medline		ALDENKAMP AP, 1991, J NEUROPSYCHOLOGICAL, V1, P199; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; BERGMAN MM, 1998, INT J COGNITIVE TECH, V3, P45; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Braun K, 1998, MEMORY, V6, P37; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Cermak LS, 1996, NEUROPSYCHOLOGY, V10, P219; CHALLIS BH, 1993, J EXP PSYCHOL LEARN, V19, P115, DOI 10.1037/0278-7393.19.1.115; CHALLIS BH, 1993, J EXP PSYCHOL LEARN, V19, P389, DOI 10.1037/0278-7393.19.2.389; CHIARAVALOTTI ND, IN PRESS CLIN REHABI; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dempster F. N., 1990, J RES DEV EDUC, V23, P97; DEMPSTER FN, 1988, AM PSYCHOL, V43, P627, DOI 10.1037/0003-066X.43.8.627; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Ebbinghaus, 1964, MEMORY CONTRIBUTION; GAY LR, 1973, J EDUC PSYCHOL, V64, P171, DOI 10.1037/h0034595; GLENBERG AM, 1979, MEM COGNITION, V7, P95, DOI 10.3758/BF03197590; GREENE RL, 1989, J EXP PSYCHOL LEARN, V15, P371, DOI 10.1037/0278-7393.15.3.371; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hintzman D, 1974, THEORIES COGNITIVE P; KEARCOLWELL JJ, 1980, J CLIN PSYCHOL, V36, P782, DOI 10.1002/1097-4679(198007)36:3<782::AID-JCLP2270360334>3.0.CO;2-K; KRUG D, 1990, J EDUC PSYCHOL, V82, P366, DOI 10.1037/0022-0663.82.2.366; LEZAK MD, 1998, NEUROPSYCHOLOGICAL A; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; PRIGATANO GP, 1999, PRINCIPLES NEUROPSYC, P256; ROEDIGER HL, 1992, J EXP PSYCHOL LEARN, V18, P3, DOI 10.1037/0278-7393.18.1.3; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; Russo R, 1998, J EXP PSYCHOL LEARN, V24, P161, DOI 10.1037/0278-7393.24.1.161; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	34	31	31	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	2003	25	1					49	58		10.1076/jcen.25.1.49.13631			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	666YD	WOS:000182203300005	12607171				2022-02-06	
J	Coelho, C; Flewellyn, L				Coelho, C; Flewellyn, L			Longitudinal assessment of coherence in an adult with fluent aphasia: A follow-up study	APHASIOLOGY			English	Article							DISCOURSE	Background: It has been suggested that individuals with fluent aphasia demonstrate microlinguistic impairments and relatively preserved macrolinguistic abilities (Glosser & Deser, 1990). However, results of a previous study in which measures of sentence production, intersentential cohesion, and story grammar were assessed longitudinally over a period of 12 months did not support this contention (Coelho, Liles, Duffy, Clarkson, & Elia, 1994). In that investigation, as the individual with fluent aphasia recovered severity of aphasia decreased and microlinguistic abilities improved, but macrolinguistic skills remained quite limited. Aims: The present study sought to clarify the discrepancy between these two studies by re-analysing the narrative samples collected by Coelho et al. for adequacy of coherence in order for similar macrolinguistic measures to be compared across studies. Methods & Procedures: Two types of story narratives were elicited from a 55-year-old male with mild-moderate anomic aphasia on a monthly basis over a 12-month period. Story narratives were analysed for local and global coherence, and coherence ratings were compared to the mean performance of three matched non-brain-injured participants. Outcomes & Results: Neither local or global coherence improved appreciably over the 12-month period and both remained moderately impaired, inspite of gains noted in microlinguistic abilities. The individual with fluent aphasia also consistently demonstrated greater difficulties with global than local coherence. Conclusions: This pattern of impaired macrolinguistic abilities, is consistent with that of individuals with Alzheimer's disease and closed head injuries, and suggests that difficulty with discourse organisation may result from focal as well as diffuse brain pathology. These findings suggest the importance of expanding assessment procedures for individuals with aphasia, particularly mild aphasia, to include macrolinguistic dimensions of discourse organisation such as the analysis of coherence and story grammar-and further, that such macrolinguistic abilities need to addressed specifically in language therapy.	Univ Connecticut, Dept Commun Sci, Storrs, CT 06269 USA; Hosp Special Care, New Britain, CT USA		Coelho, C (corresponding author), Univ Connecticut, Dept Commun Sci, Unit 1085, Storrs, CT 06269 USA.	coelho@uconn.edu					COELHO CA, 1994, CLIN APHASIOL, V22, P145; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; GLOSSER G, 1993, NARRATIVE DISCOURSE; Goodglass H, 1983, ASSESSMENT APHASIA R; HOLLINGSHEAD A, 1972, UNPUB 4 FACTOR INDEX; HUNT K, 1970, MONOGRAPHS SOC RES C, V134; PORCH BE, 1984, PORCH INDEX COMMUNIC; Ulatowska Hanna K., 1990, DISCOURSE ABILITY BR, P180, DOI 10.1007/978-1-4612-3262-9_8; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; WINTER P, 1976, BEAR FLY	10	31	33	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2003	17	2					173	182		10.1080/729255216			10	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	641UK	WOS:000180765100006					2022-02-06	
J	Soukiasian, HJ; Hui, T; Avital, I; Eby, J; Thompson, R; Kleisli, T; Margulies, DR; Cunneen, S				Soukiasian, HJ; Hui, T; Avital, I; Eby, J; Thompson, R; Kleisli, T; Margulies, DR; Cunneen, S			Decompressive craniectomy in trauma patients with severe brain injury	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Meeting of the Southern-California-Chapter of the American-College-of-Surgeons	JAN 18-20, 2002	SANTA BARBARA, CA	Amer Coll Surg, SO Calif Chapter			CEREBRAL EDEMA; HEAD-INJURY; MANAGEMENT	Decompressive craniectomy in the treatment of severe traumatic brain injury (TBI) is controversial. We conducted a retrospective review of prospectively collected data on all patients requiring surgery for TBI from 1995 through 2001 at Cedars-Sinai Medical Center. Patients were separated into two groups: Group A, craniectomy, and Group B, craniotomy. We had 120 patients; 24 (20%) had craniectomy and 96 (80%) had craniotomy. There were no significant differences in demographics or Injury Severity Scores. The craniectomy group had significantly more TBI as evidenced by more frequently collapsed basilar cisterns on CT scan (P = 0.0001). There was no significant difference in actuarial survival between the groups: 52.8 per cent in the craniectomy group and 79.2 per cent in the craniotomy group (P = 0.08). Calculated mortality for craniectomy was 37.5 percent versus 18.8 per cent for craniotomy (P = NS). We found four preoperative findings to be significant predictors of mortality: 1) Glasgow Coma Scale score, 2) Injury Severity Score, 3) Simplified Acute Physiology Score, and 4) Acute Physiology and Chronic Health Evaluation II. The type of surgery was not found to be a significant predictor of death even when adjusted for severity of injury. Craniectomy may be helpful for patients with TBI associated with preoperative CT scan evidence of basilar cistern collapse. This is evidenced by similar survival rates between the two groups despite clinical evidence of greater TBI among craniectomy patients.	Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA		Soukiasian, HJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215, Los Angeles, CA 90048 USA.						CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; GAAB M, 1979, CHILD BRAIN, V5, P484; GAAB MR, 1990, ACT NEUR S, V51, P326; GERL A, 1980, Zentralblatt fuer Neurochirurgie, V41, P125; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hieu PD, 1996, CHILD NERV SYST, V12, P270; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ogawa M, 1974, Med J Osaka Univ, V25, P73; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; RINALDI A, 1990, ACT NEUR S, V51, P394; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; WHITFIELD P, 1995, STROKE, V26, P1125; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717	24	31	33	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	DEC	2002	68	12					1066	1071					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	629WE	WOS:000180074100008	12516810				2022-02-06	
J	Gray, WP; May, K; Sundstrom, LE				Gray, WP; May, K; Sundstrom, LE			Seizure induced dentate neurogenesis does not diminish with age in rats	NEUROSCIENCE LETTERS			English	Article						seizures; neurogenesis; age; dentate gyrus	ADULT-RAT; GRANULE CELLS; GYRUS; HIPPOCAMPUS; PROLIFERATION; NEURONS; REORGANIZATION; APOPTOSIS	Neurogenesis in the mammalian dentate gyrus occurs throughout I if e, is believed to be important for the laying down of episodic memory and diminishes significantly with increasing age. Pathological insults such as seizures, hypoxia and traumatic brain injury increase dentate neurogenesis compared to age matched controls. Using unilateral intracerebroventricular kainate we show that although baseline neurogenesis is significantly lower in 3 month old rats compared to 1 month old rats, kainate increases neurogenesis to reach similar levels in both age groups. Additionally, this effect is bilateral after a unilateral intracerebroventricular kainate injection. We conclude that the potential for dentate neurogenesis is maintained despite diminishing baseline levels with increasing age and that injury signals override the age related suppression of neurogenesis. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Univ Southampton, Sch Biomed Sci, Div Clin Neurosci, Southampton SO16 7PX, Hants, England		Gray, WP (corresponding author), Univ Southampton, Sch Biomed Sci, Div Clin Neurosci, Bassett Crescent E, Southampton SO16 7PX, Hants, England.			Gray, William/0000-0001-7595-8887			ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Cameron H, 1996, J COMP NEUROL, V369, P56, DOI 10.1002/(SICI)1096-9861(19960520)369:1<56::AID-CNE4>3.0.CO;2-J; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LEWIS PD, 1978, NEUROPATH APPL NEURO, V4, P191, DOI 10.1111/j.1365-2990.1978.tb00536.x; Long JM, 1998, NEUROBIOL AGING, V19, P497, DOI 10.1016/S0197-4580(98)00088-8; Nacher J, 2001, EUR J NEUROSCI, V13, P512, DOI 10.1046/j.0953-816x.2000.01424.x; Parent JM, 1997, J NEUROSCI, V17, P3727; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SUNDSTROM LE, 1993, BRAIN RES, V609, P321, DOI 10.1016/0006-8993(93)90890-Y; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a	20	31	32	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	SEP 27	2002	330	3					235	238	PII S0304-3940(02)00810-8	10.1016/S0304-3940(02)00810-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611HP	WOS:000179010800006	12270636				2022-02-06	
J	Chan, RCK; Manly, T				Chan, RCK; Manly, T			The application of "dysexecutive syndrome" measures across cultures: Performance and checklist assessment in neurologically healthy and traumatically brain-injured Hong Kong Chinese volunteers	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						assessment; dysexecutive syndromes; brain injury; cultures	COGNITIVE-FAILURES-QUESTIONNAIRE; TEMPORAL-LOBE LESIONS; FRONTAL-LOBE; EXECUTIVE FUNCTIONS; PLANNING ABILITY; MEMORY; DAMAGE; DISORGANIZATION; VALIDITY; HUMANS	Deficits in planning, self-regulation and attention are a relatively common consequence of traumatic brain injury (TBI). Such "dysexecutive" deficits tend to be most exposed in complex, real world situations. Consequently, clinicians often have to rely on interviews, questionnaires and observation in their assessments. While there is little doubt that dysexecutive symptoms occur across different cultures, the expression of those symptoms, the way in which they are experienced by others, and the propensity of friends/relatives to report negative features may vary considerably. The cross-cultural use of standardized checklists and measures that have predominantly been studied with English speaking, Western groups therefore requires empirical support. Here a group of 68 healthy Chinese speaking volunteers were asked to complete translations of 2 UK developed questionnaires (the Dysexecutive Questionnaire and Cognitive Failures Questionnaire) measures and to perform 2 "executive" tasks (The Six Elements Test and the Tower of Hanoi). Their self ratings and the ratings of close relatives were very close to those seen in the original UK standardization samples-as was their performance on the 2 tasks. Accordingly, the conditions for assessing their clinical sensitivity were met. Comparison between 30 Chinese patients with TBI and matched controls showed that both questionnaires and tests were sensitive to the deficits in this group.	Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; MRC, Cognit & Brain Sci Unit, Cambridge, England		Chan, RCK (corresponding author), Univ Hong Kong, Dept Psychiat, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.						Arnett PA, 1997, NEUROPSYCHOLOGY, V11, P535, DOI 10.1037/0894-4105.11.4.535; Benson D.F., 1986, FRONTAL LOBES; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; DAUM I, 1995, CORTEX, V31, P413, DOI 10.1016/S0010-9452(13)80057-3; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; GEOL V, 1995, NEUROPSYCHOLOGIA, V33, P623; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Humes GE, 1997, ASSESSMENT, V4, P249, DOI 10.1177/107319119700400305; Larson GE, 1997, BRIT J PSYCHOL, V88, P29, DOI 10.1111/j.2044-8295.1997.tb02618.x; LHERMITTE F, 1986, ANN NEUROL, V19, P335, DOI 10.1002/ana.410190405; Long, 1996, ECOLOGICAL VALIDITY, P15; Luria A.R., 1966, HIGHER CORTICAL FUNC; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P52; Morris RG, 1997, COGN NEUROPSYCHOL, V14, P1007, DOI 10.1080/026432997381330; Morris RG, 1997, NEUROPSYCHOLOGIA, V35, P1147, DOI 10.1016/S0028-3932(97)00009-2; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Norman D., 1980, ATTENTION ACTION WIL; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; SCHWARTZ MF, 1991, COGN NEUROPSYCHOL, V8, P381, DOI 10.1080/02643299108253379; Schwartz MF, 1995, ANN NY ACAD SCI, V769, P321, DOI 10.1111/j.1749-6632.1995.tb38148.x; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T., 1988, NEUROPSYCHOLOGY MENT; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; TEASDALE G, 1974, LANCET, V2, P81; WHYTE J, 1994, AM J PHYS MED REHAB, V73, P2	35	31	32	1	8	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4221 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2002	8	6					771	780		10.1017/S1355617702860052			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	592CZ	WOS:000177920300005	12240741	Green Published			2022-02-06	
J	Dumas, HM; Haley, SM; Ludlow, LH; Rabin, JP				Dumas, HM; Haley, SM; Ludlow, LH; Rabin, JP			Functional recover in pediatric traumatic brain injury during inpatient rehabilitation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						inpatient; rehabilitation; pediatrics; outcome measure; brain injuries; function recovery	HEAD-INJURY; FOLLOW-UP; CHILDREN; SEVERITY	Objective: To examine changes in functional status of children with traumatic brain injury by identifying the pattern and amount of change between and within the domains of self-care, mobility, and social function during inpatient rehabilitation and to examine the relationships of age and injury severity to functional recovery. Design: Retrospective descriptive study. Seventy-nine children and adolescents with traumatic brain injury were assessed at inpatient rehabilitation hospital admission and discharge by using the Pediatric Evaluation of Disability Inventory's (PEDI) functional skills and caregiver assistance domains of self-care, mobility, and social function. Results: Admission self-care functional levels were significantly greater than mobility and social function for both PEDI scales. At discharge, significant improvement was noted within all three domains and the amount of change between domains was significantly greater for the mobility domain on both scales. Age was not related to the amount of recovery. Admission functional status was moderately negatively correlated to the change in PEDI scores (ranging from r = -0.432 to -0.681). Conclusions: Variations exist in the recovery of self-care, mobility, and social function capability and independence during inpatient rehabilitation. Self-care was the least affected. Participants showed significant improvement In all domains, with the most recovery in mobility. Children with greater functional deficits demonstrated greater functional gains.	Franciscan Childrens Hosp, Rehabil Ctr, Boston, MA 02135 USA; Res Ctr Children Special Hlth Care Needs, Boston, MA USA; Inpatient Phys Rehabil Program, Boston, MA USA; Boston Univ, Ctr Rehabil Effectiveness, Sargent Coll Hlth & Rehabil Sci, Boston, MA 02215 USA; Boston Coll, Lynch Coll Educ, Chestnut Hill, MA 02167 USA		Dumas, HM (corresponding author), Franciscan Childrens Hosp, Rehabil Ctr, 30 Warren St, Boston, MA 02135 USA.						Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BURKE W H, 1990, Brain Injury, V4, P371, DOI 10.3109/02699059009026190; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Haley S, 1992, PEDIAT EVALUATION DI; HALEY SM, 1992, PEDIAT PHYS THERAPY, V4, P24; HALEY SM, 1991, PEDIATRIC PHYSICAL T, V3, P177; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; KRIEL RL, 1993, PEDIATR NEUROL, V9, P362, DOI 10.1016/0887-8994(93)90104-K; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Nichols DS., 1996, PEDIATR PHYS THER, V8, P15, DOI DOI 10.1097/00001577-199600810-00004; OSBERG JS, 1990, AM J PHYS MED REHAB, V69, P67, DOI 10.1097/00002060-199004000-00004; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; Wright FV, 1993, CAN J REHABIL, V7, P41	29	31	31	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP	2002	81	9					661	669		10.1097/00002060-200209000-00005			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	587UD	WOS:000177661000004	12172518				2022-02-06	
J	Montgomery, V; Oliver, R; Reisner, A; Fallat, ME				Montgomery, V; Oliver, R; Reisner, A; Fallat, ME			The effect of severe traumatic brain injury on the family	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						head injury; trauma; children; family	PEDIATRIC TRAUMA; HEAD-INJURY; CHILDREN; COHORT; RECOVERY	Background: The effects of traumatic brain injury on family dynamics and finances have not been extensively studied. We designed a 30-item survey to determine the effects of the injury on the child, parent(s), and siblings, and whether parents were retrospectively content with the decisions related to aggressiveness of care. Methods: A questionnaire written on a sixth-grade reading level was mailed to 46 families of children who survived a traumatic brain injury resulting in an initial Glasgow Coma Scale score less than or equal to 7. This is a descriptive study without statistical analysis. Human Studies Committee review and informed consent were obtained. Results: Thirty-two of 46 (69.6%) surveys were completed by mail or telephone. Mean patient age at time of injury was 8.7 years, mean time since injury was 3 years, and mean Glasgow Coma Scale score was 3.7. Approximately one third of children have disabilities related to education, socialization, and/or self-care skills; require multiple health care visits each month; and require prescription medications. Over one third of families were impacted in a moderate to profoundly negative way; 30% of families reported a deterioration in finances or loss of job; and 16% reported a worsening of adult relationships. In 13 of 32 cases, modification of current housing or new housing was required to facilitate home care. Siblings were adversely affected in approximately 16 of 28 families, exhibiting behavioral problems, increased fear, and withdrawal from the injured child. Only 1 of 32 families stated that they would have considered less aggressive treatment, even if it led to the child's death. Conclusion: Traumatic brain injury of a child had a negative impact on family dynamics and/or sibling behavior in more than one third of families. Despite this, most families would not limit or withdraw care if they could reconsider decisions regarding treatment. This information can be used to counsel families.	Childrens Hlth Care Atlanta, Dept Neurosurg, Atlanta, GA USA; Kosair Childrens Hosp, Off Pastoral Care, Louisville, KY USA; Univ Louisville, Div Pediat Surg, Dept Surg, Louisville, KY 40292 USA; Univ Louisville, Dept Pediat, Louisville, KY 40292 USA		Fallat, ME (corresponding author), 233 E Gray St,Suite 708, Louisville, KY 40202 USA.						BARRY P, 1992, Brain Injury, V6, P229, DOI 10.3109/02699059209029664; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HARRIS BH, 1989, J PEDIATR SURG, V24, P103, DOI 10.1016/S0022-3468(89)80311-2; HU XH, 1993, CAN MED ASSOC J, V149, P421; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; OATES W, 1981, YOUR PARTICULAR GRIE; Osberg JS, 1996, PEDIATRICS, V98, P890; RESNICK C, 1993, SOC WORK HEALTH CARE, V18, P49, DOI 10.1300/J010v18n02_03; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015	21	31	33	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2002	52	6					1121	1124		10.1097/00005373-200206000-00016			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	562KJ	WOS:000176195700023	12045640				2022-02-06	
J	Grasso, G; Passalacqua, M; Sfacteria, A; Conti, A; Morabito, A; Mazzullo, G; De Vico, G; Buemi, M; Macri, B; Tomasello, F				Grasso, G; Passalacqua, M; Sfacteria, A; Conti, A; Morabito, A; Mazzullo, G; De Vico, G; Buemi, M; Macri, B; Tomasello, F			Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage?	JOURNAL OF NEUROSURGERY			English	Article						erythropoietin; S-100 protein; subarachnoid hemorrhage; rabbit	MINOR HEAD-INJURY; TRAUMATIC BRAIN-DAMAGE; IN-VIVO EVIDENCE; ACUTE VASOCONSTRICTION; SERUM MARKER; ACUTE STROKE; RECEPTOR; CELLS; RATS; INFARCTION	Object. Results of recent studies indicate that erythropoietin (EPO) produces a neuroprotective effect on experimental subarachnoid hemorrhage (SAH). It has been reported that S-100 protein levels increase in cerebrospinal fluid (CSF) after SAH, providing a highly prognostic indication of unfavorable outcome. This study was conducted to validate further the findings of S-100 protein as an index of brain damage and to assess whether treatment with recombinant human EPO (rhEPO) would limit the increase of S-100 protein level in CSF following experimental SAH. Methods. Thirty-two rabbits were each assigned to one of four groups: Group 1, control; Group 2, SAH; Group 3, SAH plus placebo; and Group 4, SAH plus rhEPO (each group consisted of eight rabbits). The rhEPO and placebo were administered to the rabbits after SAH had been induced, and S-100 protein levels in the CSF of these animals were measured at 24, 48, and 72 hours after the experimental procedure. In each group of animals levels of S-100 protein were compared with the mortality rate, neurological outcome, and neuronal ischemic damage. High S-100 protein levels were found in rabbits in Groups 2 and 3, which exhibited poor neurological status and harbored a high number of damaged cortical neurons. Favorable neurological outcome and significant reductions in total numbers of damaged neurons were observed in animals in Group 4 in which there were significantly lower S-100 protein concentrations compared with animals in Groups 2 and 3 (p < 0.001). Conclusions. The results of this study support the concept that determination of the S-100 protein level in CSF has prognostic value after SAH. The findings also confirm that rhEPO acts as a neuroprotective agent during experimental SAH.	Univ Messina, Policlin Univ, Dept Neurosurg, I-98122 Messina, Italy; Univ Messina, Dept Vet Pathol, I-98122 Messina, Italy; Univ Messina, Dept Internal Med, I-98122 Messina, Italy		Grasso, G (corresponding author), Univ Messina, Policlin Univ, Dept Neurosurg, Via Consolare Valeria 1, I-98122 Messina, Italy.		De Vico, Gionata/N-7268-2016; Conti, Alfredo/H-3022-2019; Sfacteria, Alessandra/AAK-1839-2020; grasso, giovanni/K-3774-2018; Morabito, Antonino/AAB-3265-2019	De Vico, Gionata/0000-0001-5953-4160; Conti, Alfredo/0000-0002-9408-2662; grasso, giovanni/0000-0001-5362-0092; Morabito, Antonino/0000-0002-5323-3620			Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P546, DOI 10.1177/000456329703400510; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; ALLCOCK JM, 1965, J NEUROSURG, V22, P21, DOI 10.3171/jns.1965.22.1.0021; Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BUEMI M, 1993, NEPHRON, V65, P440, DOI 10.1159/000187526; Buemi M, 2000, EUR J PHARMACOL, V392, P31, DOI 10.1016/S0014-2999(00)00081-9; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; ENDO S, 1988, STROKE, V19, P1420, DOI 10.1161/01.STR.19.11.1420; GARCIA JH, 1978, ACTA NEUROPATHOL, V43, P85; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Grasso G, 2001, J Neurosurg Sci, V45, P7; HAIMOTO H, 1987, LAB INVEST, V57, P489; HARDEMARK HG, 1989, ACTA NEUROCHIR, V99, P135, DOI 10.1007/BF01402322; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; ISOBE T, 1977, BIOCHIM BIOPHYS ACTA, V494, P222, DOI 10.1016/0005-2795(77)90150-7; JACOBSON LO, 1957, NATURE, V179, P633, DOI 10.1038/179633a0; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Kim JS, 1996, STROKE, V27, P1553, DOI 10.1161/01.STR.27.9.1553; MASUDA S, 1994, J BIOL CHEM, V269, P19488; MASUDA S, 1993, J BIOL CHEM, V268, P11208; MCQUEEN JD, 1967, ARCH NEUROL-CHICAGO, V16, P501, DOI 10.1001/archneur.1967.00470230053007; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Morishita E, 1996, BLOOD, V88, P465, DOI 10.1182/blood.V88.2.465.bloodjournal882465; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; PERSSON L, 1988, ACTA NEUROCHIR, V93, P116, DOI 10.1007/BF01402892; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Sadamoto Y, 1998, BIOCHEM BIOPH RES CO, V253, P26, DOI 10.1006/bbrc.1998.9748; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sehba FA, 1999, STROKE, V30, P1955, DOI 10.1161/01.STR.30.9.1955; STEFANSSON K, 1982, NATURE, V295, P63, DOI 10.1038/295063a0; TAKAYASU M, 1985, J NEUROSURG, V63, P417, DOI 10.3171/jns.1985.63.3.0417; UMANSKY F, 1983, J NEUROSURG, V58, P210, DOI 10.3171/jns.1983.58.2.0210; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yoon WH, 1997, RES COMMUN MOL PATH, V96, P227; ZANJANI ED, 1977, J LAB CLIN MED, V89, P640	43	31	34	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	2002	96	3					565	570		10.3171/jns.2002.96.3.0565			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	525ZN	WOS:000174104100015	11883842				2022-02-06	
J	Pettersen, JA				Pettersen, JA			Does rugby headgear prevent concussion? Attitudes of Canadian players and coaches	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INJURY; PERFORMANCE	Objectives: To examine the attitudes of players and coaches to the use of protective headgear, particularly with respect to the prevention of concussion. Methods: A questionnaire designed to assess attitudes to headgear was administered to 63 players from four different Canadian teams, each representing a different level of play (high school, university, community club, national). In addition, coaches from all four levels were questioned about team policies and their personal opinions about the use of headgear to prevent concussion. Results: Although the players tended to believe that the headgear could prevent concussion (62%), the coaches were less convinced (33%). Despite the players' belief that headgear offers protection against concussion, only a minority reported wearing headgear (27%) and few (24%) felt that its use should be made mandatory. Common reasons for not wearing headgear were "its use is not mandatory", "it is uncomfortable", and "it costs too much". Conclusion: Although most players in the study believe that rugby headgear may prevent concussion, only a minority reported wearing it. Coaches tended to be less convinced than the players that rugby headgear can prevent concussion.	Univ Toronto, Toronto, ON, Canada		Pettersen, JA (corresponding author), Foothills Prov Gen Hosp, Dept Clin Neurosci, 1403-29th St NW, Calgary, AB T2N 2T9, Canada.						Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Finch CF, 2001, BRIT J SPORT MED, V35, P89, DOI 10.1136/bjsm.35.2.89; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GERRARD DF, 1994, BRIT J SPORT MED, V28, P229, DOI 10.1136/bjsm.28.4.229; GRONWALL D, 1975, LANCET, V2, P995; Gronwall D, 1989, MILD HEAD INJURY, P153; *IRB, 1996, LAW 4M 98G STAND PER; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MARIADAS AC, 1989, NIMHANS J, V7, P37; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Pettersen JA, 2000, PSYCHOBIOLOGY, V28, P81; ROY S, 1974, S AFR MED J, V2, P2321; Wilson BD, 1998, SPORTS MED, V25, P333, DOI 10.2165/00007256-199825050-00005; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	19	31	32	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	FEB	2002	36	1					19	22		10.1136/bjsm.36.1.19			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	521YU	WOS:000173869600009	11867487	Green Published, Bronze			2022-02-06	
J	Bolan, B; Foster, JK; Schmand, B; Bolan, S				Bolan, B; Foster, JK; Schmand, B; Bolan, S			A comparison of three tests to detect feigned amnesia: The effects of feedback and the measurement of response latency	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SIMULATED MEMORY IMPAIRMENT; DIGIT RECOGNITION TEST; FORCED-CHOICE METHOD; HEAD-INJURY; SYMPTOM VALIDITY; NEUROPSYCHOLOGICAL TESTS; PSYCHOLOGICAL-TESTS; MALINGERING TOMM; DEFICITS	Three experiments provided validation data for an English language version of the Amsterdam Short Term Memory Test (ASTM test) developed to detect feigned memory impairment. Using a simulation design, the ASTM test compared favourably with the Test of Memory Malingering (TOMM) and appeared better than a newly-devised Digit Recognition Test (DRT). Feedback on the correctness of responses had no significant effect on performance but notable trends were apparent. Simulators were significantly slower than controls on computerised versions of the ASTM test and the TOMM. Convergent findings indicate that the English language version of the ASTM test may be useful in detecting malingering.	Univ Western Australia, Dept Psychol, Perth, WA 6009, Australia; Univ Manchester, Dept Psychol, Manchester M13 9PL, Lancs, England; Acad Med Centrum, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; Univ Manchester, Dept Comp Sci, Manchester M13 9PL, Lancs, England		Foster, JK (corresponding author), Univ Western Australia, Dept Psychol, Perth, WA 6009, Australia.						Back C., 1996, ASSESSMENT, V3, P449, DOI [https://doi.org/10.1177/107319119600300411, DOI 10.1177/107319119600300411]; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; CERCY SP, 1997, CLIN ASSESSMENT MALI; Christensen L.B., 1991, EXPT METHODOLOGY, V5th; Conover W.J., 1998, PRACTICAL NONPARAMET; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Heubrock D, 1998, EUR J PSYCHOL ASSESS, V14, P211, DOI 10.1027/1015-5759.14.3.211; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; PANKRATZ L, 1979, J CONSULT CLIN PSYCH, V47, P409, DOI 10.1037/0022-006X.47.2.409; Pankratz L., 1997, CLIN ASSESSMENT MALI; Prigatano GP, 1997, ARCH CLIN NEUROPSYCH, V12, P609, DOI 10.1016/S0887-6177(97)00020-6; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rogers R., 1997, CLIN ASSESSMENT MALI; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; SCHMAND B, UNPUB AMSTERDAM SHOR; Schmand B., 1999, AMSTERDAMSE KORTE TE; Schwartz SM, 1998, INT J LAW PSYCHIAT, V21, P261, DOI 10.1016/S0160-2527(98)00004-1; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	46	31	31	0	9	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2002	24	2					154	167		10.1076/jcen.24.2.154.1000			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	549MN	WOS:000175448100003	11992198				2022-02-06	
J	Farmer, JE; Kanne, SM; Haut, JS; Williams, J; Johnstone, B; Kirk, K				Farmer, JE; Kanne, SM; Haut, JS; Williams, J; Johnstone, B; Kirk, K			Memory functioning following traumatic brain injury in children with premorbid learning problems	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	Annual Meeting of the International-Neuropsychological-Society	FEB 14-17, 1996	CHICAGO, IL	Int Neuropsychol Soc, US PHS, Natl Inst Aging, Alzheimers Dis Cooperat Study			WIDE-RANGE ASSESSMENT; HEAD-INJURY; RECOVERY	This study examines the memory functioning of 25 children who sustained a traumatic brain injury (TBI) and who had prior learning problems, 48 children with TBI who did not have prior learning problems, and 23 noninjured controls. The children with TBI and prior learning problems displayed significantly worse memory abilities than both the control participants and the children with TBI and no prior learning problems They differed significantly from these 2 groups on measures of general memory, verbal memory, sound-symbol learning, and attention. The results suggest that children with premorbid learning problems who sustain TBI have less cognitive reserve and a lower threshold for the expression of cognitive impairments in areas that reflect preexisting learning and language problems, compared to children without premorbid learning problems.	Univ Missouri, Sch Med, Columbia, MO USA; W Virginia Univ, Hlth Sci Ctr, Morgantown, WV 26506 USA; Univ Arkansas, Med Ctr, Fayetteville, AR 72701 USA		Johnstone, B (corresponding author), DCO4646,1 Hosp Dr, Columbia, MO 65212 USA.	farmerje@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649			ADAMS W, 1991, 11 ANN M NAT AC NEUR; AYLWARD GP, 1995, J PSYCHOEDUC ASSESS, V13, P132, DOI 10.1177/073428299501300203; BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Begali V., 1992, HEAD INJURY CHILDREN; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; Burton DB, 1999, CHILD NEUROPSYCHOL, V5, P34, DOI 10.1076/chin.5.1.34.7077; CALLAHAN TS, 1993, 101 ANN M AM PSYCH A; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; Donders J, 1997, Pediatr Rehabil, V1, P179; Donders J, 2000, J HEAD TRAUMA REHAB, V15, P792, DOI 10.1097/00001199-200004000-00004; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FEAGANS L, 1993, CURRENT TOPICS HUMAN, V3, P121; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; Kramer JH, 1997, NEUROPSYCHOLOGY, V11, P577, DOI 10.1037/0894-4105.11.4.577; Kramer JH, 2000, ARCH CLIN NEUROPSYCH, V15, P83, DOI 10.1016/S0887-6177(99)00022-0; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; MCBRIDECHANG C, 1995, EDUC PSYCHOL, V30, P109, DOI 10.1207/s15326985ep3003_2; *NAT PED TRAUM REG, 2000, PHAS 3; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; Prior M., 1996, UNDERSTANDING SPECIF; Sattler J. M., 1988, ASSESSMENT CHILDREN; Savage R. C., 1994, ED DIMENSIONS ACQUIR; Sheslow D., 1990, MANUAL WIDE RANGE AS; SWANSON HL, 1998, LEARNING LEARNING DI, P107; TEPAS JJ, 1989, J PEDIATR SURG, V24, P81; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Wong B.Y, 1998, LEARNING LEARNING DI, P203; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	36	31	31	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2002	22	2					455	469		10.1207/S15326942DN2202_2			15	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	635ER	WOS:000180385900002	12537333				2022-02-06	
J	Kushimoto, S; Yamamoto, Y; Shibata, Y; Sato, H; Koido, Y				Kushimoto, S; Yamamoto, Y; Shibata, Y; Sato, H; Koido, Y			Implications of excessive fibrinolysis and alpha(2)-plasmin inhibitor deficiency in patients with severe head injury	NEUROSURGERY			English	Article						alpha(2)-plasmin inhibitor; fibrinogenolysis; fibrinolysis; head injury; intravascular coagulation; plasmin	SOMATOSENSORY-EVOKED-POTENTIALS; TRAUMATIC BRAIN INJURY; ALPHA-2-PLASMIN INHIBITOR; DEGRADATION PRODUCTS; ENZYME-IMMUNOASSAY; MONOCLONAL-ANTIBODY; IN-VITRO; COAGULATION; ABNORMALITIES; PLASMA	OBJECTIVE: To evaluate the involvement of the fibrinolytic system, especially focused on alpha (2)-plasmin inhibitor, in patients with head injury. METHODS: This study consisted of 47 patients with isolated blunt head trauma in whom blood sampling could be initiated within 3 hours after injury. Patients were divided into two groups according to Glasgow Outcome Scale score status at 3 months after injury. In Group I patients (n = 26), the outcome was characterized as good recovery or moderate disability; in Group 2 patients (n = 21), the outcome was characterized as severe disability, vegetative state, or death. RESULTS: Concentrations of thrombin-antithrombin III complex were greater than 100 mug/L in 39 of 47 patients, and concentrations in Group 2 patients were elevated significantly beyond the concentrations in Group 1 patients. Activities of alpha (2)-plasmin inhibitor in Group 2 were significantly lower than in Group 1 (P < 0.0001). In Group 1 patients, alpha (2)-plasmin inhibitor activity was greater than 60%, while in all but four Group 2 patients, the inhibitor was reduced to less than 60% of normal activity within 3 hours of injury. All patients with alpha (2)-plasmin inhibitor activity less than 60% showed a marked bleeding tendency and/or severe brain edema. Using sandwich enzyme-linked immunosorbent assay, fibrinogen degradation product and fibrin degradation product were measured separately. A significant correlation was apparent between thrombin-antithrombin III complex and fibrinogen degradation product, as well as between the complex and fibrin degradation product. Marked decreases in alpha (2)-plasmin inhibitor were noted only in patients with thrombin-antithrombin III complex concentrations exceeding 500 mug/L. CONCLUSION: Fibrinolysis and fibrinogenolysis may be involved according to the degree of coagulation activation in the pathophysiology of severe head injury. Decreased activity of alpha (2)-plasmin inhibitor indicated poor prognosis and may be an exacerbating factor in the acute phase of head trauma.	Nippon Med Coll, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138603, Japan		Kushimoto, S (corresponding author), Nippon Med Coll, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; AOKI N, 1984, SEMIN THROMB HEMOST, V10, P24, DOI 10.1055/s-2007-1004405; AOKI N, 1979, J CLIN INVEST, V63, P877, DOI 10.1172/JCI109387; AOKI N, 1984, SEMIN THROMB HEMOST, V10, P42, DOI 10.1055/s-2007-1004406; ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BENNETT B, 1972, MED CLIN N AM, V56, P95, DOI 10.1016/S0025-7125(16)32425-7; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CONFORTI G, 1994, BLOOD, V83, P994; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; FRANCIS CW, 1993, HEMOSTASIS THROMBOSI, P1076; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; ISOGAI N, 1993, JPN J CLIN PATHOL, V41, P1349; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; KOOPMAN J, 1987, J LAB CLIN MED, V109, P75; KOPPERT PW, 1988, THROMB HAEMOSTASIS, V59, P310; KOPPERT PW, 1987, THROMB HAEMOSTASIS, V57, P25; MOROI M, 1977, THROMB RES, V10, P851, DOI 10.1016/0049-3848(77)90142-6; OKAJIMA K, 1995, J LAB CLIN MED, V126, P377; OKAJIMA K, 1994, AM J HEMATOL, V45, P16, DOI 10.1002/ajh.2830450104; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; OWEN CA, 1979, J NEUROSURG, V51, P137, DOI 10.3171/jns.1979.51.2.0137; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; RABBANI LE, 1993, THROMB RES, V70, P425, DOI 10.1016/0049-3848(93)90085-3; RUDD MA, 1991, CIRCULATION, V84, P2568, DOI 10.1161/01.CIR.84.6.2568; SAKATA Y, 1980, J CLIN INVEST, V65, P290, DOI 10.1172/JCI109671; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; SORENSEN JV, 1993, SCAND J CLIN LAB INV, V53, P659, DOI 10.3109/00365519309092568; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; SUZUKI M, 1994, THROMB HAEMOSTASIS, V71, P155; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357	40	31	38	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	NOV	2001	49	5					1084	1089		10.1097/00006123-200111000-00011			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	485NG	WOS:000171760000015	11846901				2022-02-06	
J	Segers, P; Van Schil, P; Jorens, P; Van Den Brande, F				Segers, P; Van Schil, P; Jorens, P; Van Den Brande, F			Thoracic trauma : an analysis of 187 patients	ACTA CHIRURGICA BELGICA			English	Article						thoracic injuries; trauma severity indices; motorcycles; traffic accidents	CHEST TRAUMA; RUPTURE; INJURIES	A retrospective analysis of 187 cases of thoracic trauma seen between January 1, 1994 and June 30, 1999 is presented. The majority of the patients were male (male-female ratio 2.9 :1) and the average age at admission was 41.1 years. Blunt trauma, especially motor vehicle accidents (72.2%) and falls (17.1%), were the most frequent causes of chest injury (95.8%). We used the injury severity score (ISS) to assess the severity of trauma. The average ISS for the total group was 27.8 (ranges : 4-75). In only 17.6% of the patients an isolated thoracic trauma was present. Rib fractures (n = 133), pulmonary contusion (n = 110), pneumothorax (n = 78) and haemothorax (n = 65) were the most frequent lesions. Most patients (97.9%) were admitted to the intensive care department. A minority of the patients required thoracotomy (n = 19, 10.2%). Main indications for thoracotomy were pulmonary laceration (n = 5), aortic rupture (n = 3) and rupture of the diaphragm (n = 3). For the majority of cases, observation and/or tube thoracostomy (52.4%) and/or mechanical ventilation (61.0%) were sufficient. Pneumonia and adult respiratory distress syndrome were the most common complications (38.0 and 7.0% respectively). The overall mortality rate was 16.6%. Main causes of death were intracranial hypertension, sepsis combined with multiple organ failure, and hypovolaemic shock. For patients who did not survive the average ISS was 40.3. In a survival analysis the ISS was found to be the most significant determining survival (p < 0.0001), followed by neurotrauma (p = 0.05). Mortality after thoracic trauma remains relatively high, especially in case of associated neurotrauma. The ISS is a valuable score for assessing the severity of trauma and predicting outcome.	Univ Antwerp Hosp, Dept Thorac & Vasc Surg, B-2650 Edegem, Belgium		Van Schil, P (corresponding author), Univ Antwerp Hosp, Dept Thorac & Vasc Surg, Wilrijkstr 10, B-2650 Edegem, Belgium.	paul.van.schil@uza.be	Van Schil, Paul/AAC-8139-2019	Van Schil, Paul/0000-0002-1962-8821			BESSON A, 1989, COLOR ATLAS CHEST TR; CHAMPION HR, 1983, WORLD J SURG, V7, P4, DOI 10.1007/BF01655906; ENDERSON BL, 1990, J TRAUMA, V30, P666, DOI 10.1097/00005373-199006000-00002; FECZKO JD, 1992, J TRAUMA, V33, P846, DOI 10.1097/00005373-199212000-00009; GALAN G, 1992, EUR J CARDIO-THORAC, V6, P284, DOI 10.1016/1010-7940(92)90143-L; Galli R, 1998, ANN THORAC SURG, V65, P461, DOI 10.1016/S0003-4975(97)01302-7; Glinz W, 1981, CHEST TRAUMA DIAGNOS; Goverde P, 1996, ACTA CHIR BELG, V96, P233; KOTWICA Z, 1990, ACTA NEUROCHIR, V103, P109, DOI 10.1007/BF01407515; KSHETTRY VR, 1994, CLIN CHEST MED, V15, P137; LANGLAZDUNSKI L, 1999, CURR OPIN CRIT CARE, V5, P488; MATTOX KL, 1989, SURG CLIN N AM, V69, P77; MATTOX KL, 1989, SURG CLIN N AM, V69, P31; MATTOX KL, 1989, SURG CLIN N AM, V69, P59; MATTOX KL, 1989, SURG CLIN N AM, V69, P15; Pate JW, 1999, WORLD J SURG, V23, P59, DOI 10.1007/s002689900565; Rousseau H, 1999, CIRCULATION, V99, P498, DOI 10.1161/01.CIR.99.4.498; SHORR RM, 1987, ANN SURG, V206, P200, DOI 10.1097/00000658-198708000-00013; SYMBAS PN, 1992, ANN THORAC SURG, V54, P177, DOI 10.1016/0003-4975(92)91177-B; Tatou E, 2000, ANN THORAC SURG, V69, P70, DOI 10.1016/S0003-4975(99)01054-1; Trupka A, 1998, UNFALLCHIRURG, V101, P244, DOI 10.1007/s001130050265; Vasquez JC, 1997, INJURY, V28, P45, DOI 10.1016/S0020-1383(96)00133-7	22	31	32	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-5458			ACTA CHIR BELG	Acta Chir. Belg.	NOV-DEC	2001	101	6					277	282					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	512WK	WOS:000173346400006	11868503				2022-02-06	
J	Verweij, BH; Muizelaar, JP; Vinas, FC				Verweij, BH; Muizelaar, JP; Vinas, FC			Hyperacute measurement of intracranial pressure, cerebral perfusion pressure, jugular venous oxygen saturation, and laser Doppler flowmetry, before and during removal of traumatic acute subdural hematoma	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; acute subdural hematoma; intracranial pressure; jugular venous oxygen saturation; laser Doppler flowmetry; cerebral oxygen metabolism	BRAIN INJURY; HEAD-INJURY; MITOCHONDRIAL DYSFUNCTION; COMATOSE PATIENTS; BLOOD-FLOW; ISCHEMIA; MORTALITY; METABOLISM; ANTAGONIST; REVERSAL	Object. The poor prognosis for traumatic acute subdural hematoma (ASDH) might be due to underlying primary brain damage, ischemia, or both. Ischemia in ASDH is likely caused by increased intracranial pressure (ICP) leading to decreased cerebral perfusion pressure (CPP), but the degree to which these phenomena occur is unknown. The authors report data obtained before and during removal of ASDH in five cases. Methods. Five patients who underwent emergency evacuation of ASDH were monitored. In all patients, without delaying treatment, a separate surgical team (including the senior author) placed an ICP monitor and a jugular bulb catheter, and in two patients a laser Doppler probe was placed. The ICP prior to removing the bone flap in the five patients was 85, 85, 50, 59, and greater than 40 mm Hg, resulting in CPPs of 25, 3, 25, 56, and less than 50 mm Hg, respectively. Removing the bone flap as well as opening the dura and removing the blood clot produced a significant decrease in ICP and an increase in CPP. Jugular venous oxygen saturation (SjvO(2)) increased in four patients and decreased in the other during removal of the hematoma. Laser Doppler flow also increased, to 217% and 211% compared with preevacuation flow. Conclusions. Intracranial pressure is higher than previously suspected and CPP is very low in patients with ASDH. Removal of the bone flap yielded a significant reduction in ICR which was further decreased by opening the dura and evacuating the hematoma. The SjvO(2) as well as laser Doppler flow increased in all patients but one immediately after removal of the hematoma.	Univ Calif Davis, Med Ctr, Dept Neurosurg, Sacramento, CA 95817 USA; Wayne State Univ, Dept Neurosurg, Detroit, MI USA		Muizelaar, JP (corresponding author), Univ Calif Davis, Med Ctr, Dept Neurosurg, 4860 Y St,Room 3740, Sacramento, CA 95817 USA.						Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CHAMBERS JW, 1951, J NEUROSURG, V8, P263, DOI 10.3171/jns.1951.8.3.0263; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; COLES JP, 2000, REST NEUROL NEUROSCI, V16, P215; Cruz J, 1988, Acta Neurochir Suppl (Wien), V42, P35; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; RICHARDS T, 1974, SURGERY, V75, P253; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SCIAMANNA MA, 1993, ARCH BIOCHEM BIOPHYS, V305, P215, DOI 10.1006/abbi.1993.1414; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; [No title captured]; 1996, J NEUROTRAUMAA, V13, P641	30	31	36	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2001	95	4					569	572		10.3171/jns.2001.95.4.0569			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	478NQ	WOS:000171352600005	11596950				2022-02-06	
J	Kay, GG; Quig, ME				Kay, GG; Quig, ME			Impact of sedating antihistamines on safety and productivity	ALLERGY AND ASTHMA PROCEEDINGS			English	Article; Proceedings Paper	Southwest Allergy Forum (SWAF)/Eastern Allergy Conference (EAC)	JAN   10, 2001	ACAPULCO, MEXICO				PSYCHOMOTOR PERFORMANCE; LORATADINE; CHLORPHENIRAMINE; DIPHENHYDRAMINE; CETIRIZINE; COGNITION; MOOD	The use of sedating antihistamines by allergy sufferers remains common, and physicians continue to prescribe these older anti-histamines with great frequency. Precautionary statements Warning of possible drowsiness and the need for caution when driving or operating machinery, which are required for sedating antihistamines, don't appear to be having much impact. Sedating antihistamines are frequently found to be a causal factor in fatal traffic accidents and are the leading medication found on autopsy of pilots who have crashed their aircraft. Patients taking sedating antihistamines frequently don't feel sleepy, yet they have difficulty staying awake and their brain functioning is impaired. The impact on safety is found in the increased risk of traumatic work-related injuries, driving accidents, and aviation fatalities. The cognitive and psychomotor deficits translate into losses in worker productivity and student learning.	Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20057 USA		Kay, GG (corresponding author), WNI, 4910 Massachusetts Ave,NW 100, Washington, DC 20016 USA.						*AM AC ALL ASTHM I, 2000, ALL REP; Cockburn IM, 1999, J OCCUP ENVIRON MED, V41, P948, DOI 10.1097/00043764-199911000-00005; Gilmore TM, 1996, AM J IND MED, V30, P234; Hindmarch I, 1999, CLIN EXP ALLERGY, V29, P133, DOI 10.1046/j.1365-2222.1999.0290s3133.x; Kay GG, 1997, AM J MANAG CARE, V3, P1843; Kay GG, 1999, CLIN EXP ALLERGY, V29, P147, DOI 10.1046/j.1365-2222.1999.0290s3147.x; Kay GG, 1997, ARCH INTERN MED, V157, P2350, DOI 10.1001/archinte.157.20.2350; Nicholson AN, 1998, AVIAT SPACE ENVIR MD, V69, P166; Salmun LM, 2000, CLIN THER, V22, P573, DOI 10.1016/S0149-2918(00)80045-4; Soper JW, 2000, AVIAT SPACE ENVIR MD, V71, P1206; STARMER G, 1985, ACCIDENT ANAL PREV, V17, P311, DOI 10.1016/0001-4575(85)90032-6; VUURMAN EFPM, 1993, ANN ALLERGY, V71, P121; Weiler JM, 2000, ANN INTERN MED, V132, P354, DOI 10.7326/0003-4819-132-5-200003070-00004; 1998, IMS NATL DIS THERAPE	14	31	31	0	7	OCEAN SIDE PUBLICATIONS INC	PROVIDENCE	95 PITMAN ST, PROVIDENCE, RI 02906 USA	1088-5412			ALLERGY ASTHMA PROC	Allergy Asthma Proc.	SEP-OCT	2001	22	5					281	283					3	Allergy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy	491NL	WOS:000172114700003	11715216				2022-02-06	
J	Garnett, MR; Blamire, AM; Corkill, RG; Rajagopalan, B; Young, JD; Cadoux-Hudson, TAD; Styles, P				Garnett, MR; Blamire, AM; Corkill, RG; Rajagopalan, B; Young, JD; Cadoux-Hudson, TAD; Styles, P			Abnormal cerebral blood volume in regions of contused and normal appearing brain following traumatic brain injury using perfusion magnetic resonance imaging	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood volume; magnetic resonance imaging; outcome; perfusion; traumatic brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; HYPERACUTE STROKE; CONTRAST; ISCHEMIA; ARTERY; FLOW; MILD; MRI	Following traumatic brain injury, there may be secondary alterations in cerebrovascular parameters leading to ischemia and further cellular damage. To assess possible subacute hemodynamic disturbances following traumatic brain injury, we used conventional and perfusion magnetic resonance imaging (MRI) in 18 patients, on average 10 days following injury. Six of the 18 patients had focal contusions or edema visible on conventional MRI. These six patients had a significantly reduced normalized regional cerebral blood volume (rCBV) in the regions of focal pathology compared to equivalent areas in control subjects (patients 0.47 +/- 0.20 [means +/- SD], controls 1.02 +/- 0.11, p < 0.001). In addition, four of these six patients had an increased rCBV (outside control range) in the region of normal appearing brain immediately surrounding the contusion. These six patients were more significantly injured and had a worse clinical outcome compared to the remaining patients (p = 0.004, p = 0.03, respectively). There were five patients who had a region of reduced rCBV (outside control range) in a quadrant of normal appearing white matter, away from any visible abnormality, who were not more significantly injured than the remaining patients but went on to have a significantly poorer clinical outcome (p = 0.27, p = 0.01, respectively). Traumatic brain injury is a heterogeneous insult causing a variety of pathology, not all of which is visible using conventional imaging methods. The current study has shown that regions of both normal appearing and contused brain may have an abnormal rCBV and that alterations in rCBV may play a role in determining the clinical outcome of patients.	John Radcliffe Hosp, MRC, Biochem & Clin Magnet Resonance Unit, Dept Biochem, Oxford OX3 9DU, England; Oxford Radcliffe Hosp, Dept Neurosurg, Oxford, England; Oxford Radcliffe Hosp, Dept Neurol, Oxford, England; Oxford Radcliffe Hosp, Dept Anaesthet, Oxford, England		Garnett, MR (corresponding author), John Radcliffe Hosp, MRC, Biochem & Clin Magnet Resonance Unit, Dept Biochem, Headley Way, Oxford OX3 9DU, England.	mg@bioch.ox.ac.uk	Blamire, Andrew/AAU-6100-2021; Young, John D/M-9756-2016	Blamire, Andrew/0000-0002-8749-1257			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Beaulieu C, 1999, ANN NEUROL, V46, P568, DOI 10.1002/1531-8249(199910)46:4<568::AID-ANA4>3.0.CO;2-R; BELLIVEAU JW, 1990, MAGNET RESON MED, V14, P538, DOI 10.1002/mrm.1910140311; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; JENNETT B, 1975, LANCET, V1, P480; Kastrup A, 1999, J NEUROL SCI, V166, P91, DOI 10.1016/S0022-510X(99)00121-5; Kempski O, 1997, J TRAUMA, V42, pS38, DOI 10.1097/00005373-199705001-00007; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; Pierce AR, 1997, J CEREBR BLOOD F MET, V17, P183, DOI 10.1097/00004647-199702000-00008; ROBERTS TPL, 1993, J CEREBR BLOOD F MET, V13, P940, DOI 10.1038/jcbfm.1993.117; Rordorf G, 1998, STROKE, V29, P939, DOI 10.1161/01.STR.29.5.939; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schroder ML, 1998, NEUROSURGERY, V42, P1276, DOI 10.1097/00006123-199806000-00042; Sorensen AG, 1999, RADIOLOGY, V210, P519, DOI 10.1148/radiology.210.2.r99fe06519; Sorensen AG, 1996, RADIOLOGY, V199, P391, DOI 10.1148/radiology.199.2.8668784; TEASDALE G, 1974, LANCET, V2, P81; VILLRINGER A, 1988, MAGNET RESON MED, V6, P164, DOI 10.1002/mrm.1910060205; WADDINGTON W, 1998, P 6 ANN SCI M ISMRM, P2069; Warach S, 1996, J CEREBR BLOOD F MET, V16, P53, DOI 10.1097/00004647-199601000-00006; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830	36	31	33	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2001	18	6					585	593		10.1089/089771501750291828			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	445ZQ	WOS:000169488800002	11437081				2022-02-06	
J	Bondarenko, A; Chesler, M				Bondarenko, A; Chesler, M			Calcium dependence of rapid astrocyte death induced by transient hypoxia, acidosis, and extracellular ion shifts	GLIA			English	Article						ischemia; BCECF; BAPTA-AM; Na+-Ca2(+) exchange; benzamil; KB-R7943	PERMEABILITY TRANSITION; NA+/CA2+ EXCHANGE; NA+ HOMEOSTASIS; RAT; ISCHEMIA; NEURONS; SODIUM; VULNERABILITY; INHIBITION; CULTURES	Exposure to hypoxic, acidic, ion-shifted Ringer (HAIR) for 15-40 min has been shown to cause rapid astrocyte death upon reperfusion with normal media. The ion shifts of the HAIR solution included a rise in extracellular K+ (e.g., [K+](o)) and a fall in [Na+](o), [Cl-](o), and [Ca2+](o), characteristic of ischemic-traumatic brain insults. We investigated the ionic basis of the HAIR-induced injury. After HAIR exposure, reperfusion in 0 Ca2+/EGTA media completely protected astrocytes. Preincubation of cells in BAPTA-AM ester was also protective, indicating that the injury was triggered by Ca2+ influx during reperfusion. Neither nimodipine, CNQX, APV, nor TTX reduced injury. Astrocyte death could be blocked by 100 muM Ni2+ or 100 muM benzamil, suggesting involvement of Na+-Ca2+ exchange. KB-R7943, which preferentially inhibits reverse Na+-Ca2+ exchange, also protected astrocytes. Elevation of [K+](o) was not necessary for astrocyte death. However, when [Na+](o) was maintained at 151 mM throughout the HAIR protocol, cell death was markedly reduced. We postulate that [Na+](o) shifts aid reversal of Na+-Ca2+ exchange by favoring cytosolic Na+ loading. Possible means of astrocytic Na+ accumulation are discussed. GLIA 34:143-149, 2001. (C) 2001 Wiley-Liss, Inc.	NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; NYU, Sch Med, Dept Neurosurg, New York, NY 10016 USA		Chesler, M (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, 550 1st Ave, New York, NY 10016 USA.	mitch.chesler@med.nyu.edu	Bondarenko, Alexander I/B-3080-2013	Chesler, Mitchell/0000-0002-3189-8234	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034906] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34906] Funding Source: Medline		Agrawal SK, 1996, J NEUROSCI, V16, P545; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.ph.51.030189.002055; BEVENSEE M, 2000, SOC NEUR ABS, V26, P2061; BEVENSEE MO, 1995, J NEUROSCI METH, V58, P61, DOI 10.1016/0165-0270(94)00159-E; Bondarenko A, 2001, GLIA, V34, P134, DOI 10.1002/glia.1048; BONDARENKO A, 2000, SOC NEUR ABS, V26, P1893; Breder J, 2000, NEUROPHARMACOLOGY, V39, P1779, DOI 10.1016/S0028-3908(00)00027-7; Chidekel AS, 1997, EXP NEUROL, V146, P403, DOI 10.1006/exnr.1997.6544; Dubinsky JM, 1999, BIOCHEM SOC SYMP, V66, P75, DOI 10.1042/bss0660075; Duffy S, 1996, J NEUROSCI, V16, P71; DUGAN LL, 1995, J NEUROSCI, V15, P4545; GOLDMAN WF, 1994, J NEUROSCI, V14, P5834; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hoyt KR, 1998, MOL PHARMACOL, V53, P742, DOI 10.1124/mol.53.4.742; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Kristal BS, 1997, J NEUROCHEM, V69, P524; MACVICAR BA, 1991, GLIA, V4, P448, DOI 10.1002/glia.440040504; Matsuda T, 1996, EUR J NEUROSCI, V8, P951, DOI 10.1111/j.1460-9568.1996.tb01582.x; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Phillis JW, 1999, BRAIN RES, V839, P199, DOI 10.1016/S0006-8993(99)01705-9; PITTS BJR, 1979, J BIOL CHEM, V254, P6232; Reynolds IJ, 1999, ANN NY ACAD SCI, V893, P33, DOI 10.1111/j.1749-6632.1999.tb07816.x; Rose CR, 1997, J PHYSIOL-LONDON, V499, P573, DOI 10.1113/jphysiol.1997.sp021951; Rose CR, 1998, J NEUROSCI, V18, P3554; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; SHELDON C, 2000, SOC NEUR ABS, V26, P763; STYS PK, 1992, J NEUROSCI, V12, P430; TAKUMA K, 1994, GLIA, V12, P336, DOI 10.1002/glia.440120410; Vornov JJ, 1996, J NEUROCHEM, V67, P2379; YAO H, 2000, SOC NEUR ABS, V26, P1671; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x	34	31	33	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	APR 15	2001	34	2					143	149		10.1002/glia.1049			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	429NH	WOS:000168523500008	11307163				2022-02-06	
J	Allison, SC; Abraham, LD				Allison, SC; Abraham, LD			Sensitivity of qualitative and quantitative spasticity measures to clinical treatment with cryotherapy	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						ankle; Ashworth scale; cryotherapy; measurement; spasticity	MODIFIED ASHWORTH SCALE; TRAUMATIC BRAIN INJURY; ELBOW FLEXOR MUSCLES; CEREBRAL-PALSY; PRESYNAPTIC INHIBITION; HUMAN ANKLE; HYPERTONIA; REFLEXES; RELIABILITY; HEMIPARESIS	This study examined the extent to which a battery of tests could detect a reduction of plantarflexor spasticity resulting from cryotherapy. The tests included a traditional qualitative spasticity scale, three potential quantitative spasticity measures and a measure of voluntary ankle muscle function. Twenty-six adult traumatic-brain-injured subjects were examined; these included 22 males and 4 females. The mean age was 28.15 years (range: 18-57, SD 10.78). The five tests were performed in random sequence on both ankles of each subject, before and after a 20 minute cold pack application to the calf. Tests were: modified Ashworth scale (MAS) scoring; H-reflex testing with and without dorsiflexor contraction (Hdf/Hctrl ratio); H-reflex testing with and without Achilles tendon vibration (Hvib/Hctrl ratio); reflex threshold angle (RTA) and timed toe tapping (TTT). Cryotherapy resulted in lowered MAS scores consistent with a reduction in spasticity. Doubly multivariate repeated measures ANOVA revealed a significant difference (F = 24.16, P < 0.001) in test scores between the pre- and post-cryotherapy test batteries. Significant pre- and post-cryotherapy differences (P <less than or equal to> 0.03) for all dependent measures contributed to the main effect for cryotherapy. However, among the potential quantitative measures of spasticity only the RTA test demonstrated appropriate sensitivity to the reduction in spasticity. In spite of spasticity reduction, TTT performance was impaired following muscle cooling. Failure bf the H-reflex ratios to show a reduction consistent with reduced spasticity was attributed to competing alpha and gamma motoneuron effects resulting from peripheral cooling.	Acad Hlth Sci, Ft Sam Houston, TX 78234 USA; Univ Texas, Austin, TX 78712 USA		Allison, SC (corresponding author), AMEDD Ctr & Sch, Phys Therapy Branch, Ft Sam Houston, TX 78234 USA.						Allison SC, 1996, INT J REHABIL RES, V19, P67, DOI 10.1097/00004356-199603000-00007; ALLISON SC, 1995, J NEUROL, V242, P699, DOI 10.1007/BF00866923; ASHWORTH B, 1964, PRACTITIONER, V192, P540; BASSETT S W, 1958, Phys Ther Rev, V38, P333; BELL KR, 1987, ARCH PHYS MED REHAB, V68, P490; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BOORMAN GI, 1992, ABSTR SOC NEUROSCI, V18, P1408; Brouwer B, 1998, DEV MED CHILD NEUROL, V40, P168; Chiara T, 1998, ARCH PHYS MED REHAB, V79, P523, DOI 10.1016/S0003-9993(98)90066-1; DENYS EH, 1991, MUSCLE NERVE, V14, P795, DOI 10.1002/mus.880140902; Dewald J P, 1996, IEEE Trans Rehabil Eng, V4, P231, DOI 10.1109/86.547923; GILLIES JD, 1969, J PHYSIOL-LONDON, V205, P329, DOI 10.1113/jphysiol.1969.sp008968; Hagbarth K-E, 1973, HUMAN REFLEXES PATHO, P428; HECOX B, 1994, PHYSICAL AGENTS COMP, P115; Hugon M, 1973, NEW DEVELOPMENTS ELE, P277; ILES JF, 1986, J NEUROL NEUROSUR PS, V49, P937, DOI 10.1136/jnnp.49.8.937; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; KATZ RT, 1992, ARCH PHYS MED REHAB, V73, P339, DOI 10.1016/0003-9993(92)90007-J; KNUTSSON E, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P159; KNUTSSON E, 1969, Scandinavian Journal of Rehabilitation Medicine, V1, P126; LANCE JW, 1973, NEW DEVELOPMENTS ELE, V3, P444; Lehmann J. F., 1990, THERAPEUTIC HEAT COL; LEONARD CT, 1990, DEV MED CHILD NEUROL, V32, P974; LEVIN MF, 1993, J NEUROL, V240, P63, DOI 10.1007/BF00858718; MENSE S, 1978, PFLUG ARCH EUR J PHY, V374, P159, DOI 10.1007/BF00581297; MICHLOVITZ SL, 1990, THERMAL AGENTS REHAB, P63; MIGLIETTA O, 1973, AM J PHYS MED REHAB, V52, P198; MIGLIETTA OSVALDO, 1964, ARCH PHYS MED REHABIL, V45, P508; MILANOV I, 1992, J NEUROL, V239, P287; MILANOV IG, 1992, ACTA NEUROL SCAND, V85, P305; NANCE PW, 1989, PARAPLEGIA, V27, P296, DOI 10.1038/sc.1989.44; OTTOSON D, 1965, J PHYSIOL-LONDON, V180, P636, DOI 10.1113/jphysiol.1965.sp007721; PEACOCK WJ, 1991, J NEUROSURG, V74, P380, DOI 10.3171/jns.1991.74.3.0380; PETAJAN J H, 1962, Am J Phys Med, V41, P240; PIERROTDESEILLI.E, 1990, NEW TRENDS ADV TECHN, P264; POWERS RK, 1988, ANN NEUROL, V23, P115, DOI 10.1002/ana.410230203; POWERS RK, 1989, ANN NEUROL, V25, P32, DOI 10.1002/ana.410250106; PRICE R, 1993, ARCH PHYS MED REHAB, V74, P300; PRICE R, 1990, ARCH PHYS MED REHAB, V71, P745; Urbscheit N, 1971, Phys Ther, V51, P983; Wolf SL, 1996, PHYS THER, V76, P586, DOI 10.1093/ptj/76.6.586	41	31	34	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	2001	24	1					15	24		10.1097/00004356-200103000-00003			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	414XJ	WOS:000167691200003	11302460				2022-02-06	
J	Arciniegas, DB; Topkoff, JL; Rojas, DC; Sheeder, J; Teale, P; Young, DA; Sandberg, E; Reite, ML; Adler, LE				Arciniegas, DB; Topkoff, JL; Rojas, DC; Sheeder, J; Teale, P; Young, DA; Sandberg, E; Reite, ML; Adler, LE			Reduced hippocampal volume in association with P50 nonsuppression following traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							HEAD-INJURY; NICOTINIC RECEPTORS; EVOKED RELEASE; WHITE-MATTER; SCHIZOPHRENICS; ACETYLCHOLINE; RATS; NORMALIZATION; CONSCIOUSNESS; DYSFUNCTION	Traumatic brain injury (TBI) may produce persistently impaired auditory gating. This cholinergic-dependent, hippocampally mediated preattentive cognitive function that facilitates filtering of auditory stimuli may be indexed by the P50 evoked waveform to paired auditory stimuli. Abnormal P50 suppression post TBI is believed to result from injury to the hippocampus and/or its afferent cholinergic projections. This hypothesis was tested by comparing hippocampal and total brain volumes on MRI between ten P50-nonsuppressing TBI patients and ten normal control subjects matched for age, gender, and education. TBI subjects had highly significant bilateral hippocampal volume reductions, even when covaried for reductions in total brain volume. Degree of volume loss was not correlated with initial TBI severity. Findings support the hypothesis that hippocampal injury underlies P50 nonsuppression post TBI and suggest that such structural abnormalities may be observed even in "mildly" injured persons.	Vet Affairs Med Ctr, Res Serv, Denver, CO USA; Vet Affairs Med Ctr, Serv Radiol, Denver, CO USA; Vet Affairs Med Ctr, Psychiat Serv, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Psychiat, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Radiol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA		Arciniegas, DB (corresponding author), Campus Box C268-68,4200 E 9th Ave, Denver, CO 80262 USA.		Sheeder, Jeanelle/D-4960-2013; Rojas, Don/F-4296-2012; Rojas, Don/AAX-6678-2020; Arciniegas, David/A-3792-2009	Sheeder, Jeanelle/0000-0002-4463-3569; Rojas, Don/0000-0001-6560-9616; 			Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; ADLER LE, 1992, BIOL PSYCHIAT, V32, P607, DOI 10.1016/0006-3223(92)90073-9; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; Adler LE, 1999, BIOL PSYCHIAT, V46, P8, DOI 10.1016/S0006-3223(99)00085-2; ADLER LE, 1994, NEUROPSYCHOPHARMACOL, V10, P249, DOI 10.1038/npp.1994.28; ALEXANDER MP, 1982, PSYCHIAT ASPECTS NEU, P219; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Cassidy John W., 1994, P43; CAVE CB, 1992, HIPPOCAMPUS, V2, P151, DOI 10.1002/hipo.450020207; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Cohen J., 2013, STAT POWER ANAL BEHA; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DLER LE, 1991, AM PSYCH ASS 144 ANN; Eisenberg H.M., 1989, MILD HEAD INJURY, P133; Filley C., 1995, NEUROBEHAVIORAL ANAT; Filley CM, 1998, NEUROLOGY, V50, P1535, DOI 10.1212/WNL.50.6.1535; FREEDMAN R, 1993, J NEUROSCI, V13, P1965; FREEDMAN R, 1994, HARVARD REV PSYCHIAT, V2, P179, DOI 10.3109/10673229409017136; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Halliday A, 1999, TRAUMATIC BRAIN INJU, P29; Jackson GD, 1996, MRI NEUROANATOMY NEW; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; JENNETT B, 1975, LANCET, V1, P480; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCALLISTER TW, 1994, NEUROPSYCHIATRY TRAU, P35; Mesulam M -M, 1985, PRINCIPLES BEHAV NEU, P125; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mu QW, 1999, AM J NEURORADIOL, V20, P207; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Naatanen R., 1986, ADAPTATION STRESS TA, P91; Naatanen R, 1992, ATTENTION BRAIN FUNC; Nagamoto HT, 1996, BIOL PSYCHIAT, V40, P181, DOI 10.1016/0006-3223(95)00371-1; NAGAMOTO HT, 1989, BIOL PSYCHIAT, V25, P549, DOI 10.1016/0006-3223(89)90215-1; Neppe VM, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P149; NIEWENHUYS R, 1988, HUMAN CENTRAL NERVOU; REITE M, 1994, COGNITIVE BRAIN RES, V2, P13, DOI 10.1016/0926-6410(94)90016-7; SAIJA A, 1988, Journal of Neurotrauma, V5, P161, DOI 10.1089/neu.1988.5.161; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Silver JM., 1994, NEUROPSYCHIATRY TRAU; STRUB RL, 1988, NEUROBEHAVIORAL DISR; TEASDALE G, 1974, LANCET, V2, P81; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; WALDO MC, 1994, SCHIZOPHR RES, V12, P93, DOI 10.1016/0920-9964(94)90067-1; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514	55	31	33	0	3	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2001	13	2					213	221		10.1176/appi.neuropsych.13.2.213			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	432JE	WOS:000168687800007	11449028				2022-02-06	
J	Thorley, RR; Wertsch, JJ; Klingbeil, GE				Thorley, RR; Wertsch, JJ; Klingbeil, GE			Acute hypothalamic instability in traumatic brain injury: A case report	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						autonomic nervous system diseases; catatonia; closed head injuries; malignant hyperthermia; neuroleptic malignant syndrome; rehabilitation	NEUROLEPTIC MALIGNANT SYNDROME; DIENCEPHALIC SEIZURES; HYPERTHERMIA SYNDROME; METOCLOPRAMIDE; THERAPY; BROMOCRIPTINE; WITHDRAWAL; DANTROLENE; LEVODOPA; PATIENT	Acute hypothalamic instability occurs in patients with traumatic brain injury (TBI). It usually occurs in the form of autonomic dysfunction syndrome (also known as diencephalic seizures or paroxysmal sympathetic storms); however, there are other causes of acute hypothalamic instability of which the clinician must be aware. Neuroleptic malignant syndrome, malignant hyperthermia, autonomic dysfunction syndrome, and lethal catatonia are all syndromes that clinically present as signs and symptoms of acute hypothalamic instability. Because of the lethal potential of these syndromes, clinicians who care for patients with TBI must be aware of the various syndromes, their clinical presentation, and their treatment. We present a case of life-threatening acute hypothalamic instability in a patient with TBI.	Med Coll Wisconsin, Dept Phys Med & Rehabil, Milwaukee, WI 53226 USA		Thorley, RR (corresponding author), Med Coll Wisconsin, Dept Phys Med & Rehabil, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.						BAKRI YN, 1992, GYNECOL ONCOL, V44, P189, DOI 10.1016/0090-8258(92)90037-J; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BROWER RD, 1989, J CHILD NEUROL, V4, P230, DOI 10.1177/088307388900400320; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; BURKE RE, 1981, NEUROLOGY, V31, P1022, DOI 10.1212/WNL.31.8.1022; CAROFF SN, 1980, J CLIN PSYCHIAT, V41, P79; DONNET A, 1991, BIOMED PHARMACOTHER, V45, P461, DOI 10.1016/0753-3322(91)90048-X; FEUERMAN T, 1988, J NEUROSURG, V68, P297, DOI 10.3171/jns.1988.68.2.0297; FIGATALAMANCA L, 1985, NEUROLOGY, V35, P258, DOI 10.1212/WNL.35.2.258; FLETCHER R, 1981, BRIT J ANAESTH, V53, P993, DOI 10.1093/bja/53.9.993; FRIEDMAN JH, 1985, JAMA-J AM MED ASSOC, V254, P2792, DOI 10.1001/jama.254.19.2792; FRIEDMAN LS, 1987, ARCH INTERN MED, V147, P1495, DOI 10.1001/archinte.147.8.1495; GRONERT GA, 1980, ANESTH ANALG, V59, P377; HENDERSON A, 1991, AUST NZ J MED, V21, P742, DOI 10.1111/j.1445-5994.1991.tb01381.x; KISH SJ, 1990, AM J PSYCHIAT, V147, P1358; LECOUTEUR DG, 1995, AUST NZ J MED, V25, P261; MANN SC, 1986, AM J PSYCHIAT, V143, P1374; Miranda A D, 1997, Am J Crit Care, V6, P368; MORGENSON J, 1974, LANCET, V1, P461; PATTERSON JF, 1988, SOUTHERN MED J, V81, P674, DOI 10.1097/00007611-198805000-00035; PEARLMAN CA, 1986, J CLIN PSYCHOPHARM, V6, P257; POLLOCK N, 1992, ANAESTH INTENS CARE, V20, P520, DOI 10.1177/0310057X9202000427; ROBINSON MB, 1985, J NEUROL NEUROSUR PS, V48, P1304, DOI 10.1136/jnnp.48.12.1304; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; Samie M R, 1987, Mov Disord, V2, P57, DOI 10.1002/mds.870020108; SHINTANI S, 1995, J NEUROL SCI, V128, P232, DOI 10.1016/0022-510X(94)00255-M; SIMPSON DM, 1984, AM J PSYCHIAT, V141, P796; WINGARD DW, 1974, LANCET, V2, P1450	28	31	34	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2001	82	2					246	249		10.1053/apmr.2001.18698			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	400AG	WOS:000166846000016	11239318				2022-02-06	
J	Tauskela, JS; Comas, T; Hewitt, K; Monette, R; Paris, J; Hogan, M; Morley, P				Tauskela, JS; Comas, T; Hewitt, K; Monette, R; Paris, J; Hogan, M; Morley, P			Cross-tolerance to otherwise lethal N-methyl-D-aspartate and oxygen-glucose deprivation in preconditioned cortical cultures	NEUROSCIENCE			English	Article						ischemia; calpain; PSD-95; MAP-2; calcium; Fluo-4	CEREBELLAR GRANULE CELLS; HIPPOCAMPAL CA1 NEURONS; TRAUMATIC BRAIN INJURY; NMDA RECEPTOR; ISCHEMIC TOLERANCE; CALPAIN-I; GERBIL HIPPOCAMPUS; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; GLOBAL-ISCHEMIA	In vitro ischemic preconditioning induced by subjecting rat cortical cultures to nonlethal oxygen-glucose deprivation protects against a subsequent exposure to otherwise lethal oxygen-glucose deprivation. We provide evidence that attenuation of the postsynaptic,N-methyl-D-aspartate (NMDA) receptor- and Ca2+-dependent neurotoxicity underlies oxygen-glucose deprivation tolerance. It is demonstrated that extended tolerance to otherwise lethal NMDA or oxygen-glucose deprivation can be induced by either of their sublethal forms of preconditioning. These four pathways are linked. since NMDA receptor blockade during preconditioning by oxygen-glucose deprivation eliminates tolerance. These results suggest that NMDA tolerance, induced by nonlethal activation of these receptors during oxygen-glucose deprivation preconditioning, underlies oxygen-glucose deprivation tolerance. Several neurotoxic downstream Ca2+-dependent signaling events specifically linked to NMDA receptor activation are attenuated during otherwise lethal oxygen-glucose deprivation in preconditioned cultures. Specifically, calpain activation, as well as degradation of microtubule-associated protein-2 and postsynaptic density-95. are attenuated 2 h following otherwise lethal NMDA treatment alone or oxygen-glucose deprivation in preconditioned cultures. Formation of microtubule-associated protein-2-labeled dendritic varicosities is also attenuated in preconditioned cultures within 1 h of lethal oxygen-glucose deprivation or NMDA application. Intracellular Ca2+ levels, measured using the high- or low-affinity dyes Fluo-4 (K-d congruent to 345 nM) or Fluo-4FF (K-d congruent to 9.7 muM) respectively, are markedly attenuated during lethal oxygen-glucose deprivation in preconditioned cultures. Collectively. the results suggest the attenuation of the postsynaptic NMDA-mediated component of otherwise lethal oxygen-glucose deprivation through the suppression of Ca2+-dependent neurotoxic signaling, a mechanism that is initially induced by transient nonlethal activation of this receptor during ischemic preconditioning. Crown Copyright (C) 2001 Published by Elsevier Science Ltd on behalf of IBRO, All rights reserved.	Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; Univ Ottawa, Dept Mol Genet, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Neurosci Res Inst, Ottawa, ON K1H 8M5, Canada		Tauskela, JS (corresponding author), Natl Res Council Canada, Inst Biol Sci, Montreal Rd Campus,Bldg M-54, Ottawa, ON K1A 0R6, Canada.		Hogan, Matthew/AAP-4735-2020	Hogan, Matthew/0000-0003-4660-8743			Adamchik Y, 2000, NEUROSCIENCE, V99, P731, DOI 10.1016/S0306-4522(00)00229-3; Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; BILLGER M, 1988, CELL CALCIUM, V9, P33, DOI 10.1016/0143-4160(88)90036-X; BLACK MA, 1995, J NEUROCHEM, V65, P2170; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Bond A, 1999, EUR J PHARMACOL, V380, P91, DOI 10.1016/S0014-2999(99)00523-3; BRORSON JR, 1995, STROKE, V26, P1259, DOI 10.1161/01.STR.26.7.1259; Bruer U, 1997, FEBS LETT, V414, P117, DOI 10.1016/S0014-5793(97)00954-X; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; DAMSCHRODERWILLIAMS P, 1995, J NEUROCHEM, V65, P1069; Dickie BGM, 1996, NEUROSCIENCE, V72, P731, DOI 10.1016/0306-4522(95)00611-7; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farwell W, 1998, NEUROCHEM RES, V23, P539, DOI 10.1023/A:1022486619201; Gage AT, 1996, BRAIN RES, V719, P172, DOI 10.1016/0006-8993(96)00092-3; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; GOLDBERG MP, 1990, STROKE, V21, P75; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Grabb MC, 1999, J NEUROSCI, V19, P1657; Hewitt KE, 1998, J NEUROSCI RES, V54, P223, DOI 10.1002/(SICI)1097-4547(19981015)54:2<223::AID-JNR10>3.0.CO;2-5; HIMORI N, 1991, NEUROPHARMACOLOGY, V30, P1179, DOI 10.1016/0028-3908(91)90163-6; Johns L, 2000, BIOCHEM BIOPH RES CO, V276, P134, DOI 10.1006/bbrc.2000.3443; Jonas W, 2001, NEUROREPORT, V12, P335, DOI 10.1097/00001756-200102120-00031; KAKU DA, 1991, BRAIN RES, V554, P344, DOI 10.1016/0006-8993(91)90214-G; KATO H, 1992, NEUROSCI LETT, V139, P118, DOI 10.1016/0304-3940(92)90871-4; Kawai K, 1998, J CEREBR BLOOD F MET, V18, P288, DOI 10.1097/00004647-199803000-00007; KIRINO T, 1991, J CEREBR BLOOD F MET, V11, P299, DOI 10.1038/jcbfm.1991.62; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; Laferriere NB, 1999, NEUROL RES, V21, P524, DOI 10.1080/01616412.1999.11740969; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lipsky RH, 2001, J NEUROCHEM, V78, P254, DOI 10.1046/j.1471-4159.2001.00386.x; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; MARINI AM, 1993, ANN NY ACAD SCI, V679, P253, DOI 10.1111/j.1749-6632.1993.tb18305.x; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; Nath R, 1998, J NEUROCHEM, V71, P186; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P915, DOI 10.1097/00004647-199609000-00015; OSTER Y, 1993, NEUROSCI LETT, V163, P85, DOI 10.1016/0304-3940(93)90235-D; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Plamondon H, 1999, J CEREBR BLOOD F MET, V19, P1296, DOI 10.1097/00004647-199912000-00002; Pringle AK, 1999, BRAIN RES, V845, P152, DOI 10.1016/S0006-8993(99)01916-2; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; SCHURR A, 1986, BRAIN RES, V374, P244, DOI 10.1016/0006-8993(86)90418-X; Schurr A, 2001, NEUROSCI LETT, V307, P151, DOI 10.1016/S0304-3940(01)01937-1; Shamloo M, 1999, J CEREBR BLOOD F MET, V19, P173, DOI 10.1097/00004647-199902000-00009; Shimazaki K, 1998, NEUROREPORT, V9, P1875, DOI 10.1097/00001756-199806010-00038; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Stagliano NE, 1999, J CEREBR BLOOD F MET, V19, P757, DOI 10.1097/00004647-199907000-00005; Takagi N, 2000, J NEUROCHEM, V74, P169, DOI 10.1046/j.1471-4159.2000.0740169.x; Tauskela JS, 1999, BRAIN RES, V827, P143, DOI 10.1016/S0006-8993(99)01322-0; Tokunaga H, 1998, BRAIN RES, V784, P316, DOI 10.1016/S0006-8993(97)01237-7; Tremblay R, 2000, J NEUROSCI, V20, P7183; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; XU GP, 2001, J CEREB BLOOD FLO S1, V21, pS238; Ying HS, 1997, J NEUROSCI, V17, P9536	60	31	32	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2001	107	4					571	584		10.1016/S0306-4522(01)00381-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501AV	WOS:000172661600004	11720781				2022-02-06	
J	Mautes, AEM; Bergeron, M; Sharp, FR; Panter, SS; Weinzierl, M; Guenther, K; Noble, LJ				Mautes, AEM; Bergeron, M; Sharp, FR; Panter, SS; Weinzierl, M; Guenther, K; Noble, LJ			Sustained induction of heme oxygenase-1 in the traumatized spinal cord	EXPERIMENTAL NEUROLOGY			English	Article						heat shock proteins; HSP32; HSP70; heme oxygenase-1; spinal cord hemisection; microglia/macrophages; astrocytes; inflammation	HEAT-SHOCK-PROTEIN; TRANSIENT FOREBRAIN ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; FACTOR-KAPPA-B; RAT-BRAIN; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVATION; INSITU HYBRIDIZATION; OXIDATIVE STRESS; CELL-DEATH	Oxidative stress contributes to secondary injury after spinal cord trauma. Among the consequences of oxidative stress is the induction of heme oxygenase-1 (HO-1), an inducible isozyme that metabolizes heme to iron, biliverdin, and carbon monoxide. Here we examine the induction of HO-1 in the hemisected spinal cord, a model that results in reproducible degeneration in the ipsilateral white matter. HO-1 was induced in microglia and macrophages from 24 h to at least 42 days after injury. Within the first week after injury, HO-1 was induced in both the gray and the white matter. Thereafter, HO-1 expression was limited to degenerating fiber tracts. HSP70, a heat shock protein induced mainly by the presence of denatured proteins, was consistently colocalized with HO-1 in the microglia and macrophages. This study to demonstrates long-term induction of HO-1 and HSP70 in microglia and macrophages after traumatic injury and an association between induction of HO-1 and Wallerian degeneration. White matter degeneration is characterized by phagocytosis of cellular debris and remodeling of surviving tissue. This results in the metabolism, synthesis, and turnover of heme and heme proteins. Thus, sustained induction of HO-1 and HSP70 in microglia and macrophages suggests that tissue degeneration is an ongoing process, lasting 6 weeks and perhaps even longer. (C) 2000 Academic Press.	Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; San Francisco State Univ, Grad Program Phys Therapy, San Francisco, CA 94132 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Dept Vet Affairs Med Ctr, San Francisco, CA USA; Univ Saarland, Sch Med, Neurosurg Res Lab, D-66421 Homburg, Germany; Rhein Westfal TH Aachen, Dept Neurosurg, D-52074 Aachen, Germany		Mautes, AEM (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL053040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS023324] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL53040] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS23324] Funding Source: Medline		ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; ALAM J, 1992, J BIOL CHEM, V267, P21894; ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; APPLEGATE LA, 1991, CANCER RES, V51, P974; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Bauer I, 1998, HEPATOLOGY, V27, P829, DOI 10.1002/hep.510270327; Bergeron M, 1998, DEV BRAIN RES, V105, P181, DOI 10.1016/S0165-3806(97)00169-7; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CANTONI L, 1991, BIOCHEM J, V279, P891, DOI 10.1042/bj2790891; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DINARELLO CA, 1992, BACTERIAL ENDOTOXIC, P105; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Dwyer BE, 1996, MOL BRAIN RES, V38, P251, DOI 10.1016/0169-328X(95)00341-O; DWYER BE, 1995, NEUROREPORT, V6, P973, DOI 10.1097/00001756-199505090-00006; EWING JF, 1991, P NATL ACAD SCI USA, V88, P5364, DOI 10.1073/pnas.88.12.5364; EWING JF, 1993, J NEUROCHEM, V60, P1512, DOI 10.1111/j.1471-4159.1993.tb03315.x; EWING JF, 1992, MOL CELL NEUROSCI, V3, P559, DOI 10.1016/1044-7431(92)90068-D; Ewing JF, 1997, BRAIN RES PROTOC, V1, P165, DOI 10.1016/S1385-299X(96)00027-X; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Foster J, 1996, BRAIN RES, V724, P73, DOI 10.1016/0006-8993(96)00266-1; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Harrub JB, 1998, NEUROCHEM RES, V23, P703, DOI 10.1023/A:1022499107910; KADOYA C, 1995, STROKE, V26, P1035, DOI 10.1161/01.STR.26.6.1035; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; KOSHINAGA M, 1995, J NEUROTRAUM, V12, P209, DOI 10.1089/neu.1995.12.209; LAVROVSKY Y, 1993, BIOCHEM BIOPH RES CO, V196, P336, DOI 10.1006/bbrc.1993.2253; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Lee PJ, 1996, AM J RESP CELL MOL, V14, P556, DOI 10.1165/ajrcmb.14.6.8652184; Liu XZ, 1997, J NEUROSCI, V17, P5395; LONGO FM, 1993, J NEUROSCI RES, V36, P325, DOI 10.1002/jnr.490360310; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MAINES MD, 1986, J BIOL CHEM, V261, P411; MANZERRA P, 1994, SOC NEUR ABSTR, V20; MASING TE, 1989, NEUROCHEM RES, V14, P725, DOI 10.1007/BF00964949; MASSA SM, 1995, J NEUROSCI RES, V40, P807, DOI 10.1002/jnr.490400612; Massa SM, 1996, CEREBROVAS BRAIN MET, V8, P95; Matz PG, 1997, NEUROSURGERY, V40, P152, DOI 10.1097/00006123-199701000-00034; Mautes AEM, 1998, BRAIN RES, V795, P17, DOI 10.1016/S0006-8993(98)00230-3; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MITANI K, 1992, BLOOD, V79, P1255; MULLER RM, 1987, J BIOL CHEM, V262, P6795; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; Nimura T, 1996, MOL BRAIN RES, V37, P201, DOI 10.1016/0169-328X(95)00315-J; OKINAGA S, 1993, EUR J BIOCHEM, V212, P167, DOI 10.1111/j.1432-1033.1993.tb17647.x; Panizzon KL, 1996, NEUROREPORT, V7, P662, DOI 10.1097/00001756-199601310-00067; PASCHEN W, 1994, NEUROSCI LETT, V180, P5, DOI 10.1016/0304-3940(94)90900-8; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Povlishock J T, 1992, Hum Cell, V5, P345; PREMKUMAR DRD, 1995, J NEUROCHEM, V65, P1399; Richmon JD, 1998, BRAIN RES, V780, P108, DOI 10.1016/S0006-8993(97)01314-0; RIZZARDINI M, 1993, BIOCHEM J, V290, P343, DOI 10.1042/bj2900343; Sakurai M, 1997, J THORAC CARDIOV SUR, V113, P159, DOI 10.1016/S0022-5223(97)70411-2; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; SCHWARTZMAN AN, 1997, BIOCHEM PHARMACOL, V53, P1069; SHARMA HS, 1995, NEUROSCI RES, V21, P241, DOI 10.1016/0168-0102(94)00855-A; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; SMITH MA, 1995, MOL CHEM NEUROPATHOL, V24, P227, DOI 10.1007/BF02962147; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Takeda A, 1996, NEUROSCI LETT, V205, P169, DOI 10.1016/0304-3940(96)12405-8; Takizawa S, 1998, J CEREBR BLOOD F MET, V18, P559, DOI 10.1097/00004647-199805000-00011; THEODORAKIS NG, 1989, MOL CELL BIOL, V9, P3166, DOI 10.1128/MCB.9.8.3166; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87	74	31	33	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2000	166	2					254	265		10.1006/exnr.2000.7520			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	380PB	WOS:000165709300006	11085891				2022-02-06	
J	Thornton, K				Thornton, K			Improvement/rehabilitation of memory functioning with neurotherapy/QEEG biofeedback	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						auditory memory rehabilitation; EEG biofeedback; memory improvement; neurotherapy; QEEG biofeedback	CLOSED-HEAD-INJURY; REHABILITATION; REMEDIATION; PERFORMANCE; STRATEGIES; COMPLAINT; DISORDERS; PROGRAM	This article presents a new approach to the remediation of memory deficits by studying the electrophysiological functioning involved in memory and applying biofeedback techniques. A Quantitative EEG (QEEG) activation database was obtained with 59 right-handed subjects during two auditory memory tasks (prose passages and word lists). Memory performance was correlated with the QEEG variables. Clinical cases were administered the same QEEG activation study to determine their deviations from the values that predicted success for the reference group. EEG biofeedback interventions were designed to increase the value (to normal levels) of the specific electrophysiological variable that was related to successful memory function and deviant hi the subject. Case examples are presented that indicate the successful use of this intervention style in normal subjects and in subjects with brain injury; improvement cannot be fully explained by spontaneous recovery; given the time postinjury. Five cases (two normal, two subjects with brain injury, and one subject who had stereotactic surgery of the hippocampus for seizure control) are presented. Improvements ranged from 68% to 181% in the group of patients with brain injury, as a result of the interventions.	Ctr Hlth Psychol, S Plainfield, NJ 07080 USA		Thornton, K (corresponding author), Ctr Hlth Psychol, S Plainfield, NJ 07080 USA.			thornton, kirtley/0000-0002-3303-4747			Benedict R. H., 1992, J HEAD TRAUMA REHAB, V7, P83; BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; BEST DL, 1992, APPL COGNITIVE PSYCH, V6, P405, DOI 10.1002/acp.2350060505; Campbell DT., 1963, EXPT QUASI EXPT DESI; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; FRANZEN M D, 1991, Neuropsychology Review, V2, P29, DOI 10.1007/BF01108846; FREEMAN M R, 1992, Brain Injury, V6, P65, DOI 10.3109/02699059209008124; Grafman J, 1984, BEHAV ASSESSMENT TRE, P151; HARDT JV, 1978, SCIENCE, V201, P79, DOI 10.1126/science.663641; Linden Michael, 1996, BIOFEEDBACK SELF REG, V21; LUBAR JO, 1984, BIOFEEDBACK SELF-REG, V9, P1, DOI 10.1007/BF00998842; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P436; Mateer CA, 1990, COGNITIVE REHABILITA, P68; MATEER CA, 1988, NEUROPSYCHOLOGICAL S, P204; MATEER CA, 1992, REHABILITATION POSTC, P143; McKinlay W W, 1992, Brain Inj, V6, P107, DOI 10.3109/02699059209029649; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; OTHMER S, 1992, HANDOUT EEG SPECTRUM; PENICK EC, 1990, J CHEM DEPEND TREAT, V3, P1; PENISTON EG, 1991, MED PSYCHOTHERAPY, V4, P1; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Roland Per E, 1993, BRAIN ACTIVATION; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; STEINGASS HP, 1994, NEUROPSYCHOL REHABIL, V4, P49, DOI 10.1080/09602019408401455; Sterman MB, 2000, CLIN ELECTROENCEPHAL, V31, P45, DOI 10.1177/155005940003100111; TANSEY MA, 1991, AUST J PSYCHOL, V43, P147, DOI 10.1080/00049539108260139; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Thompson L, 1998, APPL PSYCHOPHYS BIOF, V23, P243, DOI 10.1023/A:1022213731956; THORNTON K, 2000, J NEUROTHER, V4; VANDAM G, 1986, AM J PSYCHOL, V99, P103, DOI 10.2307/1422307; WILSON M, 1991, ARCH VIROL         S, V2, P117; ZARIT SH, 1981, EDUC GERONTOL, V6, P11, DOI 10.1080/0380127810060102	35	31	32	0	4	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2000	15	6					1285	1296		10.1097/00001199-200012000-00008			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	378ZX	WOS:000165617400008	11056409				2022-02-06	
J	Kennedy, MRT; Yorkston, KM				Kennedy, MRT; Yorkston, KM			Accuracy of metamemory after traumatic brain injury: Predictions during verbal learning	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						brain injury memory; metamemory; unawareness; executive function	CLOSED-HEAD-INJURY; BRAIN INJURY; IMPAIRED AWARENESS; AMNESIC PATIENTS; MEMORY; JUDGMENTS; JOL; DEFICITS; ADULTS; SCALE	The primary intent of this study was to investigate the metamemory monitoring abilities of adult survivors of at least moderate traumatic brain injury (TBI) during a verbal-learning activity Eighteen survivors and 18 non-injured control participants made judgment-of-learning (JOL) predictions of their recall ability immediately after studying 3 lists of noun-pairs or after a slight delay. A secondary intent of this study was to determine if verbal retrieval attempts would enhance predictive accuracy. One half of participants made retrieval attempts during the second and third list-learning task, and the other half made retrieval attempts during the third list-learning task only. Measures of the correlation between JOL predictions and recall accuracy revealed that survivors were as accurate as controls when making delayed predictions and were less accurate when making immediate predictions. This occurred regardless of retrieval attempts. Absolute measures that compared mean JOL ratings to overall recall revealed that the survivor group was well-calibrated when making delayed JOL predictions but overestimated when making immediate JOL predictions. The non-injured control group underestimated when making both types of predictions. However, within-group variability was high. These findings are compared to those from studies that investigated metamemory beliefs in which survivors' ratings were compared to family-member ratings. Clinical implications for basing executive decisions about compensatory strategies on delayed and immediate predictions of Future recall are discussed. Additionally, a rationale is provided for the use of both relative and absolute measures of predictive accuracy in metamemory studies involving neurological clinical populations.	Univ Minnesota, Dept Commun Disorders, Minneapolis, MN 55455 USA; Univ Washington, Seattle, WA 98195 USA		Kennedy, MRT (corresponding author), Univ Minnesota, Dept Commun Disorders, 115 Shevlin Hall,164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	kenne047@tc.umn.edu					ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; AMMONS RB, 1979, PSYCHOL REP, V45, P943, DOI 10.2466/pr0.1979.45.3.943; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; CHIANG I, 1999, P RES EXP UND PROGR, P79; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DUNLOSKY J, 1992, MEM COGNITION, V20, P374, DOI 10.3758/BF03210921; DUNLOSKY J, 1994, J MEM LANG, V33, P545, DOI 10.1006/jmla.1994.1026; Dunlosky J, 1997, J MEM LANG, V36, P34, DOI 10.1006/jmla.1996.2476; DUNLOSKY J, 1997, J GERONTOL B-PSYCHOL, V52, P178; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming JM, 1996, BRAIN INJURY, V10, P1; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kelemen WL, 1997, J EXP PSYCHOL LEARN, V23, P1394, DOI 10.1037/0278-7393.23.6.1394; KENNEDY MR, 1995, AM J SPEECH-LANG PAT, V4, P159; Kertesz A., 1982, W APHASIA BATTERY; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LOVELACE EA, 1984, J EXP PSYCHOL LEARN, V10, P756, DOI 10.1037/0278-7393.10.4.756; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MCGLYNN SM, 1991, J COGNITIVE NEUROSCI, V3, P183, DOI 10.1162/jocn.1991.3.2.183; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; METCALF J, 1994, METACOGNITION; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nelson T. O., 1992, METACOGNITION CORE R; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; NELSON TO, 1994, PSYCHOL SCI, V5, P207, DOI 10.1111/j.1467-9280.1994.tb00502.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; NELSON TO, 1992, PSYCHOL SCI, V3, P317, DOI 10.1111/j.1467-9280.1992.tb00681.x; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; PARKER SA, 1976, ACTA NEUROCHIR, V34, P71, DOI 10.1007/BF01405864; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; REITAN RM, 1985, HALSTAD REITAN NEURO; ROTH DL, 1985, J CLIN PSYCHOL, V41, P521, DOI 10.1002/1097-4679(198507)41:4<521::AID-JCLP2270410412>3.0.CO;2-N; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; SCHACTER DL, 1991, AWARENESS DEFICIT BR, P127; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; Stuss D., 1991, AWARENESS DEFICIT BR, P63; TEASDALE G, 1974, LANCET, V2, P81; Trosset M W, 1996, J Int Neuropsychol Soc, V2, P315; Wechsler D, 1987, MEMORY SCALE REVISED; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005; [No title captured]	56	31	33	0	3	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1092-4388			J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	OCT	2000	43	5					1072	1086		10.1044/jslhr.4305.1072			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	365ZC	WOS:000089979500002	11063231				2022-02-06	
J	Dewey, ME; Parker, CJ				Dewey, ME; Parker, CJ		Med Res Council Cognitive Function; Analysis Grp MRC-CFA Study	Survey into health problems of elderly people: a comparison of self-report with proxy information	INTERNATIONAL JOURNAL OF EPIDEMIOLOGY			English	Article						elderly; health problems; self report and proxy information	SURROGATE RESPONDENTS; ALZHEIMERS-DISEASE; FUNCTIONAL STATUS; AGREEMENT; COMPARABILITY	Background This study was conducted as part of the Medical Research Council Cognitive Function and Ageing Study. Objective To compare information given by elderly people on their past and current health and family history of illness with similar information obtained from a relative, friend or carer. Design Screening and assessment stages of a prevalence study. Setting Three urban and two rural areas of England and Wales. Participants A subsample weighted by age and cognitive status of random population samples of people greater than or equal to 65 years, living in their own home or in a residential or nursing home, interviewed between 1991 and 1994. A relative, friend or carer identified by each elderly person to provide proxy information. Interview Computerized schedules including items on demographic details, cognitive function, lifetime illnesses, current health problems and family history of illness. Results The rate of proxy 'don't know' responses and the agreement between the elderly person and their proxy were calculated for each item, both for the overall sample and for subgroups based on characteristics of the respondent and of the proxy and on the relationship between them. Higher 'don't know' rates were found to be particularly associated with more distant relationships, questions on family history, a shorter length of time known and a lack of co-residence. Agreement was strongly related to the nature of the question and less to co-residence, with other factors such as relationship having much smaller effects. Conclusions Proxy information on past and current health problems can be almost complete and in good agreement with self-report, particularly where the proxy lives with the respondent. On family history of illness, history of head injury or boxing and current sleep problems, proxy information is likely to be less complete and show poor agreement. A proxy who is not a close relative is likely to give less complete information but agreement will not be substantially lower.	Queens Med Ctr, Sch Med, Inst Hlth Serv Res, Nottingham NG7 2UH, England		Dewey, ME (corresponding author), Queens Med Ctr, Sch Med, Inst Hlth Serv Res, Nottingham NG7 2UH, England.		Dewey, Michael E/E-2049-2010	Dewey, Michael E/0000-0002-7522-3677			Brayne C, 1998, PSYCHOL MED, V28, P319; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; FLEISS JL, 1975, BIOMETRICS, V31, P651, DOI 10.2307/2529549; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HALABI S, 1992, INT J EPIDEMIOL, V21, P607, DOI 10.1093/ije/21.3.607; HERRMANN N, 1985, AM J EPIDEMIOL, V121, P937, DOI 10.1093/oxfordjournals.aje.a114064; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; KORTEN AE, 1992, INT J EPIDEMIOL, V21, P1121, DOI 10.1093/ije/21.6.1121; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; Magaziner J, 1987, Compr Gerontol B, V1, P118; PICKLE LW, 1983, AM J EPIDEMIOL, V118, P99, DOI 10.1093/oxfordjournals.aje.a113621; ROCCA WA, 1986, J CHRON DIS, V39, P907, DOI 10.1016/0021-9681(86)90039-1; RUBENSTEIN LZ, 1984, J GERONTOL, V39, P686, DOI 10.1093/geronj/39.6.686; VANDUIJN CM, 1993, INT J EPIDEMIOL, V22, P838	16	31	31	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0300-5771			INT J EPIDEMIOL	Int. J. Epidemiol.	AUG	2000	29	4					684	697					14	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	349WW	WOS:000089069400012	10922346				2022-02-06	
J	Kulkarni, M; Armstead, WM				Kulkarni, M; Armstead, WM			Superoxide generation links nociceptin/orphanin FQ (NOC/oFQ) release to impaired N-methyl-D-aspartate cerebrovasodilation after brain injury	STROKE			English	Article						cerebral circulation; excitatory amino acids; newborn; opioids; oxygen free radicals; pigs	PIAL ARTERY VASODILATION; CEREBRAL ARTERIOLAR DILATION; OPIOID RECEPTOR FAMILY; ACTIVATION; NEWBORN; PIGLETS; CLONING; MEMBER; LOCALIZATION; RESPONSES	Background and Purpose-Although activation of the N-methyl-D-aspartate (NMDA) receptor is thought to contribute to altered cerebrovascular regulation after traumatic brain injury, the effects of such injury on the vascular response to NMDA itself has been less well appreciated. The newly described opioid nociceptin/orphanin FQ (NOC/oFQ) elicits pial artery dilation, at least in part, in a prostaglandin-dependent manner and is released into cerebrospinal fluid after fluid percussion brain injury (FPI). Generation of superoxide anion (O-2(-)) occurs after FPI, and a byproduct of cyclooxygenase metabolism is the generation of O-2(-). This study was designed to determine whether NOC/oFQ generates O-2(-), which in turn could link NOC/oFQ release to impaired NMDA-induced pi:ll :artery dilation after FPI. Methods-Injury of moderate severity (1.9 to 2.1 atm) was produced by the lateral FPI technique in anesthetized newborn pigs equipped with a closed cranial window. Superoxide dismutase-inhibitable nitroblue tetrazolium (NBT) reduction was determined as an index of O-2(-) generation. Results-Under non-brain injury conditions, topical NOC/oFQ (10(-10) mol/L, the concentration present in cerebrospinal fluid after FPI) increased superoxide dismutase-inhibitable NET reduction from 1+/-1 to 20+/-3 pmol/mm(2) but had no effect itself on pial artery diameter. Indomethacin (5 mg/kg IV) blunted such NET reduction (1 +/- 1 to 6+/-2 pmol/mm(2)), whereas the NOC/oFQ receptor antagonist [F/G] NOC/oFQ (1-13) NH2 (10(-6) mol/L) blocked NET reduction. [F/G] NOC/oFQ (1-13) NH2 and indomethacin also blunted the NET reduction observed after FPI (1+/-1 to 15+/-1 versus 1+/-1 to 4+/-1 versus 1+/-1 to 4+/-1 pmol/mm(2) for sham, NOC/oFQ antagonist, and indomethacin-treated animals, respectively). NMDA (10(-8) and 10(-6) mol/L)-induced pial artery dilation was reversed to vasoconstriction after FPI, and [F/G] NOC/oFQ (1-13) NH, attenuated such vasoconstriction (sham 9+/-1% and 16+/-1% versus Fm -7+/-1% and -12+/-1% versus FPI-[F/G] NOC/oFQ (1-13) NH2-pretreated animals -2+/-1% and -3+/-1%). Indomethacin and the free radical scavengers polyethylene glycol superoxide dismutase and catalase also partially restored NMDA-induced vasodilation. Conclusions-These data show that NOC/oFQ, in concentrations present in cerebrospinal fluid after FPI, increased O-2(-) production in a cyclooxygenase-dependent manner and contributes to such production after FPI, These data show that NOC/oFQ contributes to impaired NMDA-induced pial artery dilation after FPI, Therefore, these data suggest that cyclooxygenase-dependent O-2(-) generation links NOC/oFQ release to impaired NMDA-induced cerebrovasodilation after brain injury.	Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia, 3400 Spruce St, Philadelphia, PA 19104 USA.	armsteaw@mail.med.upenn.edu					Armstead WM, 2000, BRAIN RES, V859, P104, DOI 10.1016/S0006-8993(00)01949-1; Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH1272; ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 1999, BRAIN RES, V835, P315, DOI 10.1016/S0006-8993(99)01623-6; Armstead WM, 1997, P SOC EXP BIOL MED, V214, P210; Bari F, 1998, BRAIN RES, V780, P237, DOI 10.1016/S0006-8993(97)01196-7; Bari F, 1996, STROKE, V27, P1634, DOI 10.1161/01.STR.27.9.1634; Busija DW, 1996, AM J PHYSIOL-HEART C, V270, pH1225, DOI 10.1152/ajpheart.1996.270.4.H1225; CHEN Y, 1994, FEBS LETT, V347, P279, DOI 10.1016/0014-5793(94)00560-5; Faber ESL, 1996, BRIT J PHARMACOL, V119, P189, DOI 10.1111/j.1476-5381.1996.tb15969.x; FARACI FM, 1993, CIRC RES, V72, P476, DOI 10.1161/01.RES.72.2.476; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; FUKUDA K, 1994, FEBS LETT, V343, P42, DOI 10.1016/0014-5793(94)80603-9; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Guerrini R, 1998, BRIT J PHARMACOL, V123, P163, DOI 10.1038/sj.bjp.0701640; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; Kapusta DR, 1999, J PHARMACOL EXP THER, V289, P173; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LEFFLER CW, 1990, AM J PHYSIOL, V259, pH1230, DOI 10.1152/ajpheart.1990.259.4.H1230; LESCOHIER I, 1993, PEDIATRICS, V91, P721; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; MILLER JD, 1994, LANCET, V344, P421; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Nicol B, 1996, BRIT J PHARMACOL, V119, P1081, DOI 10.1111/j.1476-5381.1996.tb16007.x; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Thorogood MC, 1996, ANESTHESIOLOGY, V84, P614, DOI 10.1097/00000542-199603000-00017; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; Veltkamp R, 1999, STROKE, V30, P148, DOI 10.1161/01.STR.30.1.148; WEI EP, 1986, AM J PHYSIOL, V251, pH693, DOI 10.1152/ajpheart.1986.251.4.H693; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781; Zhao J, 1998, NEUROREPORT, V9, P631, DOI 10.1097/00001756-199803090-00013	36	31	31	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	AUG	2000	31	8					1990	1996		10.1161/01.STR.31.8.1990			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	340UP	WOS:000088553600039	10926968	Bronze			2022-02-06	
J	Eker, C; Schalen, W; Asgeirsson, B; Grande, PO; Ranstam, J; Nordstrom, CH				Eker, C; Schalen, W; Asgeirsson, B; Grande, PO; Ranstam, J; Nordstrom, CH			Reduced mortality after severe head injury will increase the demands for rehabilitation sevices	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-LESIONS; INTRACRANIAL HYPERTENSION; SOCIAL-ADJUSTMENT; SELF-REPORT; PSYCHIATRIC-ILLNESS; VOLUME REGULATION; THERAPY; DIHYDROERGOTAMINE; RECOVERY; CIRCULATION	Primary objective: In 1989, a new therapy to reduce intracranial pressure in severely head-injured patients was introduced in Lund. The new treatment reduced mortality significantly. The present study describes the quality of life for the survivor; Methods and procedures: The study includes 53 patients treated during 1989-1994, according to a new treatment protocol for increased intracranial pressure ('Lund concept' group). During 1982-1986, 38 patients were managed according to a protocol including high dose thiopentone ('Thiopentone' group). The two groups are compared regarding neurophysical and psychiatric symptoms as well as aspects regarding the patient's role, performance, interpersonal relationship, frictions, feelings and satisfaction in work, areas of social and leisure activities, and extended family. Results: Mortality was reduced from 47% to 8%, but the number of patients with a persistent vegetative state and/or remaining severe disability did not increase. However, the number of patients with persisting emotional and intellectual deficits increased significantly. Conclusion: The new treatment regime has dramatically increased the number of survivors after severe head trauma. Although most patients have a favourable outcome, there are more patients with remaining sequelae and disabilities, and the demand for qualified rehabilitation has increased.	Univ Lund Hosp, Dept Clin Neurosci, S-22185 Lund, Sweden		Eker, C (corresponding author), Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden.	carl-henrik.nordstrom@neurokir.lu.se	Ranstam, Jonas/A-4386-2009	Ranstam, Jonas/0000-0002-8287-7273			ASBERG M, 1978, ACTA PSYCHIAT SCAND, V271, P1; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P922, DOI 10.1111/j.1399-6576.1995.tb04199.x; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; Bond M R, 1975, Ciba Found Symp, P141; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; GLASS RM, 1978, ARCH GEN PSYCHIAT, V35, P1189; GOLDBERG DP, 1976, BRIT J PSYCHIAT, V129, P61, DOI 10.1192/bjp.129.1.61; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; HANSSON L, 1994, SOC PSYCH PSYCH EPID, V29, P83; HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MELLANDER S, 1970, CLIN SCI, V39, P183, DOI 10.1042/cs0390183; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; NILSSON F, 1995, ACTA ANAESTH SCAND, V39, P916, DOI 10.1111/j.1399-6576.1995.tb04198.x; Nilsson F, 1997, ACTA ANAESTH SCAND, V41, P1257, DOI 10.1111/j.1399-6576.1997.tb04641.x; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SCHALEN W, 1992, ACTA NEUROCHIR, V117, P153, DOI 10.1007/BF01400613; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; TEASDALE G, 1974, LANCET, V2, P81; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEISSMAN MM, 1978, J NERV MENT DIS, V166, P317, DOI 10.1097/00005053-197805000-00002; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; WHITLOCK J A JR, 1992, Brain Injury, V6, P447, DOI 10.3109/02699059209008140; WINOKUR A, 1984, BRIT J PSYCHIAT, V144, P395, DOI 10.1192/bjp.144.4.395; [No title captured]	45	31	31	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2000	14	7					605	619					15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	335AV	WOS:000088220600002	10914643				2022-02-06	
J	Serradji, N; Bensaid, O; Martin, M; Kan, E; Dereuddre-Bosquet, N; Redeuilh, C; Huet, J; Heymans, F; Lamouri, A; Clayette, P; Dong, CZ; Dormont, D; Godfroid, JJ				Serradji, N; Bensaid, O; Martin, M; Kan, E; Dereuddre-Bosquet, N; Redeuilh, C; Huet, J; Heymans, F; Lamouri, A; Clayette, P; Dong, CZ; Dormont, D; Godfroid, JJ			Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication	JOURNAL OF MEDICINAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; BIOLOGICAL-ACTIVITY; HUMAN MONOCYTES; TNF-ALPHA; RECEPTOR; DESIGN; RP-55778; EXPRESSION	Excessive levels of PAF and cells of macrophage lineage appear to play an important role in neuronal cell injury, inflammatory syndrome, and HIV replication in CNS resulting in AIDS dementia complex (ADC). The beneficial effects of PAF receptor antagonists are evident and give rise to expected therapeutic strategies for neurotrauma. Piperazine derivatives bearing a "cache-oreilles" (ear-muff) electronic distribution are able to inhibit in vitro PAF effects and, thus, could be used in pathologies where this mediator is involved. Therefore, their potential anti-HIV activity was investigated, and we find that (i) these PAF antagonists are effectively active in HIV-infected monocyte-derived macrophages (MDM) but there is no correlation between both anti-HIV and anti-PAF activities; (ii) the presence of a carbamate function (compounds 1a-d) is favorable to the antiviral activity; (iii) the lipophilicity of the substituent on the piperazinic cycle seems to be less important for the anti-PAF activity than for the antiviral one. Our leading compound, PMS 601 (compound la), presents a dual activity with IC50 of 8 and 11 mu M for anti-PAF and anti-HIV activity, respectively, without cytotoxic events at 1000 mu M in MDM. Although its mode of action is not clearly defined, these data suggest that PMS 601, which displays no effect on acellular reverse transcriptase or protease tests, deserves further investigation in the treatment of HIV-1-associated dementia.	Univ Paris 07, Lab Pharmacochim Mol, Unite Rech Pharmacochim Mol & Syst Membranaires, F-75251 Paris 05, France; CEA, Serv Neurovirol, DSV DRM, CRSSA, F-92265 Fontenay Aux Roses, France; SPI BIO, F-91741 Massy, France		Godfroid, JJ (corresponding author), Univ Paris 07, Lab Pharmacochim Mol, Unite Rech Pharmacochim Mol & Syst Membranaires, Case 7066,2 Pl Jussieu, F-75251 Paris 05, France.		Serradji, Nawal/AAJ-9599-2020				BATT JP, 1991, J LIPID MEDIATOR, V4, P343; BINISTI C, 1996, J LIPID MEDIAT CELL, V15, P125; Bouras A, 1999, J MED CHEM, V42, P957, DOI 10.1021/jm9803976; CAZENAVE JP, 1979, LAB INVEST, V41, P275; Dagenais P, 1997, J LEUKOCYTE BIOL, V61, P106, DOI 10.1002/jlb.61.1.106; DEREUDDREBOSQUE.N, 1997, AIDS RES HUM RETROV, V13, P9961; DIVE G, 1989, J LIPID MEDIATOR, V1, P201; Enting RH, 1998, AIDS, V12, P1941, DOI 10.1097/00002030-199815000-00005; FIDGOR CG, 1983, CELL BIOPHYS, V5, P105; FLOCH A, 1989, J LIPID MEDIATOR, V1, P349; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GELBARD HA, 1994, J VIROL, V68, P4628, DOI 10.1128/JVI.68.7.4628-4635.1994; HANSCH C, 1973, J MED CHEM, V16, P1207, DOI 10.1021/jm00269a003; Heymans F, 1997, J LIPID MEDIAT CELL, V15, P161, DOI 10.1016/S0929-7855(96)00550-0; HOWARD AD, 1995, CELL IMMUNOL, V164, P105, DOI 10.1006/cimm.1995.1148; Johnson CD, 1999, DIGEST SURG, V16, P93, DOI 10.1159/000018699; Karber G., 1931, ARCH EXP PATHOL PHAR, V162, P956; Kolson DL, 1998, ADV VIRUS RES, V50, P1, DOI 10.1016/S0065-3527(08)60804-0; LAMOTTEBRASSEUR J, 1991, LIPIDS, V26, P1167, DOI 10.1007/BF02536524; LAMOURI A, 1993, J MED CHEM, V36, P990, DOI 10.1021/jm00060a006; LENAOUR R, 1994, J GEN VIROL, V75, P1379, DOI 10.1099/0022-1317-75-6-1379; LeTexier L, 1996, J LIPID MEDIAT CELL, V13, P207; MARTIN M, UNPUB ANTIMICROB AGE; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; REKKER RF, 1979, EUR J MED CHEM, V14, P479; REY MA, 1984, BIOCHEM BIOPH RES CO, V121, P126, DOI 10.1016/0006-291X(84)90696-X; ROLAPLESZCZYNSKI M, 1990, J LIPID MEDIATOR, V2, pS77; Schifitto G, 1999, NEUROLOGY, V53, P391, DOI 10.1212/WNL.53.2.391; SEDIVY P, 1985, PROSTAGLANDINS, V30, P688, DOI 10.1016/0090-6980(85)90032-2; Tavet F, 1997, J LIPID MEDIAT CELL, V15, P145, DOI 10.1016/S0929-7855(96)00551-2; Walh L. M., 1989, P NATL ACAD SCI USA, V86, P621; WEISSMAN D, 1993, P NATL ACAD SCI USA, V90, P2537, DOI 10.1073/pnas.90.6.2537	32	31	35	0	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-2623			J MED CHEM	J. Med. Chem.	JUN 1	2000	43	11					2149	2154		10.1021/jm9911276			6	Chemistry, Medicinal	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	320XG	WOS:000087425700008	10841793				2022-02-06	
J	Masumura, M; Hata, R; Uramoto, H; Murayama, N; Ohno, T; Sawada, T				Masumura, M; Hata, R; Uramoto, H; Murayama, N; Ohno, T; Sawada, T			Altered expression of amyloid precursor proteins after traumatic brain injury in rats: In situ hybridization and immunohistochemical study	JOURNAL OF NEUROTRAUMA			English	Article						amyloid precursor protein; Alzheimer's disease; amyloid-beta protein; immunohistochemistry; in situ hybridization; traumatic brain injury	PROTEASE INHIBITOR DOMAIN; TRANSIENT FOCAL ISCHEMIA; BETA-APP METABOLISM; SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; MESSENGER-RNA; CEREBRAL-ISCHEMIA; AXONAL DAMAGE; DIFFERENTIAL EXPRESSION; SELECTIVE INDUCTION	The expression of alternatively spliced mRNAs for amyloid precursor protein (APP) isoforms and their translation products were examined in the rat cerebral cortex 1, 3, 6, and 12 h and 1, 3, and 7 days (12 = 4-5 in each group) after fluid-percussion brain injury. In situ hybridization studies demonstrated that the expression of APP695 mRNA decreased in and around the damaged area of the cerebral cortex exposed to fluid-percussion injury 1 h after the insult. On the other hand, APP751/770 mRNAs were increased in the regions surrounding the damaged cortical areas 1 day after the injury. An increase of immunoreactive APP was detected in the regions around the damaged cortical areas 3 h after traumatic injury and maintained for the following 3 days. The APP immunoreactivity in the damaged cortices declined to the level of sham-operated animals by post-experimental day 7, Using an anti-amyloid beta (A beta) protein (17-24) antibody, no deposits of immunoreactive A beta (17-24) were observed in any of the samples examined in these experiments. These results suggest that the induction of Kunitz-type protease inhibitor (KPI) domain-containing APP mRNAs and the increased accumulation of APP are involved in the physiological and neuropathological responses of brains under various neurodegenerative conditions, including head trauma.	Natl Cardiovasc Ctr, BF Res Inst, Suita, Osaka 5650873, Japan; Suntory Inst Biomed Res, Osaka, Japan		Masumura, M (corresponding author), Natl Cardiovasc Ctr, BF Res Inst, 7-1,5 Chome, Suita, Osaka 5650873, Japan.						ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; ALLSOP D, 1990, AM J PATHOL, V136, P255; Apelt J, 1997, INT J DEV NEUROSCI, V15, P95, DOI 10.1016/S0736-5748(96)00073-1; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; BRUGG B, 1995, P NATL ACAD SCI USA, V92, P3032, DOI 10.1073/pnas.92.7.3032; DENMAN R, 1991, ARCH BIOCHEM BIOPHYS, V288, P29, DOI 10.1016/0003-9861(91)90161-B; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Graham DI, 1996, ACT NEUR S, V66, P96; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; HOLTZMAN DM, 1992, EMBO J, V11, P619, DOI 10.1002/j.1460-2075.1992.tb05094.x; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; JOHNSON SA, 1990, SCIENCE, V248, P854, DOI 10.1126/science.2111579; KALARIA RN, 1993, NEUROREPORT, V4, P211, DOI 10.1097/00001756-199302000-00025; KANG J, 1990, BIOCHEM BIOPH RES CO, V166, P1192, DOI 10.1016/0006-291X(90)90992-V; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; Kim HS, 1998, NEUROREPORT, V9, P533; Koistinaho J, 1996, NEUROREPORT, V7, P2727, DOI 10.1097/00001756-199611040-00064; Komori N, 1997, MOL BRAIN RES, V49, P103, DOI 10.1016/S0169-328X(97)00133-2; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; Masumura M, 1996, NEUROSCI LETT, V213, P119, DOI 10.1016/0304-3940(96)12841-X; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, P28; MULLAN M, 1993, TRENDS NEUROSCI, V16, P398, DOI 10.1016/0166-2236(93)90007-9; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; NAKAMURA Y, 1992, NEUROSCI LETT, V136, P95, DOI 10.1016/0304-3940(92)90656-R; Neve RL, 1996, MOL BRAIN RES, V39, P185, DOI 10.1016/0169-328X(96)00007-1; OConnell AW, 1997, NEUROCHEM INT, V30, P313, DOI 10.1016/S0197-0186(96)00052-6; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; OYAMA F, 1991, J NEUROPATH EXP NEUR, V50, P560, DOI 10.1097/00005072-199109000-00004; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; Pierce JES, 1996, J NEUROSCI, V16, P1083; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHEA TB, 1995, BRAIN RES REV, V20, P171, DOI 10.1016/0165-0173(94)00010-M; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SISODIA SS, 1994, AMYLOID PROTEIN PREC, P121; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; SOLA C, 1993, NEUROSCIENCE, V53, P267, DOI 10.1016/0306-4522(93)90304-X; STEPHENSON DT, 1992, BRAIN RES, V593, P128, DOI 10.1016/0006-8993(92)91274-I; TANAKA S, 1989, BIOCHEM BIOPH RES CO, V165, P1406, DOI 10.1016/0006-291X(89)92760-5; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; TOMIMOTO H, 1994, J CEREBR BLOOD F MET, V14, P565, DOI 10.1038/jcbfm.1994.70; TOPPER R, 1995, ACTA NEUROPATHOL, V89, P23; WAKITA H, 1992, NEUROSCI LETT, V146, P135, DOI 10.1016/0304-3940(92)90061-B; WALLACE W, 1993, P NATL ACAD SCI USA, V90, P8712, DOI 10.1073/pnas.90.18.8712; Wallace WC, 1997, MOL BRAIN RES, V52, P201, DOI 10.1016/S0169-328X(97)00258-1; Yam PS, 1997, BRAIN RES, V760, P150, DOI 10.1016/S0006-8993(97)00290-4; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; Yokota M, 1996, J CEREBR BLOOD F MET, V16, P1219, DOI 10.1097/00004647-199611000-00016; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	65	31	33	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2000	17	2					123	134		10.1089/neu.2000.17.123			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	286MB	WOS:000085448800002	10709870				2022-02-06	
J	Chang, RCC; Hudson, PM; Wilson, BC; Liu, B; Abel, H; Hong, JS				Chang, RCC; Hudson, PM; Wilson, BC; Liu, B; Abel, H; Hong, JS			High concentrations of extracellular potassium enhance bacterial endotoxin lipopolysaccharide-induced neurotoxicity in glia-neuron mixed cultures	NEUROSCIENCE			English	Article						glia; potassium; microglia; nitric oxide; tumor necrosis factor-alpha; cerebral inflammation	NITRIC-OXIDE SYNTHASE; TNF-ALPHA; MICROGLIAL ACTIVATION; SPREADING DEPRESSION; GENE-EXPRESSION; CELL-CULTURES; BRAIN; RAT; CHANNELS; INVOLVEMENT	A sudden increase in extracellular potassium ions (K+) often occurs in cerebral ischemia and after brain trauma. This increase of extracellular K+ constitutes the basis for spreading depression across the cerebral cortex, resulting in the expansion of neuronal death after ischemic and traumatic brain injuries. Besides spreading depression, it has become clear that cerebral inflammation also is a key factor contributing to secondary brain injury in acute neurological disorders. Experiments to validate the relationship between elevated levels of extracellular K+ and inflammation have not been studied. This study aims to elucidate the roles of high concentrations of extracellular K+ in bacterial endotoxin lipopolysaccharide-induced production of inflammatory factors. Increased concentration of KCl in the medium (20 mM) significantly enhanced neurotoxicity by lipopolysaccharide in glia-neuron mixed cultures. To delineate the underlying mechanisms of increased neurotoxicity, the effects of high extracellular K+ were examined by using mixed glial cultures. KCl at 20 mM significantly enhanced nitrite, an index for nitric oxide, production by about twofold, and was pronounced from 24 to 48 h, depending on the concentration of KCl. Besides nitric oxide production of tumor necrosis factor-alpha was also enhanced. The augmentative effects of high KCl on the production of inflammatory factors were probably due to the further activation of microglia, since high KCl also enhanced the production of tumor necrosis factor-alpha in microglia-enriched cultures. The increased production of nitrite by high K+ was eliminated through use of a K+-blocker. Taken together, the results show that increases of extracellular K+ concentrations in spreading depression augment lipopolysaccharide-elicited neurotoxicity, because production of inflammatory factors such as nitric oxide and tumor necrosis factor-alpha are potentiated. Since spreading depression and cerebral inflammation are important in acute neurological disorders, the present results suggest a biochemical mechanism: elevated extracellular K+ concentrations augment glial inflammatory responses, and thus the neurotoxicity. Published by Elsevier Science Ltd.	NIEHS, Neuropharmacol Sect, Lab Pharmacol & Chem, NIH, Res Triangle Pk, NC 27713 USA		Hong, JS (corresponding author), NIEHS, Neuropharmacol Sect, Lab Pharmacol & Chem, NIH, POB 12233 MFDF1-01, Res Triangle Pk, NC 27713 USA.	hong3@niehs.nih.gov	liu, Bin/A-7695-2009; Chang, Raymond Chuen-Chung/C-1107-2009; Hong, Jau-shyong/F-1920-2019	Chang, Raymond Chuen-Chung/0000-0001-8538-7993; Hong, Jau-shyong/0000-0002-3056-8401; Cope, Heidi/0000-0003-0586-9277			Abiru Y, 1998, BRAIN RES, V809, P115, DOI 10.1016/S0006-8993(98)00849-X; Andreeva N, 1996, EXP NEUROL, V137, P255, DOI 10.1006/exnr.1996.0024; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Bronstein DM, 1995, BRAIN RES, V704, P112, DOI 10.1016/0006-8993(95)01189-7; BUSCH E, 1995, NMR BIOMED, V8, P59, DOI 10.1002/nbm.1940080203; Chang RCC, 2000, BRAIN RES, V853, P236, DOI 10.1016/S0006-8993(99)02255-6; Chen W., 1998, Society for Neuroscience Abstracts, V24, P1615; CHUNG IY, 1992, J IMMUNOL, V149, P3894; CHUNG IY, 1991, J EXP MED, V173, P801, DOI 10.1084/jem.173.4.801; Coimbra C, 1996, STROKE, V27, P1578, DOI 10.1161/01.STR.27.9.1578; COLTON CA, 1994, AM J PHYSIOL, V266, pC1650, DOI 10.1152/ajpcell.1994.266.6.C1650; DAS KP, 1995, J NEUROIMMUNOL, V62, P9, DOI 10.1016/0165-5728(95)00083-E; Dawson DA, 1996, NEUROSCI LETT, V218, P41, DOI 10.1016/S0304-3940(96)13116-5; Eder C, 1998, J NEUROSCI, V18, P7127; Eder C, 1998, AM J PHYSIOL-CELL PH, V275, pC327, DOI 10.1152/ajpcell.1998.275.2.C327; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fiebich BL, 1998, J NEUROIMMUNOL, V92, P170, DOI 10.1016/S0165-5728(98)00201-X; Galea E, 1996, J NEUROIMMUNOL, V64, P19, DOI 10.1016/0165-5728(95)00143-3; Ginis I, 1999, AM J PHYSIOL-CELL PH, V276, pC1171, DOI 10.1152/ajpcell.1999.276.5.C1171; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; Illes P, 1996, NEUROCHEM INT, V29, P13; Jeohn GH, 1998, J NEUROIMMUNOL, V85, P1, DOI 10.1016/S0165-5728(97)00204-X; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; Koistinaho J, 1999, STROKE, V30, P114, DOI 10.1161/01.STR.30.1.114; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; MORIOKA T, 1991, J CEREBR BLOOD F MET, V11, P966, DOI 10.1038/jcbfm.1991.162; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Rostworowski M, 1997, J NEUROSCI, V17, P3664; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Sun D, 1998, J NEUROIMMUNOL, V89, P122, DOI 10.1016/S0165-5728(98)00124-6; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; Taniwaki Y, 1996, NEUROSCI LETT, V217, P29; UCHIYAMATSUYUKI Y, 1995, EUR J PHARM-ENVIRON, V293, P245, DOI 10.1016/S0922-4106(05)80050-1; WOOD PL, 1995, NEUROL RES, V17, P242, DOI 10.1080/01616412.1995.11740321	35	31	31	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2000	97	4					757	764		10.1016/S0306-4522(00)00059-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	324VH	WOS:000087641700016	10842021				2022-02-06	
J	Leon-Carrion, J; Dominguez-Roldan, JM; Murillo-Cabezas, F; Dominguez-Morales, MD; Munoz-Sanchez, MA				Leon-Carrion, J; Dominguez-Roldan, JM; Murillo-Cabezas, F; Dominguez-Morales, MD; Munoz-Sanchez, MA			The role of citicholine in neuropsychological training after traumatic brain injury	NEUROREHABILITATION			English	Article; Proceedings Paper	International Conference on Recent Advances in Neurotraumatology (ICRAN 99)	NOV 20-23, 1999	TAIPEI, TAIWAN			citicholine; memory; neuropsychological rehabilitation; rCBF; traumatic brain injury	CITICOLINE; MEMORY	Objective: To report new strategies in the treatment of persistent memory deficits following traumatic brain injury (TBI) using a combination of pharmacology and neuropsychological training. Study design: Two studies were carried out. The first study measured the regional cerebral blood how (rCBF) of seven Patients with TBI with very severe memory deficits, once while resting and once one hour after the administration of citicholine (CDPc). In the second study, two groups of five patients of the same characteristics underwent an ecological neuropsychological memory rehabilitation program; during which time, one group was administered a placebo (Group A), and the other received CDPc (1 g/d v.o.) (Group B). Results: The results of Experiment 1 showed a hypoperfusion of the inferior left temporal cerebral blood flow during rest state while an induced normalization was observed after administration of the drug. Results of Experiment 2 showed no improvements in Group A's neuropsychological functions, while memory, learning processes and verbal fluency of Group B improved significantly after treatment. Conclusions: CDP-choline seems to be a drug with special affinity for cerebral areas associated with memory acting just where needed, normalizing blood flow in the hypoperfused left temporo-basal region, and making neuropsychological training effective. In general, data suggests that cognitive rehabilitation would follow the principle of first restoring and maintaining cerebral blood flow in the lesional site and then exercising function. In this study on memory rehabilitation, memory recuperation was made possible by first normalizing blood flow at the lesional site and at the same time applying neuropsychological training.	Fac Psicol, Human Neuropsychol Lab, Dept Expt Psychol, Seville 41018, Spain; Hosp Traumatol Virgen Rocio, Intens Care Unit, Seville, Spain; Ctr Brain Injury Rehabil C RE CER, Seville, Spain; Hosp Traumatol Virgen Rocio, Crit Care Dept, Seville, Spain		Leon-Carrion, J (corresponding author), Fac Psicol, Human Neuropsychol Lab, Dept Expt Psychol, Av San Francisco Javier S-N, Seville 41018, Spain.	jleon@cica.es	Murillo-Cabezas, Francisco/AAO-3348-2021; Dominguez-Roldan, Jose-Maria/M-1728-2016; IBIS, NEUROCRITICOS/C-1805-2016	Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; 			AUBINEAU P, 1977, NEUROGENIC CONTROL B, P331; AZNERIC SP, 1998, BRAIN RES, V454, P11; Benton AL, 1974, REVISED VISUAL RETEN; BIEDERMAN GB, 1970, Q J EXP PSYCHOL, V22, P384, DOI 10.1080/14640747008401911; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; Christensen AL., 1975, LURIAS NEUROPSYCHOLO; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; De Blas A., 1986, MED CLIN-BARCELONA, V87, P41; DUCKLES SP, 1986, NEURAL REGULATION BR, P235; FONLUPT P, 1985, NOVEL BIOCH PHARM CL, P169; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Hamsher K., 1989, MULTILINGUAL APHASIA; HEISTAD DD, 1980, AM J PHYSIOL, V239, P437; LADD SL, 1990, 95 ANN M AM PSYCH AS; LEONCARRION J, 1997, NEUROPSYCHOLOGICAL; LEONCARRION J, 1994, 4 C PSYCH ASS SANT C, P73; LEONCARRION J, 1998, SEVILLA COMPUTERISED; LEVIN HS, 1992, NEUROPSYCHOLOGY MEMO; LEVIN HS, 1991, J NEUROL SCI S, V103, pS24; LOPEZ G, 1987, NEUROCHEM INT, V11, P293; LOPEZ G, 1992, J NEUROCHEM, V59, P338; LOPEZ G-COVIELLA I, 1992, Journal of Nutritional Biochemistry, V3, P313; LOZANO R, 1991, J NEUROL SCI S, V103, pS31; MAYES AR, 1998, HUMAN ORGANIC MEMORY; MILLER E, 1978, PRACTICAL ASPECTS ME; OBRIST WD, 1988, HDB REGIONAL CEREBRA, P37; OBRIST WD, 1975, STROKE, V6, P301; PETTIGREW LC, 1997, INT JOINT C STROK CE; RISBERG J, 1988, HDB REGIONAL CEREBRA; RISBERG J, 1975, STROKE, V6, P14; ROSENBERG GS, 1982, AM J CLIN NUTR, V36, P709, DOI 10.1093/ajcn/36.4.709; SCHACTER DL, 1986, CLIN NEUROPSYCHOLOGY; SIVAN AB, 1952, BENTON VISUAL RETENT; Spiers PA, 1996, ARCH NEUROL-CHICAGO, V53, P441, DOI 10.1001/archneur.1996.00550050071026; SQUIRE LR, 1971, J COMP PHYSIOL PSYCH, V74, P41, DOI 10.1037/h0030325; STANES MD, 1976, PSYCHOPHARMACOLOGIA, V46, P269, DOI 10.1007/BF00421113; *US WAR DEP, 1994, ARM IND TESTS MAN RE; WARRINGTON EK, 1986, DIS NERVOUS SYSTEM; WILSON BA, 1984, EVERYDAY MEMORY ACTI; WISHAW IQ, 1989, BRAIN RES B, V23, P247; WISHAW IQ, 1985, BEHAV NEUROSCI, V99, P979; WOOD JL, 1982, FED PROC, V41, P3015; [No title captured]	44	31	32	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2000	14	1					33	40					8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	323WV	WOS:000087588700005	11455066				2022-02-06	
J	Ippolito, E; Formisano, R; Caterini, R; Farsetti, P; Penta, F				Ippolito, E; Formisano, R; Caterini, R; Farsetti, P; Penta, F			Operative treatment of heterotopic hip ossification in patients with coma after brain injury	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								In 13 joints of 12 patients who sustained traumatic brain injury, heterotopic ossifications of the hip were surgically excised at an average of 15 months after the patients' recovery from coma. All of the patients were referred by neurologists of the postcoma unit who deemed surgery necessary to speed up the rehabilitation program of the patients, Before surgery, three patients were able to ambulate, whereas nine were not ambulatory, Eight hips were ankylosed, whereas five had a severe painful limitation of joint motion, All of the patients were checked at regular intervals after the operation, and the final followup averaged 38 months. In an attempt to prevent postoperative recurrence of ossification, 100 mg of indomethacin was administered daily after surgery for 6 weeks, At followup, 10 patients could ambulate and two were able to sit in a wheelchair. patients with poor neuromuscular control tended to lose part of their postoperative range of motion, and heterotopic periarticular ossification recurred in two of them (three hips), No correlation was found between recurrence and the time that elapsed from head injury to the operation, but old ossifications continued to show osteogenic activity at the histologic level.	Univ Roma Tor Vergata, Dept Orthoped Surg, Rome, Italy; IRCCS Santa Lucia, Postcoma Neurorehabil Unit, Rome, Italy		Ippolito, E (corresponding author), Via Cattaro 28, I-00198 Rome, Italy.						Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Knelles D, 1997, J BONE JOINT SURG BR, V79B, P596, DOI 10.1302/0301-620X.79B4.6829; MOED BR, 1994, J ORTHOP TRAUMA, V8, P34, DOI 10.1097/00005131-199402000-00008; Moore KD, 1998, J BONE JOINT SURG BR, V80B, P259, DOI 10.1302/0301-620X.80B2.8157; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; RANDELLI G, 1992, J BONE JOINT SURG AM, V74A, P1344, DOI 10.2106/00004623-199274090-00007; ROBERTS P H, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P70; SCHMIDT SA, 1988, J BONE JOINT SURG AM, V70A, P834, DOI 10.2106/00004623-198870060-00005; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71	13	31	32	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	AUG	1999		365					130	138		10.1097/00003086-199908000-00018			9	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	225PR	WOS:000081970400018	10627697				2022-02-06	
J	Kasher, A; Batori, G; Soroker, N; Graves, D; Zaidel, E				Kasher, A; Batori, G; Soroker, N; Graves, D; Zaidel, E			Effects of right- and left-hemisphere damage on understanding conversational implicatures	BRAIN AND LANGUAGE			English	Article							CLOSED HEAD-INJURY; DEFICITS; ABILITY	Processing of implicatures was examined in 27 right-brain-damaged (RBD) and 31 left-brain-damaged (LBD) stroke patients with focal lesions using a new implicatures battery (IB) as part of an exploration of the neural basis and modularity of natural language pragmatics. Following Grice, we sampled implicatures of Quantity, Quality, Relation, and Manner. Verbal implicatures consisted of two-sentence conversational vignettes which are literally problematic. Nonverbal implicatures consisted mostly of famous paintings that are literally problematic (e.g., Magritte's "Le Domain d'Arnheim"). The patient has to identify and solve the problem. To compare with performance on the IB, patients also received a Hebrew adaptation of Gardner and Brownell's Right Hemisphere Communication Battery, a new test of basic speech acts (verbal and nonverbal assertions, questions, requests, and commands), a Hebrew version of the Western Aphasia Battery, and standardized neuropsychological tests. Both LED and RED patients were significantly impaired in implicature processing relative to age-matched normal controls. In general, both patient groups showed weak correlations of implicatures with extents of lesions in left perisylvian language area or its right-hemisphere (RH) homolog. However, performance of LED and RED patients on the IB revealed different patterns of correlations with other pragmatic, language, and nonlanguage tests. In LED patients, there was a greater association between performance on verbal and nonverbal implicatures and between performance on implicatures and basic speech acts than in RED patients. Given the different modes in which right-and left-hemisphere (LK) damage affect the processing of conversational implicatures, it remains to be discovered how the two hemispheres interact to process natural language pragmatics in the normal brain in real time, (C) 1999 Academic Press.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Tel Aviv Univ, Dept Philosophy, Ramat Aviv, Israel; Tel Aviv Univ, Dept Psychol, Ramat Aviv, Israel; Tel Aviv Univ, Loewenstein Rehabil Hosp, Ramat Aviv, Israel; Acad Coll Tel Aviv Jaffa, Tel Aviv, Israel		Zaidel, E (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.		Soroker, Nachum/V-7094-2019	Soroker, Nachum/0000-0003-4909-5576	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS20187] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS020187] Funding Source: NIH RePORTER		AHLSEN E, 1993, J PRAGMATICS, V19, P57, DOI 10.1016/0378-2166(93)90070-6; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Brownell H, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P309; BROWNELL HH, 1986, BRAIN LANG, V27, P310, DOI 10.1016/0093-934X(86)90022-2; Fodor J.A., 1983, MODULARITY MIND; Gardner H, 1986, RIGHT HEMISPHERE COM; Grice H.P., 1989, STUDIES WAYS WORDS; GRICE HP, 1975, SPEECH ACTS, P41; KASHER A, 1991, J PRAGMATICS, V16, P381, DOI 10.1016/0378-2166(91)90132-H; KASHER A, 1984, J PRAGMATICS, V8, P539, DOI 10.1016/0378-2166(84)90041-9; Kasher A., 1982, PHILOSOPHICA, V29, P25; Kasher A., 1998, PRAGMATICS CRITICAL; Kasher A., 1976, LANGUAGE FOCUS, P197; Kasher A., 1991, CHOMSKYAN TURN, P122; Kertesz A, 1979, APHASIA ASS DISORDER; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; Raven J., 1965, COLOURED PROGR MATRI; SPENCE SJ, 1990, J CLIN EXPT NEUROPSY, V12, P42; Sperber D., 1995, RELEVANCE COMMUNICAT; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TALAIRACH J, 1988, COPLANOR STEREOTAXIC; Tompkins C.A., 1995, RIGHT HEMISPHERE COM; VANDERVEKEN D, 1990, MEANING SPEECH ACTS, V1, P103; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; ZAIDEL E, UNPUB EFFECTS RIGHT; ZAIDEL E, UNPUB HEMISPHERIC CO; ZAIDEL E, 1988, ACAD APH ABSTR, V26, P69	32	31	37	0	9	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X			BRAIN LANG	Brain Lang.	JUL	1999	68	3					566	590		10.1006/brln.1999.2129			25	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	226TE	WOS:000082037100012	10441195				2022-02-06	
J	Morita-Fujimura, Y; Fujimura, M; Kawase, M; Murakami, K; Kim, GW; Chan, PH				Morita-Fujimura, Y; Fujimura, M; Kawase, M; Murakami, K; Kim, GW; Chan, PH			Inhibition of interleukin-1 beta converting enzyme family proteases (caspases) reduces cold injury-induced brain trauma and DNA fragmentation in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cold injury; caspase inhibitor; neuronal apoptosis; vasogenic edema	CUZN-SUPEROXIDE-DISMUTASE; FOCAL CEREBRAL-ISCHEMIA; CYTOCHROME-C; TRANSGENIC MICE; CELL-DEATH; ICE/CED-3 PROTEASE; EDEMA FORMATION; NEURONAL DEATH; APOPTOSIS; DAMAGE	The authors examined the effect of z-VAD.FMK, an inhibitor that blocks caspase family proteases, on cold injury-induced brain trauma, in which apoptosis as well as necrosis is assumed to play a role. A vehicle alone or with zVAD.FMK was administered into the cerebral ventricles of mice 15 minutes before and 24 and 48 hours after cold injury. At 24 hours after cold injury, infarction volumes in the zVAD.FMK-treated animals were significantly smaller than infarction volumes in the vehicle-treated animals, and were further decreased at 72 hours (0.92 +/- 1.80 mm(3), z-VAD.FMK treated animals: 7.46 +/- 3.53 mm(3), vehicle-treated animals: mean +/- SD, n = 7 to 8). The amount of DNA fragmentation was significantly decreased in the z-VAD.FMK-treated animals compared with the vehicle-treated animals, as shown by terminal deoxynucleotidyl transferase-mediated uridine 5'-triphosphate-biotin nick end labeling staining and DNA gel electrophoresis. By Western blot analysis, both the proform and activated form of interleukin-1 beta converting enzyme (caspase 1) were detected in the control brain, and the activated form showed moderate reduction after sold injury-induced brain trauma. These results indicate that caspase inhibitors could reduce cold injury-induced brain trauma by preventing neuronal cell death by DNA damage. The caspase family pretenses appear to contribute to the mechanisms of cell death in cold injury-induced brain trauma and to provide therapeutic targets for traumatic brain injury.	Stanford Univ, Neurosurg Labs, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Neurol Sci, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Program Neurosci, Palo Alto, CA 94304 USA		Chan, PH (corresponding author), Stanford Univ, Neurosurg Labs, Sch Med, Dept Neurosurg, 701B Welch Rd,148, Palo Alto, CA 94304 USA.		fujimura, yuiko/M-7393-2013; Morita-fujimura, Yuiko/N-4804-2014		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS14543, NS25372, NS36147] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS014543, P01NS014543, R01NS036147, R01NS025372] Funding Source: NIH RePORTER		Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Cain K, 1996, BIOCHEM J, V314, P27, DOI 10.1042/bj3140027; CHAN PH, 1995, J NEUROTRAUM, V12, P815, DOI 10.1089/neu.1995.12.815; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; D'Mello SR, 1998, J NEUROCHEM, V70, P1809; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kondo T, 1997, J NEUROSCI, V17, P4180; Liu PK, 1996, J NEUROSCI, V16, P6795; Loddick SA, 1996, NEUROREPORT, V7, P1465, DOI 10.1097/00001756-199606170-00004; Murakami K, 1997, NEUROSCIENCE, V81, P231, DOI 10.1016/S0306-4522(97)00197-8; Murakami K, 1997, ACT NEUR S, V70, P234; Namura S, 1998, J NEUROSCI, V18, P3659; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; OPPENHEIM RW, 1990, DEV BIOL, V138, P104, DOI 10.1016/0012-1606(90)90180-Q; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Thornberry NA, 1997, BRIT MED BULL, V53, P478; THORNBERRY NA, 1994, BIOCHEMISTRY-US, V33, P3934, DOI 10.1021/bi00179a020; TOMINAGA T, 1992, NEUROSCI LETT, V139, P265, DOI 10.1016/0304-3940(92)90568-R; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	34	31	36	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	1999	19	6					634	642		10.1097/00004647-199906000-00006			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	277TB	WOS:000084948700006	10366193	Bronze			2022-02-06	
J	Deb, S				Deb, S			ICD-10 codes detect only a proportion of all head injury admissions	BRAIN INJURY			English	Article								Despite criticism, the codes covering traumatic brain injury under the international Classification of Diseases have been widely used for sample collection in the epidemiological studies of head injury. Data have been collected from an Accident and Emergency department's (A&E's) case register on all head injury admissions to hospitals from a defined geographic area between 1 April 1996 and 31 March 1997, and compared with the list collected from the heath authority's central database by using the ICD-10 codes. Thirty seven per cent of the names in the A&E register appeared in the ICD-10 list, and 41% of the names in the ICD-10 list appeared in the list collected from the A&E department. The incidence of reported head injury was found to be three times higher among the 0-15 years age group compared with the 16-64 years age group (3.3% compared with 1% of the population). Among the 16-64 years age group, the peak rates of admission to hospital were in the months of February and August. Approximately 14% of all the head injury admissions stayed in hospital for more than 72 hours, another 14% stayed between 48 and 72 hours, and the rest (72%) stayed for less than 48 hours.	Cardiff Univ, Cardiff CF4 4XN, S Glam, Wales		Deb, S (corresponding author), Cardiff Univ, Heath Pk, Cardiff CF4 4XN, S Glam, Wales.	Deb@Cardiff.ac.uk		Deb, Shoumitro/0000-0002-1300-8103			ANDERSON DW, 1980, J NEUROSURG, V53, pS11; Caveness W F, 1979, Adv Neurol, V22, P1; GRAVES E, 1989, VITAL HLTH STAT SER, V13; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; *OFF POP CENS SURV, 1987, HOSP IN PAT ENQ; *PHS HEALTHC FIN A, CLIN MOD, V1; *WHO, 1978, INT CLASS DIS 9 REV; World Health Organization, 1992, INT CLASS DIS 10 REV	8	31	31	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	1999	13	5					369	373		10.1080/026990599121557			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	200LE	WOS:000080541100005	10367147				2022-02-06	
J	Karlsson, T				Karlsson, T			Multivariate analysis ('forensiometrics') - a new tool in forensic medicine. Differentiation between firearm-related homicides and suicides	FORENSIC SCIENCE INTERNATIONAL			English	Article							FATALITIES	A forensiometric model to discriminate between homicidal and suicidal firearm-fatalities is presented. It is based on a survey of all 45 homicidal and 251 suicidal firearm-fatalities that were examined at the Department of Forensic Medicine in Stockholm, Sweden during the period 1983-92. The model used 15 variables to describe 19.8% of the variation in the data and its goodness of prediction, Q(2), was 0.742. The variables ranked in falling order of covariation with homicide (i.e. correlation with or importance in the prediction of homicide) were: presence of other injuries than firearm-wounds, entrance wound in the front part of the chest except precordium, bullet path through clothes, entrance wound in upper extremity, female victim, entrance wound in abdomen, entrance wound in head except temples, central forehead and mouth, and entrance wound in back. The variables most correlated to suicide were: used firearm found close to victim's body, reported suicidal ideation, victim's age, presence of contact wound(s), male victim, presence of farewell letter and entrance wound in mouth. The model was thereafter validated on a test-set of 18 homicides and 84 suicides during 1993-95. All suicides and 16 homicides were classified by the model in agreement with the previous police and forensic medical examinations. Thus, the model's sensitivity to classify homicides is estimated to be 89% and its specificity 100%. (C) 1999 Elseviar Science Ireland Ltd. All rights reserved.	Natl Board Forens Med, Dept Forens Med, S-17126 Solna, Sweden		Karlsson, T (corresponding author), Natl Board Forens Med, Dept Forens Med, Box 1352, S-17126 Solna, Sweden.						BELL CA, 1991, AM J PUBLIC HEALTH, V81, P729, DOI 10.2105/AJPH.81.6.729; DIMALO VJM, 1985, GUNSHOT WOUNDS PRACT; Druid H, 1997, FORENSIC SCI INT, V88, P147, DOI 10.1016/S0379-0738(97)00104-7; FISCHER J, 1994, FORENSIC SCI INT, V68, P161, DOI 10.1016/0379-0738(94)90355-7; Karger B, 1997, INT J LEGAL MED, V110, P79, DOI 10.1007/s004140050035; KARISSON T, 1993, J FORENSIC SCI, V38, P1409; Karlsson T, 1998, FORENSIC SCI INT, V94, P183, DOI 10.1016/S0379-0738(98)00065-6; Karlsson T, 1998, FORENSIC SCI INT, V93, P21, DOI 10.1016/S0379-0738(98)00025-5; Karlsson T, 1999, FORENSIC SCI INT, V101, P33, DOI 10.1016/S0379-0738(99)00007-9; KRAULAND W, 1984, Archiv fuer Kriminologie, V174, P1; MISSLIWETZ J, 1983, Archiv fuer Kriminologie, V171, P143; OGUNGBEMI K, 1993, FORENSIC SCI INT, V59, P157, DOI 10.1016/0379-0738(93)90154-3; Rogde S, 1996, FORENSIC SCI INT, V80, P211, DOI 10.1016/0379-0738(96)01918-4; SCOTT KWM, 1990, MED SCI LAW, V30, P234, DOI 10.1177/002580249003000312; Sellier K., 1986, FORENSIC SCI PROGR, V1, P91; TARDIFF K, 1994, JAMA-J AM MED ASSOC, V272, P43, DOI 10.1001/jama.272.1.43; THORESEN S, 1984, Z RECHTSMED, V93, P65; UMETRI, 1997, USERS GUIDE SIMCAS V; VONHOFMAN ER, 1927, LEHRBUCH GERICHTLICH; WOLD S, 1978, TECHNOMETRICS, V20, P379	20	31	32	0	4	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	APR 26	1999	101	2					131	140		10.1016/S0379-0738(99)00017-1			10	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	199DE	WOS:000080463700006	10371045				2022-02-06	
J	Aloni, R; Katz, S				Aloni, R; Katz, S			A review of the effect of traumatic brain injury on the human sexual response	BRAIN INJURY			English	Article							HEAD-INJURY; RELATIVES; DAMAGE; FAMILY	A human sexual response format was used to describe possible sexual dysfunctions after TBI. Additional material was also included to qualify the information drawn from the above format. A number of possible conclusions were drawn, indicating that the causes and effects of sexual functioning after TBI are very confusing and that the literature does not clarify this confusion. One cannot accurately differentiate between primary and secondary sexual problems and, therefore, cannot evaluate the contribution of each problem to the presented sexual dysfunction.	Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; Beit Loewenstein Hosp, Raanana, Israel		Katz, S (corresponding author), Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel.						ALTMAN R, 1961, ANN INTERN MED, V55, P1; Berrol S, 1981, SEXUALITY PHYSICAL D, P203; BIENENFELD D, 1989, J CLIN PSYCHIAT, V50, P68; Blackerby WF, 1994, HDI PROFESSIONAL SER, V10; Blackerby WF., 1990, J HEAD TRAUMA REHAB, V5, P73, DOI [10.1097/00001199-199005020-00012, DOI 10.1097/00001199-199005020-00012]; BLAZYK S, 1983, SOCIAL WORK HLTH CAR, V8, P4; BLUMER D, 1970, AM J PSYCHIAT, V126, P8; BOLLER F, 1982, SEXUAL DYSFUNCTION N; BROOKS N, 1985, J HEAT TRAUMA REHABI, V2, P13; BURKE WH, 1988, HDI PROFESSIONAL SER, V9; BURTON LA, 1988, J NEUROLOGICAL REHAB, V2, P4; CHUSID JG, 1982, CORRELATIVE NEUROANA; CLARK JDA, 1988, CLIN ENDOCRINOL, V29, P153, DOI 10.1111/j.1365-2265.1988.tb00257.x; COX W, 1980, MED ASPECTS HUMAN SE, V14, P103; CRENSHAW LT, 1985, MED ASPECTS HUMAN SE, V19, P115; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DAVIDSON JM, 1982, CLIN ENDOCRINOLOGY M, V11, P3; DAVIS D, 1990, J HEAD TRAUMA REHAB, V5, P38; DUCHARME S, 1986, J HEAD TRAUMA REHAB, V5, P38; EDWARDS OM, 1986, MEDICINE, V65, P4; GARDEN F, 1991, SEX DISABIL, V9, P1; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; GLEN MB, 1988, J HEAD TRAUMA REHAB, V3, P86; GRIFFITH E, 1990, REHABILITATION ADULT, P205; Griffith ER, 1993, SEXUALITY PERSON TRA; HORN J, 1990, J HEAD TRAUMA REHAB, V5, P1; JOSEPH AB, 1995, J HEAD TRAUMA REHAB, V10, P2; Kaplan H.S., 1974, NEW SEX THERAPY; KAPLAN HS, 1983, EVALUATION SEXUAL DI; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KLINGBEIL GE, 1985, ARCH PHYSICAL MED RE, V65, P88; KREUTZER SJ, 1989, BRAIN INJURY, V3, P177; LEHNE GK, 1986, SEX DISABIL, V7, P3; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Lundberg PO, 1992, ANN REV SEX RES, V3, P121; MASTERS HW, 1970, HUMAN SEXUAL INADEQU; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLAUGHLIN AM, 1985, COGNITIVE REHABILITA, V11, P4; MEDLER MT, 1993, SEX DISABIL, V11, P57; MESULAM MM, 1988, PRINCIPLES BEHAV NEU; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P8; SABHESAN S, 1989, ARCH SEXUAL BEHAV, V18, P4; SOLOMON R, 1991, BRAIN INJURY, V5, P253; SOROKER N, 1996, BRAIN FUNCTION STRUC; STAMBROOK M, 1991, J CLIN EXP NEUROPSYC, V13, P521, DOI 10.1080/01688639108401068; STRAUSS D, 1991, SEX DISABIL, V9, P34; VALENTICH M, 1986, SEX DISABIL, V7, P1; ZASLER ND, 1995, PHYSICAL MED REHABIL, V9, P330; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004; Zasler ND, 1991, SEX DISABIL, V9, P11; ZASLER ND, 1998, SEXUALITY UPDATE, V1, P1; ZENCIUS A, 1990, Brain Injury, V4, P175, DOI 10.3109/02699059009026163	57	31	32	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	1999	13	4					269	280		10.1080/026990599121647			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	186RH	WOS:000079742400006	10230528				2022-02-06	
J	McKinely, BA; Parmley, CL; Tonneson, AS				McKinely, BA; Parmley, CL; Tonneson, AS			Standardized management of intracranial pressure: A preliminary clinical trial	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	25th Educational and Scientific Symposium of the Society-of-Critical-Care-Medicine	FEB 05-09, 1996	NEW ORLEANS, LA	Soc Crit Care Med		intracranial pressure (ICP); cerebral perfusion pressure (cpp); therapy algorithm; standardized protocol; computerized protocol; guidelines; severe head injury (SHI); traumatic brain injury (TBI); intensive care process	SEVERE HEAD-INJURY; MANNITOL	Objective: To test a standardized protocol for management of intracranial pressure (ICP) after severe head injury (i,e,, traumatic brain injury), consistent with published guidelines. Methods: We compared prospective use of a standardized protocol for ICP management in 12 patients with severe head injuries and retrospective ICP management using preprinted hospital orders in combination with ad hoc physician orders in 12 historical control patients with severe head injuries. With the standardized protocol, flow-chart decision logic diagrams were applied at patient bedside by critical care practitioners, with nursing shift review. Results: ICP and its variation during the first 6 intensive care unit days was less for the standardized protocol- than for the preprinted order-managed group (p <0.001), indicating better process control with the standardized protocol. ICP exceeded 25 mm Hg for less time for the standardized protocol group (182 hours; 15 +/- 23 hours/patient) than for prescribed order group (429 hours; 36 +/- 28 hours/patient) (p = 0.03). On average, ICP exceeded 20 mm Hg for 2.3 days for the standardized protocol-managed group and for 4.7 days for the prescribed order-managed group. Cerebral perfusion pressure was significantly greater and its variation less for the standardized protocol- than for the preprinted order-managed group, Fewer interventions were made for ICP management for the standardized protocol-than for the preprinted order-managed patients (601 vs. 876), suggesting more effective nursing time using the standardized protocol. Conclusion: ICP management was more consistent, and intracranial hypertension was better controlled, in patients managed according to a standardized, data-driven protocol for escalation and weaning of therapies in response to immediate patient needs, We recommend computerized implementation and a randomized clinical trial to compare the protocol with prescribed orders.	Univ Texas, Sch Med, Dept Anesthesiol, Houston, TX 77030 USA		McKinely, BA (corresponding author), Univ Texas, Sch Med, Dept Anesthesiol, 6431 Fannin,MSB 5-020, Houston, TX 77030 USA.	bmckinle@anes1.med.uth.tmc.edu					Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock MR, 1996, J NEUROTRAUM, V13, P719; Bullock R, 1995, New Horiz, V3, P448; Chesnut R M, 1995, New Horiz, V3, P581; Chesnut RM, 1998, CRIT CARE MED, V26, P210, DOI 10.1097/00003246-199802000-00009; EAST TD, 1991, INT J CLIN MONIT COM, V8, P263, DOI 10.1007/BF01739127; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GENTILELLO L, 1988, CRIT CARE MED, V16, P783, DOI 10.1097/00003246-198808000-00010; Ghajar J, 1995, New Horiz, V3, P395; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Granath P, 1997, J CONSTR STEEL RES, V42, P1, DOI 10.1016/S0143-974X(97)00021-7; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Lang E W, 1995, New Horiz, V3, P400; Marion D W, 1995, New Horiz, V3, P439; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Morris A H, 1996, Proc AMIA Annu Fall Symp, P418; Morris AH, 1997, PRINCIPLES PRACTICE, P1355; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Prielipp R C, 1995, New Horiz, V3, P456; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sailors R M, 1996, Proc AMIA Annu Fall Symp, P234; TILLETT JM, 1993, CRIT CARE MED, V21, P1005, DOI 10.1097/00003246-199307000-00014; Tonnesen A S, 1995, New Horiz, V3, P499; WALD SL, 1995, SURG CLIN N AM, V75, P225, DOI 10.1016/S0039-6109(16)46585-0; Wallace C J, 1995, Proc Annu Symp Comput Appl Med Care, P810; Wilberger J E, 1995, New Horiz, V3, P469; WILSON JA, 1994, J NEUROSURG ANESTH, V6, P139; Zornow M H, 1995, New Horiz, V3, P488	31	31	31	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	1999	46	2					271	279		10.1097/00005373-199902000-00013			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	166TT	WOS:000078593800015	10029033				2022-02-06	
J	Park, HK; Fernandez, I; Dujovny, M; Diaz, FG				Park, HK; Fernandez, I; Dujovny, M; Diaz, FG			Experimental animal models of traumatic brain injury: medical and biomechanical mechanism	CRITICAL REVIEWS IN NEUROSURGERY			English	Article						head injury; experimental animal model; diffuse axonal injury; biomechanics; cerebral ischemia; cerebral blood flow; brain retractor	CEREBRAL BLOOD-FLOW; RAT	The numerous traumatic brain injury models were designed to study the nature of the human brain injury. The properties of six experimental injury models were reviewed in this article. Weight-drop models with or without skull protection were compared in terms of experimental setup, possible error source, and biomechanical prospect. The modified percussion models with or without rigid cortical impact were contrasted with regard to reliability, histopathological production, and deformation. The focal contusion model by mechanical suction force represented isolated cortical injury without compression brain injury. As a class of traumatic brain injury, brain retraction damage was reviewed in this article.	Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI 48201 USA								ANDREWS R J, 1992, Neurological Research, V14, P12; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613	6	31	31	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0939-0146			CRIT REV NEUROSURG	Crit. Rev. Neurosurg.	JAN	1999	9	1					44	52		10.1007/s003290050108			9	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	162WM	WOS:000078370100007	9933368				2022-02-06	
J	Trepagnier, CG				Trepagnier, CG			Virtual environments for the investigation and rehabilitation of cognitive and perceptual impairments	NEUROREHABILITATION			English	Article						virtual environments; rehabilitation; autism; aphasia; cognitive; impairment	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN INJURY; WORKING-MEMORY; SPONTANEOUS-RECOVERY; EXECUTIVE FUNCTIONS; AUTISTIC-CHILDREN; APHASIA; ATTENTION; COMMUNICATION; THERAPY	Features of "virtual reality" (VR) systems and their value for the investigation and rehabilitation of cognitive and perceptual impairments are briefly described. Current and potential applications of VR technology to address six neurorehabilitation issues are discussed: (1) attention and the reduction of distraction, (2) assessment and remediation of executive function deficits, (3) investigation of impairments of coordinated movement, (4) study and rehabilitation of aphasia and other severe disorders of language, (5) task presentation for functional imaging studies of the brain, and (6) the measurement of mental load in the operation of assistive technology. Finally, a virtual reality system integrated with gaze angle sensing technology is described, and its potential for investigation and rehabilitation of face processing by individuals with autism is discussed.	Natl Rehabil Hosp, Assisted Technol Res Ctr, Rehabil Engn Serv, Washington, DC 20010 USA		Trepagnier, CG (corresponding author), Natl Rehabil Hosp, Assisted Technol Res Ctr, Rehabil Engn Serv, 102 Irving St NW, Washington, DC 20010 USA.	cyt1@mhg.edu					Aguirre GK, 1997, J NEUROSCI, V17, P2512; Alderman N, 1996, NEUROPSYCHOL REHABIL, V6, P161, DOI 10.1080/713755505; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BAENNINGER M, 1994, J EXP CHILD PSYCHOL, V57, P377, DOI 10.1006/jecp.1994.1018; BAKER E, 1975, NATURE, V254, P509, DOI 10.1038/254509a0; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; BOUCHER J, 1992, J CHILD PSYCHOL PSYC, V33, P843, DOI 10.1111/j.1469-7610.1992.tb01960.x; CHAPPELL PB, 1995, J AM ACAD CHILD PSY, V34, P1140, DOI 10.1097/00004583-199509000-00010; Cicerone KD, 1997, NEUROREHABILITATION, V8, P13, DOI 10.3233/NRE-1997-8103; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Cox CS, 1997, INT REV PSYCHIATR, V9, P45, DOI 10.1080/09540269775583; CULTON GL, 1969, J SPEECH HEAR RES, V12, P825, DOI 10.1044/jshr.1204.825; DeLuca J, 1996, DISABIL REHABIL, V18, P265, DOI 10.3109/09638289609166312; Denckla MB, 1996, J DEV BEHAV PEDIATR, V17, P114; ERICSSON KA, 1980, SCIENCE, V208, P1181, DOI 10.1126/science.7375930; Faillenot I, 1997, NEUROREPORT, V8, P859, DOI 10.1097/00001756-199703030-00010; GARDNER H, 1976, NEUROPSYCHOLOGIA, V14, P275, DOI 10.1016/0028-3932(76)90023-3; Georgiou N, 1997, MOVEMENT DISORD, V12, P386, DOI 10.1002/mds.870120318; GHAZIUDDIN M, 1994, J INTELL DISABIL RES, V38, P519; GILLBERG CL, 1992, J CHILD PSYCHOL PSYC, V33, P813, DOI 10.1111/j.1469-7610.1992.tb01959.x; Glantz K, 1996, PSYCHOTHERAPY, V33, P464, DOI 10.1037/0033-3204.33.3.464; GOLDENBERG G, 1994, BRAIN LANG, V47, P684, DOI 10.1006/brln.1994.1063; Goodenough-Trepagnier C, 1994, Assist Technol, V6, P3; GOODENOUGHTREPA.CX, 1990, P 1990 C IEEE ENG ME, V12, P1313; GOODENOUGHTREPAGNIER C, 1995, APHASIOLOGY, V9, P321, DOI 10.1080/02687039508248208; Granholm E, 1997, J ABNORM PSYCHOL, V106, P458, DOI 10.1037/0021-843X.106.3.458; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; GUNTHER W, 1992, EUR ARCH PSY CLIN N, V242, P152, DOI 10.1007/BF02191563; HOBSON RP, 1988, BRIT J PSYCHOL, V79, P441, DOI 10.1111/j.2044-8295.1988.tb02745.x; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; HYONA J, 1995, Q J EXP PSYCHOL-A, V48, P598; KRAAT AW, 1990, APHASIOLOGY, V4, P321, DOI 10.1080/02687039008249086; LENDREM W, 1985, J NEUROL NEUROSUR PS, V48, P743, DOI 10.1136/jnnp.48.8.743; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; LOVAAS OI, 1987, J CONSULT CLIN PSYCH, V55, P3, DOI 10.1037/0022-006X.55.1.3; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MCEACHIN JJ, 1993, AM J MENT RETARD, V97, P359; Mendozzi L, 1998, CYBERPSYCHOL BEHAV, V1, P79; Mialet JP, 1996, PSYCHOL MED, V26, P1009, DOI 10.1017/S0033291700035339; MIRSKY AF, 1992, J PSYCHIAT RES, V26, P383, DOI 10.1016/0022-3956(92)90042-M; Norman DA, 1993, THINGS MAKE US SMART; OCONNOR N, 1991, PSYCHOL MED, V21, P959, DOI 10.1017/S0033291700029949; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; Ozonoff S, 1997, J AUTISM DEV DISORD, V27, P59, DOI 10.1023/A:1025821222046; OZONOFF S, 1994, J CHILD PSYCHOL PSYC, V35, P1015, DOI 10.1111/j.1469-7610.1994.tb01807.x; Parente R, 1997, NEUROREHABILITATION, V8, P3, DOI 10.3233/NRE-1997-8102; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Petheram B, 1996, APHASIOLOGY, V10, P267, DOI 10.1080/02687039608248412; Pulsifer M B, 1996, J Int Neuropsychol Soc, V2, P159; RAO SM, 1995, CURR OPIN NEUROL, V8, P216, DOI 10.1097/00019052-199506000-00010; Rizzo A, 1998, CYBERPSYCHOLOGY BEHA, V1, P59, DOI DOI 10.1089/CPB.1998.1.59; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; RUTTER M, 1994, J CHILD PSYCHOL PSYC, V35, P311, DOI 10.1111/j.1469-7610.1994.tb01164.x; Steel R G T, 1986, PRINCIPLES PROCEDURE, P348; TACHI S, 1983, IEEE T BIO-MED ENG, V30, P571, DOI 10.1109/TBME.1983.325053; TANTAM D, 1989, J CHILD PSYCHOL PSYC, V30, P623, DOI 10.1111/j.1469-7610.1989.tb00274.x; Tinson D J, 1989, Int Disabil Stud, V11, P45; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Towbin Kenneth E., 1997, Current Opinion in Pediatrics, V9, P361, DOI 10.1097/00008480-199708000-00010; TREPAGNIER C, 1996, FOCUS AUTISM OTHER D, V11, P170; WAISBREN SE, 1994, ACTA PAEDIATR, V83, P98, DOI 10.1111/j.1651-2227.1994.tb13464.x; Weinrich M, 1997, BRAIN LANG, V58, P23, DOI 10.1006/brln.1997.1757; Wilson PN, 1997, DISABIL REHABIL, V19, P213, DOI 10.3109/09638289709166530; WING L, 1976, EARLY CHILDHOOD AUTI	66	31	31	3	30	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		1999	12	1					63	72					10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	191WT	WOS:000080045100007					2022-02-06	
J	Keith, MS; Stanislav, SW; Wesnes, KA				Keith, MS; Stanislav, SW; Wesnes, KA			Validity of a cognitive computerized assessment system in brain-injured patients	BRAIN INJURY			English	Article							MINI-MENTAL-STATE; VALIDATION	The primary objective of the study was to investigate the criterion validity of the Cognitive Drug Research (CDR) computerized system in assessing cognitive functioning among persons with brain injury or other organic illness. Understanding the cognitive effects of pharmacotherapy is important in improving long-term rehabilitation outcomes in persons with organic disorders. The CDR system evaluates cognitive skills of attention, short-term or working memory, long-term memory, and visuomotor and motor functioning. For validity testing, correlation coefficients were obtained from an analysis of CDR scores to IQ and Folstein Mini-Mental State Exam (MMSE) scores. Subtests of the CDR system that correlated with the MMSE were choice reaction time (R = -0.542, p = 0.04), spatial working memory (R = 0.938, p = 0.01), and word recognition (R = -0.949, p = 0.01). These tests primarily measured attention and working memory. Correlations between the CDR and IQ scores were not evident. In summary, the data suggest the CDR assessment system has high patient acceptability by persons with traumatic brain injury, and is a useful tool in assessing certain domains of cognition, specifically short-term memory, discrimination, and identification skills.	Univ Texas, Coll Pharm, Austin, TX 78712 USA; Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; Brown Sch Rehabil Ctr, Austin, TX USA; Cognit Drug Res, Reading, Berks, England		Keith, MS (corresponding author), Univ Texas, Coll Pharm, Austin, TX 78712 USA.		Wesnes, Keith A/D-7148-2018	Wesnes, Keith/0000-0002-4498-8511			CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Malloy PF, 1997, J NEUROPSYCH CLIN N, V9, P189; ROBINSON R, 1991, BIOL PSYCHIAT POSTER, V29, pS333; ROCCAFORTE WH, 1992, J AM GERIATR SOC, V40, P697, DOI 10.1111/j.1532-5415.1992.tb01962.x; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; SIMPSON PM, 1991, INT J GERIATR PSYCH, V6, P95, DOI 10.1002/gps.930060208; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Vogenthaler D R, 1987, Brain Inj, V1, P113; Wesnes K, 1988, HUMAN PSYCHOPHARMACO, V3, P27, DOI [10.1002/hup.470030106, DOI 10.1002/HUP.470030106]; WESNES KA, COGNITIVE DRUG RES L	11	31	31	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	1998	12	12					1037	1043		10.1080/026990598121945			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	150BW	WOS:000077643400004	9876863				2022-02-06	
J	Dombovy, ML; Drew-Cates, J; Serdans, R				Dombovy, ML; Drew-Cates, J; Serdans, R			Recovery and rehabilitation following subarachnoid haemorrhage: part II long-term follow-up	BRAIN INJURY			English	Article							ANEURYSM-SURGERY; HEMORRHAGE; MANAGEMENT; IMPAIRMENT; MORBIDITY; MORTALITY; DEFICITS; SAH	Background and purpose: Subarachnoid haemorrhage (SAH) accounts for 5-10% of all strokes, strikes at a mean age of 50 years and results in a pattern of deficits similar to that of traumatic brain injury. This study is an extension of a previous study which described outcome at discharge from inpatient rehabilitation. The purpose of this Follow-up study was to describe long-term functional, cognitive and psychosocial outcome in a cohort of SAH survivors who received inpatient rehabilitation Methods: Subjects were interviewed by telephone. Functional status was assessed using the Functional independence Measure (FIM) and cognitive status with the Telephone Interview for Cognitive Status (TICS). Social Function was determined via a brief questionnaire. Results: Thirty two out of 80 subjects who received inpatient rehabilitation participated in the study. The 32 did not differ from the original group of 80 on any demographic or clinical criteria. The mean time from onset of SAH to follow-up was 28 months. Total FIM scores improved significantly between discharge and follow up (p < 0.0001) and most subjects functioned at a physically independent level. However, almost 40% scored in the cognitively impaired range on the TICS. Between 40% and 50% required help with common household activities, and none returned to full-time work. Functional and cognitive outcome was not related to any demographic or clinical characteristics at SAH onset. Conclusion: The majority of SAH survivors who received inpatient rehabilitation attain physical independence, but many continue to have cognitive impairments which result in social and vocational disabilities.	Unity Hlth Syst, Dept Phys Med & Rehabil, Rochester, NY 14611 USA		Dombovy, ML (corresponding author), Unity Hlth Syst, Dept Phys Med & Rehabil, 89 Genesee St, Rochester, NY 14611 USA.						ADAMS HP, 1985, NEUROLOGY, V35, P1263, DOI 10.1212/WNL.35.9.1263; BONITA R, 1985, STROKE, V16, P591, DOI 10.1161/01.STR.16.4.591; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Dombovy ML, 1998, BRAIN INJURY, V12, P443, DOI 10.1080/026990598122412; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; GILSBACH JM, 1989, ACTA NEUROCHIR, V96, P1, DOI 10.1007/BF01403488; Granger C. V., 1986, UNIFORM DATA SYSTEM; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; HUTTER BO, 1995, BRIT J NEUROSURG, V9, P465, DOI 10.1080/02688699550041106; INAGAWA T, 1988, STROKE, V19, P170, DOI 10.1161/01.STR.19.2.170; JENNETT B, 1975, LANCET, P480; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Le Roux P, 1993, CLIN NEUROSURG, P325; LJUNGGREN B, 1985, J NEUROSURG, V62, P673, DOI 10.3171/jns.1985.62.5.0673; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Ogden J. A., 1990, NEUROPSY NEUROPSY BE, V3, P260; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; PHILLIPS LH, 1980, NEUROLOGY, V30, P1034, DOI 10.1212/WNL.30.10.1034; PLASSMAN BL, 1994, NEUROPSYCHIATRY NEUR, V7, P35; *RES FDN STAT U NE, 1990, UN DAT SET MED REH I; ROPPER AH, 1984, J NEUROSURG, V60, P909, DOI 10.3171/jns.1984.60.5.0909; SONESSON B, 1987, NEUROSURGERY, V21, P279, DOI 10.1227/00006123-198709000-00001; TIDSWELL P, 1995, NEUROLOGY, V45, P875; VIKKI J, 1977, NEUROLOGY, V27, P592	26	31	33	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1998	12	10					887	894					8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	121FR	WOS:000076003100007	9783086				2022-02-06	
J	Hicks, RR; Zhang, L; Dhillon, HS; Prasad, MR; Seroogy, KB				Hicks, RR; Zhang, L; Dhillon, HS; Prasad, MR; Seroogy, KB			Expression of trkB mRNA is altered in rat hippocampus after experimental brain trauma	MOLECULAR BRAIN RESEARCH			English	Article						traumatic brain injury; lateral fluid percussion; neurotrophin receptors; in situ hybridization; neuronal plasticity	PROTEIN-TYROSINE KINASE; NERVE GROWTH-FACTOR; MESSENGER-RNA; NEUROTROPHIN RECEPTORS; FULL-LENGTH; INJURY; NEURONS; NT-3; BDNF; FOREBRAIN	Recent investigations have shown that expression of mRNAs for the neurotrophins brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) is differentially altered in the hippocampus following traumatic brain injury. In the present study, modulation of neurotrophin receptor expression was examined in the hippocampus in a rat model of traumatic brain injury using in situ hybridization. Messenger RNA for trkB, the high-affinity receptor for BDNF and neurotrophin-4 (NT-4), was increased between 3 and 6 h bilaterally in the dentate gyrus following a lateral fluid-percussion brain injury of moderate severity (2.0-2.1 atm). No time-dependent alterations were observed for trkB mRNA in hippocampal subfields CA1 and CA3. Levels of mRNA for trkC, the high-affinity receptor for NT-3, did not change in any region of the hippocampus. These data demonstrate that lateral fluid-percussion injury modulates expression of trkB mRNA in the hippocampus and support a role for BDNF/trkB signalling mechanisms in secondary events associated with traumatic brain injury. (C) 1998 Elsevier Science B.V. All rights reserved.	Univ Kentucky, Dept Clin Sci, Lexington, KY 40536 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Surg, Lexington, KY 40536 USA		Hicks, RR (corresponding author), Univ Kentucky, Dept Clin Sci, Lexington, KY 40536 USA.	rrhick00@pop.uky.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034264, R01NS035164] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35164, NS34264] Funding Source: Medline		Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; Alcantara S, 1997, J NEUROSCI, V17, P3623; ALTAR CA, 1994, EUR J NEUROSCI, V6, P1389, DOI 10.1111/j.1460-9568.1994.tb01001.x; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON JE, 1994, DEV BRAIN RES, V77, P177, DOI 10.1016/0165-3806(94)90194-5; Frank L, 1996, EUR J NEUROSCI, V8, P1220, DOI 10.1111/j.1460-9568.1996.tb01290.x; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Goodness TP, 1997, EUR J NEUROSCI, V9, P1574, DOI 10.1111/j.1460-9568.1997.tb01515.x; Hagg T, 1998, EXP NEUROL, V149, P183, DOI 10.1006/exnr.1997.6684; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON J, 1994, CURR BIOL, V4, P662, DOI 10.1016/S0960-9822(00)00149-4; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; LAMBALLE F, 1993, EMBO J, V12, P3083, DOI 10.1002/j.1460-2075.1993.tb05977.x; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; MUDO G, 1993, NEUROSCIENCE, V57, P901, DOI 10.1016/0306-4522(93)90036-F; Numan S, 1997, EUR J NEUROSCI, V9, P489, DOI 10.1111/j.1460-9568.1997.tb01626.x; Seroogy K., 1997, NEUROCHEMISTRY PRACT, P121; Singh TD, 1997, NEUROCHEM RES, V22, P791, DOI 10.1023/A:1022075508176; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; VALENZUELA DM, 1993, ALTERNATIVE FORMS RA, P963; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C	35	31	31	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	AUG 31	1998	59	2					264	268		10.1016/S0169-328X(98)00158-2			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	123LF	WOS:000076126100014	9729420				2022-02-06	
J	Kurtz, JE; Putnam, SH; Stone, C				Kurtz, JE; Putnam, SH; Stone, C			Stability of normal personality traits after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED HEAD-INJURY; SOCIAL RECOVERY; 5-FACTOR MODEL; FOLLOW-UP; ADJUSTMENT; CHILDREN	Objective: To test the hypothesis that changes in personality traits are evident after traumatic brain injury (TBI) using current models of normal adult personality variation. Design: Comparison of inception cohort and control group at two measurement occasions. Setting: A large urban academic medical center. Participants: Retrospective personality assessments were obtained from significant others of 21 TBI patients within 30 days of injury and at 6-month follow-up and from a control group of significant others of 25 persons without neurological history twice over a 6-month interval. Main Outcome Measures: Five scales-Neuroticism, Extraversion, Openness to Experience, Agreeableness, and Conscientiousness-from the revised NEO Personality Inventory (NEO PI-R), Form R, and an observer rating scale for retrospective estimates of change (REC). Results: Significant score changes were found for only one of the five trait domains in the patient sample; controls showed minimal changes overall. Patients' Extraversion scores declined to average levels at 6-month follow-up, diminishing premorbid differences between patients and controls on this dimension. Subjective change estimates made by raters after followup reflected perceptions of increased neuroticism in patients that were inconsistent with the serial NEO PI-R data the raters provided. Conclusions: The absence of systematic changes in personality trait scores among the patients cautions against presuming that such changes account for the behavior of TBI patients.	Villanova Univ, Dept Psychol, Villanova, PA 19085 USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; Wayne State Univ, Sch Med, Rehabil Inst Michigan, Detroit, MI USA		Kurtz, JE (corresponding author), Villanova Univ, Dept Psychol, Villanova, PA 19085 USA.		Kurtz, John/AAR-2598-2021		NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5T32 HD07421-04] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007421] Funding Source: NIH RePORTER		Blumer D., 1975, PSYCHIAT ASPECTS NEU; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.ps.41.020190.002221; DODWELL D, 1988, PSYCHOL MED, V18, P495, DOI 10.1017/S0033291700008035; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GIANOTTI G, 1972, CORTEX, V8, P41; John OP., 1990, HDB PERSONALITY THEO; LEE GP, 1993, INT J NEUROSCI, V72, P157, DOI 10.3109/00207459309024104; Lezak M., 1989, ASSESSMENT BEHAV CON; McCrae, 1991, REVISED NEO PERSONAL; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MUTEN E, 1991, J PERS ASSESS, V57, P449, DOI 10.1207/s15327752jpa5703_5; NORMAN WT, 1963, J ABNORM PSYCHOL, V66, P574, DOI 10.1037/h0040291; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PRIGATANO GP, 1987, NEUROBEHAVIOURAL REC; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; STUSS DT, 1983, NEUROPSYCHOLOGY HUMA; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002	25	31	31	0	6	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1998	13	3					1	14		10.1097/00001199-199806000-00002			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZT046	WOS:000074042200002	9582175				2022-02-06	
J	Wallace, CA; Bogner, J; Corrigan, JD; Clinchot, D; Mysiw, WJ; Fugate, LP				Wallace, CA; Bogner, J; Corrigan, JD; Clinchot, D; Mysiw, WJ; Fugate, LP			Primary caregivers of persons with brain injury: life change 1 year after injury	BRAIN INJURY			English	Article							BLUNT HEAD-INJURY; FAMILY NEEDS; RELATIVES; PATIENT; STRESS; IMPACT	The impact of a traumatic brain injury on the family of the injured person is just beginning to be explored. In the current study, 61 primary caregivers were contacted at 1 year following injury. They completed the Relative and Friend Support Index, Social Support Index, Trauma Complaints List and the Life Change Question. The majority of caregivers indicated at least mild negative life change following the brain injury. Greater social support was correlated with less life change and greater injury severity was correlated with negative life change. Neither of these relationships was found to be significant at the 0.05 level. A significant positive correlation was found between caregivers' perception of deficits and the degree of negative life change. Perceived deficits accounted for the greatest amount of variance in life change followed by relative and friend support when all variables were entered into a stepwise regression. Further analyses indicated that the most significant factor of the Trauma Complaints List in predicting life change may be problems with cognition, which accounted for a significant amount of the variance in life change. Implications for counselling and further research regarding caregivers of persons with brain injury are discussed.	Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Bogner, J (corresponding author), Dodd Hall,480 W 9th Ave, Columbus, OH 43210 USA.		Corrigan, John D./E-2921-2011; Mysiw, Walter/E-3724-2011	Clinchot, Daniel/0000-0002-2810-7227			Acorn S., 1993, CANADIAN J REHABILIT, V7, P149; ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; GLECKMAN AD, 1995, BRAIN INJURY, V9, P385, DOI 10.3109/02699059509005778; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; HINKELDEY N, 1989, BRAIN INJURY, V4, P115; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lauer-Listhaus B, 1991, COUNSELING PSYCHOL Q, V4, P351, DOI 10.1080/09515079108254443; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Leathem J, 1996, BRAIN INJURY, V10, P27; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McCubbin H., 1982, FAMILY ASSESSMENT RE, P295; MCCUBBIN H, 1981, FAMILY ASSESSMENT IN, P203; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MILLER L, 1993, AM J FAM THER, V21, P111, DOI 10.1080/01926189308250910; MINTZ MC, 1995, BRAIN INJURY, V9, P173, DOI 10.3109/02699059509008190; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1984, CLOSED HEAD INJURY P, P108; PANTING A, 1972, ARCH PHYSICAL MED RE, V73, P771; *SAS I INC, 1985, SAS US GUID BAS VERS; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; SPENCE SE, 1993, BRIT J CLIN PSYCHOL, V32, P309, DOI 10.1111/j.2044-8260.1993.tb01061.x; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	34	31	33	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1998	12	6					483	493		10.1080/02699052.1998.11910751			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZU400	WOS:000074193300004	28925743				2022-02-06	
J	Cresswell, TR; Smith, RB				Cresswell, TR; Smith, RB			Bilateral anterior shoulder dislocations in bench pressing: an unusual cause	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						shoulder dislocation; anterior glenohumeral dislocation; weight training; bench pressing	FRACTURE-DISLOCATION	A case of bilateral anterior glenohumeral dislocation in a young weight trainer is presented. The patient, an insurance clerk, had been using a free weight bar in the bench press position and had become tired when the weight on the bar forced his arms into hyperextension in the mid-abducted position. The humeral shaft gradually pivoted on the bench and the humeral heads were slowly dislocated anteriorly by the weight of the bar. Simple closed reduction under sedation was performed and there were no complications. After six weeks in bilateral broad arm slings, with pendulum exercises from two weeks, the patient began to mobilise his arms and he achieved a full range of movements. This unusual mechanism of injury has not previously been reported and we recommend that bench pressing should be performed with a weight that can be "locked" to prevent crushing of the user. Furthermore, the bench should be narrow enough to allow the shoulders to overhang, allowing greater extension in the abducted position without the arm pivoting on the edge of the bench.	Royal Preston Hosp, Dept Orthopaed & Trauma, Preston PR2 9HT, Lancs, England		Cresswell, TR (corresponding author), Childrens Hosp, Dept Orthopaed & Trauma, Western Bank, Sheffield S10 2TH, S Yorkshire, England.						BRADY WJ, 1995, J EMERGENCY MED, V15, P37; BROWN RJ, 1984, INJURY, V15, P267, DOI 10.1016/0020-1383(84)90012-3; CAREWMCCOLL M, 1980, BRIT J CLIN PRACT, V34, P251; Jones M, 1987, Br J Sports Med, V21, P139; Lal M, 1992, Indian J Med Sci, V46, P209; LITCHFIELD JC, 1988, POSTGRAD MED J, V64, P450, DOI 10.1136/pgmj.64.752.450; MAFFULLI N, 1990, INJURY, V21, P254, DOI 10.1016/0020-1383(90)90020-U; MARKEL DC, 1994, ORTHOPEDICS, V17, P945; Martens C, 1995, Acta Orthop Belg, V61, P249; MARTY B, 1994, UNFALLCHIRURG, V97, P382; MATHIS RD, 1980, J EMERGENCY MED, V1, P41; MEHTA MP, 1989, ANN EMERG MED, V18, P589, DOI 10.1016/S0196-0644(89)80850-9; Mesa M, 1996, Acta Orthop Belg, V62, P116; PAGE AE, 1995, J ORTHOP TRAUMA, V9, P526, DOI 10.1097/00005131-199509060-00012; THOMAS T, 1995, CLIN RHEUMATOL, V14, P467, DOI 10.1007/BF02207684	15	31	34	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	MAR	1998	32	1					71	72		10.1136/bjsm.32.1.71			2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ZE503	WOS:000072799400025	9562170	Green Published, Bronze			2022-02-06	
J	Lannoo, E; Colardyn, F; Vandekerckhove, T; De Deyne, C; De Soete, G; Jannes, C				Lannoo, E; Colardyn, F; Vandekerckhove, T; De Deyne, C; De Soete, G; Jannes, C			Subjective complaints versus neuropsychological test performance after moderate to severe head injury	ACTA NEUROCHIRURGICA			English	Article						closed head injury; neuropsychological test performance; subjective complaints	PSYCHOSOCIAL RECOVERY; EVERYDAY MEMORY; BRAIN INJURY; BASE RATES; SYMPTOMS; DEFICITS; DISORDER	Neuropsychological test performance and subjective complaints of 85 patients with moderate to severe head injury were investigated at 6 months postinjury. The neuropsychological test battery included 10 measures of attention, memory, mental flexibility, reaction time, visuoconstruction and verbal fluency. Subjective complaints were assessed using a self-report questionnaire subdivided into four subscales (somatic, cognitive, emotional and behavioural). Ratings were obtained for the pre-injury and current status. Thirty-three trauma patients with injuries to other parts of the body than the head were used as controls. For the head injured, relatives also completed the questionnaire. Head injured patients performed significantly below trauma control patients on nearly all test measures. Head injured patients and their relatives reported a significant increase in subjective complaints since the injury on all four subscales, with no differences between patients' and relatives' reports. These changes were also reported by the trauma controls, but they report fewer changes in somatic and cognitive functioning. Exploratory canonical correlation analyses revealed no correlations between any of the four scales of the questionnaire and the test measures, nor for the head injured, the trauma controls, or the relatives, indicating no relevant relationship between subjective complaints and neuropsychological test performance.	State Univ Ghent, Dept Neuropsychol, B-9000 Ghent, Belgium; State Univ Ghent, Dept Intens Care, B-9000 Ghent, Belgium; State Univ Ghent, Dept Neurosurg, B-9000 Ghent, Belgium; State Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium; State Univ Ghent, Dept Psychiat, B-9000 Ghent, Belgium		Lannoo, E (corresponding author), State Univ Ghent Hosp, Rehabil Ctr K7, De Pintelaan 185, B-9000 Ghent, Belgium.						Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; BROWN FH, 1991, J CLIN PSYCHOL, V47, P772, DOI 10.1002/1097-4679(199111)47:6<772::AID-JCLP2270470607>3.0.CO;2-P; COUCH JR, 1995, J NEUROL REHABIL, V9, P83; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; DIKMEN SS, 1989, MILD HEAD INJURY, P229; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; GASQUOINE PG, 1992, NEUROPSYCHOLOGY, V9, P606; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRONWALL D, 1976, Proceedings of the Australian Association of Neurologists, V13, P143; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Kinsella G, 1989, Int Disabil Stud, V11, P9; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LONG CJ, 1991, J HEAD INJURY, V2, P18; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; Schmand B., 1992, NLV NEDERLANDSE LEES; SCHWARTZ AF, 1989, CORTEX, V25, P665, DOI 10.1016/S0010-9452(89)80026-7; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spreen O, 1991, COMPENDIUM NEUROPSYC; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; TRUELLE JL, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P69; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; VERMEULEN J, 1993, EPILEPSY RES, V15, P157, DOI 10.1016/0920-1211(93)90096-P; VINGERHOETS G, 1995, J PSYCHOSOM RES, V39, P843, DOI 10.1016/0022-3999(95)00021-3; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; [No title captured]	40	31	31	0	3	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1998	140	3					245	253		10.1007/s007010050091			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	ZM414	WOS:000073537600016	9638261				2022-02-06	
J	Lopez-Pison, J; Arana, T; Baldellou, A; Rebage, V; Garcia-Jimenez, MC; Pena-Segura, JL				Lopez-Pison, J; Arana, T; Baldellou, A; Rebage, V; Garcia-Jimenez, MC; Pena-Segura, JL			A study of the demand for neuropaediatric attention in a general hospital. III. Diagnosis	REVISTA DE NEUROLOGIA			Spanish	Article						diagnosis; healthcare administration; hospital; neuropaediatrics	OPEN-HEART-SURGERY; TUBEROUS-SCLEROSIS; SPINA-BIFIDA; NEUROFIBROMATOSIS TYPE-1; NEUROCUTANEOUS SYNDROMES; BRAIN-TUMORS; CHILDREN; CHILDHOOD; MRI; RADIOTHERAPY	Introduction and objectives. In order to determine the requirements for neuropaediatric attention in the Hospital Miguel Servet of Zaragoza, we studied the diagnoses of the 2,046 children evaluated during the 5 year period-May 1990 to May 1995-, when a neuropaediatrician was appointed to the hospital (which previously did not have such a specialist). Results. The most frequent problems were non-epileptic paroxystic disorders, epilepsies and febrile crises. The following is a list in descending order, of diseases affecting these children: Prenatal encephalopathies, disorders of development and behaviour, head injury (TCE), peripheral nervous system and cranial nerve disorders (which were neither traumatic nor secondary to space-occupying lesions), headaches, perinatal encephalopathies, infections and para-infectious diseases of the nervous system, cardiovascular problems, hydrocephalus, metabolic disorders, hypovision and eye disorders, neuromuscular disorders, tumours, dyskinesias, medulla problems and neurocutaneous syndromes. Conclusions. The frequency and diversity of the neurological pathology seen in childhood and the continual advances in knowledge and the related sciences are more than a single professional person can be expected to cope with. Experts are required in areas such as electroencephalography and epilepsy, neonatal neurology, the neurological aspects of intensive care, neuropsychology, neuro-oncology, neurometabolic disorders, neurogenetics and neuromuscular disorders. Neuropaediatricians are required to control illnesses with great personal, family and social impact, such as thge neurocutaneous syndromes and myelomeningocoele. Neuropaediatric services working in close inter-disciplinary collaboration with other specialists are necessary.	Hosp Miguel Servet, Secc Neuropediat, E-50009 Zaragoza, Spain; Hosp Gen Univ Guadalajara, Secc Metabolopatias, Guadalajara, Spain; Hosp Gen Univ Guadalajara, Secc Neonatal, Guadalajara, Spain; Hosp Gen Univ Guadalajara, Serv Pediat, Guadalajara, Spain; CS Miraflores, Zaragoza, Spain					Lopez Pison, Francisco Javier/0000-0002-1876-1495; PENA SEGURA, JOSE LUIS/0000-0002-9336-780X			Aicardi J, 1992, DIS NERVOUS SYSTEM C; Aicardi J., 1986, EPILEPSY CHILDREN; ALELISSA Y, 1992, DEV MED CHILD NEUROL, V34, P1085; ALEXANDER M, 1993, DEV MED CHILD NEUROL, V35, P753; ALRAJEH S, 1991, DEV MED CHILD NEUROL, V33, P1048; ANDERSON VE, 1993, TXB EPILEPSY, P47; AVIZONIS VN, 1992, NEUROPEDIATRICS, V23, P228, DOI 10.1055/s-2008-1071348; AYSUN S, 1994, PEDIATR NEUROL, V10, P40, DOI 10.1016/0887-8994(94)90065-5; AZIMULLAH PC, 1991, CHILD NERV SYST, V7, P63; BELL WE, 1978, MAJOR PROBLEMS CLIN, V8; BERG BO, 1991, BRAIN DEV-JPN, V13, P9, DOI 10.1016/S0387-7604(12)80290-7; BEYER RA, 1986, NEUROLOGY, V36, P1173, DOI 10.1212/WNL.36.9.1173; BRAAKMAN R, 1994, NEUROLOGIA CRITICA, P221; BRAFFMAN BH, 1992, RADIOLOGY, V183, P227, DOI 10.1148/radiology.183.1.1549677; BRENINGSTALL GN, 1992, PEDIATR NEUROL, V8, P267, DOI 10.1016/0887-8994(92)90363-4; CAMFIELD P, 1994, DEV MED CHILD NEUROL, V36, P887; CASSIDY SB, 1983, JAMA-J AM MED ASSOC, V249, P1302, DOI 10.1001/jama.249.10.1302; CHAPMAN CA, 1995, J CHILD NEUROL, V10, P209, DOI 10.1177/088307389501000308; CHIOFALO N, 1986, PRINCIPLES PEDIAT NE, P217; Cohen M E, 1985, Pediatr Neurol, V1, P77, DOI 10.1016/0887-8994(85)90040-2; COHEN ME, 1993, J CHILD NEUROL, V8, P287, DOI 10.1177/088307389300800401; CZARTORYSKA B, 1994, PEDIATR NEUROL, V11, P295, DOI 10.1016/0887-8994(94)90004-3; DELGADOESCUETA AV, 1994, REV NEUROL, V114, P92; DIMARIO FJ, 1992, PEDIATR NEUROL, V8, P303, DOI 10.1016/0887-8994(92)90371-5; DUFFNER PK, 1991, PEDIATR NEUROL, V7, P237, DOI 10.1016/0887-8994(91)90038-M; ELSTER AD, 1992, AM J NEURORADIOL, V13, P1078; FEJERMAN N, 1986, CONVULSIONES INFANCI; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; GARCIAPEREZ A, 1993, DEV MED CHILD NEUROL, V35, P139; GREENWALD MJ, 1992, DERMATOL CLIN, V10, P623; HUNT GM, 1995, DEV MED CHILD NEUROL, V37, P19; Ilveskoski I, 1996, NEUROPEDIATRICS, V27, P124, DOI 10.1055/s-2007-973762; ITO M, 1991, PEDIATR NEUROL, V7, P436, DOI 10.1016/0887-8994(91)90027-I; JENNET B, 1986, CHILDREN NEUROLOGICA, P176; KAISER G, 1986, PRINCIPLES PEDIAT NE, P263; KORF BR, 1992, PEDIATRICS, V90, P924; KUENZLE C, 1994, NEUROPEDIATRICS, V25, P295, DOI 10.1055/s-2008-1073043; LANSKA MJ, 1991, PEDIATR NEUROL, V7, P333, DOI 10.1016/0887-8994(91)90062-P; LopezPison J, 1997, REV NEUROLOGIA, V25, P1535; MCENERY G, 1992, DEV MED CHILD NEUROL, V34, P342; MCMURDO SK, 1987, AM J NEURORADIOL, V8, P77; MILLER G, 1994, J CHILD NEUROL, V9, P390, DOI 10.1177/088307389400900411; Miller G, 1996, J CHILD NEUROL, V11, P49, DOI 10.1177/088307389601100112; National Institutes of Health Consensus Development Conference Statement on Neurofibromatosis, 1987, ARCH NEUROL-CHICAGO, V45, P575; Nordin V, 1996, DEV MED CHILD NEUROL, V38, P297; NORTH K, 1993, J CHILD NEUROL, V8, P395, DOI 10.1177/088307389300800421; OZAND PT, 1992, J CHILD NEUROL, V7, pS4, DOI 10.1177/08830738920070010211; PACKER RJ, 1985, PEDIATRICS, V76, P194; PAMPOLS T, 1995, CROMOSOMA GEN ANOMAL, P173; PAMPOLS T, 1995, CROMOSOMA GEN ANOMAL, P445; PONT MS, 1992, AM J ROENTGENOL, V158, P1193, DOI 10.2214/ajr.158.6.1590106; RIVA D, 1991, NEUROPEDIATRICS, V22, P36, DOI 10.1055/s-2008-1071413; ROACH ES, 1992, J CHILD NEUROL, V7, P221, DOI 10.1177/088307389200700219; TRUHAN AP, 1993, ARCH DERMATOL, V129, P219, DOI 10.1001/archderm.129.2.219; UVEBRANT P, 1992, NEUROPEDIATRICS, V23, P209, DOI 10.1055/s-2008-1071343; VANDENBERG BJ, 1969, PEDIATR RES, V3, P298, DOI 10.1203/00006450-196907000-00005; VANHALL MHJA, 1992, NEUROPEDIATRICS, V23, P276, DOI 10.1055/s-2008-1071358; WANG AM, 1983, AM J NEURORADIOL, V4, P466; WELLESLEY D, 1991, DEV MED CHILD NEUROL, V33, P963; WILLIAMS BA, 1992, J CHILD NEUROL, V7, P291, DOI 10.1177/088307389200700309; WONG VCN, 1994, PEDIATR NEUROL, V11, P301, DOI 10.1016/0887-8994(94)90006-X	61	31	33	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	DEC	1997	25	148					1896	1905					10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YW287	WOS:000071917200014	9580291				2022-02-06	
J	McMillan, TM				McMillan, TM			Minor head injury	CURRENT OPINION IN NEUROLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN INJURY; WHIPLASH INJURY; SYMPTOMS; RECOVERY; AMNESIA; HYPOTHESIS; DEFICITS; MEMORY; RISK	The relationship between brief loss of consciousness, subsequent cognitive and emotional complaints, and impact on daily functioning continues to be hotly debated. The weight of current evidence suggests that uncomplicated minor head injury can cause acute cognitive impairment that is organic in aetiology, but late onset or persisting symptoms result from a psychological response. Traditionally, loss of consciousness has been a prerequisite for the definition of minor head injury but this has been challenged in recent years, although evidence does no more than draw attention to this question. Evidence to support the view that post-traumatic stress disorder can develop after head injury continues to grow. Outcomes in unselected mild head injury patients who attend hospital are not improved by provision of early follow-up. (C) Rapid Science Publishers.	St Georges Healthcare Trust, Ctr Neurosci, Wolfson Rehabil Ctr, London SW20 0NE, England; Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England		McMillan, TM (corresponding author), St Georges Healthcare Trust, Ctr Neurosci, Wolfson Rehabil Ctr, London SW20 0NE, England.						*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P424; BARRETT K, 1995, J ACCID EMERG MED, V12, P173; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLEDIN K, 1994, BRIT J MED PSYCHOL, V67, P125, DOI 10.1111/j.2044-8341.1994.tb01778.x; BONTKE C, 1996, J HEAD TRAUMA REHAB, V15, P95; BROOKS DN, 1996, NEUROLAW LETT, V6, P101; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; DIXON P, 1993, BRIT J MED PSYCHOL, V66, P193, DOI 10.1111/j.2044-8341.1993.tb01741.x; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243, DOI 10.2466/pms.1993.76.1.243; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Jacobs A, 1996, J NUCL MED, V37, P1605; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; JENKINS A, 1986, LANCET, V2, P445; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; KOLB LC, 1987, AM J PSYCHIAT, V144, P989; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MALT U, 1988, BRIT J PSYCHIAT, V150, P431; MARSH NV, 1995, BRAIN INJURY, V9, P553, DOI 10.3109/02699059509008214; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; McNeil J E, 1996, Cogn Neuropsychiatry, V1, P239, DOI 10.1080/135468096396532; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; PEARCE JMS, 1993, J NEUROL NEUROSUR PS, V56, P1328, DOI 10.1136/jnnp.56.12.1328-a; PEARCE JMS, 1995, CLIN NEUROLOGY, P134; Peterson L G, 1986, Adv Psychosom Med, V16, P84; Radanov BP, 1996, SPINE, V21, P392, DOI 10.1097/00007632-199602010-00029; Radanov BP, 1996, EUR NEUROL, V36, P48, DOI 10.1159/000117200; Ronnen HR, 1996, RADIOLOGY, V201, P93, DOI 10.1148/radiology.201.1.8816527; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SBORDONE RJ, 1992, NEUROLAW LETT, V1, P3; Schrader H, 1996, LANCET, V347, P1207, DOI 10.1016/S0140-6736(96)90733-3; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; SYMONDS C, 1962, LANCET, P1; Taylor AE, 1996, ARCH PHYS MED REHAB, V77, P529, DOI 10.1016/S0003-9993(96)90290-7; VAMEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x	61	31	31	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	1997	10	6					479	483		10.1097/00019052-199712000-00008			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	YQ035	WOS:000071340900008	9425562				2022-02-06	
J	McKee, MD; Schemitsch, EH; Vincent, LO; Sullivan, I; Yoo, D				McKee, MD; Schemitsch, EH; Vincent, LO; Sullivan, I; Yoo, D			The effect of a femoral fracture on concomitant closed head injury in patients with multiple injuries	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	Annual Meeting of the Canadian-Orthopedic-Association	MAY 26-28, 1996	QUEBEC CITY, CANADA	Canadian Orthoped Assoc		head injury; femoral fracture; multiple injuries; early reamed intramedullary nailing	FAT-EMBOLISM; SHAFT FRACTURES	Objective: We sought to determine the effect of a femoral shaft fracture, and its treatment by early intramedullary nailing, on the neurologic outcome of patients with multiple injuries with a concomitant head injury. Design: Retrospective, case-control design using a prospectively gathered trauma data base. Materials and Methods: We identified 46 patients with multiple injuries (mean Injury Severity Score [ISS] = 33.2) with closed head injuries (mean Glasgow Coma Scale [GCS] score = 7.8) and femur fractures, and matched as controls 99 patients with multiple injuries with head injuries but without femur fractures for age, sex, mechanism of injury, ISS (mean ISS = 34.0), and GCS (mean GCS score = 8.0). Follow-up parameters examined included early mortality, length of hospital or intensive-care unit stay, neuropsychological testing, and level of neurologic disability. Results: There were no significant differences in the demographics or injury parameters between the study and control groups. There were no significant differences between the two groups in terms of early mortality (study group, 28%; control group, 27%; p = not significant), length of hospital/intensive-care unit stay (study group, 17.5/6.9 days; control group, 18.0/6.3 days; p = not significant), level of neurologic disability, or results of cognitive testing. Conclusion: Our study suggests that a femoral fracture in a patient with a concomitant head injury does not increase mortality or neurologic disability, and supports the continued early intramedullary nailing of femoral fractures for these patients.	ST MICHAELS HOSP, DIV ORTHOPAED SURG, TORONTO, ON M5B 1W8, CANADA; ST MICHAELS HOSP, HEAD INJURY TEAM, TORONTO, ON M5B 1W8, CANADA; UNIV TORONTO, TORONTO, ON, CANADA				Schemitsch, Emil/G-5706-2017	Schemitsch, Emil/0000-0002-6435-9069			Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BELLAMY R, 1974, J TRAUMA, V14, P1021, DOI 10.1097/00005373-197412000-00004; FRY K, 1976, J TRAUMA, V16, P371, DOI 10.1097/00005373-197605000-00008; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; GARLAND DE, 1980, CLIN ORTHOP RELAT R, V150, P198; GARLAND DE, 1982, CLIN ORTHOP RELAT R, V166, P219; GLENN JN, 1973, J TRAUMA, V13, P958, DOI 10.1097/00005373-197311000-00004; KARZMARK P, 1992, BRAIN INJURY, V63, P213; KOTWICA Z, 1990, ACTA NEUROCHIR, V102, P19, DOI 10.1007/BF01402180; LEVY D, 1990, CLIN ORTHOP RELAT R, V261, P281; MALISANO LP, 1994, J ORTHOP TRAUMA, V8, P1, DOI 10.1097/00005131-199402000-00001; MANNING JB, 1983, J TRAUMA, V23, P322, DOI 10.1097/00005373-198304000-00009; MEEK RN, 1972, J TRAUM, V12, P432, DOI 10.1097/00005373-197205000-00015; PELL ACH, 1993, J BONE JOINT SURG BR, V75, P921, DOI 10.1302/0301-620X.75B6.8245083; PELTIER LF, 1988, CLIN ORTHOP RELAT R, V232, P263; RAYMOND C, 1983, J BONE J SURG, V146, P107; RISKA EB, 1982, J TRAUMA, V22, P891, DOI 10.1097/00005373-198211000-00001; TALUCCI RC, 1983, AM J SURG, V146, P107, DOI 10.1016/0002-9610(83)90269-6; Turchin DC, 1995, T ORTHOP RES SOC, V20, P252	20	31	31	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	1997	42	6					1041	1045		10.1097/00005373-199706000-00009			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	XH700	WOS:A1997XH70000014	9210538				2022-02-06	
J	Baxter, PJ; Gresham, A				Baxter, PJ; Gresham, A			Deaths and injuries in the eruption of Galeras Volcano, Colombia, 14 January 1993	JOURNAL OF VOLCANOLOGY AND GEOTHERMAL RESEARCH			English	Article						deaths; pathology; eruption; Galeras volcano		Six volcanologists and three tourists were killed in the crater of Galeras Volcano, Colombia, when it erupted without warning. The scientists were attending the United Nations International Decade for Natural Disaster Reduction Workshop which had been convened to improve monitoring, research and disaster mitigation at Galeras, at the time the most active and one of the most hazardous volcanoes in South America. Information on the events surrounding the eruption was obtained by sending a questionnaire to twelve scientists who had been inside the caldera at the time of the eruption or who had assisted in the search and rescue operation. The autopsy reports on the five corpses, and the few pieces of equipment and clothing retrieved from the crater area, were also studied. The main causes of death and injury were the forces at the eruptive vent and the bombardment by hot rocks ejected in the first 15 min of the emption, ranging from blocks over 1 m in size to pea-sized lapilli which fell last. Some conclusions can be drawn for the future safety of volcanologists working in craters at high altitude. Hard hats would protect against concussion from blows to the head during escape from the danger area, and a Lightweight, heat-resistant and water-repellent coverall would limit the skin bums and the risk of clothing being ignited from contact with incandescent, falling ejecta. The coverall could also be life saving by protecting immobilised casualties from hypothermia due to the rain and wind whilst waiting to be rescued, especially as the volcanic activity, cloud cover or nightfall could curtail rescue efforts. Work in hazardous craters should be strictly limited to essential tasks and periods of good visibility, and a climbing team should leave the area at least four hours before nightfall in case rescue is needed. Tourists must be warned against visiting active crater areas.			Baxter, PJ (corresponding author), UNIV CAMBRIDGE,ADDENBROOKES HOSP,SCH CLIN,HILLS RD,CAMBRIDGE CB2 2QQ,ENGLAND.						CHESTER DK, 1985, MOUNT ETNA MAKING VO; FINK J, 1995, NATURE, V373, P660, DOI 10.1038/373660a0; Munoz F.A., 1993, EOS T AM GEOPHYS UN, V74, P281, DOI [10.1029/93EO00391, DOI 10.1029/93EO00391]; *SMITHS I, 1995, GLOB VOLC NETW, V20, P11; Stix J, 1997, J VOLCANOL GEOTH RES, V77, P285, DOI 10.1016/S0377-0273(96)00100-X; TILLING RI, 1993, NATURE, V364, P277, DOI 10.1038/364277a0; TNO, 1992, METH DET POSS DAM PE; WILSON L, 1980, J VOLCANOL GEOTH RES, V8, P297, DOI 10.1016/0377-0273(80)90110-9	8	31	32	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0377-0273			J VOLCANOL GEOTH RES	J. Volcanol. Geotherm. Res.	MAY	1997	77	1-4					325	338		10.1016/S0377-0273(96)00103-5			14	Geosciences, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Geology	XC670	WOS:A1997XC67000021					2022-02-06	
J	Zapata, A; Capdevila, JL; Tarrason, G; Adan, J; Martinez, JM; Piulats, J; Trullas, R				Zapata, A; Capdevila, JL; Tarrason, G; Adan, J; Martinez, JM; Piulats, J; Trullas, R			Effects of NMDA-R1 antisense oligodeoxynucleotide administration: Behavioral and radioligand binding studies	BRAIN RESEARCH			English	Article						NMDA receptor; antisense oligodeoxynucleotide; elevated plus maze; anxiety; seizure	TRAUMATIC BRAIN INJURY; D-ASPARTATE ANTAGONIST; RECEPTOR COMPLEX; CEREBROCORTICAL NEURONS; FUNCTIONAL ANTAGONISTS; NANOMOLAR AFFINITY; RAT-BRAIN; ACID; EXCITOTOXICITY; PHENCYCLIDINE	The effects of an antisense phosphodiester oligodeoxynucleotide (ODN) directed to the NR1 subunit of the NMDA receptor mRNA and of its corresponding sense ODN were investigated in mice, Treatment with the antisense ODN significantly increased the time mice spent in the open arms of an elevated maze while the total number of arm entries was unaltered. Furthermore, seizure latencies after the administration of an ED100 dose of NMDA (150 mg/kg) were significantly higher in antisense treated animals compared to vehicle controls. At the same time, treatment with NR1 antisense ODN significantly reduced the B-max of [H-3]CGS-19755 binding (2101 fmol/mg protein) compared to both vehicle (2787 fmol/mg protein) and sense (2832+/-39 fmol/mg protein) controls without any significant change in K-D (33 nM). A corresponding reduction of [H-3]CGP-39653 binding was also observed after treatment with NR1 antisense compared to both sense and vehicle controls. In contrast, neither antisense nor sense ODNs altered the proportion of high affinity glycine sites or the potency of glycine at either high or low affinity glycine binding sites to inhibit [H-3]CGP-39653 binding. These results show that in vivo treatment with NR1 antisense ODNs to the NMDA receptor complex reduces antagonist binding al NMDA receptors and has pharmacological effects similar to those observed with some NMDA receptor antagonists. These results also suggest that treatment with antisense ODNs may provide another means to investigate allosteric modulation of receptor subtypes in vivo.	CSIC, INST INVEST BIOMED, DEPT BIOANALIT MED, UNITAT NEUROBIOL, ES-08034 BARCELONA, SPAIN; MERCK FARMA & QUIM SA, BARCELONA, SPAIN				Trullas, Ramon/D-2197-2016	Trullas, Ramon/0000-0001-7951-9881			ALLEN HL, 1990, SCIENCE, V247, P221, DOI 10.1126/science.2403696; BENNETT DA, 1990, PROG CLIN BIOL RES, V361, P519; BENNETT DA, 1986, LIFE SCI, V39, P2455, DOI 10.1016/0024-3205(86)90488-1; BENNETT DA, 1989, J PHARMACOL EXP THER, V250, P454; CHIASSON BJ, 1994, CELL MOL NEUROBIOL, V14, P507, DOI 10.1007/BF02088834; CROUCHER MJ, 1982, SCIENCE, V216, P899, DOI 10.1126/science.7079744; DANYSZ W, 1995, BEHAV PHARMACOL, V6, P455; DUNN RW, 1992, EUR J PHARMACOL, V214, P207, DOI 10.1016/0014-2999(92)90120-S; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; HARGREAVES RJ, 1994, ACTA NEUROCHIR, P15; ISHII T, 1993, J BIOL CHEM, V268, P2836; KEHNE JH, 1991, EUR J PHARMACOL, V193, P283, DOI 10.1016/0014-2999(91)90141-C; KINDY MS, 1994, NEUROSCI RES COMMUN, V14, P175; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; LAYER RT, 1995, PHARMACOL BIOCHEM BE, V52, P621, DOI 10.1016/0091-3057(95)00155-P; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Maj J, 1993, Pol J Pharmacol, V45, P349; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MELDRUM BS, 1994, NEUROLOGY, V44, P14; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; MURPHY DE, 1988, BRIT J PHARMACOL, V95, P932, DOI 10.1111/j.1476-5381.1988.tb11723.x; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; PLAZNIK A, 1994, EUR NEUROPSYCHOPHARM, V4, P503, DOI 10.1016/0924-977X(94)90299-2; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; RUNDFELDT C, 1994, BRAIN RES, V653, P125, DOI 10.1016/0006-8993(94)90380-8; SILLS MA, 1991, EUR J PHARMACOL, V192, P19, DOI 10.1016/0014-2999(91)90063-V; SOLTESZ I, 1994, NEUROSCI LETT, V181, P5, DOI 10.1016/0304-3940(94)90547-9; SUN FY, 1995, BRAIN RES, V693, P163, DOI 10.1016/0006-8993(95)00731-5; TRULLAS R, 1989, PHARMACOL BIOCHEM BE, V34, P313, DOI 10.1016/0091-3057(89)90317-1; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WAHLESTEDT C, 1994, TRENDS PHARMACOL SCI, V15, P42, DOI 10.1016/0165-6147(94)90107-4; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; WINSLOW JT, 1990, EUR J PHARMACOL, V190, P11, DOI 10.1016/0014-2999(90)94107-9; YANG GY, 1994, NEUROSURGERY, V34, P339, DOI 10.1227/00006123-199402000-00018; YEE F, 1994, CELL MOL NEUROBIOL, V14, P475, DOI 10.1007/BF02088832	40	31	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 16	1997	745	1-2					114	120		10.1016/S0006-8993(96)01134-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WX974	WOS:A1997WX97400012	9037399				2022-02-06	
J	Levinson, DM; Reeves, DL				Levinson, DM; Reeves, DL			Monitoring recovery from traumatic brain injury using automated neuropsychological assessment metrics (ANAM V1.0)	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							PERFORMANCE	Twenty-two students in the Coastline Community College Traumatic Head Injury Program completed two sessions of neuropsychological testing spaced 2-3 months apart, using ANAM V1.0. Eight (GP1) were marginally injured, seven (GP2) mildly, and seven (GP3) moderately. Comparisons of first-session accuracy scores with normative data revealed that GP1 was impaired on one test, while GPs 2 and 3 were impaired on 3 and 4 rests, respectively. Second-session accuracy scores were normal for GPs 1 and 2 on all tests, and impaired on one for GP3. Comparisons of first-session efficiency scores with normative data indicated that GP1 was significantly impaired on 2 tests, while GPs 2 and 3 were impaired on all 6. Second-session efficiency scores, were normal for GP1 on 5 tests; GPs 2 and 3 also improved but remained impaired on all 6 tests. Based on efficiency, 91% of the individuals were correctly classified. (C) 1997 National Academy of Neuropsychology.	NAVAL MED CTR, SAN DIEGO, CA USA; NATL COGNIT RECOVERY FDN, SAN DIEGO, CA USA		Levinson, DM (corresponding author), NATL COGNIT RECOVERY FDN, RES OFF, 13202 ETON PL, SANTA ANA, CA 92705 USA.						BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; BLEIBERG J, 1989, PHYSICAL MED REHABIL, V3, P95; BLEIBERG J, 1992, ARCH PHYSICAL MED RE, V73, P1994; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; LEANDOWSKI AG, 1994, 14 ANN FRONT S AM CO; LEVINSON DM, 1994, NCRFTR9401; LEVINSON DM, 1996, NCRFTR9602; LEVINSON DM, 1990, 98 AM PSYCH ASS ANN; REEVES D, 1996, NCRFTR9601; REEVES D, 1992, ANAM DOCUMENTATION, V1; Reeves D, NCRFTR9501; Reeves D, 1993, AUTOMATED NEUROPSYCH; SHINGLEDECKER CA, 1984, AFAMRLTR84; STANNY RR, 1994, UNPUB EFFECTS SUSTAI; STERNBERG S, 1969, AM SCI, V57, P421; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Tabachnick B. G., 1989, USING MULTIVARIATE S; THORNE D, 1990, THROUGHPUT SIMPLE PE; THORNE DR, 1985, NEUROBEH TOXICOL TER, V7, P415	19	31	31	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	2					155	166		10.1016/S0887-6177(96)00026-1			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	WV548	WOS:A1997WV54800007	14588427	Bronze			2022-02-06	
J	Balcer, LJ; Galetta, SL; Bagley, LJ; Pakola, SJ				Balcer, LJ; Galetta, SL; Bagley, LJ; Pakola, SJ			Localization of traumatic oculomotor nerve palsy to the midbrain exit site by magnetic resonance imaging	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article								PURPOSE: To present the magnetic resonance imaging findings for a patient with traumatic oculomotor nerve injury. METHODS: We examined a patient with a right pupil-involving oculomotor nerve palsy after severe closed head trauma. RESULTS: Magnetic resonance imaging of the brain demonstrated marked signal hypointensity on gradient-echo T-2*-weighted images consistent with hemorrhage at the midbrain exit site of the right oculomotor nerve. CONCLUSIONS: Distal fascicular damage or partial rootlet avulsion is a mechanism of injury in some traumatic oculomotor nerve palsies. Gradient echo T-2*-weighted magnetic resonance imaging is the most sensitive method to detect hemorrhagic changes associated with shearing injury.	UNIV PENN,SCH MED,DEPT NEURORADIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT OPHTHALMOL,PHILADELPHIA,PA 19104		Balcer, LJ (corresponding author), UNIV PENN,SCH MED,DEPT NEUROL,3 W GATES BLDG,3400 SPRUCE ST,PHILADELPHIA,PA 19104, USA.						ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; ATLAS SW, 1991, MAGNETIC RESONANCE I, P439; HEINZE J, 1969, MED J AUSTRALIA, V2, P1246, DOI 10.5694/j.1326-5377.1969.tb103371.x; WALTER KA, 1994, NEUROLOGY, V44, P148, DOI 10.1212/WNL.44.1.148	4	31	32	0	2	OPHTHALMIC PUBL CO	CHICAGO	77 WEST WACKER DR, STE 660, CHICAGO, IL 60601	0002-9394			AM J OPHTHALMOL	Am. J. Ophthalmol.	SEP	1996	122	3					437	439		10.1016/S0002-9394(14)72078-1			3	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	VF620	WOS:A1996VF62000023	8794724				2022-02-06	
J	Farmer, JE; Clippard, DS; LuehrWiemann, Y; Wright, E; Owings, S				Farmer, JE; Clippard, DS; LuehrWiemann, Y; Wright, E; Owings, S			Assessing children with traumatic brain injury during rehabilitation: Promoting school and community reentry	JOURNAL OF LEARNING DISABILITIES			English	Article							CLOSED-HEAD-INJURY; YOUNG-CHILDREN; SEVERITY; ADOLESCENTS; COHORT; PERFORMANCE; PREDICTORS; CHILDHOOD; RECOVERY; SCALE	Children with traumatic brain injuries (TBI) require a comprehensive, multidisciplinary evaluation during rehabilitation to promote recovery and to facilitate a smooth transition to home and school. This article summarizes the common consequences-of TBI and reviews a process-oriented approach to assessing children with moderate to severe TBI during rehabilitation. An emphasis is placed on early and regular communication among rehabilitation specialists, family members, and educators. Such collaboration permits clear identification of functional abilities and increases the child's potential for a positive long-term outcome.	ST JOHNS MERCY MED CTR, PROFESS REHABIL CTR, ST LOUIS, MO 63141 USA		Farmer, JE (corresponding author), UNIV MISSOURI, SCH MED, DEPT PHYS MED & REHABIL, COLUMBIA, MO 65211 USA.						Abidin RR., 1983, PARENTING STRESS IND; ACHENBACH TM, 1991, MANUAL CHILD BEHAVIO; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; ASHER IA, 1989, ANNOTATED INDEX OCCU; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Beery K. E., 1982, DEV TEST VISUAL MOTO; Begali V., 1992, HEAD INJURY CHILDREN; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Bruininks, 1978, BRUININKS OSERETSKY; CARNEY J, 1990, Pediatrician, V17, P222; Ciccetti D., 1984, VINELAND ADAPTIVE BE; COBBS LW, 1986, J HEAD TRAUMA REHAB, V1, P57; Colarusso RP, 1972, MOTOR FREE VISUAL PE; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; CROWLEY JA, 1991, J PEDIATR PSYCHOL, V16, P611, DOI 10.1093/jpepsy/16.5.611; DEATON AV, 1994, ED DIMENSIONS ACQUIR, P239; DEFINA A, 1991, PORTFOLIO ASSESSMENT; Delis DC, 1989, CALIFORNIA VERBAL LE; DENNEY DR, 1973, DEV PSYCHOL, V9, P275, DOI 10.1037/h0035092; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DEPAEPE JL, 1994, ED DIMENSIONS ACQUIR, P345; DEPOMPEI R, 1994, ED DIMENSIONS ACQUIR, P489; DEPOMPEI R, 1993, STAFF DEV CLIN INTER, P229; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FOLIO R, 1983, PEABODY DEV SCALES; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOODMAN Y, 1987, READING MISCUE INVEN; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; HAGEN C, 1981, RANCHO LOS AMIGOS LE; Haley S, 1992, PEDIAT EVALUATION DI; HALEY SM, 1991, PHYS MED REH CLIN N, V2, P689; HANSON SL, 1992, PHYSICAL MED REHABIL, V6, P483; Heaton R.K., 1981, WISCONSIN CARD SORTI; IVERSON GL, 1994, ANN M INT NEUR SOC C; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; JAFFE KM, 1986, J HEAD TRAUMA REHAB, V1, P30; JANUS PL, 1994, ED DIMENSIONS ACQUIR, P345; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; JORDAN FM, 1991, J SPEECH HEAR RES, V34, P572, DOI 10.1044/jshr.3403.572; JORGENSON C, 1981, WORD TEST; Kaufman A.S., 1985, KAUFMAN TEST ED ACHI; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Kovich K., 1988, HEAD INJURY GUIDE FU; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lehr E, 1990, PSYCHOL MANAGEMENT T; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS., 1982, NEUROBEHAVIORAL CONS; McCubbin HI, 1985, FAMILY INVENTORIES I; MCKEE WT, 1990, HDB SCH PSYCHOL, P821; Miller L. J., 1982, MILLER ASSESSMENT PR; MILNER M, 1990, Pediatrician, V17, P287; MOOS RH, 1976, FAM PROCESS, V15, P357, DOI 10.1111/j.1545-5300.1976.00357.x; MURPHYBERMAN V, 1987, PERCEPT MOTOR SKILL, V64, P1139, DOI 10.2466/pms.1987.64.3c.1139; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PIEPER E, 1983, POINTER, V27, P40; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; PRATT PN, 1989, OCCUPATIONAL THERAPY; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; RESCHLY D, 1992, CONTROVERSIAL ISSUES, P127; Reynolds C.R., 1994, TEST MEMORY LEARNING; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; RIVARA JB, 1994, ARCH PHYSICAL MED RE, V75, P269; Russell N, 1993, LANG SPEECH HEAR SER, V24, P67; Savage R. C., 1994, ED DIMENSIONS ACQUIR; SEMEL E, 1987, CLIN EVALUATION LANG; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sheslow D., 1990, WIDE RANGE ASSESSMEN; STORY TB, 1991, COGNITIVE REHABILITA, P251; TEASDALE G, 1974, LANCET, V2, P81; Trombly C., 1989, OCCUPATIONAL THERAPY; *VIRG DEP ED, 1992, GUID ED SERV STUD TR; WAALAND PK, 1993, BRAIN INJURY, V7, P135, DOI 10.3109/02699059309008167; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WIIG EH, 1988, TEST LANGUAGE COMPET; WOODCOCK RW, 1989, WOODCOCKJOHNSON PSYC; WORTHEN BR, 1993, PHI DELTA KAPPAN, V74, P444; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; YLVISAKER M, 1990, REHABILITATION ADULT, P558; Ylvisaker M., 1994, ED DIMENSIONS ACQUIR, P69; [No title captured]; 1991, FED REGISTER, V56, P41266	98	31	31	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-2194	1538-4780		J LEARN DISABIL-US	J. Learn. Disabil.	SEP	1996	29	5					532	548		10.1177/002221949602900508			17	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	VJ057	WOS:A1996VJ05700008	8870523				2022-02-06	
J	Bigler, ED; Blatter, DD; Johnson, SC; Anderson, CV; Russo, AA; Gale, SD; Ryser, DK; Macnamara, SE; Bailey, BJ				Bigler, ED; Blatter, DD; Johnson, SC; Anderson, CV; Russo, AA; Gale, SD; Ryser, DK; Macnamara, SE; Bailey, BJ			Traumatic brain injury, alcohol and quantitative neuroimaging: Preliminary findings	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; ATROPHY; DEFICITS; VOLUME; GRAY	Magnetic resonance (MR) quantitative neuroimaging analysis was undertaken with a large group of normal (n = 197) and traumatically brain injured (TBI, n = 99) adults. Of the TBI subjects 18 patients were identified with a history of substance-related abuse (TBI/Abuse group). Both the TBI/Abuse group and the remaining sample of TBI patients (n = 81, TBI/Non-abuse group) without a history of substance-related abuse differed significantly from the control group on most quantitative MR imaging analyses. The TBI/Abuse group displayed the greatest degree of atrophic change. However, the TBI/Abuse group had a significantly lower Glasgow Coma Scale (GCS) score, ostensibly suggesting that those with substance-related abuse suffered more severe brain injury than non-abuse TBI patients. When a subset (n = 18) of the TBI/Non-abuse group was matched by GCS, gender and age to the TBI/Abuse group, both groups differed significantly from the control group on most morphometric measures, but did not differ from one another. Results are discussed in terms of the potential adverse role that substance-related abuse, particularly alcohol, plays in the individual who sustains traumatic injury to the brain.	LDS HOSP,SALT LAKE CITY,UT		Bigler, ED (corresponding author), BRIGHAM YOUNG UNIV,DEPT PSYCHOL,POB 25543,PROVO,UT 84602, USA.						ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; BADSBERGJENSEN G, 1993, LANCET, V342, P1201; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; BIGLER ED, 1994, FUNCTIONAL NEUROIMAG, P121; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; CHARNESS ME, 1993, ALCOHOL CLIN EXP RES, V17, P2, DOI 10.1111/j.1530-0277.1993.tb00718.x; CHICK JD, 1989, ALCOHOL CLIN EXP RES, V13, P512, DOI 10.1111/j.1530-0277.1989.tb00369.x; ECKARDT M J, 1988, Advances in Alcohol and Substance Abuse, V7, P59; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; GALE SD, 1995, J INT NEUROPSYCH SOC, V1, P162; GALE SD, 1994, THESIS B YOUNG U PRO; GLUCKSMAN E, 1994, BRIT MED BULL, V50, P76, DOI 10.1093/oxfordjournals.bmb.a072886; Gronwall Dorothy, 1990, HEAD INJURY FACTS GU; JERNIGAN TL, 1991, NEUROPSYCHOPHARMACOL, V4, P175; JERNIGAN TL, 1991, ARCH GEN PSYCHIAT, V48, P881; JERNIGAN TL, 1982, PSYCHIAT RES, V7, P9, DOI 10.1016/0165-1781(82)90048-8; JERNIGAN TL, 1991, ALCOHOL CLIN EXP RES, V15, P418, DOI 10.1111/j.1530-0277.1991.tb00540.x; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; JOYCE EM, 1994, BRIT MED BULL, V50, P99, DOI 10.1093/oxfordjournals.bmb.a072888; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LOVINGER DM, 1993, ALCOHOL CLIN EXP RES, V17, P19, DOI 10.1111/j.1530-0277.1993.tb00720.x; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; MEARNS J, 1993, J CLIN PSYCHOL, V49, P714, DOI 10.1002/1097-4679(199309)49:5<714::AID-JCLP2270490515>3.0.CO;2-H; MUURONEN A, 1989, ALCOHOL CLIN EXP RES, V13, P137, DOI 10.1111/j.1530-0277.1989.tb00298.x; Osborn AG, 1994, DIAGNOSTIC NEURORADI; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; ROSENTHAL M, 1993, J HEAD TRAUMA REHABI, V8; SALAZAR AM, CHALLENGES NEUROLOGY, P55; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SHEAR PK, 1994, ALCOHOL CLIN EXP RES, V18, P172, DOI 10.1111/j.1530-0277.1994.tb00899.x; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Wechsler, 1981, WECHSLER MEMORY SCAL	40	31	31	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAR	1996	10	3					197	206		10.1080/026990596124511			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UC765	WOS:A1996UC76500003	8777391				2022-02-06	
J	Francisco, GE; Ivanhoe, CB				Francisco, GE; Ivanhoe, CB			Successful treatment of post-traumatic narcolepsy with methylphenidate - A case report	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						narcolepsy; traumatic brain injury; methylphenidate	SLEEPINESS	Narcolepsy is a rare sequela of brain injury. We report the case of a 27-yr-old male with post-traumatic narcolepsy who was successfully treated with methylphenidate. This patient sustained moderate brain injury from a motorcycle accident. Subsequently, he manifested the classic tetrad of narcolepsy: cataplexy, excessive daytime sleepiness, sleep paralysis, and hypnogogic hallucinations. There was no premorbid seizure or sleep disorder. There was no family history of sleep disorders. Polysomnography and Multiple Sleep Latency Test confirmed the diagnosis of narcolepsy. Sleep latency (time to sleep onset), rapid eye movement sleep latency (time from sleep onset to rapid eye movement sleep onset), and mean multiple sleep latency were all pathologically shortened (2.5, 66, and 1.2 min, respectively). Twenty-four hour electroencephalographic monitoring and magnetic resonance imaging of the brain were normal, as were serum chemistries. Treatment with caffeine was unsuccessful. He was then started on methylphenidate, 10 mg twice daily, which was increased to 30 mg twice daily over a 4-mo period. Cataplexy and excessive daytime sleepiness started to improve 1 mo after adjustments in methylphenidate dosing. Six months after the initiation of methylphenidate therapy, the patient is completely asymptomatic.	BAYLOR COLL MED,DEPT PHYS MED & REHABIL,HOUSTON,TX 77030; INST REHABIL & RES,BRAIN INJURY PROGRAM,HOUSTON,TX								BILLIARD M, 1986, SLEEP, V9, P149, DOI 10.1093/sleep/9.1.149; BOUNDELLE M, 1976, ADV SLEEP RES, V3, P313; CARSKADON MA, 1982, SLEEP, V5, pS67, DOI 10.1093/sleep/5.S2.S67; GOOD JL, 1989, J NEUROSURG, V71, P765, DOI 10.3171/jns.1989.71.5.0765; GUILLEMINAULT C, 1983, NEUROLOGY, V33, P1584, DOI 10.1212/WNL.33.12.1584; GUILLEMINAULT C, 1994, PRINCIPLES PRACTICE, P549; GUILLEMINAULT C, 1994, PRINCIPLES PRACTICE, P562; KALES A, 1979, ARCH NEUROL-CHICAGO, V36, P650, DOI 10.1001/archneur.1979.00500460084015; MACCARIO M, 1987, MIL MED, V152, P370, DOI 10.1093/milmed/152.7.370; MITLER MM, 1990, J CLIN NEUROPHYSIOL, V7, P93, DOI 10.1097/00004691-199001000-00008; MITLER MM, 1991, SLEEP, V14, P218, DOI 10.1093/sleep/14.3.218; PARKES JD, 1993, SLEEP, V16, P201, DOI 10.1093/sleep/16.3.201; WING YK, 1994, POSTGRAD MED J, V70, P34, DOI 10.1136/pgmj.70.819.34; YOSS RE, 1959, NEUROLOGY, V9, P171, DOI 10.1212/WNL.9.3.171; 1986, SLEEP, V9, P519	15	31	31	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN-FEB	1996	75	1					63	65		10.1097/00002060-199601000-00016			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	TY971	WOS:A1996TY97100012	8645441				2022-02-06	
J	CHAPMAN, SB; LEVIN, HS; MATEJKA, J; HARWARD, H; KUFERA, JA				CHAPMAN, SB; LEVIN, HS; MATEJKA, J; HARWARD, H; KUFERA, JA			DISCOURSE ABILITY IN CHILDREN WITH BRAIN INJURY - CORRELATIONS WITH PSYCHOSOCIAL, LINGUISTIC, AND COGNITIVE-FACTORS	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED HEAD-INJURY; ADOLESCENTS; VALIDATION; SEQUELAE	Discourse deficits have recently been documented in children with closed head injury (CHI). The relationships among discourse and other variables such as psychosocial and cognitive abilities are not well understood. This investigation represents an exploratory study to elucidate potential relationships across linguistic, cognitive, and psychosocial variables in children after CHI, ranging from mild to severe, at 3 and 12 months postinjury. The most clinically salient finding was a significant relationship between narrative discourse measures and perceived communicative competence on a well-validated psychosocial measure at 1 year after injury. Additional results suggest that receptive vocabulary and certain cognitive functions (ie, planning and semantic organization), as well as injury severity, may also be related to discourse abilities. Although the findings should be interpreted with caution, the relationships across these variables warrant further validation in pediatric populations with CHI because of the functional relevance of discourse abilities to social and academic settings.	UNIV MARYLAND,MED SYST,DIV NEUROL SURG,BALTIMORE,MD		CHAPMAN, SB (corresponding author), UNIV TEXAS,CALLIER CTR COMMUN DISORDERS,1966 INWOOD RD,DALLAS,TX 75235, USA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Applebee A., 1978, CHILDS CONCEPT STORY; BISHOP DVM, 1987, J SPEECH HEAR DISORD, V52, P156, DOI 10.1044/jshd.5202.156; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CHADWICK O, 1985, DEV MED CHILD NEUROL, V27, P72; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, IN PRESS BRAIN LANG; CHAPMAN SB, IN PRESS CONSEQUENCE; CHAPMAN SB, 1994, APR ANN C TEX SPEECH; CHAPMAN SB, 1995, HDB NEUROLOGICAL SPE; CHAPMAN SB, 1994, NOV AM SPEECH LANG H; Ciccetti D., 1984, VINELAND ADAPTIVE BE; CULHANESHELBURN.K, 1992, FEB INT NEUR SOC M S; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; DENNIS M, 1994, BRAIN LANG, V46, P129, DOI 10.1006/brln.1994.1008; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dunn LM., 1981, PEABODY PICTURE VOCA; FEAGANS L, 1986, J EDUC PSYCHOL, V78, P358, DOI 10.1037/0022-0663.78.5.358; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Frederiksen C. H., 1990, DISCOURSE ABILITY BR; GROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754; Holland A., 1980, COMMUNICATIVE ABILIT; Hunt K. W., 1965, 3 NAT COUNC TEACH EN; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Labov W., 1972, LANGUAGE INNER CITY; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; MROSS EF, 1990, DISCOURSE ABILITY BR; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PRIGATANO GP, 1993, NEUROPSYCHOL REHABIL, V3, P411, DOI 10.1080/09602019308401449; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; TEASDALE G, 1974, LANCET, V2, P81; ULATOWSKA HK, 1991, HDB GERIATRIC COMMUN; ULATOWSKA HK, 1990, DISCOURSE ABILITY BR; VANDIJK TA, 1985, HDB DISCOURSE ANAL; WESTBY C, 1989, READING DISABILITIES; WESTBY C, 1984, LANGUAGE LEARNING DI; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447	41	31	31	0	7	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1995	10	5					36	54		10.1097/00001199-199510000-00006			19	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RY617	WOS:A1995RY61700006					2022-02-06	
J	SALAZAR, AM; SCHWAB, K; GRAFMAN, JH				SALAZAR, AM; SCHWAB, K; GRAFMAN, JH			PENETRATING INJURIES IN THE VIETNAM-WAR - TRAUMATIC UNCONSCIOUSNESS, EPILEPSY, AND PSYCHOSOCIAL OUTCOME	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							HEAD-INJURY; PROGNOSTIC FACTORS; BRAIN; MORTALITY; PHENYTOIN; VETERANS; SEIZURES; CARE	The WF Caveness Vietnam Head Injury Study includes over a thousand men who survived penetrating head injuries during the Vietnam War and on whom detailed medical and follow-up data are available. This population offers unique opportunities for the study of recovery from brain injury and of brain structure-function relationships. The authors briefly review long-term outcome in this cohort with respect to traumatic unconsciousness, posttraumatic epilepsy, and elements of psychologic and psychosocial function, including returning to work.	NINCDS,BETHESDA,MD 20892		SALAZAR, AM (corresponding author), WALTER REED ARMY MED CTR,DEFENSE & VET HEAD INJURY PROGRAM,BLDG 7,ROOM 224,WASHINGTON,DC 20307, USA.						ALBERT ML, 1976, ARCH NEUROL-CHICAGO, V33, P453, DOI 10.1001/archneur.1976.00500060059013; CAREY ME, 1987, MIL MED, V152, P6; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; CAVENESS WF, 1974, HDB NEUROLOGY, P274; CORKIN S, 1984, ARCH NEUROL-CHICAGO, V41, P975, DOI 10.1001/archneur.1984.04050200081022; Credner L, 1930, Z GESAMTE NEUROL PSY, V126, P721, DOI 10.1007/BF02864129; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRAFMAN J, 1986, J NEUROSCI, V6, P301; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Jennett B, 1981, MANAGEMENT HEAD INJU; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; KRAFT JF, 1993, ARCH PHYS MED REHAB, V74, P596, DOI 10.1016/0003-9993(93)90157-6; LURIA AR, 1978, CONSCIOUSNESS SELF R, P1; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; PARENTI G, 1991, PHARM PROPHYLAXIS PO, P43; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; SALAZAR A, 1987, ADV EPILEPTOL, P753; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALAZAR AM, 1987, PROGR CLIN NEUROSCIE, V1, P225; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; SCHWARTZ B, 1967, ACTA NEUROL SCAND, V43, P513, DOI 10.1111/j.1600-0404.1967.tb05757.x; SERAFETINIDES EA, 1965, BRAIN, V88, P107, DOI 10.1093/brain/88.1.107; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TUCKER DM, 1984, PSYCHOL REV, V91, P185, DOI 10.1037/0033-295X.91.2.185; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; WILLMORE LJ, 1990, EPILEPSIA, V31, P67; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236	33	31	32	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	1042-3680			NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	1995	6	4					715	&					0	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RZ142	WOS:A1995RZ14200012	8527913				2022-02-06	
J	MILLIS, SR; KLER, S				MILLIS, SR; KLER, S			LIMITATIONS OF THE REY 15-ITEM TEST IN THE DETECTION OF MALINGERING	CLINICAL NEUROPSYCHOLOGIST			English	Article								The capacity of Rey's (1964) Fifteen-Item Test (FIT) to detect feigned memory impairment in a group of clinical malingerers was investigated. Seven malingerers were identified by significantly below chance performance on a forced-choice memory measure, the Recognition Memory Test, and were given the FIT. A reference group of 7 patients with acute moderate and severe traumatic brain injuries was also given the FIT. The brain-injured subjects recalled significantly more items on the FIT than the malingering subjects. Using a cutoff score of 7, the FIT was able to detect only 57% of the malingerers but did not misclassify any brain-injured subjects. Although possessing good specificity, the FIT appears to lack adequate sensitivity to detect feigned impairment when used as a single measure. The FIT may be sensitive primarily to blatant deceptive strategies.	REHABIL INST MICHIGAN,DETROIT,MI 48201; WAYNE STATE UNIV,SCH MED,DETROIT,MI 48202								GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; LEVIN H, 1975, J NERV MENT DIS, V167, P675; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; Rey A., 1964, EXAMEN CLIN PSYCHOL; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; TEASDALE G, 1974, LANCET, V2, P81; Warrington E, 1984, RECOGNITION MEMORY T, V1	9	31	31	0	5	SWETS ZEITLINGER BV	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL	1995	9	3					241	244		10.1080/13854049508400486			4	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	RJ646	WOS:A1995RJ64600006					2022-02-06	
J	CORRIGAN, JD; LAMBHART, GL; RUST, E				CORRIGAN, JD; LAMBHART, GL; RUST, E			A PROGRAM OF INTERVENTION FOR SUBSTANCE-ABUSE FOLLOWING TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							ALCOHOLISM SCREENING-TEST	This article describes a pilot programme initiated in 1991 to address the problems of substance abuse among persons who have experienced traumatic brain injury (TBI). The model of treatment is community-based, using an interdisciplinary staff with expertise in TBI, vocational rehabilitation, and substance abuse treatment, to support and enhance existing services in the client's own community. The primary method of intervention is resource and service coordination. Six principles that serve as the underpinnings of the model are described, as are core and supplemental services and staffing patterns. Innovative components of the programme include the theoretical model of changing addictive behaviours used to guide treatment, and the development of community teams to facilitate a coordinated and integrated approach. The programme has relatively low start-up costs and can serve both urban and rural populations. Clinical experience and initial programme evaluation results suggest that substance abuse and vocational rehabilitation goals can be effectively attained using this model of service delivery.	OHIO STATE UNIV, DEPT PHYS MED & REHABIL, COLUMBUS, OH USA				Corrigan, John D./E-2921-2011				Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P130; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; CORRIGAN JD, IN PRESS ARCH PHYSIC; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P27; Falik M, 1993, J Case Manag, V2, P39; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; KREUTZER JS, 1987, GENERAL HLTH HIST QU; MCCONNAUGHY EA, 1989, PSYCHOTHER, V26, P494, DOI 10.1037/h0085468; McLellan AT., 1990, ADDICTION SEVERITY I, V5th; MILLER WR, 1991, STAGES CHANGE READIN; OLSEN DH, 1985, FACES, V3; OLSEN DH, 1982, FAMILY SATISFACTION; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; POKORNY AD, 1972, AM J PSYCHIAT, V129, P342, DOI 10.1176/ajp.129.3.342; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Roberts-DeGennaro M, 1993, J Case Manag, V2, P106; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SKINNER HA, 1984, ANN INTERN MED, V101, P847, DOI 10.7326/0003-4819-101-6-847; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; WILLER BS, 1993, BRAIN INJURY REHABIL; [No title captured]; 1992, GUIDE INTERDISCIPLIN	25	31	31	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	1995	9	3					221	236		10.3109/02699059509008195			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QR499	WOS:A1995QR49900002	7606236				2022-02-06	
J	NAWASHIRO, H; SHIMA, K; CHIGASAKI, H				NAWASHIRO, H; SHIMA, K; CHIGASAKI, H			IMMEDIATE CEREBROVASCULAR RESPONSES TO CLOSED-HEAD INJURY IN THE RAT	JOURNAL OF NEUROTRAUMA			English	Article						CLOSED HEAD INJURY; CEREBRAL BLOOD FLOW; BLOOD-BRAIN BARRIER; AUTOREGULATION; CEREBRAL PLASMA VOLUME; INTRACRANIAL PRESSURE	CEREBRAL BLOOD-FLOW; CONCUSSIVE BRAIN INJURY; AUTOREGULATION; METABOLISM; CAPILLARY; POTASSIUM; RELEASE	Changes in cerebrovascular dynamics were investigated immediately after closed head injury in the rat using a newly developed closed head injury model developed by Marmarou et al. Intracranial pressure (ICP) and mean arterial blood pressure (MABP) were monitored before and after trauma. Regional cerebral blood flow (rCBF), regional cerebral plasma volume (rCPV), and blood-brain barrier (BBB) permeability were measured autoradiographically with iodo[C-14]antipyrine [C-14]sucrose, and [alpha-C-14]aminoisobutyric acid, respectively. rCBF responses to induced hypertension after trauma were measured by laser-Doppler flowmetry to investigate the status of autoregulation. Before injury, baseline ICP values ranged from 6 to 10 mm Ng in all animals. Immediately after trauma, ICP increased synchronously with MABP to >100 mm Hg and then rapidly returned to baseline values. MABP increased rapidly by 20% after trauma and returned to baseline values within 30 sec. At 30 sec after injury, a significant increase in rCBF was observed in five subcortical regions (p < 0.05), and a significant increase in rCPV was observed in the frontal cortex, parietal cortex, thalamus, and hypothalamus (p < 0.05). At 10 min after injury, BBB permeability (the transfer constant for [alpha(14)C]aminoisobutyric acid) was <0.1 mL/kg/min for all regions except those with a relatively permeable BBB, for example, median eminence, choroidal plexus, pineal body, and pituitary gland. Induced hypertension resulted in a prolonged increase in rCBF after trauma. Thus, in this closed head injury model, which is not associated with marked hypertension or prolonged BBB disruption, widespread increases in rCBF and impaired cerebral autoregulation were apparent immediately after injury.			NAWASHIRO, H (corresponding author), NATL DEF MED COLL,DEPT NEUROSURG,3-2 NAMIKI,TOKOROZAWA,SAITAMA 359,JAPAN.						ARUTIUNOV AI, 1974, J NEUROSURG, V40, P459, DOI 10.3171/jns.1974.40.4.0459; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; BRUSSEL T, 1991, ANESTH ANALG, V73, P758; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; EKLOF B, 1971, ACTA PHYSIOL SCAND, V82, P172, DOI 10.1111/j.1748-1716.1971.tb04956.x; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KLEIN B, 1986, AM J PHYSIOL, V251, pH1333, DOI 10.1152/ajpheart.1986.251.6.H1333; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; NILSSON B, 1975, CEREBRAL CIRCULATION; Ohno K, 1978, AM J PHYSIOL, V235, P299; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; Reivich M, 1972, Prog Brain Res, V35, P191; SHIMA K, 1991, ADV EXPT NEUROTRAUMA, V3, P84; SHIMA K, 1990, ADV EXPT NEUROTRAUMA, V2, P53; SMITH D R, 1969, Journal of Neurosurgery, V30, P664, DOI 10.3171/jns.1969.30.6.0664; TAKAHASHI H, 1981, J NEUROSURG, V55, P705; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; [No title captured]	22	31	31	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	1995	12	2					189	197		10.1089/neu.1995.12.189			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QZ508	WOS:A1995QZ50800005	7629865				2022-02-06	
J	Mathiesen, T; Kakarieka, A; Edner, G				Mathiesen, T; Kakarieka, A; Edner, G			Traumatic intracerebral lesions without extracerebral haematoma in 218 patients	ACTA NEUROCHIRURGICA			English	Article						brain injury; brain contusion; intracerebral haematoma; compound fracture; diffuse axial injury	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; CONTUSIONS; COMA	218 of the 852 patients in the HIT-2 study of head injury had intracerebral lesions only. They were analysed to get more information on the optimal treatment of these severely injured patients. The initial CT scans were reviewed to exclude patients with extra cerebral lesions, and to make a radiological diagnosis of contusion, contusion under a depressed fracture, diffuse axonal injury, or intracerebral haematoma. Deterioration after admission to hospital was seen in 71% of patients. Patients with contusions, and contusions from depressed fractures in particular showed a worse outcome than expected, while patients with diffuse injury had a tendency to improve rather than to deteriorate. Patients with intracerebral haematoma seemed to improve if the mass was evacuated. Nimodipine had an impact only in patients with contusions. Our findings mandate surgical evacuation of contusions and intracerebral haematomas in patients with lesions larger than 20 ml who also have radiological signs of a mass effect. Regardless of an apparently good clinical state in the early phase, intracerebral lesions larger than 50 ml seemed to benefit from surgery as compared to nonsurgical treatment. The findings indicated that a further refinement of diagnostic criteria may enable individually tailored head injury treatment to interfere with most important pathogenic mechanisms. More accurate-diagnoses will improve head injury treatment and outcome, and are a prerequisite for making successful pharmaceutical trials of head injury in the future.	BAYER RES CTR,WUPPERTAL,GERMANY		Mathiesen, T (corresponding author), KAROLINSKA HOSP,DEPT NEUROSURG,S-10401 STOCKHOLM,SWEDEN.		mathiesen, tiit/ABC-3627-2021	Mathiesen, Tiit/0000-0001-9463-1919			ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BECKER DP, 1990, NEUROLOGICAL SURG, P2017; COWAN DH, 1980, SEMIN HEMATOL, V17, P137; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1990, NEUROLOGICAL SURGERY, P1953; JENNET B, 1981, MANAGEMENT HEAD INJU, P71; KATAYAMA Y, 1990, ACTA NEUROCHIR WIE S, V60, P308; KWAK R, 1983, STROKE, V14, P493, DOI 10.1161/01.STR.14.4.493; MATHIESEN T, 1993, NEUROSURGERY 93, pF24; MCLAURIN RL, 1964, J NEUROSURG, P296; Miller J D, 1988, Brain Inj, V2, P83, DOI 10.3109/02699058809150934; STATHAM PF, 1989, J NEUROL NEUROSUR PS, V52, P351, DOI 10.1136/jnnp.52.3.351; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; The European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURG, V80, P797; TODD NV, 1990, NEUROCHIR WIEN S, V51, P296; [No title captured]	20	31	33	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1995	137	3-4					155	163		10.1007/BF02187188			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TL370	WOS:A1995TL37000012	8789656				2022-02-06	
J	KARLSSON, T; STJERNSTROM, EL; STJERNSTROM, H; NORLEN, K; WIKLUND, L				KARLSSON, T; STJERNSTROM, EL; STJERNSTROM, H; NORLEN, K; WIKLUND, L			CENTRAL AND REGIONAL BLOOD-FLOW DURING HYPERVENTILATION - AN EXPERIMENTAL-STUDY IN THE PIG	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						BLOOD FLOW; CARDIAC OUTPUT; HEMODYNAMICS; HYPERVENTILATION; HYPOCAPNIA; MICROSPHERES; PIG; SPLANCHNIC CIRCULATION; THERMODILUTION	END-EXPIRATORY PRESSURE; PULMONARY VASOCONSTRICTION; DOG; HEMODYNAMICS; HYPERCAPNIA; HYPOCAPNIA; LAMBS	Mechanical hyperventilation not only reduces brain oedema after neurotrauma but also affects the central and systemic circulation. We have, in pigs, measured blood flow in the pulmonary artery, the portal vein and in the femoral artery, as well as estimated the splanchnic blood flow and studied the relative perfusion using the microsphere technique in normo- and hypocarbia during intermittent positive pressure ventilation. A normoventilated control group did not change in cardiac output, portal vein blood flow, splanchnic blood flow and femoral arterial blood flow. Hyperventilation was performed to a Pco(2) Of 3.0 +/- 0.1 kPa. We found that in pigs ventilated with high tidal volume skeletal muscle blood flow did not change during the first 60 min of hyperventilation but gradually decreased thereafter. Blood flow to the cerebellum decreased soon after the induction of hyperventilation, whereas the cerebral blood flow did not decrease until the second hour of hyperventilation. Cardiac output, splanchnic perfusion and portal vein blood flow all decreased. Myocardial perfusion and arterial blood now to spleen and kidney decreased while pancreatic and liver arterial blood flows were unaffected. It is concluded that mechanical hyperventilation with low frequency and large tidal volumes reduces the flow to most tissues, where the relative decrease according to microsphere measurements is most pronounced in skeletal muscles, heart muscle and cerebellum. However, the changes in cardiac output and splanchnic blood flow were not observed when hyperventilation was induced by increased frequency, keeping the tidal volume constant.	UNIV HOSP UPPSALA,DEPT ANAESTHESIOL & INTENS CARE,UPPSALA,SWEDEN								BRADLEY EL, 1974, SURGERY, V75, P783; BRADLEY SE, 1945, J CLIN INVEST, V24, P890, DOI 10.1172/JCI101676; CAESAR J, 1961, CLIN SCI, V21, P43; CASSIDY SS, 1979, J CLIN INVEST, V64, P620, DOI 10.1172/JCI109502; CULLEN DJ, 1974, ANESTHESIOLOGY, V41, P345, DOI 10.1097/00000542-197410000-00006; FLECKENSTEIN A, 1976, S VASCULAR SMOOTH MU, P117; GARBY L, 1961, SCAND J CLIN LAB INV, V13, P642, DOI 10.3109/00365516109137338; Gordan E, 1969, CEREBRAL BLOOD FLOW, P258; HALDEN E, 1982, ACTA ANAESTH SCAND, V26, P403, DOI 10.1111/j.1399-6576.1982.tb01789.x; HARTMAN J, 1985, PHARMACOLOGIST, V27, P217; JOHNSON EE, 1972, J APPL PHYSIOL, V38, P156; LYRENE RK, 1985, PEDIATR RES, V19, P1268, DOI 10.1203/00006450-198512000-00009; MARRUBINI MLB, 1961, BRIT J ANAESTH, V36, P415; MIYAZAKI M, 1978, ANGIOLOGY, V29, P541, DOI 10.1177/000331977802900705; MORRAY JP, 1988, J PEDIATR-US, V113, P474, DOI 10.1016/S0022-3476(88)80631-0; NEILL WA, 1975, CIRCULATION, V52, P854, DOI 10.1161/01.CIR.52.5.854; PERRY MA, 1981, MEASUREMENT BLOOD FL, P161; PRICE H, 1960, ANESTHESIOLOGY, V6, P652; PRYSROBERTS C, 1968, J APPL PHYSIOL, V25, P80, DOI 10.1152/jappl.1968.25.1.80; RUBERTSSON S, 1993, SURG RES COMM, V13, P309; SCHREIBER MD, 1986, PEDIATR RES, V20, P113, DOI 10.1203/00006450-198602000-00003; SEMB BK, 1984, EUR SURG RES, V2, P133; VENUS B, 1988, CRIT CARE MED, V16, P686, DOI 10.1097/00003246-198807000-00008; WEXELS JC, 1986, CAN J PHYSIOL PHARM, V64, P1376, DOI 10.1139/y86-233; WEXELS JC, 1987, CLIN PHYSIOL, V7, P21, DOI 10.1111/j.1475-097X.1987.tb00630.x; YASUE H, 1978, CIRCULATION, V58, P56, DOI 10.1161/01.CIR.58.1.56	26	31	31	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	FEB	1994	38	2					180	186		10.1111/j.1399-6576.1994.tb03863.x			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	MY033	WOS:A1994MY03300017	8171955				2022-02-06	
J	VANLOON, J; SHIVALKAR, B; PLETS, C; GOFFIN, J; TJANDRAMAGA, TB; FLAMENG, W				VANLOON, J; SHIVALKAR, B; PLETS, C; GOFFIN, J; TJANDRAMAGA, TB; FLAMENG, W			CATECHOLAMINE RESPONSE TO A GRADUAL INCREASE OF INTRACRANIAL-PRESSURE	JOURNAL OF NEUROSURGERY			English	Article						INTRACRANIAL PRESSURE; CEREBRAL PERFUSION PRESSURE; BRAIN DEATH; CATECHOLAMINE	TRAUMATIC BRAIN INJURY; HEAD-INJURY; CIRCULATING CATECHOLAMINES; SUBARACHNOID HEMORRHAGE; CEREBROSPINAL-FLUID; CUSHING RESPONSE; BLOOD-FLOW; PLASMA; MASS	To determine the catecholamine response to progressive intracranial hypertension, intracranial pressure (ICP) was raised gradually by continuous expansion of an epidural balloon in seven dogs. Hemodynamic parameters, ICP, and cerebral perfusion pressure (CPP) were monitored continuously and serum catecholamine levels began to rise when CPP was in the low-positive range (20 to 30 mm Hg), reaching a peak just after brain death (CPP less-than-or-equal-to 0 mm Hg). There was no correlation between ICP and the catecholamine peak. Compared to control values, the mean increase was 286-fold for epinephrine and 78-fold for norepinephrine. Temporally, the catecholamine peak corresponded well with the observed hemodynamic changes. These results suggest that ischemia in certain parts of the brain stem is responsible for the hemodynamic changes observed in intracranial hypertension (such as the Cushing response), and they show that catecholamines play an important role in these hemodynamic changes.	CATHOLIC UNIV,UNIV HOSP GASTHUISBERG,DEPT CARDIAC SURG,LOUVAIN,BELGIUM; CATHOLIC UNIV,UNIV HOSP GASTHUISBERG,DEPT CLIN PHARMACOL,LOUVAIN,BELGIUM		VANLOON, J (corresponding author), CATHOLIC UNIV,UNIV HOSP GASTHUISBERG,DEPT NEUROSURG,HERESTR 49,B-3000 LOUVAIN,BELGIUM.		Shivalkar, Bharati/A-4416-2013				BECKMAN DL, 1979, P SOC EXP BIOL MED, V160, P200; BRASHEAR RE, 1971, ARCH INTERN MED, V127, P748, DOI 10.1001/archinte.127.4.748; CARPENTER MB, 1983, HUMAN NEUROANATOMY, P571; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cushing H, 1903, AM J MED SCI, V125, P1017, DOI 10.1097/00000441-190306000-00006; Cushing H, 1901, B JOHNS HOPKINS HOSP, V12, P290; DILRAJ A, 1992, NEUROSURGERY, V31, P42, DOI 10.1227/00006123-199207000-00007; DUCKER TB, 1968, J NEUROSURG, V28, P118, DOI 10.3171/jns.1968.28.2.0118; EVANS DE, 1976, J NEUROSURG, V45, P609, DOI 10.3171/jns.1976.45.6.0609; GOLDFIEN A, 1962, AM J PHYSIOL, V202, P205, DOI 10.1152/ajplegacy.1962.202.2.205; GRAF CJ, 1978, J NEUROSURG, V49, P862, DOI 10.3171/jns.1978.49.6.0862; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; KIM YI, 1980, ARCH INT PHARMACOD T, V245, P129; KORTEWEG GCJ, 1957, J NEUROPHYSIOL, V20, P100, DOI 10.1152/jn.1957.20.1.100; LANGFITT TW, 1964, J NEUROSURG, V21, P989, DOI 10.3171/jns.1964.21.11.0989; LANGFITT TW, 1964, J NEUROSURG, V21, P998, DOI 10.3171/jns.1964.21.11.0998; LEVY MN, 1968, AM J PHYSIOL, V215, P169, DOI 10.1152/ajplegacy.1968.215.1.169; LEYDEN E, 1866, VIRCHOWS ARCH, V37, P519; MARION DW, 1986, NEUROSURGERY, V18, P101, DOI 10.1227/00006123-198601000-00019; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856, DOI 10.1152/jappl.1980.49.5.856; NATELSON BH, 1985, ARCH NEUROL-CHICAGO, V42, P178, DOI 10.1001/archneur.1985.04060020096022; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; Norris JW, 1989, NEUROLOGY GENERAL ME, P159; NOVITZKY D, 1986, ANN THORAC SURG, V41, P520, DOI 10.1016/S0003-4975(10)63032-9; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; ROSNER MJ, 1982, HEAD INJURY BASIC CL, P103; SCHRADER H, 1985, ACTA NEUROL SCAND, V72, P283; SCHRADER H, 1985, ACTA NEUROL SCAND, V71, P453; SHANLIN RJ, 1988, J AM COLL CARDIOL, V12, P727, DOI 10.1016/S0735-1097(88)80065-2; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; WEINSTEI.JD, 1968, J NEUROSURG, V28, P513, DOI 10.3171/jns.1968.28.6.0513; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; [No title captured]	35	31	31	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	1993	79	5					705	709		10.3171/jns.1993.79.5.0705			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MD733	WOS:A1993MD73300009	8410249				2022-02-06	
J	ALFANO, DP; PANIAK, CE; FINLAYSON, MAJ				ALFANO, DP; PANIAK, CE; FINLAYSON, MAJ			THE MMPI AND CLOSED HEAD-INJURY - A NEUROCORRECTIVE APPROACH	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article								This study examined neurologic content bias in the MMPIs of 102 patients with closed head injury (CHI). Twenty-four items that were significantly endorsed in a pathological direction were identified. Principal components analysis of these items produced two conceptually coherent factors that together accounted for 33% of the total variance. The first factor was comprised of items primarily tapping complaints of cognitive and sensory-motor dysfunction. The second factor was comprised of items primarily tapping complaints of an emotional or somatic nature. A neurocorrective approach that took into account the contribution of the first factor items to MMPI profile configuration revealed significant alterations in mean group clinical scale elevations, and high-point and two-point code type in individual cases. The results of this study are discussed in terms of the important practical implications for neuropsychological clinicians providing assessment and intervention for patients with CHI using the MMPI.	CHEDOKE MCMASTER HOSP,HAMILTON L8N 3Z5,ONTARIO,CANADA; MCMASTER UNIV,HAMILTON L8S 4L8,ONTARIO,CANADA; GLENROSE REHABIL HOSP,EDMONTON,ALBERTA,CANADA		ALFANO, DP (corresponding author), UNIV REGINA,DEPT PSYCHOL,REGINA S4S 0A2,SASKATCHEWAN,CANADA.						Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; ALFANO DP, 1991, NEUROPSYCHOLOGY, V5, P35; BALDWIN MV, 1952, J NERV MENT DIS, V115, P299; BLISHEN BR, 1976, CAN REV SOC ANTHROP, V13, P71, DOI 10.1111/j.1755-618X.1976.tb00759.x; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BORNSTEIN RA, 1990, NEUROPSY NEUROPSY BE, V3, P200; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Dahlstrom W. G., 1972, MMPI HDB CLIN INTERP, V1; FARR SP, 1988, MMPI USE SPECIFIC PO, P214; Fidell L.S., 1983, USING MULTIVARIATE S; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GOLDEN CJ, 1984, RES METHODS CLIN PSY, P233; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; Greene R. L., 1980, MMPI INTERPRETIVE MA; GREENE RL, 1988, MMPI USE SPECIFIC PO, P1; Halstead W.C., 1947, BRAIN INTELLIGENCE; KENDALL PC, 1978, J CONSULT CLIN PSYCH, V46, P370, DOI 10.1037/0022-006X.46.2.370; Levin HS., 1982, NEUROBEHAVIORAL CONS; LUBIN B, 1985, AM PSYCHOL, V40, P857, DOI 10.1037/0003-066X.40.7.857; MACK JL, 1979, MMPI CLIN RES TRENDS, P53; MEYERINK LH, 1988, J CLIN PSYCHOL, V44, P764, DOI 10.1002/1097-4679(198809)44:5<764::AID-JCLP2270440517>3.0.CO;2-Y; SCHMIDT MM, 1990, J CLIN EXP NEUROPSYC, V12, P415; TAYLOR GP, 1970, J CONSULT CLIN PSYCH, V35, P183, DOI 10.1037/h0030127	24	31	31	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	APR	1993	6	2					111	116					6	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	KV540	WOS:A1993KV54000006					2022-02-06	
J	SCHWEITZER, JB; PARK, MR; EINHAUS, SL; ROBERTSON, JT				SCHWEITZER, JB; PARK, MR; EINHAUS, SL; ROBERTSON, JT			UBIQUITIN MARKS THE REACTIVE SWELLINGS OF DIFFUSE AXONAL INJURY	ACTA NEUROPATHOLOGICA			English	Article						UBIQUITIN; NEUROFILAMENT; DIFFUSE AXONAL INJURY; IMMUNOHISTOCHEMISTRY; HEAD TRAUMA	NONMISSILE HEAD-INJURY; BRAIN INJURY; PROTEIN; CAT	Ubiquitin is a protein that targets proteins for non-lysosomal degradation. It has been found to be present in a number of inclusions characteristic of neurodegenerative diseases. Using the fluid percussion model of closed head injury in the cat, a well-established model of diffuse axonal injury (DAI), we now report that the reactive axonal swellings and the retraction balls produced in this model stain positively with antiubiquitin immunohistochemistry. Furthermore., the affected axons become ubiquitin positive quickly (within the first 6 h after injury). Anti-ubquitin immunohistochemistry compares well with the recently reported ability of antibodies to low molecular weight neurofilament proteins to demonstrate reactive axonal change in DAI, and it could provide additional clues to the pathogenesis of axonal transection.	UNIV TENNESSEE CTR HLTH SCI,DEPT PATHOL,MEMPHIS,TN 38163; UNIV TENNESSEE CTR HLTH SCI,DEPT ANAT & NEUROBIOL,MEMPHIS,TN 38163; UNIV TENNESSEE CTR HLTH SCI,DEPT NEUROSURG,MEMPHIS,TN 38163		SCHWEITZER, JB (corresponding author), UNIV TENNESSEE CTR HLTH SCI,BRAIN INJURY RES CTR,800 MADISON AVE,RM 568 BMH-M,MEMPHIS,TN 38163, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS01230] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS001230] Funding Source: NIH RePORTER		ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; COCHRAN E, 1991, AM J PATHOL, V139, P485; DICKSON DW, 1990, LAB INVEST, V63, P87; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; HERSHKO A, 1991, TRENDS BIOCHEM SCI, V16, P265, DOI 10.1016/0968-0004(91)90101-Z; HILTON DL, 1993, IN PRESS J NEUROTRAU; MANETTO V, 1988, P NATL ACAD SCI USA, V85, P4501, DOI 10.1073/pnas.85.12.4501; MARTIN JE, 1990, BRAIN, V113, P1553, DOI 10.1093/brain/113.5.1553; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	16	31	31	1	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	APR	1993	85	5					503	507					5	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	KX439	WOS:A1993KX43900009	8388148				2022-02-06	
J	ZIMMERMAN, WD; GANZEL, TM; WINDMILL, IM; NAZAR, GB; PHILLIPS, M				ZIMMERMAN, WD; GANZEL, TM; WINDMILL, IM; NAZAR, GB; PHILLIPS, M			PERIPHERAL HEARING-LOSS FOLLOWING HEAD TRAUMA IN CHILDREN	LARYNGOSCOPE			English	Article							TEMPORAL BONE-FRACTURES; INJURY	The purpose of this prospective study was to determine the incidence and type of hearing loss occurring in children who suffered head injuries. Fifty children admitted to the neurosurgical service after sustaining head trauma were studied. Neurologic, otologic, and audiologic evaluations were performed. Diagnostic studies included skull roentgenograms and computerized tomography scans. A 32% incidence of conductive hearing loss and a 16% incidence of high-frequency sensorineural hearing loss was found in this group. All patients with temporal bone fractures had conductive hearing losses, but the presence of a skull vault fracture did not correlate with the presence, type, or degree of hearing loss. In addition, there was no correlation between either cause of injury, loss of consciousness, or Glasgow Coma Scale scores and the presence, type, or degree of hearing loss. There was a significant incidence of both sensorineural and conductive hearing loss in this series of patients, which indicates that close audiologic and otologic follow-up is necessary for all head injury patients.	UNIV LOUISVILLE,HLTH SCI CTR,SCH MED,DEPT SURG,DIV SOCIAL WELF,550 S JACKSON ST,LOUISVILLE,KY 40202; UNIV LOUISVILLE,HLTH SCI CTR,SCH MED,DEPT SURG,DIV COMMUNICAT DISORDERS,LOUISVILLE,KY 40202; UNIV LOUISVILLE,HLTH SCI CTR,SCH MED,DEPT SURG,DIV NEUROL SURG,LOUISVILLE,KY 40202								BROWNING GG, 1982, ARCH OTOLARYNGOL, V108, P474; CANNON CR, 1983, ARCH OTOLARYNGOL, V109, P285; DOES IES, 1965, ARCHIV OTOLARYNGOL, V82, P331; GOODWIN WJ, 1983, OTOLARYNG CLIN N AM, V16, P651; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; HALL JW, 1982, LARYNGOSCOPE, V92, P883; HAWKINS JE, 1984, SEMIN HEAR, V5, P115; HEALY GB, 1982, NEW ENGL J MED, V17, P1029; HOUGH JVD, 1969, ANN OTO RHINOL LARYN, V78, P210, DOI 10.1177/000348946907800202; HOWE JR, 1975, NEUROLOGY, V25, P286, DOI 10.1212/WNL.25.3.286; JERGER J, 1981, AUDITORY DISORDERS, P169; KHAN AA, 1985, OTOLARYNG HEAD NECK, V93, P177, DOI 10.1177/019459988509300210; MAKISHIMA K, 1975, ARCH OTOLARYNGOL, V101, P426; MAKISHIMA K, 1976, LARYNGOSCOPE, V86, P971, DOI 10.1288/00005537-197607000-00010; MOMOSE KJ, 1983, AM J NEURORADIOL, V4, P781; PEARSON BW, 1973, ARCH OTOLARYNGOL, V97, P81; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; SCHUKNECHT HF, 1951, ANN OTO RHINOL LARYN, V60, P273, DOI 10.1177/000348945106000201; Tos M, 1971, J Laryngol Otol, V85, P1147, DOI 10.1017/S0022215100074569; VARTIAINEN E, 1985, ACTA OTO-LARYNGOL, V99, P529, DOI 10.3109/00016488509182257; WILLSON GN, 1981, J LARYNGOL OTOL, V95, P1213, DOI 10.1017/S0022215100092057	21	31	31	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0023-852X			LARYNGOSCOPE	Laryngoscope	JAN	1993	103	1	1				87	91					5	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	KG364	WOS:A1993KG36400016	8421426				2022-02-06	
J	WEINSTABL, C; RICHLING, B; PLAINER, B; CZECH, T; SPISS, CK				WEINSTABL, C; RICHLING, B; PLAINER, B; CZECH, T; SPISS, CK			COMPARATIVE-ANALYSIS BETWEEN EPIDURAL (GAELTEC) AND SUBDURAL (CAMINO) INTRACRANIAL-PRESSURE PROBES	JOURNAL OF CLINICAL MONITORING			English	Article						MEASUREMENT TECHNIQUES-INTRACRANIAL PRESSURE; MONITORING-PRESSURE, INTRACRANIAL; EQUIPMENT-FIBEROPTIC ICP PROBE	MONITOR; DEVICE	The new fiberoptic Camino system has recently been introduced for clinical intracranial pressure (ICP) monitoring. We compared the subdural Camino system with the well-established epidural Gaeltec system in both in vitro and clinical conditions. In the in vitro experiments the intracranial vault was simulated by a tightly closed, fluid-filled box (0.9% sodium chloride) with the two probes inside. We simulated pulsating waveforms with a jet ventilator. No difference between the simulated curve patterns and values could be detected. In the clinical studies, both probes were implanted in 10 patients who had either head injuries, subarachnoid hemorrhage, or intracerebral hemorrhage. The in vivo comparison revealed no significant difference between the two systems in the recorded pressures in group 1 (ICP < 20 mm Hg). The subdurally placed Camino probe showed insignificantly lower ICP values than did the extradural Gaeltec probe. Although group 2 (ICP > 20 mm Hg) waveforms were nearly identical, significant differences (p < 0.01) in pressure measurements (systolic, diastolic, and mean) occurred (Camino, 18 +/- 3 mm Hg; Gaeltec, 27 +/- 3 mm Hg). Correlation coefficients for mean ICP values were 0.82 in group 1 and 0.49 in group 2. Problems with the Camino probe were usually mechanical and occurred in 2 patients. The problems were either easy to recognize or manifested as an ostensibly pathologic curve. No infection occurred with either system during or following implantation. The dissimilar characteristics of the two probes can be ascribed to their different extradural and subdural implantation sites. The Gaeltec probe was more durable over the period of implantation, which averaged 98 hours and ranged from 44 to 298 hours. Intracranial pressure values measured subdurally seemed to be more true to life in the high-pressure ranges. Both probes can be used for routine, continuous ICP monitoring. While subdural ICP probes can give correct values without delay and in vivo show more detail and change with ventilation, the epidural system was more durable.	UNIV VIENNA,DEPT NEUROSURG,A-1090 VIENNA,AUSTRIA		WEINSTABL, C (corresponding author), UNIV VIENNA,DEPT ANESTHESIA & GEN INTENS CARE,SPITALGASSE 23,A-1090 VIENNA,AUSTRIA.						BROCK M, 1972, INTRACRANIAL PRESSUR, V1, P1; CHEEK WR, 1979, NEUROSURGERY, V5, P666; CRUTCHFIELD JS, 1990, J NEUROSURG, V72, P482, DOI 10.3171/jns.1990.72.3.0482; DEARDEN NM, 1984, J NEUROSURG, V60, P123, DOI 10.3171/jns.1984.60.1.0123; DORSCH NWC, 1975, J NEUROSURG, V42, P249, DOI 10.3171/jns.1975.42.3.0249; GAAB MR, 1980, THESIS FM WURZBURG; GOBIET W, 1974, J NEUROSURG, V39, P272; LUNDBERG N, 1960, ACTA PSYCHIATRICA  S, V149, P1; MILLER JD, 1978, BRIT J HOSP MED, V19, P497; NORNES H, 1972, J NEUROSURG, V36, P537, DOI 10.3171/jns.1972.36.5.0537; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; POWELL MP, 1985, J NEUROSURG, V63, P745, DOI 10.3171/jns.1985.63.5.0745; SCHETTINI A, 1971, J NEUROSURG, V34, P38, DOI 10.3171/jns.1971.34.1.0038; VRIES JK, 1973, J NEUROSURG, V39, P416, DOI 10.3171/jns.1973.39.3.0416	14	31	31	0	1	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0748-1977			J CLIN MONITOR	J. Clin. Monit.	APR	1992	8	2					116	120		10.1007/BF01617429			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HP095	WOS:A1992HP09500004	1583546				2022-02-06	
J	TEASDALE, G; TEASDALE, E; HADLEY, D				TEASDALE, G; TEASDALE, E; HADLEY, D			COMPUTED TOMOGRAPHIC AND MAGNETIC-RESONANCE-IMAGING CLASSIFICATION OF HEAD-INJURY	JOURNAL OF NEUROTRAUMA			English	Article							DIFFUSE AXONAL INJURY; INTRACRANIAL-PRESSURE; CT SCAN; INTRAVENTRICULAR HEMORRHAGE; TRAUMATIC COMA; BRAIN EDEMA; MANAGEMENT; HEMATOMA; CHILDREN; LESIONS	Neuroimaging with CT and MRI is a basis for decision making in individual head-injured patients and also provides a classification of patients according to severity of damage, patterns of injury, pathophysiologic mechanisms and prognosis. Such classifications can be based on the intracranial lesions identified: subdural, extradural, and intracerebral hematomas, contusions, and shearing lesions, or indirect indications of raised intracranial pressure and brain swelling: shift, obliteration of the third ventricle and basal cisterns, and signs of ischemia. The appropriate classification for early diagnosis and acute decision making may differ from the assessment of severity of damage, prognosis and late sequelae. Parallel systems of classification, suitable for these purposes, are proposed.	UNIV GLASGOW, SO GEN HOSP, INST NEUROL SCI, DEPT NEURORADIOL, GLASGOW G51 4TF, SCOTLAND		TEASDALE, G (corresponding author), UNIV GLASGOW, SO GEN HOSP, INST NEUROL SCI, DEPT NEUROSURG, GLASGOW G51 4TF, SCOTLAND.						Adams J H, 1981, Acta Neuropathol Suppl, V7, P26; ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; AMBROSE J, 1976, LANCET, V1, P847; ARTRU F, 1989, ICP, V7, P603; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1979, CHILD BRAIN, V5, P174; BULLOCH R, 1990, IN PRESS VINKEN BRUY, V24; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; CORDOBES F, 1987, CHILD NERV SYST, V3, P235, DOI 10.1007/BF00274055; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FRENCH BN, 1977, SURG NEUROL, V7, P171; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; GALBRAITH S, 1976, BRIT MED J, V2, P1371, DOI 10.1136/bmj.2.6048.1371; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gentleman D, 1989, Br J Neurosurg, V3, P367, DOI 10.3109/02688698909002817; GRANT R, 1987, MAGN RESON IMAGING, V5, P465, DOI 10.1016/0730-725X(87)90380-8; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; Gudeman S. K., 1989, TXB HEAD INJURY, P138; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; HADLEY DM, 1988, CLIN RADIOL, V39, P131; ITO U, 1986, ACTA NEUROCHIR, V79, P120, DOI 10.1007/BF01407455; JENKINS A, 1986, LANCET, V2, P445; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KISHORE PRS, 1981, AM J NEURORADIOL, V2, P307; KLAUBER MR, 1984, J NEUROSURG, V61, P695, DOI 10.3171/jns.1984.61.4.0695; KONAYASHI S, 1983, SURG NEUROL, V20, P25; LANG D, UNPUB J NEUROSURGERY; LANG D, UNPUB MRI NEUROPATHO; LEVIN HS, 1985, ARCH NEUROL-CHICAGO, V42, P963, DOI 10.1001/archneur.1985.04060090045012; LIPPER MH, 1985, AM J NEURORADIOL, V6, P7; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; MARSHALL L, 1989, ICP, V7, P552; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; MIZUTANI T, 1990, SURG NEUROL, V33, P178, DOI 10.1016/0090-3019(90)90181-N; MURPHY A, 1983, INTRACRANIAL PRESSUR, V5, P562; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; QUENCER RM, 1990, NEURORADIOLOGY, V32, P371, DOI 10.1007/BF00588471; RABOW L, 1989, ACTA NEUROCHIR, V100, P155, DOI 10.1007/BF01403604; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; SADHU VK, 1979, RADIOLOGY, V133, P507, DOI 10.1148/133.2.507; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; Servadei F, 1988, Brain Inj, V2, P87, DOI 10.3109/02699058809150935; SNOEK J, 1979, J NEUROL NEUROSUR PS, V42, P215, DOI 10.1136/jnnp.42.3.215; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; TABADDOR K, 1982, SURG NEUROL, V18, P212, DOI 10.1016/0090-3019(82)90395-0; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TEASDALE G, UNPUB MR IMAGING OUT; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; TURAZZI S, 1987, ACTA NEUROCHIR, V85, P87, DOI 10.1007/BF01456103; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WILSON JTL, UNPUB INTERCORRELATI; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	70	31	32	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	1992	9			1			S249	S257					9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HN806	WOS:A1992HN80600023	1588613				2022-02-06	
J	DENNIS, M; SPIEGLER, BJ; HOFFMAN, HJ; HENDRICK, EB; HUMPHREYS, RP; BECKER, LE				DENNIS, M; SPIEGLER, BJ; HOFFMAN, HJ; HENDRICK, EB; HUMPHREYS, RP; BECKER, LE			BRAIN-TUMORS IN CHILDREN AND ADOLESCENTS .1. EFFECTS ON WORKING, ASSOCIATIVE AND SERIAL-ORDER MEMORY OF IQ, AGE AT TUMOR ONSET AND AGE OF TUMOR	NEUROPSYCHOLOGIA			English	Article							CRANIOPHARYNGIOMA; CHILDHOOD; MEDULLOBLASTOMA; LESIONS	Memory impairment was demonstrated in a sample of 46 children and adolescents with brain tumors. The overall distribution of memory scores was skewed positively; over half of the total number of test measures were in the lowest quarter of the score distribution; and more than three-quarters of the individual subjects had at least one memory score in the impaired range. Verbal intelligence accounted for less than one-quarter of the variance in memory scores. The type of memory impairment was analyzed in relation to various demographic and medical variables: age at onset of tumor symptoms, age or duration of tumor, sex, pre-tumor developmental disturbances, pre-tumor closed head injury, post-tumor anticonvulsant treatment and post-tumor epileptic seizures. The working memory task, in which each in a succession of heard words is stored in temporary memory long enough to be compared to or contrasted with incoming words, was unaffected by these variables, as was memory for semantically-based word-picture associations. Memory for the serial order of pictures that corresponded to heard words varied inversely with the age at tumor onset such that the later the onset, the lower the memory test performance.	TORONTO GEN HOSP,TORONTO M5G 1L7,ONTARIO,CANADA		DENNIS, M (corresponding author), HOSP SICK CHILDREN,DEPT PSYCHOL,DUNDAS SUITE,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.						AMACHER AL, 1976, CHILD BRAIN, V2, P81; Baddeley A.D., 1987, WORKING MEMORY; BAMFORD FN, 1976, CANCER, V37, P1149, DOI 10.1002/1097-0142(197602)37:2+<1149::AID-CNCR2820370825>3.0.CO;2-C; BROWN ER, 1987, J CLIN EXP NEUROPSYC, V9, P57; CARRERA R, 1983, BRAIN TUMORS YOUNG, P3; CHIN HW, 1984, CANCER-AM CANCER SOC, V53, P1952, DOI 10.1002/1097-0142(19840501)53:9<1952::AID-CNCR2820530925>3.0.CO;2-X; CLOPPER RR, 1977, PSYCHONEUROENDOCRINO, V2, P365, DOI 10.1016/0306-4530(77)90006-3; COHEN ME, 1985, NEUROL CLIN, V3, P147, DOI 10.1016/S0733-8619(18)31060-0; Cohen Michael E., 1982, MAJOR TOPICS PEDIATR, P241; DEATON AV, 1987, J CLIN EXP NEUROPSYC, V9, P25; DENNIS M, 1988, NEUROPSYCHOLOGIA, V26, P53, DOI 10.1016/0028-3932(88)90030-9; DUFFNER PK, 1983, CANCER, V51, P233, DOI 10.1002/1097-0142(19830115)51:2<233::AID-CNCR2820510211>3.0.CO;2-8; ELLENBERG L, 1987, NEUROSURGERY, V21, P638, DOI 10.1227/00006123-198711000-00006; GOLDMAN R, 1974, GOLDMANFRISTOEWOODCO; GOMEZ MR, 1985, PRACT PEDIAT, V9, P1; GRANT DB, 1982, CHILD BRAIN, V9, P201; GROSS PL, 1987, J CLIN EXP NEUROPSYC, V9, P27; HIRSCH JF, 1979, ACTA NEUROCHIR, V48, P1, DOI 10.1007/BF01406016; HOFFMAN HJ, 1985, CAN J NEUROL SCI, V12, P348, DOI 10.1017/S0317167100035514; HOFFMAN HJ, 1977, J NEUROSURG, V47, P218, DOI 10.3171/jns.1977.47.2.0218; JUDD BW, 1988, J CLIN EXP NEUROPSYC, V10, P45; KUN LE, 1983, J NEUROSURG, V58, P1, DOI 10.3171/jns.1983.58.1.0001; MURDOCK BB, 1982, HDB RES METHODS HUMA; SIEGEL LS, 1988, CAN J PSYCHOL, V42, P201, DOI 10.1037/h0084184; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1949, WECHSLER INTELLIGENC; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WINSTON KR, 1979, NEUROSURGERY, V4, P386, DOI 10.1227/00006123-197905000-00003; WOODCOCK RW, 1976, GOLDMANFRISTOEWOODCO; YATES AJ, 1979, CHILD BRAIN, V5, P31; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7	32	31	31	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia		1991	29	9					813	827		10.1016/0028-3932(91)90049-E			15	Behavioral Sciences; Neurosciences; Psychology, Experimental	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	GK875	WOS:A1991GK87500001	1944880				2022-02-06	
J	ODER, W; GOLDENBERG, G; PODREKA, I; DEECKE, L				ODER, W; GOLDENBERG, G; PODREKA, I; DEECKE, L			HM-PAO-SPECT IN PERSISTENT VEGETATIVE STATE AFTER HEAD-INJURY - PROGNOSTIC INDICATOR OF THE LIKELIHOOD OF RECOVERY	INTENSIVE CARE MEDICINE			English	Article						REGIONAL CEREBRAL BLOOD FLOW; TC-99M HEXAMETHYL-PROPYLENAMINEOXIME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; PERSISTENT VEGETATIVE STATE; APALLIC SYNDROME; HEAD INJURY; PROGNOSIS	CEREBRAL BLOOD-FLOW; PERFUSION; LESIONS; TRAUMA; MR; CT	Management of patients presenting with traumatic persistent vegetative state (PVS) calls for extensive resources. The ability to predict whether or not a patient is likely to recover is a critical issue. In 12 patients with PVS admitted consecutively for early rehabilitation after head injury, pattern of brain activity was measured by Tc-99m-hexamethyl-propylenamineoxime (Tc-99m-HM-PAO) brain SPECT (single photon emission computer tomography). All patients were re-investigated after a mean observation period of 3 years. A global reduction of cortical blood flow was a reliable predictor of poor long-term outcome, but the demonstration of only focal deficits did not reliably indicate a favourable outcome. Brain SPECT may help to improve outcome prediction in patients with traumatic PVS.			ODER, W (corresponding author), UNIV VIENNA,NEUROL CLIN,LAZARETTGASSE 14,A-1090 VIENNA,AUSTRIA.						ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BERROL S, 1986, ARCH PHYS MED REHAB, V67, P283; BINIEK R, 1989, INTENS CARE MED, V15, P212, DOI 10.1007/BF01058577; DEUTSCH G, 1983, ANN NEUROL, V13, P38, DOI 10.1002/ana.410130109; DEUTSCH G, 1987, J CEREBR BLOOD F MET, V7, P29, DOI 10.1038/jcbfm.1987.5; DEVOLDER AG, 1990, ARCH NEUROL-CHICAGO, V47, P197, DOI 10.1001/archneur.1990.00530020103022; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Gerstenbrand F., 1967, TRAUMATISCHE APALLIS; HANS P, 1989, J NEUROSURG, V71, P54, DOI 10.3171/jns.1989.71.1.0054; HANSOTIA PL, 1985, ARCH NEUROL-CHICAGO, V42, P1048, DOI 10.1001/archneur.1985.04060100030015; HEISS WD, 1972, J NEUROL SCI, V16, P373, DOI 10.1016/0022-510X(72)90045-7; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; INGVAR DH, 1972, ARCH PSYCHIAT NERVEN, V215, P219, DOI 10.1007/BF01042864; INGVAR DH, 1979, ACTA NEUROL SCAND, V60, P12, DOI 10.1111/j.1600-0404.1979.tb02947.x; INGVAR DH, 1973, ACTA NEUROL SCAND, V49, P233; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1979, Acta Neurochir Suppl (Wien), V28, P149; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; NEIRINCKX RD, 1987, J NUCL MED, V28, P191; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; PAGNI CA, 1977, ACTA NEUROCHIR, V36, P37, DOI 10.1007/BF01405985; Plum F., 1983, DIAGNOSIS STUPOR COM; PODREKA I, 1987, J NUCL MED, V28, P1657; Sato M, 1989, Neurol Med Chir (Tokyo), V29, P389, DOI 10.2176/nmc.29.389; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TEASDALE G, 1974, LANCET, V2, P81; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; ZIMMERMAN RA, 1986, AM J NEURORADIOL, V7, P757; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	44	31	31	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0342-4642			INTENS CARE MED	Intensive Care Med.		1991	17	3					149	153		10.1007/BF01704718			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN420	WOS:A1991FN42000004	2071761				2022-02-06	
J	TOMPKINS, CA; HOLLAND, AL; RATCLIFF, G; COSTELLO, A; LEAHY, LF; COWELL, V				TOMPKINS, CA; HOLLAND, AL; RATCLIFF, G; COSTELLO, A; LEAHY, LF; COWELL, V			PREDICTING COGNITIVE RECOVERY FROM CLOSED HEAD-INJURY IN CHILDREN AND ADOLESCENTS	BRAIN AND COGNITION			English	Article									UNIV MASSACHUSETTS,DEPT PSYCHIAT,WORCESTER,MA 01605; UNIV PITTSBURGH,DEPT OTORHINOLARYNGOL,PITTSBURGH,PA 15260; UNIV PITTSBURGH,DEPT PSYCHIAT,PITTSBURGH,PA 15260; HARMARVILLE REHAB CTR,PITTSBURGH,PA		TOMPKINS, CA (corresponding author), UNIV PITTSBURGH,DEPT COMMUN,1101 CATHEDRAL LEARNING,PITTSBURGH,PA 15260, USA.						[Anonymous], 1944, ARMY INDIVIDUAL TEST; ATTIAS D, 1982, ISRAEL J MED SCI, V18, P917; Beery K. E., 1982, DEV TEST VISUAL MOTO; BRUCE DA, 1979, CHILD BRAIN, V5, P174; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; COWELL VS, 1986, M AM SPEECH LANGUAGE; DELIS D, 1983, CALIFORNIA VERBAL LE; DENCKLA M B, 1974, Cortex, V10, P186; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Dunn LM., 1981, PEABODY PICTURE VOCA; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; FRATTALI CM, 1985, M AM SPEECH LANGUAGE; GARDNER M, 1979, EXPRESSIVE ONE WORD; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; GRATZ RR, 1979, J TRAUMA, V19, P551, DOI 10.1097/00005373-197908000-00001; Hollingshead AB, 1958, SOCIAL CLASS MENTAL; JACOBSON MS, 1986, PEDIATRICS, V77, P236; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KNIGHTS R, 1968, PERCEPT MOTOR SKILL, V25, P717; LEAHY LF, 1985, M AM SPEECH LANGUAGE; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, CHILD BRAIN, V5, P281; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MILLER J, 1972, MILLERYODER TEST GRA; Prather E., 1980, SCREENING TEST ADOLE; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROURKE BP, 1977, J ABNORM CHILD PSYCH, V5, P9, DOI 10.1007/BF00915756; Stein N., 1979, NEW DIRECTIONS DISCO, V2; Wechsler D., 1974, WECHSLER INTELLIGENC; YORKSTON KM, 1977, CLIN APHASIOLOGY C P, P175; [No title captured]; 1986, LANCET, P1361	33	31	31	0	3	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0278-2626			BRAIN COGNITION	Brain Cogn.	MAY	1990	13	1					86	97		10.1016/0278-2626(90)90042-M			12	Neurosciences; Psychology, Experimental	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DE048	WOS:A1990DE04800007	2346641				2022-02-06	
J	MORGAN, MK; BESSER, M; JOHNSTON, I; CHASELING, R				MORGAN, MK; BESSER, M; JOHNSTON, I; CHASELING, R			INTRACRANIAL CAROTID-ARTERY INJURY IN CLOSED HEAD TRAUMA	JOURNAL OF NEUROSURGERY			English	Article									ROYAL ALEXANDRA HOSP CHILDREN,DEPT NEUROSURG,CAMPERDOWN,NSW 2050,AUSTRALIA					Morgan, Michael/0000-0002-9841-9461			AARABI B, 1978, SURG NEUROL, V10, P233; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; DAVIS JM, 1983, NEURORADIOLOGY, V25, P55, DOI 10.1007/BF00333294; DHARKER SR, 1978, SURG NEUROL, V9, P77; DRATZ HM, 1947, J NEUROPATH EXP NEUR, V6, P286, DOI 10.1097/00005072-194707000-00009; Erikson S, 1943, ACTA RADIOL, V24, P392, DOI 10.3109/00016924309137646; GORE I, 1971, PATHOLOGY, V1, P748; HIGAZI I, 1963, J NEUROSURG, V20, P354, DOI 10.3171/jns.1963.20.4.0354; HOCKADAY TDR, 1959, J NEUROL NEUROSUR PS, V22, P229, DOI 10.1136/jnnp.22.3.229; JOHNSON AC, 1977, SURG NEUROL, V7, P49; MASTAGLIA FL, 1969, J NEUROL NEUROSUR PS, V32, P383, DOI 10.1136/jnnp.32.5.383; MILLER JDR, 1967, RADIOLOGY, V89, P95, DOI 10.1148/89.1.95; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; RECOULESARCHE D, 1976, NEUROCHIRURGIE, V22, P293; REDDY SVR, 1981, J NEUROSURG, V55, P813, DOI 10.3171/jns.1981.55.5.0813; RITCHIE G, 1961, Wis Med J, V60, P556; ROSEGAY H, 1956, NEUROLOGY, V6, P143, DOI 10.1212/WNL.6.2.143; SEDZIMIR CB, 1955, J NEUROL NEUROSUR PS, V18, P293, DOI 10.1136/jnnp.18.4.293; SULLIVAN HG, 1973, RADIOLOGY, V109, P91; THOMSON JLG, 1963, BRIT J RADIOL, V36, P840, DOI 10.1259/0007-1285-36-431-840; TORKILDSEN A, 1951, J NEUROSURG, V8, P269, DOI 10.3171/jns.1951.8.3.0269; VIGOUROUX R, 1962, NEURO-CHIR, V8, P115; WEST TET, 1976, BRIT MED J, V1, P818, DOI 10.1136/bmj.1.6013.818; YAMADA S, 1967, J TRAUM, V7, P333, DOI 10.1097/00005373-196705000-00001; YASHON D, 1964, J NEUROL NEUROSUR PS, V27, P547, DOI 10.1136/jnnp.27.6.547; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016; ZILKHA A, 1970, RADIOLOGY, V97, P543, DOI 10.1148/97.3.543	28	31	31	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	1987	66	2					192	197		10.3171/jns.1987.66.2.0192			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	F8334	WOS:A1987F833400006	3806201				2022-02-06	
J	SMITH, A				SMITH, A			DURATION OF IMPAIRED CONSCIOUSNESS AS AN INDEX OF SEVERITY IN CLOSED HEAD-INJURIES - A REVIEW	DISEASES OF THE NERVOUS SYSTEM			English	Article																	AKERLUND E, 1959, Acta Chir Scand, V117, P275; Anderson C, 1942, LANCET, V2, P1; BAY E, 1953, NEUROL PSYCHIAT, V21, P151; BIRKMAYER W, 1952, ACTA NEUROVEG, V4, P453, DOI 10.1007/BF01236396; COBB S, 1943, TRANS AM NEUROL ASSO, P113; DAILEY CA, 1956, J CLIN PSYCHOL, V12, P349, DOI 10.1002/1097-4679(195610)12:4<349::AID-JCLP2270120410>3.0.CO;2-L; DENCKER SJ, 1958, ACTA PSYCHIAT N S122, V33, P119; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; ECHLIN FA, 1956, HITM; GURDJIAN ES, 1958, HEAD INJURIES; HARRER G, 1950, DEUTSCH MED RESCH, V4, P148; HEWSON LR, 1949, J NERV MENT DIS, V109, P246, DOI 10.1097/00005053-194903000-00007; HEWSON LR, 1949, J NERV MENT DIS, V109, P158, DOI 10.1097/00005053-194902000-00006; JACKSON JH, 1931, SC, V1; JEFFERSON G, 1942, GLASGOW MED J, V20, P77; LECHNER H, 1954, Confin Neurol, V14, P219; Leigh AD, 1943, LANCET, V1, P38; LYNN JG, 1945, A RES NERV MENT DIS, V24, P296; MERRITT HH, 1955, TEXTBOOK NEUROLOGY; METTLER FA, 1945, A RES NERV MENT DIS, V24, P1; MILLER H, 1949, NEWCASTLE MED J, V24, P12; Moore BE, 1944, NEW ENGL J MED, V230, P445, DOI 10.1056/NEJM194404132301501; PENFIELD W, 1945, ARNMD, V24, P296; PHILLIPS G, 1954, J NEUROL NEUROSUR PS, V17, P1, DOI 10.1136/jnnp.17.1.1; PIA HW, 1956, ARCH LIN CHIR, V281, P652; PILCHER C, 1942, WAR MED, V9, P114; PROBST H, 1949, Z Kinderpsychiatr, V15, P186; REISNER H, 1951, Z NERVENHELK, V3, P475; Reynell WR, 1944, J MENT SCI, V90, P710; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; RUSSELL W R, 1948, Edinb Med J, V55, P92; Russell W Ritchie, 1934, Edinb Med J, V41, P129; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Symonds CP, 1943, LANCET, V1, P7; Symonds CP, 1935, LANCET, V1, P486; Symonds CP, 1936, LANCET, V1, P854; Symonds CP, 1928, BRIT MED J, V1928, P829, DOI 10.1136/bmj.2.3540.829; Taylor J., 1931, SELECTED WRITINGS JO, V1; TONNIS W, 1949, LINISCHE WOCHENSCHRI, V27, P390; TOOTH G, 1947, J NEUROL NEUROSUR PS, V10, P1, DOI 10.1136/jnnp.10.1.1; USBECK N, 1953, ARTZL WSCH, V8, P152; VORIS HC, 1950, AM J SURG, V80, P707, DOI 10.1016/0002-9610(50)90595-2; [No title captured]; [No title captured]	47	31	31	0	0	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0012-3714			DIS NERV SYST	Dis. Nerv. Syst.		1961	22	2					69	+					1	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	10490	WOS:A19611049000009					2022-02-06	
J	GROAT, R; SIMMONS, JQ				GROAT, R; SIMMONS, JQ			LOSS OF NERVE CELLS IN EXPERIMENTAL CEREBRAL CONCUSSION	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article																	BECKER RF, 1945, FED PROC, V4, P6; BECKER RF, 1946, FED PROC, V5, P7; Denny-Brown D, 1943, ANN INTERN MED, V19, P427, DOI 10.7326/0003-4819-19-3-427; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DOW RS, 1945, J NEUROPHYSIOL, V8, P161; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; Groat RA, 1944, AM J PHYSIOL, V141, P0117, DOI 10.1152/ajplegacy.1944.141.1.117; GROAT RA, UNPUB; Gurdjian E. S., 1944, SURG GYNECOL AND OBSTET, V78, P618; KOENIG H, 1945, STAIN TECHNOL, V20, P13, DOI 10.3109/10520294509107124; Pitts RF, 1939, AM J PHYSIOL, V127, P654; RHINES R, 1946, AM J PHYSIOL, V146, P344, DOI 10.1152/ajplegacy.1946.146.3.344; SPIEGEL EA, 1947, RES PUBL ASS RES NER, V26, P84; WARD JW, 1948, SCIENCE, V107, P349, DOI 10.1126/science.107.2779.349; WARD JW, 1948, J NEUROPHYSIOL, V11, P59, DOI 10.1152/jn.1948.11.2.59; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; WINDLE WF, 1946, J NEUROSURG, V3, P157, DOI 10.3171/jns.1946.3.2.0157; WINDLE WF, 1944, T AM NEUROL ASSOC, P117	21	31	31	0	1	AMER ASSN NEUROPATHOLOGISTS INC	LAWRENCE	1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.		1950	9	2					150	163		10.1097/00005072-195004000-00003			14	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	UZ248	WOS:A1950UZ24800003	15415758				2022-02-06	
J	Miller, GG				Miller, GG			Cerebral concussion	ARCHIVES OF SURGERY			English	Article																	ADAMS F, GENUINE HIPPOCRATES, V1, P254; ALQUIE, 1865, GAZ MED PARIS, P314; ALQUIE, 1865, GAZ MED PARIS, P254; ALQUIE, 1865, GAZ MED PARIS, P382; ALQUIE, 1865, GAZ MED PARIS, P463; ALQUIE, 1865, GAZ MED PARIS, P396; ALQUIE, 1865, GAZ MED PARIS, P226; ARCHIBALD E, 1908, AM PRACT SURF, V5, P147; ARCHIBLAD E, 1908, AM PRACT SURG, V5, P150; BAYLISS WM, 1920, PRINCIPLES GEN PHYSL, P427; BECK B, 1879, VIRCHOWS ARCH PATH A, V75, P207; BICKELES, 1899, MUNCHEN MED WCHNSCHR, V46, P79; BOIREL, 1677, TRAITE PLAIES TETE; BOYN, 1818, THESIS PARIS; BRESLAUERSCHUEC, 1921, BRUNS BEITR KLIN CHI, V121, P590; BRYNANT R, 1888, LANCET, V2, P405; Cannon WB, 1901, AM J PHYSIOL, V6, P91; Cushing H, 1903, AM J MED SCI, V125, P1017, DOI 10.1097/00000441-190306000-00006; Cushing H, 1901, B JOHNS HOPKINS HOSP, V12, P290; Cushing H, 1902, AM J MED SCI, V124, P375, DOI 10.1097/00000441-190209000-00001; CUSHING H, 1908, SURG HEAD SURG, V3, P182; DEUCHER, DTSCH Z CHIR, V35, P145; DURET, 1874, ARCH PHYSL, P320; FANO, 1894, REV CHIR, V141, P278; FELIZET, 1894, REV CHIR, V14, P280; FERRARI, 1901, SPEZIELLE PATHOLOGIE, P320; FISCHER H, 1871, VOLKMANN SAMML KLIN, V27, P219; FRIEDLANDER C, 1879, VIRCHOWS ARCH PATH A, V75, P24; HILL L, 1896, CEREBRAL CIRCULATION; HUTCHINSON J, 1892, BRAIN, V15, P154; KOCH W, 1874, ARCH KLIN CHIR, V17, P190; KOCHER T, 1901, SPEZIELLE PATHOLOGIE, V267; KRAMER SP, 1894, ANN SURG, V23, P163; KUSSMAUL, 1896, CEREBRAL CIRCULATION; LEGROS C, 1870, DIAGNOSIS VISCERAL L, V1; LITTRE, 1705, ACAD ROY SC PARIS, P54; MILES A, 1892, BRAIN, V15, P153; MILES A, 1892, BRAIN, V15, P157; MILES A, 1892, BRAIN, V15, P154; MOURIER, 1834, THESIS PARIS; PARE A, 1840, OCUVRES COMPLETES AM, V2, P23; PETIT JL, TRAITE MALADIES CHIR, V1, P1774; PIROGOFF, 1864, GRUND ZUGE ALLGEMEIN, P77; POLIS A, 1894, REV CHIR, V14, P275; POLIS A, 1894, REV CHIR PARIS, V14, P274; Polis A, 1894, REV CHIR, V14, P273; RAHM H, 1920, ZENTRALBL CHIR, V47, P146; SABATIER, MED OPERAT, V2, P400; SAVORY WS, 1869, ST BARTH HOSP REP, V5, P72; Scagliosi G., 1898, VIRCHOWS ARCH, V152, P487; SCHMAUS H, 1899, MUNCHEN MED WCHNSCHR, V46, P75; SCHMAUS H, 1899, MUNCHEN MED WCHNSCHR, V37, P485; STROMEYER, 1894, REV CHIR, V14, P281; TILMAN, 1899, ARCH KLIN CHIR, V59, P239; TILMANN, 1899, ARCH KLIN CHIR, V59, P236; TRENDELENBURG F, 1910, DTSCH MED WCHNSCHR, V36, P1; TROTTER W, 1923, SYSTEM SURG, V3, P468; VONBERGMANN, 1880, DTSCH CHIRURGIE, P296; VONBERGMANN, 1880, DTSCH CHIR, V30, P341; WITKOWSKIL, 1877, VIRCHOWS ARCH PATH A, V69, P498	60	31	31	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0004-0010			ARCH SURG-CHICAGO	Arch. Surg.	APR	1927	14	4					891	916		10.1001/archsurg.1927.01130160100005			26	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	V06PK	WOS:000200445600005					2022-02-06	
J	Liu, YZ; Domel, AG; Yousefsani, SA; Kondic, J; Grant, G; Zeineh, M; Camarillo, DB				Liu, Yuzhe; Domel, August G.; Yousefsani, Seyed Abdolmajid; Kondic, Jovana; Grant, Gerald; Zeineh, Michael; Camarillo, David B.			Validation and Comparison of Instrumented Mouthguards for Measuring Head Kinematics and Assessing Brain Deformation in Football Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; mTBI; Smart mouthguard; Electronic mouthguard; Anthropomorphic test dummy (ATD)	INJURY; SEVERITY	Because of the rigid coupling between the upper dentition and the skull, instrumented mouthguards have been shown to be a viable way of measuring head impact kinematics for assisting in understanding the underlying biomechanics of concussions. This has led various companies and institutions to further develop instrumented mouthguards. However, their use as a research tool for understanding concussive impacts makes quantification of their accuracy critical, especially given the conflicting results from various recent studies. Here we present a study that uses a pneumatic impactor to deliver impacts characteristic to football to a Hybrid III headform, in order to validate and compare five of the most commonly used instrumented mouthguards. We found that all tested mouthguards gave accurate measurements for the peak angular acceleration, the peak angular velocity, brain injury criteria values (mean average errors < 13, 8, 13%, respectively), and the mouthguards with long enough sampling time windows are suitable for a convolutional neural network-based brain model to calculate the brain strain (mean average errors < 9%). Finally, we found that the accuracy of the measurement varies with the impact locations yet is not sensitive to the impact velocity for the most part.	[Liu, Yuzhe; Domel, August G.; Yousefsani, Seyed Abdolmajid; Kondic, Jovana; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kondic, Jovana] Princeton Univ, Dept Elect Engn, Princeton, NJ 08540 USA; [Grant, Gerald; Camarillo, David B.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Grant, Gerald] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Zeineh, Michael] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA		Camarillo, DB (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	dcamarillo@stanford.edu	Yousefsani, Seyed Abdolmajid/ABB-8788-2021		Pac-12 Conference's Student-Athlete Health and Well-Being Initiative; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24NS098518]; Taube Stanford Children's Concussion Initiative; Office of Naval Research Young Investigator ProgramOffice of Naval Research [N00014-16-1-2949]	This research was supported by the Pac-12 Conference's Student-Athlete Health and Well-Being Initiative, the National Institutes of Health (R24NS098518), Taube Stanford Children's Concussion Initiative, and the Office of Naval Research Young Investigator Program (N00014-16-1-2949). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of funding agencies. It should be noted that the MiG mouthguard and intellectual property associated with it is owned by Stanford University. We would like to thank Dr. Michael Fanton, Dr. Hossein Vahid Alizadeh, and Dr. Sarah McGough for the insightful discussions on the development of the experimental protocol and data analysis. We also want to thank Prevent Biometrics and SWA companies for providing the mouthguards and answering any necessary questions.	Bartsch A., 2014, SAE TECHNICAL PAPER; Bridgman H, 2019, ANN BIOMED ENG, V47, P1725, DOI 10.1007/s10439-019-02267-4; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Fanton M, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4044876; Fanton M, 2019, IEEE T BIO-MED ENG, V66, P988, DOI 10.1109/TBME.2018.2866147; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Ghazi K, 2019, SCI REP-UK, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hajiaghamemar M, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046393; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Kuo C, 2018, J BIOMECH, V76, P220, DOI 10.1016/j.jbiomech.2018.05.024; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li X, 2020, ANATOMICALLY ACCURAT; Lu YC, 2019, ANN BIOMED ENG, V47, P1923, DOI 10.1007/s10439-019-02226-z; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Parivash SN, 2019, J NEUROTRAUM, V36, P2762, DOI 10.1089/neu.2018.6357; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Takhounts E.G., 2013, SAE TECHNICAL PAPER; Tiernan S, 2020, P I MECH ENG H, V234, P1472, DOI 10.1177/0954411920947850; Withnall, 2017, NFL LINEAR IMPACTOR; Wu LC, 2017, SCI REP, V8, P1; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634	37	30	30	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2580	2598		10.1007/s10439-020-02629-3		SEP 2020	19	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000573427800001	32989591	Green Submitted			2022-02-06	
J	Martin, PK; Schroeder, RW				Martin, Phillip K.; Schroeder, Ryan W.			Base Rates of Invalid Test Performance Across Clinical Non-forensic Contexts and Settings	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Base rates; Invalid; Performance validity; Non-forensic	SYMPTOM EXAGGERATION; VALIDITY; DISORDER; BELIEFS; INDEX	Objective: Base rates of invalidity in forensic neuropsychological contexts are well explored and believed to approximate 40%, whereas base rates of invalidity across clinical non-forensic contexts are relatively less known. Methods: Adult-focused neuropsychologists (n = 178) were surveyed regarding base rates of invalidity across various clinical non-forensic contexts and practice settings. Median values were calculated and compared across contexts and settings. Results: The median estimated base rate of invalidity across clinical non-forensic evaluations was 15%. When examining specific clinical contexts and settings, base rate estimates varied from 5% to 50%. Patients with medically unexplained symptoms (50%), external incentives (25%-40%), and oppositional attitudes toward testing (37.5%) were reported to have the highest base rates of invalidity. Patients with psychiatric illness, patients evaluated for attention deficit hyperactivity disorder, and patients with a history of mild traumatic brain injury were also reported to invalidate testing at relatively high base rates (approximately 20%). Conversely, patients presenting for dementia evaluation and patients with none of the previously mentioned histories and for whom invalid testing was unanticipated were estimated to produce invalid testing in only 5% of cases. Regarding practice setting, Veterans Affairs providers reported base rates of invalidity to be nearly twice that of any other clinical settings. Conclusions: Non-forensic clinical patients presenting with medically unexplained symptoms, external incentives, or oppositional attitudes are reported to invalidate testing at base rates similar to that of forensic examinees. The impact of context-specific base rates on the clinical evaluation of invalidity is discussed.	[Martin, Phillip K.; Schroeder, Ryan W.] Univ Kansas, Sch Med, Dept Psychiat & Behav Sci, Wichita, KS 67214 USA		Martin, PK (corresponding author), Univ Kansas, Sch Med, Dept Psychiat & Behav Sci, Wichita, KS 67214 USA.	pmartin4@kumc.edu					Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Boone K. B., 2017, NEUROPSYCHOLOGICAL E, P17; Braverman M, 1978, Occup Health Saf, V47, P36; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Cook CM, 2016, ARCH CLIN NEUROPSYCH, V31, P358, DOI 10.1093/arclin/acw015; Dandachi-FitzGerald B, 2016, PSYCHIAT RES, V239, P47, DOI 10.1016/j.psychres.2016.02.061; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Gouvier WD, 1999, STUD NEUROPSYCHOL DE, P27; Griffin GAE, 1996, J CONSULT CLIN PSYCH, V64, P1425, DOI 10.1037/0022-006X.64.6.1425; Harrison AG, 2010, APPL NEUROPSYCHOL, V17, P135, DOI 10.1080/09084281003715642; Johnson-Greene D, 2013, CLIN NEUROPSYCHOL, V27, P148, DOI 10.1080/13854046.2012.733732; Kemp S, 2008, J PSYCHOSOM RES, V65, P319, DOI 10.1016/j.jpsychores.2008.02.010; Lange RT, 2017, CLIN NEUROPSYCHOL, V31, P1015, DOI 10.1080/13854046.2017.1335438; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P14; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P3; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Leppma M, 2018, APPL NEUROPSYCH-ADUL, V25, P210, DOI 10.1080/23279095.2016.1277723; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Shura RD, 2017, PSYCHOL ASSESSMENT, V29, P1458, DOI 10.1037/pas0000436; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	28	30	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2020	35	6					717	725		10.1093/arclin/acaa017			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	OW5NS	WOS:000592933700007	32318712	Bronze			2022-02-06	
J	Rickard, JJS; Di-Pietro, V; Smith, DJ; Davies, DJ; Belli, A; Oppenheimer, PG				Rickard, Jonathan J. S.; Di-Pietro, Valentina; Smith, David J.; Davies, David J.; Belli, Antonio; Oppenheimer, Pola Goldberg			Rapid optofluidic detection of biomarkers for traumatic brain injury via surface-enhanced Raman spectroscopy	NATURE BIOMEDICAL ENGINEERING			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; EXTRACELLULAR N-ACETYLASPARTATE; IN-VIVO; SCATTERING DETECTION; SURROGATE MARKER; TEMPORAL WINDOW; CANAVAN DISEASE; SERS DETECTION; MILD; CARE	An optofluidic device rapidly detects, via surface-enhanced Raman scattering, picomolar concentrations of biomarkers for traumatic brain injury in finger-prick blood samples from patients. Current technologies for the point-of-care diagnosis of traumatic brain injury (TBI) lack sensitivity, require specialist handling or involve complicated and costly procedures. Here, we report the development and testing of an optofluidic device for the rapid and label-free detection, via surface-enhanced Raman scattering (SERS), of picomolar concentrations of biomarkers for TBI in biofluids. The SERS-active substrate of the device consists of electrohydrodynamically fabricated submicrometre pillars covered with a plasmon-active nanometric gold layer, integrated in an optofluidic chip. We show that the device can detect N-acetylasparate in finger-prick blood samples from patients with TBI, and that the biomarker is released immediately from the central nervous system after TBI. The simplicity, sensitivity and robustness of SERS-integrated optofluidic technology might eventually help the triaging of TBI patients and assist clinical decision making at point-of-care settings.	[Rickard, Jonathan J. S.; Oppenheimer, Pola Goldberg] Univ Birmingham, Coll Engn & Phys Sci, Sch Chem Engn, Birmingham, W Midlands, England; [Rickard, Jonathan J. S.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England; [Di-Pietro, Valentina; Belli, Antonio] Univ Birmingham, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Di-Pietro, Valentina; Davies, David J.; Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Natl Inst Hlth Res, Dept Neurosci & Ophthalmol, Birmingham, W Midlands, England; [Smith, David J.] Univ Birmingham, Coll Engn & Phys Sci, Sch Math, Edgbaston, England; [Oppenheimer, Pola Goldberg] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Trauma Management Healthcare Technol Cooperat, Healthcare Technol Inst, Birmingham, W Midlands, England		Rickard, JJS; Oppenheimer, PG (corresponding author), Univ Birmingham, Coll Engn & Phys Sci, Sch Chem Engn, Birmingham, W Midlands, England.; Rickard, JJS (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England.; Oppenheimer, PG (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Trauma Management Healthcare Technol Cooperat, Healthcare Technol Inst, Birmingham, W Midlands, England.	jjr1001@cam.ac.uk; GoldberP@bham.ac.uk	Belli, Antonio/I-3799-2015; Smith, David J/G-5775-2011	Belli, Antonio/0000-0002-3211-9933; Smith, David J/0000-0002-3427-0936; Goldberg Oppenheimer, Pola/0000-0002-1014-4724	Wellcome TrustWellcome TrustEuropean Commission [174ISSFPP]; Royal Academy of EngineeringRoyal Academy of Engineering - UK [RF1415\14\28]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [DTAARGCQ19497]; Royal Academy of Engineering Research FellowshipRoyal Academy of Engineering - UK	We acknowledge funding from the Wellcome Trust (grant no. 174ISSFPP), the Royal Academy of Engineering (grant no. RF1415\14\28) and the National Institute for Health Research (grant no. DTAARGCQ19497). P.G.O. is a Royal Academy of Engineering Research Fellowship holder. The authors also thank M. J. Rowney and F. M. Colacino for helpful discussions about the technology and insights into classification analyses. Components of the developed device were fabricated using the facilities at the Cavendish Laboratory at the Department of Physics and the Nanoscience Centre for Fabrication, University of Cambridge.	Ackermann L, 2006, ANGEW CHEM INT EDIT, V45, P2619, DOI 10.1002/anie.200504450; [Anonymous], 2016, NEUROTRAUMA; Aquino C, 2015, EMERG RADIOL, V22, P65, DOI 10.1007/s10140-014-1226-0; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Banbury C, 2019, ACS APPL MATER INTER, V11, P14437, DOI 10.1021/acsami.9b00420; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Benarroch EE, 2008, NEUROLOGY, V70, P1353, DOI 10.1212/01.wnl.0000311267.63292.6c; Brown M, 2018, J NEURORADIOLOGY, V45, P123, DOI 10.1016/j.neurad.2017.09.004; Carney N., 2016, GUIDELINES MANAGEMEN, V4th; Chang J., 2017, NANO BIOMED ENG, V9, P49, DOI DOI 10.5101/nbe.v9i1.p49-56; Chen G, 2014, RSC ADV, V4, P54434, DOI 10.1039/c4ra09251a; Chen LX, 2008, ELECTROPHORESIS, V29, P1815, DOI 10.1002/elps.200700554; Coon AL, 2006, AM J NEURORADIOL, V27, P1053; Croall Iain, 1800, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Danielson E. R., 1999, MAGNETIC RESONANCE S; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dennis EL, 2018, HUM BRAIN MAPP, V39, P3759, DOI 10.1002/hbm.24209; Di Costanzo A, 2003, EUR J RADIOL, V48, P146, DOI 10.1016/j.ejrad.2003.08.009; Di Pietro V, 2013, CLIN BIOCHEM, V46, P1902, DOI 10.1016/j.clinbiochem.2013.09.004; Dimov IK, 2011, LAB CHIP, V11, P845, DOI [10.1039/c0lc00403k, 10.1039/c01c00403k]; Dinish US, 2014, J BIOPHOTONICS, V7, P956, DOI 10.1002/jbio.201300084; Dinish US, 2014, SCI REP-UK, V4, DOI 10.1038/srep04075; Dinish US, 2012, BIOSENS BIOELECTRON, V33, P293, DOI 10.1016/j.bios.2011.12.056; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Duda R. O., 2007, PATTERN CLASSIFICATI; Durucan O., 2015, 19 INT C MIN SYST CH, P1831; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gauglitz G, 2014, HDB SPECTROSCOPY, V2nd; Goldberg Oppenheimer P., 2017, International patent, Patent No. [PCT/GB2018/050193, 2018050193]; Goldberg-Oppenheimer P, 2012, J PHYS CHEM LETT, V3, P3486, DOI 10.1021/jz301333r; Goldberg-Oppenheimer P, 2012, ADV MATER, V24, pOP175, DOI 10.1002/adma.201104159; Granger JH, 2016, CHEM SOC REV, V45, P3865, DOI 10.1039/c5cs00828j; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Han XX, 2009, ANAL BIOANAL CHEM, V394, P1719, DOI 10.1007/s00216-009-2702-3; Han XX, 2012, TRAC-TREND ANAL CHEM, V38, P67, DOI 10.1016/j.trac.2012.05.006; Tran HN, 2015, ADV NAT SCI-NANOSCI, V6, DOI 10.1088/2043-6262/6/2/023002; Hoonejani MR, 2015, NANOSCALE, V7, P16834, DOI 10.1039/c5nr04147c; Hoshino H, 2014, PEDIATR INT, V56, P477, DOI 10.1111/ped.12422; Huang SX, 2015, NANO LETT, V15, P2892, DOI 10.1021/nl5045988; Jahn IJ, 2017, ANALYST, V142, P1022, DOI 10.1039/c7an00118e; Juncker D, 2002, ANAL CHEM, V74, P6139, DOI 10.1021/ac0261449; Kahraman M, 2017, NANOPHOTONICS-BERLIN, V6, P831, DOI 10.1515/nanoph-2016-0174; Kho KW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976140; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Lim C, 2010, ANALYST, V135, P837, DOI 10.1039/b919584j; Lin D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04751; Lin SN, 1995, J NEUROSCI METH, V62, P199, DOI 10.1016/0165-0270(95)00077-1; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahajan S, 2013, J PHYS CHEM LETT, V4, P4153, DOI 10.1021/jz4018688; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McQueenie R, 2012, ANAL CHEM, V84, P5968, DOI 10.1021/ac3006445; MOFFETT JR, 2013, FRONT NEUROENERGETIC, V8; Moore TJ, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8020046; Muniz-Miranda M, 2013, THIN SOLID FILMS, V543, P118, DOI 10.1016/j.tsf.2013.02.057; NADLER JV, 1972, J NEUROCHEM, V19, P313, DOI 10.1111/j.1471-4159.1972.tb01341.x; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Park A, 2013, CHEMOMETR INTELL LAB, V121, P52, DOI 10.1016/j.chemolab.2012.11.011; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; Pennathur S, 2008, LAB CHIP, V8, P649, DOI 10.1039/b805064n; Piorek BD, 2007, P NATL ACAD SCI USA, V104, P18898, DOI 10.1073/pnas.0708596104; Premasiri WR, 2012, J PHYS CHEM B, V116, P9376, DOI 10.1021/jp304932g; Qian XM, 2008, J AM CHEM SOC, V130, P14934, DOI 10.1021/ja8062502; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Robertson C., 2015, CRITICAL CARE MANAGE, V4; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Schuff N, 2002, NEUROLOGY, V58, P928, DOI 10.1212/WNL.58.6.928; Sen J, 2005, ACTA NEUROCHIR, V147, P897, DOI 10.1007/s00701-005-0526-2; Shannon RJ, 2016, J NEUROTRAUM, V33, P319, DOI 10.1089/neu.2015.3950; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Shen AG, 2009, J RAMAN SPECTROSC, V40, P550, DOI 10.1002/jrs.2163; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SOCRATES G., 2001, INFRARED RAMAN CHARA; Srivastava SK, 2015, ANALYST, V140, P3201, DOI 10.1039/c5an00209e; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Szydzik C, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4938391; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Tshibanda J.-F. L., 2012, COMA DISORDERS CONSC, P45; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Veeramuthu V, 2018, ACAD RADIOL, V25, P1167, DOI 10.1016/j.acra.2018.01.005; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang R., 2018, FRONTIERS ADV MOL SP, P307; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21242; Wang Y, 2014, TECHNOLOGY, V2, P118, DOI 10.1142/S2339547814500125; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Xu WG, 2013, SMALL, V9, P1206, DOI 10.1002/smll.201203097; Yang SK, 2016, P NATL ACAD SCI USA, V113, P268, DOI 10.1073/pnas.1518980113; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	104	30	31	30	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2157-846X			NAT BIOMED ENG	Nat. Biomed. Eng	JUN	2020	4	6					610	623		10.1038/s41551-019-0510-4		FEB 2020	14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	LX9UU	WOS:000510821600003	32015408	Green Submitted			2022-02-06	
J	Kodali, M; Castro, OW; Kim, DK; Thomas, A; Shuai, B; Attaluri, S; Upadhya, R; Gitai, D; Madhu, LN; Prockop, DJ; Shetty, AK				Kodali, Maheedhar; Castro, Olagide W.; Kim, Dong-Ki; Thomas, Alicia; Shuai, Bing; Attaluri, Sahithi; Upadhya, Raghavendra; Gitai, Daniel; Madhu, Leelavathi N.; Prockop, Darwin J.; Shetty, Ashok K.			Intranasally Administered Human MSC-Derived Extracellular Vesicles Pervasively Incorporate into Neurons and Microglia in both Intact and Status Epilepticus Injured Forebrain	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						brain injury; exosomes; extracellular vesicles; intranasal administration; mesenchymal stem cells; microglia; microvesicles; status epilepticus; transport of extracellular vesicles	SPONTANEOUS SEIZURES; ABNORMAL NEUROGENESIS; STROMAL CELLS; OLD-AGE; EXOSOMES; MODEL; BRAIN; NEURODEGENERATION; INFLAMMATION; IMPAIRMENTS	Extracellular vesicles (EVs) derived from human bone marrow mesenchymal stem cells (hMSCs) have great promise as biologics to treat neurological and neurodegenerative conditions due to their robust antiinflammatory and neuroprotective properties. Besides, intranasal (IN) administration of EVs has caught much attention because the procedure is noninvasive, amenable for repetitive dispensation, and leads to a quick penetration of EVs into multiple regions of the forebrain. Nonetheless, it is unknown whether brain injury-induced signals are essential for the entry of IN-administered EVs into different brain regions. Therefore, in this study, we investigated the distribution of IN-administered hMSC-derived EVs into neurons and microglia in the intact and status epilepticus (SE) injured rat forebrain. Ten billion EVs labeled with PKH26 were dispensed unilaterally into the left nostril of naive rats, and rats that experienced two hours of kainate-induced SE. Six hours later, PKH26 + EVs were quantified from multiple forebrain regions using serial brain sections processed for different neural cell markers and confocal microscopy. Remarkably, EVs were seen bilaterally in virtually all regions of intact and SE-injured forebrain. The percentage of neurons incorporating EVs were comparable for most forebrain regions. However, in animals that underwent SE, a higher percentage of neurons incorporated EVs in the hippocampal CA1 subfield and the entorhinal cortex, the regions that typically display neurodegeneration after SE. In contrast, the incorporation of EVs by microglia was highly comparable in every region of the forebrain measured. Thus, unilateral IN administration of EVs is efficient for delivering EVs bilaterally into neurons and microglia in multiple regions in the intact or injured forebrain. Furthermore, incorporation of EVs by neurons is higher in areas of brain injury, implying that injury-related signals likely play a role in targeting of EVs into neurons, which may be beneficial for EV therapy in various neurodegenerative conditions including traumatic brain injury, stroke, multiple sclerosis, and Alzheimer's disease.	[Kodali, Maheedhar; Kim, Dong-Ki; Thomas, Alicia; Shuai, Bing; Attaluri, Sahithi; Upadhya, Raghavendra; Madhu, Leelavathi N.; Prockop, Darwin J.; Shetty, Ashok K.] Texas A&M Univ, Dept Mol & Cellular Med, Inst Regenerat Med, 1114 TAMU, College Stn, TX 77842 USA; [Castro, Olagide W.; Gitai, Daniel] Univ Fed Alagoas, Hlth Sci Ctr, BR-57072900 Maceio, Alagoas, Brazil		Shetty, AK (corresponding author), Texas A&M Univ, Dept Mol & Cellular Med, Inst Regenerat Med, 1114 TAMU, College Stn, TX 77842 USA.	kodali@tamu.edu; olagidewww@gmail.com; biodon2003@msn.com; aliciathomas65@gmail.com; shuai@medicine.tamhsc.edu; sahithi.attaluri@tamu.edu; sacraghu@tamu.edu; danielgitai@gmail.com; lnmadhu802@tamu.edu; prockop@tamu.edu; akskrs@tamu.edu	da Saude, Programa Ciencias/ABF-1705-2020; Madhu, Leelavathi N/AAP-2764-2021; Shetty, Ashok K/A-2428-2008; Gitai, Daniel LG/A-7982-2019; Castro, Olagide/ABA-6708-2020; Castro, Olagide/C-6781-2015; Shetty, Ashok/AAT-7273-2020	Madhu, Leelavathi N/0000-0002-5850-1786; Shetty, Ashok K/0000-0001-5049-6671; Gitai, Daniel LG/0000-0001-7056-2373; Castro, Olagide/0000-0002-1874-509X; Castro, Olagide/0000-0002-1874-509X; Shetty, Ashok/0000-0001-5049-6671	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS106907-01]; State of Texas (Emerging Technology Fund); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Government of Brazil; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS106907] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (1R01NS106907-01 to A.K.S. and D.J.P.) and the State of Texas (Emerging Technology Fund to A.K.S.). Olagide Castro and Daniel Gitai were supported by Visiting Scientist Awards from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Government of Brazil.	Dabrowska S, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1571-8; Drexel M, 2012, NEUROPHARMACOLOGY, V63, P806, DOI 10.1016/j.neuropharm.2012.06.009; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Flamant S, 2016, RADIAT RES, V186, P203, DOI 10.1667/RR14482.1; Fruhbeis C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00182; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Hattiangady B, 2012, STEM CELL TRANSL MED, V1, P696, DOI 10.5966/sctm.2012-0050; Hattiangady B, 2011, AGING DIS, V2, P1; Hemphill M, 2020, J NEUROTRAUM, V37, P2424, DOI 10.1089/neu.2018.6220; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Kalani A, 2016, INT J BIOCHEM CELL B, V79, P360, DOI 10.1016/j.biocel.2016.09.002; Katsu M, 2019, NEUROSCI LETT, V708, DOI 10.1016/j.neulet.2019.03.048; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Kodali M, 2018, BRAIN BEHAV IMMUN, V69, P499, DOI 10.1016/j.bbi.2018.01.009; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Long Q, 2017, P NATL ACAD SCI USA, V114, pE3536, DOI 10.1073/pnas.1703920114; Lu YH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00209; Madhu LN, 2019, BRAIN BEHAV IMMUN, V81, P430, DOI 10.1016/j.bbi.2019.06.040; Malloci M, 2019, ANTIOXID REDOX SIGN, V30, P813, DOI 10.1089/ars.2017.7265; Mendt M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99263; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mishra V, 2015, SCI REP-UK, V5, DOI 10.1038/srep17807; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Morad G, 2019, ACS NANO, V13, P13853, DOI 10.1021/acsnano.9b04397; Park KS, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1398-3; Pelassa I, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00091; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Rao MS, 2008, HIPPOCAMPUS, V18, P931, DOI 10.1002/hipo.20449; Rao MS, 2007, NEUROBIOL DIS, V27, P117, DOI 10.1016/j.nbd.2007.03.016; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Riazifar M, 2019, ACS NANO, V13, P6670, DOI 10.1021/acsnano.9b01004; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shetty AK, 1999, J COMP NEUROL, V414, P238, DOI 10.1002/(SICI)1096-9861(19991115)414:2<238::AID-CNE7>3.0.CO;2-A; Shetty AK, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101389; Shi M, 2014, ACTA NEUROPATHOL, V128, P639, DOI 10.1007/s00401-014-1314-y; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Upadhya D, 2019, CURR PHARM DESIGN, V25, P3500, DOI 10.2174/1381612825666191014164950; Upadhya D, 2021, EPILEPSY BEHAV, V121, DOI 10.1016/j.yebeh.2019.106499; Upadhya D, 2019, AGING DIS, V10, P915, DOI 10.14336/AD.2019.0720; Upadhya D, 2019, P NATL ACAD SCI USA, V116, P287, DOI 10.1073/pnas.1814185115; Vogel A, 2018, EBIOMEDICINE, V38, P273, DOI 10.1016/j.ebiom.2018.11.026; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Wang SS, 2018, J ALZHEIMERS DIS, V61, P1005, DOI 10.3233/JAD-170848; Webb RL, 2018, TRANSL STROKE RES, V9, P530, DOI 10.1007/s12975-017-0599-2; Webb RL, 2018, STROKE, V49, P1248, DOI 10.1161/STROKEAHA.117.020353; Wiklander OPB, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26316; Winston Charisse N, 2016, Alzheimers Dement (Amst), V3, P63, DOI 10.1016/j.dadm.2016.04.001; Zakharov Andrei, 2004, Lymphat Res Biol, V2, P139, DOI 10.1089/lrb.2004.2.139; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	56	30	30	2	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN 1	2020	21	1							181	10.3390/ijms21010181			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	KO2KF	WOS:000515378000181	31888012	Green Published, gold			2022-02-06	
J	Dumkrieger, G; Chong, CD; Ross, K; Berisha, V; Schwedt, TJ				Dumkrieger, Gina; Chong, Catherine D.; Ross, Katherine; Berisha, Visar; Schwedt, Todd J.			Static and dynamic functional connectivity differences between migraine and persistent post-traumatic headache: A resting-state magnetic resonance imaging study	CEPHALALGIA			English	Article						Post-traumatic headache; migraine; concussion; mild traumatic brain injury; functional connectivity; magnetic resonance imaging; brain imaging	TRAUMATIC BRAIN-INJURY; NETWORK CONNECTIVITY; PAIN; REGIONS	Introduction Although migraine and persistent post-traumatic headache often share phenotypic characteristics, few studies have interrogated the pathophysiological differences underlying these headache types. While there is now some indication of differences in brain structure between migraine and persistent post-traumatic headache, differences in brain function have not been adequately investigated. The objective of this study was to compare static and dynamic functional connectivity patterns in migraine versus persistent post-traumatic headache using resting-state magnetic resonance imaging. Methods This case-control study interrogated the static functional connectivity and dynamic functional connectivity patterns of 59 a priori selected regions of interest involved in pain processing. Pairwise connectivity (region of interest to region of interest) differences between migraine (n = 33) and persistent post-traumatic headache (n = 44) were determined and compared to healthy controls (n = 36) with ANOVA and subsequent t-tests. Pearson partial correlations were used to explore the relationship between headache burden (headache frequency; years lived with headache) and functional connectivity and between pain intensity at the time of imaging and functional connectivity for migraine and persistent post-traumatic headache groups, separately. Results Significant differences in static functional connectivity between migraine and persistent post-traumatic headache were found for 17 region pairs that included the following regions of interest: Primary somatosensory, secondary somatosensory, posterior insula, hypothalamus, anterior cingulate, middle cingulate, temporal pole, supramarginal gyrus, superior parietal, middle occipital, lingual gyrus, pulvinar, precuneus, cuneus, somatomotor, ventromedial prefrontal cortex, and dorsolateral prefrontal cortex. Significant differences in dynamic functional connectivity between migraine and persistent post-traumatic headache were found for 10 region pairs that included the following regions of interest: Secondary somatosensory, hypothalamus, middle cingulate, temporal pole, supramarginal gyrus, superior parietal, lingual gyrus, somatomotor, precentral, posterior cingulate, middle frontal, fusiform gyrus, parieto-occiptal, and amygdala. Although there was overlap among the regions demonstrating static functional connectivity differences and those showing dynamic functional connectivity differences between persistent post-traumatic headache and migraine, there was no overlap in the region pair functional connections. After controlling for sex and age, there were significant correlations between years lived with headache with static functional connectivity of the right dorsolateral prefrontal cortex with the right ventromedial prefrontal cortex in the migraine group and with static functional connectivity of right primary somatosensory with left supramarginal gyrus in the persistent post-traumatic headache group. There were significant correlations between headache frequency with static functional connectivity of left secondary somatosensory with right cuneus in the migraine group and with static functional connectivity of left middle cingulate with right pulvinar and right posterior insula with left hypothalamus in the persistent post-traumatic headache group. Dynamic functional connectivity was significantly correlated with headache frequency, after controlling for sex and age, in the persistent post-traumatic headache group for one region pair (right middle cingulate with right supramarginal gyrus). Dynamic functional connectivity was correlated with pain intensity at the time of imaging for the migraine cohort for one region pair (right posterior cingulate with right amygdala). Conclusions Resting-state functional imaging revealed static functional connectivity and dynamic functional connectivity differences between migraine and persistent post-traumatic headache for regions involved in pain processing. These differences in functional connectivity might be indicative of distinctive pathophysiology associated with migraine versus persistent post-traumatic headache.	[Dumkrieger, Gina; Chong, Catherine D.; Schwedt, Todd J.] Mayo Clin, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA; [Ross, Katherine] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Berisha, Visar] Arizona State Univ, Tempe, AZ USA		Schwedt, TJ (corresponding author), Mayo Clin, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	Schwedt.todd@mayo.edu		Dumkrieger, Gina/0000-0001-9519-5370; Berisha, Visar/0000-0001-8804-8874			Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Amin FM, 2018, CEPHALALGIA, V38, P1237, DOI 10.1177/0333102417729113; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chang C, 2013, NEUROIMAGE, V68, P93, DOI 10.1016/j.neuroimage.2012.11.038; Chong CD, 2019, J CEREBR BLOOD F MET, V39, P650, DOI 10.1177/0271678X17740794; Chong CD, 2018, HEADACHE, V58, P53, DOI 10.1111/head.13223; Chong CD, 2017, CEPHALALGIA, V37, P828, DOI 10.1177/0333102416652091; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Gao Q, 2016, BRAIN RES, V1632, P73, DOI 10.1016/j.brainres.2015.12.007; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Headache Classification Committee of the International Headache Society (IHS), 2018, INT CLASS HEAD DIS, P1; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Li ZJ, 2017, CEPHALALGIA, V37, P161, DOI 10.1177/0333102416641665; Liu JX, 2015, HUM BRAIN MAPP, V36, P1892, DOI 10.1002/hbm.22744; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Maniyar FH, 2014, BRAIN, V137, P232, DOI 10.1093/brain/awt320; Mickleborough MJS, 2016, BRAIN TOPOGR, V29, P419, DOI 10.1007/s10548-015-0459-x; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Russo A, 2012, CEPHALALGIA, V32, P1041, DOI 10.1177/0333102412457089; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Schwedt TJ, 2013, HEADACHE, V53, P737, DOI 10.1111/head.12081; Shen K, 2015, J NEUROSCI, V35, P5579, DOI 10.1523/JNEUROSCI.4903-14.2015; Spielberger CD., 1983, STATE TRAIT ANXIETY; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stankewitz A, 2011, J NEUROSCI, V31, P1937, DOI 10.1523/JNEUROSCI.4496-10.2011; Tedeschi G, 2016, CEPHALALGIA, V36, P139, DOI 10.1177/0333102415584360; Tessitore A, 2015, HEADACHE, V55, P794, DOI 10.1111/head.12587; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	38	30	31	1	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	OCT	2019	39	11					1366	1381		10.1177/0333102419847728			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JB9AZ	WOS:000488874800003	31042064	Bronze			2022-02-06	
J	Stemper, BD; Shah, AS; Harezlak, J; Rowson, S; Duma, S; Mihalik, JP; Riggen, LD; Brooks, A; Cameron, KL; Giza, CC; Houston, MN; Jackson, J; Posner, MA; McGinty, G; DiFiori, J; Broglio, SP; McAllister, TW; McCrea, M; Hoy, AM; Hazzard, JB; Kelly, LA; Ortega, JD; Port, N; Putukian, M; Langford, TD; Tierney, R; Goldman, JT; Benjamin, HJ; Buckley, T; Kaminski, TW; Clugston, JR; Schmidt, JD; Feigenbaum, LA; Eckner, JT; Guskiewicz, K; Miles, JD; Anderson, S; Master, CL; Collins, M; Kontos, AP; Bazarian, JJ; Chrisman, SPO; O'Donnell, P; Cameron, K; Susmarski, A; Dum, S; Rowson, S; Bullers, CT; Miles, CM; Dykhuizen, BH; Lintner, L				Stemper, Brian D.; Shah, Alok S.; Harezlak, Jaroslaw; Rowson, Steven; Duma, Stefan; Mihalik, Jason P.; Riggen, Larry D.; Brooks, Alison; Cameron, Kenneth L.; Giza, Christopher C.; Houston, Megan N.; Jackson, Jonathan; Posner, Matthew A.; McGinty, Gerald; DiFiori, John; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael; Hoy, April Marie (Reed); Hazzard, Joseph B., Jr.; Kelly, Louise A.; Ortega, Justus D.; Port, Nicholas; Putukian, Margot; Langford, T. Dianne; Tierney, Ryan; Goldman, Joshua T.; Benjamin, Holly J.; Buckley, Thomas; Kaminski, Thomas W.; Clugston, James R.; Schmidt, Julianne D.; Feigenbaum, Luis A.; Eckner, James T.; Guskiewicz, Kevin; Miles, Jessica Dysart; Anderson, Scott; Master, Christina L.; Collins, Micky; Kontos, Anthony P.; Bazarian, Jeffrey J.; Chrisman, Sara P. O.; O'Donnell, Patrick; Cameron, Kenneth; Susmarski, Adam; Dum, Stefan; Rowson, Steve; Bullers, Christopher Todd; Miles, Christopher M.; Dykhuizen, Brian H.; Lintner, Laura		CARE Consortium Investigators	Repetitive Head Impact Exposure in College Football Following an NCAA Rule Change to Eliminate Two-A-Day Preseason Practices: A Study from the NCAA-DoD CARE Consortium	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Sport-related concussion; Injury biomechanics; Traumatic brain injury; Acceleration	DIVISION-I; CONCUSSION DIAGNOSIS; PLAYERS; SEASON; FREQUENCY; LOCATION; SYSTEM; COHORT	Repetitive head impact exposure sustained by athletes of contact sports has been hypothesized to be a mechanism for concussion and a possible explanation for the high degree of variability in sport-related concussion biomechanics. In an attempt to limit repetitive head impact exposure during the football preseason, the NCAA eliminated two-a-day practices in 2017, while maintaining the total number of team practice sessions. The objective of this study was to quantify head impact exposure during the preseason and regular season in Division I college football athletes to determine whether the 2017 NCAA ruling decreased head impact exposure. 342 unique athletes from five NCAA Division I Football Bowl Subdivision (FBS) programs were consented and enrolled. Head impacts were recorded using the Head Impact Telemetry (HIT) System during the entire fall preseasons and regular seasons in 2016 and 2017. Despite the elimination of two-a-day practices, the number of preseason contact days increased in 2017, with an increase in average hourly impact exposure (i.e., contact intensity), resulting in a significant increase in total head impact burden (+ 26%) for the 2017 preseason. This finding would indicate that the 2017 NCAA ruling was not effective at reducing the head impact burden during the football preseason. Additionally, athletes sustained a significantly higher number of recorded head impacts per week (+ 40%) during the preseason than the regular season, implicating the preseason as a time of elevated repetitive head impact burden. With increased recognition of a possible association between repetitive head impact exposure and concussion, increased preseason exposure may predispose certain athletes to a higher risk of concussion during the preseason and regular season. Accordingly, efforts at reducing concussion incidence in contact sports should include a reduction in overall head impact exposure.	[Stemper, Brian D.] Marquette Univ, Joint Dept Biomed Engn, Milwaukee, WI 53233 USA; [Stemper, Brian D.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Stemper, Brian D.; Shah, Alok S.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Stemper, Brian D.; Shah, Alok S.; McCrea, Michael] Clement J Zablocki Vet Affairs Med Ctr, Neurosci Res, Milwaukee, WI USA; [Harezlak, Jaroslaw; Riggen, Larry D.] Indiana Univ, Dept Epidemiol & Biostat, Univ Sch Publ Hlth, Bloomington, IN USA; [Rowson, Steven; Duma, Stefan] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Brooks, Alison] Univ Wisconsin, Dept Orthoped, Sch Med & Publ Hlth, Madison, WI USA; [Cameron, Kenneth L.; Houston, Megan N.; Posner, Matthew A.] US Mil Acad, Keller Army Hosp, West Point, NY 10996 USA; [Jackson, Jonathan; McGinty, Gerald] US Air Force Acad, Dept Sports Med, Colorado Springs, CO 80840 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Sch Med, Dept Psychiat, Indianapolis, IN USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA; [DiFiori, John] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Hoy, April Marie (Reed)] Azusa Pacific Univ, Azusa, CA 91702 USA; [Hazzard, Joseph B., Jr.] Bloomsburg Univ, Bloomsburg, PA USA; [Kelly, Louise A.] Calif Lutheran Univ, Thousand Oaks, CA USA; [Ortega, Justus D.] Humboldt State Univ, Arcata, CA 95521 USA; [Port, Nicholas] Indiana Univ, Bloomington, IN 47405 USA; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Langford, T. Dianne; Tierney, Ryan] Temple Univ, Philadelphia, PA 19122 USA; [Giza, Christopher C.; Goldman, Joshua T.] Univ Calif Los Angeles, Los Angeles, CA USA; [Benjamin, Holly J.] Univ Chicago, Chicago, IL 60637 USA; [Buckley, Thomas; Kaminski, Thomas W.] Univ Delaware, Newark, DE 19716 USA; [Clugston, James R.] Univ Florida, Gainesville, FL 32611 USA; [Schmidt, Julianne D.] Univ Georgia, Athens, GA 30602 USA; [Feigenbaum, Luis A.] Univ Miami, Coral Gables, FL 33124 USA; [Eckner, James T.] Univ Michigan, Ann Arbor, MI 48109 USA; [Mihalik, Jason P.; Guskiewicz, Kevin] Univ N Carolina, Chapel Hill, NC 27515 USA; [Miles, Jessica Dysart] Univ North Georgia, Dahlonega, GA USA; [Anderson, Scott] Univ Oklahoma, Norman, OK 73019 USA; [Master, Christina L.] Univ Penn, Philadelphia, PA 19104 USA; [Collins, Micky; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Bazarian, Jeffrey J.] Univ Rochester, Rochester, NY 14627 USA; [Chrisman, Sara P. O.] Univ Washington, Seattle, WA 98195 USA; [Brooks, Alison] Univ Wisconsin, Madison, WI 53706 USA; [Jackson, Jonathan; McGinty, Gerald] US Air Force Acad, Colorado Springs, CO 80840 USA; [O'Donnell, Patrick] US Coast Guard Acad, New London, CT USA; [Houston, Megan N.; Cameron, Kenneth] US Mil Acad, West Point, NY 10996 USA; [Susmarski, Adam] US Naval Acad, Annapolis, MD 21402 USA; [Dum, Stefan; Rowson, Steve] Virginia Tech, Blacksburg, VA USA; [Bullers, Christopher Todd; Miles, Christopher M.] Wake Forest Univ, Winston Salem, NC 27101 USA; [Dykhuizen, Brian H.] Wilmington Coll, Wilmington, OH USA; [Lintner, Laura] Winston Salem Univ, Winston Salem, NC USA		Stemper, BD (corresponding author), Marquette Univ, Joint Dept Biomed Engn, Milwaukee, WI 53233 USA.; Stemper, BD (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.	bstemper@mcw.edu	Stemper, Brian/AAX-7611-2020; Buckley, Thomas A/B-7525-2016; Rowson, Steven/B-1270-2012; Harezlak, Jaroslaw/P-8557-2014	Buckley, Thomas A/0000-0002-0515-0150; Rowson, Steven/0000-0002-3227-0596; Chrisman, Sara/0000-0001-5373-7223; Ortega, Justus/0000-0002-9931-5605; Susmarski, Adam/0000-0003-3698-4163; Cameron, Kenneth/0000-0002-6276-4482; Harezlak, Jaroslaw/0000-0002-3070-7686; Master, Christina/0000-0002-6717-4270	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - Department of Defense (DoD); U.S. Army Medical Research Acquisition Activity, Chandler Street, Ford Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; UCLA	This investigation was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Ford Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds). The authors have no other financial conflicts of interest to disclose. UCLA would like to acknowledge the Tisch BrainSPORT program which provided funds to purchase the HIT System for their team. The study team would also like to acknowledge the HIT System operators that participated in this study: Julia Ford (UNC), Gus Hendricks (UCLA), Quinn Lukens (UW), Brett Griesemer (VT), Alex Black (VT), Lewis Young (VT), Dom Calhoun (USAFA), and Sean Roach (USMA). Results of this study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. The conclusions herein are those of the authors. They do not represent official policy of the Department of the Air Force, Department of the Army, or the Department of Defense. CARE Consortium Investigators are listed alphabetically by institution: April Marie (Reed) Hoy, MS, ATC (Azusa Pacific University); Joseph B. Hazzard Jr., EdD, ATC (Bloomsburg University); Louise A. Kelly, PhD (California Lutheran University); Justus D. Ortega, PhD (Humboldt State University); Nicholas Port, PhD (Indiana University); Margot Putukian MD (Princeton University); T. Dianne Langford, PhD, and Ryan Tierney, PhD, ATC (Temple University); Christopher C. Giza, MD and Joshua T. Goldman, MD, MBA (University of California, Los Angeles); Holly J. Benjamin MD (University of Chicago); Thomas Buckley, EdD, ATC, and Thomas W. Kaminski, PhD, ATC (University of Delaware); James R. Clugston, MD, MS (University of Florida); Julianne D. Schmidt, PhD, ATC (University of Georgia); Luis A. Feigenbaum, DPT, ATC (University of Miami); James T. Eckner, MD, MS (University of Michigan); Kevin Guskiewicz, PhD, ATC, and Jason P. Mihalik, PhD, CAT(C), ATC (University of North Carolina at Chapel Hill); Jessica Dysart Miles, PhD, ATC (University of North Georgia); Scott Anderson, ATC (University of Oklahoma); Christina L. Master, MD (University of Pennsylvania); Micky Collins, PhD, and Anthony P. Kontos, PhD (University of Pittsburgh Medical Center); Jeffrey J. Bazarian, MD, MPH (University of Rochester); Sara P.O. Chrisman, MD, MPH (University of Washington); Alison Brooks, MD, MPH (University of WisconsinMadison); Jonathan Jackson, MD, and Gerald McGinty, DPT (United States Air Force Academy); Patrick O'Donnell, MHA (United States Coast Guard Academy); Kenneth Cameron, PhD, MPH, ATC; Megan N. Houston, PhD, ATC (United States Military Academy); Adam Susmarski, MD (United States Naval Academy); Stefan Duma, PhD and Steve Rowson, PhD (Virginia Tech); Christopher Todd Bullers, MD, and Christopher M. Miles, MD (Wake Forest University); Brian H. Dykhuizen, MS, ATC (Wilmington College); Laura Lintner DO (Winston-Salem University).	Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Belson K, 2016, NY TIMES; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport Elizabeth M, 2016, Concussion, V1, pCNC19, DOI 10.2217/cnc-2016-0003; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Krill MK, 2017, PHYSICIAN SPORTSMED, V45, P26, DOI 10.1080/00913847.2017.1279520; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; The National Collegiate Athletic Association (NCAA) and I. Manual, 2017, 2017 18 NCAA DIV MAN; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z	38	30	29	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2019	47	10			SI		2073	2085		10.1007/s10439-019-02335-9			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JQ0HT	WOS:000498636800004	31388849	Green Published, hybrid			2022-02-06	
J	Bieniek, KF; Blessing, MM; Heckman, MG; Diehl, NN; Serie, AM; Paolini, MA; Boeve, BF; Savica, R; Reichard, RR; Dickson, DW				Bieniek, Kevin F.; Blessing, Melissa M.; Heckman, Michael G.; Diehl, Nancy N.; Serie, Amanda M.; Paolini, Michael A., II; Boeve, Bradley F.; Savica, Rodolfo; Reichard, R. Ross; Dickson, Dennis W.			Association between contact sports participation and chronic traumatic encephalopathy: a retrospective cohort study	BRAIN PATHOLOGY			English	Article						chronic traumatic encephalopathy; contact sports; football; tau; traumatic brain injuries	MEDICAL-RECORDS-LINKAGE; HIGH-SCHOOL FOOTBALL; DIAGNOSIS; PATHOLOGY; EVENTS; RISK	Chronic traumatic encephalopathy is a debilitating neurodegenerative disorder associated with repetitive traumatic brain injuries often sustained through prior contact sport participation. The frequency of this disorder in a diverse population, including amateur athletes, is unknown. Primary historical obituary and yearbook records were queried for 2566 autopsy cases in the Mayo Clinic Tissue Registry resulting in identification of 300 former athletes and 450 non-athletes. In these cases, neocortical tissue was screened for tau pathology with immunohistochemistry, including pathology consistent with chronic traumatic encephalopathy, blinded to exposure or demographic information. Using research infrastructure of the Rochester Epidemiology Project, a comprehensive and established medical records-linkage system of care providers in southern Minnesota and western Wisconsin, medical diagnostic billing codes pertaining to head trauma, dementia, movement disorders, substance abuse disorders and psychiatric disorders were recorded for cases and controls in a blinded manner. A total of 42 individuals had pathology consistent with, or features of, chronic traumatic encephalopathy. It was more frequent in athletes compared to non-athletes (27 cases versus 15 cases) and was largely observed in men (except for one woman). For contact sports, American football had the highest frequency of chronic traumatic encephalopathy pathology (15% of cases) and an odds ratio of 2.62 (P-value = 0.005). Cases with chronic traumatic encephalopathy pathology had higher frequencies of antemortem clinical features of dementia, psychosis, movement disorders and alcohol abuse compared to cases without chronic traumatic encephalopathy pathology. Understanding the frequency of chronic traumatic encephalopathy pathology in a large autopsy cohort with diverse exposure backgrounds provides a baseline for future prospective studies assessing the epidemiology and public health impact of chronic traumatic encephalopathy and sports-related repetitive head trauma.	[Bieniek, Kevin F.; Serie, Amanda M.; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Bieniek, Kevin F.] UT Hlth San Antonio, Long Sch Med, Dept Pathol & Lab Med, San Antonio, TX 78229 USA; [Blessing, Melissa M.; Paolini, Michael A., II; Reichard, R. Ross] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Heckman, Michael G.; Diehl, Nancy N.] Mayo Clin, Div Biomed Stat & Informat, Jacksonville, FL 32224 USA; [Boeve, Bradley F.; Savica, Rodolfo] Mayo Clin, Dept Neurol, Rochester, MN USA; [Savica, Rodolfo] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA		Bieniek, KF (corresponding author), UT Hlth San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	bieniek@uthscsa.edu	Blessing, Melissa/AAZ-1340-2020	Blessing, Melissa/0000-0002-4014-4426; Bieniek, Kevin/0000-0003-4922-864X	National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01-AG034676]; Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research Program [7AZ08]; Mayo Clinic Younkin Scholars Program on Synaptic Biology and Memory; Mayo Clinic Alzheimer's Disease Research Center Pilot Project Grant; National Institutes on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01-AG062348]	The authors would foremost like to thank the patients and their families for their selfless act of brain donation, without which this study would not be possible. The authors would like to thank Drs. Walter Rocca and Caterina Giannini for study access to the Rochester Epidemiology Project database and the Mayo Clinic Tissue Registry archives. This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health (R01-AG034676). The content is solely the responsibility of the authrs and does not necessarily represent the official views of the National Institutes of Health. We are also grateful for the training and data retrieval support of Barb Abbott, Kaitlin Schwartz and Gary Larson as well as histologic support of Linda Rousseau and Ariston Librero. This study was funded through grant support by the Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research Program (#7AZ08; KFB), Mayo Clinic Younkin Scholars Program on Synaptic Biology and Memory (KFB), Mayo Clinic Alzheimer's Disease Research Center Pilot Project Grant (KFB) and the National Institutes on Aging (R01-AG062348; KFB, DWD). All study authors declare no conflicts of interest.	Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Darby A, 2015, J NEUROPATH EXP NEUR, V74, P615; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130507; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; National Collegiate Athletic Association, 2018, NCAA SPORTS SPONS PA; National Council of Youth Sports, 2008, NCYS REP TRENDS PART; National Federation of State High School Associations, 2018, 2017 2018 HIGH SCH A; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; St Sauver JL, 2012, INT J EPIDEMIOL, V41, P1614, DOI 10.1093/ije/dys195; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Walt GS, 2018, J NEUROPATH EXP NEUR, V77, P1091, DOI 10.1093/jnen/nly092	33	30	30	6	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JAN	2020	30	1					63	74		10.1111/bpa.12757		JUL 2019	12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	QI0GP	WOS:000474105500001	31199537	Green Published, hybrid			2022-02-06	
J	Sharma, R; Shultz, SR; Robinson, MJ; Belli, A; Hibbs, ML; O'Brien, TJ; Semple, BD				Sharma, Rishabh; Shultz, Sandy R.; Robinson, Marcus J.; Belli, Antonio; Hibbs, Margaret L.; O'Brien, Terence J.; Semple, Bridgette D.			Infections after a traumatic brain injury: The complex interplay between the immune and neurological systems	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Infection; Pneumonia; Brain injury; Neurotrauma; Inflammation; Immune response; Immunosuppression	VENTILATOR-ASSOCIATED PNEUMONIA; CENTRAL-NERVOUS-SYSTEM; CONTROLLED CORTICAL IMPACT; SPINAL-CORD-INJURY; CRITICALLY-ILL PATIENTS; ACUTE ISCHEMIC-STROKE; DOUBLE-STRANDED-RNA; NOSOCOMIAL INFECTIONS; INPATIENT REHABILITATION; HEAD-INJURY	Traumatic brain injury (TBI) is a serious global health issue, being the leading cause of death and disability for individuals under the age of 45, and one of the largest causes of global neurological disability. In addition to the brain injury itself, it is increasingly appreciated that a TBI may also alter the systemic immune response in a way that renders TBI patients more vulnerable to infections in the acute post-injury period. Such infections pose an additional challenge to the patient, increasing rates of mortality and morbidity, and worsening neurological outcomes. Hospitalization, surgical interventions, and a state of immunosuppression induced by injury to the central nervous system (CNS), may all contribute to the high rate of infections seen in the population with TBI. Ongoing research to better understand the immunomodulators that underlie TBI-induced immunosuppression may aid in the development of effective therapeutic strategies to improve the recovery trajectory for patients. This review first describes the clinical scenario, posing the question of whether TBI patients are more susceptible to infections such as pneumonia, and if so, why? We then consider how cross-talk between the injured brain and the systemic immune system occurs, and further, how the additional immune challenge of an acquired infection can contribute to ongoing neuroinflammation and neurodegeneration after a TBI. Experimental models combining TBI with infection are discussed, as well as current treatment options available for this double-barreled insult. The aims of this review are to summarize current understanding of the bidirectional relationship between the CNS and the immune system when faced with a mechanical trauma combined with a concomitant infection, and to highlight key outstanding questions that remain in the field.	[Sharma, Rishabh; Shultz, Sandy R.; O'Brien, Terence J.; Semple, Bridgette D.] Monash Univ, Dept Neurosci, Cent Clin Sch, Alfred Hosp, Melbourne, Vic, Australia; [Shultz, Sandy R.; O'Brien, Terence J.; Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Med Sch, Parkville, Vic, Australia; [Robinson, Marcus J.; Hibbs, Margaret L.] Monash Univ, Dept Pathol & Immunol, Cent Clin Sch, Alfred Hosp, Melbourne, Vic, Australia; [Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Coll Med & Dent Sci, Birmingham, W Midlands, England		Semple, BD (corresponding author), Monash Univ, Dept Neurosci, Alfred Ctr, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia.	Bridgette.Semple@monash.edu	Belli, Antonio/I-3799-2015; O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	Belli, Antonio/0000-0002-3211-9933; Robinson, Marcus/0000-0001-5677-3078; Sharma, Rishabh/0000-0001-6832-9468; O'Brien, Terence/0000-0002-7198-8621	National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia; Monash UniversityMonash University	The authors gratefully acknowledge Fellowship and Project Grant support from the National Health and Medical Research Council of Australia (NHMRC) and Monash University. They also thank Ms. Bethany Semple, RN (Gold Coast University Hospital, Southport, QLD, Australia) for her critical review of the manuscript draft.	Aarabi B, 2000, NEUROSURG FOCUS, V8, P1, DOI DOI 10.3171/F0C.2000.8.1.155; Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ahlers F. S., 2018, EPILEPSIA; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Aly NYA, 2008, MED PRIN PRACT, V17, P373, DOI 10.1159/000141500; Amoo M, 2018, BRIT J NEUROSURG, V32, P585, DOI 10.1080/02688697.2018.1522416; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Andraweera N, 2016, AUST HEALTH REV, V40, P114, DOI 10.1071/AH15062; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Angus DC, 2016, JAMA-J AM MED ASSOC, V315, P1457, DOI 10.1001/jama.2016.2762; [Anonymous], 2018, LANCET, V391, P813, DOI 10.1016/S0140-6736(18)30547-6; Antunes Alessandra Armstrong, 2010, Asian J Neurosurg, V5, P68; Ascroft PB, 1941, BMJ-BRIT MED J, V1941, P739, DOI 10.1136/bmj.1.4193.739; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bang Jin Hyuk, 2015, Korean J Neurotrauma, V11, P81, DOI 10.13004/kjnt.2015.11.2.81; Barald KF, 2018, EXP NEUROL, V301, P92, DOI 10.1016/j.expneurol.2017.10.009; Bassetti M, 2015, INTENS CARE MED, V41, P776, DOI 10.1007/s00134-015-3719-z; Batistaki C, 2008, VASC PHARMACOL, V48, P85, DOI 10.1016/j.vph.2007.12.003; Bhan C, 2016, INFLAMM RES, V65, P853, DOI 10.1007/s00011-016-0970-x; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; Borger P, 1998, AM J RESP CELL MOL, V19, P400, DOI 10.1165/ajrcmb.19.3.2765; BRATHWAITE CEM, 1993, J TRAUMA, V34, P586, DOI 10.1097/00005373-199304000-00017; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cazareth J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-132; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chaudhry R, 2018, J NEUROSURG ANESTH, V30, P251, DOI 10.1097/ANA.0000000000000434; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; CHIU WC, 2014, LIVER TRANSPLANT, V21, P1068, DOI DOI 10.1111/ENE.12317; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Cirulis MM, 2016, PEDIATR CRIT CARE ME, V17, P157, DOI 10.1097/PCC.0000000000000590; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cummings CJ, 1999, J IMMUNOL, V162, P2341; CZLONKOWSKA A, 1979, J NEUROL SCI, V43, P455, DOI 10.1016/0022-510X(79)90024-8; de la Tremblaye PB, 2018, NEUROSCI BIOBEHAV R, V85, P160, DOI 10.1016/j.neubiorev.2017.05.022; DeJong G, 2013, ARCH PHYS MED REHAB, V94, pS87, DOI 10.1016/j.apmr.2012.10.037; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Delaloye J, 2013, CURR VASC PHARMACOL, V11, P123; Delano MJ, 2011, J IMMUNOL, V186, P195, DOI 10.4049/jimmunol.1002104; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Enicker B, 2014, INJURY, V45, P1355, DOI 10.1016/j.injury.2014.04.036; Ernst RK, 2003, J ENDOTOXIN RES, V9, P395, DOI 10.1179/096805103225002764; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Fabregas N, 2002, Minerva Anestesiol, V68, P285; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Giamarellos-Bourboulis EJ, 2012, EXPERT REV ANTI-INFE, V10, P369, DOI [10.1586/ERI.12.2, 10.1586/eri.12.2]; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P794, DOI 10.1001/archsurg.2011.41; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greathouse KM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0469-3; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Hamele M, 2016, J NEUROTRAUM, V33, P832, DOI 10.1089/neu.2015.4004; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Hamza B, 2015, LAB CHIP, V15, P2625, DOI 10.1039/c5lc00245a; Harms H, 2011, CEREBROVASC DIS, V32, P552, DOI 10.1159/000331922; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hauser AR, 2016, CLIN INFECT DIS, V63, P89, DOI 10.1093/cid/ciw200; Hazeldine J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002338; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Hua R, 2012, WORLD J EMERG MED, V3, P294, DOI [10.5847/wjem.j.issn.1920-8642.2012.04.010, 10.5847/wjem.j.1920-8642.2012.04.010]; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Hurley JC, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6010002; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jovanovic B, 2016, MED PRIN PRACT, V25, P435, DOI 10.1159/000447566; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Kanazawa M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102135; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Kenney MJ, 2014, COMPR PHYSIOL, V4, P1177, DOI 10.1002/cphy.c130051; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Khan HA, 2017, ASIAN PAC J TROP BIO, V7, P478, DOI 10.1016/j.apjtb.2017.01.019; Kim ID, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0438-8; Kinoshita D, 2009, PHYSIOL BEHAV, V96, P328, DOI 10.1016/j.physbeh.2008.10.018; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Kopp MA, 2017, NEUROLOGY, V88, P892, DOI [10.1212/WNL.0000000000003652, 10.1212/wnl.0000000000003652]; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kourbeti IS, 2011, BRIT J NEUROSURG, V25, P9, DOI 10.3109/02688697.2010.500411; Kovach MA, 2012, CURR OPIN INFECT DIS, V25, P321, DOI 10.1097/QCO.0b013e3283528c9b; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kuo CF, 2007, ANTIMICROB AGENTS CH, V51, P3122, DOI 10.1128/AAC.01379-06; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lomsadze G. O., 2013, GEORGIAN MED NEWS, V223, P60; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Lu Li-quan, 2003, Chin J Traumatol, V6, P302; Lukewich MK, 2014, SEMIN IMMUNOL, V26, P402, DOI 10.1016/j.smim.2014.01.004; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacFie J, 2004, BRIT MED BULL, V71, P1, DOI 10.1093/bmb/ldh029; Magnotti Louis J, 2004, Surg Infect (Larchmt), V5, P237, DOI 10.1089/sur.2004.5.237; McClellan N, 2015, ANN PHARMACOTHER, V49, P515, DOI 10.1177/1060028015570466; Medzhitov R, 2010, NAT IMMUNOL, V11, P551, DOI 10.1038/ni0710-551; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mohawk KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/258185; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Odgaard L, 2018, J NEUROSCI NURS, V50, P149, DOI 10.1097/JNN.0000000000000365; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Pandya A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28189-0; Paradisi F, 2001, CLIN MICROBIOL INFEC, V7, P34, DOI 10.1046/j.1469-0691.2001.00056.x; Park C, 2006, GLIA, V53, P248, DOI 10.1002/glia.20278; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Platzer C, 2000, J NEUROIMMUNOL, V105, P31, DOI 10.1016/S0165-5728(00)00205-8; Pletzer D, 2017, MBIO, V8, DOI 10.1128/mBio.00140-17; Plurad DS, 2013, J SURG RES, V183, P371, DOI 10.1016/j.jss.2013.01.036; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reddy D, 2015, J TROP PEDIATRICS, V61, P182, DOI 10.1093/tropej/fmv017; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Russo MV, 2018, J IMMUNOL, V200; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Saletti P. G., 2018, NEUROBIOL DIS; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shim R, 2018, BRAIN BEHAV IMMUN, V70, P10, DOI 10.1016/j.bbi.2018.03.019; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shuman EK, 2018, INFECT DIS CLIN N AM, V32, P885, DOI 10.1016/j.idc.2018.07.002; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SMITH CJ, 2004, BMC NEUROL, V4; Smith RS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004120; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stephan F, 2006, ANESTHESIOLOGY, V104, P235, DOI 10.1097/00000542-200602000-00006; Stephan F, 2002, CRIT CARE MED, V30, P315, DOI 10.1097/00003246-200202000-00009; Swearengen JR, 2018, ANIM MODEL EXP MED, V1, P100, DOI 10.1002/ame2.12020; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamayo E, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.09.001; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; Temkin N R, 1995, New Horiz, V3, P518; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Tran J, 2017, J HEAD TRAUMA REHAB, V32, P264, DOI 10.1097/HTR.0000000000000296; Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Ulndreaj A, 2016, EXPERT REV NEUROTHER, V16, P1127, DOI 10.1080/14737175.2016.1207532; Valencic L., 2015, SANAMED, V10, P185, DOI [10.5937/sanamed1503185V, DOI 10.5937/SANAMED1503185V]; Valero J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00083; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Venturi L, 2009, J NEUROTRAUM, V26, P1547, DOI [10.1089/neu.2008.0723, 10.1089/neu.2008-0723]; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Vezzani A, 2016, ACTA NEUROPATHOL, V131, P211, DOI 10.1007/s00401-015-1481-5; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Walsh JT, 2014, J IMMUNOL, V193, P5013, DOI 10.4049/jimmunol.1302401; Walsh S, 2017, NEUROTOXICOLOGY, V61, P64, DOI 10.1016/j.neuro.2016.03.011; Wang CF, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/189785; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woiciechowsky C, 1999, BRAIN RES, V816, P563, DOI 10.1016/S0006-8993(98)01238-4; Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wu Z, 2005, J NEUROIMMUNOL, V167, P90, DOI 10.1016/j.jneuroim.2005.06.025; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu Jing, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P797, DOI 10.11817/j.issn.1672-7347.2015.07.015; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Yang YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169267; Zafar SN, 2011, J NEUROTRAUM, V28, P1307, DOI 10.1089/neu.2010.1724; ZHANG XK, 1993, J LEUKOCYTE BIOL, V54, P444, DOI 10.1002/jlb.54.5.444; Zhao ZL, 2013, CHINESE MED J-PEKING, V126, P3754, DOI 10.3760/cma.j.issn.0366-6999.20130116; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	233	30	31	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JUL	2019	79						63	74		10.1016/j.bbi.2019.04.034			12	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology; Psychiatry	IH2MH	WOS:000474328400015	31029794				2022-02-06	
J	Hernandez, F; Giordano, C; Goubran, M; Parivash, S; Grant, G; Zeineh, M; Camarillo, D				Hernandez, Fidel; Giordano, Chiara; Goubran, Maged; Parivash, Sherveen; Grant, Gerald; Zeineh, Michael; Camarillo, David			Lateral impacts correlate with falx cerebri displacement and corpus callosum trauma in sports-related concussions	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Corpus callosum trauma; Mild traumatic brain injury; Finite element method; Instrumented mouthguard	DIFFUSE AXONAL INJURY; BRAIN-INJURY; HEAD; DEFORMATION; TRENDS; MODEL; ENCEPHALOPATHY; ACCELERATION; KINEMATICS; MOUTHGUARD	Corpus callosum trauma has long been implicated in mild traumatic brain injury (mTBI), yet the mechanism by which forces penetrate this structure is unknown. We investigated the hypothesis that coronal and horizontal rotations produce motion of the falx cerebri that damages the corpus callosum. We analyzed previously published head kinematics of 115 sports impacts (2 diagnosed mTBI) measured with instrumented mouthguards and used finite element (FE) simulations to correlate falx displacement with corpus callosum deformation. Peak coronal accelerations were larger in impacts with mTBI (8592rad/s(2)avg.) than those without (1412rad/s(2)avg.). From FE simulations, coronal acceleration was strongly correlated with deep lateral motion of the falx center (r=0.85), while horizontal acceleration was correlated with deep lateral motion of the falx periphery (r>0.78). Larger lateral displacement at the falx center and periphery was correlated with higher tract-oriented strains in the corpus callosum body (r=0.91) and genu/splenium (r>0.72), respectively. The relationship between the corpus callosum and falx was unique: removing the falx from the FE model halved peak strains in the corpus callosum from 35% to 17%. Consistent with model results, we found indications of corpus callosum trauma in diffusion tensor imaging of the mTBI athletes. For a measured alteration of consciousness, depressed fractional anisotropy and increased mean diffusivity indicated possible damage to the mid-posterior corpus callosum. Our results suggest that the corpus callosum may be sensitive to coronal and horizontal rotations because they drive lateral motion of a relatively stiff membrane, the falx, in the direction of commissural fibers below.	[Hernandez, Fidel; Camarillo, David] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Giordano, Chiara; Camarillo, David] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Goubran, Maged; Parivash, Sherveen; Zeineh, Michael] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Grant, Gerald] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Grant, Gerald] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA		Camarillo, D (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.; Camarillo, D (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	fidelh@alumni.stanford.edu; dcamarillo@stanford.edu		Goubran, Maged/0000-0001-5880-0818	Stanford Child Health Research Institute; Lucile Packard Foundation for Children's Health [38454]; National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [3R21EB01761101S1]; Radiology Society of North America; GE HealthcareGeneral ElectricGE Healthcare	We would like to acknowledge Dr. Svein Kleiven for providing the KTH brain model, which was used in this study to compute brain deformations and strains. We thank the Stanford Department of Athletics (Palo Alto, CA) for enabling this research. This work was supported by the Stanford Child Health Research Institute, Lucile Packard Foundation for Children's Health 38454, the National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) 3R21EB01761101S1, Radiology Society of North America, and GE Healthcare.	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Funk J, 2009, 2009010251 SAE, DOI [10.4271/2009-01-0251, DOI 10.4271/2009-01-0251]; Gazzaniga M, 1988, COGNITIVE NEUROSCIEN; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hernandez F, 2019, J NEUROTRAUM, V36, P1125, DOI 10.1089/neu.2016.4758; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knox T, 2004, P 2004 SAE MOT ENG C; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Maroon Joseph C., 2015, PLOS ONE, V10, P1; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Pendergrass EP, 1935, ANN SURG, V101, P269, DOI 10.1097/00000658-193501000-00027; Prasad P, 2008, STAPP CAR C, V52, P187; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; SCHALTENBRAND G, 1975, BRAIN LANG, V2, P70, DOI 10.1016/S0093-934X(75)80055-1; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2008, STAPP CAR C, V52, P1; UNGERLEIDER LG, 1982, ANAL VISUAL BEHAV; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	65	30	30	1	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2019	18	3					631	649		10.1007/s10237-018-01106-0			19	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	HX4TU	WOS:000467394100007	30859404	hybrid			2022-02-06	
J	Carlozzi, NE; Kallen, MA; Hanks, R; Hahn, EA; Brickell, TA; Lange, RT; French, LM; Kratz, AL; Tulsky, DS; Cella, D; Miner, JA; Ianni, PA; Sander, AM				Carlozzi, Noelle E.; Kallen, Michael A.; Hanks, Robin; Hahn, Elizabeth A.; Brickell, Tracey A.; Lange, Rael T.; French, Louis M.; Kratz, Anna L.; Tulsky, David S.; Cella, David; Miner, Jennifer A.; Ianni, Phillip A.; Sander, Angelle M.			The TBI-CareQOL Measurement System: Development and Preliminary Validation of Health-Related Quality of Life Measures for Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Caregivers; Health care; Military personnel; Quality of life; Rehabilitation; Traumatic brain injuries; Veterans	PORTLAND ADAPTABILITY INVENTORY; ITEM RESPONSE THEORY; HEAD-INJURY; FAMILY; OUTCOMES; INDIVIDUALS; BURDEN; REHABILITATION; PROGRAM; PREVALENCE	Objective: To develop a new measurement system, the Traumatic Brain Injury Caregiver Quality of Life (TBI-CareQOL), that can evaluate both general and caregiving-specific aspects of health-related quality of life (HRQOL) in caregivers of persons with traumatic brain injury (TBI). Design: New item pools were developed and refined using literature reviews, qualitative data from focus groups, and cognitive debriefing with caregivers of civilians and service members/veterans with TBI, as well as expert review, reading level assessment, and translatability review; existing item banks and new item pools were assessed using an online data capture system. Exploratory and confirmatory factor analysis, item response theory, and differential item functioning analyses were utilized to develop new caregiver-specific item banks. Known-groups validity was examined using a series of independent samples t tests comparing caregivers of low-functioning vs high-functioning persons with TBI for each of the new measures, as well as for 10 existing Patient-Reported Outcomes Measurement Information System (PROMIS) measures. Setting: Three TBI Model Systems rehabilitation hospitals, an academic medical center, and a military medical treatment facility. Participants: Caregivers (N=560) of civilians (n=344) or service members/veterans with TBI (n=216). INTERVENTIONS: Not applicable. Main outcome measures: The TBI-CareQOL measurement system (including 5 new measures and 10 existing PROMIS measures). Results: Exploratory and confirmatory factor analysis, item response theory, and differential item functioning analyses supported the development of 5 new item banks for Feelings of Loss-Self, Feelings of Loss-Person with TBI, Caregiver-Specific Anxiety, Feeling Trapped, and Caregiver Strain. In support of validity, individuals who were caring for low-functioning persons with TBI had significantly worse HRQOL than caregivers that were caring for high-functioning persons with TBI for both the new caregiver-specific HRQOL measures, and for the 10 existing PROMIS measures. Conclusions: The TBI-CareQOL includes both validated PROMIS measures and newly developed caregiver-specific measures. Together, these generic and specific measures provide a comprehensive assessment of HRQOL for caregivers of civilians and service members/veterans with TBI. (C) 2018 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Kratz, Anna L.; Miner, Jennifer A.; Ianni, Phillip A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Kallen, Michael A.; Hahn, Elizabeth A.; Cella, David] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Hanks, Robin] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Tulsky, David S.] Univ Delaware, Ctr Assessment Res & Translat, Dept Psychol & Brain Sci, Newark, DE USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	Tulsky, David/0000-0002-4335-4509; french, louis/0000-0002-9451-0604; Hanks, Robin/0000-0002-3432-4789	National Institutes of Health National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR013658]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health National Institute of Nursing Research (grant no. R01 NR013658), the National Center for Advancing Translational Sciences (grant no. UL1TR000433), and the Defense and Veterans Brain Injury Center.	Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Brouwer WBF, 2006, QUAL LIFE RES, V15, P1005, DOI 10.1007/s11136-005-5994-6; Cappelleri JC, 2014, CLIN THER, V36, P648, DOI 10.1016/j.clinthera.2014.04.006; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS110, DOI 10.1016/j.apmr.2018.06.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS43, DOI 10.1016/j.apmr.2018.06.025; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS13, DOI 10.1016/j.apmr.2018.05.033; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS85, DOI 10.1016/j.apmr.2018.05.034; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS31, DOI 10.1016/j.apmr.2018.05.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS22, DOI 10.1016/j.apmr.2018.05.027; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS102, DOI 10.1016/j.apmr.2018.05.020; Carlozzi NE, 2018, J HEAD TRAUMA REHAB, V33, P342, DOI 10.1097/HTR.0000000000000373; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Centers for Disease Control [CDC], 2000, MEAS HLTH DAYS POP A; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; CLAUSER BE, 1994, J EDUC MEAS, V31, P88; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Ferrans CE, 2005, OUTCOMES ASSESSMENT, P14; Fisher RA, 1914, BIOMETRIKA, V10, P507; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Fortune DG, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01368; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.1093/biomet/38.1-2.141; Gorsuch R.L., 1983, FACTOR ANAL; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Grimm L.G., 1995, READING UNDERSTANDIN, P99; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Heaton R. K., 2004, REVISED COMPREHENSIV; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Knight RG, 1997, J CLIN EXP NEUROPSYC, V19, P7, DOI 10.1080/01688639708403832; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Krauss Joachim K, 2015, Handb Clin Neurol, V128, P475, DOI 10.1016/B978-0-444-63521-1.00030-3; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; LAWTON MP, 1991, J GERONTOL, V46, pP181, DOI 10.1093/geronj/46.4.P181; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, MAYO PORTLAND ADAPTA; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McDonald R, 1999, TEST THEORY UNIFIED; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; MetaMetrics, 1995, LEXILE FRAM READ; MONTGOMERY RJV, 1985, FAM RELAT, V34, P19, DOI 10.2307/583753; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Paap MCS, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0500-0; Panting A, 1972, REHABILITATION, V38, P33; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Samejima F., 1969, PSYCHOMETRIC MONOGRA; Samejima F, 1996, HDB MODERN ITEM RESP, P85; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Smith A M, 1998, Rehabil Nurs, V23, P252; Tourangeau R., 1984, COGNITIVE ASPECTS SU, DOI [10.17226/930., DOI 10.17226/930]; Urbina S, 1997, PSYCHOL TESTING; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Ware J.E., 1994, SF 36 PHYS MENTAL SU; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Zaider TI, 2003, PSYCHOL MED, V33, P611, DOI 10.1017/S0033291703007414; Zarit SH., 1985, HIDDEN VICTIMS ALZHE	85	30	30	0	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S1	S12		10.1016/j.apmr.2018.08.175			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900001	30195987	Green Accepted			2022-02-06	
J	Li, D; Huang, S; Zhu, JL; Hu, TP; Han, ZL; Zhang, SS; Zhao, L; Chen, FL; Lei, P				Li, Dai; Huang, Shan; Zhu, Jialin; Hu, Tianpeng; Han, Zhaoli; Zhang, Shishuang; Zhao, Ling; Chen, Fanglian; Lei, Ping			Exosomes from MiR-21-5p-Increased Neurons Play a Role in Neuroprotection by Suppressing Rab11a-Mediated Neuronal Autophagy In Vitro After Traumatic Brain Injury	MEDICAL SCIENCE MONITOR			English	Article						Autophagy; Brain Injuries; Exosomes; MicroRNAs	EXTRACELLULAR VESICLES; INHIBITING AUTOPHAGY; MICRORNA EXPRESSION; SIGNALING PATHWAY; DOWN-REGULATION; BLOOD EXOSOMES; PROTEINS; DISEASE; INFLAMMATION; CONTRIBUTES	Background: Traumatic brain injury (TBI) produces a series of pathological processes. Recent studies have indicated that autophagy pathway is persistently activated after TBI, which may lead to deterioration of nerve injury. Our preliminary work found miR-21-5p was upregulated in both in vivo and in vitro TBI models. MicroRNAs (miRNAs) could be loaded into exosomes to perform cell-to-cell interactions. This research aimed to evaluate the therapeutic effect of neuron-derived exosomes enriched with miR-21-5p on the TBI in vitro and to further explore the possible mechanisms. Material/Methods: Brain extracts harvested from an rTBI mouse model were added to cultured HT-22 neurons to imitate the microenvironment of injured brain on in vitro cultured cells. Ultracentrifugation was performed to isolate exosomes. Transmission electron microscopy and Nano sight technology were used to examine exosomes. An in vitro model of TBI was established to study the effect of exosomal miR-21-5p on nerve injury and on neuronal autophagy regulation. Results: The expression of miR-21-5p was increased in exosomes derived from HT-22 neurons after treatment with rTBI mouse brain extracts. Autophagy was activated in HT-22 neurons after scratch injury. Exosomal miR-21-5p produced a protective effect by suppressing autophagy in a TBI model in vitro. MiR-21-5p could directly target the Rab11a 3'UTR region to reduce its translation and further suppressed Rab11a-mediated neuronal autophagy. Conclusions: The levels of miR-21-5p in neuronal exosomes increased from the acute to the chronic phase of TBI. Neuronal exosomes enriched with miR-21-5p can inhibit the activity of neuronal autophagy by targeting Rab11a, thus attenuating trauma-induced, autophagy-mediated nerve injury in vitro.	[Li, Dai; Huang, Shan; Hu, Tianpeng; Han, Zhaoli; Zhang, Shishuang; Zhao, Ling; Lei, Ping] Tianjin Med Univ Gen Hosp, Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin, Peoples R China; [Li, Dai; Huang, Shan; Hu, Tianpeng; Han, Zhaoli; Zhang, Shishuang; Zhao, Ling; Lei, Ping] Tianjin Med Univ Gen Hosp, Dept Geriatr, Tianjin, Peoples R China; [Zhu, Jialin] Tianjin Med Univ Canc Inst & Hosp, Dept Ultrasound Diag & Treatment, Tianjin, Peoples R China; [Chen, Fanglian] Tianjin Med Univ Gen Hosp, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin Neurol Inst, Tianjin, Peoples R China; [Chen, Fanglian] Minist Educ, Key Lab Post Trauma Neurorepair & Regerat Cent Ne, Tianjin, Peoples R China		Lei, P (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin, Peoples R China.; Lei, P (corresponding author), Tianjin Med Univ Gen Hosp, Dept Geriatr, Tianjin, Peoples R China.	luke88956@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772060, 81471252]; Tianjin Science FoundationNatural Science Foundation of Tianjin [16JCYBJC27200, 16JCQNJC11000, 16JCYBJC26900, 18ZXDBSY00090]; Tianjin Medical University General Hospital Youth Cultivation Foundation [ZYYFY2016001]	This research was supported by grants from the National Natural Science Foundation of China (grant no. 81772060, 81471252), Tianjin Science Foundation (grant no. 16JCYBJC27200, 16JCQNJC11000, 16JCYBJC26900, 18ZXDBSY00090), Tianjin Medical University General Hospital Youth Cultivation Foundation (grant no. ZYYFY2016001)	Au AK, 2017, NEUROCRIT CARE, V26, P348, DOI 10.1007/s12028-016-0351-x; Ban BK, 2013, MOL CELL BIOL, V33, P3907, DOI 10.1128/MCB.00627-13; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Coleman BM, 2015, SEMIN CELL DEV BIOL, V40, P89, DOI 10.1016/j.semcdb.2015.02.007; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gamez-Valero A, 2019, NEUROBIOL AGING, V74, P15, DOI 10.1016/j.neurobiolaging.2018.10.006; Gao GY, 2012, J NEUROTRAUMA; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Gao Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00095; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Ji W, 2018, NEUROCHEM RES, V43, P1863, DOI 10.1007/s11064-018-2602-z; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Jiang M, 2018, CELL PHYSIOL BIOCHEM, V47, P864, DOI [10.1159/000490078and, 10.1159/000490078]; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Klionsky DJ, 2004, NATURE, V431, P31, DOI 10.1038/431031a; Knaevelsrud H, 2013, J CELL BIOL, V202, P331, DOI 10.1083/jcb.201205129; Korkmaz G, 2012, AUTOPHAGY, V8, P165, DOI 10.4161/auto.8.2.18351; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Lamb Christopher A, 2016, Small GTPases, V7, P265; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Levine B, 2008, CELL, V132, P162; Li SP, 2018, EXP THER MED, V16, P2038, DOI 10.3892/etm.2018.6370; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Martinez B, 2017, NEURAL REGEN RES, V12, P1749, DOI 10.4103/1673-5374.219025; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Menghini R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.556; Ngolab J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0445-5; Osier N, 2018, MOL NEUROBIOL, V55, P9280, DOI 10.1007/s12035-018-1054-4; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Puri C, 2018, DEV CELL, V45, P114, DOI 10.1016/j.devcel.2018.03.008; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Rajendran L, 2014, J NEUROSCI, V34, P15482, DOI 10.1523/JNEUROSCI.3258-14.2014; Richards P, 2011, CELL DEATH DIFFER, V18, P191, DOI 10.1038/cdd.2010.127; Rivero-Rios P, 2015, BIOCHEM SOC T, V43, P390, DOI 10.1042/BST20140301; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Seca H, 2013, CURR DRUG TARGETS, V14, P1135, DOI 10.2174/13894501113149990185; Shi M, 2019, PROG NEUROBIOL, V175, P96, DOI 10.1016/j.pneurobio.2019.01.005; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Su CH, 2016, BRAIN RES, V1644, P98, DOI 10.1016/j.brainres.2016.05.011; Sun LQ, 2018, BEHAV BRAIN RES, V340, P126, DOI 10.1016/j.bbr.2016.09.020; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Szatmari Z, 2014, MOL BIOL CELL, V25, P522, DOI 10.1091/mbc.E13-10-0574; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Wang WJ, 2018, BIOMED PHARMACOTHER, V99, P725, DOI 10.1016/j.biopha.2018.01.154; Wu H, 2012, CELL SIGNAL, V24, P2179, DOI 10.1016/j.cellsig.2012.07.001; Xie W, 2018, NEUROCHEM RES, V43, P1641, DOI 10.1007/s11064-018-2580-1; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yao XF, 2018, J MOL NEUROSCI, V65, P43, DOI 10.1007/s12031-018-1067-5; Yuan MC, 2018, CURR PHARM DESIGN, V24, P2855, DOI 10.2174/1381612824666180903113136; Yuyama K, 2015, FEBS LETT, V589, P84, DOI 10.1016/j.febslet.2014.11.027; Zhang HY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00931; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	73	30	34	1	9	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	MAR 12	2019	25						1871	1885		10.12659/MSM.915727			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	HO8JV	WOS:000461197400003	30860987	Green Submitted, Green Published			2022-02-06	
J	Cheng, WH; Martens, KM; Bashir, A; Cheung, H; Stukas, S; Gibbs, E; Namjoshi, DR; Button, EB; Wilkinson, A; Barron, CJ; Cashman, NR; Cripton, PA; Wellington, CL				Cheng, Wai Hang; Martens, Kris M.; Bashir, Asma; Cheung, Honor; Stukas, Sophie; Gibbs, Ebrima; Namjoshi, Dhananjay R.; Button, Emily B.; Wilkinson, Anna; Barron, Carlos J.; Cashman, Neil R.; Cripton, Peter A.; Wellington, Cheryl L.			CHIMERA repetitive mild traumatic brain injury induces chronic behavioural and neuropathological phenotypes in wild-type and APP/PS1 mice	ALZHEIMERS RESEARCH & THERAPY			English	Article						Traumatic brain injury; CHIMERA; Alzheimer disease mice; Post-traumatic stress disorder; Spatial memory Neuroinflammation; A beta metabolism	POSTTRAUMATIC-STRESS-DISORDER; FLUID PERCUSSION INJURY; HEAD IMPACT MODEL; AXONAL PATHOLOGY; FEAR EXTINCTION; COGNITIVE DEFICITS; ALZHEIMERS-DISEASE; CONDITIONED FEAR; TERM SURVIVORS; AMYLOID-BETA	Background: The annual incidence of traumatic brain injury (TBI) in the United States is over 2.5 million, with approximately 3-5 million people living with chronic sequelae. Compared with moderate-severe TBI, the long-term effects of mild TBI (mTBI) are less understood but important to address, particularly for contact sport athletes and military personnel who have high mTBI exposure. The purpose of this study was to determine the behavioural and neuropathological phenotypes induced by the Closed-Head Impact Model of Engineered Rotational Acceleration (CHIMERA) model of mTBI in both wild-type (WT) and APP/PS1 mice up to 8 months post-injury. Methods: Male WT and APP/PS1 littermates were randomized to sham or repetitive mild TBI (rmTBI; 2 x 0.5 J impacts 24 h apart) groups at 5.7 months of age. Animals were assessed up to 8 months post-injury for acute neurological deficits using the loss of righting reflex (LRR) and Neurological Severity Score (NSS) tasks, and chronic behavioural changes using the passive avoidance (PA), Barnes maze (BM), elevated plus maze (EPM) and rotarod (RR) tasks. Neuropathological assessments included white matter damage; grey matter inflammation; and measures of A beta levels, deposition, and aducanumab binding activity. Results: The very mild CHIMERA rmTBI conditions used here produced no significant acute neurological or motor deficits in WT and APP/PS1 mice, but they profoundly inhibited extinction of fear memory specifically in APP/PS1 mice over the 8-month assessment period. Spatial learning and memory were affected by both injury and genotype. Anxiety and risk-taking behaviour were affected by injury but not genotype. CHIMERA rmTBI induced chronic white matter microgliosis, axonal injury and astrogliosis independent of genotype in the optic tract but not the corpus callosum, and it altered microgliosis in APP/PS1 amygdala and hippocampus. Finally, rmTBI did not alter long-term tau, A beta or amyloid levels, but it increased aducanumab binding activity. Conclusions: CHIMERA is a useful model to investigate the chronic consequences of rmTBI, including behavioural abnormalities consistent with features of post-traumatic stress disorder and inflammation of both white and grey matter. The presence of human A beta greatly modified extinction of fear memory after rmTBI.	[Cheng, Wai Hang; Martens, Kris M.; Bashir, Asma; Cheung, Honor; Stukas, Sophie; Namjoshi, Dhananjay R.; Button, Emily B.; Wilkinson, Anna; Barron, Carlos J.; Wellington, Cheryl L.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Pathol & Lab Med, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Gibbs, Ebrima; Cashman, Neil R.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Neurol, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Cripton, Peter A.] Univ British Columbia, Dept Mech Engn, Int Collaborat Repair Discoveries, 6250 Appl Sci Lane, Vancouver, BC V6T 1Z4, Canada		Wellington, CL (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Pathol & Lab Med, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	wcheryl@mail.ubc.ca	Cripton, Peter Alec/AAC-8268-2020	Cripton, Peter Alec/0000-0002-5067-0833; Cheung, Honor/0000-0002-9780-2522; Bashir, Asma/0000-0002-3616-9436; Cheng, Wai Hang/0000-0002-3408-9184	Weston Brain Institute [TRA140070]; Canadian Institutes of Health Research (CIHR) Masters Graduate Scholarship; University of British Columbia 4-year fellowship; CIHR Masters Graduate Scholarship; CIHR Doctoral Graduate Scholarship; Canadian Consortium for Neurodegeneration in Aging	Operating funding for this work was provided by a transformational grant from the Weston Brain Institute (TRA140070 [to CLW]). AB is supported by a Canadian Institutes of Health Research (CIHR) Masters Graduate Scholarship and a University of British Columbia 4-year fellowship. EBB is supported by a CIHR Masters Graduate Scholarship, a CIHR Doctoral Graduate Scholarship and a University of British Columbia 4-year fellowship. NRC and CLW are also supported by the Canadian Consortium for Neurodegeneration in Aging.	Acosta S.A., 2013, PLOS ONE, V8, P1; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Born HA, 2015, NEUROSCIENCE, V286, P251, DOI 10.1016/j.neuroscience.2014.11.051; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2016, BAS INF TRAUM BRAIN; Centers for Disease Control and Prevention, 2014, TBI GET THE FACTS; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Corne R, 2019, PROG NEURO-PSYCHOPH, V88, P276, DOI 10.1016/j.pnpbp.2018.07.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Elliott JE, 2018, J CLIN SLEEP MED, V14, P1177, DOI 10.5664/jcsm.7220; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Felmingham KL, 2018, PSYCHONEUROENDOCRINO, V91, P142, DOI 10.1016/j.psyneuen.2018.03.002; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gacsalyi I, 2017, NEUROPHARMACOLOGY, V125, P30, DOI 10.1016/j.neuropharm.2017.07.005; Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gatson JW, 2016, J NEUROSURG, V124, P1646, DOI 10.3171/2015.6.JNS15639; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Illouz T, 2016, BIOINFORMATICS, V32, P3314, DOI 10.1093/bioinformatics/btw376; Izquierdo I, 2016, PHYSIOL REV, V96, P695, DOI 10.1152/physrev.00018.2015; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jorge RE, 2011, TXB TRAUMATIC BRAIN, P173; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kimura R, 2008, LEARN MEMORY, V15, P837, DOI 10.1101/lm.1049608; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lalonde R, 2012, REV NEUROSCIENCE, V23, P363, DOI 10.1515/revneuro-2012-0041; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Mantua J, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/7940832; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Morse AM, 2018, MED SCI BASEL, V6, pE15; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Osier ND, 2015, BRAIN NEUROTRAUMA MO, P177; Oyelami T, 2016, ACTA NEUROBIOL EXP, V76, P282, DOI 10.21307/ane-2017-027; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robert J, 2016, BBA-MOL BASIS DIS, V1862, P1027, DOI 10.1016/j.bbadis.2015.10.005; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rodriguez RA, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00132; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salinsky M, 2018, EPILEPSIA, V59, P1945, DOI 10.1111/epi.14542; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Shi L, 2018, SLEEP MED REV, V40, P4, DOI 10.1016/j.smrv.2017.06.010; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tierney KJ, 2016, J NEUROSURG, V124, P538, DOI 10.3171/2015.4.JNS142440; Wicking M, 2016, NEUROBIOL LEARN MEM, V136, P116, DOI 10.1016/j.nlm.2016.09.016; Wixted JT, 2007, PSYCHOL SCI, V18, P133, DOI 10.1111/j.1467-9280.2007.01862.x; Wixted JT, 2004, PSYCHOL REV, V111, P864, DOI 10.1037/0033-295x.111.4.864; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Zuj DV, 2016, NEUROSCI BIOBEHAV R, V69, P15, DOI 10.1016/j.neubiorev.2016.07.014	96	30	30	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-9193			ALZHEIMERS RES THER	Alzheimers Res. Ther.	JAN 12	2019	11								6	10.1186/s13195-018-0461-0			21	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI2PR	WOS:000456288100002	30636629	Green Published, gold			2022-02-06	
J	Hale, AT; Stonko, DP; Brown, A; Lim, J; Voce, DJ; Gannon, SR; Le, TM; Shannon, CN				Hale, Andrew T.; Stonko, David P.; Brown, Amber; Lim, Jaims; Voce, David J.; Gannon, Stephen R.; Le, Truc M.; Shannon, Chevis N.			Machine-learning analysis outperforms conventional statistical models and CT classification systems in predicting 6-month outcomes in pediatric patients sustaining traumatic brain injury	NEUROSURGICAL FOCUS			English	Article						neurotrauma; traumatic brain injury; artificial neural network	ARTIFICIAL NEURAL-NETWORKS; INTENSIVE-CARE-UNIT; GLASGOW COMA SCALE; CLINICAL MEDICINE; DECISION-SUPPORT; FULL OUTLINE; UNRESPONSIVENESS; TOMOGRAPHY; DIAGNOSIS; SCORE	OBJECTIVE Modern surgical planning and prognostication requires the most accurate outcomes data to practice evidence-based medicine. For clinicians treating children following traumatic brain injury (TBI) these data are severely lacking. The first aim of this study was to assess published CT classification systems in the authors' pediatric cohort. A pediatric-specific machine-learning algorithm called an artificial neural network (ANN) was then created that robustly outperformed traditional CT classification systems in predicting TBI outcomes in children. METHODS The clinical records of children under the age of 18 who suffered a TBI and underwent head CT within 24 hours after TBI (n = 565) were retrospectively reviewed. RESULTS "Favorable" outcome (alive with Glasgow Outcome Scale [GOS] score >= 4 at 6 months postinjury, n = 533) and "unfavorable" outcome (death at 6 months or GOS score <= 3 at 6 months postinjury, n = 32) were used as the primary outcomes. The area under the receiver operating characteristic (ROC) curve (AUC) was used to delineate the strength of each CT grading system in predicting survival (Helsinki, 0.814; Rotterdam, 0.838; and Marshall, 0.781). The AUC for CT score in predicting GOS score <= 3, a measure of overall functionality, was similarly predictive (Helsinki, 0.717; Rotterdam, 0.748; and Marshall, 0.663). An ANN was then constructed that was able to predict 6-month outcomes with profound accuracy (AUC = 0.9462 +/- 0.0422). CONCLUSIONS This study showed that machine-learning can be leveraged to more accurately predict TBI outcomes in children.	[Hale, Andrew T.; Brown, Amber; Lim, Jaims; Gannon, Stephen R.; Shannon, Chevis N.] Monroe Carell Jr Childrens Hosp Vanderbilt, Surg Outcomes Ctr Kids, Nashville, TN USA; [Le, Truc M.] Monroe Carell Jr Childrens Hosp Vanderbilt, Div Pediat Crit Care Med, Nashville, TN USA; [Hale, Andrew T.] Vanderbilt Univ, Sch Med, Med Scientist Training Program, Nashville, TN 37212 USA; [Stonko, David P.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Voce, David J.; Shannon, Chevis N.] Vanderbilt Univ, Dept Neurosurg, Med Ctr, Nashville, TN USA		Hale, AT (corresponding author), Vanderbilt Childrens Hosp, Nashville, TN 37232 USA.	andrew.hale@vanderbilt.edu		Stonko, David/0000-0002-2804-2857; Hale, Andrew/0000-0003-3182-2966			BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Buscema PM, 2014, SUBST USE MISUSE, V49, P1555, DOI 10.3109/10826084.2014.933009; Cross SS, 2003, LANCET, V362, P1250, DOI 10.1016/S0140-6736(03)14612-0; FORSSTROM JJ, 1995, ANN MED, V27, P509, DOI 10.3109/07853899509002462; Gholipour C, 2015, J CLIN DIAGN RES, V9, pOC19, DOI 10.7860/JCDR/2015/9467.5828; Jamal A, 2017, WORLD J EMERG MED, V8, P55, DOI 10.5847/wjem.j.1920-8642.2017.01.010; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Momenyan S, 2017, NEUROCRIT CARE, V27, P229, DOI 10.1007/s12028-016-0324-0; Penny W, 1996, MED DECIS MAKING, V16, P386, DOI 10.1177/0272989X9601600409; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Walczak S, 2005, IEEE T INF TECHNOL B, V9, P468, DOI 10.1109/TITB.2005.847510; Wise ES, 2017, HEART SURG FORUM, V20, pE7, DOI 10.1532/hsf.1566; Yoldas O, 2012, AM J EMERG MED, V30, P1245, DOI 10.1016/j.ajem.2011.06.019; Zou Jinming, 2008, V458, P15	19	30	30	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2018	45	5							E2	10.3171/2018.8.FOCUS17773			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GY9PY	WOS:000448981700002	30453455	gold			2022-02-06	
J	Sumislawski, JJ; Kornblith, LZ; Conroy, AS; Callcut, RA; Cohen, MJ				Sumislawski, Joshua J.; Kornblith, Lucy Z.; Conroy, Amanda S.; Callcut, Rachael A.; Cohen, Mitchell Jay			Dynamic coagulability after injury: Is delaying venous thromboembolism chemoprophylaxis worth the wait?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	48th Annual Meeting of the Western-Trauma-Association (WTA)	FEB 15-MAR 03, 2018	Whistler, CANADA	Western Trauma Assoc		Trauma-induced coagulopathy; hypercoagulability; venous thromboembolism; chemoprophylaxis; thromboelastometry	MOLECULAR-WEIGHT HEPARIN; TRAUMATIC BRAIN-INJURY; RAPID THROMBELASTOGRAPHY; PULMONARY-EMBOLISM; HYPERCOAGULABILITY; PROPHYLAXIS; COAGULATION; ENOXAPARIN; THROMBOSIS; ADMISSION	BACKGROUND Severely injured patients often progress from early hypocoagulable to normal and eventually hypercoagulable states, developing increased risk for venous thromboembolism (VTE). Prophylactic anticoagulation can decrease this risk, but its initiation is frequently delayed for extended periods due to concerns for bleeding. To facilitate timely introduction of VTE chemoprophylaxis, we characterized the transition from hypo- to hypercoagulability and hypothesized that trauma-induced coagulopathy resolves within 24 hours after injury. METHODS Serial blood samples were collected prospectively from critically injured patients for 120 hours after arrival at an urban Level I trauma center. Extrinsic thromboelastometry maximum clot firmness was used to classify patients as hypocoagulable (HYPO, <49 mm), normocoagulable (NORM, 49-71 mm), or hypercoagulable (HYPER, >71 mm) at each time point. Changes in coagulability over hospital course, VTE occurrence, and timing of prophylaxis initiation were analyzed. RESULTS 898 patients (median Injury Severity Score, 13; mortality, 12%; VTE, 8%) were enrolled. Upon arrival, 3% were HYPO (90% NORM, 7% HYPER), which increased to 9% at 6 hours before down-trending. Ninety-seven percent were NORM by 24 hours, and 53% were HYPER at 120 hours. Median maximum clot firmness began in the NORM range, up-trended gradually, and entered the HYPER range at 120 hours. Patients with traumatic brain injury (TBI) followed a similar course and were not more HYPO at any time point than those without TBI. Failure to initiate prophylaxis by 72 hours was predicted by TBI and associated with VTE development (27% vs 16%, p < 0.05). CONCLUSIONS Regardless of injury pattern, trauma-induced coagulopathy largely resolves within 24 hours, after which hypercoagulability becomes increasingly more prevalent. Deferring initiation of chemoprophylaxis, which is often biased toward patients with intracranial injuries, is associated with VTE development. LEVEL OF EVIDENCE Prognostic study, level III; Therapeutic, level IV.	[Sumislawski, Joshua J.; Cohen, Mitchell Jay] Univ Colorado, Dept Surg, Denver Hlth Med Ctr, Denver, CO 80202 USA; [Kornblith, Lucy Z.; Conroy, Amanda S.; Callcut, Rachael A.] Univ Calif San Francisco, Dept Surg, Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA		Sumislawski, JJ (corresponding author), Denver Hlth Med Ctr, Dept Surg, 777 Bannock St,MC 0206, Denver, CO 80204 USA.	joshua.sumislawski@ucdenver.edu	Callcut, Rachael/ABE-1484-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UM1HL120877, K01ES026834]; United States Department of DefenseUnited States Department of Defense [W911QY-15-C-0044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM130892] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (grants UM1HL120877 to MJC and K01ES026834 to RAC) and the United States Department of Defense (contract W911QY-15-C-0044 to MJC and RAC).	Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Cannon WB, 1914, AM J PHYSIOL, V34, P232, DOI 10.1152/ajplegacy.1914.34.2.232; Chapman BC, 2013, AM J SURG, V206, P917, DOI 10.1016/j.amjsurg.2013.07.024; Christie SA, 2017, J TRAUMA ACUTE CARE, V82, P1055, DOI 10.1097/TA.0000000000001423; Cohen MJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002359; Coleman JJ, 2015, J AM COLL SURGEONS, V220, P731, DOI 10.1016/j.jamcollsurg.2014.12.032; Connelly CR, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.2069; Cothren CC, 2007, WORLD J SURG, V31, P98, DOI 10.1007/s00268-006-0304-1; Cotton BA, 2012, J TRAUMA ACUTE CARE, V72, P1470, DOI 10.1097/TA.0b013e31824d56ad; Frank B, 2017, J TRAUMA ACUTE CARE, V83, P1095, DOI 10.1097/TA.0000000000001655; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Harr JN, 2013, J TRAUMA ACUTE CARE, V74, P756, DOI 10.1097/TA.0b013e3182826d7e; Hincker A, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0549-2; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Kashuk JL, 2009, SURGERY, V146, P764, DOI 10.1016/j.surg.2009.06.054; KASHUK JL, 1982, J TRAUMA, V22, P672, DOI 10.1097/00005373-198208000-00004; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kornblith LZ, 2015, J TRAUMA ACUTE CARE, V78, P30, DOI 10.1097/TA.0000000000000490; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Kwok AM, 2016, AM J SURG, V212, P1231, DOI 10.1016/j.amjsurg.2016.09.026; Lang T, 2005, BLOOD COAGUL FIBRIN, V16, P301, DOI 10.1097/01.mbc.0000169225.31173.19; Liras IN, 2016, J TRAUMA ACUTE CARE, V80, P778, DOI 10.1097/TA.0000000000000985; Louis SG, 2014, JAMA SURG, V149, P365, DOI 10.1001/jamasurg.2013.3963; Louis SG, 2014, J TRAUMA ACUTE CARE, V76, P937, DOI 10.1097/TA.0000000000000165; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Menezes AA, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf5045; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Moore HB, 2017, AM J SURG, V214, P1041, DOI 10.1016/j.amjsurg.2017.08.036; Netto FS, 2012, INJURY, V43, P1502, DOI 10.1016/j.injury.2010.12.028; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Pommerening MJ, 2015, SURGERY, V158, P618, DOI 10.1016/j.surg.2015.06.014; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Robles AJ, 2018, J TRAUMA ACUTE CARE, V85, P148, DOI 10.1097/TA.0000000000001926; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26; Sharpe JP, 2017, J TRAUMA ACUTE CARE, V83, P1108, DOI 10.1097/TA.0000000000001640; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V76, P1270, DOI 10.1097/TA.0000000000000233; Van Haren RM, 2014, J AM COLL SURGEONS, V218, P846, DOI 10.1016/j.jamcollsurg.2013.12.039; Van Haren RM, 2014, J TRAUMA ACUTE CARE, V76, P443, DOI 10.1097/TA.0b013e3182a9d11d; Van PY, 2009, J TRAUMA, V66, P1509, DOI 10.1097/TA.0b013e3181a51e33; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	47	30	30	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2018	85	5					907	914		10.1097/TA.0000000000002048			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GZ0NG	WOS:000449060100012	30124623	Green Accepted			2022-02-06	
J	Shearer, GC; Walker, RE				Shearer, Gregory C.; Walker, Rachel E.			An overview of the biologic effects of omega-6 oxylipins in humans	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article							CYTOCHROME P450-DERIVED EICOSANOIDS; SOLUBLE EPOXIDE HYDROLASE; CORONARY-ARTERY-DISEASE; FATTY LIVER-DISEASE; ARACHIDONIC-ACID; LINOLEIC-ACID; EPOXYEICOSATRIENOIC ACIDS; INDUCED LIPOKINE; LIPID MEDIATORS; METABOLITES	Oxylipins are lipid mediators produced from polyunsaturated fatty acid (PUFA) metabolism, and are thought to be a molecular explanation for the diverse biological effects of PUFAs. Like PUFAs, oxylipins are distinguished by their omega-6 (n6) or omega-3 (n3) chemistry. We review the use of n6 oxylipins as biomarkers of disease and their use in diagnosis and risk assessment. We show cases where oxylipins derived from linoleate (LA) or arachidonate (AA) produced by the activities of lipoxygenase, cyclooxygenase, epoxygenase, omega/omega-1 hydroxylase, and autooxidation are useful as biomarkers or risk markers. HODEs, KODEs, EpOMEs, DiHOMEs, and other metabolites of LA as well as prostanoids, HETEs, KETEs, EpETrEs, and DiHETrEs, and other metabolites of AA were useful for understanding the different signaling environments in conditions from traumatic brain injury, to major coronary events, dyslipidemia, sepsis, and more. We next evaluate interventions that alter the concentrations of n6 oxylipins in plasma. We note the utility and response of each plasma fraction, and the generally increasing utility from the non-esterified, to the esterified, to the lipoprotein fractions. Finally, we review the effects which are specifically related to n6 oxylipins and most likely to be beneficial. Both n6 and n3 oxylipins work together in an exceedingly complex matrix to produce physiological effects. This overview should provide future investigators with important perspectives for the emerging utility of n6 oxylipins as products of n6 PUFAs in human health.	[Shearer, Gregory C.; Walker, Rachel E.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16801 USA		Shearer, GC (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16801 USA.	gcs13@psu.edu		Walker, Rachel/0000-0002-8845-858X	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1 R01 HL130099-01A1]	This publication was made possible in part by grant number 1 R01 HL130099-01A1 from the National Heart, Lung, and Blood Institute.	Akasaka T, 2016, AM J PHYSIOL-HEART C, V311, pH1409, DOI 10.1152/ajpheart.00473.2016; Al-Khudairy L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011094.pub2; Askari AA, 2014, BIOCHEM BIOPH RES CO, V446, P633, DOI 10.1016/j.bbrc.2014.03.020; BAER AN, 1991, BIOCHIM BIOPHYS ACTA, V1085, P45, DOI 10.1016/0005-2760(91)90230-F; Belury MA, 2018, PROSTAG LEUKOTR ESS, V132, P30, DOI 10.1016/j.plefa.2018.03.001; Boston RC, 2008, AM J PHYSIOL-REG I, V295, pR395, DOI 10.1152/ajpregu.90317.2008; Bruegel M, 2012, CRIT CARE MED, V40, P1478, DOI 10.1097/CCM.0b013e3182416f05; Burr GO, 1930, J BIOL CHEM, V86, P0587; Caligiuri SPB, 2017, CAN J PHYSIOL PHARM, V95, P961, DOI 10.1139/cjpp-2016-0615; CAMP RDR, 1985, BRIT J PHARMACOL, V85, P837, DOI 10.1111/j.1476-5381.1985.tb11082.x; Capdevila JH, 2000, J LIPID RES, V41, P163; Caro AA, 2006, FREE RADICAL BIO MED, V40, P364, DOI 10.1016/j.freeradbiomed.2005.10.044; Cui Y, 2017, INT J CANCER, V141, P2423, DOI 10.1002/ijc.31007; Deng BQ, 2017, P NATL ACAD SCI USA, V114, P12608, DOI 10.1073/pnas.1705615114; Dreisbach AW, 2008, HYPERTENSION, V51, P755, DOI 10.1161/HYPERTENSIONAHA.107.100123; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Fowler CJ, 2017, ADV PHARMACOL, V80, P31, DOI 10.1016/bs.apha.2017.03.006; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gouveia-Figueira S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132042; Hamilton JA, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0696-4; Harris WS, 2018, PROSTAG LEUKOTR ESS, V132, P34, DOI 10.1016/j.plefa.2018.03.003; Holt RR, 2015, J NUTR BIOCHEM, V26, P1458, DOI 10.1016/j.jnutbio.2015.07.012; HONN KV, 1992, PROSTAGLANDINS, V44, P413, DOI 10.1016/0090-6980(92)90137-I; Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004; Jamieson KL, 2017, PHARMACOL THERAPEUT, V179, P47, DOI 10.1016/j.pharmthera.2017.05.005; Jerschow E, 2017, J ALLER CL IMM-PRACT, V5, P998, DOI 10.1016/j.jaip.2016.11.021; Jiang HL, 2013, AM J HYPERTENS, V26, P271, DOI 10.1093/ajh/hps011; Kammerer I, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-222; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Lee YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26117; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu JB, 2014, CHEST, V146, P670, DOI 10.1378/chest.13-2568; Lynes MD, 2017, NAT MED, V23, P631, DOI 10.1038/nm.4297; Maciejewska D, 2015, PROSTAG OTH LIPID M, V121, P184, DOI 10.1016/j.prostaglandins.2015.09.003; Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39; Newman JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111471; Nording ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076575; NUGTEREN DH, 1985, BIOCHIM BIOPHYS ACTA, V834, P429, DOI 10.1016/0005-2760(85)90017-7; Oni-Orisan A, 2016, J LIPID RES, V57, P109, DOI 10.1194/jlr.M061697; OZAWA T, 1986, BIOCHEM BIOPH RES CO, V134, P1071, DOI 10.1016/0006-291X(86)90360-8; Pickens CA, 2017, METABOLISM, V70, P177, DOI 10.1016/j.metabol.2017.01.034; Plenty NL, 2018, PROSTAG OTH LIPID M, V136, P15, DOI 10.1016/j.prostaglandins.2018.03.001; Polavarapu S, 2018, ARCH MED SCI, V14, P207, DOI 10.5114/aoms.2018.72244; Ramsden CE, 2016, MOL PAIN, V12, DOI 10.1177/1744806916636386; Ramsden CE, 2012, PROSTAG LEUKOTR ESS, V87, P135, DOI 10.1016/j.plefa.2012.08.004; Reis MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182381; Rodriguez-Blanco G, 2014, PROSTATE, V74, P618, DOI 10.1002/pros.22779; Santos JM, 2017, MED HYPOTHESES, V108, P81, DOI 10.1016/j.mehy.2017.07.033; Schebb NH, 2014, PROSTAG OTH LIPID M, V113, P21, DOI 10.1016/j.prostaglandins.2014.05.002; Schinzari F, 2017, ACTA PHYSIOL, V219, P124, DOI 10.1111/apha.12630; Schmocker C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010180; Schuck RN, 2013, ATHEROSCLEROSIS, V227, P442, DOI 10.1016/j.atherosclerosis.2013.01.034; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; SETTY BNY, 1987, BIOCHEM BIOPH RES CO, V148, P528, DOI 10.1016/0006-291X(87)90908-9; Shearer GC, 2018, PROSTAG LEUKOTR ESS, V128, P1, DOI 10.1016/j.plefa.2017.10.006; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Shearer GC, 2008, PROSTAG LEUKOTR ESS, V79, P215, DOI 10.1016/j.plefa.2008.09.023; Shih PB, 2016, MOL PSYCHIATR, V21, P537, DOI 10.1038/mp.2015.26; Siangjong L, 2013, AM J PHYSIOL-HEART C, V304, pH382, DOI 10.1152/ajpheart.00690.2012; Sorokin A. V., 2018, J INVEST DERMATOL; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Spector AA, 2015, BBA-MOL CELL BIOL L, V1851, P356, DOI 10.1016/j.bbalip.2014.07.020; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stanford KI, 2018, CELL METAB, V27, P1111, DOI 10.1016/j.cmet.2018.03.020; Sun Y, 2016, J LIPID RES, V57, P1300, DOI 10.1194/jlr.P066423; Theken KN, 2012, ATHEROSCLEROSIS, V222, P530, DOI 10.1016/j.atherosclerosis.2012.03.022; Thompson DA, 2007, J BIOSCIENCES, V32, P279, DOI 10.1007/s12038-007-0028-x; Trostchansky A, 2013, ANTIOXID REDOX SIGN, V19, P1257, DOI 10.1089/ars.2012.5023; Virtanen JK, 2018, PROSTAG LEUKOTR ESS, V133, P8, DOI 10.1016/j.plefa.2018.04.002; Wagner K, 2014, PROSTAG OTH LIPID M, V113, P2, DOI 10.1016/j.prostaglandins.2014.09.001; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Wang YG, 2012, PROSTAG LEUKOTR ESS, V86, P79, DOI 10.1016/j.plefa.2011.10.006; Ward NC, 2011, CLIN SCI, V121, P501, DOI 10.1042/CS20110215; Xu XZ, 2016, ADV NUTR, V7, P1122, DOI 10.3945/an.116.012245; Yao X, 2015, PROSTAG OTH LIPID M, V118, P11, DOI 10.1016/j.prostaglandins.2015.03.005; Ye D, 2002, J PHARMACOL EXP THER, V303, P768, DOI 10.1124/jpet.303.2.768; Yi XY, 2016, STROKE, V47, P3045, DOI 10.1161/STROKEAHA.116.015146; Yoshida Y, 2015, J OLEO SCI, V64, P347, DOI 10.5650/jos.ess14281; Yu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142848; Yuan DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096510; Zhang LJ, 2017, PROSTAG LEUKOTR ESS, V120, P25, DOI 10.1016/j.plefa.2017.04.003; Zhang YD, 2001, AM J PHYSIOL-HEART C, V280, pH2430, DOI 10.1152/ajpheart.2001.280.6.H2430; Zhang YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157035; Ziboh VA, 2000, PROSTAG OTH LIPID M, V63, P3, DOI 10.1016/S0090-6980(00)00093-9; Ziboh Vincent A, 2004, Clin Dev Immunol, V11, P13; Zu LY, 2016, THROMB RES, V144, P192, DOI 10.1016/j.thromres.2016.06.031; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160	90	30	30	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	OCT	2018	137						26	38		10.1016/j.plefa.2018.06.005			13	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	GX9BW	WOS:000448094500005	30293594				2022-02-06	
J	Giacci, MK; Bartlett, CA; Smith, NM; Iyer, KS; Toomey, LM; Jiang, HB; Guagliardo, P; Kilburn, MR; Fitzgerald, M				Giacci, Marcus K.; Bartlett, Carole A.; Smith, Nicole M.; Iyer, K. Swaminathan; Toomey, Lillian M.; Jiang, Haibo; Guagliardo, Paul; Kilburn, Matt R.; Fitzgerald, Melinda			Oligodendroglia Are Particularly Vulnerable to Oxidative Damage after Neurotrauma In Vivo	JOURNAL OF NEUROSCIENCE			English	Article						myelin regulatory factor gene; NanoSIMS; oligodendrocyte precursor cell; oligodendroglia; oxidative stress; proliferation and differentiation	SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; GENE REGULATORY FACTOR; SECONDARY DEGENERATION; OPTIC-NERVE; PROGENITOR CELLS; ADULT CNS; SELECTIVE VULNERABILITY; MULTIPLE-SCLEROSIS; PRECURSOR CELLS	Loss of function following injury to the CNS is worsened by secondary degeneration of neurons and glia surrounding the injury and is initiated by oxidative damage. However, it is not yet known which cellular populations and structures are most vulnerable to oxidative damage in vivo. Using Nanoscale secondary ion mass spectrometry (NanoSIMS), oxidative damage was semiquantified within cellular subpopulations and structures of optic nerve vulnerable to secondary degeneration, following a partial transection of the optic nerve in adult female PVG rats. Simultaneous assessment of cellular subpopulations and structures revealed oligodendroglia as the most vulnerable to DNA oxidation following injury. 5-Ethynyl-2'-deoxyuridine (EdU) was used to label cells that proliferated in the first 3 d after injury. Injury led to increases in DNA, protein, and lipid damage in oligodendrocyte progenitor cells and mature oligodendrocytes at 3 d, regardless of proliferative state, associated with a decline in the numbers of oligodendrocyte progenitor cells at 7 d. O4(+) preoligodendrocytes also exhibited increased lipid peroxidation. Interestingly, EdU(+) mature oligodendrocytes derived after injury demonstrated increased early susceptibility to DNA damage and lipid peroxidation. However, EdU(+) mature oligodendrocytes with high 8-hydroxyguanosine immunoreactivity were more likely to be caspase(3+). By day 28, newly derived mature oligodendrocytes had significantly reduced myelin regulatory factor gene mRNA, indicating that the myelination potential of these cells may be reduced. The proportion of caspase(3+) oligodendrocytes remained higher in EdU(+) cells. Innovative use of NanoSIMS together with traditional immunohistochemistry and in situ hybridization have enabled the first demonstration of subpopulation specific oligodendroglial vulnerability to oxidative damage, due to secondary degeneration in vivo.	[Giacci, Marcus K.; Bartlett, Carole A.; Smith, Nicole M.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Perth, WA 6009, Australia; [Smith, Nicole M.; Iyer, K. Swaminathan] Univ Western Australia, Sch Mol Sci, Perth, WA 6009, Australia; [Jiang, Haibo; Guagliardo, Paul; Kilburn, Matt R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Bartlett, Carole A.; Toomey, Lillian M.; Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6102, Australia; [Toomey, Lillian M.; Fitzgerald, Melinda] Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, Nedlands, WA 6009, Australia		Fitzgerald, M (corresponding author), Curtin Univ, Sarich Neurosci Res Inst, 8 Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011; Smith, Nicole/L-2502-2013; Jiang, Haibo/E-6623-2015; Kilburn, Matthew/C-4515-2011	Fitzgerald, Melinda/0000-0002-4823-8179; Smith, Nicole/0000-0002-5519-8152; Toomey, Lillian/0000-0001-9435-6128; Jiang, Haibo/0000-0002-2384-4826; Guagliardo, Paul/0000-0003-3488-6754; Giacci, Marcus/0000-0002-8330-678X; Kilburn, Matthew/0000-0002-1858-8485	National Health and Medical Research Council, AustraliaNational Health and Medical Research Council of Australia [APP1061791, APP1082403]; National Health and Medical Research Council Career Development FellowshipNational Health and Medical Research Council of Australia [APP1087114]	This work was supported by the National Health and Medical Research Council, Australia APP1061791 and APP1082403. M.F. was supported by National Health and Medical Research Council Career Development Fellowship APP1087114. We thank the Australian Microscopy & Microanalysis Research Facility, the Science and Industry Endowment Fund, and the State Government of Western Australian for contributing to the Ion Probe Facility at the University of Western Australia.	Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 1998, J NEUROSCI, V18, P6241; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Covacci V, 2001, CHEM RES TOXICOL, V14, P1492, DOI 10.1021/tx010021m; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; French HM, 2009, J NEUROSCI RES, V87, P3076, DOI 10.1002/jnr.22139; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Garbern JY, 2007, CELL MOL LIFE SCI, V64, P50, DOI 10.1007/s00018-006-6182-8; Gautier HOB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9518; Guptarak J, 2014, J NEUROTRAUM, V31, P268, DOI 10.1089/neu.2013.3108; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Havrda MC, 2014, CANCER RES, V74, P1822, DOI 10.1158/0008-5472.CAN-13-1839; HERNDON RM, 1977, SCIENCE, V195, P693, DOI 10.1126/science.190678; Hornig J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003907; Juurlink BHJ, 1998, GLIA, V22, P371, DOI 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lozic I, 2016, BIOMATERIALS, V74, P200, DOI 10.1016/j.biomaterials.2015.10.001; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; LUDWIN SK, 1979, AM J PATHOL, V95, P683; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; MORI S, 1970, J COMP NEUROL, V139, P1, DOI 10.1002/cne.901390102; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nomoto K, 2008, APPL IMMUNOHISTO M M, V16, P71; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Patel MN, 2002, FREE RADICAL RES, V36, P1139, DOI 10.1080/1071576021000016391; Payne SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065710; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Rinholm JE, 2016, GLIA, V64, P810, DOI 10.1002/glia.22965; Roth AD, 2016, ADV EXP MED BIOL, V949, P167, DOI 10.1007/978-3-319-40764-7_8; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Tsai JP, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13268; Volpe JJ, 2011, ANN NEUROL, V70, P525, DOI 10.1002/ana.22533; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Walsh DM, 2016, J THEOR BIOL, V406, P17, DOI 10.1016/j.jtbi.2016.06.028; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Wegner M, 2001, MICROSC RES TECHNIQ, V52, P746, DOI 10.1002/jemt.1059; Xing YL, 2014, J NEUROSCI, V34, P14128, DOI 10.1523/JNEUROSCI.3491-13.2014; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Ye X, 2016, J PATHOL, V239, P139, DOI 10.1002/path.4715; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015; Ziabreva I, 2010, GLIA, V58, P1827, DOI 10.1002/glia.21052	68	30	30	2	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUL 18	2018	38	29					6491	6504		10.1523/JNEUROSCI.1898-17.2018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO1GR	WOS:000439698400007	29915135	Green Published, Bronze			2022-02-06	
J	Zu, ZL				Zu, Zhongliang			Towards the complex dependence of MTRasym on T-1w in amide proton transfer (APT) imaging	NMR IN BIOMEDICINE			English	Article						amide proton transfer (APT); chemical exchange saturation transfer (CEST); MRI; T-1w normalization	EXCHANGE SATURATION-TRANSFER; NUCLEAR OVERHAUSER ENHANCEMENT; PH-WEIGHTED MRI; MAGNETIZATION-TRANSFER; TRANSFER CEST; IN-VIVO; PROTEINS; SENSITIVITY; RELAXATION; PEPTIDES	Amide proton transfer (APT) imaging is a variation of chemical exchange saturation transfer MRI that has shown promise in diagnosing tumors, ischemic stroke, multiple sclerosis, traumatic brain injury, etc. Specific quantification of the APT effect is crucial for the interpretation of APT contrast in pathologies. Conventionally, magnetization transfer ratio with asymmetric analysis (MTRasym) has been used to quantify the APT effect. However, some studies indicate that MTRasym is contaminated by water longitudinal relaxation time (T-1w), and thus it is necessary to normalize T-1w in MTRasym to obtain specific quantification of the APT effect. So far, whether to use MTRasym or the T-1w-normalized MTRasym is still under debate in the field. In this paper, the influence of T-1w on the quantification of APT was evaluated through theoretical analysis, numerical simulations, and phantom studies for different experimental conditions. Results indicate that there are two types of T-1w effect (T-1w recovery and T-1w-related saturation), which have inverse influences on the steady-state MTRasym. In situations with no or weak direct water saturation (DS) effect, there is only the T-1w recovery effect, and MTRasym linearly depends on T-1w. In contrast, in situations with significant DS effects, the dependence of MTRasym on T-1w is complex, and is dictated by the competition of these two T-1w effects. Therefore, by choosing appropriate irradiation powers, MTRasym could be roughly insensitive to T-1w. Moreover, in non-steady-state acquisitions with very short irradiation time, MTRasym is also roughly insensitive to T-1w. Therefore, for steady-state APT imaging at high fields or with very low irradiation powers, where there are no significant DS effects, it is necessary to normalize T-1w to improve the specificity of MTRasym. However, in clinical MRI systems (usually low fields or non-steady-state acquisitions), T-1w normalization may not be necessary when appropriate sequence parameters are chosen.	[Zu, Zhongliang] Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Zu, Zhongliang] Vanderbilt Univ, Dept Radiol & Radiol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA		Zu, ZL (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Med Ctr North, 1161 21st Ave S,AAA-3112, Nashville, TN 37232 USA.	zhongliang.zu@vanderbilt.edu	Olagbaju, Oluwatosin/AAY-3686-2020; Zu, Zhongliang/I-1720-2019	Zu, Zhongliang/0000-0001-7361-7480	National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [EB017873]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB017873] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering, Grant/Award Number: EB017873	Cai KJ, 2017, MOL IMAGING BIOL, V19, P225, DOI 10.1007/s11307-016-0995-0; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Chen LQ, 2014, MAGN RESON MED, V72, P1408, DOI 10.1002/mrm.25053; Dula AN, 2011, MAGN RESON MED, V66, P831, DOI 10.1002/mrm.22862; Goerke S, 2014, NMR BIOMED, V27, P507, DOI 10.1002/nbm.3086; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Heo HY, 2017, MAGN RESON MED, V78, P871, DOI 10.1002/mrm.26799; Heo HY, 2017, MAGN RESON MED, V77, P1853, DOI 10.1002/mrm.26264; Heo HY, 2017, MAGN RESON MED, V77, P779, DOI 10.1002/mrm.26141; Heo HY, 2016, MAGN RESON MED, V75, P1630, DOI 10.1002/mrm.25795; Jia GA, 2011, J MAGN RESON IMAGING, V33, P647, DOI 10.1002/jmri.22480; Jokivarsi KT, 2007, MAGN RESON MED, V57, P647, DOI 10.1002/mrm.21181; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Lee DH, 2017, MAGN RESON MED, V77, P855, DOI 10.1002/mrm.26131; Li H, 2015, NMR BIOMED, V28, P1655, DOI 10.1002/nbm.3428; Li H, 2015, NMR BIOMED, V28, P200, DOI 10.1002/nbm.3243; Liu GS, 2009, MAGN RESON MED, V61, P399, DOI 10.1002/mrm.21863; Ma XY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45696; McMahon MT, 2006, MAGN RESON MED, V55, P836, DOI 10.1002/mrm.20818; Salhotra A, 2008, NMR BIOMED, V21, P489, DOI 10.1002/nbm.1216; Sun PZ, 2008, MAGN RESON MED, V60, P834, DOI 10.1002/mrm.21714; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Sun PZ, 2012, NEUROIMAGE, V60, P1, DOI 10.1016/j.neuroimage.2011.11.091; Sun PZ, 2011, J CEREBR BLOOD F MET, V31, P1743, DOI 10.1038/jcbfm.2011.23; Sun PZ, 2010, STROKE, V41, pS147, DOI 10.1161/STROKEAHA.110.595777; Sun PZ, 2005, J MAGN RESON, V175, P193, DOI 10.1016/j.jmr.2005.04.005; van Zijl PCM, 2003, MAGNET RESON MED, V49, P440, DOI 10.1002/mrm.10398; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Walker-Samuel S, 2013, NAT MED, V19, P1067, DOI 10.1038/nm.3252; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Ward KM, 2000, MAGN RESON MED, V44, P799, DOI 10.1002/1522-2594(200011)44:5<799::AID-MRM18>3.0.CO;2-S; Wermter FC, 2015, NMR BIOMED, V28, P1507, DOI 10.1002/nbm.3416; Xu JZ, 2014, NMR BIOMED, V27, P253, DOI 10.1002/nbm.3058; Yuan J, 2014, NMR BIOMED, V27, P1239, DOI 10.1002/nbm.3184; Zaiss M, 2018, MAGN RESON MED, V79, P1708, DOI 10.1002/mrm.26813; Zaiss M, 2015, NMR BIOMED, V28, P217, DOI 10.1002/nbm.3237; Zaiss M, 2014, NMR BIOMED, V27, P240, DOI 10.1002/nbm.3054; Zaiss M, 2013, PHYS MED BIOL, V58, pR221, DOI 10.1088/0031-9155/58/22/R221; Zaiss M, 2013, NMR BIOMED, V26, P1815, DOI 10.1002/nbm.3021; Zaiss M, 2013, NMR BIOMED, V26, P507, DOI 10.1002/nbm.2887; Zhang H, 2017, J CEREBR BLOOD F MET, V37, P3422, DOI 10.1177/0271678X17690165; Zhang XY, 2017, MAGN RESON MED, V78, P588, DOI 10.1002/mrm.26396; Zhao XN, 2011, MAGN RESON MED, V66, P1033, DOI 10.1002/mrm.22891; Zhou JY, 2006, PROG NUCL MAG RES SP, V48, P109, DOI 10.1016/j.pnmrs.2006.01.001; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	47	30	31	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	JUL	2018	31	7							e3934	10.1002/nbm.3934			12	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	GK2HK	WOS:000435948300005	29806717	Green Accepted			2022-02-06	
J	Erdodi, LA; Sagar, S; Seke, K; Zuccato, BG; Schwartz, ES; Roth, RM				Erdodi, Laszlo A.; Sagar, Sanya; Seke, Kristian; Zuccato, Brandon G.; Schwartz, Eben S.; Roth, Robert M.			The Stroop Test as a Measure of Performance Validity in Adults Clinically Referred for Neuropsychological Assessment	PSYCHOLOGICAL ASSESSMENT			English	Article						Stroop task; performance validity; embedded validity indicators	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; RECOGNITION MEMORY TEST; COMPLEX FIGURE TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; NEGATIVE RESPONSE BIAS; CARD SORTING TEST; WORD CHOICE TEST; SYMPTOM VALIDITY; TEST-II	This study was designed to develop performance validity indicators embedded within the Delis-Kaplan Executive Function Systems (D-KEFS) version of the Stroop task. Archival data from a mixed clinical sample of 132 patients (50% male; M-Age = 43.4; M-Education = 14.1) clinically referred for neuropsychological assessment were analyzed. Criterion measures included the Warrington Recognition Memory Test-Words and 2 composites based on several independent validity indicators. An age-corrected scaled score <= 6 on any of the 4 trials reliably differentiated psychometrically defined credible and noncredible response sets with high specificity (.87-.94) and variable sensitivity (.34 -.71). An inverted Stroop effect was less sensitive (.14 -.29), but comparably specific (.85-90) to invalid performance. Aggregating the newly developed D-KEFS Stroop validity indicators further improved classification accuracy. Failing the validity cutoffs was unrelated to self-reported depression or anxiety. However, it was associated with elevated somatic symptom report. In addition to processing speed and executive function, the D-KEFS version of the Stroop task can function as a measure of performance validity. A multivariate approach to performance validity assessment is generally superior to univariate models.	[Erdodi, Laszlo A.; Sagar, Sanya; Zuccato, Brandon G.] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Seke, Kristian] Univ Windsor, Brain Cognit Neurosci Program, Windsor, ON, Canada; [Schwartz, Eben S.] Waukesha Mem Hosp, Waukesha, WI USA; [Roth, Robert M.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA		Erdodi, LA (corresponding author), 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Sagar, Sanya/0000-0001-7381-0803			Arentsen TJ, 2013, CLIN NEUROPSYCHOL, V27, P1060, DOI 10.1080/13854046.2013.803603; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; BLONDER LX, 1989, BRAIN COGNITION, V9, P244, DOI 10.1016/0278-2626(89)90034-1; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; Considine CM, 2011, ARCH CLIN NEUROPSYCH, V26, P445, DOI 10.1093/arclin/acr041; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Delis DC., 2001, DELIS KAPLAN EXECUTI; Egeland J, 2007, APPL NEUROPSYCHOL, V14, P113, DOI 10.1080/09084280701319953; Erdodi L. A., 2016, APPL NEUROPSYCHOL, V22, P851; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Erdodi LA, 2014, APPL NEUROPSYCH-ADUL, V21, P43, DOI 10.1080/09084282.2012.724036; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Golden C., 2002, MANUAL ADULT STROOP; Green P., 2013, CLIN PRACTICE FORENS; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, ARCH PHYS MED REHAB, V90, P1117, DOI 10.1016/j.apmr.2009.01.018; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Guise BJ, 2014, J NEUROPSYCHOL, V8, P20, DOI 10.1111/jnp.12002; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lippa SM, 2010, ARCH CLIN NEUROPSYCH, V25, P146, DOI 10.1093/arclin/acq001; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; Pearson, 2009, ADV CLIN SOLUTIONS W; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; SAYKIN AJ, 1995, EPILEPSIA, V36, P1071, DOI 10.1111/j.1528-1157.1995.tb00464.x; Schroeter ML, 2007, NEUROPSYCHOLOGIA, V45, P3149, DOI 10.1016/j.neuropsychologia.2007.07.004; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Vallabhajosula B, 2001, J AM ACAD PSYCHIATRY, V29, P207; Whiteside D, 2010, CLIN NEUROPSYCHOL, V24, P315, DOI 10.1080/13854040903482822; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	78	30	31	1	8	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2018	30	6					755	766		10.1037/pas0000525			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GH5YS	WOS:000433515100005	29470092				2022-02-06	
J	Kerr, ZY; Thomas, LC; Simon, JE; McCrea, M; Guskiewicz, KM				Kerr, Zachary Y.; Thomas, Leah C.; Simon, Janet E.; McCrea, Michael; Guskiewicz, Kevin M.			Association Between History of Multiple Concussions and Health Outcomes Among Former College Football Players 15-Year Follow-up From the NCAA Concussion Study (1999-2001)	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						epidemiology; college sports; traumatic brain injury; health-related quality of life	QUALITY-OF-LIFE; STATES HIGH-SCHOOL; RECURRENT CONCUSSION; COGNITIVE IMPAIRMENT; DEPRESSION; PATIENT; SPORTS; RISK; COMORBIDITIES; QUESTIONNAIRE	Background: Previous research has examined associations between concussion history and adverse health outcomes among former professional football players. Less is known about the potential effects of concussion among former college football players without additional exposure at the professional level. Purpose: To examine the association between concussion and adverse health outcomes in a cohort of former college football players without exposure to professional football, 15 years after their playing careers ended. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A sample of 204 former collegiate football players (23.4% of eligible athletes with available contact information)all of whom played at least 1 season of football from 1999 to 2001 in the National Collegiate Athletic Association (NCAA) and had no professional football exposurecompleted a general health survey that assessed lifetime concussion history and included the following: the Veterans RAND 36 Item Health Survey, containing a physical composite score (PCS) and mental composite score (MCS); the depression module of the Patient Health Questionnaire; and the 4-item CAGE alcohol dependence questionnaire (for cutting down, annoyance by criticism, guilty feeling, and eye-openers). Multivariable binomial regression models estimated adjusted prevalence ratios (PRs) with 95% CIs while controlling for demographics and playing history covariates through forward selection model building. Results: Most participants reported a concussion history (84.3%). Overall, 22.1% and 39.2% of participants reported a PCS and an MCS <50, respectively (indicating worse health than the US national average); 19.1% reported Patient Health Questionnaire scores >= 10 (indicating moderate/severe depression); and 24.8% reported CAGE scores >= 2 (indicating alcohol dependence). The prevalence of having an MCS <50 was higher among those reporting >= 3 versus 0 concussions (PR, 2.5; 95% CI, 1.3-4.9). Controlling for body mass index (BMI), the prevalence of moderate/severe depression was higher among those reporting >= 3 versus 0 concussions (PR, 4.2; 95% CI, 1.0-16.3). Controlling for BMI, the prevalence of having a PCS <50 was higher among those reporting 3 versus 1 or 2 concussions (PR, 2.6; 95% CI, 1.3-5.0) but not 0 concussions (PR, 1.5; 95% CI, 0.6-3.6). No associations were found for alcohol dependence. Conclusion: Associations between a history of multiple concussions and adverse health outcomes were found among former collegiate football players without professional football exposure but were limited to those reporting >= 3 prior concussions. Because only 23.4% of eligible athletes responded to the survey, the possibility of ascertainment bias exists, and our findings should thus be interpreted with some caution. Continued examination within nonprofessional football populations is needed, but findings highlight the need for prevention efforts to reduce concussion incidence.	[Kerr, Zachary Y.; Thomas, Leah C.; Simon, Janet E.; McCrea, Michael; Guskiewicz, Kevin M.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.; Thomas, Leah C.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Campus Box 8700, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Thomas, Leah C.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.; Thomas, Leah C.; Guskiewicz, Kevin M.] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC 27515 USA; [Simon, Janet E.] Ohio Univ, Sch Appl Hlth & Wellness, Div Athlet Training, Athens, OH 45701 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Campus Box 8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu			National Collegiate Athletic Association's Sport Science Institute	This research was funded in part by a grant from the National Collegiate Athletic Association's Sport Science Institute, in which K.M.G. and M.M. served as co-principal investigators.	Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; BERNADT MW, 1982, LANCET, V1, P325; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; ESPN, 2011, IVY LEAG LIM FULL CO; ESPN, 2013, PAC 12 LIM CONT PRAC; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Green L., 2014, LEGAL PERSPECTIVES R; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hair JF, 1995, MULTIVARIATE DATA AN; Harrell FE Jr, 2017, REGRESSION MODELING; Hassan MK, 2003, INT J OBESITY, V27, P1227, DOI 10.1038/sj.ijo.0802396; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jones B., 2015, STATES ADOPT PLANS L; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114544107; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; KITCHENS JM, 1994, JAMA-J AM MED ASSOC, V272, P1782, DOI 10.1001/jama.272.22.1782; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Maddigan SL, 2005, QUAL LIFE RES, V14, P1311, DOI 10.1007/s11136-004-6640-4; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; National Collegiate Athletic Association, 2014, 2014 15 SPORTS MED H; National Collegiate Athletic Association, 2014, FOOTB PRACT GUID; Smith AW, 2008, HEALTH CARE FINANC R, V29, P41; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Strand V, 2004, CLIN EXP RHEUMATOL, V22, pS57; Strand V, 2008, AM J MANAG CARE, V14, P239; Strand Vibeke, 2004, Curr Rheumatol Rep, V6, P20, DOI 10.1007/s11926-004-0080-6; Swallen KC, 2005, PEDIATRICS, V115, P340, DOI 10.1542/peds.2004-0678; Ware J., 2001, SF 36 PHYS MENTAL HL; Yan LJL, 2004, OBES RES, V12, P69, DOI 10.1038/oby.2004.10; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	50	30	30	2	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2018	46	7					1733	1741		10.1177/0363546518765121			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	GH7IJ	WOS:000433616400029	29620911				2022-02-06	
J	Fortenbaugh, FC; Rothlein, D; McGlinchey, R; DeGutis, J; Esterman, M				Fortenbaugh, Francesca C.; Rothlein, David; McGlinchey, Regina; DeGutis, Joseph; Esterman, Michael			Tracking behavioral and neural fluctuations during sustained attention: A robust replication and extension	NEUROIMAGE			English	Article						Continuous performance task; Vigilance; fMRI; Default mode network; Dorsal attention network	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE; WORKING-MEMORY; TOP-DOWN; VIGILANCE; PERFORMANCE; INHIBITION; VARIABILITY; VETERANS; NETWORK	Novel paradigms have allowed for more precise measurements of sustained attention ability and fluctuations in sustained attention over time, as well as the neural basis of fluctuations and lapses in performance. However, in recent years, concerns have arisen over the replicability of neuroimaging studies and psychology more broadly, particularly given the typically small sample sizes. One recently developed paradigm, the gradual-onset continuous performance task (gradCPT) has been validated behaviorally in large samples of participants. Yet neuroimaging studies investigating the neural basis of performance on this task have only been collected in small samples. The present study completed both a robust replication of the original neuroimaging findings and extended previous results from the gradCPT task using a large sample of 140 Veteran participants. Results replicate findings that fluctuations in attentional stability are tracked over time by BOLD activity in task positive (e.g., dorsal and ventral attention networks) and task negative (e.g., default network) regions. Extending prior results, we relate this coupling between attentional stability and on-going brain activity to overall sustained attention ability and demonstrate that this coupling strength, along with across-network coupling, could be used to predict individual differences in performance. Additionally, the results extend previous findings by demonstrating that temporal dynamics across the default and dorsal attention networks are associated with lapse-likelihood on subsequent trials. This study demonstrates the reliability of the gradCPT, and underscores the utility of this paradigm in understanding attentional fluctuations, as well as individual variation and deficits in sustained attention.	[Fortenbaugh, Francesca C.; Rothlein, David; McGlinchey, Regina; DeGutis, Joseph; Esterman, Michael] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, Boston, MA 02130 USA; [Fortenbaugh, Francesca C.; Rothlein, David; DeGutis, Joseph; Esterman, Michael] VA Boston Healthcare Syst, Boston Attent & Learning Lab, Boston, MA 02130 USA; [Fortenbaugh, Francesca C.; Rothlein, David; McGlinchey, Regina; DeGutis, Joseph; Esterman, Michael] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA 02130 USA; [Fortenbaugh, Francesca C.; McGlinchey, Regina] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Rothlein, David; Esterman, Michael] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [DeGutis, Joseph] Harvard Med Sch, Dept Med, Boston, MA 02115 USA		Fortenbaugh, FC (corresponding author), 150 S Huntington Ave, Boston, MA 02130 USA.	Francesca_Fortenbaugh@hms.harvard.edu			US Department of Veterans Affairs through the Translational Research Center for TBI and Stress DisordersUS Department of Veterans Affairs [B9254-C]; VA Rehabilitation Research AMP; Development Traumatic Brain Injury National Research Center; Department of Veterans Affairs Clinical Sciences Research and Development ServiceUS Department of Veterans Affairs [IK2CX000706-01A2]; National Institutes of Health NCCIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 AT009430-01]; Department of Veterans AffairsUS Department of Veterans Affairs; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AT009430] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001327, IK2CX000706] Funding Source: NIH RePORTER	This research was support by the US Department of Veterans Affairs through the Translational Research Center for TBI and Stress Disorders (B9254-C), a VA Rehabilitation Research & Development Traumatic Brain Injury National Research Center, a Career Development award from the Department of Veterans Affairs Clinical Sciences Research and Development Service (IK2CX000706-01A2) to M.S.E., a National Institutes of Health NCCIH grant (R21 AT009430- 01) to R.M., and an Advanced Geriatric Fellowship from the Department of Veterans Affairs to F.C.F. The contents of this article do not represent the views of the Department of Veterans Affairs or the U.S. government.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Altpeter E, 2000, VISION RES, V40, P1539, DOI 10.1016/S0042-6989(00)00059-6; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Auerbach RP, 2014, PSYCHIAT RES, V220, P579, DOI 10.1016/j.psychres.2014.07.027; Avelar-Periera B., 2017, FRONT AGING NEUROSCI, V9, P1; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Berardi A, 2001, EXP AGING RES, V27, P19, DOI 10.1080/03610730126014; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Boekel W, 2015, CORTEX, V66, P115, DOI 10.1016/j.cortex.2014.11.019; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carriere JSA, 2010, PSYCHOL AGING, V25, P569, DOI 10.1037/a0019363; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Christoff K, 2016, NAT REV NEUROSCI, V17, P718, DOI 10.1038/nrn.2016.113; Clark L, 2002, BRIT J PSYCHIAT, V180, P313, DOI 10.1192/bjp.180.4.313; Clayton MS, 2015, TRENDS COGN SCI, V19, P188, DOI 10.1016/j.tics.2015.02.004; Conners C. K., 1994, CONNERS CONTINUOUS P; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Pasquale F., 2017, NEUROIMAGE, P1; Debettencourt MT, 2015, NAT NEUROSCI, V18, P470, DOI 10.1038/nn.3940; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Esterman M, 2017, CEREB CORTEX, V27, P4022, DOI 10.1093/cercor/bhw214; Esterman M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159741; Esterman M, 2015, NEUROIMAGE, V111, P542, DOI 10.1016/j.neuroimage.2015.01.044; Esterman M, 2014, J EXP PSYCHOL GEN, V143, P2287, DOI 10.1037/xge0000019; Esterman M, 2014, J NEUROSCI, V34, P1724, DOI 10.1523/JNEUROSCI.2658-13.2014; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Forster S, 2015, CEREB CORTEX, V25, P609, DOI 10.1093/cercor/bht248; Fortenbaugh FC, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.684; Fortenbaugh FC, 2017, ANN NY ACAD SCI, V1396, P70, DOI 10.1111/nyas.13318; Fortenbaugh FC, 2017, VISION RES, V131, P26, DOI 10.1016/j.visres.2016.12.002; Fortenbaugh FC, 2015, PSYCHOL SCI, V26, P1497, DOI 10.1177/0956797615594896; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Garrison KA, 2013, NEUROIMAGE, V81, P110, DOI 10.1016/j.neuroimage.2013.05.030; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johnson BP, 2015, NEUROPSYCHOLOGIA, V72, P22, DOI 10.1016/j.neuropsychologia.2015.03.015; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Konishi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132209; Kucyi A, 2017, CEREB CORTEX, V27, P1831, DOI 10.1093/cercor/bhw029; Kucyi A, 2016, P NATL ACAD SCI USA, V113, P13899, DOI 10.1073/pnas.1611743113; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; LEVY F, 1980, J CHILD PSYCHOL PSYC, V21, P77, DOI 10.1111/j.1469-7610.1980.tb00018.x; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Park M, 2012, AGE AGEING, V41, P765, DOI 10.1093/ageing/afs084; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riley E, 2017, CHRONOBIOL INT, V34, P993, DOI 10.1080/07420528.2017.1308951; Riley E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165100; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosenberg M, 2013, ATTEN PERCEPT PSYCHO, V75, P426, DOI 10.3758/s13414-012-0413-x; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Rosenberg MD, 2015, NEUROIMAGE, V114, P249, DOI 10.1016/j.neuroimage.2015.03.032; Rosseel Y., 2012, LAVAAN R PACKAGE STR, V12, DOI [10.1152/jn.01316.2004, DOI 10.1152/JN.01316.2004]; Sadaghiani S, 2015, CEREB CORTEX, V25, P2763, DOI 10.1093/cercor/bhu072; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shalev L, 2011, NEUROPSYCHOLOGIA, V49, P2584, DOI 10.1016/j.neuropsychologia.2011.05.006; Silver H, 2005, J NEUROPSYCH CLIN N, V17, P391, DOI 10.1176/appi.neuropsych.17.3.391; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Staub B, 2014, ACTA PSYCHOL, V146, P51, DOI 10.1016/j.actpsy.2013.12.003; Staub B, 2013, AGEING RES REV, V12, P459, DOI 10.1016/j.arr.2012.12.001; Swick D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00329; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Temple JG, 2000, HUM FACTORS, V42, P183, DOI 10.1518/001872000779656480; Thompson GJ, 2013, HUM BRAIN MAPP, V34, P3280, DOI 10.1002/hbm.22140; Van Vleet TM, 2013, CORTEX, V49, P679, DOI 10.1016/j.cortex.2012.03.020; Vatansever D, 2017, P NATL ACAD SCI USA, V114, P12821, DOI 10.1073/pnas.1710521114; WechslerD, 2001, WECHSLER TEST ADULT; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	89	30	30	0	25	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 1	2018	171						148	164		10.1016/j.neuroimage.2018.01.002			17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FZ5OJ	WOS:000427643700014	29307606	Green Accepted, Bronze			2022-02-06	
J	Liu, B; Gao, JM; Li, F; Gong, QH; Shi, JS				Liu, Bo; Gao, Jian-Mei; Li, Fei; Gong, Qi-Hai; Shi, Jing-Shan			Gastrodin Attenuates Bilateral Common Carotid Artery Occlusion-Induced Cognitive Deficits via Regulating A beta-Related Proteins and Reducing Autophagy and Apoptosis in Rats	FRONTIERS IN PHARMACOLOGY			English	Article						gastrodin; cognitive deficits; hippocampus; A beta-related proteins; autophagy; apoptosis	CHRONIC CEREBRAL HYPOPERFUSION; AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; MEMORY IMPAIRMENT; CELLS; MODEL; MICE; ACTIVATION	Gastrodin (GAS), an active constituent extracted from Gastrodia elata Blume, is used to treat ischemic stroke, epilepsy, dizziness, and dementia for centuries in China. This study examined its effects on vascular dementia (VD) and the underlying molecular mechanisms. VD was established by ligation of bilateral common carotid artery occlusion (BCCAO). A total of 7 days after BCCAO surgery, GAS (15, 30, and 60 mg/kg) was orally administered for 28 consecutive days to evaluate therapeutic effects. Cognitive function was tested by the Morris water maze. The neuronal morphological changes were examined via Hematoxylin-Eosin staining. Flow cytometry was used for evaluating apoptosis in the hippocampi. The target protein expression was examined by Western blot. The results showed that BCCAO induced cognitive impairment, hippocampus CA1 and CA3 pyramidal neuron damage, beta-amyloid (A beta) deposition, excessive autophagy, and apoptosis. GAS treatment significantly improved BCCAO-induced cognitive deficits and hippocampus neuron damage. Molecular analysis revealed that GAS exerted the protective effect via reducing the levels of A beta 140/42, APP, and beta-site APP-cleaving enzyme 1 expression, and increasing Ab-related protein, a disintegrin and metalloprotease 10, and insulin degrading enzyme expression. Meanwhile, GAS inhibited excessive autophagy via decreasing Beclin-1, LC3-II, and p62 levels. Furthermore, GAS inhibited apoptosis through the downregulation of Bax and upregulation of Bcl-2. Moreover, P38 MAPK signaling pathway was involved in the process. Our findings demonstrate that GAS was effective in the treatment of BCCAOinduced VD via targeting A beta-related protein formation and inhibiting autophagy and apoptosis of hippocampus neurons.	[Liu, Bo] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China; [Liu, Bo; Gao, Jian-Mei; Li, Fei; Gong, Qi-Hai; Shi, Jing-Shan] Zunyi Med Univ, Minist Educ, Key Lab Basic Pharmacol, Zunyi, Peoples R China; [Liu, Bo; Gao, Jian-Mei; Li, Fei; Gong, Qi-Hai; Shi, Jing-Shan] Zunyi Med Univ, Minist Educ, Joint Int Res Lab Ethnomed, Zunyi, Peoples R China		Shi, JS (corresponding author), Zunyi Med Univ, Minist Educ, Key Lab Basic Pharmacol, Zunyi, Peoples R China.; Shi, JS (corresponding author), Zunyi Med Univ, Minist Educ, Joint Int Res Lab Ethnomed, Zunyi, Peoples R China.	shijingshan2018@163.com	Qihai, Gong/AAM-9343-2021; shan, Shi Jing/AAX-7736-2020	shan, Shi Jing/0000-0002-2537-1751	Brainstorm Project on Social Development by Department of Science and Technology of Guizhou Province [JZ (2014) 2015]	The present study was supported by the Brainstorm Project on Social Development by Department of Science and Technology of Guizhou Province [Grant No. JZ (2014) 2015].	Cai ZY, 2017, NEUROCHEM RES, V42, P3446, DOI 10.1007/s11064-017-2391-9; Choi BR, 2011, STROKE, V42, P2595, DOI 10.1161/STROKEAHA.111.620179; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Erisgin Z, 2017, BRATISL MED J, V118, P107, DOI 10.4149/BLL_2017_022; Gao CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121338; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Han HH, 2015, NEUROREPORT, V26, P723, DOI 10.1097/WNR.0000000000000424; Han R, 2014, ACTA PHARMACOL SIN, V35, P1323, DOI 10.1038/aps.2014.62; Hu M, 2017, BEHAV BRAIN RES, V325, P79, DOI 10.1016/j.bbr.2016.11.053; Jang JH, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/309261; Jeong S, 2017, MOL CELLS, V40, P613, DOI [10.14348/molcells.2017.0096b, 10.14348/molcells.2017.0096]; Jiang GL, 2014, NEUROCHEM INT, V75, P79, DOI 10.1016/j.neuint.2014.06.003; Jiang Q, 2013, FEBS LETT, V587, P2420, DOI 10.1016/j.febslet.2013.06.011; Jin M, 2018, NEUROCHEM RES, V43, P904, DOI 10.1007/s11064-018-2496-9; Jiwa NS, 2010, J NEUROCHEM, V115, P814, DOI 10.1111/j.1471-4159.2010.06958.x; Kim G, 2018, INT J OBESITY, V42, P542, DOI 10.1038/ijo.2017.222; Kukreja L, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-16; Li M, 2016, J MOL NEUROSCI, V60, P21, DOI 10.1007/s12031-016-0758-z; Li WX, 2015, PHARMACOL BIOCHEM BE, V138, P40, DOI 10.1016/j.pbb.2015.09.001; Liu B, 2016, MOL MED REP, V14, P4144, DOI 10.3892/mmr.2016.5785; Liu Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00024; Maloney B, 2011, GENE, V488, P1, DOI 10.1016/j.gene.2011.06.004; Meineck Myriam, 2016, Medicines (Basel), V3, DOI 10.3390/medicines3040030; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; Nagatani K, 2012, SHOCK, V37, P645, DOI 10.1097/SHK.0b013e31824ed57c; Reijmer YD, 2016, J CEREBR BLOOD F MET, V36, P40, DOI 10.1038/jcbfm.2015.88; Schutte B, 1998, J NEUROSCI METH, V86, P63, DOI 10.1016/S0165-0270(98)00147-2; Shin JY, 2014, AUTOPHAGY, V10, P32, DOI 10.4161/auto.26508; Smith EE, 2017, CLIN SCI, V131, P1059, DOI 10.1042/CS20160607; Song B, 2013, NEURAL REGEN RES, V8, P2449, DOI 10.3969/j.issn.1673-5374.2013.26.006; Stargardt A, 2013, AGING CELL, V12, P499, DOI 10.1111/acel.12074; Wang XS, 2016, PHYTOTHER RES, V30, P386, DOI 10.1002/ptr.5538; Won JS, 2013, J ALZHEIMERS DIS, V34, P621, DOI 10.3233/JAD-121786; Xiong ZL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00238; Xu Y, 2014, MED MICROBIOL IMMUN, V203, P73, DOI 10.1007/s00430-013-0316-z; Xue Q, 2015, PHOTODIAGN PHOTODYN, V12, P84, DOI 10.1016/j.pdpdt.2014.12.001; Yang P, 2013, BIOCHEM PHARMACOL, V85, P1124, DOI 10.1016/j.bcp.2013.01.020; Yuksel M, 2017, BIOCHIMIE, V138, P82, DOI 10.1016/j.biochi.2017.04.012; Zhang DZ, 2017, J ADV TRANSPORT, DOI 10.1155/2017/6350562; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhang J., 2016, MET ENG COM, V3, P1, DOI DOI 10.1016/J.NEUR0SCIENCE.2016.03.024; Zhang RG, 2014, NEUROCHEM RES, V39, P172, DOI 10.1007/s11064-013-1203-0; Zhang Y, 2016, EXP THER MED, V12, P3729, DOI 10.3892/etm.2016.3849; Zhao TF, 2018, IUBMB LIFE, V70, P60, DOI 10.1002/iub.1704; Zhu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42660; Zhu ZY, 2013, J NEUROSCI, V33, P13138, DOI 10.1523/JNEUROSCI.4790-12.2013; Zou WY, 2018, MOL NEUROBIOL, V55, P776, DOI 10.1007/s12035-016-0351-z	49	30	32	3	16	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	APR 26	2018	9								405	10.3389/fphar.2018.00405			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GE1BQ	WOS:000430952200001	29755351	gold, Green Published			2022-02-06	
J	Li, MQ; Xu, T; Zhou, F; Wang, MM; Song, HX; Xiao, X; Lu, BY				Li, Maiquan; Xu, Tao; Zhou, Fei; Wang, Mengmeng; Song, Huaxin; Xiao, Xing; Lu, Baiyi			Neuroprotective Effects of Four Phenylethanoid Glycosides on H2O2-Induced Apoptosis on PC12 Cells via the Nrf2/ARE Pathway	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						Keap1; Nrf2; Neuroprotective; PC12 cells; PhGs	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; MOUSE MODEL; ANTIOXIDANT; PROTECTS; DISEASE; SYSTEM; VITRO	Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor against oxidative stress and neurodegenerative disorders. Phenylethanoid glycosides (PhGs; salidroside, acteoside, isoacteoside, and echinacoside) exhibit antioxidant and neuroprotective bioactivities. This study was performed to investigate the neuroprotective effect and molecular mechanism of PhGs. PhGs pretreatment significantly suppressed H2O2-induced cytotoxicity in PC12 cells by triggering the nuclear translocation of Nrf2 and reversing the downregulated protein expression of heme oxygenase 1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), glutamate cysteine ligase-catalytic subunit (GCLC), and glutamate-cysteine ligase modifier subunit (GCLM). Nrf2 siRNA or HO-1 inhibitor zinc protoporphyrin (ZnPP) reduced the neuroprotective effect. PhGs showed potential interaction with the Nrf2 binding site in Kelch-like ECH-association protein 1 (Keap1). This result may support the hypothesis that PhGs are activators of Nrf2. We demonstrated the potential binding between PhGs and the Keap1-activated Nrf2/ARE pathway, and that PhGs with more glycosides had enhanced effects.	[Li, Maiquan; Xu, Tao; Zhou, Fei; Wang, Mengmeng; Song, Huaxin; Lu, Baiyi] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc,Minist Agr & Rural, Natl Engn Lab Intelligent Food Technol & Equipmen, Key Lab Agroprod Nutr Evaluat,Key Lab Agroprod Po, Hangzhou 310058, Zhejiang, Peoples R China; [Xiao, Xing] Guangzhou Univ Chinese Med, Coll Clin Med 1, Guangzhou 510006, Guangdong, Peoples R China		Lu, BY (corresponding author), Zhejiang Univ, Zhejiang Key Lab Agrofood Proc,Minist Agr & Rural, Natl Engn Lab Intelligent Food Technol & Equipmen, Key Lab Agroprod Nutr Evaluat,Key Lab Agroprod Po, Hangzhou 310058, Zhejiang, Peoples R China.	11413040@zju.edu.cn; txu@zju.edu.cn; feizhou@zju.edu.cn; 11613027@zju.edu.cn; 21713034@zju.edu.cn; fushengmengxx@gmail.com; bylu@zju.edu.cn		Xu, Tao/0000-0002-7683-7785; Wang, Mengmeng/0000-0003-0856-4831	National Major R & D Program of China [2017YFD0400200]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [R15C200002]; Special Project of Agricultural Product Quality Safety Risk Assessment, Ministry of Agriculture and Rural affairs of China [GJFP2018015]	This study was supported by the National Major R & D Program of China (No. 2017YFD0400200), the Zhejiang Provincial Natural Science Foundation of China (No. R15C200002) and the Special Project of Agricultural Product Quality Safety Risk Assessment (No. GJFP2018015), Ministry of Agriculture and Rural affairs of China.	Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Buendia I, 2016, PHARMACOL THERAPEUT, V157, P84, DOI 10.1016/j.pharmthera.2015.11.003; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dong Q, 2007, CARBOHYD RES, V342, P1343, DOI 10.1016/j.carres.2007.03.017; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Fu G, 2008, CURR MED CHEM, V15, P2592, DOI 10.2174/092986708785908996; Georgiev M, 2011, FOOD CHEM, V128, P100, DOI 10.1016/j.foodchem.2011.02.083; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jiang YR, 2016, J AGR FOOD CHEM, V64, P2459, DOI 10.1021/acs.jafc.5b03474; JIMENEZ C, 1994, NAT PROD REP, V11, P591, DOI 10.1039/np9941100591; Kerr F, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006593; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kong ANT, 2001, DRUG METAB REV, V33, P255, DOI 10.1081/DMR-120000652; Koo KA, 2005, PLANTA MED, V71, P778, DOI 10.1055/s-2005-871213; Kuang R, 2009, PLANTA MED, V75, P1499, DOI 10.1055/s-0029-1185806; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Li N, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/103985; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Liang QN, 2011, ARCH TOXICOL, V85, P1267, DOI 10.1007/s00204-011-0664-7; Liu YL, 2013, J ETHNOPHARMACOL, V149, P431, DOI 10.1016/j.jep.2013.06.042; Liu YG, 2015, EUR J MED CHEM, V95, P313, DOI 10.1016/j.ejmech.2015.03.038; Maheshwari A, 2009, FEBS J, V276, P870, DOI 10.1111/j.1742-4658.2008.06831.x; Min D., 2005, CHINESE PHARMACOL B, V505, P11; Muegge I, 1999, J MED CHEM, V42, P2498, DOI 10.1021/jm990073x; Press C., 2005, VIRTUAL SCREENING DR; RICHARDSON JS, 1992, ANN NY ACAD SCI, V648, P326, DOI 10.1111/j.1749-6632.1992.tb24570.x; Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5; Sheng GQ, 2002, EUR J PHARMACOL, V451, P119, DOI 10.1016/S0014-2999(02)02240-9; Skibinski G, 2017, P NATL ACAD SCI USA, V114, P1165, DOI 10.1073/pnas.1522872114; Sun AY, 1998, J BIOMED SCI, V5, P401; Wang HQ, 2009, BRAIN RES, V1283, P139, DOI 10.1016/j.brainres.2009.05.101; Xiong LN, 2016, J MED FOOD, V19, P54, DOI 10.1089/jmf.2015.3462; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang LL, 2012, FOOD CHEM TOXICOL, V50, P2591, DOI 10.1016/j.fct.2012.05.045; Zhao Q, 2010, BRAIN RES, V1346, P224, DOI 10.1016/j.brainres.2010.05.018	39	30	32	6	26	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	APR	2018	19	4							1135	10.3390/ijms19041135			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GJ0XU	WOS:000434978700214	29642608	Green Published, gold, Green Submitted			2022-02-06	
J	Dekmak, A; Mantash, S; Shaito, A; Toutonji, A; Ramadan, N; Ghazale, H; Kassem, N; Darwish, H; Zibara, K				Dekmak, AmiraSan; Mantash, Sarah; Shaito, Abdullah; Toutonji, Amer; Ramadan, Naify; Ghazale, Hussein; Kassem, Nouhad; Darwish, Hala; Zibara, Kazem			Stem cells and combination therapy for the treatment of traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Stem cells; Combination therapy; Traumatic brain injury; Pathophysiology; Treatment; Growth factors; ROCK inhibitors	INDUCED PLURIPOTENT STEM; MARROW STROMAL CELLS; HYPERBARIC-OXYGEN THERAPY; NEUROTROPHIC FACTOR GDNF; NEURAL PROGENITOR CELLS; RHO-KINASE INHIBITOR; GROWTH-FACTOR; LONG-TERM; DECOMPRESSIVE CRANIECTOMY; NEURONAL DIFFERENTIATION	TBI is a nondegenerative, noncongenital insult to the brain from an external mechanical force; for instance a violent blow in a car accident. It is a complex injury with a broad spectrum of symptoms and has become a major cause of death and disability in addition to being a burden on public health and societies worldwide. As such, finding a therapy for TBI has become a major health concern for many countries, which has led to the emergence of many monotherapies that have shown promising effects in animal models of TBI, but have not yet proven any significant efficacy in clinical trials. In this paper, we will review existing and novel TBI treatment options. We will first shed light on the complex pathophysiology and molecular mechanisms of this disorder, understanding of which is a necessity for launching any treatment option. We will then review most of the currently available treatments for TBI including the recent approaches in the field of stem cell therapy as an optimal solution to treat TBI. Therapy using endogenous stem cells will be reviewed, followed by therapies utilizing exogenous stem cells from embryonic, induced pluripotent, mesenchymal, and neural origin. Combination therapy is also discussed as an emergent novel approach to treat TBI. Two approaches are highlighted, an approach concerning growth factors and another using ROCK inhibitors. These approaches are highlighted with regard to their benefits in minimizing the outcomes of TBI. Finally, we focus on the consequent improvements in motor and cognitive functions after stem cell therapy. Overall, this review will cover existing treatment options and recent advancements in TBI therapy, with a focus on the potential application of these strategies as a solution to improve the functional outcomes of TBI. (C) 2017 Elsevier B.V. All rights reserved.	[Dekmak, AmiraSan; Mantash, Sarah; Ramadan, Naify; Kassem, Nouhad; Zibara, Kazem] Lebanese Univ, PRASE, DSST, ER045,Lab Stem Cells,Fac Sci, Beirut, Lebanon; [Mantash, Sarah; Toutonji, Amer; Ramadan, Naify; Ghazale, Hussein] Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon; [Shaito, Abdullah] Lebanese Int Univ, Dept Biol & Chem Sci, Beirut, Lebanon; [Darwish, Hala] Amer Univ Beirut, Hariri Sch Nursing, Fac Med, Beirut, Lebanon; [Zibara, Kazem] Lebanese Univ, Fac Sci 1, Biol Dept, Lab Cardiovasc Dis & Stem Cells, Beirut, Lebanon		Zibara, K (corresponding author), Lebanese Univ, Fac Sci 1, Biol Dept, Lab Stem Cells ER045, Rafic Hariri Campus, Beirut, Lebanon.	kzibara@ul.edu.lb	Shaito, Abdullah/AAJ-4034-2020; mantash, sarah/N-1204-2016	Shaito, Abdullah/0000-0003-3524-7962; mantash, sarah/0000-0002-1599-316X; Zibara, Kazem/0000-0002-9887-072X; Darwish, Hala/0000-0001-5744-6466; Ramadan, Naify/0000-0001-7339-0263			Agostoe DV, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00047; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Aminmansour Bahram, 2014, Adv Biomed Res, V3, P35, DOI 10.4103/2277-9175.125031; An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; Anbari F, 2014, NEURAL REGEN RES, V9, P919, DOI 10.4103/1673-5374.133133; Atri A, 2008, ALZ DIS ASSOC DIS, V22, P209, DOI 10.1097/WAD.0b013e31816653bc; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Barkho BZ, 2011, CURR STEM CELL RES T, V6, P327; Bergstrom T, 2012, UPSALA J MED SCI, V117, P132, DOI 10.3109/03009734.2012.665096; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Busch H. J., 2003, J CEREB BLOOD FLOW M, V23; Cary WA, 2015, WORLD NEUROSURG, V84, P1256, DOI 10.1016/j.wneu.2015.05.076; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chen S, 2015, CELL PHYSIOL BIOCHEM, V36, P531, DOI 10.1159/000430118; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chua JY, 2011, J CEREBR BLOOD F MET, V31, P1263, DOI 10.1038/jcbfm.2010.213; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; Colombel JF, 2010, N ENGL J MED, V362; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Dadwal P, 2015, STEM CELL REP, V5, P166, DOI 10.1016/j.stemcr.2015.06.011; Dardiotis E, 2012, BRAIN INJURY PATHOGE, P23; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; del Zoppo Gregory J., 2009, V25, P34, DOI 10.1159/000209471; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ding J, 2010, MOL CELL NEUROSCI, V43, P201, DOI 10.1016/j.mcn.2009.11.001; Ding J, 2009, BRAIN BEHAV IMMUN, V23, P1083, DOI 10.1016/j.bbi.2009.05.002; Dobrowolski S., 2013, AM J NEUROSCIENCE, V4, P13, DOI DOI 10.3844/AMJNSP.2013.13.24; Donega M, 2014, JOVE-J VIS EXP, DOI 10.3791/51154; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Duan H., 2014, FASEB J S618, V28; Dunkerson J, 2014, RESTOR NEUROL NEUROS, V32, P675, DOI 10.3233/RNN-140408; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Gascon S, 2016, CELL STEM CELL, V18, P396, DOI 10.1016/j.stem.2015.12.003; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hatton J., J NEUROSURG, V105; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hosseini SM, 2015, INT J STEM CELLS, V8, P99, DOI 10.15283/ijsc.2015.8.1.99; Hou Y, 2012, NEUROSCIENCE, V200, P120, DOI 10.1016/j.neuroscience.2011.10.030; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Huat TJ, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-91; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Ichikawa H, 2012, CRYOBIOLOGY, V64, P12, DOI 10.1016/j.cryobiol.2011.11.005; Isaksson J., ACTA NEUROPATHOL, V102; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kouchi Z, 2011, J BIOL CHEM, V286, P8459, DOI 10.1074/jbc.M110.171223; Kubo T., CURR PHARM DES, V13; Lam PK, 2013, J CLIN NEUROSCI, V20, P300, DOI 10.1016/j.jocn.2012.03.028; Lee HS, 2015, J CELL BIOCHEM, V116, P310, DOI 10.1002/jcb.24969; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li Q, 2011, CELL MOL NEUROBIOL, V31, P243, DOI 10.1007/s10571-010-9614-9; Li XS, 1998, MOL BRAIN RES, V57, P92, DOI 10.1016/S0169-328X(98)00075-8; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Lim HS, 2013, BIOMOL THER, V21, P447, DOI 10.4062/biomolther.2013.041; Llorens-Bobadilla E., CELL STEM CELL, V17; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martinez-Monedero R, 2007, HEARING RES, V227, P48, DOI 10.1016/j.heares.2006.12.015; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mert T, 2015, INFLAMMATION, V38, P1302, DOI 10.1007/s10753-014-0101-1; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Motawea HK, 2014, J CYTOL MOL BIOL, V1; Mouhieddine TH, 2014, NEURAL REGEN RES, V9, P901, DOI 10.4103/1673-5374.133129; MUIZELAAR JP, 1995, J NEUROSURG, V83, P942; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; PECHADRE JC, 1991, PRESSE MED, V20, P841; Perez-Pinzon Miguel A, 1996, CNS Drug Rev, V2, P257; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Prakash A, 2012, J PEDIATR NEUROSCI, V7, P4, DOI 10.4103/1817-1745.97610; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; REILLY PL, 1975, LANCET, V2, P375; Reitz M, 2012, STEM CELL TRANSL MED, V1, P866, DOI 10.5966/sctm.2012-0045; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Rizvanov AA, 2011, EXP BIOL MED, V236, P91, DOI 10.1258/ebm.2010.010172; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rolfe A, 2015, BRAIN NEUROTRAUMA MO; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Rostami E, 2016, METHODS MOL BIOL, V1462, P47, DOI 10.1007/978-1-4939-3816-2_4; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salzwedel K, 2007, AIDS REV, V9, P162; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Scalfani MT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.008; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Song J, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.134; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Sun D., 2011, J NEUROTRAUMA, V28; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang H., 2015, BRAIN INJURY, P1; Tieves Kelly S, 2005, WMJ, V104, P22; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Utsunomiya T, 2001, BRIT J PHARMACOL, V134, P1724, DOI 10.1038/sj.bjp.0704410; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Wang Y, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-18; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wennersten A., J NEUROSURG, V100; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Wiesenhofer B, 2000, ACTA NEUROPATHOL, V99, P131, DOI 10.1007/PL00007416; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Wu JH, 2012, CELL MOL NEUROBIOL, V32, P1187, DOI 10.1007/s10571-012-9845-z; Xie ZY, 2016, STEM CELLS, V34, P627, DOI 10.1002/stem.2238; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu X, 2010, BIOTECHNOL PROGR, V26, P781, DOI 10.1002/btpr.358; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Zhang AM, 2012, MOL MED REP, V6, P1315, DOI 10.3892/mmr.2012.1069; Zhang Z, 2006, CELL MOL BIOL LETT, V11, P12, DOI 10.2478/s11658-006-0002-x; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; ZHOU YL, 1995, PHYSIOL BEHAV, V57, P1107, DOI 10.1016/0031-9384(95)00019-F; Zhou Zheng, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P217; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	164	30	31	0	28	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		49	62		10.1016/j.bbr.2016.12.039			14	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400006	28043902				2022-02-06	
J	Cashen, K; Reeder, R; Dalton, HJ; Berg, RA; Shanley, TP; Newth, CJL; Pollack, MM; Wessel, D; Carcillo, J; Harrison, R; Dean, JM; Tamburro, R; Meert, KL				Cashen, Katherine; Reeder, Ron; Dalton, Heidi J.; Berg, Robert A.; Shanley, Thomas P.; Newth, Christopher J. L.; Pollack, Murray M.; Wessel, David; Carcillo, Joseph; Harrison, Rick; Dean, J. Michael; Tamburro, Robert; Meert, Kathleen L.		Eunice Kennedy Shriver Natl Inst	Hyperoxia and Hypocapnia During Pediatric Extracorporeal Membrane Oxygenation: Associations With Complications, Mortality, and Functional Status Among Survivors*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						child; extracorporeal membrane oxygenation; hyperoxia; hypocapnia; neonate	ARTERIAL CARBON-DIOXIDE; TRAUMATIC BRAIN-INJURY; VASOACTIVE-INOTROPIC SCORE; CARDIAC-ARREST; CARDIOPULMONARY BYPASS; HOSPITAL MORTALITY; CLINICAL-OUTCOMES; LIFE-SUPPORT; RESUSCITATION; CHILDREN	Objectives: To determine the frequency of hyperoxia and hypocapnia during pediatric extracorporeal membrane oxygenation and their relationships to complications, mortality, and functional status among survivors. Design: Secondary analysis of data collected prospectively by the Collaborative Pediatric Critical Care Research Network. Setting: Eight Collaborative Pediatric Critical Care Research Network-affiliated hospitals. Patients: Age less than 19 years and treated with extracorporeal membrane oxygenation. Interventions: Hyperoxia was defined as highest Pao(2) greater than 200 Torr (27 kPa) and hypocapnia as lowest Paco(2) less than 30 Torr (3.9 kPa) during the first 48 hours of extracorporeal membrane oxygenation. Functional status at hospital discharge was evaluated among survivors using the Functional Status Scale. Measurements and Main Results: Of 484 patients, 420 (86.7%) had venoarterial extracorporeal membrane oxygenation and 64 (13.2%) venovenous; 69 (14.2%) had extracorporeal membrane oxygenation initiated during cardiopulmonary resuscitation. Hyperoxia occurred in 331 (68.4%) and hypocapnia in 98 (20.2%). Hyperoxic patients had higher mortality than patients without hyperoxia (167 [50.5%] vs 48 [31.4%]; p < 0.001), but no difference in functional status among survivors. Hypocapnic patients were more likely to have a neurologic event (49 [50.0%] vs 143 (37.0%]; p = 0.021) or hepatic dysfunction (49 [50.0%] vs 121 [31.3%]; p < 0.001) than patients without hypocapnia, but no difference in mortality or functional status among survivors. On multivariable analysis, factors independently associated with increased mortality included highest Pao(2) and highest blood lactate concentration in the first 48 hours of extracorporeal membrane oxygenation, congenital diaphragmatic hernia, and being a preterm neonate. Factors independently associated with lower mortality included meconium aspiration syndrome. Conclusions: Hyperoxia is common during pediatric extracorporeal membrane oxygenation and associated with mortality. Hypocapnia appears to occur less often and although associated with complications, an association with mortality was not observed.	[Cashen, Katherine; Meert, Kathleen L.] Wayne State Univ, Dept Pediat, Childrens Hosp Michigan, Div Crit Care, Detroit, MI 48202 USA; [Reeder, Ron; Dean, J. Michael] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Dalton, Heidi J.] Inova Fairfax Hosp, Dept Pediat, Falls Church, VA USA; [Berg, Robert A.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Shanley, Thomas P.] Northwestern Univ, Dept Pediat, Ann & Robert H Lurie Childrens Hosp Chicago, Sch Med, Chicago, IL 60611 USA; [Newth, Christopher J. L.] Childrens Hosp Los Angeles, Dept Anesthesiol & Crit Care Med, Los Angeles, CA 90027 USA; [Pollack, Murray M.; Wessel, David] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA; [Carcillo, Joseph] Childrens Hosp Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Harrison, Rick] Univ Calif Los Angeles, Dept Pediat, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; [Tamburro, Robert] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Trauma & Crit Illness Branch, NIH, Bethesda, MD USA		Meert, KL (corresponding author), Wayne State Univ, Dept Pediat, Childrens Hosp Michigan, Div Crit Care, Detroit, MI 48202 USA.	kmeert@med.wayne.edu		Shanley, Thomas/0000-0001-8936-377X	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human ServicesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U10HD050096, U10HD049981, U10HD049983, U10HD050012, U10HD063108, U10HD063106, U10HD063114, U01HD049934]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Maquet and Innovative extracorporeal membrane oxygenation (ECMO) Concepts; Springer Publishing; International Pediatric Research Foundation; Raynes McCarty Law Firm; Philips Research North America; Covidien; U.S. Food and Drug Administration Office of Orphan Product Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U10HD063106, U10HD049981, U10HD063108, UG1HD063108, UG1HD050096, U01HD049934, UG1HD049981, U10HD063114, U10HD050096, U10HD049983, U10HD050012] Funding Source: NIH RePORTER	Supported, in part, by the following cooperative agreements from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services: U10HD050096, U10HD049981, U10HD049983, U10HD050012, U10HD063108, U10HD063106, U10HD063114, and U01HD049934.; All authors received support for article research from the National Institutes of Health (NIH). Drs. Reeder's, Berg's, Shanley's, Newth's, Pollack's, and Carcillo's institutions received funding from the National Institute of Child Health and Human Development. Drs. Dalton's, Wessel's, Harrison's, Dean's, and Meert's institutions received funding from the NIH. Dr. Dalton received funding from Maquet and Innovative extracorporeal membrane oxygenation (ECMO) Concepts, and she disclosed off-label product use of ECMO. Dr. Shanley received funding from Springer Publishing, International Pediatric Research Foundation (travel support for biannual meeting), and Raynes McCarty Law Firm. Dr. Newth received funding from Philips Research North America and Covidien. Dr. Tamburro received funding from Springer Publishing; he disclosed government work; and he disclosed receiving grant support from the U.S. Food and Drug Administration Office of Orphan Product Development to study the use of exogenous surfactant in acute lung injury among pediatric hematopoietic cell patients; Ony, Inc. provided the medication free of charge for that trial.	Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Bembea Melania M, 2013, J Extra Corpor Technol, V45, P26; Bennett KS, 2013, CRIT CARE MED, V41, P1534, DOI 10.1097/CCM.0b013e318287f54c; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Caputo M, 2009, J THORAC CARDIOV SUR, V138, P206, DOI 10.1016/j.jtcvs.2008.12.028; Dalton HJ, 2017, AM J RESP CRIT CARE, V196, P762, DOI 10.1164/rccm.201609-1945OC; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; del Castillo J, 2012, RESUSCITATION, V83, P1456, DOI 10.1016/j.resuscitation.2012.07.019; Ferguson LP, 2012, CIRCULATION, V126, P335, DOI 10.1161/CIRCULATIONAHA.111.085100; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Gaies MG, 2014, PEDIATR CRIT CARE ME, V15, P529, DOI 10.1097/PCC.0000000000000153; Gaies MG, 2010, PEDIATR CRIT CARE ME, V11, P234, DOI 10.1097/PCC.0b013e3181b806fc; Guerra-Wallace MM, 2013, PEDIATR CRIT CARE ME, V14, pE143, DOI 10.1097/PCC.0b013e3182720440; Hayes RA, 2013, PERFUSION-UK, V28, P184, DOI 10.1177/0267659112473172; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1067-6; Howard TS, 2016, PEDIATR CRIT CARE ME, V17, P1045, DOI 10.1097/PCC.0000000000000943; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Klinger G, 2005, ARCH DIS CHILD-FETAL, V90, pF49, DOI 10.1136/adc.2003.048785; Man AMES, 2015, ANAESTHESIA, V70, P1307, DOI 10.1111/anae.13218; McDonald CI, 2014, EUR J CARDIO-THORAC, V46, P937, DOI 10.1093/ejcts/ezt637; Munshi L, 2017, CRIT CARE MED, V45, P1997, DOI 10.1097/CCM.0000000000002643; O'Brien NF, 2013, PEDIATR CRIT CARE ME, V14, pE126, DOI 10.1097/PCC.0b013e3182712d62; ORTIZ RM, 1987, PEDIATR CLIN N AM, V34, P39; Pappas A, 2011, J PEDIATR-US, V158, P752, DOI 10.1016/j.jpeds.2010.10.019; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Quarti A, 2013, PERFUSION-UK, V28, P152, DOI 10.1177/0267659112464382; Ramaiah VK, 2013, CHILD NERV SYST, V29, P629, DOI 10.1007/s00381-012-1984-5; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Roberts BW, 2013, CIRCULATION, V127, P2107, DOI 10.1161/CIRCULATIONAHA.112.000168; Schneider AG, 2013, RESUSCITATION, V84, P927, DOI 10.1016/j.resuscitation.2013.02.014; SHORT BL, 1993, PEDIATR RES, V33, P289, DOI 10.1203/00006450-199303000-00018; Solaiman O, 2013, J NEUROSURG ANESTH, V25, P254, DOI 10.1097/ANA.0b013e3182806465; Sznycer-Taub NR, 2016, PEDIATR CRIT CARE ME, V17, P350, DOI 10.1097/PCC.0000000000000655; Thiagarajan RR, 2017, ASAIO J, V63, P60, DOI 10.1097/MAT.0000000000000475; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032	37	30	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2018	19	3					245	253		10.1097/PCC.0000000000001439			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	FY1EK	WOS:000426554400014	29319634	Green Accepted			2022-02-06	
J	Foster, L; Peketi, P; Allen, T; Senior, T; Duncan, O; Alderson, A				Foster, Leon; Peketi, Prashanth; Allen, Thomas; Senior, Terry; Duncan, Olly; Alderson, Andrew			Application of Auxetic Foam in Sports Helmets	APPLIED SCIENCES-BASEL			English	Article						auxetic foam; helmet; concussion; sport; protection; impact attenuation	NEGATIVE POISSONS RATIO; DIFFUSE AXONAL INJURY; FINITE-ELEMENT MODEL; SAFETY APPLICATIONS; POLYURETHANE FOAMS; HEAD ACCELERATION; FOOTBALL PLAYERS; BRAIN-INJURY; CONCUSSION; FABRICATION	This investigation explored the viability of using open cell polyurethane auxetic foams to augment the conformable layer in a sports helmet and improve its linear impact acceleration attenuation. Foam types were compared by examining the impact severity on an instrumented anthropomorphic headform within a helmet consisting of three layers: a rigid shell, a stiff closed cell foam, and an open cell foam as a conformable layer. Auxetic and conventional foams were interchanged to act as the helmet's conformable component. Attenuation of linear acceleration was examined by dropping the combined helmet and headform on the front and the side. The helmet with auxetic foam reduced peak linear accelerations (p < 0.05) relative to its conventional counterpart at the highest impact energy in both orientations. Gadd Severity Index reduced by 11% for frontal impacts (38.9 J) and 44% for side impacts (24.3 J). The conformable layer within a helmet can influence the overall impact attenuating properties. The helmet fitted with auxetic foam can attenuate impact severity more than when fitted with conventional foam, and warrants further investigation for its potential to reduce the risk of traumatic brain injuries in sport specific impacts.	[Foster, Leon; Senior, Terry] Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield S1 1WB, S Yorkshire, England; [Peketi, Prashanth] Adidas Futures Team, Portland, OR 97217 USA; [Allen, Thomas] Manchester Metropolitan Univ, Sch Engn, Manchester M1 5GD, Lancs, England; [Duncan, Olly; Alderson, Andrew] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield S1 1WB, S Yorkshire, England		Foster, L (corresponding author), Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield S1 1WB, S Yorkshire, England.	l.i.foster@shu.ac.uk; prashanth.peketi@adidas.com; t.allen@mmu.ac.uk; T.Senior@shu.ac.uk; Oliver.H.Duncan@student.shu.ac.uk; a.alderson@shu.ac.uk	Duncan, Olly/AAL-4259-2020	Duncan, Olly/0000-0001-9503-1464; Allen, Thomas/0000-0003-4910-9149; Foster, Leon/0000-0002-1551-0316			Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Alderson A, 2005, Proceedings of the ASME Aerospace Division, P503; Allen T, 2015, PHYS STATUS SOLIDI B, V252, P1631, DOI 10.1002/pssb.201451715; Allen T., 2017, AUXETIC FOAM SNOW SP, P145; Allen T, 2017, PHYS STATUS SOLIDI B, V254, DOI 10.1002/pssb.201700596; Allen T, 2015, PROCEDIA ENGINEER, V112, P104, DOI 10.1016/j.proeng.2015.07.183; [Anonymous], 2014, 02210M12 NOCSAE DOC; [Anonymous], 2011, 00113M15 NOCSAE DOC; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Critchley R, 2013, PHYS STATUS SOLIDI B, V250, P1963, DOI 10.1002/pssb.201248550; Critchley R, 2013, ADV ENG MATER, V15, P980, DOI 10.1002/adem.201300030; Dickson TJ, 2017, SCAND J MED SCI SPOR, V27, P236, DOI 10.1111/sms.12642; DiMasi F.P., 1995, P 39 STAPP CAR CRASH; Duncan O, 2017, ACTA MATER, V126, P426, DOI 10.1016/j.actamat.2017.01.004; Duncan O., 2018, PROCEEDINGS, V2, P250; Duncan O, 2016, PROCEDIA ENGINEER, V147, P384, DOI 10.1016/j.proeng.2016.06.323; Duncan O, 2016, SMART MATER STRUCT, V25, DOI 10.1088/0964-1726/25/5/054014; Ekeland A., 2017, INJURY TRENDS RECREA, P3; Gadd C, 1966, 660793 SAE; Ge CF, 2013, J CELL PLAST, V49, P521, DOI 10.1177/0021955X13503844; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gibson LJ., 1997, CELLULAR SOLIDS STRU, V2, P175, DOI DOI 10.1017/CBO9781139878326.007; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Honarmandi P., 2012, P ASME 2012 INT MECH, P883; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; King A., 2003, P IRCOBI C LISB PORT; Kis M, 2004, CAN J NEUROL SCI, V31, P499, DOI 10.1017/S031716710000370X; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; Lisiecki J, 2013, PHYS STATUS SOLIDI B, V250, P1988, DOI 10.1002/pssb.201384232; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Martz EO, 1996, CELL POLYM, V15, P229; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P193, DOI 10.1177/1754337111431024; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Sanami M, 2014, PROCEDIA ENGINEER, V72, P453, DOI 10.1016/j.proeng.2014.06.079; Scarpa F, 2005, PHYS STATUS SOLIDI B, V242, P681, DOI 10.1002/pssb.200460386; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; U. S. Department of Transportation, 1999, FED MOT VEH SAF STAN, p208E; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Vanden Bosche K., 2017, P I MECH ENG H, V23, P1; Von Holst H., 1999, Protective Helmet, Patent No. [US6658671B1, 6658671]	50	30	31	6	23	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-3417			APPL SCI-BASEL	Appl. Sci.-Basel	MAR	2018	8	3							354	10.3390/app8030354			12	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	GA5JI	WOS:000428369400037		gold, Green Accepted, Green Submitted			2022-02-06	
J	Lalonde, G; Bernier, A; Beaudoin, C; Gravel, J; Beauchamp, MH				Lalonde, Gabrielle; Bernier, Annie; Beaudoin, Cindy; Gravel, Jocelyn; Beauchamp, Miriam H.			Investigating social functioning after early mild TBI: the quality of parent-child interactions	JOURNAL OF NEUROPSYCHOLOGY			English	Article						paediatric; traumatic brain injury; concussion; parent-child; social interactions; outcome; social skills	TRAUMATIC-BRAIN-INJURY; MUTUALLY RESPONSIVE ORIENTATION; EXECUTIVE FUNCTION OUTCOMES; YOUNG-CHILDREN; FAMILY BURDEN; MOTHER-CHILD; PSYCHOSOCIAL OUTCOMES; PRESCHOOL-CHILDREN; FOLLOW-UP; BEHAVIOR	The young brain is particularly vulnerable to injury due to inherent physiological and developmental factors, and even mild forms of traumatic brain injury (mTBI) can sometimes result in cognitive and behavioural difficulties. Despite the high prevalence of paediatric mTBI, little is known of its impact on children's social functioning. Parent-child relationships represent the centre of young children's social environments and are therefore ideal contexts for studying the potential effects of mTBI on children's social functioning. The aim of this study was to assess the quality of parent-child interactions after mTBI using observational assessment methods and parental report. The sample included 130 children (18-60months at recruitment) divided into three groups: children with uncomplicated mTBI (n=47), children with orthopaedic injury (OI, n=27), and non-injured children (NI, n=56). The quality of parent-child interactions was assessed 6months post-injury using the Mutually Responsive Orientation (MRO) scale, an observational measure which focuses on the dyadic nature of parent-child exchanges, and the Parental Stress Index questionnaire (Parent-Child Dysfunctional Interaction (PCDI) domain). Significant differences with medium effect sizes were found between the mTBI group and the NI group on the MRO, but not between the OI group and the other two groups. PCDI scores did not differ across groups, suggesting that observational measures may be more sensitive to changes in parent-child interactions after TBI. The current findings have implications for children's post-injury social development and highlight the importance of monitoring social outcomes even after minor head injuries.	[Lalonde, Gabrielle; Beaudoin, Cindy; Gravel, Jocelyn; Beauchamp, Miriam H.] Ste Justine Res Ctr, Montreal, PQ, Canada; [Lalonde, Gabrielle; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Gravel, Jocelyn] Ste Justine Hosp, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca					Abidin, 1995, PARENTING STRESS IND; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Aksan N, 2006, DEV PSYCHOL, V42, P833, DOI 10.1037/0012-1649.42.5.833; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Aspland Helen, 2003, Child Adolesc Ment Health, V8, P136, DOI 10.1111/1475-3588.00061; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Bayley N., 2006, BAYLEY SCALES INFANT; Beauchamp M., 2010, PRINCIPLES PRACTICE, P315, DOI 10.1017/CBO9780511674815.024; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Belsky J., 1988, CLIN IMPLICATIONS AT, P45; Bendikas EA, 2011, REHABIL PSYCHOL, V56, P374, DOI 10.1037/a0025634; Bernier A, 2012, DEVELOPMENTAL SCI, V15, P12, DOI 10.1111/j.1467-7687.2011.01093.x; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Biringen Z, 2000, Attach Hum Dev, V2, P188; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Bordeleau S, 2012, J FAM PSYCHOL, V26, P254, DOI 10.1037/a0027366; Boss P, 2014, ENCY QUALITY LIFE WE, P2202; CAMPBELL SB, 1995, DEV PSYCHOL, V31, P349, DOI 10.1037/0012-1649.31.3.349; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cowan P.A., 2003, NORMAL FAMILY PROCES, P424, DOI [10.4324/9780203428436_chapter_16, DOI 10.4324/9780203428436_CHAPTER_16]; Crowe LM, 2013, CHILD NEUROPSYCHOL, V19, P113, DOI 10.1080/09297049.2011.651079; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; DeKeyser R.M., 2000, STUD SECOND LANG ACQ, V22, P499, DOI [10.1017/S0272263100004022, DOI 10.1017/S0272263100004022]; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; Deonandan R., 2000, CHRONIC DIS CANADA, V21, P1; Eddy JM, 1998, J ABNORM CHILD PSYCH, V26, P53, DOI 10.1023/A:1022634807098; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fairbanks JM, 2013, REHABIL PSYCHOL, V58, P223, DOI 10.1037/a0033119; Faul M, 2010, TRAUMATIC BRAIN INJU; FERGUSSON DM, 1993, J ABNORM CHILD PSYCH, V21, P245, DOI 10.1007/BF00917534; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Haskett ME, 2006, J CLIN CHILD ADOLESC, V35, P302, DOI 10.1207/s15374424jccp3502_14; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Huelke DF, 1998, P ANN C ASS, P93; Josie KL, 2008, J HEAD TRAUMA REHAB, V23, P357, DOI 10.1097/01.HTR.0000341431.29133.a8; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kochanska G, 2005, J CHILD PSYCHOL PSYC, V46, P19, DOI 10.1111/j.1469-7610.2004.00348.x; Kochanska G, 2002, CURR DIR PSYCHOL SCI, V11, P191, DOI 10.1111/1467-8721.00198; Kochanska G, 1997, CHILD DEV, V68, P94, DOI 10.2307/1131928; Kochanska G, 2000, CHILD DEV, V71, P417, DOI 10.1111/1467-8624.00154; Kochanska G, 2008, CHILD DEV, V79, P30, DOI 10.1111/j.1467-8624.2007.01109.x; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Locke LM, 2002, CLIN PSYCHOL REV, V22, P895, DOI 10.1016/S0272-7358(02)00133-2; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McKay JM, 1996, CURR PSYCHOL, V15, P223, DOI 10.1007/BF02686879; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MEGA MS, 2001, FRONTAL LOBES NEUROP, P15; Morsbach SK, 2006, CLIN CHILD FAM PSYCH, V9, P1, DOI 10.1007/s10567-006-0001-5; MoutonSimien P, 1997, J ABNORM CHILD PSYCH, V25, P59, DOI 10.1023/A:1025759408417; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Paniak C, 2000, BRAIN INJURY, V14, P219; Poggi G, 2005, BRAIN INJURY, V19, P777, DOI 10.1080/0269905500110132; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; SPARROW SS, 1984, INTERVIEW EDITION EX; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Tarabulsy GM, 2005, DEV PSYCHOL, V41, P212, DOI 10.1037/0012-1649.41.1.212; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Thurber S., 2012, ARCH ASSESSMENT PSYC, V2, P73; Trenchard SO, 2013, BRAIN INJURY, V27, P1217, DOI 10.3109/02699052.2013.812240; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Walz NC, 2009, DEV NEUROPSYCHOL, V34, P507, DOI 10.1080/87565640902964490; Wechsler D., 2002, WECHSLER PRESCHOOL P; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zareie S., 2014, THESIS	94	30	30	3	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2018	12	1					1	22		10.1111/jnp.12104			22	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY2GG	WOS:000426632900001	27012315				2022-02-06	
J	Delco, ML; Bonnevie, ED; Bonassar, LJ; Fortier, LA				Delco, Michelle L.; Bonnevie, Edward D.; Bonassar, Lawrence J.; Fortier, Lisa A.			Mitochondrial dysfunction is an acute response of articular chondrocytes to mechanical injury	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						cartilage; mechanobiology; osteoarthritis; posttraumatic; mitochondria	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC OSTEOARTHRITIS; OXYGEN-TENSION; GLUCOSE-CONCENTRATION; OXIDANT RELEASE; CARTILAGE; DEATH; CULTURE; IMPACT; MECHANOTRANSDUCTION	Mitochondrial (MT) dysfunction is known to occur in chondrocytes isolated from end-stage osteoarthritis (OA) patients, but the role of MT dysfunction in the initiation and early pathogenesis of post-traumatic OA (PTOA) remains unclear. The objective of this study was to investigate chondrocyte MT function immediately following mechanical injury in cartilage, and to determine if the response to injury differed between a weight bearing region (medial femoral condyle; MFC) and a non-weight bearing region (distal patellofemoral groove; PFG) of the same joint. Cartilage was harvested from the MFC and PFG of 10 neonatal bovids, and subjected to injurious compression at varying magnitudes (5-17MPa, 5-34GPa/s) using a rapid single-impact model. Chondrocyte MT respiratory function, MT membrane polarity, chondrocyte viability, and cell membrane damage were assessed in situ. Cartilage impact resulted in MT depolarization and impaired MT respiratory function within 2h of injury. Cartilage from a non-weight bearing region of the joint (PFG) was more sensitive to impact-induced MT dysfunction and chondrocyte death than cartilage from a weight-bearing surface (MFC). Our findings suggest that MT dysfunction is an acute response of chondrocytes to cartilage injury, and that MT may play a key mechanobiological role in the initiation and early pathogenesis of PTOA. Clinical significance: Direct therapeutic targeting of MT function in the early post-injury time frame may provide a strategy to block perpetuation of tissue damage and prevent the development of PTOA. (c) 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:739-750, 2018.	[Delco, Michelle L.; Fortier, Lisa A.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Bonnevie, Edward D.; Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Bonassar, Lawrence J.] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY USA		Fortier, LA (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.	laf4@cornell.edu			Weill Cornell Medical College [5 UL1 TR000457-09]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32OD011000-20]; Harry M. Zweig Memorial Fund for Equine Research; National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [1K08AR068470]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002384, UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [K08AR068470] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32OD011000] Funding Source: NIH RePORTER	Grant sponsor: Weill Cornell Medical College; Grant number: 5 UL1 TR000457-09; Grant sponsor: National Institutes of Health; Grant number: 5T32OD011000-20; Grant sponsor: Harry M. Zweig Memorial Fund for Equine Research; Grant sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases; Grant number: 1K08AR068470.	Alexander PG, 2013, CARTILAGE, V4, P52, DOI 10.1177/1947603512455195; Ali MH, 2004, AM J PHYSIOL-LUNG C, V287, pL486, DOI 10.1152/ajplung.00389.2003; Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; Bonnevie ED, 2016, OSTEOARTHR CARTILAGE, V24, pS46, DOI 10.1016/j.joca.2016.01.107; Bonnevie ED, 2015, CARTILAGE, V6, P226, DOI 10.1177/1947603515595071; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brouillette MJ, 2014, BIOMECH MODEL MECHAN, V13, P565, DOI 10.1007/s10237-013-0518-8; Buckwalter Joseph A, 2012, HSS J, V8, P37, DOI 10.1007/s11420-011-9251-y; CHAMPAGNE AM, 1987, EXP CELL RES, V171, P404, DOI 10.1016/0014-4827(87)90172-8; Cheng DS, 2012, PM&R, V4, pS82, DOI 10.1016/j.pmrj.2012.02.009; Chubinskaya S, 2013, CARTILAGE, V4, p13S, DOI 10.1177/1947603513487457; Cillero-Pastor B, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-235; Cole B. J, 2009, BIOL JOINT RECONSTRU; Coleman MC, 2016, ARTHRITIS RHEUMATOL, V68, P662, DOI 10.1002/art.39460; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Delco ML, 2017, J ORTHOP RES, V35, P440, DOI 10.1002/jor.23462; Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164; Farnsworth NL, 2012, J BIOMECH, V45, P2556, DOI 10.1016/j.jbiomech.2012.07.035; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Garrido CP, 2009, OSTEOARTHR CARTILAGE, V17, P1244, DOI 10.1016/j.joca.2009.03.007; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; Goetz JE, 2017, J ORTHOP RES, V35, P590, DOI 10.1002/jor.23327; Goodwin W, 2010, J ORTHOP RES, V28, P1057, DOI 10.1002/jor.21091; Grimshaw MJ, 2000, OSTEOARTHR CARTILAGE, V8, P386, DOI 10.1053/joca.1999.0314; Heywood HK, 2006, J CELL PHYSIOL, V206, P402, DOI 10.1002/jcp.20491; Huser CAA, 2007, ARTHRITIS RHEUM-US, V56, P2322, DOI 10.1002/art.22717; Huser CAM, 2006, OSTEOARTHR CARTILAGE, V14, P1002, DOI 10.1016/j.joca.2006.03.012; Jadin KD, 2005, J HISTOCHEM CYTOCHEM, V53, P1109, DOI 10.1369/jhc.4A6511.2005; Johnson K, 2000, ARTHRITIS RHEUM-US, V43, P1560, DOI 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.3.CO;2-J; Kramer WC, 2011, INT J CLIN EXP MED, V4, P285; Kurz B, 2004, ARTHRITIS RHEUM, V50, P123, DOI 10.1002/art.11438; Leary S., 2013, AVMA GUIDELINES EUTH; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Madeti BK, 2015, FRONT MECH ENG, V10, P176, DOI 10.1007/s11465-014-0306-x; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; MAROUDAS A, 1970, BIOPHYS J, V10, P365, DOI 10.1016/S0006-3495(70)86307-X; Martin JA, 2009, J BONE JOINT SURG AM, V91A, P1890, DOI 10.2106/JBJS.H.00545; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Novakofski KD, 2015, OSTEOARTHR CARTILAGE, V23, P1130, DOI 10.1016/j.joca.2015.02.023; Ohashi T, 2006, BIORHEOLOGY, V43, P201; Olsen RKJ, 2015, J INHERIT METAB DIS, V38, P703, DOI 10.1007/s10545-015-9861-5; Pagano G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/541230; Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1; Ruiz-Romero C, 2009, MOL CELL PROTEOMICS, V8, P172, DOI 10.1074/mcp.M800292-MCP200; Sauter E, 2012, J ORTHOP RES, V30, P593, DOI 10.1002/jor.21552; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Schneider N, 2007, CELL BIOL INT, V31, P878, DOI 10.1016/j.cellbi.2007.02.002; Schuh RA, 2011, J NEUROSCI RES, V89, P1979, DOI 10.1002/jnr.22650; Silverberg JL, 2013, J ORTHOP RES, V31, P686, DOI 10.1002/jor.22303; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652; Strobel S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2942; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Szafranski JD, 2004, OSTEOARTHR CARTILAGE, V12, P937, DOI 10.1016/j.joca.2004.08.004; Zhou SD, 2004, ARTHRITIS RHEUM-US, V50, P3915, DOI 10.1002/art.20675	58	30	31	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	FEB	2018	36	2			SI		739	750		10.1002/jor.23651			12	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	FY3PP	WOS:000426733700022	28696002	Green Accepted			2022-02-06	
J	Mayinger, MC; Merchant-Borna, K; Hufschmidt, J; Muehlmann, M; Weir, IR; Rauchmann, BS; Shenton, ME; Koerte, IK; Bazarian, JJ				Mayinger, Michael Christian; Merchant-Borna, Kian; Hufschmidt, Jakob; Muehlmann, Marc; Weir, Isabelle Ruth; Rauchmann, Boris-Stephan; Shenton, Martha Elizabeth; Koerte, Inga Katharina; Bazarian, Jeffrey John			White matter alterations in college football players: a longitudinal diffusion tensor imaging study	BRAIN IMAGING AND BEHAVIOR			English	Article						TBSS; Diffusion tensor imaging; White matter; Longitudinal; High magnitude impact; Sports; Athletics; Subconcussive head trauma; Human studies; Football; Repetitive head impacts; Fractional anisotropy	TRAUMATIC BRAIN-INJURY; PROFESSIONAL SOCCER PLAYERS; SPORTS-RELATED CONCUSSION; HEAD IMPACTS; AXONAL INJURY; DETECTS; DAMAGE; MRI; ENCEPHALOPATHY; EXPOSURE	The aim of this study was to evaluate longitudinal changes in the diffusion characteristics of brain white matter (WM) in collegiate athletes at three time points: prior to the start of the football season (T1), after one season of football (T2), followed by six months of no-contact rest (T3). Fifteen male collegiate football players and 5 male non-athlete student controls underwent diffusion MR imaging and computerized cognitive testing at all three timepoints. Whole-brain tract-based spatial statistics (TBSS) were used to compare fractional anisotropy (FA), radial diffusivity (RD), axial diffusivity (AD), and trace between all timepoints. Average diffusion values were obtained from statistically significant clusters for each individual. No athlete suffered a concussion during the study period. After one season of play (T1 to T2), we observed a significant increase in trace in a cluster located in the brainstem and left temporal lobe, and a significant increase in FA in the left parietal lobe. After six months of no-contact rest (T2 to T3), there was a significant decrease in trace and FA in clusters that were partially overlapping or in close proximity with the initial clusters (T1 to T2), with no significant changes from T1 to T3. Repetitive head impacts (RHI) sustained during a single football season may result in alterations of the brain's WM in collegiate football players. These changes appear to return to baseline after 6 months of no-contact rest, suggesting remission of WM alterations. Our preliminary results suggest that collegiate football players might benefit from periods without exposure to RHI.	[Mayinger, Michael Christian; Koerte, Inga Katharina] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Mayinger, Michael Christian; Hufschmidt, Jakob; Muehlmann, Marc; Rauchmann, Boris-Stephan; Shenton, Martha Elizabeth; Koerte, Inga Katharina; Bazarian, Jeffrey John] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Mayinger, Michael Christian; Hufschmidt, Jakob; Muehlmann, Marc; Rauchmann, Boris-Stephan; Shenton, Martha Elizabeth; Koerte, Inga Katharina; Bazarian, Jeffrey John] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Merchant-Borna, Kian; Weir, Isabelle Ruth] Univ Rochester, Sch Med & Dent, Emergency Med, Rochester, NY USA; [Hufschmidt, Jakob] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Dept Pediat Neurol, Munich, Germany; [Muehlmann, Marc; Rauchmann, Boris-Stephan] Ludwig Maximilians Univ Munchen, Inst Clin Radiol, Munich, Germany; [Shenton, Martha Elizabeth] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA		Koerte, IK (corresponding author), Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany.; Koerte, IK (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA.; Koerte, IK (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA.	ikoerte@bwh.harvard.edu	Koerte, Inga Katharina/AAW-3031-2021		National Football League Charities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM074905] Funding Source: NIH RePORTER	This study was funded in part by the National Football League Charities.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; Davenport E. M., 2016, CONCUSSION 00 CNC19; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fox RJ, 2011, AM J NEURORADIOL, V32, P85, DOI 10.3174/ajnr.A2238; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Hanggi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124222; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Li XC, 2013, EUR J RADIOL, V82, pE707, DOI 10.1016/j.ejrad.2013.07.018; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Luker R., 2011, SPORTSBUISNESSDAILY, V14; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McGraw KO, 1996, PSYCHOL METHODS, V1, P390, DOI 10.1037//1082-989X.1.4.390; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Peled S, 2007, IEEE T MED IMAGING, V26, P1448, DOI 10.1109/TMI.2007.906787; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Reeves AG, 1981, DISORDERS NERVOUS SY; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; United States Census Bureau, 2009, PART SEL SPORTS ACT; Wang X, 2014, NEUROIMAGE, V88, P32, DOI 10.1016/j.neuroimage.2013.10.066; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	68	30	30	1	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	FEB	2018	12	1					44	53		10.1007/s11682-017-9672-4			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FW4TM	WOS:000425307500005	28092023				2022-02-06	
J	Novgorodov, SA; Voltin, JR; Gooz, MA; Li, L; Lemasters, JJ; Gudz, TI				Novgorodov, Sergei A.; Voltin, Joshua R.; Gooz, Monika A.; Li, Li; Lemasters, John J.; Gudz, Tatyana I.			Acid sphingomyelinase promotes mitochondrial dysfunction due to glutamate-induced regulated necrosis	JOURNAL OF LIPID RESEARCH			English	Article						brain lipids; ferroptosis; glutamate/cystine antiporter; lipids/peroxidation; mitochondria; sphingolipids; sirtuin; oligodendrocytes	DELTA-MEDIATED PHOSPHORYLATION; ANTIPORTER SYSTEM X(C)(-); NONAPOPTOTIC CELL-DEATH; TRAUMATIC BRAIN-INJURY; PERMEABILITY TRANSITION; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; CYSTINE/GLUTAMATE ANTIPORTER; THERAPEUTIC OPPORTUNITIES; NEUTRAL CERAMIDASE	Inhibiting the glutamate/cystine antiporter system x(c)(-), a key antioxidant defense machinery in the CNS, could trigger a novel form of regulated necrotic cell death, ferroptosis. The underlying mechanisms of system xc. dependent cell demise were elucidated using primary oligodendrocytes (OLs) treated with glutamate to block system xc. function. Pharmacological analysis revealed ferroptosis as a major contributing factor to glutamate-initiated OL death. A sphingolipid profile showed elevations of ceramide species and sphingosine that were preventable by inhibiting of an acid sphingomyelinase (ASM) activity. OL survival was enhanced by both downregulating ASM expression and blocking ASM activity. Glutamate-induced ASM activation seems to involve posttranscriptional mechanisms and was associated with a decreased GSH level. Further investigation of the mechanisms of OL response to glutamate revealed enhanced reactive oxygen species production, augmented lipid peroxidation, and opening of the mitochondrial permeability transition pore that were attenuated by hindering ASM. Of note, knocking down sirtuin 3, a deacetylase governing the mitochondrial antioxidant system, reduced OL survival. The data highlight the importance of the mitochondrial compartment in regulated necrotic cell death and accentuate the novel role of ASM in disturbing mitochondrial functions during OL response to glutamate toxicity, which is essential for pathobiology in stroke and traumatic brain injury.	[Novgorodov, Sergei A.; Voltin, Joshua R.; Gudz, Tatyana I.] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Gooz, Monika A.; Li, Li; Lemasters, John J.] Med Univ South Carolina, Dept Drug Discovery, Charleston, SC 29425 USA; [Gudz, Tatyana I.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA		Gudz, TI (corresponding author), Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA.; Gudz, TI (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA.	gudz@musc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS083544, R01DK073336, P30 GM103339]; Veterans Affairs Merit AwardUS Department of Veterans Affairs [I01BX002991]; US Public Health ServiceUnited States Department of Health & Human ServicesUnited States Public Health Service [S10OD018113]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK073336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS083544] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002991] Funding Source: NIH RePORTER	This work was supported in part by National Institutes of Health Grants R01NS083544 (T.I.G.) and R01DK073336 (J.J.L.), Veterans Affairs Merit Award I01BX002991 (T.I.G.). The Lipidomics Core facility at the Medical University of South Carolina was supported, in part, by National Institutes of Health Grant P30 GM103339. The Cell Imaging Core facility at Medical University of South Carolina was supported, in part, by US Public Health Service Grant S10OD018113. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht P, 2010, CNS NEUROL DISORD-DR, V9, P373, DOI 10.2174/187152710791292567; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Bai AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177805; Beckmann N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00331; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Brennan-Minnella AM, 2015, ANTIOXID REDOX SIGN, V22, P161, DOI 10.1089/ars.2013.5767; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x; Chatelut M, 1998, FEBS LETT, V426, P102, DOI 10.1016/S0014-5793(98)00325-1; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Gulbins E, 2013, NAT MED, V19, P934, DOI 10.1038/nm.3214; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Henry Brian, 2013, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-7091-1368-4_4; Herr I, 1999, BRAIN RES, V826, P210, DOI 10.1016/S0006-8993(99)01288-3; Hill BG, 2012, J MOL CELL CARDIOL, V52, P559, DOI 10.1016/j.yjmcc.2011.07.009; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kassmann CM, 2008, CURR OPIN NEUROL, V21, P235, DOI 10.1097/WCO.0b013e328300c71f; Kim YA, 2013, BIOMOL THER, V21, P358, DOI 10.4062/biomolther.2013.065; Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Lee JK, 2014, J EXP MED, V211, P1551, DOI 10.1084/jem.20132451; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Li X, 2012, CELL PHYSIOL BIOCHEM, V30, P815, DOI 10.1159/000341460; Maldonado EN, 2016, J BIOL CHEM, V291, P19642, DOI 10.1074/jbc.M116.734814; Martinez TN, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-45; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Miller OG, 2015, ARCH TOXICOL, V89, P1439, DOI 10.1007/s00204-015-1496-7; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; NOVGORODOV SA, 1991, BIOCHIM BIOPHYS ACTA, V1058, P242, DOI 10.1016/S0005-2728(05)80243-9; Novgorodov SA, 2016, J BIOL CHEM, V291, P1957, DOI 10.1074/jbc.M115.668228; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; Novgorodov Sergei A, 2011, Int J Biochem Mol Biol, V2, P347; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Ohtani R, 2004, BRAIN RES, V1023, P31, DOI 10.1016/j.brainres.2004.07.024; OKA A, 1993, J NEUROSCI, V13, P1441; Panov AV, 2005, MOL CELL BIOCHEM, V269, P143, DOI 10.1007/s11010-005-3454-9; Pap EHW, 1999, FEBS LETT, V453, P278, DOI 10.1016/S0014-5793(99)00696-1; Qiu HW, 2003, J BIOL CHEM, V278, P32744, DOI 10.1074/jbc.M303022200; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rosin C, 2004, J NEUROCHEM, V90, P1173, DOI 10.1111/j.1471-4159.2004.02584.x; Roth AG, 2009, ANGEW CHEM INT EDIT, V48, P7560, DOI 10.1002/anie.200903288; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Spitzer S, 2016, NEUROPHARMACOLOGY, V110, P574, DOI 10.1016/j.neuropharm.2016.06.014; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Sundaram K, 2016, BIOCHEM J, V473, P743, DOI 10.1042/BJ20150586; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028	84	30	31	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	FEB	2018	59	2					312	329		10.1194/jlr.M080374			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW0IM	WOS:000424977400012	29282302	Green Published, hybrid			2022-02-06	
J	Pugh, MJ; Swan, AA; Carlson, KF; Jaramillo, CA; Eapen, BC; Dillahunt-Aspillaga, C; Amuan, ME; Delgado, RE; McConnell, K; Finley, EP; Grafman, JH				Pugh, Mary Jo; Swan, Alicia A.; Carlson, Kathleen F.; Jaramillo, Carlos A.; Eapen, Blessen C.; Dillahunt-Aspillaga, Christina; Amuan, Megan E.; Delgado, Roxana E.; McConnell, Kimberly; Finley, Erin P.; Grafman, Jordan H.		Trajectories Resilience Complex	Traumatic Brain Injury Severity, Comorbidity, Social Support, Family Functioning, and Community Reintegration Among Veterans of the Afghanistan and Iraq Wars	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Mental health; Rehabilitation; Stress disorders, post-traumatic; Veterans	QUALITY-OF-LIFE; REHABILITATION; ASSOCIATIONS; PREVALENCE; OUTCOMES; HEALTH	Objective: To examine the association between traumatic brain injury (TBI) severity; social, family, and community reintegration outcomes; and return to work status among post-9/11 veterans in Department of Veterans Affairs (VA) care. Design: Retrospective observational cohort study. Setting: Mail/online survey fielded to a national sample of veterans. Participants: Sample of post-9/11 veterans with at least 3 years of VA care stratified according to TBI severity and comorbidities who completed and returned surveys (N=2023). Interventions: Not applicable. Main Outcome Measures: Deployment Risk and Resilience Inventory-2 family functioning and social support subscales; Military to Civilian Questionnaire; and employment status. Results: Bivariate analyses revealed that veterans with every classification of TBI severity reported significantly more difficulty on social, family, and community reintegration outcomes than those with no TBI. In the fully adjusted model, veterans with unclassified and moderate/severe TBI reported significantly more difficulty with community reintegration and were less likely to be employed relative to those with no TBI; those with unclassified TBI also reported significantly more difficulty with family functioning. Veterans with mild TBI also reported significantly more difficulty with community reintegration. Conclusions: This study provides insight into long-term outcomes associated with TBI in post-9/11 veterans and suggests that exposure to TBI has a negative effect on social and family functioning, community reintegration, and return to work even after controlling for comorbidity, deployment experiences, and sociodemographic characteristics. Additional research is required to explicate what appears to be complex interactions among TBI severity, psychosocial well-being, combat exposures, and socioeconomic resources in this population. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Pugh, Mary Jo; Swan, Alicia A.; Jaramillo, Carlos A.; Eapen, Blessen C.; Delgado, Roxana E.; McConnell, Kimberly; Finley, Erin P.] South Texas Vet Hlth Care Syst, Vet Hlth Adm, San Antonio, TX 78229 USA; [Pugh, Mary Jo; Delgado, Roxana E.; McConnell, Kimberly] Univ Texas Hlth San Antonio, Dept Epidemiol, San Antonio, TX USA; [Pugh, Mary Jo; Delgado, Roxana E.; McConnell, Kimberly] Univ Texas Hlth San Antonio, Dept Biostat, San Antonio, TX USA; [Pugh, Mary Jo; Finley, Erin P.] Univ Texas Hlth San Antonio, Div Gen & Hosp Med, San Antonio, TX USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR USA; [Carlson, Kathleen F.] Natl Ctr Rehabil Auditory Res, Portland, OR USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Eapen, Blessen C.] Univ Texas Hlth San Antonio, Dept Rehabil Med, San Antonio, TX USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Child & Family Studies, Rehab & Mental Hlth Counseling Program, Tampa, FL USA; [Dillahunt-Aspillaga, Christina] James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res, Tampa, FL USA; [Amuan, Megan E.] Edith Nourse Rogers Mem VA Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Finley, Erin P.; Trajectories Resilience Complex] Univ Texas Hlth San Antonio, Dept Psychiat, San Antonio, TX USA; [Grafman, Jordan H.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Feinberg Sch Med,Dept Psychiat, Dept Phys Med & Rehabil,Cognit Neurol & Alzheimer, Chicago, IL 60611 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Feinberg Sch Med, Dept Neurol,Cognit Neurol & Alzheimers Ctr,Dept P, Chicago, IL 60611 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Psychol, Chicago, IL 60611 USA		Pugh, MJ (corresponding author), South Texas Vet Hlth Care Syst, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.	pughm@uthscsa.edu	Pugh, Mary Jo/K-5336-2019; Swan, Alicia A/O-3536-2018	Pugh, Mary Jo/0000-0003-4196-7763; Swan, Alicia A/0000-0003-2412-0499	Department of Veterans Affairs Health Services Research & Development ServiceUS Department of Veterans Affairs [DHI 09-237]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs (Chronic Effects of Neurotrauma Consortium)US Department of Veterans Affairs [W81XWH-13-2-0095]; American Congress of Rehabilitation Medicine	Supported by Department of Veterans Affairs Health Services Research & Development Service (grant no. DHI 09-237); the Frankel Foundation; the United Services Automobile Association, who provided the gift card incentive to survey participants; and use of TBI algorithm developed as part of a study funded by the U.S. Army Medical Research and Material Command; and the U.S. Department of Veterans Affairs (Chronic Effects of Neurotrauma Consortium) (award no. W81XWH-13-2-0095).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Brundage John F, 2015, MSMR, V22, P2; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Department of Defense, 2015, POSTD HLTH ASS PDHA; Department of Defense Department of Veterans Affairs, 2016, VA DOD CLIN PRACT GU; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DILLMAN DA, 1991, ANNU REV SOCIOL, V17, P225, DOI 10.1146/annurev.so.17.080191.001301; Dillman DA., 2014, INTERNET PHONE MAIL, V4th; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Eapen BC, 2013, CURR PHYS MED REHABI, V1, P151, DOI DOI 10.1007/S40141-013-0023-0; Falvo MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1124; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; McAndrew LM, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-73; Military Health System and the Defense Health Agency, SURV CAS DEF; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vogt D, 2017, SOC PSYCH PSYCH EPID, V52, P341, DOI 10.1007/s00127-016-1321-5; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	32	30	31	1	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S40	S49		10.1016/j.apmr.2017.05.021			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900006	28648681				2022-02-06	
S	Raine, A		Widiger, T; Cannon, TD		Raine, Adrian			Antisocial Personality as a Neurodevelopmental Disorder	ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 14	Annual Review of Clinical Psychology		English	Article; Book Chapter						psychopathy; conduct disorder; imaging; epigenetics; neurocognition; prevention	CALLOUS-UNEMOTIONAL TRAITS; AGE 3 YEARS; MATERNAL CIGARETTE-SMOKING; TRAUMATIC BRAIN-INJURY; PRENATAL EXPOSURE; BEHAVIOR PROBLEMS; PSYCHOPATHIC TRAITS; EXTERNALIZING BEHAVIOR; CORTICAL THICKNESS; PREFRONTAL CORTEX	Although antisocial personality disorder (APD) is one of the most researched personality disorders, it is still surprisingly resistant to treatment. This lack of clinical progress may be partly due to the failure to view APD as a neurodevelopmental disorder and to consider early interventions. After first defining what constitutes a neurodevelopmental disorder, this review evaluates the extent to which APD meets neurodevelopmental criteria, covering structural and functional brain imaging, neurocognition, genetics and epigenetics, neurochemistry, and early health risk factors. Prevention and intervention strategies for APD are then outlined, focusing on addressing early biological and health systems, followed by forensic and clinical implications. It is argued both that APD meets criteria for consideration as a neurodevelopmental disorder and that consideration should be given both to the possibility that early onset conduct disorder is neurodevelopmental in nature, and also to the inclusion of psychopathy as a specifier in future Diagnostic and Statistical Manual revisions of APD.	[Raine, Adrian] Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA; [Raine, Adrian] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Raine, Adrian] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA		Raine, A (corresponding author), Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA.; Raine, A (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.; Raine, A (corresponding author), Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA.	araine@sas.upenn.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Archer J, 2005, AGGRESS VIOLENT BEH, V10, P241, DOI 10.1016/j.avb.2004.01.001; Astill RG, 2012, PSYCHOL BULL, V138, P1109, DOI 10.1037/a0028204; Barkataki I, 2006, BEHAV BRAIN RES, V169, P239, DOI 10.1016/j.bbr.2006.01.009; Beach SRH, 2011, PSYCHOSOM MED, V73, P83, DOI 10.1097/PSY.0b013e3181fdd074; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berryessa CM, 2015, J MENT HEALTH RES IN, V8, P140, DOI 10.1080/19315864.2015.1040176; Bishop DVM, 2008, RUTTERS CHILD ADOLES, V208, P32, DOI DOI 10.1002/9781444300895.CH3.PP.32-41; Blair RJR, 2008, PHILOS T R SOC B, V363, P2557, DOI 10.1098/rstb.2008.0027; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Boivin MJ, 2015, NATURE, V527, pS155, DOI 10.1038/nature16029; Bos PA, 2016, PSYCHONEUROENDOCRINO, V68, P194, DOI 10.1016/j.psyneuen.2016.03.006; Brook M, 2013, J ABNORM PSYCHOL, V122, P156, DOI 10.1037/a0030261; Bublitz MH, 2012, NICOTINE TOB RES, V14, P388, DOI 10.1093/ntr/ntr191; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Casement MD, 2014, DEV COGN NEUROS-NETH, V8, P18, DOI 10.1016/j.dcn.2013.12.003; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Checknita D, 2015, BRIT J PSYCHIAT, V206, P216, DOI 10.1192/bjp.bp.114.144964; Choy O, 2016, STOCKH CRIM S STOCKH; Dadds MR, 2014, DEV PSYCHOPATHOL, V26, P33, DOI 10.1017/S0954579413000497; Damasio A., 1994, DESCARTES ERROR EMOT; Decety J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00489; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Duke AA, 2013, PSYCHOL BULL, V139, P1148, DOI 10.1037/a0031544; Esbensen AJ, 2016, INT REV RES DEV DISA, V51, P153, DOI 10.1016/bs.irrdd.2016.07.005; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Frick PJ, 2003, DEV PSYCHOL, V39, P246, DOI 10.1037/0012-1649.39.2.246; Gajos JM, 2016, NEUROSCI BIOBEHAV R, V69, P147, DOI 10.1016/j.neubiorev.2016.07.017; Gao Y, 2010, AM J PSYCHIAT, V167, P56, DOI 10.1176/appi.ajp.2009.09040499; Gao Y, 2009, CAN J PSYCHIAT, V54, P813, DOI 10.1177/070674370905401204; Genkinger JM, 2015, ENVIRON RES, V140, P136, DOI 10.1016/j.envres.2015.03.017; Gibbon S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007668.pub2; Glenn AL, 2014, NAT REV NEUROSCI, V15, P54, DOI 10.1038/nrn3640; Glenn AL, 2010, BIOL PSYCHIAT, V67, P52, DOI 10.1016/j.biopsych.2009.06.018; Goldstein AN, 2014, ANNU REV CLIN PSYCHO, V10, P679, DOI 10.1146/annurev-clinpsy-032813-153716; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Gregory S, 2012, ARCH GEN PSYCHIAT, V69, P962, DOI 10.1001/archgenpsychiatry.2012.222; Guillemin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086822; Haghighi A, 2013, JAMA PSYCHIAT, V70, P98, DOI 10.1001/archgenpsychiatry.2012.1101; Hanson JL, 2015, BIOL PSYCHIAT, V77, P314, DOI 10.1016/j.biopsych.2014.04.020; Herpers PCM, 2014, DEV PSYCHOPATHOL, V26, P245, DOI 10.1017/S0954579413000527; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Hyde LW, 2014, J ABNORM PSYCHOL, V123, P214, DOI 10.1037/a0035467; Jiang WX, 2017, SCI REP-UK, V7, DOI 10.1038/srep43002; Jiang WX, 2016, NEUROSCIENCE, V337, P143, DOI 10.1016/j.neuroscience.2016.08.052; Joseph J, 2014, HUM BRAIN MAPP, V35, P659, DOI 10.1002/hbm.22209; Khalifa N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007667.pub2; Kiehl KA, 2006, PSYCHIAT RES, V142, P107, DOI 10.1016/j.psychres.2005.09.013; Kirk U, 2015, SOC COGN AFFECT NEUR, V10, P752, DOI 10.1093/scan/nsu112; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Koenigs M, 2011, MOL PSYCHIATR, V16, P792, DOI 10.1038/mp.2010.124; Kolla NJ, 2015, NEUROPSYCHOPHARMACOL, V40, P2596, DOI 10.1038/npp.2015.106; Kopsida E, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00066; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Kumari V, 2014, AUST NZ J PSYCHIAT, V48, P153, DOI 10.1177/0004867413512690; Kumari V, 2009, SCHIZOPHR RES, V110, P47, DOI 10.1016/j.schres.2009.01.009; Larkby CA, 2011, J AM ACAD CHILD PSY, V50, P262, DOI 10.1016/j.jaac.2010.12.004; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; Liljegren M, 2015, JAMA NEUROL, V72, P295, DOI 10.1001/jamaneurol.2014.3781; Liu JH, 2004, AM J PSYCHIAT, V161, P2005, DOI 10.1176/appi.ajp.161.11.2005; Liu JH, 2015, INT J MOL SCI, V16, P18129, DOI 10.3390/ijms160818129; Liu JH, 2014, NUTRIENTS, V6, P530, DOI 10.3390/nu6020530; Liu JH, 2011, AGGRESS VIOLENT BEH, V16, P63, DOI 10.1016/j.avb.2010.12.003; Liu JH, 2009, J RES ADOLESCENCE, V19, P93, DOI 10.1111/j.1532-7795.2009.00583.x; Loeber R, 2000, J ABNORM CHILD PSYCH, V28, P353, DOI 10.1023/A:1005169026208; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Marsh AA, 2011, PSYCHIAT RES-NEUROIM, V194, P279, DOI 10.1016/j.pscychresns.2011.07.008; Matthys W, 2012, CLIN CHILD FAM PSYCH, V15, P234, DOI 10.1007/s10567-012-0118-7; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Millan MJ, 2013, NEUROPHARMACOLOGY, V68, P2, DOI 10.1016/j.neuropharm.2012.11.015; Moffitt T., 2001, SEX DIFFERENCES ANTI; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Moffitt TE, 2015, AM J PSYCHIAT, V172, P967, DOI 10.1176/appi.ajp.2015.14101266; Moffitt TE, 2015, CRIMINOLOGY, V53, P121, DOI 10.1111/1745-9125.12061; Montoya ER, 2013, PSYCHONEUROENDOCRINO, V38, P1362, DOI 10.1016/j.psyneuen.2012.12.001; Morales S, 2016, DEVELOPMENTAL SCI, V19, P853, DOI 10.1111/desc.12320; Narayan VM, 2007, AM J PSYCHIAT, V164, P1418, DOI 10.1176/appi.ajp.2007.06101631; Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455; O'Brien TC, 2013, NEUROTOXICOL TERATOL, V40, P67, DOI 10.1016/j.ntt.2013.09.002; OBrien BS, 1996, J ABNORM CHILD PSYCH, V24, P223, DOI 10.1007/BF01441486; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; Olfson M, 2015, JAMA PSYCHIAT, V72, P867, DOI 10.1001/jamapsychiatry.2015.0500; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pansky B., 1988, REV NEUROSCIENCE; Pappadopulos E, 2006, J CAN ACAD CHILD ADO, V15, P27; Pardini DA, 2014, BIOL PSYCHIAT, V75, P73, DOI 10.1016/j.biopsych.2013.04.003; Patrick C. J., 2007, HDB PERSONALITY DISO, P109; Peterson BS, 2015, JAMA PSYCHIAT, V72, P531, DOI 10.1001/jamapsychiatry.2015.57; Pratt TC, 2016, CRIMINOLOGY, V54, P587, DOI 10.1111/1745-9125.12115; Provencal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089839; Pujara M, 2014, SOC COGN AFFECT NEUR, V9, P794, DOI 10.1093/scan/nst054; Raine A, 2002, J ABNORM CHILD PSYCH, V30, P311, DOI 10.1023/A:1015754122318; Raine A, 2003, AM J PSYCHIAT, V160, P1627, DOI 10.1176/appi.ajp.160.9.1627; Raine A, 2002, DEV PSYCHOPATHOL, V14, P25, DOI 10.1017/S0954579402001025; Raine A, 2001, PSYCHOPHYSIOLOGY, V38, P254, DOI 10.1111/1469-8986.3820254; Raine A., 2013, ANATOMY VIOLENCE BIO; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Raine A, 2006, ANNU REV CLIN PSYCHO, V2, P291, DOI 10.1146/annurev.clinpsy.2.022305.095318; Raine A, 2017, J CHILD PSYCHOL PSYC, V58, P728, DOI 10.1111/jcpp.12693; Raine A, 2015, J CHILD PSYCHOL PSYC, V56, P509, DOI 10.1111/jcpp.12314; Raine A, 2010, BRIT J PSYCHIAT, V197, P186, DOI 10.1192/bjp.bp.110.078485; Rautiainen MR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.155; Rosenstrom T, 2017, BEHAV GENET, V47, P265, DOI 10.1007/s10519-016-9833-z; Sadeh A, 2015, DEV NEUROPSYCHOL, V40, P122, DOI 10.1080/87565641.2014.973498; Samuelson M, 2007, PRISON J, V87, P254, DOI 10.1177/0032885507303753; Sarkar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155475; SARWAR M, 1989, AM J NEURORADIOL, V10, P989; Semiz UB, 2008, TURK PSIKIYATR DERG, V19, P373; Shao YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112222; Storebo OJ, 2016, J ATTEN DISORD, V20, P815, DOI 10.1177/1087054713512150; Swayze VW, 1997, PEDIATRICS, V99, P232, DOI 10.1542/peds.99.2.232; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Toro R, 2008, NEUROPSYCHOPHARMACOL, V33, P1019, DOI 10.1038/sj.npp.1301484; Tottenham N, 2016, NEUROSCI BIOBEHAV R, V70, P217, DOI 10.1016/j.neubiorev.2016.07.030; Treit S, 2013, J NEUROSCI, V33, P10098, DOI 10.1523/JNEUROSCI.5004-12.2013; Tremblay RE, 2010, J CHILD PSYCHOL PSYC, V51, P341, DOI 10.1111/j.1469-7610.2010.02211.x; Tuvblad C, 2014, PSYCHOL ASSESSMENT, V26, P704, DOI 10.1037/a0036711; Vassos E, 2014, MOL PSYCHIATR, V19, P471, DOI 10.1038/mp.2013.31; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Wakschlag L, 2017, AM J PSYCHIAT; Wang DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039501; White SF, 2013, J CHILD PSYCHOL PSYC, V54, P575, DOI 10.1111/j.1469-7610.2012.02603.x; Widiger T. A., 2006, HDB PSYCHOPATHY, P156; Wilson HA, 2014, INT J FORENSIC MENT, V13, P36, DOI 10.1080/14999013.2014.890682; Yang YL, 2015, PSYCHIAT RES-NEUROIM, V231, P333, DOI 10.1016/j.pscychresns.2015.01.017; Yang YL, 2012, NEUROREPORT, V23, P702, DOI 10.1097/WNR.0b013e328355a62a; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yang YL, 2009, ARCH GEN PSYCHIAT, V66, P986, DOI 10.1001/archgenpsychiatry.2009.110; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Yorifuji T, 2017, ENVIRON INT, V99, P192, DOI 10.1016/j.envint.2016.11.016; Zhang HM, 2017, ENVIRON HEALTH PERSP, V125, P746, DOI 10.1289/EHP478	137	30	32	2	33	ANNUAL REVIEWS	PALO ALTO	4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA	1548-5943			ANNU REV CLIN PSYCHO	Annu. Rev. Clin. Psychol.		2018	14						259	289		10.1146/annurev-clinpsy-050817084819			31	Psychology, Clinical; Psychology	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	BK2KR	WOS:000433057100010	29401045				2022-02-06	
J	Kamimori, GH; Reilly, LA; LaValle, CR; Da Silva, UBO				Kamimori, G. H.; Reilly, L. A.; LaValle, C. R.; Da Silva, U. B. Olaghere			Occupational overpressure exposure of breachers and military personnel	SHOCK WAVES			English	Article						Breachers; Breaching; Blast exposure; Overpressure; Impulse; Blast gauge; K equation; Minimum safe distance	CHRONIC TRAUMATIC ENCEPHALOPATHY; LOW-LEVEL BLAST; FOOTBALL-LEAGUE PLAYER; BRAIN-INJURY; BIOMARKER	Military and law enforcement personnel may be routinely and repetitively exposed to low-level blast (LLB) overpressure during training and in operations. This repeated exposure has been associated with symptoms similar to that reported for sports concussion. This study reports LLB exposure for various military and law enforcement sources in operational training environments. Peak overpressure and impulse data are presented from indoor breaching, outdoor breaching, shotgun door breaching, small arms discharge, and mortar and artillery fire missions. Data were collected using the Black Box Biometrics (B3) Blast Gauge sensors. In all cases, sensors were attached to the operators and, where possible, also statically mounted to walls or other fixed structures. Peak overpressures from below 1 psi (7 kPa) to over 12 psi (83 kPa) were recorded; all values reported are uncorrected for incidence angle to the blast exposure source. The results of these studies indicate that the current minimum safe distance calculations are often inaccurate for both indoor and outdoor breaching scenarios as true environmental exposure can consistently exceed the 4 psi (28 kPa) incident safe threshold prescribed by U.S. Army doctrine. While ballistic (shotgun) door breaching and small arms firing only expose the operator to low peak exposure levels, the sheer number of rounds fired during training may result in an excessive cumulative exposure. Mortar and artillery crew members received significantly different overpressure and impulse exposures based on their position (job) relative to the weapon. As both the artillery and mortar crews commonly fire hundreds of rounds during a single training session they are also likely to receive high cumulative exposures. These studies serve to provide the research community with estimates for typical operator exposure across a range of operational scenarios or in the discharge of various weapons systems.	[Kamimori, G. H.; Reilly, L. A.; LaValle, C. R.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Da Silva, U. B. Olaghere] Naval Med Res Ctr, Neurotrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Reilly, LA (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	lucas.a.reilly3.ctr@mail.mil		LaValle, Christina/0000-0003-1529-4761; Olaghere da Silva, Uade/0000-0003-1755-4985	Office of the Assistant Secretary of Defense for Health Affairs; Broad Agency Announcement Award [W81XWH-16-2-0001, JCP-5, RAD3]; Environmental Sensors in Training (ESiT) program; Washington County (OR) Sheriff's Department, 35th Engineers (Fort Leonard Wood, MO); Las Vegas (NV) Special Weapons and Tactics, Infantry Mortar Leaders Course (Fort Benning, GA); Big Deuce (Fort Sill, OK)	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award No. W81XWH-16-2-0001, JCP-5, RAD3 and the Environmental Sensors in Training (ESiT) program. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. Thanks to the staff of the Walter Reed Army Institute of Research and Naval Medical Research Center for their assistance in the completion of the studies described herein and the preparation of this manuscript. We would like to acknowledge the support of the units involved in these studies: Washington County (OR) Sheriff's Department, 35th Engineers (Fort Leonard Wood, MO), Las Vegas (NV) Special Weapons and Tactics, Infantry Mortar Leaders Course (Fort Benning, GA) and the Big Deuce (Fort Sill, OK). The authors would like to thank Anthony Misistia for his additional contributions to the project and submission of the final manuscript.	[Anonymous], 2016, HEADQ DEP ARM PUBL; Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Branch M., 2013, TECH REP; Capo-Aponte JE, 2015, J REHABIL RES DEV, V52, P273, DOI 10.1682/JRRD.2014.09.0204; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Cranz C., 1916, TXB BALLISTICS; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; FEMA, 2004, BUILD DES HOM SEC; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guard, 2015, US INT AMM TECHN GUI; HIRSCH FG, 1968, ANN NY ACAD SCI, V152, P147, DOI 10.1111/j.1749-6632.1968.tb11972.x; Hopkinson B, 1915, BRIT ORDNANCE BOARD; Kamimori G.H., 2015, WATER MITIGATION BLA; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thiel K.J., 2016, 201606 USAARL	27	30	30	2	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	NOV	2017	27	6					837	847		10.1007/s00193-017-0738-4			11	Mechanics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Mechanics	FN4BE	WOS:000415946600003					2022-02-06	
J	Brenner, LA; Stearns-Yoder, KA; Hoffberg, AS; Penzenik, ME; Starosta, AJ; Hernandez, TD; Hadidi, DA; Lowry, CA				Brenner, Lisa A.; Stearns-Yoder, Kelly A.; Hoffberg, Adam S.; Penzenik, Molly E.; Starosta, Amy J.; Hernandez, Theresa D.; Hadidi, Daniel A.; Lowry, Christopher A.			Growing literature but limited evidence: A systematic review regarding prebiotic and probiotic interventions for those with traumatic brain injury and/or posttraumatic stress disorder	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Bifidobacteria; Lactobacilli; Persistent post-concussive symptoms; Posttraumatic stress disorder; Prebiotic; Probiotic; PTSD; Synbiotic; TBI; Traumatic brain injury; Systematic review	LACTOBACILLUS-HELVETICUS R0052; BIFIDOBACTERIUM-LONGUM R0175; ANXIETY-LIKE BEHAVIOR; IN-VITRO; MODULATION; MEDICINE; PTSD; COMPLEMENTARY; RESILIENCE; SOLDIERS	Traumatic brain injury (TBI) is highly prevalent among a wide range of populations, including civilians, military personnel, and Veterans. TBI sequelae may be further exacerbated by symptoms associated with frequently occurring comorbid psychiatric conditions, including posttraumatic stress disorder (PTSD). This is particularly true among the population of military personnel from recent conflicts in Iraq and Afghanistan, with a history of mild TBI (mTBI) and PTSD. The need for efficacious treatments for TBI and comorbid PTSD is significant, and evidence-based interventions for these frequently co-occurring conditions are limited. Based on findings suggesting that inflammation may be an underlying mechanism of both conditions, anti-inflammatory/immunoregulatory agents, including probiotics, may represent a novel strategy to treat TBI and/or PTSD-related symptoms. The focus of this systematic review was to identify and evaluate existing research regarding prebiotic and probiotic interventions for the populations of individuals with a history of TBI and/or PTSD. Only 4 studies were identified (3 severe TBI, 1 PTSD, 0 co-occurring TBI and PTSD). Although findings suggested some promise, work in this area is nascent and results to date do not support some claims within the extensive coverage of probiotics in the popular press. Published by Elsevier Inc.	[Brenner, Lisa A.; Stearns-Yoder, Kelly A.; Hoffberg, Adam S.; Penzenik, Molly E.; Starosta, Amy J.; Hernandez, Theresa D.; Hadidi, Daniel A.; Lowry, Christopher A.] Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, Denver, CO USA; [Brenner, Lisa A.; Hernandez, Theresa D.; Hadidi, Daniel A.; Lowry, Christopher A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat & Neurol, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.; Stearns-Yoder, Kelly A.; Lowry, Christopher A.] Mil & Vet Microbiome Consortium Res & Educ MVM Co, Denver, CO USA; [Hernandez, Theresa D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Hernandez, Theresa D.; Hadidi, Daniel A.; Lowry, Christopher A.] Univ Colorado, Ctr Neurosci, Anschutz Med Campus, Aurora, CO USA; [Lowry, Christopher A.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Lowry, Christopher A.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA		Brenner, LA (corresponding author), Rocky Mt MIRECC, Eastern Colorado Hlth Care Syst, 1055 Clermont St, Denver, CO 80220 USA.	lisa.brenner@va.gov	Starosta, Amy/AAV-1665-2020; Brenner, Lisa A./AAG-2442-2019	Hoffberg, Adam/0000-0002-7036-936X			Abbott Laboratories Inc., PROD INF TWOCAL HN; Abbott Laboratories Inc., PROD INF PIVOT 1 5 C; Allen AP, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.191; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Barnes Patricia M, 2004, Adv Data, P1; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Bercik P, 2010, GASTROENTEROLOGY, V139, P2102, DOI 10.1053/j.gastro.2010.06.063; Betthauser LM, 2014, MED CARE, V52, pS50, DOI 10.1097/MLR.0000000000000219; Bramley H, 2016, SPORTS MED ARTHROSC, V24, P123, DOI 10.1097/JSA.0000000000000111; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; ClinicalTrials. gov, BIOL SIGN PROB THOS; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW TBI NUMB; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gocan AG, 2012, HORM MOL BIOL CLIN I, V10, P301, DOI 10.1515/hmbci-2011-0135; Hartling L, 2010, DEV TESTING TOOL CLA; Hernandez TD, 2016, BRAIN RES, V1640, P139, DOI 10.1016/j.brainres.2016.01.025; Higgins JPT, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge C, 2015, JAMA INTERN MED, V175, P53, DOI 10.1001/jamainternmed.2014.3375; Jones ML, 2012, EUR J CLIN NUTR, V66, P1234, DOI 10.1038/ejcn.2012.126; Karl JP, 2017, AM J PHYSIOL-GASTR L, V312, pG559, DOI 10.1152/ajpgi.00066.2017; Likotrafiti E, 2014, ANAEROBE, V27, P50, DOI 10.1016/j.anaerobe.2014.03.009; Lowry Christopher A, 2016, Curr Environ Health Rep, V3, P270, DOI 10.1007/s40572-016-0100-5; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mahajan Girish Badrinath, 2012, Front Biosci (Elite Ed), V4, P240; Matchar DB, 2012, METHODS GUIDE MED TE; McFadden KL, 2011, J NEUROTRAUM, V28, P21, DOI 10.1089/neu.2010.1515; Messaoudi M, 2011, GUT MICROBES, V2, P256, DOI 10.4161/gmic.2.4.16108; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Miller AH, 2015, JAMA PSYCHIAT, V72, P527, DOI 10.1001/jamapsychiatry.2015.22; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Painter TJ, 2015, INT J SURG, V21, P70, DOI 10.1016/j.ijsu.2015.07.008; Pena JA, 2005, INFECT IMMUN, V73, P912, DOI 10.1128/IAI.73.2.912-920.2005; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Reber SO, 2016, PSYCHONEUROENDOCRINO, V74, P221, DOI 10.1016/j.psyneuen.2016.08.031; Reber SO, 2016, P NATL ACAD SCI USA, V113, pE3130, DOI 10.1073/pnas.1600324113; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rodgers KM, 2014, J NEUROTRAUM, V31, P487, DOI [10.1089/NEU.2013.3090, 10.1089/neu.2013.3090]; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Rook GAW, 2004, SPRINGER SEMIN IMMUN, V25, P237, DOI 10.1007/s00281-003-0148-9; Savignac HM, 2015, BEHAV BRAIN RES, V287, P59, DOI 10.1016/j.bbr.2015.02.044; Savignac HM, 2014, NEUROGASTROENT MOTIL, V26, P1615, DOI 10.1111/nmo.12427; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Tan M., 2009, MC TIMES        1218; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tillisch K, 2013, GASTROENTEROLOGY, V144, P1394, DOI 10.1053/j.gastro.2013.02.043; Tubelius Py, 2005, Environ Health, V4, P25, DOI 10.1186/1476-069X-4-25; VA Health Services Research & Development, EV BAS SYNTH PROGR; Viswanathan M., 2013, ASSESSING RISK BIAS, P2013; Viswanathan M., METHODS GUIDE EFFECT, P2008; Viswanathan M, 2012, J CLIN EPIDEMIOL, V65, P163, DOI 10.1016/j.jclinepi.2011.05.008; World Health Organization, GUID EV PROB FOOD; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003	63	30	30	0	39	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2017	65						57	67		10.1016/j.bbi.2017.06.003			11	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology; Psychiatry	FC6YD	WOS:000406986700007	28606462				2022-02-06	
J	Broglio, SP; Lapointe, A; O'Connor, KL; McCrea, M				Broglio, Steven P.; Lapointe, Andrew; O'Connor, Kathryn L.; McCrea, Michael			Head Impact Density: A Model To Explain the Elusive Concussion Threshold	JOURNAL OF NEUROTRAUMA			English	Article						concussion; head impacts; linear and rotational acceleration	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; FOOTBALL PLAYERS; POSTCONCUSSION SYNDROME; BIOMECHANICS; EXPOSURE; SEVERITY; RECOVERY	Concussion is a heterogeneous injury occurring throughout a range of impact magnitudes. Consequently, research focusing on a single or set of variables at the time of injury to understand concussive biomechanics has been thwarted by low injury prediction sensitivity. The current study examined the role of Impact Density in estimating concussive injury risk. Head impact data were collected across seven high school football seasons with the Head Impact Telemetry System (HIT System). Over the study period, 29 concussions were included for data analysis. The linear acceleration of the concussive impact was matched to a Control athlete, along with impacts in the 24 h before. Linear and rotational acceleration for the 19 impacts leading into the final event and the cumulative accelerations over time were evaluated. Analyses indicated no difference in impact counts within the final 24 h, or impact magnitudes for linear and rotational acceleration among the final 20 impacts (p > 0.05). A novel metric, Impact Density, was calculated from the final 20 impacts by summing the acceleration magnitude divided by time from the previous impact. Analyses indicated the Concussed athletes incurred a significantly higher linear (concussed: 255.4g/sec (standard error of the mean [SEM] = 40.1), controls: 145.4g/sec (SEM = 23.8), p = 0.016), and rotational (Concussed: 10311.3 rad/s/s/s (SEM = 1883.7), Controls: 6083.8 rad/s/s/s (SEM=1115.9), p = 0.029) Impact Density than the Control athletes. Similar to other investigations, there was no difference in individual linear or rotational impact magnitude in the 20 impacts before and including the injury. The measure of Impact Density, however, revealed differences between the Concussed and Control athletes. These data suggest that the biomechanical threshold for concussion fluctuates downwardly with a greater impact magnitude and number with a return to pre-impact levels with time, suggesting physiological vulnerability to repeated head impacts. The current results highlight that time between impacts, not just impact magnitude, influences risk for concussion.	[Broglio, Steven P.; Lapointe, Andrew; O'Connor, Kathryn L.] Univ Michigan, Injury Ctr, Neurotrauma Res Lab, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA		Broglio, SP (corresponding author), Univ Michigan, Injury Ctr, Neurotrauma Res Lab, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	broglio@umich.edu	Lapointe, Andrew/L-5698-2019	Lapointe, Andrew/0000-0002-9360-6428; Van Pelt, Kathryn/0000-0002-5494-2357	Skyline High School (Ann Arbor, MI); Father Gabriel Richard High School (Ann Arbor, MI); National Institutes of Health: National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS081691-01]; Unity High School (Tolono, IL)	The authors would like to thank the football players and staff of Unity High School (Tolono, IL), Skyline High School (Ann Arbor, MI), and Father Gabriel Richard High School (Ann Arbor, MI) for their support of this project. In addition, we thank Douglas Martini, PhD, and Richelle Williams, PhD, ATC, for their assistance. The project was supported partly by The National Institutes of Health: National Institute of Neurological Disorders and Stroke (1R15NS081691-01).	Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gregory S., 2015, TIME; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2016, J ATTEN DISORD; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sefton J. M., 2004, J ATHL TRAINING, V39, pS52; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	30	30	0	24	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2675	2683		10.1089/neu.2016.4767			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700001	28381134	Green Published			2022-02-06	
J	Leeper, CM; Neal, MD; McKenna, CJ; Gaines, BA				Leeper, Christine M.; Neal, Matthew D.; McKenna, Christine J.; Gaines, Barbara A.			Trending Fibrinolytic Dysregulation Fibrinolysis Shutdown in the Days After Injury Is Associated With Poor Outcome in Severely Injured Children	ANNALS OF SURGERY			English	Article; Proceedings Paper	137th Annual Meeting of the American-Surgical-Association (ASA)	APR 20-22, 2017	Philadelphia, PA	Amer Surg Assoc		coagulopathy; massive transfusion; pediatric; trauma; traumatic brain injury	ADMISSION RAPID THROMBELASTOGRAPHY; ACUTE TRAUMATIC COAGULOPATHY; PRINCIPAL COMPONENT ANALYSIS; PEDIATRIC TRAUMA; MORTALITY; CHILDREN; COAGULATION; TIME; HYPERFIBRINOLYSIS; PREVALENCE	Objective: To trend fibrinolysis after injury and determine the influence of traumatic brain injury (TBI) and massive transfusion on fibrinolysis status. Background: Admission fibrinolytic derangement is common in injured children and adults, and is associated with poor outcome. No studies examine fibrinolysis days after injury. Methods: Prospective study of severely injured children at a level 1 pediatric trauma center. Rapid thromboelastography was obtained on admission and daily for up to 7 days. Standard definitions of hyperfibrinolysis (HF; LY30 >= 3), fibrinolysis shutdown (SD; LY30 <= 0.8), and normal (LY30 = 0.9-2.9) were applied. Antifibrinolytic use was documented. Outcomes were death, disability, and thromboembolic complications. Wilcoxon rank-sum and Fisher exact tests were performed. Exploratory subgroups included massively transfused and severe TBI patients. Results: In all, 83 patients were analyzed with median (interquartile ranges) age 8 (4-12) and Injury Severity Score 22 (13-34), 73.5% blunt mechanism, 47% severe TBI, 20.5% massively transfused. Outcomes were 14.5% mortality, 43.7% disability, and 9.8% deep vein thrombosis. Remaining in or trending to SD was associated with death (P = 0.007), disability (P = 0.012), and deep vein thrombosis (P = 0.048). Median LY30 was lower on post-trauma day (PTD) 1 to PTD4 in patients with poor compared with good outcome; median LY30 was lower on PTD1 to PTD3 in TBI patients compared with non-TBI patients. HF without associated shutdown was not related to poor outcome, but extreme HF (LY30 >30%, n = 3) was lethal. Also, 50% of massively transfused patients in hemorrhagic shock demonstrated SD physiology on admission. All with HF (fc31.2%) corrected after hemostatic resuscitation without tranexamic acid. Conclusions: Fibrinolysis shutdown is common postinjury and predicts poor outcomes. Severe TBI is associated with sustained shutdown. Empiric anti-fibrinolytics for children should be questioned; thromboelastography-directed selective use should be considered for documented HF.	[Leeper, Christine M.; Neal, Matthew D.; Gaines, Barbara A.] Univ Pittsburgh, Dept Surg, Med Ctr, Div Gen Surg & Trauma, Pittsburgh, PA USA; [Leeper, Christine M.; McKenna, Christine J.; Gaines, Barbara A.] UPMC, Childrens Hosp Pittsburgh, 7th Floor,Fac Pavil,One Childrens Hosp Dr, Pittsburgh, PA 15224 USA		Leeper, CM (corresponding author), UPMC, Childrens Hosp Pittsburgh, 7th Floor,Fac Pavil,One Childrens Hosp Dr, Pittsburgh, PA 15224 USA.	leepercm@upmc.edu			University of Pittsburgh Clinical and Translational Science InstituteUniversity of Pittsburgh [UL1 TR000005]; Vascular Medicine Institute; Hemophilia Center of Western Pennsylvania; Institute for Transfusion Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER	This publication was made possible by grant number UL1 TR000005 (University of Pittsburgh Clinical and Translational Science Institute), the Vascular Medicine Institute, the Hemophilia Center of Western Pennsylvania, and the Institute for Transfusion Medicine.	Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Calkins CM, 2002, J TRAUMA, V53, P1058, DOI 10.1097/00005373-200212000-00005; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Centers for Disease Control and Prevention, 2015, 10 LEAD CAUS DEATH A; Chapman MP, 2015, J TRAUMA ACUTE CARE, V79, P925, DOI 10.1097/TA.0000000000000871; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Chin TL, 2014, SURGERY, V156, P570, DOI 10.1016/j.surg.2014.04.030; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Eckert MJ, 2014, J TRAUMA ACUTE CARE, V77, P852, DOI 10.1097/TA.0000000000000443; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; HARDAWAY RM, 1962, ANN SURG, V155, P325; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Kunitake RC, 2017, J TRAUMA ACUTE CARE, V82, P302, DOI 10.1097/TA.0000000000001313; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Leeper CM, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26415; Leeper CM, 2017, J TRAUMA ACUTE CARE, V82, P27, DOI 10.1097/TA.0000000000001308; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Leeper CM, 2017, AC SURG C LAS VEG NV; Liras IN, 2017, J AM COLL SURGEONS, V224, P625, DOI 10.1016/j.jamcollsurg.2016.12.046; Liras IN, 2015, SURGERY, V158, P812, DOI 10.1016/j.surg.2015.05.004; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; Moore HB, 2016, 58 ANN M AM SOC HEAM; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Rizoli S, 2013, J TRAUMA ACUTE CARE, V74, P1229; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Suominen P, 1998, INJURY, V29, P425; Vogel AM, 2013, J PEDIATR SURG, V48, P1371, DOI 10.1016/j.jpedsurg.2013.03.036; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	35	30	31	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	SEP	2017	266	3					508	515		10.1097/SLA.0000000000002355			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	FD2UR	WOS:000407390800013	28650356				2022-02-06	
J	Candefjord, S; Winges, J; Malik, AA; Yu, YN; Rylander, T; McKelvey, T; Fhager, A; Elam, M; Persson, M				Candefjord, Stefan; Winges, Johan; Malik, Ahzaz Ahmad; Yu, Yinan; Rylander, Thomas; McKelvey, Tomas; Fhager, Andreas; Elam, Mikael; Persson, Mikael			Microwave technology for detecting traumatic intracranial bleedings: tests on phantom of subdural hematoma and numerical simulations	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Traumatic brain injury; Intracranial bleedings; Microwave technology; Subdural hematoma phantom; Finite element method	MORTALITY; DEVICE; SYSTEM; TIME	Traumatic brain injury is the leading cause of death and severe disability for young people and a major public health problem for elderly. Many patients with intracranial bleeding are treated too late, because they initially show no symptoms of severe injury and are not transported to a trauma center. There is a need for a method to detect intracranial bleedings in the prehospital setting. In this study, we investigate whether broadband microwave technology (MWT) in conjunction with a diagnostic algorithm can detect subdural hematoma (SDH). A human cranium phantom and numerical simulations of SDH are used. Four phantoms with SDH 0, 40, 70 and 110 mL are measured with a MWT instrument. The simulated dataset consists of 1500 observations. Classification accuracy is assessed using fivefold cross-validation, and a validation dataset never used for training. The total accuracy is 100 and 82-96 % for phantom measurements and simulated data, respectively. Sensitivity and specificity for bleeding detection were 100 and 96 %, respectively, for the simulated data. SDH of different sizes is differentiated. The classifier requires training dataset size in order of 150 observations per class to achieve high accuracy. We conclude that the results indicate that MWT can detect and estimate the size of SDH. This is promising for developing MWT to be used for prehospital diagnosis of intracranial bleedings.	[Candefjord, Stefan; Winges, Johan; Malik, Ahzaz Ahmad; Yu, Yinan; Rylander, Thomas; McKelvey, Tomas; Fhager, Andreas; Persson, Mikael] Chalmers Univ Technol, Dept Signals & Syst, S-41296 Gothenburg, Sweden; [Candefjord, Stefan; Yu, Yinan; McKelvey, Tomas; Fhager, Andreas; Elam, Mikael; Persson, Mikael] Sahlgrens Univ Hosp, MedTech West, Roda Straket 10 B, S-41345 Gothenburg, Sweden; [Candefjord, Stefan] SAFER Vehicle & Traff Safety Ctr Chalmers, Gothenburg, Sweden; [Elam, Mikael] Sahlgrens Univ Hosp, Clin Neurophysiol, Bla Straket 5, S-41345 Gothenburg, Sweden		Candefjord, S (corresponding author), Chalmers Univ Technol, Dept Signals & Syst, S-41296 Gothenburg, Sweden.; Candefjord, S (corresponding author), Sahlgrens Univ Hosp, MedTech West, Roda Straket 10 B, S-41345 Gothenburg, Sweden.; Candefjord, S (corresponding author), SAFER Vehicle & Traff Safety Ctr Chalmers, Gothenburg, Sweden.	stefan.candefjord@chalmers.se	McKelvey, Tomas/R-7193-2019; Winges, Johan/A-6770-2016	McKelvey, Tomas/0000-0003-2982-5535; /0000-0001-7942-2190; Winges, Johan/0000-0001-8889-7884	Swedish Research CouncilSwedish Research CouncilEuropean Commission [dnr 2010-4627]	This work was supported in part by the Swedish Research Council (dnr 2010-4627) in the project "Model-based Reconstruction and Classification Based on Near-Field Microwave Measurements." This work has been carried out at SAFER-Vehicle and Traffic Safety Centre at Chalmers, Sweden and CHASE-Chalmers Antenna Systems Excellence Centre. The computations were performed on resources at Chalmers Centre for Computational Science and Engineering (C3SE) provided by the Swedish National Infrastructure for Computing (SNIC). The Department of Anatomy at Sahlgrenska Academy, University of Gothenburg, assisted with development of the hematoma phantom.	Andreuccetti D., 1997, INTERNET RESOURCE CA; BREIMAN L, 1992, INT STAT REV, V60, P291, DOI 10.2307/1403680; Bulters D, 2009, ANAESTHESIA, V64, P277, DOI 10.1111/j.1365-2044.2008.05779.x; Candefjord S, 2013, 35 ANN INT C IEEE EM, P1948; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; GABRIEL C., 1996, ALOETR19960037 RAD R; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Guo L, 2015, IEEE ANTENN WIREL PR, V14, DOI 10.1109/LAWP.2015.2396054; Guo L, 2015, IEEE T ANTENN PROPAG, V63, P3531, DOI 10.1109/TAP.2015.2434394; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Ireland D, 2013, IET MICROW ANTENNA P, V7, P909, DOI 10.1049/iet-map.2013.0054; Jin J. M, 2002, FINITE ELEMENT METHO; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Liu NT, 2014, MED BIOL ENG COMPUT, V52, P193, DOI 10.1007/s11517-013-1130-x; Mahmood Q, 2015, J ELECTROMAG ANAL AP, V7, P152, DOI [DOI 10.4236/JEMAA.2015.75017, DOI 10.4236/jemaa.2015.75017]; Manwaring PK, 2013, ANESTH ANALG, V117, P866, DOI 10.1213/ANE.0b013e318290c7b7; Marion DW, 2006, NEUROSURGERY, V58, P655; Mobashsher AT, 2014, IEEE T MICROW THEORY, V62, P1826, DOI 10.1109/TMTT.2014.2342669; Mohammed BJ, 2014, IEEE T INSTRUM MEAS, V63, P117, DOI 10.1109/TIM.2013.2277562; Nyfors E, 1989, IND MICROWAVE SENSOR; Oh T, 2011, MED BIOL ENG COMPUT, V49, P593, DOI 10.1007/s11517-011-0761-z; Oja E, 1983, ELECT ELECT ENG RES; Persson Mikael, 2009, 2009 3rd European Conference on Antennas and Propagation. EuCAP 2009, P1873; Persson M, 2014, IEEE T BIO-MED ENG, V61, P2806, DOI 10.1109/TBME.2014.2330554; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; ROEBUCK BD, 1975, J FOOD SCI, V40, P899, DOI 10.1111/j.1365-2621.1975.tb02228.x; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Semenov SY, 2008, INT J ANTENN PROPAG, V2008, DOI 10.1155/2008/254830; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Walter S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013758; Zamani A, 2016, IEEE T MICROW THEORY, V64, P653, DOI 10.1109/TMTT.2015.2513398; Zamani A, 2015, IEEE T ANTENN PROPAG, V63, P4921, DOI 10.1109/TAP.2015.2479238; Zeng XZZ, 2011, IEEE T INSTRUM MEAS, V60, P3939, DOI 10.1109/TIM.2011.2141250	38	30	30	0	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	AUG	2017	55	8					1177	1188		10.1007/s11517-016-1578-6			12	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	FD1PX	WOS:000407310300004	27738858	hybrid, Green Published			2022-02-06	
J	Carlozzi, NE; Goodnight, S; Casaletto, KB; Goldsmith, A; Heaton, RK; Wong, AWK; Baum, CM; Gershon, R; Heinemann, AW; Tulsky, DS				Carlozzi, N. E.; Goodnight, S.; Casaletto, K. B.; Goldsmith, A.; Heaton, R. K.; Wong, A. W. K.; Baum, C. M.; Gershon, R.; Heinemann, A. W.; Tulsky, D. S.			Validation of the NIH Toolbox in Individuals with Neurologic Disorders	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Cognition; Emotion; Motor; Sensory; NIHTB; Disability; Spinal cord injury; Traumatic brain injury; Stroke; Assessment; Outcomes assessment (health care)	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; MEASURING EPISODIC MEMORY; OF-THE-LITERATURE; COGNITION BATTERY; HEAD-INJURY; PROCESSING SPEED; EXECUTIVE FUNCTION; STROKE PATIENTS; DEPRESSIVE SYMPTOMS	Objective: Individuals with spinal cord injury (SCI), traumatic brain injury (TBI), and stroke experience a variety of neurologically related deficits across multiple domains of function. The NIH Toolbox for the Assessment of Neurological and Behavioral Function (NIHTB) examines motor, sensation, cognition, and emotional functioning. The purpose of this paper is to establish the validity of the NIHTB in individuals with neurologic conditions. Methods: Community-dwelling individuals with SCI (n = 209), TBI (n = 184), or stroke (n = 211) completed the NIHTB. Relative risks for impaired performance were examined relative to a matched control groups. Results: The largest group differences were observed on the Motor domain and for the Fluid Cognition measures. All groups were at increased risk for motor impairment relative to normative standards and matched controls. Fluid cognitive abilities varied across groups such that individuals with stroke and TBI performed more poorly than individuals with SCI; increased relative risks for impaired fluid cognition were seen for individuals in the stroke and TBI groups, but not for those in the SCI group. All three neurologic groups performed normally on most measures in the Sensation Battery, although TBI participants evidenced increased risk for impaired odor identification and the stroke group showed more vision difficulties. On the Emotion Battery, participants in all three groups showed comparably poor psychological well-being, social satisfaction, and self-efficacy, whereas the TBI group also evidenced slightly increased negative affect. Conclusions: Data provide support for the validity of the NIHTB in individuals with neurologic conditions.	[Carlozzi, N. E.; Goodnight, S.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Casaletto, K. B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94122 USA; [Goldsmith, A.; Heinemann, A. W.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Heaton, R. K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA; [Wong, A. W. K.; Baum, C. M.] Washington Univ, Occupat Therapy, St Louis, MO 63108 USA; [Wong, A. W. K.; Baum, C. M.] Washington Univ, Dept Neurol, St Louis, MO 63108 USA; [Gershon, R.] Northwestern Univ, Dept Med Social Sci, Chicago, IL 60611 USA; [Gershon, R.] Northwestern Univ, Dept Preventat Med, Chicago, IL 60611 USA; [Heinemann, A. W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Tulsky, D. S.] Univ Delaware, Dept Phys Therapy, Ctr Assessment Res & Translat, Newark, DE 19713 USA; [Tulsky, D. S.] Kessler Fdn, W Orange, NJ 07052 USA		Carlozzi, NE (corresponding author), Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685; Tulsky, David/0000-0002-4335-4509	NIDILRR RRTC on Improving Measurement of Medical Rehabilitation Outcomes [H133B090024]; Federal funds from the Blueprint for Neuroscience Research, National Institutes of Health [HHS-N-260-2006-00007-C]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [F31-DA035708]; Foundation for Rehabilitation Psychology Dissertation Award; Craig H. Neilsen Foundation [290474]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U2CCA186878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER	This study was supported by the NIDILRR RRTC on Improving Measurement of Medical Rehabilitation Outcomes (Award number: H133B090024, PI: Heinemann). This project was also supported in part with Federal funds from the Blueprint for Neuroscience Research, National Institutes of Health, under Contract No. HHS-N-260-2006-00007-C. Co-Author, Kaitlin Casaletto, was supported in part by NIDA F31-DA035708 and the Foundation for Rehabilitation Psychology Dissertation Award. Co-Author, Alex Wong, was supported in part by the Craig H. Neilsen Foundation (Award number: 290474, PI: Wong).	Alschuler KN, 2013, J SPINAL CORD MED, V36, P483, DOI 10.1179/2045772312Y.0000000072; Babakhanyan I., 2016, J INT NEUROPSYCHO S1, V22, P65; Barker-Collo S, 2010, NEUROEPIDEMIOLOGY, V35, P255, DOI 10.1159/000319894; Barrett AM, 2014, CURR OPIN NEUROL, V27, P653, DOI 10.1097/WCO.0000000000000148; Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P34, DOI 10.1111/mono.12033; Beaumont JL, 2013, NEUROLOGY, V80, pS87, DOI 10.1212/WNL.0b013e3182872e70; BOTHIG S, 1989, INT J EPIDEMIOL, V18, pS29; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Carlozzi N. E., 2017, VALIDATING NIH TOOLB; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Carlozzi NE, 2013, MONOGR SOC RES CHILD, V78, P88, DOI 10.1111/mono.12036; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen M. L., REHABILITAT IN PRESS; Coldwell SE, 2013, NEUROLOGY, V80, pS20, DOI 10.1212/WNL.0b013e3182872e38; Cook KF, 2013, NEUROLOGY, V80, pS49, DOI 10.1212/WNL.0b013e3182872e80; Cyranowski JM, 2013, HEALTH PSYCHOL, V32, P293, DOI 10.1037/a0028586; Dalton P, 2013, NEUROLOGY, V80, pS32, DOI 10.1212/WNL.0b013e3182872eb4; Dancause N, 2002, NEUROPSYCHOLOGIA, V40, P1313, DOI 10.1016/S0028-3932(01)00218-4; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2014, J INT NEUROPSYCH SOC, V20, P611, DOI 10.1017/S1355617714000460; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DITUNNO JF, 1992, ARCH PHYS MED REHAB, V73, P431; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Droste DW, 2014, CLIN MED INSIGHTS-CA, V8, P9, DOI 10.4137/CMC.S15225; Dudley-Javoroski S, 2006, DISABIL REHABIL, V28, P103, DOI 10.1080/09638280500163828; Dunn W, 2013, NEUROLOGY, V80, pS41, DOI 10.1212/WNL.0b013e3182872c54; Enderby P M, 1987, Int Rehabil Med, V8, P166; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Gefen A, 2014, OSTOMY WOUND MANAG, V60, P34; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Haisma J, 2007, CLIN REHABIL, V21, P932, DOI 10.1177/0269215507079134; Heaton R.M., 2004, REV COMPREHENSIVE NO; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Hess MJ, 2003, J SPINAL CORD MED, V26, P335, DOI 10.1080/10790268.2003.11753702; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Huang CY, 2015, SPINAL CORD, V53, P413, DOI 10.1038/sc.2014.158; Ivnik RJ, 2001, CLIN NEUROPSYCHOL, V15, P114, DOI 10.1076/clin.15.1.114.1904; Jones C, 2013, NEUROREHABILITATION, V32, P351, DOI 10.3233/NRE-130855; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Krueger H, 2013, SPINAL CORD, V51, P260, DOI 10.1038/sc.2013.3; Kupst MJ, 2015, ANXIETY STRESS COPIN, V28, P531, DOI 10.1080/10615806.2014.994204; Lazzaro I, 2013, J CLIN NEUROPHYSIOL, V30, P59, DOI 10.1097/WNP.0b013e31827edb0c; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Li YQ, 2012, J REHABIL MED, V44, P534, DOI 10.2340/16501977-1005; Lightbody CE, 2007, J ADV NURS, V60, P595, DOI 10.1111/j.1365-2648.2007.04508.x; Lightbody CE, 2007, J ADV NURS, V57, P505, DOI 10.1111/j.1365-2648.2006.04135.x; Loranger M, 2000, PSYCHOL REP, V87, P893, DOI 10.2466/PR0.87.7.893-900; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Murray RF, 2007, SPINAL CORD, V45, P429, DOI 10.1038/sj.sc.3102022; Narayan R. K., 1990, REHABILITATION ADULT; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Pilkonis PA, 2013, PSYCHIAT RES, V206, P88, DOI 10.1016/j.psychres.2012.09.034; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Recio AC, 2012, J SPINAL CORD MED, V35, P58, DOI 10.1179/2045772311Y.0000000044; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; Ribaric-Jankes K, 2009, SPINAL CORD, V47, P401, DOI 10.1038/sc.2008.163; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Rine RM, 2013, NEUROLOGY, V80, pS25, DOI 10.1212/WNL.0b013e3182872c6a; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rothwell K, 2013, CLIN REHABIL, V27, P264, DOI 10.1177/0269215512457403; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Salsman JM, 2014, QUAL LIFE RES, V23, P205, DOI 10.1007/s11136-013-0452-3; Salsman JM, 2013, NEUROLOGY, V80, pS76, DOI 10.1212/WNL.0b013e3182872e11; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Sigurdardottir S, 2016, NEUROPSYCHOLOGY, V30, P98, DOI 10.1037/neu0000206; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Soekadar S.R., 2014, NEUROBIOLOGY DIS; Steuer E, 2014, J NEUROTRAUM, V31, P1277, DOI 10.1089/neu.2013.3296; Su CY, 2015, ARCH CLIN NEUROPSYCH, V30, P148, DOI 10.1093/arclin/acu057; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; Tulsky D., 2017, VALIDATING NIH TOOLB; Tulsky DS, 2014, J INT NEUROPSYCH SOC, V20, P599, DOI 10.1017/S135561771400040X; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Varma R, 2013, NEUROLOGY, V80, pS37, DOI 10.1212/WNL.0b013e3182876e0a; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001; Waters R L, 1998, J Spinal Cord Med, V21, P195; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P67; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Westermann A, 2012, PAIN, V153, P1537, DOI 10.1016/j.pain.2012.02.031; Whyte J, 2005, PHYS MED REHABILITAT; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; World Health Organization, 1990, WHO MONICA PROJ; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	113	30	31	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2017	32	5					555	573		10.1093/arclin/acx020			19	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FC8RL	WOS:000407108500005	28334392	Bronze, Green Published			2022-02-06	
J	Hawley, C; Sakr, M; Scapinello, S; Salvo, J; Wrenn, P				Hawley, Carol; Sakr, Magdy; Scapinello, Sarah; Salvo, Jesse; Wrenn, Paul			Traumatic brain injuries in older adults-6 years of data for one UK trauma centre: retrospective analysis of prospectively collected data	EMERGENCY MEDICINE JOURNAL			English	Article							SEVERE HEAD-INJURY; GLASGOW COMA SCALE; MORTALITY; SEVERITY; EPIDEMIOLOGY; PREDICTION; VALIDATION; SYSTEM; DEATH; MODEL	Objectives Our aim was to determine the incidence of traumatic brain injury (TBI) in older adults and investigate the relationship between injury characteristics and outcomes. Methods Retrospective analysis of prospectively collected data submitted to Trauma Audit and Research Network (TARN) database for a major trauma centre in the West Midlands, UK, from 2008 to 2014. The Mayo Scale was used to categorise TBI. All patients were aged >= 65 years and were admitted with head or brain injuries meeting TARN inclusion criteria: injury resulting in immediate admission to hospital for 3 days, admitted to a high dependency area or death following trauma. We determined age, gender, mechanism of injury, Injury Severity Score, presenting Glasgow Coma Scale (GCS) and Mayo Score, and the association of outcome (Glasgow Outcome Scale (GOS)) with age and clinical presentation. Results 4413 patients were admitted with trauma meeting TARN criteria: 1389 were >= 65 years and 45% (624) had TBI. For patients >= 65 years with TBI, mean age was 79 (range 65-99); 56% were men. Falls accounted for 85% of all TBIs. Most TBIs were moderate/severe (80%) by the Mayo criteria. Of the 279 patients with subdural haematoma, 28% had neurosurgery. Most patients survived TBI (78%); 57% had a good outcome on GOS at discharge (not requiring care package). Mortality was associated with increased age (17% in ages 65-74 years, 19% in 75-84 years, 30% in >= 85 years, p=0.03). Outcome was significantly associated with injury severity (p=0.0001). Conclusions Patients with TBI represented 45% of all trauma cases meeting TARN inclusion criteria. Falls at home accounted for most TBIs. Most had moderate/severe TBI, yet over half made a good recovery on GOS. Our data indicate that injury prevention initiatives should focus on home safety. Further research is needed to examine rehabilitation and follow-up after hospital discharge.	[Hawley, Carol] Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England; [Sakr, Magdy] Univ Hosp Coventry & Warwickshire, Dept Emergency Med, Coventry, W Midlands, England; [Scapinello, Sarah] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Salvo, Jesse; Wrenn, Paul] Univ Hosp Coventry & Warwickshire, Dept Emergency Care, Coventry, W Midlands, England		Hawley, C (corresponding author), Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England.	c.a.hawley@warwick.ac.uk	Hawley, Carmel Mary/C-4905-2011; Hawley, Carol/AAG-3830-2019	Hawley, Carmel Mary/0000-0002-1392-5649; 	University of Warwick under University Research Scholarship Scheme	SS received a bursary from the University of Warwick under the University Research Scholarship Scheme. The researchers are independent of the above funding.	Boye NDA, 2013, TRAUMA, V15, P29, DOI 10.1177/1460408612463145; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Centers for Disease Control and Prevention, 2013, INJ PREV CONTR TRAUM; Centres for Disease Control and Prevention, 2013, HOM RECR SAF FALLS O; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Health and Social Care Information Centre, 2012, ACC EM ATT ENGL 2012; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Office of National Statistics, 2013, POP EST UK ENGL WAL; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5166; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Swann I, 1999, TRAUMA, V1, P143; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Trauma audit and research network, 2014, PROC MAN; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	28	30	32	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	AUG	2017	34	8					509	+		10.1136/emermed-2016-206506			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FB0SF	WOS:000405854100005	28052919	Bronze, Green Published			2022-02-06	
J	Mukai, T; Mori, Y; Shimazu, T; Takahashi, A; Tsunoda, H; Yamaguchi, S; Kiryu, S; Tojo, A; Nagamura-Inoue, T				Mukai, Takeo; Mori, Yuka; Shimazu, Takahisa; Takahashi, Atsuko; Tsunoda, Hajime; Yamaguchi, Satoru; Kiryu, Shigeru; Tojo, Arinobu; Nagamura-Inoue, Tokiko			INTRAVENOUS INJECTION OF UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELLS ATTENUATES REACTIVE GLIOSIS AND HYPOMYELINATION IN A NEONATAL INTRAVENTRICULAR HEMORRHAGE MODEL	NEUROSCIENCE			English	Article						mesenchymal stromal cell; umbilical cord; intraventricular hemorrhage; cerebral palsy; brain-derived neurotrophic factor; Hepatocyte growth factor	HEPATOCYTE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; STEM-CELLS; FUNCTIONAL RECOVERY; PERIVENTRICULAR/INTRAVENTRICULAR HEMORRHAGE; IMMUNOSUPPRESSIVE PROPERTIES; NEUROLOGICAL RECOVERY; BLOOD-BRAIN; THERAPY; MYELINATION	Intraventricular hemorrhage (IVH) is a frequent complication of preterm newborns, resulting in cerebral palsy and cognitive handicap as well as hypoxic ischemic encephalopathy and periventricular leukomalacia. In this study, we investigated the restorative effect on neonatal IVH by umbilical cord-derived mesenchymal stromal cells (UC-MSCs) cultured in serum-free medium (RM medium) for clinical application. UC-MSCs were cultured with alpha MEM medium supplemented with FBS or RM. A neonatal IVH mouse model at postnatal day 5 was generated by intraventricular injection of autologous blood, and mice were intravenously administered 1 x 10(5) UC-MSCs two days after IVH. Brain magnetic resonance imaging was performed at postnatal day 15, 22 and neurological behavioral measurements were performed at postnatal day 23, accompanied by histopathological analysis and cytokine bead assays in serum after IVH with or without UC-MSCs. Both UC-MSCs cultured with aMEM and RM met the criteria of MSCs and improved behavioral outcome of IVH mice. Moreover the RM group exhibited significant behavioral improvement compared to the control group. Histopathological analysis revealed UC-MSCs cultured with RM significantly attenuated periventricular reactive gliosis, hypomyelination, and periventricular cell death observed after IVH. Furthermore, human brain-derived neurotrophic factor and hepatocyte growth factor were elevated in the serum, cerebrospinal fluid and brain tissue of neonatal IVH model mice 24 h after UC-MSCs administration. These results suggest UC-MSCs attenuate neonatal IVH by protecting gliosis and apoptosis of the injured brain, and intravenous injection of UC-MSCs cultured in RM may be feasible for neonatal IVH in clinic. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Mukai, Takeo; Tojo, Arinobu] Univ Tokyo, Inst Med Sci, Ctr Adv Med Res, Div Mol Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Mukai, Takeo; Mori, Yuka; Shimazu, Takahisa; Takahashi, Atsuko; Tojo, Arinobu; Nagamura-Inoue, Tokiko] Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Tsunoda, Hajime] NTT Med Ctr Tokyo Hosp, Dept Obstet, Shinagawa Ku, 5-9-22 Higashigotannda, Tokyo 1410022, Japan; [Yamaguchi, Satoru] Yamaguchi Hosp, Dept Obstet, 5-24-2 Nishifuna, Funabashi, Chiba 2730031, Japan; [Kiryu, Shigeru] Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan		Nagamura-Inoue, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tokikoni@ims.u-tokyo.ac.jp	Kiryu, Shigeru/B-6867-2019; Mukai, Takeo/H-8335-2019	Kiryu, Shigeru/0000-0003-1440-9483; Mukai, Takeo/0000-0001-6648-1271	Japan Agency for Medical Research and Development/Ministry of Health, Labor and WelfareJapan Agency for Medical Research and Development (AMED) [16Abk0104010h0015]; Ministry of Education, Culture, Sports, Science and Technology (JSPS KAKENHI)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP26293251]	This study was supported by Grants-in-Aids for Scientific Research from the Japan Agency for Medical Research and Development/Ministry of Health, Labor and Welfare (16Abk0104010h0015) and from the Ministry of Education, Culture, Sports, Science and Technology (JSPS KAKENHI Grant Number JP26293251). We specially thank Dr. Ota, Y. and Mr. Onoda for his excellent assistance with immunohistochemistry and the staff of NTT Medical Center Hospital and Yamaguchi Hospital, Tokyo, for their assistance with the collection of UC and CB.	Abellaneda JM, 2015, TRANSPL P, V47, P132, DOI 10.1016/j.transproceed.2014.11.016; Ahn So Yoon, 2014, Korean J Pediatr, V57, P251, DOI 10.3345/kjp.2014.57.6.251; Ahn SY, 2013, STROKE, V44, P497, DOI 10.1161/STROKEAHA.112.679092; Bieback Karen, 2007, Curr Stem Cell Res Ther, V2, P310, DOI 10.2174/157488807782793763; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Chua CO, 2009, STROKE, V40, P3369, DOI 10.1161/STROKEAHA.109.549212; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Cotten CM, 2014, J PEDIATR-US, V164, P973, DOI 10.1016/j.jpeds.2013.11.036; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dummula K, 2011, J NEUROSCI, V31, P12068, DOI 10.1523/JNEUROSCI.0013-11.2011; Georgiadis P, 2008, STROKE, V39, P3378, DOI 10.1161/STROKEAHA.107.510883; Gnecchi Massimiliano, 2009, V482, P281, DOI 10.1007/978-1-59745-060-7_18; Gram M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-100; Gruber HE, 2010, TISSUE ENG PT A, V16, P2843, DOI [10.1089/ten.tea.2009.0709, 10.1089/ten.TEA.2009.0709]; Guo ZY, 2015, NEURAL REGEN RES, V10, P651, DOI 10.4103/1673-5374.155442; Han DM, 2011, CYTOTHERAPY, V13, P913, DOI 10.3109/14653249.2011.579958; He HP, 2015, INT J HEMATOL, V102, P368, DOI 10.1007/s12185-015-1844-7; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jin JL, 2013, CURR NEUROVASC RES, V10, P11, DOI 10.2174/156720213804805936; Kadoyama K, 2007, NEUROSCI RES, V59, P446, DOI 10.1016/j.neures.2007.08.017; Kienstra KA, 2007, J AM ASSOC LAB ANIM, V46, P50; Kim ES, 2012, PEDIATR RES, V72, P277, DOI 10.1038/pr.2012.71; Koh SH, 2008, BRAIN RES, V1229, P233, DOI 10.1016/j.brainres.2008.06.087; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Liu AM, 2010, NEUROSURGERY, V67, P357, DOI 10.1227/01.NEU.0000371983.06278.B3; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Ment LR, 2015, SEMIN PERINATOL, V39, P592, DOI 10.1053/j.semperi.2015.09.006; Mori Y, 2015, TISSUE ENG PART C-ME, V21, P367, DOI [10.1089/ten.tec.2014.0385, 10.1089/ten.TEC.2014.0385]; Mukai T, 2015, CYTOTHERAPY; Mukerji A, 2015, PEDIATRICS, V136, P1132, DOI 10.1542/peds.2015-0944; Pan WH, 2006, EXP NEUROL, V201, P99, DOI 10.1016/j.expneurol.2006.03.026; Peckham H, 2016, GLIA, V64, P255, DOI 10.1002/glia.22927; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Pollock K, 2016, MOL THER, V24, P965, DOI 10.1038/mt.2016.12; Qi ZH, 2017, NEUROSCI LETT, V637, P120, DOI 10.1016/j.neulet.2016.11.038; STURROCK RR, 1980, J ANAT, V130, P391; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; Vinukonda G, 2013, EXP NEUROL, V247, P630, DOI 10.1016/j.expneurol.2013.02.018; Vinukonda G, 2010, BRAIN, V133, P2264, DOI 10.1093/brain/awq107; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wang XD, 2015, CYTOTHERAPY, V17, P224, DOI 10.1016/j.jcyt.2014.09.010; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Wang YY, 2016, MOL NEUROBIOL, V53, P3448, DOI 10.1007/s12035-015-9263-6; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Xiang JJ, 2009, CYTOTHERAPY, V11, P516, DOI 10.1080/14653240902960429; Xiao JH, 2010, NEUROSIGNALS, V18, P186, DOI 10.1159/000323170; Xue MZ, 2003, J NEUROPATH EXP NEUR, V62, P1154, DOI 10.1093/jnen/62.11.1154; Yan HL, 2002, J NEUROSCI RES, V69, P597, DOI 10.1002/jnr.10323; Zhu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097423; Zhu Y, 2014, ACTA PHARMACOL SIN, V35, P585, DOI 10.1038/aps.2014.9	56	30	30	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 4	2017	355						175	187		10.1016/j.neuroscience.2017.05.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY6EQ	WOS:000404075700015	28504197				2022-02-06	
J	Cusimano, MD; Topolovec-Vranic, J; Zhang, S; Mullen, SJ; Wong, M; Ilie, G				Cusimano, Michael D.; Topolovec-Vranic, Jane; Zhang, Stanley; Mullen, Sarah J.; Wong, Mattew; Ilie, Gabriela			Factors Influencing the Underreporting of Concussion in Sports: A Qualitative Study of Minor Hockey Participants	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; attitude; traumatic brain injury; adolescent; sports	BRAIN-INJURY; ICE HOCKEY; RECURRENT CONCUSSION; FOOTBALL PLAYERS; RETURN; GUIDELINES; EPIDEMIOLOGY; MANAGEMENT; KNOWLEDGE	Objective: The present study is to identify factors contributing to underreporting of concussion in adolescent athletes. Design: Qualitative interviews. Setting: Participants were interviewed in an office environment. Participants: Interviews were conducted with 31 minor hockey players, 10 parents, 6 coaches, 4 trainers, 2 managers, and one game official. Players were 13 to 15 year old. With selective sampling, an inductive approach of analyzing the interviews was undertaken and themes were identified and analyzed. Assessment of Risk Factors: Underreporting is a complex phenomenon. A number of risk factors related to hockey culture, players, reference others, and rules of play were assessed. Main Outcome Measures: Reasons not reporting concussion is accepted in minor hockey. Results: Aspects of hockey culture such as an overemphasis on winning games and upheld misperceptions about the risks associated with concussion were identified as relevant to the underreporting of concussions. Various factors relevant to the underreporting of concussions include player's motivation to win, group membership dynamics such as a player's role as the team's "enforcer," coaches' own motivation to win to further their own opportunities in the sport, and parents' personal financial interest or alternative agenda in terms of time commitments and their child's future career prospects. Conclusions: Our findings indicate that underreporting of concussion among those players interviewed appears to be prevalent and associated with misconceptions about injury risk, and a culture that both reinforces and encourages underreporting with tacit or overt complicity of parents and coaches. Our findings support the need to alter the culture of violence and tough play in hockey by education, rule changes, economic measures, and changes in governance of the sport. Interviewing more stakeholders and policy makers would shed light on such potential interventions.	[Cusimano, Michael D.; Zhang, Stanley; Mullen, Sarah J.; Wong, Mattew; Ilie, Gabriela] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Injury Prevent Res Off,Dept Surg,Div Neurosurg, Toronto, ON, Canada; [Cusimano, Michael D.] Canadian Brain Injury & Violence Res Team, Toronto, ON, Canada; [Cusimano, Michael D.; Topolovec-Vranic, Jane] St Michaels Hosp, Li KaShing Knowledge Inst, Trauma & Neurosurg Program, Keenan Res Ctr, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, Educ & Publ Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Topolovec-Vranic, Jane/A-5293-2013; Cusimano, Michael/X-4059-2019; Ilie, Gabriela/AAM-9122-2021	Topolovec-Vranic, Jane/0000-0001-7695-4212; 	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	M. D. Cusimano is currently receiving a grant (#TIR-103946) from the Canadian Institutes of Health Research and Ontario Neurotrauma Foundation.	Ackery A, 2009, CAN J NEUROL SCI, V36, P207, DOI 10.1017/S0317167100120281; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bauman J, 2005, CLIN J SPORT MED, V15, P432, DOI 10.1097/01.jsm.0000186682.21040.82; Canadian Broadcasting Corporation, 2003, HOCK NIGHT CAN COACH; CANTU RV, 1994, J NEUROSURG, V80, P592; Charmaz K., 2014, BROKERAGE CLOSURE IN; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Cusimano Michael D, 2011, Open Med, V5, pe57; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Denzin N.K., 2011, SAGE HDB QUALITATIVE; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; FICK DS, 1995, POSTGRAD MED, V97, P53, DOI 10.1080/00325481.1995.11945958; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Fuld GL, 2009, PEDIATRICS, V124, P1495, DOI 10.1542/peds.2009-2146; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lear AM, 2012, J FAM PRACTICE, V61, P323; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Murphy A, 2012, PM&R, V4, P419, DOI 10.1016/j.pmrj.2012.03.013; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Smith M D, 1979, Can J Appl Sport Sci, V4, P76; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	40	30	30	1	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2017	27	4					375	380		10.1097/JSM.0000000000000372			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	EZ4EA	WOS:000404663800012	28653965				2022-02-06	
J	Jalloh, I; Helmy, A; Howe, DJ; Shannon, RJ; Grice, P; Mason, A; Gallagher, CN; Stovell, MG; van der Heide, S; Murphy, MP; Pickard, JD; Menon, DK; Carpenter, TA; Hutchinson, PJ; Carpenter, KLH				Jalloh, Ibrahim; Helmy, Adel; Howe, Duncan J.; Shannon, Richard J.; Grice, Peter; Mason, Andrew; Gallagher, Clare N.; Stovell, Matthew G.; van der Heide, Susan; Murphy, Michael P.; Pickard, John D.; Menon, David K.; Carpenter, T. Adrian; Hutchinson, Peter J.; Carpenter, Keri L. H.			Focally perfused succinate potentiates brain metabolism in head injury patients	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Traumatic brain injury (human); microdialysis; nuclear magnetic resonance spectroscopy; cerebral metabolism; succinate	ACID DIMETHYL ESTER; CEREBRAL MICRODIALYSIS; RAT-BRAIN; C-13-LABELED MICRODIALYSIS; SLC13 FAMILY; C-13 NMR; LACTATE; GLUCOSE; TRANSPORTERS; GLYCEROL	Following traumatic brain injury, complex cerebral energy perturbations occur. Correlating with unfavourable outcome, high brain extracellular lactate/pyruvate ratio suggests hypoxic metabolism and/or mitochondrial dysfunction. We investigated whether focal administration of succinate, a tricarboxylic acid cycle intermediate interacting directly with the mitochondrial electron transport chain, could improve cerebral metabolism. Microdialysis perfused disodium 2,3-C-13(2) succinate (12mmol/L) for 24h into nine sedated traumatic brain injury patients' brains, with simultaneous microdialysate collection for ISCUS analysis of energy metabolism biomarkers (nine patients) and nuclear magnetic resonance of C-13-labelled metabolites (six patients). Metabolites 2,3-C-13(2) malate and 2,3-C-13(2) glutamine indicated tricarboxylic acid cycle metabolism, and 2,3-C-13(2) lactate suggested tricarboxylic acid cycle spinout of pyruvate (by malic enzyme or phosphoenolpyruvate carboxykinase and pyruvate kinase), then lactate dehydrogenase-mediated conversion to lactate. Versus baseline, succinate perfusion significantly decreased lactate/pyruvate ratio (p=0.015), mean difference -12%, due to increased pyruvate concentration (+17%); lactate changed little (-3%); concentrations decreased for glutamate (-43%) (p=0.018) and glucose (-15%) (p=0.038). Lower lactate/pyruvate ratio suggests better redox status: cytosolic NADH recycled to NAD(+) by mitochondrial shuttles (malate-aspartate and/or glycerol 3-phosphate), diminishing lactate dehydrogenase-mediated pyruvate-to-lactate conversion, and lowering glutamate. Glucose decrease suggests improved utilisation. Direct tricarboxylic acid cycle supplementation with 2,3-C-13(2) succinate improved human traumatic brain injury brain chemistry, indicated by biomarkers and C-13-labelling patterns in metabolites.	[Jalloh, Ibrahim; Helmy, Adel; Shannon, Richard J.; Gallagher, Clare N.; Stovell, Matthew G.; van der Heide, Susan; Pickard, John D.; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Howe, Duncan J.; Grice, Peter; Mason, Andrew] Univ Cambridge, Dept Chem, Cambridge, England; [Pickard, John D.; Menon, David K.; Carpenter, T. Adrian; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Gallagher, Clare N.] Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Calgary, AB, Canada; [Murphy, Michael P.] MRC Mitochondrial Biol Unit, Cambridge, England; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge, England		Jalloh, I; Carpenter, KLH (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	ibrahim.jalloh@cantab.net; klc1000@wbic.cam.ac.uk	Helmy, Adel/AAS-3084-2020; Murphy, Michael/C-2120-2009	Helmy, Adel/0000-0002-0531-0556; Carpenter, Keri/0000-0001-8236-7727; Murphy, Michael/0000-0003-1115-9618	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Medical Research Council/Royal College of Surgeons of England Clinical Research Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251]; Raymond and Beverly Sackler Fellowship; National Institute for Health Research Senior Investigator Awards; National Institute for Health Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237, G0600986, MC_U105663142, G1002277] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0001237, MC_U105663142, G0600986, G1002277, G1000183B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090, NF-SI-0508-10327, NIHR-RP-R3-12-013] Funding Source: researchfish	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Medical Research Council (Grant Nos. G0600986 ID79068 and G1002277 ID98489) and National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: IJ - Medical Research Council (Grant no. G1002277 ID 98489) and National Institute for Health Research Biomedical Research Centre, Cambridge; KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); CG - the Canadian Institute of Health Research; AH - Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship (Grant no. G0802251) and Raymond and Beverly Sackler Fellowship; DKM and JDP - National Institute for Health Research Senior Investigator Awards; PJH - National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge.	ALDRIDGE WN, 1959, BIOCHEM J, V73, P270, DOI 10.1042/bj0730270; Bergeron MJ, 2013, MOL ASPECTS MED, V34, P299, DOI 10.1016/j.mam.2012.12.001; Carpenter KLH, 2014, EUR J PHARM SCI, V57, P87, DOI 10.1016/j.ejps.2013.12.012; CERDAN S, 1990, J BIOL CHEM, V265, P12916; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; Cruz F, 1998, J NEUROCHEM, V70, P2613; Cruz F, 1999, NMR BIOMED, V12, P451, DOI 10.1002/(SICI)1099-1492(199911)12:7<451::AID-NBM571>3.3.CO;2-5; ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529; Ferreira FL, 2000, HORM METAB RES, V32, P335, DOI 10.1055/s-2007-978647; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gonzalez SV, 2005, J NEUROCHEM, V95, P284, DOI 10.1111/j.1471-4159.2005.03365.x; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Kekuda R, 1999, J BIOL CHEM, V274, P3422, DOI 10.1074/jbc.274.6.3422; Kerby D.S, 2014, COMPR PSYCHOL, V3, P11; Lamp J, 2011, J BIOL CHEM, V286, P17777, DOI 10.1074/jbc.M111.232744; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; Malaisse WJ, 1997, NUTRITION, V13, P330; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Murugan M, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00019; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Nguyen NHT, 2007, J NEUROCHEM, V101, P1694, DOI 10.1111/j.1471-4159.2006.04433.x; Pajor AM, 1999, ANNU REV PHYSIOL, V61, P663, DOI 10.1146/annurev.physiol.61.1.663; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; Protti A, 2006, CRIT CARE, V10, DOI 10.1186/cc5014; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/BSE0470001, 10.1042/bse0470001]; Sanganahalli BG, 2013, J CEREBR BLOOD F MET, V33, P1115, DOI 10.1038/jcbfm.2013.61; Schlessinger A, 2014, J BIOL CHEM, V289, P16998, DOI 10.1074/jbc.M114.554790; Shannon RJ, 2014, BRIT J CLIN PHARMACO, V78, P981, DOI 10.1111/bcp.12414; Sonnewald U, 2014, J NEUROCHEM, V131, P399, DOI 10.1111/jnc.12812; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tyson RL, 2003, BRAIN RES, V992, P43, DOI 10.1016/j.brainres.2003.08.027; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606	45	30	31	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2017	37	7					2626	2638		10.1177/0271678X16672665			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	EY3XE	WOS:000403907700026	27798266	Green Submitted, Green Published			2022-02-06	
J	Kowalski, RG; Haarbauer-Krupa, JK; Bell, JM; Corrigan, JD; Hammond, FM; Torbey, MT; Hofmann, MC; Dams-O'Connor, K; Miller, AC; Whiteneck, GG				Kowalski, Robert G.; Haarbauer-Krupa, Juliet K.; Bell, Jeneita M.; Corrigan, John D.; Hammond, Flora M.; Torbey, Michel T.; Hofmann, Melissa C.; Dams-O'Connor, Kristen; Miller, A. Cate; Whiteneck, Gale G.			Acute Ischemic Stroke After Moderate to Severe Traumatic Brain Injury Incidence and Impact on Outcome	STROKE			English	Article						acute ischemic stroke; cognition; outcome; stroke; traumatic brain injury	TISSUE-PLASMINOGEN ACTIVATOR; HEALTH-CARE PROFESSIONALS; ENDOVASCULAR TREATMENT; YOUNG-ADULTS; RISK; EPIDEMIOLOGY; REHABILITATION; MULTICENTER; ORIENTATION; RELIABILITY	Background and Purpose-Traumatic brain injury (TBI) leads to nearly 300 000 annual US hospitalizations and increased lifetime risk of acute ischemic stroke (AIS). Occurrence of AIS immediately after TBI has not been well characterized. We evaluated AIS acutely after TBI and its impact on outcome. Methods-A prospective database of moderate to severe TBI survivors, admitted to inpatient rehabilitation at 22 Traumatic Brain Injury Model Systems centers and their referring acute-care hospitals, was analyzed. Outcome measures were AIS incidence, duration of posttraumatic amnesia, Functional Independence Measure, and Disability Rating Scale, at rehabilitation discharge. Results-Between October 1, 2007, and March 31, 2015, 6488 patients with TBI were enrolled in the Traumatic Brain Injury Model Systems National Database. One hundred and fifty-nine (2.5%) patients had a concurrent AIS, and among these, median age was 40 years. AIS was associated with intracranial mass effect and carotid or vertebral artery dissection. High-velocity events more commonly caused TBI with dissection. AIS predicted poorer outcome by all measures, accounting for a 13.3-point reduction in Functional Independence Measure total score (95% confidence interval, -16.8 to -9.7; P<0.001), a 1.9-point increase in Disability Rating Scale (95% confidence interval, 1.3-2.5; P<0.001), and an 18.3-day increase in posttraumatic amnesia duration (95% confidence interval, 13.1-23.4; P<0.001). Conclusions-Ischemic stroke is observed acutely in 2.5% of moderate to severe TBI survivors and predicts worse functional and cognitive outcome. Half of TBI patients with AIS were aged <= 40 years, and AIS patients more often had cervical dissection. Vigilance for AIS is warranted acutely after TBI, particularly after high-velocity events.	[Kowalski, Robert G.; Hofmann, Melissa C.; Whiteneck, Gale G.] Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA; [Haarbauer-Krupa, Juliet K.; Bell, Jeneita M.] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Atlanta, GA USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Wexner Med Ctr, Columbus, OH 43210 USA; [Torbey, Michel T.] Ohio State Univ, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA; [Torbey, Michel T.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Torbey, Michel T.] Ohio State Univ, Dept Neurol Surg, Div Cerebrovasc Dis & Neurocrit Care, Wexner Med Ctr, Columbus, OH 43210 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Miller, A. Cate] NIDILRR, Adm Community Living, US Dept HHS, Detroit, MI USA		Kowalski, RG (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	rkowalski@craighospital.org	Corrigan, John D./E-2921-2011		Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR)US Department of Education [H133A110006]; US Department of Health and Human Services (HHS)	This research was supported by an interagency agreement between the US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), and the US Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) with supplemental funding to the NIDRR-funded Traumatic Brain Injury Model Systems National Data and Statistical Center (grant no. H133A110006; online-only Data Supplement).	Aarnio K, 2016, NEUROLOGY, V86, P1872, DOI 10.1212/WNL.0000000000002689; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Centers for Disease Control and Prevention, TBI GET FACTS; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Chen GS, 2016, J NEUROTRAUM, V33, P1263, DOI 10.1089/neu.2015.4063; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Demaerschalk BM, 2016, STROKE, V47, P581, DOI 10.1161/STR.0000000000000086; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kwon HS, 2016, J STROKE CEREBROVASC, V25, P1503, DOI 10.1016/j.jstrokecerebrovasdis.2016.02.034; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Mandalenakis Z, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003071; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ramirez L, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003233; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutten-Jacobs LCA, 2013, ANN NEUROL, V74, P592, DOI 10.1002/ana.23953; Saver JL, 2015, INT J STROKE, V10, P439, DOI 10.1111/ijs.12459; Smajlovic D, 2015, VASC HEALTH RISK MAN, V11, P157, DOI 10.2147/VHRM.S53203; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tibaek M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003158; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zivin JA, 2009, ANN NEUROL, V66, P6, DOI 10.1002/ana.21750	35	30	31	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUL	2017	48	7					1802	+		10.1161/STROKEAHA.117.017327			17	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Cardiovascular System & Cardiology	EY5TX	WOS:000404044100033	28611087	Green Accepted, Green Published, Bronze			2022-02-06	
J	Masoudi, A; Dargahi, L; Abbaszadeh, F; Pourgholami, MH; Asgari, A; Manoochehri, M; Jorjani, M				Masoudi, Alireza; Dargahi, Leila; Abbaszadeh, Fatemeh; Pourgholami, Mohammad Hosein; Asgari, Alireza; Manoochehri, Mehdi; Jorjani, Masoumeh			Neuroprotective effects of astaxanthin in a rat model of spinal cord injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Astaxanthin; Neuroprotection; Spinal cord injury; Apoptosis	EARLY BRAIN-INJURY; OXIDATIVE STRESS; FUNCTIONAL RECOVERY; TRAUMATIC BRAIN; SUBARACHNOID HEMORRHAGE; ELECTROLYTIC LESION; SPINOTHALAMIC TRACT; CEREBRAL-ISCHEMIA; IN-VITRO; APOPTOSIS	Spinal cord injury (SCI) often leads to constant neurological deficits and long-term unalterable disability. Apoptosis plays an important role in the initiation of the secondary injury cascades leading to progressive tissue damage and severely functional deficits after SCI. Although the primary mechanical destructive events cannot be reversed, a therapeutic intervention could be carried out in order to moderate the secondary injury damage several hours to weeks after injury. Astaxanthin (AST) is a strong antioxidant and anti-inflammatory agents with the potential to render anti-apoptotic and neuroprotective effects. In the current study, we examined the therapeutic potential of AST on adult rats after severe SCI contusion. Results of BBB scores showed that AST improved motor function after SCI compared to control groups. Westem blot analysis showed reduced expression of Box and Cleaved-caspase-3 proteins and increased expression of the Bcl-2 protein in response to AST treatment (p < 0.05). The histology results also showed that AST considerably preserved myelinated white matter and the number of motor neurons. This study is the first to report that AST reduces neuronal apoptosis, diminishes pathological tissue damage and improves functional recovery after SCI. The observed prominent neuroprotective effects, introduces AST as a promising therapy for SCI.	[Masoudi, Alireza; Jorjani, Masoumeh] Shahid Beheshti Univ Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran; [Dargahi, Leila; Abbaszadeh, Fatemeh; Jorjani, Masoumeh] Shahid Beheshti Univ Med Sci, Neurobiol Res Ctr, Tehran, Iran; [Pourgholami, Mohammad Hosein] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Asgari, Alireza] Baqiyatallah Univ Med Sci, Sport Physiol Res Ctr, Tehran, Iran; [Asgari, Alireza] AJA Med Sci Univ, Aerosp Med Res Ctr, Tehran, Iran; [Manoochehri, Mehdi] Shahroud Univ Med Sci, Sch Med, Shahroud, Iran		Jorjani, M (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran.	msjorjani@sbmu.ac.ir	Masoudi, Alireza/AAZ-9879-2021; Dargahi, Leila/K-4693-2017; Jorjani, Masoumeh/AAV-5596-2021	Masoudi, Alireza/0000-0002-5598-9384; Dargahi, Leila/0000-0001-7777-5435; 	School of Medicine and Neurobiology Research Center of Shahid Beheshti University of Medical Sciences [B-N-28-1394]	This study was performed as part of a Ph.D. thesis project funded by School of Medicine and Neurobiology Research Center (Grant No. B-N-28-1394) of Shahid Beheshti University of Medical Sciences.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Al-Amin MM, 2015, BEHAV BRAIN RES, V286, P112, DOI 10.1016/j.bbr.2015.02.041; Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; Aydemir S., 2015, SPIN CORD; Bai WS, 2012, AFR J PHARM PHARMACO, V6, P2559, DOI 10.5897/AJPP12.855; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bastani NE, 2012, ARCH PHYS MED REHAB, V93, P2223, DOI 10.1016/j.apmr.2012.06.021; Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x; Chan KC, 2009, J FOOD SCI, V74, pH225, DOI 10.1111/j.1750-3841.2009.01274.x; Chang CH, 2010, J MED FOOD, V13, P548, DOI 10.1089/jmf.2009.1291; Chen HC, 2014, SPINAL CORD, V52, P24, DOI 10.1038/sc.2013.140; Chen WP, 2014, INT IMMUNOPHARMACOL, V19, P174, DOI 10.1016/j.intimp.2013.12.007; Chen WF, 2015, CNS NEUROSCI THER, V21, P698, DOI 10.1111/cns.12429; Choi HD, 2011, BRIT J NUTR, V105, P220, DOI 10.1017/S0007114510003454; Chu W., 2015, NEUROCHEM RES, V40; Ciftci U, 2016, ULUS TRAVMA ACIL CER, V22, P423, DOI 10.5505/tjtes.2016.44575; Costa P, 2014, SPINAL CORD, V52, P749, DOI 10.1038/sc.2014.138; Cruz CD, 2015, ADV DRUG DELIVER REV, V82-83, P153, DOI 10.1016/j.addr.2014.11.007; Dong LY, 2013, MAR DRUGS, V11, P960, DOI 10.3390/md11030960; Du F., 2016, ACTA BIOCH POL, V63; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fassett RG, 2009, FUTUR CARDIOL, V5, P333, DOI 10.2217/FCA.09.19; Fatima G, 2015, SPINAL CORD, V53, P3, DOI 10.1038/sc.2014.178; Ghanbari A, 2014, EXP BRAIN RES, V232, P415, DOI 10.1007/s00221-013-3749-0; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Hall ED, 2016, J NEUROTRAUM, V33, P972, DOI 10.1089/neu.2016.4473; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; Ikeda Y, 2008, J NEUROCHEM, V107, P1730, DOI 10.1111/j.1471-4159.2008.05743.x; Jongen P. J., 2016, J NEUROL, P1; Kidd P, 2011, ALTERN MED REV, V16, P355; Kim JH, 2009, J MICROBIOL BIOTECHN, V19, P1355, DOI 10.4014/jmb.0906.06003; Kupcinskas L, 2008, PHYTOMEDICINE, V15, P391, DOI 10.1016/j.phymed.2008.04.004; Lee DH, 2011, FOOD CHEM TOXICOL, V49, P271, DOI 10.1016/j.fct.2010.10.029; Lee DH, 2010, J CLIN BIOCHEM NUTR, V47, P121, DOI 10.3164/jcbn.10-29; Lee J. Y., 2016, NEUROPHARMACOLOGY; Li ZR, 2013, MOL VIS, V19, P1656; Lin TY, 2010, J AGR FOOD CHEM, V58, P8271, DOI 10.1021/jf101689t; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Liu X., 2009, FORUM NUTR; Liu XB, 2009, BRAIN RES, V1254, P18, DOI 10.1016/j.brainres.2008.11.076; Lu YP, 2010, BRAIN RES, V1360, P40, DOI 10.1016/j.brainres.2010.09.016; Lu Y, 2015, NEUROSCI LETT, V597, P49, DOI 10.1016/j.neulet.2015.04.018; Luo Y, 2015, MOL MED REP, V12, P7132, DOI 10.3892/mmr.2015.4274; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Nagai J., 2015, SCI REP, V5; Nakae A., 2011, BIOMED RES INT; Naseri K, 2013, J MOL NEUROSCI, V49, P470, DOI 10.1007/s12031-012-9840-3; Ormond DR, 2012, J NEUROSURG-SPINE, V16, P497, DOI 10.3171/2012.1.SPINE11769; Ozdemir US, 2015, MOL NEUROBIOL, V53, P1; Park JS, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-18; Robert AA, 2012, NEUROL SCI, V33, P785, DOI 10.1007/s10072-011-0829-4; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sakurai M, 2003, J THORAC CARDIOV SUR, V125, P370, DOI 10.1067/mtc.2003.112; Samantaray S, 2008, J PINEAL RES, V44, P348, DOI 10.1111/j.1600-079X.2007.00534.x; Sharif-Alhoseini M., 2014, TOPICS PARAPLEGIA IN; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Shul'ga A E, 2014, Ross Fiziol Zh Im I M Sechenova, V100, P145; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Song XD, 2014, J CELL MOL MED, V18, P2198, DOI 10.1111/jcmm.12347; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; Tsuchida M, 2014, J MOL NEUROSCI, V54, P380, DOI 10.1007/s12031-014-0338-z; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Wang HQ, 2010, BRAIN RES, V1360, P159, DOI 10.1016/j.brainres.2010.08.100; Wang WG, 2015, NEUROL SCI, V36, P521, DOI 10.1007/s10072-014-1965-4; Wu HJ, 2015, CELL MOL NEUROBIOL, V35, P85, DOI 10.1007/s10571-014-0116-z; Wu Q, 2014, MAR DRUGS, V12, P6125, DOI 10.3390/md12126125; Wu WQ, 2014, FOOD FUNCT, V5, P158, DOI 10.1039/c3fo60400d; Wu YC, 2013, J NEUROTRAUM, V30, P441, DOI 10.1089/neu.2012.2622; Yamagishi R., 2014, MOL VIS; Yan M, 2014, SPINAL CORD, V52, P803, DOI 10.1038/sc.2014.135; Yao M, 2015, J NEUROTRAUM, V32, P381, DOI 10.1089/neu.2014.3520; Yu H., 2016, J SPINE, V5, P1; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang N, 2012, INDIAN J MED RES, V135, P287; Zhang XS, 2014, MAR DRUGS, V12, P4291, DOI 10.3390/md12084291; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730; Zheng D, 2014, NEUROPHARMACOLOGY, V84, P13, DOI 10.1016/j.neuropharm.2014.04.013; Zhou LP, 2015, J SURG RES, V195, P559, DOI 10.1016/j.jss.2015.02.026	81	30	30	1	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN 30	2017	329						104	110		10.1016/j.bbr.2017.04.026			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EY4YV	WOS:000403985100014	28442361				2022-02-06	
J	Echemendia, RJ; Meeuwisse, W; McCrory, P; Davis, GA; Putukian, M; Leddy, J; Makdissi, M; Sullivan, SJ; Broglio, SP; Raftery, M; Schneider, K; Kissick, J; McCrea, M; Dvorak, J; Sills, AK; Aubry, M; Engebretsen, L; Loosemore, M; Fuller, G; Kutcher, J; Ellenbogen, R; Guskiewicz, K; Patricios, J; Herring, S				Echemendia, Ruben J.; Meeuwisse, Willem; McCrory, Paul; Davis, Gavin A.; Putukian, Margot; Leddy, John; Makdissi, Michael; Sullivan, S. John; Broglio, Steven P.; Raftery, Martin; Schneider, Kathryn; Kissick, James; McCrea, Michael; Dvorak, Jiri; Sills, Allen K.; Aubry, Mark; Engebretsen, Lars; Loosemore, Mike; Fuller, Gordon; Kutcher, Jeffrey; Ellenbogen, Richard; Guskiewicz, Kevin; Patricios, Jon; Herring, Stanley			The Concussion Recognition Tool 5th Edition (CRT5): Background and rationale	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; ZURICH	The Concussion Recognition Tool 5 (CRT5) is the most recent revision of the Pocket Sport Concussion Assessment Tool 2 that was initially introduced by the Concussion in Sport Group in 2005. The CRT5 is designed to assist non-medically trained individuals to recognise the signs and symptoms of possible sport-related concussion and provides guidance for removing an athlete from play/sport and to seek medical attention. This paper presents the development of the CRT5 and highlights the differences between the CRT5 and prior versions of the instrument.	[Echemendia, Ruben J.] Univ Orthoped Ctr, Dept Concuss Care Clin, State Coll, PA USA; [Echemendia, Ruben J.] Univ Missouri, Kansas City, MO 64110 USA; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Sports Injury Prevent Res Ctr, Calgary, AB, Canada; [McCrory, Paul] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Davis, Gavin A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Davis, Gavin A.; Makdissi, Michael] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Putukian, Margot] Princeton Univ, Dept Athlet Med, Princeton, NJ 08544 USA; [Leddy, John] Univ Buffalo, Concuss Management Clin, UBMD Orthopaed & Sports Med, Buffalo, NY USA; [Leddy, John] SUNY Buffalo, Dept Orthopaed, Buffalo, NY USA; [Sullivan, S. John] Univ Otago, Sch Physiotherapy, Dunedin, New Zealand; [Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Raftery, Martin] World Rugby, Dublin, Ireland; [Schneider, Kathryn] Ctr Fac Kinesiol, Sport Injury Prevent Res, Calgary, AB, Canada; [Schneider, Kathryn] Alberta Childrens Hosp Res Inst Child & Maternal, Cumming Sch Med, Calgary, AB, Canada; [Schneider, Kathryn] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Kissick, James] Carleton Univ, Sport Med Clin, Ottawa, ON, Canada; [Kissick, James] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Kissick, James] Int Paralymp Comm Med Comm, Ottawa, ON, Canada; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Dvorak, Jiri] Schulthess Clin, Neurol Dept, Zurich, Switzerland; [Sills, Allen K.] Vanderbilt Univ, Dept Neurosurg, Franklin, TN USA; [Aubry, Mark] Int Ice Hockey Federat, Zurich, Switzerland; [Engebretsen, Lars] Oslo Univ Hosp, Med & Sci Dept, Oslo, Norway; [Loosemore, Mike] Univ Coll Hosp, Inst Sport Exercise & Hlth, London, England; [Fuller, Gordon] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England; [Kutcher, Jeffrey] Sports Neurol Clin, Brighton, MI USA; [Ellenbogen, Richard] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Guskiewicz, Kevin] Univ N Carolina, Sports Med Res Lab, Chapel Hill, NC USA; [Patricios, Jon] Univ Pretoria, Fac Hlth Sci, Johannesburg, South Africa; [Patricios, Jon] Univ Witwatersrand, Dept Emergency Med, Johannesburg, South Africa; [Herring, Stanley] Dept Rehabil Med, Seattle, WA USA; [Herring, Stanley] Dept Orthopaed, Seattle, WA USA; [Herring, Stanley] Dept Sports Med & Neurol Surg, Seattle, WA USA		Echemendia, RJ (corresponding author), Univ Orthoped Ctr, Concuss Care Clin, 101 Regent Ct, State Coll, PA 16801 USA.	rechemendia@comcast.net	McCrory, Paul/Q-8688-2019; Echemendia, Ruben/R-6939-2019	makdissi, michael/0000-0003-0334-7133; Fuller, Gordon Ward/0000-0001-8532-3500; Patricios, Jon/0000-0002-6829-4098; Davis, Gavin/0000-0001-8293-4496; McCrory, Paul/0000-0003-4850-0568; Schneider, Kathryn/0000-0002-5951-5899	National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2015-04-005] Funding Source: researchfish		Davis GA, 2017, BRIT J SPORTS MED; Echemendia R, 2017, BRIT J SPORTS MED; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721	6	30	30	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2017	51	11					870	871		10.1136/bjsports-2017-097508			2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EW3QP	WOS:000402416500006	28446450	Green Submitted, Green Accepted			2022-02-06	
J	Sanderson, J; Weathers, M; Snedaker, K; Gramlich, K				Sanderson, Jimmy; Weathers, Melinda; Snedaker, Katherine; Gramlich, Kelly			"I Was Able to Still Do My Job on the Field and Keep Playing": An Investigation of Female and Male Athletes' Experiences With (Not) Reporting Concussions	COMMUNICATION & SPORT			English	Article						concussions; pain principle; hegemonic masculinity; gender and sport; muted group theory	SCHOOL; MASCULINITY; PERFORMANCE; KNOWLEDGE; IDENTITY	This research applied muted group theory to investigate female and male athletes' experiences with not reporting concussions sustained during athletic competition. Using snowball-sampling techniques, a total of 365 women and 247 men completed an online open-ended questionnaire about their reasons for not reporting a concussion. Results indicated that male athletes were more likely to continue to play through and not report a concussion than female athletes. Participants also indicated that they did not report concussions due to (a) perceived lack of resources, (b) perceived lack of severity, (c) conformance to sport cultural norms, which was comprised of two subthemes: adherence to the pain principle and team allegiance. The results suggest that efforts to address concussion management in sport need to focus on the communicative and structural elements that privilege hegemonic masculinity and playing through pain, as they contribute to muting athletes in advocating for their health.	[Sanderson, Jimmy] Clemson Univ, Clemson Online, Clemson, SC USA; [Weathers, Melinda; Gramlich, Kelly] Clemson Univ, Dept Commun Studies, Clemson, SC USA; [Snedaker, Katherine] Pink Concuss, Stamford, CT USA		Sanderson, J (corresponding author), Clemson Univ, Clemson Online, Snowflake, AZ 85937 USA.	jsande6@clemson.edu		Snedaker, Katherine/0000-0002-3865-3926			Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; ARDENER S, 1978, DEFINING FEMALES NAT; ARDENER S, 1975, PERCEIVING WOMEN; Bagilhole B, 2006, J GENDER STUD, V15, P35, DOI 10.1080/09589230500486900; Bandura A, 1986, SOCIAL FDN THOUGHT A; Beck CS, 2014, HEALTH COMMUN, V29, P244, DOI 10.1080/10410236.2012.741668; Bloom GA, 2008, EUR J SPORT SCI, V8, P295, DOI 10.1080/17461390802251836; Branch J., 2011, DEREK BOOGARD BRAIN; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cantu R., 2012, CONCUSSIONS OUR KIDS; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Charlesworth H, 2004, SPORTING BODIES DAMA, P163; Connell R.W., 1995, MASCULINITIES; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cream A, 2003, INT J LANG COMM DIS, V38, P379, DOI 10.1080/13682820310001598166; Diamond D., 2013, HEAD INJURY PRACTICE; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gal S., 1994, WOMEN LANGUAGE DEBAT, P407; Gee S, 2009, SOCIOL SPORT J, V26, P578, DOI 10.1123/ssj.26.4.578; Gerschick T., 1994, MASCULINITIES, V2, P34; Graham T., 2014, BROKE AND BROKEN; Henley N. M., 1994, WOMEN LANGUAGE DEBAT, P383; Hogg MA, 2006, COMMUN THEOR, V16, P7, DOI 10.1111/j.1468-2885.2006.00003.x; Hopmann DN, 2012, COMMUN METHODS MEAS, V6, P145, DOI 10.1080/19312458.2012.703832; Houston M., 1991, DISCOURSE SOC, V2, P387, DOI 10.1177/0957926591002004001; Kassing JW, 2009, WESTERN J COMM, V73, P182, DOI 10.1080/10570310902856063; Katzowitz J., 2013, REACTIONS FRONTLINE; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kirk M., 2013, LEAGUE DENIAL DOCUME; Lindlof TR, 2017, QUALITATIVE COMMUNIC; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Meares M. M., 2003, ANN C INT COMM ASS S; Meares MM, 2004, J APPL COMMUN RES, V32, P4, DOI 10.1080/0090988042000178121; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Messner M. A., 2002, TAKING FIELD WOMEN M; Messner MA, 1994, SEX VIOLENCE POWER S; Messner MA, 2014, SOCIOL SPORT J, V31, P102, DOI 10.1123/ssj.2013-0111; Orbe M. P., 1998, CONSTRUCTING COCULTU; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Roderick M., 2000, INT REV SOCIOL SPORT, V35, P67; Rodgers K., 2014, NFL CRITICAL CULTURA, P142; Sabo D., 1994, ANN M NAT ATHL TRAIN; Sage G., 2013, SOCIOLOGY N AM SPORT; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Sheridan B. (Producer), 2012, HEAD GAMES DOCUMENTA; Steinfeldt M, 2012, J APPL SPORT PSYCHOL, V24, P115, DOI 10.1080/10413200.2011.603405; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Suter EA, 2006, J SOC PERS RELAT, V23, P349, DOI 10.1177/0265407506064201; Svokos A., 2014, MAJORITY HIGH SCH KI; TRUJILLO N, 1991, CRIT STUD MASS COMM, V8, P290, DOI 10.1080/15295039109366799; Wall CJ, 1999, EUR J WOMENS STUD, V6, P21, DOI 10.1177/135050689900600103; Weber AF, 2013, J ATHL TRAINING, V48, P153, DOI 10.4085/1062-6050-48.1.07; Wolverton B., 2013, COACH MAKES CALL ATH; Ye Hee Lee M., 2014, MORE ATHLETIC TRAINE; Young, 2004, SPORTING BODIES DAMA, P59; Young K., 1995, Journal of Sport and Social Issues, V19, P45, DOI 10.1177/019372395019001004; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175	59	30	30	2	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	JUN	2017	5	3					267	287		10.1177/2167479515623455			21	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	FG7US	WOS:000410631200001					2022-02-06	
J	Bosco, FM; Parola, A; Sacco, K; Zettin, M; Angeleri, R				Bosco, Francesca M.; Parola, Alberto; Sacco, Katiuscia; Zettin, Marina; Angeleri, Romina			Communicative-pragmatic disorders in traumatic brain injury: The role of theory of mind and executive functions	BRAIN AND LANGUAGE			English	Article						Communication; Pragmatics; Irony; Deceit; Non-verbal; Theory of mind; Executive functions; Cognitive flexibility; Working memory; Planning	CLOSED-HEAD-INJURY; PREFRONTAL LESIONS; SOCIAL COGNITION; IMPAIRMENTS; LANGUAGE; ADULTS; COMPREHENSION; DEFICITS; ABILITY; CHILDREN	Previous research has shown that communicative-pragmatic ability, as well as executive functions (EF) and Theory of Mind (ToM), may be impaired in individuals with traumatic brain injury (TBI). However, the role of such cognitive deficits in explaining communicative-pragmatic difficulty in TBI has still not been fully investigated. The study examined the relationship between EF (working memory, planning and flexibility) and ToM and communicative-pragmatic impairment in patients with TBI. 30 individuals with TBI and 30 healthy controls were assessed using the Assessment Battery of Communication (ABaCo), and a set of cognitive, EF and ToM, tasks. The results showed that TBI participants performed poorly in comprehension and production tasks in the ABaCo, using both linguistic and extralinguistic means of expression, and that they were impaired in EF and ToM abilities. Cognitive difficulties were able to predict the pragmatic performance of TBI individuals, with both executive functions and ToM contributing to explaining patients' scores on the ABaCo. (C) 2017 Elsevier Inc. All rights reserved.	[Bosco, Francesca M.; Parola, Alberto; Sacco, Katiuscia] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Bosco, Francesca M.; Sacco, Katiuscia] Inst Neurosci Turin, Turin, Italy; [Zettin, Marina] Ctr Puzzle, Turin, Italy; [Angeleri, Romina] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Parola, A (corresponding author), Dipartimento Psicol, Via Po 14, I-10123 Turin, Italy.	alparola@unito.it	bosco, francesca marina/B-6746-2013; Parola, alberto/AAK-3748-2020	bosco, francesca marina/0000-0001-6101-8587; PAROLA, ALBERTO/0000-0002-6039-0907	University of Turin, Department of Psychology	This research was supported by the University of Turin, Department of Psychology, "Ex-60% fund", Action B.	Altman D., 1991, PRACT STAT MED RES, P403; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2016, MINERVA PSICH, V57, P93; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; [Anonymous], 2014, MINERVA PSICHIATRICA; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bambini V, 2016, BRAIN LANG, V153, P1, DOI 10.1016/j.bandl.2015.12.002; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Bara Bruno, 2010, COGNITIVE PRAGMATICS; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Bosco F. M., 2016, FRONTIERS PSYCHOL, V7; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Bosco FM, 2012, J COMMUN DISORD, V45, P181, DOI 10.1016/j.jcomdis.2012.01.005; Braun C M, 1989, Brain Inj, V3, P345, DOI 10.3109/02699058909004559; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2007, NEUROPSYCHOLOGIA, V45, P1725, DOI 10.1016/j.neuropsychologia.2006.12.021; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Cummings L, 2009, CLINICAL PRAGMATICS, P1; CUMMINGS L, 2005, PRAGMATICS MULTIDISC; Cummings L., 2014, PRAGMATIC DISORDERS; Cummings L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01286; Dardier V, 2011, J COMMUN DISORD, V44, P359, DOI 10.1016/j.jcomdis.2011.02.001; Della Sala S., 1984, ADV HEPATIC ENCEPHAL, P448; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; ELITHORN A, 1955, J NEUROL NEUROSUR PS, V18, P287, DOI 10.1136/jnnp.18.4.287; ELITHORN A, 1964, NEUROPSYCHOLOGIA, V2, P327, DOI 10.1016/0028-3932(64)90039-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Happe F, 2002, MIND LANG, V17, P24, DOI 10.1111/1468-0017.00187; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Huber W., 1983, AACHENER APHASIE TES; Johnco C, 2013, J ANXIETY DISORD, V27, P576, DOI 10.1016/j.janxdis.2012.10.004; Johnson JE, 2012, BRAIN INJURY, V26, P1118, DOI 10.3109/02699052.2012.666370; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Levinson F. C., 1983, PRAGMATICS; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; MCDONALD S, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI DOI 10.1017/S1355617713000428.PUBMED:23351330; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Murphy A, 2015, APHASIOLOGY, V29, P151, DOI 10.1080/02687038.2014.959411; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P278; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; Perkins M., 2000, PRAGMATICS CLIN APPL, P7; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Sacco K, 2008, J COGN SCI, V9, P111; Sacco K., 2016, FRONTIERS BEHAV NEUR, V10; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P8; Stemmer B., 1999, PRAGMATICS BRAIN LAN, V68; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Sullivan JR, 2009, APPL NEUROPSYCHOL, V16, P62, DOI 10.1080/09084280802644243; TEASDALE G, 1974, LANCET, V2, P81; Thomas E, 2014, NEUROPSYCHOL REV, V24, P514, DOI 10.1007/s11065-014-9272-7; Tirassa M, 2006, CONSCIOUS COGN, V15, P197, DOI 10.1016/j.concog.2005.06.005; Tirassa M, 2006, COGN SYST RES, V7, P128, DOI 10.1016/j.cogsys.2006.01.002; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; WINNER E, 1977, BRAIN, V100, P717, DOI 10.1093/brain/100.4.717	95	30	31	1	55	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	MAY	2017	168						73	83		10.1016/j.bandl.2017.01.007			11	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	ER4GK	WOS:000398756900007	28161678	Green Published			2022-02-06	
J	Diaz, MF; Vaidya, AB; Evans, SM; Lee, HJ; Aertker, BM; Alexander, AJ; Price, KM; Ozuna, JA; Liao, GP; Aroom, KR; Xue, HS; Gu, L; Omichi, R; Bedi, S; Olson, SD; Cox, CS; Wenzel, PL				Diaz, Miguel F.; Vaidya, Abishek B.; Evans, Siobahn M.; Lee, Hyun J.; Aertker, Benjamin M.; Alexander, Alexander J.; Price, Katherine M.; Ozuna, Joyce A.; Liao, George P.; Aroom, Kevin R.; Xue, Hasen; Gu, Liang; Omichi, Rui; Bedi, Supinder; Olson, Scott D.; Cox, Charles S.; Wenzel, Pamela L.			Biomechanical Forces Promote Immune Regulatory Function of Bone Marrow Mesenchymal Stromal Cells	STEM CELLS			English	Article						Biomechanical force; Mesenchymal stromal cells; Immunomodulation; Inflammation; Shear stress; Traumatic brain injury	FLUID SHEAR-STRESS; ACTIVATED MICROGLIAL/MACROPHAGE RESPONSE; TRAUMATIC BRAIN-INJURY; STEM-CELLS; HEME OXYGENASE-1; GENE-EXPRESSION; BLOOD-FLOW; INTERLEUKIN-10; INFLAMMATION; MACROPHAGES	Mesenchymal stromal cells (MSCs) are believed to mobilize from the bone marrow in response to inflammation and injury, yet the effects of egress into the vasculature on MSC function are largely unknown. Here we show that wall shear stress (WSS) typical of fluid frictional forces present on the vascular lumen stimulates antioxidant and anti-inflammatory mediators, as well as chemokines capable of immune cell recruitment. WSS specifically promotes signaling through NFB-COX2-prostaglandin E-2 (PGE(2)) to suppress tumor necrosis factor- (TNF-) production by activated immune cells. Ex vivo conditioning of MSCs by WSS improved therapeutic efficacy in a rat model of traumatic brain injury, as evidenced by decreased apoptotic and M1-type activated microglia in the hippocampus. These results demonstrate that force provides critical cues to MSCs residing at the vascular interface which influence immunomodulatory and paracrine activity, and suggest the potential therapeutic use of force for MSC functional enhancement. Stem Cells2017;35:1259-1272	[Diaz, Miguel F.; Vaidya, Abishek B.; Evans, Siobahn M.; Lee, Hyun J.; Aertker, Benjamin M.; Alexander, Alexander J.; Price, Katherine M.; Ozuna, Joyce A.; Liao, George P.; Aroom, Kevin R.; Xue, Hasen; Gu, Liang; Omichi, Rui; Bedi, Supinder; Olson, Scott D.; Cox, Charles S.; Wenzel, Pamela L.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Childrens Regenerat Med Program, Dept Pediat Surg, Houston, TX 77030 USA; [Diaz, Miguel F.; Vaidya, Abishek B.; Evans, Siobahn M.; Lee, Hyun J.; Alexander, Alexander J.; Price, Katherine M.; Ozuna, Joyce A.; Gu, Liang; Omichi, Rui; Cox, Charles S.; Wenzel, Pamela L.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Ctr Stem Cell & Regenerat Med, Houston, TX 77030 USA; [Alexander, Alexander J.; Price, Katherine M.; Ozuna, Joyce A.] Rice Univ, Dept BioSci, Houston, TX USA; [Omichi, Rui] Tokushima Univ, Sch Med, Fac Med, Tokushima, Japan		Wenzel, PL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Childrens Regenerat Med Program, Ctr Stem Cell & Regenerat Med, Dept Pediat Surg,McGovern Med Sch,Brown Fdn Inst, 1825 Pressler St,SRB 637A, Houston, TX 77030 USA.	pamela.l.wenzel@uth.tmc.edu	Vaidya, Abishek/AAR-4515-2021; Wenzel, Pamela/AAJ-1944-2021; Stefanadis, Christodoulos/ABH-2232-2020	Wenzel, Pamela/0000-0002-4530-015X; Stefanadis, Christodoulos/0000-0001-5974-6454; Aroom, Kevin/0000-0003-1504-0585; Olson, Scott/0000-0001-8032-3755; Vaidya, Abishek/0000-0001-8458-7950; Alexander, Alexander/0000-0002-0590-6536; Gu, Liang/0000-0001-6130-8752	State of Texas Emerging Technology Fund; American Society of Hematology Scholar Award; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01DK092365]; Mission Connect: a Program of the TIRR Foundation [014-121, 016-118]; Ruth L. Kirschstein National Research Service Award from the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T35DK007676]; Cancer Prevention and Research Institute of Texas [RP110776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK007676, K01DK092365] Funding Source: NIH RePORTER	We wish to thank Zhengmei Mao for imaging support and Naama Toledano Furman for flow cytometry. This work was supported by grants from the State of Texas Emerging Technology Fund, American Society of Hematology Scholar Award, National Institutes of Health K01DK092365, and Mission Connect: a Program of the TIRR Foundation (014-121, 016-118) to P.L.W. L.G. is the recipient of a Ruth L. Kirschstein National Research Service Award T35DK007676 from the National Institutes of Health. Flow cytometry instrumentation was supported in part through the Cancer Prevention and Research Institute of Texas (RP110776).	Achille V, 2011, J CELL BIOCHEM, V112, P1817, DOI 10.1002/jcb.23100; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Chabannes D, 2007, BLOOD, V110, P3691, DOI 10.1182/blood-2007-02-075481; Chamberlain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025663; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Dahlen E, 1998, J IMMUNOL, V160, P3585; DAVIES PF, 1986, P NATL ACAD SCI USA, V83, P2114, DOI 10.1073/pnas.83.7.2114; Davies PF, 1997, ANNU REV PHYSIOL, V59, P527, DOI 10.1146/annurev.physiol.59.1.527; Di Francesco L, 2009, CIRC RES, V104, P506, DOI 10.1161/CIRCRESAHA.108.191114; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Glossop JR, 2009, GENE EXPR PATTERNS, V9, P381, DOI 10.1016/j.gep.2009.01.001; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee HJ, 2013, DIFFERENTIATION, V86, P92, DOI 10.1016/j.diff.2013.06.004; Li Nan, 2015, Methods Mol Biol, V1212, P183, DOI 10.1007/7651_2014_95; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Lu H, 2004, ANAL CHEM, V76, P5257, DOI 10.1021/ac049837t; Mendez-Ferrer S, 2015, ANN NY ACAD SCI, V1335, P32, DOI 10.1111/nyas.12641; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moll G, 2015, STEM CELLS DEV, V24, P2269, DOI 10.1089/scd.2015.0120; Mougiakakos D, 2011, BLOOD, V117, P4826, DOI 10.1182/blood-2010-12-324038; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Prockop DJ, 2013, STEM CELLS, V31, P2042, DOI 10.1002/stem.1400; Rozenberg A, 2016, STEM CELL TRANSL MED, V5, P1506, DOI 10.5966/sctm.2015-0243; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sheikh S, 2003, BLOOD, V102, P2828, DOI 10.1182/blood-2003-01-0080; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Sun YY, 2012, J ELECTRON MATER, V41, P519, DOI 10.1007/s11664-011-1800-0; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; Valles G, 2015, BIOMATERIALS, V37, P124, DOI 10.1016/j.biomaterials.2014.10.028; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Wan M, 2012, STEM CELLS, V30, P2498, DOI 10.1002/stem.1208; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yang YH, 2016, STEM CELLS, V34, P2525, DOI 10.1002/stem.2405; Yuan L, 2013, STEM CELLS DEV, V22, P2384, DOI 10.1089/scd.2012.0717	54	30	32	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	MAY	2017	35	5					1259	1272		10.1002/stem.2587			14	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	ET1HC	WOS:000400017200013	28181347	Green Accepted, Bronze			2022-02-06	
J	Zeleznikow-Johnston, A; Burrows, EL; Renoir, T; Hannan, AJ				Zeleznikow-Johnston, Ariel; Burrows, Emma L.; Renoir, Thibault; Hannan, Anthony J.			Environmental enrichment enhances cognitive flexibility in C57BL/6 mice on a touchscreen reversal learning task	NEUROPHARMACOLOGY			English	Article						Cognitive stimulation; Physical activity; Cognition; Brain reserve; Metabotropic glutamate receptor 5; Cognitive enhancers	MEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL NEUROGENESIS; WORKING-MEMORY; SPATIAL MEMORY; PATTERN SEPARATION; TESTING METHOD; MOUSE MODEL; DOPAMINE; EXERCISE	Environmental enrichment (EE) is any positive modification of the 'standard housing' (SH) conditions in which laboratory animals are typically held, usually involving increased opportunity for cognitive stimulation and physical activity. EE has been reported to enhance baseline performance of wild-type animals on traditional cognitive behavioural tasks. Recently, touchscreen operant testing chambers have emerged as a way of performing rodent cognitive assays, providing greater reproducibility, translatability and automatability. Cognitive tests in touchscreen chambers are performed over numerous trials and thus experimenters have the power to detect subtle enhancements in performance. We used touchscreens to analyse the effects of EE on reversal learning, visual discrimination and hippocampal-dependent spatial pattern separation and working memory. We hypothesized that EE would enhance the performance of mice on cognitive touchscreen tasks. Our hypothesis was partially supported in that EE induced enhancements in cognitive flexibility as observed in visual discrimination and reversal learning improvements. However, no other significant effects of EE on cognitive performance were observed. EE decreased the activity level of mice in the touchscreen chambers, which may influence the enrichment level of the animals. Although we did not see enhancements on all hypothesized parameters, our testing paradigm is capable of detecting EE-induced improved cognitive flexibility in mice, which has implications for both understanding the mechanisms of EE and improving screening of putative cognitive-enhancing therapeutics.(C) 2017 Elsevier Ltd. All rights reserved.	[Zeleznikow-Johnston, Ariel; Burrows, Emma L.; Renoir, Thibault; Hannan, Anthony J.] Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Hannan, Anthony J.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia		Hannan, AJ (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.	anthony.hannan@florey.edu.au	; Burrows, Emma/M-1547-2016	Hannan, Anthony/0000-0001-7532-8922; Burrows, Emma/0000-0002-6675-4679; Zeleznikow-Johnston, Ariel/0000-0002-7497-8242	National Health and Medical Research Council (NHMRC) Australian Research Council (ARC) Dementia Research Development FellowshipAustralian Research Council; ARC FT3 Future FellowshipAustralian Research Council [FT100100835]; Australian Government Research Training Program ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science; NHMRCNational Health and Medical Research Council of Australia [GNT1126885]; State Government of Victoria	ELB is supported by a National Health and Medical Research Council (NHMRC) Australian Research Council (ARC) Dementia Research Development Fellowship. AJH is an NHMRC Principal Research Fellow (GNT1117148) and has been supported by an ARC FT3 Future Fellowship (FT100100835). TR is an ARC DECRA Fellow. AZJ is supported by the Australian Government Research Training Program Scholarship. This work was supported by an NHMRC Project Grant (GNT1126885). We would also like to acknowledge the operational infrastructure support from the State Government of Victoria. The authors declare no conflict of interest.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Birch AM, 2013, HIPPOCAMPUS, V23, P437, DOI 10.1002/hipo.22103; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Cain ME, 2006, BEHAV PROCESS, V73, P360, DOI 10.1016/j.beproc.2006.08.007; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Clemenson GD, 2015, HIPPOCAMPUS, V25, P385, DOI 10.1002/hipo.22380; COMERY TA, 1995, NEUROBIOL LEARN MEM, V63, P217, DOI 10.1006/nlme.1995.1025; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Del Arco A, 2007, BEHAV BRAIN RES, V176, P267, DOI 10.1016/j.bbr.2006.10.006; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Engmann O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10099; Garthe A, 2016, HIPPOCAMPUS, V26, P261, DOI 10.1002/hipo.22520; Graybeal C, 2011, NAT NEUROSCI, V14, P1507, DOI 10.1038/nn.2954; Guzzetta A, 2009, J NEUROSCI, V29, P6042, DOI 10.1523/JNEUROSCI.5548-08.2009; Hannan AJ, 2014, NEUROPATH APPL NEURO, V40, P13, DOI 10.1111/nan.12102; Harati H, 2011, NEUROBIOL AGING, V32, P718, DOI 10.1016/j.neurobiolaging.2009.03.012; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kent BA, 2015, CURR OPIN BEHAV SCI, V4, P179, DOI 10.1016/j.cobeha.2015.06.009; Kim CH, 2015, PSYCHOPHARMACOLOGY, V232, P3935, DOI 10.1007/s00213-015-4017-8; Kim MS, 2016, J CEREBR BLOOD F MET, V36, P2122, DOI 10.1177/0271678X15613525; Kishi T, 2015, INT HEART J, V56, P110, DOI 10.1536/ihj.14-168; Lambert TJ, 2005, NEUROBIOL LEARN MEM, V83, P206, DOI 10.1016/j.nlm.2004.12.001; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Makowiecki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048703; Mallien AS, 2016, HORM BEHAV, V81, P97, DOI 10.1016/j.yhbeh.2016.03.009; McAllister KAL, 2013, NEUROBIOL LEARN MEM, V101, P120, DOI 10.1016/j.nlm.2013.01.010; McOmish CE, 2007, EXPERT OPIN THER TAR, V11, P899, DOI 10.1517/14728222.11.7.899; Mora-Gallegos A, 2015, NEUROBIOL LEARN MEM, V118, P96, DOI 10.1016/j.nlm.2014.11.012; Mustroph ML, 2012, NEUROSCIENCE, V219, P62, DOI 10.1016/j.neuroscience.2012.06.007; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI 10.1016/j.specom 2004.02.004; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Roedel A, 2006, LAB ANIM-UK, V40, P371, DOI 10.1258/002367706778476343; Rogers J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.52; Sampedro-Piquero P, 2015, NEUROSCIENCE, V307, P14, DOI 10.1016/j.neuroscience.2015.08.038; Sampedro-Piquero P, 2013, BRAIN RES BULL, V98, P1, DOI 10.1016/j.brainresbull.2013.06.006; Schrijver NCA, 2004, BEHAV BRAIN RES, V152, P307, DOI 10.1016/j.bbr.2003.10.016; Segovia G, 2008, BEHAV BRAIN RES, V187, P304, DOI 10.1016/j.bbr.2007.09.024; Shepherd A., 2016, J MOL NEUROSCI, P1; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Talpos JC, 2010, NEUROBIOL LEARN MEM, V94, P341, DOI 10.1016/j.nlm.2010.07.006; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Thiriet N, 2008, BRAIN RES, V1222, P31, DOI 10.1016/j.brainres.2008.05.030; Varty GB, 2000, BIOL PSYCHIAT, V47, P864, DOI 10.1016/S0006-3223(99)00269-3; Waltz JA, 2007, SCHIZOPHR RES, V93, P296, DOI 10.1016/j.schres.2007.03.010; Zhu J, 2005, J NEUROCHEM, V93, P1434, DOI 10.1111/j.1471-4159.2005.03130.x	54	30	30	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	MAY 1	2017	117						219	226		10.1016/j.neuropharm.2017.02.009			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	ET8FG	WOS:000400533800021	28196627				2022-02-06	
J	Crichton, AJ; Babl, F; Oakley, E; Greenham, M; Hearps, S; Delzoppo, C; Hutchison, J; Beauchamp, M; Anderson, VA				Crichton, Alison J.; Babl, Franz; Oakley, Ed; Greenham, Mardee; Hearps, Stephen; Delzoppo, Carmel; Hutchison, Jamie; Beauchamp, Miriam; Anderson, Vicki A.			Prediction of Multidimensional Fatigue After Childhood Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; depression; fatigue; sleep-wake disturbance; traumatic brain injury	QUALITY-OF-LIFE; PEDIATRIC MULTIPLE-SCLEROSIS; ACUTE LYMPHOBLASTIC-LEUKEMIA; GENERIC CORE SCALES; SICKLE-CELL-DISEASE; MINOR HEAD-INJURY; PSYCHOMETRIC PROPERTIES; CEREBRAL-PALSY; FOLLOW-UP; CHILDREN	Objectives: To determine (1) the presence of fatigue symptoms and predictors of fatigue after childhood brain injury and examine (2) the feasibility, reliability, and validity of a multidimensional fatigue measure (PedsQL Multidimensional Fatigue Scale [ MFS]) obtained from parent and child perspectives. Setting: Emergency and intensive care units of a hospital in Melbourne, Australia. Participants: Thirty-five families (34 parent-proxies and 32 children) aged 8 to 18 years (mean child age = 13.29 years) with traumatic brain injury (TBI) of all severities (27 mild, 5 moderate, and 3 severe) admitted to the Royal Children's Hospital. Design: Longitudinal prospective study. Fatigue data collected at 6-week follow-up (mean = 6.9 weeks). Main Outcome Measures: Postinjury child-and parent-rated fatigue (PedsQL MFS), mood, sleep, and pain based on questionnaire report: TBI severity (mild vs moderate/severe TBI). Results: A score greater than 2 standard deviations below healthy control data indicated the presence of abnormal fatigue, rates of which were higher compared with normative data for both parent and child reports (47% and 29%). Fatigue was predicted by postinjury depression and sleep disturbance for parent, but not child ratings. Fatigue, as rated by children, was not significantly predicted by TBI severity or other symptoms. The PedsQL MFS demonstrated acceptable measurement properties in child TBI participants, evidenced by good feasibility and reliability (Cronbach alpha values >0.90). Interrater reliability between parent and child reports was poor to moderate. Conclusions: Results underscore the need to assess fatigue and associated sleep-wake disturbance and depression after child TBI from both parent and child perspectives.	[Crichton, Alison J.; Babl, Franz; Greenham, Mardee; Hearps, Stephen; Delzoppo, Carmel; Anderson, Vicki A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Crichton, Alison J.] Monash Childrens, Victorian Pediat Rehabil Serv, Melbourne, Vic, Australia; [Crichton, Alison J.; Babl, Franz; Oakley, Ed; Greenham, Mardee; Anderson, Vicki A.] Univ Melbourne, Melbourne, Vic, Australia; [Babl, Franz; Oakley, Ed; Delzoppo, Carmel; Anderson, Vicki A.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Hutchison, Jamie] Hosp Sick Children, Res Inst, Toronto, ON, Canada; [Beauchamp, Miriam] Univ Montreal, Montreal, PQ, Canada		Crichton, AJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Crit Care & Neurosci Theme, Flemington Rd, Parkville, Vic 3052, Australia.	ali.crichton@mcri.edu.au	Hearps, Stephen/L-6853-2016; Greenham, Mardee/AAR-1711-2020	Hearps, Stephen/0000-0003-2984-1172	Ontario Neurotrauma Foundation, Toronto, Canada; Victorian Neurotrauma Initiative, Melbourne, Australia; Moving Ahead Seed Grant; National Health and Medical Research Council Postgraduate Scholarship, Canberra, Australia; Neurosciences Victoria Brain and Mind Scholarship, Melbourne, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; National Health and Medical Research Council Centre for Research Excellence Grant in Paediatric Emergency Medicine, Canberra, Australia; Royal Children's Hospital Foundation grant	This work is supported by a jointly awarded grant from the Ontario Neurotrauma Foundation, Toronto, Canada, and the Victorian Neurotrauma Initiative, Melbourne, Australia; a Moving Ahead Seed Grant; a National Health and Medical Research Council Postgraduate Scholarship (Alison Crichton, awarded 2014), Canberra, Australia; a Neurosciences Victoria Brain and Mind Scholarship, Melbourne, Australia (Alison Crichton, awarded 2012); the Victorian Government's Infrastructure Support Program, Melbourne, Australia, and in part funded by a National Health and Medical Research Council Centre for Research Excellence Grant in Paediatric Emergency Medicine, Canberra, Australia. Franz Babl was in part funded by a Royal Children's Hospital Foundation grant.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Chambers CT, 1996, PAIN, V68, P307, DOI 10.1016/S0304-3959(96)03209-5; Christodoulou C, 2005, ISS CLIN COGN NEUROP, P19; Crichton A, 2015, PEDIATRICS, V135, pE1015, DOI 10.1542/peds.2014-2440; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dampier C, 2010, PEDIATR BLOOD CANCER, V55, P485, DOI 10.1002/pbc.22497; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Dieruf K, 2009, PEDIATR PHYS THER, V21, P45, DOI 10.1097/PEP.0b013e31818ec835; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Falk AC, 2013, SCAND J CARING SCI, V27, P51, DOI 10.1111/j.1471-6712.2012.00999.x; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gold JI, 2009, CLIN J PAIN, V25, P407, DOI 10.1097/AJP.0b013e318192bfb1; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Gordijn MS, 2013, PEDIATR BLOOD CANCER, V60, P479, DOI 10.1002/pbc.24261; Goretti B, 2012, MULT SCLER J, V18, P329, DOI 10.1177/1352458511420846; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hilger T, 2009, ADV CLIN EXP MED, V18, P169; Hockenberry Marilyn J, 2010, Oncol Nurs Forum, V37, pE16, DOI 10.1188/10.ONF.E16-E27; Holland AA, 2014, CHILD NEUROPSYCHOL, V20, P71, DOI 10.1080/09297049.2012.748888; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Ketelslegers IA, 2010, EUR J PAEDIATR NEURO, V14, P320, DOI 10.1016/j.ejpn.2009.09.004; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Kovacs M., 2011, CHILDRENS DEPRESSION; Levine J, 2009, PHYS MED REH CLIN N, V20, P347, DOI 10.1016/j.pmr.2008.12.006; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; MacAllister WS, 2009, MULT SCLER J, V15, P1502, DOI 10.1177/1352458509345902; Marcus SB, 2009, CLIN GASTROENTEROL H, V7, P554, DOI 10.1016/j.cgh.2009.01.022; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Meeske K, 2004, CANCER, V101, P2116, DOI 10.1002/cncr.20609; Mort S, 2011, ONCOL NURS FORUM, V38, pE445, DOI 10.1188/11.ONF.E445-E454; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Nauta MH, 2004, BEHAV RES THER, V42, P813, DOI 10.1016/S0005-7967(03)00200-6; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Nunnally J., 1994, PSYCHOMETRIC THEORY; Owens JA, 2000, SLEEP, V23, P1043; Owens JA, 2000, ARCH PEDIAT ADOL MED, V154, P549, DOI 10.1001/archpedi.154.6.549; Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776; Perdikaris P, 2008, INT NURS REV, V55, P412, DOI 10.1111/j.1466-7657.2008.00644.x; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; SCOTT PJ, 1977, ANN RHEUM DIS, V36, P186, DOI 10.1136/ard.36.2.186; Selewski DT, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-29; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Spence SH, 1997, J ABNORM PSYCHOL, V106, P280, DOI 10.1037/0021-843X.106.2.280; StataCorp, 2013, STATA STAT SOFTW REL; TEASDALE G, 1974, LANCET, V2, P81; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2015, QUAL LIFE RES, V24, P1921, DOI 10.1007/s11136-014-0914-2; Varni JW, 2013, QUAL LIFE RES, V22, P2581, DOI 10.1007/s11136-013-0370-4; Varni JW, 2010, INT J PEDIATR OBES, V5, P34, DOI 10.3109/17477160903111706; Varni JW, 2009, PEDIATR DIABETES, V10, P321, DOI 10.1111/j.1399-5448.2008.00482.x; Varni JW, 2006, DEV MED CHILD NEUROL, V48, P442, DOI 10.1017/S001216220600096X; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Whitsett SF, 2008, J PEDIATR ONCOL NURS, V25, P86, DOI 10.1177/1043454208315546; Wong D L, 1988, Pediatr Nurs, V14, P9; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	70	30	30	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					107	116		10.1097/HTR.0000000000000248			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700011	27455435				2022-02-06	
J	Tyburski, AL; Cheng, L; Assari, S; Darvish, K; Elliott, MB				Tyburski, Ashley L.; Cheng, Lan; Assari, Soroush; Darvish, Kurosh; Elliott, Melanie B.			Frequent mild head injury promotes trigeminal sensitivity concomitant with microglial proliferation, astrocytosis, and increased neuropeptide levels in the trigeminal pain system	JOURNAL OF HEADACHE AND PAIN			English	Article						Post-traumatic headache; Migraine; Concussion; Traumatic brain injury; Trigeminal; Microglia; Astrocytosis; Calcitonin gene-related peptide	TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; POSTTRAUMATIC HEADACHE; MILITARY PERSONNEL; NERVE-STIMULATION; MOUSE MODEL; CONCUSSION; ALLODYNIA; MIGRAINE; RATS	Background: Frequent mild head injuries or concussion along with the presence of headache may contribute to the persistence of concussion symptoms. Methods: In this study, the acute effects of recovery between mild head injuries and the frequency of injuries on a headache behavior, trigeminal allodynia, was assessed using von Frey testing up to one week after injury, while histopathological changes in the trigeminal pain pathway were evaluated using western blot, ELISA and immunohistochemistry. Results: A decreased recovery time combined with an increased mild closed head injury (CHI) frequency results in reduced trigeminal allodynia thresholds compared to controls. The repetitive CHI group with the highest injury frequency showed the greatest reduction in trigeminal thresholds along with greatest increased levels of calcitonin gene-related peptide (CGRP) in the trigeminal nucleus caudalis. Repetitive CHI resulted in astrogliosis in the central trigeminal system, increased GFAP protein levels in the sensory barrel cortex, and an increased number of microglia cells in the trigeminal nucleus caudalis. Conclusions: Headache behavior in rats is dependent on the injury frequency and recovery interval between mild head injuries. A worsening of headache behavior after repetitive mild head injuries was concomitant with increases in CGRP levels, the presence of astrocytosis, and microglia proliferation in the central trigeminal pathway. Signaling between neurons and proliferating microglia in the trigeminal pain system may contribute to the initiation of acute headache after concussion or other traumatic brain injuries.	[Tyburski, Ashley L.; Cheng, Lan; Elliott, Melanie B.] Thomas Jefferson Univ, Dept Neurosurg, 1020 Locust St, Philadelphia, PA 19107 USA; [Assari, Soroush; Darvish, Kurosh] Temple Univ, Philadelphia, PA 19122 USA		Elliott, MB (corresponding author), Thomas Jefferson Univ, Dept Neurosurg, 1020 Locust St, Philadelphia, PA 19107 USA.	Melanie.elliott@jefferson.edu			DoDUnited States Department of Defense [W81XWH-14-1-0594, W81WH-12-1-0326]	Research Support from DoD Awards W81XWH-14-1-0594, W81WH-12-1-0326 to MBE.	Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Edvinsson L, 1998, J AUTONOM NERV SYST, V70, P15, DOI 10.1016/S0165-1838(98)00033-2; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Elliott MB, 2010, NEUROSCIENCE, V170, P929, DOI 10.1016/j.neuroscience.2010.07.041; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Grinberg YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019294; Gu N, 2016, CELL REP, V16, P605, DOI 10.1016/j.celrep.2016.06.018; Hazra A., 2014, J NEUROSCI RES; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Honore P, 2000, Prog Brain Res, V129, P357; Katiyar KS, 2017, J TISSUE ENG REGEN M, V11, P2737, DOI 10.1002/term.2168; Kirifides ML, 2001, J COMP NEUROL, V435, P325, DOI 10.1002/cne.1033; Kjeldgaard D, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-81; Kontos Anthony P, 2016, Pediatr Neurol Briefs, V30, P19, DOI 10.15844/pedneurbriefs-30-3-2; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Malhotra R, 2016, ANN INDIAN ACAD NEUR, V19, P175, DOI 10.4103/0972-2327.182302; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Mouton P. R., 2002, PRINCIPLES PRACTICES; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Neelakantan H, 2012, EUR J PHARMACOL, V686, P55, DOI 10.1016/j.ejphar.2012.04.042; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Oshinsky ML, 2014, PAIN, V155, P1037, DOI 10.1016/j.pain.2014.02.009; Oshinsky ML, 2012, HEADACHE, V52, P1336, DOI 10.1111/j.1526-4610.2012.02247.x; Oshinsky ML, 2006, HEADACHE, V46, pS39, DOI 10.1111/j.1526-4610.2006.00489.x; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Recober A, 2010, DRUG NEWS PERSPECT, V23, P112, DOI 10.1358/dnp.2010.23.2.1475909; Recober A, 2009, J NEUROSCI, V29, P8798, DOI 10.1523/JNEUROSCI.1727-09.2009; Rossi HL, 2016, NEUROSCIENCE, V331, P99, DOI 10.1016/j.neuroscience.2016.06.022; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Shimizu K, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-75; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Tao YX, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-30; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Ward SJ, 2014, BRIT J PHARMACOL, V171, P636, DOI 10.1111/bph.12439; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	64	30	30	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	FEB 7	2017	18								16	10.1186/s10194-017-0726-1			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ0DW	WOS:000397742900001	28176234	gold, Green Published			2022-02-06	
J	Gudi, V; Gai, LJ; Herder, V; Tejedor, LS; Kipp, M; Amor, S; Suhs, KW; Hansmann, F; Beineke, A; Baumgartner, W; Stangel, M; Skripuletz, T				Gudi, Viktoria; Gai, Lijie; Herder, Vanessa; Tejedor, Laura Salinas; Kipp, Markus; Amor, Sandra; Suehs, Kurt-Wolfram; Hansmann, Florian; Beineke, Andreas; Baumgaertner, Wolfgang; Stangel, Martin; Skripuletz, Thomas			Synaptophysin Is a Reliable Marker for Axonal Damage	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Axonal damage; Demyelination; Inflammation; Synaptophysin.	AMYLOID PRECURSOR PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; CUPRIZONE-INDUCED DEMYELINATION; CULTURED HIPPOCAMPAL-NEURONS; VIRUS-INDUCED DEMYELINATION; SYNAPTIC VESICLE PROTEIN; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE	Synaptophysin is an abundant membrane protein of synaptic vesicles. The objective of this study was to determine the utility of identifying synaptophysin accumulations (spheroids/ovoids/bulbs) in CNS white matter as an immunohistochemical marker of axonal damage in demyelinating and neuroinflammatory conditions. We studied the cuprizone toxicity and Theiler's murine encephalomyelitis virus (TMEV) infection models of demyelination and analyzed CNS tissue from patients with multiple sclerosis (MS). Synaptophysin colocalized with the amyloid precursor protein (APP), a wellknown marker of axonal damage. In the cuprizone model, numerous pathological synaptophysin/APP-positive spheroids/ovoids were identified in the corpus callosum at the onset of demyelination; the extent of synaptophysin/APP-positive vesicle aggregates correlated with identified reactive microglia; during late and chronic demyelination, the majority of synaptophysin/APP-positive spheroids/ovoids resolved but a few remained, indicating persistent axonal damage; in the remyelination phase, scattered large synaptophysin/APPpositive bulbs persisted. In the TMEV model, only a few large-to medium-sized synaptophysin/APP-positive bulbs were found in demyelinated areas. In MS patient tissue samples, the bulbs appeared exclusively at the inflammatory edges of lesions. In conclusion, our data suggest that synaptophysin as a reliable marker of axonal damage in the CNS in inflammatory/demyelinating conditions.	[Gudi, Viktoria; Gai, Lijie; Tejedor, Laura Salinas; Suehs, Kurt-Wolfram; Stangel, Martin; Skripuletz, Thomas] Hannover Med Sch, Dept Neurol, Clin Neuroimmunol & Neurochem, Hannover, Germany; [Herder, Vanessa; Hansmann, Florian; Beineke, Andreas; Baumgaertner, Wolfgang] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Herder, Vanessa; Tejedor, Laura Salinas; Hansmann, Florian; Beineke, Andreas; Stangel, Martin] Ctr Syst Neurosci, Hannover, Germany; [Kipp, Markus] Ludwig Maximilians Univ Munchen, Dept Anat 2, Munich, Germany; [Amor, Sandra] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Skripuletz, Thomas] Hannover Med Sch, Dept Neurol, Carl-Neuberg-Str-1, D-30625 Hannover, Germany		Skripuletz, T (corresponding author), Hannover Med Sch, Dept Neurol, Carl-Neuberg-Str-1, D-30625 Hannover, Germany.	Skripuletz.Thomas@MH-Hannover.de	Stangel, Martin/AAH-5345-2020; Herder, Vanessa/AAG-6647-2020	Hansmann, Florian/0000-0001-6064-7728; Herder, Vanessa/0000-0003-4814-1382			BANATI RB, 1995, J CEREBR BLOOD F MET, V15, P647, DOI 10.1038/jcbfm.1995.80; Benardais K, 2014, GLIA, V62, P1659, DOI 10.1002/glia.22706; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Brady ST, 1999, J NEUROSCI, V19, P7278, DOI 10.1523/JNEUROSCI.19-17-07278.1999; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Centonze D, 2010, CELL DEATH DIFFER, V17, P1083, DOI 10.1038/cdd.2009.179; Clarner T, 2011, J MOL NEUROSCI, V43, P268, DOI 10.1007/s12031-010-9419-9; COCHRAN E, 1991, AM J PATHOL, V139, P485; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; DAHL D, 1989, ACTA NEUROPATHOL, V79, P154, DOI 10.1007/BF00294373; Dale Jeffrey M, 2012, J Amino Acids, V2012, P382107, DOI 10.1155/2012/382107; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; Dashiell SM, 2002, J NEUROCHEM, V81, P1263, DOI 10.1046/j.1471-4159.2002.00927.x; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; GEHRMANN J, 1995, GLIA, V15, P141, DOI 10.1002/glia.440150206; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Gonzalez-Jamett AM, 2010, J NEUROSCI, V30, P10683, DOI 10.1523/JNEUROSCI.5210-09.2010; Grosse-Veldmann R, 2016, MOL NEUROBIOL, V53, P4905, DOI 10.1007/s12035-015-9420-y; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Gudi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022623; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hares K, 2014, MULT SCLER J, V20, P812, DOI 10.1177/1352458513508836; Herder V, 2012, J NEUROIMMUNOL, V244, P84, DOI 10.1016/j.jneuroim.2012.01.010; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P877, DOI 10.1038/nrm2807; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Horikawa HPM, 2002, MOL CELL NEUROSCI, V21, P454, DOI 10.1006/mcne.2002.1191; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Katsuse O, 2003, J NEUROL SCI, V211, P29, DOI 10.1016/S0022-510X(03)00037-6; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kornek B, 2001, BRAIN, V124, P1114, DOI 10.1093/brain/124.6.1114; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Korzhevskii D E, 2007, Morfologiia, V131, P75; Kreutzer M, 2012, BRAIN PATHOL, V22, P454, DOI 10.1111/j.1750-3639.2011.00541.x; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; Lindner M, 2009, NEUROSCI LETT, V453, P120, DOI 10.1016/j.neulet.2009.02.004; Mallozzi C, 2013, BBA-MOL CELL RES, V1833, P110, DOI 10.1016/j.bbamcr.2012.10.022; Mancardi G, 2001, J NEUROL SCI, V184, P41, DOI 10.1016/S0022-510X(00)00490-1; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Muresan Z, 2004, HUM MOL GENET, V13, P475, DOI 10.1093/hmg/ddh054; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Ohyama A, 2001, BIOCHEM BIOPH RES CO, V280, P988, DOI 10.1006/bbrc.2001.4236; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Paus T, 2014, NEUROSCIENCE, V276, P117, DOI 10.1016/j.neuroscience.2014.01.055; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Petzold A, 2008, EXP NEUROL, V213, P326, DOI 10.1016/j.expneurol.2008.06.008; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Roy S, 2000, J NEUROSCI, V20, P6849, DOI 10.1523/JNEUROSCI.20-18-06849.2000; Roy S, 2007, J NEUROSCI, V27, P3131, DOI 10.1523/JNEUROSCI.4999-06.2007; Sato Fumitaka, 2011, Pathophysiology, V18, P31, DOI 10.1016/j.pathophys.2010.04.011; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Schirmer L, 2011, BRAIN PATHOL, V21, P428, DOI 10.1111/j.1750-3639.2010.00466.x; Shea TB, 2008, EUR J NEUROSCI, V27, P1893, DOI 10.1111/j.1460-9568.2008.06165.x; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Skripuletz T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14935; Skripuletz T, 2015, BRAIN, V138, P398, DOI 10.1093/brain/awu358; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Skripuletz T, 2010, BRAIN PATHOL, V20, P301, DOI 10.1111/j.1750-3639.2009.00271.x; SOLA C, 1993, NEUROSCIENCE, V53, P267, DOI 10.1016/0306-4522(93)90304-X; Stagi M, 2005, J NEUROSCI, V25, P352, DOI 10.1523/JNEUROSCI.3887-04.2005; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; TATEOSTROFF B, 1989, P NATL ACAD SCI USA, V86, P745, DOI 10.1073/pnas.86.2.745; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsunoda I, 2003, AM J PATHOL, V162, P1259, DOI 10.1016/S0002-9440(10)63922-3; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; Ulrich R, 2006, J NEUROPATH EXP NEUR, V65, P783, DOI 10.1097/01.jnen.0000229990.32795.0d; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	105	30	30	3	16	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	FEB	2017	76	2					109	125		10.1093/jnen/nlw114			17	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	EP1NA	WOS:000397150400004	28177496	Bronze			2022-02-06	
J	Kyyriainen, J; Ndode-Ekane, XE; Pitkanen, A				Kyyriainen, Jenni; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asla			Dynamics of PDGFR beta Expression in Different Cell Types after Brain Injury	GLIA			English	Article						NG2 cell; pericyte; status epilepticus; traumatic brain injury; urokinase-type plasminogen activator receptor	FACTOR RECEPTOR-BETA; PLASMINOGEN-ACTIVATOR RECEPTOR; SMOOTH-MUSCLE-CELLS; MOUSE MODEL; RAT-BRAIN; PERICYTES; DEFICIENT; NG2; INVOLVEMENT; EPILEPTOGENESIS	Platelet-derived growth factor receptor beta (PDGFR beta) is upregulated after brain injury and its depletion results in the blood-brain barrier (BBB) damage. We investigated the time-window and localization of PDGFR beta expression in mice with intrahippocampal kainic acid-induced status epilepticus (SE) and in rats with lateral fluid-percussion-induced traumatic brain injury (TBI). Tissue immunohistochemistry was evaluated at several time-points after SE and TBI. The distribution of PDGFR beta was analyzed, and its cell type-specific expression was verified with double/triple-labeling of astrocytes (GFAP), NG2 cells, and endothelial cells (RECA-1). In normal mouse hippocampus, we found evenly distributed PDGFR beta+ parenchymal cells. In double-labeling, all NG2+ and 40%-60% GFAP+ cells were PDGFR beta+. After SE, PDGFR beta+ cells clustered in the ipsilateral hilus (178% of that in controls at fourth day, 225% at seventh day, P<0.05) and in CA3 (201% at seventh day, P<0.05), but the total number of PDGFR beta+ cells was not altered. As in controls, PDGFR beta-immunoreactivity was detected in parenchymal NG2+ and GFAP+ cells. We also observed PDGFR beta+ structural pericytes, detached reactive pericytes, and endothelial cells. After TBI, PDGFR beta+ cells clustered in the perilesional cortex and thalamus, particularly during the first post-injury week. PDGFR beta immunopositivity was observed in NG2+ and GFAP+ cells, structural pericytes, detached reactive pericytes, and endothelial cells. In some animals, PDGFR beta vascular staining was observed around the cortical glial scar for up to 3 months. Our data revealed an acute accumulation of PDGFR beta+ BBB-related cells in degenerating brain areas, which can be long lasting, suggesting an active role for PDGFR beta-signaling in blood vessel and post-injury tissue recovery.	[Kyyriainen, Jenni; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	Academy of FinlandAcademy of FinlandEuropean Commission; COST Action ECMNETEuropean Cooperation in Science and Technology (COST) [BM1001]; ERA-NET Neuron [TBI Epilepsy]; Doctoral Program in Molecular Medicine; Epilepsy Foundation; Finnish Epilepsy Research Foundation	Grant sponsor: The Academy of Finland, COST Action ECMNET [BM1001], ERA-NET Neuron [TBI Epilepsy], Doctoral Program in Molecular Medicine, Epilepsy Foundation and Finnish Epilepsy Research Foundation.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Arimura K, 2012, CURR NEUROVASC RES, V9, P1; Beazely MA, 2009, J BIOL CHEM, V284, P8054, DOI 10.1074/jbc.M805384200; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Dityatev A, 2014, PROG BRAIN RES, V214, pXIII, DOI 10.1016/B978-0-444-63486-3.09998-9; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Fuhrman B, 2009, CARDIOVASC RES, V84, P145, DOI 10.1093/cvr/cvp184; Garbelli R, 2015, NEUROSCIENCE, V306, P18, DOI 10.1016/j.neuroscience.2015.07.090; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Gril B, 2013, AM J PATHOL, V182, P2368, DOI 10.1016/j.ajpath.2013.02.043; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hill RA, 2014, GLIA, V62, P1195, DOI 10.1002/glia.22664; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Ishii Y, 2008, MOL CELL NEUROSCI, V37, P507, DOI 10.1016/j.mcn.2007.11.006; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Ishitsuka K, 2012, MICROVASC RES, V83, P352, DOI 10.1016/j.mvr.2012.02.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kiyan J, 2005, EMBO J, V24, P1787, DOI 10.1038/sj.emboj.7600669; Lahtinen L, 2009, NEUROSCIENCE, V163, P316, DOI 10.1016/j.neuroscience.2009.06.019; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Makihara N, 2015, EXP NEUROL, V264, P127, DOI 10.1016/j.expneurol.2014.12.007; Malla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013731; Meirelles LD, 2016, FRONT BIOSCI-LANDMRK, V21, P130, DOI 10.2741/4380; Milesi S, 2014, NEUROBIOL DIS, V71, P151, DOI 10.1016/j.nbd.2014.07.010; Morita S, 2014, CELL BIOCHEM FUNCT, V32, P51, DOI 10.1002/cbf.2971; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; NEHLS V, 1992, CELL TISSUE RES, V270, P469, DOI 10.1007/BF00645048; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2014, PROG BRAIN RES, V214, P229, DOI 10.1016/B978-0-444-63486-3.00011-6; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Renner O, 2003, MOL BRAIN RES, V113, P44, DOI 10.1016/S0169-328X(03)00085-8; Roder C, 2010, ACTA NEUROCHIR, V152, P2153, DOI 10.1007/s00701-010-0711-9; Rubina KA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1235, DOI 10.1134/S0006297915100041; Sano H, 2001, CIRCULATION, V103, P2955, DOI 10.1161/01.CIR.103.24.2955; Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thomas WE, 1999, BRAIN RES REV, V31, P42, DOI 10.1016/S0165-0173(99)00024-7; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2015, SEMIN CELL DEV BIOL, V38, P26, DOI 10.1016/j.semcdb.2014.10.003; van Vliet EA, 2014, NEUROSCIENCE, V277, P455, DOI 10.1016/j.neuroscience.2014.07.030; Vasefi MS, 2013, J NEUROCHEM, V125, P26, DOI 10.1111/jnc.12157; Virgintino D, 2012, ANGIOGENESIS, V15, P761, DOI 10.1007/s10456-012-9292-y; Weissberg I., 2011, EPILEPSY RES TREAT, V2011, DOI DOI 10.1155/2011/143908; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1; Zhao YJ, 2012, MOL MED REP, V6, P739, DOI 10.3892/mmr.2012.1007	67	30	30	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	FEB	2017	65	2					322	341		10.1002/glia.23094			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK1ER	WOS:000393669100008	27778377				2022-02-06	
J	Meier, TB; Bellgowan, PSF; Mayer, AR				Meier, Timothy B.; Bellgowan, Patrick S. F.; Mayer, Andrew R.			Longitudinal assessment of local and global functional connectivity following sports-related concussion	BRAIN IMAGING AND BEHAVIOR			English	Article						fMRI; Mild traumatic brain injury; Regional homogeneity; Resting state	DEFAULT-MODE NETWORK; COLLEGIATE FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; RESTING-STATE FMRI; PERFORMANCE; RECOVERY; HOMOGENEITY; PHASE	Growing evidence suggests that sports-related concussions (SRC) may lead to acute changes in intrinsic functional connectivity, although most studies to date have been cross-sectional in nature with relatively modest sample sizes. We longitudinally assessed changes in local and global resting state functional connectivity using metrics that do not require a priori seed or network selection (regional homogeneity; ReHo and global brain connectivity; GBC, respectively). A large sample of collegiate athletes (N = 43) was assessed approximately one day (1.74 days post-injury, N = 34), one week (8.44 days, N = 34), and one month post-concussion (32.47 days, N = 30). Healthy contact sport-athletes served as controls (N = 51). Concussed athletes showed improvement in mood symptoms at each time point (p's < 0.05), but had significantly higher mood scores than healthy athletes at every time point (p's < 0.05). In contrast, self-reported symptoms and cognitive deficits improved over time following concussion (p's < 0.001), returning to healthy levels by one week post-concussion. ReHo in sensorimotor, visual, and temporal cortices increased over time post-concussion, and was greatest at one month post-injury. Conversely, ReHo in the frontal cortex decreased over time following SRC, with the greatest decrease evident at one month post-concussion. Differences in ReHo relative to healthy athletes were primarily observed at one month post-concussion rather than the more acute time points. Contrary to our hypothesis, no significant cross-sectional or longitudinal differences in GBC were observed. These results are suggestive of a delayed onset of local connectivity changes following SRC.	[Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Meier, Timothy B.; Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM 87106 USA; [Meier, Timothy B.] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Bellgowan, Patrick S. F.] NINDS, NIH, North Bethesda, MD 20892 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Meier, TB (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Meier, TB (corresponding author), Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM 87106 USA.; Meier, TB (corresponding author), Laureate Inst Brain Res, Tulsa, OK 74136 USA.	tmeier@mcw.edu		Bellgowan, Patrick/0000-0002-6753-8302	Laureate Institute for Brain Research; William K. Warren Foundation	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by The William K. Warren Foundation. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. Dr. Meier had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors thank the psychiatric assessment team, the MRI technicians, and Dr. Rashmi Singh at the Laureate Institute for Brain Research for their assistance in data collection and Christopher Nerio, David Polanski, Dr. Thomas Allen, and Dr. Lamont Cavanagh for athlete referral and injury oversight.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chen G, 2013, NEUROIMAGE, V73, P176, DOI 10.1016/j.neuroimage.2013.01.047; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gotts SJ, 2012, BRAIN, V135, P2711, DOI 10.1093/brain/aws160; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones TB, 2010, NEUROIMAGE, V49, P401, DOI 10.1016/j.neuroimage.2009.07.051; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Singh R, 2016, J NEUROL NEUROSUR PS, V87, P670, DOI 10.1136/jnnp-2015-311369; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Taylor PA, 2013, BRAIN CONNECT, V3, P523, DOI 10.1089/brain.2013.0154; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; Zhu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065884; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	57	30	30	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	FEB	2017	11	1					129	140		10.1007/s11682-016-9520-y			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET8TT	WOS:000400575300011	26821253				2022-02-06	
J	Mayeux, J; Katz, P; Edwards, S; Middleton, JW; Molina, PE				Mayeux, Jacques; Katz, Paige; Edwards, Scott; Middleton, Jason W.; Molina, Patricia E.			Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability	JOURNAL OF NEUROTRAUMA			English	Article						endocannabinoids; MAGL; neuroinflammation; TBI; 2-AG	DEPOLARIZATION-INDUCED SUPPRESSION; LONG-TERM POTENTIATION; DIFFUSE AXONAL INJURY; AMYLOID-BETA; ALZHEIMERS-DISEASE; ENDOGENOUS CANNABINOIDS; MICROGLIAL ACTIVATION; HIPPOCAMPAL SYNAPSES; PROTECTS NEURONS; HEAD-INJURY	Traumatic brain injury (TBI) is an increasingly prevalent condition affecting soldiers, athletes, and motor vehicle accident victims. Unfortunately, it currently lacks effective therapeutic interventions. TBI is defined as a primary mechanical insult followed by a secondary cascade involving inflammation, apoptosis, release of reactive oxygen species, and excitotoxicity, all of which can cause synaptic changes, altered neuronal signaling, and, ultimately, behavioral changes. Previously we showed that preventing degradation of the endocannabinoid (EC) 2-acylglycerol (2-AG) with JZL184 after mild TBI attenuated neuroinflammation and improved recovery of neurobehavioral function during the early 24 h post-TBI period. The aim of this study was to extend the timeline of observations to 2 weeks post-injury and to investigate JZL184's impact on synaptic transmission, which we view as a potential mechanism for TBI-induced cellular and behavioral pathology. Adult male rats underwent mild TBI (mTBI) followed by a single intraperitoneal injection of JZL184 or vehicle 30min postinjury. JZL184 administered-TBI animals showed improved neurobehavioral recovery compared with vehicle-injected TBI animals beginning 24 h post-injury and persisting for 2 weeks. JZL184-treated animals had significantly diminished gray and white matter astrocyte activation when compared with vehicle-treated animals at day 7 post-TBI. JZL184 administration significantly attenuated the increased pGluR1 S845/GluR1 and pERK 1/2/ERK and the increases in miniature excitatory postsynaptic potential (mEPSC) frequency and amplitude observed in layer 5 pyramidal neurons at 10 days post-TBI. These results suggest a neuroprotective role for ECs in ameliorating the TBI-induced neurobehavioral, neuroinflammatory, and glutamate dyshomeostasis from mTBI. Further studies elucidating the cellular mechanisms involved are warranted.	[Mayeux, Jacques; Katz, Paige; Edwards, Scott; Molina, Patricia E.] Louisiana State Univ, Hlth Sci Ctr, Alcohol & Drug Abuse Ctr Excellence, Dept Physiol, 1901 Perdido St,Room 7212, New Orleans, LA 70112 USA; [Middleton, Jason W.] Louisiana State Univ, Hlth Sci Ctr, Alcohol & Drug Abuse Ctr Excellence, Dept Cell Biol & Anat, New Orleans, LA USA		Molina, PE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Alcohol & Drug Abuse Ctr Excellence, Dept Physiol, 1901 Perdido St,Room 7212, New Orleans, LA 70112 USA.	pmolin@lsuhsc.edu	Molina, Patricia E./AAK-9814-2021	Molina, Patricia E./0000-0002-3598-384X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AA007577, AA020839];  [DOD-W81XWH-11-2-0011]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R00AA020839, T32AA007577] Funding Source: NIH RePORTER	This work was supported by NIH training (AA007577, JM, PK) and research grants AA020839 (SE), and DOD-W81XWH-11-2-0011 (PM). The authors would like to thank Dr. Nicholas Gilpin for scientific discussions during the preparation of this article and Kylie Mills for assistance with animal behavior and surgery experiments. Paige Katz was a post-doctoral fellow at LSUHSC during the completion of these studies but has since completed her fellowship.	Abraham WC, 1996, BRAIN RES, V722, P217, DOI 10.1016/0006-8993(96)00130-8; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Alger BE, 2002, PROG NEUROBIOL, V68, P247; BARNES CA, 1995, NEURON, V15, P751, DOI 10.1016/0896-6273(95)90166-3; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P395, DOI 10.1007/s00401-011-0932-x; Chen X, 2011, NEUROSCIENCE, V178, P159, DOI 10.1016/j.neuroscience.2011.01.024; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Du HZ, 2011, BRIT J PHARMACOL, V163, P1533, DOI 10.1111/j.1476-5381.2011.01444.x; Edwards S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.70; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Fuzik J, 2013, NEUROSCIENCE, V228, P371, DOI 10.1016/j.neuroscience.2012.10.042; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; HAWKINS RD, 1984, PSYCHOL REV, V91, P375, DOI 10.1037/0033-295X.91.3.375; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; Jeffery KJ, 1997, HIPPOCAMPUS, V7, P95; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kimura A, 2000, J NEUROPHYSIOL, V84, P1894, DOI 10.1152/jn.2000.84.4.1894; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; McIntosh TK, 1996, LAB INVEST, V74, P315; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Prow NA, 2008, J NEUROCHEM, V105, P1276, DOI 10.1111/j.1471-4159.2008.05230.x; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Sarne Y, 2005, CNS NEUROL DISORD-DR, V4, P677, DOI 10.2174/156800705774933005; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Xu JY, 2015, NEUROSCIENTIST, V21, P152, DOI 10.1177/1073858414524632; Xu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010306; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang JC, 2005, BRAIN RES, V1050, P110, DOI 10.1016/j.brainres.2005.05.032; Zhang J, 2008, J BIOL CHEM, V283, P22601, DOI 10.1074/jbc.M800524200	65	30	30	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					436	443		10.1089/neu.2016.4452			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800019	27189876	Green Published			2022-02-06	
J	Treble-Barna, A; Zang, HY; Zhang, NH; Taylor, HG; Yeates, KO; Wade, S				Treble-Barna, Amery; Zang, Huaiyu; Zhang, Nanhua; Taylor, H. Gerry; Yeates, Keith Owen; Wade, Shari			Long-Term Neuropsychological Profiles and Their Role as Mediators of Adaptive Functioning after Traumatic Brain Injury in Early Childhood	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; neuropsychology; outcome measures; pediatric brain injury	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EVERYDAY EXECUTIVE FUNCTION; TEMPORAL-LOBE EPILEPSY; CLOSED-HEAD INJURY; RECOVERY 10 YEARS; YOUNG-CHILDREN; ACADEMIC-ACHIEVEMENT; DEVELOPMENTAL DISORDERS; COGNITIVE PREDICTORS; ORTHOPEDIC INJURY	The objectives of the study were to characterize long-term neuropsychological outcomes following traumatic brain injury (TBI) sustained during early childhood, and determine whether identified neuropsychological impairments mediated the effect of TBI on long-term adaptive functioning. Participants included 16 children with severe TBI, 42 children with moderate TBI, and 72 children with orthopedic injuries (OI) sustained between ages 3 and 7 years. Children completed neuropsychological tests and caregivers completed a structured interview of child adaptive functioning at 6.9 (+/- 1.10) years post-injury. Profile analysis and multiple mediator modeling were employed. Children with severe TBI demonstrated poorer fluid reasoning and inhibitory control than both children with moderate TBI and OI, as well as slower processing speed than the OI group. Both fluid reasoning and processing speed were significant independent mediators of the effect of severe TBI on adaptive functioning. No neuropsychological measure significantly mediated the effect of moderate TBI on adaptive functioning. Children sustaining early severe TBI demonstrate persisting neuropsychological impairments into adolescence and young adulthood. The impact of severe TBI on children's long-term adaptive functioning is mediated in part by its effects on fluid reasoning and processing speed.	[Treble-Barna, Amery; Wade, Shari] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Treble-Barna, Amery] Univ Cincinnati, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Rainbow Child Dev Ctr, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp, Dept Psychol,Res Inst, Calgary, AB, Canada		Treble-Barna, A (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Treble-Barna, A (corresponding author), Univ Cincinnati, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Amery.Treble-Barna@cchmc.org	Zang, Huaiyu/AAY-6603-2021; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Zhang, Nanhua/0000-0001-5796-3404	Institutional Clinical and Translational Science Award, NIH/NCRR [1UL1RR026314]; National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; Trauma Research grants from the State of Ohio Emergency Medical Services; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	This publication was supported by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 1UL1RR026314. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health (NIH). Additional support provided to Dr. Wade included grant R01 HD42729 from National Institute of Child Health and Human Development (NICHD) and Trauma Research grants from the State of Ohio Emergency Medical Services.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Ashford JM, 2014, J NEURO-ONCOL, V118, P193, DOI 10.1007/s11060-014-1420-7; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Benson D.F., 1986, FRONTAL LOBES; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Carpentieri S, 1996, J AUTISM DEV DISORD, V26, P611, DOI 10.1007/BF02172350; Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Clark CAC, 2013, DEV PSYCHOL, V49, P1481, DOI 10.1037/a0030578; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Crowe LM, 2014, J HEAD TRAUMA REHAB, V29, P217, DOI 10.1097/HTR.0b013e31829babfd; Crowe LM, 2013, CHILD NEUROPSYCHOL, V19, P113, DOI 10.1080/09297049.2011.651079; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Culbertson WC, 1998, ARCH CLIN NEUROPSYCH, V13, P285, DOI 10.1016/S0887-6177(97)00033-4; Culhane-Shelburne K, 2002, J INT NEUROPSYCH SOC, V8, P623, DOI 10.1017/S1355617702801308; Davis BE, 2006, DEV MED CHILD NEUROL, V48, P253, DOI 10.1017/S0012162206000569; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M., 1988, LANGUAGE YOUNG DAMAG, V7; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Gonzalez LM, 2007, EPILEPSIA, V48, P124, DOI 10.1111/j.1528-1167.2006.00907.x; Harris R. J., 1985, PRIMER MULTIVARIATE, V2nd; Hedvall A, 2013, SCI WORLD J, DOI 10.1155/2013/158263; Hodges K, 1998, J BEHAV HEALTH SER R, V25, P325, DOI 10.1007/BF02287471; Hodges K, 1997, J MENT HEALTH ADMIN, V24, P278, DOI 10.1007/BF02832662; Hodges K., 1994, CHILD ADOLESCENT FUN; Hodges K., 1996, J CHILD FAM STUD, V5, P445, DOI [10.1007/BF02233865, DOI 10.1007/BF02233865]; Hodges K., 2005, CAFAS MANUAL TRAININ; Jacobson LA, 2011, CHILD NEUROPSYCHOL, V17, P255, DOI 10.1080/09297049.2010.535654; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Kurowski B. G., 2015, J HEAD TRAUMA REHABI; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Liss M, 2001, J AUTISM DEV DISORD, V31, P219, DOI 10.1023/A:1010707417274; LOVELAND KA, 1991, AM J MENT RETARD, V96, P13; Luria A.R., 1966, HIGHER CORTICAL FUNC; Manly T, 1999, TEA CH TEST EVERYDAY; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Molfese VJ, 2010, CONTEMP EDUC PSYCHOL, V35, P116, DOI 10.1016/j.cedpsych.2010.03.004; Murray A, 2014, J INTELL DISABIL RES, V58, P777, DOI 10.1111/jir.12092; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nowrangi MA, 2014, J NEUROPSYCH CLIN N, V26, P114, DOI 10.1176/appi.neuropsych.12070176; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Nybo T, 1999, BRAIN INJURY, V13, P759; Papazoglou A, 2013, J INT NEUROPSYCH SOC, V19, P189, DOI 10.1017/S1355617712001191; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Raghubar KP, 2013, J INT NEUROPSYCH SOC, V19, P254, DOI 10.1017/S1355617712001312; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Roberts RJ, 1996, DEV NEUROPSYCHOL, V12, P105, DOI 10.1080/87565649609540642; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; ROSZKOWSKI MJ, 1980, PSYCHOL SCHOOLS, V17, P452, DOI 10.1002/1520-6807(198010)17:4<452::AID-PITS2310170406>3.0.CO;2-F; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; SCHATZ J, 1995, J AUTISM DEV DISORD, V25, P51, DOI 10.1007/BF02178167; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Spreen O., 1985, DEV NEUROPSYCHOLOGY; Stahl L, 2005, CHILD NEUROPSYCHOL, V11, P175, DOI 10.1080/092970490911315; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; TEASDALE G, 1974, LANCET, V2, P81; van Aken L, 2016, ACTA NEUROPSYCHIATR, V28, P31, DOI 10.1017/neu.2015.46; Verger K, 2000, BRAIN INJURY, V14, P495; Waber DP, 2006, DEV NEUROPSYCHOL, V29, P459, DOI 10.1207/s15326942dn2903_5; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Walsh KS, 2015, CHILD NEUROPSYCHOL, V21, P78, DOI 10.1080/09297049.2013.876491; Ware AL, 2012, ALCOHOL CLIN EXP RES, V36, P1431, DOI 10.1111/j.1530-0277.2011.01718.x; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2004, WECHSLER INTELLIGENC, Vfourth; Willoughby MT, 2012, CHILD NEUROPSYCHOL, V18, P79, DOI 10.1080/09297049.2011.578572; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zelazo PD, 1998, DEV PSYCHOL, V34, P203, DOI 10.1037/0012-1649.34.2.203	109	30	31	2	33	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					353	362		10.1089/neu.2016.4476			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800010	27080734	Green Published			2022-02-06	
J	Kislin, M; Sword, J; Fomitcheva, IV; Croom, D; Pryazhnikov, E; Lihavainen, E; Toptunov, D; Rauvala, H; Ribeiro, AS; Khiroug, L; Kirov, SA				Kislin, Mikhail; Sword, Jeremy; Fomitcheva, Ioulia V.; Croom, Deborah; Pryazhnikov, Evgeny; Lihavainen, Eero; Toptunov, Dmytro; Rauvala, Heikki; Ribeiro, Andre S.; Khiroug, Leonard; Kirov, Sergei A.			Reversible Disruption of Neuronal Mitochondria by Ischemic and Traumatic Injury Revealed by Quantitative Two-Photon Imaging in the Neocortex of Anesthetized Mice	JOURNAL OF NEUROSCIENCE			English	Article						brain trauma; dendrite; mitochondria; stroke; structural dynamics; two-photon in vivo imaging	PERMEABILITY TRANSITION; FLUORESCENT PROTEIN; CEREBRAL-ISCHEMIA; DENDRITIC SPINES; TRANSGENIC MICE; CELL-DEATH; FUSION; TRANSIENT; CALCIUM; FISSION	Mitochondria play a variety of functional roles in cortical neurons, from metabolic support and neuroprotection to the release of cytokines that trigger apoptosis. In dendrites, mitochondrial structure is closely linked to their function, and fragmentation (fission) of the normally elongated mitochondria indicates loss of their function under pathological conditions, such as stroke and brain trauma. Using in vivo two-photon microscopy in mouse brain, we quantified mitochondrial fragmentation in a full spectrum of cortical injuries, ranging from severe to mild. Severe global ischemic injury was induced by bilateral common carotid artery occlusion, whereas severe focal stroke injury was induced by Rose Bengal photosensitization. The moderate and mild traumatic injury was inflicted by focal laser lesion and by mild photo-damage, respectively. Dendritic and mitochondrial structural changes were tracked longitudinally using transgenic mice expressing fluorescent proteins localized either in cytosol or in mitochondrial matrix. In response to severe injury, mitochondrial fragmentation developed in parallel with dendritic damage signified by dendritic beading. Reconstruction from serial section electron microscopy confirmed mitochondrial fragmentation. Unlike dendritic beading, fragmentation spread beyond the injury core in focal stroke and focal laser lesion models. In moderate and mild injury, mitochondrial fragmentation was reversible with full recovery of structural integrity after 1-2 weeks. The transient fragmentation observed in the mild photo-damage model was associated with changes in dendritic spine density without any signs of dendritic damage. Our findings indicate that alterations in neuronal mitochondria structure are very sensitive to the tissue damage and can be reversible in ischemic and traumatic injuries.	[Kislin, Mikhail; Pryazhnikov, Evgeny; Rauvala, Heikki; Khiroug, Leonard] Univ Helsinki, Neurosci Ctr, FI-00014 Helsinki, Finland; [Pryazhnikov, Evgeny; Toptunov, Dmytro; Khiroug, Leonard] Neurotar Ltd, FI-00790 Helsinki, Finland; [Lihavainen, Eero; Ribeiro, Andre S.] Tampere Univ Technol, Dept Signal Proc, Lab Biosyst Dynam, FI-33101 Tampere, Finland; [Sword, Jeremy; Croom, Deborah; Kirov, Sergei A.] Augusta Univ, Brain & Behav Discovery Inst, Med Coll Georgia, 1120 15th St,CB 3706, Augusta, GA 30912 USA; [Fomitcheva, Ioulia V.; Kirov, Sergei A.] Augusta Univ, Dept Neurosurg, Med Coll Georgia, Augusta, GA 30912 USA		Kirov, SA (corresponding author), Augusta Univ, Brain & Behav Discovery Inst, Med Coll Georgia, 1120 15th St,CB 3706, Augusta, GA 30912 USA.; Khiroug, L (corresponding author), Univ Helsinki, In Vivo Microscopy Unit, Neurosci Ctr, POB 56,Viikinkaari 4, FI-00014 Helsinki, Finland.; Kirov, SA (corresponding author), Augusta Univ, Med Coll Georgia, Multiphoton Imaging Lab, Dept Neurosurg, 1120 15th St,CB 3706, Augusta, GA 30912 USA.	leonard.khirug@helsinki.fi; skirov13@gmail.com	Kislin, Mikhail/ABC-6334-2021; Ribeiro, Andre S/G-4294-2014	Kislin, Mikhail/0000-0002-5447-8881; Ribeiro, Andre S/0000-0002-7255-5211	Academy of FinlandAcademy of FinlandEuropean Commission [SA-126321, 295027, 305342]; FGSN; CIMO; University of Helsinki; Emil Aaltonen Foundation; Jane and Aatos Erkko Foundation [610536]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS083858]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS083858, R01NS083858] Funding Source: NIH RePORTER	This work was supported by the Academy of Finland Grant SA-126321, FGSN, CIMO, and University of Helsinki to L.K., Emil Aaltonen Foundation to E.L., Academy of Finland Grants 295027 and 305342, and Jane and Aatos Erkko Foundation Grant 610536 to A.S.R., and by National Institutes of Health Grant NS083858 to S.A.K. We thank Libby Perry and Brendan Marshall (Electron Microscopy Core at the Medical College of Georgia) for assistance with electron microscopy; and Julia Kolikova (Neurotar Ltd) and Marina Tibeykina (In Vivo Microscopy Unit at the University of Helsinki) for assistance with animal surgeries.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Bahar S, 2000, J NEUROPHYSIOL, V84, P311; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chandrasekaran K, 2006, J NEUROSCI, V26, P13123, DOI 10.1523/JNEUROSCI.4191-06.2006; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen SB, 2011, J NEUROSCI METH, V195, P222, DOI 10.1016/j.jneumeth.2010.12.018; Dirnagl U, 2012, ANN NY ACAD SCI, V1268, P21, DOI 10.1111/j.1749-6632.2012.06691.x; Dreier JP, 2013, NEUROSCIENTIST, V19, P25, DOI 10.1177/1073858412453340; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; GARCIA JH, 1978, ACTA NEUROPATHOL, V43, P85; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; Kirov AS, 2014, PATHOLOGICAL POTENTI, P127; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kirov SA, 1999, J NEUROSCI, V19, P2876; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kremneva E, 2013, CELL CALCIUM, V53, P85, DOI 10.1016/j.ceca.2012.10.003; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Labat-gest Vivien, 2013, J Vis Exp, DOI 10.3791/50370; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lihavainen E, 2015, J MICROSC-OXFORD, V260, P338, DOI 10.1111/jmi.12301; Lihavainen E, 2012, BIOINFORMATICS, V28, P1050, DOI 10.1093/bioinformatics/bts073; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; Liu RR, 2009, J BIOL CHEM, V284, P36109, DOI 10.1074/jbc.M109.055301; Liu WT, 2012, J NEUROSCI RES, V90, P1183, DOI 10.1002/jnr.23016; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Owens K, 2015, J BIOENERG BIOMEMBR, V47, P13, DOI 10.1007/s10863-014-9575-7; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Paveliev M, 2014, JOVE-J VIS EXP, DOI 10.3791/51559; Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212; Peron S, 2015, CURR OPIN NEUROBIOL, V32, P115, DOI 10.1016/j.conb.2015.03.016; Pivovarova NB, 2004, J NEUROSCI, V24, P5611, DOI 10.1523/JNEUROSCI.0531-04.2004; Popov V, 2005, J COMP NEUROL, V492, P50, DOI 10.1002/cne.20682; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Risher WC, 2012, GLIA, V60, P1709, DOI 10.1002/glia.22390; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shitara H, 2001, FEBS LETT, V500, P7, DOI 10.1016/S0014-5793(01)02574-1; Sigler A, 2008, J NEUROSCI METH, V170, P35, DOI 10.1016/j.jneumeth.2007.12.015; Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; Stetler RA, 2013, J CEREBR BLOOD F MET, V33, P22, DOI 10.1038/jcbfm.2012.158; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Sword J, 2017, J CEREBR BLOOD F MET, V37, P1626, DOI 10.1177/0271678X16639328; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; TOMIMOTO H, 1992, BRAIN RES, V598, P87, DOI 10.1016/0006-8993(92)90171-5; TOMIMOTO H, 1994, NEUROSCIENCE, V63, P957, DOI 10.1016/0306-4522(94)90564-9; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wappler EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063206; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Yang O, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528610; Yin W, 2008, STROKE, V39, P3057, DOI 10.1161/STROKEAHA.108.520114; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	79	30	31	0	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	JAN 11	2017	37	2					333	348		10.1523/JNEUROSCI.1510-16.2017			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ9CZ	WOS:000393525500012	28077713	Bronze			2022-02-06	
J	Dieterich, AV; Andrade, RJ; Le Sant, G; Falla, D; Petzke, F; Hug, F; Nordez, A				Dieterich, Angela V.; Andrade, Ricardo J.; Le Sant, Guillaume; Falla, Deborah; Petzke, Frank; Hug, Francois; Nordez, Antoine			Shear wave elastography reveals different degrees of passive and active stiffness of the neck extensor muscles	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Muscle activation; Cervical spine; Ultrasound; Shear wave elastography; Neck; Shear modulus; Synergist	2000-2010 TASK-FORCE; LOW-BACK-PAIN; ELASTIC-MODULUS; SKELETAL-MUSCLE; CERVICAL-SPINE; ACTIVATION; CONTRACTION; DETERMINANTS; BIOMECHANICS; RELIABILITY	The neck extensor muscles contribute to spinal support and posture while performing head and neck motion. Muscle stiffness relates to passive elasticity (support) and active tensioning (posture and movement) of muscle. It was hypothesized that support and motion requirements are reflected in the distribution of stiffness between superficial and deep neck extensor muscles. In ten healthy participants, shear modulus (stiffness) of five neck extensor muscles was determined in prone at rest and during isometric head lift at three intensities using shear wave elastography. Shear modulus differed between muscles (P < 0.001), and was larger for the deeper muscles: (median (interquartile range)) trapezius 7.7 kPa (4.4), splenius capitis 6.5 kPa (2.5), semispinalis capitis 8.9 kPa (2.8), semispinalis cervicis 9.5 kPa (2.5), multifidus 14.9 kPa (1.4). Shear modulus differed between the resting condition and head lift (P < 0.001) but not between levels of head lift intensity. Shear wave elastography revealed highest passive and active stiffness of the deep neck extensor muscles most close to the spine. The highest active increase of stiffness during the head lift was found in the semispinalis cervicis muscle. The non-invasive, clinically applicable estimates of muscle stiffness have potential for the assessment of muscular changes associated with neck pain/injury.	[Dieterich, Angela V.; Petzke, Frank] Univ Med Ctr, Anasthesiol Klin, Schmerzmed, Robert Koch Str 40, D-37075 Gottingen, Germany; [Andrade, Ricardo J.; Le Sant, Guillaume; Hug, Francois; Nordez, Antoine] Univ Nantes, Fac Sport Sci, Lab Movement Interact Performance EA 4334, Nantes, France; [Andrade, Ricardo J.] Univ Lisbon, Fac Human Movement, Cruz Quebrada Dafundo, Portugal; [Le Sant, Guillaume] Sch Physiotherapy IFM3R, Nantes, France; [Falla, Deborah] Univ Birmingham, Coll Life & Environm Sci, Sch Sport Exercise & Rehabil Sci, Ctr Precis Rehabil Spinal Pain CPR Spine, Birmingham, W Midlands, England; [Hug, Francois] Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld, Australia		Dieterich, AV (corresponding author), Univ Med Ctr, Anasthesiol Klin, Schmerzmed, Robert Koch Str 40, D-37075 Gottingen, Germany.	angela.dieterich@bccn.uni-goettingen.de	Andrade, Ricardo J./I-1792-2019; Falla, Deborah/ABA-7734-2021	Andrade, Ricardo J./0000-0001-5316-7531; Falla, Deborah/0000-0003-1689-6190; Dieterich, Angela/0000-0002-8522-8746; Le Sant, Guillaume/0000-0001-7614-6389			Anderson JS, 2005, SPINE, V30, pE86, DOI 10.1097/01.brs.0000153700.97830.02; Bergmark A, 1989, ACTA ORTHOP SCAND S, V230, P20; Borst J, 2011, CLIN BIOMECH, V26, P343, DOI 10.1016/j.clinbiomech.2010.11.019; Boudreau SA, 2014, EXP BRAIN RES, V232, P2011, DOI 10.1007/s00221-014-3891-3; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; Boyd-Clark LC, 2001, J ANAT, V199, P709, DOI 10.1046/j.1469-7580.2001.19960709.x; Brandenburg JE, 2014, ARCH PHYS MED REHAB, V95, P2207, DOI 10.1016/j.apmr.2014.07.007; Chernak LA, 2013, PHYSIOL MEAS, V34, P713, DOI 10.1088/0967-3334/34/6/713; CLEMENS HJ, 1972, ARCH ORTHOPAD UNFALL, V73, P220, DOI 10.1007/BF01880731; Conley MS, 1997, J APPL PHYSIOL, V83, P2105, DOI 10.1152/jappl.1997.83.6.2105; Cortez CD, 2016, DIAGN INTERV IMAG, V97, P71, DOI 10.1016/j.diii.2015.05.010; Deffieux T, 2012, IEEE T ULTRASON FERR, V59, P2390, DOI 10.1109/TUFFC.2012.2472; Dubois G, 2015, ULTRASOUND MED BIOL, V41, P2284, DOI 10.1016/j.ultrasmedbio.2015.04.020; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Elliott JM, 2010, ARCH PHYS MED REHAB, V91, P1418, DOI 10.1016/j.apmr.2010.05.014; Falla D, 2007, EXP BRAIN RES, V182, P99, DOI 10.1007/s00221-007-0974-4; Falla D, 2014, PAIN, V155, P944, DOI 10.1016/j.pain.2014.01.027; Field A., 2017, DISCOVERING STAT USI, V5th; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Gizzi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137844; Herzog W, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00174; Hogg-Johnson S, 2009, J MANIP PHYSIOL THER, V32, pS46, DOI 10.1016/j.jmpt.2008.11.010; Holm LW, 2009, J MANIP PHYSIOL THER, V32, pS61, DOI 10.1016/j.jmpt.2008.11.011; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hug F, 2015, EXERC SPORT SCI REV, V43, P125, DOI 10.1249/JES.0000000000000049; Hug F, 2014, MED SCI SPORT EXER, V46, P2317, DOI 10.1249/MSS.0000000000000363; Hug F, 2013, J ELECTROMYOGR KINES, V23, P1413, DOI 10.1016/j.jelekin.2013.08.014; Juul Kristensen B, 2013, J REHABIL MED, V45, P376; Keshner EA, 1999, J VESTIBUL RES-EQUIL, V9, P423; Koo TK, 2013, J BIOMECH, V46, P2053, DOI 10.1016/j.jbiomech.2013.05.016; Kuo WH, 2013, ULTRASOUND MED BIOL, V39, P1356, DOI 10.1016/j.ultrasmedbio.2012.11.015; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lee JP, 2009, J ELECTROMYOGR KINES, V19, P391, DOI 10.1016/j.jelekin.2007.11.007; Leong HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067199; Lieber R.L., 2010, SKELETAL MUSCLE STRU; Lieber RL, 2013, AM J PHYSIOL-CELL PH, V305, pC241, DOI 10.1152/ajpcell.00173.2013; Loram ID, 2007, J PHYSIOL-LONDON, V584, P661, DOI 10.1113/jphysiol.2007.140046; MacDonald D, 2016, ULTRASOUND MED BIOL, V42, P1018, DOI 10.1016/j.ultrasmedbio.2015.12.002; Miyamoto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124311; NOLAN JP, 1988, SPINE, V13, P9, DOI 10.1097/00007632-198801000-00003; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; O'Leary S, 2011, ARCH PHYS MED REHAB, V92, P929, DOI 10.1016/j.apmr.2010.12.021; Panjabi MM, 2003, J ELECTROMYOGR KINES, V13, P371, DOI 10.1016/S1050-6411(03)00044-0; Peolsson A, 2010, MANUAL THER, V15, P567, DOI 10.1016/j.math.2010.06.007; PETIT J, 1990, J NEUROPHYSIOL, V63, P190, DOI 10.1152/jn.1990.63.1.190; Rezasoltani A, 2013, J BODYW MOV THER, V17, P200, DOI 10.1016/j.jbmt.2012.07.001; Rezasoltani A, 2010, MANUAL THER, V15, P400, DOI 10.1016/j.math.2010.02.010; RICHMOND FJR, 1982, J NEUROPHYSIOL, V48, P49, DOI 10.1152/jn.1982.48.1.49; Sakanaka TE, 2016, J PHYSIOL-LONDON, V594, P781, DOI 10.1113/JP271137; Siegmund GP, 2007, J BIOMECH ENG-T ASME, V129, P66, DOI 10.1115/1.2401185; Toursel T, 2002, J APPL PHYSIOL, V92, P1465, DOI 10.1152/japplphysiol.00621.2001; Valkeinen H, 2002, EUR J APPL PHYSIOL, V88, P247, DOI 10.1007/s00421-002-0709-y; Vasavada AN, 2002, EXP BRAIN RES, V147, P437, DOI 10.1007/s00221-002-1275-6; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Ward SR, 2009, J BIOMECH, V42, P1384, DOI 10.1016/j.jbiomech.2008.09.042; Yavuz A, 2015, MED ULTRASON, V17, P49, DOI 10.11152/mu.2013.2066.171.yvz; Yoshitake Y, 2014, MUSCLE NERVE, V50, P103, DOI 10.1002/mus.24104	59	30	33	4	18	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	JAN	2017	117	1					171	178		10.1007/s00421-016-3509-5			8	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	EL0LG	WOS:000394313300017	27913924	Green Submitted			2022-02-06	
J	He, ZL; Zhou, YL; Huang, Y; Wang, QQ; Zheng, BB; Zhang, HY; Li, JW; Liu, YL; Wu, FZ; Zhang, X; Tong, SL; Wang, MF; Wang, ZG; He, H; Xu, HZ; Xiao, J				He, Zili; Zhou, Yulong; Huang, Yan; Wang, Qingqing; Zheng, Binbin; Zhang, Hongyu; Li, Jiawei; Liu, Yanlong; Wu, Fenzan; Zhang, Xie; Tong, Songlin; Wang, Maofeng; Wang, Zhouguang; He, Huacheng; Xu, Huazi; Xiao, Jian			Dl-3-n-butylphthalide improves functional recovery in rats with spinal cord injury by inhibiting endoplasmic reticulum stress-induced apoptosis	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Dl-3-n-butylphthalide; apoptosis; ER stress; spinal cord injury	FOCAL CEREBRAL-ISCHEMIA; BETA-CELL FUNCTION; ER-STRESS; DIABETIC-RATS; MOUSE MODEL; C-KIT; MICE; SURVIVAL; BARRIER; ONSET	Endoplasmic reticulum (ER) stress-induced apoptosis occurs in the spinal cord following traumatic spinal cord injury (SCI). Dl-3-n-butylphthalide (NBP) exerts an neuroprotective effects against both ischemic brain injury and neurodegenerative diseases; however, the relationship between ER stress-induced apoptosis and the therapeutic effect of NBP in SCI remains unclear. In this study, moderate spinal cord injuries were induced in Sprague-Dawley (SD) rats with a vascular clip. NBP was administered by oral (80 mg/kg/d) gavage 2 h before injury and then once daily for 28 d thereafter. Neurological recovery was assessed using the Basso, Beattie, and Bresnahan (BBB) locomotion rating scale, the inclined plane test, and the footprint analysis. Neuronal cell death was examined by TUNEL staining at 7 days post-injury. ER stress and apoptosis-related proteins were quantified by immunofluorescence staining and western blotting both in vivo and in vitro. Our results showed that NBP significantly decreased spinal cord lesion cavity area and improved locomotor recovery in SD rats after SCI. NBP also decreased neuronal apoptosis and inhibited activation of the caspase 3 cascade. Upregulation of ER stress-related proteins, such as GRP78, ATF-6, ATF-4, PDI, XBP-1, and CHOP, was reversed by NBP treatment in SD rats with SCI. Similarly, NBP effectively ameliorated ER stress and apoptosis-related protein expression induced by incubation with thapsigargin (TG) in PC12 cells. Our findings demonstrate that NBP treatment alleviates secondary SCI by inhibiting ER stress-induced apoptosis, thereby promoting neurological and locomoter functional recovery.	[He, Zili; Zhou, Yulong; Wang, Qingqing; Zheng, Binbin; Li, Jiawei; Xu, Huazi; Xiao, Jian] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Wenzhou 325035, Zhejiang, Peoples R China; [He, Zili; Zhou, Yulong; Huang, Yan; Zhang, Hongyu; Liu, Yanlong; Wang, Zhouguang; He, Huacheng; Xiao, Jian] Wenzhou Med Univ, Sch Pharm, Mol Pharmacol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China; [Zhang, Hongyu; Wang, Maofeng] Wenzhou Med Univ, Dept Biomed Sci Lab, Affiliated Dongyang Hosp, Dongyang 322100, Zhejiang, Peoples R China; [Wu, Fenzan; Tong, Songlin] Wenzhou Med Univ, Affiliated Cixi Peoples Hosp, Dept Neurosurg, Ningbo 315300, Zhejiang, Peoples R China; [Zhang, Xie] Li Hui Li Hosp, Dept Gastroenterol, Ningbo Med Treatment Ctr, Ningbo 315040, Zhejiang, Peoples R China; [Zheng, Binbin] Wenzhou Med Univ, Taizhou Hosp, Dept Orthopaed, Linhai 317000, Zhejiang, Peoples R China		Xiao, J (corresponding author), Wenzhou Med Univ, Sch Pharm, Wenzhou 325035, Zhejiang, Peoples R China.; Xu, HZ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Wenzhou 325000, Peoples R China.	spinexu@163.com; xfxj2000@126.com	He, Huacheng/F-1941-2018; Zhouguang, Wang/F-7918-2017	He, Huacheng/0000-0001-5177-0636; Zhouguang, Wang/0000-0001-9903-0362	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81572237, 81572227, 81501953, 81601980]; Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [Y14H170002, Q16H090023, LY17H090017]; Technologies Science and technology Program of Zhejiang Provincial [2016C33107]; Ningbo City Natural Science Foundation [2015A610213, 2015A610208]	This study was partially supported by a research grant from National Natural Science Foundation of China (81572237, 81572227, 81501953, 81601980), Zhejiang Provincial Natural Science Foundation (Y14H170002, Q16H090023, LY17H090017), Technologies Science and technology Program of Zhejiang Provincial (2016C33107) and Ningbo City Natural Science Foundation (2015A610213, 2015A610208).	Chang Q, 2003, ACTA PHARMACOL SIN, V24, P796; Chong ZZ, 1999, ACTA PHARMACOL SIN, V20, P696; Dai Z, 2008, NEUROPHARMACOLOGY, V55, P1307, DOI 10.1016/j.neuropharm.2008.08.030; Deng W, 1997, Chin Med Sci J, V12, P102; Dong Gao-xiang, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P93; Feng XH, 2012, NEUROPHARMACOLOGY, V62, P1004, DOI 10.1016/j.neuropharm.2011.10.009; Feng ZC, 2012, DIABETOLOGIA, V55, P2214, DOI 10.1007/s00125-012-2566-5; Feng ZC, 2015, DIABETES, V64, P3852, DOI 10.2337/db15-0054; Feng ZC, 2013, AM J PHYSIOL-ENDOC M, V304, pE557, DOI 10.1152/ajpendo.00453.2012; Feng ZC, 2012, LAB INVEST, V92, P543, DOI 10.1038/labinvest.2011.200; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hu JY, 2014, CELL BIOCHEM BIOPHYS, V69, P363, DOI 10.1007/s12013-013-9808-0; Huai YP, 2013, NEURAL REGEN RES, V8, P1733, DOI 10.3969/j.issn.1673-5374.2013.19.001; Huang JZ, 2010, NEUROSCI LETT, V475, P89, DOI 10.1016/j.neulet.2010.03.053; Katoh K, 1996, NEUROSCI LETT, V216, P9; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kuang XH, 2010, NEUROCHEM INT, V57, P738, DOI 10.1016/j.neuint.2010.08.010; Li JM, 2010, BRAIN RES, V1359, P216, DOI 10.1016/j.brainres.2010.08.061; Li JM, 2014, DIABETOLOGIA, V57, P754, DOI 10.1007/s00125-013-3147-y; Li L, 2009, BRAIN RES, V1290, P91, DOI 10.1016/j.brainres.2009.07.020; Lin J. F., 1996, Yaoxue Xuebao, V31, P166; Liu X. G., 1995, Yaoxue Xuebao, V30, P896; Mecha M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.71; Ohri SS, 2011, GLIA, V59, P1489, DOI 10.1002/glia.21191; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Peng Y, 2008, NEUROSCI LETT, V434, P224, DOI 10.1016/j.neulet.2008.01.080; Peng Y, 2009, EUR J PHARMACOL, V621, P38, DOI 10.1016/j.ejphar.2009.08.036; Sakurai M, 2005, J THORAC CARDIOV SUR, V130, P640, DOI 10.1016/j.jtcvs.2005.01.007; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Wang FX, 2016, SCI REP-UK, V6, DOI 10.1038/srep19396; Yamauchi T, 2007, BRAIN RES, V1169, P24, DOI 10.1016/j.brainres.2007.06.093; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Zhang HY, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-130; Zhang T, 2010, NEUROL RES, V32, P390, DOI 10.1179/016164110X12670144526264; Zhao C., 2016, IEEE JOURNAL OF BIOM, P1; Zhou KL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17130; Zhou YL, 2016, INT J BIOL SCI, V12, P87, DOI 10.7150/ijbs.13229	38	30	34	1	7	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2017	9	3					1075	1087					13	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	ER7XK	WOS:000399028800021	28386335				2022-02-06	
J	Winkler, EA; Yue, JK; Ferguson, AR; Temkin, NR; Stein, MB; Barber, J; Yuh, EL; Sharma, S; Satris, GG; McAllister, TW; Rosand, J; Sorani, MD; Lingsma, HF; Tarapore, PE; Burchard, EG; Hui, DL; Eng, C; Wang, KKW; Mukherjee, P; Okonkwo, DO; Diaz-Arrastia, R; Manley, GT				Winkler, Ethan A.; Yue, John K.; Ferguson, Adam R.; Temkin, Nancy R.; Stein, Murray B.; Barber, Jason; Yuh, Esther L.; Sharma, Sourabh; Satris, Gabriela G.; McAllister, Thomas W.; Rosand, Jonathan; Sorani, Marco D.; Lingsma, Hester F.; Tarapore, Phiroz E.; Burchard, Esteban G.; Hui, Donglei; Eng, Celeste; Wang, Kevin K. W.; Mukherjee, Pratik; Okonkwo, David O.; Diaz-Arrastia, Ramon; Manley, Geoffrey T.		TRACK-TBI Investigators	COMT Val(158)Met polymorphism is associated with post-traumatic stress disorder and functional outcome following mild traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Traumatic brain injury; Genetic factors; PTSD; Outcome measures; Human studies	CATECHOL-O-METHYLTRANSFERASE; COMMON DATA ELEMENTS; PSYCHIATRIC-DISORDERS; PSYCHOLOGICAL HEALTH; GENE POLYMORPHISMS; GENOTYPE; RESILIENCE; RISK; SCHIZOPHRENIA; ABNORMALITIES	Mild traumatic brain injury (mTBI) results in variable clinical trajectories and outcomes. The source of variability remains unclear, but may involve genetic variations, such as single nucleotide polymorphisms (SNPs). A SNP in catechol-o-methyltransferase (COMT) is suggested to influence development of post traumatic stress disorder (PTSD), but its role in TBI remains unclear. Here, we utilize the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study to investigate whether the COMT Val(158)Met polymorphism is associated with PTSD and global functional outcome as measured by the PTSD Checklist - Civilian Version and Glasgow Outcome Scale Extended (GOSE), respectively. Results in 93 predominately Caucasian subjects with mTBI show that the COMT Met(158) allele is associated with lower incidence of PTSD (univariate odds ratio (OR) of 0.25, 95% CI [0.09-0.69]) and higher GOSE scores (univariate OR 2.87, 95% CI [1.20-6.861) 6-months following injury. The COMT Val(158)Met genotype and PTSD association persists after controlling for race (multivariable OR of 0.29, 95% CI [0.10-0.83]) and pre-existing psychiatric disorders/substance abuse (multivariable OR of 0.32, 95% CI [0.11-0.97]). PTSD emerged as a strong predictor of poorer outcome on GOSE (multivariable OR 0.09, 95% CI 10.03-0.26]), which persists after controlling for age, GCS, and race. When accounting for PTSD in multivariable analysis, the association of COMT genotype and GOSE did not remain significant (multivariable OR 1.73, 95% CI [0.69-4.35]). Whether COMT genotype indirectly influences global functional outcome through PTSD remains to be determined and larger studies in more diverse populations are needed to confirm these findings. (C) 2016 Elsevier Ltd. All rights reserved.	[Winkler, Ethan A.; Yue, John K.; Ferguson, Adam R.; Sharma, Sourabh; Satris, Gabriela G.; Sorani, Marco D.; Tarapore, Phiroz E.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Winkler, Ethan A.; Yue, John K.; Ferguson, Adam R.; Sharma, Sourabh; Satris, Gabriela G.; Sorani, Marco D.; Tarapore, Phiroz E.; Mukherjee, Pratik; Manley, Geoffrey T.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Temkin, Nancy R.] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family & Preventat Med, San Diego, CA 92103 USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Rosand, Jonathan] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Rosand, Jonathan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Burchard, Esteban G.; Hui, Donglei; Eng, Celeste] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32610 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Diaz-Arrastia, Ramon] Ctr Neurosci & Regenerat Med, Bethesda, MD USA		Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Ferguson, Adam/0000-0001-7102-1608; Diaz-Arrastia, Ramon/0000-0001-6051-3594; Temkin, Nancy/0000-0002-6392-5292; Wang, Kevin/0000-0002-9343-6473	DOD USAMRAAUnited States Department of Defense [W81XWH-13-1-0441];  [NIH RC2 NS069409];  [NIH RC2 NS069409-02S1];  [NIH U01 NS086090-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC2NS069409, U01NS086090] Funding Source: NIH RePORTER	This work was supported by the following grants: NIH RC2 NS069409, NIH RC2 NS069409-02S1, NIH U01 NS086090-01, DOD USAMRAA W81XWH-13-1-0441.	Agren T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.5; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Association A. P., 1994, DIAGN STAT MAN MENT; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Clark R, 2013, J PSYCHIATR RES, V47, P1849, DOI 10.1016/j.jpsychires.2013.08.013; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Faul M, 2010, TRAUMATIC BRAIN INJU; Gatt JM, 2015, J PSYCHIATR RES, V60, P1, DOI 10.1016/j.jpsychires.2014.09.014; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Hapke U, 2006, EUR ARCH PSY CLIN N, V256, P299, DOI 10.1007/s00406-006-0654-6; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Heinz A, 2006, REV NEUROSCIENCE, V17, P359; Hill Shirley Y, 2013, Adv J Mol Imaging, V3, P43; Ho BC, 2005, MOL PSYCHIATR, V10, P287, DOI 10.1038/sj.mp.4001616; Hong SB, 2015, HUM BRAIN MAPP, V36, P367, DOI 10.1002/hbm.22634; Humphreys KL, 2014, J CHILD ADOL PSYCHOP, V24, P454, DOI 10.1089/cap.2014.0077; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kang JI, 2013, NEUROPSYCHOBIOLOGY, V68, P174, DOI 10.1159/000353257; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Klucken T, 2015, HUM BRAIN MAPP, V36, P1093, DOI 10.1002/hbm.22688; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Lonsdorf TB, 2009, PSYCHOL SCI, V20, P198, DOI 10.1111/j.1467-9280.2009.02280.x; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Valente NLM, 2011, J MOL NEUROSCI, V43, P516, DOI 10.1007/s12031-010-9474-2; McAllister, 2004, J NEUROPSYCHIATRY CL, V16, P238; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Ohnishi T, 2006, BRAIN, V129, P399, DOI 10.1093/brain/awh702; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Raczka KA, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.10; Sandweiss DA, 2011, ARCH GEN PSYCHIAT, V68, P496, DOI 10.1001/archgenpsychiatry.2011.44; Stein DJ, 2006, CNS SPECTRUMS, V11, P745, DOI 10.1017/S1092852900014863; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Wang YJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/293687; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Weathers F. W., 1993, 9 ANN CONV INT SOC T; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wilker S, 2014, NEUROBIOL LEARN MEM, V112, P75, DOI 10.1016/j.nlm.2013.08.015; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Willmott C, 2013, BRAIN INJURY, V27, P1281, DOI 10.3109/02699052.2013.809553; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Witte AV, 2012, BRAIN RES BULL, V88, P418, DOI 10.1016/j.brainresbull.2011.11.012; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	61	30	30	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	2017	35						109	116		10.1016/j.jocn.2016.09.017			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EI2YS	WOS:000392356700024	27769642	Green Accepted, Green Submitted			2022-02-06	
J	Wright, WG; Tierney, RT; McDevitt, J				Wright, W. G.; Tierney, R. T.; McDevitt, J.			Visual-vestibular processing deficits in mild traumatic brain injury	JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION			English	Article						Concussion; near point convergence; optokinetic stimulation; virtual reality; posture	SPORTS-RELATED CONCUSSION; OPTOKINETIC NYSTAGMUS; POSTURAL CONTROL; HEAD-INJURY; FOOTBALL; MOTION; REHABILITATION; STIMULATION; ASSESSMENTS; ENVIRONMENT	BACKGROUND: The search for reliable and valid signs and symptoms of mild traumatic brain injury (mTBI), commonly synonymous with concussion, has lead to a growing body of evidence that individuals with long-lasting, unremitting impairments often experience visual and vestibular symptoms, such as dizziness, postural and gait disturbances. OBJECTIVE: Investigate the role of visual-vestibular processing deficits following concussion. METHODS: A number of clinically accepted vestibular, oculomotor, and balance assessments as well as a novel virtual reality (VR)-based balance assessment device were used to assess adults with post-acute concussion (n = 14) in comparison to a healthy age-matched cohort (n = 58). RESULTS: Significant between-group differences were found with the VR-based balance device (p = 0.001), with dynamic visual motion emerging as the most discriminating balance condition. The symptom reports collected after performing the oculomotor and vestibular tests: rapid alternating horizontal eye saccades, optokinetic stimulation, and gaze stabilization, were all sensitive to health status (p < 0.05), despite the absence of oculomotor abnormalities being observed, except for near-point convergence. The BESS, King-Devick, and Dynamic Visual Acuity tests did not detect between-group differences. CONCLUSION: Postural and visual-vestibular tasks most closely linked to spatial and self-motion perception had the greatest discriminatory outcomes. The current findings suggest that mesencephalic and parieto-occipital centers and pathways may be involved in concussion.	[Wright, W. G.; McDevitt, J.] Temple Univ, Dept Phys Therapy, Neuromotor Sci Program, Philadelphia, PA 19122 USA; [Wright, W. G.] Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA; [Tierney, R. T.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [McDevitt, J.] East Stroudsburg Univ, Dept Athlet Training, East Stroudsburg, PA USA		Wright, WG (corresponding author), Coll Publ Hlth, Dept PT, 3307N Broad St 215-204-5152 Lab Main Campus, Philadelphia, PA 19140 USA.	wrightw@temple.edu			Department of Defense, Army Rapid Innovation FundUnited States Department of Defense [W81XWH-13-C-0189]	This study was funded, in part, by the Department of Defense, Army Rapid Innovation Fund Award No. W81XWH-13-C-0189 (WGW).	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alosco ML, 2012, INT J ATHL THER TRAI, V17, P22, DOI 10.1123/ijatt.17.5.22; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baker C.S., 2014, PHYSL REP, V2, P1; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Buttner-Ennever JA, 1997, CURR OPIN NEUROBIOL, V7, P872, DOI 10.1016/S0959-4388(97)80149-3; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Ciufredda KJ, 2009, OPTOM VIS DEV, V40, P16; COHEN B, 1977, J PHYSIOL-LONDON, V270, P321, DOI 10.1113/jphysiol.1977.sp011955; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Dubnov-Raz G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00780; Eichner ER, 1998, INT J SPORTS MED, V19, pS150, DOI 10.1055/s-2007-971983; Field A., 1998, BRIT PSYCHOL SOC MAT, V6, P13; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Keshner EA, 2000, J VESTIBUL RES-EQUIL, V10, P207; Keshner EA, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-18; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; LONGRIDGE NS, 1984, OTOLARYNG HEAD NECK, V92, P671, DOI 10.1177/019459988409200614; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; NeuroCom. A division of Natus, SETT STAND BAL MOB S; Previc F H, 1992, J Vestib Res, V2, P285; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; VANDIE GC, 1986, BRAIN RES, V383, P185, DOI 10.1016/0006-8993(86)90019-3; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Wenzel R, 1996, BRAIN, V119, P101, DOI 10.1093/brain/119.1.101; Wright W. G., DISABILITY REHABILIT, V10, P1; Wright WG, 2015, 2015 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION PROCEEDINGS (ICVR), P72, DOI 10.1109/ICVR.2015.7358591; Wright WG, 2009, IEEE ENG MED BIO, P1157, DOI 10.1109/IEMBS.2009.5333425; Wright WG, 2005, J VESTIBUL RES-EQUIL, V15, P185; Wright WG, 2003, ANN NY ACAD SCI, V1004, P531, DOI 10.1196/annals.1303.069	58	30	31	1	26	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0957-4271	1878-6464		J VESTIBUL RES-EQUIL	J. Vestib. Res.-Equilib. Orientat.		2017	27	1					27	37		10.3233/VES-170607			11	Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	ES3LW	WOS:000399432100004	28387693				2022-02-06	
J	Hu, FH; Lamprecht, MR; Wei, L; Morrison, B; Min, W				Hu, Fanghao; Lamprecht, Michael R.; Wei, Lu; Morrison, Barclay; Min, Wei			Bioorthogonal chemical imaging of metabolic activities in live mammalian hippocampal tissues with stimulated Raman scattering	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; NEWLY SYNTHESIZED PROTEINS; LONG-TERM POTENTIATION; IN-VIVO; DENTATE GYRUS; ORGANOTYPIC CULTURES; CLICK CHEMISTRY; LIVING SYSTEMS; SLICE CULTURES; MICROSCOPY	Brain is an immensely complex system displaying dynamic and heterogeneous metabolic activities. Visualizing cellular metabolism of nucleic acids, proteins, and lipids in brain with chemical specificity has been a long-standing challenge. Recent development in metabolic labeling of small biomolecules allows the study of these metabolisms at the global level. However, these techniques generally require nonphysiological sample preparation for either destructive mass spectrometry imaging or secondary labeling with relatively bulky fluorescent labels. In this study, we have demonstrated bioorthogonal chemical imaging of DNA, RNA, protein and lipid metabolism in live rat brain hippocampal tissues by coupling stimulated Raman scattering microscopy with integrated deuterium and alkyne labeling. Heterogeneous metabolic incorporations for different molecular species and neurogenesis with newly-incorporated DNA were observed in the dentate gyrus of hippocampus at the single cell level. We further applied this platform to study metabolic responses to traumatic brain injury in hippocampal slice cultures, and observed marked upregulation of protein and lipid metabolism particularly in the hilus region of the hippocampus within days of mechanical injury. Thus, our method paves the way for the study of complex metabolic profiles in live brain tissue under both physiological and pathological conditions with single-cell resolution and minimal perturbation.	[Hu, Fanghao; Wei, Lu; Min, Wei] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Lamprecht, Michael R.; Morrison, Barclay] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Min, Wei] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10027 USA		Min, W (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.; Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.; Min, W (corresponding author), Columbia Univ, Kavli Inst Brain Sci, New York, NY 10027 USA.	bm2119@columbia.edu; wm2256@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Wei, Lu/0000-0001-9170-2283	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2EB016573, EB020892]; US Army Research Office [W911NF-12-1-0594]; Alfred P. Sloan FoundationAlfred P. Sloan Foundation; Camille and Henry Dreyfus Foundation; Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-10-1-0526]; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [DP2EB016573, R01EB020892] Funding Source: NIH RePORTER	We thank Y. Shen and L. Shi for helpful discussions. W. M. acknowledges support from NIH Director's New Innovator Award (Grant 1DP2EB016573), NIH R01 (Grant EB020892), the US Army Research Office (Grant W911NF-12-1-0594), the Alfred P. Sloan Foundation, and the Camille and Henry Dreyfus Foundation. B.M. acknowledges support from the Army Research Laboratory (Grant W911NF-10-1-0526). M.R.L acknowledges support from a National Science Foundation Graduate Research Fellowship.	Alfonso-Garcia A, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.061003; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Camp CH, 2015, NAT PHOTONICS, V9, P295, DOI 10.1038/NPHOTON.2015.60; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chen ZX, 2014, J AM CHEM SOC, V136, P8027, DOI 10.1021/ja502706q; Cheng JX, 2015, SCIENCE, V350, DOI 10.1126/science.aaa8870; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Fu D, 2014, J AM CHEM SOC, V136, P8820, DOI 10.1021/ja504199s; Grammel M, 2013, NAT CHEM BIOL, V9, P475, DOI 10.1038/nchembio.1296; Hang HC, 2011, ACCOUNTS CHEM RES, V44, P699, DOI 10.1021/ar200063v; Hong SL, 2014, ANGEW CHEM INT EDIT, V53, P5827, DOI 10.1002/anie.201400328; Hu FH, 2015, ANGEW CHEM INT EDIT, V54, P9821, DOI 10.1002/anie.201502543; Hu FH, 2014, ANALYST, V139, P2312, DOI 10.1039/c3an02281a; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jao CY, 2009, P NATL ACAD SCI USA, V106, P15332, DOI 10.1073/pnas.0907864106; Ji MB, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0195; Krafft C, 2016, CHEM SOC REV, V45, P1819, DOI 10.1039/c5cs00564g; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lamprecht MR, 2017, J NEUROTRAUM, V34, P97, DOI 10.1089/neu.2015.4306; Lamprecht MR, 2015, J NEUROTRAUM, V32, P1361, DOI 10.1089/neu.2015.3912; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lee HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07930; Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06807; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Ozeki Y, 2012, NAT PHOTONICS, V6, P844, DOI [10.1038/nphoton.2012.263, 10.1038/NPHOTON.2012.263]; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Scharfman HE, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00106; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suhalim JL, 2012, J BIOPHOTONICS, V5, P387, DOI 10.1002/jbio.201200002; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Weeks T, 2009, OPT EXPRESS, V17, P17044, DOI 10.1364/OE.17.017044; Wei L, 2016, ACCOUNTS CHEM RES, V49, P1494, DOI 10.1021/acs.accounts.6b00210; Wei L, 2015, ACS CHEM BIOL, V10, P901, DOI 10.1021/cb500787b; Wei L, 2014, NAT METHODS, V11, P410, DOI [10.1038/NMETH.2878, 10.1038/nmeth.2878]; Wei L, 2013, P NATL ACAD SCI USA, V110, P11226, DOI 10.1073/pnas.1303768110; Yamakoshi H, 2012, J AM CHEM SOC, V134, P20681, DOI 10.1021/ja308529n; Yamakoshi H, 2011, J AM CHEM SOC, V133, P6102, DOI 10.1021/ja108404p; Yuet KP, 2014, ANN BIOMED ENG, V42, P299, DOI 10.1007/s10439-013-0878-3; Yuste R., 2010, IMAGING LAB MANUAL; Zhang DL, 2014, ACCOUNTS CHEM RES, V47, P2282, DOI 10.1021/ar400331q; Zhang D, 2011, J PHYS CHEM LETT, V2, P1248, DOI 10.1021/jz200516n; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	62	30	30	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 21	2016	6								39660	10.1038/srep39660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF9IO	WOS:000390644100001	28000773	Green Submitted, Green Published, gold, Green Accepted			2022-02-06	
J	Naeser, MA; Martin, PI; Ho, MD; Krengel, MH; Bogdanova, Y; Knight, JA; Yee, MK; Zafonte, R; Frazier, J; Hamblin, MR; Koo, BB				Naeser, Margaret A.; Martin, Paula I.; Ho, Michael D.; Krengel, Maxine H.; Bogdanova, Yelena; Knight, Jeffrey A.; Yee, Megan K.; Zafonte, Ross; Frazier, Judith; Hamblin, Michael R.; Koo, Bang-Bon			Transcranial, Red/Near-Infrared Light-Emitting Diode Therapy to Improve Cognition in Chronic Traumatic Brain Injury	PHOTOMEDICINE AND LASER SURGERY			English	Article						traumatic brain injury; TBI; photobiomodulation; PBM; TBI treatment; cognitive dysfunction; light-emitting diodes; LED; postconcussion syndrome; sports head injury; PTSD; LLLT	POSTTRAUMATIC-STRESS-DISORDER; LEVEL LASER THERAPY; COLLEGIATE FOOTBALL PLAYERS; DEFAULT MODE NETWORK; INTRINSIC CONNECTIVITY NETWORKS; CONTROLLED CORTICAL IMPACT; ALTERED WORKING-MEMORY; DIFFUSE AXONAL INJURY; FUNCTIONAL CONNECTIVITY; HEAD-INJURY	Objective: We review the general topic of traumatic brain injury (TBI) and our research utilizing transcranial photobiomodulation (tPBM) to improve cognition in chronic TBI using red/near-infrared (NIR) light-emitting diodes (LEDs) to deliver light to the head. tPBM improves mitochondrial function increasing oxygen consumption, production of adenosine triphosphate (ATP), and improving cellular energy stores. Nitric oxide is released from the cells increasing regional blood flow in the brain. Review of published studies: In our previously published study, 11 chronic TBI patients with closed-head TBI caused by different accidents (motor vehicle accident, sports-related, improvised explosive device blast injury) and exhibiting long-lasting cognitive dysfunction received 18 outpatient treatments (Monday, Wednesday, Friday for 6 weeks) starting at 10 months to 8 years post-TBI. LED therapy is nonthermal, painless, and noninvasive. An LED-based device classified as nonsignificant risk (FDA cleared) was used. Each LED cluster head (5.35 cm diameter, 500mW, 22.2 mW/cm(2)) was applied for 9 min 45 sec (13 J/cm(2)) using 11 locations on the scalp: midline from front-to-back hairline and bilaterally on frontal, parietal, and temporal areas. Testing was performed before and after transcranial LED (tLED; at 1 week, 1 month, and at 2 months after the 18th treatment) and showed significant improvements in executive function and verbal memory. There were also fewer post-traumatic stress disorder (PTSD) symptoms reported. Ongoing studies: Ongoing, current studies involve TBI patients who have been treated with tLED using either 26 J/cm(2) per LED location on the head or treated with intranasal only (iLED) using red (633 nm) and NIR (810 nm) diodes placed into the nostrils. The NIR iLED is hypothesized to deliver photons to the hippocampus, and the red 633 nm iLED is believed to increase melatonin. Results have been similar to the previously published tLED study. Actigraphy sleep data showed increased time asleep (on average one additional hour per night) after the 18th tLED or iLED treatment. LED treatments may be performed in the home. Sham-controlled studies with veterans who have cognitive dysfunction from Gulf War Illness, blast TBI, and TBI/PTSD are currently ongoing.	[Naeser, Margaret A.; Martin, Paula I.; Ho, Michael D.; Krengel, Maxine H.; Bogdanova, Yelena; Knight, Jeffrey A.; Yee, Megan K.] VA Boston Healthcare Syst 12A, 150 So Huntington Ave, Boston, MA 02130 USA; [Naeser, Margaret A.; Martin, Paula I.; Ho, Michael D.; Krengel, Maxine H.; Yee, Megan K.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Bogdanova, Yelena; Knight, Jeffrey A.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Knight, Jeffrey A.] VA Boston Healthcare Syst, Behav Sci Div, Natl Ctr PTSD, Boston, MA USA; [Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross] Harvard Med Sch, Dept Dermatol, Boston, MA USA; [Zafonte, Ross] Spaulding Rehabil Hosp, Charlestown, MA USA; [Frazier, Judith] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hamblin, Michael R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Hamblin, Michael R.] Spaulding Rehabil Hosp, TBI Res Program, Charlestown, MA USA; [Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA; [Koo, Bang-Bon] Boston Univ, Ctr Biomed Imaging, Boston, MA 02215 USA		Naeser, MA (corresponding author), VA Boston Healthcare Syst 12A, 150 So Huntington Ave, Boston, MA 02130 USA.	mnaeser@bu.edu	Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605; Bogdanova, Yelena/0000-0003-0439-8098; Ho, Michael/0000-0002-6648-7806; Krengel, Maxine/0000-0001-7632-590X	PTSD; Army Medical Department Advanced Medical Technology Initiative; Veterans AffairsUS Department of Veterans Affairs [I21RX001773] Funding Source: NIH RePORTER	Additional pilot clinical studies with tLED are being carried out at the VA Boston Healthcare System. Dr. Jeffrey Knight at the National Center for PTSD has received VA funding to carry out a pilot study using real versus sham tLED to see whether PBM can reduce symptoms of PTSD and improve cognitive function in veterans who had suffered TBI. Dr. Yelena Bogdanova is conducting a similar study of real versus sham tLED and iLED to improve sleep and cognition in veterans who have sustained TBI. Dr. Margaret Naeser is conducting a trial with VA funding to test whether real versus sham tLED and iLED can improve cognitive function in veterans suffering from Gulf War Illness. Dr. Carole Palumbo is testing the ability of tLED and iLED applied to active duty soldiers who have suffered blast TBI with funding from the Army Medical Department Advanced Medical Technology Initiative. Dr. Palumbo is an investigator at the U.S. Army Institute of Environmental Medicine.	Aimbire F, 2005, LASER MED SCI, V20, P11, DOI 10.1007/s10103-005-0339-9; Albertini R, 2007, INFLAMM RES, V56, P228, DOI 10.1007/s00011-007-6211-6; Avci P, 2014, LASER SURG MED, V46, P144, DOI 10.1002/lsm.22170; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Boelen DHE, 2011, J NEUROPSYCHOL, V5, P73, DOI 10.1348/174866410X516434; Bogdanova Y., 2014, ARCH PHYS MED REHAB, V95, pe77; Bogdanova Y, 2015, J HEAD TRAUMA REHAB, V30, pE101; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Castano AP, 2007, LASER SURG MED, V39, P543, DOI 10.1002/lsm.20516; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Daniels JK, 2013, PSYCHOL TRAUMA-US, V5, P142, DOI 10.1037/a0026946; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Delis DC., 2001, DELIS KAPLAN EXECUTI; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Faul M., 2013, TRAUMATIC BRAIN INJU; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang YY, 2013, J BIOPHOTONICS, V6, P829, DOI 10.1002/jbio.201200157; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krewer C, 2016, J NEUROTRAUM, V33, P1544, DOI 10.1089/neu.2015.4109; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2011, INT J PSYCHOPHYSIOL, V82, P107, DOI 10.1016/j.ijpsycho.2011.06.022; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McAllister TW., 2002, J NEUROPSYCHIATRY CL, V14, P116; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mi XQ, 2004, PHOTOMED LASER SURG, V22, P477, DOI 10.1089/pho.2004.22.477; Migliario M, 2014, LASER MED SCI, V29, P1463, DOI 10.1007/s10103-014-1556-x; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Naeser M, 2012, PROCD SOC BEHV, V61, P138, DOI 10.1016/j.sbspro.2012.10.116; Naeser MA, 2015, PROC SPIE, V9467, DOI 10.1117/12.2176345; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Saltmarche AE, PHOTOMED LA IN PRESS; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Sompol P, 2006, J MOL NEUROSCI, V29, P279, DOI 10.1385/JMN:29:3:279; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tuby H, 2006, LASER SURG MED, V38, P682, DOI 10.1002/lsm.20377; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Zafonte R, 2009, PROG BRAIN RES, V177, P293, DOI 10.1016/S0079-6123(09)17720-8; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; ZHANG YH, 1994, INFECT IMMUN, V62, P4140, DOI 10.1128/IAI.62.10.4140-4144.1994; Zhao JX, 2012, J ATHL TRAINING, V47, P673, DOI 10.4085/1062-6050-47.6.08	131	30	34	2	24	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1549-5418	1557-8550		PHOTOMED LASER SURG	Photomed. Laser Surg.	DEC	2016	34	12					610	626		10.1089/pho.2015.4037			17	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EH5ZN	WOS:000391852000004	28001756				2022-02-06	
J	Duan, HM; Li, XG; Wang, C; Hao, P; Song, W; Li, ML; Zhao, W; Gao, YD; Yang, ZY				Duan, Hongmei; Li, Xiaoguang; Wang, Cong; Hao, Peng; Song, Wei; Li, Manli; Zhao, Wen; Gao, Yudan; Yang, Zhaoyang			Functional hyaluronate collagen scaffolds induce NSCs differentiation into functional neurons in repairing the traumatic brain injury	ACTA BIOMATERIALIA			English	Article						Traumatic brain injury; Neural stem cell; bFGF; Neuron; Functional neural network	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; HUMAN FIBROBLASTS; STEM-CELLS; MULTIELECTRODE ARRAY; GROWTH-FACTOR; LONG-TERM; CONVERSION; MOUSE; RECOVERY	The traumatic brain injury (TBI) usually causes brain tissue defects, including neuronal death or loss, which ultimately results in dysfunction in some degree. The cell replacement therapy is now one of the most promising methods for such injury. There are currently various methods to induce the differentiation of stem cells into neurons, but all extremely complex, slow and unstable. Here we report that the sodium hyaluronate collagen scaffold loaded with bFGF (bFGF-controlled releasing system, bFGF-CRS) can induce neural stem cells (NSCs) to differentiate into multi-type and mature functional neurons at a high percentage of 82 +/- 1.528% in two weeks. The quantitative real-time (QRT) PCR results reveal that a long-term activation of bFGF receptors could up-regulate ERK/MAPK signal pathways, thus facilitating the formation of presynaptic and postsynaptic structure among the induced neuronal cells (iN cells). The functional synaptic connections established among iN cells were detected by the planar multielectrode dish system. When jointly transplanting the bFGF-CRS and NSCs into the CA1 zone of the rat TBI area, the results suggested that bFGF-CRS provided an optimal microenvironment, which promoted survival, neuronal differentiation of transplanted NSCs and functional synapse formation not only among iN cells but also between iN cells and the host brain tissue in TBI rats, consequently leading to the cognitive function recovery of TBI rats. These findings in vitro and in vivo may lay a foundation for the application of bFGF-CRS and shed light on the delivery of exogenous cells or nutrients to the CNS injury or disease area. Statement of Significance A sodium hyaluronate collagen scaffold was specifically functionalized with nutrient-bFGF which can induce the differentiation of neural stem cells (NSCs) into multi-type and mature functional neurons at a high percentage in two week. When jointly transplanting the bFGF-CRS and NSCs into the CA1 zone of the traumatic brain injured area of adult rats, the bFGF-CRS could provide an optimal microenvironment, which promoted survival, migration and neuronal differentiation of transplanted NSCs and functional synapse formation among iN cells, as well as between iN cells and host brain tissue in TBI rats, consequently leading to the cognitive function recovery of TBI rats. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Duan, Hongmei; Li, Xiaoguang; Wang, Cong; Hao, Peng; Zhao, Wen; Gao, Yudan; Yang, Zhaoyang] Captial Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing 100069, Peoples R China; [Song, Wei] Captial Med Univ, Sch Rehabil Med, Beijing 100068, Peoples R China; [Song, Wei] China Rehabil Res Ctr, Beijing 100068, Peoples R China; [Li, Manli] Beihang Univ, Sch Biol Sci & Med Engn, Dept Biomed Engn, Beijing 100191, Peoples R China		Yang, ZY (corresponding author), Captial Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing 100069, Peoples R China.	wack_lily@163.com		Duan, Hongmei/0000-0003-2261-2182; hao, peng/0000-0002-8509-8232	State Key Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31130022, 31320103903, 31271037]; National Science and Technology Pillar Program of China [2012BAI17B04]; International Cooperation in Science and Technology Projects of the Ministry of Science Technology of China [2014DFA30640]; National Ministry of Education Special Fund for Excellent Doctoral Dissertation [201356]; Special Funds for Excellent Doctoral Dissertation of Beijing, China [20111000601]	We express heartfelt thanks to Hui Qiao (Ningxia Medical University) and Liwei Zhang (Science China Press) for their kind help and constructive comments. This work was supported by the State Key Program of National Natural Science Foundation of China (Grants 31130022, 31320103903 & 31271037), the National Science and Technology Pillar Program of China (Grant 2012BAI17B04), the International Cooperation in Science and Technology Projects of the Ministry of Science Technology of China (Grant 2014DFA30640), the National Ministry of Education Special Fund for Excellent Doctoral Dissertation (Grant 201356), and the Special Funds for Excellent Doctoral Dissertation of Beijing, China (Grant 20111000601).	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Cao ZY, 2012, HUM MOL GENET, V21, P2923, DOI 10.1093/hmg/dds118; Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032; Duan HM, 2015, P NATL ACAD SCI USA, V112, P13360, DOI 10.1073/pnas.1510176112; Gao YD, 2016, REGEN BIOMATER, V3, P115, DOI 10.1093/rb/rbw004; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Ito D, 2013, BRAIN RES, V1534, P22, DOI 10.1016/j.brainres.2013.08.004; Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349; Leong C, 2013, STEM CELL RES, V11, P1314, DOI 10.1016/j.scr.2013.09.002; Lessard A, 2010, EXP NEUROL, V223, P634, DOI 10.1016/j.expneurol.2010.02.013; Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pimashkin A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00087; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Qu XB, 2015, CELL MOL NEUROBIOL, V35, P913, DOI 10.1007/s10571-015-0186-6; Rang C. E., 2010, J CONTROL RELEASE, V144, P25; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xu Y, 2006, NEUROSCI LETT, V397, P174, DOI 10.1016/j.neulet.2005.12.051; Yang ZY, 2015, P NATL ACAD SCI USA, V112, P13354, DOI 10.1073/pnas.1510194112; Yang ZY, 2010, BIOMATERIALS, V31, P4846, DOI 10.1016/j.biomaterials.2010.02.015; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhao XY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-55	36	30	35	3	45	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	NOV	2016	45						182	195		10.1016/j.actbio.2016.08.043			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	EB3VZ	WOS:000387298300013	27562609				2022-02-06	
J	Hallock, H; Collins, D; Lampit, A; Deol, K; Fleming, J; Valenzuela, M				Hallock, Harry; Collins, Daniel; Lampit, Amit; Deol, Kiran; Fleming, Jennifer; Valenzuela, Michael			Cognitive Training for Post-Acute Traumatic Brain Injury: A Systematic Review and Meta-Analysis	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						traumatic brain injury; TBI; closed head injury; cognitive training; cognitive outcome; neuropsychological outcome; rehabilitation	OF-THE-LITERATURE; REHABILITATION; INTERVENTION; IMPAIRMENT; MODERATE; THERAPY; ADULTS; BIAS	Objective: To quantitatively aggregate effects of cognitive training (CT) on cognitive and functional outcome measures in patients with traumatic brain injury (TBI) more than 12 months post-injury. Design: We systematically searched six databases for non-randomized and randomized controlled trials of CT in TBI patients at least 12-months post-injury reporting cognitive and/or functional outcomes. Main Measures: Efficacy was measured as standardized mean difference (Hedges' g) of post-training change. We investigated heterogeneity across studies using subgroup analyses and meta-regressions. Results: Fourteen studies encompassing 575 patients were included. The effect of CT on overall cognition was small and statistically significant (g = 0.22, 95%CI 0.05 to 0.38; p = 0.01), with low heterogeneity (I-2 = 11.71%) and no evidence of publication bias. A moderate effect size was found for overall functional outcomes (g = 0.32, 95%Cl 0.08 to 0.57, p = 0.01) with low heterogeneity (I-2 I= 14.27%) and possible publication bias. Statistically significant effects were also found only for executive function (g = 0.20, 95%CI 0.02 to 0.39, p = 0.03) and verbal memory (g = 0.32, 95%CI 0.14 to 0.50, p < 0.01). Conclusion: Despite limited studies in this field, this meta-analysis indicates that CT is modestly effective in improving cognitive and functional outcomes in patients with post-acute TBI and should therefore play a more significant role in TBI rehabilitation.	[Hallock, Harry; Collins, Daniel; Lampit, Amit; Valenzuela, Michael] Univ Sydney, Brain & Mind Ctr, Regenerat Neurosci Grp, Sydney, NSW, Australia; [Lampit, Amit] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Deol, Kiran] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld, Australia; [Fleming, Jennifer] Metro South Hosp & Hlth Serv, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia		Valenzuela, M (corresponding author), Univ Sydney, Brain & Mind Ctr, Regenerat Neurosci Grp, Sydney, NSW, Australia.	michael.valenzuela@sydney.edu.au		Collins, Daniel/0000-0003-2195-9037; Valenzuela, Michael/0000-0001-7162-6607; Lampit, Amit/0000-0001-6522-8397	NHMRCNational Health and Medical Research Council of Australia [1083064]	JF is supported by an NHMRC project grant (ID 1083064). AL is an ARC-NHMRC Dementia Research Development Fellow (ID 1108520). MV is an NHMRC Clinical Career Development Research Fellow (ID 1112813).	Ardila A, 2013, J NEUROLOGICAL DISOR, V1, P1, DOI DOI 10.4172/2329-6895.1000114; Bahar-Fuchs A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003260.pub2; Baribeau J, 1989, J NEUROL REHABIL, V3, P71; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Borenstein M., 2009, INTRO META ANAL; Buschert V, 2010, NAT REV NEUROL, V6, P508, DOI 10.1038/nrneurol.2010.113; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clare L, 2003, COCHRANE DATABASE SY; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gates N, 2010, CURR PSYCHIAT REP, V12, P20, DOI 10.1007/s11920-009-0085-y; Gleser L. J., 2009, HDB RES SYNTHESIS ME; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Leung IHK, 2015, NEUROLOGY, V85, P1843, DOI 10.1212/WNL.0000000000002145; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Maher CG, 2003, PHYS THER REHABIL J, V83, P713, DOI 10.1093/ptj/83.8.713; Man DWK, 2006, BRAIN INJURY, V20, P981, DOI 10.1080/13561820600909852; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Nelson LA, 2013, NEUROPSYCHOLOGY, V27, P666, DOI 10.1037/a0034117; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; Pa J, 2009, ANN NEUROL, V65, P414, DOI 10.1002/ana.21591; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Rice-Oxley M, 1999, CLIN REHABIL, V13, P7, DOI 10.1191/026921599668051623; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Ruff R. M., 1989, J HEAD TRAUMA REHAB, V4, P20, DOI [10.1097/00001199-198909000-00006, DOI 10.1097/00001199-198909000-00006]; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Sohlberg M., 2001, COGNITIVE REHABILITA; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Strauss ShermanEMS, 2006, COMPENDIUM NEUROPSYC; Thomas-Stonell N, 1994, J HEAD TRAUMA REHAB, V9, P25, DOI DOI 10.1097/00001199-199412000-00005; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Toril P, 2014, PSYCHOL AGING, V29, P706, DOI 10.1037/a0037507; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Wilson M., 2014, SCAND J TRAUMA RE S1, V22, pA7, DOI [10.1186/1757-7241-22-S1-A7, DOI 10.1186/1757-7241-22-S1-A7]; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855	53	30	30	1	21	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	OCT 27	2016	10								537	10.3389/fnhum.2016.00537			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DZ9AL	WOS:000386165200001	27833541	Green Published, gold			2022-02-06	
J	Li, X; Wang, HD; Gao, YY; Li, LW; Tang, C; Wen, GD; Zhou, Y; Zhou, ML; Mao, L; Fan, YW				Li, Xiang; Wang, Handong; Gao, Yongyue; Li, Liwen; Tang, Chao; Wen, Guodao; Zhou, Yuan; Zhou, Mengliang; Mao, Lei; Fan, Youwu			Protective Effects of Quercetin on Mitochondrial Biogenesis in Experimental Traumatic Brain Injury via the Nrf2 Signaling Pathway	PLOS ONE			English	Article							CEREBRAL ISCHEMIA-REPERFUSION; INDUCED OXIDATIVE STRESS; MEMORY-IMPAIRMENT; INDUCED APOPTOSIS; ACTIVATION; MICE; INFLAMMATION; ENHANCEMENT; HEPATITIS; NRF2/HO-1	The present investigation was carried out to elucidate a possible molecular mechanism related to the protective effect of quercetin administration against oxidative stress on various mitochondrial respiratory complex subunits with special emphasis on the role of nuclear factor erythroid 2-related factor 2 (Nrf2) in mitochondrial biogenesis. Recently, quercetin has been proved to have a protective effect against mitochondria damage after traumatic brain injury (TBI). However, its precise role and underlying mechanisms in traumatic brain injury are not yet fully understood. The aim of the present study was to investigate the effect of quercetin on the potential mechanism of these effects in a weight-drop model of TBI in male mice that were treated with quercetin or vehicle via intraperitoneal injection administrated 30 min after TBI. In this experiment, ICR mice were divided into four groups: A sham group, TBI group, TBI + vehicle group, and TBI + quercetin group. Brain samples were collected 24 h later for analysis. Quercetin treatment resulted in an upregulation of Nrf2 expression and cytochrome c, malondialdehyde (MDA) and superoxide dismutase ( SOD) levels were restored by quercetin treatment. Quercetin markedly promoted the translocation of Nrf2 protein from the cytoplasm to the nucleus. These observations suggest that quercetin improves mitochondrial function in TBI models, possibly by activating the Nrf2 pathway.	[Li, Xiang; Wang, Handong; Gao, Yongyue; Li, Liwen; Tang, Chao; Wen, Guodao; Zhou, Yuan; Zhou, Mengliang; Mao, Lei; Fan, Youwu] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China		Wang, HD; Mao, L; Fan, YW (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com; njmaolei@126.com; njywfan@163.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371357]; Nanjing Military Region Foundation, PLA Grant [14MS104, 15MS126]	This work was supported by the National Natural Science Foundation of China (81371357) and the Nanjing Military Region Foundation, PLA Grant (14MS104, 15MS126).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Baburamani AA, 2015, INT J MOL SCI, V16, P22509, DOI 10.3390/ijms160922509; Bachmetov L, 2012, J VIRAL HEPATITIS, V19, pE81, DOI 10.1111/j.1365-2893.2011.01507.x; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Bournival J, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/921941; Carrasco-Pozo C, 2016, J NUTR BIOCHEM, V27, P289, DOI 10.1016/j.jnutbio.2015.09.016; Chen C, 2012, J ASIAN NAT PROD RES, V14, P877, DOI 10.1080/10286020.2012.702108; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Hindy N, 2014, EUR J TRAUMA EMERG S, V40, P481, DOI 10.1007/s00068-013-0337-8; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Go KL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/183469; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Halder S, 2016, BIOL TRACE ELEM RES, V171, P391, DOI 10.1007/s12011-015-0544-8; Halder S, 2016, DRUG CHEM TOXICOL, V39, P272, DOI 10.3109/01480545.2015.1092042; Hu YY, 2015, BRAIN RES, V1605, P39, DOI 10.1016/j.brainres.2015.02.015; Kambe Y, 2016, J MOL NEUROSCI; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kimura T, 2016, AMINO ACIDS; Kompanje EJO, 2007, SCI ENG ETHICS, V13, P371, DOI 10.1007/s11948-007-9027-4; Kulkarni GV, 1998, EXP CELL RES, V245, P170, DOI 10.1006/excr.1998.4245; Kysenius K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107129; Lawrence NJ, 2008, DNA REPAIR, V7, P281, DOI 10.1016/j.dnarep.2007.10.005; Lei XF, 2016, MOL MED REP, V13, P412, DOI 10.3892/mmr.2015.4534; Li RR, 2015, INT J MED SCI, V12, P432, DOI 10.7150/ijms.11402; Liu P, 2015, RESTOR NEUROL NEUROS, V33, P143, DOI 10.3233/RNN-140446; Liu WC, 2017, J NEUROSURG, V127, P8, DOI 10.3171/2016.4.JNS152909; Liu Y, 2015, J NEUROL SCI, V351, P88, DOI 10.1016/j.jns.2015.02.045; Marcolin E, 2012, J NUTR, V142, P1821, DOI 10.3945/jn.112.165274; Petzold A, 2007, NEUROL RES, V29, P691, DOI 10.1179/016164107X240080; Sanganahalli BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063317; Sharma DR, 2015, NEUROTOXICOLOGY, V51, P116, DOI 10.1016/j.neuro.2015.10.002; Sharma DR, 2013, NEUROTOX RES, V23, P336, DOI 10.1007/s12640-012-9351-6; Shen J, 2007, BIOCHEM PHARMACOL, V73, P1901, DOI 10.1016/j.bcp.2007.03.009; Wang L, 2015, INT J CLIN EXP PATHO, V8, P11503; Whitman SA, 2013, EXP CELL RES, V319, P2673, DOI 10.1016/j.yexcr.2013.07.015; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060	40	30	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164237	10.1371/journal.pone.0164237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	WOS:000389046900009	27780244	Green Published, gold, Green Submitted			2022-02-06	
J	Saadoun, S; Papadopoulos, MC				Saadoun, Samira; Papadopoulos, Marios C.			Spinal cord injury: is monitoring from the injury site the future?	CRITICAL CARE			English	Article						Blood pressure; CNS injury; Clinical trial; Microdialysis; Monitoring; Neurocritical care; Spinal cord injury; Surgery	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; CLINICAL-TRIALS; INTRASPINAL PRESSURE; PERFUSION-PRESSURE; ICCP PANEL; INTRATHECAL PRESSURE; VASOPRESSOR USAGE; ANIMAL-MODEL; GUIDELINES	This paper challenges the current management of acute traumatic spinal cord injury based on our experience with monitoring from the injury site in the neurointensive care unit. We argue that the concept of bony decompression is inadequate. The concept of optimum spinal cord perfusion pressure, which differs between patients, is introduced. Such variability suggests individualized patient treatment. Failing to optimize spinal cord perfusion limits the entry of systemically administered drugs into the injured cord. We conclude that monitoring from the injury site helps optimize management and should be subjected to a trial to determine whether it improves outcome.	[Saadoun, Samira; Papadopoulos, Marios C.] St Georges Univ London, Acad Neurosurg Unit, Cranmer Terrace, London SW17 0RE, England		Papadopoulos, MC (corresponding author), St Georges Univ London, Acad Neurosurg Unit, Cranmer Terrace, London SW17 0RE, England.	mpapadop@sgul.ac.uk		Papadopoulos, Marios/0000-0001-9174-4176; Saadoun, Samira/0000-0002-5480-5678	Wings for Life spinal cord research foundation; Neurosciences Research Foundation (Fletcher Fund)	Supported by the Wings for Life spinal cord research foundation and the Neurosciences Research Foundation (Fletcher Fund).	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Awwad Waleed, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS261, DOI 10.1007/s00590-013-1409-5; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bydon M, 2014, WORLD NEUROSURG, V82, P848, DOI 10.1016/j.wneu.2013.02.062; Chen S, 2016, J NEUROCHEM IN PRESS; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cozzens JW, 2013, NEUROSURGERY, V72, P2, DOI 10.1227/NEU.0b013e3182772981; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Han JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002827; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Hurlbert RJ, 2008, CAN J NEUROL SCI, V35, P41, DOI 10.1017/S031716710000754X; Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Jones CF, 2012, SPINE, V37, pE1422, DOI 10.1097/BRS.0b013e31826ba7cd; KATOH S, 1995, PARAPLEGIA, V33, P506, DOI 10.1038/sc.1995.110; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Lammertse D, 2007, SPINAL CORD, V45, P232, DOI 10.1038/sj.sc.3102010; Lassmann H, 2003, J NEUROL SCI, V206, P187, DOI 10.1016/S0022-510X(02)00421-5; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Maas A, 2016, NEUROSURGERY, V78, P368; Nagoshi N, 2015, EXPERT OPIN INV DRUG, V24, P645, DOI 10.1517/13543784.2015.1009629; Papadopoulos MC, 2015, NEUROSURGERY, V77, pE500, DOI 10.1227/NEU.0000000000000862; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Readdy WJ, 2015, J NEUROSURG-SPINE, V23, P574, DOI 10.3171/2015.2.SPINE14746; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Smith JS, 2010, J BONE JOINT SURG AM, V92A, P1206, DOI 10.2106/JBJS.I.00740; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Tuszynski MH, 2007, SPINAL CORD, V45, P222, DOI 10.1038/sj.sc.3102009; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; van Middendorp JJ, 2013, J NEUROTRAUM, V30, P1781, DOI 10.1089/neu.2013.2932; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Werndle MC, 2016, ACTA NEUROCHIR SUPPL, V122, P323, DOI 10.1007/978-3-319-22533-3_64; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050	45	30	31	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	OCT 5	2016	20								308	10.1186/s13054-016-1490-3			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX7RZ	WOS:000384588300001	27716379	Green Accepted, Green Published, gold			2022-02-06	
J	Yuan, J; Wang, AH; He, Y; Si, ZH; Xu, S; Zhang, SC; Wang, K; Wang, DW; Liu, YM				Yuan, Jing; Wang, Aihua; He, Yan; Si, Zhihua; Xu, Shan; Zhang, Shanchao; Wang, Kun; Wang, Dawei; Liu, Yiming			Cordycepin attenuates traumatic brain injury-induced impairments of blood-brain barrier integrity in rats	BRAIN RESEARCH BULLETIN			English	Article						Cordycepin; Traumatic brain injury; Blood-brain barrier integrity; Neuroprotective; Anti-oxidative; Anti-inflammatory	CEREBRAL-ISCHEMIA; TIGHT JUNCTION; OCCLUDIN; PATHWAY; MICE; PERMEABILITY; DYSFUNCTION; DEFICITS; STRESS	Loss of blood-brain barrier (BBB) integrity is a downstream event caused by traumatic brain injury (TBI). BBB integrity is affected by certain physiological conditions, including inflammation and oxidative stress. Cordycepin is a susbtance with anti-inflammatory and anti-oxidative effects. Therefore, it is necessary to investigate whether cordycepin affects TBI-induced impairments of BBB integrity. Using TBI rats as the in vivo model and applying multiple techniques, including stroke severity evaluation, Evans blue assessment, quantitative real-time PCR, Western blotting and ELISA, we investigated the dose-dependent protective effects of cordycepin on the TBI-induced impairments of BBB integrity. Cordycepin treatment attenuated the TBI-induced impairments in a dose-dependent manner, and played a role in protecting BBB integrity. Cordycepin was able to alleviate TBI-induced loss of tight junction proteins zonula occludens protein-1 (ZO-1) and occludin, which are important for BBB integrity. Moreover, cordycepin suppressed pro-inflammatory factors, including IL-1 beta, iNOS, MPO and MMP-9, and promoted anti-inflammation-associated factors arginase 1 and IL-10. Furthermore, cordycepin inhibited NADPH oxidase (NOX) expression and activity following TBI, probably through NOX1, but not NOX2 and NOX4. Cordycepin has protective effects against brain damages induced by TBI. The protection of cordycepin on BBB integrity was probably achieved through recovery of tight junction proteins, inhibition of local inflammation, and prevention of NOX activity. (C) 2016 Elsevier Inc. All rights reserved.	[Yuan, Jing; Wang, Aihua; He, Yan; Si, Zhihua; Xu, Shan; Zhang, Shanchao] Shandong Univ, Qianfoshan Hosp, Dept Neurol, 16766 Jingshi Rd, Jinan 250014, Peoples R China; [Wang, Kun] Shandong Univ, Qianfoshan Hosp, Dept Gen Surg, 16766 Jingshi Rd, Jinan 250014, Peoples R China; [Wang, Dawei] Shandong Univ, Shandong Prov Hosp, Dept Orthoped, 324 Jingwu Rd, Jinan 250021, Peoples R China; [Liu, Yiming] Shandong Univ, Qilu Hosp, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Peoples R China		Wang, K (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Gen Surg, 16766 Jingshi Rd, Jinan 250014, Peoples R China.; Wang, DW (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Orthoped, 324 Jingwu Rd, Jinan 250021, Peoples R China.; Liu, YM (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Peoples R China.	qywangkun1981@sohu.com; wangdwsd@126.com; yimingliusdql@yeah.net		Wang, Dawei/0000-0002-6151-5839; zhang, Shanchao/0000-0002-5543-4530	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201392]	This work was supported by National Natural Science Foundation of China (81201392).	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Balda MS, 2000, J CELL BIOCHEM, V78, P85, DOI 10.1002/(SICI)1097-4644(20000701)78:1<85::AID-JCB8>3.3.CO;2-6; Carone D, 2015, BRAIN RES, V1615, P31, DOI 10.1016/j.brainres.2015.04.025; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Chen JW, 2008, BRAIN, V131, P1123, DOI 10.1093/brain/awn004; Chen W, 2015, EXP BRAIN RES, V233, P2823, DOI 10.1007/s00221-015-4352-3; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Fouda Abdelrahman Y, 2013, Exp Transl Stroke Med, V5, P12, DOI 10.1186/2040-7378-5-12; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Huang J, 2013, STROKE, V44, P190, DOI 10.1161/STROKEAHA.112.670299; Jin ML, 2014, NEUROTOXICOLOGY, V41, P102, DOI 10.1016/j.neuro.2014.01.005; Lacaz-Vieira F, 1999, J MEMBRANE BIOL, V168, P289, DOI 10.1007/s002329900518; Liu WJ, 2014, BRAIN RES, V1573, P17, DOI 10.1016/j.brainres.2014.05.022; Liu WL, 2008, J NEUROCHEM, V107, P1196, DOI 10.1111/j.1471-4159.2008.05664.x; Ma L, 2015, NUTR RES, V35, P431, DOI 10.1016/j.nutres.2015.04.011; Park ES, 2014, CARDIOVASC TOXICOL, V14, P1, DOI 10.1007/s12012-013-9232-0; Pazar A, 2016, J PINEAL RES, V60, P74, DOI 10.1111/jpi.12292; Ramesh T, 2012, EXP GERONTOL, V47, P979, DOI 10.1016/j.exger.2012.09.003; Shao AW, 2014, CNS NEUROSCI THER, V20, P182, DOI 10.1111/cns.12194; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Tuli HS, 2013, LIFE SCI, V93, P863, DOI 10.1016/j.lfs.2013.09.030; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang YL, 2014, J NEUROCHEM, V129, P827, DOI 10.1111/jnc.12695; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yu Q, 2015, CELL PHYSIOL BIOCHEM, V36, P1539, DOI 10.1159/000430317	28	30	32	4	18	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	OCT	2016	127						171	176		10.1016/j.brainresbull.2016.09.010			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED7YH	WOS:000389088100021	27646481				2022-02-06	
J	Ebenezer, PJ; Wilson, CB; Wilson, LD; Nair, AR; Francis, J				Ebenezer, Philip J.; Wilson, C. Brad; Wilson, Leslie D.; Nair, Anand R.; Francis, J.			The Anti-Inflammatory Effects of Blueberries in an Animal Model of Post-Traumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							OXIDATIVE STRESS; PROTECTIVE ROLE; BRAIN-INJURY; INFLAMMATION; MICE; ACTIVATION; ANXIETY; ACID; HIPPOCAMPUS; VACCINATION	Post-traumatic stress disorder (PTSD) is a trauma and stressor-related disorder that results in a prolonged stress response. It is associated with increased oxidative stress and inflammation in the prefrontal cortex (PFC) and hippocampus (HC). The only approved therapy for PTSD is selective serotonin re-uptake inhibitors (SSRIs), but their efficacy ismarginal. Recently, we demonstrated that over-production of norepinephrine (NE) as the possible reason for the lack of efficacy of SSRIs. Hence, there is a need for novel therapeutic approaches for the treatment of PTSD. In this study, we investigated the anti-inflammatory role of blueberries in modulating inflammatory markers and neurotransmitter levels in PTSD. Rats were fed either a blueberry enriched (2%) or a control diet. Rats were exposed to cats for one hour on days 1 and 11 of a 31-day schedule to simulate traumatic conditions. The rats were also subjected to psychosocial stress via daily cage cohort changes. At the end of the study, the rats were euthanized and the PFC and HC were isolated. Monoamines were measured by high-performance liquid chromatography. Reactive oxygen species (ROS), gene and protein expression levels of inflammatory cytokines were alsomeasured. In our PTSD-model, NE levels were increased and 5-HT levels were decreased when compared to control. In contrast, a blueberry enriched diet increased 5-HT without affecting NE levels. The rate limiting enzymes tyrosine hydroxylase and tryptophan hydroxylase were also studied and they confirmed our findings. The enhanced levels free radicals, gene and protein expression of inflammatory cytokines seen in the PTSD group were normalized with a blueberry enriched diet. Decreased anxiety in this group was shown by improved performance on the elevated plus-maze. These findings indicate blueberries can attenuate oxidative stress and inflammation and restore neurotransmitter imbalances in a ratmodel of PTSD.	[Ebenezer, Philip J.; Wilson, C. Brad; Nair, Anand R.; Francis, J.] Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Wilson, Leslie D.] Louisiana State Univ, Sch Vet Med, Pathobiol Sci, Baton Rouge, LA 70803 USA		Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	jfrancis@lsu.edu			Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program [W81XWH-15-1-0061]; United States Highbush Blueberry Council	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program 2014 under Award No. W81XWH-15-1-0061 and United States Highbush Blueberry Council for JF. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense or United States Highbush Blueberry Council. There was no additional external funding received for this study.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Alam Q., 2015, CURR PHARM DESIGN; Baker DG, 2001, NEUROIMMUNOMODULAT, V9, P209, DOI 10.1159/000049028; Bollinger JL, 2016, BRAIN BEHAV IMMUN, V52, P88, DOI 10.1016/j.bbi.2015.10.003; Brewin CR, 2000, J TRAUMA STRESS, V13, P499, DOI 10.1023/A:1007741526169; Chaki S, 2003, EUR J PHARMACOL, V464, P49, DOI 10.1016/S0014-2999(03)01368-2; Chaki S, 2003, J PHARMACOL EXP THER, V304, P818, DOI 10.1124/jpet.102.044826; Chang CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011971; Chuang CY, 2014, FREE RADICAL RES, V48, P970, DOI 10.3109/10715762.2014.920087; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Denev P, 2014, FOOD CHEM, V157, P37, DOI 10.1016/j.foodchem.2014.02.022; Diamond DM, 2016, J NEUROSCI RES, V94, P437, DOI 10.1002/jnr.23684; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Eyre H, 2012, BRAIN BEHAV IMMUN, V26, P251, DOI 10.1016/j.bbi.2011.09.015; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Garate I, 2013, BIOL PSYCHIAT, V73, P32, DOI 10.1016/j.biopsych.2012.07.005; Hohne C, 2013, BRAIN, V136, P1746, DOI 10.1093/brain/awt064; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Huang M, 2012, J ETHNOPHARMACOL, V143, P228, DOI 10.1016/j.jep.2012.06.028; Jesudason EP, 2007, MOL CELL BIOCHEM, V298, P69, DOI 10.1007/s11010-006-9353-x; Jesudason EP, 2005, BRAIN RES BULL, V65, P361, DOI 10.1016/j.brainresbull.2005.01.010; Jiang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152371; Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001; Joseph SV, 2014, J AGR FOOD CHEM, V62, P3886, DOI 10.1021/jf4044056; Lemieux A, 2008, BRAIN BEHAV IMMUN, V22, P994, DOI 10.1016/j.bbi.2008.02.005; Liu YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127813; Loganovsky KN, 2013, CNS SPECTRUMS, V18, P95, DOI 10.1017/S109285291200096X; Maddox SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054463; Masilamoni JG, 2005, BBA-MOL BASIS DIS, V1740, P411, DOI 10.1016/j.bbadis.2004.11.002; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nair AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111976; Nair AR, 2014, FREE RADICAL BIO MED, V71, P16, DOI 10.1016/j.freeradbiomed.2014.03.012; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Nawaz MI, 2015, J RECEPT SIG TRANSD, V35, P340, DOI 10.3109/10799893.2014.984309; Nie H, 2014, PROG NEURO-PSYCHOPH, V51, P16, DOI 10.1016/j.pnpbp.2014.01.002; Oosthuizen Frasia, 2005, Neuropsychiatr Dis Treat, V1, P109, DOI 10.2147/nedt.1.2.109.61049; Potter KA, 2014, ACTA BIOMATER, V10, P2209, DOI 10.1016/j.actbio.2014.01.018; Poulose SM, 2014, BRAIN RES, V1593, P9, DOI 10.1016/j.brainres.2014.10.028; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Sasaki T, 2016, EXP NEUROL, V275, P220, DOI 10.1016/j.expneurol.2015.11.003; Schneider BL, 2016, J NEUROTRAUM, V33, P1614, DOI 10.1089/neu.2015.4190; Shukitt-Hale B, 2012, GERONTOLOGY, V58, P518, DOI 10.1159/000341101; Tataranno ML, 2015, CLIN PERINATOL, V42, P529, DOI 10.1016/j.clp.2015.04.011; Taverniti V, 2014, J AGR FOOD CHEM, V62, P8346, DOI 10.1021/jf502180j; Varman DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127945; Vida C, 2014, CURR PHARM DESIGN, V20, P4656; Viggiano Davide, 2004, Neural Plasticity, V11, P97, DOI 10.1155/NP.2004.97; Weston CSE, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00037; Wilson CB, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00256; Wilson CB, 2014, BEHAV BRAIN RES, V268, P72, DOI 10.1016/j.bbr.2014.03.029; Wilson CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089104; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; Wolf EG, 2015, UNDERSEA HYPERBAR M, V42, P313; Zhao MY, 2015, J FOOD SCI, V80, pH869, DOI 10.1111/1750-3841.12815; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	58	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160923	10.1371/journal.pone.0160923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	WOS:000383255200009	27603014	gold, Green Submitted, Green Published			2022-02-06	
J	Jonkergouw, J; van de Vijfeijken, SECM; Nout, E; Theys, T; Van de Casteele, E; Folkersma, H; Depauw, PRAM; Becking, AG				Jonkergouw, J.; van de Vijfeijken, S. E. C. M.; Nout, E.; Theys, T.; Van de Casteele, E.; Folkersma, H.; Depauw, P. R. A. M.; Becking, A. G.			Outcome in patient-specific PEEK cranioplasty: A two-center cohort study of 40 implants	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Cranioplasty; Craniectomy; Patient specific implant; PEEK; Computer aided-design and modelling; Cranial vault reconstruction	AFFECTING GRAFT INFECTION; TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; DECOMPRESSIVE CRANIECTOMY; AUTOLOGOUS BONE; POLYETHERETHERKETONE IMPLANTS; CALVARIAL RECONSTRUCTION; CRANIAL DEFECTS; COMPLICATIONS; MANAGEMENT	Objective: The best material choice for cranioplasty following craniectomy remains a subject to discussion. Complication rates after cranioplasty tend to be high. Computer-assisted 3-dimensional modelling of polyetheretherketone (PEEK) was recently introduced for cranial reconstruction. The aim of this study was to evaluate patient- and surgery-related characteristics and risk factors that predispose patients to cranioplasty complications. Material and methods: This retrospective study included a total of 40 cranial PEEK implants in 38 patients, performed at two reference centers in the Netherlands from 2011 to 2014. Complications were registered and patient- and surgery-related data were carefully analysed. Results: The overall complication rate of PEEK cranioplasty was 28%. Complications included infection (13 %), postoperative haematoma (10 %), cerebrospinal fluid leak (2.5 %) and wound-related problems (2.5 %). All postoperative infections required removal of the implant. Nonetheless removed implants could be successfully re-used after re-sterilization. Conclusion: Although overall complication rates after PEEK cranioplasty remain high, outcomes are satisfactory, as our results compare favourably to recent literature reports on cranial vault reconstruction. (C) 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Jonkergouw, J.; Nout, E.] Dept Oral & Maxillofacial Surg Tilburg, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands; [Jonkergouw, J.] Univ Hosp Leuven, Dept Oral & Maxillofacial Surg, Herestr 49, B-3000 Leuven, Belgium; [van de Vijfeijken, S. E. C. M.; Becking, A. G.] Acad Med Ctr, Dept Oral & Maxillofacial Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van de Vijfeijken, S. E. C. M.; Becking, A. G.] Acad Ctr Dent Amsterdam ACTA, Gustav Mahlerlaan 3004, NL-1081 LA Amsterdam, Netherlands; [Theys, T.] Univ Hosp Leuven, Dept Neurosurg, Herestr 49, B-3000 Leuven, Belgium; [Van de Casteele, E.] Univ Antwerp, IMinds Vis Lab, Dept Phys, Antwerp, Belgium; [Folkersma, H.] Acad Med Ctr, Neurosurg Ctr Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Depauw, P. R. A. M.] Dept Neurosurg Tilburg, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands		van de Vijfeijken, SECM (corresponding author), Acad Med Ctr, Dept Oral & Maxillofacial Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.e.vandevijfefiken@amc.uva.nl	Theys, Tom/AAG-4536-2019	Theys, Tom/0000-0001-7595-3234; Van de Casteele, Elke/0000-0003-0395-3002			Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158; Bonda DJ, 2015, NEUROSURGERY, V77, P814, DOI 10.1227/NEU.0000000000000899; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cheng Cheng-Hsin, 2014, Clin Neurol Neurosurg, V124, P85, DOI 10.1016/j.clineuro.2014.06.029; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Diedler Jennifer, 2009, J Intensive Care Med, V24, P168, DOI 10.1177/0885066609332808; Ducic J, 2002, J ORAL MAXIL SURG, V60, P272, DOI 10.1053/joms.2002.30575; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Dujovny M, 1997, SURG NEUROL, V48, P294, DOI 10.1016/S0090-3019(97)00277-2; Goh RCW, 2010, J PLAST RECONSTR AES, V63, P1479, DOI 10.1016/j.bjps.2009.08.010; Goldstein JA, 2013, CURR OPIN OTOLARYNGO, V21, P400, DOI 10.1097/MOO.0b013e328363003e; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Hanasono MM, 2009, ANN PLAS SURG, V62, P653, DOI 10.1097/SAP.0b013e318184abc7; Hill CS, 2012, BRIT J NEUROSURG, V26, P832, DOI 10.3109/02688697.2012.692839; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul S, 2012, PLAST RECONSTR SURG, V130, P1110, DOI 10.1097/PRS.0b013e318267d4de; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kim H, 2013, ACTA NEUROCHIR, V155, P2171, DOI 10.1007/s00701-013-1877-8; Klinger DR, 2014, WORLD NEUROSURG, V82, pE525, DOI 10.1016/j.wneu.2013.08.005; Kshettry VR, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822fef2c; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013; Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150; Lethaus B, 2014, J CRANIOFAC SURG, V25, P206, DOI 10.1097/SCS.0000000000000396; Lethaus B, 2012, J NEUROTRAUM, V29, P1077, DOI 10.1089/neu.2011.1794; Lethaus B, 2011, J CRANIO MAXILL SURG, V39, P435, DOI 10.1016/j.jcms.2010.10.003; Mak CHK, 2013, VASC HEALTH RISK MAN, V9, P353, DOI 10.2147/VHRM.S34046; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Morley NC, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003435; Perez-Bovet J, 2012, ACTA NEUROCHIR, V154, P1717, DOI 10.1007/s00701-012-1323-3; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; RIFKINSONMANN S, 1988, NEUROSURGERY, V23, P411, DOI 10.1227/00006123-198810000-00001; Rosenthal G, 2014, NEUROSURGERY, V75, P523, DOI 10.1227/NEU.0000000000000477; Sahoo N, 2010, J CRANIOFAC SURG, V21, P79, DOI 10.1097/SCS.0b013e3181c3ba58; Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; STULA D, 1982, J MAXILLOFAC SURG, V10, P142, DOI 10.1016/S0301-0503(82)80030-1; Sundseth J, 2014, ACTA NEUROCHIR, V156, P805, DOI 10.1007/s00701-013-1992-6; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Walcott BP, 2013, J NEUROSURG, V118, P757, DOI 10.3171/2013.1.JNS121626; Whitfield PC, 2001, NEUROSURGERY, V49, P225, DOI 10.1097/00006123-200107000-00042; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Zanaty M, 2015, J NEUROSURG, P1	50	30	32	2	18	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	SEP	2016	44	9					1266	1272		10.1016/j.jcms.2016.07.005			7	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	DY0GX	WOS:000384776400023	27524384				2022-02-06	
J	Meehan, WP; O'Brien, MJ; Geminiani, E; Mannix, R				Meehan, William P., III; O'Brien, Michael J.; Geminiani, Ellen; Mannix, Rebekah			Initial symptom burden predicts duration of symptoms after concussion	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Mild traumatic brain injury; Sports; Head trauma; Sports injury	SPORT-RELATED CONCUSSION; COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; PROTRACTED RECOVERY; PROLONGED RECOVERY; AGE; MANAGEMENT; MIGRAINE; HEAD	Objectives: To determine which variables predict prolonged (>28 days) duration of symptoms after a concussion. Design: We conducted a prospective cohort study of adult (>18yo) patients cared for in a specialty concussion clinic. Methods: Symptoms were assessed using the Post-Concussion Symptom Scale (PCSS) developed at the 3rd International Conference on Concussion in Sports. Possible predictors including age, sex, loss of consciousness, amnesia, history of prior concussion, prior treatment for headaches, history of migraines, and family history of concussions, were measured by self-report. We recorded a PCSS score at each clinical visit and defined time to symptom resolution as the number of days between the date of injury and date of last symptoms. Results: Of 64 adult patients included in the study, 53.3% were male; 20.3% reported experiencing a loss of consciousness at the time of injury while 23.4% reported amnesia. Patients ranged in age from 18 to 27 years (mean 21 2 years). Most concussions (92.2%) occurred during sports. The mean initial PCSS score for those suffering symptoms for longer than 28 days was significantly higher than those who symptoms resolved within 28 days (42.5 vs. 19.2, p<0.01). Of all potential predictor variables, only the initial PCSS score was independently associated with the odds of symptoms lasting longer than 28 days (aOR 1.037; 95% CI 1.011, 1.063). Conclusions: Among adult patients with concussions, those with a higher symptom burden after injury have an increased odds of suffering from prolonged symptoms. Other potential predictor variables are not associated with the risk of prolonged recovery. (C) 2015 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Meehan, William P., III; O'Brien, Michael J.; Geminiani, Ellen; Mannix, Rebekah] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Meehan, William P., III; O'Brien, Michael J.; Geminiani, Ellen] Boston Childrens Hosp, Div Sports Med, Sports Concuss Clin, Boston, MA USA; [Meehan, William P., III; O'Brien, Michael J.; Mannix, Rebekah] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Meehan, William P., III; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA		Meehan, WP (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA.; Meehan, WP (corresponding author), Boston Childrens Hosp, Div Sports Med, Sports Concuss Clin, Boston, MA USA.; Meehan, WP (corresponding author), Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA.; Meehan, WP (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA USA.	William.meehan@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD040128-06A]; NFL Players Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health (NIH) T32 HD040128-06A (Meehan) and the NFL Players Association (Meehan).	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; BERNEY J, 1994, CHILD NERV SYST, V10, P517, DOI 10.1007/BF00335074; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Sperandei S, 2013, BIOCHEM MEDICA, V24, P12; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x	25	30	30	1	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	SEP	2016	19	9					722	725		10.1016/j.jsams.2015.12.002			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DV3DJ	WOS:000382800900007	26718812	Green Accepted			2022-02-06	
J	Bigler, ED				Bigler, Erin D.			Systems Biology, Neuroimaging, Neuropsychology, Neuroconnectivity and Traumatic Brain Injury	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						traumatic brain injury (TBI); neuroimaging; computed tomography (CT); magnetic resonance imaging (MRI); systems biology; connectivity; neuropsychology; quantitative image analysis	WHITE-MATTER; STRUCTURAL CONNECTOME; STATE; MILD; CONSEQUENCES; DAMAGE; NEUROPATHOLOGY; ORGANIZATION; CONNECTIVITY; PERFORMANCE	The patient who sustains a traumatic brain injury (TBI) typically undergoes neuroimaging studies, usually in the form of computed tomography (CT) and magnetic resonance imaging (MRI). In most cases the neuroimaging findings are clinically assessed with descriptive statements that provide qualitative information about the presence/absence of visually identifiable abnormalities; though little if any of the potential information in a scan is analyzed in any quantitative manner, except in research settings. Fortunately, major advances have been made, especially during the last decade, in regards to image quantification techniques, especially those that involve automated image analysis methods. This review argues that a systems biology approach to understanding quantitative neuroimaging findings in TBI provides an appropriate framework for better utilizing the information derived from quantitative neuroimaging and its relation with neuropsychological outcome. Different image analysis methods are reviewed in an attempt to integrate quantitative neuroimaging methods with neuropsychological outcome measures and to illustrate how different neuroimaging techniques tap different aspects of TBI-related neuropathology. Likewise, how different neuropathologies may relate to neuropsychological outcome is explored by examining how damage influences brain connectivity and neural networks. Emphasis is placed on the dynamic changes that occur following TBI and how best to capture those pathologies via different neuroimaging methods. However, traditional clinical neuropsychological techniques are not well suited for interpretation based on contemporary and advanced neuroimaging methods and network analyses. Significant improvements need to be made in the cognitive and behavioral assessment of the brain injured individual to better interface with advances in neuroimaging-based network analyses. By viewing both neuroimaging and neuropsychological processes within a systems biology perspective could represent a significant advancement for the field.	[Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Ctr Neurosci, Provo, UT 84602 USA		Bigler, ED (corresponding author), Brigham Young Univ, Ctr Neurosci, Dept Psychol, Provo, UT 84602 USA.	erin_bigler@byu.edu			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R01HD048946, 3R01HD048946-05S1]; Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0095]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	Parts of the research written about in this review were supported by the National Institute of Child Health and Human Development (Grant Nos. 5R01HD048946 and 3R01HD048946-05S1) and the USA. Army Medical Research and Material Command under Award No. W81XWH-13-2-0095 (Chronic Effects of Neurotrauma Consortium). The views and opinions expressed in this article are those of the author and do not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. EDB co-directs the Neuropsychological Assessment and Research Laboratory at Brigham Young University which provides forensic consultation. Tracy Abildskov, Naomi Goodrich-Hunsaker, Ph.D. and Trevor Huff assisted with creating some of the images used in this review and Jo Ann Petrie, Ph.D. also provided assistance with manuscript preparation.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; An G, 2012, INT J BURNS TRAUMA, V2, P1; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Benarroch EE, 2015, NEUROLOGY, V85, P1417, DOI 10.1212/WNL.0000000000002044; Bigler E. D., 2016, SPORTS MED IN PRESS; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P442, DOI 10.1017/S1355617704103111; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler E, 2015, NEUROPSYCHOL REV, V25, P224, DOI 10.1007/s11065-015-9290-0; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2009, NEUROPSYCHOL REV, V19, P9, DOI 10.1007/s11065-009-9086-1; Binet A., 1905, ANN PSYCHOL, V12, P191, DOI [10.3406/psy.1904.3675, DOI 10.3406/PSY.1904.3675]; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2012, CORTEX, V48, P1262, DOI 10.1016/j.cortex.2012.07.001; CHAPPELL PM, 1992, RADIOLOGY, V183, P719, DOI 10.1148/radiology.183.3.1584926; CIPOLOTTI L, 1995, J NEUROL NEUROSUR PS, V58, P655, DOI 10.1136/jnnp.58.6.655; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Cromwell HC, 2011, NEUROSCI BIOBEHAV R, V35, P2026, DOI 10.1016/j.neubiorev.2011.02.008; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Das S, 2016, NEUROIMAGE, V124, P1188, DOI 10.1016/j.neuroimage.2015.08.076; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Filley CM, 2011, NEUROL CLIN, V29, P81, DOI 10.1016/j.ncl.2010.10.003; Filley CM, 2010, NEUROPSYCHOL REV, V20, P158, DOI 10.1007/s11065-010-9127-9; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gean A. D., 2015, BRAIN INJURY APPL WA; Gean AD, 1994, IMAGING HEAD TRAUMA; Gozzi A, 2016, NEUROIMAGE, V127, P496, DOI 10.1016/j.neuroimage.2015.12.017; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Insel TR, 2013, NEURON, V80, P561, DOI 10.1016/j.neuron.2013.09.041; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Jang SH, 2015, AM J PHYS MED REHAB, V94, P250, DOI 10.1097/PHM.0000000000000274; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jokinen H, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00455; Khan AR, 2015, NEUROBIOL AGING, V36, pS60, DOI 10.1016/j.neurobiolaging.2014.04.036; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002; Koerte IK, 2016, TRANSLATIONAL RES TR; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kuceyeski A, 2015, HUM BRAIN MAPP, V36, P2147, DOI 10.1002/hbm.22761; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Lisman J, 2015, NEURON, V86, P864, DOI 10.1016/j.neuron.2015.03.032; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maxwell W.L., 2015, BRAIN NEUROTRAUMA MO; McAndrews MP, 2014, NEUROIMAG CLIN N AM, V24, P585, DOI 10.1016/j.nic.2014.07.008; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mirzaalian H, 2016, NEUROIMAGE, V135, P311, DOI 10.1016/j.neuroimage.2016.04.041; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nilsson J, 2014, J INT NEUROPSYCH SOC, V20, P262, DOI 10.1017/S1355617713001458; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Parsons TD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00660; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Ross L, 1990, Arch Clin Neuropsychol, V5, P273, DOI 10.1016/0887-6177(90)90026-L; Ross L K, 1990, Arch Clin Neuropsychol, V5, P347, DOI 10.1016/0887-6177(90)90014-G; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Sorg C, 2015, CLIN NEURORADIOL, V25, P177, DOI 10.1007/s00062-015-0438-3; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; Sullivan E, 2015, NEUROPSYCHOL REV, V25, P221, DOI 10.1007/s11065-015-9296-7; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Toga AW, 2015, J AM MED INFORM ASSN, V22, P1126, DOI 10.1093/jamia/ocv077; Tracy JI, 2015, CURR OPIN NEUROL, V28, P158, DOI 10.1097/WCO.0000000000000178; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Ueda Y, 2016, MED BIOL ENG COMPUT, V54, P1341, DOI 10.1007/s11517-015-1380-x; van der Helm PA, 2012, COGN PROCESS, V13, P13, DOI 10.1007/s10339-011-0425-9; Vodovotz Y., 2015, TRANSLATIONAL SYSTEM; Wilde E. A., BRAIN INJ IN PRESS; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wu MJ, 2017, NEUROIMAGE, V145, P254, DOI 10.1016/j.neuroimage.2016.02.016; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yu C, 2015, BRAIN NEUROTRAUMA MO; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239	102	30	30	0	25	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5137		FRONT SYST NEUROSCI	Front. Syst. Neurosci.	AUG 9	2016	10								55	10.3389/fnsys.2016.00055			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT0OW	WOS:000381183900001	27555810	gold, Green Published			2022-02-06	
J	Ballester, BR; Maier, M; Mozo, RMSS; Castaneda, V; Duff, A; Verschure, PFMJ				Rubio Ballester, Belen; Maier, Martina; Segundo Mozo, Rosa Maria San; Castaneda, Victoria; Duff, Armin; Verschure, Paul F. M. J.			Counteracting learned non-use in chronic stroke patients with reinforcement-induced movement therapy	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Stroke; Rehabilitation; Deductive medicine; Learned non-use; Virtual reality	TRAUMATIC BRAIN-INJURY; VIRTUAL-REALITY; FUNCTIONAL RECOVERY; UPPER-LIMB; REHABILITATION; ARM; NEUROREHABILITATION; RELIABILITY; INTEGRATION; ADJUSTMENT	Background: After stroke, patients who suffer from hemiparesis tend to suppress the use of the affected extremity, a condition called learned non-use. Consequently, the lack of training may lead to the progressive deterioration of motor function. Although Constraint-Induced Movement Therapies (CIMT) have shown to be effective in treating this condition, the method presents several limitations, and the high intensity of its protocols severely compromises its adherence. We propose a novel rehabilitation approach called Reinforcement-Induced Movement Therapy (RIMT), which proposes to restore motor function through maximizing arm use. This is achieved by exposing the patient to amplified goal-oriented movements in VR that match the intended actions of the patient. We hypothesize that through this method we can increase the patients self-efficacy, reverse learned non-use, and induce long-term motor improvements. Methods: We conducted a randomized, double-blind, longitudinal clinical study with 18 chronic stroke patients. Patients performed 30 minutes of daily VR-based training during six weeks. During training, the experimental group experienced goal-oriented movement amplification in VR. The control group followed the same training protocol but without movement amplification. Evaluators blinded to group designation performed clinical measurements at the beginning, at the end of the training and at 12-weeks follow-up. We used the Fugl-Meyer Assessment for the upper extremities (UE-FM) (Sanford et al., Phys Ther 73:447-454, 1993) as a primary outcome measurement of motor recovery. Secondary outcome measurements included the Chedoke Arm and Hand Activity Inventory (CAHAI-7) (Barreca et al., Arch Phys Med Rehabil 6:1616-1622, 2005) for measuring functional motor gains in the performance of Activities of Daily Living (ADLs), the Barthel Index (BI) for the evaluation of the patient's perceived independence (Collin et al., Int Disabil Stud 10:61-63, 1988), and the Hamilton scale (Knesevich et al., Br J Psychiatr J Mental Sci 131:49-52, 1977) for the identification of improvements in mood disorders that could be induced by the reinforcement-based intervention. In order to study and predict the effects of this intervention we implemented a computational model of recovery after stroke. Results: While both groups showed significant motor gains at 6-weeks post-treatment, only the experimental group continued to exhibit further gains in UE-FM at 12-weeks follow-up (p < .05). This improvement was accompanied by a significant increase in arm-use during training in the experimental group. Conclusions: Implicitly reinforcing arm-use by augmenting visuomotor feedback as proposed by RIMT seems beneficial for inducing significant improvement in chronic stroke patients. By challenging the patients' self-limiting believe system and perceived low self-efficacy this approach might counteract learned non-use.	[Rubio Ballester, Belen; Maier, Martina; Duff, Armin; Verschure, Paul F. M. J.] Univ Pompeu Fabra, Lab Synthet Percept Emot & Cognit Syst, Roc Boronat 138, Barcelona, Spain; [Verschure, Paul F. M. J.] ICREA, Barcelona, Spain; [Segundo Mozo, Rosa Maria San; Castaneda, Victoria] Hosp Univ Joan XXIII Tarragona, Serv Med Fis & Rehabil, Tarragona, Spain		Verschure, PFMJ (corresponding author), Univ Pompeu Fabra, Lab Synthet Percept Emot & Cognit Syst, Roc Boronat 138, Barcelona, Spain.; Verschure, PFMJ (corresponding author), ICREA, Barcelona, Spain.	paul.verschure@upf.edu	Maier, Martina/AAT-5438-2021; LUO, JINGJING/AAZ-6697-2021	LUO, JINGJING/0000-0002-3222-1276; Rubio Ballester, Belen/0000-0003-3496-5356; Maier, Martina/0000-0001-8898-5657	ERCEuropean Research Council (ERC)European Commission [FP7-IDEAS-ERC 341196]; ECEuropean CommissionEuropean Commission Joint Research Centre [H2020-EU.1.2.2. 641321]; MINECOSpanish Government; ICREAICREA Funding Source: Custom	This project was supported through ERC project cDAC (FP7-IDEAS-ERC 341196), EC H2020 project socSMCs (H2020-EU.1.2.2. 641321) and MINECO project SANAR (Gobierno de Espana).	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; ANDREWS K, 1979, RHEUMATOL REHABIL, V18, P43, DOI 10.1093/rheumatology/18.1.43; Arbib MA, 2008, MIND SOC, V7, P43, DOI DOI 10.1007/S11299-007-0041-7; Ballester BR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0039-z; Ballester BR, 2015, INT C VIRT REH ICVR; Ballester BR, 2015, IEEE INT C REH ROB I; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barreca SR, 2005, ARCH PHYS MED REHAB, V86, P1616, DOI 10.1016/j.apmr.2005.03.017; Bonaiuto J, 2010, BIOL CYBERN, V102, P341, DOI 10.1007/s00422-010-0371-0; Cameirao MS, 2012, STROKE, V43, P2720, DOI 10.1161/STROKEAHA.112.653196; Cameirao MS, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-48; Collin C, 1988, Int Disabil Stud, V10, P61; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dettmers C, 2005, ARCH PHYS MED REHAB, V86, P204, DOI 10.1016/j.apmr.2004.05.007; DONNELLAN KS, 1968, PHILOS REV, V77, P203, DOI 10.2307/2183321; FOLKMAN S, 1988, SOC SCI MED, V26, P309, DOI 10.1016/0277-9536(88)90395-4; Han CE, 2013, NEUROREHAB NEURAL RE, V27, P439, DOI 10.1177/1545968312471904; Han CE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000133; Herzfeld DJ, 2014, SCIENCE, V345, P1349, DOI 10.1126/science.1253138; ILLERT M, 1976, EXP BRAIN RES, V26, P509; Jones F, 2006, DISABIL REHABIL, V28, P841, DOI 10.1080/09638280500534952; KNESEVICH JW, 1977, BRIT J PSYCHIAT, V131, P49, DOI 10.1192/bjp.131.1.49; Kwakkel G, 2015, LANCET NEUROL, V14, P224, DOI 10.1016/S1474-4422(14)70160-7; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Lucca LF, 2009, J REHABIL MED, V41, P1003, DOI 10.2340/16501977-0405; Marcos E., 2013, BMC NEUROSCI, V14, P408, DOI [10.1186/1471-2202-14-S1-P408, DOI 10.1186/1471-2202-14-S1-P408]; Marcos E, 2013, NEURON, V78, P249, DOI 10.1016/j.neuron.2013.02.006; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Nirme J, 2011, IEEE ENG MED BIO, P6749, DOI 10.1109/IEMBS.2011.6091665; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Page SJ, 2002, CLIN REHABIL, V16, P55, DOI 10.1191/0269215502cr473oa; Page SJ, 2005, NEUROREHAB NEURAL RE, V19, P27, DOI 10.1177/1545968304272701; Prochnow D, 2013, EUR J NEUROSCI, V37, P1441, DOI 10.1111/ejn.12157; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; SANFORD J, 1993, PHYS THER, V73, P447, DOI 10.1093/ptj/73.7.447; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Schweighofer N, 2009, PHYS THER, V89, P1327, DOI 10.2522/ptj.20080402; Shelton FDAP, 2001, NEUROREHAB NEURAL RE, V15, P229, DOI 10.1177/154596830101500311; Smania N, 2012, NEUROREHAB NEURAL RE, V26, P1035, DOI 10.1177/1545968312446003; Sterr A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00204; Stins JF, 2001, LATERALITY, V6, P347; Sutton R. S., 1998, INTRO REINFORCEMENT, DOI [10.1109/tnn.1998.712192, DOI 10.1109/TNN.1998.712192]; Taub E, 2006, Eura Medicophys, V42, P241; Taub E, 2003, J REHABIL MED, V35, P34, DOI 10.1080/16501960310010124; Timmermans AAA, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-1; Verschure PFMJ, 2012, BIOL INSPIR COGN ARC, V1, P55, DOI 10.1016/j.bica.2012.04.005; Verschure PFMJ, 2003, NATURE, V425, P620, DOI 10.1038/nature02024; Viana R, 2012, TOP STROKE REHABIL, V19, P104, DOI 10.1310/tsr1902-104; Wolf SL, 2002, NEUROLOGIST, V8, P325, DOI 10.1097/00127893-200211000-00001; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408	51	30	32	0	36	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	AUG 9	2016	13								74	10.1186/s12984-016-0178-x			15	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	DT2UT	WOS:000381338000001	27506203	Green Published, gold, Green Submitted			2022-02-06	
J	Douglas, JM; Bracy, CA; Snow, PC				Douglas, Jacinta M.; Bracy, Christine A.; Snow, Pamela C.			Return to Work and Social Communication Ability Following Severe Traumatic Brain Injury	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							CLOSED HEAD-INJURY; VOCATIONAL-REHABILITATION; SUPPORTED EMPLOYMENT; DISCOURSE ABILITIES; ADULTS; TBI; QUESTIONNAIRE; OUTCOMES; PREDICTION; SKILLS	Purpose: Return to competitive employment presents a major challenge to adults who survive traumatic brain injury (TBI). This study was undertaken to better understand factors that shape employment outcome by comparing the communication profiles and self-awareness of communication deficits of adults who return to and maintain employment with those who do not. Method: Forty-six dyads (46 adults with TBI, 46 relatives) were recruited into 2 groups based on the current employment status (employed or unemployed) of participants with TBI. Groups did not differ in regard to sex, age, education, preinjury employment, injury severity, or time postinjury. The La Trobe Communication Questionnaire (Douglas, O'Flaherty, & Snow, 2000) was used to measure communication. Group comparisons on La Trobe Communication Questionnaire scores were analyzed by using mixed 2 x 2 analysis of variance (between factor: employment status; within factor: source of perception). Results: Analysis yielded a significant group main effect (p = .002) and a significant interaction (p = .004). The employed group reported less frequent difficulties (self and relatives). Consistent with the interaction, unemployed participants perceived themselves to have less frequent difficulties than their relatives perceived, whereas employed participants reported more frequent difficulties than their relatives. Conclusion: Communication outcome and awareness of communication deficits play an important role in reintegration to the workplace following TBI.	[Douglas, Jacinta M.; Bracy, Christine A.] La Trobe Univ, Bundoora, Vic, Australia; [Douglas, Jacinta M.] Summer Fdn, Box Hill, Vic, Australia; [Snow, Pamela C.] La Trobe Univ, Bendigo, Vic, Australia		Douglas, JM (corresponding author), La Trobe Univ, Bundoora, Vic, Australia.; Douglas, JM (corresponding author), Summer Fdn, Box Hill, Vic, Australia.	J.Douglas@latrobe.edu.au		Douglas, Jacinta/0000-0003-0940-6624; Snow, Pamela/0000-0002-2426-8349			Athanasou J., 2008, INT J DISABIL MANAG, V3, P54; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Hoofien D, 2001, BRAIN INJURY, V15, P189; Isaki E, 2000, BRAIN INJURY, V14, P441; Kertesz A., 1982, W APHASIA BATTERY; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pink B.N., 2006, AUSTR NZ STANDARD CL; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Snow PC, 2000, BRAIN INJURY, V14, P397; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Turkstra L., 1995, BRAIN INJURY, V10, P319; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; [No title captured]	73	30	30	0	14	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	JUN	2016	59	3					511	520		10.1044/2015_JSLHR-L-15-0025			10	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	EA7AW	WOS:000386781500009	27124205				2022-02-06	
J	Khalaj, AJ; Hasselmann, J; Augello, C; Moore, S; Tiwari-Woodruff, SK				Khalaj, Anna J.; Hasselmann, Jonathan; Augello, Catherine; Moore, Spencer; Tiwari-Woodruff, Seema K.			Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article; Proceedings Paper	8th International Meeting on Steroids and Nervous System	2015	Torino, ITALY			Estrogen receptor ligands; Multiple sclerosis; Demyelination; Remyelination; Experimental autoimmune; encephalomyelitis; Axon degeneration	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS LESIONS; BETA-AGONIST; PROGENITOR CELLS; SELECTIVE LIGANDS; MAMMALIAN TARGET; GENE-EXPRESSION; ERK1/2 MAPK; MOUSE MODEL; IN-VIVO	Demyelination in multiple sclerosis (MS) leads to significant, progressive axonal and neuronal degeneration. Currently existing immunosuppressive and immunomodulatory therapies alleviate MS symptoms and slow, but fail to prevent or reverse, disease progression. Restoration of damaged myelin sheath by replenishment of mature oligodendrocytes (OLs) should not only restore saltatory axon conduction, but also provide a major boost to axon survival. Our previous work has shown that therapeutic treatment with the modestly selective generic estrogen receptor (ER) beta agonist diarylpropionitrile (DPN) confers functional neuroprotection in a chronic experimental autoimmune encephalomyelitis (EAE) mouse model of MS by stimulating endogenous remyelination. Recently, we found that the more potent, selective ER beta agonist indazole-chloride (Ind-Cl) improves clinical disease and motor performance. Importantly, electrophysiological measures revealed improved corpus callosal conduction and reduced axon refractoriness. This Ind-Cl treatment-induced functional remyelination was attributable to increased OL progenitor cell (OPC) and mature OL numbers. At the intracellular signaling level, transition of early to late OPCs requires ERK1/2 signaling, and transition of immature to mature OLs requires mTOR signaling; thus, the PI3K/Akt/mTOR pathway plays a major role in the late stages of OL differentiation and myelination. Indeed, therapeutic treatment of EAE mice with various ER beta agonists results in increased brain-derived neurotrophic factor (BDNF) and phosphorylated (p) Akt and p-mTOR levels. It is notable that while DPN's neuroprotective effects occur in the presence of peripheral and central inflammation, Ind-Cl is directly neuroprotective, as demonstrated by remyelination effects in the cuprizone-induced demyelination model, as well as immunomodulatory. Elucidating the mechanisms by which ER agonists and other directly remyelinating agents modulate endogenous OPC and OL regulatory signaling is critical to the development of effective remyelinating drugs. The discovery of signaling targets to induce functional remyelination will valuably contribute to the treatment of demyelinating neurological diseases, including MS, stroke, and traumatic brain and spinal cord injury. Published by Elsevier Ltd.	[Khalaj, Anna J.; Hasselmann, Jonathan; Augello, Catherine; Moore, Spencer; Tiwari-Woodruff, Seema K.] Univ Calif Riverside, Sch Med, Div Biomed Sci, Rm 205,311 Sch Med Res Bldg,900 Univ Ave, Riverside, CA 92521 USA; [Tiwari-Woodruff, Seema K.] Univ Calif Riverside, Neurosci Grad Program, Riverside, CA 92521 USA		Tiwari-Woodruff, SK (corresponding author), Univ Calif Riverside, Sch Med, Div Biomed Sci, Rm 205,311 Sch Med Res Bldg,900 Univ Ave, Riverside, CA 92521 USA.	seema.tiwari-woodruff@ucr.edu		Moore, Spencer/0000-0001-9811-9007; Hasselmann, Jonathan/0000-0003-2630-9850	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081141, R21NS075198] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS075198, R01 NS081141] Funding Source: Medline		ABRAMSKY O, 1994, ANN NEUROL, V36, pS38, DOI 10.1002/ana.410360712; Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; ALMAZAN G, 1985, DEV NEUROSCI-BASEL, V7, P45, DOI 10.1159/000112275; Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Bhatt A, 2014, NEURAL REGEN RES, V9, P1347, DOI 10.4103/1673-5374.137586; Bibollet-Bahena O, 2009, J NEUROCHEM, V109, P1440, DOI 10.1111/j.1471-4159.2009.06071.x; Blakemore WF, 2008, J NEUROL SCI, V265, P43, DOI 10.1016/j.jns.2007.08.004; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; Bonetti A, 2009, J NEUROIMMUNOL, V208, P119, DOI 10.1016/j.jneuroim.2009.01.003; Bonora M, 2014, CELL DEATH DIFFER, V21, P1198, DOI 10.1038/cdd.2014.35; Bourikas D, 2010, MOL CELL NEUROSCI, V45, P363, DOI 10.1016/j.mcn.2010.07.009; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Burns KA, 2012, ARCH TOXICOL, V86, P1491, DOI 10.1007/s00204-012-0868-5; Carroll VM, 2012, J MED CHEM, V55, P528, DOI 10.1021/jm201436k; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216; Choi SR, 2012, BRAIN, V135, P2925, DOI 10.1093/brain/aws189; Christaki E, 2010, J INFECT DIS, V201, P1250, DOI 10.1086/651276; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Crawford DK, 2010, BRAIN, V133, P2999, DOI 10.1093/brain/awq237; Cunningham M., 2016, CLIN REV ALLERG IMMU, V40, P66; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; DASILVA JAP, 1992, CLIN RHEUMATOL, V11, P189, DOI 10.1007/BF02207955; De Angelis M, 2005, J MED CHEM, V48, P1132, DOI 10.1021/jm049223g; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; DSouza SD, 1996, J NEUROSCI RES, V43, P289, DOI 10.1002/(SICI)1097-4547(19960201)43:3<289::AID-JNR4>3.0.CO;2-F; Dubois-Dalcq M, 2000, PATHOL BIOL, V48, P80; Elloso MM, 2005, J ENDOCRINOL, V185, P243, DOI 10.1677/joe.1.06063; Fancy S. P., 2016, ANNU REV NEUROSCI, V34, P21; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; FRESSINAUD C, 1995, J NEUROSCI RES, V40, P285, DOI 10.1002/jnr.490400302; Friese MA, 2009, ANN NEUROL, V66, P132, DOI 10.1002/ana.21744; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Guardiola-Diaz HM, 2012, GLIA, V60, P476, DOI 10.1002/glia.22281; HAMMERLING GJ, 1991, IMMUNOL REV, V122, P47, DOI 10.1111/j.1600-065X.1991.tb00596.x; Harris H. A., 2016, E SCHERING FDN S P, V2006, P149; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Harris HA, 2005, HUM REPROD, V20, P936, DOI 10.1093/humrep/deh711; Hellwig K, 2014, EUR NEUROL, V72, P39, DOI 10.1159/000367640; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Hirahara Y, 2009, GLIA, V57, P153, DOI 10.1002/glia.20742; Hohlfeld R., 2015, LANCET NEUROL; Hollenbach JA, 2015, J AUTOIMMUN, V64, P13, DOI 10.1016/j.jaut.2015.06.010; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Ishii A, 2014, J NEUROSCI, V34, P16031, DOI 10.1523/JNEUROSCI.3360-14.2014; JANSSON L, 1994, J NEUROIMMUNOL, V53, P203, DOI 10.1016/0165-5728(94)90030-2; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Juarez A. Lopez, 2015, BRAIN RES IN PRESS; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Khalaj AJ, 2013, P NATL ACAD SCI USA, V110, P19125, DOI [10.1073/pnas.311763110, 10.1073/pnas.1311763110]; Kim S, 1999, NEUROLOGY, V52, P1230, DOI 10.1212/WNL.52.6.1230; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P506, DOI 10.2174/187152712801661248; Kipp M, 2012, FRONT NEUROENDOCRIN, V33, P1, DOI 10.1016/j.yfrne.2012.01.001; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Kumar S, 2013, NEUROBIOL DIS, V56, P131, DOI 10.1016/j.nbd.2013.04.005; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lopez-Diego RS, 2008, NAT REV DRUG DISCOV, V7, P909, DOI 10.1038/nrd2358; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Maeda Y, 2001, ANN NEUROL, V49, P776, DOI 10.1002/ana.1015; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; MCMORRIS FA, 1988, J NEUROSCI RES, V21, P199, DOI 10.1002/jnr.490210212; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Miller DH, 2014, MULT SCLER J, V20, P527, DOI 10.1177/1352458513519840; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Minutolo F, 2011, MED RES REV, V31, P364, DOI 10.1002/med.20186; Mohler ML, 2010, EXPERT OPIN THER PAT, V20, P507, DOI 10.1517/13543771003657164; Moore SM, 2014, P NATL ACAD SCI USA, V111, P18061, DOI 10.1073/pnas.1411294111; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; Nakatani H, 2013, J NEUROSCI, V33, P9752, DOI 10.1523/JNEUROSCI.0805-13.2013; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Nicoletti F, 2010, AUTOIMMUN DIS, V2010, DOI 10.4061/2010/757432; Nielsen HH, 2006, GLIA, V54, P105, DOI 10.1002/glia.20357; NOLL E, 1993, DEVELOPMENT, V118, P563; Paruthiyil S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006271; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Preston M, 2013, ANN NEUROL, V73, P266, DOI 10.1002/ana.23788; PRINEAS JW, 1993, ANN NEUROL, V33, P137, DOI 10.1002/ana.410330203; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; Prokai L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1290; Qi YC, 2002, TRENDS NEUROSCI, V25, P223, DOI 10.1016/S0166-2236(02)02145-8; Raine CS, 1999, ANN NEUROL, V46, P144, DOI 10.1002/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K; RASCOL A, 1982, REV NEUROL, V138, P921; Roman-Blas JA, 2010, ARTHRIT CARE RES, V62, P1588, DOI 10.1002/acr.20275; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012; Shimizu T, 2005, DEV BIOL, V282, P397, DOI 10.1016/j.ydbio.2005.03.020; Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Srivastava DP, 2010, J NEUROSCI, V30, P13454, DOI 10.1523/JNEUROSCI.3264-10.2010; Stovall DW, 2009, CURR OPIN INVEST DR, V10, P365; Takao T, 2004, J NEUROCHEM, V89, P660, DOI 10.1111/j.1471-4159.2004.02370.x; Takebayashi H, 2015, GLIA, V63, P1350, DOI 10.1002/glia.22863; Tedesco R, 2001, CHEM BIOL, V8, P277, DOI 10.1016/S1074-5521(01)00006-0; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Tiwari-Woodruff S, 2009, J NEUROL SCI, V286, P81, DOI 10.1016/j.jns.2009.04.023; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; van der Valk P, 2000, NEUROPATH APPL NEURO, V26, P2, DOI 10.1046/j.1365-2990.2000.00217.x; Van't Veer A, 2009, J NEUROSCI RES, V87, P69, DOI 10.1002/jnr.21841; VANDERPAL RHM, 1988, J NEUROSCI RES, V19, P483, DOI 10.1002/jnr.490190412; Vondran MW, 2010, GLIA, V58, P848, DOI 10.1002/glia.20969; Voskuhl RR, 2016, LANCET NEUROL, V15, P35, DOI 10.1016/S1474-4422(15)00322-1; Wang Ling, 2002, Sci STKE, V2002, ppe29, DOI 10.1126/stke.2002.138.pe29; Wang XL, 2009, MOL IMMUNOL, V46, P2413, DOI 10.1016/j.molimm.2009.04.014; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Weiser MJ, 2009, ENDOCRINOLOGY, V150, P1817, DOI 10.1210/en.2008-1355; Wood TL, 2013, ASN NEURO, V5, P63, DOI 10.1042/AN20120092; Wu WF, 2013, P NATL ACAD SCI USA, V110, P3543, DOI 10.1073/pnas.1300313110; Zeger M, 2007, GLIA, V55, P400, DOI 10.1002/glia.20469; Zhang YJ, 2015, EXP NEUROL, V266, P68, DOI 10.1016/j.expneurol.2015.02.006; Zhang Z, 2004, J NEUROCHEM, V89, P674, DOI 10.1111/j.1471-4159.2004.02388.x; Zhao LQ, 2015, AGEING RES REV, V24, P178, DOI 10.1016/j.arr.2015.08.001	133	30	30	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	JUN	2016	160				SI		43	52		10.1016/j.jsbmb.2016.01.006			10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	DN1QM	WOS:000376840500007	26776441	Green Accepted			2022-02-06	
J	Levine, J; Kwon, E; Paez, P; Yan, WH; Czerwieniec, G; Loo, JA; Sofroniew, MV; Wanner, IB				Levine, Jaclynn; Kwon, Eunice; Paez, Pablo; Yan, Weihong; Czerwieniec, Gregg; Loo, Joseph A.; Sofroniew, Michael V.; Wanner, Ina-Beate			Traumatically injured astrocytes release a proteomic signature modulated by STAT3-dependent cell survival	GLIA			English	Article						trauma; proteome; astrocyte; mechanoporation; biomarker	FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD-INJURY; ALPHA-B-CRYSTALLIN; STRETCH-INDUCED INJURY; IN-VITRO TRAUMA; BRAIN-INJURY; WHITE-MATTER; CULTURED ASTROCYTES; CEREBROSPINAL-FLUID; CEREBRAL CONTUSION	Molecular markers associated with CNS injury are of diagnostic interest. Mechanical trauma generates cellular deformation associated with membrane permeability with unknown molecular consequences. We used an in vitro model of stretch-injury and proteomic analyses to determine protein changes in murine astrocytes and their surrounding fluids. Abrupt pressure-pulse stretching resulted in the rapid release of 59 astrocytic proteins with profiles reflecting cell injury and cell death, i.e., mechanoporation and cell lysis. This acute trauma-release proteome was overrepresented with metabolic proteins compared with the uninjured cellular proteome, bearing relevance for post-traumatic metabolic depression. Astrocyte-specific deletion of signal transducer and activator of transcription 3 (STAT3-CKO) resulted in reduced stretch-injury tolerance, elevated necrosis and increased protein release. Consistent with more lysed cells, more protein complexes, nuclear and transport proteins were released from STAT3-CKO versus nontransgenic astrocytes. STAT3-CKO astrocytes had reduced basal expression of GFAP, lactate dehydrogenase B (LDHB), aldolase C (ALDOC), and astrocytic phosphoprotein 15 (PEA15), and elevated levels of tropomyosin (TPM4) and actinin 4 (ACTN4). Stretching caused STAT3-dependent cellular depletion of PEA15 and GFAP, and its filament disassembly in subpopulations of injured astrocytes. PEA15 and ALDOC signals were low in injured astrocytes acutely after mouse spinal cord crush injury and were robustly expressed in reactive astrocytes 1 day postinjury. In contrast, crystallin (CRYAB) was present in acutely injured astrocytes, and absent from uninjured and reactive astrocytes, demonstrating novel marker differences among postinjury astrocytes. These findings reveal a proteomic signature of traumatically-injured astrocytes reflecting STAT3-dependent cellular survival with potential diagnostic value. GLIA 2016;64:668-694	[Levine, Jaclynn; Kwon, Eunice; Wanner, Ina-Beate] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Paez, Pablo] SUNY Buffalo, Dept Pharmacol & Toxicol, Hunter James Kelly Res Inst, Sch Med & Biomed Sci,NYS Ctr Excellence, Buffalo, NY 14260 USA; [Yan, Weihong; Czerwieniec, Gregg; Loo, Joseph A.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Proteom, Los Angeles, CA USA; [Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA		Wanner, IB (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, 635 Charles E Young Dr South,NRB 260, Los Angeles, CA 90095 USA.	iwanner@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020; Paez, Pablo Martin/ABI-7783-2020	Paez, Pablo Martin/0000-0001-9362-9454	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21NS072606, R01NS057624, R01GM104610]; Craig H. Neilsen Foundation [82776]; Dr. Miriam and Sheldon Adelson Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS072606, R01NS057624] Funding Source: NIH RePORTER	Grant sponsor: NIH; Grant number: 1R21NS072606 to IBW; R01NS057624 to MVS; and R01GM104610 to JAL; Grant sponsor: Craig H. Neilsen Foundation (82776 to IBW).; Grant sponsor: Dr. Miriam and Sheldon Adelson Medical Research Foundation (to MVS).	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Barbee KA, 2005, ANN NY ACAD SCI, V1066, P67, DOI 10.1196/annals.1363.006; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; BIANCHI R, 1994, BBA-MOL CELL RES, V1223, P354, DOI 10.1016/0167-4889(94)90095-7; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CANONNEHERGAUX F, 1994, NEUROCHEM INT, V25, P545, DOI 10.1016/0197-0186(94)90153-8; Cao X, 2010, NEUROSCI LETT, V479, P118, DOI 10.1016/j.neulet.2010.05.040; CHIU FC, 1981, J NEUROCHEM, V37, P147, DOI 10.1111/j.1471-4159.1981.tb05302.x; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; CIESIELSKITRESKA J, 1984, EUR J BIOCHEM, V138, P465, DOI 10.1111/j.1432-1033.1984.tb07939.x; Colombo JA, 1997, J BRAIN RES, V38, P503; DEARMOND SJ, 1983, BRAIN RES, V262, P275, DOI 10.1016/0006-8993(83)91018-1; desVellis J, 2009, PROTOCOLS NEURAL CEL, P193; DisDomenico F, 2010, BRAIN RES, V1362, P1; Dziennis S, 2007, J NEUROSCI, V27, P7268, DOI 10.1523/JNEUROSCI.1558-07.2007; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Estelles A, 1996, J BIOL CHEM, V271, P14800, DOI 10.1074/jbc.271.25.14800; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fern RF, 2014, GLIA, V62, P1780, DOI 10.1002/glia.22722; FERRIER R, 1994, CELL MOTIL CYTOSKEL, V28, P303, DOI 10.1002/cm.970280404; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; FRANKE WW, 1982, CELL, V30, P103, DOI 10.1016/0092-8674(82)90016-2; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Godell CM, 1997, P NATL ACAD SCI USA, V94, P4751, DOI 10.1073/pnas.94.9.4751; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Harrington MG, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-10; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Ito U, 2009, STROKE, V40, P2173, DOI 10.1161/STROKEAHA.108.534990; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Karl J, 2000, BRAIN RES, V853, P32, DOI 10.1016/S0006-8993(99)02224-6; Kazanis I, 2005, BRAIN RES REV, V50, P377, DOI 10.1016/j.brainresrev.2005.09.003; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Klopstein A, 2012, J NEUROSCI, V32, P14478, DOI 10.1523/JNEUROSCI.0923-12.2012; Koyama Y, 1999, AM J PATHOL, V154, P1563, DOI 10.1016/S0002-9440(10)65409-0; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Lukaszevicz AC, 2002, J CEREBR BLOOD F MET, V22, P289, DOI 10.1097/00004647-200203000-00006; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Martinez A, 2008, J NEUROPATH EXP NEUR, V67, P1122, DOI 10.1097/NEN.0b013e31818e06f3; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mills LR, 2004, NEUROIMAGE, V21, P1069, DOI 10.1016/j.neuroimage.2003.10.041; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; NEWCOMBE J, 1986, J NEUROCHEM, V47, P1713, DOI 10.1111/j.1471-4159.1986.tb13079.x; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Reich NC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290pe61; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Salter MG, 2008, J CEREBR BLOOD F MET, V28, P588, DOI 10.1038/sj.jcbfm.9600555; Sandoval M, 2013, BRAIN RES, V1520, P1, DOI 10.1016/j.brainres.2013.04.049; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Shen S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-11; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Sjodin MOD, 2010, J CHROMATOGR B, V878, P2003, DOI 10.1016/j.jchromb.2010.05.036; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sondej MA, 2011, SAMPLE PREPARATION IN BIOLOGICAL MASS SPECTROMETRY, P829, DOI 10.1007/978-94-007-0828-0_39; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Takeda K, 1998, J IMMUNOL, V161, P4652; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; TOPP KS, 1989, GLIA, V2, P201, DOI 10.1002/glia.440020309; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wanner IB, 2012, METHODS MOL BIOL, V814, P189, DOI 10.1007/978-1-61779-452-0_14; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	91	30	31	0	11	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAY	2016	64	5					668	694		10.1002/glia.22953			27	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI0OR	WOS:000373197000002	26683444	Green Accepted			2022-02-06	
J	Silverberg, ND; Berkner, PD; Atkins, JE; Zafonte, R; Iverson, GL				Silverberg, Noah D.; Berkner, Paul D.; Atkins, Joseph E.; Zafonte, Ross; Iverson, Grant L.			Relationship Between Short Sleep Duration and Preseason Concussion Testing	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sleep deprivation; sleep initiation and maintenance disorders; cognition; athletes; brain concussion	COGNITIVE PERFORMANCE; SEX-DIFFERENCES; POOR SLEEP; DEPRIVATION; ADOLESCENTS; SYMPTOMS; HEADACHE; METAANALYSIS; VARIABLES; STUDENTS	Objective: Baseline, preseason assessment of cognition, symptoms, and balance has been recommended as part of a comprehensive sport concussion management program. We examined the relationship between sleep and baseline test results. We hypothesized that adolescents who slept fewer hours the night before would report more symptoms and perform more poorly on cognitive testing than students who had a full night sleep. Design: Cross-sectional observation study. Setting: Preseason concussion testing for high school athletes. Participants: A large sample (n = 2928) of student athletes from Maine, USA, between the ages of 13 and 18 years completed preseason testing. Participants with developmental problems, a history of treatment for neurological or psychiatric problems, recent concussion, or 3 or more prior concussions were excluded. Assessment of Risk Factors: Athletes were divided into 4 groups based on their sleep duration the night before testing. Main Outcome Measures: Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT; ImPACT Applications, Inc, Pittsburgh, PA) cognitive composite scores and the embedded Post-Concussion Symptom Scale. Results: Sleep was not related to any ImPACT cognitive composite score, after covarying for age and controlling for multiple comparisons. In contrast, there were sleep duration, sex, and sleep duration by sex effects on the Post-Concussion Symptom Scale. The effect of sleep duration on symptom reporting was more pronounced in girls. Supplementary analyses suggested that sleep insufficiency was associated with a diverse array of postconcussion-like symptoms. Conclusions: Poor sleep the night before baseline or postinjury testing may be an important confound when assessing postconcussion symptoms. Girls may be more vulnerable to experiencing and reporting symptoms following insufficient sleep. Clinical Relevance: Clinicians should routinely ask how the athlete slept the night before preseason baseline testing and consider deferring the symptom assessment or later retesting athletes who slept poorly.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Rehabil Res Program, Vancouver, BC V5Z 1M9, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC V5Z 1M9, Canada; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA; [Atkins, Joseph E.] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Zafonte, Ross] Harvard Univ, Massachusetts Gen Hosp, Brigham & Womens Hosp,Sch Med, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Zafonte, Ross; Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Zafonte, Ross; Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca	Meijer, Anna/K-5118-2016	Iverson, Grant/0000-0001-7348-9570	Goldfarb Center for Public Policy and Civic Engagement/Colby College; Bill and Joan Alfond Foundation; Harvard Integrated Program to Protect and Improve the Health of NFLPA Members; Vancouver Coastal Health Research Institute	Supported in part by the Goldfarb Center for Public Policy and Civic Engagement/Colby College, and the Bill and Joan Alfond Foundation. R. Zafonte was supported in part by the Harvard Integrated Program to Protect and Improve the Health of NFLPA Members. N.D. Silverberg receives salary support from the Vancouver Coastal Health Research Institute.	Beebe DW, 2008, J CHILD PSYCHOL PSYC, V49, P915, DOI 10.1111/j.1469-7610.2008.01885.x; BLAU JN, 1990, CEPHALALGIA, V10, P157, DOI 10.1046/j.1468-2982.1990.1004157.x; Bruni O, 2008, SLEEP MED, V9, P542, DOI 10.1016/j.sleep.2007.08.010; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ferrara M, 2001, SLEEP MED REV, V5, P155, DOI 10.1053/smrv.2000.0138; Hillman DR, 2013, MED J AUSTRALIA, V199, pS7, DOI 10.5694/mja13.10620; Iverson GL, 2006, CLIN NEUROPSYCHOL, V20, P695, DOI 10.1080/138540491005857; Kamphuis J, 2012, SLEEP MED, V13, P327, DOI 10.1016/j.sleep.2011.12.006; Knutson KL, 2005, AM J HUM BIOL, V17, P418, DOI 10.1002/ajhb.20405; Lee KA, 1999, J ADOLESCENT HEALTH, V24, P16, DOI 10.1016/S1054-139X(98)00074-3; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Meerlo P, 2002, J NEUROENDOCRINOL, V14, P397, DOI 10.1046/j.0007-1331.2002.00790.x; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Minkel JD, 2012, EMOTION, V12, P1015, DOI 10.1037/a0026871; Miyata S, 2013, J SLEEP RES, V22, P535, DOI 10.1111/jsr.12054; Miyata S, 2010, NEUROSCI LETT, V469, P229, DOI 10.1016/j.neulet.2009.12.001; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Motomura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056578; O'Brien MJ, 2012, J BONE JOINT SURG AM, V94A, P1975, DOI 10.2106/JBJS.K.00958; Oginska H, 2014, J SLEEP RES, V23, P339, DOI 10.1111/jsr.12115; Owens JA, 2005, J DEV BEHAV PEDIATR, V26, P312, DOI 10.1097/00004703-200508000-00011; PENETAR D, 1993, PSYCHOPHARMACOLOGY, V112, P359, DOI 10.1007/BF02244933; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Pilcher JJ, 1997, J AM COLL HEALTH, V46, P121, DOI 10.1080/07448489709595597; Ratcliff R, 2009, PSYCHON B REV, V16, P742, DOI 10.3758/PBR.16.4.742; Tran DP, 2013, CRANIO, V31, P165, DOI 10.1179/crn.2013.026; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; Vikram M, 2012, CLIN TER, V163, P383; Wilkinson R.T., 1966, PSYCHON SCI, V5, P471; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	38	30	30	2	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2016	26	3					226	231		10.1097/JSM.0000000000000241			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	DL4KX	WOS:000375605800012	26247549				2022-02-06	
J	Daiutolo, BV; Tyburski, A; Clark, SW; Elliott, MB				Daiutolo, Brittany V.; Tyburski, Ashley; Clark, Shannon W.; Elliott, Melanie B.			Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						trigeminovascular system; traumatic brain injury; post-traumatic headache; pain; post-traumatic migraine	GENE-RELATED PEPTIDE; NITRIC-OXIDE SYNTHASE; TRIGEMINOVASCULAR SYSTEM; PROSTAGLANDIN E-2; SELECTIVE-INHIBITION; RECEPTOR ANTAGONISTS; GLIAL ACTIVATION; LIGHT AVERSION; MIGRAINE; CGRP	The pain-signaling molecules, nitric oxide synthase (NOS) and calcitonin gene-related peptide (CGRP), are implicated in the pathophysiology of post-traumatic headache (PTH) as they are for migraine. This study assessed the changes of inducible NOS (iNOS) and its cellular source in the trigeminal pain circuit, as well as the relationship between iNOS and CGRP after controlled cortical impact (CCI) injury in mice. The effects of a CGRP antagonist (MK8825) and sumatriptan on iNOS messenger RNA (mRNA) and protein were compared to vehicle at 2 weeks postinjury. Changes in CGRP levels in the trigeminal nucleus caudalis (TNC) in iNOS knockouts with CCI were compared to wild-type (WT) mice at 3 days and 2 weeks post injury. Trigeminal allodynia and photosensitivity were measured. MK8825 and sumatriptan increased allodynic thresholds in CCI groups compared to vehicle (p < 0.01), whereas iNOS knockouts were not different from WT. Photosensitivity was attenuated in MK8825 mice and iNOS knockouts compared to WT (p < 0.05). MK8825 and sumatriptan reduced levels of iNOS mRNA and iNOS immunoreactivity in the TNC and ganglia (p < 0.01). Differences in iNOS cellular localization were found between the trigeminal ganglia and TNC. Although the knockout of iNOS attenuated CGRP at 3 days (p < 0.05), it did not reduce CGRP at 2 weeks. CGRP immunoreactivity was found in the meningeal layers post-CCI, while negligible in controls. Findings support the importance of interactions between CGRP and iNOS in mediating allodynia, as well as the individual roles in photosensitivity. Mitigating prolonged increases in CGRP may be a promising intervention for treating acute PTH.	[Daiutolo, Brittany V.; Tyburski, Ashley; Clark, Shannon W.; Elliott, Melanie B.] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA		Elliott, MB (corresponding author), Thomas Jefferson Univ, Dept Neurosurg, 1020 Locust St,Jefferson Alumni Hall,Room 236, Philadelphia, PA 19107 USA.	melanie.elliott@jefferson.edu					Akerman S, 2002, BRIT J PHARMACOL, V137, P62, DOI 10.1038/sj.bjp.0704842; Amenta PS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0191-6; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Antonova M, 2012, CEPHALALGIA, V32, P822, DOI 10.1177/0333102412451360; Bartfai T, 2001, NATURE, V410, P425, DOI 10.1038/35068663; Bates EA, 2010, CEPHALALGIA, V30, P170, DOI 10.1111/j.1468-2982.2009.01864.x; Bechade C, 2014, GLIA, V62, P956, DOI 10.1002/glia.22652; Bell IM, 2012, BIOORG MED CHEM LETT, V22, P3941, DOI 10.1016/j.bmcl.2012.04.105; Bellamy J, 2006, EUR J NEUROSCI, V23, P2057, DOI 10.1111/j.1460-9568.2006.04742.x; Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Bernstein C, 2012, J CLIN NEUROL, V8, P89, DOI 10.3988/jcn.2012.8.2.89; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; Burstein R, 2014, CEPHALALGIA, V34, P853, DOI 10.1177/0333102414527648; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; De Alba J, 2006, PAIN, V120, P170, DOI 10.1016/j.pain.2005.10.028; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Dieterle A, 2011, CEPHALALGIA, V31, P31, DOI 10.1177/0333102410375725; Dobson CF, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00647.x; Dussor G, 2014, ACS CHEM NEUROSCI, V5, P1085, DOI 10.1021/cn500083e; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Edvinsson L, 1998, J AUTONOM NERV SYST, V70, P15, DOI 10.1016/S0165-1838(98)00033-2; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Feistel S, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-93; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Fischer MJM, 2010, EXPERT OPIN INV DRUG, V19, P815, DOI 10.1517/13543784.2010.490829; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goadsby PJ, 2012, CEPHALALGIA, V32, P3, DOI 10.1177/0333102411430267; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hoffmann J, 2012, CURR TREAT OPTION NE, V14, P50, DOI 10.1007/s11940-011-0155-4; Hughes FJ, 1999, J BIOL CHEM, V274, P1776, DOI 10.1074/jbc.274.3.1776; Kaiser EA, 2012, J NEUROSCI, V32, P15439, DOI 10.1523/JNEUROSCI.3265-12.2012; Kawabata A, 2011, BIOL PHARM BULL, V34, P1170, DOI 10.1248/bpb.34.1170; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Lenaerts ME, 2008, CEPHALALGIA, V28, P12, DOI 10.1111/j.1468-2982.2008.01608.x; Lennerz JK, 2008, J COMP NEUROL, V507, P1277, DOI 10.1002/cne.21607; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; Levy D, 2011, ANN NEUROL, V69, P600, DOI 10.1002/ana.22422; Li J, 2008, BRAIN RES, V1196, P22, DOI 10.1016/j.brainres.2007.12.028; Liu Y, 2008, BRAIN RES, V1208, P103, DOI 10.1016/j.brainres.2008.02.078; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Maihofner C, 2000, NEUROSCI LETT, V290, P71, DOI 10.1016/S0304-3940(00)01302-1; May A, 1999, J CEREBR BLOOD F MET, V19, P115, DOI 10.1097/00004647-199902000-00001; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Mouton P. R., 2002, PRINCIPLES PRACTICES; Neeb L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017360; Noseda R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103929; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Olesen J, 2010, NEUROTHERAPEUTICS, V7, P183, DOI 10.1016/j.nurt.2010.03.006; Olesen J, 2008, PHARMACOL THERAPEUT, V120, P157, DOI 10.1016/j.pharmthera.2008.08.003; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Recober A, 2010, DRUG NEWS PERSPECT, V23, P112, DOI 10.1358/dnp.2010.23.2.1475909; Recober A, 2009, J NEUROSCI, V29, P8798, DOI 10.1523/JNEUROSCI.1727-09.2009; Recober A, 2009, CURR OPIN NEUROL, V22, P241, DOI 10.1097/WCO.0b013e32832b2427; Russo AF, 2015, ANNU REV PHARMACOL, V55, P533, DOI 10.1146/annurev-pharmtox-010814-124701; Russo Andrew F, 2009, Mol Cell Pharmacol, V1, P264; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Seiler K, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-74; Shivanand K, 2011, DARU, V19, P224; Tanabe M, 2009, NEUROPHARMACOLOGY, V56, P702, DOI 10.1016/j.neuropharm.2008.12.003; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Thompson S, 2010, BEHAV NEUROSCI, V124, P821, DOI 10.1037/a0021568; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wang XJ, 2010, HEADACHE, V50, P579, DOI 10.1111/j.1526-4610.2010.01632.x; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	86	30	30	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2016	33	8					748	760		10.1089/neu.2015.4087			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DJ0ZM	WOS:000373932900005	26472135	Green Published			2022-02-06	
J	Donker-Cools, BHPM; Wind, H; Frings-Dresen, MHW				Donker-Cools, Birgit H. P. M.; Wind, Haije; Frings-Dresen, Monique H. W.			Prognostic factors of return to work after traumatic or non-traumatic acquired brain injury	DISABILITY AND REHABILITATION			English	Article						Acquired brain injury; return to work; stroke; traumatic brain injury; vocational rehabilitation	TERM-FOLLOW-UP; ISCHEMIC-STROKE; POSTTRAUMATIC AMNESIA; MULTICENTER ANALYSIS; EMPLOYMENT OUTCOMES; RACIAL-DIFFERENCES; ACUTE PREDICTORS; DISABILITY; POPULATION; REHABILITATION	Purpose: To investigate and to determine evidence of prognostic factors for return to work (RTW) after acquired brain injury (ABI). Method: A systematic literature search was conducted in PubMed (2008-2014), applying terms for ABI and RTW. In addition, studies published after 2003 of a previous review on the same topic were added. The methodological quality of the included studies was assessed and evidence was classified. Results: Twenty-seven studies were included. There is strong evidence that a high education level is positively associated with RTW after traumatic ABI; a low education level, unemployment and length of stay in rehabilitation are negatively associated, and a clear tendency has been deduced from the studies that conscious state in the Emergency Department is not associated with RTW. After non-traumatic ABI, there is strong evidence that independence in activities of daily living is positively associated with RTW and aetiology of stroke is not. Conclusions: This study confirms earlier findings that after both traumatic and non-traumatic ABI injury related factors in the Emergency Department are not associated with RTW. In addition, it provides further evidence that personal factors after traumatic ABI and activity-related factors after non-traumatic ABI are strongly associated with RTW.Implications for RehabilitationWe found strong evidence for a significant association between RTW and personal factors (education level, unemployment) after traumatic ABI, and activities of daily living (ADL) after non-traumatic ABI.We advise to focus on work-related activities during the RTW process besides ADL-training and pay attention to and support patients at risk for not returning to work.	[Donker-Cools, Birgit H. P. M.; Wind, Haije; Frings-Dresen, Monique H. W.] Univ Amsterdam, Coronel Inst Occupat Hlth, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; [Donker-Cools, Birgit H. P. M.; Wind, Haije; Frings-Dresen, Monique H. W.] Res Ctr Insurance Med, Amsterdam, Netherlands		Donker-Cools, BHPM (corresponding author), Univ Amsterdam, Coronel Inst Occupat Hlth, Acad Med Ctr, POB 22700, NL-1100 DE Amsterdam, Netherlands.	b.h.cools@amc.uva.nl					Alaszewski A, 2007, DISABIL REHABIL, V29, P1858, DOI 10.1080/09638280601143356; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Borghouts JAJ, 1998, PAIN, V77, P1, DOI 10.1016/S0304-3959(98)00058-X; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Busch MA, 2009, J NEUROL NEUROSUR PS, V80, P888, DOI 10.1136/jnnp.2008.163295; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; de Croon EM, 2004, ANN RHEUM DIS, V63, P1362, DOI 10.1136/ard.2003.020115; Dekkers-Sanchez PM, 2008, OCCUP ENVIRON MED, V65, P153, DOI 10.1136/oem.2007.034983; Detaille SI, 2009, SCAND J WORK ENV HEA, V35, P261, DOI 10.5271/sjweh.1337; Doucet T., 2012, Annals of Physical and Rehabilitation Medicine, V55, P112, DOI 10.1016/j.rehab.2012.01.007; Esbjornsson E, 2013, BRAIN INJURY, V27, P521, DOI 10.3109/02699052.2012.743179; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Glozier N, 2008, STROKE, V39, P1526, DOI 10.1161/STROKEAHA.107.503219; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Hackett ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041795; Hannerz H, 2012, J OCCUP REHABIL, V22, P456, DOI 10.1007/s10926-012-9367-z; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jang Y, 2005, ARCH PHYS MED REHAB, V86, P681, DOI 10.1016/j.apmr.2004.10.025; Kauranen T, 2013, J NEUROL NEUROSUR PS, V84, P316, DOI 10.1136/jnnp-2012-302629; Kersten P, 2002, DISABIL REHABIL, V24, P860, DOI 10.1080/09638280210142167; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kuluski K, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.22252; Mailles A, 2012, CLIN INFECT DIS, V54, P1455, DOI 10.1093/cid/cis226; Medin J, 2006, DISABIL REHABIL, V28, P1051, DOI 10.1080/09638280500494819; Naess H, 2009, J STROKE CEREBROVASC, V18, P247, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.005; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Palmcrantz S, 2012, DISABIL REHABIL, V34, P817, DOI 10.3109/09638288.2011.621507; Saeki S, 2010, J REHABIL MED, V42, P254, DOI 10.2340/16501977-0503; Saeki Satoru, 2004, J Stroke Cerebrovasc Dis, V13, P160, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.006; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tanaka H, 2011, ARCH PHYS MED REHAB, V92, P743, DOI 10.1016/j.apmr.2010.12.009; Trygged S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-742; U.S. Centers for Disease Control and Prevention, 2012 STROK STAT; van der Giezen AM, 2000, PAIN, V87, P285, DOI 10.1016/S0304-3959(00)00292-X; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Waje-Andreassen U, 2013, EUR J NEUROL, V20, P818, DOI 10.1111/ene.12073; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wilz R, 2009, DISABIL REHABIL, V31, P1487; Wolfenden B, 2009, INT J REHABIL RES, V32, P93, DOI 10.1097/MRR.0b013e328325a358; World Health Organization, 2007, INT CLASS FUNCT DIS; Wozniak MA, 1999, STROKE, V30, P2568, DOI 10.1161/01.STR.30.12.2568	51	30	30	1	43	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	APR 9	2016	38	8					733	741		10.3109/09638288.2015.1061608			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DA6BF	WOS:000367886000003	26138021				2022-02-06	
J	Hobbs, JG; Young, JS; Bailes, JE				Hobbs, Jonathan G.; Young, Jacob S.; Bailes, Julian E.			Sports-related concussions: diagnosis, complications, and current management strategies	NEUROSURGICAL FOCUS			English	Article						concussion; mild traumatic brain injury; chronic traumatic encephalopathy; subconcussion	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; STATES HIGH-SCHOOL; KING-DEVICK TEST; CEREBRAL CONCUSSION; AXONAL INJURY; CEREBROSPINAL-FLUID; POSTURAL CONTROL; TEMPORAL WINDOW; COGNITIVE IMPAIRMENT	Sports-related concussions (SRCs) are traumatic events that affect up to 3.8 million athletes per year. The initial diagnosis and management is often instituted on the field of play by coaches, athletic trainers, and team physicians. SRCs are usually transient episodes of neurological dysfunction following a traumatic impact, with most symptoms resolving in 7-10 days; however, a small percentage of patients will suffer protracted symptoms for years after the event and may develop chronic neurodegenerative disease. Rarely, SRCs are associated with complications, such as skull fractures, epidural or subdural hematomas, and edema requiring neurosurgical evaluation. Current standards of care are based on a paradigm of rest and gradual return to play, with decisions driven by subjective and objective information gleaned from a detailed history and physical examination. Advanced imaging techniques such as functional MRI, and detailed understanding of the complex pathophysiological process underlying SRCs and how they affect the athletes acutely and long-term, may change the way physicians treat athletes who suffer a concussion. It is hoped that these advances will allow a more accurate assessment of when an athlete is truly safe to return to play, decreasing the risk of secondary impact injuries, and provide avenues for therapeutic strategies targeting the complex biochemical cascade that results from a traumatic injury to the brain.	[Hobbs, Jonathan G.; Young, Jacob S.] Univ Chicago, Pritzker Sch Med, Dept Surg, Neurosurg Sect, Chicago, IL 60637 USA; [Bailes, Julian E.] Univ Chicago, Pritzker Sch Med, Dept Neurosurg, NorthShore Univ HealthSyst, Evanston, IL USA		Hobbs, JG (corresponding author), Univ Chicago, Dept Surg, Neurosurg Sect, MC 3026,J341,5841 S Maryland Ave, Chicago, IL 60637 USA.	jonathan.hobbs@uchospitals.edu	Young, Jacob/AAE-6194-2020				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bigler ED, 2012, NEUROSCI LETT, V509, P1, DOI 10.1016/j.neulet.2011.12.009; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cheng X, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/760758; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kakuda T, 2002, BIOL PHARM BULL, V25, P1513, DOI 10.1248/bpb.25.1513; Kakuda T, 2011, PHARMACOL RES, V64, P162, DOI 10.1016/j.phrs.2011.03.010; Kalimo H, 1981, Acta Neuropathol Suppl, V7, P20; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lardner AL, 2014, NUTR NEUROSCI, V17, P145, DOI 10.1179/1476830513Y.0000000079; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mandel SA, 2011, J ALZHEIMERS DIS, V25, P187, DOI 10.3233/JAD-2011-101803; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McClain R, 2015, PRIMARY CARE, V42, P77, DOI 10.1016/j.pop.2014.09.005; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Petraglia Anthony L, 2011, Surg Neurol Int, V2, P146, DOI 10.4103/2152-7806.85987; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Quintana A, 2008, DEV NEUROBIOL, V68, P195, DOI 10.1002/dneu.20584; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yu CH, 2011, J VET SCI, V12, P299, DOI 10.4142/jvs.2011.12.3.299; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	155	30	30	0	42	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2016	40	4							E5	10.3171/2016.1.FOCUS15617			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI4NL	WOS:000373476500011	27032922	gold			2022-02-06	
J	Li, XW; Tzeng, SY; Liu, XY; Tammia, M; Cheng, YH; Rolfe, A; Sun, D; Zhang, N; Green, JJ; Wen, XJ; Mao, HQ				Li, Xiaowei; Tzeng, Stephany Y.; Liu, Xiaoyan; Tammia, Markus; Cheng, Yu-Hao; Rolfe, Andrew; Sun, Dong; Zhang, Ning; Green, Jordan J.; Wen, Xuejun; Mao, Hai-Quan			Nanoparticle-mediated transcriptional modification enhances neuronal differentiation of human neural stem cells following transplantation in rat brain	BIOMATERIALS			English	Article						Nanoparticles; Transfection; Neurogenin-2; Neuronal differentiation; Traumatic brain injury	GENE DELIVERY; PRECURSOR CELLS; GROWTH-FACTOR; DNA DELIVERY; TRANSFECTION; SURVIVAL; ADULT; EXPRESSION; GENERATION; VECTORS	Strategies to enhance survival and direct the differentiation of stem cells in vivo following transplantation in tissue repair site are critical to realizing the potential of stem cell-based therapies. Here we demonstrated an effective approach to promote neuronal differentiation and maturation of human fetal tissue derived neural stem cells (hNSCs) in a brain lesion site of a rat traumatic brain injury model using biodegradable nanoparticle-mediated transfection method to deliver key transcriptional factor neurogenin-2 to hNSCs when transplanted with a tailored hyaluronic acid (HA) hydrogel, generating larger number of more mature neurons engrafted to the host brain tissue than non-transfected cells. The nanoparticle-mediated transcription activation method together with an HA hydrogel delivery matrix provides a translatable approach for stem cell-based regenerative therapy. (C) 2016 Elsevier Ltd. All rights reserved.	[Li, Xiaowei; Tzeng, Stephany Y.; Tammia, Markus; Cheng, Yu-Hao; Green, Jordan J.; Mao, Hai-Quan] Johns Hopkins Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21287 USA; [Li, Xiaowei; Tammia, Markus; Green, Jordan J.; Mao, Hai-Quan] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Tzeng, Stephany Y.; Green, Jordan J.] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Liu, Xiaoyan; Zhang, Ning] Virginia Commonwealth Univ, Sch Engn, Dept Biomed Engn, Richmond, VA 23284 USA; [Rolfe, Andrew; Sun, Dong] Virginia Commonwealth Univ, Dept Neurosurg, Med Coll Virginia, Richmond, VA 23298 USA; [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Wen, Xuejun] Virginia Commonwealth Univ, Sch Engn, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA; [Wen, Xuejun] Virginia Commonwealth Univ, 601 West Main St, Richmond, VA 23284 USA		Mao, HQ (corresponding author), Johns Hopkins Univ, 113 Maryland Hall,3400 N Charles St, Baltimore, MD 21218 USA.	xwen@vcu.edu; hmao@jhu.edu	Green, Jordan/B-9001-2009; Cheng, Yu-Hao/D-3686-2016	Green, Jordan/0000-0003-4176-3808; Mao, Hai-Quan/0000-0002-4262-9988; Cheng, Yu-Hao/0000-0002-7472-8518	U.S. National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS085714, R21NS078710-02]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [1R01EB016721]; U.S. National Science FoundationNational Science Foundation (NSF) [CBET 1312970]; Stiftelsen Olle Engkvist ByggmastareSwedish Research Council; Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt; Hans Werthen fonden; Maryland Stem Cell Research Fund [2013MSCRF-00042169]; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1312970] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY001765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB016721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS085714, R21NS078710] Funding Source: NIH RePORTER	This work was supported by the U.S. National Institute of Neurological Disorders and Stroke (R21NS085714 to H.-Q. M. and R21NS078710-02 to D. S.), National Institute of Biomedical Imaging and Bioengineering (1R01EB016721 to J. J. G.), and the U.S. National Science Foundation Faculty Early Career Awards (CBET 1312970 to N.Z.). M.T. acknowledges partial support by fellowships from Stiftelsen Olle Engkvist Byggmastare, the Foundation Blanceflor Boncompagni-Ludovisi, nee Bildt, and Hans Werthen fonden. X.-W. L acknowledges a postdoctoral fellowship from the Maryland Stem Cell Research Fund (2013MSCRF-00042169).	Aldskogius H, 2009, STEM CELLS, V27, P1592, DOI 10.1002/stem.77; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; CHANEY WG, 1986, SOMAT CELL MOLEC GEN, V12, P237, DOI 10.1007/BF01570782; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031547; DeKosky ST, 2004, J NEUROTRAUM, V21, P491, DOI 10.1089/089771504774129838; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Deng B, 2013, BIOMATERIALS, V34, P8786, DOI 10.1016/j.biomaterials.2013.07.076; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Guerrero-Cazares H, 2014, ACS NANO, V8, P5141, DOI 10.1021/nn501197v; Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135; Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x; Hovakimyan M, 2012, ANN ANAT, V194, P429, DOI 10.1016/j.aanat.2012.05.003; Jandial R, 2008, MOL THER, V16, P450, DOI 10.1038/sj.mt.6300402; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; Li X., 2013, METHODS COMPOSITIONS; Li XW, 2014, STEM CELL TRANSL MED, V3, P662, DOI 10.5966/sctm.2013-0015; Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151; Li XW, 2012, MED HYPOTHESES, V79, P274, DOI 10.1016/j.mehy.2012.05.010; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Lynn DM, 2001, J AM CHEM SOC, V123, P8155, DOI 10.1021/ja016288p; Montserrat N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168013; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Nauta A, 2013, MOL THER, V21, P445, DOI 10.1038/mt.2012.234; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pickard MR, 2011, BIOMATERIALS, V32, P2274, DOI 10.1016/j.biomaterials.2010.12.007; Sunshine J, 2009, ADV MATER, V21, P4947, DOI 10.1002/adma.200901718; Sunshine JC, 2011, THER DELIV, V2, P493, DOI 10.4155/TDE.11.14; Tammia M., 2012, DMSO SHOCK YIELDS HI; Tseng TC, 2014, BIOMATERIALS, V35, P2630, DOI 10.1016/j.biomaterials.2013.12.021; Tzeng SY, 2013, J BIOMED MATER RES A, V101, P1837, DOI 10.1002/jbm.a.34616; Tzeng SY, 2013, ADV HEALTHC MATER, V2, P468, DOI 10.1002/adhm.201200257; Tzeng SY, 2012, BIOMATERIALS, V33, P8142, DOI 10.1016/j.biomaterials.2012.07.036; Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang F, 2009, GENE THER, V16, P533, DOI 10.1038/gt.2008.182; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189	39	30	31	3	74	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	APR	2016	84						157	166		10.1016/j.biomaterials.2016.01.037			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	DF5BT	WOS:000371367500014	26828681	Bronze, Green Accepted			2022-02-06	
J	Jarrett, M; Tam, R; Hernandez-Torres, E; Martin, N; Perera, W; Zhao, YS; Shahinfard, E; Dadachanji, S; Taunton, J; Li, DKB; Rauscher, A				Jarrett, Michael; Tam, Roger; Hernandez-Torres, Enedino; Martin, Nancy; Perera, Warren; Zhao, Yinshan; Shahinfard, Elham; Dadachanji, Shiroy; Taunton, Jack; Li, David K. B.; Rauscher, Alexander			A Prospective Pilot Investigation of Brain Volume, White Matter Hyperintensities, and Hemorrhagic Lesions after Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						concussion; mTBI; MRI; neuroimaging; brain volume; susceptibility-weighted imaging; white matter hyperintensities	ROBUST; SPORT; ENCEPHALOPATHY; OPTIMIZATION; REGISTRATION; DEHYDRATION; PREVALENCE; MRI	Traumatic brain injury (TBI) is among the most common neurological disorders. Hemorrhagic lesions and white matter hyperintensities (VVMH) are radiological features associated with moderate and severe TBI. Brain volume reductions have also been observed during the months following injury. In concussion, no signs of injury are observed on conventional magnetic resonance imaging (MRI), which may be a true feature of concussion or merely due to the limited sensitivity of imaging techniques used so far. Moreover, it is not known whether volume reductions are due to the resolution of trauma related edema or a true volume loss. Forty-five collegiate-level ice hockey players (20 females) and 15 controls (9 females), 40 players underwent 3-T MRI for hemorrhages [multi-echo susceptibility-weighted imaging (SWI)], WMH (three-dimensional fluid-attenuated inversion recovery), and brain volume at the beginning and the end of the hockey season. Concussed athletes underwent additional imaging and neuropsychological testing at 3 days, 2 weeks, and 2 months after injury. At the end of the hockey season, brain volume was reduced compared to controls by 0.32% (p < 0.034) in the whole cohort and by 0.26% (p < 0.09) in the concussed athletes. Two weeks and 2 months after concussion, brain volume was reduced by 0.08% (p = 0.027) and 0.23% (p = 0.035), respectively. In athletes, the WMH were significantly closer to the interface between gray matter and white matter compared to controls. No significant changes in the number of WMH over the duration of the study were found in athletes. No microhemorrhages were detected as a result of concussion or playing a season of ice hockey. We conclude that mild TBI does not lead to transient increases in brain volume and no new microbleeds or WMH are detectable after concussion. Brain volume reductions appear by 2 weeks after concussion and persist until at least 2 months after concussion. Brain volume is reduced between the beginning and the end of the ice hockey season.	[Jarrett, Michael; Hernandez-Torres, Enedino; Li, David K. B.; Rauscher, Alexander] Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Tam, Roger; Li, David K. B.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Tam, Roger; Li, David K. B.] Univ British Columbia, MS MRI Res Grp, Vancouver, BC V5Z 1M9, Canada; [Martin, Nancy] Richmond Hosp, Dept Radiol, Richmond, BC, Canada; [Martin, Nancy] Burnaby Hosp, Dept Radiol, Burnaby, BC, Canada; [Martin, Nancy] Delta Hosp, Dept Radiol, Delta, BC, Canada; [Perera, Warren] St Vincents Hosp, Dept Med Imaging, Melbourne, Vic, Australia; [Zhao, Yinshan; Shahinfard, Elham] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 1W5, Canada; [Dadachanji, Shiroy; Taunton, Jack] Univ British Columbia, Fac Med, Div Sports Med, Vancouver, BC, Canada; [Rauscher, Alexander] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V5Z 1M9, Canada; [Rauscher, Alexander] Univ British Columbia, Dept Pediat, Div Neurol, Vancouver, BC V6T 1W5, Canada		Rauscher, A (corresponding author), Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada.; Rauscher, A (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V5Z 1M9, Canada.; Rauscher, A (corresponding author), Univ British Columbia, Dept Pediat, Div Neurol, Vancouver, BC V6T 1W5, Canada.	rauscher@physics.ubc.ca	Hernandez-Torres, Enedino/AAG-2483-2019	Hernandez-Torres, Enedino/0000-0003-2873-5693; Shahinfard, Elham/0000-0002-3526-0086; Rauscher, Alexander/0000-0002-1961-8252; Jarrett, Michael/0000-0002-3702-2014	London Drugs Award for Research Excellence; Canadian Institutes for Health Research New Investigator AwardCanadian Institutes of Health Research (CIHR); CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT)	Funding was provided by the London Drugs Award for Research Excellence. AR is supported by a Canadian Institutes for Health Research New Investigator Award. EH-T is supported by a grant from CONACYT.	Baayen R.H., 2008, ANAL LINGUISTIC DATA; Bates D., 2014, R PACKAGE VERSION, V1, P1; Bigler E.D, 2015, BRAIN NEUROTRAUMA MO, P433; Biller A, 2015, AM J NEURORADIOL, V36, P2277, DOI 10.3174/ajnr.A4508; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Denk C, 2010, J MAGN RESON IMAGING, V31, P185, DOI 10.1002/jmri.21995; Duning T, 2005, NEUROLOGY, V64, P548, DOI 10.1212/01.WNL.0000150542.16969.CC; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gunter JL, 2009, MED PHYS, V36, P2193, DOI 10.1118/1.3116776; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hartwigsen G, 2010, J COMPUT ASSIST TOMO, V34, P596, DOI 10.1097/RCT.0b013e3181d9c2bb; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kempton MJ, 2009, HUM BRAIN MAPP, V30, P291, DOI 10.1002/hbm.20500; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Watson P, 2010, MED SCI SPORT EXER, V42, P2197, DOI 10.1249/MSS.0b013e3181e39788; Wiggermann V, 2016, AM J NEURORADIOL, V37, P259, DOI 10.3174/ajnr.A4514; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilson D, 2014, EXPERT REV NEUROTHER, V14, P661, DOI 10.1586/14737175.2014.918506; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	36	30	31	0	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 12	2016	7								11	10.3389/fneur.2016.00011			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE2CB	WOS:000370432700001	26903944	gold, Green Published			2022-02-06	
J	Aisiku, IP; Yamal, JM; Doshi, P; Rubin, ML; Benoit, JS; Hannay, J; Tilley, BC; Gopinath, S; Robertson, CS				Aisiku, Imoigele P.; Yamal, Jose-Miguel; Doshi, Pratik; Rubin, Maria Laura; Benoit, Julia S.; Hannay, Julia; Tilley, Barbara C.; Gopinath, Shankar; Robertson, Claudia S.			The incidence of ARDS and associated mortality in severe TBI using the Berlin definition	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; adult respiratory distress syndrome; acute lung injury	RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; TRAUMATIC BRAIN-INJURY; CLINICAL-TRIAL; UNITED-STATES; BLUNT TRAUMA; HEAD-INJURY; OUTCOMES; CARE	BACKGROUND: The incidence of adult respiratory distress syndrome (ARDS) in severe traumatic brain injury (TBI) is poorly reported. Recently, a new definition for ARDS was proposed, the Berlin definition. The percentage of patients represented by TBI in the Berlin criteria study is limited. This study describes the incidence and associated mortality of ARDS in TBI patients. METHODS: The study was an analysis of the safety of erythropoietin administration and transfusion threshold on the incidence of ARDS in severe TBI patients. Three reviewers independently assessed all patients enrolled in the study for acute lung injury/ARDS using the Berlin and the American-European Consensus Conference (AECC) definitions. A Cox proportional hazards model was used to assess the relationship between ARDS and mortality and 6-month Glasgow Outcome Scale (GOS) score. RESULTS: Two hundred patients were enrolled in the study. Of the patients, 21% (41 of 200) and 26% (52 of 200) developed ARDS using the AECC and Berlin definitions, respectively, with a median time of 3 days (interquartile range, 3) after injury. ARDS by either definition was associated with increased mortality (p = 0.04) but not with differences in functional outcome as measured by the GOS score at 6 months. Adjusted analysis using the Berlin criteria showed an increased mortality associated with ADS (p = 0.01). CONCLUSION: Severe TBI is associated with an incidence of ARDS ranging from 20% to 25%. The incidence is comparable between the Berlin and AECC definitions. ARDS is associated with increased mortality in severe TBI patients, but further studies are needed to validate these findings. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Aisiku, Imoigele P.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Yamal, Jose-Miguel; Rubin, Maria Laura; Tilley, Barbara C.] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA; [Doshi, Pratik] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med & Internal Med, Houston, TX 77030 USA; [Benoit, Julia S.] Univ Houston, Dept Basic Vis Sci, Houston, TX USA; [Hannay, Julia] Univ Houston, Coll Optometry, Texas Inst Measurement Evaluat & Stat, Houston, TX USA; [Hannay, Julia] Univ Houston, Dept Psychol, Houston, TX USA; [Gopinath, Shankar; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Aisiku, IP (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.	iaisiku@partners.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01-NS38660]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This study was supported by the NIH grant P01-NS38660.	Acker JE, 2007, STROKE, V38, P3097, DOI 10.1161/STROKEAHA.107.186094; ASHBAUGH DG, 1967, LANCET, V2, P319; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; Bordes J, 2014, BURNS, V40, P562, DOI 10.1016/j.burns.2014.03.004; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Britos M, 2011, CRIT CARE MED, V39, P2025, DOI 10.1097/CCM.0b013e31821cb774; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Miller PR, 2002, AM SURGEON, V68, P845; Needham DM, 2006, CRIT CARE, V10, DOI 10.1186/cc3948; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3	20	30	33	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2016	80	2					308	312		10.1097/TA.0000000000000903			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DK9EY	WOS:000375234800026	26491799	Green Accepted			2022-02-06	
J	Kasamatsu, T; Cleary, M; Bennett, J; Howard, K; McLeod, TV				Kasamatsu, Tricia; Cleary, Michelle; Bennett, Jason; Howard, Keith; McLeod, Tamara Valovich			Examining Academic Support After Concussion for the Adolescent Student-Athlete: Perspectives of the Athletic Trainer	JOURNAL OF ATHLETIC TRAINING			English	Article						sport-related concussion; academic accommodations; return to learn	COGNITIVE REST; RETURN; RECOMMENDATIONS; MANAGEMENT; KNOWLEDGE; LEARN	Context: Student-athletes may require cognitive rest and academic support after concussion. Athletic trainers (ATs) in secondary schools are uniquely positioned to provide medical care and to collaborate with school professionals while managing concussions. However, little is known regarding return-to-learn policies and their implementation in secondary schools. Objective: To examine ATs' perspectives on return to learn, cognitive rest, and communication with school professionals after concussion. Design: Cross-sectional study. Setting: Web-based survey. Patients or Other Participants: A total of 1124 secondary school ATs completed the survey (28.5% response rate). The majority of participants were employed full time (752/1114 [67.5%]) in public schools (911/1117 [81.6%]). Main Outcome Measure(s): School and AT employment characteristics, demographics, number of concussions evaluated annually, and perceptions of school professionals' familiarity with ATs' responsibilities were independent variables. Results: Of the ATs, 44% reported having an existing return-to-learn policy. The strongest predictor of a return-to-learn policy was frequent communication with teachers after concussion (odds ratio = 1.5; 95% confidence interval = 1.2, 1.7). Most ATs recommended complete cognitive rest (eg, no reading, television; 492/1087 [45.3%]) or limited cognitive activity based upon symptoms (391/1087 [36.0%]). Common academic accommodations were postponed due dates (789/954 [82.7%]), rest breaks (765/954 [80.2%]), and partial attendance (740/954 [77.6%]). Athletic trainers self-reported as primary monitors of health (764/1037 [73.7%]) and academic progression (359/1011 [35.5%]). The strongest predictor of ATs' communication with school professionals was their perception of school professionals' understanding of ATs' roles. Conclusions: Overall, ATs followed best practices for cognitive rest and return to learn after concussion. Although ATs are central to the management of student-athletes' physical health after concussion, school professionals may be better suited to monitor academic progress. Increased communication between the AT and school professionals is recommended to monitor recovery and facilitate academic support for symptomatic student-athletes.	[Kasamatsu, Tricia] Calif State Univ Fullerton, 800 North State Coll Blvd, Fullerton, CA 92831 USA; [Cleary, Michelle; Bennett, Jason; Howard, Keith] Chapman Univ, Orange, CA USA; [McLeod, Tamara Valovich] AT Still Univ, Mesa, AZ USA		Kasamatsu, T (corresponding author), Calif State Univ Fullerton, 800 North State Coll Blvd, Fullerton, CA 92831 USA.	tkasamatsu@fullerton.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Kasamatsu, Tricia M./0000-0002-6911-6955			Adams WM, 2014, J ATHL TRAINING, V49, P469, DOI 10.4085/1062-6050-49.3.01; [Anonymous], 2013, REAP BEN GOOD CONC M; [Anonymous], 2012, HEADS SCH KNOW YOUR; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Covassin T, 2013, BRAIN INJURY, V27, P1589, DOI 10.3109/02699052.2013.823656; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Mensch J, 2005, J ATHL TRAINING, V40, P333; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	25	30	30	0	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2016	51	2					153	161		10.4085/1062-6050-51.4.02			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DK2OW	WOS:000374755300007	26942658	Bronze, Green Published			2022-02-06	
J	Meehan, WP; Taylor, AM; Berkner, P; Sandstrom, NJ; Peluso, MW; Kurtz, MM; Pascual-Leone, A; Mannix, R				Meehan, William P., III; Taylor, Alex M.; Berkner, Paul; Sandstrom, Noah J.; Peluso, Mark W.; Kurtz, Matthew M.; Pascual-Leone, Alvaro; Mannix, Rebekah			Division III Collision Sports Are Not Associated with Neurobehavioral Quality of Life	JOURNAL OF NEUROTRAUMA			English	Article						athletics; chronic traumatic encephalopathy; concussions; head injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; SUBCONCUSSIVE HEAD TRAUMA; LEAGUE PLAYER; IMPACTS; CONCUSSION; BRAIN; INJURY; COHORT	We sought to determine whether the exposure to the sub-concussive blows that occur during division III collegiate collision sports affect later life neurobehavioral quality-of-life measures. We conducted a cross-sectional study of alumni from four division III colleges, targeting those between the ages of 40-70 years, using several well-validated quality-of-life measures for executive function, general concerns, anxiety, depression, emotional and behavior dyscontrol, fatigue, positive affect, sleep disturbance, and negative consequences of alcohol use. We used multivariable linear regression to assess for associations between collision sport participation and quality-of-life measures while adjusting for covariates including age, gender, race, annual income, highest educational degree, college grades, exercise frequency, and common medical conditions. We obtained data from 3702 alumni, more than half of whom (2132) had participated in collegiate sports, 23% in collision sports, 23% in non-contact sports. Respondents with a history of concussion had worse self-reported health on several measures. When subjects with a history of concussion were removed from the analyses in order to assess for any potential effect of sub-concussive blows alone, negative consequences of alcohol use remained higher among collision sport athletes (-coefficient 1.957, 95% CI 0.827-3.086). There were, however, no other significant associations between exposure to collision sports during college and any other quality-of-life measures. Our results suggest that, in the absence of a history of concussions, participation in collision sports at the Division III collegiate level is not a risk factor for worse long-term neurobehavioral outcomes, despite exposure to repeated sub-concussive blows.	[Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Meehan, William P., III; Taylor, Alex M.; Mannix, Rebekah] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Meehan, William P., III; Taylor, Alex M.] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA USA; [Meehan, William P., III; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Taylor, Alex M.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Berkner, Paul] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Sandstrom, Noah J.] Williams Coll, Dept Psychol, Williamstown, MA 01267 USA; [Peluso, Mark W.] Middlebury Coll, Middlebury, VT 05753 USA; [Kurtz, Matthew M.] Wesleyan Univ, Dept Psychol, Middletown, CT USA; [Pascual-Leone, Alvaro] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA		Meehan, WP (corresponding author), Micheli Ctr Sports Injury Prevent, 9 Hope Ave,Suite 100, Waltham, MA 02453 USA.	william.meehan@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020; Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR025758] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069776, T32 HD040128, R21HD07616] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21 MH099196] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS085491, R21 NS082870, R01NS073601] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128, R01HD069776] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD007616] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH099196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS082870, R01NS073601, R21NS085491] Funding Source: NIH RePORTER		Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Brenner J, 2007, J AM COLL HEALTH, V56, P267, DOI 10.3200/JACH.56.3.267-272; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gershon Richard C, 2010, J Appl Meas, V11, P304; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harris D., 2012, ABC NEWS; Hinton PS, 2011, PHYSICIAN SPORTSMED, V39, P11, DOI 10.3810/psm.2011.09.1916; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Lorente FO, 2003, ALCOHOL ALCOHOLISM, V38, P427, DOI 10.1093/alcalc/agg105; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Robbins L., 2012, REAL CLEAR SPOR 1206; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512	25	30	30	1	41	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					254	259		10.1089/neu.2015.3930			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800011	26193380	Green Published			2022-02-06	
S	Osier, N; Dixon, CE		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Osier, Nicole; Dixon, C. Edward			The Controlled Cortical Impact Model of Experimental Brain Trauma: Overview, Research Applications, and Protocol	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury (TBI); Experimental brain injury; Preclinical; Animal model; Controlled cortical impact (CCI); Common data elements (CDE)	LATERAL FLUID PERCUSSION; ENVIRONMENTAL ENRICHMENT; COGNITIVE DEFICITS; CEREBRAL CONCUSSION; DEPENDENT RESPONSE; HEMORRHAGIC-SHOCK; AXONAL INJURY; MOUSE MODEL; HEAD-INJURY; RAT MODEL	Controlled cortical impact (CCI) is a commonly used and highly regarded model of brain trauma that uses a pneumatically or electromagnetically controlled piston to induce reproducible and well-controlled injury. The CCI model was originally used in ferrets and it has since been scaled for use in many other species. This chapter will describe the historical development of the CCI model, compare and contrast the pneumatic and electromagnetic models, and summarize key short-and long-term consequences of TBI that have been gleaned using this model. In accordance with the recent efforts to promote high-quality evidence through the reporting of common data elements (CDEs), relevant study details-that should be reported in CCI studies-will be noted.	[Osier, Nicole; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Osier, Nicole] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA		Osier, N (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Osier, N (corresponding author), Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15260 USA.		Osier, Nicole/Q-7913-2017	Osier, Nicole/0000-0002-2903-6774	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079061, R01NS091062, R01NS084967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR014957, T32NR009759] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001127] Funding Source: NIH RePORTER; VAUS Department of Veterans Affairs [1I01RX001127-01A1] Funding Source: Federal RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS091062, R01 NS084967, R01 NS079061] Funding Source: Medline; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31 NR014957, T32 NR009759] Funding Source: Medline; RRD VA [I01 RX001127] Funding Source: Medline		Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cannon WB, 1901, AM J PHYSIOL, V6, P91; Chauhan NB, 2011, RESTOR NEUROL NEUROS, V29, P23, DOI 10.3233/RNN-2011-0573; Chauhan NB, 2010, BRAIN RES, V1360, P177, DOI 10.1016/j.brainres.2010.09.010; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Costine BA, 2012, J NEUROTRAUM, V29, P2689, DOI 10.1089/neu.2012.2428; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GOVONS SR, 1972, EXP NEUROL, V34, P121, DOI 10.1016/0014-4886(72)90193-8; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hoane Michael R, 2004, Clin Calcium, V14, P65; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kline AE, 2001, HEAD TRAUMA, P65; Kramer S P, 1896, Ann Surg, V23, P163, DOI 10.1097/00000658-189601000-00031; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; MCDONALD JW, 1989, EXP NEUROL, V106, P289, DOI 10.1016/0014-4886(89)90162-3; McPherson RW, 1994, NEUROBIOLOGY CENTRAL; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA A K, 1971, International Journal of Neuroscience, V1, P371, DOI 10.3109/00207457109146986; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Shin SS, 2013, J NEUROTRAUM, V30, P259, DOI 10.1089/neu.2012.2462; Shin SS, 2012, J NEUROTRAUM, V29, P843, DOI 10.1089/neu.2011.1966; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; Tomasevic G, 2012, J NEUROSURG, V116, P1368, DOI 10.3171/2012.2.JNS11888; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015	69	30	31	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						177	192		10.1007/978-1-4939-3816-2_11	10.1007/978-1-4939-3816-2		16	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500013	27604719	Green Accepted			2022-02-06	
J	Rodriguez-Rodriguez, A; Egea-Guerrero, JJ; Gordillo-Escobar, E; Enamorado-Enamorado, J; Hernandez-Garcia, C; de Azua-Lopez, ZR; Vilches-Arenas, A; Guerrero, JM; Murillo-Cabezas, F				Rodriguez-Rodriguez, Ana; Jose Egea-Guerrero, Juan; Gordillo-Escobar, Elena; Enamorado-Enamorado, Judy; Hernandez-Garcia, Conary; Ruiz de Azua-Lopez, Zaida; Vilches-Arenas, Angel; Miguel Guerrero, Juan; Murillo-Cabezas, Francisco			S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Traumatic brain injury; S100B; Neuron-Specific Enolase; Mortality; Biomarkers	SERUM BIOMARKERS; S100-BETA PROTEIN; PROGNOSTIC VALUE; NSE; ASSOCIATION; MARKER; S-100B; DAMAGE; MODEL	Objective: To determine temporal profile and prognostic ability of S100B protein and neuron-specific enolase (NSE) for prediction of short/long-term mortality in patients suffering from severe traumatic brain injury (sTBI). Methods: Ninety-nine patients with sTBI were included in the study. Blood samples were drawn on admission and on subsequent 24, 48, 72, and 96 h. Results: 15.2% of patients died in NeuroCritical Care Unit, and 19.2% died within 6 months of the accident. S100B concentrations were significantly higher in patients who died compared to survivors. NSE levels were different between groups just at 48 h. In the survival group, S100B levels decreased from 1st to 5th sample (p < 0.001); NSE just from 1st to 3rd (p < 0.001) and then stabilized. Values of S100B and NSE in non-survival patients did not significantly vary over the four days post sTBI. ROC-analysis showed that all S100B samples were useful tools for predicting mortality, the best the 72 h sample (AUC 0.848 for discharge mortality, 0.855 for six-month mortality). NSE ROC-analysis indicated that just the 48-h sample predicted mortality (AUC 0.733 for discharge mortality, 0.720 for six-month mortality). Conclusion: S100B protein showed higher prognostic capacity than NSE to predict short/long-term mortality in sTBI patients.	[Rodriguez-Rodriguez, Ana; Jose Egea-Guerrero, Juan; Gordillo-Escobar, Elena; Enamorado-Enamorado, Judy; Ruiz de Azua-Lopez, Zaida; Murillo-Cabezas, Francisco] Univ Seville, Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, IBIS,CSIC, Avda Manuel Siurot S-N, Seville 41013, Spain; [Hernandez-Garcia, Conary; Miguel Guerrero, Juan] Univ Seville, Virgen del Rocio Univ Hosp, Dept Clin Biochem, IBIS,CSIC, Seville 41013, Spain; [Vilches-Arenas, Angel] Univ Seville, Dept Stat, Seville 41013, Spain		Egea-Guerrero, JJ (corresponding author), Univ Seville, Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, IBIS,CSIC, Avda Manuel Siurot S-N, Seville 41013, Spain.	juanj.egea.sspa@juntadeandalucia.es	Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROINMUNO/O-9306-2015; Guerrero, Josep M./Y-2929-2019; Egea-Guerrero, Juan Jose JJ/P-5080-2014; Vilches-Arenas, Angel/C-1167-2015; IBIS, NEUROCRITICOS/C-1805-2016	Guerrero, Josep M./0000-0001-5236-4592; Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; Vilches-Arenas, Angel/0000-0003-2197-3760; Ruiz de Azua Lopez, Zaida/0000-0002-9157-600X; Guerrero, Juan Miguel/0000-0001-7553-0119			Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Gonzalez-Mao MC, 2011, CLIN LAB, V57, P587; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Jauch EC, 2006, STROKE, V37, P2508, DOI 10.1161/01.STR.0000242290.01174.9e; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Lesko MM, 2014, BRAIN INJURY, V28, P987, DOI 10.3109/02699052.2014.890743; MARANGOS PJ, 1980, J NEUROCHEM, V34, P1254, DOI 10.1111/j.1471-4159.1980.tb09967.x; Morrison Gavin, 2013, Pathophysiology, V20, P49, DOI 10.1016/j.pathophys.2012.02.006; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Petrova DT, 2013, CLIN BIOCHEM, V46, P1298, DOI 10.1016/j.clinbiochem.2013.06.018; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Schultke E, 2009, CAN J NEUROL SCI, V36, P612, DOI 10.1017/S031716710000812X; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Soto-Hernandez Jose L, 2008, Neurosurgery, V62, pE1384, DOI 10.1227/01.neu.0000333328.42706.db; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181	37	30	37	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	2					130	137		10.1080/01616412.2016.1144410			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK8BQ	WOS:000375152400007	27078699				2022-02-06	
J	Brown, JA; Dalecki, M; Hughes, C; Macpherson, AK; Sergio, LE				Brown, Jeffrey A.; Dalecki, Marc; Hughes, Cindy; Macpherson, Alison K.; Sergio, Lauren E.			Cognitive-motor integration deficits in young adult athletes following concussion	BMC SPORTS SCIENCE MEDICINE AND REHABILITATION			English	Article						Mild traumatic brain injury; Prediction model; Movement control; Return to play protocol; Eye-hand coordination		Background: The ability to perform visually-guided motor tasks requires the transformation of visual information into programmed motor outputs. When the guiding visual information does not align spatially with the motor output, the brain processes rules to integrate the information for an appropriate motor response. Here, we look at how performance on such tasks is affected in young adult athletes with concussion history. Methods: Participants displaced a cursor from a central to peripheral targets on a vertical display by sliding their finger along a touch sensitive screen in one of two spatial planes. The addition of a memory component, along with variations in cursor feedback increased task complexity across conditions. Results: Significant main effects between participants with concussion history and healthy controls without concussion history were observed in timing and accuracy measures. Importantly, the deficits were distinctly more pronounced for participants with concussion history compared to healthy controls, especially when the brain had to control movements having two levels of decoupling between vision and action. A discriminant analysis correctly classified athletes with a history of concussion based on task performance with an accuracy of 94 %, despite the majority of these athletes being rated asymptomatic by current standards. Conclusions: These findings correspond to our previous work with adults at risk of developing dementia, and support the use of cognitive motor integration as an enhanced assessment tool for those who may have mild brain dysfunction. Such a task may provide a more sensitive metric of performance relevant to daily function than what is currently in use, to assist in return to play/work/learn decisions.	[Brown, Jeffrey A.; Dalecki, Marc; Hughes, Cindy; Macpherson, Alison K.; Sergio, Lauren E.] York Univ, Sch Kinesiol & Hlth Sci, 357 Bethune Coll,4700 Keele St, Toronto, ON M3J 1P3, Canada; [Dalecki, Marc; Sergio, Lauren E.] York Univ, Ctr Vis Res, Toronto, ON, Canada; [Hughes, Cindy; Macpherson, Alison K.; Sergio, Lauren E.] York Univ, Sport Med Team, Toronto, ON, Canada; [Sergio, Lauren E.] Southlake Reg Hlth Ctr, Newmarket, ON, Canada		Sergio, LE (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, 357 Bethune Coll,4700 Keele St, Toronto, ON M3J 1P3, Canada.	lsergio@yorku.ca	Sergio, Lauren/AAK-3274-2020	Brown, Jeffrey/0000-0002-5661-1172	Ontario Neurotrauma Foundation; Canadian Institutes of Health Research operating grantCanadian Institutes of Health Research (CIHR) [125915]; Donald Sanderson Memorial Trust	The authors gratefully acknowledge Laura Cruz, MD and Tracey Meloche, CATA for their assistance with the athletes, and the York University Lions organization. Funding provided by the Ontario Neurotrauma Foundation (JB), Canadian Institutes of Health Research operating grant # 125915 (LS, AM), and the Donald Sanderson Memorial Trust (LS, AM, CH).	Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; Gail A, 2009, J NEUROSCI, V29, P9490, DOI 10.1523/JNEUROSCI.1095-09.2009; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gorbet DJ, 2007, EUR J NEUROSCI, V25, P1228, DOI 10.1111/j.1460-9568.2007.05358.x; Gorbet DJ, 2009, BRAIN RES, V1284, P77, DOI 10.1016/j.brainres.2009.05.057; Gorbet DJ, 2004, NEUROIMAGE, V23, P1100, DOI 10.1016/j.neuroimage.2004.07.043; Granek J, 2013, PLOS ONE, V8, P1; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hawkins KM, 2015, J ALZHEIMERS DIS, V44, P867, DOI 10.3233/JAD-142079; Hawkins KM, 2014, J ALZHEIMERS DIS, V42, P607, DOI 10.3233/JAD-140051; Hawkins KM, 2013, J COGNITIVE NEUROSCI, V25, P436, DOI 10.1162/jocn_a_00318; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Locklin J, 2010, SPORTS MED, V40, P183, DOI 10.2165/11319440-000000000-00000; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Salek Y, 2011, EUR NEUROL, V66, P283, DOI 10.1159/000331049; Sayegh PF, 2014, J NEUROPHYSIOL, V111, P2210, DOI 10.1152/jn.00793.2013; Sayegh PF, 2013, J NEUROPHYSIOL, V110, P952, DOI 10.1152/jn.00764.2012; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Tippett WJ, 2007, EUR NEUROL, V58, P1, DOI 10.1159/000102160; Tippett WJ, 2006, BRAIN RES, V1102, P92, DOI 10.1016/j.brainres.2006.04.049; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Verweij BH, 1997, CLIN NEUROL NEUROSUR, V99, P102; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	38	30	30	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-1847			BMC SPORTS SCI MED R	BMC Sports Sci. Med. Rehabil.	DEC	2015	7	1							25	10.1186/s13102-015-0019-4			12	Rehabilitation; Sport Sciences	Emerging Sources Citation Index (ESCI)	Rehabilitation; Sport Sciences	V30RK	WOS:000215579500024	26491541	Green Published, gold			2022-02-06	
J	Unsal, C; Kanter, M; Aktas, C; Erboga, M				Unsal, Cuneyt; Kanter, Mehmet; Aktas, Cevat; Erboga, Mustafa			Role of quercetin in cadmium-induced oxidative stress, neuronal damage, and apoptosis in rats	TOXICOLOGY AND INDUSTRIAL HEALTH			English	Article						Cadmium; quercetin; oxidative stress; neuronal damage; neuronal apoptosis; rats	TRAUMATIC BRAIN-INJURY; SUPEROXIDE-DISMUTASE; CORTICAL-NEURONS; IN-VIVO; GLUTATHIONE; NEUROTOXICITY; EXPRESSION; METALLOTHIONEIN; NEPHROTOXICITY; CYTOTOXICITY	The present study was carried out to evaluate the neuroprotective effect of quercetin (QE) in protecting the cadmium (Cd)-induced neuronal injury in frontal cortex of rats. A total of 30 adult male Sprague-Dawley rats were randomly divided into three groups of 10 animals each: control, Cd treated and Cd treated with QE. The Cd-treated group was injected subcutaneously with cadmium chloride (CdCl2) dissolved in saline at a dose of 2 ml/kg/day for 30 days, resulting in a dosage of 1 mg/kg Cd. The rats in QE-treated groups were given QE (15 mg/kg body weight) once a day intraperitoneally starting 2 days prior to Cd injection, during the study period. Rats were sacrificed at the end of the study and the frontal cortex tissues were removed for biochemical and histopathological investigation. To date, there is no available information on the effect of QE on neuronal injury after Cd exposure. Rats intoxicated with Cd for 30 days, significantly increased tissue malondialdehyde (MDA) levels and significantly decreased enzymatic antioxidants superoxide dismutase, glutathione peroxidase and catalase in the frontal cortex tissue. Administration of QE with Cd significantly diminished the levels of MDA and significantly elevated the levels of enzymatic antioxidants in the frontal cortex tissue. The histopathological studies in the brain of rats also supported that QE markedly reduced the Cd-induced histopathological changes and well preserved the normal histological architecture of the frontal cortex tissue. The caspase-3 immunopositivity was increased in degenerating neurons of the Cd group. Treatment with QE markedly reduced the immunoreactivity of degenerating neurons. In conclusion, the results of the current study suggest that QE may be beneficial in combating the Cd-induced neurotoxicity in the brain of rats. We believe that further preclinical research into the utility of QE may indicate its usefulness as a potential treatment for neurodegeneration after Cd exposure in rats.	[Unsal, Cuneyt] Namik Kemal Univ, Dept Psychiat, Tekirdag, Turkey; [Kanter, Mehmet] Istanbul Medeniyet Univ, Dept Histol & Embryol, Istanbul, Turkey; [Aktas, Cevat; Erboga, Mustafa] Namik Kemal Univ, Dept Histol & Embryol, Tekirdag, Turkey		Kanter, M (corresponding author), Univ Istanbul Medeniyet, Dept Histol & Embryol, TR-34710 Istanbul, Turkey.	mkanter65@yahoo.com	Aktas, Cevat/D-8468-2011				AEBI H, 1984, METHOD ENZYMOL, V105, P121; AFANASEV IB, 1989, BIOCHEM PHARMACOL, V38, P1763, DOI 10.1016/0006-2952(89)90410-3; Aktoz T, 2012, BALK MED J, V29, P56, DOI 10.5152/balkanmedj.2011.014; Bar-Sela S, 2001, Int J Occup Environ Health, V7, P109; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Bondy SC, 1997, FREE RADICAL TOXICOL, P221; Bressler JP, 2007, HUM EXP TOXICOL, V26, P221, DOI 10.1177/0960327107070573; Cho JY, 2006, NEUROSCI LETT, V404, P330, DOI 10.1016/j.neulet.2006.06.010; Choi YJ, 2003, J NUTR, V133, P985, DOI 10.1093/jn/133.4.985; Choudhuri S, 1996, TOXICOL LETT, V84, P127, DOI 10.1016/0378-4274(95)03444-7; Chuang SM, 2000, CARCINOGENESIS, V21, P1423, DOI 10.1093/carcin/21.7.1423; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Dean RT, 1997, BIOCHEM J, V324, P1; El-Missiry MA, 2000, J BIOCHEM MOL TOXIC, V14, P238, DOI 10.1002/1099-0461(2000)14:5<238::AID-JBT2>3.0.CO;2-X; Farombi EO, 2012, ANDROLOGIA, V44, P273, DOI 10.1111/j.1439-0272.2012.01279.x; Figueiredo-Pereira ME, 1998, J BIOL CHEM, V273, P12703, DOI 10.1074/jbc.273.21.12703; Galan A, 2000, J BIOL CHEM, V275, P11418, DOI 10.1074/jbc.275.15.11418; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Inal ME, 2002, METHOD FIND EXP CLIN, V24, P209, DOI 10.1358/mf.2002.24.4.678452; Kanter M, 2012, TOXICOLOGY IND HLTH; Kanter M, 2012, FOOD CHEM TOXICOL, V50, P719, DOI 10.1016/j.fct.2011.11.051; Kerman M, 2012, J MOL HISTOL, V43, P49, DOI 10.1007/s10735-011-9376-9; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Koizumi T, 1996, TOXICOLOGY, V114, P125, DOI 10.1016/S0300-483X(96)03477-4; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; Kumar R, 1996, TOXICOL LETT, V89, P65, DOI 10.1016/S0378-4274(96)03780-0; LAUGHTON MJ, 1991, BIOCHEM PHARMACOL, V42, P1673, DOI 10.1016/0006-2952(91)90501-U; Li XL, 2012, EXP THER MED, V4, P125, DOI 10.3892/etm.2012.562; Lopez E, 2006, FREE RADICAL BIO MED, V40, P940, DOI 10.1016/j.freeradbiomed.2005.10.062; Lopez E, 2003, BRIT J PHARMACOL, V138, P901, DOI 10.1038/sj.bjp.0705111; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Morales AI, 2006, FOOD CHEM TOXICOL, V44, P2092, DOI 10.1016/j.fct.2006.07.012; Morales AI, 2006, TOXICOL APPL PHARM, V210, P128, DOI 10.1016/j.taap.2005.09.006; Nishimura Y, 2006, TOXICOL IN VITRO, V20, P211, DOI 10.1016/j.tiv.2005.06.006; NORDBERG M, 1984, ENVIRON HEALTH PERSP, V54, P13, DOI 10.2307/3429785; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okuda B, 1997, CLIN NEUROL NEUROSUR, V99, P263, DOI 10.1016/S0303-8467(97)00090-5; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pandey AK, 2011, BRAIN RES, V1383, P289, DOI 10.1016/j.brainres.2011.01.085; Prabu SM, 2010, EUR REV MED PHARMACO, V14, P903; Prabu SM, 2010, J FOOD SCI, V75, pT132, DOI 10.1111/j.1750-3841.2010.01757.x; Renugadevi J, 2010, EXP TOXICOL PATHOL, V62, P471, DOI 10.1016/j.etp.2009.06.006; Risso-de Faverney C, 2001, AQUAT TOXICOL, V53, P65, DOI 10.1016/S0166-445X(00)00154-5; Schultke E, 2005, J NEUROTRAUM, V22, P1475, DOI 10.1089/neu.2005.22.1475; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Seok SM, 2006, TOXICOL LETT, V165, P212, DOI 10.1016/j.toxlet.2006.04.007; Shagirtha K, 2011, EUR REV MED PHARMACO, V15, P1039; Shimada H, 1998, J TOXICOL ENV HEAL A, V54, P159; SHUKLA GS, 1987, LIFE SCI, V41, P2215, DOI 10.1016/0024-3205(87)90518-2; SHUKLA GS, 1989, IND HEALTH, V27, P59, DOI 10.2486/indhealth.27.59; SUN Y, 1988, CLIN CHEM, V34, P497; Viaene MK, 2000, OCCUP ENVIRON MED, V57, P19, DOI 10.1136/oem.57.1.19; Vicente-Sanchez C, 2008, FOOD CHEM TOXICOL, V46, P2279, DOI 10.1016/j.fct.2008.03.009; Wu XW, 2001, J OCCUP ENVIRON MED, V43, P898, DOI 10.1097/00043764-200110000-00009; Xu CY, 1996, TOXICOLOGY, V107, P1, DOI 10.1016/0300-483X(95)03195-L; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhu YG, 2006, BRAIN RES, V1090, P35, DOI 10.1016/j.brainres.2006.03.063	59	30	33	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0748-2337	1477-0393		TOXICOL IND HEALTH	Toxicol. Ind. Health	DEC	2015	31	12					1106	1115		10.1177/0748233713486960			10	Public, Environmental & Occupational Health; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Toxicology	CX5MK	WOS:000365745600006	23645211				2022-02-06	
J	Kerr, ZY; Snook, EM; Lynall, RC; Dompier, TP; Sales, L; Parsons, JT; Hainline, B				Kerr, Zachary Y.; Snook, Erin M.; Lynall, Robert C.; Dompier, Thomas P.; Sales, Latrice; Parsons, John T.; Hainline, Brian			Concussion-Related Protocols and Preparticipation Assessments Used for Incoming Student-Athletes in National Collegiate Athletic Association Member Institutions	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; return-to-play guidelines; evaluation	STATES HIGH-SCHOOL; FOOTBALL PLAYERS; MANAGEMENT; SENSITIVITY; SPORT; EPIDEMIOLOGY; SPECIFICITY; EDUCATION; SYMPTOMS; SYSTEM	Context: National Collegiate Athletic Association (NCAA) legislation requires that member institutions have policies to guide the recognition and management of sport-related concussions. Identifying the nature of these policies and the mechanisms of their implementation can help identify areas of needed improvement. Objective: To estimate the characteristics and prevalence of concussion-related protocols and preparticipation assessments used for incoming NCAA student-athletes. Design: Cross-sectional study. Setting: Web-based survey. Patients or Other Participants: Head athletic trainers from all 1113 NCAA member institutions were contacted; 327 (29.4%) completed the survey. Intervention(s): Participants received an e-mail link to the Web-based survey. Weekly reminders were sent during the 4-week window. Main Outcome Measure(s): Respondents described concussion-related protocols and preparticipation assessments (eg, concussion history, neurocognitive testing, balance testing, symptom checklists). Descriptive statistics were compared by division and football program status. Results: Most universities provided concussion education to student-athletes (95.4%), had return-to-play policies (96.6%), and obtained the number of previous concussions sustained by incoming student-athletes (97.9%). Fewer had return-to-learn policies (63.3%). Other concussion-history-related information (eg, symptoms, hospitalization) was more often collected by Division I universities. Common preparticipation neurocognitive and balance tests were the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT; 77.1%) and Balance Error Scoring System (46.5%). In total, 43.7% complied with recommendations for preparticipation assessments that included concussion history, neurocognitive testing, balance testing, and symptom checklists. This was due to moderate use of balance testing (56.6%); larger proportions used concussion history (99.7%), neurocognitive testing (83.2%), and symptom checklists (91.7%). More Division I universities (55.2%) complied with baseline assessment recommendations than Division II (38.2%, chi(2) = 5.49, P =.02) and Division III (36.1%, chi(2) = 9.11, P =.002) universities. Conclusions: National Collegiate Athletic Association member institutions implement numerous strategies to monitor student-athletes. Division II and III universities may need additional assistance to collect in-depth concussion histories and conduct balance testing. Universities should continue developing or adapting (or both) return-to-learn policies.	[Kerr, Zachary Y.; Snook, Erin M.; Dompier, Thomas P.] Datalys Ctr Sports Injury Res & Prevent, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA; [Lynall, Robert C.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC USA; [Sales, Latrice; Parsons, John T.; Hainline, Brian] Natl Collegiate Athlet Assoc, Indianapolis, IN USA		Kerr, ZY (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA.	zkerr@datalyscenter.org	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Kerr, Zachary/0000-0003-1423-1259			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Braithwaite D, 2003, FAM PRACT, V20, P545, DOI 10.1093/fampra/cmg509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Dick R, 2007, J ATHL TRAINING, V42, P221; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Klossner D, 2013 14 NCAA SPORTS; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	31	30	30	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2015	50	11					1174	1181		10.4085/1062-6050-50.11.11			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DK2OO	WOS:000374754500008	26540099	Bronze, Green Submitted, Green Published			2022-02-06	
J	Dawes, AJ; Sacks, GD; Cryer, HG; Gruen, JP; Preston, C; Gorospe, D; Cohen, M; McArthur, DL; Russell, MM; Maggard-Gibbons, M; Ko, CY				Dawes, Aaron J.; Sacks, Greg D.; Cryer, H. Gill; Gruen, J. Peter; Preston, Christy; Gorospe, Deidre; Cohen, Marilyn; McArthur, David L.; Russell, Marcia M.; Maggard-Gibbons, Melinda; Ko, Clifford Y.		Los Angeles Cty Trauma Consortium	Compliance With Evidence-Based Guidelines and Interhospital Variation in Mortality for Patients With Severe Traumatic Brain Injury	JAMA SURGERY			English	Article							BLOOD-STREAM INFECTIONS; CARE QUALITY MEASURES; INTRACRANIAL-PRESSURE; UNITED-STATES; SURGICAL OUTCOMES; ASSOCIATION; IMPROVEMENT; HOSPITALS; SURVEILLANCE; ADJUSTMENT	IMPORTANCE Compliance with evidence-based guidelines in traumatic brain injury (TBI) has been proposed as a marker of hospital quality. However, the association between hospital-level compliance rates and risk-adjusted clinical outcomes for patients with TBI remains poorly understood. OBJECTIVE To examine whether hospital-level compliance with the Brain Trauma Foundation guidelines for intracranial pressure monitoring and craniotomy is associated with risk-adjusted mortality rates for patients with severe TBI. DESIGN, SETTING, AND PARTICIPANTS All adult patients (N = 734) who presented to a regional consortium of 14 hospitals from January 1, 2009, through December 31, 2010, with severe TBI (ie, blunt head trauma, Glasgow Coma Scale score of < 9, and abnormal intracranial findings from computed tomography of the head). Data analysis took place from December 2013 through January 2015. We used hierarchical mixed-effects models to assess the association between hospital-level compliance with Brain Trauma Foundation guidelines and mortality rates after adjusting for patient-level demographics, severity of trauma (eg, mechanism of injury and Injury Severity Score), and TBI-specific variables (eg, cranial nerve reflexes and findings from computed tomography of the head). MAIN OUTCOMES AND MEASURES Hospital-level risk-adjusted inpatient mortality rate and hospital-level compliance with Brain Trauma Foundation guidelines for intracranial pressure monitoring and craniotomy. RESULTS Unadjusted mortality rates varied by site from 20.0% to 50.0% (median, 42.6; interquartile range, 35.5-46.2); risk-adjusted rates varied from 24.3% to 56.7% (median, 41.1; interquartile range, 36.4-47.8). Overall, only 338 of 734 patients (46.1%) with an appropriate indication underwent placement of an intracranial pressure monitor and only 134 of 335 (45.6%) underwent craniotomy. Hospital-level compliance ranged from 9.6% to 65.2% for intracranial pressure monitoring and 6.7% to 76.2% for craniotomy. Despite widespread variation in compliance across hospitals, we found no association between hospital-level compliance rates and risk-adjusted patient outcomes (Spearman. = 0.030 [P = .92] for ICP monitoring and Spearman. = -0.066 [P = .83] for craniotomy). CONCLUSIONS AND RELEVANCE Hospital-level compliance with evidence-based guidelines has minimal association with risk-adjusted outcomes in patients with severe TBI. Our results suggest that caution should be taken before using compliance with these measures as independent quality metrics. Given the complexity of TBI care, outcomes-based metrics, including functional recovery, may be more accurate than current process measures at determining hospital quality.	[Dawes, Aaron J.; Sacks, Greg D.; Cryer, H. Gill; Cohen, Marilyn; Russell, Marcia M.; Maggard-Gibbons, Melinda; Ko, Clifford Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Dawes, Aaron J.; Sacks, Greg D.] Univ Calif Los Angeles, Robert Wood Johnson Clin Scholars Program, Los Angeles, CA 90095 USA; [Dawes, Aaron J.; Russell, Marcia M.; Maggard-Gibbons, Melinda; Ko, Clifford Y.] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Surg, Los Angeles, CA USA; [Gruen, J. Peter] Univ So Calif, Dept Neurosurg, Los Angeles, CA USA; [Preston, Christy; Gorospe, Deidre] Cty Los Angeles Dept Hlth Serv, Emergency Med Serv Agcy, Los Angeles, CA USA; [McArthur, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA		Dawes, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ronald Reagan UCLA Med Ctr, Dept Surg, 757 Westwood Plaza,Room B7-11, Los Angeles, CA 90095 USA.	adawes@mednet.ucla.edu	Dawes, Aaron/I-1680-2019	Dawes, Aaron/0000-0003-4574-6765	Veterans Affairs Robert Wood Johnson Clinical Scholars Program; Veterans Affairs Office of Academic Affiliations	This study was supported by the Veterans Affairs Robert Wood Johnson Clinical Scholars Program (Drs Dawes and Sacks) and the Veterans Affairs Office of Academic Affiliations (Dr Dawes).	Adams JL., 2009, RELIABILITY PROVIDER; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Ayanian JZ, 2002, MILBANK Q, V80, P569, DOI 10.1111/1468-0009.00023; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Berwick DM, 2015, JAMA-J AM MED ASSOC, V313, P469, DOI 10.1001/jama.2015.4; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Birkmeyer JD, 2004, J AM COLL SURGEONS, V198, P626, DOI 10.1016/j.jamcollsurg.2003.11.017; Bratton S. L., 2007, J NEUROTRAUMA S1, V24, pS37; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cohen ME, 2013, J AM COLL SURGEONS, V217, P336, DOI 10.1016/j.jamcollsurg.2013.02.027; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Dimick JB, 2012, ANN SURG, V255, P703, DOI 10.1097/SLA.0b013e31824b46ff; Dimick JB, 2010, HEALTH SERV RES, V45, P1614, DOI 10.1111/j.1475-6773.2010.01158.x; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V115, P191, DOI 10.3171/2011.4.JNS101116a; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P1170, DOI 10.1001/archsurg.2011.247; Hawn MT, 2008, J AM COLL SURGEONS, V206, P814, DOI 10.1016/j.jamcollsurg.2007.12.013; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Howell EA, 2014, JAMA-J AM MED ASSOC, V312, P1531, DOI 10.1001/jama.2014.13381; Karamanos E, 2014, AM J SURG, V208, P363, DOI 10.1016/j.amjsurg.2013.10.026; Kernisan LP, 2009, JAMA-J AM MED ASSOC, V301, P1341, DOI 10.1001/jama.2009.422; Khuri SF, 2001, ANN SURG, V234, P370, DOI 10.1097/00000658-200109000-00011; Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Qian F, 2011, MED CARE, V49, P1082, DOI 10.1097/MLR.0b013e318238f26b; Ryan AM, 2009, INQUIRY-J HEALTH CAR, V46, P274, DOI 10.5034/inquiryjrnl_46.03.274; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shafi S, 2014, J AM COLL SURGEONS, V219, P189, DOI 10.1016/j.jamcollsurg.2014.04.005; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694	45	30	31	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	OCT	2015	150	10					965	972		10.1001/jamasurg.2015.1678			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	DA1WB	WOS:000367585200010	26200744	Bronze			2022-02-06	
J	Martinez-Valverde, T; Vidal-Jorge, M; Martinez-Saez, E; Castro, L; Arikan, F; Cordero, E; Radoi, A; Poca, MA; Simard, JM; Sahuquillo, J				Martinez-Valverde, Tamara; Vidal-Jorge, Marian; Martinez-Saez, Elena; Castro, Lidia; Arikan, Fuat; Cordero, Esteban; Radoi, Andreea; Poca, Maria-Antonia; Simard, J. Marc; Sahuquillo, Juan			Sulfonylurea Receptor 1 in Humans with Post-Traumatic Brain Contusions	JOURNAL OF NEUROTRAUMA			English	Article						brain contusion; brain edema; human; immunofluorescence; sulfonyurea receptor 1	SENSITIVE POTASSIUM CHANNELS; CEREBRAL CONTUSION; INJURY; ATP; GLIBENCLAMIDE; DAMAGE; EDEMA; MODEL; ASTROCYTES; EXPRESSION	Post-traumatic brain contusions (PTBCs) are traditionally considered primary injuries and can increase in size, generate perilesional edema, cause mass effect, induce neurological deterioration, and cause death. Most patients experience a progressive increase in pericontusional edema, and nearly half, an increase in the hemorrhagic component itself. The underlying molecular pathophysiology of contusion-induced brain edema and hemorrhagic progression remains poorly understood. The aim of this study was to investigate sulfonylurea 1/transient receptor potential melastatin 4 (SUR1-TRPM4) ion channel SUR1 expression in various cell types (neurons, astrocytes, endothelial cells, microglia, macrophages, and neutrophils) of human brain contusions and whether SUR1 up-regulation was related to time postinjury. Double immunolabeling of SUR1 and cell-type- specific proteins was performed in 26 specimens from traumatic brain injury patients whose lesions were surgically evacuated. Three samples from limited brain resections performed for accessing extra-axial skull-base tumors or intraventricular lesions were controls. We found SUR1 was significantly overexpresed in all cell types and was especially prominent in neurons and endothelial cells (ECs). The temporal pattern depended on cell type: 1) In neurons, SUR1 increased within 48h of injury and stabilized thereafter; 2) in ECs, there was no trend; 3) in glial cells and microglia/macrophages, a moderate increase was observed over time; and 4) in neutrophils, it decreased with time. Our results suggest that up-regulation of SUR1 in humans point to this channel as one of the important molecular players in the pathophysiology of PTBCs. Our findings reveal opportunities to act therapeutically on the mechanisms of growth of traumatic contusions and therefore reduce the number of patients with neurological deterioration and poor neurological outcomes.	[Martinez-Valverde, Tamara; Vidal-Jorge, Marian; Castro, Lidia; Arikan, Fuat; Radoi, Andreea; Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona 08035, Spain; [Martinez-Saez, Elena] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Pathol, Barcelona 08035, Spain; [Arikan, Fuat; Cordero, Esteban; Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona 08035, Spain; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA		Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net	Poca, Maria A./B-8475-2008; Radoi, Andreea/C-9682-2016; Vidal-Jorge, Marian/D-4402-2017; Arikan, Fuat/F-8900-2016; Radoi, Andreea/N-5613-2019; Sahuquillo, Juan/B-3577-2008; Castro, Lidia/J-3976-2017; Martinez-Saez, Elena/E-9097-2018	Poca, Maria A./0000-0002-3831-0536; Vidal-Jorge, Marian/0000-0002-3459-9336; Arikan, Fuat/0000-0002-9459-0915; Radoi, Andreea/0000-0002-0677-3544; Sahuquillo, Juan/0000-0003-0713-5875; Castro, Lidia/0000-0001-8513-7388; Martinez-Saez, Elena/0000-0001-6004-5364; Cordero Asanza, Esteban/0000-0003-0464-3014	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)Instituto de Salud Carlos III [PI10/00302, PI11/00700]; European Regional DevelopmentEuropean Commission; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [FI11/00195]; Fundacio Institut de Recerca HUVH [PRED-VHIR-2012-26]	This work was supported, in part, by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) with grants PI10/00302 and PI11/00700, which were cofinanced by the European Regional Development and awarded to Dr. Poca and Dr. Sahuquillo, respectively. T. Martinez-Valverde and A. Raloi are recipients of a predoctoral grant from the Instituto de Salud Carlos III (grant no.: FI11/00195) and from Fundacio Institut de Recerca HUVH (grant no.: PRED-VHIR-2012-26), respectively.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; [Anonymous], 2000, JAMA, V284, P3043; ASHCROFT SJH, 1992, BIOCHIM BIOPHYS ACTA, V1175, P45, DOI 10.1016/0167-4889(92)90008-Y; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Clancy B, 1998, J NEUROSCI METH, V83, P97, DOI 10.1016/S0165-0270(98)00066-1; Davis ME, 2004, J BIOL CHEM, V279, P163, DOI 10.1074/jbc.M307528200; Eriskat J., 1994, INTRACRANIAL PRESSUR, P339; Fox J., 2019, R COMPANION APPL REG, V3 rd; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Ghajar J., 2006, NEUROSURGERY, V58, pI, DOI DOI 10.1093/NEUROSURGERY/58.SUPPL_3.S2-VI; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Katayama Y, 1998, ACT NEUR S, V71, P289; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawamata T, 2007, PROG BRAIN RES, V161, P235, DOI 10.1016/S0079-6123(06)61016-9; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kunte H, 2012, ANN NEUROL, V72, P799, DOI 10.1002/ana.23680; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Latchman DS, 1997, INT J BIOCHEM CELL B, V29, P1305, DOI 10.1016/S1357-2725(97)00085-X; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; Liss B, 2001, NEWS PHYSIOL SCI, V16, P214; Maeda T, 2003, ACT NEUR S, V86, P329; Mehta RI, 2013, J NEUROPATH EXP NEUR, V72, P871, DOI 10.1097/NEN.0b013e3182a32e40; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; R Development Core Team, 2011, R LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; RStudio, 2013, RSTUDIO INT DEV ENV; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Simard JM, 2008, PEDIATR RES, V64, P648, DOI 10.1203/PDR.0b013e318186e5a9; Simard PF, 2011, TRANSL STROKE RES, V2, P227, DOI 10.1007/s12975-011-0070-8; Spitzer N, 2011, J NEUROSCI METH, V197, P48, DOI 10.1016/j.jneumeth.2011.01.029; SULLIVAN HC, 1993, BRAIN RES, V612, P336, DOI 10.1016/0006-8993(93)91682-I; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Verstraeten SV, 2010, BBA-BIOMEMBRANES, V1798, P1739, DOI 10.1016/j.bbamem.2010.06.010; Vilalta A, 2006, J NEUROTRAUM, V23, P772; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yokota Hiroyuki, 2007, Journal of Nippon Medical School, V74, P332, DOI 10.1272/jnms.74.332; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	54	30	31	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2015	32	19					1478	1487		10.1089/neu.2014.3706			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CR8NC	WOS:000361609500006	26398596	Green Published			2022-02-06	
J	Xia, Y; Kong, L; Yao, YJ; Jiao, YA; Song, J; Tao, ZY; You, Z; Yang, JX				Xia, Yang; Kong, Liang; Yao, Yingjia; Jiao, Yanan; Song, Jie; Tao, Zhenyu; You, Zhong; Yang, Jingxian			Osthole confers neuroprotection against cortical stab wound injury and attenuates secondary brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Osthole; Cortical stab wound injury; Secondary brain injury; Anti-inflammation; Anti-apoptosis	NEURAL STEM-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; BCL-2 PROTEIN FAMILY; INFLAMMATORY RESPONSE; BONE-MARROW; SPINAL-CORD; ANTIINFLAMMATORY MECHANISM; NATURAL COUMARIN	Background: Neuroendoscopy is an innovative technique for neurosurgery that can nonetheless result in traumatic brain injury. The accompanying neuroinflammation may lead to secondary tissue damage, which is the major cause of delayed neuronal death after surgery. The present study investigated the capacity of osthole to prevent secondary brain injury and the underlying mechanism of action in a mouse model of stab wound injury. Methods: A mouse model of cortical stab wound injury was established by inserting a needle into the cerebral cortex for 20 min to mimic neuroendoscopy. Mice received an intraperitoneal injection of osthole 30 min after surgery and continued for 14 days. Neurological severity was evaluated 12 h and up to 21 days after the trauma. Brains were collected 3-21 days post-injury for histological analysis, immunocytochemistry, quantitative real-time PCR, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and enzyme-linked immunosorbent assays. Results: Neurological function improved in mice treated with osthole and was accompanied by reduced brain water content and accelerated wound closure relative to untreated mice. Osthole treatment reduced the number of macrophages/microglia and peripheral infiltrating of neutrophils and lowered the level of the proinflammatory cytokines interleukin-6 and tumor necrosis factor a in the lesioned cortex. Osthole-treated mice had fewer TUNEL + apoptotic neurons surrounding the lesion than controls, indicating increased neuronal survival. Conclusions: Osthole reduced secondary brain damage by suppressing inflammation and apoptosis in a mouse model of stab wound injury. These results suggest a new strategy for promoting neuronal survival and function after neurosurgery to improve long-term patient outcome.	[Xia, Yang; You, Zhong] Univ Oxford, Dept Engn, Oxford OX1 3LZ, England; [Kong, Liang; Yao, Yingjia; Jiao, Yanan; Song, Jie; Tao, Zhenyu; Yang, Jingxian] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China		Yang, JX (corresponding author), Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China.	jingxianyang@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81173580]	This work was supported by the National Natural Science Foundation of China (grant No. 81173580).	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bitto A, 2012, CRIT CARE MED, V40, P945, DOI 10.1097/CCM.0b013e318236efde; Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002; Casanova F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094919; Casanova F, 2014, J NEUROSCI METH, V237, P79, DOI 10.1016/j.jneumeth.2014.08.012; Chao XD, 2010, BRAIN RES, V1363, P206, DOI 10.1016/j.brainres.2010.09.052; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Chen XH, 2010, EUR J PHARMACOL, V629, P40, DOI 10.1016/j.ejphar.2009.12.008; Chen ZW, 2015, NEUROCHEM RES, V40, P186, DOI 10.1007/s11064-014-1483-z; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Ding D, 2015, J CLIN NEUROSCI, DOI [10.1016/jjocn.2015.01.004, DOI 10.1016/JJOCN.2015.01.004]; Fan J, 2010, NEUROSCI LETT, V473, P196, DOI 10.1016/j.neulet.2010.02.045; Farkas G, 1998, NEUROSCI LETT, V242, P147, DOI 10.1016/S0304-3940(98)00060-3; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gao Z, 2014, J PHARMACOL SCI, V124, P54, DOI 10.1254/jphs.13144FP; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; HOZUMI I, 1990, BRAIN RES, V524, P64, DOI 10.1016/0006-8993(90)90492-T; Hu Y, 2013, BIOL PHARM BULL, V36, P1950, DOI 10.1248/bpb.b13-00561; Ji HJ, 2010, EUR J PHARMACOL, V636, P96, DOI 10.1016/j.ejphar.2010.03.038; Kassam AB, 2009, J NEUROSURG, V110, P116, DOI 10.3171/2008.7.JNS08226; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; KELLY PJ, 1988, J NEUROSURG, V69, P301, DOI 10.3171/jns.1988.69.2.0301; Kotipatruni RR, 2011, NEUROCHEM RES, V36, P2063, DOI 10.1007/s11064-011-0530-2; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Nishihara T, 2000, J NEUROSURG, V92, P1053, DOI 10.3171/jns.2000.92.6.1053; Okamoto T, 2001, JPN J PHARMACOL, V85, P95, DOI 10.1254/jjp.85.95; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Su ZD, 2010, GLIA, V58, P901, DOI 10.1002/glia.20972; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Takarada-Iemata M, 2014, J NEUROCHEM, V130, P374, DOI 10.1111/jnc.12729; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Villapol S, 2013, EXP NEUROL, V250, P353, DOI 10.1016/j.expneurol.2013.10.008; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wallenquist U, 2012, RESTOR NEUROL NEUROS, V30, P9, DOI 10.3233/RNN-2011-0606; Wang HH, 2012, NEUROIMMUNOMODULAT, V19, P304, DOI 10.1159/000339302; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Waran V, 2009, J NEUROSURG, V111, P1127, DOI 10.3171/2009.4.JNS081506; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Xie F, 2013, TOXICOL APPL PHARM, V272, P598, DOI 10.1016/j.taap.2013.07.020; Yabe JT, 2001, CELL MOTIL CYTOSKEL, V50, P1, DOI 10.1002/cm.1037; Yang JX, 2014, MOL THER, V22, P440, DOI 10.1038/mt.2013.241; Yang JX, 2010, AM J PATHOL, V177, P1989, DOI 10.2353/ajpath.2010.091203; Yang JX, 2009, J CLIN INVEST, V119, P3678, DOI 10.1172/JCI37914; Yang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002864; Yang LL, 2003, PLANTA MED, V69, P1091, DOI 10.1055/s-2003-45188; Yin F, 2014, BRAIN RES, V1561, P1, DOI 10.1016/j.brainres.2014.02.047; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; You L, 2009, NAT PROD COMMUN, V4, P297; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang N, 2013, INT J MOL SCI, V14, P18657, DOI 10.3390/ijms140918657; Zhang N, 2012, EUR J PHARMACOL, V697, P32, DOI 10.1016/j.ejphar.2012.10.008; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	72	30	31	2	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	SEP 4	2015	12								155	10.1186/s12974-015-0373-x			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CQ7LT	WOS:000360786300001	26337552	gold, Green Published			2022-02-06	
J	Boltz, MM; Podany, AB; Hollenbeak, CS; Armen, SB				Boltz, Melissa M.; Podany, Abigail B.; Hollenbeak, Christopher S.; Armen, Scott B.			Injuries and outcomes associated with traumatic falls in the elderly population on oral anticoagulant therapy	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Elderly; Trauma; Falls; Oral anticoagulation	BRAIN-INJURY; PREINJURY WARFARIN; INTRACRANIAL HEMORRHAGE; HEAD-INJURY; MORTALITY; RISK; ANTIPLATELET; CLOPIDOGREL; INCREASE; IMPACT	Introduction: Fall risk for older adults is a multi-factorial public health problem as 90% of geriatric injuries are caused by traumatic falls. The CDC estimated 33% of adults >65 years incurred a fall in 2011, with 30% resulting in moderate injury. While much has been written about overall risk to trauma patients on oral anticoagulant (OAC) therapy, less has been reported on outcomes in the elderly trauma population. We used data from the National Trauma Data Bank (NTDB) to identify the types of injury and complications incurred, length of stay, and mortality associated with OACs in elderly patients sustaining a fall. Methods: Using standard NTDB practices, data were collected on elderly patients (>= 65 years) on OACs with diagnosis of fall as the primary mechanism of injury from 2007 to 2010. Univariate analysis was used to determine patient variables influencing risk of fall on OACs. Odds ratios were calculated for types of injury sustained and post-trauma complications. Logistic regression was used to determine mortality associated with type of injury incurred. Results: Of 118,467 elderly patients sampled, OAC use was observed in 444. Predisposing risk factors for fall on OACs were >1 comorbidity (p < 0.0001). Patients on OACs were 188% and 370% more likely to develop 2 and >3 complications (p < 0.0001); the most significant being ARDS and ARF (p < 0.0001). The mortality rate on OACs was 16%. Injuries to the GI tract, liver, spleen, and kidney (p < 0.0002) were more likely to occur. However, if patients suffered a mortality, the most significant injuries were skull fractures and intracranial haemorrhage (p < 0.0001). Conclusions: Risks of anticoagulation in elderly trauma patients are complex. While OAC use is a predictor of 30-day mortality after fall, the injuries sustained are markedly different between the elderly who die and those who do not. As a result there is a greater need for healthcare providers to identify preventable and non-preventable risks factors indicative of falls in the anti-coagulated elderly patient. (C) 2015 Elsevier Ltd. All rights reserved.	[Boltz, Melissa M.; Podany, Abigail B.; Hollenbeak, Christopher S.; Armen, Scott B.] Penn State Univ, Coll Med, Dept Surg, Hershey, PA 17033 USA; [Hollenbeak, Christopher S.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA		Hollenbeak, CS (corresponding author), Penn State Univ, Coll Med, Dept Surg, 500 Univ Dr,H151, Hershey, PA 17033 USA.	boltzm@ccf.org; apodany@hmc.psu.edu; chollenbeak@psu.edu; sarmen@hmc.psu.edu	Hollenbeak, Christopher S./A-5309-2019	Hollenbeak, Christopher S./0000-0002-3362-814X			Bradburn E, 2012, J TRAUMA ACUTE CARE, V73, P435, DOI 10.1097/TA.0b013e31825c7cf4; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Karni A, 2001, AM SURGEON, V67, P1098; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; National Trauma Data Bank, 2013, ANN REP 2012; National Trauma Data Bank, 2013, DAT DICT 2013; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Sellers MB, 2011, AM HEART J, V161, P241, DOI 10.1016/j.ahj.2010.11.002; Williams TM, 2008, J TRAUMA, V65, P772, DOI 10.1097/TA.0b013e3181877ff7; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	19	30	30	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2015	46	9					1765	1771		10.1016/j.injury.2015.06.013			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CS9LO	WOS:000362412800013	26117415				2022-02-06	
J	Littleton, AC; Register-Mihalik, JK; Guskiewicz, KM				Littleton, Ashley C.; Register-Mihalik, Johna K.; Guskiewicz, Kevin M.			Test-Retest Reliability of a Computerized Concussion Test: CNS Vital Signs	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; psychometrics; cognition; computerized neurocognitive testing; Concussion Vital Signs	SPORT-RELATED CONCUSSION; AGE-RELATED DIFFERENCES; HIGH-SCHOOL; ONLINE VERSION; IMPACT; BATTERY; ASSESSMENTS; PERFORMANCE; MANAGEMENT; RECOVERY	Background: Neurocognitive testing is an important concussion evaluation tool, but for neurocognitive tests to be useful, their psychometric properties must be well established. Test-retest reliability of computerized neurocognitive tests can influence their clinical utility. The reliability for a commonly used computerized neurocognitive test, CNS Vital Signs, is not well established. The purpose of this study was to examine test-retest reliability and reliable change indices for CNS Vital Signs in a healthy, physically active college population. Hypothesis: CNS Vital Signs yields acceptable test-retest reliability, with greater reliability between the second and third test administration compared with between the first and second administration. Study Design: Cohort study. Level of Evidence: Level 3. Methods: Forty healthy, active volunteers (16 men, 24 women; mean age, 21.05 +/- 2.17 years) reported to a clinical laboratory for 3 sessions, 1 week apart. At each session, participants were administered CNS Vital Signs. Outcomes included standard scores for the following CNS Vital Signs domains: verbal memory, visual memory, psychomotor speed, cognitive flexibility, complex attention, processing speed, reaction time, executive functioning, and reasoning. Results: Participants performed significantly better on the second session and/or third session than they did on the first testing session on 6 of 9 neurocognitive domains. Pearson r test-retest correlations between sessions ranged from 0.11 to 0.87. Intraclass correlation coefficients ranged from 0.10 to 0.86. Conclusion: Clinicians should consider using reliable change indices to account for practice effects, identify meaningful score changes due to pathology, and inform clinical decisions. Clinical Relevance: This study highlights the importance of clinicians understanding the psychometric properties of computerized neurocognitive tests when using them in the management of sport-related concussion. If CNS Vital Signs is administered twice within a small time frame (such as 1 week), athletes should be expected to improve between the first and second administration.	[Littleton, Ashley C.; Register-Mihalik, Johna K.; Guskiewicz, Kevin M.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC 27515 USA; [Littleton, Ashley C.; Register-Mihalik, Johna K.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Hall CB 8700, Chapel Hill, NC 27599 USA; [Littleton, Ashley C.; Register-Mihalik, Johna K.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27599 USA		Littleton, AC (corresponding author), Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC 27515 USA.; Littleton, AC (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Hall CB 8700, Chapel Hill, NC 27599 USA.	alittlet@live.unc.edu			American Academy of Neurology; NATA; University of Kentucky; Allied Health education	The following author declared potential conflicts of interest: Johna K. Register-Mihalik, PhD, ATC, has received payment for lectures from American Academy of Neurology, NATA, University of Kentucky, and Allied Health education and has received payment for development of educational presentations from Allied Health Education. CNS Vital Signs LLC provided their product free of charge to the researchers.	Broglio SP, 2007, J ATHL TRAINING, V42, P504; CNS Vital Signs LLC, FREQ ASK QUEST; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Leckie RL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00985; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Voss MW, 2011, NEUROSCIENCE, V199, P166, DOI 10.1016/j.neuroscience.2011.10.009	25	30	30	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP-OCT	2015	7	5					443	447		10.1177/1941738115586997			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	V20NT	WOS:000214894000011	26502421	Green Published			2022-02-06	
J	McGlade, E; Rogowska, J; Yurgelun-Todd, D				McGlade, Erin; Rogowska, Jadwiga; Yurgelun-Todd, Deborah			Sex differences in orbitofrontal connectivity in male and female veterans with TBI	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic Brain Injury; Orbitofrontal; Functional connectivity; Aggression	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; RESTING-STATE; AGGRESSIVE-BEHAVIOR; GENDER-DIFFERENCES; OEF/OIF VETERANS; MENSTRUAL-CYCLE; MILD TBI; PTSD	More female soldiers are now serving in combat theaters than at any other time. However, little is known about possible sex differences underlying the neuropathology and manifestation of one of modern war's signature injuries, traumatic brain injury (TBI). The paucity of information regarding sex differences in TBI is particularly evident when examining changes in executive function and emotion regulation associated with post concussive events. The current study objective was to observe whether patterns of orbitofrontal (OFC) functional connectivity would differ between female veterans with TBI and their male counterparts. The study further sought to determine whether OFC connectivity might be differentially associated with clinical measures of aggression and hostility. Seventeen female veterans and 24 male veterans, age 18 to 25, who met criteria for TBI completed resting state magnetic resonance imaging (MRI) and clinical assessment measures. Imaging data were analyzed using left and right seed regions of the OFC, and regression analyses were conducted to observe the relationship between resting state connectivity and self-reported aggression. Females and males in this study differed in OFC connectivity, with females demonstrating greater connectivity between left and right OFC and parietal and occipital regions and males demonstrating greater connectivity between left and right OFC and frontal and temporal regions. Significant associations between resting state connectivity and clinical measures were found only in male veterans. These findings suggest that TBI may interact with sex-specific patterns of brain connectivity in male and female veterans and exert divergent effects on clinical profiles of aggression post-injury.	[McGlade, Erin; Yurgelun-Todd, Deborah] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [McGlade, Erin; Yurgelun-Todd, Deborah] VISN 19 MIRECC, Salt Lake City, UT USA; [McGlade, Erin; Rogowska, Jadwiga; Yurgelun-Todd, Deborah] Univ Utah, Inst Brain, Salt Lake City, UT USA		McGlade, E (corresponding author), Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA.	erin.mcglade@hsc.utah.edu	McGlade, Erin C/K-1157-2016	McGlade, Erin C/0000-0003-2234-1984	Department of Veterans Affairs Salt Lake City Mental Illness Research, Education & Clinical Center (MIRECC) [1I01CX000253-01]; Military Suicide Research Consortium (MSRC) - Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0178]; Veterans AffairsUS Department of Veterans Affairs [I01CX000253] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs Salt Lake City Mental Illness Research, Education & Clinical Center (MIRECC), Merit Review 1I01CX000253-01 (PI Yurgelun-Todd), and the Military Suicide Research Consortium (MSRC), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-10-2-0178. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Veterans Affairs, MSRC, or Department of Defense.	Afari N, 2015, MIL MED, V180, P296, DOI 10.7205/MILMED-D-14-00255; Angkaw AC, 2013, MIL MED, V178, P1044, DOI 10.7205/MILMED-D-13-00061; Antonucci AS, 2006, PSYCHIAT RES-NEUROIM, V147, P213, DOI 10.1016/j.pscychresns.2005.05.016; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Berman KF, 1997, P NATL ACAD SCI USA, V94, P8836, DOI 10.1073/pnas.94.16.8836; Beyer F, 2015, CEREB CORTEX, V25, P3057, DOI 10.1093/cercor/bhu101; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Bradley C, 2007, J FAM VIOLENCE, V22, P197, DOI 10.1007/s10896-007-9072-4; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Campbell S. B., 2015, J TRAUMA DISSOCIATIO, P1, DOI [10.1080/15299732.2014, DOI 10.1080/15299732.2014]; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Cleverley K, 2012, J AM ACAD CHILD PSY, V51, P1037, DOI 10.1016/j.jaac.2012.07.010; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Congressional Budget Office, 2012, VET HLTH ADM TREATM, DOI [11-2012/reports/02-09-PTSD_0.pdf, DOI 11-2012/REPORTS/02-09-PTSD_0.PDF]; Corcoran K, 2000, MEASURES CLIN PRACTI, V2; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Craske MG, 2012, DEPRESS ANXIETY, V29, P253, DOI 10.1002/da.21930; Cuthbert BN, 2014, PSYCHOPHYSIOLOGY, V51, P1205, DOI 10.1111/psyp.12342; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Damasio A., 1994, DESCARTES ERROR EMOT; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Denson TF, 2006, J PERS SOC PSYCHOL, V90, P1032, DOI 10.1037/0022-3514.90.6.1032; Department of Veterans Affairs, 2013, AM WARS; DERMAN RJ, 1995, AM J MED, V98, pS137, DOI 10.1016/S0002-9343(99)80072-2; Elbogen EB, 2013, J NERV MENT DIS, V201, P872, DOI 10.1097/NMD.0b013e3182a6e76b; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fernandez G, 2003, J NEUROSCI, V23, P3790; Flanagan Julianne C, 2014, Ment Health Subst Use, V7, P315; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gallaway MS, 2012, AGGRESSIVE BEHAV, V38, P357, DOI 10.1002/ab.21436; Gansler DA, 2011, PSYCHIAT RES-NEUROIM, V191, P16, DOI 10.1016/j.pscychresns.2010.09.003; Goldstein JM, 2005, NEUROPSYCHOLOGY, V19, P509, DOI 10.1037/0894-4105.19.4.509; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamilton M, 1969, BRIT J PSYCHIAT, V3, P76; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Joffe H, 2006, MENOPAUSE, V13, P411, DOI 10.1097/01.gme.0000189618.48774.7b; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Karairmak O, 2014, PSYCHIAT RES, V219, P536, DOI 10.1016/j.psychres.2014.05.024; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; LaMotte AD, 2014, PSYCHOL ASSESSMENT, V26, P8, DOI 10.1037/a0034579; Love AR, 2015, J INTERPERS VIOLENCE, V30, P2344, DOI 10.1177/0886260514552445; Luxton DD, 2010, DEPRESS ANXIETY, V27, P1027, DOI 10.1002/da.20730; Maccoby E.E., 1974, PSYCHOL SEX DIFFEREN; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Miles SR, 2016, J INTERPERS VIOLENCE, V31, P1795, DOI 10.1177/0886260515570746; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pietrini P, 2000, AM J PSYCHIAT, V157, P1772, DOI 10.1176/appi.ajp.157.11.1772; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Reardon AF, 2014, J ANXIETY DISORD, V28, P488, DOI 10.1016/j.janxdis.2014.05.001; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Reynolds WM, 1998, J SCHOOL PSYCHOL, V36, P295, DOI 10.1016/S0022-4405(98)00010-7; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Rudebeck PH, 2008, COGN AFFECT BEHAV NE, V8, P485, DOI 10.3758/CABN.8.4.485; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tharp AT, 2016, J INTERPERS VIOLENCE, V31, P1095, DOI 10.1177/0886260514564067; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; United States Department of Veterans Affairs, 2014, TRENDS UT VA PROGR S; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Whalley HC, 2009, BIPOLAR DISORD, V11, P840, DOI 10.1111/j.1399-5618.2009.00768.x; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	93	30	30	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					535	549		10.1007/s11682-015-9379-3			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CR8LQ	WOS:000361604300014	25864195	Green Published, hybrid			2022-02-06	
J	Sharma, D; Holowaychuk, MK				Sharma, Diya; Holowaychuk, Marie K.			Retrospective evaluation of prognostic indicators in dogs with head trauma: 72 cases (January-March 2011)	JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE			English	Article						canine; perfusion; prognosis; severity score; traumatic brain injury	GLASGOW COMA SCALE; SEVERE BRAIN-INJURY; HYPERGLYCEMIA; PATIENT; SEVERITY; MANAGEMENT; ILLNESS; PATHOPHYSIOLOGY; SYSTEM; SCORE	Objective To investigate the prognostic value of clinical and laboratory variables and scoring systems in dogs with head trauma. Design Retrospective study (January-March, 2011). Setting University teaching hospital. Animals Seventy-two client-owned dogs with a history of head trauma occurring 5 days prior to hospital admission. Dogs were excluded if they had an unconfirmed history of trauma, preexisting neurologic disease, or insufficient data available in the medical record. Interventions None. Measurements and Main Results Data from hospital admission were collected, including vital signs; blood pressure; pulse oximetry; venous blood gases and electrolyte concentrations; plasma lactate and blood glucose concentrations; PCV; total plasma protein concentration; activated clotting time; WBC count; and serum albumin, creatinine, total bilirubin, and BUN concentrations. Modified Glasgow Coma Scale (MGCS), mentation, and animal trauma triage (ATT) scores were also calculated. Treatment with mannitol, hypertonic saline (HS), corticosteroids, benzodiazepines, or phenobarbital, and requirement for endotracheal intubation were also recorded. Outcome was classified as survival or nonsurvival to hospital discharge. Decreased pulse oximetry, pH, bicarbonate concentration, or base excess, and increased potassium concentration, lactate concentration, BUN concentration, ATT score, or mentation score were risk factors for nonsurvival. Decreased MGCS score was the strongest predictor of nonsurvival; a score 11 was 84% sensitive and 73% specific for predicting nonsurvival. Dogs were more likely to die before discharge if they required HS or endotracheal intubation. Conclusions Dogs that did not survive following head trauma were more likely to have poor perfusion, severe concurrent injuries reflected by increased ATT scores, severe traumatic brain injury as evidenced by decreased MGCS or increased mentation scores, or requirement for HS administration or endotracheal intubation.	[Sharma, Diya; Holowaychuk, Marie K.] Univ Guelph, Ontario Vet Coll, Hlth Sci Ctr, Guelph, ON N1G 2W1, Canada		Holowaychuk, MK (corresponding author), Crit Care Vet Consulting, Calgary, AB, Canada.	criticalcarevet@outlook.com					Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Armitage-Chan EA, 2007, J VET EMERG CRIT CAR, V17, P5, DOI 10.1111/j.1476-4431.2006.00194.x; Buck BD, 2002, J PHARM PRACTICE, V15, P167, DOI 10.1106/55K6-GR05-T1PW; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Dewey CW, 2000, VET CLIN N AM-SMALL, V30, P207, DOI 10.1016/S0195-5616(00)50010-2; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Hall KE, 2014, JAVMA-J AM VET MED A, V244, P300, DOI 10.2460/javma.244.3.300; Hayes G, 2010, J VET INTERN MED, V24, P1034, DOI 10.1111/j.1939-1676.2010.0552.x; Hayes G, 2010, J VET INTERN MED, V24, P457, DOI 10.1111/j.1939-1676.2010.0483.x; Hayes GM, 2009, J VET EMERG CRIT CAR, V19, P629, DOI 10.1111/j.1476-4431.2009.00478.x; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Knieriem M, 2007, COMP CONT EDUC PRACT, V29, P360; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; MARGULIES DR, 1994, AM SURGEON, V60, P387; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Platt S, 2005, IN PRACTICE, V27, P31, DOI 10.1136/inpract.27.1.31; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Proulx J, 1998, COMP CONT EDUC PRACT, V20, P897; RaeGrant AD, 1996, J TRAUMA, V40, P401, DOI 10.1097/00005373-199603000-00013; Rockar R. A., 1994, Journal of Veterinary Emergency & Critical Care, V4, P77, DOI 10.1111/j.1476-4431.1994.tb00118.x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; SHORES A, 1983, CURRENT VET THERAPY, P847; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; STARMARK JE, 1991, LANCET, V337, P1042, DOI 10.1016/0140-6736(91)92705-7; Streeter EM, 2009, JAVMA-J AM VET MED A, V235, P405, DOI 10.2460/javma.235.4.405; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124; Syring RS, 2005, VET CLIN N AM-SMALL, V35, P343, DOI 10.1016/j.cvsm.2004.10.007; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]	33	30	30	0	31	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1479-3261	1476-4431		J VET EMERG CRIT CAR	J. Vet. Emerg. Crit. Care	SEP-OCT	2015	25	5					631	639		10.1111/vec.12328			9	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	CT6ZE	WOS:000362961600008	26112259				2022-02-06	
J	Schofield, PW; Malacova, E; Preen, DB; D'Este, C; Tate, R; Reekie, J; Wand, H; Butler, T				Schofield, Peter W.; Malacova, Eva; Preen, David B.; D'Este, Catherine; Tate, Robyn; Reekie, Joanne; Wand, Handan; Butler, Tony			Does Traumatic Brain Injury Lead to Criminality? A Whole-Population Retrospective Cohort Study Using Linked Data	PLOS ONE			English	Article							HEAD-INJURY; PSYCHIATRIC-ILLNESS; AFGHANISTAN; DISORDERS; PRISONERS; IRAQ; TBI	Background Traumatic brain injury (TBI) may be a risk factor for criminal behaviour however multiple factors potentially confound the association. Methods Record linkage and Cox proportional hazards regression analyses were used to examine the association between hospital-recorded TBI (n = 7,694) and subsequent first criminal conviction in a retrospective cohort matched 1: 3 with 22,905 unaffected community controls and full-sibling controls (n = 2,397). Aboriginality, substance abuse, social disadvantage, and mental illness were included in analyses as potential confounders Results In multivariable models, relative to general population controls, TBI was associated with any conviction (males: Hazard Ratio (HR) = 1.58 (95% CI 1.46 to 1.72); females: HR = 1.52 (95% CI 1.28 to 1.81)); and similar Hazard Ratios were obtained for the sibling analyses in males (HR = 1.68 (95% CI 1.31-2.18)) and females (HR 1.27 (95% CI 0.71-2.29)). TBI was also associated with violent convictions relative to the general population, (males: HR = 1.65 (95% CI 1.42 to 1.92); females HR = 1.73 (95% CI 1.21 to 2.47)), and in analyses with sibling controls in men (HR = 1.89 (95% CI 1.20-3.00)), but not in women (HR 0.73, 95% CI 0.29-1.81)). Conclusion The results support a modest causal link between TBI and criminality after comprehensive adjustment for confounding. Reducing the rate of TBI, a major public health imperative, might have benefits in terms of crime reduction.	[Schofield, Peter W.] Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia; [Schofield, Peter W.] Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Malacova, Eva; Preen, David B.] Univ Western Australia, Sch Populat Hlth, Ctr Hlth Serv Res, Perth, WA 6009, Australia; [D'Este, Catherine] Australian Natl Univ, Natl Ctr Epidemiol & Publ Hlth, Canberra, ACT, Australia; [Tate, Robyn] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Reekie, Joanne; Wand, Handan; Butler, Tony] UNSW Australia, Kirby Inst, Sydney, NSW, Australia		Schofield, PW (corresponding author), Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia.	peter.schofield@hnehealth.nsw.gov.au	Preen, David/H-5663-2014	Preen, David/0000-0002-2982-2169; Butler, Tony/0000-0002-2679-2769; Schofield, Peter/0000-0001-8298-8590	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [533504]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K006525/1] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K006525/1] Funding Source: UKRI	Funding was supplied by the National Health and Medical Research Council (grant # 533504) to TB, PWS, RT, DBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, AUSTR VERS INT CLASS, V1; [Anonymous], 2010, INT STAT CLASS DIS R; Australian Bureau of Statistics, 2006, SOC IND AR SEIFA TEC; BIJUR PE, 1990, PEDIATRICS, V86, P337; Briffa TG, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-111; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Cobb BK, 1995, J ADOLESCENT HEALTH, V17, P381, DOI 10.1016/1054-139X(95)00059-2; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Frisell T, 2012, BEHAV GENET, V42, P3, DOI 10.1007/s10519-011-9483-0; Hodgins S, 1996, ARCH GEN PSYCHIAT, V53, P489, DOI 10.1001/archpsyc.1996.01830060031004; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hosmer DW, 1999, APPL SURVIVAL ANAL R; Institute for Digital Research and Education, INTR TO SAS; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Lahey BB, 2010, CURR DIR PSYCHOL SCI, V19, P319, DOI 10.1177/0963721410383977; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mayhew P, 2003, TRENDS ISS CRIME CRI, V247, P1; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Mulder E, 2011, INT J OFFENDER THER, V55, P118, DOI 10.1177/0306624X09356683; Preen D, 2003, AUST EPIDEMIOL, V10, P24; Rowe DC, 1997, CRIMINOLOGY, V35, P177, DOI 10.1111/j.1745-9125.1997.tb00874.x; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Sourander A, 2011, SOC PSYCH PSYCH EPID, V46, P1211, DOI 10.1007/s00127-010-0292-1; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017	37	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2015	10	7							e0132558	10.1371/journal.pone.0132558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1QN	WOS:000358194900058	26172545	Green Published, gold			2022-02-06	
J	Moore, IS; Ranson, C; Mathema, P				Moore, Isabel S.; Ranson, Craig; Mathema, Prabhat			Injury Risk in International Rugby Union Three-Year Injury Surveillance of the Welsh National Team	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						injury epidemiology; rugby; concussion; hematoma	DATA-COLLECTION PROCEDURES; WORLD ATHLETICS CHAMPIONSHIPS; CONSENSUS STATEMENT; SPORTS INJURIES; CUP 2011; EPIDEMIOLOGY; CONCUSSION; FOOTBALL; DEFINITIONS; PLAYERS	Background: Within international Rugby Union, only injury rates during the Rugby World Cup have been reported. Therefore, injury rates and types during other international tournaments are unknown. Purpose: To assess the 3-year incidence, severity, nature, and causes of match and training injuries sustained during different international tournaments played by the Welsh national Rugby Union team. Study Design: Descriptive epidemiology study. Methods: Injury data for all players (n = 78) selected for 1 national Rugby Union team over a 3-year period were analyzed using the international consensus statement methods. Player height (cm) and mass (kg) were recorded. Tournaments were grouped for comparisons as: autumn tournaments (2012 and 2013), Rugby World Cup (RWC; 2011), Six Nations (2012, 2013, and 2014), and summer tournaments (2012, 2013, and 2014). Injury incidence (injuries/1000 hours), prevalence (% of players unavailable), and severity (days lost) were calculated for each tournament. Injury location, type, and cause of match and training injuries were analyzed. Results: Match injury incidence was highest during autumn tournaments (262.5/1000 match-hours) and lowest during the RWC (178.6/1000 match-hours). Summer tournaments had the highest training incidence (5.5 injuries/1000 training-hours). Mild injuries were most likely during the RWC (risk ratio [RR], 2.02; 95% CI, 1.26-3.24), while severe injuries were most likely during autumn tournaments (RR, 3.27; 95% CI, 1.70-6.29). Quadriceps hematomas (18.8/1000 match-hours; 95% CI, 11.3-31.1) and concussions (13.8/1000 match-hours; 95% CI, 7.6-24.8) were the most common match injuries, with shoulder dislocations being the most severe (111 mean days lost per injury). Conclusion: Injury rates were considerably higher than those previously reported for multiple teams during RWC tournaments. Further investigation of injury rates and risk factors is recommended to accurately gauge their impact within international Rugby Union, particularly with regard to lower limb hematoma, concussion, and shoulder injuries.	[Moore, Isabel S.; Ranson, Craig; Mathema, Prabhat] Cardiff Metropolitan Univ, Cardiff Sch Sport, Cardiff CF23 6XD, S Glam, Wales		Moore, IS (corresponding author), Cardiff Metropolitan Univ, Cardiff Sch Sport, Sports Injury Res Grp, Cyncoed Campus, Cardiff CF23 6XD, S Glam, Wales.	imoore@cardiffmet.ac.uk	Ranson, Craig/AAQ-5452-2020	Moore, Isabel/0000-0002-4746-3390			Alonso JM, 2010, BRIT J SPORT MED, V44, P1100, DOI 10.1136/bjsm.2010.078030; Best JP, 2005, BRIT J SPORT MED, V39, P812, DOI 10.1136/bjsm.2004.016402; Bohu Y, 2015, BRIT J SPORT MED, V49, P1535, DOI 10.1136/bjsports-2014-093718; Brooks JHM, 2011, BRIT J SPORT MED, V45, P765, DOI 10.1136/bjsm.2009.066985; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P288, DOI 10.1136/bjsm.2004.013391; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Brooks JHM, 2006, SPORTS MED, V36, P459, DOI 10.2165/00007256-200636060-00001; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finch CF, 2014, BRIT J SPORT MED, V48, P1276, DOI 10.1136/bjsports-2012-091729; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hagglund M, 2013, BRIT J SPORT MED, V47, P738, DOI 10.1136/bjsports-2013-092215; Harris DA, 2010, BRIT J SPORT MED, V44, P200, DOI 10.1136/bjsm.2008.047449; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Headey J, 2007, AM J SPORT MED, V35, P1537, DOI 10.1177/0363546507300691; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Lynch E, 2013, PAK J MED SCI, V29, P1400; Alonso JM, 2009, CLIN J SPORT MED, V19, P26, DOI 10.1097/JSM.0b013e318191c8e7; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moore I, 2014, BRIT J SPORT MED, V48, P642; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Orchard JW, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.012732; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Ranson C, 2013, BRIT J SPORT MED, V47, P637, DOI 10.1136/bjsports-2012-091783; Roberts SP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003998; Rugby Football Union, 2014, ENGL PROF RUGB INJ S; Timpka T, 2014, BRIT J SPORT MED, V48, P483, DOI 10.1136/bjsports-2013-093241; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Usman J, J SCI MED SPORT, DOI [10.1016/jsams.2014.07.020, DOI 10.1016/JSAMS.2014.07.020]; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Rugby, WORLD RUGB RANK	38	30	30	1	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JUL	2015	3	7							2325967115596194	10.1177/2325967115596194			9	Orthopedics; Sport Sciences	Emerging Sources Citation Index (ESCI)	Orthopedics; Sport Sciences	DE1KB	WOS:000370384700008	26674339	Green Published, gold, Green Accepted			2022-02-06	
J	Schiehser, DM; Twamley, EW; Liu, L; Matevosyan, A; Filoteo, JV; Jak, AJ; Orff, HJ; Hanson, KL; Sorg, SF; Delano-Wood, L				Schiehser, Dawn M.; Twamley, Elizabeth W.; Liu, Lin; Matevosyan, Adelina; Filoteo, J. Vincent; Jak, Amy J.; Orff, Henry J.; Hanson, Karen L.; Sorg, Scott F.; Delano-Wood, Lisa			The Relationship Between Postconcussive Symptoms and Quality of Life in Veterans With Mild to Moderate Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							HEAD-INJURY; FATIGUE; COMPLAINTS; INSOMNIA; WHOQOL	Objective: To assess the relationship between postconcussive symptoms and quality of life (QOL) in Veterans with mild to moderate traumatic brain injury (TBI). Methods: Sixty-one Operation Enduring Freedom/Operation Iraqi Freedom/Persian Gulf War Veterans with a history of mild or moderate TBI, more than 6 months postinjury, and 21 demographically matched Veteran controls were administered self-report measures of QOL (World Health Organization Quality of Life-BREF) and postconcussive symptom severity (Neurobehavioral Symptom Inventory). Results: Perceived QOL was significantly worse in Veterans with mild-moderate TBI than in controls. In the TBI group, QOL was predominantly associated with affective symptoms, and moderate to strong correlations with fatigue and depression were evident across all QOL areas. Multivariate analyses revealed depression and fatigue to be the best predictors of Psychological, Social, and Environmental QOL, whereas sleep difficulty best predicted Physical QOL in mild-moderate TBI. Conclusion: Veterans with post-acute mild-moderate TBI evidence worse QOL than demographically matched Veteran controls. Affective symptoms, and specifically those of fatigue, depression, and sleep difficulty, appear to be the most relevant postconcussive symptoms predicting QOL in this population. These findings underscore the importance of examining specific symptoms as they relate to post-acute TBI QOL and provide guidance for treatment and intervention studies.	[Schiehser, Dawn M.; Twamley, Elizabeth W.; Matevosyan, Adelina; Filoteo, J. Vincent; Jak, Amy J.; Hanson, Karen L.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, San Diego, CA USA; [Schiehser, Dawn M.; Twamley, Elizabeth W.; Filoteo, J. Vincent; Jak, Amy J.; Orff, Henry J.; Hanson, Karen L.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Liu, Lin] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Twamley, Elizabeth W.; Jak, Amy J.; Orff, Henry J.; Hanson, Karen L.; Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Sorg, Scott F.] VA Puget Sound Hlth Care Syst, Seattle, WA USA		Schiehser, DM (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	dschiehser@ucsd.edu			VA Career Development award; Department of Defense awardUnited States Department of Defense	This study was supported by VA Career Development (D.M.S. and L.D-W.) and Department of Defense (L.D-W.) awards. The authors thank Russell Kim, Elisa Lanni, and Norman Luc for their help with data collection and compilation. They also thank the patients, staff, and volunteers associated with the VA San Diego Healthcare System for their involvement in this study.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; [Anonymous], 2014, DOD WORLDWIDE NUMBER; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Den Oudsten BL, 2007, MOVEMENT DISORD, V22, P1528, DOI 10.1002/mds.21567; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Tanielian T., 2008, INVISIBLE WOUNDS WAR; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512	31	30	30	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2015	30	4					E21	E28		10.1097/HTR.0000000000000065			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CM8JB	WOS:000357944800003	24922041				2022-02-06	
J	Yang, LY; Chu, YH; Tweedie, D; Yu, QS; Pick, CG; Hoffer, BJ; Greig, NH; Wang, JY				Yang, L-Y.; Chu, Y-H.; Tweedie, D.; Yu, Q-S.; Pick, C. G.; Hoffer, B. J.; Greig, N. H.; Wang, J-Y			Post-trauma administration of the pifithrin-alpha oxygen analog improves histological and functional outcomes after experimental traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury (TBI); p53; Pifithrin-alpha (PFT-alpha); PFT-alpha oxygen analog; Apoptosis; Controlled cortical impact	HIPPOCAMPAL CA1 NEURONS; FOCAL CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; CELL-DEATH; PROTEIN EXPRESSION; DOPAMINE NEURONS; P53 INHIBITORS; MESSENGER-RNA; DNA-DAMAGE; CNS INJURY	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Programmed death of neuronal cells plays a crucial role in acute and chronic neurodegeneration following TBI. The tumor suppressor protein p53, a transcription factor, has been recognized as an important regulator of apoptotic neuronal death. The p53 inactivator pifithrin-alpha (PET-alpha) has been shown to be neuroprotective against stroke. A previous cellular study indicated that PFT-alpha oxygen analog (PFT-alpha (O)) is more stable and active than PET-alpha. We aimed to investigate whether inhibition of p53 using PFT-alpha or PET-alpha (O) would be a potential neuroprotective strategy for TBI. To evaluate whether these drugs protect against excitotoxicity in vitro, primary rat cortical cultures were challenged with glutamate (50 mM) in the presence or absence of various concentrations of the p53 inhibitors PFT-alpha or PET-alpha (O). Cell viability was estimated by LDH assay. In vivo, adult Sprague Dawley rats were subjected to controlled cortical impact (CCI, with 4 m/s velocity, 2 mm deformation). Five hours after injury, PET-alpha or PET-alpha (O) (2 mg/kg, i.v.) was administered to animals. Sensory and motor functions were evaluated by behavioral tests at 24 h after TBI. The p53-positive neurons were identified by double staining with cell-specific markers. Levels of mRNA encoding for p53-regulated genes (BAX, PUMA, Bcl-2 and p21) were measured by reverse transcription followed by real time-PCR from TBI animals without or with PET-alpha/PET-alpha (O) treatment We found that PET-alpha(O) (10 mu M) enhanced neuronal survival against glutamate-induced cytotoxicity in vitro more effectively than PET-alpha (10 mu M). In vivo PET-alpha (O) treatment enhanced functional recovery and decreased contusion volume at 24 h post-injury. Neuroprotection by PET-alpha (O) treatment also reduced p53-positive neurons in the cortical contusion region. In addition, p53-regulated PUMA mRNA levels at 8 h were significantly reduced by PET-alpha (O) administration after TBI. PFT-alpha (O) treatment also decreased phospho-p53 positive neurons in the cortical contusion region. Our data suggest that PET-alpha (O) provided a significant reduction of cortical cell death and protected neurons from glutamate-induced excitotoxicity in vitro, as well as improved neurological functional outcome and reduced brain injury in vivo via anti-apoptotic mechanisms. The inhibition of p53-induced apoptosis by PFT-alpha (O) provides a useful tool to evaluate reversible apoptotic mechanisms and may develop into a novel therapeutic strategy for TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Yang, L-Y.; Chu, Y-H.; Wang, J-Y] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan; [Tweedie, D.; Yu, Q-S.; Greig, N. H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Pick, C. G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Pick, C. G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Hoffer, B. J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Wang, J-Y] Taipei Med Univ, Dept Physiol, Coll Med, Sch Med, Taipei 110, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, 250 Wu Hsing St, Taipei 110, Taiwan.	jywang2010@tmu.edu.tw	Pick, Chaim/D-4789-2009	Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST103-2321-B-038-002]; Intramural Research Program, National Institute on Aging, NIH, USA; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000994, ZIAAG000311] Funding Source: NIH RePORTER	This study was supported in part by a grant from the Ministry of Science and Technology (MOST103-2321-B-038-002 to JY Wang), Taiwan, and by the Intramural Research Program, National Institute on Aging, NIH, USA.	ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Biswas SC, 2005, NEUROCHEM RES, V30, P839, DOI 10.1007/s11064-005-6877-5; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chou J, 2011, CELL TRANSPLANT, V20, P1351, DOI 10.3727/096368910X557173; Covini N, 1999, EUR J NEUROSCI, V11, P781, DOI 10.1046/j.1460-9568.1999.00485.x; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Culmsee C, 2003, J NEUROSCI, V23, P8586; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Endo H, 2006, BIOCHEM SOC T, V34, P1283, DOI 10.1042/BST0341283; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Eve DJ, 2007, BRAIN RES, V1150, P174, DOI 10.1016/j.brainres.2007.02.088; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Felts PA, 2005, BRAIN, V128, P1649, DOI 10.1093/brain/awh516; Gilman CP, 2003, NEUROMOL MED, V3, P159, DOI 10.1385/NMM:3:3:159; Greig NH, 2004, ANN NY ACAD SCI, V1035, P290, DOI 10.1196/annals.1332.018; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Huang YN, 2009, TOXICOL APPL PHARM, V240, P315, DOI 10.1016/j.taap.2009.06.021; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kuroki K, 2009, NEUROSCI LETT, V451, P237, DOI 10.1016/j.neulet.2009.01.019; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; LI Y, 1994, STROKE, V25, P849, DOI 10.1161/01.STR.25.4.849; Li Y, 1997, BRAIN RES, V765, P301, DOI 10.1016/S0006-8993(97)00524-6; Liang ZQ, 2007, BRAIN RES, V1145, P190, DOI 10.1016/j.brainres.2007.01.130; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; Nair VD, 2006, J BIOL CHEM, V281, P39550, DOI 10.1074/jbc.M603950200; Nakajima Y, 2010, TOHOKU J EXP MED, V221, P229, DOI 10.1620/tjem.221.229; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Niizuma K, 2009, STROKE, V40, P618, DOI 10.1161/STROKEAHA.108.524447; Pietrancosta N, 2006, J MED CHEM, V49, P3645, DOI 10.1021/jm060318n; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj/cdd/4400998; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sohn D, 2009, CELL DEATH DIFFER, V16, P869, DOI 10.1038/cdd.2009.17; Spaethling JM, 2007, PROG BRAIN RES, V161, P27, DOI 10.1016/S0079-6123(06)61003-0; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tomasevic G, 1999, MOL BRAIN RES, V70, P304, DOI 10.1016/S0169-328X(99)00146-1; Toth A, 2006, AM J PHYSIOL-HEART C, V291, pH52, DOI 10.1152/ajpheart.01046.2005; Trimmer PA, 1996, NEURODEGENERATION, V5, P233, DOI 10.1006/neur.1996.0031; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Verweij BH, 2007, PROG BRAIN RES, V161, P111, DOI 10.1016/S0079-6123(06)61008-X; Watanabe H, 1999, BRAIN RES, V837, P38, DOI 10.1016/S0006-8993(99)01652-2; Whiting M. D., 2006, ANIMAL MODELS COGNIT; Yang W, 2008, J TOXICOL ENV HEAL A, V71, P289, DOI 10.1080/15287390701738467; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; Zhu XX, 2002, J MED CHEM, V45, P5090, DOI 10.1021/jm020044d	65	30	31	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2015	269						56	66		10.1016/j.expneurol.2015.03.015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CJ6YH	WOS:000355640600006	25819102	Green Accepted			2022-02-06	
J	Green, GA; Pollack, KM; D'Angelo, J; Schickendantz, MS; Caplinger, R; Weber, K; Valadka, A; McAllister, TW; Dick, RW; Mandelbaum, B; Curriero, FC				Green, Gary A.; Pollack, Keshia M.; D'Angelo, John; Schickendantz, Mark S.; Caplinger, Roger; Weber, Kathleen; Valadka, Alex; McAllister, Thomas W.; Dick, Randall W.; Mandelbaum, Bert; Curriero, Frank C.			Mild Traumatic Brain Injury in Major and Minor League Baseball Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						professional baseball; traumatic brain injury; sports injury; concussion	SURVEILLANCE SYSTEM; CONCUSSION RATES; HIGH-SCHOOL; COLLEGIATE; EPIDEMIOLOGY; FOOTBALL; SPORTS; HEAD	Background: Although mild traumatic brain injury (MTBI) is not as common in professional baseball as in collision sports, it does occur and frequently results in significant loss of time away from the sport. To date, no study has investigated MTBI among an entire cohort of professional baseball players. Purpose: To investigate MTBIs in major and minor league baseball players to determine the most common mechanisms of injury, activity at time of injury, position, level of play, and time lost, as well as ultimately inform prevention efforts. A secondary objective was to document the association between MTBI and return to play using several different measures. Study Design: Descriptive epidemiologic study. Methods: Data were captured from a newly implemented league-wide injury surveillance system that records injuries among all professional baseball players as entered by certified athletic trainers and physicians. The MTBIs were identified with respect to level of play, activity, field location, and mechanism of injury. Time loss was assessed by 3 measures of return to play, and MTBI game rates were reported as injuries per 1000 athlete-exposures. Data were combined over the 2011-2012 seasons for analysis, and results were presented separately for minor and major league players. Chi-square tests were used to test the hypothesis of equal proportions between the various categories of MTBI injury characteristics. Results: There were 41 reported MTBIs in the major leagues and 266 in the minor leagues over the 2-year period under study. The overall MTBI game rate across both major and minor league ball clubs was 0.42 per 1000 athlete-exposures. The median time lost was 9 days. Mild traumatic brain injury accounted for 1% of all injuries resulting in time lost from play. For MTBIs that occurred while fielding, catchers were significantly overrepresented. No differences were noted among the 3 measures of time lost. Conclusion: Mild traumatic brain injury is an important problem in professional baseball players, especially for catchers. This study provides a foundation for future inquiry to reduce the incidence of MTBI in those positions at greatest risk and to provide a baseline as rules and equipment evolve.	Major League Baseball, New York, NY USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA		Green, GA (corresponding author), Pacific Palisades Med Grp, 15200 Sunset Blvd,Suite 107, Pacific Palisades, CA 90272 USA.	ggreen@mednet.ucla.edu			Office of the Commissioner of Major League Baseball; Major League Baseball Players Association	The authors acknowledge the contribution and the research support by the Office of the Commissioner of Major League Baseball and Jon Coyles, as well as the Major League Baseball Players Association and Drs Stephen Fealy and John Golfinos for their support and review of the manuscript. Finally, the authors acknowledge the dedication of the ATCs in collecting and entering data.	Ahmad CS, 2014, AM J SPORT MED, V42, P1464, DOI 10.1177/0363546514529083; Associated Press, 2007, CONC SYMPT FORC MATH; Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Dick R, 2007, J ATHL TRAINING, V42, P183; Dick R, 2007, J ATHL TRAINING, V42, P173; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; National Research Council, 2014, SPORT REL CONC YOUTH; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; R Development Core Team, 2012, R LANG ENV STAT COMP; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rosenbaum DA, 2014, INT J SPORTS MED, V35, P704, DOI 10.1055/s-0033-1363253; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Stovitz SD, 2012, BRIT J SPORT MED, V46, P960, DOI 10.1136/bjsports-2011-090693; Weinbaum W, 2014, PITCHERS PROTECTIVE	19	30	30	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2015	43	5					1118	1126		10.1177/0363546514568089			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	CH4CV	WOS:000353980000017	25660188				2022-02-06	
J	Schnakers, C; Giacino, JT; Lovstad, M; Habbal, D; Boly, M; Di, HB; Majerus, S; Laureys, S				Schnakers, Caroline; Giacino, Joseph T.; Lovstad, Marianne; Habbal, Dina; Boly, Melanie; Di, Haibo; Majerus, Steve; Laureys, Steven			Preserved Covert Cognition in Noncommunicative Patients With Severe Brain Injury?	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						vegetative state; minimally conscious state; consciousness; attention; event-related potentials	MINIMALLY CONSCIOUS STATE; EVENT-RELATED POTENTIALS; VEGETATIVE STATE; ATTENTIONAL NETWORKS; OWN NAME; DISORDERS; STIMULUS; P300; AWARENESS; COMA	Background. Despite recent evidence suggesting that some severely brain-injured patients retain some capacity for top-down processing (covert cognition), the degree of sparing is unknown. Objective. Top-down attentional processing was assessed in patients in minimally conscious (MCS) and vegetative states (VS) using an active event-related potential (ERP) paradigm. Methods. A total of 26 patients were included (38 +/- 12 years old, 9 traumatic, 21 patients >1 year postonset): 8 MCS+, 8 MCS-, and 10 VS patients. There were 14 healthy controls (30 +/- 8 years old). The ERP paradigm included (1) a passive condition and (2) an active condition, wherein the participant was instructed to voluntarily focus attention on his/her own name. In each condition, the participant's own name was presented 100 times (ie, 4 blocks of 25 stimuli). Results. In 5 MCS+ patients as well as in 3 MCS- patients and 1 VS patient, an enhanced P3 amplitude was observed in the active versus passive condition. Relative to controls, patients showed a response that was (1) widely distributed over frontoparietal areas and (2) not present in all blocks (3 of 4). In patients with covert cognition, the amplitude of the response was lower in frontocentral electrodes compared with controls but did not differ from that in the MCS+ group. Conclusion. The results indicate that volitional top-down attention is impaired in patients with covert cognition. Further investigation is crucially needed to better understand top-down cognitive functioning in this population because this may help refine brain-computer interface-based communication strategies.	[Schnakers, Caroline; Habbal, Dina; Boly, Melanie; Laureys, Steven] Univ Hosp Liege, B-4000 Liege, Belgium; [Schnakers, Caroline; Habbal, Dina; Boly, Melanie; Majerus, Steve; Laureys, Steven] Univ Liege, B-4000 Liege, Belgium; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Boston, MA USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Boston, MA USA; [Giacino, Joseph T.] JFK Johnson Rehabil Inst, Edison, NJ USA; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Lovstad, Marianne] Univ Oslo, Oslo, Norway; [Di, Haibo] Hangzhou Normal Univ, Hangzhou, Zhejiang, Peoples R China		Schnakers, C (corresponding author), Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, B30, B-4000 Liege, Belgium.	c.schnakers@gmail.com	Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; Giacino, Joseph/AAF-1952-2021	Laureys, Steven/0000-0002-3096-3807; Giacino, Joseph/0000-0002-7916-9698; Majerus, Steve/0000-0002-8206-8097; Boly, Melanie/0000-0001-9584-0907	National Funds for Scientific Research (MCF/DM) [A 4/5]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870861]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Funds for Scientific Research (A 4/5, MCF/DM) and the National Natural Science Foundation of China (30870861).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cass M, 1997, BIOL PSYCHOL, V46, P51, DOI 10.1016/S0301-0511(96)05233-7; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Croft RJ, 2003, PSYCHOPHYSIOLOGY, V40, P322, DOI 10.1111/1469-8986.00036; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Eichenlaub JB, 2012, BRAIN RES, V1447, P65, DOI 10.1016/j.brainres.2012.01.072; Fan J, 2009, BRAIN COGNITION, V70, P209, DOI 10.1016/j.bandc.2009.02.002; Faugeras F, 2011, NEUROLOGY, V77, P264, DOI 10.1212/WNL.0b013e3182217ee8; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1017/S0048577298961479; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KNIGHT RT, 1980, ELECTROEN CLIN NEURO, V50, P112, DOI 10.1016/0013-4694(80)90328-4; Kuebler A, 2007, CURR OPIN NEUROL, V20, P643, DOI 10.1097/WCO.0b013e3282f14782; La Porta F, 2013, ARCH PHYS MED REHAB, V94, P527, DOI 10.1016/j.apmr.2012.09.035; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Lechinger J, 2013, CLIN NEUROPHYSIOL, V124, P27, DOI 10.1016/j.clinph.2012.05.016; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Mertens R, 1997, EVOKED POTENTIAL, V104, P488, DOI 10.1016/S0168-5597(97)00041-5; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nachev P, 2010, PROG NEUROBIOL, V91, P68, DOI 10.1016/j.pneurobio.2010.01.009; Naci L, 2012, ANN NEUROL, V72, P312, DOI 10.1002/ana.23656; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Polich J, 1997, INT J PSYCHOPHYSIOL, V25, P169, DOI 10.1016/S0167-8760(96)00742-8; POLICH J, 1994, ELECTROEN CLIN NEURO, V92, P253, DOI 10.1016/0168-5597(94)90068-X; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Posner MI, 2006, NEURAL NETWORKS, V19, P1422, DOI 10.1016/j.neunet.2006.08.004; Posner MI, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00064; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Sorger B, 2012, CURR BIOL, V22, P1333, DOI 10.1016/j.cub.2012.05.022; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5	51	30	33	1	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAY	2015	29	4					308	317		10.1177/1545968314547767			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CE8DL	WOS:000352071400002	25160566	Green Published			2022-02-06	
J	Zetterberg, H; Blennow, K				Zetterberg, Henrik; Blennow, Kaj			Fluid markers of traumatic brain injury	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article							CEREBROSPINAL-FLUID; MILD; TAU; BIOMARKERS; PROTEOLYSIS; IMPAIRMENT; CONCUSSION; SYMPTOMS	Traumatic brain injury (TBI) occurs when an external force traumatically injures the brain. Whereas severe TBI can be diagnosed using a combination of clinical signs and standard neuroimaging techniques, mild TBI (also called concussion) is more difficult to detect This is where fluid markers of injury to different cell types and subcellular compartments in the central nervous system come into play. These markers are often proteins, peptides or other molecules with selective or high expression in the brain, which can be measured in the cerebrospinal fluid or blood as they leak out or get secreted in response to the injury. Here, we review the literature on fluid markers of neuronal, axonal and astroglial injury to diagnose mild TBI and to predict clinical outcome in patients with head trauma. We also discuss chronic traumatic encephalopathy, a progressive neurodegenerative disease in individuals with a history of multiple mild TBIs in a biomarker context This article is part of a Special Issue entitled Traumatic Brain Injury'. (C) 2015 Elsevier Inc. All rights reserved.	[Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Clin Neurochem Lab, Inst Neurosci & Physiol, S-43180 Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England		Zetterberg, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, S-43180 Molndal, Sweden.	henrik.zetterberg@gu.se			Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish State Support for Clinical Research; Torsten Soderberg Foundation; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Wolfson Foundation	Work in the authors' laboratories is supported by the Swedish Research Council, the Swedish State Support for Clinical Research, the Torsten Soderberg Foundation, the Knut and Alice Wallenberg Foundation and the Wolfson Foundation.	Blennow K., 2015, NAT MED IN PRESS; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CORSELLIS JAN, 1989, BRIT MED J, V298, P105, DOI 10.1136/bmj.298.6666.105; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Lemoine J, 2012, EXPERT REV MOL DIAGN, V12, P333, DOI [10.1586/ERM.12.32, 10.1586/erm.12.32]; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McMahon P.J., 2015, J NEUROTRAU IN PRESS; Neselius S., 2015, KNEE SURG S IN PRESS; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shi M, 2011, J ALZHEIMERS DIS, V27, P299, DOI 10.3233/JAD-2011-110731; Siman R., 2015, J NEUROTRAU IN PRESS; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zetterberg H, 2010, EUR NEUROL, V63, P326, DOI 10.1159/000311703	33	30	30	0	25	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	MAY	2015	66		B		SI		99	102		10.1016/j.mcn.2015.02.003			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK7FT	WOS:000356398900005	25659491				2022-02-06	
J	Dromerick, AW; Edwardson, MA; Edwards, DF; Giannetti, ML; Barth, J; Brady, KP; Chan, E; Tan, MT; Tamboli, I; Chia, R; Orquiza, M; Padilla, RM; Cheema, AK; Mapstone, ME; Fiandaca, MS; Federoff, HJ; Newport, EL				Dromerick, Alexander W.; Edwardson, Matthew A.; Edwards, Dorothy F.; Giannetti, Margot L.; Barth, Jessica; Brady, Kathaleen P.; Chan, Evan; Tan, Ming T.; Tamboli, Irfan; Chia, Ruth; Orquiza, Michael; Padilla, Robert M.; Cheema, Amrita K.; Mapstone, Mark E.; Fiandaca, Massimo S.; Federoff, Howard J.; Newport, Elissa L.			Critical periods after stroke study: translating animal stroke recovery experiments into a clinical trial	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						stroke rehabilitation; cerebrovascular disorders; critical period; motor recovery; multi-omics; adaptive randomization	UPPER-EXTREMITY FUNCTION; CONSTRAINT-INDUCED MOVEMENT; RESEARCH ARM TEST; EARLY REHABILITATION; INTERRATER RELIABILITY; REACHING MOVEMENTS; TRUNK RESTRAINT; GENE-EXPRESSION; TRAUMATIC BRAIN; TIME-COURSE	Introduction: Seven hundred ninety-five thousand Americans will have a stroke this year, and half will have a chronic hemiparesis. Substantial animal literature suggests that the mammalian brain has much potential to recover from acute injury using mechanisms of neuroplasticity, and that these mechanisms can be accessed using training paradigms and neurotransmitter manipulation. However, most of these findings have not been tested or confirmed in the rehabilitation setting, in large part because of the challenges in translating a conceptually straightforward laboratory experiment into a meaningful and rigorous clinical trial in humans. Through presentation of methods for a Phase II trial, we discuss these issues and describe our approach. Methods: In rodents there is compelling evidence for timing effects in rehabilitation; motor training delivered at certain times after stroke may be more effective than the same training delivered earlier or later, suggesting that there is a critical or sensitive period for strongest rehabilitation training effects. If analogous critical/sensitive periods can be identified after human stroke, then existing clinical resources can be better utilized to promote recovery. The Critical Periods after Stroke Study (CPASS) is a phase II randomized, controlled trial designed to explore whether such a sensitive period exists. We will randomize 64 persons to receive an additional 20 h of upper extremity therapy either immediately upon rehab admission, 2-3 months after stroke onset, 6 months after onset, or to an observation-only control group. The primary outcome measure will be the Action Research Arm Test (ARAT) at 1 year. Blood will be drawn at up to 3 time points for later biomarker studies. Conclusion: CPASS is an example of the translation of rodent motor recovery experiments into the clinical setting; data obtained from this single site randomized controlled trial will be used to finalize the design of a Phase III trial.	[Dromerick, Alexander W.; Edwardson, Matthew A.; Giannetti, Margot L.; Barth, Jessica; Brady, Kathaleen P.; Chan, Evan; Newport, Elissa L.] Georgetown Univ, Ctr Brain Plast & Recovery, Dept Rehabil Med, Washington, DC USA; [Dromerick, Alexander W.; Edwardson, Matthew A.; Giannetti, Margot L.; Barth, Jessica; Brady, Kathaleen P.; Chan, Evan; Newport, Elissa L.] MedStar Natl Rehabil Hosp, Washington, DC USA; [Dromerick, Alexander W.; Edwardson, Matthew A.; Fiandaca, Massimo S.; Federoff, Howard J.; Newport, Elissa L.] Georgetown Univ, Dept Neurol, Washington, DC USA; [Edwards, Dorothy F.] Univ Wisconsin, Dep Kinesiol & Occupat Therapy, Madison, WI USA; [Tan, Ming T.] Georgetown Univ, Dept Biostat, Washington, DC USA; [Tamboli, Irfan; Chia, Ruth; Orquiza, Michael; Padilla, Robert M.; Fiandaca, Massimo S.; Federoff, Howard J.] Georgetown Univ, Dept Neurosci, Washington, DC USA; [Cheema, Amrita K.] Georgetown Univ, Dept Oncol, Washington, DC USA; [Cheema, Amrita K.] Georgetown Univ, Dept Biochem, Washington, DC USA; [Mapstone, Mark E.] Univ Rochester, Dept Neurol, Rochester, NY USA		Dromerick, AW (corresponding author), MedStar Natl Rehabil Hosp, Ctr Brain Plast & Res, Dept Rehabil Med, 102 Irving St NW, Washington, DC USA.	alexander.w.dromerick@gunet.georgetown.edu	Chia, Ruth/AAF-4900-2021; Edwards, Dorothy/L-6720-2016	Chia, Ruth/0000-0002-4709-7423; Fiandaca, Massimo/0000-0002-8376-1934; Edwardson, Matthew/0000-0002-0327-5531; Giannetti, Margot/0000-0002-5259-9081	Center for Brain Plasticity and Recovery at Georgetown University; MedStar National Rehabilitation Hospital; National Institute for Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U10N5086513]; National Institute for Deafness and Communicative DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K18 DC014558]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K18DC014558] Funding Source: NIH RePORTER	This work is supported by the Center for Brain Plasticity and Recovery at Georgetown University and MedStar National Rehabilitation Hospital, the National Institute for Neurological Diseases and Stroke (1U10N5086513) and the National Institute for Deafness and Communicative Disorders (K18 DC014558).	ATKINSON AC, 1982, BIOMETRIKA, V69, P61, DOI 10.1093/biomet/69.1.61; Baum C.M., 2008, ACTIVITY CARD SORT, V2nd; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carey LM, 2015, INT J STROKE, V10, P636, DOI 10.1111/ijs.12190; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; Carter AR, 2010, CURR NEUROL NEUROSCI, V10, P158, DOI 10.1007/s11910-010-0091-9; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; De Weerdt WJG., 1985, PHYSIOTHER CAN, V37, P65, DOI DOI 10.3138/PTC.37.2.065; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dromerick AW, 2009, NEUROLOGY, V73, P195, DOI 10.1212/WNL.0b013e3181ab2b27; Dromerick Alexander W, 2006, NeuroRx, V3, P428, DOI 10.1016/j.nurx.2006.07.004; Duncan PW, 2011, NEW ENGL J MED, V364, P2026, DOI 10.1056/NEJMoa1010790; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; FEIGENSON JS, 1977, STROKE, V8, P8; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gagnon D, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-151; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Han C, 2013, CLIN REHABIL, V27, P75, DOI 10.1177/0269215512447223; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; Hess EH., 1973, IMPRINTING EARLY EXP; Hsieh CL, 1998, AGE AGEING, V27, P107, DOI 10.1093/ageing/27.2.107; Hubbard IJ, 2015, NEUROREHAB NEURAL RE, V29, P703, DOI 10.1177/1545968314562647; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ingvaldsen RP, 1997, HUM MOVEMENT SCI, V16, P705, DOI 10.1016/S0167-9457(97)00022-5; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kollen BJ, 2009, STROKE, V40, pE89, DOI 10.1161/STROKEAHA.108.533828; KOTILA M, 1984, STROKE, V15, P1039, DOI 10.1161/01.STR.15.6.1039; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Lang CE, 2006, ARCH PHYS MED REHAB, V87, P1605, DOI 10.1016/j.apmr.2006.09.003; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; LAWSON REED, 1963, OHIO JOUR SCI, V63, P87; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Lin JH, 2009, PHYS THER, V89, P840, DOI 10.2522/ptj.20080285; Liu N, 2014, STROKE, V45, P3502, DOI 10.1161/STROKEAHA.114.005661; Lum PS, 2009, TOP STROKE REHABIL, V16, P237, DOI 10.1310/tsr1604-237; Lum PS, 2004, IEEE T NEUR SYS REH, V12, P186, DOI 10.1109/TNSRE.2004.827225; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; MARLER P, 1970, AM SCI, V58, P669; Mathiowetz V., 1992, MEASUREMENT NEUROLOG, P171; Maulden SA, 2005, ARCH PHYS MED REHAB, V86, pS34, DOI 10.1016/j.apmr.2005.08.119; Mead GE, 2000, J NEUROL NEUROSUR PS, V68, P558, DOI 10.1136/jnnp.68.5.558; Medical Research Council, 1976, AIDS EX PER NERV SYS; Meinert C.L, 1986, CLIN TRIALS DESIGN C; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Michaelsen SM, 2006, STROKE, V37, P186, DOI 10.1161/01.STR.0000196940.20446.c9; Michaelsen SM, 2004, STROKE, V35, P1914, DOI 10.1161/01.STR.0000132569.33572.75; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P852, DOI 10.1016/0003-9993(94)90108-2; Nave AH, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-197; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ostwald SK, 2009, TOP STROKE REHABIL, V16, P80, DOI 10.1310/tsr1601-80; Page SJ, 2001, J REHABIL RES DEV, V38, P583; Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583; Pollock A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001920.pub2; Rossi PW, 1997, J NEUROL REHABIL, V11, P27; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SIGNORINI DF, 1993, STAT MED, V12, P2343, DOI 10.1002/sim.4780122410; SIVENIUS J, 1985, STROKE, V16, P928, DOI 10.1161/01.STR.16.6.928; Skinner BF., 1938, BEHAV ORGANISMS EXPT; Stark SL, 2005, ARCH PHYS MED REHAB, V86, P344, DOI 10.1016/j.apmr.2004.03.020; SUNDERLAND A, 1992, J NEUROL NEUROSUR PS, V55, P530, DOI 10.1136/jnnp.55.7.530; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Taub E., 2011, MOTOR ACTIVITY LOG M; Thorndike E. L., 1898, PSYCHOL REV MONOGRAP, V2, P1, DOI DOI 10.1037/H0092987; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; van der Lee JH, 2002, CLIN REHABIL, V16, P646, DOI 10.1191/0269215502cr534oa; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wade D. T., 1992, MEASURE MOTOR IMPAIR, P154; Wade D. T., 1992, MEASUREMENTS NEUROLO, P155; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; Ween JE, 1996, NEUROLOGY, V47, P388, DOI 10.1212/WNL.47.2.388; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390; Winstein CJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-5; Woldag H, 2010, J REHABIL MED, V42, P582, DOI 10.2340/16501977-0558; Wolf SL, 2010, STROKE, V41, P2309, DOI 10.1161/STROKEAHA.110.588723; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Wong DL, 2001, WONGS ESSENTIALS PED, P1301; WYLIE CM, 1970, GERIATRICS, V25, P107; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Yuan A., 2014, J CLIN TRIALS, V4, P181, DOI [10.4172/2167-0870.1000181, DOI 10.4172/2167-0870.1000181]; Zhou XM, 2011, J NEUROSCI, V31, P5625, DOI 10.1523/JNEUROSCI.6470-10.2011	97	30	32	2	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	APR 29	2015	9								231	10.3389/fnhum.2015.00231			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CK1ZA	WOS:000356007300002	25972803	gold, Green Published			2022-02-06	
J	Jak, AJ; Gregory, A; Orff, HJ; Colon, C; Steele, N; Schiehser, DM; Delano-Wood, L; Jurick, SM; Twamley, EW				Jak, Amy J.; Gregory, Amber; Orff, Henry J.; Colon, Candice; Steele, Norma; Schiehser, Dawn M.; Delano-Wood, Lisa; Jurick, Sarah M.; Twamley, Elizabeth W.			Neuropsychological performance in treatment-seeking Operation Enduring Freedom/Operation Iraqi Freedom Veterans with a history of mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Veterans; Validity; Concussion; Neuropsychology	POSTCONCUSSION SYNDROME; SYMPTOM COMPLAINTS; OUTCOMES; CONTEXT; BLAST; TBI	Introduction: Clinical neuropsychological presentation of treatment-seeking Veterans with a remote history of mild traumatic brain injury (mTBI) is widely variable. This manuscript seeks to better characterize cognitive concerns in the post-acute phase following mTBI and to identify the neuropsychological profiles of a large sample of clinically referred Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) Veterans with a history of mTBI and current cognitive complaints. We hypothesized that a minority of cases would exhibit valid and widespread neuropsychological deficits. Method: Retrospective chart reviews of neuropsychological testing and mental health symptoms and diagnoses were conducted on 411 clinically referred OEF/OIF/OND Veterans with a history of mTBI. Groups were created based on scores on performance validity measures and based on overall neuropsychological performance. Results: A total of 29.9% of the sample performed below normative expectations on at least one performance validity test (PVT). Of those Veterans performing adequately on PVTs, 60% performed within normal limits on virtually all neuropsychological measures administered, leaving only 40% performing below expectations on two or more measures. Mood and neurobehavioral symptoms were significantly elevated in Veterans performing below cutoff on PVTs compared to Veterans who performed within normative expectations or those with valid deficits. Neurobehavioral symptoms were significantly correlated with mental health symptom reports but not with injury variables. Conclusions: In summary, in a large sample of clinically referred Veterans with persistent cognitive complaints after mild TBI, a third demonstrated invalid clinical neuropsychological testing, and, of those performing at or above cutoff on PVTs, over half performed within normative expectations across most neuropsychological tests administered. Results highlight the importance of objective assessment of cognitive functioning in this population as subjective reports do not correspond to objective assessment in the majority of cases.	[Jak, Amy J.; Steele, Norma] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Jak, Amy J.; Orff, Henry J.; Schiehser, Dawn M.; Delano-Wood, Lisa; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Jak, Amy J.; Orff, Henry J.; Schiehser, Dawn M.; Delano-Wood, Lisa; Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Gregory, Amber] Univ Alabama Birmingham, Birmingham, AL USA; [Colon, Candice; Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Jurick, Sarah M.] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA USA		Jak, AJ (corresponding author), 3350 La Jolla Village Dr,151B, San Diego, CA USA.	ajak@ucsd.edu			Office of Research & Development, Veterans Health Administration	Salary support for D. M. Schiehser was provided by a Career Development Award from the Office of Research & Development, Veterans Health Administration.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT, 1993, BECK ANXIETY INVENTO; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs/ Department of Defense ( VA/ DoD), 2009, VA DOD CLIN PRACT GU; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Grant DA, 2000, WISCONSIN CARD SORTI; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; GRONWALL D, 1974, LANCET, V2, P605; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tombaugh T.N., 1996, TEST MEMORY MALINGER; US Dept of Veterans Affairs, 2013, ANN BEN REP FISC YEA; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; World Health Organization, 1992, INT STAT CLASS DIS R, V10	43	30	30	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR 21	2015	37	4					379	388		10.1080/13803395.2015.1020769			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CI7GP	WOS:000354931400004	25850338				2022-02-06	
J	Kroshus, E; Baugh, CM; Hawrilenko, M; Daneshvar, DH				Kroshus, Emily; Baugh, Christine M.; Hawrilenko, Matt; Daneshvar, Daniel H.			Pilot Randomized Evaluation of Publically Available Concussion Education Materials: Evidence of a Possible Negative Effect	HEALTH EDUCATION & BEHAVIOR			English	Article						behavior change; concussion; education; injury; sport	TRAUMATIC BRAIN-INJURY; ICE HOCKEY; KNOWLEDGE; COLLEGE; EPIDEMIOLOGY; SYMPTOMS; BEHAVIOR; PLAYERS; MODELS; IMPACT	Many states and sports leagues are instituting concussion policies aimed at reducing risk of morbidity and mortality; many include mandates about the provision of concussion education to youth athletes. However, there is limited evidence if educational materials provided under these typically vague mandates are in fact effective in changing concussion risk-related behavior or any cognition predictive of risk-related behavior. The purpose of this pilot randomized controlled study was to conduct a theory-driven evaluation of three publically available concussion education materials: two videos and one informational handout. Participants were 256 late adolescent males from 12 teams in a single league of ice hockey competition in the United States. Randomization of educational condition occurred at the team level. Written surveys assessing postimpact symptom reporting behavior, concussion knowledge, and concussion reporting cognitions were completed by participants immediately before receiving their educational intervention, 1 day after, and 1 month after. Results indicated no change in any measure over any time interval, with the exception of perceived underreporting norms. In one of the video conditions, perceived underreporting norms increased significantly 1 day after viewing the video. Possible content and viewing environment-related reasons for this increase are discussed. Across all conditions, perceived underreporting norms increased 1 month after intervention receipt, raising the possibility that late in the competitive season underreporting may be perceived as normative. The need for the development of theory-driven concussion education materials, drawing on best practices from health behavior scholars, is discussed.	[Kroshus, Emily] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Baugh, Christine M.; Daneshvar, Daniel H.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Hawrilenko, Matt] Clark Univ, Worcester, MA 01610 USA		Kroshus, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 677 Huntington Ave, Boston, MA 02115 USA.	emk329@mail.harvard.edu	Meijer, Anna/K-5118-2016; Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Daneshvar, Daniel/0000-0003-3691-9513	Head Games, The Movie	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Christine M. Baugh and Daniel H. Daneshvar received funding from Head Games, The Movie.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2013, 2013 14 NCAA SPORTS; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Baugh C. M., J LAW MED E IN PRESS; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Centers for Disease Control and Prevention, 2013, HEADS CONC HIGH SCH; Chan DKC, 2012, SPORTS MED, V42, P725, DOI 10.2165/11633040-000000000-00000; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Gielen AC, 2003, EPIDEMIOL REV, V25, P65, DOI 10.1093/epirev/mxg004; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64; James S., 2012, HEAD GAMES MOTION PI; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Keats MR, 2012, SPORTS MED, V42, P175, DOI 10.2165/11597050-000000000-00000; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E., 2014, NORMS ATHLETIC UNPUB; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; MLL Communications, 2013, SPORTS LEG I PARTN M; National Athletic Trainers' Association/National Academy of Neuropsychology, CONC HOCK SIGNS SYMP; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sarris CE, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12224; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Verhagen EALM, 2010, SPORTS MED, V40, P899, DOI 10.2165/11536890-000000000-00000; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	40	30	30	0	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.	APR	2015	42	2					153	162		10.1177/1090198114543011			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CF0IX	WOS:000352228000003	25128434				2022-02-06	
J	Jang, SH; Kim, SH; Lim, HW; Yeo, SS				Jang, Sung Ho; Kim, Seong Ho; Lim, Hyoung Won; Yeo, Sang Seok			Recovery of Injured Lower Portion of the Ascending Reticular Activating System in a Patient with Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Diffusion Tensor Imaging; Ascending Reticular Activating System; Consciousness	AROUSAL SYSTEM; CONSCIOUSNESS; DISORDERS; COMA	The authors report on a patient with traumatic brain injury who showed recovery of an injured lower portion of the ascending reticular activating system (ARAS) between the pontine reticular formation and the thalamus. A 57-yr-old male patient experienced head trauma. After 4 mos from onset, he exhibited impaired alertness, with a score of 7 on the Glasgow Coma Scale. At 40 mos after onset, the patient had a full Glasgow Coma Scale score of 15. The lower portion of the ARAS was reconstructed using the probabilistic tractography method. On 4-mo diffusion tensor tractography, the fractional anisotropy and the tract volume of the lower portion of the right ARAS were lower by more than 2 SDs of those of control subjects. By contrast, on 40-mo diffusion tensor tractography, the fractional anisotropy and the tract volume values of the lower portion of the right ARAS were within 2 SDs of those of the control subjects. The increment fractional anisotropy and the FV value of the lower portion of the right ARAS on 40-mo diffusion tensor tractography indicated recovery of the injured lower ARAS. As a result, recovery of an injured lower portion of the ARAS in a patient with traumatic brain injury was demonstrated.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu, South Korea; [Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu, South Korea; [Lim, Hyoung Won; Yeo, Sang Seok] Dankook Univ, Coll Hlth Sci, Dept Phys Therapy, Cheonan Si 330714, Chungnam, South Korea		Yeo, SS (corresponding author), Dankook Univ, Coll Hlth Sci, Dept Phys Therapy, 119 Dandae Ro, Cheonan Si 330714, Chungnam, South Korea.						Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Hesse S, 2003, CNS DRUGS, V17, P1093, DOI 10.2165/00023210-200317150-00004; Kwon HG, 2012, J REHABIL MED, V44, P280, DOI 10.2340/16501977-0931; Lovstad M, 2014, J HEAD TRAUMA REHAB, V29, pE31, DOI 10.1097/HTR.0000000000000017; Seo JP, 2013, AM J NEURORADIOL, V34, P1359, DOI 10.3174/ajnr.A3389; TEASDALE G, 1974, LANCET, V2, P81; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416	11	30	31	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2015	94	3					250	253		10.1097/PHM.0000000000000274			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CC2VT	WOS:000350203500011	25700167				2022-02-06	
J	Maki-Marttunen, V; Kuusinen, V; Brause, M; Perakyla, J; Polvivaara, M; Ribeiro, RD; Ohman, J; Hartikainen, KM				Maki-Marttunen, Veronica; Kuusinen, Venla; Brause, Maarja; Perakyla, Jari; Polvivaara, Markus; Ribeiro, Rodolfo dos Santos; Ohman, Juha; Hartikainen, Kaisa M.			Enhanced Attention Capture by Emotional Stimuli in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						attention; response inhibition; mTBI; emotion; EEG	FUNCTIONAL CONNECTIVITY; NEURAL MECHANISMS; COGNITIVE CONTROL; HEAD-INJURY; DEPRESSION; SYMPTOMS; MODERATE; COMPETE; ERP	Mild traumatic brain injury (mTBI) may be associated with compromised executive functioning and altered emotional reactivity. Despite frequent affective and cognitive symptoms in mTBI, objective evidence for brain dysfunction is often lacking. Previously we have reported compromised performance in symptomatic mTBI patients in an executive reaction time (RT) test, a computer-based RT test engaging several executive functions simultaneously. Here, we investigated the cognitive control processes in mTBI in context of threat-related stimuli. We used behavioral measures and event-related potentials (ERP) to investigate attentional capture by task-relevant and task-irrelevant emotional stimuli during a Go-NoGo task requiring cognitive control. We also assessed subjective cognitive, somatic, and emotional symptoms with questionnaires. Twenty-seven subjects with previous mTBI and 17 controls with previous ankle injury participated in the study over 9 months post-injury. Electroencephalogram (EEG) was recorded while patients performed a modified executive RT-test. N2-P3 ERP component was used as a general measure of allocated attentional and executive processing resources. Although at the time of the testing, the mTBI and the control groups did not differ in symptom endorsement, mTBI patients reported having had more emotional symptoms overall since the injury than controls. The overall RT-test performance levels did not differ between groups. However, when threat-related emotional stimuli were used as Go-signals, the mTBI group was faster than the control group. In comparison to neutral stimuli, threat-related stimuli were associated with increased N2-P3 amplitude in all conditions. This threat-related enhancement of the N2-P3 complex was greater in mTBI patients than in controls in response to Go signals and NoGo signals, independent of relevance. We conclude that mTBI may be associated with enhanced attentional and executive resource allocation to threat-related stimuli. Along with behavioral evidence for enhanced attention allocation to threat stimuli, increased brain responses to threat were observed in mTBI. Enhanced attention capture by threat-related emotional stimuli may reflect inefficient top-down control of bottom-up influences of emotion, and might contribute to affective symptoms in mTBI.	[Maki-Marttunen, Veronica; Kuusinen, Venla; Brause, Maarja; Perakyla, Jari; Polvivaara, Markus; Ribeiro, Rodolfo dos Santos; Hartikainen, Kaisa M.] Tampere Univ Hosp, Behav Neurol Res Unit, Tampere 33520, Finland; [Ohman, Juha; Hartikainen, Kaisa M.] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere 33520, Finland		Hartikainen, KM (corresponding author), Tampere Univ Hosp, Behav Neurol Res Unit, POB 2000, Tampere 33520, Finland.	kaisa.hartikainen@uta.fi	Maki-Marttunen, Veronica/AAA-5157-2022	Hartikainen, Kaisa/0000-0001-7278-9635; Ohman, Juha/0000-0002-6592-1367	Academy of FinlandAcademy of FinlandEuropean Commission; Competitive Research Fund of Pirkanmaa Hospital District	This research was supported by the Academy of Finland and the Competitive Research Fund of Pirkanmaa Hospital District.	Albert J, 2012, HUM BRAIN MAPP, V33, P2147, DOI 10.1002/hbm.21347; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bishop SJ, 2008, ANN NY ACAD SCI, V1129, P141, DOI 10.1196/annals.1417.016; Bombardier CH, 2010, PHYS MED REH CLIN N, V21, P281, DOI 10.1016/j.pmr.2009.12.005; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Daffner KR, 2000, J COGNITIVE NEUROSCI, V12, P393, DOI 10.1162/089892900562219; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Hartikainen KM, 2007, NEUROREPORT, V18, P1929, DOI 10.1097/WNR.0b013e3282f1ca18; Hartikainen KM, 2014, J CLIN EXP NEUROPSYC, V36, P540, DOI 10.1080/13803395.2014.913554; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Hartikainen KM, 2012, NEUROREPORT, V23, P447, DOI 10.1097/WNR.0b013e3283531e74; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hartikainen KM, 2010, NEUROREPORT, V21, P344, DOI 10.1097/WNR.0b013e328336eeb3; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Kaiser S, 2006, INT J PSYCHOPHYSIOL, V61, P279, DOI 10.1016/j.ijpsycho.2005.09.006; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Maki-Marttunen V, 2014, NEUROREPORT, V25, P1038, DOI 10.1097/WNR.0000000000000223; Matthews G, 2000, BEHAV MODIF, V24, P69, DOI 10.1177/0145445500241004; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Pessoa Luiz, 2010, Dialogues Clin Neurosci, V12, P433; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Solbakk AK, 2000, J CLIN EXP NEUROPSYC, V22, P743, DOI 10.1076/jcen.22.6.743.953; Spinella M, 2007, J GEN PSYCHOL, V134, P101, DOI 10.3200/GENP.134.1.101-111; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; Zhang WH, 2012, BIOL PSYCHOL, V89, P444, DOI 10.1016/j.biopsycho.2011.12.011	46	30	31	0	22	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2015	32	4					272	279		10.1089/neu.2014.3557			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CB0KN	WOS:000349314900008	25274125	Bronze, Green Published			2022-02-06	
J	Ogata, K; Sumida, K; Miyata, K; Kushida, M; Kuwamura, M; Yamate, J				Ogata, Keiko; Sumida, Kayo; Miyata, Kaori; Kushida, Masahiko; Kuwamura, Mitsuru; Yamate, Jyoji			Circulating miR-9*and miR-384-5p as Potential Indicators for Trimethyltin-induced Neurotoxicity	TOXICOLOGIC PATHOLOGY			English	Article						microRNAs; biomarker; serum; neurotoxicity; trimethyltin; hippocampus	CHROMATIN-REMODELING COMPLEXES; HIPPOCAMPAL DENTATE GYRUS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ADULT MICE; MICRORNAS; RAT; EXPRESSION; CELLS; APOPTOSIS	Circulating microRNAs (miRNAs) show promise as biomarkers due to their tissue-specific expression and high stability. This study was conducted to investigate whether nervous system-enriched miR-9* and hippocampus-enriched miR-384-5p could be indicators of neurotoxicity in serum. Rats were given a single administration of trimethyltin (TMT) chloride at 6, 9, or 12 mg/kg by gavage, and brain and serum were collected 1, 4, and 7 days after administration. MiR-9* and miR-384-5p levels in serum and hippocampus were analyzed by reverse transcriptase polymerase chain reaction (RT-PCR), and their neurotoxicity detection sensitivities were compared with nervous symptoms, auditory response, and histopathology. TMT caused tremor, hypersensitivity, and decreased auditory response at 12 mg/kg on day 1 and at 9 mg/kg on day 4. Histopathologically, neural cell death and glial reaction were observed in brain (mainly hippocampus) at 12 mg/kg on day 1, 4, and 7 and at 6 and 9 mg/kg on day 4 and 7. MiR-9* and miR-384-5p levels were elevated in serum at 9 and 12 mg/kg on days 4 and 7 (at 9 mg/kg on day 7, miR-9* only) but were not changed in hippocampus. These miRNAs were considered to be elevated with the evolution of neural cell death and were thus considered possible novel indicators of neurotoxicity.	[Ogata, Keiko; Sumida, Kayo; Miyata, Kaori; Kushida, Masahiko] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka 5548558, Japan; [Ogata, Keiko; Kuwamura, Mitsuru; Yamate, Jyoji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Lab Vet Pathol, Osaka, Japan		Ogata, K (corresponding author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, 1-98,Kasugadenaka 3 Chome, Osaka 5548558, Japan.	ogatak2@sc.sumitomo-chem.co.jp					Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BALABAN CD, 1988, NEUROSCIENCE, V26, P337, DOI 10.1016/0306-4522(88)90150-9; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao YY, 2013, APOPTOSIS, V18, P260, DOI 10.1007/s10495-013-0802-1; BOULDIN TW, 1981, AM J PATHOL, V104, P237; BROWN AW, 1979, AM J PATHOL, V97, P59; BUSHNELL PJ, 1985, TOXICOL APPL PHARM, V79, P134, DOI 10.1016/0041-008X(85)90375-8; Corvino V, 2005, BRAIN RES BULL, V65, P471, DOI 10.1016/j.brainresbull.2005.02.031; Corvino V, 2013, NEUROCHEM RES, V38, P240, DOI 10.1007/s11064-012-0932-9; CROFTON KM, 1990, TOXICOL APPL PHARM, V105, P123, DOI 10.1016/0041-008X(90)90364-Z; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dogini DB, 2008, J MOL NEUROSCI, V35, P331, DOI 10.1007/s12031-008-9068-4; DYER RS, 1982, NEUROBEH TOXICOL TER, V4, P127; EASTMAN CL, 1987, NEUROTOXICOL TERATOL, V9, P329, DOI 10.1016/0892-0362(87)90026-2; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; FECHTER LD, 1986, HEARING RES, V23, P275, DOI 10.1016/0378-5955(86)90116-4; Fiedorowicz A, 2001, BRAIN RES, V912, P116, DOI 10.1016/S0006-8993(01)02675-0; Figiel I, 2002, NEUROTOXICOLOGY, V23, P77, DOI 10.1016/S0161-813X(02)00006-2; Geloso MC, 2011, NEUROCHEM INT, V58, P729, DOI 10.1016/j.neuint.2011.03.009; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; He XJ, 2007, ACTA BIOCH BIOPH SIN, V39, P708, DOI 10.1111/j.1745-7270.2007.00324.x; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Jenkins SM, 2004, TOXICOL LETT, V147, P63, DOI 10.1016/j.toxlet.2003.10.023; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Kaur P, 2012, J TOXICOLOGY, V2012, P1, DOI [10.2353/ajpath.2010.091202, DOI 10.2353/AJPATH.2010.091202]; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Little AR, 2012, NEUROTOXICOL TERATOL, V34, P72, DOI 10.1016/j.ntt.2011.09.012; Liu Y, 1996, TOXICOL IN VITRO, V10, P567, DOI 10.1016/S0887-2333(96)00036-7; Margis R, 2011, J BIOTECHNOL, V152, P96, DOI 10.1016/j.jbiotec.2011.01.023; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morita M, 2008, NEUROSCIENCE, V153, P1135, DOI 10.1016/j.neuroscience.2008.01.078; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Ogita K, 2005, J NEUROSCI RES, V82, P609, DOI 10.1002/jnr.20678; Ogita Kiyokazu, 2012, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V32, P281; Omar F. L., 2009, CLIN CHEM, V55, P1977; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Perretta G, 1993, Ann Ist Super Sanita, V29, P167; Qing Y, 2013, ARCH TOXICOL, V87, P1273, DOI 10.1007/s00204-013-1021-9; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; RUPPERT PH, 1984, TOXICOL LETT, V22, P33, DOI 10.1016/0378-4274(84)90042-0; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shintani N, 2007, YAKUGAKU ZASSHI, V127, P451, DOI 10.1248/yakushi.127.451; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI 10.1586/EPR.09.17; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Su YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037395; Sukata T, 2011, TOXICOL LETT, V200, P46, DOI 10.1016/j.toxlet.2010.10.013; Tal TL, 2012, NEUROTOXICOLOGY, V33, P530, DOI 10.1016/j.neuro.2012.02.013; Tokarz P, 2012, ACTA BIOCHIM POL, V59, P467; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang ES, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-165; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang XX, 2010, J ENVIRON SCI HEAL B, V45, P648, DOI 10.1080/03601234.2010.502435; Wei XW, 2013, NEUROCHEM RES, V38, P1605, DOI 10.1007/s11064-013-1062-8; Yokota Takanori, 2009, Brain and Nerve (Tokyo), V61, P167; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; YOUNG JS, 1986, TOXICOL APPL PHARM, V82, P87, DOI 10.1016/0041-008X(86)90441-2; Zhang ZP, 2010, INT J BIOCHEM CELL B, V42, P367, DOI 10.1016/j.biocel.2009.11.023; Zhao JJ, 2006, CHILD NERV SYST, V22, P1419, DOI 10.1007/s00381-006-0173-9	65	30	31	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	FEB	2015	43	2					198	208		10.1177/0192623314530533			11	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Toxicology	CC4RO	WOS:000350341100004	24777749				2022-02-06	
J	Rao, V; Koliatsos, V; Ahmed, F; Lyketsos, C; Kortte, K				Rao, Vani; Koliatsos, Vassilis; Ahmed, Faizi; Lyketsos, Constantine; Kortte, Kathleen			Neuropsychiatric Disturbances Associated with Traumatic Brain Injury: A Practical Approach to Evaluation and Management	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; neuropsychiatry; postconcussion; depression; posttraumatic stress disorder; chronic traumatic encephalopathy; anxiety; mood; mania; behavior; psychosis; apathy; sleep	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; DEPRESSION FOLLOWING MILD; II PSYCHIATRIC-DISORDERS; FOOTBALL-LEAGUE PLAYER; HEAD-INJURY; MAJOR DEPRESSION; RISK-FACTORS; AXIS-I; POSTCONCUSSIVE SYMPTOMS	Traumatic brain injury (TBI) causes a wide variety of neuropsychiatric disturbances associated with great functional impairments and low quality of life. These disturbances include disorders of mood, behavior, and cognition, and changes in personality. The diagnosis of specific neuropsychiatric disturbances can be difficult because there is significant symptom overlap. Systematic clinical evaluations are necessary to make the diagnosis and formulate a treatment plan that often requires a multipronged approach. Management of TBI-associated neuropsychiatric disorders should always include nonpharmacological interventions, including education, family involvement, supportive and behavioral psychotherapies, and cognitive rehabilitation. Pharmacological treatments include antidepressants, anticonvulsants, antipsychotics, dopaminergic agents, and cholinesterase inhibitors. However, evidence-based treatments are extremely limited, and management relies on clinical empiricism and resemblance of TBI neuropsychiatric symptom profiles with those of idiopathic psychiatric disorders. Although the understanding of TBI-associated neuropsychiatric disorders has improved in the last decade, further research is needed including prospective, longitudinal studies to explore biomarkers that will assist with management and prognosis as well as randomized-controlled studies to validate pharmacological and nonpharmacological treatments. The current review summarizes the available literature in support of a structured, systematic evaluation approach and treatment options as well as recommendations for further research directions.	[Rao, Vani; Koliatsos, Vassilis; Ahmed, Faizi; Lyketsos, Constantine] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD 21224 USA; [Koliatsos, Vassilis] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21224 USA; [Koliatsos, Vassilis] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Neuropathol, Baltimore, MD 21224 USA; [Kortte, Kathleen] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Div Rehabil Psychol & Neuropsychol, Baltimore, MD USA		Rao, V (corresponding author), Johns Hopkins Univ, Dept Psychiat & Behav Sci, 5300 Alpha Commons Dr,4th Floor,Suite 425, Baltimore, MD 21224 USA.	vrao@jhmi.edu					American Psychiatric Association, 2013, DIAGN STAT UAL MENT; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; [Anonymous], 2010, RIM CARE COMPANION J; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bedard Michel, 2012, Adv Mind Body Med, V26, P14; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1080/j.1440-1614.2000.00758.x; CAMPBELL JJ, 1994, J NEUROPSYCH CLIN N, V6, P411; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; CLARK AF, 1987, BRIT J PSYCHIAT, V150, P841, DOI 10.1192/bjp.150.6.841; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cripe LI, 1987, COGNITIVE REHABILITA, V5, P18; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; EPSTEIN NB, 1981, HDB FAMILY THERAPY, P444; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Fann JR, 2014, J NEUROTRAUMA; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; GRAY BG, 1992, J NUCL MED, V33, P52; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Haskins E.C., 2012, COGNITIVE REHABILITA; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kant R, 1999, J NEUROPSYCH CLIN N, V11, P32, DOI 10.1176/jnp.11.1.32; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kant R, 2002, NEUROREHABILITATION, V17, P325; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koliatsos V. E., 2015, BRAIN NEUROTRAUMA MO; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Kortte KB, 2004, REHABIL PSYCHOL, V49, P187, DOI 10.1037/0090-5550.49.3.187; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEWIS L, 1990, J NERV MENT DIS, V178, P69, DOI 10.1097/00005053-199002000-00001; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Meyer A, 2000, J NEUROPSYCH CLIN N, V12, P407, DOI 10.1176/appi.neuropsych.12.3.407; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Neikrug AB, 2010, GERONTOLOGY, V56, P181, DOI 10.1159/000236900; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Omalu BI, NEUROSURGERY, P1092; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Rao V, 2007, AM J PSYCHIAT, V164, P728, DOI 10.1176/appi.ajp.164.5.728; Rao V, 2006, EUR J PSYCHIAT, V20, P65, DOI 10.4321/s0213-61632006000200002; Rao V, 2013, PSYCHOSOMATICS, V54, P403, DOI 10.1016/j.psym.2013.01.001; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Shan RSLP, 2004, AM J PHYS MED REHAB, V83, P421, DOI 10.1097/00002060-200406000-00003; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Sigurdardottir S, 2014, J HEAD TRAUMA REHABI; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; Starkstein SE, 2014, PSYCHIAT CLIN N AM, V37, P103, DOI 10.1016/j.psc.2013.10.002; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Takayanagi Y, 2013, J NEUROPSYCH CLIN N, V25, P292, DOI 10.1176/appi.neuropsych.12040093; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; van Reekum R, 2013, MANAGEMENT ADULTS TR, P283; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; YUDOFSKY S, 1981, AM J PSYCHIAT, V138, P218	146	30	30	1	31	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					64	82		10.1055/s-0035-1544241			19	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC4AP	WOS:000350293300010	25714869				2022-02-06	
J	Babcock, L; Yuan, WH; Leach, J; Nash, T; Wade, S				Babcock, Lynn; Yuan, Weihong; Leach, James; Nash, Tiffany; Wade, Shari			White matter alterations in youth with acute mild traumatic brain injury	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Mild traumatic brain injury; child; diffusion tensor imaging; acute		PURPOSE: To examine acute alterations in white matter (WM) diffusion based on diffusion tensor imaging (DTI) in youth with mild traumatic brain injury (mTBI) relative to orthopedic injury (OI) controls. METHODS: A prospective cohort study of 23 patients with mTBI and 20 OI controls ages 11- 16 years were recruited from the emergency department (ED). DTI was performed within 96 hours. Voxel based analysis quantified group differences for DTI indices: fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). The Post Concussion Symptom Scale assessed symptom burden. RESULTS: Youth with mTBI had significantly higher symptom burdens in the ED and at scanning than controls. The mTBI group had significantly higher levels of FA and AD in several WM regions including the middle temporal gyrus WM, superior temporal gyrus WM, anterior corona radiata, and superior longitudinal fasciculus. The mTBI group had significantly lower levels of MD and/or RD in a fewWM regions including the middle frontal gyrus WM and anterior corona radiata. Diffusion alterations correlated poorly with acute symptom burden. CONCLUSIONS: Alterations of diffusivity were detected in spatially heterogeneous WM regions shortly after mTBI in youth. The pattern of alterations may reflect restrictive water diffusion inWM early post- injury.	[Babcock, Lynn] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, Cincinnati, OH USA; [Yuan, Weihong; Leach, James; Nash, Tiffany] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Radiol, Cincinnati, OH USA; [Wade, Shari] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH USA		Babcock, L (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave,ML 2008, Cincinnati, OH 45229 USA.	lynn.babcock@cchmc.org		Babcock, Lynn/0000-0002-2658-6893	National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000078, KL2 RR026315]; Cincinnati Children's Hospital Medical Center Division of Emergency Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000078, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR026315] Funding Source: NIH RePORTER	This study was funded in part by (1) National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2 TR000078 (KL2 RR026315); and (2) Cincinnati Children's Hospital Medical Center Division of Emergency Medicine.	Achenbach T, 1983, MANUAL CHILD BEHAV C; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Eierud C, 2013, 19 ANN M ORG HUM BRA; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaiser D, 2015, BRAIN IMAGING BEHAV, V9, P32, DOI 10.1007/s11682-014-9327-7; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Mori S., 2007, INTRO DIFFUSION TENS; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Schmithorst VJ, 2011, EAR HEARING, V32, P156, DOI 10.1097/AUD.0b013e3181f7a481; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yan P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046286, 10.1371/journal.pone.0037837]	51	30	30	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2015	8	4					285	296		10.3233/PRM-150347			12	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7LK	WOS:000448290900003	26684069	Green Accepted			2022-02-06	
J	Hadanny, A; Golan, H; Fishlev, G; Bechor, Y; Volkov, O; Suzin, G; Ben-Jacob, E; Efrati, S				Hadanny, A.; Golan, H.; Fishlev, G.; Bechor, Y.; Volkov, O.; Suzin, G.; Ben-Jacob, E.; Efrati, S.			Hyperbaric oxygen can induce neuroplasticity and improve cognitive functions of patients suffering from anoxic brain damage	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Anoxic brain damage; rehabilitation; cognitive symptoms; hyperbaric oxygen therapy; SPECT	CEREBRAL-PALSY; INJURY; THERAPY; CHILDREN; SEQUELAE; CORTEX; REHABILITATION; SURVIVORS	Purpose: Cognitive impairment may occur in 42-50% of cardiac arrest survivors. Hyperbaric oxygen therapy (HBO2) has recently been shown to have neurotherapeutic effects in patients suffering from chronic cognitive impairments (CCI) consequent to stroke and mild traumatic brain injury. The objective of this study was to assess the neurotherapeutic effect of HBO2 in patients suffering from CCI due to cardiac arrest. Methods: Retrospective analysis of patients with CCI caused by cardiac arrest, treated with 60 daily sessions of HBO2. Evaluation included objective computerized cognitive tests (NeuroTrax), Activity of Daily Living (ADL) and Quality of life questionnaires. The results of these tests were compared with changes in brain activity as assessed by single photon emission computed tomography (SPECT) brain imaging. Results: The study included 11 cases of CCI patients. Patients were treated with HBO2, 0.5-7.5 years (mean 2.6 +/- 0.6 years) after the cardiac arrest. HBO2 was found to induce modest, but statistically significant improvement in memory, attention and executive function (mean scores) of 12%, 20% and 24% respectively. The clinical improvements were found to be well correlated with increased brain activity in relevant brain areas as assessed by computerized analysis of the SPECT imaging. Conclusions: Although further research is needed, the results demonstrate the beneficial effects of HBO2 on CCI in patients after cardiac arrest, even months to years after the acute event.	[Hadanny, A.; Fishlev, G.; Bechor, Y.; Suzin, G.; Efrati, S.] Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel; [Hadanny, A.; Golan, H.; Fishlev, G.; Volkov, O.; Efrati, S.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Golan, H.; Volkov, O.] Assaf Harofeh Med Ctr, Nucl Imaging Div, IL-70300 Zerifin, Israel; [Ben-Jacob, E.; Efrati, S.] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Ben-Jacob, E.; Efrati, S.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Ben-Jacob, E.] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel		Hadanny, A (corresponding author), Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, IL-70300 Zerifin, Israel.	Amir.had@gmail.com; efratishai@013.net	Golan, Haim/K-2831-2019		Assaf HaRofeh Medical Center research fund	The study was funded by the Assaf HaRofeh Medical Center research fund.	Achiron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071058; Allen BS, 2012, EUR J CARDIO-THORAC, V41, P1132, DOI 10.1093/ejcts/ezr315; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Barrett KF, 1998, NEUROLOGY, V50, pA178; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Collet JP, 2001, LANCET, V357, P582, DOI 10.1016/S0140-6736(00)04054-X; Doniger GA, 2006, BEHAV NEUROSCI, V120, P804, DOI 10.1037/0735-7044.120.4.804; Doniger GM, 2014, GUIDE NORMATIVE DATA; Donker SCV, 2001, SAMJ S AFR MED J, V91, P909; Donker SCV, 1999, S AFR MED J, V89, P360; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Efrati S, 2014, UNDERSEA HYPERBAR M, V41, P71; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; FitzGerald A, 2010, BRAIN INJURY, V24, P1311, DOI 10.3109/02699052.2010.506864; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Guo MF, 2011, FOLIA NEUROPATHOL, V49, P79; Hardy P, 2002, DEV MED CHILD NEUROL, V44, P436; Hopkins RO, 2012, NEUROREHABILITATION, V31, P319, DOI 10.3233/NRE-2012-0799; JACOBS EA, 1969, NEW ENGL J MED, V281, P753, DOI 10.1056/NEJM196910022811402; JAIN K., 2009, TXB HYPERBARIC MED; JASZCZAK RJ, 1979, PHYS MED BIOL, V24, P1123, DOI 10.1088/0031-9155/24/6/003; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Lim C, 2014, J REHABIL MED, V46, P691, DOI 10.2340/16501977-1816; Melton J.L., 2005, PSYCHOMETRIC EVALUAT; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; Montgomery D, 1999, UNDERSEA HYPERBAR M, V26, P235; Moulaert VRMP, 2009, RESUSCITATION, V80, P297, DOI 10.1016/j.resuscitation.2008.10.034; Mukherjee A, 2014, UNDERSEA HYPERBAR M, V41, P77; Neubauer RA, 1998, NEUROL RES, V20, pS33; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rossignol Daniel A, 2007, BMC Pediatr, V7, P36, DOI 10.1186/1471-2431-7-36; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Simon ES., 2003, ACTA NEUROPSYCHOLOGI, V1, P407, DOI DOI 10.5604/17307503/9168; Tapeantong Toungrat, 2009, Journal of the Medical Association of Thailand, V92, P1374; Thaler A, 2012, NEUROLOGY, V79, P1027, DOI 10.1212/WNL.0b013e3182684646; van Alem AP, 2004, AM HEART J, V148, P416, DOI 10.1016/j.ahj.2004.01.031; Zur D, 2015, J NEURO-OPHTHALMOL, V35, P26, DOI 10.1097/WNO.0000000000000199	47	30	38	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	4					471	486		10.3233/RNN-150517			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ1IP	WOS:000360350900006	26409406	Green Published, Green Submitted			2022-02-06	
J	Lazarus, RC; Buonora, JE; Jacobowitz, DM; Mueller, GP				Lazarus, Rachel C.; Buonora, John E.; Jacobowitz, David M.; Mueller, Gregory P.			Protein carbonylation after traumatic brain injury: cell specificity, regional susceptibility, and gender differences	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Carbonylation; Reactive oxygen species; Reactive carbonyl species; Traumatic brain injury; Median eminence; Dorsal third ventricle; Astrocytes; Ependymal cells; Free radicals	ALZHEIMERS-DISEASE BRAIN; OXIDATIVE STRESS; LIPID-PEROXIDATION; PROTEOMIC IDENTIFICATION; HYPOTHALAMIC TANYCYTES; ASTROCYTES; PROGESTERONE; ACCUMULATION; DYSFUNCTION; METABOLISM	Protein carbonylation is a well-documented and quantifiable consequence of oxidative stress in several neuropathologies, including multiple sclerosis, Alzheimer's disease, and Parkinson's disease. Although oxidative stress is a hallmark of traumatic brain injury (TB!), little work has explored the specific neural regions and cell types in which protein carbonylation occurs. Furthermore, the effect of gender on protein carbonylation after TBI has not been studied. The present investigation was designed to determine the regional and cell specificity of TBI-induced protein carbonylation and how this response to injury is affected by gender. Immunohistochemistry was used to visualize protein carbonylation in the brains of adult male and female Sprague-Dawley rats subjected to controlled cortical impact (CCI) as an injury model of TBI. Cell-specific markers were used to colocalize the presence of carbonylated proteins in specific cell types, including astrocytes, neurons, microglia, and oligodendrocytes. Results also indicated that the injury lesion site, ventral portion of the dorsal third ventricle, and ventricular lining above the median eminence showed dramatic increases in protein carbonylation after injury. Specifically, astrocytes and limited regions of ependymal cells adjacent to the dorsal third ventricle and the median eminence were most susceptible to postinjury protein carbonylation. However, these patterns of differential susceptibility to protein carbonylation were gender dependent, with males showing significantly greater protein carbonylation at sites distant from the lesion. Proteomic analyses were also conducted and determined that the proteins most affected by carbonylation in response to TBI include glial fibrillary acidic protein, dihydropyrimidase-related protein 2, fructose-bisphosphate aldolase C, and fructose-bisphosphate aldolase A. Many other proteins, however, were not carbonylated by CCI. These findings indicate that there is both regional and protein specificity in protein carbonylation after TBI. The marked increase in carbonylation seen in ependymal layers distant from the lesion suggests a mechanism involving the transmission of a cerebral spinal fluid-borne factor to these sites. Furthermore, this process is affected by gender, suggesting that hormonal mechanisms may serve a protective role against oxidative stress. Published by Elsevier Inc.	[Lazarus, Rachel C.; Buonora, John E.; Jacobowitz, David M.; Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA; [Jacobowitz, David M.; Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Mueller, GP (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Gregory.mueller@usuhs.edu			Uniformed Services University of the Health Services [T0702554, R07028414]; TriService Nursing Research Program [N12-P12]	The authors thank Dr. Regina Day for her assistance in preparation of this publication. Support for this work included funding from the Uniformed Services University of the Health Services (T0702554 and R07028414) and TriService Nursing Research Program (N12-P12). The views expressed are the private views of the authors and do not necessary reflect the official policy or position of the Uniformed Services University of the Health Sciences, the Department of the Army, the Department of Defense, or the United States government.	Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Azimzadeh O, 2011, PROTEOMICS, V11, P3299, DOI 10.1002/pmic.201100178; Barrett P, 2006, J ENDOCRINOL, V191, P687, DOI 10.1677/joe.1.06929; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Bizzozero OA, 2005, J NEUROSCI RES, V81, P687, DOI 10.1002/jnr.20587; Bosken J. M., 2012, SPRINGER PROTOCOLS H; Butterfield DA, 2012, ANTIOXID REDOX SIGN, V17, P1610, DOI 10.1089/ars.2011.4109; Carini M., 2010, MASS SPECTROMETRIC S, P173; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Clausen F., 2004, ACTA U UPSALIENSIS C, V77; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Desagher S, 1996, J NEUROSCI, V16, P2553; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Faul M., 2010, INJ PREV, V16; Gracy RW, 1999, BIOL PROCED ONLINE, V2, P39; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Johanson C, 2011, TOXICOL PATHOL, V39, P186, DOI 10.1177/0192623310394214; Kavakli HS, 2010, SCI RES ESSAYS, V5, P2832; Kent T., 2008, 1 BAYL COLL MED; Kernt M, 2013, J GLAUCOMA, V22, P404, DOI 10.1097/IJG.0b013e31824caf90; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Lushchak VI, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P420; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; Merkulova M, 2011, AM J PHYSIOL-CELL PH, V300, pC1442, DOI 10.1152/ajpcell.00076.2010; NAVARRO A, 1995, HISTOL HISTOPATHOL, V10, P861; NOBLE PG, 1994, BRAIN RES, V633, P83, DOI 10.1016/0006-8993(94)91525-3; Oikawa S, 2014, FREE RADICAL RES, V48, P694, DOI 10.3109/10715762.2014.901509; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Papadopoulos MC, 1998, NEUROSCIENCE, V82, P915; Peruzzo B, 2004, CELL TISSUE RES, V317, P147, DOI 10.1007/s00441-004-0899-1; Peuchen S, 1997, PROG NEUROBIOL, V52, P261, DOI 10.1016/S0301-0082(97)00010-5; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Rangarajan ES, 2010, J BIOL CHEM, V285, P11983, DOI 10.1074/jbc.M109.092049; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rzigalinski B.A., 2011, NANOMEDICINE HLTH DI, P100; Schinder AF, 1996, J NEUROSCI, V16, P6125; Selley ML, 1998, FREE RADICAL BIO MED, V25, P169, DOI 10.1016/S0891-5849(98)00021-5; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Sugino N, 1996, ENDOCRINOLOGY, V137, P749, DOI 10.1210/en.137.2.749; Sultana R, 2010, J ALZHEIMERS DIS, V19, P341, DOI 10.3233/JAD-2010-1222; Suzuki Y, 2003, J NEUROCHEM, V86, P1042, DOI 10.1046/j.1471-4159.2003.01920.x; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zheng JZ, 2010, J NEUROSCI RES, V88, P3376, DOI 10.1002/jnr.22488	61	30	30	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	JAN	2015	78						89	100		10.1016/j.freeradbiomed.2014.10.507			12	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	AZ4GB	WOS:000348178700009	25462645	hybrid			2022-02-06	
J	Scicchitano, F; Constanti, A; Citraro, R; De Sarro, G; Russo, E				Scicchitano, Francesca; Constanti, Andrew; Citraro, Rita; De Sarro, Giovambattista; Russo, Emilio			Statins and Epilepsy: Preclinical Studies, Clinical Trials and Statin-Anticonvulsant Drug Interactions	CURRENT DRUG TARGETS			English	Article						Adverse effects; atorvastatin; epileptogenesis; fluvastatin; lovastatin; pravastatin; seizures; simvastatin; statin-antiepileptic drug (AED) interactions; statins	COA REDUCTASE INHIBITORS; ATORVASTATIN TREATMENT; INDUCED EXCITOTOXICITY; ANTIEPILEPTIC DRUGS; STATUS-EPILEPTICUS; INDUCED SEIZURES; NITRIC-OXIDE; CELL-DEATH; RAT MODEL; SIMVASTATIN	3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors (statins) are potent cholesterol-lowering drugs which also possess beneficial antioxidant, antiinflammatory, immunomodulatory, and antiexcitotoxic effects. In addition, statins have proven neuroprotective effects in several neurological diseases: stroke, cerebral ischemia, Alzheimer's and Parkinson's disease, multiple sclerosis and traumatic brain injury. Relatively few studies have investigated the potential anti-seizure properties of statins in epilepsy and the possible underlying protective mechanisms that may be involved. This review summarizes the currently available data concerning statin effects in modulating seizure activity (sometimes adversely) and epileptogenesis in different experimental models as well as in clinical studies. Furthermore, we analyze the consequences of some of the more commonly reported statin-anticonvulsant drug interactions in the literature, discuss some of the adverse effects of statins encountered in clinical practice and comment on the potential future usefulness of statins in epilepsy therapy.	[Scicchitano, Francesca; Citraro, Rita; De Sarro, Giovambattista; Russo, Emilio] Magna Graecia Univ Catanzaro, Sch Med, Dept Hlth Sci, Catanzaro, Italy; [Constanti, Andrew] UCL Sch Pharm, Dept Pharmacol, London, England		Russo, E (corresponding author), Univ Catanzaro, Sch Med, Dept Hlth Sci, Via T Campanella 115, I-88100 Catanzaro, Italy.	erusso@unicz.it	Russo, Emilio/G-5241-2010; gallelli, luca/A-5180-2011	Russo, Emilio/0000-0002-1279-8123; gallelli, luca/0000-0003-0858-7902; De Sarro, Giovambattista/0000-0002-7629-6579; Citraro, Rita/0000-0001-6746-6751	Commission European Social Fund; Region of Calabria (Italy)	The Commission European Social Fund and Region of Calabria (Italy) are kindly acknowledged for student economical support.	Agarwal R, 2006, AM J CARDIOL, V97, P748, DOI 10.1016/j.amjcard.2005.09.110; Albayda J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0433-8; Arntz HR, 2000, AM J CARDIOL, V86, P1293, DOI 10.1016/S0002-9149(00)01230-3; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; Bravo AER, 2005, DRUG SAFETY, V28, P263; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Bullman J, 2011, EPILEPSIA, V52, P1351, DOI 10.1111/j.1528-1167.2011.03118.x; Candrilli SD, 2010, EPILEPSY RES, V91, P260, DOI 10.1016/j.eplepsyres.2010.07.021; Canevini MP, 2010, EPILEPSIA, V51, P797, DOI 10.1111/j.1528-1167.2010.02520.x; Caron G, 2007, PHARM RES-DORDR, V24, P480, DOI 10.1007/s11095-006-9199-7; Citraro R, 2014, EPILEPSIA, V55, P1284, DOI 10.1111/epi.12686; Clarke RM, 2008, J BIOL CHEM, V283, P1808, DOI 10.1074/jbc.M707442200; Cucchiara B, 2001, J NEUROL SCI, V187, P81, DOI 10.1016/S0022-510X(01)00529-9; D'Ambrosio R, 2013, EXPERT REV NEUROTHER, V13, P615, DOI [10.1586/ern.13.54, 10.1586/ERN.13.54]; Dedeurwaerdere S, 2012, EPILEPSIA, V53, P1113, DOI 10.1111/j.1528-1167.2012.03520.x; Etminan M, 2010, NEUROLOGY, V75, P1496, DOI 10.1212/WNL.0b013e3181f96253; Eyal S, 2014, EPILEPSY BEHAV, V31, P369, DOI 10.1016/j.yebeh.2013.09.041; Falcao A, 2013, EPILEPSY RES, V106, P244, DOI 10.1016/j.eplepsyres.2013.04.009; Friedman A, 2011, EPILEPSIA, V52, P33, DOI 10.1111/j.1528-1167.2011.03034.x; Funck VR, 2011, EPILEPSIA, V52, P2094, DOI 10.1111/j.1528-1167.2011.03261.x; Gouveia TLF, 2011, EPILEPSY BEHAV, V20, P1, DOI 10.1016/j.yebeh.2010.10.001; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gidal BE, 2009, NEUROLOGY, V72, P419, DOI 10.1212/01.wnl.0000341789.77291.8d; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Gotto AM, 2012, AM J CARDIOL, V110, p15A, DOI 10.1016/j.amjcard.2012.04.003; Heverin M, 2012, BRAIN RES, V1480, P81, DOI 10.1016/j.brainres.2012.08.018; Huang WJ, 2013, MOL MED REP, V8, P1337, DOI 10.3892/mmr.2013.1660; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; Kesim M, 2012, J PAK MED ASSOC, V62, P1187; Khandwala HM, 2006, SOUTH MED J, V99, P1385, DOI 10.1097/01.smj.0000251470.39036.ea; Kulkarni SK, 2009, DRUG TODAY, V45, P135, DOI 10.1358/dot.2009.45.2.1322481; Landmark CJ, 2012, EXPERT REV CLIN PHAR, V5, P281, DOI [10.1586/ecp.12.10, 10.1586/ECP.12.10]; Lee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038789; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Ma T, 2009, J NEUROSCI, V29, P11226, DOI 10.1523/JNEUROSCI.6150-08.2009; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Miesbach W, 2005, J NEUROL SCI, V238, P93, DOI 10.1016/j.jns.2005.06.008; Miller AE, 2008, PHARMACOTHERAPY, V28, P553, DOI 10.1592/phco.28.5.553; Minder CM, 2013, CURR OPIN CARDIOL, V28, P554, DOI 10.1097/HCO.0b013e32836429e6; Mirhadi K., 2011, Global Veterinaria, V7, P386; Mlodinow SG, 2014, J FAM PRACTICE, V63, P497; Moazzami K, 2013, FUND CLIN PHARMACOL, V27, P387, DOI 10.1111/j.1472-8206.2012.01038.x; Moezi L, 2012, EPILEPSY BEHAV, V23, P399, DOI 10.1016/j.yebeh.2012.02.001; Naval NS, 2009, NEUROL RES, V31, P425, DOI 10.1179/174313208X353686; Nejm MB, 2013, EPILEPSY BEHAV, V28, P10, DOI 10.1016/j.yebeh.2013.03.024; Neuhaus O, 2004, LANCET NEUROL, V3, P369, DOI 10.1016/S1474-4422(04)00770-7; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; Piermartiri TCB, 2010, EXP NEUROL, V226, P274, DOI 10.1016/j.expneurol.2010.08.030; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Rangel P, 2005, ARQ NEURO-PSIQUIAT, V63, P972, DOI 10.1590/S0004-282X2005000600013; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Reiss AB, 2009, THESCIENTIFICWORLDJO, V9, P1242, DOI 10.1100/tsw.2009.141; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Russo E, 2013, PHARMACOL RES, V70, P1, DOI 10.1016/j.phrs.2012.12.002; Sasa M, 2006, J PHARMACOL SCI, V100, P487, DOI 10.1254/jphs.CPJ06010X; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Serbanescu I, 2004, J LIPID RES, V45, P2038, DOI 10.1194/jlr.M400097-JLR200; Shafaroodi H, 2012, NEUROL RES, V34, P847, DOI 10.1179/1743132812Y.0000000080; Sierra-Marcos A, 2015, EUR J NEUROL, V22, P402, DOI 10.1111/ene.12428; Simic I, 2015, CURR PHARM DESIGN, V21, P1220, DOI 10.2174/1381612820666141013134447; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stepien KM, 2012, EUR J PHARMACOL, V674, P20, DOI 10.1016/j.ejphar.2011.10.030; Sun JH, 2012, INT J MOL MED, V30, P739, DOI 10.3892/ijmm.2012.1076; Tan KM, 2008, BRIT J CLIN PHARMACO, V65, P147, DOI 10.1111/j.1365-2125.2007.02982.x; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; Ucar M, 2004, EUR J CLIN PHARMACOL, V59, P879, DOI 10.1007/s00228-003-0700-5; Uzum G, 2010, EPILEPSY BEHAV, V19, P284, DOI 10.1016/j.yebeh.2010.07.024; van Vliet EA, 2011, EPILEPSIA, V52, P1319, DOI 10.1111/j.1528-1167.2011.03073.x; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wang LN, 2010, NEUROSCI LETT, V471, P152, DOI 10.1016/j.neulet.2010.01.030; Weber MS, 2006, J NEUROIMMUNOL, V178, P140, DOI 10.1016/j.jneuroim.2006.06.006; Williams D, 2002, CLIN PHARMACOKINET, V41, P343, DOI 10.2165/00003088-200241050-00003; Wood WG, 2010, ANN NY ACAD SCI, V1199, P69, DOI 10.1111/j.1749-6632.2009.05359.x; Xie CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024966; Yanuck D, 2012, INT J NEUROSCI, V122, P619, DOI 10.3109/00207454.2012.704455; Zacco A, 2003, J NEUROSCI, V23, P11104	89	30	30	0	11	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-4501	1873-5592		CURR DRUG TARGETS	Curr. Drug Targets		2015	16	7					747	756		10.2174/1389450116666150330114850			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CN9QV	WOS:000358784800006	25901524				2022-02-06	
J	Kontos, AP; Huppert, TJ; Beluk, NH; Elbin, RJ; Henry, LC; French, J; Dakan, SM; Collins, MW				Kontos, A. P.; Huppert, T. J.; Beluk, N. H.; Elbin, R. J.; Henry, L. C.; French, J.; Dakan, S. M.; Collins, M. W.			Brain activation during neurocognitive testing using functional near-infrared spectroscopy in patients following concussion compared to healthy controls	BRAIN IMAGING AND BEHAVIOR			English	Article						Concussion; Mild Traumatic Brain Injury; Neurocognitive Testing; Near Infrared Spectroscopy	SPORTS-RELATED CONCUSSION; RETURN-TO-PLAY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SEX-DIFFERENCES; STROOP TASK; INJURY; MILD; ABNORMALITIES; FMRI	There is no accepted clinical imaging modality for concussion, and current imaging modalities including fMRI, DTI, and PET are expensive and inaccessible to most clinics/patients. Functional near-infrared spectroscopy (fNIRS) is a non-invasive, portable, and low-cost imaging modality that can measure brain activity. The purpose of this study was to compare brain activity as measured by fNIRS in concussed and age-matched controls during the performance of cognitive tasks from a computerized neurocognitive test battery. Participants included nine currently symptomatic patients aged 18-45 years with a recent (15-45 days) sport-related concussion and five age-matched healthy controls. The participants completed a computerized neurocognitive test battery while wearing the fNIRS unit. Our results demonstrated reduced brain activation in the concussed subject group during word memory, (spatial) design memory, digit-symbol substitution (symbol match), and working memory (X's and O's) tasks. Behavioral performance (percent-correct and reaction time respectively) was lower for concussed participants on the word memory, design memory, and symbol match tasks than controls. The results of this preliminary study suggest that fNIRS could be a useful, portable assessment tool to assess reduced brain activation and augment current approaches to assessment and management of patients following concussion.	[Kontos, A. P.; Elbin, R. J.; Henry, L. C.; French, J.; Dakan, S. M.; Collins, M. W.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; [Huppert, T. J.; Beluk, N. H.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15203 USA; [Huppert, T. J.] Univ Pittsburgh, Dept Biomed Engn, Pittsburgh, PA 15203 USA; [Kontos, A. P.] Univ Pittsburgh, UPMC Ctr Sports Med, UPMC Sports Med Concuss Program, Dept Orthopaed Surg,Sch Med, Pittsburgh, PA 15203 USA		Kontos, AP (corresponding author), Univ Pittsburgh, UPMC Ctr Sports Med, UPMC Sports Med Concuss Program, Dept Orthopaed Surg,Sch Med, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310	University of Pittsburgh Department of Radiology; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024827] Funding Source: NIH RePORTER	Funding for this study was provided by the University of Pittsburgh Department of Radiology.	Abdelnour AF, 2009, NEUROIMAGE, V46, P133, DOI 10.1016/j.neuroimage.2009.01.033; Abdelnour F, 2010, BIOMED OPT EXPRESS, V1, P1084, DOI 10.1364/BOE.1.001084; Abdelnour F, 2011, BIOMED OPT EXPRESS, V2, P1, DOI 10.1364/BOE.2.000001; Adelson PD, 1998, ACT NEUR S, V71, P250; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Cope M, 1988, Adv Exp Med Biol, V222, P183; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Custo A, 2006, APPL OPTICS, V45, P4747, DOI 10.1364/AO.45.004747; Dehghani H, 2009, COMMUN NUMER METH EN, V25, P711, DOI 10.1002/cnm.1162; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Giza CC, 2001, J ATHL TRAINING, V36, P228; Haitsma IK, 2007, PROG BRAIN RES, V161, P207, DOI 10.1016/S0079-6123(06)61014-5; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Huppert TJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976432; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Leon-Carrion J, 2008, BEHAV BRAIN RES, V193, P248, DOI 10.1016/j.bbr.2008.06.013; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mattout J, 2006, NEUROIMAGE, V30, P753, DOI 10.1016/j.neuroimage.2005.10.037; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Weatherall A, 2012, ACTA ANAESTH SCAND, V56, P172, DOI 10.1111/j.1399-6576.2011.02591.x	50	30	31	0	31	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2014	8	4					621	634		10.1007/s11682-014-9289-9			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4SA	WOS:000346920400015	24477579	Green Accepted			2022-02-06	
